Citrus Sinensis ID: 013105

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------45
Protein Sequence
MALIKSFTWKIILPSCIKATNKPSCMSKVHVSNQVSTQRLLLTDVSNPGSPISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDIPIGPFVYTVVPPGDHGHGQKSCGQKKNEKRGDGGKEKEDKKEEKGRNRRRKRRRVRVVRSRDVYSDTALYKALGTSLYSPRN
Secondary Structure (PSIPRED)
ccEEEEEEEEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHcccccccccccccccEEEEEEEcccccccccccEEEEEEcccccccHHHHHHHHHHHHHcccccccccEEEEEEcccEEEEEEEEcccccHHHHccccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHcccccccccccccHHHHHHHHHHccccccccccccccHHHHcccccccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccHHHHcccHHHHHHHHHHccccccccHHHHHHHcccccccccc
Secondary Structure Prediction (SSPRO)
cccEcccccHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHHcccccccccEEEEEEccccccccccEEEEEEEEcccccccHHHHHHHHHHHHHHcccccEEEEEEEEccccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHccccccccccccHHHEEEcccccEEEccccccEEccccccccEEEEEEcccccccHHHHHccccccccHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHccccHHHHccHHHcccccHHHHHHHHHHHHHHHHccHcccccHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHcccccHHHHHHHcccccccccc
Coil and Loop (DISEMBL)
MALIKSFTWKIIlpscikatnkpscmskvhvsnqvstQRLLltdvsnpgspislnelssslvgsnlhvfTLKELQMITHnfsrsdylgeggfgkvykgcvddnlrpglkAQTVAVKVLdvngsqghREWLAEVIFLgqlkhphlvnligyccedeHRLLVYEYMALGNLHDQLFKNysstlpwlTRIKIAIGAARCLAFLhgeekpviyrdfkasnilldsdynaklsdfglatdgpqgedshittcvmgtegyaapeyintghlttmCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQClshnpksrptmTTVVKALEplldlndipigpfvytvvppgdhghgqkscgqkknekrgdggkekedkkeekgrnrrrkrrrvRVVRSRDVYSDTALYKAlgtslysprn
Flexible Loop (DISEMBL)
MALIKSFTWKIILPSCIKATNKPSCMSKVHVSNQVSTQRLLLTDVSNPGSPISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLtgrrsveknrckrekdlvewarpmlkdftkldqiidSRLEDRYSTEGAKRLAAVAHQClshnpksrptMTTVVKALEPLLDLNDIPIGPFVYTVVPPGDhghgqkscgqkknekrgdggkekedkkeekgrnrrrkrrrvrvvrsrdvysdtalykalgtslysprn
Low Complexity Region (SEG)
MALIKSFTWKIILPSCIKATNKPSCMSKVHVSNQVSTQRLLLTDVSNPGSPISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDIPIGPFVYTVVPPGDHGHGQKSCGQkknekrgdggkekedkkeekgrnrrrkrrrvrvvrSRDVYSDTALYKALGTSLYSPRN
Disordered region (IsUnstruct)
**LIKSFTWKIILPSCIKATNKPSCMSKVHVSNQVSTQRLLLT****************SLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG***EDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLS*******TMTTVVKALEPLLDLNDIPIGPFVYTVVP**************************************************DVYSDTALYKALG********
Disordered Region (DISOPRED)
*ALIK**TWKI********************************************************VFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL***************************************************************************************
Disordered Region (DISEMBL)
MALIKSFTWKIILPSCIKATNKPSCMSKVHVSNQVSTQRLLLTDVSNPGSPISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDIPIGPFVYTVVPPG*********************************************RSRDVYSDTALYKALGTSLYSPRN
Disordered Region (DISPRO)
****KSFTWKIILPSCIK*********************************************SNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN**PI********************************************************************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MALIKSFTWKIILPSCIKATNKPSCMSKVHVSNQVSTQRLLLTDVSNPGSPISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDIPIGPFVYTVVPPGDHGHGQKSCGQKKNEKRGDGGKEKEDKKEEKGRNRRRKRRRVRVVRSRDVYSDTALYKALGTSLYSPRN
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	449	2.2.26 [Sep-21-2011]
Q9CAH1	450	Putative receptor-like pr	yes	no	0.975	0.973	0.613	1e-146
Q8GXZ3	410	Serine/threonine-protein	no	no	0.710	0.778	0.610	1e-111
Q9LFP7	493	Probable receptor-like pr	no	no	0.755	0.687	0.530	2e-99
Q9FM85	408	Probable receptor-like pr	no	no	0.699	0.769	0.561	1e-98
P46573	412	Protein kinase APK1B, chl	no	no	0.681	0.742	0.572	7e-98
Q06548	410	Protein kinase APK1A, chl	no	no	0.710	0.778	0.556	3e-96
Q9SRH7	490	Receptor-like serine/thre	no	no	0.741	0.679	0.530	6e-96
P43293	389	Probable serine/threonine	no	no	0.668	0.771	0.557	4e-95
Q8H186	389	Probable receptor-like pr	no	no	0.674	0.778	0.562	2e-94
O48814	395	Serine/threonine-protein	no	no	0.672	0.764	0.555	3e-94

>sp|Q9CAH1|Y1725_ARATH Putative receptor-like protein kinase At1g72540 OS=Arabidopsis thaliana GN=At1g72540 PE=2 SV=1

 Score =  517 bits (1332), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 278/453 (61%), Positives = 334/453 (73%), Gaps = 15/453 (3%)

Query: 7   FTWK-IILP-SCIKATNK-------PSCMSKVHVSNQVST-QRLLLTDVSNPGSPISLNE 56
           F+WK I LP SCI  TN+       P     + +S Q S   R+ ++D SN  S ISLN+
Sbjct: 3   FSWKNICLPISCINNTNQKKTTTTNPPKEKLLLLSRQTSVPSRVYMSDFSN--STISLND 60

Query: 57  LSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVK 116
            S+S    N+H+FT +EL+ IT  FS+ ++LGEGGFG+VYKG VDD+L+ GLK Q VAVK
Sbjct: 61  FSNSFF-INIHIFTYEELKTITQGFSKYNFLGEGGFGEVYKGFVDDSLKTGLKDQPVAVK 119

Query: 117 VLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKN 176
            L   G QGHREWLAEVI LGQLKHPHLVNL+GYCCED+ RLLVYEYM  GNL D LF+ 
Sbjct: 120 ALKREGGQGHREWLAEVIILGQLKHPHLVNLVGYCCEDDERLLVYEYMERGNLEDHLFQK 179

Query: 177 YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG 236
           Y   LPWLTR+KI +GAA+ L FLH +EKPVIYRDFK SNILL SD+++KLSDFGLATDG
Sbjct: 180 YGGALPWLTRVKILLGAAKGLEFLHKQEKPVIYRDFKPSNILLSSDFSSKLSDFGLATDG 239

Query: 237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE 296
            + EDS+ T  VMGTEGYAAPEYI+ G+LTTM DVFSFGVVLLE+LT R++VEK R +R 
Sbjct: 240 SEEEDSNFTKSVMGTEGYAAPEYISAGNLTTMSDVFSFGVVLLEMLTARKAVEKYRAQRG 299

Query: 297 KDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
           ++LVEWARPMLKD  KL++IID  LE +YS EG ++ AA+A+QCLSHNPKSRPTMTTVVK
Sbjct: 300 RNLVEWARPMLKDPNKLERIIDPSLEGKYSVEGIRKAAALAYQCLSHNPKSRPTMTTVVK 359

Query: 357 ALEPLLDLNDIPIGPFVYTVVPPGDHGHGQKSCGQKKNEKRGDGGKEKEDKKEEKGRNRR 416
            LEP+LDL DI  GPFVY V   G     +  C  K + K      EK+ K   + R  R
Sbjct: 360 TLEPILDLKDIQNGPFVYIVPVAGVSEVHEIKC--KDDVKVVKEETEKDAKVFPRHRAGR 417

Query: 417 RKRRRVRVVRSRDVYSDTALYKALGTSLYSPRN 449
           R RR+ + +RSR VYSDTALYK+LGTSLY+P N
Sbjct: 418 RNRRKHKAMRSRAVYSDTALYKSLGTSLYNPAN 450

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1

 Score =  402 bits (1033), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 196/321 (61%), Positives = 249/321 (77%), Gaps = 2/321 (0%)

Query: 42  LTDVSNPGSPISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDY-LGEGGFGKVYKGCV 100
           ++D+S+P +P   ++  + +  + +  FTL EL+ IT +F R DY LGEGGFG VYKG +
Sbjct: 30  VSDLSDPSTPRFRDDSRTPISYAQVIPFTLFELETITKSF-RPDYILGEGGFGTVYKGYI 88

Query: 101 DDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLV 160
           DDNLR GLK+  VAVKVL+  G QGHREWL EV FLGQL+HP+LV LIGYCCED+HRLLV
Sbjct: 89  DDNLRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLV 148

Query: 161 YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD 220
           YE+M  G+L + LF+  ++ L W  R+ IA+GAA+ LAFLH  E+PVIYRDFK SNILLD
Sbjct: 149 YEFMLRGSLENHLFRKTTAPLSWSRRMMIALGAAKGLAFLHNAERPVIYRDFKTSNILLD 208

Query: 221 SDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLE 280
           SDY AKLSDFGLA  GPQG+++H++T VMGT GYAAPEY+ TGHLT   DV+SFGVVLLE
Sbjct: 209 SDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLE 268

Query: 281 LLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQC 340
           +LTGR+SV+K R  +E++LV+WARP L D  KL QIID RLE++YS   A++  ++A+ C
Sbjct: 269 MLTGRKSVDKTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYC 328

Query: 341 LSHNPKSRPTMTTVVKALEPL 361
           LS NPK+RP M+ VV+ LEPL
Sbjct: 329 LSQNPKARPLMSDVVETLEPL 349

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1

 Score =  362 bits (930), Expect = 2e-99,   Method: Compositional matrix adjust.
 Identities = 185/349 (53%), Positives = 245/349 (70%), Gaps = 10/349 (2%)

Query: 34  QVSTQRLLLTDVSNPGSPISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFG 93
           QVS+        S+  +P+   EL+   + S+L  FT  +L++ T NF     LGEGGFG
Sbjct: 98  QVSSTTTTSNAESSSSTPVISEELN---ISSHLRKFTFNDLKLSTRNFRPESLLGEGGFG 154

Query: 94  KVYKGCVDDN----LRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIG 149
            V+KG +++N    ++PG    TVAVK L+ +G QGH+EWLAE+ FLG L HP+LV L+G
Sbjct: 155 CVFKGWIEENGTAPVKPGT-GLTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVG 213

Query: 150 YCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE-KPVI 208
           YC ED+ RLLVYE+M  G+L + LF+  S  LPW  R+KIA+GAA+ L+FLH E  KPVI
Sbjct: 214 YCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLSFLHEEALKPVI 272

Query: 209 YRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTM 268
           YRDFK SNILLD+DYNAKLSDFGLA D P    +H++T VMGT GYAAPEY+ TGHLT+ 
Sbjct: 273 YRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSK 332

Query: 269 CDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTE 328
            DV+SFGVVLLE+LTGRRS++KNR   E +LVEWARP L D  +  +++D RLE  +S +
Sbjct: 333 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIK 392

Query: 329 GAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDIPIGPFVYTVV 377
           GA+++  +A QCLS +PK RP M+ VV+AL+PL  L D+    + +  +
Sbjct: 393 GAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPLPHLKDMASSSYYFQTM 441

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FM85|Y5564_ARATH Probable receptor-like protein kinase At5g56460 OS=Arabidopsis thaliana GN=At5g56460 PE=1 SV=1

 Score =  360 bits (925), Expect = 1e-98,   Method: Compositional matrix adjust.
 Identities = 178/317 (56%), Positives = 228/317 (71%), Gaps = 3/317 (0%)

Query: 48  PGSPISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNL--R 105
           P +P  + +L      + L  FT +EL+ IT NF +   LG GGFG VYKG + ++L  +
Sbjct: 43  PSNPKEVEDLRRDSAANPLIAFTYEELKNITSNFRQDRVLGGGGFGSVYKGFIKEDLGDQ 102

Query: 106 PGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYM 164
              +   VAVKV D + S QGHREWLAEVIFLGQL HP+LV LIGYCCED HR+L+YEYM
Sbjct: 103 EVPEPLPVAVKVHDGDNSFQGHREWLAEVIFLGQLSHPNLVKLIGYCCEDNHRVLIYEYM 162

Query: 165 ALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYN 224
           A G++ + LF      L W  R+KIA GAA+ LAFLH  +KPVIYRDFK SNILLD DYN
Sbjct: 163 ARGSVENNLFSRVLLPLSWAIRMKIAFGAAKGLAFLHEAKKPVIYRDFKTSNILLDMDYN 222

Query: 225 AKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           AKLSDFGLA DGP G+ SH++T +MGT GYAAPEYI TGHLT   DV+SFGVVLLELLTG
Sbjct: 223 AKLSDFGLAKDGPVGDKSHVSTRIMGTYGYAAPEYIMTGHLTPGSDVYSFGVVLLELLTG 282

Query: 285 RRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHN 344
           R+S++K+R  RE++L++WA P+LK+  K+  I+D ++   Y  +  ++ A +A+ CL+ N
Sbjct: 283 RKSLDKSRPTREQNLIDWALPLLKEKKKVLNIVDPKMNCEYPVKAVQKAAMLAYHCLNRN 342

Query: 345 PKSRPTMTTVVKALEPL 361
           PK+RP M  +V +LEPL
Sbjct: 343 PKARPLMRDIVDSLEPL 359

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2

 Score =  357 bits (917), Expect = 7e-98,   Method: Compositional matrix adjust.
 Identities = 178/311 (57%), Positives = 224/311 (72%), Gaps = 5/311 (1%)

Query: 61  LVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT---VAVKV 117
           L   NL  FT  EL+  T NF     LGEGGFG V+KG +D+      K  T   +AVK 
Sbjct: 49  LQSPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKK 108

Query: 118 LDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK-- 175
           L+ +G QGH+EWLAEV +LGQ  HP+LV LIGYC EDEHRLLVYE+M  G+L + LF+  
Sbjct: 109 LNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRG 168

Query: 176 NYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD 235
           +Y   L W  R+K+A+GAA+ LAFLH  E  VIYRDFK SNILLDS+YNAKLSDFGLA D
Sbjct: 169 SYFQPLSWTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSDFGLAKD 228

Query: 236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKR 295
           GP G+ SH++T +MGT GYAAPEY+ TGHLTT  DV+S+GVVLLE+L+GRR+V+KNR   
Sbjct: 229 GPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPG 288

Query: 296 EKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVV 355
           E+ LVEWARP+L +  KL ++ID+RL+D+YS E A ++A +A +CL+   K RP M  VV
Sbjct: 289 EQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVV 348

Query: 356 KALEPLLDLND 366
             LE +  LN+
Sbjct: 349 SHLEHIQTLNE 359

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1

 Score =  352 bits (903), Expect = 3e-96,   Method: Compositional matrix adjust.
 Identities = 183/329 (55%), Positives = 231/329 (70%), Gaps = 10/329 (3%)

Query: 43  TDVSNPGSPISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDD 102
           + VS   SP +  E+   L   NL  F+  EL+  T NF     LGEGGFG V+KG +D+
Sbjct: 33  SSVSVRPSPRTEGEI---LQSPNLKSFSFAELKSATRNFRPDSVLGEGGFGCVFKGWIDE 89

Query: 103 NL----RPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL 158
                 RPG     +AVK L+ +G QGH+EWLAEV +LGQ  H HLV LIGYC EDEHRL
Sbjct: 90  KSLTASRPG-TGLVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHRHLVKLIGYCLEDEHRL 148

Query: 159 LVYEYMALGNLHDQLFKN--YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASN 216
           LVYE+M  G+L + LF+   Y   L W  R+K+A+GAA+ LAFLH  E  VIYRDFK SN
Sbjct: 149 LVYEFMPRGSLENHLFRRGLYFQPLSWKLRLKVALGAAKGLAFLHSSETRVIYRDFKTSN 208

Query: 217 ILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGV 276
           ILLDS+YNAKLSDFGLA DGP G+ SH++T VMGT GYAAPEY+ TGHLTT  DV+SFGV
Sbjct: 209 ILLDSEYNAKLSDFGLAKDGPIGDKSHVSTRVMGTHGYAAPEYLATGHLTTKSDVYSFGV 268

Query: 277 VLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAV 336
           VLLELL+GRR+V+KNR   E++LVEWA+P L +  K+ ++ID+RL+D+YS E A ++A +
Sbjct: 269 VLLELLSGRRAVDKNRPSGERNLVEWAKPYLVNKRKIFRVIDNRLQDQYSMEEACKVATL 328

Query: 337 AHQCLSHNPKSRPTMTTVVKALEPLLDLN 365
           + +CL+   K RP M+ VV  LE +  LN
Sbjct: 329 SLRCLTTEIKLRPNMSEVVSHLEHIQSLN 357

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1

 Score =  351 bits (901), Expect = 6e-96,   Method: Compositional matrix adjust.
 Identities = 181/341 (53%), Positives = 239/341 (70%), Gaps = 8/341 (2%)

Query: 43  TDVSNPGSPISLNELSSSL-VGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVD 101
           T  SN  S +S   +S  L + S+L  F+  +L++ T NF     LGEGGFG V+KG V+
Sbjct: 97  TTTSNAESSLSTPIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVE 156

Query: 102 DN----LRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR 157
           +N    ++PG    TVAVK L+ +G QGH+EWLAE+ +LG L HP+LV L+GYC ED+ R
Sbjct: 157 ENGTAPVKPG-TGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQR 215

Query: 158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE-KPVIYRDFKASN 216
           LLVYE+M  G+L + LF+  S  LPW  R+KIA+GAA+ L+FLH E  KPVIYRDFK SN
Sbjct: 216 LLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSN 274

Query: 217 ILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGV 276
           ILLD +YNAKLSDFGLA D P    +H++T VMGT GYAAPEY+ TGHLT+  DV+SFGV
Sbjct: 275 ILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGV 334

Query: 277 VLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAV 336
           VLLE+LTGRRS++KNR   E +LVEWARP L D  +  +++D RLE  +S +GA+++  +
Sbjct: 335 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQL 394

Query: 337 AHQCLSHNPKSRPTMTTVVKALEPLLDLNDIPIGPFVYTVV 377
           A QCLS + K RP M+ VV+ L+PL  L D+    + +  +
Sbjct: 395 AAQCLSRDSKIRPKMSEVVEVLKPLPHLKDMASASYYFQTM 435

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2

 Score =  348 bits (894), Expect = 4e-95,   Method: Compositional matrix adjust.
 Identities = 171/307 (55%), Positives = 226/307 (73%), Gaps = 7/307 (2%)

Query: 61  LVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNL----RPGLKAQTVAVK 116
           L  +NL  F+L EL+  T NF     +GEGGFG V+KG +D++     +PG     +AVK
Sbjct: 48  LQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPG-TGIVIAVK 106

Query: 117 VLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK- 175
            L+  G QGHREWLAE+ +LGQL HP+LV LIGYC E+EHRLLVYE+M  G+L + LF+ 
Sbjct: 107 RLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRR 166

Query: 176 -NYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT 234
             +   L W TR+++A+GAAR LAFLH  +  VIYRDFKASNILLDS+YNAKLSDFGLA 
Sbjct: 167 GTFYQPLSWNTRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLAR 226

Query: 235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCK 294
           DGP G++SH++T VMGT+GYAAPEY+ TGHL+   DV+SFGVVLLELL+GRR+++KN+  
Sbjct: 227 DGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPV 286

Query: 295 REKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTV 354
            E +LV+WARP L +  +L +++D RL+ +YS   A ++A +A  C+S + KSRPTM  +
Sbjct: 287 GEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEI 346

Query: 355 VKALEPL 361
           VK +E L
Sbjct: 347 VKTMEEL 353

May play a role in the regulation of plant growth and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1

 Score =  346 bits (888), Expect = 2e-94,   Method: Compositional matrix adjust.
 Identities = 176/313 (56%), Positives = 224/313 (71%), Gaps = 10/313 (3%)

Query: 57  LSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT---V 113
           LSS+ V S    F+  EL++ T NF     +GEGGFG V++G +D+      K+ +   +
Sbjct: 41  LSSTTVKS----FSFNELKLATRNFRSDSVVGEGGFGCVFRGWLDETTLTPTKSSSGLVI 96

Query: 114 AVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQL 173
           AVK L+ +G QGHREWL E+ +LGQL HP+LV LIGYC EDE RLLVYE+M  G+L + L
Sbjct: 97  AVKRLNPDGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKGSLENHL 156

Query: 174 FKNYSST---LPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDF 230
           F N +     L W+ RIK+A+ AA+ LAFLH +   VIYRD KASNILLDSD+NAKLSDF
Sbjct: 157 FANGNKDFKPLSWILRIKVALDAAKGLAFLHSDPVKVIYRDIKASNILLDSDFNAKLSDF 216

Query: 231 GLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEK 290
           GLA DGP GE S+++T VMGT GYAAPEY++TGHL    DV+SFGVVLLELL GR++++ 
Sbjct: 217 GLARDGPMGEQSYVSTRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQALDH 276

Query: 291 NRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT 350
           NR  +E++LV+WARP L    K+  I+D+RL  +Y  EGA RLA++A QCLS  PKSRPT
Sbjct: 277 NRPAKEQNLVDWARPYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKSRPT 336

Query: 351 MTTVVKALEPLLD 363
           M  VV+AL  L D
Sbjct: 337 MDQVVRALVQLQD 349

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1

 Score =  345 bits (886), Expect = 3e-94,   Method: Compositional matrix adjust.
 Identities = 174/313 (55%), Positives = 226/313 (72%), Gaps = 11/313 (3%)

Query: 57  LSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNL----RPGLKAQT 112
           LSS+ V S    FT  EL++ T NF     +GEGGFG V+KG +D++     +PG     
Sbjct: 47  LSSTPVKS----FTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPG-TGLV 101

Query: 113 VAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQ 172
           +AVK L+  G QGHREWL E+ +LGQL HP+LV LIGYC EDEHRLLVYE+M  G+L + 
Sbjct: 102 IAVKKLNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENH 161

Query: 173 LFKN--YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDF 230
           LF+   Y   LPW  R+ +A+ AA+ LAFLH +   VIYRD KASNILLD+DYNAKLSDF
Sbjct: 162 LFRRGAYFKPLPWFLRVNVALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSDF 221

Query: 231 GLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEK 290
           GLA DGP G+ S+++T VMGT GYAAPEY+++GHL    DV+SFGV+LLE+L+G+R+++ 
Sbjct: 222 GLARDGPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDH 281

Query: 291 NRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT 350
           NR  +E++LV+WARP L    K+  I+D+RL+ +Y  E A R+A+VA QCLS  PKSRPT
Sbjct: 282 NRPAKEENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPT 341

Query: 351 MTTVVKALEPLLD 363
           M  VV+AL+ L D
Sbjct: 342 MDQVVRALQQLQD 354

Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	449
255560609	455	Protein kinase APK1B, chloroplast precur	0.968	0.956	0.672	1e-173
224073690	434	predicted protein [Populus trichocarpa]	0.953	0.986	0.657	1e-163
224119500	368	predicted protein [Populus trichocarpa]	0.817	0.997	0.724	1e-156
356519790	463	PREDICTED: putative receptor-like protei	0.973	0.943	0.618	1e-155
356558926	451	PREDICTED: putative receptor-like protei	0.979	0.975	0.643	1e-154
357514029	475	Kinase-like protein [Medicago truncatula	0.975	0.922	0.620	1e-154
224068458	454	predicted protein [Populus trichocarpa]	0.973	0.962	0.603	1e-152
225429710	440	PREDICTED: serine/threonine-protein kina	0.935	0.954	0.603	1e-151
225444724	442	PREDICTED: serine/threonine-protein kina	0.959	0.975	0.611	1e-149
350537699	464	auxin-regulated dual specificity cytosol	0.953	0.922	0.600	1e-146

>gi|255560609|ref|XP_002521318.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] gi|223539396|gb|EEF40986.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis]

 Score =  614 bits (1584), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 308/458 (67%), Positives = 371/458 (81%), Gaps = 23/458 (5%)

Query: 5   KSFTWKIILPSCIKATNKPSCMSKVHVSNQVSTQRLLLTDVSNPGSPISLNELSSSLVGS 64
           K ++WK +   C++    P    KVHVS+++++QRL LTD+SNPGSP+S+++LSSS+   
Sbjct: 4   KKYSWKFLFLGCLR-NQFPLPEPKVHVSHRITSQRLSLTDLSNPGSPLSVSDLSSSIF-- 60

Query: 65  NLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ 124
           NLHVFTLKEL+  T N S+S+YLGEGGFG VYKG + D LRPGLKAQ+VAVK LD++GSQ
Sbjct: 61  NLHVFTLKELKTATQNLSKSNYLGEGGFGAVYKGFITDKLRPGLKAQSVAVKALDLDGSQ 120

Query: 125 GHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWL 184
           GHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYM  GNL + LFK YS+ LPWL
Sbjct: 121 GHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMERGNLENLLFKRYSAALPWL 180

Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI 244
           TR+KIA+GAA+ LAFLH EEKPVIYRDFKASN+LLD+D+NAKLSDFGLATDGPQG++SHI
Sbjct: 181 TRLKIALGAAKGLAFLHEEEKPVIYRDFKASNVLLDADFNAKLSDFGLATDGPQGDESHI 240

Query: 245 TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR 304
           +T VMGTEGYAAPEYI TGHLT M DVFSFGVVLLELLTGRRSV+KNR  RE++LV+WAR
Sbjct: 241 STRVMGTEGYAAPEYIMTGHLTAMSDVFSFGVVLLELLTGRRSVDKNRPSREQNLVKWAR 300

Query: 305 PMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL 364
           P+LKD  KLD I+D RLE +YSTEGA++ AA+A+QCLSH+ KSRP+MT+VVK LE LL+L
Sbjct: 301 PLLKDHHKLDLIMDPRLEGQYSTEGARKAAALAYQCLSHHCKSRPSMTSVVKTLESLLEL 360

Query: 365 NDIPIGPFVYTVVPPGDHGHGQKSCGQKKNEKRG--DGGKEKEDKK---------EEKGR 413
           NDIP+G FVY +VP      G+K   +++ EK+   +   E ED K         +EK R
Sbjct: 361 NDIPMGTFVY-IVP----SEGKKEIDEQEKEKQSEIECKIENEDGKNCEVKPLDMKEKSR 415

Query: 414 NR----RRKRRRVRVVRSRDVYSDTALYKALGTSLYSP 447
           +R    RR RRR++ +RSR V+SDTALYK LGTSLYSP
Sbjct: 416 HRYQKGRRHRRRIKSLRSRAVHSDTALYKTLGTSLYSP 453

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224073690|ref|XP_002304131.1| predicted protein [Populus trichocarpa] gi|222841563|gb|EEE79110.1| predicted protein [Populus trichocarpa]

 Score =  581 bits (1498), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 297/452 (65%), Positives = 358/452 (79%), Gaps = 24/452 (5%)

Query: 3   LIKSFTWKIILPSCIKAT-NKPSCMSKVHVSNQVSTQRLLLTDVSNPGSPISLNELSSSL 61
           ++K FTWK +L  C++   ++P          Q  +QRL L+D+SNP SPIS ++LS S+
Sbjct: 2   VLKKFTWKSVLLGCLRGERSRPE-------PKQTCSQRLSLSDLSNPVSPISFSDLSISI 54

Query: 62  VGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN 121
              NLHVFTLKELQ +T+ FS+S+YLGEGGFG VYKG +DD LRPGLKAQ VAVKVLD++
Sbjct: 55  F--NLHVFTLKELQTVTNEFSKSNYLGEGGFGAVYKGFIDDKLRPGLKAQPVAVKVLDLD 112

Query: 122 GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTL 181
           GSQGHREWLAE+IFLGQLKH HLVNLIGYC E+EHRLLVYEY+  G+L ++LF  YS+ L
Sbjct: 113 GSQGHREWLAEIIFLGQLKHRHLVNLIGYCGEEEHRLLVYEYIERGSLENKLFNRYSAAL 172

Query: 182 PWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGED 241
           PWLTR+KIA+G A+ LAFLH EEKPVIYRDFKASN+LL+SDYNAKLSDFGLA DGP+G+D
Sbjct: 173 PWLTRLKIAVGTAKGLAFLHEEEKPVIYRDFKASNVLLESDYNAKLSDFGLAMDGPEGDD 232

Query: 242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVE 301
           +H+TT VMGTEGYAAPEYI TGHLTTM DVFSFGVVLLEL+TGRRSV+KNR  RE++LV+
Sbjct: 233 THVTTPVMGTEGYAAPEYIMTGHLTTMSDVFSFGVVLLELITGRRSVDKNRPNREQNLVK 292

Query: 302 WARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL 361
           WARP LKD  KLDQI+D RLE +YS+EGA++ AA+A+QCLSH+PKSRPTM TVVK LEPL
Sbjct: 293 WARPQLKDPRKLDQIMDPRLEGQYSSEGARKAAALAYQCLSHHPKSRPTMRTVVKTLEPL 352

Query: 362 LDLNDIPIGPFVYTVVPPGDHGHGQKSCGQKKNEKRGDGGKEKEDKKEEKG----RNRRR 417
           L L DIPIGPFVY +VP         + G+  ++    G + K+ + +EKG    R   R
Sbjct: 353 LALTDIPIGPFVY-IVP---------NEGKILSDLEKKGKERKQVEIKEKGCDRHRKGHR 402

Query: 418 KRRRVRVVRSRDVYSDTALYKALGTSLYSPRN 449
            RRR + +RSR VYSDT LYK +GT LYSPRN
Sbjct: 403 HRRRTKSLRSRAVYSDTTLYKTIGTGLYSPRN 434

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224119500|ref|XP_002331176.1| predicted protein [Populus trichocarpa] gi|222873297|gb|EEF10428.1| predicted protein [Populus trichocarpa]

 Score =  558 bits (1437), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 271/374 (72%), Positives = 312/374 (83%), Gaps = 7/374 (1%)

Query: 3   LIKSFTWKIILPSCIKATNKPSCMSKVHVSNQVSTQRLLLTDVSNPGSPISLNELSSSLV 62
           ++K FTWK ILP C+K+ +     S      Q+ +QRL ++D SNPGSPIS ++LSSS+ 
Sbjct: 1   VLKKFTWKSILPGCLKSES-----SSYPEPKQICSQRLSISDFSNPGSPISFSDLSSSIF 55

Query: 63  GSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG 122
             NLHVF LKEL+ ITH FS+S+YLGEGGFG VYKG +DD LRPGLKAQ VAVK LD +G
Sbjct: 56  --NLHVFALKELRTITHEFSKSNYLGEGGFGAVYKGFIDDKLRPGLKAQPVAVKALDPDG 113

Query: 123 SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLP 182
           SQGHREWLAEVIFLGQLKH HLVNLIGYCCEDEHRLLVYEY+  GNL D+LF  YS+ LP
Sbjct: 114 SQGHREWLAEVIFLGQLKHRHLVNLIGYCCEDEHRLLVYEYVERGNLEDKLFYRYSAALP 173

Query: 183 WLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS 242
           WLTR+KIA+GAA+ LAFLH EEKPVIYRDFKASN+LLDSDYNAKLSDFGLATDGP+G+ +
Sbjct: 174 WLTRLKIAVGAAKGLAFLHEEEKPVIYRDFKASNVLLDSDYNAKLSDFGLATDGPEGDRT 233

Query: 243 HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEW 302
           HITT VMGTEGYAAPEYI TGHLTTM DVFSFGVVLLELLTGRRSV+KN   RE++LV+W
Sbjct: 234 HITTPVMGTEGYAAPEYIMTGHLTTMSDVFSFGVVLLELLTGRRSVDKNLPNREQNLVKW 293

Query: 303 ARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
           ARP LKD  KL+QI+D RLE +YSTEGA++ A +A+QCLSH+ KSRPTM+TVV+ LE LL
Sbjct: 294 ARPQLKDPRKLEQIMDPRLEGQYSTEGARKAAGLAYQCLSHHSKSRPTMSTVVRTLEQLL 353

Query: 363 DLNDIPIGPFVYTV 376
           DL D P G FVY V
Sbjct: 354 DLTDTPTGTFVYIV 367

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356519790|ref|XP_003528552.1| PREDICTED: putative receptor-like protein kinase At1g72540-like [Glycine max]

 Score =  553 bits (1425), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 288/466 (61%), Positives = 350/466 (75%), Gaps = 29/466 (6%)

Query: 5   KSFTWKIILPSCIKATNKPSCMSKVHVSNQVSTQRLLLTDVSNPGSPIS--LNELSSSLV 62
           K   W+ ++  C KAT   S  S   VS + S+ R+ L+D+S         +++LS+SLV
Sbjct: 4   KRLQWRSLVLGCFKATKNQSLESPNIVSKKSSSSRIFLSDLSLSDYSSVSIMSDLSNSLV 63

Query: 63  GSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG 122
           GSNL +FT +EL  +THNFS+S+YLGEGGFGKV+KG +DDNL+PGLKAQTVAVK L+++G
Sbjct: 64  GSNLRIFTYQELSEVTHNFSKSNYLGEGGFGKVFKGFIDDNLKPGLKAQTVAVKALNLDG 123

Query: 123 SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLP 182
            QGHREWLAEV+FLGQLKH HLVNLIGYCCEDEHRLLVYEYM  GNL ++LFK Y + LP
Sbjct: 124 KQGHREWLAEVVFLGQLKHRHLVNLIGYCCEDEHRLLVYEYMERGNLEEKLFKGYLAALP 183

Query: 183 WLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS 242
           WLTRIKIAIGAA+ L FLH EEKPVIYRD KASNILLD+DYNAKLSDFGLA DGP+ + +
Sbjct: 184 WLTRIKIAIGAAKGLMFLHEEEKPVIYRDIKASNILLDADYNAKLSDFGLAIDGPEKDQT 243

Query: 243 HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEW 302
           HITT VMGT GYAAPEYI TGHLTTM DV+SFGVVLLELLTG++SV+K R  RE+DLVEW
Sbjct: 244 HITTRVMGTHGYAAPEYIMTGHLTTMSDVYSFGVVLLELLTGKKSVDKKRPTREQDLVEW 303

Query: 303 ARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
           ARP+LKD  KL++I+D+RLED+YSTEGA++ AA+A+QCLSH+ K+RPTM TVV+ LEPLL
Sbjct: 304 ARPLLKDSHKLERIMDTRLEDQYSTEGARKFAALAYQCLSHHAKARPTMRTVVRTLEPLL 363

Query: 363 DLNDIPIGPFVYTVVPPGDHGHGQKSCGQKKNEKRGDGGKEKEDK--------------- 407
           +L DIP+GPFVY VVP  +          K NEK  +    + ++               
Sbjct: 364 ELKDIPVGPFVY-VVPSEEE-------STKVNEKVTENEHVEINQGELKNKEKEEEEKGD 415

Query: 408 ----KEEKGRNRRRKRRRVRVVRSRDVYSDTALYKALGTSLYSPRN 449
                  + R  RR RRRV+ +RS   YSDTALYK LGT+LYSP+ 
Sbjct: 416 KKEKGHHRQRKSRRNRRRVKPLRSLTAYSDTALYKTLGTNLYSPKQ 461

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356558926|ref|XP_003547753.1| PREDICTED: putative receptor-like protein kinase At1g72540-like [Glycine max]

 Score =  552 bits (1423), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 290/451 (64%), Positives = 351/451 (77%), Gaps = 11/451 (2%)

Query: 5   KSFTWKIILPSCIKATNKPSCMSKVHVSNQVSTQRLLLTDVSNPGSPIS--LNELSSSLV 62
           K   W+ ++  C KAT   S  S   VS + S+ R+ L+D+S         +++LS+SLV
Sbjct: 4   KRLQWRSLVLGCFKATKNQSLESPNIVSKKSSSSRIFLSDLSLSDYSSVSIMSDLSNSLV 63

Query: 63  GSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG 122
           GSNL +FT +EL  +THNFS+S+YLGEGGFGKVYKG +DDNL+ GLKAQTVAVK L+++G
Sbjct: 64  GSNLRIFTYQELSEVTHNFSKSNYLGEGGFGKVYKGFIDDNLKRGLKAQTVAVKALNLDG 123

Query: 123 SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLP 182
            QGHREWLAEVIFLGQLKH HLVNLIGYCCEDEHRLLVYEYM  GNL ++LFK Y + LP
Sbjct: 124 KQGHREWLAEVIFLGQLKHRHLVNLIGYCCEDEHRLLVYEYMERGNLEEKLFKGYLAALP 183

Query: 183 WLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS 242
           WLTRIKIAIGAA+ L FLH EEKPVIYRD KASNILLDSDYN KLSDFGLA DGP+ + +
Sbjct: 184 WLTRIKIAIGAAKGLMFLHEEEKPVIYRDIKASNILLDSDYNPKLSDFGLAIDGPEKDQT 243

Query: 243 HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEW 302
           HITT VMGT GYAAPEYI TGHLTTM DV+SFGVVLLELLTG++SV+K R  RE+DLVEW
Sbjct: 244 HITTHVMGTHGYAAPEYIMTGHLTTMSDVYSFGVVLLELLTGKKSVDKKRPTREQDLVEW 303

Query: 303 ARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
           ARP+LKD  KL++I+D+RLED+YSTEGA++ AA+A+QCLSH+ K+RPTM TVV+ LEPLL
Sbjct: 304 ARPLLKDSHKLERIMDTRLEDQYSTEGARKFAALAYQCLSHHAKARPTMRTVVRTLEPLL 363

Query: 363 DLNDIPIGPFVYTVVPPGDHGHGQKSCGQKKNEKRGDGGKEKEDKKEEKGRN----RRRK 418
           +L DIP+GPFVY V    D     K+   + +    + G+ K  +KEEKG +     RR 
Sbjct: 364 ELKDIPVGPFVYVVPSEED-----KTKVNENDHVEINQGELKTKEKEEKGHHRQRKSRRN 418

Query: 419 RRRVRVVRSRDVYSDTALYKALGTSLYSPRN 449
           RRRV+ +RS   +SDTALYK LGT+LYSP+ 
Sbjct: 419 RRRVKPLRSLTAHSDTALYKTLGTNLYSPKQ 449

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357514029|ref|XP_003627303.1| Kinase-like protein [Medicago truncatula] gi|355521325|gb|AET01779.1| Kinase-like protein [Medicago truncatula]

 Score =  550 bits (1418), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 288/464 (62%), Positives = 347/464 (74%), Gaps = 26/464 (5%)

Query: 5   KSFTWKIILPSCIKATNKPSCMSKVHVSNQVSTQRLLLTDVSNPGSPISLNELSSSLVGS 64
           K   WK  +  C K  N PS  +   VS +  + R+ L+D+S+  SP  +++LS+SLVGS
Sbjct: 4   KKIQWKSFVLGCFKDKN-PSLETPKFVSKKTGSCRISLSDLSDYSSPSVMSDLSNSLVGS 62

Query: 65  NLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ 124
           NLH+FT KEL+ IT+NF +S++LGEGGFGKVYKG +DD LRP L  Q VAVK L+++G Q
Sbjct: 63  NLHIFTCKELKEITNNFDKSNFLGEGGFGKVYKGFIDDKLRPTLVPQAVAVKALNLDGKQ 122

Query: 125 GHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWL 184
           GHREWLAEVIFLGQLKH +LVNLIGYC EDEHRLLVYEYM  G+L ++LFK Y +TLPWL
Sbjct: 123 GHREWLAEVIFLGQLKHRNLVNLIGYCYEDEHRLLVYEYMERGSLEEKLFKGYLATLPWL 182

Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI 244
           TRIKIAIGAA+ LAFLH EEKPVIYRD KASNILLD+DYNAKLSDFGLA DGP  + +HI
Sbjct: 183 TRIKIAIGAAKGLAFLHEEEKPVIYRDVKASNILLDADYNAKLSDFGLAIDGPDKDQTHI 242

Query: 245 TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR 304
           TT VMGT GYAAPEYINTG LTTM DV+SFGVVLLELLTG++SV+K R  RE+DLVEWAR
Sbjct: 243 TTRVMGTHGYAAPEYINTGRLTTMSDVYSFGVVLLELLTGKKSVDKKRTPREQDLVEWAR 302

Query: 305 PMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL 364
           P LKD  +L++IIDSRLED+YS EGA++LA + +QCLSH+ KSRPTM TVVK LE ++ L
Sbjct: 303 PSLKDSHRLERIIDSRLEDQYSIEGARKLAMLTYQCLSHHDKSRPTMRTVVKTLEHVMKL 362

Query: 365 NDIPIGPFVYTVVP-------------------PGDHGHGQKSCGQKKNEKRGDGGKEKE 405
           NDIPIG FVY V P                     D     K   + K+E++G    EK 
Sbjct: 363 NDIPIGHFVY-VAPIEVTNIEVSLNVDKKGNENERDENEINKRVVKSKDEEKG----EKN 417

Query: 406 DKKEEKGRNRRRKRRRVR-VVRSRDVYSDTALYKALGTSLYSPR 448
           +K  +  R  R  RRRV+ +++SR V+SDTALYK LGTSLYSP+
Sbjct: 418 EKGHQSQRKSRSDRRRVKPLMKSRSVHSDTALYKTLGTSLYSPK 461

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224068458|ref|XP_002326125.1| predicted protein [Populus trichocarpa] gi|222833318|gb|EEE71795.1| predicted protein [Populus trichocarpa]

 Score =  543 bits (1398), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 269/446 (60%), Positives = 337/446 (75%), Gaps = 9/446 (2%)

Query: 4   IKSFTWKIILPSCIKATNKPSCMSKVHVSNQVSTQRLLLTDVSNPGSPISLNE-LSSSLV 62
           ++  TW+ ++ SC K         K  V+ Q S QR+ ++D+SNP +   L+E LS SL 
Sbjct: 3   VEKTTWRSMVSSCFKPNEISPSKPKKIVTKQTSFQRISMSDLSNPST---LSEDLSISLA 59

Query: 63  GSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG 122
           GSNLHVFTL EL++IT NF+ S++LGEGGFG V+KG +DD LRPGLKAQ VAVK+LD++G
Sbjct: 60  GSNLHVFTLPELKVITQNFAASNFLGEGGFGPVHKGFIDDKLRPGLKAQPVAVKLLDLDG 119

Query: 123 SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLP 182
           SQGHREWLAEVIFLGQL+HPHLV LIGYCCE+EHRLLVYEYM  G+L +QLF+ YS +LP
Sbjct: 120 SQGHREWLAEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLP 179

Query: 183 WLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS 242
           W  R KIA+GAA+ LAFLH  EKPVIYRDFKASNILLDSDY  KLSDFGLA DGP+G D+
Sbjct: 180 WSARTKIAVGAAKGLAFLHESEKPVIYRDFKASNILLDSDYTPKLSDFGLAKDGPEGSDT 239

Query: 243 HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEW 302
           H++T VMGT+GYAAPEYI TGHLT+  DV+SFGVVLLELLTGRRSV+K+R +RE++LVEW
Sbjct: 240 HVSTRVMGTQGYAAPEYIMTGHLTSRSDVYSFGVVLLELLTGRRSVDKSRPQREQNLVEW 299

Query: 303 ARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
           ARPML D  KL +I+D RLE +YS  GA++ A +A+QCLSH PK RPTM+ VV  L+PL 
Sbjct: 300 ARPMLNDPRKLGRIMDPRLEGQYSETGARKAAELAYQCLSHRPKHRPTMSIVVNTLDPLK 359

Query: 363 DLNDIPIGPFVYTVVPPGDHGHGQKSCGQKKNEKRGDGGKEKEDKKEEKGRNRRRKRRRV 422
           D  D+PIGPFVYTV          K C  K++E +    KEK  ++ ++ +  R ++R+ 
Sbjct: 360 DFEDVPIGPFVYTVPTENLKEDDNKECETKRDETK----KEKNGQQHQRHQLHRGQKRQG 415

Query: 423 RV-VRSRDVYSDTALYKALGTSLYSP 447
           R   RS  ++S+TAL +  G  L+SP
Sbjct: 416 RSRPRSPTIHSETALSQNHGNGLHSP 441

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225429710|ref|XP_002280196.1| PREDICTED: serine/threonine-protein kinase At5g01020 [Vitis vinifera]

 Score =  541 bits (1393), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 263/436 (60%), Positives = 331/436 (75%), Gaps = 16/436 (3%)

Query: 7   FTWKIILPSCIKATNKPSCMSKVHVSNQVSTQRLLLTDVSNPGSPISLNELSSSLVGSNL 66
            TWK I+P C K     +   K  V  Q S QRL L+D+SNPGSP+S++++S+SL+GSNL
Sbjct: 5   ITWKTIMPGCYKTETPIAESRKKPVLKQGSFQRLSLSDLSNPGSPLSVDDISNSLIGSNL 64

Query: 67  HVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGH 126
           + FTL EL+ ITHNFS S+ LGEGGFG VYKG +D+ LRP LKAQ VAVK+LD++G QGH
Sbjct: 65  YTFTLAELREITHNFSPSNLLGEGGFGPVYKGFIDEKLRPKLKAQPVAVKLLDLDGLQGH 124

Query: 127 REWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTR 186
           REWLAE+IFLGQL+HPHLV LIGYCCEDEHRLL+YEYMA G+L +QLF+ YS+ LPW  R
Sbjct: 125 REWLAEIIFLGQLRHPHLVKLIGYCCEDEHRLLIYEYMARGSLENQLFRRYSAALPWSAR 184

Query: 187 IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITT 246
           +KI  GAA+ LAFLH  +KPVIYRDFKASNILLD DY AKLSDFGLA DGP+G+++H++T
Sbjct: 185 MKILFGAAKGLAFLHEGDKPVIYRDFKASNILLDPDYTAKLSDFGLAKDGPEGDETHVST 244

Query: 247 CVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPM 306
            +MGT GYAAPEYI TGHLTTM DV+SFGVVLLE+++G+RS++K R  RE++LVEWARPM
Sbjct: 245 RIMGTHGYAAPEYIMTGHLTTMSDVYSFGVVLLEVISGKRSMDKTRPSREQNLVEWARPM 304

Query: 307 LKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLND 366
           LKD  KLD++IDSRLE  +ST+GA++ A +A++CLSH  K+RP M+ VVK LEPL D +D
Sbjct: 305 LKDPRKLDRVIDSRLEGLFSTKGAQKAAELAYKCLSHQAKARPAMSDVVKILEPLQDFDD 364

Query: 367 IPIGPFVYTVVPP----GDHGHGQKSCGQKKNEKRGDGGKEKEDKKEEKGRNRRRKRRRV 422
             I PFVY VVP     GD    +K    ++ ++R DG +           NR   R R+
Sbjct: 365 TVISPFVY-VVPAEGEVGDESESEKDISHQEIKERDDGQQ-----------NRPAWRHRI 412

Query: 423 RVVRSRDVYSDTALYK 438
           ++  S   YS++ALYK
Sbjct: 413 KLPLSLVAYSESALYK 428

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225444724|ref|XP_002277991.1| PREDICTED: serine/threonine-protein kinase At5g01020 [Vitis vinifera] gi|297738561|emb|CBI27806.3| unnamed protein product [Vitis vinifera]

 Score =  533 bits (1374), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 272/445 (61%), Positives = 332/445 (74%), Gaps = 14/445 (3%)

Query: 4   IKSFTWKIILPSCIKATNKPSCMSKVHV-SNQVSTQRLLLTDVSNPGSPISLNELSSSLV 62
           +K  TW+ + P+C  +    S   K  V + Q S QR+ ++D+SNPGS +S  +LS+SL+
Sbjct: 3   VKKITWRSVFPACYGSEKMASKRRKAAVVAKQTSFQRISISDLSNPGSTLS-EDLSTSLM 61

Query: 63  GSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG 122
           GSNLHVFTL EL++I  NFS ++++GEGGFG V+KG +DD LRPGLKAQ VAVK+LD+ G
Sbjct: 62  GSNLHVFTLTELKVICQNFSSNNFIGEGGFGPVHKGFIDDKLRPGLKAQPVAVKLLDLEG 121

Query: 123 SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLP 182
            QGHREWL EVIFLGQL+HPHLV LIGYCCEDEHRLLVYEYM  G+L +QLF+ YS +LP
Sbjct: 122 LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEDEHRLLVYEYMPRGSLENQLFRRYSVSLP 181

Query: 183 WLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS 242
           W TR+KIA+GAA+ LAFLH  EKPVIYRDFKASNILLDSD+  KLSDFGLA DGP+G+D+
Sbjct: 182 WSTRMKIALGAAKGLAFLHEAEKPVIYRDFKASNILLDSDHTPKLSDFGLAKDGPEGDDT 241

Query: 243 HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEW 302
           H++T VMGT+GYAAPEYI TGHLT M DV+SFGVVLLELLTGRRSV+K R  RE++L EW
Sbjct: 242 HVSTRVMGTQGYAAPEYIMTGHLTAMSDVYSFGVVLLELLTGRRSVDKTRPNREQNLAEW 301

Query: 303 ARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
           ARP L D  KL +I+D RLE +YS  GA+  AA+A+QCLSH PK RPTM+TVVK LEPL 
Sbjct: 302 ARPQLNDSRKLARIMDPRLEGQYSEAGAQSAAALAYQCLSHRPKHRPTMSTVVKTLEPLQ 361

Query: 363 DLNDIPIGPFVYTVVPPGDHGHGQKSCGQKKNEKRGDGGKEKEDKKEEKGRNRRRKRRRV 422
           D N+IP+G FVYTV    D           K E +  G  +KE KKE   +     R R+
Sbjct: 362 DYNEIPVGTFVYTVPSEND---------LPKEETKEGGEAQKEPKKESSHQGH---RHRM 409

Query: 423 RVVRSRDVYSDTALYKALGTSLYSP 447
           R  +S  +YS+TAL + L  S  SP
Sbjct: 410 RSPKSPTIYSETALRQNLRNSPNSP 434

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|350537699|ref|NP_001234561.1| auxin-regulated dual specificity cytosolic kinase [Solanum lycopersicum] gi|14484938|gb|AAK62821.1|AF332960_1 auxin-regulated dual specificity cytosolic kinase [Solanum lycopersicum] gi|270303597|gb|ACZ71039.1| auxin-regulated dual specificity cytosolic kinase [Solanum lycopersicum]

 Score =  525 bits (1353), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 266/443 (60%), Positives = 337/443 (76%), Gaps = 15/443 (3%)

Query: 9   WKIILPSCIKATNKPSCMSKVHVSNQVST--QRLLLTDVSNPGSP--ISLNELSS-SLVG 63
           WK +LP+C K  N  S    +  S Q+++   RL  +D+S       ISL++LSS +++G
Sbjct: 8   WKSVLPNCFKGNNVRSEAKVMENSKQMNSDHHRLAFSDISTDSRSVLISLDDLSSNAVIG 67

Query: 64  SNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS 123
           SNLHVFT +EL++IT +FS +++LG+GGFG V+KG +DD ++PGL AQ VAVK+LD++G+
Sbjct: 68  SNLHVFTYEELKLITSDFSSANFLGKGGFGPVHKGFIDDKIKPGLDAQPVAVKLLDLDGN 127

Query: 124 QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPW 183
           QGH+EWL EV+FLGQL+H HLV LIGYC E+E RLLVYEYMA GNL DQLF  YSS LPW
Sbjct: 128 QGHQEWLTEVVFLGQLRHHHLVKLIGYCWEEEQRLLVYEYMARGNLEDQLFSRYSSCLPW 187

Query: 184 LTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSH 243
           LTRIKI +GAA+ LAFLHGEEKPVIYRDFKASNILLDSDY AKLSDFGLA DGP+G+D+H
Sbjct: 188 LTRIKIMVGAAKGLAFLHGEEKPVIYRDFKASNILLDSDYRAKLSDFGLAKDGPEGDDTH 247

Query: 244 ITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA 303
           ++T VMGT GYAAPEYI TGHLT+  DV+SFGVVLLEL+TGRR+++K R  +E+ LV+WA
Sbjct: 248 VSTRVMGTHGYAAPEYIMTGHLTSKSDVYSFGVVLLELITGRRAMDKKRPLKERILVDWA 307

Query: 304 RPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD 363
           RPML+D  KLD+I+D RLE +YST+GAK++AA+A+QCLSH+P+SRPTM+ +VK LEP+LD
Sbjct: 308 RPMLRDPHKLDRIMDPRLEGQYSTQGAKKVAALAYQCLSHHPRSRPTMSNIVKILEPVLD 367

Query: 364 LNDIPIGPFVYTVVPPG--DHGHGQKSCGQKKNEKRGDGGKEKE-DKKEEKGRNRRRKRR 420
           + DIP+GPFVY VVP    D G        K N++   G +E E D   E   +   K+R
Sbjct: 368 MKDIPMGPFVY-VVPSSKPDKGTEIGELKTKVNDENKAGVRENEVDNAGENREDGNAKQR 426

Query: 421 RV------RVVRSRDVYSDTALY 437
           RV      R+     VYSDT LY
Sbjct: 427 RVGHRYKHRLKTDASVYSDTHLY 449

Source: Solanum lycopersicum

Species: Solanum lycopersicum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	449
TAIR|locus:2030185	450	AT1G72540 [Arabidopsis thalian	0.819	0.817	0.646	2.3e-133
TAIR|locus:2064712	462	RIPK "RPM1-induced protein kin	0.835	0.811	0.621	1.5e-124
TAIR|locus:2157101	494	AT5G35580 [Arabidopsis thalian	0.770	0.700	0.631	8.2e-115
TAIR|locus:2057770	424	ARSK1 "root-specific kinase 1"	0.730	0.773	0.638	1.9e-113
TAIR|locus:2200863	424	AT1G61590 [Arabidopsis thalian	0.804	0.851	0.560	2.3e-103
TAIR|locus:2150019	410	AT5G01020 [Arabidopsis thalian	0.710	0.778	0.610	5.4e-102
TAIR|locus:2060167	442	AT2G07180 [Arabidopsis thalian	0.708	0.719	0.565	1.6e-95
TAIR|locus:2147805	493	AT5G15080 [Arabidopsis thalian	0.734	0.669	0.547	2.3e-93
TAIR|locus:2161093	408	AT5G56460 [Arabidopsis thalian	0.699	0.769	0.561	7.3e-91
TAIR|locus:2095517	453	AT3G28690 [Arabidopsis thalian	0.732	0.726	0.539	1.9e-90

TAIR|locus:2030185 AT1G72540 [Arabidopsis thaliana (taxid:3702)]

 Score = 1231 (438.4 bits), Expect = 2.3e-133, Sum P(2) = 2.3e-133
 Identities = 247/382 (64%), Positives = 295/382 (77%)

Query:     7 FTWK-IILP-SCIKATNK-------PSCMSKVHVSNQVST-QRLLLTDVSNPGSPISLNE 56
             F+WK I LP SCI  TN+       P     + +S Q S   R+ ++D SN  S ISLN+
Sbjct:     3 FSWKNICLPISCINNTNQKKTTTTNPPKEKLLLLSRQTSVPSRVYMSDFSN--STISLND 60

Query:    57 LSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVK 116
              S+S    N+H+FT +EL+ IT  FS+ ++LGEGGFG+VYKG VDD+L+ GLK Q VAVK
Sbjct:    61 FSNSFF-INIHIFTYEELKTITQGFSKYNFLGEGGFGEVYKGFVDDSLKTGLKDQPVAVK 119

Query:   117 VLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKN 176
              L   G QGHREWLAEVI LGQLKHPHLVNL+GYCCED+ RLLVYEYM  GNL D LF+ 
Sbjct:   120 ALKREGGQGHREWLAEVIILGQLKHPHLVNLVGYCCEDDERLLVYEYMERGNLEDHLFQK 179

Query:   177 YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG 236
             Y   LPWLTR+KI +GAA+ L FLH +EKPVIYRDFK SNILL SD+++KLSDFGLATDG
Sbjct:   180 YGGALPWLTRVKILLGAAKGLEFLHKQEKPVIYRDFKPSNILLSSDFSSKLSDFGLATDG 239

Query:   237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE 296
              + EDS+ T  VMGTEGYAAPEYI+ G+LTTM DVFSFGVVLLE+LT R++VEK R +R 
Sbjct:   240 SEEEDSNFTKSVMGTEGYAAPEYISAGNLTTMSDVFSFGVVLLEMLTARKAVEKYRAQRG 299

Query:   297 KDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
             ++LVEWARPMLKD  KL++IID  LE +YS EG ++ AA+A+QCLSHNPKSRPTMTTVVK
Sbjct:   300 RNLVEWARPMLKDPNKLERIIDPSLEGKYSVEGIRKAAALAYQCLSHNPKSRPTMTTVVK 359

Query:   357 ALEPLLDLNDIPIGPFVYTVVP 378
              LEP+LDL DI  GPFVY +VP
Sbjct:   360 TLEPILDLKDIQNGPFVY-IVP 380

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2064712 RIPK "RPM1-induced protein kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 1224 (435.9 bits), Expect = 1.5e-124, P = 1.5e-124
 Identities = 238/383 (62%), Positives = 293/383 (76%)

Query:     1 MALIKSFTWKIILPSCI-------KATNKPSCMSKVHVSNQVSTQRLLLTDVSNPGSPIS 53
             MA+ K  +W+ ++  C+        ++ KP   + V +  Q S QRL + D+SNP S   
Sbjct:     1 MAVKKKVSWRSLIVGCLGDPETLMASSKKPKRKNDV-IKKQSSFQRLSILDMSNPSSNTL 59

Query:    54 LNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTV 113
               +LS SL GS+LHVFTL EL++IT +FS +++LGEGGFG V+KG +DD LRPGLKAQ V
Sbjct:    60 SEDLSISLAGSDLHVFTLAELKVITQSFSSTNFLGEGGFGPVHKGFIDDKLRPGLKAQPV 119

Query:   114 AVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQL 173
             AVK+LD+ G QGHREWL EV+FLGQLKH +LV LIGYCCE+EHR LVYE+M  G+L +QL
Sbjct:   120 AVKLLDLEGLQGHREWLTEVMFLGQLKHKNLVKLIGYCCEEEHRTLVYEFMPRGSLENQL 179

Query:   174 FKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA 233
             F+ YS++LPW TR+KIA GAA  L FLH  E PVIYRDFKASNILLDSDY AKLSDFGLA
Sbjct:   180 FRRYSASLPWSTRMKIAHGAATGLQFLHEAENPVIYRDFKASNILLDSDYTAKLSDFGLA 239

Query:   234 TDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRC 293
              DGP+G+D+H++T VMGT+GYAAPEYI TGHLT   DV+SFGVVLLELLTGRRSV+K R 
Sbjct:   240 KDGPEGDDTHVSTRVMGTQGYAAPEYIMTGHLTARSDVYSFGVVLLELLTGRRSVDKKRS 299

Query:   294 KREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTT 353
              RE++LV+WARPML D  KL +I+D RLE +YS  GA++ A +A+QCLSH PK+RP M+ 
Sbjct:   300 SREQNLVDWARPMLNDPRKLSRIMDPRLEGQYSETGARKAATLAYQCLSHRPKNRPCMSA 359

Query:   354 VVKALEPLLDLNDIPIGPFVYTV 376
             VV  L  L D NDIP+G F YTV
Sbjct:   360 VVSILNDLKDYNDIPMGTFTYTV 382

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009625 "response to insect" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0016036 "cellular response to phosphate starvation" evidence=RCA

GO:0019375 "galactolipid biosynthetic process" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0042631 "cellular response to water deprivation" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2157101 AT5G35580 [Arabidopsis thaliana (taxid:3702)]

 Score = 1132 (403.5 bits), Expect = 8.2e-115, P = 8.2e-115
 Identities = 219/347 (63%), Positives = 271/347 (78%)

Query:    31 VSNQVSTQRLLLTDVSNPGSPISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEG 90
             ++ Q S   L + D+SNP S     +LS SL GS+LHVFT  EL++IT +FS S++LGEG
Sbjct:    26 ITKQKSFLGLSILDISNPSSTTLSEDLSISLAGSDLHVFTQAELRVITQSFSSSNFLGEG 85

Query:    91 GFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGY 150
             GFG V+KG +DD LRPGLKAQ VAVK+LD++G QGHRE++ EV+ LG+LKHP+LV LIGY
Sbjct:    86 GFGPVHKGFIDDKLRPGLKAQPVAVKLLDLDGLQGHREFMTEVMCLGKLKHPNLVKLIGY 145

Query:   151 CCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYR 210
             CCE+ HRLLVYE+M  G+L  QLF+  S  LPW TR+ IA  AA+ L FLH  EKP+IYR
Sbjct:   146 CCEEAHRLLVYEFMPRGSLESQLFRRCSLPLPWTTRLNIAYEAAKGLQFLHEAEKPIIYR 205

Query:   211 DFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCD 270
             DFKASNILLDSDY AKLSDFGLA DGPQG+D+H++T VMGT+GYAAPEYI TGHLT   D
Sbjct:   206 DFKASNILLDSDYTAKLSDFGLAKDGPQGDDTHVSTRVMGTQGYAAPEYIMTGHLTAKSD 265

Query:   271 VFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGA 330
             V+SFGVVLLELLTGR+SV+  R  R++ LVEWARPML D  KL +I+D RLED+YS  GA
Sbjct:   266 VYSFGVVLLELLTGRKSVDIARSSRKETLVEWARPMLNDARKLGRIMDPRLEDQYSETGA 325

Query:   331 KRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL-NDIPIGPFVYTV 376
             ++ A +A+QCL + PK+RP ++TVV  L+ + D  +DIPIG F YTV
Sbjct:   326 RKAATLAYQCLRYRPKTRPDISTVVSVLQDIKDYKDDIPIGIFTYTV 372

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2057770 ARSK1 "root-specific kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1119 (399.0 bits), Expect = 1.9e-113, P = 1.9e-113
 Identities = 210/329 (63%), Positives = 269/329 (81%)

Query:    38 QRLLLTDVSNPGSPIS-LNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVY 96
             +RL L+D+S+P SP+S +++LS S     L +FTL EL++ITHNFSRS+ LGEGGFG VY
Sbjct:    44 KRLSLSDISDPSSPMSVMDDLSHSFTSQKLRLFTLSELRVITHNFSRSNMLGEGGFGPVY 103

Query:    97 KGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH 156
             KG +DD ++PG++AQ VAVK LD++G QGHREWLAE++FLGQL + HLV LIG+CCE+E 
Sbjct:   104 KGFIDDKVKPGIEAQPVAVKALDLHGHQGHREWLAEILFLGQLSNKHLVKLIGFCCEEEQ 163

Query:   157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASN 216
             R+LVYEYM  G+L +QLF+  S  + W  R+KIA+GAA+ LAFLH  EKPVIYRDFK SN
Sbjct:   164 RVLVYEYMPRGSLENQLFRRNSLAMAWGIRMKIALGAAKGLAFLHEAEKPVIYRDFKTSN 223

Query:   217 ILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGV 276
             ILLDSDYNAKLSDFGLA DGP+GE +H+TT VMGT+GYAAPEYI TGHLTTM DV+SFGV
Sbjct:   224 ILLDSDYNAKLSDFGLAKDGPEGEHTHVTTRVMGTQGYAAPEYIMTGHLTTMNDVYSFGV 283

Query:   277 VLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAV 336
             VLLEL+TG+RS++  R +RE+ LVEWARPML+D  KL++IID RL +++ TE A+  A++
Sbjct:   284 VLLELITGKRSMDNTRTRREQSLVEWARPMLRDQRKLERIIDPRLANQHKTEAAQVAASL 343

Query:   337 AHQCLSHNPKSRPTMTTVVKALEPLLDLN 365
             A++CLS +PK RPTM  VVK LE + +++
Sbjct:   344 AYKCLSQHPKYRPTMCEVVKVLESIQEVD 372

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2200863 AT1G61590 [Arabidopsis thaliana (taxid:3702)]

 Score = 1024 (365.5 bits), Expect = 2.3e-103, P = 2.3e-103
 Identities = 209/373 (56%), Positives = 266/373 (71%)

Query:    27 SKVHVSNQVSTQRLLLTDVSNPGSPISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDY 86
             SK H+    S +RL   D+S   S   +NE  +  +G++L  F + EL+MIT +FS +  
Sbjct:    46 SKNHLGPLPSFRRLSFADLSRSSSA-RINEDLAQTLGADLVDFQMCELKMITQSFSGNYL 104

Query:    87 LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
             LGEGGFGKVYKG VDD LR  LKAQ VAVK+LD+ G QGHREWL+EVIFLGQLKHP+LV 
Sbjct:   105 LGEGGFGKVYKGYVDDYLRQSLKAQPVAVKLLDIEGLQGHREWLSEVIFLGQLKHPNLVK 164

Query:   147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
             LIGYCCE+E R+L+YE+M  G+L + LF+  S +LPW TR+KIA+ AA+ LAFLH  E P
Sbjct:   165 LIGYCCEEEERVLIYEFMPRGSLENHLFRRISLSLPWATRLKIAVAAAKGLAFLHDLESP 224

Query:   207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
             +IYRDFK SNILLDSD+ AKLSDFGLA  GP+G  SH+TT VMGT GYAAPEY++TGHLT
Sbjct:   225 IIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSKSHVTTRVMGTYGYAAPEYVSTGHLT 284

Query:   267 TMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYS 326
             T  DV+S+GVVLLELLTGRR+ EK+R K ++++++W++P L    +L  ++D RL  +YS
Sbjct:   285 TKSDVYSYGVVLLELLTGRRATEKSRPKNQQNIIDWSKPYLTSSRRLRCVMDPRLAGQYS 344

Query:   327 TEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDI-------PIGPFVY--TVV 377
              + AK  A +A QC+S NPK RP M  VV+ALE L+   D+       P+ P      V 
Sbjct:   345 VKAAKDTALLALQCVSPNPKDRPKMLAVVEALESLIHYKDMAVSSGHWPLSPKSQGGKVS 404

Query:   378 PP--GDHGHGQKS 388
             P   GDH  G+KS
Sbjct:   405 PKVRGDHRSGRKS 417

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2150019 AT5G01020 [Arabidopsis thaliana (taxid:3702)]

 Score = 1011 (360.9 bits), Expect = 5.4e-102, P = 5.4e-102
 Identities = 196/321 (61%), Positives = 249/321 (77%)

Query:    42 LTDVSNPGSPISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDY-LGEGGFGKVYKGCV 100
             ++D+S+P +P   ++  + +  + +  FTL EL+ IT +F R DY LGEGGFG VYKG +
Sbjct:    30 VSDLSDPSTPRFRDDSRTPISYAQVIPFTLFELETITKSF-RPDYILGEGGFGTVYKGYI 88

Query:   101 DDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLV 160
             DDNLR GLK+  VAVKVL+  G QGHREWL EV FLGQL+HP+LV LIGYCCED+HRLLV
Sbjct:    89 DDNLRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLV 148

Query:   161 YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD 220
             YE+M  G+L + LF+  ++ L W  R+ IA+GAA+ LAFLH  E+PVIYRDFK SNILLD
Sbjct:   149 YEFMLRGSLENHLFRKTTAPLSWSRRMMIALGAAKGLAFLHNAERPVIYRDFKTSNILLD 208

Query:   221 SDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLE 280
             SDY AKLSDFGLA  GPQG+++H++T VMGT GYAAPEY+ TGHLT   DV+SFGVVLLE
Sbjct:   209 SDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLE 268

Query:   281 LLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQC 340
             +LTGR+SV+K R  +E++LV+WARP L D  KL QIID RLE++YS   A++  ++A+ C
Sbjct:   269 MLTGRKSVDKTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYC 328

Query:   341 LSHNPKSRPTMTTVVKALEPL 361
             LS NPK+RP M+ VV+ LEPL
Sbjct:   329 LSQNPKARPLMSDVVETLEPL 349

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000394 "RNA splicing, via endonucleolytic cleavage and ligation" evidence=RCA

GO:0009086 "methionine biosynthetic process" evidence=RCA

GO:0032880 "regulation of protein localization" evidence=RCA

TAIR|locus:2060167 AT2G07180 [Arabidopsis thaliana (taxid:3702)]

 Score = 950 (339.5 bits), Expect = 1.6e-95, P = 1.6e-95
 Identities = 181/320 (56%), Positives = 238/320 (74%)

Query:    48 PGSPISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDY-LGEGGFGKVYKGCVDDNLRP 106
             P +P ++ +L S+    N+ +FT +E+++ T  F R DY LGEGGFG VYKG +D+++R 
Sbjct:    57 PLAPKNIKDLQSNPGYENVDIFTYEEMKIATKQF-RPDYILGEGGFGVVYKGVIDESVRV 115

Query:   107 GLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMAL 166
             G K+  VA+K L+  G QG REWLAEV +LGQL HP+LV LIGYCCED+HRLLVYEYMA+
Sbjct:   116 GFKSTKVAIKELNPEGFQGDREWLAEVNYLGQLSHPNLVKLIGYCCEDDHRLLVYEYMAM 175

Query:   167 GNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAK 226
             G+L   LF+    TL W  R+KIA+ AA+ LAFLHG E+ +IYRD K +NILLD  YNAK
Sbjct:   176 GSLEKHLFRRVGCTLTWTKRMKIALDAAKGLAFLHGAERSIIYRDLKTANILLDEGYNAK 235

Query:   227 LSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRR 286
             LSDFGLA DGP+G+ +H++T VMGT GYAAPEY+ TGHLT+  DV+ FGV+LLE+L G+R
Sbjct:   236 LSDFGLAKDGPRGDQTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYGFGVLLLEMLLGKR 295

Query:   287 SVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPK 346
             +++K+R  RE +LVEWARP+L    KL +IID R++ +Y T+   ++A +A+QCLS NPK
Sbjct:   296 AMDKSRACREHNLVEWARPLLNHNKKLLRIIDPRMDGQYGTKALMKVAGLAYQCLSQNPK 355

Query:   347 SRPTMTTVVKALEPLLDLND 366
              RP M  VV+ LE L D  D
Sbjct:   356 GRPLMNHVVEVLETLKDDGD 375

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)]

 Score = 910 (325.4 bits), Expect = 2.3e-93, Sum P(2) = 2.3e-93
 Identities = 185/338 (54%), Positives = 240/338 (71%)

Query:    43 TDVSNPGSPISLNELSSSL-VGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVD 101
             T  SN  S  S   +S  L + S+L  FT  +L++ T NF     LGEGGFG V+KG ++
Sbjct:   103 TTTSNAESSSSTPVISEELNISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIE 162

Query:   102 DN----LRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR 157
             +N    ++PG    TVAVK L+ +G QGH+EWLAE+ FLG L HP+LV L+GYC ED+ R
Sbjct:   163 ENGTAPVKPGT-GLTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQR 221

Query:   158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE-KPVIYRDFKASN 216
             LLVYE+M  G+L + LF+  S  LPW  R+KIA+GAA+ L+FLH E  KPVIYRDFK SN
Sbjct:   222 LLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSN 280

Query:   217 ILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGV 276
             ILLD+DYNAKLSDFGLA D P    +H++T VMGT GYAAPEY+ TGHLT+  DV+SFGV
Sbjct:   281 ILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGV 340

Query:   277 VLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAV 336
             VLLE+LTGRRS++KNR   E +LVEWARP L D  +  +++D RLE  +S +GA+++  +
Sbjct:   341 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQL 400

Query:   337 AHQCLSHNPKSRPTMTTVVKALEPLLDLNDIPIGPFVY 374
             A QCLS +PK RP M+ VV+AL+PL  L D+    + +
Sbjct:   401 AAQCLSRDPKIRPKMSDVVEALKPLPHLKDMASSSYYF 438

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2161093 AT5G56460 [Arabidopsis thaliana (taxid:3702)]

 Score = 906 (324.0 bits), Expect = 7.3e-91, P = 7.3e-91
 Identities = 178/317 (56%), Positives = 228/317 (71%)

Query:    48 PGSPISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNL--R 105
             P +P  + +L      + L  FT +EL+ IT NF +   LG GGFG VYKG + ++L  +
Sbjct:    43 PSNPKEVEDLRRDSAANPLIAFTYEELKNITSNFRQDRVLGGGGFGSVYKGFIKEDLGDQ 102

Query:   106 PGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYM 164
                +   VAVKV D + S QGHREWLAEVIFLGQL HP+LV LIGYCCED HR+L+YEYM
Sbjct:   103 EVPEPLPVAVKVHDGDNSFQGHREWLAEVIFLGQLSHPNLVKLIGYCCEDNHRVLIYEYM 162

Query:   165 ALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYN 224
             A G++ + LF      L W  R+KIA GAA+ LAFLH  +KPVIYRDFK SNILLD DYN
Sbjct:   163 ARGSVENNLFSRVLLPLSWAIRMKIAFGAAKGLAFLHEAKKPVIYRDFKTSNILLDMDYN 222

Query:   225 AKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
             AKLSDFGLA DGP G+ SH++T +MGT GYAAPEYI TGHLT   DV+SFGVVLLELLTG
Sbjct:   223 AKLSDFGLAKDGPVGDKSHVSTRIMGTYGYAAPEYIMTGHLTPGSDVYSFGVVLLELLTG 282

Query:   285 RRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHN 344
             R+S++K+R  RE++L++WA P+LK+  K+  I+D ++   Y  +  ++ A +A+ CL+ N
Sbjct:   283 RKSLDKSRPTREQNLIDWALPLLKEKKKVLNIVDPKMNCEYPVKAVQKAAMLAYHCLNRN 342

Query:   345 PKSRPTMTTVVKALEPL 361
             PK+RP M  +V +LEPL
Sbjct:   343 PKARPLMRDIVDSLEPL 359

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)]

 Score = 902 (322.6 bits), Expect = 1.9e-90, P = 1.9e-90
 Identities = 183/339 (53%), Positives = 237/339 (69%)

Query:    46 SNPGSPISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDN-- 103
             S   +P+   EL  S   S L +F   +L++ T NF     LGEGGFG V+KG +++N  
Sbjct:    71 SGSSTPLMSGELKYS---SKLRIFMFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGT 127

Query:   104 --LRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVY 161
               ++PG    TVAVK L+ +G QGH+EWLAE+ FLG L HP LV L+GYC E++ RLLVY
Sbjct:   128 APVKPGT-GLTVAVKTLNPDGLQGHKEWLAEINFLGNLVHPSLVKLVGYCMEEDQRLLVY 186

Query:   162 EYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE-EKPVIYRDFKASNILLD 220
             E+M  G+L + LF+  +  LPW  R+KIA+GAA+ LAFLH E EKPVIYRDFK SNILLD
Sbjct:   187 EFMPRGSLENHLFRR-TLPLPWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD 245

Query:   221 SDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLE 280
              +YNAKLSDFGLA D P  + SH++T VMGT GYAAPEY+ TGHLTT  DV+SFGVVLLE
Sbjct:   246 GEYNAKLSDFGLAKDAPDEKKSHVSTRVMGTYGYAAPEYVMTGHLTTKSDVYSFGVVLLE 305

Query:   281 LLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQC 340
             +LTGRRSV+K+R   E++LVEW RP L D  +  +++D RLE  YS +GA++   VA QC
Sbjct:   306 ILTGRRSVDKSRPNGEQNLVEWVRPHLLDKKRFYRLLDPRLEGHYSIKGAQKATQVAAQC 365

Query:   341 LSHNPKSRPTMTTVVKALEPLLDLNDIPIGPFVYTVVPP 379
             L+ + K+RP M+ VV+AL+PL +L D       +  + P
Sbjct:   366 LNRDSKARPKMSEVVEALKPLPNLKDFASSSSSFQTMQP 404

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9CAH1	Y1725_ARATH	2, ., 7, ., 1, 1, ., 1	0.6136	0.9755	0.9733	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.914
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: gw1.158.7.1 hypothetical protein (368 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	449
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-54
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-53
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-49
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-49
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-47
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-45
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-44
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-36
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-34
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-33
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-32
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-30
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-29
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-29
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-28
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-28
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-27
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-27
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-27
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-27
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-26
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	8e-26
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-25
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-25
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	9e-24
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-23
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-23
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-23
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-22
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-22
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-22
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-22
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-22
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-22
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	9e-22
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	9e-22
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-21
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-21
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-21
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-21
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-21
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-21
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-21
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-20
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-20
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-20
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-20
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	8e-20
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	8e-20
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	9e-20
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	9e-20
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-19
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-19
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-19
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-19
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-19
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-19
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-19
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-19
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-19
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-19
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-19
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-19
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	6e-19
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-19
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	9e-19
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-18
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-18
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-18
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-18
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-18
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-18
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-18
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-18
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-18
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-18
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-18
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-18
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-18
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	8e-18
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	9e-18
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-17
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-17
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-17
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-17
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-17
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-17
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-17
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-17
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-17
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-17
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-17
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-17
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-17
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	7e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-17
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	8e-17
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	8e-17
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	8e-17
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-16
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-16
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-16
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-16
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-16
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-16
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-16
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-16
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-16
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-16
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-16
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	9e-16
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	9e-16
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	9e-16
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-15
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-15
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-15
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-15
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-15
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-15
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-15
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-15
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-15
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-15
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-15
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-15
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-15
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	7e-15
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	8e-15
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	9e-15
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-14
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-14
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-14
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-14
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-14
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-14
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-14
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-14
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-14
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-14
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-14
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	6e-14
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	8e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	8e-14
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-14
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	9e-14
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-13
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-13
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-13
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-13
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-13
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-13
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-13
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-13
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-13
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-13
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-13
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-13
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	8e-13
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	8e-13
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-12
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-12
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-12
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-12
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-12
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-12
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-12
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-12
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-12
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-12
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-12
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-12
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	5e-12
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	5e-12
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	6e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-12
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-12
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	6e-12
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-12
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-12
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	7e-12
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	8e-12
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	9e-12
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-11
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-11
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	6e-11
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-11
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	7e-11
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-10
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-10
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-10
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-10
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-10
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-10
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-10
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	7e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	8e-10
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-09
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-09
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	7e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	9e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-08
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-08
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	6e-08
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	8e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	9e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	9e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-07
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-07
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-07
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	7e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	8e-07
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	9e-07
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-06
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-06
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-06
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	8e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	9e-06
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-05
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	6e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	9e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	9e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	9e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	0.001
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.002
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.002
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.004

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  181 bits (462), Expect = 2e-54
 Identities = 86/279 (30%), Positives = 129/279 (46%), Gaps = 35/279 (12%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLV 145
           LGEG FG+VYKG +      G K   VAVK L  + S+    E+L E   + +L HP++V
Sbjct: 7   LGEGAFGEVYKGKLKGK--GGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            L+G C E+E   +V EYM  G+L   L +     L     +  A+  AR + +L    K
Sbjct: 65  KLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLE--SK 121

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG---YAAPEYINT 262
             I+RD  A N L+  +   K+SDFGL+ D    +         G +    + APE +  
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD----YYRKRGGKLPIRWMAPESLKE 177

Query: 263 GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKR---EKDLVEWARPMLKDFTKLDQIIDS 319
           G  T+  DV+SFGV+L E+ T          ++        E     LK+  +L Q  + 
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFT--------LGEQPYPGMSNEE-VLEYLKNGYRLPQPPNC 228

Query: 320 RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL 358
             E          L  +  QC + +P+ RPT + +V+ L
Sbjct: 229 PPE----------LYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  178 bits (455), Expect = 3e-53
 Identities = 88/279 (31%), Positives = 131/279 (46%), Gaps = 34/279 (12%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLV 145
           LGEG FG+VYKG +    +   K   VAVK L  + S+    E+L E   + +L HP++V
Sbjct: 7   LGEGAFGEVYKGTLKG--KGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            L+G C E+E  ++V EYM  G+L D L KN    L     +  A+  AR + +L    K
Sbjct: 65  KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--SK 122

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG---YAAPEYINT 262
             I+RD  A N L+  +   K+SDFGL+ D    +       V G +    + APE +  
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD----YYKVKGGKLPIRWMAPESLKE 178

Query: 263 GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKR---EKDLVEWARPMLKDFTKLDQIIDS 319
           G  T+  DV+SFGV+L E+ T          +         E     LK   +L +  + 
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFT--------LGEEPYPGMSNAE-VLEYLKKGYRLPKPPNC 229

Query: 320 RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL 358
             E          L  +  QC + +P+ RPT + +V+ L
Sbjct: 230 PPE----------LYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  169 bits (430), Expect = 2e-49
 Identities = 90/291 (30%), Positives = 129/291 (44%), Gaps = 45/291 (15%)

Query: 85  DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPH 143
             LGEG FG+VYKG +        K   VAVK L  + S+  R ++L E   + +L HP+
Sbjct: 1   KKLGEGAFGEVYKGKLKGK---DGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPN 57

Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNLHD-------QLFKNYSSTLPWLTRIKIAIGAARC 196
           +V L+G C E+E   LV EYM  G+L D              STL     +  AI  A+ 
Sbjct: 58  VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117

Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG--- 253
           + +L    K  ++RD  A N L+  D   K+SDFGL+ D    +          T G   
Sbjct: 118 MEYLA--SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY-----RKKTGGKLP 170

Query: 254 --YAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFT 311
             + APE +  G  T+  DV+SFGV+L E+ T               L     P L +  
Sbjct: 171 IRWMAPESLKDGIFTSKSDVWSFGVLLWEIFT---------------LGATPYPGLSNEE 215

Query: 312 KLDQIID-SRLE--DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
            L+ +    RL   +    E    L  +   C   +P+ RPT + +V+ LE
Sbjct: 216 VLEYLRKGYRLPKPEYCPDE----LYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  167 bits (424), Expect = 3e-49
 Identities = 71/198 (35%), Positives = 99/198 (50%), Gaps = 14/198 (7%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFLGQLKHPHLV 145
           LGEGGFG VY        R     + VA+K++    S    E  L E+  L +L HP++V
Sbjct: 1   LGEGGFGTVYLA------RDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIV 54

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            L G   ++ H  LV EY   G+L D L K     L     ++I +     L +LH    
Sbjct: 55  KLYGVFEDENHLYLVMEYCEGGSLKD-LLKENEGKLSEDEILRILLQILEGLEYLH--SN 111

Query: 206 PVIYRDFKASNILLDSD-YNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI-NTG 263
            +I+RD K  NILLDSD    KL+DFGL+       D  +   ++GT  Y APE +   G
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLL--TSDKSLLKTIVGTPAYMAPEVLLGKG 169

Query: 264 HLTTMCDVFSFGVVLLEL 281
           + +   D++S GV+L EL
Sbjct: 170 YYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  163 bits (414), Expect = 3e-47
 Identities = 82/289 (28%), Positives = 131/289 (45%), Gaps = 54/289 (18%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGHREWLAEVIFLGQLKHPHLV 145
           LGEG FG+VYKG +            VAVK L      +   E+L E   + +L HP++V
Sbjct: 7   LGEGAFGEVYKGTLKG--DGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            L+G C + E   +V EYM  G+L D L + +   L     +++A+  A+ + +L    K
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLE--SK 121

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA-----APEYI 260
             ++RD  A N L+  +   K+SDFGL+ D  + +            G       APE +
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY-----RKRGGGKLPIKWMAPESL 176

Query: 261 NTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDS 319
             G  T+  DV+SFGV+L E+ T G +                  P + +     ++++ 
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPY----------------PGMSNE----EVLE- 215

Query: 320 RLEDRYSTEGAKRLAAVAH----------QCLSHNPKSRPTMTTVVKAL 358
            LED Y      RL    +          QC +++P+ RPT + +V+ L
Sbjct: 216 LLEDGY------RLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  158 bits (401), Expect = 2e-45
 Identities = 83/273 (30%), Positives = 117/273 (42%), Gaps = 44/273 (16%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFLGQLKHPHLV 145
           LGEG FGKVY    D         + VA+KV+     +  RE  L E+  L +LKHP++V
Sbjct: 7   LGEGSFGKVYL-ARDKKTG-----KLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            L     +++   LV EY   G+L D L K    +          I     L +LH   K
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQI--LSALEYLH--SK 116

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
            +++RD K  NILLD D + KL+DFGLA          +TT V GT  Y APE +     
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GTPEYMAPEVLLGKGY 173

Query: 266 TTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRY 325
               D++S GV+L ELLTG+                   P      +L ++     + + 
Sbjct: 174 GKAVDIWSLGVILYELLTGK-------------------PPFPGDDQLLELFKKIGKPKP 214

Query: 326 S--------TEGAKRLAAVAHQCLSHNPKSRPT 350
                    +  AK L     + L  +P+ R T
Sbjct: 215 PFPPPEWDISPEAKDLI---RKLLVKDPEKRLT 244

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  155 bits (395), Expect = 1e-44
 Identities = 85/276 (30%), Positives = 125/276 (45%), Gaps = 32/276 (11%)

Query: 87  LGEGGFGKVYKGC-VDDNLRPGLKAQTVAVKVL--DVNGSQGHREWLAEVIFLGQLKHPH 143
           LG G FG VYK              + VAVK+L      S+  +    E+  L +L HP+
Sbjct: 7   LGSGSFGTVYKAKHKGTG-------KIVAVKILKKRSEKSKKDQTARREIRILRRLSHPN 59

Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE 203
           +V LI    + +H  LV EY   G+L D L +     L      KIA+   R L +LH  
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG--GPLSEDEAKKIALQILRGLEYLH-- 115

Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTG 263
              +I+RD K  NILLD +   K++DFGLA      + S   T  +GT  Y APE +  G
Sbjct: 116 SNGIIHRDLKPENILLDENGVVKIADFGLAKK--LLKSSSSLTTFVGTPWYMAPEVLLGG 173

Query: 264 -HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLE 322
                  DV+S GV+L ELLTG+                    +L     + +I+   LE
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGK-------------PPFSGENILDQLQLIRRILGPPLE 220

Query: 323 --DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
             +   + G++    +  +CL+ +P  RPT   +++
Sbjct: 221 FDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  132 bits (335), Expect = 5e-36
 Identities = 66/206 (32%), Positives = 104/206 (50%), Gaps = 14/206 (6%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK 140
           F   + +G+GGFG+VYK             + VA+KV+ +   +   + + E+  L + K
Sbjct: 2   FEILEKIGKGGFGEVYKA-RHKRTG-----KEVAIKVIKLESKEKKEKIINEIQILKKCK 55

Query: 141 HPHLVNLIG-YCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAF 199
           HP++V   G Y  +DE   +V E+ + G+L   L K+ + TL       +     + L +
Sbjct: 56  HPNIVKYYGSYLKKDE-LWIVMEFCSGGSL-KDLLKSTNQTLTESQIAYVCKELLKGLEY 113

Query: 200 LHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEY 259
           LH     +I+RD KA+NILL SD   KL DFGL+    Q  D+     ++GT  + APE 
Sbjct: 114 LH--SNGIIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEV 168

Query: 260 INTGHLTTMCDVFSFGVVLLELLTGR 285
           IN        D++S G+  +EL  G+
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  127 bits (321), Expect = 7e-34
 Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 22/215 (10%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGH--REWLAEVIFLG 137
            ++R + LG G FG VY     D        + +AVK ++++G           E+  L 
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDT------GELMAVKSVELSGDSEEELEALEREIRILS 54

Query: 138 QLKHPHLVNLIGYCCEDE--HRLLVYEYMALGNLHDQLFKNYS----STLPWLTRIKIAI 191
            L+HP++V   G   ++E     +  EY++ G+L   L K +       +   TR +I  
Sbjct: 55  SLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL-KKFGKLPEPVIRKYTR-QILE 112

Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
           G    LA+LH     +++RD K +NIL+DSD   KL+DFG A      E    T  V GT
Sbjct: 113 G----LAYLH--SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166

Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRR 286
             + APE I         D++S G  ++E+ TG+ 
Sbjct: 167 PYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  126 bits (318), Expect = 1e-33
 Identities = 71/208 (34%), Positives = 103/208 (49%), Gaps = 14/208 (6%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLG 137
           N+   D +G G FG VYKG    NL  G     VA+K + +     +  +  + E+  L 
Sbjct: 1   NYQLGDLIGRGAFGVVYKGL---NLETG---DFVAIKQISLEKIKEEALKSIMQEIDLLK 54

Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
            LKHP++V  IG     +   ++ EY   G+L  Q+ K +    P            + L
Sbjct: 55  NLKHPNIVKYIGSIETSDSLYIILEYAENGSLR-QIIKKFG-PFPESLVAVYVYQVLQGL 112

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAP 257
           A+LH  E+ VI+RD KA+NIL   D   KL+DFG+AT     + S     V+GT  + AP
Sbjct: 113 AYLH--EQGVIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTPYWMAP 168

Query: 258 EYINTGHLTTMCDVFSFGVVLLELLTGR 285
           E I     +T  D++S G  ++ELLTG 
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  122 bits (309), Expect = 3e-32
 Identities = 86/288 (29%), Positives = 127/288 (44%), Gaps = 56/288 (19%)

Query: 84  SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHREWLAEVIFLGQLKH 141
              +G+G FG V  G          + Q VAVK L  D   +Q    +LAE   +  L+H
Sbjct: 11  GATIGKGEFGDVMLGD--------YRGQKVAVKCLKDDSTAAQ---AFLAEASVMTTLRH 59

Query: 142 PHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLH 201
           P+LV L+G   +     +V EYMA G+L D L     + +    ++  A+     + +L 
Sbjct: 60  PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL- 118

Query: 202 GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG-----YAA 256
            EEK  ++RD  A N+L+  D  AK+SDFGLA +  QG+DS          G     + A
Sbjct: 119 -EEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDS----------GKLPVKWTA 167

Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ 315
           PE +     +T  DV+SFG++L E+ + GR              V + R  LKD      
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGR--------------VPYPRIPLKDVVP--- 210

Query: 316 IIDSRLEDRY---STEGA-KRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
                +E  Y   + EG    +  V   C   +P  RPT   + + L 
Sbjct: 211 ----HVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  118 bits (297), Expect = 2e-30
 Identities = 81/283 (28%), Positives = 119/283 (42%), Gaps = 28/283 (9%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLV 145
           LG+G FG VY+G     +  G     VA+K ++ N S   R E+L E   + +    H+V
Sbjct: 14  LGQGSFGMVYEGLAK-GVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFK-----NYSSTLPWLTRIKI---AIGAARCL 197
            L+G     +  L+V E MA G+L   L         +  L   T  K    A   A  +
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAP 257
           A+L    K  ++RD  A N ++  D   K+ DFG+  D  + +        +    + AP
Sbjct: 133 AYLA--AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 258 EYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII 317
           E +  G  TT  DV+SFGVVL E+ T               L E     L +   L  +I
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT---------------LAEQPYQGLSNEEVLKFVI 235

Query: 318 DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEP 360
           D    D        +L  +   C  +NPK RPT   +V +L+ 
Sbjct: 236 DGGHLDL-PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  115 bits (289), Expect = 4e-29
 Identities = 79/295 (26%), Positives = 126/295 (42%), Gaps = 41/295 (13%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLV 145
           LGEG FGKV     D  L      Q VAVK L+ +G + HR ++  E+  L  L H ++V
Sbjct: 12  LGEGHFGKVELCRYD-PLGDNTGEQ-VAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 146 NLIGYCCEDEHR---LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
              G  CE        L+ EY+  G+L D L ++    +     +  +    + + +L  
Sbjct: 70  KYKG-VCEKPGGRSLRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLG- 126

Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG-----YAAP 257
             +  I+RD  A NIL++S+   K+SDFGLA   P+ +D +     +   G     + AP
Sbjct: 127 -SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYY----YVKEPGESPIFWYAP 181

Query: 258 EYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII 317
           E + T   ++  DV+SFGV L EL T            +      A  +        Q+I
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFT--------YG--DPSQSPPAEFLRMIGIAQGQMI 231

Query: 318 DSRLEDRYSTEGAKRLAAVAH----------QCLSHNPKSRPTMTTVVKALEPLL 362
            +RL +    +  +RL                C    P+ RP+   ++  ++ L 
Sbjct: 232 VTRLLELL--KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  113 bits (286), Expect = 6e-29
 Identities = 76/285 (26%), Positives = 127/285 (44%), Gaps = 39/285 (13%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLV 145
           +G G FG+V +G +     PG K   VA+K L    S   R ++L E   +GQ  HP+++
Sbjct: 12  IGGGEFGEVCRGRL---KLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            L G   +    +++ EYM  G+L D+  +           + +  G A  + +L   E 
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSL-DKFLRENDGKFTVGQLVGMLRGIASGMKYL--SEM 125

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINT 262
             ++RD  A NIL++S+   K+SDFGL     + EDS  T    G +    + APE I  
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGL---SRRLEDSEATYTTKGGKIPIRWTAPEAIAY 182

Query: 263 GHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRL 321
              T+  DV+SFG+V+ E+++ G R              + +          +Q +   +
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERPYW-----------DMS----------NQDVIKAV 221

Query: 322 EDRYSTEGAKRLAAVAHQ----CLSHNPKSRPTMTTVVKALEPLL 362
           ED Y         +  +Q    C   +   RPT + +V  L+ ++
Sbjct: 222 EDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  111 bits (280), Expect = 4e-28
 Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 11/197 (5%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG+V++G   + +R       VA+K+L  +     +++  EV  L +L+H HL++
Sbjct: 14  LGSGYFGEVWEGLWKNRVR-------VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L   C   E   ++ E M  G+L   L       LP  + I +A   A  +A+L  EE+ 
Sbjct: 67  LFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL--EEQN 124

Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
            I+RD  A NIL+  D   K++DFGLA      ED ++++       + APE  + G  +
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLAR--LIKEDVYLSSDKKIPYKWTAPEAASHGTFS 182

Query: 267 TMCDVFSFGVVLLELLT 283
           T  DV+SFG++L E+ T
Sbjct: 183 TKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  114 bits (284), Expect = 7e-28
 Identities = 82/283 (28%), Positives = 125/283 (44%), Gaps = 29/283 (10%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREW---LAEVIFLGQLKHP- 142
           LGEG FG+VY              + VA+KVL        +E    L E+  L  L HP 
Sbjct: 8   LGEGSFGEVYLA---------RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYS-STLPWLTRIKIAIGAARCLAFLH 201
           ++V L  +  ++    LV EY+  G+L D L K      L     + I       L +LH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 202 GEEKPVIYRDFKASNILLDSDYN-AKLSDFGLA----TDGPQGEDSHITTCVMGTEGYAA 256
              K +I+RD K  NILLD D    KL DFGLA      G       + +  +GT GY A
Sbjct: 119 --SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 257 PEYI---NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKL 313
           PE +   +  + ++  D++S G+ L ELLTG    E    K      +  + +L+  T  
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE--KNSSATSQTLKIILELPTPS 234

Query: 314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
              + S L        +K  + +  + L+ +PK+R + ++ + 
Sbjct: 235 ---LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  109 bits (274), Expect = 2e-27
 Identities = 73/209 (34%), Positives = 92/209 (44%), Gaps = 29/209 (13%)

Query: 87  LGEGGFGKVYKGCV---DDNLRPGLKAQTVAVKVLD-----VNGSQGHREWLAEVIFLGQ 138
           LG+G FGKV    V   D         +  A+KVL            H   L E   L +
Sbjct: 1   LGKGSFGKVL--LVRKKDTG-------KLYAMKVLKKKKIIKRKEVEHT--LTERNILSR 49

Query: 139 LKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA-IGAARC 196
           + HP +V L  Y  + E +L LV EY   G L   L            R   A I  A  
Sbjct: 50  INHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHL-SKEGRFSEERARFYAAEIVLA-- 105

Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L +LH     +IYRD K  NILLD+D + KL+DFGLA +         T C  GT  Y A
Sbjct: 106 LEYLH--SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC--GTPEYLA 161

Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           PE +         D +S GV+L E+LTG+
Sbjct: 162 PEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  109 bits (274), Expect = 2e-27
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 19/203 (9%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFLGQLKHPHLV 145
           +G+G FG VYKG +  N         VAVK          +  +L E   L Q  HP++V
Sbjct: 3   IGKGNFGDVYKGVLKGNTE-------VAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIV 55

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            LIG C + +   +V E +  G+L   L K   + L     +++++ AA  + +L  E K
Sbjct: 56  KLIGVCVQKQPIYIVMELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYL--ESK 112

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE----GYAAPEYIN 261
             I+RD  A N L+  +   K+SDFG++ +    E+  I T   G +     + APE +N
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSRE----EEGGIYTVSDGLKQIPIKWTAPEALN 168

Query: 262 TGHLTTMCDVFSFGVVLLELLTG 284
            G  T+  DV+S+G++L E  + 
Sbjct: 169 YGRYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  108 bits (273), Expect = 4e-27
 Identities = 74/203 (36%), Positives = 100/203 (49%), Gaps = 18/203 (8%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ-GHREWLAEVIFLGQLKHPHLV 145
           LG G FG V KG     L    K   VAVK L       G +E+L E   + QL HP +V
Sbjct: 3   LGHGNFGSVVKGVY---LMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIV 59

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            LIG  C+ E  +LV E   LG L   L K     +P     ++A   A  +A+L  E K
Sbjct: 60  RLIG-VCKGEPLMLVMELAPLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYL--ESK 114

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG-----YAAPEYI 260
             ++RD  A N+LL + + AK+SDFG++     G D +  T    T G     + APE I
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYAPECI 170

Query: 261 NTGHLTTMCDVFSFGVVLLELLT 283
           N G  ++  DV+S+GV L E  +
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  108 bits (273), Expect = 4e-27
 Identities = 70/203 (34%), Positives = 100/203 (49%), Gaps = 18/203 (8%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG+V+ G  +   +       VAVK L   G+     +L E   + +L+H  LV 
Sbjct: 14  LGAGQFGEVWMGTWNGTTK-------VAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLVQ 65

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L   C E+E   +V EYM+ G+L D L       L     + +A   A  +A+L  E + 
Sbjct: 66  LYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL--ESRN 123

Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINTG 263
            I+RD  A NIL+  +   K++DFGLA      ED   T    G +    + APE  N G
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLAR---LIEDDEYTAR-EGAKFPIKWTAPEAANYG 179

Query: 264 HLTTMCDVFSFGVVLLELLT-GR 285
             T   DV+SFG++L E++T GR
Sbjct: 180 RFTIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  108 bits (271), Expect = 1e-26
 Identities = 67/218 (30%), Positives = 108/218 (49%), Gaps = 10/218 (4%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLGQLKHPHL 144
           LG G FG VYKG     +  G K +  VA+KVL +    + ++E L E   +  + HPH+
Sbjct: 15  LGSGAFGTVYKGVW---IPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHV 71

Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           V L+G C   +   L+ + M LG L D + +N+   +     +   +  A+ +++L  EE
Sbjct: 72  VRLLGICLSSQV-QLITQLMPLGCLLDYV-RNHKDNIGSQYLLNWCVQIAKGMSYL--EE 127

Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGH 264
           K +++RD  A N+L+ +  + K++DFGLA      E  +          + A E I    
Sbjct: 128 KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRI 187

Query: 265 LTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVE 301
            T   DV+S+GV + EL+T G +  E        DL+E
Sbjct: 188 YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  105 bits (264), Expect = 8e-26
 Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 12/207 (5%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA-EVIFLGQ 138
           +  R   LG+G  G VYK       +P    +  A+K + V+G +  R+ L  E+  L  
Sbjct: 2   DLERVKVLGQGSSGVVYKVR----HKP--TGKIYALKKIHVDGDEEFRKQLLRELKTLRS 55

Query: 139 LKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLA 198
            + P++V   G   ++    +V EYM  G+L D L K      P L    IA    + L 
Sbjct: 56  CESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA--YIARQILKGLD 113

Query: 199 FLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPE 258
           +LH +   +I+RD K SN+L++S    K++DFG++       D   T    GT  Y +PE
Sbjct: 114 YLHTKRH-IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV--GTVTYMSPE 170

Query: 259 YINTGHLTTMCDVFSFGVVLLELLTGR 285
            I     +   D++S G+ LLE   G+
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  103 bits (260), Expect = 3e-25
 Identities = 72/290 (24%), Positives = 116/290 (40%), Gaps = 53/290 (18%)

Query: 80  NFSRSDYLGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNG-SQGHREW-LAEVIFL 136
            +     +G+G FGKVY      D        +   +K +D++  S+  RE  L EV  L
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDG-------KLYVLKEIDLSNMSEKEREDALNEVKIL 53

Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST---------LPWLTRI 187
            +L HP+++       E     +V EY   G+L  ++ K              L W  ++
Sbjct: 54  KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKI-KKQKKEGKPFPEEQILDWFVQL 112

Query: 188 KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC 247
            +A      L +LH   + +++RD K  NI L S+   KL DFG++            T 
Sbjct: 113 CLA------LKYLH--SRKILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSSTVDLAKTV 163

Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML 307
           V GT  Y +PE           D++S G VL EL T +   E                +L
Sbjct: 164 V-GTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFE-------------GENLL 209

Query: 308 KDFTKLDQIID---SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTV 354
           +   K   I+      +  +YS+E    L  +    L  +P+ RP++  +
Sbjct: 210 ELALK---ILKGQYPPIPSQYSSE----LRNLVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  104 bits (260), Expect = 4e-25
 Identities = 68/210 (32%), Positives = 106/210 (50%), Gaps = 18/210 (8%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLV 145
           LGEG FGKVYKG +       L A +VA+K L  N   +  +E+  E   +  L+HP++V
Sbjct: 13  LGEGAFGKVYKGELT-GPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIV 71

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKN--------------YSSTLPWLTRIKIAI 191
            L+G C +++   +++EY+A G+LH+ L +N                S+L     + IAI
Sbjct: 72  CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131

Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
             A  + +L       ++RD  A N L+      K+SDFGL+ D    +   + +  +  
Sbjct: 132 QIAAGMEYLSSHH--FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLEL 281
             +  PE I  G  TT  D++SFGVVL E+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 99.5 bits (248), Expect = 9e-24
 Identities = 74/206 (35%), Positives = 102/206 (49%), Gaps = 25/206 (12%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG+V+ G  + +         VA+K L   GS     +LAE   + QL+HP LV 
Sbjct: 14  LGAGQFGEVWMGYYNGH-------TKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVR 65

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     + E   ++ EYM  G+L D L       L     I +A   A  +AF+  E K 
Sbjct: 66  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI--ERKN 122

Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG------YAAPEYI 260
            I+RD +A+NIL+      K++DFGLA      ED+  T      EG      + APE I
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLAR---LIEDNEYT----AREGAKFPIKWTAPEAI 175

Query: 261 NTGHLTTMCDVFSFGVVLLELLT-GR 285
           N G  T   DV+SFG++L E++T GR
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 98.5 bits (246), Expect = 2e-23
 Identities = 76/269 (28%), Positives = 118/269 (43%), Gaps = 32/269 (11%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLV 145
           LG G  G V K      +      + +AVK + +       ++ L E+  L +   P++V
Sbjct: 9   LGAGNSGVVSK------VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIV 62

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
              G    +    +  EYM  G+L D++ K     +P     KIA+   + L +LH + K
Sbjct: 63  GFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK 121

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
            +I+RD K SNIL++S    KL DFG++    Q  +S   T V GT  Y APE I     
Sbjct: 122 -IIHRDVKPSNILVNSRGQIKLCDFGVSG---QLVNSLAKTFV-GTSSYMAPERIQGNDY 176

Query: 266 TTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDS---RL- 321
           +   D++S G+ L+EL TGR                   P    F  L  I++    RL 
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPP-----------ENDPPDGIFELLQYIVNEPPPRLP 225

Query: 322 EDRYSTEGAKRLAAVAHQCLSHNPKSRPT 350
             ++S +         + CL  +P+ RP+
Sbjct: 226 SGKFSPD----FQDFVNLCLIKDPRERPS 250

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 97.7 bits (244), Expect = 3e-23
 Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 21/203 (10%)

Query: 87  LGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLV 145
           LGEG +G VYK    +         Q VA+KV+ V      +E + E+  L Q   P++V
Sbjct: 11  LGEGSYGSVYKAIHKETG-------QVVAIKVVPVEEDL--QEIIKEISILKQCDSPYIV 61

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI---GAARCLAFLHG 202
              G   ++    +V EY   G++ D + K  + TL   T  +IA       + L +LH 
Sbjct: 62  KYYGSYFKNTDLWIVMEYCGAGSVSD-IMKITNKTL---TEEEIAAILYQTLKGLEYLHS 117

Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT 262
            +K  I+RD KA NILL+ +  AKL+DFG++           T  V+GT  + APE I  
Sbjct: 118 NKK--IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQE 173

Query: 263 GHLTTMCDVFSFGVVLLELLTGR 285
                  D++S G+  +E+  G+
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 98.1 bits (245), Expect = 5e-23
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 20/202 (9%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           +GEG  G+VYK   D         + VA+K + +   Q     + E++ +   KHP++V+
Sbjct: 27  IGEGASGEVYK-ATDRA-----TGKEVAIKKMRLR-KQNKELIINEILIMKDCKHPNIVD 79

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC---LAFLHGE 203
                   +   +V EYM  G+L D + +N+      +   +IA         L +LH  
Sbjct: 80  YYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR----MNEPQIAYVCREVLQGLEYLHS- 134

Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTG 263
            + VI+RD K+ NILL  D + KL+DFG A    + +    +  V+GT  + APE I   
Sbjct: 135 -QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVI-KR 190

Query: 264 HL-TTMCDVFSFGVVLLELLTG 284
                  D++S G++ +E+  G
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 96.9 bits (241), Expect = 1e-22
 Identities = 80/283 (28%), Positives = 129/283 (45%), Gaps = 25/283 (8%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFLGQLKHPHLV 145
           LGEG FGKV   C D         + VAVK L     Q +   W  E+  L  L H ++V
Sbjct: 12  LGEGHFGKVSLYCYDPANDG--TGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 146 NLIGYCCEDEHR---LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKI-AIGAARCLAFLH 201
              G CC ++      L+ EY+ LG+L D L K+  +    L ++ + A      +A+LH
Sbjct: 70  KYKG-CCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLN----LAQLLLFAQQICEGMAYLH 124

Query: 202 GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG-----YAA 256
              +  I+RD  A N+LLD+D   K+ DFGLA   P+G + +        +G     + A
Sbjct: 125 S--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR----EDGDSPVFWYA 178

Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI 316
            E +     +   DV+SFGV L ELLT   S +    K E +++   +  +    +L ++
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQM-TVVRLIEL 236

Query: 317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
           ++  +         + +  +   C     K RPT  +++  L+
Sbjct: 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 96.7 bits (241), Expect = 1e-22
 Identities = 76/290 (26%), Positives = 118/290 (40%), Gaps = 30/290 (10%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL-DVNGSQGHREWLAEVIFLGQ 138
           + +    LG G FG+VY+G              VAVK L +    Q   ++L E + + +
Sbjct: 7   SITLLRALGHGAFGEVYEGLYR-GRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65

Query: 139 LKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKN-----YSSTLPWLTRIKIAIGA 193
             H ++V LIG   E   R ++ E MA G+L   L +N       S+L     +  A   
Sbjct: 66  FNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV 125

Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDS---DYNAKLSDFGLATDGPQGEDSHITTCVMG 250
           A+   +L  EE   I+RD  A N LL        AK++DFG+A D  +          M 
Sbjct: 126 AKGCKYL--EENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML 183

Query: 251 TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE-KDLVEWARPMLKD 309
              +  PE    G  T+  DV+SFGV+L E+ +        R  +E  + V         
Sbjct: 184 PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV--------- 234

Query: 310 FTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
                     RL+      G   +  +   C  H P+ RP   T+++ ++
Sbjct: 235 ------TGGGRLDPPKGCPG--PVYRIMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =   99 bits (249), Expect = 3e-22
 Identities = 90/306 (29%), Positives = 133/306 (43%), Gaps = 40/306 (13%)

Query: 73  ELQMITHNFSRS-------------DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD 119
           ELQ      S+S             + +  G  G  YKG    N       Q V  ++ D
Sbjct: 671 ELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKN-----GMQFVVKEIND 725

Query: 120 VNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSS 179
           VN         +E+  +G+L+HP++V LIG C  ++   L++EY+   NL + L      
Sbjct: 726 VNSIP-----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-----R 775

Query: 180 TLPWLTRIKIAIGAARCLAFLHGEEKP-VIYRDFKASNILLDSDYNAKLSDFGLATDGPQ 238
            L W  R KIAIG A+ L FLH    P V+  +     I++D      L    L+  G  
Sbjct: 776 NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---LSLPGLL 832

Query: 239 GEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKD 298
             D   T C + +  Y APE   T  +T   D++ FG++L+ELLTG+   +         
Sbjct: 833 CTD---TKCFISS-AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS- 887

Query: 299 LVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAA--VAHQCLSHNPKSRPTMTTVVK 356
           +VEWAR    D   LD  ID  +    S    + +    +A  C + +P +RP    V+K
Sbjct: 888 IVEWARYCYSD-CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946

Query: 357 ALEPLL 362
            LE   
Sbjct: 947 TLESAS 952

Length = 968

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 95.4 bits (238), Expect = 4e-22
 Identities = 78/294 (26%), Positives = 123/294 (41%), Gaps = 64/294 (21%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA-EVIFLGQL 139
           F+  + +G+G FG+VYK     + R     Q VA+KV+D+  ++   E +  E+ FL Q 
Sbjct: 3   FTLLECIGKGSFGEVYKAI---DKRTN---QVVAIKVIDLEEAEDEIEDIQQEIQFLSQC 56

Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI---GAARC 196
           + P++    G   +     ++ EY   G+  D L K        L    IA         
Sbjct: 57  RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGK-----LDETYIAFILREVLLG 110

Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI--TTCVMGTEGY 254
           L +LH E K  I+RD KA+NILL  + + KL+DFG++    Q   +     T V GT  +
Sbjct: 111 LEYLHEEGK--IHRDIKAANILLSEEGDVKLADFGVSG---QLTSTMSKRNTFV-GTPFW 164

Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLELLTGR------------RSVEKNRCKREKDLVEW 302
            APE I         D++S G+  +EL  G               + KN      +  ++
Sbjct: 165 MAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPS-LEGNKF 223

Query: 303 ARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
           ++P  KDF                             CL+ +PK RP+   ++K
Sbjct: 224 SKP-FKDFV--------------------------SLCLNKDPKERPSAKELLK 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 94.8 bits (236), Expect = 5e-22
 Identities = 85/284 (29%), Positives = 120/284 (42%), Gaps = 59/284 (20%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL-DVNGSQGHREWLAEVIFLGQLKHPHLV 145
           LG+G FG V +G   +    G K   VAVK L     S    ++L E   +  L H +L+
Sbjct: 3   LGDGSFGVVRRG---EWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLI 59

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            L G        ++V E   LG+L D+L K+        T    A+  A  + +L  E K
Sbjct: 60  RLYGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL--ESK 116

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITT---------CVMGTEGYAA 256
             I+RD  A NILL SD   K+ DFGL    PQ ED ++           C        A
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWC--------A 168

Query: 257 PEYINTGHLTTMCDVFSFGVVLLEL----------LTGRRSVEKNRCKREKDLVEWARPM 306
           PE + T   +   DV+ FGV L E+          L+G + ++K    +E + +E  RP 
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKK--IDKEGERLE--RP- 223

Query: 307 LKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT 350
                      ++  +D Y          V  QC +HNP  RPT
Sbjct: 224 -----------EACPQDIY---------NVMLQCWAHNPADRPT 247

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 94.1 bits (234), Expect = 8e-22
 Identities = 68/276 (24%), Positives = 120/276 (43%), Gaps = 37/276 (13%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHL 144
           +G+G FG V+K     +       +  A+K +D++    +   E + E   L +L   ++
Sbjct: 8   IGKGSFGVVFKVVRKAD------KRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLP----WLTRIKIAIGAARCLAFL 200
           +       +     +V EY   G+LH  L       LP    W   I+I +G    LA L
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAHL 117

Query: 201 HGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI 260
           H   K +++RD K+ N+ LD+  N K+ D G+A      ++++    ++GT  Y +PE  
Sbjct: 118 H--SKKILHRDIKSLNLFLDAYDNVKIGDLGVAK--LLSDNTNFANTIVGTPYYLSPELC 173

Query: 261 NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSR 320
                    DV++ GVVL E  TG+   + N    +  L+              +II   
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFDAN---NQGALIL-------------KIIRGV 217

Query: 321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                S   +++LA +  QCL+ + + RP    +++
Sbjct: 218 FPP-VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 94.3 bits (234), Expect = 9e-22
 Identities = 61/210 (29%), Positives = 111/210 (52%), Gaps = 13/210 (6%)

Query: 82  SRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLK 140
           ++   +G G FG+V++G +     PG K   VA+K L    ++  R ++L+E   +GQ  
Sbjct: 8   TKQKVIGAGEFGEVFRGILK---MPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64

Query: 141 HPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFL 200
           H +++ L G   + +  +++ EYM  G L D+  +++         + +  G A  + +L
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123

Query: 201 HGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGEDSHITTCVMGTEGYAAP 257
              +   ++RD  A NIL++S+   K+SDFGL+    D P+G  ++ T+       + AP
Sbjct: 124 --SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG--TYTTSGGKIPIRWTAP 179

Query: 258 EYINTGHLTTMCDVFSFGVVLLELLT-GRR 286
           E I     T+  DV+SFG+V+ E+++ G R
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGER 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 94.2 bits (234), Expect = 9e-22
 Identities = 70/209 (33%), Positives = 103/209 (49%), Gaps = 13/209 (6%)

Query: 86  YLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHL 144
           +LG G FG+VY+G   D L PG     VAVK L    + Q  +E+L E   +    HP++
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61

Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTL--PWLT---RIKIAIGAARCLAF 199
           V L+G C  +E + ++ E M  G+L   L          P LT    + I +  A+   +
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121

Query: 200 LHGEEKPVIYRDFKASNILL-----DSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           L  E+   I+RD  A N L+     D+D   K+ DFGLA D  + +        +    +
Sbjct: 122 L--EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179

Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLELLT 283
            APE +  G  TT  DV+SFGV++ E+LT
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 93.6 bits (233), Expect = 1e-21
 Identities = 67/199 (33%), Positives = 89/199 (44%), Gaps = 13/199 (6%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFLGQLKHPHLV 145
           +GEG FG VY+G         +    VAVK      S   RE +L E   + Q  HPH+V
Sbjct: 14  IGEGQFGDVYQGVYMSPENEKIA---VAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            LIG    +    +V E   LG L   L  N  S L   + I  +   +  LA+L    K
Sbjct: 71  KLIG-VITENPVWIVMELAPLGELRSYLQVNKYS-LDLASLILYSYQLSTALAYLES--K 126

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE--GYAAPEYINTG 263
             ++RD  A N+L+ S    KL DFGL+      ED        G     + APE IN  
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSR---YLEDESYYKASKGKLPIKWMAPESINFR 183

Query: 264 HLTTMCDVFSFGVVLLELL 282
             T+  DV+ FGV + E+L
Sbjct: 184 RFTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 93.6 bits (233), Expect = 1e-21
 Identities = 65/203 (32%), Positives = 101/203 (49%), Gaps = 18/203 (8%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG+V++G + +N  P      VAVK L   G+   +++LAE   + +L+HP L+ 
Sbjct: 14  LGAGQFGEVWEG-LWNNTTP------VAVKTLKP-GTMDPKDFLAEAQIMKKLRHPKLIQ 65

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L   C  +E   +V E M  G+L + L       L     I +A   A  +A+L  E + 
Sbjct: 66  LYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL--EAQN 123

Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINTG 263
            I+RD  A N+L+  +   K++DFGLA    +     I     G +    + APE     
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLA----RVIKEDIYEAREGAKFPIKWTAPEAALYN 179

Query: 264 HLTTMCDVFSFGVVLLELLT-GR 285
             +   DV+SFG++L E++T GR
Sbjct: 180 RFSIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 93.0 bits (231), Expect = 2e-21
 Identities = 76/283 (26%), Positives = 128/283 (45%), Gaps = 40/283 (14%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G +G+VY+G      +  L   TVAVK L  +  +   E+L E   + ++KHP+LV 
Sbjct: 14  LGGGQYGEVYEGVWK---KYSL---TVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 66

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L+G C  +    ++ E+M  GNL D L +     +  +  + +A   +  + +L  E+K 
Sbjct: 67  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL--EKKN 124

Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINTG 263
            I+RD  A N L+  ++  K++DFGL+     G+     T   G +    + APE +   
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGD---TYTAHAGAKFPIKWTAPESLAYN 180

Query: 264 HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLED 323
             +   DV++FGV+L E+ T   S                 P +     L Q+ +  LE 
Sbjct: 181 KFSIKSDVWAFGVLLWEIATYGMS---------------PYPGI----DLSQVYE-LLEK 220

Query: 324 RYSTEGAK----RLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
            Y  E  +    ++  +   C   NP  RP+   + +A E + 
Sbjct: 221 GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 92.5 bits (230), Expect = 2e-21
 Identities = 73/282 (25%), Positives = 117/282 (41%), Gaps = 39/282 (13%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDV-NGSQGHRE-WLAEVIFLG 137
           +F     LG+G +G VYK      ++     Q  A+K +D+ + SQ  RE  + E+  L 
Sbjct: 1   DFKVLKKLGKGSYGSVYK------VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILA 54

Query: 138 QLKHPHLVNLIGY--CCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRI--KIAIG 192
            + HP   N+I Y     D ++L +V EY   G+L   + K          +   +I I 
Sbjct: 55  SVNHP---NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQ 111

Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE 252
             R L  LH  E+ +++RD K++NILL ++   K+ D G++    +     +    +GT 
Sbjct: 112 LLRGLQALH--EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGTP 165

Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK 312
            Y APE       +   D++S G +L E+ T     E             AR M     K
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE-------------ARSMQDLRYK 212

Query: 313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTV 354
           + +     +   YS +    L       L   PK RP    +
Sbjct: 213 VQRGKYPPIPPIYSQD----LQNFIRSMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 92.9 bits (231), Expect = 3e-21
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 18/211 (8%)

Query: 87  LGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVL-DVNGSQGHREWLAEVIFLGQLKHPHL 144
           LGEG FGKV+ G C   +L P    + VAVK L +   +   +++  E   L   +H ++
Sbjct: 13  LGEGAFGKVFLGEC--YHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 145 VNLIGYCCEDEHRLLVYEYMALGNL---------HDQLFKNYSSTLPWLTR---IKIAIG 192
           V   G C E +  ++V+EYM  G+L              K+  S +  LT    ++IA+ 
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE 252
            A  + +L  +    ++RD    N L+  D   K+ DFG++ D    +   +    M   
Sbjct: 131 IASGMVYLASQH--FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188

Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
            +  PE I     TT  DV+SFGVVL E+ T
Sbjct: 189 RWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 93.2 bits (232), Expect = 4e-21
 Identities = 68/211 (32%), Positives = 96/211 (45%), Gaps = 32/211 (15%)

Query: 87  LGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHREWL--AEVIFLGQ 138
           LG+G FGKV     KG            +  AVKVL  DV       E     + +    
Sbjct: 3   LGKGSFGKVLLAELKG----------TDELYAVKVLKKDVILQDDDVECTMTEKRVLALA 52

Query: 139 LKHPHLVNLIGYCC--EDEHRLLVYEYMALGNL--HDQLFKNYSSTLPWLTRIKIAIGAA 194
            KHP L  L  + C    +    V EY+  G+L  H Q    +          +I +G  
Sbjct: 53  GKHPFLTQL--HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLG-- 108

Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
             L FLH  E+ +IYRD K  N+LLDS+ + K++DFG+  +G  G  +  T C  GT  Y
Sbjct: 109 --LQFLH--ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC--GTPDY 162

Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE ++        D ++ GV+L E+L G+
Sbjct: 163 IAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 92.5 bits (231), Expect = 4e-21
 Identities = 68/211 (32%), Positives = 102/211 (48%), Gaps = 21/211 (9%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQG-HREWLAEVIFLG 137
           + + + LGEG +G VYK   D         + VA+K   LD N  +G     L E+  L 
Sbjct: 1   YEKLEKLGEGTYGVVYK-ARDKK-----TGEIVALKKIRLD-NEEEGIPSTALREISLLK 53

Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIK-IAIGAARC 196
           +LKHP++V L+     +    LV+EY  + +L  +        L     IK I     R 
Sbjct: 54  ELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLK-KYLDKRPGPLS-PNLIKSIMYQLLRG 110

Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD-GPQGEDSHITTCVMGTEGYA 255
           LA+ H     +++RD K  NIL++ D   KL+DFGLA   G        T  V+ T  Y 
Sbjct: 111 LAYCH--SHRILHRDLKPQNILINRDGVLKLADFGLARAFGI--PLRTYTHEVV-TLWYR 165

Query: 256 APEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
           APE +  + H +T  D++S G +  E++TG+
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 90.8 bits (226), Expect = 1e-20
 Identities = 63/220 (28%), Positives = 91/220 (41%), Gaps = 24/220 (10%)

Query: 88  GEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHREWLAEVIFLGQLKHPHL 144
           G+G FGKV      D        +  A+K +           R  L E   L +L HP L
Sbjct: 9   GKGAFGKVCIVQKRDT------KKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFL 62

Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNY----SSTLPWLTRIKIAIGAARCLAFL 200
           VNL     ++E+  LV + +  G+L   L +           W+  I +A      L +L
Sbjct: 63  VNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLA------LEYL 116

Query: 201 HGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI 260
           H   K +I+RD K  NILLD   +  ++DF +AT         +TT   GT GY APE +
Sbjct: 117 H--SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVL 171

Query: 261 NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV 300
                +   D +S GV   E L G+R    +       + 
Sbjct: 172 CRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR 211

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 89.2 bits (221), Expect = 4e-20
 Identities = 68/218 (31%), Positives = 106/218 (48%), Gaps = 23/218 (10%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHREWLAEVIFLGQLKHPHL 144
           +GEG FG V +G            Q VAVK +  DV      + +L E   + +L H +L
Sbjct: 14  IGEGEFGAVLQG--------EYTGQKVAVKNIKCDVTA----QAFLEETAVMTKLHHKNL 61

Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           V L+G    +    +V E M+ GNL + L     + +  +  ++ ++  A  + +L  E 
Sbjct: 62  VRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL--ES 118

Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGH 264
           K +++RD  A NIL+  D  AK+SDFGLA  G  G D+           + APE +    
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-----KWTAPEALKHKK 173

Query: 265 LTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVE 301
            ++  DV+S+GV+L E+ + GR    K   K  K+ VE
Sbjct: 174 FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE 211

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 90.1 bits (223), Expect = 4e-20
 Identities = 69/217 (31%), Positives = 112/217 (51%), Gaps = 29/217 (13%)

Query: 85  DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG-HREWLAEVIFLGQL-KHP 142
           D +GEG FG+V +  +    + GLK    A+K+L    S+  HR++  E+  L +L  HP
Sbjct: 8   DVIGEGNFGQVIRAMIK---KDGLK-MNAAIKMLKEFASENDHRDFAGELEVLCKLGHHP 63

Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKN--------------YSSTLPWLTRIK 188
           +++NL+G C    +  +  EY   GNL D L K+               +STL     ++
Sbjct: 64  NIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123

Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
            A   A  + +L   EK  I+RD  A N+L+  +  +K++DFGL+    +GE+ ++    
Sbjct: 124 FASDVATGMQYL--SEKQFIHRDLAARNVLVGENLASKIADFGLS----RGEEVYVKK-T 176

Query: 249 MG--TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           MG     + A E +N    TT  DV+SFGV+L E+++
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 88.8 bits (221), Expect = 7e-20
 Identities = 74/282 (26%), Positives = 116/282 (41%), Gaps = 52/282 (18%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWL-AEVIFLGQLKHPHL 144
           +G+G FG V K      +R     + +  K +D    ++  ++ L +EV  L +LKHP++
Sbjct: 8   IGKGSFGTVRK------VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61

Query: 145 VNLIGYCCEDEHRL---------LVYEYMALGNLHDQLFKNYSST---LP----WLTRIK 188
           V    Y      R+         +V EY   G+L  QL +        +     W    +
Sbjct: 62  V---RYY----DRIIDRSNQTLYIVMEYCEGGDL-AQLIQKCKKERKYIEEEFIWRILTQ 113

Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
           + +    C          V++RD K +NI LD++ N KL DFGLA        S   T V
Sbjct: 114 LLLALYECHNRSDPGNT-VLHRDLKPANIFLDANNNVKLGDFGLAKILGHD-SSFAKTYV 171

Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
            GT  Y +PE +N        D++S G ++ EL                     AR  L+
Sbjct: 172 -GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT-------------ARNQLQ 217

Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT 350
             +K+ +    R+  RYS+E    L  V    L+ +P  RP+
Sbjct: 218 LASKIKEGKFRRIPYRYSSE----LNEVIKSMLNVDPDKRPS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 88.3 bits (219), Expect = 8e-20
 Identities = 66/206 (32%), Positives = 95/206 (46%), Gaps = 8/206 (3%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           N+ R   LG+G FG+VY  C D +    L  + V          +       E+  L  L
Sbjct: 3   NWRRGKLLGQGAFGRVYL-CYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAF 199
           +H  +V   G   +DE   +  EYM  G++ DQL K Y +    +TR K        + +
Sbjct: 62  QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTR-KYTRQILEGVEY 119

Query: 200 LHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHIT--TCVMGTEGYAAP 257
           LH     +++RD K +NIL DS  N KL DFG A+   Q   S  T    V GT  + +P
Sbjct: 120 LHSNM--IVHRDIKGANILRDSAGNVKLGDFG-ASKRLQTICSSGTGMKSVTGTPYWMSP 176

Query: 258 EYINTGHLTTMCDVFSFGVVLLELLT 283
           E I+        DV+S G  ++E+LT
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 88.9 bits (221), Expect = 8e-20
 Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 22/217 (10%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQT----------VAVKVLDVNGSQGHR-EWLAEVIF 135
           LGEG FG+V+    D       KA            VAVKVL  + S   R ++L EV  
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72

Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLH---------DQLFKNYSSTLPWLTR 186
           L +L  P++  L+G C  D    ++ EYM  G+L+                S +L + T 
Sbjct: 73  LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132

Query: 187 IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITT 246
           + +A   A  + +L  E    ++RD    N L+  +Y  K++DFG++ +    +   +  
Sbjct: 133 LYMATQIASGMRYL--ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQG 190

Query: 247 CVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
                  + A E +  G  TT  DV++FGV L E+LT
Sbjct: 191 RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 88.8 bits (221), Expect = 9e-20
 Identities = 61/233 (26%), Positives = 94/233 (40%), Gaps = 40/233 (17%)

Query: 79  HNFSRSDYLGEGGFGKVYKGC-VDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVI 134
            +F     +GEG F  V      + N       +  A+K+LD   +   +  +    E  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETN-------KEYAIKILDKRQLIKEKKVKYVKIEKE 53

Query: 135 FLGQLK-HPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRI--KIA 190
            L +L  HP ++ L  Y  +DE  L  V EY   G L   + K  S           +I 
Sbjct: 54  VLTRLNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEIL 112

Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-----TDGPQGEDSHIT 245
           +     L +LH   K +I+RD K  NILLD D + K++DFG A        P+      T
Sbjct: 113 LA----LEYLHS--KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166

Query: 246 TCVM-------------GTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
                            GT  Y +PE +N        D+++ G ++ ++LTG+
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 88.9 bits (220), Expect = 9e-20
 Identities = 73/226 (32%), Positives = 103/226 (45%), Gaps = 38/226 (16%)

Query: 87  LGEGGFGKVYKGCVDD-NLRPGLKAQTVAVKVLDVNGSQGH-REWLAEVIFLGQLKHPHL 144
           LGEG FGKV K        R G    TVAVK+L  N S    R+ L+E   L Q+ HPH+
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYT--TVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLH----------------------DQLFKNYSSTLP 182
           + L G C +D   LL+ EY   G+L                         L       L 
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 183 WLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS 242
               I  A   +R + +L   E  +++RD  A N+L+      K+SDFGL+ D  + EDS
Sbjct: 126 MGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE-EDS 182

Query: 243 HITTCVMGTEG-----YAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           ++      ++G     + A E +     TT  DV+SFGV+L E++T
Sbjct: 183 YVKR----SKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 87.7 bits (217), Expect = 1e-19
 Identities = 70/203 (34%), Positives = 104/203 (51%), Gaps = 24/203 (11%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHREWLAEVIFLGQLKHPHL 144
           LG G FG V KG      +     +TVAVK+L  D N      E L E   + QL +P++
Sbjct: 3   LGSGNFGTVKKGM----YKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYI 58

Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRI--KIAIGAARCLAFLHG 202
           V +IG  CE E  +LV E   LG L+  L KN   T   +T +  ++++G    + +L  
Sbjct: 59  VRMIG-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMG----MKYL-- 111

Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG-----YAAP 257
           EE   ++RD  A N+LL + + AK+SDFGL+      E+ +       T G     + AP
Sbjct: 112 EETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK----THGKWPVKWYAP 167

Query: 258 EYINTGHLTTMCDVFSFGVVLLE 280
           E +N    ++  DV+SFGV++ E
Sbjct: 168 ECMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 88.4 bits (220), Expect = 1e-19
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 20/213 (9%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN----GSQG-HREWLAEVI 134
            + +   LGEG +  VYK    +        + VA+K + +        G +   L E+ 
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKET------GRIVAIKKIKLGERKEAKDGINFTALREIK 54

Query: 135 FLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIK-IAIGA 193
            L +LKHP+++ L+       +  LV+E+M   +L +++ K+ S  L     IK   +  
Sbjct: 55  LLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDL-EKVIKDKSIVLT-PADIKSYMLMT 111

Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
            R L +LH     +++RD K +N+L+ SD   KL+DFGLA     G  +   T  + T  
Sbjct: 112 LRGLEYLH--SNWILHRDLKPNNLLIASDGVLKLADFGLARS--FGSPNRKMTHQVVTRW 167

Query: 254 YAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE +    H     D++S G +  ELL   
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 88.1 bits (218), Expect = 1e-19
 Identities = 82/287 (28%), Positives = 127/287 (44%), Gaps = 38/287 (13%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLV 145
           LG+G FG VY+G   D ++ G     VAVK ++ + S   R E+L E   +      H+V
Sbjct: 14  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLF-------KNYSSTLPWLTR-IKIAIGAARCL 197
            L+G   + +  L+V E MA G+L   L         N     P L   I++A   A  +
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG---- 253
           A+L+   K  ++RD  A N ++  D+  K+ DFG+  D  + +         G +G    
Sbjct: 133 AYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR-----KGGKGLLPV 185

Query: 254 -YAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK 312
            + APE +  G  TT  D++SFGVVL E+ +               L E     L +   
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQV 230

Query: 313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
           L  ++D    D+      +R+  +   C   NPK RPT   +V  L+
Sbjct: 231 LKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 87.8 bits (218), Expect = 1e-19
 Identities = 82/292 (28%), Positives = 118/292 (40%), Gaps = 65/292 (22%)

Query: 83  RSDYLGEGGFGKVYKGC-VDDNLRPGLKAQTVAVKVLDVNGSQG--HREWLAEVIFLGQL 139
           R + +G G FGKVY    +D         + +AVK + +  +     +E   E+  L  L
Sbjct: 4   RGNKIGGGTFGKVYTAVNLDTG-------ELMAVKEIRIQDNDPKTIKEIADEMKVLELL 56

Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAF 199
           KHP+LV   G     E   +  EY + G L + L   +   L         +     LA+
Sbjct: 57  KHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELL--EHGRILDEHVIRVYTLQLLEGLAY 114

Query: 200 LHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA--------TDGPQGEDSHITTCVMGT 251
           LH     +++RD K +NI LD +   KL DFG A        T G + +       + GT
Sbjct: 115 LH--SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS------LAGT 166

Query: 252 EGYAAPEYI----NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA---- 303
             Y APE I      GH     D++S G V+LE+ TG+R         E D  E+     
Sbjct: 167 PAYMAPEVITGGKGKGHGRAA-DIWSLGCVVLEMATGKRPWS------ELD-NEFQIMFH 218

Query: 304 -----RPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT 350
                +P + D              + S EG   L     +CL  +PK RPT
Sbjct: 219 VGAGHKPPIPD------------SLQLSPEGKDFLD----RCLESDPKKRPT 254

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 87.8 bits (217), Expect = 2e-19
 Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 23/203 (11%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG+V+ G  +++ +       VAVK L   G+   + +L E   +  L+H  LV 
Sbjct: 14  LGAGQFGEVWMGYYNNSTK-------VAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVR 65

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     ++E   ++ EYMA G+L D L  +    +     I  +   A  +A++  E K 
Sbjct: 66  LYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI--ERKN 123

Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG------YAAPEYI 260
            I+RD +A+N+L+      K++DFGLA      ED+  T      EG      + APE I
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLAR---VIEDNEYT----AREGAKFPIKWTAPEAI 176

Query: 261 NTGHLTTMCDVFSFGVVLLELLT 283
           N G  T   DV+SFG++L E++T
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 88.1 bits (218), Expect = 2e-19
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 22/214 (10%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLK-AQTVAVKVL-DVNGSQGHREWLAEVIFLGQLKHPHL 144
           LGE  FGK+YKG +     PG+  AQ VA+K L D+N  Q   E+  E   + +L HP++
Sbjct: 13  LGECAFGKIYKGHL---YLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNI 69

Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFK---------------NYSSTLPWLTRIKI 189
           V L+G   +++   +++EY+  G+LH+ L                    S+L     + I
Sbjct: 70  VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129

Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM 249
           AI  A  + +L       +++D  A NIL+    + K+SD GL+ +    +   +    +
Sbjct: 130 AIQIAAGMEYLSSHF--FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 250 GTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
               +  PE I  G  ++  D++SFGVVL E+ +
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 87.9 bits (218), Expect = 2e-19
 Identities = 86/306 (28%), Positives = 131/306 (42%), Gaps = 63/306 (20%)

Query: 87  LGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK----H 141
           LGEG FG+V K   V  +     +  TVAVK+L  + ++  ++    V  +  +K    H
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPN--ETSTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKH 75

Query: 142 PHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKN------YSSTLPWLTRIKI------ 189
            +++NL+G C ++    +V EY A GNL D L          S   P      +      
Sbjct: 76  KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135

Query: 190 --AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC 247
             A   AR + FL    K  I+RD  A N+L+  D+  K++DFGLA D       HI   
Sbjct: 136 SFAYQVARGMEFL--ASKKCIHRDLAARNVLVTEDHVMKIADFGLARD-----IHHIDYY 188

Query: 248 VMGTEG-----YAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS------VEKNRCKRE 296
              T G     + APE +     T   DV+SFGV+L E+ T   S      VE+      
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE------ 242

Query: 297 KDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
             L +    +LK+  ++++  +   E          L  +   C    P  RPT   +V+
Sbjct: 243 --LFK----LLKEGYRMEKPQNCTQE----------LYHLMRDCWHEVPSQRPTFKQLVE 286

Query: 357 ALEPLL 362
            L+ +L
Sbjct: 287 DLDRML 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 87.0 bits (215), Expect = 2e-19
 Identities = 77/278 (27%), Positives = 124/278 (44%), Gaps = 42/278 (15%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           +G+G FG V  G          +   VAVK +  + +   + +LAE   + QL+H +LV 
Sbjct: 14  IGKGEFGDVMLG--------DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 63

Query: 147 LIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
           L+G   E++  L +V EYMA G+L D L     S L     +K ++     + +L  E  
Sbjct: 64  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EAN 121

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
             ++RD  A N+L+  D  AK+SDFGL  +    +D+           + APE +     
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREKKF 176

Query: 266 TTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRY 325
           +T  DV+SFG++L E+ +  R             V + R  LKD       +  R+E  Y
Sbjct: 177 STKSDVWSFGILLWEIYSFGR-------------VPYPRIPLKD-------VVPRVEKGY 216

Query: 326 STEGAKRLAAVAH----QCLSHNPKSRPTMTTVVKALE 359
             +       V +    QC   +  +RP+   + + LE
Sbjct: 217 KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 87.2 bits (216), Expect = 2e-19
 Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 18/220 (8%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFLGQLKHPH 143
           LG+GGFG+V   C     +     +  A K LD   +   +G +  L E   L ++    
Sbjct: 1   LGKGGFGEVC-AC-----QVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF 54

Query: 144 LVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR-CLAFLH 201
           +V+L  Y  E +  L LV   M  G+L    +  Y+   P     +    AA+      H
Sbjct: 55  IVSL-AYAFETKDDLCLVMTLMNGGDLK---YHIYNVGEPGFPEARAIFYAAQIICGLEH 110

Query: 202 GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN 261
             ++ ++YRD K  N+LLD   N ++SD GLA +   G+         GT GY APE + 
Sbjct: 111 LHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVLQ 167

Query: 262 TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVE 301
                   D F+ G  L E++ GR    + + K EK+ ++
Sbjct: 168 GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 87.2 bits (216), Expect = 2e-19
 Identities = 72/286 (25%), Positives = 126/286 (44%), Gaps = 38/286 (13%)

Query: 87  LGEGGFGKVYKGCVDDNLR-PGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHL 144
           +G G FG+V +G     L+ PG +   VA+K L    + +  R++L+E   +GQ  HP++
Sbjct: 12  IGAGEFGEVCRG----RLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67

Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           ++L G   +    +++ E+M  G L D   +        +  + +  G A  + +L   E
Sbjct: 68  IHLEGVVTKSRPVMIITEFMENGAL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYL--SE 124

Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYIN 261
              ++RD  A NIL++S+   K+SDFGL+            T  +G +    + APE I 
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184

Query: 262 TGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSR 320
               T+  DV+S+G+V+ E+++ G R               W      D +  D I  + 
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERPY-------------W------DMSNQDVI--NA 223

Query: 321 LEDRYSTEGAKRLAAVAHQ----CLSHNPKSRPTMTTVVKALEPLL 362
           +E  Y            HQ    C   +  +RP    +V  L+ ++
Sbjct: 224 IEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 86.7 bits (215), Expect = 3e-19
 Identities = 71/284 (25%), Positives = 116/284 (40%), Gaps = 52/284 (18%)

Query: 87  LGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHP 142
           LG G FG V    ++G +D           VA+K++   G+    +++ E   + +L HP
Sbjct: 12  LGSGQFGVVHLGKWRGKID-----------VAIKMIR-EGAMSEDDFIEEAKVMMKLSHP 59

Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR--CLAFL 200
           +LV L G C +     +V EYMA G L      NY          +  +      C A  
Sbjct: 60  NLVQLYGVCTKQRPIFIVTEYMANGCL-----LNYLRERKGKLGTEWLLDMCSDVCEAME 114

Query: 201 HGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGEDSHITTCVMGTE---GY 254
           + E    I+RD  A N L+  D   K+SDFGLA    D     D +  T   GT+    +
Sbjct: 115 YLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD-----DQY--TSSQGTKFPVKW 167

Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD 314
           A PE  +    ++  DV+SFGV++ E+ +  +   +     E  +VE    +   + +L 
Sbjct: 168 APPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVE---SVSAGY-RLY 221

Query: 315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL 358
           +                 +  + + C    P+ RP    ++  L
Sbjct: 222 R----------PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 86.7 bits (214), Expect = 4e-19
 Identities = 70/217 (32%), Positives = 112/217 (51%), Gaps = 29/217 (13%)

Query: 85  DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG-HREWLAEVIFLGQL-KHP 142
           D +GEG FG+V K  +    + GL+    A+K +    S+  HR++  E+  L +L  HP
Sbjct: 1   DVIGEGNFGQVLKARIK---KDGLR-MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 56

Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKN--------------YSSTLPWLTRIK 188
           +++NL+G C    +  L  EY   GNL D L K+               +STL     + 
Sbjct: 57  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116

Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
            A   AR + +L   +K  I+RD  A NIL+  +Y AK++DFGL+    +G++ ++    
Sbjct: 117 FAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVYVKK-T 169

Query: 249 MG--TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           MG     + A E +N    TT  DV+S+GV+L E+++
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 85.9 bits (213), Expect = 5e-19
 Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 25/208 (12%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGH---REWLAEVIFLGQLKH 141
           LG G FG VY+G   D+          AVK   L  +G  G    ++   E+  L +L+H
Sbjct: 8   LGSGSFGSVYEGLNLDD------GDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH 61

Query: 142 PHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWL---TRIKIAIGAARCLA 198
           P++V  +G   E+++  +  E +  G+L   L K  S   P +   TR +I +G    L 
Sbjct: 62  PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILLG----LE 116

Query: 199 FLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPE 258
           +LH   +  ++RD K +NIL+D++   KL+DFG+A    Q  +        G+  + APE
Sbjct: 117 YLHD--RNTVHRDIKGANILVDTNGVVKLADFGMAK---QVVEFSFAKSFKGSPYWMAPE 171

Query: 259 YIN-TGHLTTMCDVFSFGVVLLELLTGR 285
            I   G      D++S G  +LE+ TG+
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 86.8 bits (215), Expect = 6e-19
 Identities = 70/203 (34%), Positives = 98/203 (48%), Gaps = 26/203 (12%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREW---LAEVIFLGQLKHPH 143
           +G G FG VY        R     + VA+K +  +G Q + +W   + EV FL QL+HP+
Sbjct: 23  IGHGSFGAVYFA------RDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 144 LVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
            +   G C   EH   LV EY  LG+  D + + +   L  +    I  GA + LA+LH 
Sbjct: 77  TIEYKG-CYLREHTAWLVMEY-CLGSASD-ILEVHKKPLQEVEIAAICHGALQGLAYLHS 133

Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLAT-DGPQGEDSHITTCVMGTEGYAAPEYI- 260
            E+  I+RD KA NILL      KL+DFG A+   P           +GT  + APE I 
Sbjct: 134 HER--IHRDIKAGNILLTEPGTVKLADFGSASLVSP-------ANSFVGTPYWMAPEVIL 184

Query: 261 --NTGHLTTMCDVFSFGVVLLEL 281
             + G      DV+S G+  +EL
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 86.0 bits (213), Expect = 6e-19
 Identities = 75/281 (26%), Positives = 115/281 (40%), Gaps = 27/281 (9%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHREWLAEVIFLGQLKHPH 143
           LG G FG+V+          G +   V VK L        Q   E+  E+    +L H +
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGE-TLVLVKALQKTKDENLQ--SEFRRELDMFRKLSHKN 69

Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYS-----STLPWLTRIKIAIGAARCLA 198
           +V L+G C E E   ++ EY  LG+L   L    S        P  T+ K+A+     L 
Sbjct: 70  VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129

Query: 199 FLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPE 258
             H      ++RD  A N L+ S    K+S   L+ D    E   +   ++    + APE
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR-WLAPE 188

Query: 259 YINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIID 318
            +     +T  DV+SFGV++ E+ T                 E     L D   L+++  
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT---------------QGELPFYGLSDEEVLNRLQA 233

Query: 319 SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
            +LE         RL  +  +C + NPK RP+ + +V AL 
Sbjct: 234 GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 86.2 bits (213), Expect = 9e-19
 Identities = 70/219 (31%), Positives = 112/219 (51%), Gaps = 33/219 (15%)

Query: 85  DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL-KHPH 143
           D +GEG FG+V K  +    + GL+      ++ +      HR++  E+  L +L  HP+
Sbjct: 13  DVIGEGNFGQVLKARIK---KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 69

Query: 144 LVNLIGYCCEDEHRLLVY---EYMALGNLHDQLFKN--------------YSSTLPWLTR 186
           ++NL+G C   EHR  +Y   EY   GNL D L K+               +STL     
Sbjct: 70  IINLLGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 187 IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITT 246
           +  A   AR + +L   +K  I+RD  A NIL+  +Y AK++DFGL+    +G++ ++  
Sbjct: 127 LHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVYVKK 180

Query: 247 CVMG--TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
             MG     + A E +N    TT  DV+S+GV+L E+++
Sbjct: 181 -TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 85.9 bits (213), Expect = 1e-18
 Identities = 63/209 (30%), Positives = 87/209 (41%), Gaps = 27/209 (12%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDV-NGSQGHREWLAEVIFLGQLKHPHLV 145
           LGEG  G V K C   N          A+K +         ++ L E+      K P++V
Sbjct: 9   LGEGAGGSVTK-CRLKN-----TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIV 62

Query: 146 NLIGYCCEDEHRLLVY---EYMALGNLHDQLFKNYSSTLPWLTRI------KIAIGAARC 196
              G    DE    +    EY   G+L D ++K          RI      KIA    + 
Sbjct: 63  KYYG-AFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRG---GRIGEKVLGKIAESVLKG 117

Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L++LH   + +I+RD K SNILL      KL DFG++ +         T    GT  Y A
Sbjct: 118 LSYLH--SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSFYMA 171

Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           PE I     +   DV+S G+ LLE+   R
Sbjct: 172 PERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 40/216 (18%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FGKVYK     +   GL A   A K++ +   +   +++ E+  L + KHP++V 
Sbjct: 13  LGDGAFGKVYKA---QHKETGLFA---AAKIIQIESEEELEDFMVEIDILSECKHPNIVG 66

Query: 147 LIGYCCEDEHRLLVYEYM---ALGNLHDQLFKNYSSTLPWLTRIKIA-IGAARC--LAFL 200
           L      +    ++ E+    AL ++  +L +        LT  +I  +       L FL
Sbjct: 67  LYEAYFYENKLWILIEFCDGGALDSIMLELERG-------LTEPQIRYVCRQMLEALNFL 119

Query: 201 HGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGEDSHITTCVMGTEGYAAP 257
           H     VI+RD KA NILL  D + KL+DFG++       Q  D+ I     GT  + AP
Sbjct: 120 H--SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-----GTPYWMAP 172

Query: 258 EYINTGHLTTM--------CDVFSFGVVLLELLTGR 285
           E +      T          D++S G+ L+EL    
Sbjct: 173 EVVAC---ETFKDNPYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 77/275 (28%), Positives = 120/275 (43%), Gaps = 38/275 (13%)

Query: 81  FSRSDYLGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA-EVIFLGQ 138
           + R + +G G +G VY+G  V          + VA+K+++++        +  EV  L Q
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTG-------RVVALKIINLDTPDDDVSDIQREVALLSQ 55

Query: 139 LKHPHLVNLIGY--CCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
           L+     N+  Y        RL ++ EY   G++   L K       +++ I   +  A 
Sbjct: 56  LRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVR-TLMKAGPIAEKYISVIIREVLVA- 113

Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L ++H  +  VI+RD KA+NIL+ +  N KL DFG+A    Q      T   +GT  + 
Sbjct: 114 -LKYIH--KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWM 168

Query: 256 APEYINTGHL-TTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD 314
           APE I  G    T  D++S G+ + E+ TG          R   L+  ++P         
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP--------- 219

Query: 315 QIIDSRLEDR-YSTEGAKRLAAVAHQCLSHNPKSR 348
                RLED  YS    + +AA    CL   PK R
Sbjct: 220 ----PRLEDNGYSKLLREFVAA----CLDEEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 84.5 bits (209), Expect = 2e-18
 Identities = 78/301 (25%), Positives = 127/301 (42%), Gaps = 59/301 (19%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE---WLAEVIFLGQLKHPH 143
           LGEG FG V +G +    +       VAVK + ++    + E   +L+E   +    HP+
Sbjct: 7   LGEGEFGSVMEGQLS---QDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPN 62

Query: 144 LVNLIGYCCEDEHR------LLVYEYMALGNLHDQLFKNYSST------LPWLTRIKIAI 191
           ++ LIG C E          +++  +M  G+LH  L   YS        LP  T +K  +
Sbjct: 63  VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL--YSRLGGLPEKLPLQTLLKFMV 120

Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT---DGP---QGEDSHIT 245
             A  + +L    +  I+RD  A N +L  D    ++DFGL+     G    QG  + + 
Sbjct: 121 DIALGMEYL--SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 178

Query: 246 TCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS----VEKNRCKREKDLVE 301
              +  E  A   Y      T+  DV++FGV + E+ T  ++    VE +          
Sbjct: 179 VKWIAIESLADRVY------TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYD------ 226

Query: 302 WARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL 361
                L+   +L Q  D  L++ Y          + + C   +PK RPT T + + LE +
Sbjct: 227 ----YLRHGNRLKQPEDC-LDELY---------DLMYSCWRADPKDRPTFTKLREVLENI 272

Query: 362 L 362
           L
Sbjct: 273 L 273

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 84.9 bits (211), Expect = 2e-18
 Identities = 62/226 (27%), Positives = 97/226 (42%), Gaps = 48/226 (21%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDV-NGSQGH-REWLAEVIFLGQ 138
           + +   +GEG +G+VYK     N + G   + VA+K + + N  +G     + E+  L +
Sbjct: 1   YEKIAQIGEGTYGQVYKA---RNKKTG---ELVALKKIRMENEKEGFPITAIREIKLLQK 54

Query: 139 LKHPHLVNLIGYCCEDEHR--LLVYEYMA--LGNLHDQLFKNYSSTLPWLTRIKIAIGAA 194
           L+HP++V L             +V+EYM   L  L D               +K      
Sbjct: 55  LRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDS------------PEVKFTESQI 102

Query: 195 RC--------LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITT 246
           +C        L +LH     +++RD K SNIL+++D   KL+DFGLA       +S   T
Sbjct: 103 KCYMKQLLEGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYT 159

Query: 247 CVMGTEGYAAPE-------YINTGHLTTMCDVFSFGVVLLELLTGR 285
             + T  Y  PE       Y          D++S G +L EL  G+
Sbjct: 160 NRVITLWYRPPELLLGATRY------GPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 84.3 bits (209), Expect = 2e-18
 Identities = 63/218 (28%), Positives = 94/218 (43%), Gaps = 30/218 (13%)

Query: 84  SDY-----LGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGSQGH-REWLAEVIFL 136
            DY     +G G    VY   C+ +N       + VA+K +D+   Q    E   EV  +
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNN-------EKVAIKRIDLEKCQTSVDELRKEVQAM 53

Query: 137 GQLKHPHLVNLIGYCC---EDEHRLLVYEYMALGNLHDQL-FKNYSSTLPWLTRIKIAIG 192
            Q  HP   N++ Y       +   LV  Y++ G+L D +        L       +   
Sbjct: 54  SQCNHP---NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKE 110

Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFG----LATDGPQGEDSHITTCV 248
             + L +LH   +  I+RD KA NILL  D + K++DFG    LA  G +      T   
Sbjct: 111 VLKGLEYLHSNGQ--IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT--F 166

Query: 249 MGTEGYAAPEYINTGH-LTTMCDVFSFGVVLLELLTGR 285
           +GT  + APE +   H      D++SFG+  +EL TG 
Sbjct: 167 VGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 84.1 bits (208), Expect = 3e-18
 Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 34/223 (15%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLV 145
           +G+G FG+V++      L P      VAVK+L    S     ++  E   + +  HP++V
Sbjct: 13  IGQGAFGRVFQARAP-GLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIV 71

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTR------------------- 186
            L+G C   +   L++EYMA G+L++ L          L+                    
Sbjct: 72  KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131

Query: 187 -IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL-----ATDGPQGE 240
            + IA   A  +A+L   E+  ++RD    N L+  +   K++DFGL     + D  +  
Sbjct: 132 QLCIAKQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 241 DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           ++           +  PE I     TT  DV+++GVVL E+ +
Sbjct: 190 ENDAIPI-----RWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 83.9 bits (207), Expect = 4e-18
 Identities = 77/278 (27%), Positives = 126/278 (45%), Gaps = 33/278 (11%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA-EVIFLGQL 139
           F++ + +G+G FG+VYKG +D+  +     + VA+K++D+  ++   E +  E+  L Q 
Sbjct: 6   FTKLERIGKGSFGEVYKG-IDNRTK-----EVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59

Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAF 199
             P++    G   +     ++ EY+  G+  D L K       ++  I   I   + L +
Sbjct: 60  DSPYITRYYGSYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREI--LKGLDY 116

Query: 200 LHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHIT-TCVMGTEGYAAPE 258
           LH E K  I+RD KA+N+LL    + KL+DFG+A    Q  D+ I     +GT  + APE
Sbjct: 117 LHSERK--IHRDIKAANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPE 171

Query: 259 YINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIID 318
            I         D++S G+  +EL  G          R   L+    P             
Sbjct: 172 VIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP------------- 218

Query: 319 SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
             LE +YS    K        CL+ +P+ RPT   ++K
Sbjct: 219 PTLEGQYS----KPFKEFVEACLNKDPRFRPTAKELLK 252

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 83.5 bits (206), Expect = 4e-18
 Identities = 68/282 (24%), Positives = 123/282 (43%), Gaps = 38/282 (13%)

Query: 82  SRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKH 141
           +    +G G FG V+ G         L+ + VA+K +   G+    +++ E   + +L H
Sbjct: 7   TLVQEIGSGQFGLVWLGY-------WLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSH 58

Query: 142 PHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLH 201
           P LV L G C E     LV+E+M  G L D L +         T + + +     +A+L 
Sbjct: 59  PKLVQLYGVCTERSPICLVFEFMEHGCLSDYL-RAQRGKFSQETLLGMCLDVCEGMAYL- 116

Query: 202 GEEKPVIYRDFKASNILLDSDYNAKLSDFGLA--TDGPQGEDSHITTCVMGTE---GYAA 256
            E   VI+RD  A N L+  +   K+SDFG+       Q   S       GT+    +++
Sbjct: 117 -ESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST------GTKFPVKWSS 169

Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI 316
           PE  +    ++  DV+SFGV++ E+ +  ++  +NR   E         +++      ++
Sbjct: 170 PEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---------VVETINAGFRL 220

Query: 317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL 358
              RL        ++ +  +   C    P+ RP+ + ++  L
Sbjct: 221 YKPRL-------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 84.3 bits (208), Expect = 4e-18
 Identities = 68/201 (33%), Positives = 94/201 (46%), Gaps = 22/201 (10%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREW---LAEVIFLGQLKHPH 143
           +G G FG VY              + VAVK +  +G Q + +W   + EV FL QLKHP+
Sbjct: 29  IGHGSFGAVYFATNSHT------NEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE 203
            +   G   ++    LV EY  LG+  D L + +   L  +    I  GA + LA+LH  
Sbjct: 83  TIEYKGCYLKEHTAWLVMEY-CLGSASD-LLEVHKKPLQEVEIAAITHGALQGLAYLHSH 140

Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI--- 260
               I+RD KA NILL      KL+DFG A+       S      +GT  + APE I   
Sbjct: 141 NM--IHRDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFVGTPYWMAPEVILAM 192

Query: 261 NTGHLTTMCDVFSFGVVLLEL 281
           + G      DV+S G+  +EL
Sbjct: 193 DEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 83.5 bits (206), Expect = 5e-18
 Identities = 65/215 (30%), Positives = 93/215 (43%), Gaps = 26/215 (12%)

Query: 87  LGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLV 145
           LGEG FGKV+   C   NL P      VAVK L        +++  E   L  L+H H+V
Sbjct: 13  LGEGAFGKVFLAEC--HNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIV 70

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSS----------------TLPWLTRIKI 189
              G C E    L+V+EYM  G+L ++  +++                  TL  +  I  
Sbjct: 71  RFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129

Query: 190 AIGAARC-LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
            I +    LA LH      ++RD    N L+      K+ DFG++ D    +   +    
Sbjct: 130 QIASGMVYLASLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 184

Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           M    +  PE I     TT  D++SFGVVL E+ T
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 83.5 bits (207), Expect = 5e-18
 Identities = 75/292 (25%), Positives = 109/292 (37%), Gaps = 50/292 (17%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVK-VLDVNGSQG-HREWLAEVIFLGQLKHPHL 144
           +GEG +G V K C +         + VA+K   +    +   +  L EV  L QL+H ++
Sbjct: 9   VGEGAYGVVLK-CRNKA-----TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENI 62

Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           VNL           LV+EY+    L + L +     LP            + +A+ H   
Sbjct: 63  VNLKEAFRRKGRLYLVFEYVE-RTLLELL-EASPGGLPPDAVRSYIWQLLQAIAYCHS-- 118

Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPE----YI 260
             +I+RD K  NIL+      KL DFG A        S +T  V  T  Y APE      
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLVGDT 177

Query: 261 NTGHLTTMCDVFSFGVVLLELLTGR-----RSVEKNRCKREKDLVEWARPMLKDFTKLDQ 315
           N G      DV++ G ++ ELL G       S        + D +   +  L       Q
Sbjct: 178 NYG---KPVDVWAIGCIMAELLDGEPLFPGDS--------DIDQLYLIQKCLGPLPPSHQ 226

Query: 316 II---DSR--------------LEDRYSTEGAKRLAAVAHQCLSHNPKSRPT 350
            +   + R              LE RY  + +         CL  +PK R T
Sbjct: 227 ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT 278

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 82.7 bits (205), Expect = 7e-18
 Identities = 68/210 (32%), Positives = 96/210 (45%), Gaps = 31/210 (14%)

Query: 90  GGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-----WLAEVIFLGQLKHPHL 144
           G +G+V+        +        A+KV  +  +   R+      L E   L Q + P++
Sbjct: 4   GAYGRVFLA------KKKSTGDIYAIKV--IKKADMIRKNQVDQVLTERDILSQAQSPYV 55

Query: 145 VNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA-IGAARCLAFLHG 202
           V L  Y  + +  L LV EY+  G+L   L +N  S    + RI IA I  A  L +LH 
Sbjct: 56  VKLY-YSFQGKKNLYLVMEYLPGGDLA-SLLENVGSLDEDVARIYIAEIVLA--LEYLHS 111

Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGE-------DSHITTCVMGTEGYA 255
               +I+RD K  NIL+DS+ + KL+DFGL+  G           +      V GT  Y 
Sbjct: 112 NG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPDYI 168

Query: 256 APEYI-NTGHLTTMCDVFSFGVVLLELLTG 284
           APE I   GH  T  D +S G +L E L G
Sbjct: 169 APEVILGQGHSKT-VDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 82.7 bits (204), Expect = 8e-18
 Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 13/204 (6%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFLGQLKHPHLV 145
           LG G FG++ +GC+     P  +   VA+  L    S   R  +LAE + LGQ  H ++V
Sbjct: 13  LGTGRFGELCRGCLK---LPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            L G        ++V EYM+ G L D   + +   L     + +  G A  + +L   E 
Sbjct: 70  RLEGVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLASGMKYL--SEM 126

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG--YAAPEYINTG 263
             +++   A  +L++SD   K+S F       + +   I T + G     +AAPE I   
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183

Query: 264 HLTTMCDVFSFGVVLLELLT-GRR 286
           H ++  DV+SFG+V+ E+++ G R
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 82.8 bits (204), Expect = 9e-18
 Identities = 75/278 (26%), Positives = 126/278 (45%), Gaps = 33/278 (11%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA-EVIFLGQL 139
           F++ + +G+G FG+V+KG +D+  +     + VA+K++D+  ++   E +  E+  L Q 
Sbjct: 6   FTKLEKIGKGSFGEVFKG-IDNRTQ-----KVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59

Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAF 199
             P++    G   +D    ++ EY+  G+  D L           T ++  +   + L +
Sbjct: 60  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDY 116

Query: 200 LHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHIT-TCVMGTEGYAAPE 258
           LH E+K  I+RD KA+N+LL      KL+DFG+A    Q  D+ I     +GT  + APE
Sbjct: 117 LHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPE 171

Query: 259 YINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIID 318
            I      +  D++S G+  +EL  G     +    +   L+    P             
Sbjct: 172 VIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP------------- 218

Query: 319 SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
             LE  YS    K L      CL+  P  RPT   ++K
Sbjct: 219 PTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 18/203 (8%)

Query: 85  DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPH 143
           + LG+G FG+V+KG + D          VAVK    +  Q  + ++L+E   L Q  HP+
Sbjct: 1   ELLGKGNFGEVFKGTLKDK-------TPVAVKTCKEDLPQELKIKFLSEARILKQYDHPN 53

Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE 203
           +V LIG C + +   +V E +  G+    L K     L     +K A+ AA  +A+L  E
Sbjct: 54  IVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYL--E 110

Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYI 260
            K  I+RD  A N L+  +   K+SDFG++    + ED  I +     +    + APE +
Sbjct: 111 SKNCIHRDLAARNCLVGENNVLKISDFGMS----RQEDDGIYSSSGLKQIPIKWTAPEAL 166

Query: 261 NTGHLTTMCDVFSFGVVLLELLT 283
           N G  ++  DV+S+G++L E  +
Sbjct: 167 NYGRYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 63/211 (29%), Positives = 91/211 (43%), Gaps = 29/211 (13%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWL-AEVIFLGQL-KHPHL 144
           LG G FGKV +       +       VAVK+L        RE L +E+  +  L  H ++
Sbjct: 43  LGAGAFGKVVEATAYGLSKSD-AVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101

Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           VNL+G C      L++ EY   G+L + L +   S L     +  +   A+ +AFL    
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL--AS 159

Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA--------- 255
           K  I+RD  A N+LL      K+ DFGLA D            +M    Y          
Sbjct: 160 KNCIHRDLAARNVLLTHGKIVKICDFGLARD------------IMNDSNYVVKGNARLPV 207

Query: 256 ---APEYINTGHLTTMCDVFSFGVVLLELLT 283
              APE I     T   DV+S+G++L E+ +
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 73/208 (35%), Positives = 104/208 (50%), Gaps = 27/208 (12%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL--------DVNGSQGHREWLAEVIFLGQ 138
           LG+G FGKV+   +   +      Q  A+KVL        D   ++  R+ LAEV     
Sbjct: 4   LGQGSFGKVF---LVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV----- 55

Query: 139 LKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
             HP +V L  Y  + E +L L+ +++  G+L  +L K    T      +K  + A   L
Sbjct: 56  -NHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE---EDVKFYL-AELAL 109

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAP 257
           A  H     +IYRD K  NILLD + + KL+DFGL+ +    E    + C  GT  Y AP
Sbjct: 110 ALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC--GTVEYMAP 167

Query: 258 EYIN-TGHLTTMCDVFSFGVVLLELLTG 284
           E +N  GH T   D +SFGV++ E+LTG
Sbjct: 168 EVVNRRGH-TQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 82.0 bits (202), Expect = 2e-17
 Identities = 75/281 (26%), Positives = 129/281 (45%), Gaps = 39/281 (13%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA-EVIFLGQL 139
           F++ + +G+G FG+V+KG +D+  +     Q VA+K++D+  ++   E +  E+  L Q 
Sbjct: 6   FTKLERIGKGSFGEVFKG-IDNRTQ-----QVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59

Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAF 199
             P++    G   +     ++ EY+  G+  D L           T +K  +   + L +
Sbjct: 60  DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDY 116

Query: 200 LHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHIT-TCVMGTEGYAAPE 258
           LH E+K  I+RD KA+N+LL    + KL+DFG+A    Q  D+ I     +GT  + APE
Sbjct: 117 LHSEKK--IHRDIKAANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPE 171

Query: 259 YINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARP--MLKDFTK-LDQ 315
            I      +  D++S G+  +EL  G          R   L+    P  +  +F+K   +
Sbjct: 172 VIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKE 231

Query: 316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
            ID+                    CL+ +P  RPT   ++K
Sbjct: 232 FIDA--------------------CLNKDPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 82.0 bits (202), Expect = 2e-17
 Identities = 71/282 (25%), Positives = 126/282 (44%), Gaps = 28/282 (9%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLV 145
           LG+G FG VY+G     ++   + + VA+K ++   S   R E+L E   + +    H+V
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFK-------NYSSTLPWLTR-IKIAIGAARCL 197
            L+G   + +  L++ E M  G+L   L         N     P L + I++A   A  +
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAP 257
           A+L+  +   ++RD  A N ++  D+  K+ DFG+  D  + +        +    + +P
Sbjct: 133 AYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190

Query: 258 EYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII 317
           E +  G  TT  DV+SFGVVL E+ T               L E     + +   L  ++
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGMSNEQVLRFVM 235

Query: 318 DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
           +  L D+        L  +   C  +NPK RP+   ++ +++
Sbjct: 236 EGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 81.5 bits (201), Expect = 2e-17
 Identities = 59/201 (29%), Positives = 105/201 (52%), Gaps = 12/201 (5%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLV 145
           +G G FG+V  G +     PG +   VA+K L    ++  R ++L+E   +GQ  HP+++
Sbjct: 12  IGAGEFGEVCSGRLK---LPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
           +L G   + +  ++V EYM  G+L D   + +      +  + +  G A  + +L   + 
Sbjct: 69  HLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGMKYL--SDM 125

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGEDSHITTCVMGTEGYAAPEYINT 262
             ++RD  A NIL++S+   K+SDFGL+    D P  E ++ T        + APE I  
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP--EAAYTTRGGKIPIRWTAPEAIAY 183

Query: 263 GHLTTMCDVFSFGVVLLELLT 283
              T+  DV+S+G+V+ E+++
Sbjct: 184 RKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 81.4 bits (201), Expect = 2e-17
 Identities = 58/222 (26%), Positives = 108/222 (48%), Gaps = 28/222 (12%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWL------- 130
            + + + +G+G +G+VY      N+  G   + +AVK +++    +  H           
Sbjct: 2   KWVKGELIGKGTYGRVYLAL---NVTTG---EMMAVKQVELPATIAGRHDSRQKDMVKAL 55

Query: 131 -AEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRI-- 187
            +E+  L  L H ++V  +G+   +E+  +  EY+  G++     + Y      L R   
Sbjct: 56  RSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSI-GSCLRTYGRFEEQLVRFFT 114

Query: 188 -KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITT 246
            ++  G    LA+LH   K +++RD KA N+L+D+D   K+SDFG++       D+    
Sbjct: 115 EQVLEG----LAYLH--SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNM 168

Query: 247 CVMGTEGYAAPEYINTGH--LTTMCDVFSFGVVLLELLTGRR 286
            + G+  + APE I++     +   D++S G V+LE+  GRR
Sbjct: 169 SMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 81.3 bits (201), Expect = 2e-17
 Identities = 70/278 (25%), Positives = 120/278 (43%), Gaps = 33/278 (11%)

Query: 87  LGEGGFGK--VYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHP 142
           LG+G FG+  +Y+   DD+L        V  K +++     +  R+ L E++ L  L+HP
Sbjct: 8   LGKGAFGEATLYRRTEDDSL--------VVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59

Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
           +++    +  +D   L+  EY   G L+D++ +           +         ++++H 
Sbjct: 60  NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH- 118

Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT 262
            +  +++RD K  NI L      KL DFG++      E S   T V GT  Y +PE    
Sbjct: 119 -KAGILHRDIKTLNIFLTKAGLIKLGDFGISKI-LGSEYSMAETVV-GTPYYMSPELCQG 175

Query: 263 GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLE 322
                  D+++ G VL ELLT +R+ +             A   L    K+ Q   + + 
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLKRTFD-------------ATNPLNLVVKIVQGNYTPVV 222

Query: 323 DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEP 360
             YS+E    L ++ H  L  +P+ RPT   V+     
Sbjct: 223 SVYSSE----LISLVHSLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 81.5 bits (201), Expect = 2e-17
 Identities = 58/201 (28%), Positives = 101/201 (50%), Gaps = 13/201 (6%)

Query: 87  LGEGGFGKVYKGC---VDDNLRPGLKAQTVAVKVL-DVNGSQGHREWLAEVIFLGQLKHP 142
           LG G FG V+KG      D+++       VA+K + D +G Q  +E    ++ +G L H 
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKI-----PVAIKTIQDRSGRQTFQEITDHMLAMGSLDHA 69

Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
           ++V L+G C     +L V +   LG+L D + ++  S  P    +   +  A+ + +L  
Sbjct: 70  YIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRL-LNWCVQIAKGMYYL-- 125

Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT 262
           EE  +++R+  A NILL SD   +++DFG+A      +  +  +       + A E I  
Sbjct: 126 EEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF 185

Query: 263 GHLTTMCDVFSFGVVLLELLT 283
           G  T   DV+S+GV + E+++
Sbjct: 186 GRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 82.1 bits (202), Expect = 3e-17
 Identities = 79/284 (27%), Positives = 119/284 (41%), Gaps = 38/284 (13%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREW---LAEVIFLG 137
           F+    +G G FG VY        R     + VA+K +  +G Q + +W   + EV FL 
Sbjct: 27  FTDLREIGHGSFGAVYFA------RDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQ 80

Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           ++KHP+ +   G    +    LV EY  LG+  D L + +   L  +    I  GA + L
Sbjct: 81  RIKHPNSIEYKGCYLREHTAWLVMEY-CLGSASD-LLEVHKKPLQEVEIAAITHGALQGL 138

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAP 257
           A+LH     +I+RD KA NILL      KL+DFG A+              +GT  + AP
Sbjct: 139 AYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAP 190

Query: 258 EYI---NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD 314
           E I   + G      DV+S G+  +EL            +R+  L       +   + L 
Sbjct: 191 EVILAMDEGQYDGKVDVWSLGITCIEL-----------AERKPPLFN-----MNAMSALY 234

Query: 315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL 358
            I  +      S E +         CL   P+ RPT   ++K +
Sbjct: 235 HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 80.7 bits (199), Expect = 4e-17
 Identities = 81/299 (27%), Positives = 127/299 (42%), Gaps = 43/299 (14%)

Query: 81  FSRSDYLGEGGFGKVYKGCV--DDNLRPGLKAQTVAVKVL--DVNGSQGHREWLAEVIFL 136
           F+    LG+G FG V +  +  +D        Q VAVK+L  D+  S    E+L E   +
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDG-----SFQKVAVKMLKADIFSSSDIEEFLREAACM 55

Query: 137 GQLKHPHLVNLIGYCCEDEHR------LLVYEYMALGNLHDQLFKNYSS----TLPWLTR 186
            +  HP+++ LIG       +      +++  +M  G+LH  L  +       TLP  T 
Sbjct: 56  KEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTL 115

Query: 187 IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITT 246
           ++  I  A  + +L    K  I+RD  A N +L+ +    ++DFGL+     G D +   
Sbjct: 116 VRFMIDIASGMEYL--SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSG-DYYRQG 172

Query: 247 CVMGTE-GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR- 304
           C       + A E +     TT  DV++FGV + E++T        R +     VE +  
Sbjct: 173 CASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT--------RGQTPYAGVENSEI 224

Query: 305 -PMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
              L    +L Q  D  LED Y          +  QC S  PK RP+   +   LE + 
Sbjct: 225 YNYLIKGNRLKQPPDC-LEDVYE---------LMCQCWSPEPKCRPSFQHLRDQLELIW 273

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 80.4 bits (198), Expect = 4e-17
 Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 12/200 (6%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLV 145
           LG G FG V KG      +   K   VA+KVL     +  R E + E   + QL +P++V
Sbjct: 3   LGSGNFGCVKKGV----YKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIV 58

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            +IG  CE E  +LV E  + G L+ +        +     +++    +  + +L  E K
Sbjct: 59  RMIG-VCEAEALMLVMEMASGGPLN-KFLSGKKDEITVSNVVELMHQVSMGMKYL--EGK 114

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE--GYAAPEYINTG 263
             ++RD  A N+LL + + AK+SDFGL +     +DS+      G     + APE IN  
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGL-SKALGADDSYYKARSAGKWPLKWYAPECINFR 173

Query: 264 HLTTMCDVFSFGVVLLELLT 283
             ++  DV+S+G+ + E  +
Sbjct: 174 KFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 80.7 bits (199), Expect = 5e-17
 Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 33/222 (14%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVK-VLDVNGSQGHREWLAEVI---- 134
            + +   LG G F   Y+       R       +AVK V  V  +   +E + E +    
Sbjct: 1   EWLKGQQLGTGAFSSCYQA------RDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEI 54

Query: 135 -FLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGA 193
             + +L HPH++ ++G  CED H  L  E+MA G++   L   Y +    +  I      
Sbjct: 55  RLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSV-SHLLSKYGAFKEAVI-INYTEQL 112

Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDSD-YNAKLSDFG----LATDGP-----QGEDSH 243
            R L++LH  E  +I+RD K +N+L+DS     +++DFG    LA  G      QG+   
Sbjct: 113 LRGLSYLH--ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ--- 167

Query: 244 ITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
               ++GT  + APE +        CDV+S G V++E+ T +
Sbjct: 168 ----LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 81.5 bits (202), Expect = 5e-17
 Identities = 66/215 (30%), Positives = 109/215 (50%), Gaps = 33/215 (15%)

Query: 86  YLGEGGFGKVYKGCVDDNLRPGLKAQTVAVK-VLDV--NGSQGHREWLAEVIFLGQLK-H 141
            LG+G +G V+K  +D   +     + VA+K + D   N +   R +  E++FL +L  H
Sbjct: 14  KLGKGAYGIVWK-AIDRRTK-----EVVALKKIFDAFRNATDAQRTF-REIMFLQELGDH 66

Query: 142 PHLVNLIGYCCEDEHR-------LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA 194
           P++V L+     +  +        LV+EYM   +LH  +  N    L  + +  I     
Sbjct: 67  PNIVKLL-----NVIKAENDKDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLL 117

Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGEDSHITTCVMGT 251
           + L ++H     VI+RD K SNILL+SD   KL+DFGLA   ++  +  ++ + T  + T
Sbjct: 118 KALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175

Query: 252 EGYAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE  + +   T   D++S G +L E+L G+
Sbjct: 176 RWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 81.0 bits (200), Expect = 5e-17
 Identities = 70/212 (33%), Positives = 95/212 (44%), Gaps = 34/212 (16%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---------DVNGSQGHREWLAEVIFLG 137
           LG+G FGKV    +          +  A+K L         DV  +   R  LA    L 
Sbjct: 3   LGKGSFGKVMLAELKG------TNEFFAIKALKKDVVLEDDDVECTMVERRVLA----LA 52

Query: 138 QLKHPHLVNLIGYCC--EDEHRLLVYEYMALGNL--HDQLFKNYSSTLPWLTRIKIAIGA 193
             +HP L +L  +C     EH   V EY+  G+L  H Q    +          +I  G 
Sbjct: 53  W-EHPFLTHL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICG- 108

Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
              L FLH  +K +IYRD K  N+LLD D + K++DFG+  +   GE    T C  GT  
Sbjct: 109 ---LQFLH--KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC--GTPD 161

Query: 254 YAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE +         D +SFGV+L E+L G+
Sbjct: 162 YIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 80.5 bits (198), Expect = 7e-17
 Identities = 65/217 (29%), Positives = 94/217 (43%), Gaps = 16/217 (7%)

Query: 79  HNFSRSDYLGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLG 137
           HN      LGEG FGKV+   C   NL P      VAVK L        +++  E   L 
Sbjct: 5   HNIVLKRELGEGAFGKVFLAECY--NLCPEQDKILVAVKTLKDASDNARKDFHREAELLT 62

Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK-----------NYSSTLPWLTR 186
            L+H H+V   G C E +  ++V+EYM  G+L+  L             N  + L     
Sbjct: 63  NLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQM 122

Query: 187 IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITT 246
           + IA   A  + +L  +    ++RD    N L+  +   K+ DFG++ D    +   +  
Sbjct: 123 LHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG 180

Query: 247 CVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
             M    +  PE I     TT  DV+S GVVL E+ T
Sbjct: 181 HTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 80.2 bits (198), Expect = 7e-17
 Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 32/212 (15%)

Query: 87  LGEGGFGKVYKGCVD---DNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPH 143
           LG+G FG V     D   DN       + VAVK L  + ++  R++  E+  L  L+H +
Sbjct: 12  LGKGNFGSVELCRYDPLQDN-----TGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDN 66

Query: 144 LVNLIGYCCEDEHR--LLVYEYMALGNLHDQLFKN-----YSSTLPWLTRIKIAIGAARC 196
           +V   G C     R   LV EY+  G+L D L K+     +   L + ++I        C
Sbjct: 67  IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI--------C 118

Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG--- 253
               +   K  ++RD    NIL++S+   K+ DFGL    PQ ++ +         G   
Sbjct: 119 KGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVR----EPGESP 174

Query: 254 --YAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
             + APE +     +   DV+SFGVVL EL T
Sbjct: 175 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 80.0 bits (197), Expect = 8e-17
 Identities = 71/233 (30%), Positives = 104/233 (44%), Gaps = 18/233 (7%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFLGQLKHPH 143
           LG+GGFG+V    V +        +  A K LD   +    G +  L E   L ++  P 
Sbjct: 1   LGKGGFGEVCAVQVKNT------GKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPF 54

Query: 144 LVNLIGYCCEDE-HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
           +VNL  Y  E + H  LV   M  G+L   ++      L  + R+ I   A      LH 
Sbjct: 55  IVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLE-MERV-IHYSAQITCGILHL 111

Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT 262
               ++YRD K  N+LLD   N +LSD GLA +   G+     T   GT GY APE +  
Sbjct: 112 HSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKE 168

Query: 263 GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ 315
              +   D F+ G  + E++ GR   + ++ K  K+  E  R  L+D  K + 
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE--ELKRRTLEDEVKFEH 219

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 79.6 bits (196), Expect = 8e-17
 Identities = 75/278 (26%), Positives = 113/278 (40%), Gaps = 44/278 (15%)

Query: 87  LGEGGFGKVYKGC-VDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLV 145
           +GEG FG+      V+ + +  +K   +      V  S+       E + L ++KHP++V
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSR------KEAVLLAKMKHPNIV 61

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLP------WLTRIKIAIGAARCLAF 199
                   D H  +V EY   G+L  ++        P      W  ++        CL  
Sbjct: 62  AFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQM--------CLGV 113

Query: 200 LHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT--DGPQGEDSHITTCVMGTEGYAAP 257
            H  EK V++RD K+ NI L  +   KL DFG A     P    ++  T V GT  Y  P
Sbjct: 114 QHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG---AYACTYV-GTPYYVPP 169

Query: 258 EYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII 317
           E           D++S G +L EL T +   + N          W   +L    K+ Q  
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN---------SWKNLIL----KVCQGS 216

Query: 318 DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVV 355
              L   YS E    L ++  Q    NP+SRP+ TT++
Sbjct: 217 YKPLPSHYSYE----LRSLIKQMFKRNPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 79.8 bits (197), Expect = 8e-17
 Identities = 62/201 (30%), Positives = 98/201 (48%), Gaps = 10/201 (4%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD-VNGSQGHREWLAEVIFLGQLKHPHLV 145
           +G+G FG VY G + D+     +    AVK L+ +   +   ++L E I +    HP+++
Sbjct: 3   IGKGHFGCVYHGTLIDSDG---QKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVL 59

Query: 146 NLIGYCCEDEHR-LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           +L+G C   E   L+V  YM  G+L     ++ +        I   +  A+ + +L    
Sbjct: 60  SLLGICLPSEGSPLVVLPYMKHGDLR-NFIRSETHNPTVKDLIGFGLQVAKGMEYL--AS 116

Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGE--DSHITTCVMGTEGYAAPEYINT 262
           K  ++RD  A N +LD  +  K++DFGLA D    E    H  T       + A E + T
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176

Query: 263 GHLTTMCDVFSFGVVLLELLT 283
              TT  DV+SFGV+L EL+T
Sbjct: 177 QKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 29/211 (13%)

Query: 85  DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREW------LAEVIFLGQ 138
             +GEG +G VYK       R  L  + VA+K +                 L E+  L +
Sbjct: 5   GKIGEGTYGVVYKA------RDKLTGEIVAIKKI----KLRFESEGIPKTALREIKLLKE 54

Query: 139 LKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIK-IAIGAARCL 197
           L HP+++ L+          LV+E+M   +L+ +L K+    LP  + IK       + L
Sbjct: 55  LNHPNIIKLLDVFRHKGDLYLVFEFM-DTDLY-KLIKDRQRGLP-ESLIKSYLYQLLQGL 111

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA--TDGPQGEDSHITTCVMGTEGYA 255
           AF H     +++RD K  N+L++++   KL+DFGLA     P    +H       T  Y 
Sbjct: 112 AFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV----TRWYR 165

Query: 256 APEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
           APE +      +T  D++S G +  ELL+ R
Sbjct: 166 APELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 79.2 bits (195), Expect = 1e-16
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 21/215 (9%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVK--VLDVN----GSQGHREWLAEVI 134
           +++ + LG+G +G VY G  +       + Q +AVK   LD +      + + +   EV 
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTN-------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVD 54

Query: 135 FLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA 194
            L  LKH ++V  +G C +D    +  E++  G++   L  N    LP     K      
Sbjct: 55  LLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQIL 112

Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFG----LATDGPQGEDSHITTCVMG 250
             +A+LH     V++RD K +N++L  +   KL DFG    LA  G  G  S++   + G
Sbjct: 113 DGVAYLH--NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170

Query: 251 TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           T  + APE IN        D++S G  + E+ TG+
Sbjct: 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 83/280 (29%), Positives = 120/280 (42%), Gaps = 42/280 (15%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG+V+ G  +   R       VA+K L   G+     +L E   + +L+H  LV 
Sbjct: 14  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 65

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     E E   +V EYM+ G+L D L       L     + +A   A  +A++  E   
Sbjct: 66  LYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV--ERMN 122

Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINTG 263
            ++RD +A+NIL+  +   K++DFGLA      ED+  T    G +    + APE    G
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTA-RQGAKFPIKWTAPEAALYG 178

Query: 264 HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLED 323
             T   DV+SFG++L EL T  R        RE                LDQ+     E 
Sbjct: 179 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------------VLDQV-----ER 218

Query: 324 RYS----TEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
            Y      E  + L  +  QC    P+ RPT   +   LE
Sbjct: 219 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 79.6 bits (196), Expect = 2e-16
 Identities = 64/222 (28%), Positives = 110/222 (49%), Gaps = 33/222 (14%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGL---------KAQTVAVKVL--DVNGSQGHREWLAEVIF 135
           LGEG FG+V+  C  + L   L         +   VAVK+L  DV       ++L E+  
Sbjct: 13  LGEGQFGEVHL-CEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT-KTARNDFLKEIKI 70

Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKN-------YSSTLPWLTR-- 186
           + +LK+P+++ L+G C  D+   ++ EYM  G+L+  L +        +++ +P ++   
Sbjct: 71  MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130

Query: 187 -----IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGED 241
                ++IA G  + LA L+      ++RD    N L+ + Y  K++DFG++ +   G+ 
Sbjct: 131 LLYMAVQIASG-MKYLASLN-----FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184

Query: 242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
             I    +    + A E I  G  TT  DV++FGV L E+ T
Sbjct: 185 YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 79.1 bits (196), Expect = 2e-16
 Identities = 68/221 (30%), Positives = 102/221 (46%), Gaps = 44/221 (19%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           +F     LG G FG+V    +  +   G   +  A+K+L            A+++ L Q+
Sbjct: 2   DFEFIKTLGTGSFGRV---MLVRHKGSG---KYYALKILSK----------AKIVKLKQV 45

Query: 140 KH-------------PHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLT 185
           +H             P LVNL G   +D+  L LV EY+  G L   L K+     P   
Sbjct: 46  EHVLNEKRILQSIRHPFLVNLYG-SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPV-A 103

Query: 186 RIKIA-IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI 244
           R   A +  A  L +LH  +  ++YRD K  N+LLDSD   K++DFG A    + +    
Sbjct: 104 RFYAAQVVLA--LEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAK---RVKGRTY 156

Query: 245 TTCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTG 284
           T C  GT  Y APE I + G+     D ++ G+++ E+L G
Sbjct: 157 TLC--GTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 78.4 bits (194), Expect = 2e-16
 Identities = 70/209 (33%), Positives = 96/209 (45%), Gaps = 30/209 (14%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD-----VNGSQGHREWLAEVIFLGQLKH 141
           LG GGFG+V    V        K +T A+K +        G Q H    +E   L +  H
Sbjct: 1   LGVGGFGRVEL--VKVKS----KNRTFALKCVKKRHIVETGQQEH--IFSEKEILEECNH 52

Query: 142 PHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK--NYSSTLPWLTRIKIA--IGAARCL 197
           P +V L     + ++  ++ EY   G L   L     +     +  R  IA  + A    
Sbjct: 53  PFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDE---YTARFYIACVVLA---F 106

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAP 257
            +LH   + +IYRD K  N+LLDS+   KL DFG A     G+ +  T C  GT  Y AP
Sbjct: 107 EYLH--NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW-TFC--GTPEYVAP 161

Query: 258 EYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
           E I N G+     D +S G++L ELLTGR
Sbjct: 162 EIILNKGY-DFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 78.6 bits (194), Expect = 2e-16
 Identities = 64/225 (28%), Positives = 107/225 (47%), Gaps = 35/225 (15%)

Query: 74  LQMIT------HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR 127
           LQ++               +GEG  G V   C+  +   G   + VAVK +D+   Q  R
Sbjct: 8   LQLVVDPGDPRSYLDNFVKIGEGSTGIV---CIATDKSTG---RQVAVKKMDLRKQQ-RR 60

Query: 128 EWL-AEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTR 186
           E L  EV+ +   +HP++V +       +   +V E++  G L D +      T   +  
Sbjct: 61  ELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV------THTRMNE 114

Query: 187 IKIAIGAARCL---AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFG----LATDGPQG 239
            +IA      L   +FLH   + VI+RD K+ +ILL SD   KLSDFG    ++ + P+ 
Sbjct: 115 EQIATVCLAVLKALSFLHA--QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR 172

Query: 240 EDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           +       ++GT  + APE I+     T  D++S G++++E++ G
Sbjct: 173 KS------LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 79.2 bits (195), Expect = 2e-16
 Identities = 69/212 (32%), Positives = 98/212 (46%), Gaps = 34/212 (16%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---------DVNGSQGHREWLAEVIFLG 137
           LG+G FGKV+   +          Q  A+K L         DV  +   +  L+      
Sbjct: 3   LGKGSFGKVFLAELKGT------NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA---- 52

Query: 138 QLKHPHLVNLIGYCC--EDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLT--RIKIAIGA 193
             +HP L +L  YC     E+   V EY+  G+L   +   +   LP  T    +I  G 
Sbjct: 53  -WEHPFLTHL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICG- 108

Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
              L FLH   K ++YRD K  NILLD+D + K++DFG+  +   G+    T C  GT  
Sbjct: 109 ---LQFLH--SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC--GTPD 161

Query: 254 YAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE +      T  D +SFGV+L E+L G+
Sbjct: 162 YIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 16/203 (7%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDV---NGSQGHREWLAEVIFLGQLKHPH 143
           +GEG  G V+K    +        +TVA+K + +    G   + + L E+  L   +HP+
Sbjct: 8   IGEGAHGIVFKAKDRET------GETVALKKVALRRLEGGIPN-QALREIKALQACQHPY 60

Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE 203
           +V L+         +LV EYM   +L + L ++    LP            + +A++H  
Sbjct: 61  VVKLLDVFPHGSGFVLVMEYM-PSDLSEVL-RDEERPLPEAQVKSYMRMLLKGVAYMHAN 118

Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI-NT 262
              +++RD K +N+L+ +D   K++DFGLA    + E    +  V  T  Y APE +   
Sbjct: 119 G--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYGA 175

Query: 263 GHLTTMCDVFSFGVVLLELLTGR 285
                  D+++ G +  ELL G 
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 18/212 (8%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFLGQLKHPHLV 145
           LGE  FGKVYKG +     PG + Q VA+K L        RE +  E +   +L+HP++V
Sbjct: 13  LGEDRFGKVYKGHLFGT-APGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLF--------------KNYSSTLPWLTRIKIAI 191
            L+G   +++   +++ Y +  +LH+ L               K   STL     + I  
Sbjct: 72  CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131

Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
             A  + FL      V+++D    N+L+    N K+SD GL  +    +   +    +  
Sbjct: 132 QIAAGMEFLSSHH--VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189

Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
             + +PE I  G  +   D++S+GVVL E+ +
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 77.8 bits (192), Expect = 5e-16
 Identities = 86/291 (29%), Positives = 135/291 (46%), Gaps = 44/291 (15%)

Query: 84  SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREW-LAEVIFLGQLKHP 142
           SD L EG FG+++ G + D      K + V VK +  + S+      L E   L  L H 
Sbjct: 11  SDLLQEGTFGRIFYGILIDEK--PGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQ 68

Query: 143 HLVNLIGYCCED-EHRLLVYEYMALGNLHDQLF--------KNYSSTLPWLTRIKIAIGA 193
           +++ ++  C ED E   ++Y YM  GNL  +LF         N    L     + +AI  
Sbjct: 69  NILPILHVCIEDGEPPFVLYPYMNWGNL--KLFLQQCRLGEANNPQALSTQQLVHMAIQI 126

Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD-GPQGEDSHITTCVMGTE 252
           A  +++LH  ++ VI++D  A N ++D +   K++D  L+ D  P   D H   C+   E
Sbjct: 127 ACGMSYLH--KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPM--DYH---CLGDNE 179

Query: 253 G----YAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPML 307
                + A E +     ++  DV+SFGV+L EL+T G+          E D  E A   L
Sbjct: 180 NRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYV------EIDPFEMAA-YL 232

Query: 308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL 358
           KD  +L Q I+   E          L AV   C + +P+ RP+ + +V+ L
Sbjct: 233 KDGYRLAQPINCPDE----------LFAVMACCWALDPEERPSFSQLVQCL 273

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 78.0 bits (192), Expect = 5e-16
 Identities = 72/264 (27%), Positives = 120/264 (45%), Gaps = 40/264 (15%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK 140
           ++R + +G+G  G VY   +D         Q VA+K +++         + E++ + + K
Sbjct: 21  YTRFEKIGQGASGTVYTA-IDVAT-----GQEVAIKQMNLQQQPKKELIINEILVMRENK 74

Query: 141 HPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC---- 196
           HP++VN +      +   +V EY+A G+L D + +         T +     AA C    
Sbjct: 75  HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---------TCMDEGQIAAVCRECL 125

Query: 197 --LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL-ATDGPQGEDSHITTCVMGTEG 253
             L FLH  +  VI+RD K+ NILL  D + KL+DFG  A   P  E S  +T V GT  
Sbjct: 126 QALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPY 180

Query: 254 YAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV-----------EW 302
           + APE +         D++S G++ +E++ G          R   L+           E 
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEK 240

Query: 303 ARPMLKDFTKLDQIIDSRLEDRYS 326
              + +DF  L++ ++  +E R S
Sbjct: 241 LSAIFRDF--LNRCLEMDVEKRGS 262

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 78.2 bits (193), Expect = 6e-16
 Identities = 67/214 (31%), Positives = 94/214 (43%), Gaps = 39/214 (18%)

Query: 87  LGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHREWLAEV-IFL-- 136
           LG G FGKV    YK             +  A+K L   D+         + E  IF   
Sbjct: 7   LGRGHFGKVLLAEYKK----------TGELYAIKALKKGDIIARDEVESLMCEKRIFETA 56

Query: 137 GQLKHPHLVNLIGYCC--EDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA 194
              +HP LVNL  + C   ++H   V EY A G+L   +  +  S          A+  A
Sbjct: 57  NSERHPFLVNL--FACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSE-------PRAVFYA 107

Query: 195 RC----LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG 250
            C    L +LH  E  ++YRD K  N+LLD++   K++DFGL  +G    D   T C  G
Sbjct: 108 ACVVLGLQYLH--ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC--G 163

Query: 251 TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           T  + APE +     T   D +  GV++ E+L G
Sbjct: 164 TPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 77.4 bits (190), Expect = 9e-16
 Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 19/212 (8%)

Query: 87  LGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLV 145
           LGEG FGKV+   C   NL P      VAVK L        +++  E   L  L+H H+V
Sbjct: 13  LGEGAFGKVFLAECY--NLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLH--------------DQLFKNYSSTLPWLTRIKIAI 191
              G C + +  ++V+EYM  G+L+              D   +     L     + IA 
Sbjct: 71  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130

Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
             A  + +L  +    ++RD    N L+ ++   K+ DFG++ D    +   +    M  
Sbjct: 131 QIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188

Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
             +  PE I     TT  DV+SFGV+L E+ T
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 79.9 bits (197), Expect = 9e-16
 Identities = 51/191 (26%), Positives = 90/191 (47%), Gaps = 16/191 (8%)

Query: 111 QTVAVKVLDVNGSQGHRE---WLAEVIFLGQLKHPHLVNLIGY-CCEDEHRLLVYEYMAL 166
             VA+K+L  +  +   +   +  E     +L HP++V L+            V+EY+  
Sbjct: 4   HEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPG 63

Query: 167 GNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILL---DSDY 223
             L + L  +    LP     ++ +     LA  H   + +++RD K  NI++       
Sbjct: 64  RTLREVLAAD--GALPAGETGRLMLQVLDALACAH--NQGIVHRDLKPQNIMVSQTGVRP 119

Query: 224 NAKLSDFGLATDGPQGEDSHITTC-----VMGTEGYAAPEYINTGHLTTMCDVFSFGVVL 278
           +AK+ DFG+ T  P   D+ + T      V+GT  Y APE +    +T   D++++G++ 
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179

Query: 279 LELLTGRRSVE 289
           LE LTG+R V+
Sbjct: 180 LECLTGQRVVQ 190

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 77.4 bits (190), Expect = 9e-16
 Identities = 68/218 (31%), Positives = 107/218 (49%), Gaps = 20/218 (9%)

Query: 71  LKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHRE 128
           LKE ++      R   LG G FG VYKG     +  G   +  VA+K+L +  G + + E
Sbjct: 4   LKETEL-----KRVKVLGSGAFGTVYKGIW---VPEGETVKIPVAIKILNETTGPKANVE 55

Query: 129 WLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK---NYSSTLPWLT 185
           ++ E + +  + HPHLV L+G C     +L V + M  G L D + +   N  S L    
Sbjct: 56  FMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNW 114

Query: 186 RIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHIT 245
            ++IA G       ++ EE+ +++RD  A N+L+ S  + K++DFGLA      E  +  
Sbjct: 115 CVQIAKG------MMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA 168

Query: 246 TCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
                   + A E I+    T   DV+S+GV + EL+T
Sbjct: 169 DGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 64/201 (31%), Positives = 94/201 (46%), Gaps = 22/201 (10%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREW---LAEVIFLGQLKHPH 143
           +G G FG VY        R    ++ VA+K +  +G Q + +W   + EV FL +L+HP+
Sbjct: 23  IGHGSFGAVYFA------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE 203
            +   G    +    LV EY  LG+  D L + +   L  +    +  GA + LA+LH  
Sbjct: 77  TIQYRGCYLREHTAWLVMEY-CLGSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134

Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI--- 260
              +I+RD KA NILL      KL DFG A+              +GT  + APE I   
Sbjct: 135 N--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEVILAM 186

Query: 261 NTGHLTTMCDVFSFGVVLLEL 281
           + G      DV+S G+  +EL
Sbjct: 187 DEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 67/203 (33%), Positives = 98/203 (48%), Gaps = 18/203 (8%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG+V+ G  + N +       VAVK L   G+     +L E   + +L+H  LV 
Sbjct: 14  LGNGQFGEVWMGTWNGNTK-------VAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQ 65

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     E E   +V EYM+ G+L D L       L     + +A   A  +A++  E   
Sbjct: 66  LYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI--ERMN 122

Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINTG 263
            I+RD +++NIL+      K++DFGLA      ED+  T    G +    + APE    G
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLAR---LIEDNEYTA-RQGAKFPIKWTAPEAALYG 178

Query: 264 HLTTMCDVFSFGVVLLELLTGRR 286
             T   DV+SFG++L EL+T  R
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 67/206 (32%), Positives = 93/206 (45%), Gaps = 24/206 (11%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREW---LAE-VIFLGQLKHP 142
           +G+G FGKV         +     +  AVKVL        +E    +AE  + L  +KHP
Sbjct: 3   IGKGSFGKVLLA------KHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHP 56

Query: 143 HLVNLIGYCCEDEHRL-LVYEYMALGNL--HDQLFKNYSSTLPWLTRIKI-AIGAARCLA 198
            LV L  Y  +   +L  V +Y+  G L  H Q  +++        R +  A   A  L 
Sbjct: 57  FLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP-----RARFYAAEIASALG 110

Query: 199 FLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPE 258
           +LH     +IYRD K  NILLDS  +  L+DFGL  +G +   +  T C  GT  Y APE
Sbjct: 111 YLH--SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC--GTPEYLAPE 166

Query: 259 YINTGHLTTMCDVFSFGVVLLELLTG 284
            +         D +  G VL E+L G
Sbjct: 167 VLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 63/239 (26%), Positives = 100/239 (41%), Gaps = 33/239 (13%)

Query: 142 PHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLH 201
           P++V   G    D    +  E+M  G+L DQ+ K  +  +P     KI+I   R L +L 
Sbjct: 59  PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKK-AGRIPENILGKISIAVLRGLTYLR 116

Query: 202 GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN 261
            E+  +++RD K SNIL++S    KL DFG++    Q  DS   + V GT  Y +PE + 
Sbjct: 117 -EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV-GTRSYMSPERLQ 171

Query: 262 TGHLTTMCDVFSFGVVLLELLTGR--------------------RSVEKNRCKREKDLVE 301
             H T   D++S G+ L+E+  GR                        K   +       
Sbjct: 172 GTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231

Query: 302 WARPMLKDFTKLDQIIDS---RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA 357
            +   +  F  LD I++    +L     ++  +        CL  NPK R  +  + K 
Sbjct: 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDK---CLKKNPKERADLKELTKH 287

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 67/205 (32%), Positives = 95/205 (46%), Gaps = 20/205 (9%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHREW-LAEVIFLGQLKHPH 143
           LG+G FGKV         R G   +  A+K+L  DV       E  + E   L     P 
Sbjct: 8   LGKGSFGKVMLA-----ERKGTD-ELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61

Query: 144 LVNLIGYCCEDEHRL-LVYEYMALGNL--HDQLFKNYSSTLPWLTRIKIAIGAARCLAFL 200
            +  +  C +   RL  V EY+  G+L  H Q    +          +IAIG    L FL
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG----LFFL 117

Query: 201 HGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI 260
           H   K +IYRD K  N++LD++ + K++DFG+  +   G  +  T C  GT  Y APE I
Sbjct: 118 H--SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC--GTPDYIAPEII 173

Query: 261 NTGHLTTMCDVFSFGVVLLELLTGR 285
                    D ++FGV+L E+L G+
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 65/231 (28%), Positives = 104/231 (45%), Gaps = 44/231 (19%)

Query: 87  LGEGGFGKVYKGCVDD-----------NLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVI 134
           LGEG FG+V+   V +           N+R G +   VAVK+L  + ++  R ++L EV 
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKG-RPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 135 FLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNL-----HDQLFK-------------- 175
            L +LK P+++ L+G C +++   ++ EYM  G+L        L                
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131

Query: 176 ----NYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFG 231
               +YSS L    +I   +     L F+H        RD    N L+  +   K++DFG
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSSLNFVH--------RDLATRNCLVGENLTIKIADFG 183

Query: 232 LATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELL 282
           ++ +   G+   I    +    + A E I  G  TT  DV++FGV L E+L
Sbjct: 184 MSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 32/216 (14%)

Query: 79  HNFSRSDYLGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHREWLA 131
            +F   + LG G FG+V    +KG            +  A+K L   ++   +  +    
Sbjct: 18  SDFEMGETLGTGSFGRVRIAKHKG----------TGEYYAIKCLKKREILKMKQVQHVAQ 67

Query: 132 EVIFLGQLKHPHLVNLI-GYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKI 189
           E   L +L HP +VN++  +  +DE+R+  + E++  G    +LF +      +   +  
Sbjct: 68  EKSILMELSHPFIVNMMCSF--QDENRVYFLLEFVVGG----ELFTHLRKAGRFPNDVAK 121

Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM 249
              A   LAF +   K +IYRD K  N+LLD+  + K++DFG A   P   D   T C  
Sbjct: 122 FYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP---DRTFTLC-- 176

Query: 250 GTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTG 284
           GT  Y APE I + GH     D ++ GV+L E + G
Sbjct: 177 GTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 75.3 bits (185), Expect = 3e-15
 Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 17/210 (8%)

Query: 85  DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHL 144
           D +G G FGKV  G     +    KA+ V  ++           +L EV    +L HP++
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMS---KARVVVKELRASATPDEQLLFLQEVQPYRELNHPNV 57

Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKN---YSSTLPWLTRIKIAIGAARCLAFLH 201
           +  +G C E    LLV E+  LG+L + L  N    +         ++A   A  L +LH
Sbjct: 58  LQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117

Query: 202 GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITT-CVMGTEGYAAPEYI 260
             +   I+ D    N  L +D + K+ D+GLA +    ED +IT  C      + APE +
Sbjct: 118 --QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYP-EDYYITKDCHAVPLRWLAPELV 174

Query: 261 NTGH-------LTTMCDVFSFGVVLLELLT 283
                       T   +++S GV + EL T
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 74.6 bits (184), Expect = 4e-15
 Identities = 74/290 (25%), Positives = 121/290 (41%), Gaps = 61/290 (21%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           +G G +G VYK     ++  G   + VA+KV+ +           E+  L + +HP++V 
Sbjct: 11  IGSGTYGDVYKA---RDIATG---ELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI---GAARCLAFLHGE 203
             G     +   +V EY   G+L D     Y  T   L+ ++IA       + LA+LH  
Sbjct: 65  YFGSYLRRDKLWIVMEYCGGGSLQDI----YQVTRGPLSELQIAYVCRETLKGLAYLH-- 118

Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV------MGTEGYAAP 257
           E   I+RD K +NILL  D + KL+DFG++          +T  +      +GT  + AP
Sbjct: 119 ETGKIHRDIKGANILLTEDGDVKLADFGVSA--------QLTATIAKRKSFIGTPYWMAP 170

Query: 258 EYIN---TGHLTTMCDVFSFGVVLLELLTG---RRSVEKNRC-----KREKDLVEWARPM 306
           E       G     CD+++ G+  +EL         +   R      K          P 
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFP-----PPK 225

Query: 307 LKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
           LKD            ++++S            +CL+ +PK RPT T +++
Sbjct: 226 LKD------------KEKWSPV----FHDFIKKCLTKDPKKRPTATKLLQ 259

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 75.7 bits (186), Expect = 4e-15
 Identities = 73/227 (32%), Positives = 104/227 (45%), Gaps = 35/227 (15%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---------DVNGSQGHREWLAEVIFLG 137
           LG+G FGKV           G   +  A+KVL         DV+ +   +  LA      
Sbjct: 3   LGKGSFGKVMLA-----ELKG-TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALA---- 52

Query: 138 QLKHPHLVNLIGYCC-EDEHRLL-VYEYMALGNLHDQLFKNYSSTLPWLTRIKI-AIGAA 194
             KHP L  L  +CC + + RL  V EY+  G+L  Q+ ++     P   R +  A    
Sbjct: 53  -AKHPFLTAL--HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEP---RSRFYAAEVT 106

Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
             L FLH     VIYRD K  NILLD++ + KL+DFG+  +G     +  T C  GT  Y
Sbjct: 107 LALMFLH--RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC--GTPDY 162

Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVE 301
            APE +         D ++ GV++ E++ G+   E +    E DL E
Sbjct: 163 IAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD---NEDDLFE 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 75.1 bits (184), Expect = 4e-15
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 21/208 (10%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK 140
           ++R + +G+G  G V+   +D         Q VA+K +++         + E++ + +LK
Sbjct: 21  YTRYEKIGQGASGTVFTA-IDVAT-----GQEVAIKQINLQKQPKKELIINEILVMKELK 74

Query: 141 HPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLA-- 198
           +P++VN +      +   +V EY+A G+L D +      T   +   +IA     CL   
Sbjct: 75  NPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV------TETCMDEAQIAAVCRECLQAL 128

Query: 199 -FLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL-ATDGPQGEDSHITTCVMGTEGYAA 256
            FLH  +  VI+RD K+ N+LL  D + KL+DFG  A   P  E S  +T V GT  + A
Sbjct: 129 EFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMA 183

Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTG 284
           PE +         D++S G++ +E++ G
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 74.8 bits (184), Expect = 4e-15
 Identities = 69/244 (28%), Positives = 113/244 (46%), Gaps = 21/244 (8%)

Query: 112 TVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLH 170
            +A KV+ +   S   ++ L E+  + + + P++V+  G    + +  +  E+M  G+L 
Sbjct: 32  VMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL- 90

Query: 171 DQLFKNYSSTLPWLTRI--KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLS 228
           D+++K      P    I  KIA+     L +L+   + +++RD K SNIL++S    KL 
Sbjct: 91  DRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVHR-IMHRDIKPSNILVNSRGQIKLC 146

Query: 229 DFGLATDGPQGE--DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRR 286
           DFG++     GE  +S   T V GT  Y +PE I  G  T   DV+S G+ ++EL  G+ 
Sbjct: 147 DFGVS-----GELINSIADTFV-GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKF 200

Query: 287 SVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPK 346
               +      D      PM      L QI+        S++  + L      CL  +P 
Sbjct: 201 PFAFS----NIDDDGQDDPM-GILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPT 255

Query: 347 SRPT 350
            RPT
Sbjct: 256 ERPT 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 74.7 bits (183), Expect = 5e-15
 Identities = 71/216 (32%), Positives = 102/216 (47%), Gaps = 22/216 (10%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA---EVIFL 136
           N+ R   LG+G FG+VY  C D +    L A+ V     D    +  +E  A   E+  L
Sbjct: 3   NWRRGKLLGQGAFGRVYL-CYDVDTGRELAAKQVQ---FDPESPETSKEVSALECEIQLL 58

Query: 137 GQLKHPHLVNLIGYCCED--EHRLLVY-EYMALGNLHDQLFKNYSSTLPWLTRIKIAIGA 193
             L+H  +V   G C  D  E  L ++ EYM  G++ DQL K Y +    +TR K     
Sbjct: 59  KNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTR-KYTRQI 115

Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFG----LATDGPQGEDSHITTCVM 249
              +++LH     +++RD K +NIL DS  N KL DFG    L T    G        V 
Sbjct: 116 LEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTG---IRSVT 170

Query: 250 GTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           GT  + +PE I+        DV+S G  ++E+LT +
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 75.2 bits (185), Expect = 5e-15
 Identities = 68/209 (32%), Positives = 105/209 (50%), Gaps = 27/209 (12%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD----VNGSQGHREWLAEVIFLGQLKHP 142
           LG+GG+GKV++         G   +  A+KVL     V   +      AE   L  +KHP
Sbjct: 4   LGKGGYGKVFQVRKVTGADTG---KIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 143 HLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKN----YSSTLPWLTRIKIAIGAARCL 197
            +V+LI Y  +   +L L+ EY++ G L   L +       +   +L+ I +A+      
Sbjct: 61  FIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALE----- 114

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ-GEDSHITTCVMGTEGYAA 256
              H  ++ +IYRD K  NILLD+  + KL+DFGL  +    G  +H T C  GT  Y A
Sbjct: 115 ---HLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH-TFC--GTIEYMA 168

Query: 257 PEYI-NTGHLTTMCDVFSFGVVLLELLTG 284
           PE +  +GH   + D +S G ++ ++LTG
Sbjct: 169 PEILMRSGHGKAV-DWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 73.9 bits (181), Expect = 7e-15
 Identities = 71/206 (34%), Positives = 104/206 (50%), Gaps = 25/206 (12%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG+V+    +       K   VAVK +   GS     +LAE   +  L+H  LV 
Sbjct: 14  LGAGQFGEVWMATYN-------KHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVK 65

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     + E   ++ E+MA G+L D L  +  S  P    I  +   A  +AF+  E++ 
Sbjct: 66  LHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI--EQRN 122

Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG------YAAPEYI 260
            I+RD +A+NIL+ +    K++DFGLA      ED+  T      EG      + APE I
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLAR---VIEDNEYT----AREGAKFPIKWTAPEAI 175

Query: 261 NTGHLTTMCDVFSFGVVLLELLT-GR 285
           N G  T   DV+SFG++L+E++T GR
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 73.9 bits (181), Expect = 7e-15
 Identities = 68/273 (24%), Positives = 117/273 (42%), Gaps = 26/273 (9%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL-DVNGSQGHREWLAEVIFLGQLKHPHLV 145
           +G G FG+V+ G +  +  P      VAVK   +        ++L E   L Q  HP++V
Sbjct: 3   IGRGNFGEVFSGRLRADNTP------VAVKSCRETLPPDLKAKFLQEARILKQYSHPNIV 56

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            LIG C + +   +V E +  G+    L +     L     I++   AA  + +L  E K
Sbjct: 57  RLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYL--ESK 113

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
             I+RD  A N L+      K+SDFG++ +   G  +           + APE +N G  
Sbjct: 114 HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173

Query: 266 TTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRY 325
           ++  DV+SFG++L E  +       N   ++       R  ++   +L    +   +  Y
Sbjct: 174 SSESDVWSFGILLWEAFSLGAVPYANLSNQQ------TREAIEQGVRL-PCPELCPDAVY 226

Query: 326 STEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL 358
                     +  +C  ++P  RP+ +TV + L
Sbjct: 227 R---------LMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 74.6 bits (183), Expect = 8e-15
 Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 27/218 (12%)

Query: 87  LGEGGFGKVYK--GCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL----- 139
           LGEG FG+V +      D  RP  +  TVAVK+L  N +      LA++I   +L     
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPD-QTVTVAVKMLKDNATDKD---LADLISEMELMKLIG 75

Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQL--------------FKNYSSTLPWLT 185
           KH +++NL+G C ++    ++ EY A GNL + L               K     L +  
Sbjct: 76  KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 186 RIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHIT 245
            +  A   AR + +L  E +  I+RD  A N+L+  D   K++DFGLA      +    T
Sbjct: 136 LVSCAYQVARGMEYL--ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193

Query: 246 TCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           +       + APE +     T   DV+SFG+++ E+ T
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 74.7 bits (183), Expect = 9e-15
 Identities = 82/296 (27%), Positives = 131/296 (44%), Gaps = 37/296 (12%)

Query: 87  LGEGGFGKVY--KGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL--KHP 142
           LGEG FG+V   +    D  +P  K  TVAVK+L  + +      L   + + ++  KH 
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPN-KPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHK 78

Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK------NYS--------STLPWLTRIK 188
           +++NL+G C +D    ++ EY + GNL + L        +YS          L +   + 
Sbjct: 79  NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138

Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
            A   AR + +L    +  I+RD  A N+L+  D   K++DFGLA D    +    TT  
Sbjct: 139 CAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
                + APE +     T   DV+SFGV+L E+ T   S            VE    +LK
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS------PYPGIPVEELFKLLK 250

Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL 364
           +  ++D+  +   E          L  +  +C    P  RPT   +V+ L+ +L +
Sbjct: 251 EGHRMDKPANCTHE----------LYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 73.6 bits (180), Expect = 1e-14
 Identities = 79/277 (28%), Positives = 120/277 (43%), Gaps = 36/277 (12%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG+V+ G  +   +       VA+K L   G+     +L E   + +L+H  LV 
Sbjct: 14  LGQGCFGEVWMGTWNGTTK-------VAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVP 65

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     E E   +V E+M  G+L D L +     L     + +A   A  +A++  E   
Sbjct: 66  LYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI--ERMN 122

Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINTG 263
            I+RD +A+NIL+  +   K++DFGLA      ED+  T    G +    + APE    G
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLAR---LIEDNEYTA-RQGAKFPIKWTAPEAALYG 178

Query: 264 HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLED 323
             T   DV+SFG++L EL+T  R        RE                L+Q+   R   
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---------------VLEQV--ERGYR 221

Query: 324 RYSTEGA-KRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
               +G  + L  +   C   +P  RPT   +   LE
Sbjct: 222 MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 75/263 (28%), Positives = 117/263 (44%), Gaps = 51/263 (19%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FGKVYK     N   G+ A   A KV+D    +   +++ E+  L    HP++V 
Sbjct: 13  LGDGAFGKVYKA---QNKETGVLA---AAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 66

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL-AFLHGEEK 205
           L+     + +  ++ E+ A G +   + +        LT  +I +   + L A  +  E 
Sbjct: 67  LLDAFYYENNLWILIEFCAGGAVDAVMLELERP----LTEPQIRVVCKQTLEALNYLHEN 122

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGEDSHITTCVMGTEGYAAPEYINT 262
            +I+RD KA NIL   D + KL+DFG++   T   Q  DS I     GT  + APE +  
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVV-- 175

Query: 263 GHLTTMC------------DVFSFGVVLLEL---------LTGRRSVEKNRCKREKDLVE 301
                MC            DV+S G+ L+E+         L   R + K        L +
Sbjct: 176 -----MCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQ 230

Query: 302 WAR--PMLKDFTK--LDQIIDSR 320
            +R     KDF K  L++ +D+R
Sbjct: 231 PSRWSSEFKDFLKKCLEKNVDAR 253

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 77/275 (28%), Positives = 116/275 (42%), Gaps = 36/275 (13%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFLG 137
           F +   LG+GGFG+V   C       G   +  A K L+   +   +G    L E   L 
Sbjct: 2   FRQYRVLGKGGFGEV---CACQVRATG---KMYACKRLEKKRIKKRKGESMALNEKQILE 55

Query: 138 QLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR- 195
           ++    +VNL  Y  E +  L LV   M  G+L    F  Y+   P     +    AA  
Sbjct: 56  KVNSQFVVNL-AYAYETKDALCLVLTIMNGGDLK---FHIYNMGNPGFEEERALFYAAEI 111

Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
                    +  +YRD K  NILLD   + ++SD GLA   P+GE        +GT GY 
Sbjct: 112 LCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SIRGRVGTVGYM 168

Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTGRRSV--EKNRCKREKDLVEWARPMLKDFTKL 313
           APE +N    T   D +  G ++ E++ G+      K + KRE    E  R +L+     
Sbjct: 169 APEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE----EVDRRVLET---- 220

Query: 314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSR 348
                   E+ YS + ++   ++    L+ +PK R
Sbjct: 221 --------EEVYSAKFSEEAKSICKMLLTKDPKQR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 74.2 bits (182), Expect = 1e-14
 Identities = 72/228 (31%), Positives = 103/228 (45%), Gaps = 37/228 (16%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---------DVNGSQGHREWLAEVIFLG 137
           LG+G FGKV    + ++       +  AVKVL         DV  +   +  L+    L 
Sbjct: 3   LGKGSFGKVMLARLKES------GRLYAVKVLKKDVILQDDDVECTMTEKRILS----LA 52

Query: 138 QLKHPHLVNLIGYCC-EDEHRLL-VYEYMALGNL--HDQLFKNYSSTLPWLTRIKIAIGA 193
           +  HP L  L  YCC +   RL  V E++  G+L  H Q  + +          +I    
Sbjct: 53  R-NHPFLTQL--YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIT--- 106

Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
              L FLH  +K +IYRD K  N+LLD + + KL+DFG+  +G     +  T C  GT  
Sbjct: 107 -SALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC--GTPD 161

Query: 254 YAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVE 301
           Y APE +         D ++ GV+L E+L G    E    + E DL E
Sbjct: 162 YIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE---AENEDDLFE 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 73.8 bits (181), Expect = 2e-14
 Identities = 69/213 (32%), Positives = 97/213 (45%), Gaps = 36/213 (16%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---------DVNGSQGHREWLAEVIFLG 137
           LG+G FGKV    +        K +  AVK L         DV  +   +  LA      
Sbjct: 3   LGKGSFGKVLLAELKG------KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA---- 52

Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNL--HDQ---LFKNYSSTLPWLTRIKIAIG 192
             ++P L +L       EH   V E++  G+L  H Q    F  Y +T       +I  G
Sbjct: 53  -WENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF---YAAEIVCG 108

Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE 252
               L FLH   K +IYRD K  N++LD D + K++DFG+  +   G++   T C  GT 
Sbjct: 109 ----LQFLH--SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC--GTP 160

Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
            Y APE +     T   D +SFGV+L E+L G+
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 34/216 (15%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHREWLAEVIFL 136
           +  R   +G G FG+V+       +R  +     A+KV+   +V   +  +    E   L
Sbjct: 2   DLERIKTVGTGTFGRVHL------VRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVL 55

Query: 137 GQLKHPHLVNLIGYCCEDEHRLL--VYEYMALGNLHDQL-----FKNYSSTLPWLTRIKI 189
            ++ HP ++ L  +  E + R L  + EY+  G L   L     F N S+ L + + I  
Sbjct: 56  KEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSN-STGLFYASEIVC 112

Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM 249
           A+       +LH +E  ++YRD K  NILLD + + KL+DFG A    +  D   T C  
Sbjct: 113 AL------EYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAK---KLRDRTWTLC-- 159

Query: 250 GTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTG 284
           GT  Y APE I + GH     D ++ G+++ E+L G
Sbjct: 160 GTPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 69/215 (32%), Positives = 97/215 (45%), Gaps = 21/215 (9%)

Query: 80  NFSRSDYLGEGGFGKVY----KGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
           NF     LG G +GKV+     G  D      L A  V  K   V  ++       E   
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAG---KLYAMKVLKKATIVQKAKTAEHTRTERQV 57

Query: 136 LGQLKH-PHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGA 193
           L  ++  P LV L  Y  + + +L L+ +Y+  G L   L   Y       + +++ I  
Sbjct: 58  LEAVRRCPFLVTL-HYAFQTDTKLHLILDYVNGGELFTHL---YQREHFTESEVRVYIAE 113

Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD-GPQGEDSHITTCVMGTE 252
              LA  H  +  +IYRD K  NILLDS+ +  L+DFGL+ +   + E+   + C  GT 
Sbjct: 114 I-VLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC--GTI 170

Query: 253 GYAAPEYINT---GHLTTMCDVFSFGVVLLELLTG 284
            Y APE I     GH     D +S GV+  ELLTG
Sbjct: 171 EYMAPEVIRGGSGGH-DKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 80/296 (27%), Positives = 129/296 (43%), Gaps = 50/296 (16%)

Query: 87  LGEGGFGKVYKGCV--DDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHL 144
           LGEG FG V +G +  DD++   LK     +K+     S+   ++L+E + + +  HP++
Sbjct: 7   LGEGEFGSVMEGQLNQDDSI---LKVAVKTMKIAICTRSE-MEDFLSEAVCMKEFDHPNV 62

Query: 145 VNLIGYCCEDEHR------LLVYEYMALGNLHDQLFKNYSST------LPWLTRIKIAIG 192
           + LIG C +          +++  +M  G+LH  L   YS        LP    +K    
Sbjct: 63  MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLL--YSRLGDCPQYLPTQMLVKFMTD 120

Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT---DGP---QGEDSHITT 246
            A  + +L    K  I+RD  A N +L+ + N  ++DFGL+    +G    QG  + +  
Sbjct: 121 IASGMEYL--SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178

Query: 247 CVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPM 306
             +  E  A   Y      TT  DV+SFGV + E+ T  R           ++ ++    
Sbjct: 179 KWIAIESLADRVY------TTKSDVWSFGVTMWEIAT--RGQTPYPGVENSEIYDY---- 226

Query: 307 LKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
           L+   +L Q  D  L+  YS         +   C   NPK RP+  T+   LE  L
Sbjct: 227 LRQGNRLKQPPDC-LDGLYS---------LMSSCWLLNPKDRPSFETLRCELEKAL 272

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 68/204 (33%), Positives = 93/204 (45%), Gaps = 20/204 (9%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEV-IFLGQLKHP 142
           +G+G FGKV         +  L  +  AVKVL    V   +  +  +AE  + L  +KHP
Sbjct: 3   IGKGSFGKVLLA------KRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHP 56

Query: 143 HLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGA-ARCLAFL 200
            LV L  Y  +   +L  V +++  G L   L +  S   P   R +      A  L +L
Sbjct: 57  FLVGL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP---RARFYAAEIASALGYL 112

Query: 201 HGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI 260
           H     ++YRD K  NILLDS  +  L+DFGL  +G    D+  T C  GT  Y APE I
Sbjct: 113 HSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC--GTPEYLAPEVI 168

Query: 261 NTGHLTTMCDVFSFGVVLLELLTG 284
                    D +  G VL E+L G
Sbjct: 169 RKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 72.6 bits (178), Expect = 2e-14
 Identities = 79/292 (27%), Positives = 124/292 (42%), Gaps = 57/292 (19%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLV 145
           LG+G F K++KG   +    G   +T V +KVLD +       +      + QL H HLV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 146 NLIGYC-CEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
              G C C DE  ++V EY+  G+L   L KN  + +    ++++A   A  L FL  E+
Sbjct: 63  LNYGVCVCGDES-IMVQEYVKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFL--ED 118

Query: 205 KPVIYRDFKASNILLDSDYNA--------KLSDFGLATDGPQGEDSHITTCVMGTE---- 252
           K + + +  A N+LL  + +         KLSD G            I+  V+  E    
Sbjct: 119 KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG------------ISITVLPKEILLE 166

Query: 253 --GYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKD 309
              +  PE I N  +L+   D +SFG  L E+ +G                       K 
Sbjct: 167 RIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGD---------------------KP 205

Query: 310 FTKLDQIIDSRL-EDRYSTEGAK--RLAAVAHQCLSHNPKSRPTMTTVVKAL 358
            + LD     +  EDR+     K   LA + +QC+ + P  RP+   +++ L
Sbjct: 206 LSALDSQKKLQFYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 72.6 bits (178), Expect = 3e-14
 Identities = 69/277 (24%), Positives = 119/277 (42%), Gaps = 36/277 (12%)

Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFL 136
            +    + LG G  G VYK          L  + +AVKV  LD+   +  ++ ++E+  L
Sbjct: 1   QDIQYQEILGHGNGGTVYKAYHL------LTRRILAVKVIPLDIT-VELQKQIMSELEIL 53

Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
            +   P+++   G    +    +  E+M  G+L      +    +P     +IA+   + 
Sbjct: 54  YKCDSPYIIGFYGAFFVENRISICTEFMDGGSL------DVYRKIPEHVLGRIAVAVVKG 107

Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L +L   +  +++RD K SN+L+++    KL DFG++T   Q  +S I    +GT  Y A
Sbjct: 108 LTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVST---QLVNS-IAKTYVGTNAYMA 161

Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTGR---RSVEKNRCKREKDLVEWARPMLKDFTKL 313
           PE I+        DV+S G+  +EL  GR     ++KN+              L     L
Sbjct: 162 PERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS------------LMPLQLL 209

Query: 314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT 350
             I+D         + +++      QC+   PK RP 
Sbjct: 210 QCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPA 246

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 22/213 (10%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK     N   G   + VA+K   LD          + E+  L 
Sbjct: 1   NFQKVEKIGEGTYGVVYKA---RNKLTG---EVVALKKIRLDTETEGVPSTAIREISLLK 54

Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +L HP++V L+     +    LV+E++       Q  K +    P L+ I + +  +   
Sbjct: 55  ELNHPNIVKLLDVIHTENKLYLVFEFL------HQDLKKFMDASP-LSGIPLPLIKSYLF 107

Query: 198 AFLHG----EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
             L G        V++RD K  N+L++++   KL+DFGLA     G      T  + T  
Sbjct: 108 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLW 165

Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +   + +T  D++S G +  E++T R
Sbjct: 166 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 21/208 (10%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK 140
           ++R + +G+G  G VY      ++  G   Q VA+K +++         + E++ + + K
Sbjct: 21  YTRFEKIGQGASGTVYTAI---DIATG---QEVAIKQMNLQQQPKKELIINEILVMRENK 74

Query: 141 HPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLA-- 198
           +P++VN +      +   +V EY+A G+L D +      T   +   +IA     CL   
Sbjct: 75  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQAL 128

Query: 199 -FLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL-ATDGPQGEDSHITTCVMGTEGYAA 256
            FLH  +  VI+RD K+ NILL  D + KL+DFG  A   P  E S  +T V GT  + A
Sbjct: 129 DFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMA 183

Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTG 284
           PE +         D++S G++ +E++ G
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 81/302 (26%), Positives = 130/302 (43%), Gaps = 47/302 (15%)

Query: 87  LGEGGFGKVY--KGCVDDNLRPGLKAQTVAVKVLDVNGSQGH-REWLAEVIFLGQL-KHP 142
           LGEG FG+V   +    D  +P  +   VAVK+L  + ++    + ++E+  +  + KH 
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPN-RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 84

Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQL--------------FKNYSSTLPWLTRIK 188
           +++NL+G C +D    ++ EY + GNL + L               +     L +   + 
Sbjct: 85  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144

Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
            A   AR + +L    K  I+RD  A N+L+  D   K++DFGLA D       HI    
Sbjct: 145 CAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD-----IHHIDYYK 197

Query: 249 MGTEG-----YAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA 303
             T G     + APE +     T   DV+SFGV+L E+ T   S            VE  
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------VEEL 251

Query: 304 RPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD 363
             +LK+  ++D+           +     L  +   C    P  RPT   +V+ L+ +L 
Sbjct: 252 FKLLKEGHRMDK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301

Query: 364 LN 365
           L 
Sbjct: 302 LT 303

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 71/265 (26%), Positives = 122/265 (46%), Gaps = 30/265 (11%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           +GEG  G V   C+    R     + VAVK++D+   Q       EV+ +   +H ++V 
Sbjct: 29  IGEGSTGIV---CI---AREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVE 82

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI---GAARCLAFLHGE 203
           +       E   ++ E++  G L D + +        L   +IA       + L +LH +
Sbjct: 83  MYKSYLVGEELWVLMEFLQGGALTDIVSQTR------LNEEQIATVCESVLQALCYLHSQ 136

Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFG----LATDGPQGEDSHITTCVMGTEGYAAPEY 259
              VI+RD K+ +ILL  D   KLSDFG    ++ D P+ +       ++GT  + APE 
Sbjct: 137 G--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS------LVGTPYWMAPEV 188

Query: 260 INTGHLTTMCDVFSFGVVLLELLTGRRS-VEKNRCKREKDLVEWARPMLKDFTKLDQIID 318
           I+     T  D++S G++++E++ G       +  +  K L +   P LK+  K+  ++ 
Sbjct: 189 ISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLR 248

Query: 319 SRLEDRYSTEGAKRLAAVAHQCLSH 343
             LE   + E  +R  A A + L H
Sbjct: 249 DFLERMLTREPQER--ATAQELLDH 271

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 72.0 bits (176), Expect = 5e-14
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 38/211 (18%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FGKVYK     N   G  A   A KV++    +   +++ E+  L    HP++V 
Sbjct: 20  LGDGAFGKVYKA---KNKETGALA---AAKVIETKSEEELEDYMVEIEILATCNHPYIVK 73

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFK-NYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
           L+G    D    ++ E+   G +   + + +   T P +  I   +  A  L +LH    
Sbjct: 74  LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEA--LQYLH--SM 129

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGEDSHITTCVMGTEGYAAPEYINT 262
            +I+RD KA N+LL  D + KL+DFG++       Q  DS I     GT  + APE +  
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVV-- 182

Query: 263 GHLTTMC------------DVFSFGVVLLEL 281
                MC            D++S G+ L+E+
Sbjct: 183 -----MCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 71.1 bits (174), Expect = 6e-14
 Identities = 78/284 (27%), Positives = 122/284 (42%), Gaps = 52/284 (18%)

Query: 87  LGEGGFGKVY--KGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA--EVIFLGQLKHP 142
           +GEG FGK+Y  K   D        ++   +K +D+       +  +  EVI L ++KHP
Sbjct: 8   IGEGSFGKIYLAKAKSD--------SEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59

Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNL-------HDQLFKNYSSTLPWLTRIKIAIGAAR 195
           ++V       E+    +V EY   G+L          LF      L W  +I        
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSE-DQILSWFVQIS------- 111

Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSD-YNAKLSDFGLATDGPQGEDSH--ITTCVMGTE 252
            L   H  ++ +++RD K+ NI L  +   AKL DFG+A    Q  DS     TCV GT 
Sbjct: 112 -LGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR---QLNDSMELAYTCV-GTP 166

Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK 312
            Y +PE           D++S G VL EL T +   E N   +   LV           K
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ---LV----------LK 213

Query: 313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
           + Q   + +   +S +    L ++  Q    +P+ RP++T+++K
Sbjct: 214 ICQGYFAPISPNFSRD----LRSLISQLFKVSPRDRPSITSILK 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 72.2 bits (177), Expect = 7e-14
 Identities = 53/154 (34%), Positives = 79/154 (51%), Gaps = 24/154 (15%)

Query: 141 HPHLVNLIGYCCEDEHRL-LVYEYMALGNL--HDQLFKNYSSTLP------WLTRIKIAI 191
           HP LV L   C + E RL  V E+++ G+L  H Q        LP      +   I +A 
Sbjct: 55  HPFLVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQ----RQRKLPEEHARFYSAEISLA- 108

Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
                L FLH  E+ +IYRD K  N+LLD++ + KL+D+G+  +G +  D+  T C  GT
Sbjct: 109 -----LNFLH--ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC--GT 159

Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE +         D ++ GV++ E++ GR
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 71.2 bits (175), Expect = 8e-14
 Identities = 67/204 (32%), Positives = 92/204 (45%), Gaps = 21/204 (10%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVK--VLDVNGSQGHREWLAEVIFLGQLKHPHL 144
           +GEG +G V+K C +         Q VA+K  V   +     +  L E+  L QLKHP+L
Sbjct: 9   IGEGSYGVVFK-CRNRETG-----QIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNL 62

Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           VNLI          LV+EY     L++   +     +P     KI     + + F H   
Sbjct: 63  VNLIEVFRRKRKLHLVFEYCDHTVLNE--LEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN 120

Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLA--TDGPQGEDSHITTCVMGTEGYAAPEYI-- 260
              I+RD K  NIL+      KL DFG A    GP  +    T  V  T  Y APE +  
Sbjct: 121 --CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD---YTDYV-ATRWYRAPELLVG 174

Query: 261 NTGHLTTMCDVFSFGVVLLELLTG 284
           +T +   + DV++ G V  ELLTG
Sbjct: 175 DTQYGPPV-DVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 71.3 bits (175), Expect = 8e-14
 Identities = 52/171 (30%), Positives = 79/171 (46%), Gaps = 31/171 (18%)

Query: 188 KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC 247
           KIA+   + L +LH  +  VI+RD K SN+L++ +   KL DFG++       DS   T 
Sbjct: 107 KIAVSIVKALEYLH-SKLSVIHRDVKPSNVLINRNGQVKLCDFGISG---YLVDSVAKTI 162

Query: 248 VMGTEGYAAPEYIN----TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA 303
             G + Y APE IN            DV+S G+ ++EL TGR   +            W 
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS-----------WK 211

Query: 304 RPMLKDFTKLDQIIDS---RL-EDRYSTEGAKRLAAVAHQCLSHNPKSRPT 350
            P    F +L Q+++    +L  +++S E         ++CL  N K RP 
Sbjct: 212 TP----FQQLKQVVEEPSPQLPAEKFSPE----FQDFVNKCLKKNYKERPN 254

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 71.0 bits (175), Expect = 8e-14
 Identities = 65/219 (29%), Positives = 95/219 (43%), Gaps = 49/219 (22%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREW-----LAEVIFLGQLK- 140
           LG+G FG VY      N   G   + VA+K +     +    W     L EV  L +L  
Sbjct: 7   LGDGTFGSVYLA---RNKETG---ELVAIKKM----KKKFYSWEECMNLREVKSLRKLNE 56

Query: 141 HPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIK-----IAIGAAR 195
           HP++V L     E++    V+EYM  GNL+ QL K+        + I+     I  G   
Sbjct: 57  HPNIVKLKEVFRENDELYFVFEYME-GNLY-QLMKDRKGKPFSESVIRSIIYQILQG--- 111

Query: 196 CLAFLH--GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI------TTC 247
            LA +H  G      +RD K  N+L+      K++DFGLA          I      T  
Sbjct: 112 -LAHIHKHG----FFHRDLKPENLLVSGPEVVKIADFGLA--------REIRSRPPYTDY 158

Query: 248 VMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
           V  T  Y APE +  +   ++  D+++ G ++ EL T R
Sbjct: 159 V-STRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 71.6 bits (175), Expect = 9e-14
 Identities = 53/155 (34%), Positives = 77/155 (49%), Gaps = 12/155 (7%)

Query: 134 IFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNL--HDQLFKNYSSTLPWLTRIKIA 190
           +F     +P LV L   C +   RL LV EY+  G+L  H Q  +            +I 
Sbjct: 48  VFEQASSNPFLVGLHS-CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEIC 106

Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG 250
           I     L FLH  E+ +IYRD K  N+LLD+D + KL+D+G+  +G    D+  T C  G
Sbjct: 107 IA----LNFLH--ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC--G 158

Query: 251 TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           T  Y APE +         D ++ GV++ E++ GR
Sbjct: 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 70.3 bits (172), Expect = 1e-13
 Identities = 70/276 (25%), Positives = 123/276 (44%), Gaps = 36/276 (13%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG V+ G      R  +K   VA+K ++  G+    +++ E   + +L HP LV 
Sbjct: 12  LGSGQFGVVHLG----KWRAQIK---VAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQ 63

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L G C + +   +V E+M  G L + L +           + +++    C    + E   
Sbjct: 64  LYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSK---DMLLSMCQDVCEGMEYLERNS 120

Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINTG 263
            I+RD  A N L+ S    K+SDFG+       +D + ++   G +    ++ PE  N  
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTR--YVLDDEYTSSS--GAKFPVKWSPPEVFNFS 176

Query: 264 HLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLE 322
             ++  DV+SFGV++ E+ T G+   EK   K   ++VE         ++  ++   +L 
Sbjct: 177 KYSSKSDVWSFGVLMWEVFTEGKMPFEK---KSNYEVVE-------MISRGFRLYRPKLA 226

Query: 323 DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL 358
                E       V + C    P+ RPT   +++A+
Sbjct: 227 SMTVYE-------VMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 72/286 (25%), Positives = 121/286 (42%), Gaps = 41/286 (14%)

Query: 80  NFSRSDYLGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ 138
           NF     +G G F +VY+  C+ D +   LK     V++ D+  ++   + + E+  L Q
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKK----VQIFDLMDAKARADCIKEIDLLKQ 58

Query: 139 LKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQL--FKNYSSTLPWLTRIKIAIGAARC 196
           L HP+++       ED    +V E    G+L   +  FK     +P  T  K  +    C
Sbjct: 59  LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV--QLC 116

Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC--VMGTEGY 254
            A  H   + V++RD K +N+ + +    KL D GL     +   S  T    ++GT  Y
Sbjct: 117 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG----RFFSSKTTAAHSLVGTPYY 172

Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLEL------LTGRRSVEKNRCKREKDLVEWARPMLK 308
            +PE I+        D++S G +L E+        G +    + CK+ +           
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--------- 223

Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTV 354
           D+  L         D YS E    L  + + C++ +P+ RP +T V
Sbjct: 224 DYPPLPS-------DHYSEE----LRQLVNMCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 71.1 bits (174), Expect = 1e-13
 Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 26/219 (11%)

Query: 87  LGEGGFGKVY------------KGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEV 133
           LGEG FG+V+            K    D    G +   VAVK+L  + ++  R ++L E+
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDV--SGNQPVLVAVKMLREDANKNARNDFLKEI 70

Query: 134 IFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLH---------DQLFKNYSSTLPWL 184
             + +LK P+++ L+  C   +   ++ EYM  G+L+         +   K    T+ + 
Sbjct: 71  KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130

Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI 244
           T I +A   A  + +L       ++RD    N L+  +Y  K++DFG++ +   G+   I
Sbjct: 131 TLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188

Query: 245 TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
               +    + + E I  G  TT  DV++FGV L E+LT
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 55/176 (31%), Positives = 90/176 (51%), Gaps = 9/176 (5%)

Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI 191
           E+  L +   P++V   G    D    +  E+M  G+L DQ+ K  +  +P     K++I
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKE-AKRIPEEILGKVSI 110

Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
              R LA+L  E+  +++RD K SNIL++S    KL DFG++    Q  DS   + V GT
Sbjct: 111 AVLRGLAYLR-EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV-GT 165

Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML 307
             Y +PE +   H +   D++S G+ L+EL  GR  +     K  + +  + RP++
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI--FGRPVV 219

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 70/206 (33%), Positives = 94/206 (45%), Gaps = 24/206 (11%)

Query: 87  LGEGGFGKVY--KGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREW---LAEV-IFLGQLK 140
           +G+G FGKV   K   D +          AVKVL        +E    +AE  + L  LK
Sbjct: 3   IGKGSFGKVLLAKRKSDGSF--------YAVKVLQKKTILKKKEQNHIMAERNVLLKNLK 54

Query: 141 HPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKI-AIGAARCLA 198
           HP LV L  Y  +   +L  V +Y+  G L   L +      P   R +  A   A  + 
Sbjct: 55  HPFLVGL-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP---RARFYAAEVASAIG 110

Query: 199 FLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPE 258
           +LH     +IYRD K  NILLDS  +  L+DFGL  +G + E++  T C  GT  Y APE
Sbjct: 111 YLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC--GTPEYLAPE 166

Query: 259 YINTGHLTTMCDVFSFGVVLLELLTG 284
            +         D +  G VL E+L G
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 69/284 (24%), Positives = 122/284 (42%), Gaps = 33/284 (11%)

Query: 78  THNFSRSDYLGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFL 136
             NF     +G+G F  VYK  C+ D     LK     V++ ++  ++  ++ L E+  L
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKK----VQIFEMMDAKARQDCLKEIDLL 56

Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQL--FKNYSSTLPWLTRIKIAIGAA 194
            QL HP+++  +    E+    +V E    G+L   +  FK     +P  T  K  +   
Sbjct: 57  KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116

Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITT---CVMGT 251
             L  +H   K +++RD K +N+ + +    KL D GL   G     S  TT    ++GT
Sbjct: 117 SALEHMH--SKRIMHRDIKPANVFITATGVVKLGDLGL---GRFF--SSKTTAAHSLVGT 169

Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFT 311
             Y +PE I+        D++S G +L E+   +     ++             +     
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----------LYSLCK 218

Query: 312 KLDQIIDSRL-EDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTV 354
           K+++     L  D YS E    L  +  +C++ +P+ RP ++ V
Sbjct: 219 KIEKCDYPPLPADHYSEE----LRDLVSRCINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 70.3 bits (172), Expect = 2e-13
 Identities = 69/224 (30%), Positives = 102/224 (45%), Gaps = 31/224 (13%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFLGQLKH-- 141
           +G GGFG+VY GC     R     +  A+K LD   +   QG    L E I L  +    
Sbjct: 2   IGRGGFGEVY-GC-----RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 55

Query: 142 -PHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC-LA 198
            P +V  + Y      +L  + + M  G+LH  L     S     +  ++   AA   L 
Sbjct: 56  CPFIV-CMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGVFSEAEMRFYAAEIILG 109

Query: 199 FLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPE 258
             H   + V+YRD K +NILLD   + ++SD GLA D  + +  H +   +GT GY APE
Sbjct: 110 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS---VGTHGYMAPE 165

Query: 259 YINTG-HLTTMCDVFSFGVVLLELLTGR------RSVEKNRCKR 295
            +  G    +  D FS G +L +LL G       ++ +K+   R
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 209

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 65/222 (29%), Positives = 102/222 (45%), Gaps = 25/222 (11%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFLGQLKH-- 141
           +G GGFG+VY GC     R     +  A+K LD   +   QG    L E I L  +    
Sbjct: 2   IGRGGFGEVY-GC-----RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 55

Query: 142 -PHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKN--YSSTLPWLTRIKIAIGAARCLA 198
            P +V +       +    + + M  G+LH  L ++  +S         +I +G      
Sbjct: 56  CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLE---- 111

Query: 199 FLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPE 258
             H   + V+YRD K +NILLD   + ++SD GLA D  + +  H +   +GT GY APE
Sbjct: 112 --HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS---VGTHGYMAPE 165

Query: 259 YINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDL 299
            +  G    +  D FS G +L +LL G     +++ K + ++
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 67/240 (27%), Positives = 109/240 (45%), Gaps = 32/240 (13%)

Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI 191
           E+  L +   P++V   G    D    +  E+M  G+L DQ+ K  +  +P     K++I
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKK-AGRIPEQILGKVSI 110

Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
              + L +L  E+  +++RD K SNIL++S    KL DFG++    Q  DS   + V GT
Sbjct: 111 AVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV-GT 165

Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFT 311
             Y +PE +   H +   D++S G+ L+E+  GR  +                    D  
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP-----------------PDAK 208

Query: 312 KLDQIIDSRLE-DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD--LNDIP 368
           +L+ +    +E D   +E + R         S+ P SRP M     A+  LLD  +N+ P
Sbjct: 209 ELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPM-----AIFELLDYIVNEPP 263

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 69.9 bits (171), Expect = 2e-13
 Identities = 70/290 (24%), Positives = 123/290 (42%), Gaps = 53/290 (18%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQ 138
           + +   +GEG FGK         ++     +   +K ++++    +   E   EV  L  
Sbjct: 2   YVKVKKIGEGSFGKAIL------VKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSN 55

Query: 139 LKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLP------WLTRIKIAIG 192
           +KHP++V       E+ +  +V +Y   G+L+ ++        P      W  +I     
Sbjct: 56  MKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQI----- 110

Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHIT---TCVM 249
              CLA  H  ++ +++RD K+ NI L  D   KL DFG+A    +  +S +    TC+ 
Sbjct: 111 ---CLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIA----RVLNSTVELARTCI- 162

Query: 250 GTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKD 309
           GT  Y +PE           D+++ G VL E+ T + + E       K+LV      LK 
Sbjct: 163 GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM---KNLV------LK- 212

Query: 310 FTKLDQIIDSR---LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                 II      +   YS +    L  +  Q    NP+ RP++ ++++
Sbjct: 213 ------IIRGSYPPVSSHYSYD----LRNLVSQLFKRNPRDRPSVNSILE 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 69.6 bits (171), Expect = 3e-13
 Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 32/210 (15%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDV-NGSQG-HREWLAEVIFLGQLK---H 141
           +GEG +G VYK       R     + VA+K + V    +G     L E+  L QL+   H
Sbjct: 7   IGEGAYGTVYKA------RDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 142 PHLVNLIGYC--CEDEHRL---LVYEYMALGNLHDQLFKNYSSTLP-----WLTRIKIAI 191
           P++V L+  C     +  L   LV+E++   +L   L K     LP      L R ++  
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMR-QLLR 118

Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
           G    + FLH     +++RD K  NIL+ SD   K++DFGLA       +  +T+ V+ T
Sbjct: 119 G----VDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLAR--IYSFEMALTSVVV-T 169

Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLEL 281
             Y APE +      T  D++S G +  EL
Sbjct: 170 LWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 30/218 (13%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA---EVIFL 136
           N+     LG G FG+VY  C D +    L  + V     D +  +  +E  A   E+  L
Sbjct: 3   NWRLGKLLGRGAFGEVYL-CYDADTGRELAVKQVP---FDPDSQETSKEVNALECEIQLL 58

Query: 137 GQLKHPHLVNLIGYCCED--EHRLLVY-EYMALGNLHDQLFKNYSSTLPWLTRIKIAIGA 193
             L+H  +V   G C  D  E +L ++ EYM  G++ DQL K Y +    +TR +     
Sbjct: 59  KNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTR-RYTRQI 115

Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC------ 247
            + +++LH     +++RD K +NIL DS  N KL DFG A+   Q      T C      
Sbjct: 116 LQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFG-ASKRIQ------TICMSGTGI 166

Query: 248 --VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
             V GT  + +PE I+        DV+S    ++E+LT
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 69.0 bits (169), Expect = 3e-13
 Identities = 81/301 (26%), Positives = 126/301 (41%), Gaps = 74/301 (24%)

Query: 87  LGEGGFGKVYKGCV----DDNLRPGLKAQTVAVKVLDVNGSQGHREWLA--EVI-FLGQL 139
           LG+G F  +YKG +    D ++    +  +V +KVL       HR+ LA  E    + QL
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG----SDHRDSLAFFETASLMSQL 58

Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSS-TLPWLTRIKIAIGAARCLA 198
            H HLV L G C  DE+ ++V EY+  G L   L +  ++ +L W   + +A   A  L 
Sbjct: 59  SHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALH 115

Query: 199 FLHGEEKPVIYRDFKASNILL-----DSDYN--AKLSDFGLATDGPQGEDSHITTCVMGT 251
           +L  E+K +++ +    NIL+     +  Y    KLSD G            I   V+  
Sbjct: 116 YL--EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG------------IPITVLSR 161

Query: 252 E------GYAAPEYINTGH--LTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA 303
           E       + APE I  G   LT   D +SFG  LLE+           C   +      
Sbjct: 162 EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI-----------CSNGE------ 204

Query: 304 RPMLKDFTKLDQIIDSRLEDRYSTEG------AKRLAAVAHQCLSHNPKSRPTMTTVVKA 357
               +  + L     S  E  Y  +          LA + +QC +++P  RP+   +++ 
Sbjct: 205 ----EPLSTLSS---SEKERFYQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRD 257

Query: 358 L 358
           L
Sbjct: 258 L 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 69.8 bits (170), Expect = 3e-13
 Identities = 57/209 (27%), Positives = 102/209 (48%), Gaps = 23/209 (11%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK 140
           ++R + +G+G  G VY      ++  G   Q VA++ +++         + E++ + + K
Sbjct: 22  YTRFEKIGQGASGTVYTAM---DVATG---QEVAIRQMNLQQQPKKELIINEILVMRENK 75

Query: 141 HPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLA-- 198
           +P++VN +      +   +V EY+A G+L D +      T   +   +IA     CL   
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQAL 129

Query: 199 -FLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD--GPQGEDSHITTCVMGTEGYA 255
            FLH  +  VI+RD K+ NILL  D + KL+DFG        Q + S +    +GT  + 
Sbjct: 130 EFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM----VGTPYWM 183

Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           APE +         D++S G++ +E++ G
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 69.7 bits (170), Expect = 4e-13
 Identities = 51/155 (32%), Positives = 79/155 (50%), Gaps = 12/155 (7%)

Query: 134 IFLGQLKHPHLVNLIGYCCEDEHRLL-VYEYMALGNL--HDQLFKNYSSTLPWLTRIKIA 190
           +F     HP LV L   C + E RL  V EY+  G+L  H Q  +            +I+
Sbjct: 48  VFEQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 106

Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG 250
           +     L +LH  E+ +IYRD K  N+LLDS+ + KL+D+G+  +G +  D+  T+   G
Sbjct: 107 LA----LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCG 158

Query: 251 TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           T  Y APE +         D ++ GV++ E++ GR
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 69.6 bits (170), Expect = 4e-13
 Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 23/212 (10%)

Query: 81  FSRSDYLGEGGFGKVYKGC---VDDNLRPGLKAQTVAVKVL-DVNGSQGHREWLAEVIFL 136
           F +   LG G FG VYKG      + ++       VA+K L +    + ++E L E   +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKI-----PVAIKELREATSPKANKEILDEAYVM 63

Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST-----LPWLTRIKIAI 191
             + +PH+  L+G C     +L + + M  G L D + ++  +      L W  +I    
Sbjct: 64  ASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---- 118

Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
             A+ + +L  EE+ +++RD  A N+L+ +  + K++DFGLA      E  +        
Sbjct: 119 --AKGMNYL--EERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174

Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
             + A E I     T   DV+S+GV + EL+T
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 68.9 bits (168), Expect = 5e-13
 Identities = 75/273 (27%), Positives = 120/273 (43%), Gaps = 32/273 (11%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFLG 137
           F     LG+GGFG+V   C       G   +  A K L+   +   +G    L E   L 
Sbjct: 2   FRHYRVLGKGGFGEV---CACQVRATG---KMYACKKLEKKRIKKRKGEAMALNEKRILE 55

Query: 138 QLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR- 195
           ++    +V+L  Y  E +  L LV   M  G+L    F  Y+   P     +    AA  
Sbjct: 56  KVNSRFVVSL-AYAYETKDALCLVLTIMNGGDLK---FHIYNMGNPGFDEQRAIFYAAEL 111

Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
           C      + + ++YRD K  NILLD   + ++SD GLA   P+GE        +GT GY 
Sbjct: 112 CCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYM 168

Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ 315
           APE IN    T   D +  G ++ E++ G+    K + + +++ V+  R + +D      
Sbjct: 169 APEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD--RRVKED------ 220

Query: 316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSR 348
                 ++ YS + ++   ++    L+ NPK R
Sbjct: 221 ------QEEYSEKFSEDAKSICRMLLTKNPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 68.5 bits (168), Expect = 5e-13
 Identities = 68/225 (30%), Positives = 97/225 (43%), Gaps = 39/225 (17%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL- 139
           F   + +GEG +GKVYK     + + G   Q VA+K++D+   +   E   E   L +  
Sbjct: 8   FELVEVIGEGTYGKVYKA---RHKKTG---QLVAIKIMDIIEDE-EEEIKEEYNILRKYS 60

Query: 140 KHPHLVNLIG-------YCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIK---- 188
            HP++    G          +D+   LV E    G++ D L K          R+K    
Sbjct: 61  NHPNIATFYGAFIKKNPPGNDDQ-LWLVMELCGGGSVTD-LVKG---LRKKGKRLKEEWI 115

Query: 189 --IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT--DGPQGEDSHI 244
             I     R LA+LH  E  VI+RD K  NILL  +   KL DFG++   D   G  +  
Sbjct: 116 AYILRETLRGLAYLH--ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN-- 171

Query: 245 TTCVMGTEGYAAPEYIN-----TGHLTTMCDVFSFGVVLLELLTG 284
            T + GT  + APE I              DV+S G+  +EL  G
Sbjct: 172 -TFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 68.3 bits (167), Expect = 8e-13
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 24/214 (11%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGH-REWLAEVIFLGQ 138
           NF + + LGEG +  VYKG      R     + VA+K + ++  +G     + E+  + +
Sbjct: 1   NFKQLEKLGEGTYATVYKG------RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKE 54

Query: 139 LKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST------LPWLTRIKIAIG 192
           LKH ++V L      +   +LV+EYM      D+  K Y  T      L   T       
Sbjct: 55  LKHENIVRLHDVIHTENKLMLVFEYM------DKDLKKYMDTHGVRGALDPNTVKSFTYQ 108

Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE 252
             + +AF H  E  V++RD K  N+L++     KL+DFGLA       ++     V  T 
Sbjct: 109 LLKGIAFCH--ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TL 164

Query: 253 GYAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            Y AP+  + +   +T  D++S G ++ E++TGR
Sbjct: 165 WYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 67.9 bits (166), Expect = 8e-13
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 34/213 (15%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G +G VY                +A+K +    S+  +    E+     LKH ++V 
Sbjct: 16  LGKGTYGIVYAARDLSTQV------RIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQ 69

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQL------FKNYSSTLPWLTRIKIAIGAARCLAFL 200
            +G   E+    +  E +  G+L   L       K+   T+ + T+ +I  G    L +L
Sbjct: 70  YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-QILEG----LKYL 124

Query: 201 HGEEKPVIYRDFKASNILLDSDYNA--KLSDFG----LATDGPQGEDSHITTCVMGTEGY 254
           H  +  +++RD K  N+L+++ Y+   K+SDFG    LA   P       T    GT  Y
Sbjct: 125 H--DNQIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGINP------CTETFTGTLQY 175

Query: 255 AAPEYINTGH--LTTMCDVFSFGVVLLELLTGR 285
            APE I+ G        D++S G  ++E+ TG+
Sbjct: 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 67.6 bits (165), Expect = 1e-12
 Identities = 70/279 (25%), Positives = 113/279 (40%), Gaps = 31/279 (11%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA--EVIFLG 137
            + +   +G G FG V+  C           + V +K + V          A  E   L 
Sbjct: 1   KYEKIRVVGRGAFGIVHL-CRRKA-----DQKLVIIKQIPVEQMTKDERLAAQNECQVLK 54

Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
            L HP+++       ED+  ++V EY   G L + + K  +S L   T +   +     L
Sbjct: 55  LLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI--LL 112

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYN-AKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           A  H   K +++RD K  NILLD      K+ DFG++        S   T V+GT  Y +
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-VVGTPCYIS 169

Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI 316
           PE           D+++ G VL EL + +R+ E               P L    K+   
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-----------PAL--VLKIMSG 216

Query: 317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVV 355
             + + DRYS +    L  +    L+ +P  RP ++ ++
Sbjct: 217 TFAPISDRYSPD----LRQLILSMLNLDPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 67.6 bits (165), Expect = 1e-12
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 23/212 (10%)

Query: 87  LGEGGFGKVYKGCVDDNLRPG--LKAQTVAVKVLDVNGSQGHREWLA----EVIFLGQLK 140
           +G G FG VY G    N   G  +  + V +  +  +     R  L     E+  L +L+
Sbjct: 8   IGSGSFGSVYLGM---NASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64

Query: 141 HPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTR---IKIAIGAARCL 197
           H ++V  +G   + +H  +  EY+  G++   L  NY +    L R    +I  G    L
Sbjct: 65  HENIVQYLGSSLDADHLNIFLEYVPGGSVA-ALLNNYGAFEETLVRNFVRQILKG----L 119

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFG----LATDGPQGEDSHITTCVMGTEG 253
            +LH   + +I+RD K +NIL+D+    K+SDFG    L  +    + +     + G+  
Sbjct: 120 NYLH--NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177

Query: 254 YAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           + APE +     T   D++S G +++E+LTG+
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 15/207 (7%)

Query: 80  NFSRSDYLGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ 138
           NF     +G G F +VY+  C+ D     LK     V++ ++  ++  ++ + E+  L Q
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKK----VQIFEMMDAKARQDCVKEIDLLKQ 58

Query: 139 LKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQL--FKNYSSTLPWLTRIKIAIGAARC 196
           L HP+++  +    ED    +V E    G+L   +  FK     +P  T  K  +    C
Sbjct: 59  LNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFV--QLC 116

Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC--VMGTEGY 254
            A  H   + V++RD K +N+ + +    KL D GL     +   S  T    ++GT  Y
Sbjct: 117 SAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG----RFFSSKTTAAHSLVGTPYY 172

Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLEL 281
            +PE I+        D++S G +L E+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 78/296 (26%), Positives = 131/296 (44%), Gaps = 37/296 (12%)

Query: 87  LGEGGFGKVY--KGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL--KHP 142
           LGEG FG+V   +    D  +P  +A TVAVK+L  + ++     L   + + ++  KH 
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 81

Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPW---LTR-----------IK 188
           +++NL+G C +D    ++ EY + GNL + L       + +   + R           + 
Sbjct: 82  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141

Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
                AR + +L  ++   I+RD  A N+L+  +   K++DFGLA D    +    TT  
Sbjct: 142 CTYQVARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
                + APE +     T   DV+SFGV++ E+ T   S            VE    +LK
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS------PYPGIPVEELFKLLK 253

Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL 364
           +  ++D+  +   E          L  +   C    P  RPT   +V+ L+ +L L
Sbjct: 254 EGHRMDKPANCTNE----------LYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 63/203 (31%), Positives = 87/203 (42%), Gaps = 17/203 (8%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE---WLAEVIFLGQLKHPH 143
           LG+G FGKV        +R     +  A+K+L         E    L E   L   +HP 
Sbjct: 3   LGKGTFGKVIL------VREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPF 56

Query: 144 LVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
           L  L  Y  +   RL  V EY   G L   L +    +          I +A  L +LH 
Sbjct: 57  LTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LGYLH- 112

Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT 262
               V+YRD K  N++LD D + K++DFGL  +G     +  T C  GT  Y APE +  
Sbjct: 113 -SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC--GTPEYLAPEVLED 169

Query: 263 GHLTTMCDVFSFGVVLLELLTGR 285
                  D +  GVV+ E++ GR
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 46/199 (23%), Positives = 79/199 (39%), Gaps = 44/199 (22%)

Query: 159 LVYEYM----------ALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVI 208
           LV EY+           LG L +   K Y + +               +  LH   + +I
Sbjct: 74  LVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEV------------VLGVEDLHQ--RGII 119

Query: 209 YRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTM 268
           +RD K  N+L+D   + KL+DFGL+ +G + +        +GT  Y APE I       M
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETILGVGDDKM 173

Query: 269 CDVFSFGVVLLELLTGRR------------SVEKNRCKREKDLVEWARPMLKDFTKLDQI 316
            D +S G V+ E L G              ++   R    +++ E+  P   D   ++++
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDL--INRL 231

Query: 317 IDSRLEDRYSTEGAKRLAA 335
           +      R    G + + +
Sbjct: 232 LCMDPAKRLGANGYQEIKS 250

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 68/261 (26%), Positives = 118/261 (45%), Gaps = 22/261 (8%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           +GEG  G V   C+      G   + VAVK +D+   Q       EV+ +    H ++V+
Sbjct: 30  IGEGSTGIV---CIATEKHTG---KQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVD 83

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           +       +   +V E++  G L D +     +     T   + +   R L++LH +   
Sbjct: 84  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT---VCLSVLRALSYLHNQG-- 138

Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
           VI+RD K+ +ILL SD   KLSDFG        ++      ++GT  + APE I+     
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQ--VSKEVPKRKSLVGTPYWMAPEVISRLPYG 196

Query: 267 TMCDVFSFGVVLLELLTGR----RSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLE 322
           T  D++S G++++E++ G             +R +D +    P +KD  K+  ++   L+
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLP---PRVKDSHKVSSVLRGFLD 253

Query: 323 DRYSTEGAKRLAAVAHQCLSH 343
                E ++R  A A + L H
Sbjct: 254 LMLVREPSQR--ATAQELLQH 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 67/225 (29%), Positives = 106/225 (47%), Gaps = 24/225 (10%)

Query: 87  LGEGGFGKVYKGCV---DDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHP 142
           LG G FG VYKG      +N++       VA+KVL  N S + ++E L E   +  +  P
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKI-----PVAIKVLRENTSPKANKEILDEAYVMAGVGSP 69

Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST-----LPWLTRIKIAIGAARCL 197
           ++  L+G C     +L V + M  G L D + +N         L W  +I      A+ +
Sbjct: 70  YVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGM 122

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAP 257
           ++L  EE  +++RD  A N+L+ S  + K++DFGLA      E  +          + A 
Sbjct: 123 SYL--EEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180

Query: 258 EYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVE 301
           E I     T   DV+S+GV + EL+T G +  +    +   DL+E
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE 225

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 71/267 (26%), Positives = 117/267 (43%), Gaps = 32/267 (11%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFLGQLKHPH 143
           LG+GGFG+V   C       G   +  A K L+   +   +G    L E   L ++    
Sbjct: 8   LGKGGFGEV---CACQVRATG---KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 144 LVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR-CLAFLH 201
           +V+L  Y  E +  L LV   M  G+L    F  Y+   P     +    AA        
Sbjct: 62  VVSL-AYAYETKDALCLVLTLMNGGDLK---FHIYNMGNPGFDEERAVFYAAEITCGLED 117

Query: 202 GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN 261
              + ++YRD K  NILLD   + ++SD GLA + P+GE        +GT GY APE + 
Sbjct: 118 LHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---TIRGRVGTVGYMAPEVVK 174

Query: 262 TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRL 321
               T   D +  G ++ E++ G+    + + K +++ VE  R + +D            
Sbjct: 175 NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE--RRVKED------------ 220

Query: 322 EDRYSTEGAKRLAAVAHQCLSHNPKSR 348
           ++ YS + ++   ++  Q L+ +P  R
Sbjct: 221 QEEYSEKFSEAARSICRQLLTKDPGFR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 67.0 bits (164), Expect = 3e-12
 Identities = 70/235 (29%), Positives = 96/235 (40%), Gaps = 51/235 (21%)

Query: 84  SDY-----LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG-HREWLAEVIFLG 137
            DY     LGEG FG+VYK                  K+L  N   G     L E+  L 
Sbjct: 8   RDYEILGKLGEGTFGEVYKARQIKT-----GRVVALKKILMHNEKDGFPITALREIKILK 62

Query: 138 QLKHPHLVNLIGYCCE--DEHR------LLVYEYMALGNLHD--QLFKNYSSTLPWLTRI 187
           +LKHP++V LI    E  D+ +       +V  YM     HD   L +N          +
Sbjct: 63  KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD----HDLSGLLEN--------PSV 110

Query: 188 KIAIGAARC--LAFLHG----EEKPVIYRDFKASNILLDSDYNAKLSDFGLA-------- 233
           K+     +C  L  L G     E  +++RD KA+NIL+D+    K++DFGLA        
Sbjct: 111 KLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170

Query: 234 --TDGPQGEDSHITTCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
               G  G     T  V+ T  Y  PE +      TT  D++  G V  E+ T R
Sbjct: 171 NPKGGGGGGTRKYTNLVV-TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 67.4 bits (164), Expect = 3e-12
 Identities = 62/229 (27%), Positives = 97/229 (42%), Gaps = 29/229 (12%)

Query: 68  VFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD----VNGS 123
           V  +++LQM   ++     +G G FG+V        +R     +  A+K+L     +  S
Sbjct: 32  VRKIRKLQMKAEDYDVVKVIGRGAFGEV------QLVRHKSSQKVYAMKLLSKFEMIKRS 85

Query: 124 QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPW 183
                W  E   +     P +V L     +D++  +V EYM  G+L + L  NY     W
Sbjct: 86  DSAFFW-EERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKW 143

Query: 184 ----LTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQG 239
                  + +A+ A   +  +H        RD K  N+LLD   + KL+DFG      + 
Sbjct: 144 AKFYTAEVVLALDAIHSMGLIH--------RDVKPDNMLLDKHGHLKLADFGTCMKMDET 195

Query: 240 EDSHITTCVMGTEGYAAPEYINT----GHLTTMCDVFSFGVVLLELLTG 284
                 T V GT  Y +PE + +    G+    CD +S GV L E+L G
Sbjct: 196 GMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 66.2 bits (162), Expect = 4e-12
 Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 48/225 (21%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG------SQGHREWLAEVI 134
           + + + +GEG +G VYK     +   G   + VA+K + +        S   RE    + 
Sbjct: 1   YQKVEKIGEGTYGVVYKAR---DKLTG---EIVALKKIRLETEDEGVPSTAIRE----IS 50

Query: 135 FLGQLKHPHLVNL--IGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI 191
            L +L HP++V L  + +    E++L LV+E++      D   K Y  + P        +
Sbjct: 51  LLKELNHPNIVRLLDVVHS---ENKLYLVFEFL------DLDLKKYMDSSP-----LTGL 96

Query: 192 GAA----------RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGED 241
                        + +A+ H     V++RD K  N+L+D +   KL+DFGLA     G  
Sbjct: 97  DPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLAR--AFGVP 152

Query: 242 SHITTCVMGTEGYAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
               T  + T  Y APE  + +   +T  D++S G +  E++  R
Sbjct: 153 VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 66.3 bits (162), Expect = 4e-12
 Identities = 77/304 (25%), Positives = 123/304 (40%), Gaps = 64/304 (21%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA--EVIFLGQLKHPHL 144
           +GEG +G V K C           Q VA+K    +      + +A  E+  L QL+H +L
Sbjct: 9   VGEGSYGMVMK-CKHKE-----TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENL 62

Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           VNLI      +   LV+E++    L D   + Y + L      K      R + F H   
Sbjct: 63  VNLIEVFRRKKRLYLVFEFVDHTVLDD--LEKYPNGLDESRVRKYLFQILRGIEFCHSHN 120

Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYAAPEYI--N 261
             +I+RD K  NIL+      KL DFG A T    GE   + T  + T  Y APE +  +
Sbjct: 121 --IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYTDYVATRWYRAPELLVGD 175

Query: 262 TGHLTTMCDVFSFGVVLLELLTGR-------------RSVEK--NRCKREKDL------- 299
           T +   + D+++ G ++ E+LTG                ++   N   R +++       
Sbjct: 176 TKYGRAV-DIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234

Query: 300 -------VEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMT 352
                  V+   P+ K F KL  +                +  +A QCL  +P  RP+ +
Sbjct: 235 AGMRLPEVKEIEPLEKRFPKLSGL----------------VLDLAKQCLRIDPDDRPSSS 278

Query: 353 TVVK 356
            ++ 
Sbjct: 279 QLLH 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 69/210 (32%), Positives = 96/210 (45%), Gaps = 22/210 (10%)

Query: 87  LGEGGFGKVY----KGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHP 142
           LG+G FGKV     KG  D+     +  + V ++  DV  +   +  LA     G  K P
Sbjct: 8   LGKGSFGKVMLAERKG-TDELYAIKILKKDVVIQDDDVECTMVEKRVLA---LSG--KPP 61

Query: 143 HLVNLIGYCCEDEHRL-LVYEYMALGNL--HDQLFKNYSSTLPWLTRIKIAIGAARCLAF 199
            L  L   C +   RL  V EY+  G+L    Q    +          +IAIG    L F
Sbjct: 62  FLTQLHS-CFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG----LFF 116

Query: 200 LHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEY 259
           LH   K +IYRD K  N++LDS+ + K++DFG+  +     D   T    GT  Y APE 
Sbjct: 117 LH--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--DGVTTKTFCGTPDYIAPEI 172

Query: 260 INTGHLTTMCDVFSFGVVLLELLTGRRSVE 289
           I         D ++FGV+L E+L G+   E
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 65.7 bits (160), Expect = 4e-12
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 26/204 (12%)

Query: 87  LGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHP 142
           LG G FG V    ++G  D           VA+K++   GS    E++ E   + +L H 
Sbjct: 12  LGTGQFGVVKYGKWRGQYD-----------VAIKMIK-EGSMSEDEFIEEAKVMMKLSHE 59

Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
            LV L G C +     +V EYM+ G L + L + +         +++       +A+L  
Sbjct: 60  KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL-REHGKRFQPSQLLEMCKDVCEGMAYL-- 116

Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEY 259
           E K  I+RD  A N L+D     K+SDFGL+      E     T  +G++    ++ PE 
Sbjct: 117 ESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPPEV 172

Query: 260 INTGHLTTMCDVFSFGVVLLELLT 283
           +     ++  DV++FGV++ E+ +
Sbjct: 173 LLYSKFSSKSDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 66.0 bits (161), Expect = 4e-12
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 22/218 (10%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKA--QTVAVKVLD---VNGSQGHREWLAEVIFLGQLKH 141
           LG+GGFG+V   C        ++A  +  A K L+   +   +G+   + E   L ++  
Sbjct: 1   LGKGGFGEVS-AC-------QMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHS 52

Query: 142 PHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFL 200
             +V+L  Y  + +  L LV   M  G+L   ++ N     P     +     A+ ++ L
Sbjct: 53  RFIVSL-AYAFQTKTDLCLVMTIMNGGDLRYHIY-NVDEENPGFPEPRACFYTAQIISGL 110

Query: 201 -HGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEY 259
            H  ++ +IYRD K  N+LLD+D N ++SD GLA +   G+    T    GT G+ APE 
Sbjct: 111 EHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPEL 168

Query: 260 INTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREK 297
           +         D F+ GV L E++  R      R + EK
Sbjct: 169 LQGEEYDFSVDYFALGVTLYEMIAARGPF---RARGEK 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 24/214 (11%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKA--QTVAVKVL--DVNGSQGHREW-LAEVI 134
           +F+    LG+G FGKV        +    K   +  A+K+L  DV       E  + E  
Sbjct: 1   DFNFLMVLGKGSFGKV--------MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKR 52

Query: 135 FLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNL--HDQLFKNYSSTLPWLTRIKIAI 191
            L     P  +  +  C +   RL  V EY+  G+L  H Q    +          +I++
Sbjct: 53  VLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISV 112

Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
           G    L FLH   + +IYRD K  N++LDS+ + K++DFG+  +     D   T    GT
Sbjct: 113 G----LFFLH--RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--HMVDGVTTRTFCGT 164

Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE I         D +++GV+L E+L G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 66.5 bits (162), Expect = 5e-12
 Identities = 67/215 (31%), Positives = 98/215 (45%), Gaps = 22/215 (10%)

Query: 80  NFSRSDYLGEGGFGKVY----KGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
           NF     LG G +GKV+        D      L A  V  K   V  ++       E   
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTG---KLYAMKVLQKAALVQKAKTVEHTRTERNV 57

Query: 136 LGQLKH-PHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFK--NYSSTLPWLTRIKIAI 191
           L  ++  P LV L  Y  + E +L L+ +Y++ G +   L++  N+S        ++   
Sbjct: 58  LEHVRQSPFLVTL-HYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED-----EVRFYS 111

Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
           G    LA  H  +  ++YRD K  NILLDS+ +  L+DFGL+ +    E+   T    GT
Sbjct: 112 GEI-ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS-EEKERTYSFCGT 169

Query: 252 EGYAAPEYI--NTGHLTTMCDVFSFGVVLLELLTG 284
             Y APE I    GH     D +S G+++ ELLTG
Sbjct: 170 IEYMAPEIIRGKGGH-GKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 65.7 bits (160), Expect = 5e-12
 Identities = 73/293 (24%), Positives = 124/293 (42%), Gaps = 55/293 (18%)

Query: 85  DYLGEGGFGKVYKGCV----DDNLRPGLKAQTVAV--KVLDVNGSQGHRE----WLAEVI 134
           ++LG G   ++Y G +    DD        + + V  KVLD      HR+    +     
Sbjct: 1   EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLD----PSHRDISLAFFETAS 56

Query: 135 FLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTL---PWLTRIKIAI 191
            + Q+ H H+V L G C  D   ++V E++  G L   LF +  S +   PW  + K+A 
Sbjct: 57  MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL--DLFMHRKSDVLTTPW--KFKVAK 112

Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILL-----DSDYNA--KLSDFGLATDGPQGEDSHI 244
             A  L++L  E+K +++ +    NILL     D +     KLSD G+       ++   
Sbjct: 113 QLASALSYL--EDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQE--- 167

Query: 245 TTCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA 303
             CV     + APE + ++ +L+   D +SFG  L E+        K++   EK+     
Sbjct: 168 --CVERIP-WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEG 224

Query: 304 RPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
           + ML                   T   K LA +   C++++P  RP    +++
Sbjct: 225 QCML------------------VTPSCKELADLMTHCMNYDPNQRPFFRAIMR 259

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 65.5 bits (160), Expect = 6e-12
 Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 37/221 (16%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA--EVIFLG 137
           ++++ + +GEG +G VYKG    N + G   Q VA+K + +   +      A  E+  L 
Sbjct: 1   DYTKIEKIGEGTYGVVYKG---RNKKTG---QIVAMKKIRLESEEEGVPSTAIREISLLK 54

Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLP------------WLT 185
           +L+HP++V L     ++    L++E++++        K Y  +LP            +L 
Sbjct: 55  ELQHPNIVCLQDVLMQESRLYLIFEFLSMD------LKKYLDSLPKGQYMDAELVKSYLY 108

Query: 186 RIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHIT 245
           +I   I       F H   + V++RD K  N+L+D+    KL+DFGLA     G    + 
Sbjct: 109 QILQGI------LFCH--SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVY 158

Query: 246 TCVMGTEGYAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           T  + T  Y APE  + +   +T  D++S G +  E+ T +
Sbjct: 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 65.4 bits (159), Expect = 6e-12
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 33/215 (15%)

Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ 138
           H++     +G G +G VYK     NL  G   +  AVK++ +           E+  + +
Sbjct: 9   HDYELIQRVGSGTYGDVYKA---RNLHTG---ELAAVKIIKLEPGDDFSLIQQEIFMVKE 62

Query: 139 LKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI---GAAR 195
            KH ++V   G     E   +  EY   G+L D     Y  T P L+ ++IA       +
Sbjct: 63  CKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDI----YHVTGP-LSELQIAYVCRETLQ 117

Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV------M 249
            LA+LH + K  ++RD K +NILL  + + KL+DFG+A        + IT  +      +
Sbjct: 118 GLAYLHSKGK--MHRDIKGANILLTDNGDVKLADFGVA--------AKITATIAKRKSFI 167

Query: 250 GTEGYAAPEYI---NTGHLTTMCDVFSFGVVLLEL 281
           GT  + APE       G    +CD+++ G+  +EL
Sbjct: 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 65.8 bits (160), Expect = 6e-12
 Identities = 69/272 (25%), Positives = 120/272 (44%), Gaps = 30/272 (11%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFLG 137
           F +   LG+GGFG+V   C       G   +  A K L+   +   +G    L E   L 
Sbjct: 2   FRQYRVLGKGGFGEV---CACQVRATG---KMYACKKLEKKRIKKRKGESMALNEKQILE 55

Query: 138 QLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
           ++    +V+L  Y  E +  L LV   M  G+L   ++    +       +  A  A  C
Sbjct: 56  KVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYA--AEIC 112

Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
                  ++ ++YRD K  NILLD   + ++SD GLA   P+G+        +GT GY A
Sbjct: 113 CGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMA 169

Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI 316
           PE +     T   D ++ G +L E++ G+   ++ + K +++ VE    ++K+       
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---RLVKE------- 219

Query: 317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSR 348
               +++ YS + +    ++    L  +PK R
Sbjct: 220 ----VQEEYSEKFSPDARSLCKMLLCKDPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 65.6 bits (160), Expect = 6e-12
 Identities = 75/284 (26%), Positives = 124/284 (43%), Gaps = 53/284 (18%)

Query: 85  DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLGQLKHP 142
           D LG+G +G VYK      +       T+A+K   L+++ S+   + + E+  L +   P
Sbjct: 7   DELGKGNYGSVYK------VLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSP 59

Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTL----PWLTRIKIA-IGAARCL 197
           ++V+  G    +    +  EYM  G+L D+L+    +T       L RI  A +   + L
Sbjct: 60  YIVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAP 257
                EE  +I+RD K +N+L++ +   KL DFG++ +      + +    +G + Y AP
Sbjct: 119 K----EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGN----LVASLAKTNIGCQSYMAP 170

Query: 258 EYINTGHL------TTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKD-- 309
           E I +G        T   DV+S G+ +LE+  GR                   P      
Sbjct: 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP---------------PETYANI 215

Query: 310 FTKLDQIIDS---RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT 350
           F +L  I+D     L   YS +    +A    +CL+  P  RPT
Sbjct: 216 FAQLSAIVDGDPPTLPSGYSDDAQDFVA----KCLNKIPNRRPT 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 66.2 bits (161), Expect = 6e-12
 Identities = 63/203 (31%), Positives = 88/203 (43%), Gaps = 17/203 (8%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE---WLAEVIFLGQLKHPH 143
           LG+G FGKV        +R     +  A+K+L         E    + E   L   +HP 
Sbjct: 3   LGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 56

Query: 144 LVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
           L  L  Y  +   RL  V EY   G L   L +    T          I +A  L +LH 
Sbjct: 57  LTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA--LEYLHS 113

Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT 262
            +  V+YRD K  N++LD D + K++DFGL  +G     +  T C  GT  Y APE +  
Sbjct: 114 RD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC--GTPEYLAPEVLED 169

Query: 263 GHLTTMCDVFSFGVVLLELLTGR 285
                  D +  GVV+ E++ GR
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 65.7 bits (160), Expect = 6e-12
 Identities = 66/199 (33%), Positives = 89/199 (44%), Gaps = 11/199 (5%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           +G+G FGKV +    D  R  + A     K   V+ S+     LAE   L Q+  P +V 
Sbjct: 1   IGKGSFGKVMQVRKRDTQR--IYALKTIRKAHIVSRSEVTHT-LAERTVLAQVNCPFIVP 57

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L       E   LV  ++  G L   L +     L   +R +    A    A  +  +  
Sbjct: 58  LKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDL---SRARFYT-AELLCALENLHKFN 113

Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
           VIYRD K  NILLD   +  L DFGL     + +D   T C  GT  Y APE +  GH  
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC--GTPEYLAPELL-LGHGY 170

Query: 267 TMC-DVFSFGVVLLELLTG 284
           T   D ++ GV+L E+LTG
Sbjct: 171 TKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 65.9 bits (161), Expect = 6e-12
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 29/217 (13%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR--EWLAEVIFLG 137
            F + + +GEG +G VY+       R     + VA+K + ++  +       L E+  L 
Sbjct: 8   EFEKLNRIGEGTYGIVYRA------RDTTSGEIVALKKVRMDNERDGIPISSLREITLLL 61

Query: 138 QLKHPHLVNLIGYCCED--EHRLLVYEYMALGNLHD--QLFKNYSSTLPWLTRIK-IAIG 192
            L+HP++V L         +   LV EY       D   L  N  +     +++K + + 
Sbjct: 62  NLRHPNIVELKEVVVGKHLDSIFLVMEYCE----QDLASLLDNMPTPFS-ESQVKCLMLQ 116

Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA--TDGPQGEDSHITTCVMG 250
             R L +LH  E  +I+RD K SN+LL      K++DFGLA     P      +T  V+ 
Sbjct: 117 LLRGLQYLH--ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK---PMTPKVV- 170

Query: 251 TEGYAAPEYI--NTGHLTTMCDVFSFGVVLLELLTGR 285
           T  Y APE +   T + TT  D+++ G +L ELL  +
Sbjct: 171 TLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 65.5 bits (160), Expect = 7e-12
 Identities = 66/232 (28%), Positives = 102/232 (43%), Gaps = 29/232 (12%)

Query: 62  VGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN 121
           +    +   L +L+ +         +G G  G+VYK      +R       +AVK +   
Sbjct: 5   IDGQKYPADLNDLENLGE-------IGSGTCGQVYK------MRFKKTGHVMAVKQMRRT 51

Query: 122 G-SQGHREWLAEV-IFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSS 179
           G  + ++  L ++ + L     P++V   GY   D    +  E M+     D+L K    
Sbjct: 52  GNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS--TCLDKLLKRIQG 109

Query: 180 TLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQG 239
            +P     K+ +   + L +L  E+  VI+RD K SNILLD+  N KL DFG++     G
Sbjct: 110 PIPEDILGKMTVAIVKALHYLK-EKHGVIHRDVKPSNILLDASGNVKLCDFGIS-----G 163

Query: 240 E--DSHITTCVMGTEGYAAPEYIN----TGHLTTMCDVFSFGVVLLELLTGR 285
              DS   T   G   Y APE I+            DV+S G+ L+EL TG+
Sbjct: 164 RLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 65.8 bits (160), Expect = 8e-12
 Identities = 64/205 (31%), Positives = 90/205 (43%), Gaps = 20/205 (9%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE---WLAEVIFLGQLKHPH 143
           LG+G FGKV        ++     +  A+K+L         E    L E   L   +HP 
Sbjct: 3   LGKGTFGKVIL------VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 56

Query: 144 LVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKN--YSSTLPWLTRIKIAIGAARCLAFL 200
           L  L  Y  +   RL  V EY   G L   L +   +S         +I       L +L
Sbjct: 57  LTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV----SALDYL 111

Query: 201 HGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI 260
           H E K V+YRD K  N++LD D + K++DFGL  +G +   +  T C  GT  Y APE +
Sbjct: 112 HSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC--GTPEYLAPEVL 168

Query: 261 NTGHLTTMCDVFSFGVVLLELLTGR 285
                    D +  GVV+ E++ GR
Sbjct: 169 EDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 64.7 bits (157), Expect = 9e-12
 Identities = 63/212 (29%), Positives = 94/212 (44%), Gaps = 14/212 (6%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           N+     LG+G FG+VY  C D +    L  + V         S+       E+  L  L
Sbjct: 3   NWRLGKLLGQGAFGRVYL-CYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61

Query: 140 KHPHLVNLIGYCCEDEHRLL--VYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
            H  +V   G   +   R L    E+M  G++ DQL K+Y +    +TR K        +
Sbjct: 62  LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTR-KYTRQILEGV 119

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFG----LATDGPQGEDSHITTCVMGTEG 253
           ++LH     +++RD K +NIL DS  N KL DFG    L T    G        V GT  
Sbjct: 120 SYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTG---MKSVTGTPY 174

Query: 254 YAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           + +PE I+        D++S G  ++E+LT +
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 68/283 (24%), Positives = 127/283 (44%), Gaps = 38/283 (13%)

Query: 85  DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-----WLAEVIFLG-Q 138
           ++LG G FG VYK    +N +  L  + + V        +  R+      ++EV  +  Q
Sbjct: 6   EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65

Query: 139 LKHPHLVNLIGYCCEDEHRLLVYEYM---ALGNLHDQLFK---NYSSTLPWLTRIKIAIG 192
           L+HP++V       E++   +V + +    LG   + L +    ++    W   +++ + 
Sbjct: 66  LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125

Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE 252
               L +LH +EK +++RD   +NI+L  D    ++DFGLA    +  +S +T+ V+GT 
Sbjct: 126 ----LRYLH-KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ--KQPESKLTS-VVGTI 177

Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK 312
            Y+ PE +         DV++FG +L ++ T +                    ML   TK
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-------------MLSLATK 224

Query: 313 L-DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTV 354
           + + + +   E  YS      +  V   CL+ + ++RP +  V
Sbjct: 225 IVEAVYEPLPEGMYSE----DVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 62/223 (27%), Positives = 99/223 (44%), Gaps = 27/223 (12%)

Query: 70  TLKELQMITHNFSRSDYLGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQG 125
             ++ +M   +F+    LG G FG+V    YK   +++  P      VA+K  + +    
Sbjct: 21  PKRKNKMKYEDFNFIRTLGTGSFGRVILATYK---NEDFPP------VAIKRFEKSKIIK 71

Query: 126 HREW---LAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLP 182
            ++     +E   L  + HP  VNL G   ++ +  LV E++  G     L +N     P
Sbjct: 72  QKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN--KRFP 129

Query: 183 WLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS 242
               +     A   L F + +   ++YRD K  N+LLD D   K++DFG A      +  
Sbjct: 130 --NDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK---VVDTR 184

Query: 243 HITTCVMGTEGYAAPE-YINTGHLTTMCDVFSFGVVLLELLTG 284
             T C  GT  Y APE  +N GH     D ++ G+ + E+L G
Sbjct: 185 TYTLC--GTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 63/204 (30%), Positives = 91/204 (44%), Gaps = 17/204 (8%)

Query: 87  LGEGGFGKVYKGCVDDNLRP-GLK--AQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPH 143
           +G+G FG+VY+    D  R   +K  ++   V   +V  + G R  L   +     + P 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLD---ESPF 57

Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNL--HDQLFKNYSSTLPWLTRIKIAIGAARCLAFLH 201
           +V L      D    LV +YM+ G L  H Q    +S       R K  I A   LA  H
Sbjct: 58  IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED-----RAKFYI-AELVLALEH 111

Query: 202 GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPE-YI 260
             +  ++YRD K  NILLD+  +  L DFGL+       D+  T    GT  Y APE  +
Sbjct: 112 LHKYDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLL 169

Query: 261 NTGHLTTMCDVFSFGVVLLELLTG 284
           +    T   D +S GV++ E+  G
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 33/214 (15%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           +F     +G G +G VYK     N+  G   +  A+KV+ +   +       E+I +   
Sbjct: 10  DFELIQRIGSGTYGDVYKA---RNVNTG---ELAAIKVIKLEPGEDFAVVQQEIIMMKDC 63

Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLA- 198
           KH ++V   G     +   +  E+   G+L D     Y  T P L+  +IA  +   L  
Sbjct: 64  KHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDI----YHVTGP-LSESQIAYVSRETLQG 118

Query: 199 --FLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV------MG 250
             +LH + K  ++RD K +NILL  + + KL+DFG++        + IT  +      +G
Sbjct: 119 LYYLHSKGK--MHRDIKGANILLTDNGHVKLADFGVS--------AQITATIAKRKSFIG 168

Query: 251 TEGYAAPEYI---NTGHLTTMCDVFSFGVVLLEL 281
           T  + APE       G    +CD+++ G+  +EL
Sbjct: 169 TPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 61/203 (30%), Positives = 91/203 (44%), Gaps = 17/203 (8%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFLGQLKHPH 143
           LG+G FGKV        +R     +  A+K+L    +         L E   L   +HP 
Sbjct: 3   LGKGTFGKVIL------VREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPF 56

Query: 144 LVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
           L +L  Y  + + RL  V EY+  G L   L +    +          I +A  L +LH 
Sbjct: 57  LTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSA--LDYLHS 113

Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT 262
            +  ++YRD K  N++LD D + K++DFGL  +G     +  T C  GT  Y APE +  
Sbjct: 114 GK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC--GTPEYLAPEVLED 169

Query: 263 GHLTTMCDVFSFGVVLLELLTGR 285
                  D +  GVV+ E++ GR
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 64.0 bits (156), Expect = 4e-11
 Identities = 55/168 (32%), Positives = 78/168 (46%), Gaps = 33/168 (19%)

Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L +LH     +++RD K  N+L++S+   K+ DFGLA      E  H+T  V+ T+ Y
Sbjct: 114 RGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQYY 170

Query: 255 AAPEYINTG--HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK 312
            APE I  G  H T+  D++S G +  ELL  R             L +   P+     +
Sbjct: 171 RAPE-ILMGSRHYTSAVDIWSVGCIFAELLGRRI------------LFQAQSPI----QQ 213

Query: 313 LDQIID----SRLED-RYSTEGAKRLAAVAHQCLS-HNPKSRPTMTTV 354
           LD I D      LE  R + EGA+     AH     H P S P + T+
Sbjct: 214 LDLITDLLGTPSLEAMRSACEGAR-----AHILRGPHKPPSLPVLYTL 256

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 62.6 bits (152), Expect = 5e-11
 Identities = 64/210 (30%), Positives = 95/210 (45%), Gaps = 23/210 (10%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLV 145
           +G G FGKV  G V+    P   AQ V VK L V+ S Q   ++L E      L+H +L+
Sbjct: 3   IGNGWFGKVILGEVNSGYTP---AQVV-VKELRVSASVQEQMKFLEEAQPYRSLQHSNLL 58

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQL-----FKNYSSTLPWLTRIKIAIGAARCLAFL 200
             +G C E    LLV E+  LG+L   L      +  +     L R+   I     L  L
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIA----LGLL 114

Query: 201 HGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE-GYAAPEY 259
           H  +   I+ D    N LL +D   K+ D+GL+ +  + ED ++T   +     + APE 
Sbjct: 115 HLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYK-EDYYVTPDQLWVPLRWIAPEL 173

Query: 260 INTGH-------LTTMCDVFSFGVVLLELL 282
           ++  H        T   +V+S GV + EL 
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 63.3 bits (155), Expect = 5e-11
 Identities = 54/167 (32%), Positives = 83/167 (49%), Gaps = 20/167 (11%)

Query: 130 LAEVIFLGQLKHPHLVNLI-----GYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWL 184
           L E+  L  L+H +++ L+         +     +V E M   +LH ++ K   S  P L
Sbjct: 47  LREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLH-KVIK---SPQP-L 100

Query: 185 T--RIK-IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA--TDGPQG 239
           T   I+       R L +LH     VI+RD K SNIL++S+ + K+ DFGLA   D  + 
Sbjct: 101 TDDHIQYFLYQILRGLKYLH--SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158

Query: 240 EDSHITTCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
           E   +T  V+ T  Y APE + ++   T   D++S G +  ELLT +
Sbjct: 159 EKGFLTEYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 65/216 (30%), Positives = 99/216 (45%), Gaps = 23/216 (10%)

Query: 80  NFSRSDYLGEGGFGKVY---KGCVDDNLR----PGLKAQTVAVKVLDVNGSQGHREWLAE 132
           NF     LG G +GKV+   K    D+ +      LK  T+  K      ++  R+ L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 133 VIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI 191
           +      + P LV L  Y  + + +L L+ +Y+  G L   L +           ++I  
Sbjct: 61  I-----RQSPFLVTL-HYAFQTDTKLHLILDYINGGELFTHLSQRERFKE---QEVQIYS 111

Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
           G    LA  H  +  +IYRD K  NILLDS+ +  L+DFGL+ +  + E     +   GT
Sbjct: 112 GEI-VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGT 169

Query: 252 EGYAAPEYI---NTGHLTTMCDVFSFGVVLLELLTG 284
             Y AP+ +   + GH     D +S GV++ ELLTG
Sbjct: 170 IEYMAPDIVRGGDGGH-DKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 21/209 (10%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR--EWLAEVIFLGQLK---H 141
           +GEG +GKV+K     +L+ G   + VA+K + V   +       + EV  L  L+   H
Sbjct: 9   IGEGAYGKVFKA---RDLKNG--GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 63

Query: 142 PHLVNLIGYCC----EDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
           P++V L   C     + E +L LV+E++   +L   L K     +P  T   +     R 
Sbjct: 64  PNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRG 122

Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L FLH     V++RD K  NIL+ S    KL+DFGLA            T V+ T  Y A
Sbjct: 123 LDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWYRA 177

Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           PE +      T  D++S G +  E+   +
Sbjct: 178 PEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 63.2 bits (154), Expect = 6e-11
 Identities = 59/230 (25%), Positives = 93/230 (40%), Gaps = 53/230 (23%)

Query: 72  KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA 131
           K+ Q++T        +G+GG+G+V+     D        + VA+K +     +     L 
Sbjct: 1   KDFQILTQ-------VGQGGYGQVFLAKKKDT------GEIVALKRM----KKSLLFKLN 43

Query: 132 EVI-------FLGQLKHPHLVNLIGYCCEDEHRLLVYEYM----------ALGNLHDQLF 174
           EV         L   K   LV L+    +DE+  L  EY+           LG L +   
Sbjct: 44  EVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHA 103

Query: 175 KNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT 234
           + Y      +  +  A+ A   L ++H        RD K  N L+D+  + KL+DFGL+ 
Sbjct: 104 RFY------MAEMFEAVDALHELGYIH--------RDLKPENFLIDASGHIKLTDFGLSK 149

Query: 235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
                 +S     V+G+  Y APE +         D +S G +L E L G
Sbjct: 150 GIVTYANS-----VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 62.6 bits (152), Expect = 6e-11
 Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 11/202 (5%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWL-AEVIFLGQLKHPHLV 145
           LGEG FGKV + C  D        + VAVK L       H   L  E+  L  L H ++V
Sbjct: 12  LGEGHFGKV-ELCRYDP-EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69

Query: 146 NLIGYCCEDEHR--LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE 203
              G C ED      L+ E++  G+L + L +N  + +    ++K A+   + + +L   
Sbjct: 70  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSR 128

Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC--VMGTEGYAAPEYIN 261
           +   ++RD  A N+L++S++  K+ DFGL T   + +  + T    +     + APE + 
Sbjct: 129 Q--YVHRDLAARNVLVESEHQVKIGDFGL-TKAIETDKEYYTVKDDLDSPVFWYAPECLI 185

Query: 262 TGHLTTMCDVFSFGVVLLELLT 283
                   DV+SFGV L ELLT
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 18/203 (8%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEV-IFLGQLKHP 142
           +G+G FGKV         R   + +  AVKVL        +  +  ++E  + L  +KHP
Sbjct: 3   IGKGSFGKVLLA------RHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 56

Query: 143 HLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLH 201
            LV L  +  +   +L  V +Y+  G L   L +      P        I +A  L +LH
Sbjct: 57  FLVGL-HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASA--LGYLH 113

Query: 202 GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN 261
                ++YRD K  NILLDS  +  L+DFGL  +  +   +  T C  GT  Y APE ++
Sbjct: 114 SLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC--GTPEYLAPEVLH 169

Query: 262 TGHLTTMCDVFSFGVVLLELLTG 284
                   D +  G VL E+L G
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 63.1 bits (154), Expect = 6e-11
 Identities = 65/249 (26%), Positives = 97/249 (38%), Gaps = 62/249 (24%)

Query: 79  HNFSRSDYLGEGGFGKVY----KGCVDDNLRPGLKAQTVAVKVLD----VNGSQGHREWL 130
            +F +   LG+G  G+V+    KG            +  A+KVLD    +  ++  R  L
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKG----------TGKLFALKVLDKKEMIKRNKVKRV-L 49

Query: 131 AEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLP------WL 184
            E   L  L HP L  L      + +  LV +Y   G L   L +     L       + 
Sbjct: 50  TEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYA 109

Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT---------- 234
             + +A      L +LH     ++YRD K  NILL    +  LSDF L+           
Sbjct: 110 AEVLLA------LEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161

Query: 235 -DGPQG----------------EDSHITTCVMGTEGYAAPEYIN-TGHLTTMCDVFSFGV 276
               +G                E S  +   +GTE Y APE I+  GH  +  D ++ G+
Sbjct: 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGI 220

Query: 277 VLLELLTGR 285
           +L E+L G 
Sbjct: 221 LLYEMLYGT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 62.4 bits (152), Expect = 7e-11
 Identities = 41/101 (40%), Positives = 54/101 (53%), Gaps = 7/101 (6%)

Query: 188 KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC 247
           KIA+   + L +L  EE  +I+RD K SNILLD + N KL DFG++    Q  DS   T 
Sbjct: 111 KIAVATVKALNYLK-EELKIIHRDVKPSNILLDRNGNIKLCDFGISG---QLVDSIAKTR 166

Query: 248 VMGTEGYAAPEYINTGHLT---TMCDVFSFGVVLLELLTGR 285
             G   Y APE I+           DV+S G+ L E+ TG+
Sbjct: 167 DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 22/211 (10%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQL 139
           + + + LGEG +  V+KG      R  L    VA+K + +   +G     + EV  L  L
Sbjct: 8   YIKLEKLGEGTYATVFKG------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL 61

Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNY---SSTLPWLTRIKIAI-GAAR 195
           KH ++V L      D+   LV+EY+      D+  K Y      +  +  +KI +    R
Sbjct: 62  KHANIVTLHDIVHTDKSLTLVFEYL------DKDLKQYMDDCGNIMSMHNVKIFLYQILR 115

Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            LA+ H   + V++RD K  N+L++     KL+DFGLA        ++    V  T  Y 
Sbjct: 116 GLAYCH--RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYR 171

Query: 256 APE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            P+  + +   +T  D++  G +  E+ +GR
Sbjct: 172 PPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 68/262 (25%), Positives = 113/262 (43%), Gaps = 24/262 (9%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           +GEG  G V    V  +       + VAVK +D+   Q       EV+ +   +H ++V 
Sbjct: 28  IGEGSTGIVCIATVKSS------GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG---- 202
           +       +   +V E++  G L D +           TR+     AA CLA L      
Sbjct: 82  MYNSYLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCLAVLKALSVL 132

Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT 262
             + VI+RD K+ +ILL  D   KLSDFG        ++      ++GT  + APE I+ 
Sbjct: 133 HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKSLVGTPYWMAPELISR 190

Query: 263 GHLTTMCDVFSFGVVLLELLTGRRS-VEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRL 321
                  D++S G++++E++ G      +   K  K + +   P LK+  K+   +   L
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFL 250

Query: 322 EDRYSTEGAKRLAAVAHQCLSH 343
           +     + A+R  A A + L H
Sbjct: 251 DRLLVRDPAQR--ATAAELLKH 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 62/226 (27%), Positives = 94/226 (41%), Gaps = 29/226 (12%)

Query: 71  LKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD----VNGSQGH 126
           + +L+M   +F     +G G FG+V        +R     Q  A+K+L     +  S   
Sbjct: 35  ITKLRMKAEDFDVIKVIGRGAFGEVQL------VRHKSSKQVYAMKLLSKFEMIKRSDSA 88

Query: 127 REWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPW--- 183
             W  E   +       +V L     +D++  +V EYM  G+L + L  NY     W   
Sbjct: 89  FFW-EERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARF 146

Query: 184 -LTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS 242
               + +A+ A   + F+H        RD K  N+LLD   + KL+DFG           
Sbjct: 147 YTAEVVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198

Query: 243 HITTCVMGTEGYAAPEYINT----GHLTTMCDVFSFGVVLLELLTG 284
              T V GT  Y +PE + +    G+    CD +S GV L E+L G
Sbjct: 199 RCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 61.9 bits (151), Expect = 2e-10
 Identities = 70/242 (28%), Positives = 98/242 (40%), Gaps = 54/242 (22%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHREWLAEVIFL 136
           +F     +G G FG+V+   V D    G   Q  A+KVL   D+          AE   L
Sbjct: 2   DFEVIKVIGRGAFGEVW--LVRDK-DTG---QVYAMKVLRKSDMIKRNQIAHVRAERDIL 55

Query: 137 GQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLP------WLTRIKI 189
                P +V L  Y  +DE  L LV EYM  G+L + L +      P      ++  + +
Sbjct: 56  ADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIR--KDVFPEETARFYIAELVL 112

Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQG-------EDS 242
           A+ +   L F+H        RD K  NIL+D+D + KL+DFGL     +         DS
Sbjct: 113 ALDSVHKLGFIH--------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDS 164

Query: 243 HITTC--------------------VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELL 282
           H                         +GT  Y APE +        CD +S GV+L E+L
Sbjct: 165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224

Query: 283 TG 284
            G
Sbjct: 225 YG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 22/226 (9%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQL 139
           + + D LGEG +  V+KG      R  L    VA+K + +   +G     + EV  L  L
Sbjct: 7   YVKLDKLGEGTYATVFKG------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL 60

Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNY---SSTLPWLTRIKIAI-GAAR 195
           KH ++V L      +    LV+EY+      D   K Y      L  +  +KI +    R
Sbjct: 61  KHANIVTLHDIIHTERCLTLVFEYL------DSDLKQYLDNCGNLMSMHNVKIFMFQLLR 114

Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L++ H  ++ +++RD K  N+L++     KL+DFGLA        ++    V  T  Y 
Sbjct: 115 GLSYCH--KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYR 170

Query: 256 APE-YINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV 300
            P+  + +   +T  D++  G +L E+ TGR     +  K E  L+
Sbjct: 171 PPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 61/226 (26%), Positives = 96/226 (42%), Gaps = 29/226 (12%)

Query: 71  LKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD----VNGSQGH 126
           +++L+M   ++     +G G FG+V        +R     +  A+K+L     +  S   
Sbjct: 35  IRDLRMKAEDYEVVKVIGRGAFGEV------QLVRHKSTRKVYAMKLLSKFEMIKRSDSA 88

Query: 127 REWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPW--- 183
             W  E   +     P +V L     +D +  +V EYM  G+L + L  NY     W   
Sbjct: 89  FFW-EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF 146

Query: 184 -LTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS 242
               + +A+ A   + F+H        RD K  N+LLD   + KL+DFG      +    
Sbjct: 147 YTAEVVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198

Query: 243 HITTCVMGTEGYAAPEYINT----GHLTTMCDVFSFGVVLLELLTG 284
              T V GT  Y +PE + +    G+    CD +S GV L E+L G
Sbjct: 199 RCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 8/92 (8%)

Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H     +I+RD K SNI ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 129 RGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 181

Query: 255 AAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
            APE + N  H     D++S G ++ ELLTG+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 66/230 (28%), Positives = 101/230 (43%), Gaps = 55/230 (23%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL------DVNGSQGHREWL 130
           IT+ +     +G G FG V   C   + R  L  Q VA+K +       V   + +RE  
Sbjct: 8   ITNRYVDLQPVGMGAFGLV---C---SARDQLTGQNVAIKKIMKPFSTPVLAKRTYRE-- 59

Query: 131 AEVIFLGQLKHPHLVNL----------IGYCCE----DEHRLLVYEYMALGNLHDQLFKN 176
             +  L  L+H ++++L          I +  E    D HRLL         L  Q F  
Sbjct: 60  --LKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLL-----TSRPLEKQ-FIQ 111

Query: 177 YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG 236
           Y     +L +I       R L ++H     V++RD K SNIL++ + + K+ DFGLA   
Sbjct: 112 Y-----FLYQI------LRGLKYVH--SAGVVHRDLKPSNILINENCDLKICDFGLA--- 155

Query: 237 PQGEDSHITTCVMGTEGYAAPEYINTGH-LTTMCDVFSFGVVLLELLTGR 285
            + +D  +T  V  T  Y APE + T        D++S G +  E+L G+
Sbjct: 156 -RIQDPQMTGYV-STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 60.3 bits (146), Expect = 3e-10
 Identities = 69/266 (25%), Positives = 108/266 (40%), Gaps = 59/266 (22%)

Query: 113 VAVKVLDVNGSQGHREWLAEVIF-----LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALG 167
           V +KVLD      HR+ +A   F     + Q+ H HL  + G C      ++V E++  G
Sbjct: 47  VVLKVLD----PSHRD-IALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHG 101

Query: 168 NLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILL-------D 220
            L D   +     +P   +I +A   A  L++L  E+K +++ +  A NILL        
Sbjct: 102 PL-DVCLRKEKGRVPVAWKITVAQQLASALSYL--EDKNLVHGNVCAKNILLARLGLAEG 158

Query: 221 SDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLL 279
           +    KLSD G++      E+       +    + APE +     L+T  D +SFG  LL
Sbjct: 159 TSPFIKLSDPGVSFTALSREER------VERIPWIAPECVPGGNSLSTAADKWSFGTTLL 212

Query: 280 EL-------LTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKR 332
           E+       L  R   EK R   +K                          R      K 
Sbjct: 213 EICFDGEVPLKERTPSEKERFYEKKH-------------------------RLPEPSCKE 247

Query: 333 LAAVAHQCLSHNPKSRPTMTTVVKAL 358
           LA +  QCL++ P  RP+  T+++ L
Sbjct: 248 LATLISQCLTYEPTQRPSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 59.7 bits (144), Expect = 5e-10
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 31/220 (14%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK 140
           F   + +G G +G+VYKG      R     Q  A+KV+DV G +   E   E+  L   K
Sbjct: 8   FELVELVGNGTYGQVYKG------RHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLK--K 58

Query: 141 HPHLVNLIGYCCE---------DEHRLLVYEYMALGNLHDQLFKNYSSTLP--WLTRIKI 189
           + H  N+  Y            D+   LV E+   G++ D +     +TL   W+  I  
Sbjct: 59  YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 118

Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM 249
            I   R L+ LH  +  VI+RD K  N+LL  +   KL DFG++    +      T   +
Sbjct: 119 EI--LRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FI 172

Query: 250 GTEGYAAPEYINTGH-----LTTMCDVFSFGVVLLELLTG 284
           GT  + APE I              D++S G+  +E+  G
Sbjct: 173 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 59.6 bits (144), Expect = 7e-10
 Identities = 62/217 (28%), Positives = 92/217 (42%), Gaps = 44/217 (20%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDV-NGSQG-HREWLAEVIFLGQLK---H 141
           +G G +G VYK       R       VA+K + V     G     + EV  L +L+   H
Sbjct: 8   IGVGAYGTVYKA------RDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61

Query: 142 PHLVNLIGYCC----EDEHRL-LVYEYMALGNLHDQLFKNYSSTLPW----LTRIKIAIG 192
           P++V L+  C     + E ++ LV+E++      DQ  + Y   +P        IK  + 
Sbjct: 62  PNIVRLMDVCATSRTDRETKVTLVFEHV------DQDLRTYLDKVPPPGLPAETIKDLMR 115

Query: 193 AARC-LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG- 250
                L FLH     +++RD K  NIL+ S    KL+DFGLA          I +C M  
Sbjct: 116 QFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLA---------RIYSCQMAL 164

Query: 251 -----TEGYAAPEYINTGHLTTMCDVFSFGVVLLELL 282
                T  Y APE +      T  D++S G +  E+ 
Sbjct: 165 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 60.3 bits (146), Expect = 8e-10
 Identities = 48/164 (29%), Positives = 72/164 (43%), Gaps = 27/164 (16%)

Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT--DGPQGEDSHITTCVMGTEGY 254
           LA  H   K +I+RD K++NILL S+   KL DFG +        +D   T C  GT  Y
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC--GTPYY 211

Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD 314
            APE       +   D+FS GV+L ELLT +R                      D   ++
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF--------------------DGENME 251

Query: 315 QIIDSRLEDRYS---TEGAKRLAAVAHQCLSHNPKSRPTMTTVV 355
           +++   L  RY       +  +  +    LS +PK RP+ + ++
Sbjct: 252 EVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLL 295

Length = 496

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 59.2 bits (144), Expect = 1e-09
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 4/93 (4%)

Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEG 253
           R L ++H     V++RD K SN+LL+++ + K+ DFGLA    P+ + +   T  + T  
Sbjct: 117 RGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174

Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +N+   T   D++S G +L E+L+ R
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 22/211 (10%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQL 139
           + + D LGEG +  VYKG      R  L    VA+K + +   +G     + EV  L  L
Sbjct: 8   YIKLDKLGEGTYATVYKG------RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL 61

Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNY---SSTLPWLTRIKIAI-GAAR 195
           KH ++V L      ++   LV+EY+      D+  K Y         +  +K+ +    R
Sbjct: 62  KHANIVTLHDIIHTEKSLTLVFEYL------DKDLKQYLDDCGNSINMHNVKLFLFQLLR 115

Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L + H   + V++RD K  N+L++     KL+DFGLA        ++    V  T  Y 
Sbjct: 116 GLNYCH--RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYR 171

Query: 256 APE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            P+  + +   +T  D++  G +  E+ TGR
Sbjct: 172 PPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 54/179 (30%), Positives = 79/179 (44%), Gaps = 31/179 (17%)

Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDSDYNA-KLSDFGLATDGPQGEDSHITTCVMGTE 252
           AR + FL    +  I+RD  A NILL S+ N  K+ DFGLA D  +  D           
Sbjct: 183 ARGMEFL--ASRKCIHRDLAARNILL-SENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239

Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS------VEKNRCKREKDLVEWARPM 306
            + APE I     TT  DV+SFGV+L E+ +   S      +++  C+R K+      P 
Sbjct: 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAP- 298

Query: 307 LKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN 365
                             Y+T     + ++   C  +NP+ RPT + +V+ L  LL  N
Sbjct: 299 -----------------EYATP---EIYSIMLDCWHNNPEDRPTFSELVEILGDLLQEN 337

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 62/220 (28%), Positives = 93/220 (42%), Gaps = 31/220 (14%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK 140
           F   + +G G +G+VYKG      R     Q  A+KV+DV   +   E   E+  L   K
Sbjct: 18  FELVEVVGNGTYGQVYKG------RHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLK--K 68

Query: 141 HPHLVNLIGY---------CCEDEHRLLVYEYMALGNLHDQLFKNYSSTLP--WLTRIKI 189
           + H  N+  Y            D+   LV E+   G++ D +     + L   W+  I  
Sbjct: 69  YSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR 128

Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM 249
            I   R LA LH  +  VI+RD K  N+LL  +   KL DFG++    +      T   +
Sbjct: 129 EI--LRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FI 182

Query: 250 GTEGYAAPEYINTGH-----LTTMCDVFSFGVVLLELLTG 284
           GT  + APE I              D++S G+  +E+  G
Sbjct: 183 GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 54/178 (30%), Positives = 78/178 (43%), Gaps = 29/178 (16%)

Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
           AR + FL    +  I+RD  A NILL  +   K+ DFGLA D  +  D            
Sbjct: 184 ARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241

Query: 254 YAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS------VEKNRCKREKDLVEWARPML 307
           + APE I     TT  DV+SFGV+L E+ +   S      + +  C+R           L
Sbjct: 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR-----------L 290

Query: 308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN 365
           KD T++      R  +  + E    +  +   C   +PK RPT + +V+ L  LL  N
Sbjct: 291 KDGTRM------RAPENATPE----IYRIMLACWQGDPKERPTFSALVEILGDLLQEN 338

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 25/214 (11%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLGQ 138
           + + + +GEG +G VYK       R  +  +T+A+K   L+          + E+  L +
Sbjct: 4   YEKVEKIGEGTYGVVYKA------RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKE 57

Query: 139 LKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTR----IKIAI-GA 193
           ++H ++V L      ++   LV+EY+ L        K +  + P   +    IK  +   
Sbjct: 58  MQHGNIVRLQDVVHSEKRLYLVFEYLDLD------LKKHMDSSPDFAKNPRLIKTYLYQI 111

Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDSDYNA-KLSDFGLATDGPQGEDSHITTCVMGTE 252
            R +A+ H     V++RD K  N+L+D   NA KL+DFGLA     G      T  + T 
Sbjct: 112 LRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTFTHEVVTL 167

Query: 253 GYAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            Y APE  + + H +T  D++S G +  E++  +
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 69/250 (27%), Positives = 107/250 (42%), Gaps = 40/250 (16%)

Query: 51  PISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKA 110
           P+     SSS   S+    +            R + +G G  G VYK       R     
Sbjct: 46  PLPPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRL---- 101

Query: 111 QTVAVKVLDVNGSQGHREWLA-EVIFLGQLKHPHLVNLIGYCCED------EHRLLVYEY 163
              A+KV+  N     R  +  E+  L  + HP++V      C D      E ++L+ E+
Sbjct: 102 --YALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK-----CHDMFDHNGEIQVLL-EF 153

Query: 164 MALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY 223
           M  G+L           L  + R +I  G    +A+LH   + +++RD K SN+L++S  
Sbjct: 154 MDGGSLEGTHI-ADEQFLADVAR-QILSG----IAYLH--RRHIVHRDIKPSNLLINSAK 205

Query: 224 NAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT--------GHLTTMCDVFSFG 275
           N K++DFG++    Q  D       +GT  Y +PE INT        G+     D++S G
Sbjct: 206 NVKIADFGVSRILAQTMDP--CNSSVGTIAYMSPERINTDLNHGAYDGYAG---DIWSLG 260

Query: 276 VVLLELLTGR 285
           V +LE   GR
Sbjct: 261 VSILEFYLGR 270

Length = 353

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 60/252 (23%), Positives = 100/252 (39%), Gaps = 17/252 (6%)

Query: 104 LRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEY 163
            R     + V  K + +N  +      +E+  L    H  +V        D+  LL+ EY
Sbjct: 87  TRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146

Query: 164 MALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY 223
            + G+L+ Q+ +     LP+       +     LA      + +++RD K++NI L    
Sbjct: 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG 206

Query: 224 NAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
             KL DFG +          + +   GT  Y APE       +   D++S GV+L ELLT
Sbjct: 207 IIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266

Query: 284 GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSH 343
             R   K   +RE                + Q++  +  D +    +  + A+    LS 
Sbjct: 267 LHRPF-KGPSQRE---------------IMQQVLYGKY-DPFPCPVSSGMKALLDPLLSK 309

Query: 344 NPKSRPTMTTVV 355
           NP  RPT   ++
Sbjct: 310 NPALRPTTQQLL 321

Length = 478

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 14/201 (6%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG-HREWLAEVIFLGQLKHPHLV 145
           LGEG +  VYKG    N       Q VA+KV+ +   +G     + E   L  LKH ++V
Sbjct: 13  LGEGSYATVYKGISRIN------GQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV 66

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            L       E    V+EYM   +L   + ++     P+  R+       R LA++HG+  
Sbjct: 67  LLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHGQH- 123

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPE-YINTGH 264
            +++RD K  N+L+      KL+DFGLA        ++ +  V  T  Y  P+  +    
Sbjct: 124 -ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATD 180

Query: 265 LTTMCDVFSFGVVLLELLTGR 285
            ++  D++  G + +E+L G+
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 56.8 bits (137), Expect = 5e-09
 Identities = 59/218 (27%), Positives = 87/218 (39%), Gaps = 40/218 (18%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ------LK 140
           +G G FGKV        +        V VK L  N S   +       FL Q      L+
Sbjct: 3   IGNGWFGKVLLS----EIYTDTGVARVVVKELKANASSKEQN-----EFLQQGDPYRILQ 53

Query: 141 HPHLVNLIGYCCEDEHRLLVYEYMALGNL------HDQLFKNYSSTLPWLTRIKIAIGAA 194
           HP+++  +G C E    LLV+EY  LG+L           +N    L  L R+   I A 
Sbjct: 54  HPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLL--LQRMACEIAAG 111

Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQG-EDSHITT--CVMGT 251
             +  +H  +   ++ D    N  L SD   K+ D+G+   GP   ++ +I T       
Sbjct: 112 --VTHMH--KHNFLHSDLALRNCFLTSDLTVKVGDYGI---GPSRYKEDYIETEDDKCVP 164

Query: 252 EGYAAPEYINTGH-------LTTMCDVFSFGVVLLELL 282
             + APE +   H        T   +V++ GV L EL 
Sbjct: 165 LRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 56.7 bits (137), Expect = 7e-09
 Identities = 58/236 (24%), Positives = 98/236 (41%), Gaps = 56/236 (23%)

Query: 86  YLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-------------GSQG-HREWLA 131
           +LGEG +GKV K   D         + VA+K + +              G  G H   L 
Sbjct: 16  HLGEGTYGKVEKA-YDTLTG-----KIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR 69

Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI 191
           E+  + ++KH +++ L+    E +   LV + MA  +L  ++            +I++  
Sbjct: 70  ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLK-KVVDR---------KIRLTE 118

Query: 192 GAARC--------LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT-------DG 236
              +C        L  LH  +   ++RD   +NI ++S    K++DFGLA          
Sbjct: 119 SQVKCILLQILNGLNVLH--KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176

Query: 237 PQGEDSH------ITTCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
              +D        +T+ V+ T  Y APE +          D++S G +  ELLTG+
Sbjct: 177 TLSKDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 56.2 bits (135), Expect = 8e-09
 Identities = 54/208 (25%), Positives = 101/208 (48%), Gaps = 16/208 (7%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQ 138
           ++ + + LGEG +  VYKG      +  +  + VA+KV+ +   +G     + E   L  
Sbjct: 6   SYEKLEKLGEGSYATVYKG------KSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKG 59

Query: 139 LKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI-GAARCL 197
           LKH ++V L       E   LV+EY+   +L   + K+     P    +K+ +    R L
Sbjct: 60  LKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHP--ENVKLFLFQLLRGL 116

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAP 257
           +++H  ++ +++RD K  N+L+      KL+DFGLA    +   SH  +  + T  Y  P
Sbjct: 117 SYIH--QRYILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPP 172

Query: 258 E-YINTGHLTTMCDVFSFGVVLLELLTG 284
           +  + +   +T  D++  G + +E++ G
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 56.8 bits (137), Expect = 9e-09
 Identities = 57/205 (27%), Positives = 81/205 (39%), Gaps = 22/205 (10%)

Query: 87  LGEGGFGKVYKGCV--DDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHL 144
           L  G  G+V+  C    D  R     + V VK +    + G      E+  L  + H  +
Sbjct: 100 LTPGSEGEVFV-CTKHGDEQR-----KKVIVKAVTGGKTPG-----REIDILKTISHRAI 148

Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFK--NYSSTLPWLTRIKIAIGAARCLAFLHG 202
           +NLI       +R      M +      LF   + S  LP    I I       LA+LHG
Sbjct: 149 INLI-----HAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG 203

Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT 262
             + +I+RD K  NI LD   NA L DFG A       D+       GT    +PE +  
Sbjct: 204 --RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLAL 261

Query: 263 GHLTTMCDVFSFGVVLLELLTGRRS 287
                  D++S G+VL E+     +
Sbjct: 262 DPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 34/90 (37%), Positives = 50/90 (55%), Gaps = 6/90 (6%)

Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGEDSHITTCVMGTEGYAAPE-YINT 262
           V++RD K  N+L+++D   K+ DFGLA   ++ P      +T  V  T  Y APE  ++ 
Sbjct: 126 VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-ATRWYRAPEIMLSF 184

Query: 263 GHLTTMCDVFSFGVVLLELLTGRRSVEKNR 292
              T   DV+S G +L ELL GR+ V K +
Sbjct: 185 QSYTKAIDVWSVGCILAELL-GRKPVFKGK 213

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 44/217 (20%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL------DVNGSQGHREWLAEVIFLGQLK 140
           +G G +G V   C   + R G K   VA+K L      ++   + +RE    +  L  +K
Sbjct: 23  VGSGAYGTV---CSALDRRTGAK---VAIKKLYRPFQSELFAKRAYRE----LRLLKHMK 72

Query: 141 HPHLVNLIGYCCEDEHR------LLVYEYMA--LGNL--HDQLFKNYSSTLPWLTRIKIA 190
           H +++ L+     D          LV  +M   LG L  H++L ++         RI+  
Sbjct: 73  HENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSED---------RIQFL 123

Query: 191 I-GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM 249
           +    + L ++H     +I+RD K  N+ ++ D   K+ DFGLA    +  DS +T  V+
Sbjct: 124 VYQMLKGLKYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGLA----RQTDSEMTGYVV 177

Query: 250 GTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
            T  Y APE I N  H T   D++S G ++ E+LTG+
Sbjct: 178 -TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 57/224 (25%), Positives = 94/224 (41%), Gaps = 45/224 (20%)

Query: 86  YLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA-----EVIFLGQLK 140
            +G G +G+VYK     N + G   +  A+K     G +     ++     E+  L +LK
Sbjct: 7   CIGRGTYGRVYKA-KRKNGKDG---KEYAIKKFK--GDKEQYTGISQSACREIALLRELK 60

Query: 141 HPHLVNLIGYCCEDEHRL--LVYEYMALGNLHD--QLFKNYSSTLPWLTRIKIAIGAARC 196
           H ++V+L+    E   +   L+++Y      HD  Q+ K +        R+ I     + 
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAE----HDLWQIIKFHRQA----KRVSIPPSMVKS 112

Query: 197 LAF--LHG----EEKPVIYRDFKASNILLDSDYNA----KLSDFGLA------TDGPQGE 240
           L +  L+G        V++RD K +NIL+  +       K+ D GLA             
Sbjct: 113 LLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172

Query: 241 DSHITTCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLT 283
           D      V+ T  Y APE +    H T   D+++ G +  ELLT
Sbjct: 173 DP-----VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 68/226 (30%), Positives = 99/226 (43%), Gaps = 26/226 (11%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDV-NGSQGHR-EWLAEVIFLGQ 138
           F     +GEG +G+VYK       R     + VA+K + + N  +G     + E+  L Q
Sbjct: 9   FDIIGQIGEGTYGQVYKA------RDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62

Query: 139 LKHPHLVNLIGYCCEDEHRL----------LVYEYMALGNLHDQLFKNYSSTLPWLTRIK 188
           L H ++VNL     + +  L          LV+EYM     HD L     S L   +   
Sbjct: 63  LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD----HD-LMGLLESGLVHFSEDH 117

Query: 189 IAIGAARCLAFL-HGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC 247
           I     + L  L +  +K  ++RD K SNILL++    KL+DFGLA      E    T  
Sbjct: 118 IKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNK 177

Query: 248 VMGTEGYAAPE-YINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNR 292
           V+ T  Y  PE  +         DV+S G +L EL T +   + N+
Sbjct: 178 VI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ 222

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)

Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 131 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 183

Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.4 bits (131), Expect = 4e-08
 Identities = 46/151 (30%), Positives = 70/151 (46%), Gaps = 30/151 (19%)

Query: 150 YCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLP------WLTRIKIAIGAARCLAFLHG 202
           Y  +DE+ L LV +Y   G+L   L K +   LP      +L  + +AI +   L ++H 
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVLAIDSVHQLGYVH- 125

Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFG----LATDGPQGEDSHITTCVMGTEGYAAPE 258
                  RD K  N+LLD + + +L+DFG    L  DG     +  +   +GT  Y +PE
Sbjct: 126 -------RDIKPDNVLLDKNGHIRLADFGSCLRLLADG-----TVQSNVAVGTPDYISPE 173

Query: 259 YIN-----TGHLTTMCDVFSFGVVLLELLTG 284
            +       G     CD +S GV + E+L G
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 54.3 bits (131), Expect = 6e-08
 Identities = 54/197 (27%), Positives = 79/197 (40%), Gaps = 54/197 (27%)

Query: 131 AEVIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKI 189
           AE   L +  +P +V L  Y  +DE+ L L+ EY+  G++   L K   +     TR  I
Sbjct: 50  AERDILAEADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMK-KDTFTEEETRFYI 107

Query: 190 -----AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT---------- 234
                AI +   L ++H        RD K  N+LLD+  + KLSDFGL T          
Sbjct: 108 AETILAIDSIHKLGYIH--------RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159

Query: 235 ----DGPQGEDSHITTC----------------------VMGTEGYAAPE-YINTGHLTT 267
                     +                             +GT  Y APE ++ TG+   
Sbjct: 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NK 218

Query: 268 MCDVFSFGVVLLELLTG 284
            CD +S GV++ E+L G
Sbjct: 219 ECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 53.2 bits (128), Expect = 7e-08
 Identities = 46/160 (28%), Positives = 72/160 (45%), Gaps = 20/160 (12%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVK--VLDVNGSQGHREWLAEVIFLG 137
            + + + +GEG +G V+K       +     + VA+K   LD +        L E+  L 
Sbjct: 1   KYEKLEKIGEGTYGTVFKA------KNRETHEIVALKRVRLDDDDEGVPSSALREICLLK 54

Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA----IGA 193
           +LKH ++V L      D+   LV+EY       DQ  K Y  +       +I        
Sbjct: 55  ELKHKNIVRLYDVLHSDKKLTLVFEYC------DQDLKKYFDSCNGDIDPEIVKSFMFQL 108

Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA 233
            + LAF H     V++RD K  N+L++ +   KL+DFGLA
Sbjct: 109 LKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLA 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 53.7 bits (129), Expect = 8e-08
 Identities = 69/256 (26%), Positives = 101/256 (39%), Gaps = 68/256 (26%)

Query: 81  FSRSDYLGEGGFGKVYKGC-VDDNLRPGLKAQTVAVKVL---DVNGSQGHREWLAEVIFL 136
           F +   +G G FG+V     VD N          A+K L   DV          AE   L
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTN-------ALYAMKTLRKADVLMRNQAAHVKAERDIL 55

Query: 137 GQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKN--YSSTLP--WLTRIKIAI 191
            +  +  +V L  Y  +D+  L  V +Y+  G++   L +   +   L   ++  +  AI
Sbjct: 56  AEADNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAI 114

Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD---------------- 235
            +   + F+H        RD K  NIL+D D + KL+DFGL T                 
Sbjct: 115 ESVHKMGFIH--------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHH 166

Query: 236 -----GPQGEDSHITTCVM--------------------GTEGYAAPEYI-NTGHLTTMC 269
                 P  E S I  C +                    GT  Y APE +  TG+ T +C
Sbjct: 167 RQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLC 225

Query: 270 DVFSFGVVLLELLTGR 285
           D +S GV+L E+L G+
Sbjct: 226 DWWSVGVILYEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 69/228 (30%), Positives = 99/228 (43%), Gaps = 26/228 (11%)

Query: 71  LKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWL 130
           L+ L   T  +   + +G+G +GKVYK     N + G  A   AVK+LD   S    E  
Sbjct: 14  LESLGDPTDTWEIIETIGKGTYGKVYKVT---NKKDGSLA---AVKILDPI-SDVDEEIE 66

Query: 131 AEVIFLGQL-KHPHLVNLIGYCCEDEHRL-----LVYEYMALGNLHDQLFKNYSSTLPWL 184
           AE   L  L  HP++V   G   + +  +     LV E    G++  +L K        L
Sbjct: 67  AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSV-TELVKGLLICGQRL 125

Query: 185 TRIKIAI---GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGED 241
               I+    GA   L  LH     +I+RD K +NILL ++   KL DFG++        
Sbjct: 126 DEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 183

Query: 242 SHITTCVMGTEGYAAPEYINTGH-----LTTMCDVFSFGVVLLELLTG 284
              T+  +GT  + APE I             CDV+S G+  +EL  G
Sbjct: 184 RRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 53.5 bits (128), Expect = 9e-08
 Identities = 48/174 (27%), Positives = 75/174 (43%), Gaps = 48/174 (27%)

Query: 150 YCCEDEHRL-LVYEYMALGNLHDQLFK----NYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           Y  +D+  L L+ E++  G++   L K    +  +T  ++    +AI A   L F+H   
Sbjct: 68  YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIH--- 124

Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLA---------------TDGPQGEDS------- 242
                RD K  N+LLD+  + KLSDFGL                T  P  + S       
Sbjct: 125 -----RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSK 179

Query: 243 -----------HITTCVMGTEGYAAPE-YINTGHLTTMCDVFSFGVVLLELLTG 284
                       +    +GT  Y APE ++ TG+   +CD +S GV++ E+L G
Sbjct: 180 RKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 51/178 (28%), Positives = 76/178 (42%), Gaps = 29/178 (16%)

Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
           A+ + FL    +  I+RD  A NILL  +   K+ DFGLA D  +  D            
Sbjct: 189 AKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246

Query: 254 YAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS------VEKNRCKREKDLVEWARPML 307
           + APE I     T   DV+SFGV+L E+ +   S      +++  C+R           L
Sbjct: 247 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-----------L 295

Query: 308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN 365
           K+ T++      R  D  + E  + +      C    P  RPT + +V+ L  LL  N
Sbjct: 296 KEGTRM------RAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLGNLLQAN 343

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 38/170 (22%)

Query: 136 LGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNL-------HDQLFKNYSSTLPWLTRI 187
           L     P +  L  Y  +D+  L LV EY   G+L        DQ  ++ +    +L  +
Sbjct: 55  LSISNSPWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQF--YLAEL 111

Query: 188 KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI-TT 246
            +AI +   + ++H        RD K  N+L+D   + KL+DFG A       +  + + 
Sbjct: 112 VLAIHSVHQMGYVH--------RDIKPENVLIDRTGHIKLADFGSA--ARLTANKMVNSK 161

Query: 247 CVMGTEGYAAPEYINTGHLTTM-----------CDVFSFGVVLLELLTGR 285
             +GT  Y APE      LTTM           CD +S GV+  E++ GR
Sbjct: 162 LPVGTPDYIAPEV-----LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 54/227 (23%), Positives = 98/227 (43%), Gaps = 24/227 (10%)

Query: 132 EVIFLGQLKHPHLVNLI-GYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA 190
           E   L QLKHP++V     +  ED    +V  +   G+L+ +L +     LP    ++  
Sbjct: 49  EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWF 108

Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG 250
           +  A  L +LH  EK +++RD K  N+ L      K+ D G+A       D  + + ++G
Sbjct: 109 VQIAMALQYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIG 164

Query: 251 TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF 310
           T  Y +PE  +        DV++ G  + E+ T + +                    KD 
Sbjct: 165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA-----------------KDM 207

Query: 311 TKL-DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
             L  +II+ +L      + +  L  +    LS  P+ RP++ ++++
Sbjct: 208 NSLVYRIIEGKLP-PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 62/219 (28%), Positives = 101/219 (46%), Gaps = 29/219 (13%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVK-VLDVNGSQGHR-EWLAEVIFLGQ 138
           + +   +G+G FG+V+K       R     Q VA+K VL  N  +G     L E+  L  
Sbjct: 14  YEKLAKIGQGTFGEVFKA------RHKKTKQIVALKKVLMENEKEGFPITALREIKILQL 67

Query: 139 LKHPHLVNLIGYC-----CEDEHR---LLVYEYMA--LGNLHDQLFKNYSSTLPWLTRI- 187
           LKH ++VNLI  C       + ++    LV+E+    L  L     KN   TL  + ++ 
Sbjct: 68  LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSN--KNVKFTLSEIKKVM 125

Query: 188 KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA--TDGPQGEDSHIT 245
           K+ +     L ++H  +  +++RD KA+NIL+  D   KL+DFGLA      +    +  
Sbjct: 126 KMLLNG---LYYIHRNK--ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180

Query: 246 TCVMGTEGYAAPE-YINTGHLTTMCDVFSFGVVLLELLT 283
           T  + T  Y  PE  +         D++  G ++ E+ T
Sbjct: 181 TNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 21/154 (13%)

Query: 142 PHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLP------WLTRIKIAIGAAR 195
           P++V L  Y   ++   LV ++   G L   + K     +P      W   + +A+ A  
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK--FLNIPEECVKRWAAEMVVALDA-- 100

Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
               LH   + ++ RD   +NILLD   + +L+ F   ++    EDS     V     Y 
Sbjct: 101 ----LH--REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEV---EDSCDGEAV--ENMYC 149

Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTGRRSVE 289
           APE       T  CD +S G +L ELLTG+  VE
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVE 183

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 47/154 (30%), Positives = 69/154 (44%), Gaps = 19/154 (12%)

Query: 85  DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPH 143
           D LGEG +  VYKG      R  L  Q VA+K + +   +G     + E   L  LKH +
Sbjct: 11  DKLGEGSYATVYKG------RSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHAN 64

Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPW---LTRIKIAI-GAARCLAF 199
           +V L       +   LV+EY+      D   K Y         +  +++ +    R LA+
Sbjct: 65  IVTLHDIIHTKKTLTLVFEYL------DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAY 118

Query: 200 LHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA 233
            H     V++RD K  N+L+      KL+DFGLA
Sbjct: 119 CHQRR--VLHRDLKPQNLLISERGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 5/92 (5%)

Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H     V++RD K SN+LL+++ + K+ DFGLA      E     T  + T  Y
Sbjct: 119 RGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWY 174

Query: 255 AAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
            APE + N    TT  DV+S G +  ELL  +
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 59/228 (25%), Positives = 101/228 (44%), Gaps = 55/228 (24%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF----- 135
           ++    +G G +G V   C   + R G K   VA+K L        R + +E IF     
Sbjct: 17  YTSLKQVGSGAYGSV---CSAIDKRTGEK---VAIKKL-------SRPFQSE-IFAKRAY 62

Query: 136 --LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWL--------- 184
             L  LKH    N+IG         L+  + +  +  +  F+++   +P++         
Sbjct: 63  RELTLLKHMQHENVIG---------LLDVFTSAVSGDE--FQDFYLVMPYMQTDLQKIMG 111

Query: 185 -----TRIKIAIGAARC-LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ 238
                 +++  +    C L ++H     +I+RD K  N+ ++ D   K+ DFGLA    +
Sbjct: 112 HPLSEDKVQYLVYQMLCGLKYIH--SAGIIHRDLKPGNLAVNEDCELKILDFGLA----R 165

Query: 239 GEDSHITTCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
             D+ +T  V+ T  Y APE I N  H     D++S G ++ E+LTG+
Sbjct: 166 HADAEMTGYVV-TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 34/223 (15%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVK--VLDVNGSQGHREWLAEVIFLG 137
            + + + +GEG +GKVYK     +   G   + VA+K   L+++        L E+  L 
Sbjct: 2   AYEKLEKIGEGTYGKVYKA---RDKNTG---KLVALKKTRLEMDEEGIPPTALREISLLQ 55

Query: 138 QLKH-PHLVNLIGYCCEDEHR-----LLVYEYMA--LGNLHDQLFKNYSSTLPWLT---- 185
            L    ++V L+     +E        LV+EY+   L    D   +     LP  T    
Sbjct: 56  MLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSF 115

Query: 186 RIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNA-KLSDFGL--ATDGPQGEDS 242
             ++  G A C    HG    V++RD K  N+L+D      K++D GL  A   P    +
Sbjct: 116 MYQLLKGVAHCHK--HG----VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYT 169

Query: 243 HITTCVMGTEGYAAPE-YINTGHLTTMCDVFSFGVVLLELLTG 284
           H       T  Y APE  + + H +T  D++S G +  E+   
Sbjct: 170 HEIV----TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 46/153 (30%), Positives = 71/153 (46%), Gaps = 24/153 (15%)

Query: 145 VNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLP------WLTRIKIAIGAARCL 197
           +  + Y  +DE+ L LV +Y   G+L   L   +   LP      +L  + IAI +   L
Sbjct: 63  ITTLHYAFQDENNLYLVMDYYVGGDLL-TLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV-MGTEGYAA 256
            ++H        RD K  NIL+D + + +L+DFG        ED  + + V +GT  Y +
Sbjct: 122 HYVH--------RDIKPDNILMDMNGHIRLADFGSCLK--LMEDGTVQSSVAVGTPDYIS 171

Query: 257 PEYINT-----GHLTTMCDVFSFGVVLLELLTG 284
           PE +       G     CD +S GV + E+L G
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 65/225 (28%), Positives = 98/225 (43%), Gaps = 53/225 (23%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVK-VLDV--NGSQGHREWLAEVIFLGQLKHPH 143
           +G+G +G V   C   +   G   + VA+K + DV  + S   R  L E+  L  L+HP 
Sbjct: 8   IGKGSYGVV---CSAIDTHTG---EKVAIKKINDVFEHVSDATR-ILREIKLLRLLRHPD 60

Query: 144 LVNLIGYCCEDEHRLL------------VYEYMALGNLHDQLFKNYSSTLP-----WLTR 186
           +V       E +H +L            V+E M   +LH Q+ K      P     +L +
Sbjct: 61  IV-------EIKHIMLPPSRREFKDIYVVFELME-SDLH-QVIKANDDLTPEHHQFFLYQ 111

Query: 187 IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA----TDGPQGEDS 242
           +       R L ++H     V +RD K  NIL ++D   K+ DFGLA     D P    +
Sbjct: 112 L------LRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT---A 160

Query: 243 HITTCVMGTEGYAAPEYINT--GHLTTMCDVFSFGVVLLELLTGR 285
              T  + T  Y APE   +     T   D++S G +  E+LTG+
Sbjct: 161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 50.8 bits (121), Expect = 5e-07
 Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 13/201 (6%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL-DVNGSQGHREW-LAEVIFLGQLKHPHL 144
           +GEG +G V K       R     + VA+K   D   ++  +E  L E+  L  LK  ++
Sbjct: 9   VGEGAYGVVLK------CRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62

Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           V L           LV+EY+   N+ + L +  +   P   R  I     + + + H  +
Sbjct: 63  VELKEAFRRRGKLYLVFEYVE-KNMLELLEEMPNGVPPEKVRSYI-YQLIKAIHWCHKND 120

Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGH 264
             +++RD K  N+L+  +   KL DFG A +  +G +++ T  V  T  Y +PE +    
Sbjct: 121 --IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV-ATRWYRSPELLLGAP 177

Query: 265 LTTMCDVFSFGVVLLELLTGR 285
                D++S G +L EL  G+
Sbjct: 178 YGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 39/147 (26%), Positives = 57/147 (38%), Gaps = 14/147 (9%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLGQLKHPHL 144
             +     + K    + L        VAVK   LD    +  +    E+I   QL+HP+ 
Sbjct: 10  FEDLMIVHLAKHKPTNTL--------VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPN- 60

Query: 145 VNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE 203
           +         +  L +V   MA G+  D L  ++   LP L    I       L ++H  
Sbjct: 61  ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH-- 118

Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDF 230
            K  I+R  KAS+ILL  D    LS  
Sbjct: 119 SKGFIHRSVKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 50.8 bits (121), Expect = 7e-07
 Identities = 60/234 (25%), Positives = 109/234 (46%), Gaps = 40/234 (17%)

Query: 73  ELQMITHNFSRS--------DYLGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGS 123
           E +MI ++ +RS        + +G G FG VY+  C+D        ++ VA+K +  +  
Sbjct: 52  EEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICID-------TSEKVAIKKVLQDPQ 104

Query: 124 QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL--------LVYEYMALGNLHDQLFK 175
             +RE    ++ +  L H +++ L  Y   +  +         +V E++    +H +  K
Sbjct: 105 YKNRE----LLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVH-KYMK 158

Query: 176 NYS---STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD-YNAKLSDFG 231
           +Y+     LP       +    R LA++H   K + +RD K  N+L+D + +  KL DFG
Sbjct: 159 HYARNNHALPLFLVKLYSYQLCRALAYIH--SKFICHRDLKPQNLLIDPNTHTLKLCDFG 216

Query: 232 LATDGPQGEDSHITTCVMGTEGYAAPE-YINTGHLTTMCDVFSFGVVLLELLTG 284
            A +   G+ S    C   +  Y APE  +   + TT  D++S G ++ E++ G
Sbjct: 217 SAKNLLAGQRSVSYIC---SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 50.4 bits (120), Expect = 8e-07
 Identities = 46/174 (26%), Positives = 73/174 (41%), Gaps = 48/174 (27%)

Query: 150 YCCEDEHRL-LVYEYMALGNLHDQLFKNYS----STLPWLTRIKIAIGAARCLAFLHGEE 204
           Y  +D+  L L+ E++  G++   L K  +     T  ++    +AI +   L F+H   
Sbjct: 68  YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIH--- 124

Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS---------------------- 242
                RD K  N+LLDS  + KLSDFGL T   +   +                      
Sbjct: 125 -----RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSK 179

Query: 243 -----------HITTCVMGTEGYAAPE-YINTGHLTTMCDVFSFGVVLLELLTG 284
                       +    +GT  Y APE ++ TG+   +CD +S GV++ E+L G
Sbjct: 180 RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 50.0 bits (119), Expect = 9e-07
 Identities = 65/210 (30%), Positives = 92/210 (43%), Gaps = 22/210 (10%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-HPHLV 145
           +G+G +GKV+K     N + G KA   AVK+LD        E  AE   L  L  HP++V
Sbjct: 26  IGKGTYGKVFKVL---NKKNGSKA---AVKILDPI-HDIDEEIEAEYNILKALSDHPNVV 78

Query: 146 NLIG-YCCED----EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA-IGAARCLAF 199
              G Y  +D    +   LV E    G++ D L K +      +    IA I     +  
Sbjct: 79  KFYGMYYKKDVKNGDQLWLVLELCNGGSVTD-LVKGFLKRGERMEEPIIAYILHEALMGL 137

Query: 200 LHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEY 259
            H      I+RD K +NILL ++   KL DFG++           T+  +GT  + APE 
Sbjct: 138 QHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPEV 195

Query: 260 INTGH-----LTTMCDVFSFGVVLLELLTG 284
           I             CDV+S G+  +EL  G
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 66/258 (25%), Positives = 102/258 (39%), Gaps = 68/258 (26%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ-GHREWLAEVIFLGQL 139
           F +   LG G FG+V   C  D     L A     K   +N +Q  H +  AE   L + 
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDT--HALYAMKTLRKKDVLNRNQVAHVK--AERDILAEA 58

Query: 140 KHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLP------WLTRIKIAIG 192
            +  +V L  Y  +D+  L  V +Y+  G++   L +      P      ++  + +AI 
Sbjct: 59  DNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIE 115

Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT------------------ 234
           +   + F+H        RD K  NIL+D D + KL+DFGL T                  
Sbjct: 116 SVHKMGFIH--------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIR 167

Query: 235 -DGPQGED--SHITTC------------------------VMGTEGYAAPEYINTGHLTT 267
            D  +  D    ++ C                        ++GT  Y APE +     T 
Sbjct: 168 QDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ 227

Query: 268 MCDVFSFGVVLLELLTGR 285
           +CD +S GV+L E+L G+
Sbjct: 228 LCDWWSVGVILFEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 24/153 (15%)

Query: 145 VNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLP------WLTRIKIAIGAARCL 197
           +  + Y  +DE+ L LV +Y   G+L   L   +   LP      ++  + +AI +   L
Sbjct: 63  ITTLHYAFQDENYLYLVMDYYVGGDLL-TLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL 121

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV-MGTEGYAA 256
            ++H        RD K  N+LLD + + +L+DFG        +D  + + V +GT  Y +
Sbjct: 122 HYVH--------RDIKPDNVLLDMNGHIRLADFGSCLK--MNQDGTVQSSVAVGTPDYIS 171

Query: 257 PEYINT-----GHLTTMCDVFSFGVVLLELLTG 284
           PE +       G     CD +S GV + E+L G
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 62/280 (22%), Positives = 118/280 (42%), Gaps = 41/280 (14%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVA-VKVLDVNGSQGHREWLAEVIFLGQLKHPHLV 145
           LG+G FG VY    D       + + +  + V ++N ++  +    E   L +L HP +V
Sbjct: 8   LGKGSFGTVYL-VKDKKAVAEERLKVLKEIPVGELNPNETVQANQ-EAQLLSKLDHPAIV 65

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQL--FKNYSSTLP------WLTRIKIAIGAARCL 197
                  E +   ++ EY    +L  +L   K+   TL       W  ++ + +      
Sbjct: 66  KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH----- 120

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAP 257
            ++H  ++ +++RD KA NI L ++   K+ DFG++       D  + T   GT  Y +P
Sbjct: 121 -YMH--QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCD--LATTFTGTPYYMSP 174

Query: 258 EYINTGHLTTMCDVFSFGVVLLELLTGRRSVE-KNRCKREKDLVEWARPMLKDFTKLDQI 316
           E +      +  D++S G +L E+     + E +N       +VE   P           
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTP----------- 223

Query: 317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
               L + YS    ++L ++    L+ +P  RP+   +++
Sbjct: 224 ---SLPETYS----RQLNSIMQSMLNKDPSLRPSAAEILR 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 49.7 bits (118), Expect = 2e-06
 Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 8/92 (8%)

Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H     +I+RD K SN+ ++ D   ++ DFGLA    Q +D    T  + T  Y
Sbjct: 129 RGLKYIH--SAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDE--MTGYVATRWY 181

Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELL G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 35/123 (28%), Positives = 54/123 (43%), Gaps = 2/123 (1%)

Query: 161 YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD 220
           Y+      + + L  + S  L  L  +      AR + FL    K  ++RD  A N+LL 
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL--ASKNCVHRDLAARNVLLA 271

Query: 221 SDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLE 280
                K+ DFGLA D     +            + APE I     TT+ DV+S+G++L E
Sbjct: 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWE 331

Query: 281 LLT 283
           + +
Sbjct: 332 IFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 47.7 bits (114), Expect = 5e-06
 Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 43/214 (20%)

Query: 87  LGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVL--------DVNGSQGHREWLAEVIFLG 137
           +GEG F +V K              +  A+K +         VN        L E+  L 
Sbjct: 7   IGEGTFSEVLKAQSRKTG-------KYYAIKCMKKHFKSLEQVNN-------LREIQALR 52

Query: 138 QLK-HPHLVNLIGYCCEDEH-RL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA 194
           +L  HP+++ LI    + +  RL LV+E M + NL++ L K     LP            
Sbjct: 53  RLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYE-LIKGRKRPLPEKRVKSYMYQLL 110

Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFG----LATDGPQGEDSHITTCVMG 250
           + L  +H     + +RD K  NIL+  D   KL+DFG    + +  P  E  +I+     
Sbjct: 111 KSLDHMHR--NGIFHRDIKPENILIK-DDILKLADFGSCRGIYSKPPYTE--YIS----- 160

Query: 251 TEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLT 283
           T  Y APE + T G+     D+++ G V  E+L+
Sbjct: 161 TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 47.6 bits (114), Expect = 6e-06
 Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 43/224 (19%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-----WLAEVI 134
            + + + + EG +G VY+       R     + VA+K L +   +  +E      L E+ 
Sbjct: 6   EYEKLNRIEEGTYGVVYRA------RDKKTGEIVALKKLKM---EKEKEGFPITSLREIN 56

Query: 135 FLGQLKHPHLVNL--IGYCCEDEHRLLVYEYMALGNLHD--QLFKNYSSTLPWLTRIKIA 190
            L +L+HP++V +  +      +   +V EY+     HD   L +               
Sbjct: 57  ILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE----HDLKSLMETMKQPF--------L 104

Query: 191 IGAARCL--------AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS 242
               +CL        A LH  +  +++RD K SN+LL++    K+ DFGLA     G   
Sbjct: 105 QSEVKCLMLQLLSGVAHLH--DNWILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPL 160

Query: 243 HITTCVMGTEGYAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
              T ++ T  Y APE  +     +T  D++S G +  ELLT +
Sbjct: 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 47.5 bits (113), Expect = 8e-06
 Identities = 48/180 (26%), Positives = 74/180 (41%), Gaps = 37/180 (20%)

Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE- 252
           A+ + FL    K  I+RD  A N+LL     AK+ DFGLA D     DS+    V G   
Sbjct: 222 AQGMDFL--ASKNCIHRDVAARNVLLTDGRVAKICDFGLARD--IMNDSNYV--VKGNAR 275

Query: 253 ---GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS------VEKNRCKREKDLVEWA 303
               + APE I     T   DV+S+G++L E+ +  +S      V     K  K   + +
Sbjct: 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS 335

Query: 304 RPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD 363
           RP   DF   +                  + ++   C +  P  RPT + + + ++  L 
Sbjct: 336 RP---DFAPPE------------------IYSIMKMCWNLEPTERPTFSQISQLIQRQLG 374

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 47.3 bits (112), Expect = 9e-06
 Identities = 35/123 (28%), Positives = 48/123 (39%), Gaps = 45/123 (36%)

Query: 208 IYRDFKASNILLDSDYNAKLSDFGLAT--------------DGP---------QGEDSHI 244
           I+RD K  NIL+D D + KL+DFGL T              D           +  D   
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 245 TTC----------------------VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELL 282
             C                      ++GT  Y APE +     T +CD +S GV+L E+L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 283 TGR 285
            G+
Sbjct: 243 VGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 6/95 (6%)

Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA--TDGPQGEDSHITTCVMGTE 252
           R L ++H     VI+RD K SN+L++ D   ++ DFG+A        E  +  T  + T 
Sbjct: 118 RGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175

Query: 253 GYAAPEYINTGH-LTTMCDVFSFGVVLLELLTGRR 286
            Y APE + +    TT  D++S G +  E+L GRR
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 35/123 (28%), Positives = 53/123 (43%), Gaps = 2/123 (1%)

Query: 161 YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD 220
           Y   A          N S  L ++  +  +   A  + FL    K  ++RD  A N+L+ 
Sbjct: 216 YLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFL--ASKNCVHRDLAARNVLIC 273

Query: 221 SDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLE 280
                K+ DFGLA D  +  +            + APE I     TT+ DV+SFG++L E
Sbjct: 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWE 333

Query: 281 LLT 283
           + T
Sbjct: 334 IFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 44/178 (24%), Positives = 76/178 (42%), Gaps = 14/178 (7%)

Query: 105 RPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYM 164
           +PG +   V +K+    G +G    L E + L  + HP ++ +           +V  + 
Sbjct: 87  KPG-QPDPVVLKI----GQKGTT--LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139

Query: 165 ALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYN 224
           +  +L+  L K  S  LP    + I       L +LH +   +I+RD K  NI ++    
Sbjct: 140 S-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQ 195

Query: 225 AKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELL 282
             + D G A   P    + +   + GT    APE +      +  D++S G+VL E+L
Sbjct: 196 VCIGDLG-AAQFPVVAPAFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 68/316 (21%), Positives = 120/316 (37%), Gaps = 74/316 (23%)

Query: 87  LGEGGFGKVY----KGCVDDNLRPGLKAQTVAVKVLDVNGSQG---HREWLAEVIFLGQL 139
           +G+GG G+VY      C          ++ VA+K +  + S+     + +L E      L
Sbjct: 10  IGKGGMGEVYLAYDPVC----------SRRVALKKIREDLSENPLLKKRFLREAKIAADL 59

Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMAL--GNLHDQLFKNY------------SSTLPWLT 185
            HP +V +   C + +    VY  M    G     L K+              +++    
Sbjct: 60  IHPGIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFL 116

Query: 186 RIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS-------DYNAKLS-----DFGLA 233
            I   I A   + ++H   K V++RD K  NILL         D+ A +      +  L 
Sbjct: 117 SIFHKICAT--IEYVH--SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172

Query: 234 TDGPQGEDSHITTCVM----GTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVE 289
            D  +    + +  +     GT  Y APE +     +   D+++ GV+L ++LT      
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232

Query: 290 KNRCKREKDLVEWARPMLKDFTKL--DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKS 347
           +                 K   K+    +I S +E     E    L+ +A + L+ +P  
Sbjct: 233 R-----------------KKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAE 275

Query: 348 R-PTMTTVVKALEPLL 362
           R  ++  + + LEP L
Sbjct: 276 RYSSVQELKQDLEPHL 291

Length = 932

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 29/79 (36%), Positives = 42/79 (53%), Gaps = 3/79 (3%)

Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
           +I+RD K SNI++ SD   K+ DFGLA     G    +T  V+ T  Y APE I      
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVV-TRYYRAPEVILGMGYK 195

Query: 267 TMCDVFSFGVVLLELLTGR 285
              D++S G ++ E++ G 
Sbjct: 196 ENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 59/250 (23%), Positives = 99/250 (39%), Gaps = 36/250 (14%)

Query: 97  KGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA----EVIFLGQLKHPHLVNLIGYCC 152
           +GCV ++  P    Q V VK            W A    E   L +L HP ++ L+    
Sbjct: 182 EGCVFESSHPDY-PQRVVVKA----------GWYASSVHEARLLRRLSHPAVLALL---- 226

Query: 153 EDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLA---FLHGEEKPVIY 209
            D   +     + L      L+    + L  L   ++   A + L+   ++HGE   +I+
Sbjct: 227 -DVRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIH 283

Query: 210 RDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMC 269
           RD K  N+L++   +  L DFG A        +     + GT    APE +     T   
Sbjct: 284 RDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSV 343

Query: 270 DVFSFGVVLLE-------LLTGRRSVEKNRCKRE-KDLVEWARPMLKDFTKLDQIIDSRL 321
           D++S G+V+ E       L +  R  E+     +   ++  A+  + +F    Q   SRL
Sbjct: 344 DIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP---QHAGSRL 400

Query: 322 EDRYSTEGAK 331
             +Y    A+
Sbjct: 401 VSQYRHRAAR 410

Length = 461

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 45.5 bits (108), Expect = 3e-05
 Identities = 52/221 (23%), Positives = 92/221 (41%), Gaps = 39/221 (17%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G  G V+   VD +       + VAVK + +   Q  +  L E+  + +L H ++V 
Sbjct: 13  LGCGSNGLVFSA-VDSDCD-----KRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 147 LIGYCCEDEHRL--------------LVYEYMA--LGNL--HDQLFKNYSSTLPWLTRIK 188
           +          L              +V EYM   L N+     L + ++          
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLF------- 119

Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDS-DYNAKLSDFGLA--TDGPQGEDSHIT 245
                 R L ++H     V++RD K +N+ +++ D   K+ DFGLA   D P        
Sbjct: 120 -MYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVD-PHYSHKGYL 175

Query: 246 TCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
           +  + T+ Y +P  + +  + T   D+++ G +  E+LTG+
Sbjct: 176 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 29/84 (34%), Positives = 42/84 (50%), Gaps = 3/84 (3%)

Query: 201 HGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI 260
           H     +I+RD K SNI++ SD   K+ DFGLA        + + T  + T  Y APE I
Sbjct: 138 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVI 194

Query: 261 NTGHLTTMCDVFSFGVVLLELLTG 284
                    D++S G ++ EL+ G
Sbjct: 195 LGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.8 bits (106), Expect = 5e-05
 Identities = 57/206 (27%), Positives = 77/206 (37%), Gaps = 63/206 (30%)

Query: 131 AEVIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKI 189
           AE   L +   P +V+L  Y  +D   L L+ E++  G+L   L K Y +    +TR  +
Sbjct: 50  AERDVLAESDSPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIK-YDTFSEDVTRFYM 107

Query: 190 A-----IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS-- 242
           A     I A   L F+H        RD K  NIL+D   + KLSDFGL+T   +  DS  
Sbjct: 108 AECVLAIEAVHKLGFIH--------RDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159

Query: 243 ---------------------------------HITT----------CVMGTEGYAAPEY 259
                                             I T            +GT  Y APE 
Sbjct: 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE- 218

Query: 260 INTGH-LTTMCDVFSFGVVLLELLTG 284
           I         CD +S G ++ E L G
Sbjct: 219 IFLQQGYGQECDWWSLGAIMFECLIG 244

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 45.1 bits (106), Expect = 6e-05
 Identities = 56/253 (22%), Positives = 103/253 (40%), Gaps = 24/253 (9%)

Query: 49  GSPISLNELSSSLVGSNLHVFT-LKELQMITHNFSRSDYLGEGGFGKVY----------- 96
            S +  +E      G        LK       +F   D L  G FGK++           
Sbjct: 117 ASHLDFDEAPPDAAGPVPLAQAKLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEA 176

Query: 97  ---KGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE 153
              +G    N       + +A +V    GS+   +   E++ LG+L H +++ +      
Sbjct: 177 EARRGVNSTNQGKPKCERLIAKRVK--AGSRAAIQLENEILALGRLNHENILKIEEILRS 234

Query: 154 DEHRLLV---YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYR 210
           + +  ++   Y++     ++D+ F      L   TR  I       + ++H  +K +I+R
Sbjct: 235 EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIH--DKKLIHR 291

Query: 211 DFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCD 270
           D K  NI L+ D    L DFG A    +  ++     V GT    +PE +       + D
Sbjct: 292 DIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWV-GTVATNSPEILAGDGYCEITD 350

Query: 271 VFSFGVVLLELLT 283
           ++S G++LL++L+
Sbjct: 351 IWSCGLILLDMLS 363

Length = 501

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 44.0 bits (104), Expect = 9e-05
 Identities = 50/236 (21%), Positives = 94/236 (39%), Gaps = 34/236 (14%)

Query: 132 EVIFLGQLKHPHLVNLIGY---CCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRI 187
           E+  L ++   +++ + G+     +D  RL L+ EY   G L + L K     L + T++
Sbjct: 68  EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD--LSFKTKL 125

Query: 188 KIAIGAARCLAFLHG-EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITT 246
            +AI   + L  L+    KP  Y++  + + L+  +Y  K+   GL          ++  
Sbjct: 126 DMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNF 183

Query: 247 CVMGTEGYAAPEYINT--GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR 304
            V     Y + + +N      T   D++S GVVL E+ TG+   E               
Sbjct: 184 MV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN-------------- 224

Query: 305 PMLKDFTKL-DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
                  ++ D II+     +   +    +  +   C SH+   RP +  ++  L 
Sbjct: 225 ---LTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277

Length = 283

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 44.0 bits (104), Expect = 9e-05
 Identities = 47/160 (29%), Positives = 72/160 (45%), Gaps = 23/160 (14%)

Query: 141 HPHLVNLIGYCCED--EHRLLVYEYMALGNLHDQLFKNYSSTLPW-LTRIKIAIGAARCL 197
           +P +V++  +C  +   H  +V EY+  G+    L KN    LP  + R+  A      L
Sbjct: 60  NPFVVSM--FCSFETKRHLCMVMEYVEGGDCA-TLLKNIG-ALPVDMARMYFA-ETVLAL 114

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL--------ATDGPQGEDSHIT---- 245
            +LH     +++RD K  N+L+ S  + KL+DFGL         T+  +G     T    
Sbjct: 115 EYLH--NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172

Query: 246 -TCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
              V GT  Y APE I         D ++ G++L E L G
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 35/109 (32%), Positives = 51/109 (46%), Gaps = 19/109 (17%)

Query: 87  LGEGGFGKVYKGCV-----DDNLRPGLKAQTVAVKVLDVNGSQGHREWL-AEVIFLGQL- 139
           LG G FGKV +        +DN         VAVK+L  +     RE L +E+  L  L 
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDN------VLRVAVKMLKASAHTDEREALMSELKILSHLG 99

Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHD------QLFKNYSSTLP 182
           +H ++VNL+G C      L++ EY   G+L +      + F N+   LP
Sbjct: 100 QHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALP 148

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 31/86 (36%), Positives = 44/86 (51%), Gaps = 5/86 (5%)

Query: 201 HGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYAAPEY 259
           H     +I+RD K SNI++ SD   K+ DFGLA T G     S + T  + T  Y APE 
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG----TSFMMTPYVVTRYYRAPEV 196

Query: 260 INTGHLTTMCDVFSFGVVLLELLTGR 285
           I         D++S G ++ E++ G 
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 40/159 (25%), Positives = 67/159 (42%), Gaps = 10/159 (6%)

Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSS--TLPWLTRIKI 189
           E   L  + HP ++ L G    ++   L+     L      L+   ++   +     + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI-----LPRYKTDLYCYLAAKRNIAICDILAI 187

Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM 249
                R + +LH  E  +I+RD KA NI ++   +  L DFG A   P   +++      
Sbjct: 188 ERSVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFGAAC-FPVDINANKYYGWA 244

Query: 250 GTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSV 288
           GT    APE +         D++S G+VL E+ T   S+
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 34/94 (36%), Positives = 47/94 (50%), Gaps = 10/94 (10%)

Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE- 252
           A+ ++FL    K  I+RD  A NILL      K+ DFGLA D     DS+    V G   
Sbjct: 224 AKGMSFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARD--IRNDSNYV--VKGNAR 277

Query: 253 ---GYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
               + APE I     T   DV+S+G++L E+ +
Sbjct: 278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 43.2 bits (101), Expect = 2e-04
 Identities = 30/83 (36%), Positives = 43/83 (51%), Gaps = 5/83 (6%)

Query: 201 HGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYAAPEY 259
           H     +I+RD K SNI++ SD   K+ DFGLA T G     S + T  + T  Y APE 
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG----TSFMMTPYVVTRYYRAPEV 189

Query: 260 INTGHLTTMCDVFSFGVVLLELL 282
           I         D++S G ++ E++
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 41.6 bits (97), Expect = 5e-04
 Identities = 62/251 (24%), Positives = 111/251 (44%), Gaps = 39/251 (15%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           +G G +G VYK    D    G   +  A+K   + G+        E+  L +LKHP++++
Sbjct: 9   VGRGTYGHVYKAKRKD----GKDDRDYALK--QIEGTGISMSACREIALLRELKHPNVIS 62

Query: 147 L--IGYCCEDEHRLLVYEYMALGNLHD--QLFKNYSSTLPWLTRIKIAIGAARCLAF--- 199
           L  +     D    L+++Y      HD   + K + ++      +++  G  + L +   
Sbjct: 63  LQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 118

Query: 200 -----LHGEEKPVIYRDFKASNILLDSDY----NAKLSDFGLAT--DGPQGEDSHITTCV 248
                LH     V++RD K +NIL+  +       K++D G A   + P    + +   V
Sbjct: 119 DGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176

Query: 249 MGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML 307
           + T  Y APE +    H T   D+++ G +  ELLT   S     C++E   ++ + P  
Sbjct: 177 V-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT---SEPIFHCRQED--IKTSNPYH 230

Query: 308 KDFTKLDQIID 318
            D  +LD+I +
Sbjct: 231 HD--QLDRIFN 239

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 41.0 bits (96), Expect = 9e-04
 Identities = 31/91 (34%), Positives = 45/91 (49%), Gaps = 6/91 (6%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHL- 144
           LG G FGKV +      +      +TVAVK+L     +  ++  + E+  L  + H HL 
Sbjct: 15  LGRGAFGKVIQASAFG-IEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGH-HLN 72

Query: 145 -VNLIGYCCEDEHRLLV-YEYMALGNLHDQL 173
            VNL+G C +    L+V  EY   GNL + L
Sbjct: 73  VVNLLGACTKPGGPLMVIVEYCKFGNLSNYL 103

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 62/245 (25%), Positives = 103/245 (42%), Gaps = 31/245 (12%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           +G G +G VYK    D    G   +  A+K   + G+        E+  L +LKHP+++ 
Sbjct: 9   VGRGTYGHVYKAKRKD----GKDEKEYALK--QIEGTGISMSACREIALLRELKHPNVIA 62

Query: 147 L--IGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST------LPWLTRIKIAIGAARCLA 198
           L  +     D    L+++Y      H   F   S        LP      +       + 
Sbjct: 63  LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122

Query: 199 FLHGEEKPVIYRDFKASNILLDSDY----NAKLSDFGLAT--DGPQGEDSHITTCVMGTE 252
           +LH     V++RD K +NIL+  +       K++D G A   + P    + +   V+ T 
Sbjct: 123 YLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TF 179

Query: 253 GYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFT 311
            Y APE +    H T   D+++ G +  ELLT   S     C++E   ++ + P   D  
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT---SEPIFHCRQED--IKTSNPFHHD-- 232

Query: 312 KLDQI 316
           +LD+I
Sbjct: 233 QLDRI 237

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 30/103 (29%), Positives = 48/103 (46%), Gaps = 4/103 (3%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG-HREWLAEVIFLGQL-KHPHL 144
           LG G FGKV +      +       TVAVK+L    +   H+  ++E+  L  +  H ++
Sbjct: 15  LGHGAFGKVVEASAF-GIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNV 73

Query: 145 VNLIGYCCEDEHRLLV-YEYMALGNLHDQLFKNYSSTLPWLTR 186
           VNL+G C +    L+V  E+   GNL + L        P+  +
Sbjct: 74  VNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREK 116

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 40.6 bits (95), Expect = 0.002
 Identities = 45/151 (29%), Positives = 72/151 (47%), Gaps = 21/151 (13%)

Query: 90  GGFGKVYKGCVDDNLRPGLKAQTVAVKVLD----VNGSQGHREWLAEVIFLGQLKHPHLV 145
           G FGKVY G      R    ++  AVKV+     +N +  H +  AE   L   K P +V
Sbjct: 15  GAFGKVYLG------RKKNNSKLYAVKVVKKADMINKNMVH-QVQAERDALALSKSPFIV 67

Query: 146 NLIGYCCEDEHRL-LVYEYMALGNLHDQL--FKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
           +L  Y  +  + + LV EY+  G++   L  +  +         +K     A  L +LH 
Sbjct: 68  HLY-YSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEE----MAVKYISEVALALDYLH- 121

Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLA 233
               +I+RD K  N+L+ ++ + KL+DFGL+
Sbjct: 122 -RHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 38.7 bits (90), Expect = 0.004
 Identities = 31/87 (35%), Positives = 42/87 (48%), Gaps = 7/87 (8%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAE----VIFLGQLKHP 142
           LG G FGKV +      L     A TVAVK+L  +     RE L      + +LG   H 
Sbjct: 43  LGAGAFGKVVEATAY-GLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN--HI 99

Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNL 169
           ++VNL+G C      L++ EY   G+L
Sbjct: 100 NIVNLLGACTVGGPTLVITEYCCYGDL 126

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	449
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.98
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.98
KOG1152	772	consensus Signal transduction serine/threonine kin	99.98
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.86
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.86
PRK10345	210	hypothetical protein; Provisional	99.84
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.83
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.81
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.81
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.81
smart00090	237	RIO RIO-like kinase.	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.77
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.76
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.76
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.73
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.69
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.67
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.67
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.56
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.53
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.45
KOG1243	690	consensus Protein kinase [General function predict	99.41
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.41
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.39
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.39
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.35
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.31
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.3
KOG3087	229	consensus Serine/threonine protein kinase [General	99.3
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.2
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.08
COG4248	637	Uncharacterized protein with protein kinase and he	99.04
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.04
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.92
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.88
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.85
PRK09902	216	hypothetical protein; Provisional	98.74
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.7
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.69
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.6
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.52
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.35
PF01636	239	APH: Phosphotransferase enzyme family This family	98.34
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.3
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.27
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.25
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.24
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.22
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.18
PLN02876	822	acyl-CoA dehydrogenase	98.15
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.14
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.89
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.87
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.82
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.81
PRK10593	297	hypothetical protein; Provisional	97.74
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.71
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.69
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.67
PRK05231	319	homoserine kinase; Provisional	97.59
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.5
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.49
PLN02236	344	choline kinase	97.2
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.15
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.12
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.78
PLN02756	418	S-methyl-5-thioribose kinase	96.69
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.68
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.66
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.38
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.37
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.25
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.24
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.09
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.08
KOG2270	520	consensus Serine/threonine protein kinase involved	96.01
PRK12396	409	5-methylribose kinase; Reviewed	95.94
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.9
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	95.49
PTZ00384	383	choline kinase; Provisional	95.49
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.23
COG2334	331	Putative homoserine kinase type II (protein kinase	94.79
PRK06148	1013	hypothetical protein; Provisional	94.54
PRK11768	325	serine/threonine protein kinase; Provisional	94.43

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-52  Score=386.32  Aligned_cols=253  Identities=29%  Similarity=0.421  Sum_probs=213.1

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC-CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC-EE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE-HR  157 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~  157 (449)
                      +.+..+.||+|..|+||++.++.      +++.+|+|++... +....+++.+|+++++..+|||||.+|++|..+. ..
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~------t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i  153 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKP------TGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI  153 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcC------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence            45566789999999999997665      7899999999644 3445678999999999999999999999999998 59


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      +|+||||++|+|.+.+...  +.+++...-.++.++++||.|||. ..+||||||||+|||++..|.+||||||.+....
T Consensus       154 sI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~-~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv  230 (364)
T KOG0581|consen  154 SICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHE-ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV  230 (364)
T ss_pred             EeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh-ccCeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence            9999999999999988665  679999999999999999999994 2679999999999999999999999999998765


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII  317 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (449)
                      ..    ...+++||..|||||.+.+..|+.++||||||++++|+++|+.||......           ...-+.-+..++
T Consensus       231 nS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-----------~~~~~~Ll~~Iv  295 (364)
T KOG0581|consen  231 NS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-----------YLDIFELLCAIV  295 (364)
T ss_pred             hh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-----------CCCHHHHHHHHh
Confidence            43    345678999999999999999999999999999999999999999764110           001111222233


Q ss_pred             cccccccCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          318 DSRLEDRYSTE-GAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       318 ~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      +. .++..+.+ +++++.+++..||++||.+|||+.++++|
T Consensus       296 ~~-ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  296 DE-PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             cC-CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            32 34445554 88899999999999999999999999998

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-51  Score=396.39  Aligned_cols=289  Identities=55%  Similarity=0.921  Sum_probs=247.7

Q ss_pred             CccccCHHHHHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCc
Q 013105           65 NLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHL  144 (449)
Q Consensus        65 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI  144 (449)
                      ....|++.++..++++|.....||+|+||.||+|...+       +..||||.+.........+|.+|+.+|.+++|||+
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-------~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nl  133 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-------GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNL  133 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-------CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCc
Confidence            56779999999999999999999999999999998875       47899998875443214569999999999999999


Q ss_pred             ceeeeEEEeCC-EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CeeeccCCCCceEEcCC
Q 013105          145 VNLIGYCCEDE-HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK-PVIYRDFKASNILLDSD  222 (449)
Q Consensus       145 v~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~ivHrDikp~Nill~~~  222 (449)
                      |+++|||.+.+ ..+||+|||.+|+|.++|.......++|..+++|+.++|.||+|||.... .||||||||+|||||++
T Consensus       134 v~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~  213 (361)
T KOG1187|consen  134 VKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED  213 (361)
T ss_pred             ccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC
Confidence            99999999998 59999999999999999987543388999999999999999999997433 69999999999999999


Q ss_pred             CcEEEeeeccccCCCCCCCCceeeec-CCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHH
Q 013105          223 YNAKLSDFGLATDGPQGEDSHITTCV-MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVE  301 (449)
Q Consensus       223 ~~~kl~DfGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~  301 (449)
                      +++||+|||+|+..+.. ... .... .||.+|+|||.+..+..+.++||||||++|+||++|+.+.+.........+..
T Consensus       214 ~~aKlsDFGLa~~~~~~-~~~-~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~  291 (361)
T KOG1187|consen  214 FNAKLSDFGLAKLGPEG-DTS-VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVE  291 (361)
T ss_pred             CCEEccCccCcccCCcc-ccc-eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHH
Confidence            99999999999765431 111 1112 79999999999988899999999999999999999999988766555666889


Q ss_pred             hhhhhhccccchhHhhccccc-ccCCH-HHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          302 WARPMLKDFTKLDQIIDSRLE-DRYST-EGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                      |+.+.+... .+..++|..+. ..+.. .....+..+...|++.+|.+||+|.+|++.|+.+..
T Consensus       292 w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  292 WAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            987777765 78888888876 55554 566779999999999999999999999999865543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.6e-52  Score=402.67  Aligned_cols=258  Identities=27%  Similarity=0.441  Sum_probs=218.9

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ..|...++||+|||+.||.+.+..      +|+.||+|++...   .....+.+.+|++|.++|+|||||+++++|++.+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~------tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~   91 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLD------TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN   91 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcC------CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC
Confidence            469999999999999999998755      6899999999742   3445677899999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      +.|||+|+|..++|..++.++  +.+++.++..+..||+.||.|||  +++|||||||..|+||+++.++||+|||||..
T Consensus        92 nVYivLELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH--~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~  167 (592)
T KOG0575|consen   92 NVYIVLELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLH--SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQ  167 (592)
T ss_pred             ceEEEEEecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHH--hcCceecccchhheeecCcCcEEecccceeee
Confidence            999999999999999988754  78999999999999999999999  67799999999999999999999999999998


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      .......  ..+.+|||.|.|||++....++..+||||+||+||.||+|++||+.....+...-+..             
T Consensus       168 le~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~-------------  232 (592)
T KOG0575|consen  168 LEYDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL-------------  232 (592)
T ss_pred             ecCcccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh-------------
Confidence            7654333  3446799999999999989999999999999999999999999987543322221111             


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCCCCC
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDIP  368 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~  368 (449)
                         .  .-.+|..++.+..+||.++|+.||.+|||+++|+.|  .++.....|
T Consensus       233 ---~--~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h--~Ff~~g~~p  278 (592)
T KOG0575|consen  233 ---N--EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH--PFFKSGFTP  278 (592)
T ss_pred             ---c--CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC--HhhhCCCcC
Confidence               0  112344667779999999999999999999999987  555444333

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-52  Score=388.39  Aligned_cols=254  Identities=25%  Similarity=0.383  Sum_probs=210.4

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-------chHHHHHHHHHHHhcCCCCCcceee
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-------QGHREWLAEVIFLGQLKHPHLVNLI  148 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~nIv~~~  148 (449)
                      .+.+.|.+.+.||+|+||.|-+|..+.      +++.||||+++....       .......+|+++|++|+|||||+++
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~------tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~  242 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKK------TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIK  242 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcc------cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEe
Confidence            356778999999999999999997776      699999999974321       1233467999999999999999999


Q ss_pred             eEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC---CcE
Q 013105          149 GYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD---YNA  225 (449)
Q Consensus       149 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~---~~~  225 (449)
                      ++|...+..||||||+.||+|.+.+..+  +.+.+..-..++.|++.|+.|||  +.||+||||||+|||+..+   -.+
T Consensus       243 d~f~~~ds~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH--~~GI~HRDiKPeNILl~~~~e~~ll  318 (475)
T KOG0615|consen  243 DFFEVPDSSYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLH--SQGIIHRDIKPENILLSNDAEDCLL  318 (475)
T ss_pred             eeeecCCceEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHH--HcCcccccCCcceEEeccCCcceEE
Confidence            9999999999999999999999999876  67777778899999999999999  7889999999999999766   679


Q ss_pred             EEeeeccccCCCCCCCCceeeecCCCCccccccccccCC---CCcccchhhhHHHHHHHHhCCCcccccccccchhhHHh
Q 013105          226 KLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGH---LTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEW  302 (449)
Q Consensus       226 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~  302 (449)
                      ||+|||+|+....   ...+.+.+|||.|.|||++.+..   +..++|+|||||+||-+|+|.+||.+.....       
T Consensus       319 KItDFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-------  388 (475)
T KOG0615|consen  319 KITDFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-------  388 (475)
T ss_pred             Eecccchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-------
Confidence            9999999997653   34577789999999999996553   3448899999999999999999998754322       


Q ss_pred             hhhhhccccchhHhhccc--ccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          303 ARPMLKDFTKLDQIIDSR--LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                              .-.+++....  +.+..-..++++..+||.+||..||++|||+.|+|+|
T Consensus       389 --------sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  389 --------SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             --------cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence                    0111121211  1122335677889999999999999999999999998

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-51  Score=378.68  Aligned_cols=252  Identities=29%  Similarity=0.420  Sum_probs=206.6

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ..+|.+.+.||.|+||+||+|.++.      ++..||||.+...  .....+.+..|+.+|+.++|||||.+++++..++
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~------~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~   82 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKK------SGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD   82 (429)
T ss_pred             cccceehhhccCcceEEEEEeEecc------CCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC
Confidence            4678899999999999999997766      5799999999765  4445566889999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC------CcEEEee
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD------YNAKLSD  229 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~------~~~kl~D  229 (449)
                      .+|||||||.||+|.+++.++  +.+++.+...++.|++.||++||  +++||||||||+||||+..      -.+||+|
T Consensus        83 ~i~lVMEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~--~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIAD  158 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLH--ENNIIHRDLKPQNILLSTTARNDTSPVLKIAD  158 (429)
T ss_pred             eEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCCcceEEeccCCCCCCCceEEecc
Confidence            999999999999999999876  68999999999999999999999  7889999999999999765      4689999


Q ss_pred             eccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcc
Q 013105          230 FGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKD  309 (449)
Q Consensus       230 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  309 (449)
                      ||+|+.+..+.   ...+.+|++.|||||++..+.|+.|+|+||+|++||+|++|++||......+-...+...      
T Consensus       159 FGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~------  229 (429)
T KOG0595|consen  159 FGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKG------  229 (429)
T ss_pred             cchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcc------
Confidence            99999876433   345578999999999999999999999999999999999999999865433222211111      


Q ss_pred             ccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          310 FTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                               ....+..+......+.+|+...++.+|.+|-+..+...+
T Consensus       230 ---------~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~  268 (429)
T KOG0595|consen  230 ---------NEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDH  268 (429)
T ss_pred             ---------ccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence                     111112223333445677777888888888777666554

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-52  Score=370.18  Aligned_cols=260  Identities=24%  Similarity=0.371  Sum_probs=211.9

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeee-EEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIG-YCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~-~~~~~~  155 (449)
                      .+|++.+.||.|+||.||++....      ++..+|.|.+...  +....+.+..|+.+|++|+|||||++++ .+.++.
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~------~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~   92 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLL------DGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN   92 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeecc------CcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence            357788999999999999997665      6889999999744  3444567899999999999999999998 344444


Q ss_pred             -EEEEEEEecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhcC--CCCeeeccCCCCceEEcCCCcEEEeee
Q 013105          156 -HRLLVYEYMALGNLHDQLFK--NYSSTLPWLTRIKIAIGAARCLAFLHGE--EKPVIYRDFKASNILLDSDYNAKLSDF  230 (449)
Q Consensus       156 -~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~~ivHrDikp~Nill~~~~~~kl~Df  230 (449)
                       -++||||||.+|+|...+..  .....+++..+++++.|++.||..+|+.  ..-|+||||||.||+|+.+|.+||+||
T Consensus        93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf  172 (375)
T KOG0591|consen   93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF  172 (375)
T ss_pred             hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence             48999999999999998853  4557899999999999999999999963  233999999999999999999999999


Q ss_pred             ccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccc
Q 013105          231 GLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF  310 (449)
Q Consensus       231 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  310 (449)
                      ||++.+...  .....+.+|||+||+||.+.+..|+.++||||+||++|||+.-++||.+..      +...        
T Consensus       173 GL~r~l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~~~L--------  236 (375)
T KOG0591|consen  173 GLGRFLSSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------LLSL--------  236 (375)
T ss_pred             hhHhHhcch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------HHHH--------
Confidence            999977543  334556889999999999999999999999999999999999999998752      2111        


Q ss_pred             cchhHhhcccccccCC-HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          311 TKLDQIIDSRLEDRYS-TEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       311 ~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                         ...+...--++.+ ...+.++..||..|+..||+.||+...++..+..-++
T Consensus       237 ---~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~l~  287 (375)
T KOG0591|consen  237 ---CKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSELD  287 (375)
T ss_pred             ---HHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHHhc
Confidence               1111222222334 5678889999999999999999997777766655433

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-50  Score=385.79  Aligned_cols=256  Identities=32%  Similarity=0.524  Sum_probs=214.4

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcE-EEEEEeccCCcc--hHHHHHHHHHHHhcCCCCCcceeeeEEEeCC-E
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVLDVNGSQ--GHREWLAEVIFLGQLKHPHLVNLIGYCCEDE-H  156 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~-vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~  156 (449)
                      ..+.+.||.|+||+||+|.+..        +. ||||++......  ....|.+|+.+|.+++|||||+++|++.+.. .
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g--------~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~  114 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRG--------TDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGS  114 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCC--------ceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            3445569999999999999875        45 999999754322  2568999999999999999999999999887 7


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-eeeccCCCCceEEcCCC-cEEEeeecccc
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP-VIYRDFKASNILLDSDY-NAKLSDFGLAT  234 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-ivHrDikp~Nill~~~~-~~kl~DfGla~  234 (449)
                      ++|||||+++|+|.+++.......+++..++.++.+|++||.|||  +.+ ||||||||+|||++.++ ++||+|||+++
T Consensus       115 ~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH--~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr  192 (362)
T KOG0192|consen  115 LCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH--SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSR  192 (362)
T ss_pred             eEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh--cCCCeeecccChhhEEEcCCCCEEEECCCccce
Confidence            999999999999999998755678999999999999999999999  566 99999999999999998 99999999998


Q ss_pred             CCCCCCCCceeeecCCCCccccccccc--cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccc
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYIN--TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK  312 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  312 (449)
                      ......  ...+...||+.|||||++.  ...|+.++||||||++||||+||+.||......                ..
T Consensus       193 ~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~----------------~~  254 (362)
T KOG0192|consen  193 EKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV----------------QV  254 (362)
T ss_pred             eecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH----------------HH
Confidence            654322  2233367999999999999  568999999999999999999999999875421                11


Q ss_pred             hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                      ...++....++.++..+++.+..|+..||+.||..||++.+++..|+.+...
T Consensus       255 ~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~  306 (362)
T KOG0192|consen  255 ASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH  306 (362)
T ss_pred             HHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence            1122233344555566888899999999999999999999999999987653

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-50  Score=371.25  Aligned_cols=251  Identities=27%  Similarity=0.403  Sum_probs=210.4

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      .++|++.++||+|+||+||.+...+      +++.+|+|+++..   ..........|..+|..++||+||+++..|++.
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~d------t~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~   97 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKD------TGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTE   97 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcc------cCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccC
Confidence            4679999999999999999997765      7999999999744   334566788999999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +.+|||+||+.||.|...|.++  +.+++..+.-++..|+.||.|||  ++|||||||||+|||||.+|+++|+||||++
T Consensus        98 ~kLylVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH--~~gIiyRDlKPENILLd~~GHi~LtDFgL~k  173 (357)
T KOG0598|consen   98 EKLYLVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLH--SKGIIYRDLKPENILLDEQGHIKLTDFGLCK  173 (357)
T ss_pred             CeEEEEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHH--hCCeeeccCCHHHeeecCCCcEEEeccccch
Confidence            9999999999999999999876  68999999999999999999999  8889999999999999999999999999999


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ......  ..+..++||+.|||||++.+..|+..+|+||||+++|||++|.+||.+.......+.+              
T Consensus       174 ~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I--------------  237 (357)
T KOG0598|consen  174 EDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKI--------------  237 (357)
T ss_pred             hcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHH--------------
Confidence            654332  2345578999999999999999999999999999999999999999876433222211              


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCC----CHHHHHHH
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRP----TMTTVVKA  357 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~eil~~  357 (449)
                        .... ....+.-.+.+.++++.++|..||++|.    ++.+|-+|
T Consensus       238 --~~~k-~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H  281 (357)
T KOG0598|consen  238 --LKGK-LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH  281 (357)
T ss_pred             --hcCc-CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence              1111 1122333566799999999999999994    55565544

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.4e-50  Score=380.75  Aligned_cols=284  Identities=23%  Similarity=0.305  Sum_probs=221.6

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeC-
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCED-  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-  154 (449)
                      .+.|+.++.||+|.||.||+|.+..      +++.||+|.+..+.  ........+||.||++|.||||+++.++..+. 
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~------tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~  189 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLE------TGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL  189 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecc------cCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC
Confidence            3568888999999999999997665      79999999998664  44456678999999999999999999998876 


Q ss_pred             -CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          155 -EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       155 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                       ..+|||+|||+ -+|..++.. ..-.+++.++..++.|++.||.|||  .+||+|||||.+|||||.+|.+||+|||||
T Consensus       190 ~~siYlVFeYMd-hDL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH--~~gvlHRDIK~SNiLidn~G~LKiaDFGLA  265 (560)
T KOG0600|consen  190 SGSIYLVFEYMD-HDLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCH--SRGVLHRDIKGSNILIDNNGVLKIADFGLA  265 (560)
T ss_pred             CceEEEEEeccc-chhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHh--hcCeeeccccccceEEcCCCCEEeccccce
Confidence             78999999998 578776643 3467899999999999999999999  788999999999999999999999999999


Q ss_pred             cCCCCCCCCceeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhh--hhhhccc
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA--RPMLKDF  310 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~--~~~~~~~  310 (449)
                      +.+....... .+..+-|.||+|||++.|. .|+.++|+||.||||.||++|++.|.+..+..+.+.+-..  .+....|
T Consensus       266 r~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W  344 (560)
T KOG0600|consen  266 RFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW  344 (560)
T ss_pred             eeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence            9776544333 4455679999999998764 7999999999999999999999999998766665544211  1111111


Q ss_pred             c--chhHhhcccccccC-------CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCCCCCCCCcee
Q 013105          311 T--KLDQIIDSRLEDRY-------STEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDIPIGPFVY  374 (449)
Q Consensus       311 ~--~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~~~~~~  374 (449)
                      .  .+...........+       ...++....+|+..+|..||.+|.|+.++|+.  +++...+.+..|...
T Consensus       345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s--eyF~t~p~~~~p~~L  415 (560)
T KOG0600|consen  345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS--EYFTTEPLPCDPSSL  415 (560)
T ss_pred             ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC--cccccCCCCCCcccC
Confidence            1  11100000111111       12345668899999999999999999999986  555555555555443

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.2e-50  Score=360.87  Aligned_cols=266  Identities=26%  Similarity=0.337  Sum_probs=209.3

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-c-hHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-Q-GHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      +.|+....+|+|+||+||++.+++      +|+.||||.+..... . -.+-.++|+++|++|+|+|+|.++++|.....
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~------TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrk   75 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKD------TGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRK   75 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCC------cccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcce
Confidence            457888899999999999996555      799999999864332 2 23457899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      ++||+|||+. ++.+.+.+. ...++...+.++++|++.|+.|+|  ++++|||||||+||||+.+|.+||||||+|+..
T Consensus        76 lhLVFE~~dh-TvL~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cH--k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L  151 (396)
T KOG0593|consen   76 LHLVFEYCDH-TVLHELERY-PNGVPSELVKKYLYQLLKAIHFCH--KNNCIHRDIKPENILITQNGVVKLCDFGFARTL  151 (396)
T ss_pred             eEEEeeecch-HHHHHHHhc-cCCCCHHHHHHHHHHHHHHhhhhh--hcCeecccCChhheEEecCCcEEeccchhhHhh
Confidence            9999999985 555555543 467888999999999999999999  667999999999999999999999999999976


Q ss_pred             CCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhh--------hhh
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR--------PML  307 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~--------~~~  307 (449)
                      ..  .....+.++.|.||+|||.+.| ..|+..+||||+||++.||++|.+.|.+....+....+....        ..+
T Consensus       152 ~~--pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF  229 (396)
T KOG0593|consen  152 SA--PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIF  229 (396)
T ss_pred             cC--CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHh
Confidence            53  2223556778999999999976 789999999999999999999999999987665554432211        111


Q ss_pred             ccccchhHhhccc------ccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          308 KDFTKLDQIIDSR------LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       308 ~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ...+.+..+.-+.      .+..+ +..+.-+.++++.||..||++|++.++++.|
T Consensus       230 ~~N~~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  230 SSNPFFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             ccCCceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            1111111111110      11111 2344578999999999999999999999987

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-49  Score=378.47  Aligned_cols=253  Identities=25%  Similarity=0.352  Sum_probs=212.8

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcC-CCCCcceeeeEEE
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQL-KHPHLVNLIGYCC  152 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~  152 (449)
                      -.++|.+++.||+|+|++|++|+...      +++.||||++...   ......-+..|-.+|.+| .||.|++++..|+
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~------t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQ  144 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKA------TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQ  144 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecC------CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEee
Confidence            34789999999999999999998776      6899999999643   222234466788899999 7999999999999


Q ss_pred             eCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecc
Q 013105          153 EDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL  232 (449)
Q Consensus       153 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGl  232 (449)
                      +...+|+|+||+++|+|.++|.+.  +.+++.....++.+|+.||+|||  ++|||||||||+|||||.+|+++|+|||.
T Consensus       145 D~~sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH--~~GIIHRDlKPENILLd~dmhikITDFGs  220 (604)
T KOG0592|consen  145 DEESLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLH--SNGIIHRDLKPENILLDKDGHIKITDFGS  220 (604)
T ss_pred             cccceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHH--hcCceeccCChhheeEcCCCcEEEeeccc
Confidence            999999999999999999999876  78999999999999999999999  78899999999999999999999999999


Q ss_pred             ccCCCCCCCC-----------ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHH
Q 013105          233 ATDGPQGEDS-----------HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVE  301 (449)
Q Consensus       233 a~~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~  301 (449)
                      |..+......           .....++||..|.+||++.....++.+|||+||||||+|+.|.+||.+..+.     ..
T Consensus       221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-----li  295 (604)
T KOG0592|consen  221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-----LI  295 (604)
T ss_pred             cccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-----HH
Confidence            9866432211           1124589999999999999999999999999999999999999999875321     11


Q ss_pred             hhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          302 WARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                                 +..++.  +.-.+++..++.+.+|+.++|..||.+|+|+.+|-+|
T Consensus       296 -----------FqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  296 -----------FQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             -----------HHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence                       111111  1223455666789999999999999999999999987

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-49  Score=372.68  Aligned_cols=268  Identities=23%  Similarity=0.335  Sum_probs=216.5

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHH--HHHHHHHHhcCC-CCCcceeeeEEE
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE--WLAEVIFLGQLK-HPHLVNLIGYCC  152 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-h~nIv~~~~~~~  152 (449)
                      .+.++|.+.+.||.|+||.||+|+...      ++..||||.++..-.. .++  -++|+..|++|+ |||||++.+++.
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~------~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~   79 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKE------TGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIR   79 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecC------CCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhh
Confidence            456789999999999999999997765      6888999999743222 333  468999999998 999999999999


Q ss_pred             eCC-EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeec
Q 013105          153 EDE-HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFG  231 (449)
Q Consensus       153 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfG  231 (449)
                      +.+ .+|+|||||+ .+|++++..+ +..+++..+..|+.||+.||+|+|  .+|+.|||+||+|||+..+..+||+|||
T Consensus        80 d~~~~L~fVfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiH--k~GfFHRDlKPENiLi~~~~~iKiaDFG  155 (538)
T KOG0661|consen   80 DNDRILYFVFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIH--KHGFFHRDLKPENILISGNDVIKIADFG  155 (538)
T ss_pred             ccCceEeeeHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHH--hcCcccccCChhheEecccceeEecccc
Confidence            988 9999999997 8999999877 789999999999999999999999  8889999999999999988899999999


Q ss_pred             cccCCCCCCCCceeeecCCCCcccccccc-ccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhh--hhhhc
Q 013105          232 LATDGPQGEDSHITTCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA--RPMLK  308 (449)
Q Consensus       232 la~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~--~~~~~  308 (449)
                      +|+......   ..+.++.|.||+|||++ +.+.|+.++||||+|||++|+.+-++.|.+..+.++...+--+  .+...
T Consensus       156 LARev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~  232 (538)
T KOG0661|consen  156 LAREVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKD  232 (538)
T ss_pred             cccccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccc
Confidence            999765432   35567889999999987 5678999999999999999999999999988665554433111  11111


Q ss_pred             ccc---chhHhhcccccc-------cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          309 DFT---KLDQIIDSRLED-------RYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       309 ~~~---~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .+.   .+...+.-.++.       ...+.++.++.+||.+||+.||.+|||+.++++|
T Consensus       233 ~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  233 SWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             cchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            111   112222211111       1223377889999999999999999999999998

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-48  Score=375.61  Aligned_cols=256  Identities=30%  Similarity=0.439  Sum_probs=215.7

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEE
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLV  160 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  160 (449)
                      +...+.||+|.||.||.|.++.       ...||+|.++.. ....+.|.+|+++|++|+|+|||+++++|..++.+|||
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~-------~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV  279 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNG-------STKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV  279 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcC-------CCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence            4456779999999999999986       357999999743 44457888999999999999999999999998899999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCC
Q 013105          161 YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGE  240 (449)
Q Consensus       161 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~  240 (449)
                      ||||+.|+|.++|.......+...+.+.++.|||+|++||+  ++++|||||...||||+++..+||+|||||+...++.
T Consensus       280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe--s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~  357 (468)
T KOG0197|consen  280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE--SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE  357 (468)
T ss_pred             EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH--hCCccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence            99999999999999866788999999999999999999999  6779999999999999999999999999999544333


Q ss_pred             CCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHhhcc
Q 013105          241 DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDS  319 (449)
Q Consensus       241 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (449)
                      .. ......-...|.|||.+....++.++|||||||+||||+| |+.||.+....+..                 ..++.
T Consensus       358 Y~-~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~-----------------~~le~  419 (468)
T KOG0197|consen  358 YT-ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVL-----------------ELLER  419 (468)
T ss_pred             ee-ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHH-----------------HHHhc
Confidence            21 1111123568999999999999999999999999999999 88888876433222                 22233


Q ss_pred             cccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          320 RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       320 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                      ..+-+.|..||+.+.+||..||..+|++|||++.+...|+++...
T Consensus       420 GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  420 GYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             cCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            334445778899999999999999999999999999999887653

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.1e-48  Score=340.13  Aligned_cols=279  Identities=24%  Similarity=0.346  Sum_probs=220.3

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc--hHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ--GHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      .+|...+.||+|.||.||+|++..      +++.||||.++..+..  -....++|++.|+.++|+||+.++++|-..+.
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~------t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~   75 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTE------TGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSN   75 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecC------CCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCc
Confidence            467888999999999999998766      6999999999865322  13467899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      +.||+||++ .+|...+..+ ...+....+..++.++++||+|||  .+.|+||||||.|+|++.+|.+||+|||+|+.+
T Consensus        76 l~lVfEfm~-tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H--~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f  151 (318)
T KOG0659|consen   76 LSLVFEFMP-TDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCH--SKWILHRDLKPNNLLISSDGQLKIADFGLARFF  151 (318)
T ss_pred             eEEEEEecc-ccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHH--hhhhhcccCCccceEEcCCCcEEeecccchhcc
Confidence            999999997 7888777554 567889999999999999999999  777999999999999999999999999999987


Q ss_pred             CCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHh--hhhhhccccc-
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEW--ARPMLKDFTK-  312 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~--~~~~~~~~~~-  312 (449)
                      ......  ....+-|.+|+|||.+.| ..|+..+|+||.|||+.||+-|.+.|.+....++...+-.  ..+....|+. 
T Consensus       152 ~~p~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~  229 (318)
T KOG0659|consen  152 GSPNRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEM  229 (318)
T ss_pred             CCCCcc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccc
Confidence            654433  223367999999998865 4799999999999999999999999998766555543321  1222222222 


Q ss_pred             --hhHhhccc-----ccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCCCCCCCC
Q 013105          313 --LDQIIDSR-----LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDIPIGP  371 (449)
Q Consensus       313 --~~~~~~~~-----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~~~  371 (449)
                        +.....-.     ....+-+.++.++.+|+..||..||.+|+++.+++++  .++...+.|+.+
T Consensus       230 ~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~--~yf~~~P~pt~~  293 (318)
T KOG0659|consen  230 TSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH--PYFKSLPLPTPP  293 (318)
T ss_pred             cccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc--hhhhcCCCCCCh
Confidence              22221111     1112344566778999999999999999999999997  555545444443

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-48  Score=364.15  Aligned_cols=255  Identities=29%  Similarity=0.431  Sum_probs=209.1

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC--E
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE--H  156 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--~  156 (449)
                      .+|...+.||+|+||.||++...+      ++...|||.+........+.+.+|+.+|.+++|||||+++|......  .
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~------~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~   90 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKK------TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDE   90 (313)
T ss_pred             chhhhhccccCccceEEEEEEecC------CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence            457778899999999999998876      37899999998664444677889999999999999999999855444  6


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC-CCcEEEeeeccccC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS-DYNAKLSDFGLATD  235 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~-~~~~kl~DfGla~~  235 (449)
                      ++++|||+.+|+|.+++.+..+ .+++..+..+..|+++||.|||  ++|||||||||+|||++. ++.+||+|||++..
T Consensus        91 ~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylH--s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~  167 (313)
T KOG0198|consen   91 YNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLH--SKGIVHCDIKPANILLDPSNGDVKLADFGLAKK  167 (313)
T ss_pred             eEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHH--hCCEeccCcccceEEEeCCCCeEEeccCccccc
Confidence            9999999999999999988755 8999999999999999999999  788999999999999999 79999999999986


Q ss_pred             CCC-CCCCceeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccch
Q 013105          236 GPQ-GEDSHITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       236 ~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      ... ...........||+.|||||++..+ ....++|||||||++.||+||++||....     ....          .+
T Consensus       168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-----~~~~----------~~  232 (313)
T KOG0198|consen  168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-----EEAE----------AL  232 (313)
T ss_pred             cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-----chHH----------HH
Confidence            653 1122223456799999999999853 34469999999999999999999998630     0000          01


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ..+......+.++..++++..+++.+|+..||++|||+.++|.|
T Consensus       233 ~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h  276 (313)
T KOG0198|consen  233 LLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH  276 (313)
T ss_pred             HHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence            11111122335667788889999999999999999999999998

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.7e-47  Score=365.68  Aligned_cols=248  Identities=29%  Similarity=0.452  Sum_probs=212.7

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc--chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      ++|.+.+.||+|+||.||+|..+.      +.+.||+|.+++...  .+.+.+.+|++|++.++||||+.++++|++..+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~------t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~   75 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKY------TIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAH   75 (808)
T ss_pred             cchhHHHHhcCCccceeeeccccc------ceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccce
Confidence            578899999999999999995544      789999999986543  345678999999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++|.||+.| +|+.++...  +.+++..+..++.+++.||.|||  +++|+|||+||.|||++..|.+|+||||+|+..
T Consensus        76 ~~vVte~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLh--s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m  150 (808)
T KOG0597|consen   76 LWVVTEYAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLH--SNRILHRDMKPQNILLEKGGTLKLCDFGLARAM  150 (808)
T ss_pred             EEEEehhhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH--hcCcccccCCcceeeecCCCceeechhhhhhhc
Confidence            9999999985 999999765  78999999999999999999999  677999999999999999999999999999976


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHh
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI  316 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (449)
                      ..  .....+.+.|||.|||||++.+..|+..+|+|||||++|||++|++||.....      ...+.....+       
T Consensus       151 ~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si------~~Lv~~I~~d-------  215 (808)
T KOG0597|consen  151 ST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI------TQLVKSILKD-------  215 (808)
T ss_pred             cc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH------HHHHHHHhcC-------
Confidence            54  34456677899999999999999999999999999999999999999975421      1111111111       


Q ss_pred             hcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                           +..++...+..+..+++.+|.+||..|.|-.+++.|
T Consensus       216 -----~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  216 -----PVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             -----CCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence                 122345777789999999999999999999999986

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-47  Score=367.05  Aligned_cols=251  Identities=24%  Similarity=0.385  Sum_probs=215.6

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      ..|.....||+|+-|.||.|....      +++.||||.++.......+-+++|+.+|+..+|+|||.+++.|...+.+|
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~------~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLW  346 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKIS------TKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELW  346 (550)
T ss_pred             hhhcchhhhccccccceeeeeecc------CCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeE
Confidence            458888899999999999997665      58889999999877666677899999999999999999999999899999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCC
Q 013105          159 LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~  238 (449)
                      +|||||+||+|.|.+...   .+++.++..|+.+++.||+|||  .+||+|||||.+|||++.+|.+||+|||++.....
T Consensus       347 VVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH--~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~  421 (550)
T KOG0578|consen  347 VVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLH--ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE  421 (550)
T ss_pred             EEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHH--hcceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence            999999999999988664   5899999999999999999999  78899999999999999999999999999987665


Q ss_pred             CCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhc
Q 013105          239 GEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIID  318 (449)
Q Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (449)
                      ...  .....+|||+|||||++....|++++||||||++++||+.|.+||-.........++.      .         .
T Consensus       422 ~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa------~---------n  484 (550)
T KOG0578|consen  422 EQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------T---------N  484 (550)
T ss_pred             ccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh------h---------c
Confidence            432  3455789999999999999999999999999999999999999997643322222111      0         1


Q ss_pred             ccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          319 SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       319 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ....-..+..++..+.+++.+||+.|+++|+++.|+|+|
T Consensus       485 g~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  485 GTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            122223456677889999999999999999999999998

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-46  Score=350.67  Aligned_cols=264  Identities=25%  Similarity=0.345  Sum_probs=214.7

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ..++|++.+.||.|.-++||+|....      +++.||||+++.+.. .....+.+|++.|+.++||||+.++..|..+.
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p------~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~   97 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIP------TNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS   97 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecc------cCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence            35689999999999999999996655      679999999987643 33688899999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      .+|+||.||.+|++.+.+.......+++..+..|+.++++||.|||  .+|.||||||+.||||+.+|.|||+|||.+..
T Consensus        98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH--~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~  175 (516)
T KOG0582|consen   98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH--QNGHIHRDVKAGNILIDSDGTVKLADFGVSAS  175 (516)
T ss_pred             eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH--hcCceecccccccEEEcCCCcEEEcCceeeee
Confidence            9999999999999999999888888999999999999999999999  88899999999999999999999999998765


Q ss_pred             CCCCC-CCcee-eecCCCCccccccccc--cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcc-c
Q 013105          236 GPQGE-DSHIT-TCVMGTEGYAAPEYIN--TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKD-F  310 (449)
Q Consensus       236 ~~~~~-~~~~~-~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~  310 (449)
                      ..... ..... ..++||++|||||++.  ...|+.|+||||||++..||.+|..||....+....      ...+++ .
T Consensus       176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL------l~tLqn~p  249 (516)
T KOG0582|consen  176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL------LLTLQNDP  249 (516)
T ss_pred             ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH------HHHhcCCC
Confidence            43322 22222 5578999999999963  457999999999999999999999999865322111      111111 1


Q ss_pred             cchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      +...   ............+..+.+++..||++||.+|||+++++++
T Consensus       250 p~~~---t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  250 PTLL---TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             CCcc---cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            1000   1111122223455679999999999999999999999986

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-46  Score=363.29  Aligned_cols=257  Identities=26%  Similarity=0.398  Sum_probs=210.4

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC----Cc-chHHHHHHHHHHHhcCC-CCCcceeee
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN----GS-QGHREWLAEVIFLGQLK-HPHLVNLIG  149 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~nIv~~~~  149 (449)
                      ...+.|.+.+.||+|+||.|+.|....      ++..||+|+++..    .. .....+.+|+.+++.+. ||||+++++
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~------t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~e   87 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRL------TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLE   87 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeecc------CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEE
Confidence            345789999999999999999997665      5799999987643    12 23445668999999998 999999999


Q ss_pred             EEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC-CcEEEe
Q 013105          150 YCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD-YNAKLS  228 (449)
Q Consensus       150 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~-~~~kl~  228 (449)
                      ++.....+|+||||+.||+|++++.+.  +.+.+.....++.|++.|++|||  .+||+||||||+|||++.+ +++||+
T Consensus        88 v~~t~~~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H--~~gi~HRDLK~ENilld~~~~~~Kl~  163 (370)
T KOG0583|consen   88 VFATPTKIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCH--SRGIVHRDLKPENILLDGNEGNLKLS  163 (370)
T ss_pred             EEecCCeEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHH--hCCEeeCCCCHHHEEecCCCCCEEEe
Confidence            999999999999999999999999873  68888999999999999999999  7889999999999999999 999999


Q ss_pred             eeccccCCCCCCCCceeeecCCCCccccccccccCC-C-CcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhh
Q 013105          229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGH-L-TTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPM  306 (449)
Q Consensus       229 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~  306 (449)
                      |||++.....  ........+||+.|+|||++.+.. | +.++||||+||+||.|++|..||..........      . 
T Consensus       164 DFG~s~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~------k-  234 (370)
T KOG0583|consen  164 DFGLSAISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYR------K-  234 (370)
T ss_pred             ccccccccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHH------H-
Confidence            9999997741  122345577999999999998877 7 478999999999999999999998632111110      0 


Q ss_pred             hccccchhHhhcccccccCCHHH-HHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          307 LKDFTKLDQIIDSRLEDRYSTEG-AKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                               +...  .-.++..+ +.++..|+.+||..||.+|+|+.+|+.+  .++..
T Consensus       235 ---------i~~~--~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h--~w~~~  280 (370)
T KOG0583|consen  235 ---------IRKG--EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH--PWFQK  280 (370)
T ss_pred             ---------HhcC--CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC--hhhcc
Confidence                     1111  11122333 6779999999999999999999999954  55544

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.2e-46  Score=359.22  Aligned_cols=254  Identities=23%  Similarity=0.337  Sum_probs=208.2

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      .++|++++.||+|+||.||+|.-++      +|..+|+|+++...   ......++.|-.+|....+|+||++|..|++.
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~------Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~  213 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKD------TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK  213 (550)
T ss_pred             cccchhheeeccccceeEEEEEEcc------CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC
Confidence            4789999999999999999997766      79999999998543   34456678899999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +++||||||++||++..+|.+.  ..|++.....++.+++.|+..||  ..|+|||||||+|+|||..|++||+||||+.
T Consensus       214 ~~LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH--~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~  289 (550)
T KOG0605|consen  214 EYLYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIH--QLGYIHRDIKPDNLLIDAKGHIKLSDFGLST  289 (550)
T ss_pred             CeeEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHH--HcCcccccCChhheeecCCCCEeeccccccc
Confidence            9999999999999999999776  78999999999999999999999  8889999999999999999999999999985


Q ss_pred             CCCCC----------------------CCC-----------------------ceeeecCCCCccccccccccCCCCccc
Q 013105          235 DGPQG----------------------EDS-----------------------HITTCVMGTEGYAAPEYINTGHLTTMC  269 (449)
Q Consensus       235 ~~~~~----------------------~~~-----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~  269 (449)
                      -....                      ...                       ......+|||.|||||++.+..|+..+
T Consensus       290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c  369 (550)
T KOG0605|consen  290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC  369 (550)
T ss_pred             hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence            22110                      000                       001135799999999999999999999


Q ss_pred             chhhhHHHHHHHHhCCCcccccccccchh-hHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCC
Q 013105          270 DVFSFGVVLLELLTGRRSVEKNRCKREKD-LVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSR  348 (449)
Q Consensus       270 DvwslG~vl~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  348 (449)
                      |+||||||+||||.|-+||.+..+...-. +..|...+           .    -+-...++++..+||.+||. ||++|
T Consensus       370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l-----------~----fP~~~~~s~eA~DLI~rll~-d~~~R  433 (550)
T KOG0605|consen  370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL-----------K----FPEEVDLSDEAKDLITRLLC-DPENR  433 (550)
T ss_pred             cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc-----------c----CCCcCcccHHHHHHHHHHhc-CHHHh
Confidence            99999999999999999999875543322 22221111           1    11112334779999999999 99999


Q ss_pred             C---CHHHHHHH
Q 013105          349 P---TMTTVVKA  357 (449)
Q Consensus       349 P---s~~eil~~  357 (449)
                      .   .+.||-+|
T Consensus       434 LG~~G~~EIK~H  445 (550)
T KOG0605|consen  434 LGSKGAEEIKKH  445 (550)
T ss_pred             cCcccHHHHhcC
Confidence            5   67888776

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-46  Score=366.85  Aligned_cols=248  Identities=25%  Similarity=0.363  Sum_probs=210.6

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      +-|++++.||+|+-|.|-+|.+      ..+|+.+|||++....   ......+.+|+-+|+.+.||||+++|++++++.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh------~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~   85 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKH------AETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ   85 (786)
T ss_pred             cceeccccccCCCCceehhhhc------ccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc
Confidence            4488899999999999999954      4589999999997542   223456788999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ++|+|.||++||.|++++.++  +.+++.+..+++.||+.|+.|||  ..+|+||||||+|+|||..+++||+|||+|..
T Consensus        86 ~lylvlEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH--~~~icHRDLKpENlLLd~~~nIKIADFGMAsL  161 (786)
T KOG0588|consen   86 HLYLVLEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCH--AFNICHRDLKPENLLLDVKNNIKIADFGMASL  161 (786)
T ss_pred             eEEEEEEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHh--hhcceeccCCchhhhhhcccCEeeeccceeec
Confidence            999999999999999999887  78999999999999999999999  66799999999999999999999999999986


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCC-CcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHL-TTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ...+.   ...+.||+|.|.|||++.|..| +.++||||+|||||.||+|+.||++....   .+...+..         
T Consensus       162 e~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir---~LLlKV~~---------  226 (786)
T KOG0588|consen  162 EVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR---VLLLKVQR---------  226 (786)
T ss_pred             ccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH---HHHHHHHc---------
Confidence            54432   3455679999999999999988 67999999999999999999999854221   12111111         


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                          .  .-.+|..++.++++|+.+||..||+.|.|+++|++|
T Consensus       227 ----G--~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  227 ----G--VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             ----C--cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence                0  112345667789999999999999999999999998

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-46  Score=334.79  Aligned_cols=237  Identities=27%  Similarity=0.382  Sum_probs=203.4

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ++|++.+.||.|+||.|.++..+.      ++..+|+|+++...   ....+...+|..+|+.+.||+++++++.+.+.+
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~------~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~  117 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKH------SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS  117 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEcc------CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC
Confidence            578889999999999999997665      58899999997543   233455678999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      .+||||||+.||.|..++.+.  +.+++....-++.+|+.||+|||  .++|++|||||+|||||.+|.+||+|||.|+.
T Consensus       118 ~lymvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH--~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~  193 (355)
T KOG0616|consen  118 NLYMVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLH--SLDIIYRDLKPENLLLDQNGHIKITDFGFAKR  193 (355)
T ss_pred             eEEEEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHH--hcCeeeccCChHHeeeccCCcEEEEeccceEE
Confidence            999999999999999999764  68999999999999999999999  67799999999999999999999999999996


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ...     .+.+.+|||.|+|||++....|+.++|+|||||++|||+.|.+||....+...                ...
T Consensus       194 v~~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i----------------Y~K  252 (355)
T KOG0616|consen  194 VSG-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI----------------YEK  252 (355)
T ss_pred             ecC-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH----------------HHH
Confidence            543     25668899999999999999999999999999999999999999987643211                122


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCC
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSR  348 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  348 (449)
                      ++...  -.+|.-.+.++.+|+..+|+.|-.+|
T Consensus       253 I~~~~--v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  253 ILEGK--VKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             HHhCc--ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence            22221  12455566679999999999999999

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.9e-46  Score=338.63  Aligned_cols=288  Identities=22%  Similarity=0.295  Sum_probs=223.6

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc--hHHHHHHHHHHHhcCCCCCcceeeeEEEe--C
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ--GHREWLAEVIFLGQLKHPHLVNLIGYCCE--D  154 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~  154 (449)
                      ++|+....|++|+||.||+|.++.      +++.||+|.++.....  .--..++|+.+|.+++|||||.+..+..-  -
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~------t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~  149 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKK------TDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM  149 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCC------cceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc
Confidence            457788899999999999996554      7899999999865322  12346899999999999999999988754  4


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +..|||||||+ -+|..++... ...+...++..+..|++.|++|||  .+.|+|||||++|+|++..|.+||+|||+|+
T Consensus       150 d~iy~VMe~~E-hDLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH--~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR  225 (419)
T KOG0663|consen  150 DKIYIVMEYVE-HDLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLH--DNWILHRDLKTSNLLLSHKGILKIADFGLAR  225 (419)
T ss_pred             ceeeeeHHHHH-hhHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHh--hceeEecccchhheeeccCCcEEecccchhh
Confidence            67999999998 6888877654 368889999999999999999999  7889999999999999999999999999999


Q ss_pred             CCCCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhh--hhh---hc
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA--RPM---LK  308 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~--~~~---~~  308 (449)
                      .+....  ...+..+-|.||+|||++.+ ..|+.++|+||+|||+.||+++++.|.+....++.+.+-..  .+.   +.
T Consensus       226 ~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwp  303 (419)
T KOG0663|consen  226 EYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWP  303 (419)
T ss_pred             hhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCC
Confidence            765542  23455667999999999865 46999999999999999999999999988765555433111  111   11


Q ss_pred             cccchhHhhccc--------ccccCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCCCCCCCCceeeecCC
Q 013105          309 DFTKLDQIIDSR--------LEDRYSTE-GAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDIPIGPFVYTVVPP  379 (449)
Q Consensus       309 ~~~~~~~~~~~~--------~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~~~~~~~~~~~  379 (449)
                      .+..+...-...        +...+... .++.-.+|+..+|..||.+|.|+++.|+|  .++...+.|..|-..+..|.
T Consensus       304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e~P~p~~P~~~Pt~P~  381 (419)
T KOG0663|consen  304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRETPLPIDPSMFPTWPA  381 (419)
T ss_pred             CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--cccccCCCCCChhhcCCCcc
Confidence            111111110111        11122221 45778899999999999999999999998  77877777777766665554


Q ss_pred             C
Q 013105          380 G  380 (449)
Q Consensus       380 ~  380 (449)
                      .
T Consensus       382 k  382 (419)
T KOG0663|consen  382 K  382 (419)
T ss_pred             c
Confidence            3

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6.8e-46  Score=362.61  Aligned_cols=268  Identities=29%  Similarity=0.411  Sum_probs=207.9

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcC-CCCCcceeeeEEEeC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQL-KHPHLVNLIGYCCED  154 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~  154 (449)
                      ..++|++.+.||+|+||.||+|.+... .....+..||+|++.... ......+.+|+.++..+ +||||+++++++...
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGI-DKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEecc-CCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            346799999999999999999976421 122346789999997432 23345788999999999 899999999988764


Q ss_pred             -CEEEEEEEecCCCChHHHHhhcC--------------------------------------------------------
Q 013105          155 -EHRLLVYEYMALGNLHDQLFKNY--------------------------------------------------------  177 (449)
Q Consensus       155 -~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------  177 (449)
                       ...++||||+++|+|.+++....                                                        
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence             46899999999999999986531                                                        


Q ss_pred             ----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCc
Q 013105          178 ----SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG  253 (449)
Q Consensus       178 ----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~  253 (449)
                          ...+++.....++.|++.||.|||  ++||+||||||+|||++.++.+||+|||+++...............+++.
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHH--HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence                124777888999999999999999  78899999999999999999999999999986533222112223346788


Q ss_pred             cccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHH
Q 013105          254 YAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKR  332 (449)
Q Consensus       254 y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (449)
                      |+|||++.+..++.++|||||||+||||++ |..||.+......  ...              .+........+..++..
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~~--------------~~~~~~~~~~~~~~~~~  305 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FCQ--------------RLKDGTRMRAPENATPE  305 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HHH--------------HHhcCCCCCCCCCCCHH
Confidence            999999988889999999999999999997 9999976432111  100              00000111123345567


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          333 LAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       333 l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                      +.+|+.+||+.||++|||+.++++.|+.++.
T Consensus       306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         306 IYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-46  Score=342.11  Aligned_cols=269  Identities=24%  Similarity=0.311  Sum_probs=214.3

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEec--cCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEe-
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD--VNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE-  153 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-  153 (449)
                      +...|...+.||+|+||.|+.|.+..      +++.||||.+.  .......++..+|+.+|+.++|+||+.+++++.. 
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~------t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~   93 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKR------TGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPP   93 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcC------CCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccc
Confidence            34567668899999999999998876      57999999997  4556667888999999999999999999999865 


Q ss_pred             ----CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEee
Q 013105          154 ----DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSD  229 (449)
Q Consensus       154 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~D  229 (449)
                          -+..|+|+|+|+ .+|...+..+  ..++......+++|+++||.|+|  +.+|+||||||.|+|++.+..+||||
T Consensus        94 ~~~~f~DvYiV~elMe-tDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiH--SAnViHRDLKPsNll~n~~c~lKI~D  168 (359)
T KOG0660|consen   94 SRDKFNDVYLVFELME-TDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIH--SANVIHRDLKPSNLLLNADCDLKICD  168 (359)
T ss_pred             cccccceeEEehhHHh-hHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhh--cccccccccchhheeeccCCCEEecc
Confidence                367899999995 7888888654  45999999999999999999999  66799999999999999999999999


Q ss_pred             eccccCCCCCCCCceeeecCCCCcccccccc-ccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhc
Q 013105          230 FGLATDGPQGEDSHITTCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK  308 (449)
Q Consensus       230 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  308 (449)
                      ||+|+...........+..+-|.+|+|||++ ....|+.++||||+||||.||++|++.|.+.+......++....+...
T Consensus       169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~  248 (359)
T KOG0660|consen  169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS  248 (359)
T ss_pred             ccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence            9999976543223334667789999999987 456899999999999999999999999999876666555433222111


Q ss_pred             cccchhH--------hhcc-cccc-----cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          309 DFTKLDQ--------IIDS-RLED-----RYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       309 ~~~~~~~--------~~~~-~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       ...+..        .+.+ +..+     ..-+...+...+|+.+||..||.+|+|++|.|+|
T Consensus       249 -~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  249 -EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             -HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence             011111        1111 0011     1123456778999999999999999999999998

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-47  Score=355.80  Aligned_cols=250  Identities=26%  Similarity=0.407  Sum_probs=212.8

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      ..|...+.||+|.||.||+|.+..      +++.||+|+++... .....++.+|+.+|.+++++||.++|+.+..+..+
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~------t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~L   86 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNK------TKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKL   86 (467)
T ss_pred             cccccchhccccccceeeeeeecc------ccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccH
Confidence            357777899999999999998776      68999999998764 44567889999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      +++||||.||++.+.+...  ..+.+.....++.+++.||.|||  ..+.+|||||+.|||+..+|.+||+|||++....
T Consensus        87 wiiMey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH--~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~  162 (467)
T KOG0201|consen   87 WIIMEYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLH--SEKKIHRDIKAANILLSESGDVKLADFGVAGQLT  162 (467)
T ss_pred             HHHHHHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhh--hcceecccccccceeEeccCcEEEEecceeeeee
Confidence            9999999999999998653  44577888889999999999999  6669999999999999999999999999998765


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII  317 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (449)
                      .....  ...++||+.|||||++.+..|+.++||||||++.+||++|.+|+....+....                 .++
T Consensus       163 ~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl-----------------flI  223 (467)
T KOG0201|consen  163 NTVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL-----------------FLI  223 (467)
T ss_pred             chhhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE-----------------Eec
Confidence            54332  36688999999999999889999999999999999999999999865332111                 112


Q ss_pred             cccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          318 DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       318 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ....++.+...+++.+.+++..||++||+.||++.++++|
T Consensus       224 pk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  224 PKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             cCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            2223344444667779999999999999999999999987

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-46  Score=345.60  Aligned_cols=252  Identities=24%  Similarity=0.367  Sum_probs=212.9

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceeeeEEE
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLIGYCC  152 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~  152 (449)
                      ....+|++.+.||+|.||.|-+|..+.      .|+.||||.++.+.   .++.-.+.+|++||..|+||||+.+|.+|+
T Consensus        50 nlkHRyE~~etLGkGTYGKVk~A~e~~------sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFE  123 (668)
T KOG0611|consen   50 NLKHRYEITETLGKGTYGKVKLAYEHK------SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFE  123 (668)
T ss_pred             chhhHHHHHHHhcCCcccceeehhhcc------CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhc
Confidence            345689999999999999999996654      68999999997553   444556789999999999999999999999


Q ss_pred             eCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecc
Q 013105          153 EDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL  232 (449)
Q Consensus       153 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGl  232 (449)
                      ..+.+.|||||..+|.|+|++.+.  +.+++.+...++.||+.|+.|||  .++++|||||.+|||+|.++++||+||||
T Consensus       124 NkdKIvivMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCH--knrVvHRDLKLENILLD~N~NiKIADFGL  199 (668)
T KOG0611|consen  124 NKDKIVIVMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCH--KNRVVHRDLKLENILLDQNNNIKIADFGL  199 (668)
T ss_pred             CCceEEEEEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHh--hccceecccchhheeecCCCCeeeeccch
Confidence            999999999999999999999876  78999999999999999999999  78899999999999999999999999999


Q ss_pred             ccCCCCCCCCceeeecCCCCccccccccccCCC-CcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcccc
Q 013105          233 ATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL-TTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFT  311 (449)
Q Consensus       233 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  311 (449)
                      +..+....   ...+++|++-|.+||++.|..| ++.+|.||||++||.|+.|..||++.+.......            
T Consensus       200 SNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQ------------  264 (668)
T KOG0611|consen  200 SNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQ------------  264 (668)
T ss_pred             hhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHH------------
Confidence            98765433   3556789999999999999888 7899999999999999999999998643221111            


Q ss_pred             chhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 013105          312 KLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE  359 (449)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  359 (449)
                          +-.....   .+..|.+..-||++||-.||++|.|+.+|..|..
T Consensus       265 ----Is~GaYr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  265 ----ISRGAYR---EPETPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             ----hhccccc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence                1111111   1222334677999999999999999999999843

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-45  Score=362.35  Aligned_cols=252  Identities=30%  Similarity=0.439  Sum_probs=212.1

Q ss_pred             HHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCC-CCCcceeeeE
Q 013105           75 QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLK-HPHLVNLIGY  150 (449)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~  150 (449)
                      ..-.++|.+.++||+|+||+|+++..+.      +++.+|||++++.   ...+.+..+.|.+|+.... ||.++.++..
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~------~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~  437 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKG------TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC  437 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcC------CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc
Confidence            3445789999999999999999998876      5889999999865   3556777888999988875 9999999999


Q ss_pred             EEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeee
Q 013105          151 CCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDF  230 (449)
Q Consensus       151 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~Df  230 (449)
                      |++.+++|+||||+.||++..+.   ....+++..+.-++..++.||.|||  ++||||||||.+|||||.+|++||+||
T Consensus       438 fQT~~~l~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH--~~~IIYRDlKLdNiLLD~eGh~kiADF  512 (694)
T KOG0694|consen  438 FQTKEHLFFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLH--ENGIIYRDLKLDNLLLDTEGHVKIADF  512 (694)
T ss_pred             cccCCeEEEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHH--hcCceeeecchhheEEcccCcEEeccc
Confidence            99999999999999999943332   2368999999999999999999999  788999999999999999999999999


Q ss_pred             ccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccc
Q 013105          231 GLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF  310 (449)
Q Consensus       231 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  310 (449)
                      |+++.......  .+.+++|||.|||||++.+..|+.++|+|||||+|||||.|..||.+.+..+.   .          
T Consensus       513 GlcKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~---F----------  577 (694)
T KOG0694|consen  513 GLCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV---F----------  577 (694)
T ss_pred             ccccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH---H----------
Confidence            99997653332  46678899999999999999999999999999999999999999998643221   1          


Q ss_pred             cchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 013105          311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT-----MTTVVKA  357 (449)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~  357 (449)
                         +.++.  ....||..++.+...|++++|..||++|.-     +.+|.+|
T Consensus       578 ---dsI~~--d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~h  624 (694)
T KOG0694|consen  578 ---DSIVN--DEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKH  624 (694)
T ss_pred             ---HHHhc--CCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhC
Confidence               11111  133467778889999999999999999964     4555554

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-45  Score=320.77  Aligned_cols=250  Identities=26%  Similarity=0.392  Sum_probs=214.3

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      .++|.+++.||+|.||.||.|..+.      ++-.||+|++....   .....++.+|++|-..|+||||+++|++|.+.
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekk------s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~   94 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKK------SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS   94 (281)
T ss_pred             hhhccccccccCCccccEeEeeecc------CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence            3679999999999999999997765      57899999996432   33346788999999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      ...||++||...|+|+..|.......+++.....++.|++.||.|+|  .++||||||||+|+|++..+.+||+|||.+.
T Consensus        95 ~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h--~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV  172 (281)
T KOG0580|consen   95 KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH--LKRVIHRDIKPENLLLGSAGELKIADFGWSV  172 (281)
T ss_pred             ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc--cCCcccCCCCHHHhccCCCCCeeccCCCcee
Confidence            99999999999999999999777788999999999999999999999  8889999999999999999999999999998


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ..+.+    .....+||..|.+||+..+..++..+|+|++|++.||++.|.+||+.....+...                
T Consensus       173 ~~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYk----------------  232 (281)
T KOG0580|consen  173 HAPSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYK----------------  232 (281)
T ss_pred             ecCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHH----------------
Confidence            65532    2445679999999999999999999999999999999999999998764221111                


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .+..  ..-.++..++....++|.+|+.++|.+|.+..++++|
T Consensus       233 rI~k--~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  233 RIRK--VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             HHHH--ccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence            1111  1122345666779999999999999999999999988

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.6e-45  Score=352.43  Aligned_cols=252  Identities=24%  Similarity=0.377  Sum_probs=215.5

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      ++|...+.+|+|+||.++++..+.      .+..+++|.+....  ....+...+|+.++++++|||||.+++.|.+++.
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~------~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~   77 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKS------DDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQ   77 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhcc------CCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCc
Confidence            578999999999999999985444      57799999998653  2334467899999999999999999999999888


Q ss_pred             -EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          157 -RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       157 -~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                       .+|||+||+||+|.+.|.+..+..+++..+..++.|++.|+.|||  ++.|+|||||+.||+++.++.|+|+|||+|+.
T Consensus        78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH--~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~  155 (426)
T KOG0589|consen   78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH--ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKI  155 (426)
T ss_pred             eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH--hhhhhcccchhhhhhccccCceeecchhhhhh
Confidence             999999999999999998887788999999999999999999999  77899999999999999999999999999998


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      .....  ....+.+||+.||+||++.+.+|+.++|||||||++|||++-+++|...+...   ++.             +
T Consensus       156 l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~-------------k  217 (426)
T KOG0589|consen  156 LNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LIL-------------K  217 (426)
T ss_pred             cCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHH-------------H
Confidence            76543  23556789999999999999999999999999999999999999998753221   111             1


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      + ......+.+...+.++..++..||..+|..||++.++|.+
T Consensus       218 i-~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  218 I-NRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             H-hhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            1 1111234556667789999999999999999999999986

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.4e-44  Score=343.18  Aligned_cols=253  Identities=27%  Similarity=0.385  Sum_probs=205.2

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      .|+..+.||+|+||.||+|.+..      +++.||+|.+....   ......+.+|+.++..++|+||+++++++.+.+.
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~   74 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRA------TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDA   74 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEec------CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCe
Confidence            37788999999999999998765      57899999986432   2223457889999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||+.+|+|.+++.......+++..+..++.|++.||.|||  +++|+||||||+|||++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~  152 (285)
T cd05631          75 LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ--RERIVYRDLKPENILLDDRGHIRISDLGLAVQI  152 (285)
T ss_pred             EEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEc
Confidence            999999999999998886654557899999999999999999999  788999999999999999999999999999864


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHh
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI  316 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (449)
                      ....   ......||..|+|||++.+..++.++|||||||++|||++|+.||.............             ..
T Consensus       153 ~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~-------------~~  216 (285)
T cd05631         153 PEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD-------------RR  216 (285)
T ss_pred             CCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH-------------HH
Confidence            3322   1233569999999999998899999999999999999999999998653221111100             00


Q ss_pred             hcccccccCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 013105          317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT-----MTTVVKA  357 (449)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~  357 (449)
                      +. .....++...+..+.+|+.+||+.||.+||+     ++++++|
T Consensus       217 ~~-~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         217 VK-EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             hh-cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            00 0111233445667999999999999999997     7888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-45  Score=352.56  Aligned_cols=268  Identities=26%  Similarity=0.404  Sum_probs=217.2

Q ss_pred             CHHHHHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCccee
Q 013105           70 TLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNL  147 (449)
Q Consensus        70 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~  147 (449)
                      ...++++..+++.+.+.||+|.||+||+|.|++         .||||+++...  ....+.|.+|+..+++-+|.||+-+
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLF  453 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLF  453 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeeccccc---------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheee
Confidence            346777777888899999999999999999976         49999998654  3456789999999999999999999


Q ss_pred             eeEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEE
Q 013105          148 IGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKL  227 (449)
Q Consensus       148 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl  227 (449)
                      .|+|..+.. .||..+|+|-+|+.+|.-.. ..+...+.+.|+.|++.|+.|||  .++|||||||..||++.+++.|||
T Consensus       454 MG~~~~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLH--AK~IIHrDLKSnNIFl~~~~kVkI  529 (678)
T KOG0193|consen  454 MGACMNPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLH--AKNIIHRDLKSNNIFLHEDLKVKI  529 (678)
T ss_pred             ehhhcCCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhh--hhhhhhhhccccceEEccCCcEEE
Confidence            999988776 99999999999999986543 57888999999999999999999  788999999999999999999999


Q ss_pred             eeeccccCCCCCCCCceeeecCCCCcccccccccc---CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhh
Q 013105          228 SDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT---GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR  304 (449)
Q Consensus       228 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~  304 (449)
                      +||||+................|...|||||+++.   .+|+..+||||||||+|||++|..||.....+..    -|. 
T Consensus       530 gDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI----ifm-  604 (678)
T KOG0193|consen  530 GDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI----IFM-  604 (678)
T ss_pred             ecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe----EEE-
Confidence            99999975433333333444568899999999953   4689999999999999999999999984321111    110 


Q ss_pred             hhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          305 PMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                        +...      ....-.......+++++.+|+..||..++++||.+.+|+..|+.++.
T Consensus       605 --VGrG------~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  605 --VGRG------YLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             --eccc------ccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence              0000      00011112245678899999999999999999999999998888765

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.1e-45  Score=368.57  Aligned_cols=268  Identities=28%  Similarity=0.449  Sum_probs=224.2

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc-hHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ-GHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      ..+....+.||+|+||+||+|.... ..+....+.||||.++..... ...+|.+|+++|..|+|||||+++|+|.+++.
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~-l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYG-LLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP  563 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccC-CCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence            3456667889999999999997765 345567789999999866554 67889999999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCc
Q 013105          157 RLLVYEYMALGNLHDQLFKNY------------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYN  224 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~  224 (449)
                      +|+|+|||..|||.++|....            ..+++..+.+.|+.|||.||.||-  ++.+|||||-..|+||.++..
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs--~~~FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS--SHHFVHRDLATRNCLVGENLV  641 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCcccccchhhhhceeccceE
Confidence            999999999999999996532            123888999999999999999999  455999999999999999999


Q ss_pred             EEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhh
Q 013105          225 AKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWA  303 (449)
Q Consensus       225 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~  303 (449)
                      |||+||||++..-..++......-.-...|||||.+..+.|+.++|||||||+|||+++ |+.||.+....+..+.+   
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i---  718 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI---  718 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH---
Confidence            99999999997655554443333334679999999999999999999999999999998 89999876433322222   


Q ss_pred             hhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCC
Q 013105          304 RPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN  365 (449)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  365 (449)
                                   -.... -..+..+|.++.+||..||+.+|++||+++||-..|+.+....
T Consensus       719 -------------~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s  766 (774)
T KOG1026|consen  719 -------------RAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS  766 (774)
T ss_pred             -------------HcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence                         12222 4457788999999999999999999999999999999886644

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-45  Score=352.23  Aligned_cols=243  Identities=27%  Similarity=0.438  Sum_probs=204.5

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEE
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLV  160 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  160 (449)
                      ..-++-||+|+.|.||+|.++        ++.||||.++.-.       ..+|+-|++|+||||+.+.|+|.....+|||
T Consensus       126 IsELeWlGSGaQGAVF~Grl~--------netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIi  190 (904)
T KOG4721|consen  126 ISELEWLGSGAQGAVFLGRLH--------NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCII  190 (904)
T ss_pred             hhhhhhhccCcccceeeeecc--------CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence            344577999999999999775        5789999885221       2478899999999999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCC
Q 013105          161 YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGE  240 (449)
Q Consensus       161 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~  240 (449)
                      ||||..|-|...|...  ..+.......+..+||.|+.|||.|+  |||||||.-||||+.+..|||+|||-++..... 
T Consensus       191 MEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-  265 (904)
T KOG4721|consen  191 MEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKELSDK-  265 (904)
T ss_pred             eeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhhhhh-
Confidence            9999999999999765  67888888999999999999999655  999999999999999999999999998865432 


Q ss_pred             CCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhccc
Q 013105          241 DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSR  320 (449)
Q Consensus       241 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (449)
                        .....+.||..|||||++.....+.|+|||||||||||||||..||..-...    .+            +..+-...
T Consensus       266 --STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AI------------IwGVGsNs  327 (904)
T KOG4721|consen  266 --STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AI------------IWGVGSNS  327 (904)
T ss_pred             --hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----ee------------EEeccCCc
Confidence              2344578999999999999999999999999999999999999999753211    11            11111223


Q ss_pred             ccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcc
Q 013105          321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL  361 (449)
Q Consensus       321 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  361 (449)
                      +.-..+..+|+.+.-|++.||+..|..||++.+|+.||+.+
T Consensus       328 L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  328 LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            34456778889999999999999999999999999998754

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=341.55  Aligned_cols=259  Identities=26%  Similarity=0.337  Sum_probs=206.7

Q ss_pred             HHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--------------cchHHHHHHHHHHHhcCC
Q 013105           75 QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--------------SQGHREWLAEVIFLGQLK  140 (449)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~  140 (449)
                      ....++|++.+.||+|.||.|-+|....      +++.||||++....              ....+...+|+.+|++++
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~------~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~  166 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEV------DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH  166 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecC------CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC
Confidence            3456789999999999999999995544      68999999996321              112357889999999999


Q ss_pred             CCCcceeeeEEEeC--CEEEEEEEecCCCChHHHHhhcCCCC-CCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCce
Q 013105          141 HPHLVNLIGYCCED--EHRLLVYEYMALGNLHDQLFKNYSST-LPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNI  217 (449)
Q Consensus       141 h~nIv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~-l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Ni  217 (449)
                      |||||+++++..+.  +.+|||+|||..|.+...=   .... +.+.+.+.++.+++.||+|||  .+|||||||||+|+
T Consensus       167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH--~QgiiHRDIKPsNL  241 (576)
T KOG0585|consen  167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLH--YQGIIHRDIKPSNL  241 (576)
T ss_pred             CcCeeEEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHH--hcCeeccccchhhe
Confidence            99999999999764  7899999999999875322   1234 889999999999999999999  67799999999999


Q ss_pred             EEcCCCcEEEeeeccccCCCCCCCC---ceeeecCCCCccccccccccCC----CCcccchhhhHHHHHHHHhCCCcccc
Q 013105          218 LLDSDYNAKLSDFGLATDGPQGEDS---HITTCVMGTEGYAAPEYINTGH----LTTMCDVFSFGVVLLELLTGRRSVEK  290 (449)
Q Consensus       218 ll~~~~~~kl~DfGla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~vl~elltg~~pf~~  290 (449)
                      ||+.+|++||+|||.+.....+...   ......+|||.|+|||.+.++.    .+.+.||||+||+||.|+.|+.||.+
T Consensus       242 Ll~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~  321 (576)
T KOG0585|consen  242 LLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD  321 (576)
T ss_pred             EEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence            9999999999999999866333211   1122367999999999986632    36789999999999999999999986


Q ss_pred             cccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 013105          291 NRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEP  360 (449)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  360 (449)
                      ....                .-.++++..++.-+..+++.+++.+||.+||.+||+.|.++.+|..|...
T Consensus       322 ~~~~----------------~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv  375 (576)
T KOG0585|consen  322 DFEL----------------ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV  375 (576)
T ss_pred             chHH----------------HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence            5311                12233444444433344667789999999999999999999999988543

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=5.8e-44  Score=353.44  Aligned_cols=265  Identities=26%  Similarity=0.367  Sum_probs=206.5

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcC-CCCCcceeeeEEEeCC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQL-KHPHLVNLIGYCCEDE  155 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~  155 (449)
                      .++|++.+.||+|+||.||+|.+... ....++..||||+++... ......+.+|+.+|..+ +||||+++++++...+
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~-~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGL-FKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEecc-ccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            45789999999999999999975421 122356789999997442 23345688999999999 8999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcC----------------------------------------------------------
Q 013105          156 HRLLVYEYMALGNLHDQLFKNY----------------------------------------------------------  177 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  177 (449)
                      ..++||||+++|+|.+++....                                                          
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            9999999999999999986432                                                          


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCC
Q 013105          178 ---------------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS  242 (449)
Q Consensus       178 ---------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~  242 (449)
                                     ...+++..+..++.|++.||.|||  +++|+||||||+|||++.++.+||+|||++.........
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                           124678888999999999999999  678999999999999999999999999999865433221


Q ss_pred             ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHhhcccc
Q 013105          243 HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRL  321 (449)
Q Consensus       243 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (449)
                      .......++..|+|||++.+..++.++|||||||++|||++ |..||.......  .....              +....
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~--------------~~~~~  334 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKM--------------IKEGY  334 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHH--------------HHhCc
Confidence            11222335678999999998899999999999999999998 888986532111  11111              11111


Q ss_pred             cccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcc
Q 013105          322 EDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL  361 (449)
Q Consensus       322 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  361 (449)
                      ....+...+.++.+|+..||+.||++|||+.+|++.|+..
T Consensus       335 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         335 RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            1111223356799999999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.1e-44  Score=353.56  Aligned_cols=266  Identities=26%  Similarity=0.386  Sum_probs=207.7

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcC-CCCCcceeeeEEEeCC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQL-KHPHLVNLIGYCCEDE  155 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~  155 (449)
                      .++|++.+.||+|+||.||+|.+... ........||+|++.... ......+.+|+.+++.+ +|+||+++++++...+
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGL-GKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecC-CcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            45788999999999999999986432 112345689999997543 23345688999999999 8999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcC----------------------------------------------------------
Q 013105          156 HRLLVYEYMALGNLHDQLFKNY----------------------------------------------------------  177 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  177 (449)
                      ..++||||+.+|+|.+++....                                                          
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            9999999999999999885421                                                          


Q ss_pred             ----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCCceeee
Q 013105          178 ----------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC  247 (449)
Q Consensus       178 ----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~  247 (449)
                                ...+++..++.++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++..............
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH--~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA--SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH--HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                      124677888999999999999999  78899999999999999999999999999986543322112222


Q ss_pred             cCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHhhcccccccCC
Q 013105          248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYS  326 (449)
Q Consensus       248 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (449)
                      ..++..|+|||++.+..++.++|||||||++|||++ |+.||........  ..              ..+........+
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~--------------~~~~~~~~~~~~  337 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FY--------------KMVKRGYQMSRP  337 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HH--------------HHHHcccCccCC
Confidence            335678999999988889999999999999999997 9999975432110  00              011111111122


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccc
Q 013105          327 TEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL  362 (449)
Q Consensus       327 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  362 (449)
                      ...+.++.+++.+||+.||++|||+.+|++.|+.++
T Consensus       338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            234567999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=5.2e-44  Score=347.02  Aligned_cols=243  Identities=26%  Similarity=0.368  Sum_probs=199.8

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVY  161 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  161 (449)
                      +.||+|+||.||+|....      +++.||+|++...   .......+.+|+.+++.++||||+++++++...+..|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   74 (323)
T cd05571           1 KLLGKGTFGKVILVREKA------TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVM   74 (323)
T ss_pred             CeeeeCCCeEEEEEEECC------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEE
Confidence            469999999999997765      5789999999743   2233456788999999999999999999999999999999


Q ss_pred             EecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCC
Q 013105          162 EYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGED  241 (449)
Q Consensus       162 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~  241 (449)
                      ||+.+|+|.+++...  ..+++..+..++.|++.||+|||  ++||+||||||+|||++.++.+||+|||++....... 
T Consensus        75 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH--~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-  149 (323)
T cd05571          75 EYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLH--SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-  149 (323)
T ss_pred             eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-
Confidence            999999999988764  57899999999999999999999  7789999999999999999999999999987533221 


Q ss_pred             CceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccc
Q 013105          242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRL  321 (449)
Q Consensus       242 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (449)
                       .......||+.|+|||++.+..++.++|||||||++|||++|..||...........                +...  
T Consensus       150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~----------------~~~~--  210 (323)
T cd05571         150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----------------ILME--  210 (323)
T ss_pred             -CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHH----------------HHcC--
Confidence             123345699999999999988999999999999999999999999975432111100                0000  


Q ss_pred             cccCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013105          322 EDRYSTEGAKRLAAVAHQCLSHNPKSRP-----TMTTVVKA  357 (449)
Q Consensus       322 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  357 (449)
                      ...++...+.++.+++.+||+.||++||     ++.++++|
T Consensus       211 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         211 EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            1122344566799999999999999999     89999886

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.4e-43  Score=345.15  Aligned_cols=265  Identities=25%  Similarity=0.364  Sum_probs=207.4

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      .++|++.+.||+|+||.||++.+..      ++..+|+|++..... .....+.+|+++|+.++||||+++++++..++.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   77 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKP------SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE   77 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECC------CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            4689999999999999999998765      578999999975432 334578899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.++|+|||++...
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~-~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  154 (331)
T cd06649          78 ISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (331)
T ss_pred             EEEEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhh-cCCEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence            99999999999999998664  468899999999999999999994 236999999999999999999999999998765


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccc------
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF------  310 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~------  310 (449)
                      ....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||.............  .+.....      
T Consensus       155 ~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~  228 (331)
T cd06649         155 IDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG--RPVVDGEEGEPHS  228 (331)
T ss_pred             cccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc--ccccccccCCccc
Confidence            3321    233569999999999998899999999999999999999999997543211110000  0000000      


Q ss_pred             --------------------------cchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          311 --------------------------TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       311 --------------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                                                .....+.....+.......+.++.+|+.+||+.||++|||+.++++|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                      00000111111111112356779999999999999999999999987

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-44  Score=343.19  Aligned_cols=246  Identities=23%  Similarity=0.320  Sum_probs=203.9

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ++|++.+.||+|+||.||+|....      +++.||+|++....   ......+.+|+.+++.++||||+++++++.+.+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   74 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRI------SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR   74 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcC------CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC
Confidence            468899999999999999997765      47899999996432   223456788999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..++||||+.+|+|.+++...  ..+++.....++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~  150 (291)
T cd05612          75 FLYMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLH--SKEIVYRDLKPENILLDKEGHIKLTDFGFAKK  150 (291)
T ss_pred             eEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHeEECCCCCEEEEecCcchh
Confidence            999999999999999998764  57889999999999999999999  77899999999999999999999999999986


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ....     .....||+.|+|||++.+..++.++|||||||++|+|++|..||..........                .
T Consensus       151 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~----------------~  209 (291)
T cd05612         151 LRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYE----------------K  209 (291)
T ss_pred             ccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----------------H
Confidence            5332     223469999999999998889999999999999999999999997643211110                0


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT-----MTTVVKA  357 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~  357 (449)
                      +...  ...++...+..+.+|+.+||+.||.+||+     ++++++|
T Consensus       210 i~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         210 ILAG--KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             HHhC--CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            0111  11123344567899999999999999995     8999887

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-46  Score=324.35  Aligned_cols=254  Identities=22%  Similarity=0.345  Sum_probs=209.0

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      +.++|++.+.||+|.|+.|+++....      +|+.+|+|+++..  .....+++.+|++|-+.|+||||+++.+.+.+.
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~------tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~   82 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKT------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE   82 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhcc------chHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccc
Confidence            55778889999999999999985544      7999999999743  334678899999999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC---CCcEEEeeec
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS---DYNAKLSDFG  231 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~---~~~~kl~DfG  231 (449)
                      ...|||+|+|.|++|..-|..+  ...++...-.++.||+++|.|+|  .++|||||+||+|+|+..   ..-+||+|||
T Consensus        83 ~~~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH--~n~IvHRDvkP~nllLASK~~~A~vKL~~FG  158 (355)
T KOG0033|consen   83 SFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCH--SNGIVHRDLKPENLLLASKAKGAAVKLADFG  158 (355)
T ss_pred             ceeEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHH--hcCceeccCChhheeeeeccCCCceeecccc
Confidence            9999999999999998777654  45677778889999999999999  778999999999999943   3469999999


Q ss_pred             cccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcccc
Q 013105          232 LATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFT  311 (449)
Q Consensus       232 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  311 (449)
                      +|.....   .......+|||.|||||++....|+..+|||+.||+||-||.|.+||.+.+.....+.+.      ..  
T Consensus       159 vAi~l~~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~------~g--  227 (355)
T KOG0033|consen  159 LAIEVND---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIK------AG--  227 (355)
T ss_pred             eEEEeCC---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHh------cc--
Confidence            9997762   334556789999999999999999999999999999999999999998753322211111      00  


Q ss_pred             chhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          312 KLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                            +-....++-+.+.++..+|+.+||..||.+|.|+.|.|.|
T Consensus       228 ------~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  228 ------AYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             ------ccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence                  0011222334556678999999999999999999999987

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.5e-44  Score=332.07  Aligned_cols=255  Identities=26%  Similarity=0.344  Sum_probs=211.9

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      +.|++.+.||.|.-|+||++...+      ++..+|+|+++...   .....+...|-+||..+.||.++.+|..|+.+.
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~------t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~  150 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRG------TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK  150 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecC------CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence            457778899999999999998876      46899999997542   334556778999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..|+|||||.||+|..+.+++....+++..+.-++..++.||+|||  ..|||+|||||+||||-++|++-|+||.|+..
T Consensus       151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH--mlGivYRDLKPENILvredGHIMLsDFDLS~~  228 (459)
T KOG0610|consen  151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH--MLGIVYRDLKPENILVREDGHIMLSDFDLSLR  228 (459)
T ss_pred             eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH--hhceeeccCCcceeEEecCCcEEeeecccccc
Confidence            9999999999999999999999999999999999999999999999  78899999999999999999999999999763


Q ss_pred             CCC---------------------------------CCC---------------------CceeeecCCCCccccccccc
Q 013105          236 GPQ---------------------------------GED---------------------SHITTCVMGTEGYAAPEYIN  261 (449)
Q Consensus       236 ~~~---------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~  261 (449)
                      ...                                 ...                     ......++||-.|+|||++.
T Consensus       229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~  308 (459)
T KOG0610|consen  229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR  308 (459)
T ss_pred             CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence            311                                 000                     01122468999999999999


Q ss_pred             cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhc
Q 013105          262 TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCL  341 (449)
Q Consensus       262 ~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  341 (449)
                      |...+.++|+|+|||+|||||.|..||.+......                +..++.....-+-.+..+..+.+||+++|
T Consensus       309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T----------------l~NIv~~~l~Fp~~~~vs~~akDLIr~LL  372 (459)
T KOG0610|consen  309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET----------------LRNIVGQPLKFPEEPEVSSAAKDLIRKLL  372 (459)
T ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh----------------HHHHhcCCCcCCCCCcchhHHHHHHHHHh
Confidence            99999999999999999999999999998643322                12222222221122355677999999999


Q ss_pred             cCCCCCCCC----HHHHHHH
Q 013105          342 SHNPKSRPT----MTTVVKA  357 (449)
Q Consensus       342 ~~dP~~RPs----~~eil~~  357 (449)
                      .+||.+|.-    +.||-+|
T Consensus       373 vKdP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  373 VKDPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             ccChhhhhccccchHHhhcC
Confidence            999999987    8888876

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.4e-44  Score=330.09  Aligned_cols=268  Identities=24%  Similarity=0.290  Sum_probs=208.8

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc--chHHHHHHHHHHHhcCCCCC-cceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLKHPH-LVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~  155 (449)
                      ..|...+.||+|+||+||+|....      +|+.||+|.+.....  ..-....+|+.+|+.|+|+| |+.+++++.+.+
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~------~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~   84 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKR------TGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSN   84 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEec------CCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecc
Confidence            456667889999999999997765      689999999986543  23356789999999999999 999999998877


Q ss_pred             ------EEEEEEEecCCCChHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEE
Q 013105          156 ------HRLLVYEYMALGNLHDQLFKNYS--STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKL  227 (449)
Q Consensus       156 ------~~~lv~e~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl  227 (449)
                            .+++||||++ -+|..++.....  ..++...+..++.|++.||+|||  +++|+||||||+||||+.+|.+||
T Consensus        85 ~~~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H--~~~IlHRDLKPQNlLi~~~G~lKl  161 (323)
T KOG0594|consen   85 NHRGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH--SHGILHRDLKPQNLLISSSGVLKL  161 (323)
T ss_pred             cccccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH--hCCeecccCCcceEEECCCCcEee
Confidence                  8899999997 799999876543  36777889999999999999999  677999999999999999999999


Q ss_pred             eeeccccCCCCCCCCceeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHh--hh
Q 013105          228 SDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEW--AR  304 (449)
Q Consensus       228 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~--~~  304 (449)
                      +|||+|+.......  ..+..++|.+|+|||++.+. .|+..+||||+|||++||+++++.|.+....++...+-.  ..
T Consensus       162 aDFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGt  239 (323)
T KOG0594|consen  162 ADFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGT  239 (323)
T ss_pred             eccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCC
Confidence            99999996543222  24456789999999999776 799999999999999999999999998765433332211  11


Q ss_pred             hhhccccchhHhhccc--cc-----ccCCHHHH---HHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          305 PMLKDFTKLDQIIDSR--LE-----DRYSTEGA---KRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       305 ~~~~~~~~~~~~~~~~--~~-----~~~~~~~~---~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      +....|+......+-.  ..     ..+....+   .+..+++.+||+.+|.+|.|+..++.|
T Consensus       240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            2222222222221111  11     11111112   478999999999999999999999998

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=5.2e-44  Score=347.86  Aligned_cols=246  Identities=25%  Similarity=0.375  Sum_probs=203.5

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ++|.+.+.||+|+||.||+|.+..      +++.||+|++...   .......+.+|+.+++.++||||+++++++.+++
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   91 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKG------TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN   91 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECC------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC
Confidence            578999999999999999998765      5789999999643   2233456889999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..|+||||+.+|+|.+++...  ..+++.....++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++..
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  167 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLH--SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKK  167 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHEEECCCCCEEEeeccCceE
Confidence            999999999999999998764  56888889999999999999999  77899999999999999999999999999986


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ....     .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.......                ..
T Consensus       168 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----------------~~  226 (329)
T PTZ00263        168 VPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY----------------EK  226 (329)
T ss_pred             cCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH----------------HH
Confidence            5332     12346999999999999888999999999999999999999999754321110                00


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT-----MTTVVKA  357 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~  357 (449)
                      +....  ..++...+..+.+|+.+||+.||.+||+     +.+++.|
T Consensus       227 i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        227 ILAGR--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             HhcCC--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            11111  1122234556899999999999999986     6888877

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.6e-43  Score=339.22  Aligned_cols=270  Identities=24%  Similarity=0.385  Sum_probs=205.4

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCC----------CCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcce
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLR----------PGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVN  146 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~----------~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~  146 (449)
                      .++|++.+.||+|+||.||+|.+.....          ....+..||+|++.... ......+.+|+.++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3578999999999999999998654210          11234579999997543 233457889999999999999999


Q ss_pred             eeeEEEeCCEEEEEEEecCCCChHHHHhhcC-----------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 013105          147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNY-----------------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIY  209 (449)
Q Consensus       147 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH  209 (449)
                      +++++.+.+..++||||+.+|+|.+++....                 ...+++.....++.|++.||.|||  +.||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~ivH  161 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS--SLNFVH  161 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH--HCCccc
Confidence            9999999999999999999999999885431                 124677888999999999999999  678999


Q ss_pred             ccCCCCceEEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh--CCCc
Q 013105          210 RDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT--GRRS  287 (449)
Q Consensus       210 rDikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt--g~~p  287 (449)
                      |||||+|||++.++.+||+|||++................++..|+|||++.+..++.++|||||||++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999986543332222233446789999999988889999999999999999987  5567


Q ss_pred             ccccccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 013105          288 VEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE  359 (449)
Q Consensus       288 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  359 (449)
                      |.......   ............       ........+..++..+.+|+.+||+.||++|||+.+|.+.|+
T Consensus       242 ~~~~~~~~---~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         242 YGELTDEQ---VIENAGEFFRDQ-------GRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCcCCHHH---HHHHHHHHhhhc-------cccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            76532211   111111100000       000011112345567999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.1e-43  Score=336.09  Aligned_cols=262  Identities=31%  Similarity=0.492  Sum_probs=210.7

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      ++|++.+.||+|+||.||+|..... ........||+|.+..... .....+.+|+.++..++||||+++++++...+..
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGP-NERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecC-CCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            4688899999999999999987652 1123456899999874432 3345688999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYS--------------STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY  223 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~  223 (449)
                      +++|||+.+|+|.+++.....              ..+++...+.++.|++.||.|||  .++++|+||||+||+++.++
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH--~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS--SHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccccceEEEcCCC
Confidence            999999999999999865421              45788899999999999999999  77899999999999999999


Q ss_pred             cEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHh
Q 013105          224 NAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEW  302 (449)
Q Consensus       224 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~  302 (449)
                      .++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||.+......   .. 
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~---~~-  237 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV---IE-  237 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH-
Confidence            999999999986543322222333456889999999988889999999999999999998 9999876432211   11 


Q ss_pred             hhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 013105          303 ARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEP  360 (449)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  360 (449)
                                   .+........+..++.++.+|+.+||+.||.+||++.+|+++|+.
T Consensus       238 -------------~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         238 -------------MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             -------------HHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                         111111222345667889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-44  Score=346.63  Aligned_cols=254  Identities=22%  Similarity=0.286  Sum_probs=205.9

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ++|++.+.||+|+||.||+|.+..      +++.||+|++...   .......+.+|+.++..++||||+++++++.+.+
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~   74 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKD------TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE   74 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECC------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC
Confidence            468999999999999999998765      4789999999743   2233456788999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..||||||++||+|.+++...  ..+++.....++.|++.||.|||  .++|+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~  150 (333)
T cd05600          75 YLYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALH--ELGYIHRDLKPENFLIDASGHIKLTDFGLSKG  150 (333)
T ss_pred             EEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEECCCCCEEEEeCcCCcc
Confidence            999999999999999998654  56889999999999999999999  77899999999999999999999999999985


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ...     ......||+.|+|||++.+..++.++|||||||++|||++|..||...........+....          .
T Consensus       151 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------~  215 (333)
T cd05600         151 IVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK----------E  215 (333)
T ss_pred             ccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc----------c
Confidence            533     1234569999999999998899999999999999999999999997643221111110000          0


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .+...........++.++.+++.+||..+|.+||++.++++|
T Consensus       216 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         216 TLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             cccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            000000000012446678999999999999999999999987

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.6e-43  Score=335.70  Aligned_cols=246  Identities=20%  Similarity=0.295  Sum_probs=199.4

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcch---HHHHHHHHHHHhcCCCCCcceeeeEEEe----CCEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG---HREWLAEVIFLGQLKHPHLVNLIGYCCE----DEHR  157 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~~~~----~~~~  157 (449)
                      ..||+|++|.||+|.+.        ++.||||.+.......   .+.+.+|+.+|.+++||||+++++++.+    ....
T Consensus        26 ~~i~~g~~~~v~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~   97 (283)
T PHA02988         26 VLIKENDQNSIYKGIFN--------NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRL   97 (283)
T ss_pred             eEEeeCCceEEEEEEEC--------CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCce
Confidence            57999999999999773        6789999997543322   4667899999999999999999999877    3578


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+.+|+|.+++...  ..+++.....++.+++.||.|||. ..+++||||||+|||++.++.+||+|||++....
T Consensus        98 ~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~  174 (283)
T PHA02988         98 SLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYK-YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS  174 (283)
T ss_pred             EEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHh-cCCCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence            9999999999999999764  578889999999999999999993 1368899999999999999999999999988543


Q ss_pred             CCCCCceeeecCCCCcccccccccc--CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINT--GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ..     .....|+..|+|||++.+  ..++.++|||||||++|||++|+.||........   ...             
T Consensus       175 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~---~~~-------------  233 (283)
T PHA02988        175 SP-----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI---YDL-------------  233 (283)
T ss_pred             cc-----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH---HHH-------------
Confidence            22     123458999999999975  6789999999999999999999999986432111   110             


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccc
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL  362 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  362 (449)
                      +.........+..+++.+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       234 i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        234 IINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             HHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            11111112233356778999999999999999999999999988763

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-44  Score=351.90  Aligned_cols=273  Identities=33%  Similarity=0.478  Sum_probs=221.7

Q ss_pred             HHHHHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCccee
Q 013105           71 LKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNL  147 (449)
Q Consensus        71 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~  147 (449)
                      ...|+...++-.+.+.||+|+||.||+|.+...  .......||||..+..   ......++++|+++|++++|||||++
T Consensus       149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~--~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~  226 (474)
T KOG0194|consen  149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLK--NGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRF  226 (474)
T ss_pred             ccccEEeccCccccceeecccccEEEEEEEEec--CCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence            345566667777789999999999999988752  1111223899999852   34566789999999999999999999


Q ss_pred             eeEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEE
Q 013105          148 IGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKL  227 (449)
Q Consensus       148 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl  227 (449)
                      ||++.....++||||+|.||+|.++|.++. ..++..+.+.++.+.+.||+|||  .+++|||||-.+|+|++.++.+||
T Consensus       227 yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh--~k~~IHRDIAARNcL~~~~~~vKI  303 (474)
T KOG0194|consen  227 YGVAVLEEPLMLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLH--SKNCIHRDIAARNCLYSKKGVVKI  303 (474)
T ss_pred             EEEEcCCCccEEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHH--HCCCcchhHhHHHheecCCCeEEe
Confidence            999999999999999999999999998763 37999999999999999999999  788999999999999999999999


Q ss_pred             eeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhh
Q 013105          228 SDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPM  306 (449)
Q Consensus       228 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~  306 (449)
                      +|||+++........  .....-...|+|||.+....|+.++|||||||++||+++ |..||.+.......         
T Consensus       304 SDFGLs~~~~~~~~~--~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~---------  372 (474)
T KOG0194|consen  304 SDFGLSRAGSQYVMK--KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK---------  372 (474)
T ss_pred             CccccccCCcceeec--cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH---------
Confidence            999999865421111  101123578999999998899999999999999999999 78899876433111         


Q ss_pred             hccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCCC
Q 013105          307 LKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLND  366 (449)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~  366 (449)
                             ..++....+...+...|.++..++.+||..||++||+|.++.+.|+.+.....
T Consensus       373 -------~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  373 -------AKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             -------HHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence                   11212233344455777889999999999999999999999999998876554

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2e-43  Score=336.99  Aligned_cols=268  Identities=22%  Similarity=0.273  Sum_probs=203.8

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      ++|.+.+.||+|+||.||+|.+..      +++.||+|++....  ......+.+|+.+++.++||||+++++++...+.
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKE------TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGK   74 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECC------CCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCE
Confidence            468999999999999999998765      57899999987442  2334567889999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||+.++.+..+. .. ...+++..+..++.|++.||.|||  ..+|+||||||+||+++.++.+||+|||++...
T Consensus        75 ~~lv~e~~~~~~l~~~~-~~-~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  150 (287)
T cd07848          75 LYLVFEYVEKNMLELLE-EM-PNGVPPEKVRSYIYQLIKAIHWCH--KNDIVHRDIKPENLLISHNDVLKLCDFGFARNL  150 (287)
T ss_pred             EEEEEecCCCCHHHHHH-hc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCcEEEeeccCcccc
Confidence            99999999987665443 22 356889999999999999999999  778999999999999999999999999999865


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhh-hhhhc-------
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA-RPMLK-------  308 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~-~~~~~-------  308 (449)
                      ...... ......||+.|+|||++.+..++.++|||||||++|||++|++||............... .+...       
T Consensus       151 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07848         151 SEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY  229 (287)
T ss_pred             cccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence            432211 123356899999999998888999999999999999999999999865332211111100 00000       


Q ss_pred             cccchhHhhcc------cccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          309 DFTKLDQIIDS------RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       309 ~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ...........      .....+...++..+.+|+.+||+.||++|||++++++|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            00000000000      00011122356679999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=6.1e-43  Score=347.67  Aligned_cols=268  Identities=26%  Similarity=0.400  Sum_probs=210.2

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCC-CCCcceeeeEEEeC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLK-HPHLVNLIGYCCED  154 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~  154 (449)
                      -.++|.+.+.||+|+||.||+|++... .....+..||||++..... ...+.+.+|+.+|..+. ||||+++++++.+.
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~-~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGL-SRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEccc-CCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            356899999999999999999987532 1122345799999975432 33457889999999996 99999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcC---------------------------------------------------------
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNY---------------------------------------------------------  177 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------  177 (449)
                      +..||||||+++|+|.+++....                                                         
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            99999999999999999885421                                                         


Q ss_pred             -------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEc
Q 013105          178 -------------------------------------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD  220 (449)
Q Consensus       178 -------------------------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~  220 (449)
                                                           ...+++..+..++.|++.||.|||  .++|+||||||+|||++
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivH~dikp~Nill~  271 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA--SKNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChHhEEEe
Confidence                                                 124677888999999999999999  77899999999999999


Q ss_pred             CCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhh
Q 013105          221 SDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDL  299 (449)
Q Consensus       221 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~  299 (449)
                      .++.+||+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||........  .
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--~  349 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--F  349 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--H
Confidence            999999999999986543222222233457788999999988889999999999999999997 9999875421110  0


Q ss_pred             HHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          300 VEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                      ..              .+........+..++..+.+++.+||+.||++||++.+|.+.|+.++.
T Consensus       350 ~~--------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         350 YN--------------KIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             HH--------------HHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            00              001111112234556779999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=359.43  Aligned_cols=262  Identities=26%  Similarity=0.310  Sum_probs=215.1

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC-CCCcceeeeE-EEe--
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-HPHLVNLIGY-CCE--  153 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~-~~~--  153 (449)
                      ..++++.+.|.+|||+.||+|.+..      .+..||+|++-..+....+.+.+|+++|+.|+ |+|||.+++. ...  
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~------~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~  109 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVK------GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS  109 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecC------CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence            4567888999999999999998876      34899999998777888889999999999997 9999999993 221  


Q ss_pred             ----CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEee
Q 013105          154 ----DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSD  229 (449)
Q Consensus       154 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~D  229 (449)
                          .-.++|.||||.||.|-|++..+....|.+.++++|+.++++|+++||.....|||||||-+||||+.+|+.||||
T Consensus       110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCD  189 (738)
T KOG1989|consen  110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCD  189 (738)
T ss_pred             CCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCc
Confidence                1356899999999999999987666679999999999999999999998888899999999999999999999999


Q ss_pred             eccccCCCCCCCCcee-------eecCCCCcccccccc---ccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhh
Q 013105          230 FGLATDGPQGEDSHIT-------TCVMGTEGYAAPEYI---NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDL  299 (449)
Q Consensus       230 fGla~~~~~~~~~~~~-------~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~  299 (449)
                      ||.|............       -...-|+.|+|||++   .+...++|+|||+|||+||-|+....||+.....     
T Consensus       190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-----  264 (738)
T KOG1989|consen  190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-----  264 (738)
T ss_pred             ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----
Confidence            9999854332211000       012369999999987   5678999999999999999999999999864211     


Q ss_pred             HHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCC
Q 013105          300 VEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN  365 (449)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  365 (449)
                                     .++.....-+-.+..+..|..||..||+.||.+||++-+++..+-.+....
T Consensus       265 ---------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  265 ---------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             ---------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence                           122222222223567788999999999999999999999999988877654

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.4e-43  Score=341.91  Aligned_cols=243  Identities=24%  Similarity=0.363  Sum_probs=199.5

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVY  161 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  161 (449)
                      +.||+|+||.||++....      ++..||+|++...   .......+.+|+.+++.++||||+++++++...+..|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   74 (328)
T cd05593           1 KLLGKGTFGKVILVREKA------SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVM   74 (328)
T ss_pred             CeeeeCCCEEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEE
Confidence            469999999999997765      5789999999743   2334567788999999999999999999999999999999


Q ss_pred             EecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCC
Q 013105          162 EYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGED  241 (449)
Q Consensus       162 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~  241 (449)
                      ||+.+|+|.+++...  ..+++.....++.|++.||.|||  .++|+||||||+|||++.++.+||+|||++....... 
T Consensus        75 Ey~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-  149 (328)
T cd05593          75 EYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLH--SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-  149 (328)
T ss_pred             eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-
Confidence            999999999888654  57899999999999999999999  7789999999999999999999999999987543221 


Q ss_pred             CceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccc
Q 013105          242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRL  321 (449)
Q Consensus       242 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (449)
                       .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........      ..          .  .
T Consensus       150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~------~~----------~--~  210 (328)
T cd05593         150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL------IL----------M--E  210 (328)
T ss_pred             -cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH------hc----------c--C
Confidence             122345699999999999888999999999999999999999999975432111100      00          0  0


Q ss_pred             cccCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013105          322 EDRYSTEGAKRLAAVAHQCLSHNPKSRP-----TMTTVVKA  357 (449)
Q Consensus       322 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  357 (449)
                      ...++...+.++.+++.+||+.||++||     ++.++++|
T Consensus       211 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         211 DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            1122344566789999999999999997     89999987

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.8e-43  Score=357.94  Aligned_cols=254  Identities=22%  Similarity=0.287  Sum_probs=206.1

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLL  159 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  159 (449)
                      .|.+.+.||+|+||.||+|....+     .+..||+|.+..........+.+|+.+|+.++||||+++++++..++..||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~-----~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l  142 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSD-----PKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL  142 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCC-----CCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence            488999999999999999976542     257889998765555555667889999999999999999999999999999


Q ss_pred             EEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          160 VYEYMALGNLHDQLFKN--YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       160 v~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ||||+.||+|.+++...  ....+++.....++.|++.||.|||  .++|+||||||+|||++.++.+||+|||++....
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH--~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~  220 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH--SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS  220 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--hCCEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence            99999999999887542  2356888999999999999999999  6789999999999999999999999999998654


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII  317 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (449)
                      ...........+||+.|+|||++.+..++.++|||||||++|||++|+.||........   ..             .+.
T Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~---~~-------------~~~  284 (478)
T PTZ00267        221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI---MQ-------------QVL  284 (478)
T ss_pred             CccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH-------------HHH
Confidence            43222223446699999999999988999999999999999999999999975422111   00             000


Q ss_pred             cccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          318 DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       318 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .. .....+..++..+.+++.+||+.||++||++.+++.+
T Consensus       285 ~~-~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        285 YG-KYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             hC-CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            10 0112233455679999999999999999999999764

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.6e-43  Score=342.88  Aligned_cols=267  Identities=28%  Similarity=0.412  Sum_probs=208.4

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcC-CCCCcceeeeEEEe-C
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQL-KHPHLVNLIGYCCE-D  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~-~  154 (449)
                      .++|++.+.||+|+||.||+|...+. ....+++.||+|++.... ......+..|+.++.++ +|+||+++++++.. +
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~-~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGI-EKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             HHHhhhhcccccCcCceEEecccccc-ccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            45799999999999999999975432 223356899999987432 23345678899999999 79999999998865 4


Q ss_pred             CEEEEEEEecCCCChHHHHhhcC---------------------------------------------------------
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNY---------------------------------------------------------  177 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------  177 (449)
                      ...+++|||+++++|.+++....                                                         
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            67889999999999999885432                                                         


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccc
Q 013105          178 --SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA  255 (449)
Q Consensus       178 --~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~  255 (449)
                        ...+++..+..++.|++.||.|||  ++||+||||||+|||++.++.++|+|||++................++..|+
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH--~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence              126788999999999999999999  7889999999999999999999999999998654332222223345677899


Q ss_pred             cccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHH
Q 013105          256 APEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLA  334 (449)
Q Consensus       256 aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  334 (449)
                      |||++.+..++.++|||||||+||||++ |..||.+......  +..              .+........+...+.++.
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~--------------~~~~~~~~~~~~~~~~~~~  306 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCR--------------RLKEGTRMRAPEYATPEIY  306 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHH--------------HHhccCCCCCCccCCHHHH
Confidence            9999998999999999999999999998 9999975321110  000              0011111112234456799


Q ss_pred             HHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          335 AVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       335 ~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                      +++.+||+.+|++||++.+++++|+.++.
T Consensus       307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.3e-43  Score=341.31  Aligned_cols=266  Identities=23%  Similarity=0.355  Sum_probs=205.1

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      .++|++.+.||+|+||.||+|.+..      ++..+|+|++..... .....+.+|+++++.++||||+++++++.+++.
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   77 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKP------SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE   77 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECC------CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCE
Confidence            4789999999999999999997765      578899999875422 334568899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||+.+|+|.+++...  ..+++.....++.+++.||.|||+ ..+|+||||||+|||++.++.+||+|||++...
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~-~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  154 (333)
T cd06650          78 ISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (333)
T ss_pred             EEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence            99999999999999998764  468889999999999999999994 246999999999999999999999999998754


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhh----------
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPM----------  306 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~----------  306 (449)
                      ....    .....||..|+|||++.+..++.++|||||||++|+|++|+.||..................          
T Consensus       155 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (333)
T cd06650         155 IDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR  230 (333)
T ss_pred             hhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence            3221    22346899999999999888999999999999999999999999754321111100000000          


Q ss_pred             ------------------hccccchhHhhcccccccCC-HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          307 ------------------LKDFTKLDQIIDSRLEDRYS-TEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       307 ------------------~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                                        .........+... .....+ ...+.++.+|+.+||+.||++|||+.+++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNE-PPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             cCCccchhhhhcccccccccHHHHHHHHhcC-CCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                              0000000000000 011111 1245678999999999999999999999987

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=6.2e-43  Score=330.07  Aligned_cols=260  Identities=24%  Similarity=0.377  Sum_probs=207.8

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      .++|++.+.||+|+||.||+|.+...   ...+..||+|.++.... .....+.+|+.++..++||||+++++++..++.
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~---~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLP---SKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecC---CCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            35688999999999999999987532   22467899999975432 334568899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||+.+|+|.+++... ...+++..++.++.|++.||+|||  +.+++||||||+|||++.++.++++|||.+...
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH--~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLS--EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH--HCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            99999999999999988764 347889999999999999999999  788999999999999999999999999987654


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ..... .......++..|+|||.+.+..++.++|||||||++|||++ |..||........   ....            
T Consensus       158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~~~~------------  221 (266)
T cd05064         158 KSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---IKAV------------  221 (266)
T ss_pred             cccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHHH------------
Confidence            32211 11112335678999999988899999999999999999775 9999976432211   1110            


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcc
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL  361 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  361 (449)
                        ........+..++..+.+++.+||+.+|.+||++.+|++.|..+
T Consensus       222 --~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         222 --EDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             --HCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence              01111122345667799999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.2e-43  Score=344.53  Aligned_cols=248  Identities=24%  Similarity=0.319  Sum_probs=203.9

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      .++|.+.+.||+|+||.||+|.+...     .+..||+|++...   .......+.+|+.++..++||||+++++++.+.
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~  103 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNE-----DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE  103 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECC-----CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence            45799999999999999999986542     2468999998632   233445688899999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +..|+||||+.+|+|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++.
T Consensus       104 ~~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~  179 (340)
T PTZ00426        104 SYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQ--SLNIVYRDLKPENLLLDKDGFIKMTDFGFAK  179 (340)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEccCCCHHHEEECCCCCEEEecCCCCe
Confidence            9999999999999999998765  56889999999999999999999  7889999999999999999999999999998


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      .....     .....||+.|+|||++.+..++.++|||||||++|||++|..||..........      .         
T Consensus       180 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~------~---------  239 (340)
T PTZ00426        180 VVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQ------K---------  239 (340)
T ss_pred             ecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHH------H---------
Confidence            64321     233569999999999988889999999999999999999999997643211100      0         


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRP-----TMTTVVKA  357 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  357 (449)
                       +...  ...++...+..+.+++.+||+.||++|+     +++++++|
T Consensus       240 -i~~~--~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        240 -ILEG--IIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             -HhcC--CCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence             0111  0112334456688999999999999995     89999887

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.6e-43  Score=334.93  Aligned_cols=267  Identities=22%  Similarity=0.306  Sum_probs=202.7

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      ++|.+.+.||.|+||.||+|....      ++..||+|+++... ......+.+|+.+++.++||||+++++++.+.+..
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   78 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKL------TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCL   78 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECC------CCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            569999999999999999997765      57899999997543 22345677899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+. |+|.+++... ...+++.....++.|++.||+|||  ++||+||||||+|||++.++.+||+|||++....
T Consensus        79 ~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~  154 (288)
T cd07871          79 TLVFEYLD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCH--KRKILHRDLKPQNLLINEKGELKLADFGLARAKS  154 (288)
T ss_pred             EEEEeCCC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence            99999997 5898887653 345788899999999999999999  7789999999999999999999999999987543


Q ss_pred             CCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhh--h---hhcccc
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR--P---MLKDFT  311 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~--~---~~~~~~  311 (449)
                      ....  ......|++.|+|||++.+ ..++.++|||||||++|+|++|++||.+..............  +   .+....
T Consensus       155 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07871         155 VPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT  232 (288)
T ss_pred             CCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence            2221  1223458999999998865 568999999999999999999999998654333222111100  0   000000


Q ss_pred             ---chhHhhccccc----ccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          312 ---KLDQIIDSRLE----DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       312 ---~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                         ...........    .......+.++.+|+.+||+.||.+|||+.++++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence               00000000000    00012235678999999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.1e-43  Score=340.67  Aligned_cols=243  Identities=26%  Similarity=0.374  Sum_probs=198.8

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVY  161 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  161 (449)
                      +.||+|+||.||++....      ++..||+|++...   .......+.+|+.+++.++||||+++++++...+..|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   74 (323)
T cd05595           1 KLLGKGTFGKVILVREKA------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   74 (323)
T ss_pred             CeeeeCCCEEEEEEEECC------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEE
Confidence            469999999999997765      5789999999743   2233456778999999999999999999999999999999


Q ss_pred             EecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCC
Q 013105          162 EYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGED  241 (449)
Q Consensus       162 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~  241 (449)
                      ||+.+|+|..++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++........
T Consensus        75 E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  150 (323)
T cd05595          75 EYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  150 (323)
T ss_pred             eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC
Confidence            999999998888654  57899999999999999999999  77899999999999999999999999999875322211


Q ss_pred             CceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccc
Q 013105          242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRL  321 (449)
Q Consensus       242 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (449)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........                +...  
T Consensus       151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~----------------~~~~--  210 (323)
T cd05595         151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL----------------ILME--  210 (323)
T ss_pred             --ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHH----------------HhcC--
Confidence              12335699999999999988999999999999999999999999975432111100                0000  


Q ss_pred             cccCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013105          322 EDRYSTEGAKRLAAVAHQCLSHNPKSRP-----TMTTVVKA  357 (449)
Q Consensus       322 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  357 (449)
                      ...++..+++++.+++.+||+.||++||     ++.++++|
T Consensus       211 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         211 EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            1112344566789999999999999998     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=338.85  Aligned_cols=254  Identities=26%  Similarity=0.312  Sum_probs=214.6

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc---chHHHHHHHHHHHhcCC-CCCcceeeeEE
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS---QGHREWLAEVIFLGQLK-HPHLVNLIGYC  151 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~nIv~~~~~~  151 (449)
                      .+...|.+.+.||.|.||.||++....      +++.+|+|++.....   .....+.+|+.+|+++. ||||+.++++|
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~------tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~  105 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKS------TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF  105 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecC------CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            355679999999999999999997766      589999999975432   23467889999999998 99999999999


Q ss_pred             EeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC----CcEEE
Q 013105          152 CEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD----YNAKL  227 (449)
Q Consensus       152 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~----~~~kl  227 (449)
                      ++....++|||++.||.|.+.+...   .+++.....++.|++.++.|||  ..||+||||||+|+|+...    +.+|+
T Consensus       106 e~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH--~~gvvHrDlKpEN~L~~~~~~~~~~ik~  180 (382)
T KOG0032|consen  106 EDPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLH--SLGVVHRDLKPENLLLASKDEGSGRIKL  180 (382)
T ss_pred             EcCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCHHHeeeccccCCCCcEEE
Confidence            9999999999999999999999876   3999999999999999999999  6889999999999999543    47999


Q ss_pred             eeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhh
Q 013105          228 SDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML  307 (449)
Q Consensus       228 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~  307 (449)
                      +|||++.....   .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.+.........+...    
T Consensus       181 ~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~----  253 (382)
T KOG0032|consen  181 IDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG----  253 (382)
T ss_pred             eeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC----
Confidence            99999997765   23466688999999999999899999999999999999999999999876433222111100    


Q ss_pred             ccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                                +..+....-...+..+.+++..||..||..|+|+.++|+|
T Consensus       254 ----------~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  254 ----------DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             ----------CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                      0122333445567779999999999999999999999997

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1e-43  Score=310.06  Aligned_cols=266  Identities=24%  Similarity=0.309  Sum_probs=210.7

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC-
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED-  154 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-  154 (449)
                      +..++|++.+.||+|||+-||++....      ++..||+|.+.....++.+..++|++..++++||||++++++...+ 
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s------~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~   91 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLS------TGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREE   91 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccC------cccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence            345789999999999999999996444      6889999999888777888899999999999999999999876433 


Q ss_pred             ----CEEEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEe
Q 013105          155 ----EHRLLVYEYMALGNLHDQLFKN--YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLS  228 (449)
Q Consensus       155 ----~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~  228 (449)
                          ...||+++|...|+|.+.+...  .+..+++.+.+.|+.++++||.+||.....++||||||.|||+.+.+.++|.
T Consensus        92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~  171 (302)
T KOG2345|consen   92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLM  171 (302)
T ss_pred             ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEE
Confidence                4589999999999999998653  3457899999999999999999999655569999999999999999999999


Q ss_pred             eeccccCCCCCCCCcee-------eecCCCCccccccccc---cCCCCcccchhhhHHHHHHHHhCCCcccccccccchh
Q 013105          229 DFGLATDGPQGEDSHIT-------TCVMGTEGYAAPEYIN---TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKD  298 (449)
Q Consensus       229 DfGla~~~~~~~~~~~~-------~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~  298 (449)
                      |||.++...........       ....-|..|+|||.+.   +...++++|||||||+||+|+.|..||+..-.     
T Consensus       172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-----  246 (302)
T KOG2345|consen  172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-----  246 (302)
T ss_pred             eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----
Confidence            99998865432211110       1123588999999985   34578999999999999999999999975321     


Q ss_pred             hHHhhhhhhccccchhHhhcc-cccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccc
Q 013105          299 LVEWARPMLKDFTKLDQIIDS-RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL  362 (449)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  362 (449)
                                ....+.-.+.. ...-+-....++.+.+++++||+.||.+||++.+++.+++.+.
T Consensus       247 ----------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  247 ----------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ----------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                      11111111111 1111111226677999999999999999999999999988764

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-43  Score=336.90  Aligned_cols=241  Identities=27%  Similarity=0.340  Sum_probs=196.8

Q ss_pred             ccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEEEe
Q 013105           87 LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEY  163 (449)
Q Consensus        87 lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  163 (449)
                      ||+|+||.||+|.+..      +++.||+|++...   .......+.+|+.++..++||||+++++++.+.+..|+||||
T Consensus         1 lg~G~~g~Vy~~~~~~------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   74 (312)
T cd05585           1 IGKGSFGKVMQVRKRD------TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAF   74 (312)
T ss_pred             CCcCCCeEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcC
Confidence            7999999999998765      4789999998642   233445678899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCCc
Q 013105          164 MALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSH  243 (449)
Q Consensus       164 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~~  243 (449)
                      +.+|+|.+++...  ..+++..+..++.|++.||.|||  +++|+||||||+|||++.++.++|+|||++.......  .
T Consensus        75 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~  148 (312)
T cd05585          75 INGGELFHHLQRE--GRFDLSRARFYTAELLCALENLH--KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--D  148 (312)
T ss_pred             CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--C
Confidence            9999999998764  56889999999999999999999  7889999999999999999999999999987543222  1


Q ss_pred             eeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccccc
Q 013105          244 ITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLED  323 (449)
Q Consensus       244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (449)
                      ......||+.|+|||++.+..++.++|||||||++|||++|..||.......      ....          +...  ..
T Consensus       149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~~~----------~~~~--~~  210 (312)
T cd05585         149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MYRK----------ILQE--PL  210 (312)
T ss_pred             ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HHHH----------HHcC--CC
Confidence            2334569999999999998899999999999999999999999997542211      1111          1111  11


Q ss_pred             cCCHHHHHHHHHHHHHhccCCCCCCCC---HHHHHHH
Q 013105          324 RYSTEGAKRLAAVAHQCLSHNPKSRPT---MTTVVKA  357 (449)
Q Consensus       324 ~~~~~~~~~l~~li~~cl~~dP~~RPs---~~eil~~  357 (449)
                      .++...+..+.+++.+||+.||.+||+   +.+++.|
T Consensus       211 ~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         211 RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            233445667999999999999999975   5666665

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.3e-42  Score=330.08  Aligned_cols=261  Identities=26%  Similarity=0.402  Sum_probs=207.9

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc-hHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ-GHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      ++|.+.+.||+|+||.||+|.+... .....+..||+|.+...... ....+.+|++++..++|+||+++++++......
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHL-EPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccc-cCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            4688889999999999999977542 22234678999999755433 456789999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcE
Q 013105          158 LLVYEYMALGNLHDQLFKNY------------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNA  225 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~  225 (449)
                      ++||||+++++|.+++....            ...+++.....++.|++.||.|||  .+|++||||||+||+++.++.+
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH--~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA--SQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh--hCCeeccccccceEEEcCCCeE
Confidence            99999999999999986542            245788899999999999999999  7789999999999999999999


Q ss_pred             EEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhh
Q 013105          226 KLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWAR  304 (449)
Q Consensus       226 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~  304 (449)
                      +|+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||.......   ..... 
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~~-  237 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIECI-  237 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH-
Confidence            9999999875433221111223346788999999998899999999999999999998 999987543211   11110 


Q ss_pred             hhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 013105          305 PMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE  359 (449)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  359 (449)
                                   ........+...+..+.+++.+||+.||++||++.|+++.|+
T Consensus       238 -------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         238 -------------TQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             -------------HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence                         011111122345567999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1e-42  Score=327.95  Aligned_cols=257  Identities=25%  Similarity=0.422  Sum_probs=209.4

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      ..+|.+.+.||+|+||.||+|.+..      .+..||+|++... ......+.+|+.+++.++|+||+++++++...+..
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~------~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   77 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEec------CCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence            3468888999999999999998865      4788999998743 33456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+.+++|.+++.......+++..++.++.|++.||+|||  .++++||||||+|||++.++.+||+|||++....
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~  155 (263)
T cd05052          78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  155 (263)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeecccCcceEEEcCCCcEEeCCCccccccc
Confidence            99999999999999997665567899999999999999999999  7889999999999999999999999999998654


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI  316 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (449)
                      ..... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+......   ..              .
T Consensus       156 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~---~~--------------~  217 (263)
T cd05052         156 GDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YE--------------L  217 (263)
T ss_pred             cceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH--------------H
Confidence            32211 1112234668999999988899999999999999999998 9999875422111   00              0


Q ss_pred             hcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcc
Q 013105          317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL  361 (449)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  361 (449)
                      +........+..++..+.+++.+||+.||++||++.++++.|+.+
T Consensus       218 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         218 LEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             HHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            111111223344567799999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9.7e-44  Score=327.36  Aligned_cols=262  Identities=24%  Similarity=0.299  Sum_probs=201.2

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC--C--
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED--E--  155 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~--  155 (449)
                      .|...+++|.|+||.||+|....      +++.||||..-.+...    --+|+++|+.+.|||||++.-+|...  .  
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e------~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~   94 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRE------TEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDE   94 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcC------CCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence            46667899999999999998876      4789999998544321    23599999999999999999888653  2  


Q ss_pred             -EEEEEEEecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC-CcEEEeeec
Q 013105          156 -HRLLVYEYMALGNLHDQLFK--NYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD-YNAKLSDFG  231 (449)
Q Consensus       156 -~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~-~~~kl~DfG  231 (449)
                       ...+|||||+ .+|.+.+..  ..+..++...+.-+..|+++||.|||  ..||+||||||.|+|+|.+ |.+||||||
T Consensus        95 ~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh--~~~IcHRDIKPqNlLvD~~tg~LKicDFG  171 (364)
T KOG0658|consen   95 VYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH--SHGICHRDIKPQNLLVDPDTGVLKICDFG  171 (364)
T ss_pred             hHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH--hcCcccCCCChheEEEcCCCCeEEeccCC
Confidence             3458999997 799888863  23467888888999999999999999  6789999999999999977 899999999


Q ss_pred             cccCCCCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhh--h--
Q 013105          232 LATDGPQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARP--M--  306 (449)
Q Consensus       232 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~--~--  306 (449)
                      .|+....+.....   ..-|..|+|||.+.| .+|+.+.||||.|||+.||+-|++.|.+.........+-.+..  .  
T Consensus       172 SAK~L~~~epniS---YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e  248 (364)
T KOG0658|consen  172 SAKVLVKGEPNIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRE  248 (364)
T ss_pred             cceeeccCCCcee---EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHH
Confidence            9998776554422   334899999999865 5899999999999999999999999998765544433211110  0  


Q ss_pred             -----hcc--ccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          307 -----LKD--FTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       307 -----~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                           -.+  .....++.......-+....++++.+|+.++|..+|.+|.++.+++.|
T Consensus       249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence                 000  001111111111112345567789999999999999999999999987

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2e-42  Score=329.48  Aligned_cols=261  Identities=26%  Similarity=0.416  Sum_probs=206.7

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      .+|++.+.||+|+||.||+|.+..  .....+..+++|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~--~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   82 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYL--PGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV   82 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEec--CCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence            468888999999999999998643  122246789999997433 33346788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC
Q 013105          158 LLVYEYMALGNLHDQLFKNY---------------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD  222 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~---------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~  222 (449)
                      |+||||+.+++|.+++....               ...+++...+.++.+++.||.|||  +++|+||||||+|||++.+
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS--SHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hcCeehhccccceEEEcCC
Confidence            99999999999999985432               234788889999999999999999  7889999999999999999


Q ss_pred             CcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHH
Q 013105          223 YNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVE  301 (449)
Q Consensus       223 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~  301 (449)
                      +.+||+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||.+.....   ...
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~---~~~  237 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE---VIE  237 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHH
Confidence            9999999999986543332222333446778999999988889999999999999999998 999986542111   111


Q ss_pred             hhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 013105          302 WARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEP  360 (449)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  360 (449)
                      .              +........+..++..+.+++.+||+.||++||++.+|+++|..
T Consensus       238 ~--------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         238 M--------------VRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             H--------------HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            1              01111112233455679999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.5e-42  Score=341.05  Aligned_cols=249  Identities=25%  Similarity=0.329  Sum_probs=195.9

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      ++|...+.||+|+||.||+|.+..      +++.||||++..... .....+.+|+.+++.++|+||+++++++..++..
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  147 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRP------TGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI  147 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECC------CCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence            456677899999999999998765      478999999964432 2345688999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+.+|+|.+.      ....+..+..++.|++.||.|||  +++|+||||||+|||++.++.+||+|||++....
T Consensus       148 ~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~  219 (353)
T PLN00034        148 QVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLH--RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA  219 (353)
T ss_pred             EEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence            999999999998653      23556777889999999999999  7789999999999999999999999999998654


Q ss_pred             CCCCCceeeecCCCCcccccccccc-----CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccc
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINT-----GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK  312 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  312 (449)
                      ....  ......||..|+|||++..     ...+.++|||||||++|||++|+.||..............          
T Consensus       220 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~----------  287 (353)
T PLN00034        220 QTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA----------  287 (353)
T ss_pred             cccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH----------
Confidence            3221  1233569999999998742     2345689999999999999999999974321111111000          


Q ss_pred             hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                          +........+..++.++.+||.+||+.||++|||+.++++|
T Consensus       288 ----~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        288 ----ICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ----HhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                00011122234556679999999999999999999999997

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.2e-42  Score=332.12  Aligned_cols=268  Identities=26%  Similarity=0.346  Sum_probs=199.7

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcC---CCCCcceeeeEEE-
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQL---KHPHLVNLIGYCC-  152 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~-  152 (449)
                      ++|++.+.||+|+||.||+|.+...     .+..||+|++....  ......+.+|+.+++.+   .||||+++++++. 
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~   75 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKN-----GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   75 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCC-----CCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEec
Confidence            4689999999999999999977432     36789999987432  22234556677776665   6999999999985 


Q ss_pred             ----eCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEe
Q 013105          153 ----EDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLS  228 (449)
Q Consensus       153 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~  228 (449)
                          .....++||||+. ++|.+++.......+++..+..++.|++.||.|||  .+||+||||||+|||++.++.+||+
T Consensus        76 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH--~~~iiH~dlkp~Nil~~~~~~~kl~  152 (290)
T cd07862          76 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLA  152 (290)
T ss_pred             ccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEEcCCCCEEEc
Confidence                2456899999996 68999987665567899999999999999999999  7889999999999999999999999


Q ss_pred             eeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhH-Hhhh-hh
Q 013105          229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV-EWAR-PM  306 (449)
Q Consensus       229 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~-~~~~-~~  306 (449)
                      |||++......   .......||+.|+|||++.+..++.++|||||||++|||++|.+||.+.........+ .... +.
T Consensus       153 Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~  229 (290)
T cd07862         153 DFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG  229 (290)
T ss_pred             cccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence            99999755432   1233456899999999998888999999999999999999999999865432211111 1000 00


Q ss_pred             hccccchh----Hhhcccc---cccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          307 LKDFTKLD----QIIDSRL---EDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       307 ~~~~~~~~----~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ...+....    .......   .....+..+..+.+++.+||+.||++|||+.++++|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            00000000    0000000   001112345678899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.2e-42  Score=345.11  Aligned_cols=254  Identities=23%  Similarity=0.312  Sum_probs=198.9

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      .|.+.+.||+|+||+||+|.+..      +++.||+|++...   .......+.+|+.+++.++||||+++++++.+.+.
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~   75 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVD------THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDN   75 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECC------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCE
Confidence            58889999999999999998765      5789999999643   22334568899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      +|+||||++||+|.+++...  ..+++..+..++.|++.||.|||  ..||+||||||+|||++.++.+||+|||++...
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH--~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          76 LYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVH--KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             EEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence            99999999999999998764  56888899999999999999999  788999999999999999999999999997533


Q ss_pred             CCCCC---------------------------------------------CceeeecCCCCccccccccccCCCCcccch
Q 013105          237 PQGED---------------------------------------------SHITTCVMGTEGYAAPEYINTGHLTTMCDV  271 (449)
Q Consensus       237 ~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv  271 (449)
                      .....                                             .......+||+.|+|||++.+..++.++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di  231 (381)
T cd05626         152 RWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW  231 (381)
T ss_pred             ccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccce
Confidence            11000                                             000123569999999999988889999999


Q ss_pred             hhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHh--ccCCCCCCC
Q 013105          272 FSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQC--LSHNPKSRP  349 (449)
Q Consensus       272 wslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c--l~~dP~~RP  349 (449)
                      |||||++|||++|..||...........+      .. .       ...........++.++.+++.+|  +..+|..||
T Consensus       232 wSlG~il~elltG~~Pf~~~~~~~~~~~i------~~-~-------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~  297 (381)
T cd05626         232 WSVGVILFEMLVGQPPFLAPTPTETQLKV------IN-W-------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRN  297 (381)
T ss_pred             eehhhHHHHHHhCCCCCcCCCHHHHHHHH------Hc-c-------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCC
Confidence            99999999999999999764322111000      00 0       00000011113455688899884  455666699


Q ss_pred             CHHHHHHH
Q 013105          350 TMTTVVKA  357 (449)
Q Consensus       350 s~~eil~~  357 (449)
                      ++.+++.|
T Consensus       298 ~~~~~l~h  305 (381)
T cd05626         298 GADDIKAH  305 (381)
T ss_pred             CHHHHhcC
Confidence            99999987

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-43  Score=346.10  Aligned_cols=254  Identities=22%  Similarity=0.301  Sum_probs=201.5

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ++|++.+.||+|+||.||+|....      +++.||||++...   .......+.+|+.++..++||||+++++++.+++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~   74 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKD------TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN   74 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC
Confidence            478999999999999999998765      5789999999743   2233456778999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..|+||||+.+|+|.+++...  ..+++..+..++.|++.||.|||  +++|+||||||+|||++.++.++|+|||++..
T Consensus        75 ~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH--~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  150 (364)
T cd05599          75 YLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIH--KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTG  150 (364)
T ss_pred             eEEEEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeEECCCCCEEEeeccccee
Confidence            999999999999999998764  56899999999999999999999  77899999999999999999999999999875


Q ss_pred             CCCCCCCc------------------------------------eeeecCCCCccccccccccCCCCcccchhhhHHHHH
Q 013105          236 GPQGEDSH------------------------------------ITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLL  279 (449)
Q Consensus       236 ~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~  279 (449)
                      ........                                    .....+||+.|+|||++.+..++.++|||||||++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~  230 (364)
T cd05599         151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY  230 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHH
Confidence            32211000                                    011246999999999998889999999999999999


Q ss_pred             HHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCC---HHHHHH
Q 013105          280 ELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT---MTTVVK  356 (449)
Q Consensus       280 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~eil~  356 (449)
                      ||++|..||...........      ... +.       ...........++.+.++|.+||. +|.+|++   +.++++
T Consensus       231 el~~G~~Pf~~~~~~~~~~~------i~~-~~-------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         231 EMLVGYPPFCSDNPQETYRK------IIN-WK-------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             HhhcCCCCCCCCCHHHHHHH------HHc-CC-------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            99999999976532211100      000 00       000000011235568899999997 9999997   999988


Q ss_pred             H
Q 013105          357 A  357 (449)
Q Consensus       357 ~  357 (449)
                      |
T Consensus       296 h  296 (364)
T cd05599         296 H  296 (364)
T ss_pred             C
Confidence            6

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.2e-42  Score=342.99  Aligned_cols=255  Identities=22%  Similarity=0.282  Sum_probs=197.9

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ++|++.+.||+|+||+||+|....      +++.||+|++....   ......+.+|+.++..++|+||+++++.+.+..
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~   74 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKD------TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL   74 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECC------CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            478999999999999999997765      57899999996431   233456778999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..|+||||++||+|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH--~~givHrDlKp~NILi~~~~~vkL~DFGla~~  150 (363)
T cd05628          75 NLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIH--QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTG  150 (363)
T ss_pred             eEEEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeEecCCCHHHeEECCCCCEEEeeccCccc
Confidence            999999999999999999764  57899999999999999999999  78899999999999999999999999999875


Q ss_pred             CCCCCC---------------------------------CceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHH
Q 013105          236 GPQGED---------------------------------SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELL  282 (449)
Q Consensus       236 ~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ell  282 (449)
                      ......                                 .......+||+.|+|||++.+..++.++|||||||++|||+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell  230 (363)
T cd05628         151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML  230 (363)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHH
Confidence            432110                                 00112357999999999999889999999999999999999


Q ss_pred             hCCCcccccccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhcc--CCCCCCCCHHHHHHH
Q 013105          283 TGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLS--HNPKSRPTMTTVVKA  357 (449)
Q Consensus       283 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPs~~eil~~  357 (449)
                      +|..||.+.........+      .....      ....+..  ...++++.+++.+++.  .++..||++++|++|
T Consensus       231 ~G~~Pf~~~~~~~~~~~i------~~~~~------~~~~p~~--~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         231 IGYPPFCSETPQETYKKV------MNWKE------TLIFPPE--VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             hCCCCCCCCCHHHHHHHH------HcCcC------cccCCCc--CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            999999764322111100      00000      0000110  1234567788887654  233346899999987

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-43  Score=344.53  Aligned_cols=254  Identities=26%  Similarity=0.354  Sum_probs=205.8

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ++|.+.+.||+|+||.||+|.+..      +++.||||++...   .......+.+|+.++..++||||+++++++.+++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKD------TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE   74 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECC------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCC
Confidence            478999999999999999998765      5789999999743   2234566888999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..|+||||+.+++|.+++...  ..+++..+..++.|++.||.|||  .+||+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH--~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~  150 (350)
T cd05573          75 HLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVH--KLGFIHRDIKPDNILIDADGHIKLADFGLCKK  150 (350)
T ss_pred             eEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEeecCCCCcc
Confidence            999999999999999999765  67899999999999999999999  68899999999999999999999999999986


Q ss_pred             CCCCC---------------------------CCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcc
Q 013105          236 GPQGE---------------------------DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSV  288 (449)
Q Consensus       236 ~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf  288 (449)
                      .....                           .........||+.|+|||++.+..++.++|||||||+||||++|+.||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf  230 (350)
T cd05573         151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF  230 (350)
T ss_pred             CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCC
Confidence            54322                           001123356999999999999889999999999999999999999999


Q ss_pred             cccccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHH
Q 013105          289 EKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT-MTTVVKA  357 (449)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~~  357 (449)
                      ...........      ... +.       ..........+++.+.++|.+||. ||.+||+ +.++++|
T Consensus       231 ~~~~~~~~~~~------i~~-~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         231 YSDTLQETYNK------IIN-WK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCCCHHHHHHH------Hhc-cC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            76532111100      000 00       000001111246679999999997 9999999 9999987

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.5e-42  Score=338.19  Aligned_cols=256  Identities=25%  Similarity=0.338  Sum_probs=202.2

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC----CcchHHHHHHHHHHHhcC-CCCCcceeeeEEEeC
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN----GSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCED  154 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~  154 (449)
                      +|++.+.||+|+||.||++....+   ..++..||+|++...    .......+..|+.++..+ +|+||+.+++++..+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTG---HDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE   77 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEccc---CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC
Confidence            588899999999999999876431   235789999998632    122345677899999999 599999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +..++||||+.+|+|.+++...  ..+++..+..++.|++.||.|||  +++|+||||||+|||++.++.+||+|||++.
T Consensus        78 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          78 AKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLH--KLGIVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            9999999999999999998764  56889999999999999999999  7789999999999999999999999999998


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccch
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      ........ ......||+.|+|||++.+. .++.++|||||||++|||++|..||............  ...        
T Consensus       154 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--~~~--------  222 (332)
T cd05614         154 EFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV--SRR--------  222 (332)
T ss_pred             cccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH--HHH--------
Confidence            65332221 23345799999999999765 4789999999999999999999999743221111100  000        


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRP-----TMTTVVKA  357 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  357 (449)
                        +..  ....++...+..+.+++.+||+.||++||     ++.++++|
T Consensus       223 --~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         223 --ILK--CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             --Hhc--CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence              000  11223334566789999999999999999     77788876

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.5e-42  Score=329.37  Aligned_cols=264  Identities=23%  Similarity=0.390  Sum_probs=206.0

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      ...++|++.+.||+|+||.||+|.+..... ...+..||+|++.... ......+.+|+.+++.++||||+++++++..+
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVK-DEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCC-CCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            356789999999999999999998754211 2345789999986432 23345688999999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEE
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNY--------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAK  226 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~k  226 (449)
                      ...++||||+.+|+|.+++....        ...+++..+..++.|++.||.|||  +.+++|+||||+|||++.++.++
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCcchheEEEcCCCCEE
Confidence            99999999999999999986532        123567888999999999999999  67899999999999999999999


Q ss_pred             EeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhh
Q 013105          227 LSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARP  305 (449)
Q Consensus       227 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~  305 (449)
                      |+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.....   .....  
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~~~~--  234 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VLRFV--  234 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH--
Confidence            999999875433222111122345788999999988889999999999999999999 788886542211   11100  


Q ss_pred             hhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 013105          306 MLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE  359 (449)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  359 (449)
                                 ... .....+..++..+.+++.+||+.||++|||+.+++++|+
T Consensus       235 -----------~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         235 -----------MEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             -----------HcC-CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence                       000 011122344567999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=6.1e-43  Score=339.85  Aligned_cols=244  Identities=26%  Similarity=0.378  Sum_probs=198.2

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVY  161 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  161 (449)
                      +.||+|+||.||++....      ++..||+|++...   .......+..|++++..++||||+++++++..++..|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~   74 (325)
T cd05594           1 KLLGKGTFGKVILVKEKA------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM   74 (325)
T ss_pred             CeeeeCCCEEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEE
Confidence            469999999999997755      5789999999743   2233456778999999999999999999999999999999


Q ss_pred             EecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCC
Q 013105          162 EYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGED  241 (449)
Q Consensus       162 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~  241 (449)
                      ||+.+|+|..++...  ..+++..+..++.|++.||.|||+ .+||+||||||+|||++.++.+||+|||++........
T Consensus        75 E~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~-~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~  151 (325)
T cd05594          75 EYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA  151 (325)
T ss_pred             eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh-cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc
Confidence            999999999888654  578999999999999999999993 26899999999999999999999999999875332211


Q ss_pred             CceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccc
Q 013105          242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRL  321 (449)
Q Consensus       242 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (449)
                        ......||+.|+|||++.+..++.++|||||||++|||++|..||...........+                ...  
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i----------------~~~--  211 (325)
T cd05594         152 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI----------------LME--  211 (325)
T ss_pred             --ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH----------------hcC--
Confidence              123456999999999998889999999999999999999999999754321111100                000  


Q ss_pred             cccCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013105          322 EDRYSTEGAKRLAAVAHQCLSHNPKSRP-----TMTTVVKA  357 (449)
Q Consensus       322 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  357 (449)
                      ...++...+.++.+++.+||+.||++|+     ++.++++|
T Consensus       212 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         212 EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            1112334556789999999999999996     89999987

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.7e-42  Score=330.09  Aligned_cols=266  Identities=25%  Similarity=0.375  Sum_probs=211.9

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      .+|.+.+.||+|+||.||+|.+... ........+++|.+..........+.+|+.+++.++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~-~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNL-SPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeecc-CCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            4588889999999999999976432 122345679999987555444567889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCc
Q 013105          159 LVYEYMALGNLHDQLFKNY--------------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYN  224 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~  224 (449)
                      +||||+.+++|.+++..+.              ...+++..++.++.|++.||.|||  +++|+||||||+|||++.++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA--SQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccCcceEEEccCCc
Confidence            9999999999999986542              234788999999999999999999  788999999999999999999


Q ss_pred             EEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhh
Q 013105          225 AKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWA  303 (449)
Q Consensus       225 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~  303 (449)
                      ++|+|||++................|+..|+|||.+.+..++.++|||||||++|||++ |..||.......   .....
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~  238 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIECI  238 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH
Confidence            99999999975543222122223456789999999988889999999999999999998 999986543211   11110


Q ss_pred             hhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          304 RPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                                    ........+..++..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       239 --------------~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         239 --------------TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             --------------hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence                          00011112233456799999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=5.5e-43  Score=344.43  Aligned_cols=266  Identities=26%  Similarity=0.322  Sum_probs=210.8

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC-C-----CCcceeeeE
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-H-----PHLVNLIGY  150 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~nIv~~~~~  150 (449)
                      +.-+|.+.++||+|+||.|.+|.+..      +++.||||+++.. .....+...|+.+|..|+ |     -|+|+++++
T Consensus       184 i~~rY~V~e~LGkGtFGQVvk~~d~~------T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~  256 (586)
T KOG0667|consen  184 IAYRYEVLEVLGKGSFGQVVKAYDHK------TGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY  256 (586)
T ss_pred             eEEEEEEEEEecccccceeEEEEecC------CCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence            33478999999999999999998876      6899999999743 445667788999999996 4     489999999


Q ss_pred             EEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC--CcEEEe
Q 013105          151 CCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD--YNAKLS  228 (449)
Q Consensus       151 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~--~~~kl~  228 (449)
                      |...+++|||+|.+. -+|++++..+.-..++...+..++.||+.||.+||  +.+|||+||||+||||..-  ..+||+
T Consensus       257 F~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~--~l~IIHcDLKPENILL~~~~r~~vKVI  333 (586)
T KOG0667|consen  257 FYFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH--ELGIIHCDLKPENILLKDPKRSRIKVI  333 (586)
T ss_pred             cccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCChhheeeccCCcCceeEE
Confidence            999999999999996 89999999888888999999999999999999999  7889999999999999654  379999


Q ss_pred             eeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhh---
Q 013105          229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARP---  305 (449)
Q Consensus       229 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~---  305 (449)
                      |||.|+.......     ...-+..|+|||++.|..|+.+.||||||||++||++|.+.|.+..+.+....+.-+..   
T Consensus       334 DFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp  408 (586)
T KOG0667|consen  334 DFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPP  408 (586)
T ss_pred             ecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCC
Confidence            9999997654322     45578999999999999999999999999999999999999998766554433211100   


Q ss_pred             --hhccccchhHhhcc---------------------------------ccc-------ccCCHHHHHHHHHHHHHhccC
Q 013105          306 --MLKDFTKLDQIIDS---------------------------------RLE-------DRYSTEGAKRLAAVAHQCLSH  343 (449)
Q Consensus       306 --~~~~~~~~~~~~~~---------------------------------~~~-------~~~~~~~~~~l~~li~~cl~~  343 (449)
                        +++........++.                                 ..+       ..........+.+++.+||..
T Consensus       409 ~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~  488 (586)
T KOG0667|consen  409 PKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEW  488 (586)
T ss_pred             HHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhcc
Confidence              00000000000000                                 000       001112345689999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 013105          344 NPKSRPTMTTVVKA  357 (449)
Q Consensus       344 dP~~RPs~~eil~~  357 (449)
                      ||.+|+|+.++++|
T Consensus       489 dP~~R~tp~qal~H  502 (586)
T KOG0667|consen  489 DPAERITPAQALNH  502 (586)
T ss_pred             CchhcCCHHHHhcC
Confidence            99999999999998

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2e-42  Score=332.86  Aligned_cols=268  Identities=22%  Similarity=0.320  Sum_probs=200.0

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      .++|.+.+.||+|+||.||+|....      +++.||+|++..... .....+.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   77 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKV------NGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKET   77 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECC------CCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCe
Confidence            3679999999999999999997764      578999999975432 223467789999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||+. ++|.+++... ...++...+..++.|++.||.|||  +++|+||||||+|||++.++.+||+|||++...
T Consensus        78 ~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  153 (303)
T cd07869          78 LTLVFEYVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIH--QRYILHRDLKPQNLLISDTGELKLADFGLARAK  153 (303)
T ss_pred             EEEEEECCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEECCCCcceec
Confidence            999999996 7888877654 356888899999999999999999  778999999999999999999999999998754


Q ss_pred             CCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccc-hhhHHhh--hhhhccccc
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE-KDLVEWA--RPMLKDFTK  312 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~-~~~~~~~--~~~~~~~~~  312 (449)
                      ....  .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+...... .......  .+....+..
T Consensus       154 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (303)
T cd07869         154 SVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPG  231 (303)
T ss_pred             cCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccc
Confidence            3221  11233458999999999865 4588999999999999999999999976432111 0000000  000000000


Q ss_pred             hhH---hhcccc----cccCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          313 LDQ---IIDSRL----EDRYS-----TEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       313 ~~~---~~~~~~----~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ...   ......    .....     ...+..+.+|+.+||+.||++|||+.++++|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence            000   000000    00000     0123568899999999999999999999987

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=9.1e-43  Score=355.58  Aligned_cols=258  Identities=25%  Similarity=0.310  Sum_probs=207.5

Q ss_pred             HHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEE
Q 013105           75 QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCC  152 (449)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~  152 (449)
                      +...++|.+.+.||+|+||.||+|.+..      +++.||||++....  ......+.+|+.++..++|+||+++++.+.
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~  101 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVS------DGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFA  101 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcC------CCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeeccee
Confidence            3445789999999999999999997765      57899999997543  333456788999999999999999988775


Q ss_pred             eCC--------EEEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC
Q 013105          153 EDE--------HRLLVYEYMALGNLHDQLFKN--YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD  222 (449)
Q Consensus       153 ~~~--------~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~  222 (449)
                      ..+        .+++||||+.+|+|.+++...  ....+++..+..++.|++.||.|||  .++|+||||||+|||++.+
T Consensus       102 ~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH--~~~IiHrDLKP~NILl~~~  179 (496)
T PTZ00283        102 KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH--SKHMIHRDIKSANILLCSN  179 (496)
T ss_pred             cccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEeCC
Confidence            432        368999999999999988653  2356889999999999999999999  7789999999999999999


Q ss_pred             CcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHh
Q 013105          223 YNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEW  302 (449)
Q Consensus       223 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~  302 (449)
                      +.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||........      
T Consensus       180 ~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~------  253 (496)
T PTZ00283        180 GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV------  253 (496)
T ss_pred             CCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------
Confidence            99999999999865433222223446799999999999988999999999999999999999999975422110      


Q ss_pred             hhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          303 ARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ...          ... ......+..+++++.+++.+||+.||.+||++.+++.+
T Consensus       254 ~~~----------~~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        254 MHK----------TLA-GRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHH----------Hhc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            000          001 11122344566779999999999999999999999876

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-43  Score=345.67  Aligned_cols=254  Identities=23%  Similarity=0.283  Sum_probs=198.8

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ++|.+.+.||+|+||.||+|....      +++.||||++...   .......+.+|+.++..++||||+++++++.+++
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~   74 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKD------TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ   74 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECC------CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence            478999999999999999997765      5789999998643   2233456788999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..|+||||+.||+|.+++...  ..+++..+..++.|++.||.|||  +.||+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH--~~givHrDlkp~NIll~~~~~~kl~DfGla~~  150 (377)
T cd05629          75 YLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVH--KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTG  150 (377)
T ss_pred             eeEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEECCCCCEEEeecccccc
Confidence            999999999999999998754  56888899999999999999999  78899999999999999999999999999863


Q ss_pred             CCCCCCC---------------------------------------------ceeeecCCCCccccccccccCCCCcccc
Q 013105          236 GPQGEDS---------------------------------------------HITTCVMGTEGYAAPEYINTGHLTTMCD  270 (449)
Q Consensus       236 ~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~D  270 (449)
                      .......                                             ......+||+.|+|||++.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  230 (377)
T cd05629         151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECD  230 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCcee
Confidence            2210000                                             0001246999999999998889999999


Q ss_pred             hhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCC--
Q 013105          271 VFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSR--  348 (449)
Q Consensus       271 vwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R--  348 (449)
                      ||||||++|||++|.+||...........      ... +.       ....-......+.++.+++.+||. +|.+|  
T Consensus       231 iwSlGvil~elltG~~Pf~~~~~~~~~~~------i~~-~~-------~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~  295 (377)
T cd05629         231 WWSLGAIMFECLIGWPPFCSENSHETYRK------IIN-WR-------ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLG  295 (377)
T ss_pred             eEecchhhhhhhcCCCCCCCCCHHHHHHH------HHc-cC-------CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCC
Confidence            99999999999999999975432111100      000 00       000000011244568899999997 67765  


Q ss_pred             -CCHHHHHHH
Q 013105          349 -PTMTTVVKA  357 (449)
Q Consensus       349 -Ps~~eil~~  357 (449)
                       +++.+++.|
T Consensus       296 r~~~~~~l~h  305 (377)
T cd05629         296 RGGAHEIKSH  305 (377)
T ss_pred             CCCHHHHhcC
Confidence             599999987

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-42  Score=323.55  Aligned_cols=261  Identities=26%  Similarity=0.415  Sum_probs=208.4

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      .++|++.+.||+|+||.||+|.+...   ......||+|+++... ......+.+|+.++..++||||+++++++...+.
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~---~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLP---GKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP   79 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccC---CCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence            35789999999999999999988642   1235689999987543 2334578899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||+.+++|.+++.... ..+++..++.++.|++.||.|||  +++|+|+||||+|||++.++.++|+|||++...
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh--~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          80 VMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLS--EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            999999999999999986643 47899999999999999999999  788999999999999999999999999999876


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      .............++..|+|||.+.+..++.++|||||||++|+|++ |..||.......   .....            
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~------------  221 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAV------------  221 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHH------------
Confidence            42222211222335678999999988889999999999999999998 999986542111   11110            


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcc
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL  361 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  361 (449)
                        ........+..++..+.+++.+||+.+|++||++.+|+++|+.+
T Consensus       222 --~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         222 --EDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             --HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence              00001112234456799999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.3e-42  Score=328.98  Aligned_cols=267  Identities=26%  Similarity=0.393  Sum_probs=211.0

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      .++|.+.+.||+|+||.||++..... .....+..+|+|.+..........+.+|+.++.+++||||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~-~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNL-CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccC-CCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            35788999999999999999975431 11234567999998755545566789999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcC-----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEE
Q 013105          158 LLVYEYMALGNLHDQLFKNY-----------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAK  226 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~k  226 (449)
                      ++||||+.+++|.+++....           ...+++..++.++.|++.||.|||  .+|++||||||+|||++.++.++
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH--~~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA--SQHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccCcceEEEccCCcEE
Confidence            99999999999999986532           235899999999999999999999  78899999999999999999999


Q ss_pred             EeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhh
Q 013105          227 LSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARP  305 (449)
Q Consensus       227 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~  305 (449)
                      |+|||++................++..|+|||++.+..++.++|||||||++|+|++ |.+||.......   .....  
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~~i--  235 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIECI--  235 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH--
Confidence            999999985533221111222345778999999988889999999999999999998 899986543211   11100  


Q ss_pred             hhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          306 MLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                                 .... ....+..++..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       236 -----------~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         236 -----------TQGR-VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             -----------HcCC-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence                       0000 0111223455699999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-42  Score=329.65  Aligned_cols=253  Identities=26%  Similarity=0.375  Sum_probs=204.8

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      +|++.+.||+|+||.||++.+..      +++.||+|++....   ......+.+|+.+++.++||||+++++.+.+++.
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRA------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA   74 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcC------CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCe
Confidence            47888999999999999997654      47899999986432   1223456789999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||+.+|+|.+++.......+++..+..++.|++.||.|||  +++|+||||||+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~  152 (285)
T cd05605          75 LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH--RERIVYRDLKPENILLDDYGHIRISDLGLAVEI  152 (285)
T ss_pred             EEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH--HCCcEecCCCHHHEEECCCCCEEEeeCCCceec
Confidence            999999999999998887655567899999999999999999999  678999999999999999999999999998765


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHh
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI  316 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (449)
                      .....   .....|++.|+|||++.+..++.++|||||||++|||++|..||.+..........             ...
T Consensus       153 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~-------------~~~  216 (285)
T cd05605         153 PEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV-------------ERR  216 (285)
T ss_pred             CCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH-------------HHH
Confidence            33221   22346899999999998888999999999999999999999999764321111000             000


Q ss_pred             hcccccccCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013105          317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRP-----TMTTVVKA  357 (449)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  357 (449)
                      +. .....++...+..+.+|+.+||+.||++||     ++.+++++
T Consensus       217 ~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         217 VK-EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             hh-hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            00 011223345667799999999999999999     88899876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.3e-43  Score=311.49  Aligned_cols=256  Identities=25%  Similarity=0.362  Sum_probs=208.5

Q ss_pred             HHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc----chH----HHHHHHHHHHhcC-CCCCcc
Q 013105           75 QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS----QGH----REWLAEVIFLGQL-KHPHLV  145 (449)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~----~~~~~E~~~l~~l-~h~nIv  145 (449)
                      +.+.+.|.-.+.||.|..+.|-+++...      +++.+|+|++.....    ...    +.-.+|+.||+++ .||||+
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~------t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II   86 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKE------TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYII   86 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcc------cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEE
Confidence            4566788899999999999999987665      688999999974321    112    2345799999998 599999


Q ss_pred             eeeeEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcE
Q 013105          146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNA  225 (449)
Q Consensus       146 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~  225 (449)
                      .+.++++.+...++|+|.|+.|.|.|++...  -.+++.....|+.|+.+|+.|||  .++||||||||+|||++++.++
T Consensus        87 ~l~D~yes~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylH--a~~IVHRDLKpENILlddn~~i  162 (411)
T KOG0599|consen   87 DLQDVYESDAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLH--ARNIVHRDLKPENILLDDNMNI  162 (411)
T ss_pred             EeeeeccCcchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHH--HhhhhhcccChhheeeccccce
Confidence            9999999999999999999999999999775  68999999999999999999999  7779999999999999999999


Q ss_pred             EEeeeccccCCCCCCCCceeeecCCCCcccccccccc------CCCCcccchhhhHHHHHHHHhCCCcccccccccchhh
Q 013105          226 KLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT------GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDL  299 (449)
Q Consensus       226 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~  299 (449)
                      ||+|||.|.....+..   ....+|||+|+|||.+..      ..|+..+|+||+|++||.|+.|.+||.-.........
T Consensus       163 ~isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~  239 (411)
T KOG0599|consen  163 KISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRM  239 (411)
T ss_pred             EEeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHH
Confidence            9999999998876653   455789999999999853      4688899999999999999999999975422111111


Q ss_pred             HHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          300 VEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      +      +...        -.+..+--.+.+....+||.+||+.||.+|.|++|+|+|
T Consensus       240 I------meGk--------yqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  240 I------MEGK--------YQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             H------Hhcc--------cccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            1      1100        001111123455668999999999999999999999987

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.2e-42  Score=339.49  Aligned_cols=267  Identities=23%  Similarity=0.339  Sum_probs=199.0

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC---
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED---  154 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~---  154 (449)
                      +|++.+.||+|+||.||+|....      ++..||||++...  .......+.+|+.+++.++||||+++++++...   
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   74 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTH------TGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR   74 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECC------CCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence            58889999999999999998765      5789999998642  223345688999999999999999999988643   


Q ss_pred             --CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecc
Q 013105          155 --EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL  232 (449)
Q Consensus       155 --~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGl  232 (449)
                        ...|+||||+. ++|.+++...  ..+++.....++.|++.||.|||  ++||+||||||+|||++.++.+||+|||+
T Consensus        75 ~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIll~~~~~~kL~Dfg~  149 (338)
T cd07859          75 EFKDIYVVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIH--TANVFHRDLKPKNILANADCKLKICDFGL  149 (338)
T ss_pred             CCceEEEEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCcEEEccCcc
Confidence              35899999995 7898888654  46899999999999999999999  67899999999999999999999999999


Q ss_pred             ccCCCCCCCC-ceeeecCCCCcccccccccc--CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhh--hh
Q 013105          233 ATDGPQGEDS-HITTCVMGTEGYAAPEYINT--GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARP--ML  307 (449)
Q Consensus       233 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~--~~  307 (449)
                      +......... .......||+.|+|||++.+  ..++.++|||||||++|||++|++||.+...............  ..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  229 (338)
T cd07859         150 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP  229 (338)
T ss_pred             ccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            9854322111 11234569999999999865  5789999999999999999999999976533221111100000  00


Q ss_pred             ccc-----cchhHhh---cccccccC---CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          308 KDF-----TKLDQII---DSRLEDRY---STEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       308 ~~~-----~~~~~~~---~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ...     ......+   ........   .+..+..+.+++.+||+.||++|||+++++++
T Consensus       230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            000     0000000   00000000   11234568899999999999999999999987

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3e-42  Score=333.75  Aligned_cols=264  Identities=23%  Similarity=0.335  Sum_probs=206.8

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      .+|++.+.||+|+||.||+|.+..+  .......||+|++.... ......+.+|+.+++.++||||+++++++... ..
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPE--GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecC--CCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            5699999999999999999987542  11223459999987443 33456788999999999999999999998764 57


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++|+||+.+|+|.+++... ...+++...+.++.|++.||+|||  +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH--~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          84 QLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE--ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHH--hcCeeccccchhheEecCCCcEEEcccccccccc
Confidence            8999999999999998764 246888899999999999999999  7789999999999999999999999999998654


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI  316 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (449)
                      ............++..|+|||.+.+..++.++|||||||++|||++ |..||.+......   ..              .
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~---~~--------------~  223 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SS--------------I  223 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HH--------------H
Confidence            4332221222334678999999988899999999999999999998 9999975422111   10              1


Q ss_pred             hcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCC
Q 013105          317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN  365 (449)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  365 (449)
                      +........+..++.++.+++.+||..||.+||++.+++..|..+....
T Consensus       224 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         224 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             HhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            1111111112334556899999999999999999999999988876543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-42  Score=342.92  Aligned_cols=262  Identities=21%  Similarity=0.271  Sum_probs=199.8

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      .++|.+.+.||+|+||.||+|.+..      +++.||+|...      ...+.+|+++++.++||||+++++++..+...
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~------~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~  158 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNK------TCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFT  158 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECC------CCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence            3679999999999999999998765      57899999753      23467899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++|||++. ++|..++...  ..+++..++.++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++....
T Consensus       159 ~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH--~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~  233 (391)
T PHA03212        159 CLILPRYK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPV  233 (391)
T ss_pred             EEEEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence            99999995 7888888654  46889999999999999999999  6789999999999999999999999999997532


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCccccccccc-----chhhHHhhhhh---hcc
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKR-----EKDLVEWARPM---LKD  309 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~-----~~~~~~~~~~~---~~~  309 (449)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++|..||.......     ...+.......   ...
T Consensus       234 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~  312 (391)
T PHA03212        234 DINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE  312 (391)
T ss_pred             cccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence            2111 12234569999999999988899999999999999999999998875432111     00000000000   000


Q ss_pred             c-----cchhHhh----cc--cccc---c--CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          310 F-----TKLDQII----DS--RLED---R--YSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       310 ~-----~~~~~~~----~~--~~~~---~--~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      +     ..+....    ..  ....   .  .....+.++.+|+.+||+.||.+|||+.|++++
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            0     0000000    00  0000   0  012356789999999999999999999999986

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2e-42  Score=336.06  Aligned_cols=246  Identities=28%  Similarity=0.420  Sum_probs=197.6

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHH---hcCCCCCcceeeeEEEeC
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFL---GQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l---~~l~h~nIv~~~~~~~~~  154 (449)
                      |++.+.||+|+||.||+|.+..      +++.||||+++..   .......+.+|++++   +.++||||+++++++.+.
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~   74 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKK------TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE   74 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC
Confidence            6778999999999999998765      5789999999643   223345566676655   566899999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +..|+||||+.+|+|...+..   ..+++.....++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++.
T Consensus        75 ~~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH--~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~  149 (324)
T cd05589          75 DHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLH--ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK  149 (324)
T ss_pred             CEEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH--hCCeEecCCCHHHeEECCCCcEEeCcccCCc
Confidence            999999999999999887754   46899999999999999999999  7889999999999999999999999999987


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+........                
T Consensus       150 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~----------------  211 (324)
T cd05589         150 EGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD----------------  211 (324)
T ss_pred             cCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH----------------
Confidence            533222  12334569999999999998899999999999999999999999997643211110                


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRP-----TMTTVVKA  357 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  357 (449)
                      .+...  ...++..++..+.+++.+||+.||.+||     ++.+++++
T Consensus       212 ~i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         212 SIVND--EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             HHHhC--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence            00010  1112334566789999999999999999     57777765

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-43  Score=330.95  Aligned_cols=251  Identities=24%  Similarity=0.348  Sum_probs=214.5

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcch--HHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG--HREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      +.+=|.+.+.||+|.|+.|-+|      ++..+|..||||+++...-..  ...+.+|++.|+.++|||||++|++....
T Consensus        16 IAGLYDLekTlG~GHFAVVKLA------rHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ   89 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLA------RHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ   89 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhh------hhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc
Confidence            3455888899999999999998      677799999999998664333  34688999999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEc-CCCcEEEeeeccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD-SDYNAKLSDFGLA  233 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~-~~~~~kl~DfGla  233 (449)
                      ..+|||+|+-++|+|+++|.++. ..+.+....+++.||+.|+.|+|  ...+|||||||+||++. .-|-+||.|||++
T Consensus        90 TKlyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCH--qLHVVHRDLKPENVVFFEKlGlVKLTDFGFS  166 (864)
T KOG4717|consen   90 TKLYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCH--QLHVVHRDLKPENVVFFEKLGLVKLTDFGFS  166 (864)
T ss_pred             ceEEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHh--hhhhhcccCCcceeEEeeecCceEeeecccc
Confidence            99999999999999999998764 67889999999999999999999  77799999999999875 5588999999999


Q ss_pred             cCCCCCCCCceeeecCCCCccccccccccCCCC-cccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccc
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT-TMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK  312 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  312 (449)
                      ..+.++..   ....+|+..|-|||++.|..|+ +++||||||||||.|++|++||+.....+.                
T Consensus       167 Nkf~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET----------------  227 (864)
T KOG4717|consen  167 NKFQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET----------------  227 (864)
T ss_pred             ccCCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh----------------
Confidence            98877654   4456799999999999988885 689999999999999999999986543322                


Q ss_pred             hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      +-.+++.  .-..|..++.++.+||..||..||.+|.+.++|..+
T Consensus       228 LTmImDC--KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  228 LTMIMDC--KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             hhhhhcc--cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence            2222232  233567888999999999999999999999999876

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.4e-42  Score=335.34  Aligned_cols=246  Identities=28%  Similarity=0.379  Sum_probs=198.2

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC----CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN----GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLV  160 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  160 (449)
                      +.||+|+||.||++....+   ...++.||+|++...    .......+.+|+.+|+.++||||+++++++..++..|+|
T Consensus         2 ~~lg~G~~g~V~~~~~~~~---~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv   78 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTG---ADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLI   78 (323)
T ss_pred             ceeeecCCeEEEEEEEccc---CCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEE
Confidence            5799999999999976432   235789999998642    122334567899999999999999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCC
Q 013105          161 YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGE  240 (449)
Q Consensus       161 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~  240 (449)
                      |||+.+|+|.+++...  ..+++.....++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++.......
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          79 LEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLH--QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             EeCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            9999999999988664  56788888899999999999999  7789999999999999999999999999987543222


Q ss_pred             CCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhccc
Q 013105          241 DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSR  320 (449)
Q Consensus       241 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (449)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........                ..+... 
T Consensus       155 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~----------------~~~~~~-  215 (323)
T cd05584         155 T--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI----------------DKILKG-  215 (323)
T ss_pred             C--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHH----------------HHHHcC-
Confidence            1  123356999999999998888999999999999999999999999764321110                011111 


Q ss_pred             ccccCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013105          321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRP-----TMTTVVKA  357 (449)
Q Consensus       321 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  357 (449)
                       ....+..+++.+.+++.+||+.||++||     ++.+++++
T Consensus       216 -~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         216 -KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             -CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence             1122334556789999999999999999     88998886

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.7e-42  Score=335.15  Aligned_cols=248  Identities=25%  Similarity=0.368  Sum_probs=199.8

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCC-CCcceeeeEEEeCC
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKH-PHLVNLIGYCCEDE  155 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~~~  155 (449)
                      +|++.+.||+|+||.||+|....      +++.||+|++...   .......+..|.+++..+.| ++|+.+++++.+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKG------TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD   74 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC
Confidence            58889999999999999998765      4789999999743   23345667889999999976 56888999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..|+||||+++|+|.+++...  ..+++.....++.|++.||.|||  .+||+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~  150 (324)
T cd05587          75 RLYFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKE  150 (324)
T ss_pred             EEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEEcCCCCEEEeecCccee
Confidence            999999999999999988654  56888999999999999999999  77899999999999999999999999999875


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.....   .....            
T Consensus       151 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~i------------  213 (324)
T cd05587         151 NIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQSI------------  213 (324)
T ss_pred             cCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHH------------
Confidence            322221  2334569999999999998899999999999999999999999997643211   11100            


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM-----TTVVKA  357 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~eil~~  357 (449)
                       ..  ....++...+..+.+++.+||+.||.+|++.     .++++|
T Consensus       214 -~~--~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         214 -ME--HNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             -Hc--CCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence             00  0112233455678999999999999999986     566655

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.6e-42  Score=323.67  Aligned_cols=256  Identities=26%  Similarity=0.396  Sum_probs=206.9

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      .++|++.+.||+|+||.||+|....       +..||+|.+... ....+.+.+|+.+++.++|+||+++++++...+..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~-------~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNN-------STKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI   76 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecC-------CceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            3578999999999999999997653       467999988643 23356788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      +++|||+.+++|.+++.......+++..+..++.+++.||+|||  ..+++||||||+||+++.++.++|+|||++....
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH--~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  154 (261)
T cd05072          77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE--RKNYIHRDLRAANVLVSESLMCKIADFGLARVIE  154 (261)
T ss_pred             EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccchhhEEecCCCcEEECCCccceecC
Confidence            99999999999999997765667889999999999999999999  6789999999999999999999999999998654


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI  316 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (449)
                      ..... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......   ......            
T Consensus       155 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~------------  218 (261)
T cd05072         155 DNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQ------------  218 (261)
T ss_pred             CCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHH------------
Confidence            32211 1222345678999999988889999999999999999998 999997542111   111100            


Q ss_pred             hcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcc
Q 013105          317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL  361 (449)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  361 (449)
                        ..........++..+.+++.+||+.+|++||+++++++.|+.+
T Consensus       219 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         219 --RGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             --cCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence              0001111223456789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.3e-42  Score=327.97  Aligned_cols=261  Identities=25%  Similarity=0.401  Sum_probs=206.9

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc-hHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ-GHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      +|.+.+.||+|+||.||+|.+... .....+..||+|++...... ....+.+|+.++..++||||+++++++...+..+
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~-~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGT-APGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecC-CCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            467788999999999999987653 12234678999999754332 2356788999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCc
Q 013105          159 LVYEYMALGNLHDQLFKNY--------------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYN  224 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~  224 (449)
                      +++||+.+++|.+++....              ...+++..+..++.|++.||.|||  ++||+||||||+|||++.++.
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH--~~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS--SHHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--HcCccccccchhheEecCCCc
Confidence            9999999999999985321              235788889999999999999999  778999999999999999999


Q ss_pred             EEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhh
Q 013105          225 AKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWA  303 (449)
Q Consensus       225 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~  303 (449)
                      +||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.....   .... 
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~-  238 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VIEM-  238 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH-
Confidence            99999999886543332222334456789999999988889999999999999999998 888887542211   1111 


Q ss_pred             hhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 013105          304 RPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEP  360 (449)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  360 (449)
                                   +.......++..++..+.+++..||+.+|++||++.+|+..|+.
T Consensus       239 -------------i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         239 -------------IRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -------------HHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                         11111122344567779999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.4e-42  Score=324.76  Aligned_cols=256  Identities=27%  Similarity=0.418  Sum_probs=211.0

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      ..+|++.+.||.|+||.||+|.+..       +..+|+|++..........+..|+.+++.++|+||+++++++.+.+..
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   77 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-------RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPV   77 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-------CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCe
Confidence            3568889999999999999997754       578999999866555567788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+.+++|.+++.......+++..+..++.|++.||.|||  ++||+|+||||+||+++.++.+||+|||++....
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~  155 (261)
T cd05148          78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE--EQNSIHRDLAARNILVGEDLVCKVADFGLARLIK  155 (261)
T ss_pred             EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccCcceEEEcCCceEEEccccchhhcC
Confidence            99999999999999998766667899999999999999999999  7889999999999999999999999999997654


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI  316 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (449)
                      .....  .....++..|+|||.+.+..++.++||||||+++|+|++ |..||........   ....             
T Consensus       156 ~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~---~~~~-------------  217 (261)
T cd05148         156 EDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV---YDQI-------------  217 (261)
T ss_pred             Ccccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH---HHHH-------------
Confidence            32211  123346778999999988889999999999999999998 8999975431111   1100             


Q ss_pred             hcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcc
Q 013105          317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL  361 (449)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  361 (449)
                       ........+..+++.+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       218 -~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         218 -TAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             -HhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence             01111122345566799999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=5e-42  Score=329.98  Aligned_cols=267  Identities=26%  Similarity=0.382  Sum_probs=210.7

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcC-CCCCcceeeeEEEe
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQL-KHPHLVNLIGYCCE  153 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~  153 (449)
                      ...++|.+.+.||+|+||.||+|.+... .....+..||+|+++... ......+.+|+.+++++ +||||+++++++..
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  110 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGL-SKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI  110 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecC-CCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence            3446799999999999999999976432 223346689999987543 23345688999999999 79999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      .+..++||||+.+|+|.+++.......+++.+...++.+++.||.|||  +++|+|+||||+|||++.++.++|+|||++
T Consensus       111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeehhhhccceEEEcCCCeEEECCCccc
Confidence            999999999999999999997654455899999999999999999999  678999999999999999999999999999


Q ss_pred             cCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccc
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTK  312 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  312 (449)
                      ................++..|+|||.+.+..++.++|||||||++|||++ |..||........  +..           
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~-----------  255 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYK-----------  255 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHH-----------
Confidence            86543322112223346788999999988889999999999999999998 9999875422111  100           


Q ss_pred             hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcc
Q 013105          313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL  361 (449)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  361 (449)
                         .+........+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       256 ---~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         256 ---LIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ---HHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence               0111111111223456799999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-42  Score=322.74  Aligned_cols=257  Identities=27%  Similarity=0.389  Sum_probs=207.2

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      ..++|++.+.||+|+||.||+|.+..       +..||+|.++... .....+.+|+.++++++||||+++++++...+.
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~-------~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNN-------TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEP   75 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecC-------CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCC
Confidence            34678999999999999999997643       4679999987543 335678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||+.+++|.+++.......+++..+..++.+++.||.|||  ++||+|+||||+||+++.++.++|+|||++...
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  153 (261)
T cd05068          76 IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE--AQNYIHRDLAARNVLVGENNICKVADFGLARVI  153 (261)
T ss_pred             eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCCcceEEEcCCCCEEECCcceEEEc
Confidence            999999999999999997665567899999999999999999999  788999999999999999999999999999865


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ...... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||.+........   .             
T Consensus       154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~---~-------------  216 (261)
T cd05068         154 KEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ---Q-------------  216 (261)
T ss_pred             cCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH---H-------------
Confidence            422111 1111223457999999988889999999999999999999 999997543211110   0             


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcc
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL  361 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  361 (449)
                       +........+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       217 -~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         217 -VDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             -HHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence             001111112334556799999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.9e-42  Score=334.69  Aligned_cols=250  Identities=24%  Similarity=0.390  Sum_probs=197.6

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcC-CCCCcceeeeEEEeCCEEEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCEDEHRLLV  160 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv  160 (449)
                      +.||+|+||.||+|.+..      +++.||+|+++..   .......+..|..++..+ +||||+++++++.+.+..|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv   74 (329)
T cd05588           1 RVIGRGSYAKVLLVELKK------TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFV   74 (329)
T ss_pred             CeEeeCCCeEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEE
Confidence            469999999999998765      5789999999743   223345678899999888 699999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCC
Q 013105          161 YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGE  240 (449)
Q Consensus       161 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~  240 (449)
                      |||+++|+|.+++...  ..+++..+..++.|++.||.|||  .+||+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~e~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~  150 (329)
T cd05588          75 IEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLH--ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG  150 (329)
T ss_pred             EeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEECCCCCEEECcCccccccccCC
Confidence            9999999999888654  57999999999999999999999  7889999999999999999999999999987432211


Q ss_pred             CCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCccccccccc--chhhHHhhhhhhccccchhHhhc
Q 013105          241 DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKR--EKDLVEWARPMLKDFTKLDQIID  318 (449)
Q Consensus       241 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  318 (449)
                      .  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  ......+..         ..+..
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~---------~~~~~  219 (329)
T cd05588         151 D--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLF---------QVILE  219 (329)
T ss_pred             C--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHH---------HHHHc
Confidence            1  2234569999999999998899999999999999999999999996432111  000001100         00111


Q ss_pred             ccccccCCHHHHHHHHHHHHHhccCCCCCCCC------HHHHHHH
Q 013105          319 SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT------MTTVVKA  357 (449)
Q Consensus       319 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~eil~~  357 (449)
                      .  ....+..++..+.+++.+||+.||.+||+      +.++++|
T Consensus       220 ~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         220 K--QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             C--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence            1  11223345567899999999999999997      6777766

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.3e-42  Score=344.29  Aligned_cols=254  Identities=22%  Similarity=0.275  Sum_probs=199.7

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ++|++.+.||+|+||.||+|....      +++.||+|++...   .......+.+|+.+|+.++|+||+++++.+.+++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~   74 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVD------TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD   74 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECC------CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence            368999999999999999997765      5889999998632   1223456788999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      .+|+||||+++|+|.+++...  ..+++.....++.|++.||.|||  .+||+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~  150 (376)
T cd05598          75 NLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVH--KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (376)
T ss_pred             EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence            999999999999999998764  56888888999999999999999  77899999999999999999999999999753


Q ss_pred             CCCCCC-----------------------------------------CceeeecCCCCccccccccccCCCCcccchhhh
Q 013105          236 GPQGED-----------------------------------------SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSF  274 (449)
Q Consensus       236 ~~~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  274 (449)
                      ......                                         .......+||+.|+|||++.+..++.++|||||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  230 (376)
T cd05598         151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  230 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeec
Confidence            210000                                         000123569999999999998899999999999


Q ss_pred             HHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCC---CH
Q 013105          275 GVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRP---TM  351 (449)
Q Consensus       275 G~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~  351 (449)
                      ||++|||++|+.||...........+      . .+.       ..........++..+.+++.+|+ .+|.+|+   ++
T Consensus       231 Gvilyell~G~~Pf~~~~~~~~~~~i------~-~~~-------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~  295 (376)
T cd05598         231 GVILYEMLVGQPPFLADTPAETQLKV------I-NWE-------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGA  295 (376)
T ss_pred             cceeeehhhCCCCCCCCCHHHHHHHH------h-ccC-------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCH
Confidence            99999999999999865322111100      0 000       00000111234556788888876 5999999   89


Q ss_pred             HHHHHH
Q 013105          352 TTVVKA  357 (449)
Q Consensus       352 ~eil~~  357 (449)
                      .++++|
T Consensus       296 ~ell~h  301 (376)
T cd05598         296 DEIKAH  301 (376)
T ss_pred             HHHhCC
Confidence            999987

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.3e-42  Score=343.32  Aligned_cols=253  Identities=23%  Similarity=0.288  Sum_probs=198.0

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      .|.+.+.||+|+||.||+|....      +++.||+|++....   ......+.+|+.+++.++||||+++++.+.+++.
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~   75 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVD------TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN   75 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECC------CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCE
Confidence            58889999999999999997765      57899999986432   2334567889999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .|+||||+++|+|.+++.+.  ..+++.....++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||++...
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH--~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~  151 (382)
T cd05625          76 LYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVH--KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (382)
T ss_pred             EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence            99999999999999998664  56888889999999999999999  778999999999999999999999999997532


Q ss_pred             CCCCC---------------------------------------------CceeeecCCCCccccccccccCCCCcccch
Q 013105          237 PQGED---------------------------------------------SHITTCVMGTEGYAAPEYINTGHLTTMCDV  271 (449)
Q Consensus       237 ~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv  271 (449)
                      .....                                             .......+||+.|+|||++.+..++.++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di  231 (382)
T cd05625         152 RWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW  231 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeE
Confidence            11000                                             000123469999999999998899999999


Q ss_pred             hhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCC-
Q 013105          272 FSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT-  350 (449)
Q Consensus       272 wslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-  350 (449)
                      |||||+||||++|++||...........+      ...        ............++++.+++.+|+ .+|.+|++ 
T Consensus       232 wSlGvil~elltG~~Pf~~~~~~~~~~~i------~~~--------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~  296 (382)
T cd05625         232 WSVGVILYEMLVGQPPFLAQTPLETQMKV------INW--------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGK  296 (382)
T ss_pred             EechHHHHHHHhCCCCCCCCCHHHHHHHH------Hcc--------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCC
Confidence            99999999999999999764322111000      000        000000111234556788888876 59999987 


Q ss_pred             --HHHHHHH
Q 013105          351 --MTTVVKA  357 (449)
Q Consensus       351 --~~eil~~  357 (449)
                        +.+++.|
T Consensus       297 ~~~~ei~~h  305 (382)
T cd05625         297 NGADEIKAH  305 (382)
T ss_pred             CCHHHHhcC
Confidence              8888876

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.2e-42  Score=341.50  Aligned_cols=253  Identities=22%  Similarity=0.272  Sum_probs=202.1

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      ..++|++.+.||+|+||.||+|....      ++..||+|++...   .......+.+|+.+++.++||||+++++++.+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~  114 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKS------SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD  114 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECC------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            34679999999999999999997765      5789999999632   22333457789999999999999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      ++..|+||||+.||+|.+++..   ..+++.....++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDLkp~NILl~~~~~~kL~DfG~~  189 (370)
T cd05596         115 DKYLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIH--SMGFIHRDVKPDNMLLDKSGHLKLADFGTC  189 (370)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEEcCCCCEEEEeccce
Confidence            9999999999999999998864   35788888999999999999999  778999999999999999999999999999


Q ss_pred             cCCCCCCCCceeeecCCCCccccccccccC----CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcc
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINTG----HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKD  309 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  309 (449)
                      ........ .......||+.|+|||++.+.    .++.++|||||||++|||++|..||.........            
T Consensus       190 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------------  256 (370)
T cd05596         190 MKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------------  256 (370)
T ss_pred             eeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH------------
Confidence            76433211 112335699999999998643    4789999999999999999999999864321110            


Q ss_pred             ccchhHhhcccccccCC--HHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 013105          310 FTKLDQIIDSRLEDRYS--TEGAKRLAAVAHQCLSHNPKS--RPTMTTVVKA  357 (449)
Q Consensus       310 ~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~  357 (449)
                          ..+........++  ...+..+.+++..||+.+|.+  |+++.+++.|
T Consensus       257 ----~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         257 ----SKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             ----HHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence                1111110001111  134567899999999999988  9999999988

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.9e-42  Score=333.73  Aligned_cols=243  Identities=26%  Similarity=0.396  Sum_probs=193.9

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcC-CCCCcceeeeEEEeCCEEEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCEDEHRLLV  160 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv  160 (449)
                      +.||+|+||.||+|.+..      +++.||+|+++..   .......+..|..++..+ +||||+++++++..++..|+|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv   74 (316)
T cd05592           1 KVLGKGSFGKVMLAELKG------TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFV   74 (316)
T ss_pred             CeeeeCCCeEEEEEEECC------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEE
Confidence            369999999999998765      5789999999743   223344556677777654 899999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCC
Q 013105          161 YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGE  240 (449)
Q Consensus       161 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~  240 (449)
                      |||+.||+|.+++...  ..+++.....++.|++.||.|||  +++|+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~e~~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH--~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  150 (316)
T cd05592          75 MEYLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLH--KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE  150 (316)
T ss_pred             EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC
Confidence            9999999999888654  56889999999999999999999  7889999999999999999999999999997543222


Q ss_pred             CCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhccc
Q 013105          241 DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSR  320 (449)
Q Consensus       241 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (449)
                        .......||+.|+|||++.+..++.++|||||||++|||++|..||.+......   ..   ..          ..  
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~---~~---~i----------~~--  210 (316)
T cd05592         151 --GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL---FD---SI----------LN--  210 (316)
T ss_pred             --CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH---HH---HH----------Hc--
Confidence              123345699999999999988899999999999999999999999976432111   10   00          00  


Q ss_pred             ccccCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHHHH
Q 013105          321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMT-TVVKA  357 (449)
Q Consensus       321 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil~~  357 (449)
                      ....++..++.++.+++.+||+.||.+||++. +++++
T Consensus       211 ~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05592         211 DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH  248 (316)
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence            01123344566789999999999999999875 55554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3e-42  Score=334.41  Aligned_cols=243  Identities=28%  Similarity=0.402  Sum_probs=196.6

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcC-CCCCcceeeeEEEeCCEEEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCEDEHRLLV  160 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv  160 (449)
                      +.||+|+||.||+|.+..      +++.||+|++...   .......+..|..++..+ +||||+++++++.+++..|+|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv   74 (321)
T cd05591           1 KVLGKGSFGKVMLAELKG------TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFV   74 (321)
T ss_pred             CccccCCCeEEEEEEECC------CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEE
Confidence            469999999999998765      5789999998743   223345677888888866 799999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCC
Q 013105          161 YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGE  240 (449)
Q Consensus       161 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~  240 (449)
                      |||+++|+|..++...  ..+++.....++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~  150 (321)
T cd05591          75 MEYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLH--RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG  150 (321)
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEEeecccceecccCC
Confidence            9999999999888654  56888999999999999999999  7789999999999999999999999999987543222


Q ss_pred             CCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhccc
Q 013105          241 DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSR  320 (449)
Q Consensus       241 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (449)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........   ..   .          +... 
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~---~~---~----------i~~~-  211 (321)
T cd05591         151 V--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL---FE---S----------ILHD-  211 (321)
T ss_pred             c--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH---HH---H----------HHcC-
Confidence            1  12345699999999999988999999999999999999999999976532111   11   0          0010 


Q ss_pred             ccccCCHHHHHHHHHHHHHhccCCCCCCC-------CHHHHHHH
Q 013105          321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRP-------TMTTVVKA  357 (449)
Q Consensus       321 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-------s~~eil~~  357 (449)
                       ...++..++.++.+++.+||+.||++||       ++.++++|
T Consensus       212 -~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         212 -DVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             -CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence             0112223456789999999999999999       78888876

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.1e-42  Score=334.09  Aligned_cols=243  Identities=28%  Similarity=0.404  Sum_probs=196.4

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcC-CCCCcceeeeEEEeCCEEEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCEDEHRLLV  160 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv  160 (449)
                      +.||+|+||.||+|.+..      +++.||+|++...   .......+..|..++..+ +||||+++++++...+.+|+|
T Consensus         1 ~~lg~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv   74 (320)
T cd05590           1 RVLGKGSFGKVMLARLKE------SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFV   74 (320)
T ss_pred             CeeeeCCCeEEEEEEEcC------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEE
Confidence            469999999999998765      5789999998642   233455677888888876 699999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCC
Q 013105          161 YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGE  240 (449)
Q Consensus       161 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~  240 (449)
                      |||+.+|+|.+++...  ..+++..+..++.|++.||.|||  +++|+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~Ey~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH--~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~  150 (320)
T cd05590          75 MEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG  150 (320)
T ss_pred             EcCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC
Confidence            9999999999888664  56889999999999999999999  7889999999999999999999999999987533221


Q ss_pred             CCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhccc
Q 013105          241 DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSR  320 (449)
Q Consensus       241 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (449)
                        .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........   .   ...          .. 
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~---~---~i~----------~~-  211 (320)
T cd05590         151 --KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF---E---AIL----------ND-  211 (320)
T ss_pred             --CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH---H---HHh----------cC-
Confidence              1233456999999999999888999999999999999999999999764321111   1   000          10 


Q ss_pred             ccccCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 013105          321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM------TTVVKA  357 (449)
Q Consensus       321 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~eil~~  357 (449)
                       ...++...+.++.+++.+||+.||++||++      .+++.|
T Consensus       212 -~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         212 -EVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             -CCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence             011223345678999999999999999998      667665

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=8.5e-42  Score=326.41  Aligned_cols=264  Identities=30%  Similarity=0.415  Sum_probs=207.4

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      +|++.+.||+|+||.||+|..... ........+++|.+..... .....+.+|+.+++.++||||+++++.+...+..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~-~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRL-KGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecC-CCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            478889999999999999987532 1122346799998864432 33467889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCc
Q 013105          159 LVYEYMALGNLHDQLFKNY----------------------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASN  216 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~N  216 (449)
                      ++|||+.+|+|.+++....                      ...+++...+.++.|++.||.|||  +.+|+||||||+|
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~ivH~dikp~n  157 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA--EMKLVHRDLAARN  157 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH--HCCeehhhhhhhe
Confidence            9999999999999875421                      135788899999999999999999  7789999999999


Q ss_pred             eEEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCccccccccc
Q 013105          217 ILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKR  295 (449)
Q Consensus       217 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~  295 (449)
                      ||++.++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.+.....
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999985533222111222345778999999988889999999999999999998 999997543211


Q ss_pred             chhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          296 EKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                         +...              +........+..++.++.+++..||+.+|++||++.++++.|+.++.
T Consensus       238 ---~~~~--------------~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         238 ---LFNL--------------LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             ---HHHH--------------HhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence               1111              11111112233455679999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=6.1e-42  Score=340.37  Aligned_cols=269  Identities=25%  Similarity=0.406  Sum_probs=209.1

Q ss_pred             HHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCC-CCCcceeeeEEE
Q 013105           75 QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLK-HPHLVNLIGYCC  152 (449)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~  152 (449)
                      +...++|.+.+.||+|+||.||+|.+... .....+..||+|+++.... .....+.+|+.+|..+. ||||+++++++.
T Consensus        33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~-~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          33 EMPRDNLVLGRTLGSGAFGRVVEATAHGL-SHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             eecHHHeehhhhccCCCceeEEEEEEcCC-CCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            33445688889999999999999987642 2233567899999975432 23456889999999997 999999999999


Q ss_pred             eCCEEEEEEEecCCCChHHHHhhcCC------------------------------------------------------
Q 013105          153 EDEHRLLVYEYMALGNLHDQLFKNYS------------------------------------------------------  178 (449)
Q Consensus       153 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------  178 (449)
                      ..+..++||||+.+|+|.+++.+...                                                      
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            99999999999999999999865321                                                      


Q ss_pred             ------------------------------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCc
Q 013105          179 ------------------------------------------STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASN  216 (449)
Q Consensus       179 ------------------------------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~N  216 (449)
                                                                ..+++...+.++.|++.||.|||  .++|+||||||+|
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrdlkp~N  269 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA--SKNCVHRDLAARN  269 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh--cCCcCcccCCcce
Confidence                                                      23566778889999999999999  7889999999999


Q ss_pred             eEEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCccccccccc
Q 013105          217 ILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKR  295 (449)
Q Consensus       217 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~  295 (449)
                      ||++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            9999999999999999985432221111223357889999999988889999999999999999998 888986532111


Q ss_pred             chhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccc
Q 013105          296 EKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL  362 (449)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  362 (449)
                      .  ..              ..+........+..++.++.+|+.+||+.+|.+||++.+|++.|+.++
T Consensus       350 ~--~~--------------~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         350 Q--FY--------------NAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             H--HH--------------HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            0  00              001111111223345667999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=7e-42  Score=332.85  Aligned_cols=250  Identities=25%  Similarity=0.393  Sum_probs=196.5

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcC-CCCCcceeeeEEEeCCEEEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCEDEHRLLV  160 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv  160 (449)
                      +.||+|+||.||+|.+..      +++.||+|++...   .......+.+|+.++.++ +||||+++++++...+..|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   74 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKK------TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   74 (329)
T ss_pred             CeeeeCCCeEEEEEEECC------CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEE
Confidence            469999999999998765      5789999999743   223345677888888776 799999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCC
Q 013105          161 YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGE  240 (449)
Q Consensus       161 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~  240 (449)
                      |||+.+|+|..++...  ..+++.....++.|++.||.|||  .++|+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~E~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~  150 (329)
T cd05618          75 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  150 (329)
T ss_pred             EeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC
Confidence            9999999998888654  57899999999999999999999  7789999999999999999999999999987532221


Q ss_pred             CCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccch--hhHHhhhhhhccccchhHhhc
Q 013105          241 DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREK--DLVEWARPMLKDFTKLDQIID  318 (449)
Q Consensus       241 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  318 (449)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|..||.........  ....+...         .+..
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~---------~i~~  219 (329)
T cd05618         151 D--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ---------VILE  219 (329)
T ss_pred             C--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHH---------HHhc
Confidence            1  123456999999999999889999999999999999999999999632111100  00000000         0011


Q ss_pred             ccccccCCHHHHHHHHHHHHHhccCCCCCCCC------HHHHHHH
Q 013105          319 SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT------MTTVVKA  357 (449)
Q Consensus       319 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~eil~~  357 (449)
                      .  ...++...+..+.+++.+||+.||++||+      +.++++|
T Consensus       220 ~--~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         220 K--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             C--CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            1  11234445667899999999999999998      4677765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-42  Score=326.73  Aligned_cols=255  Identities=34%  Similarity=0.550  Sum_probs=198.8

Q ss_pred             CcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEE
Q 013105           83 RSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVY  161 (449)
Q Consensus        83 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  161 (449)
                      +.+.||.|.||.||+|.+..  .....+..|+||++..... .....+.+|++.+++++||||+++++++...+..++||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~--~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQ--KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEES--TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEc--ccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccc
Confidence            45789999999999999983  2344678999999965433 34678999999999999999999999999888899999


Q ss_pred             EecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCC
Q 013105          162 EYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGED  241 (449)
Q Consensus       162 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~  241 (449)
                      ||+.+|+|.+++.......+++..+..++.|++.||.|||  +++++|+||+++|||++.++.+||+|||++........
T Consensus        81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh--~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH--SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH--HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccc
Confidence            9999999999998875678999999999999999999999  66799999999999999999999999999986632222


Q ss_pred             CceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHhhccc
Q 013105          242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSR  320 (449)
Q Consensus       242 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (449)
                      ........+...|+|||.+.+..++.++||||||+++|||++ |+.||.......   ....             + ...
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~~~~-------------~-~~~  221 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---IIEK-------------L-KQG  221 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---HHHH-------------H-HTT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccc-------------c-ccc
Confidence            222222346778999999988889999999999999999999 778886542111   1111             1 111


Q ss_pred             ccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 013105          321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL  358 (449)
Q Consensus       321 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  358 (449)
                      .....+..++..+.+++..||+.||++|||+.+|++.|
T Consensus       222 ~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  222 QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            11223344566799999999999999999999999875

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.3e-42  Score=340.05  Aligned_cols=254  Identities=22%  Similarity=0.292  Sum_probs=201.1

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEE
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCC  152 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~  152 (449)
                      ...++|++.+.||+|+||.||+|.+..      +++.||+|++...   .......+.+|+.+++.++||||+++++++.
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~  113 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKS------SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ  113 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECC------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            345789999999999999999998765      5789999998632   2223455778999999999999999999999


Q ss_pred             eCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecc
Q 013105          153 EDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL  232 (449)
Q Consensus       153 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGl  232 (449)
                      +++..|+||||+.||+|.+++...   .+++.....++.|++.||.|||  +++|+||||||+|||++.++.+||+|||+
T Consensus       114 ~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH--~~~IvHrDLKp~NILl~~~~~~kL~DFG~  188 (370)
T cd05621         114 DDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIH--SMGLIHRDVKPDNMLLDKHGHLKLADFGT  188 (370)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHEEECCCCCEEEEeccc
Confidence            999999999999999999988643   5788899999999999999999  77899999999999999999999999999


Q ss_pred             ccCCCCCCCCceeeecCCCCccccccccccC----CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhc
Q 013105          233 ATDGPQGEDSHITTCVMGTEGYAAPEYINTG----HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK  308 (449)
Q Consensus       233 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  308 (449)
                      +........ .......||+.|+|||++.+.    .++.++|||||||++|||++|..||.........           
T Consensus       189 a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~-----------  256 (370)
T cd05621         189 CMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY-----------  256 (370)
T ss_pred             ceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH-----------
Confidence            986533221 112345699999999998653    3788999999999999999999999764321110           


Q ss_pred             cccchhHhhcccccccCC--HHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 013105          309 DFTKLDQIIDSRLEDRYS--TEGAKRLAAVAHQCLSHNPKS--RPTMTTVVKA  357 (449)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~  357 (449)
                           ..+........++  ...+..+.+++..||..++.+  |+++.++++|
T Consensus       257 -----~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         257 -----SKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             -----HHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                 1111111011111  234567889999999865544  8999999997

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.1e-41  Score=324.09  Aligned_cols=262  Identities=26%  Similarity=0.373  Sum_probs=207.1

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      ..+|.+.+.||+|+||.||++..... .....+..+|+|.+..........+.+|+++++.++|+||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~-~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNL-LPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL   82 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecC-CCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence            35688899999999999999965431 22334678999998765555567889999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCC-------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCc
Q 013105          158 LLVYEYMALGNLHDQLFKNYS-------------STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYN  224 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~-------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~  224 (449)
                      +++|||+.+++|.+++.....             ..+++..+..++.|++.||+|||  +.|++||||||+|||++.++.
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA--SLHFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH--HCCeecccccHhhEEEcCCCC
Confidence            999999999999999865421             35788999999999999999999  788999999999999999999


Q ss_pred             EEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhh
Q 013105          225 AKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWA  303 (449)
Q Consensus       225 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~  303 (449)
                      ++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |.+||............   
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~---  237 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI---  237 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH---
Confidence            99999999875433221111122335678999999988889999999999999999998 99998653221111100   


Q ss_pred             hhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 013105          304 RPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE  359 (449)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  359 (449)
                                    ........+..++..+.+++.+||+.||.+||++.+|++.|+
T Consensus       238 --------------~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         238 --------------TQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             --------------HcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                          010111122345567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.2e-42  Score=332.58  Aligned_cols=243  Identities=27%  Similarity=0.397  Sum_probs=194.7

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcC-CCCCcceeeeEEEeCCEEEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQL-KHPHLVNLIGYCCEDEHRLLV  160 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv  160 (449)
                      +.||+|+||.||+|.+..      ++..||+|+++...   ......+..|..++..+ +||||+++++++.+++..|+|
T Consensus         1 ~~lg~G~~g~V~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   74 (316)
T cd05620           1 KVLGKGSFGKVLLAELKG------KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFV   74 (316)
T ss_pred             CeeeeCCCeEEEEEEECC------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEE
Confidence            469999999999998765      57899999997431   23345567788888754 899999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCC
Q 013105          161 YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGE  240 (449)
Q Consensus       161 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~  240 (449)
                      |||+.+|+|.+++...  ..+++.....++.|++.||+|||  ++||+||||||+|||++.++.++|+|||++.......
T Consensus        75 ~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  150 (316)
T cd05620          75 MEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLH--SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD  150 (316)
T ss_pred             ECCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC
Confidence            9999999999988664  56888999999999999999999  7789999999999999999999999999987532222


Q ss_pred             CCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhccc
Q 013105          241 DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSR  320 (449)
Q Consensus       241 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (449)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|..||.......   ......             .. 
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~~~~~~-------------~~-  211 (316)
T cd05620         151 N--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---LFESIR-------------VD-  211 (316)
T ss_pred             C--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHH-------------hC-
Confidence            1  2334569999999999998899999999999999999999999997643211   111100             00 


Q ss_pred             ccccCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHHHH
Q 013105          321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMT-TVVKA  357 (449)
Q Consensus       321 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil~~  357 (449)
                       ...++..++.++.+++.+||+.||++||++. ++++|
T Consensus       212 -~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h  248 (316)
T cd05620         212 -TPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGH  248 (316)
T ss_pred             -CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence             1112233456789999999999999999984 66655

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=5.9e-42  Score=327.85  Aligned_cols=268  Identities=29%  Similarity=0.393  Sum_probs=210.5

Q ss_pred             HHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcC-CCCCcceeeeEEE
Q 013105           75 QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQL-KHPHLVNLIGYCC  152 (449)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~  152 (449)
                      ....++|++.+.||+|+||.||+|...... .......+|+|.+.... ......+.+|+.++..+ +|+||+++++++.
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~-~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLD-NPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCC-CCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            344567889999999999999999876421 12345689999987542 23345688999999999 7999999999999


Q ss_pred             eCCEEEEEEEecCCCChHHHHhhc--------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceE
Q 013105          153 EDEHRLLVYEYMALGNLHDQLFKN--------------YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNIL  218 (449)
Q Consensus       153 ~~~~~~lv~e~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nil  218 (449)
                      .++..+++|||+.+|+|.+++...              ....+++..++.++.|++.||.|||  +++|+||||||+|||
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~ivH~dlkp~Nil  164 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA--SKKCIHRDLAARNVL  164 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--HCCccccccceeeEE
Confidence            999999999999999999998642              2356889999999999999999999  788999999999999


Q ss_pred             EcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccch
Q 013105          219 LDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREK  297 (449)
Q Consensus       219 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~  297 (449)
                      ++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.........
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  244 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF  244 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence            99999999999999986543322111222335678999999988889999999999999999997 99998754221111


Q ss_pred             hhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccc
Q 013105          298 DLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL  362 (449)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  362 (449)
                      .                 .+........+..++..+.+|+.+||..||++|||+.++++.|+.+.
T Consensus       245 ~-----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         245 K-----------------LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             H-----------------HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            1                 01111111223344567999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.3e-41  Score=318.14  Aligned_cols=249  Identities=26%  Similarity=0.414  Sum_probs=198.1

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEEEe
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEY  163 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  163 (449)
                      +.||+|+||.||+|.+..      +++.||+|.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   74 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRA------DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL   74 (252)
T ss_pred             CccCcccCccEEEEEEec------CCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEee
Confidence            469999999999998865      47889999886432 23346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCCc
Q 013105          164 MALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSH  243 (449)
Q Consensus       164 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~~  243 (449)
                      +.+++|.+++... ...+++..++.++.|++.||.|||  +++|+|+||||+|||++.++.+||+|||++..........
T Consensus        75 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  151 (252)
T cd05084          75 VQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLE--SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS  151 (252)
T ss_pred             ccCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH--hCCccccccchheEEEcCCCcEEECccccCcccccccccc
Confidence            9999999988654 346889999999999999999999  7889999999999999999999999999987543221111


Q ss_pred             eeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHhhccccc
Q 013105          244 ITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLE  322 (449)
Q Consensus       244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (449)
                      ......++..|+|||.+.+..++.++|||||||++|||++ |..||...........                 +.....
T Consensus       152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~-----------------~~~~~~  214 (252)
T cd05084         152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA-----------------IEQGVR  214 (252)
T ss_pred             cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHH-----------------HHcCCC
Confidence            1111123457999999988889999999999999999998 8888865322111110                 011111


Q ss_pred             ccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 013105          323 DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE  359 (449)
Q Consensus       323 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  359 (449)
                      ...+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus       215 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            1223345667999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.9e-42  Score=333.21  Aligned_cols=248  Identities=27%  Similarity=0.362  Sum_probs=199.4

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcC-CCCCcceeeeEEEeCC
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQL-KHPHLVNLIGYCCEDE  155 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~  155 (449)
                      +|.+.+.||+|+||.||+|....      +++.||+|++....   ......+..|..++..+ +|++|+.+++++.+.+
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKG------TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD   74 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC
Confidence            58889999999999999997765      57899999997432   22334566788888777 5899999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..|+||||+.+|+|.+++...  ..+++..+..++.|++.||.|||  +.||+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~  150 (323)
T cd05616          75 RLYFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             EEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCEEecCCCHHHeEECCCCcEEEccCCCcee
Confidence            999999999999999888664  56889999999999999999999  77899999999999999999999999999875


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      .....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+......   ...             
T Consensus       151 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~---~~~-------------  212 (323)
T cd05616         151 NMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---FQS-------------  212 (323)
T ss_pred             cCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH---HHH-------------
Confidence            43221  123345699999999999988999999999999999999999999976432111   110             


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM-----TTVVKA  357 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~eil~~  357 (449)
                      +...  ...++...+.++.+++.+||+.||.+|+++     .++++|
T Consensus       213 i~~~--~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         213 IMEH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             HHhC--CCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence            0111  112234456678999999999999999985     566554

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-42  Score=361.51  Aligned_cols=267  Identities=28%  Similarity=0.448  Sum_probs=216.9

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC-CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      .+-...+.||+|.||.||.|...+. ........||||.+... +.+...+|++|..+|+.++|||||+++|++.+....
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~-~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDV-PGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecC-CCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            4456678899999999999998764 11122456999998754 455667899999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhc-----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecc
Q 013105          158 LLVYEYMALGNLHDQLFKN-----YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL  232 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~-----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGl  232 (449)
                      +|++|||+||+|..+|.+.     ....+.....+.++.+||+|+.||+  ++++|||||..+|+||+....+||+|||+
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe--~~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE--SKHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH--hCCCcCcchhhhheeecccCcEEEcccch
Confidence            9999999999999999764     2467889999999999999999999  78899999999999999999999999999


Q ss_pred             ccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhcccc
Q 013105          233 ATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFT  311 (449)
Q Consensus       233 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  311 (449)
                      |++....+.......-+-...|||||.+..+.++.++|||||||+|||++| |..||...+..+...             
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~-------------  915 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL-------------  915 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH-------------
Confidence            995544333222222223468999999999999999999999999999999 888887653222111             


Q ss_pred             chhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCC
Q 013105          312 KLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN  365 (449)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  365 (449)
                         ...... +-+.+..||+.+.+||..||+.+|++||++..|++.+..+.+..
T Consensus       916 ---~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  916 ---DVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             ---HHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence               111111 33456778889999999999999999999999999888776543

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=7.8e-42  Score=330.64  Aligned_cols=243  Identities=27%  Similarity=0.393  Sum_probs=194.4

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhc-CCCCCcceeeeEEEeCCEEEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQ-LKHPHLVNLIGYCCEDEHRLLV  160 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~-l~h~nIv~~~~~~~~~~~~~lv  160 (449)
                      +.||+|+||.||+|.+..      +++.||+|+++..   .......+..|..++.. ++||||+++++++.+.+..++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   74 (316)
T cd05619           1 KMLGKGSFGKVFLAELKG------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFV   74 (316)
T ss_pred             CeeeeCCCEEEEEEEECC------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEE
Confidence            469999999999998765      4789999999743   12334556678888876 4899999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCC
Q 013105          161 YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGE  240 (449)
Q Consensus       161 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~  240 (449)
                      |||+++|+|.+++...  ..+++.....++.|++.||.|||  +++|+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~ey~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH--~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  150 (316)
T cd05619          75 MEYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLH--SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD  150 (316)
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC
Confidence            9999999999988654  56888899999999999999999  7789999999999999999999999999987533222


Q ss_pred             CCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhccc
Q 013105          241 DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSR  320 (449)
Q Consensus       241 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (449)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|..||.......   ......             .. 
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~i~-------------~~-  211 (316)
T cd05619         151 A--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQSIR-------------MD-  211 (316)
T ss_pred             C--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHHHHH-------------hC-
Confidence            1  1334569999999999998889999999999999999999999997643211   111000             00 


Q ss_pred             ccccCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHHHH
Q 013105          321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMT-TVVKA  357 (449)
Q Consensus       321 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil~~  357 (449)
                       ...++...+.++.+++.+||+.||++||++. ++++|
T Consensus       212 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05619         212 -NPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQH  248 (316)
T ss_pred             -CCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence             0112233456689999999999999999997 66554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-41  Score=318.44  Aligned_cols=253  Identities=26%  Similarity=0.346  Sum_probs=204.9

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-----chHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-----QGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      ++|.+.+.||+|++|.||+|....      ++..||+|.+.....     .....+.+|+.++++++||||+++++++.+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~------~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   75 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVD------TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD   75 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcC------CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc
Confidence            578999999999999999997654      478999999864321     123567889999999999999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      ++..++||||+++++|.+++...  ..++......++.|++.||.|||  +.+|+|+||+|+||+++.++.++|+|||++
T Consensus        76 ~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nilv~~~~~~~l~dfg~~  151 (263)
T cd06625          76 DETLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLH--SNMIVHRDIKGANILRDSAGNVKLGDFGAS  151 (263)
T ss_pred             CCeEEEEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence            99999999999999999988764  56888999999999999999999  788999999999999999999999999998


Q ss_pred             cCCCCCCCCc-eeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccc
Q 013105          234 TDGPQGEDSH-ITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK  312 (449)
Q Consensus       234 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  312 (449)
                      .......... ......|+..|+|||++.+..++.++|||||||++|||++|+.||.........               
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---------------  216 (263)
T cd06625         152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI---------------  216 (263)
T ss_pred             eeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH---------------
Confidence            7543221111 012345788999999999888999999999999999999999999753211100               


Q ss_pred             hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       ............+..++..+.+++.+||..+|.+|||+.+++++
T Consensus       217 -~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         217 -FKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             -HHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence             00111111222344566679999999999999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.8e-42  Score=337.37  Aligned_cols=254  Identities=20%  Similarity=0.255  Sum_probs=202.3

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ++|.+.+.||+|+||.||+|....      +++.||+|+++...   ......+.+|+.+++.++|+||+++++++.+.+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~   74 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKA------TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD   74 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC
Confidence            468999999999999999997765      57899999997432   223456788999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..++||||+++|+|.+++... ...+++.....++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH--~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~  151 (330)
T cd05601          75 NLYLVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVH--QMGYVHRDIKPENVLIDRTGHIKLADFGSAAR  151 (330)
T ss_pred             eEEEEECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH--HCCeEcccCchHheEECCCCCEEeccCCCCeE
Confidence            999999999999999998664 357899999999999999999999  77899999999999999999999999999986


Q ss_pred             CCCCCCCceeeecCCCCccccccccc------cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcc
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYIN------TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKD  309 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  309 (449)
                      ....... ......||+.|+|||++.      ...++.++|||||||++|||++|..||..........      .....
T Consensus       152 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~------~i~~~  224 (330)
T cd05601         152 LTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN------NIMNF  224 (330)
T ss_pred             CCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHH------HHHcC
Confidence            5432221 223346999999999986      4567899999999999999999999997643211110      00000


Q ss_pred             ccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          310 FTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                              .....-......+..+.+|+..||+ +|.+|||+.+++.|
T Consensus       225 --------~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         225 --------QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             --------CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence                    0000000112345668999999998 99999999999986

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-41  Score=319.98  Aligned_cols=259  Identities=25%  Similarity=0.427  Sum_probs=203.5

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE--
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH--  156 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~--  156 (449)
                      |.+.+.||+|+||.||+|....+   ...+..||+|++....  ......+.+|+.+++.++||||+++++++.....  
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   77 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQD---DGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ   77 (273)
T ss_pred             CccccccCcCCCceEEEEEEecC---CCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence            56788999999999999987642   1235789999987543  2334578899999999999999999998866554  


Q ss_pred             ----EEEEEEecCCCChHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEe
Q 013105          157 ----RLLVYEYMALGNLHDQLFKN----YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLS  228 (449)
Q Consensus       157 ----~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~  228 (449)
                          .+++|||+.+|+|..++...    ....+++.....++.|++.||.|||  +.+|+||||||+||++++++.+||+
T Consensus        78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~  155 (273)
T cd05035          78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS--NRNFIHRDLAARNCMLREDMTVCVA  155 (273)
T ss_pred             cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH--hCCeeccccchheEEECCCCeEEEC
Confidence                79999999999999888543    2246889999999999999999999  7789999999999999999999999


Q ss_pred             eeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhh
Q 013105          229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPML  307 (449)
Q Consensus       229 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  307 (449)
                      |||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......   ......    
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~----  228 (273)
T cd05035         156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYL----  228 (273)
T ss_pred             CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----
Confidence            9999986543322111222335678999999988889999999999999999999 88998654321   111111    


Q ss_pred             ccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcc
Q 013105          308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL  361 (449)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  361 (449)
                                ........+..++..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       229 ----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         229 ----------RHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             ----------HcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                      01111122344566799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.2e-41  Score=323.67  Aligned_cols=247  Identities=25%  Similarity=0.371  Sum_probs=197.3

Q ss_pred             ccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEEEe
Q 013105           87 LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEY  163 (449)
Q Consensus        87 lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  163 (449)
                      ||+|+||+||++.+..      +++.||+|.+....   ......+..|+.+++.++|+||+++.+++..+...++||||
T Consensus         1 lg~G~~g~Vy~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   74 (280)
T cd05608           1 LGKGGFGEVSACQMRA------TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTI   74 (280)
T ss_pred             CCCCCceeEEEEEEcc------CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeC
Confidence            7999999999997765      57899999986432   22335677899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCC
Q 013105          164 MALGNLHDQLFKN--YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGED  241 (449)
Q Consensus       164 ~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~  241 (449)
                      +++|+|.+++...  ....+++..+..++.|++.||.|||  +++|+||||||+||+++.++.++|+|||++........
T Consensus        75 ~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  152 (280)
T cd05608          75 MNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH--QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS  152 (280)
T ss_pred             CCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc
Confidence            9999998887542  3356899999999999999999999  77899999999999999999999999999976543222


Q ss_pred             CceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccc
Q 013105          242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRL  321 (449)
Q Consensus       242 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (449)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........  ...          .....  
T Consensus       153 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~--~~~----------~~~~~--  216 (280)
T cd05608         153 --KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE--LKQ----------RILND--  216 (280)
T ss_pred             --cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHH--HHH----------hhccc--
Confidence              12335689999999999988999999999999999999999999975422111000  000          00010  


Q ss_pred             cccCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013105          322 EDRYSTEGAKRLAAVAHQCLSHNPKSRP-----TMTTVVKA  357 (449)
Q Consensus       322 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  357 (449)
                      ...++..++..+.+++.+||+.||++||     +++++++|
T Consensus       217 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         217 SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            1122344566799999999999999999     77888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.1e-42  Score=323.70  Aligned_cols=263  Identities=27%  Similarity=0.391  Sum_probs=208.3

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ..++|.+.+.||+|+||.||+|.+.... ....+..||+|.+.... ......+.+|+.++..++||||+++++++....
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVV-KGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ   82 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccC-CCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence            3567899999999999999999876521 12345789999986443 233456889999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEE
Q 013105          156 HRLLVYEYMALGNLHDQLFKNY--------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKL  227 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl  227 (449)
                      ..++||||+.+|+|.+++....        ...+++..++.++.|++.||.|||  .++|+||||||+|||++.++.+||
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA--AKKFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccccccChheEEEcCCCCEEE
Confidence            9999999999999999986532        234678889999999999999999  788999999999999999999999


Q ss_pred             eeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhh
Q 013105          228 SDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPM  306 (449)
Q Consensus       228 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~  306 (449)
                      +|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......   .....   
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~---  234 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLKFV---  234 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHHHH---
Confidence            99999875543322222233456789999999988889999999999999999998 999987543211   11111   


Q ss_pred             hccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 013105          307 LKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE  359 (449)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  359 (449)
                                 ........+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus       235 -----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         235 -----------IDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             -----------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence                       011111123334677999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=8e-42  Score=330.97  Aligned_cols=243  Identities=29%  Similarity=0.433  Sum_probs=197.5

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcC-CCCCcceeeeEEEeCCEEEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCEDEHRLLV  160 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv  160 (449)
                      +.||+|+||.||+|.+..      +++.||+|++...   .......+..|..++..+ +||||+++++++.+.+..|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv   74 (318)
T cd05570           1 KVLGKGSFGKVLLAELKG------TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFV   74 (318)
T ss_pred             CeeeeCCCeEEEEEEECC------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEE
Confidence            469999999999998765      5789999999743   233345677888999888 699999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCC
Q 013105          161 YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGE  240 (449)
Q Consensus       161 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~  240 (449)
                      |||+.||+|.+++...  ..+++.....++.|++.||.|||  +++|+||||||+|||++.++.++|+|||++.......
T Consensus        75 ~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  150 (318)
T cd05570          75 MEYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLH--ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG  150 (318)
T ss_pred             EcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC
Confidence            9999999999888654  57899999999999999999999  7789999999999999999999999999987532222


Q ss_pred             CCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhccc
Q 013105          241 DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSR  320 (449)
Q Consensus       241 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (449)
                      .  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ...   .          +... 
T Consensus       151 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~---~~~---~----------i~~~-  211 (318)
T cd05570         151 V--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE---LFQ---S----------ILED-  211 (318)
T ss_pred             C--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH---HHH---H----------HHcC-
Confidence            1  1233468999999999998899999999999999999999999997543111   110   0          0010 


Q ss_pred             ccccCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 013105          321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM-----TTVVKA  357 (449)
Q Consensus       321 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~eil~~  357 (449)
                       ...++..++..+.+|+.+||+.||.+||++     .+++++
T Consensus       212 -~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         212 -EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             -CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence             111233456678999999999999999999     888876

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.8e-41  Score=318.14  Aligned_cols=251  Identities=25%  Similarity=0.394  Sum_probs=200.3

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      ++|++.+.||+|+||.||+|.+..       +..+|+|.+... ......+.+|+.+++.++||||+++++++...+..+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-------~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   75 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-------QIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLY   75 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-------CceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEE
Confidence            457888999999999999997754       457999988633 233467889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCC
Q 013105          159 LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~  238 (449)
                      +||||+++|+|.+++.... ..+++.....++.+++.||.|||  .++|+||||||+||+++.++.++|+|||++.....
T Consensus        76 iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05114          76 IVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLE--RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD  152 (256)
T ss_pred             EEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH--HCCccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence            9999999999999886542 46889999999999999999999  78899999999999999999999999999886433


Q ss_pred             CCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHhh
Q 013105          239 GEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII  317 (449)
Q Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (449)
                      .... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.......   ......   ..        
T Consensus       153 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~~~~i~---~~--------  217 (256)
T cd05114         153 DEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---VVEMIS---RG--------  217 (256)
T ss_pred             Ccee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH---CC--------
Confidence            2211 1112235668999999988889999999999999999999 899997543211   111110   00        


Q ss_pred             cccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 013105          318 DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL  358 (449)
Q Consensus       318 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  358 (449)
                         .....+...+..+.+++.+||+.||++||++.++++.|
T Consensus       218 ---~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         218 ---FRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence               00111222345689999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.5e-41  Score=321.43  Aligned_cols=262  Identities=24%  Similarity=0.325  Sum_probs=203.2

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      ++|++.+.||+|+||.||+|.+..+  .......+++|.+.... .....++..|+.++..+.||||+++++++. ....
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~--~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~   83 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPE--GDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASL   83 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCC--CCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCcc
Confidence            4688889999999999999987642  11112358888875432 223456778888999999999999999875 4567


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++++||+.+|+|.+++... ...+++.....++.|++.||.|||  +++++||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH--~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLE--EHRMVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH--HCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            8999999999999998654 356899999999999999999999  7889999999999999999999999999998654


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI  316 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (449)
                      ............|+..|+|||.+.+..++.++|||||||++|||++ |..||.+.......+..                
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~----------------  224 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL----------------  224 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----------------
Confidence            3322222233456788999999988889999999999999999998 99999764322111111                


Q ss_pred             hcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                       ........+..++.++..++.+||..||++|||+.++++.|..+..
T Consensus       225 -~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         225 -EKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             -HCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence             1111111112234568889999999999999999999999888765

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.3e-41  Score=321.16  Aligned_cols=273  Identities=29%  Similarity=0.420  Sum_probs=206.2

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeC--CEE
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCED--EHR  157 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~  157 (449)
                      |++.+.||+|+||+||++.+..  .....+..||+|++..... .....+.+|+++|+.++||||+++++++...  ...
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDP--ANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL   83 (283)
T ss_pred             ceeceecccCCCcEEEEeeEcc--ccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence            3888999999999999876543  2233577899999975432 3346788999999999999999999987653  468


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+.+++|.+++...   .+++..+..++.|++.||.|||  +++|+||||||+|||++.++.++|+|||++....
T Consensus        84 ~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLH--SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHH--HCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence            9999999999999998653   5899999999999999999999  7789999999999999999999999999998654


Q ss_pred             CCCCCc-eeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHh
Q 013105          238 QGEDSH-ITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI  316 (449)
Q Consensus       238 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (449)
                      ...... ......++..|+|||.+.+..++.++|||||||++|||++|..||....... .+....... ......+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~-~~~~~~~~~~  236 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQG-QMTVVRLIEL  236 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhccccc-ccchhhhhhh
Confidence            322111 1122335677999999988889999999999999999999999986432110 011100000 0000111111


Q ss_pred             hcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccc
Q 013105          317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL  362 (449)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  362 (449)
                      .........+..++..+.+++..||+.||++|||+.++++.|+.+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            2222222234456678999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2e-41  Score=321.70  Aligned_cols=247  Identities=28%  Similarity=0.398  Sum_probs=195.6

Q ss_pred             ccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEEEe
Q 013105           87 LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEY  163 (449)
Q Consensus        87 lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  163 (449)
                      ||+|+||.||++....      +++.||+|.+....   ......+..|+++++.++||||+++++++.++...++||||
T Consensus         1 lg~G~~g~Vy~~~~~~------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~   74 (277)
T cd05607           1 LGKGGFGEVCAVQVKN------TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSL   74 (277)
T ss_pred             CCCCCceEEEEEEEcc------CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEec
Confidence            7999999999997765      58899999986321   12233456799999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCCc
Q 013105          164 MALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSH  243 (449)
Q Consensus       164 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~~  243 (449)
                      +.|++|.+++.......+++..+..++.|++.||.|||  +.||+||||||+|||++.++.++|+|||++.......   
T Consensus        75 ~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---  149 (277)
T cd05607          75 MNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH--SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---  149 (277)
T ss_pred             CCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---
Confidence            99999998887665567889999999999999999999  7889999999999999999999999999987654322   


Q ss_pred             eeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccccc
Q 013105          244 ITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLED  323 (449)
Q Consensus       244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (449)
                      ......|+..|+|||++.+..++.++|||||||++|||++|..||..........  .......          ..... 
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~--~~~~~~~----------~~~~~-  216 (277)
T cd05607         150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE--ELKRRTL----------EDEVK-  216 (277)
T ss_pred             eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH--HHHHHhh----------ccccc-
Confidence            1233568999999999988889999999999999999999999997542211110  0000000          00000 


Q ss_pred             cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          324 RYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       324 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .....++.++.+|+.+||+.||++||++.++++.
T Consensus       217 ~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~  250 (277)
T cd05607         217 FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDD  250 (277)
T ss_pred             cccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence            0112345678999999999999999999776644

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.8e-41  Score=331.92  Aligned_cols=268  Identities=27%  Similarity=0.385  Sum_probs=205.2

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcC-CCCCcceeeeEEEe-C
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQL-KHPHLVNLIGYCCE-D  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~-~  154 (449)
                      .++|++.+.||+|+||.||+|.+... ....+++.||||+++... ......+.+|+.++..+ +||||+++++++.. +
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccC-CccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            46799999999999999999976431 123357889999997543 23345688999999999 68999999998765 4


Q ss_pred             CEEEEEEEecCCCChHHHHhhcC---------------------------------------------------------
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNY---------------------------------------------------------  177 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------  177 (449)
                      ...++||||+.+|+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            56789999999999999986431                                                         


Q ss_pred             --------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCCceeeecC
Q 013105          178 --------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM  249 (449)
Q Consensus       178 --------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  249 (449)
                              ...+++.....++.|++.||.|||  +++|+||||||+|||++.++.+||+|||++................
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                    123677888899999999999999  7889999999999999999999999999998653322211122234


Q ss_pred             CCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHhhcccccccCCHH
Q 013105          250 GTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTE  328 (449)
Q Consensus       250 gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (449)
                      ++..|+|||.+.+..++.++|||||||++|+|++ |..||........  ....              +........+..
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~--------------~~~~~~~~~~~~  306 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRR--------------LKEGTRMRAPDY  306 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HHHH--------------HhccCCCCCCCC
Confidence            5678999999988889999999999999999997 9999865322111  1000              000001111122


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          329 GAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       329 ~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                      .+..+.+++..||+.||++|||+.+|+++|+.+++.
T Consensus       307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            345689999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.7e-41  Score=323.58  Aligned_cols=252  Identities=26%  Similarity=0.397  Sum_probs=203.5

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      |++.+.||+|+||.||+|.+..      +++.||+|.+....   ......+.+|+.+++.++|+||+.+++.+.+.+..
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~   75 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRA------TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDAL   75 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcC------CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEE
Confidence            6778899999999999998765      57899999986432   12234567899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+.|++|.+++.......+++..+..++.|++.||.|||  +.+|+||||||+||+++.++.++|+|||++....
T Consensus        76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~  153 (285)
T cd05630          76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH--QERIVYRDLKPENILLDDHGHIRISDLGLAVHVP  153 (285)
T ss_pred             EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCCCHHHEEECCCCCEEEeeccceeecC
Confidence            99999999999999887655557899999999999999999999  7889999999999999999999999999987543


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII  317 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (449)
                      ....   .....|+..|+|||++.+..++.++|||||||++|+|++|..||.............             ...
T Consensus       154 ~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~-------------~~~  217 (285)
T cd05630         154 EGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE-------------RLV  217 (285)
T ss_pred             CCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH-------------hhh
Confidence            3221   223468999999999988889999999999999999999999997542211110000             000


Q ss_pred             cccccccCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 013105          318 DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT-----MTTVVKA  357 (449)
Q Consensus       318 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~  357 (449)
                      . .....++..++..+.+|+..||+.||++|||     +.++++|
T Consensus       218 ~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         218 K-EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             h-hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence            0 0011223345567899999999999999999     8899987

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.2e-41  Score=330.91  Aligned_cols=250  Identities=25%  Similarity=0.364  Sum_probs=197.7

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcC-CCCCcceeeeEEEeCCEEEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCEDEHRLLV  160 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv  160 (449)
                      +.||+|+||.||+|....      .++.||+|++...   .......+.+|+.++.++ +||||+.+++++.+.+.+|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   74 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKK------NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLV   74 (327)
T ss_pred             CeeeeCCCeEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEE
Confidence            469999999999998765      4789999999743   223345678899999888 699999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCC
Q 013105          161 YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGE  240 (449)
Q Consensus       161 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~  240 (449)
                      |||+++|+|..++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  150 (327)
T cd05617          75 IEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLH--ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG  150 (327)
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC
Confidence            9999999999888654  57899999999999999999999  7789999999999999999999999999987532211


Q ss_pred             CCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhccc
Q 013105          241 DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSR  320 (449)
Q Consensus       241 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (449)
                        .......||+.|+|||++.+..++.++|||||||++|||++|..||.................         .+... 
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~---------~~~~~-  218 (327)
T cd05617         151 --DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ---------VILEK-  218 (327)
T ss_pred             --CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHH---------HHHhC-
Confidence              123345799999999999988999999999999999999999999964322111111111100         00111 


Q ss_pred             ccccCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 013105          321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM------TTVVKA  357 (449)
Q Consensus       321 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~eil~~  357 (449)
                       ...++...+..+.+++.+||+.||++|+++      .++++|
T Consensus       219 -~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         219 -PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             -CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence             112334455678999999999999999984      577665

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.4e-41  Score=318.47  Aligned_cols=256  Identities=28%  Similarity=0.390  Sum_probs=205.5

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      .++|++.+.||+|+||.||+|.+.+       ...||+|++.... .....+.+|+++++.++||||+++++++. .+..
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~-------~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~   75 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNG-------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPI   75 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecC-------CceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCc
Confidence            4679999999999999999997654       2469999997432 23457889999999999999999999875 4568


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+.+|+|.+++.......+++..+..++.+++.||.|||  +.+++|+||||+||+++.++.++|+|||++....
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~  153 (262)
T cd05071          76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIE  153 (262)
T ss_pred             EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH--HCCccccccCcccEEEcCCCcEEeccCCceeecc
Confidence            99999999999999997655566889999999999999999999  7889999999999999999999999999997554


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI  316 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (449)
                      ..... ......++..|+|||++.+..++.++|||||||++|||++ |..||............                
T Consensus       154 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~----------------  216 (262)
T cd05071         154 DNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV----------------  216 (262)
T ss_pred             ccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH----------------
Confidence            32211 1122346778999999988889999999999999999999 88888754321111100                


Q ss_pred             hcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccc
Q 013105          317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL  362 (449)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  362 (449)
                       ........+..++..+.+++.+||+.||++||++.++++.|+.++
T Consensus       217 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         217 -ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             -hcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence             001111223456677999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.9e-41  Score=316.30  Aligned_cols=251  Identities=26%  Similarity=0.396  Sum_probs=207.6

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      +|.+.+.||+|+||.||+|....      ++..|++|.+...  .......+.+|+++++.++||||+++++++.+.+..
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKA------DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKL   74 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcC------CCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEE
Confidence            47788999999999999998765      4789999998743  234456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+.+++|.+++.......+++...+.++.+++.||.|||  +.|++|+||||+||+++.++.++|+|||++....
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH--~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~  152 (256)
T cd08529          75 NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH--SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS  152 (256)
T ss_pred             EEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEEeCCCCEEEcccccceecc
Confidence            99999999999999997765567899999999999999999999  7889999999999999999999999999988654


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII  317 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (449)
                      ....  ......|++.|+|||++.+..++.++|||||||++|+|++|+.||......   ....             .+.
T Consensus       153 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~-------------~~~  214 (256)
T cd08529         153 DNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALIL-------------KII  214 (256)
T ss_pred             Cccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHH-------------HHH
Confidence            3221  123346899999999998888999999999999999999999999754311   1000             000


Q ss_pred             cccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          318 DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       318 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      . ......+..++..+.+++.+||+.+|++||++.+++++
T Consensus       215 ~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         215 R-GVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             c-CCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            1 11122233556679999999999999999999999976

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.1e-41  Score=328.42  Aligned_cols=269  Identities=27%  Similarity=0.394  Sum_probs=210.1

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCC-CCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcC-CCCCcceeeeEEEe
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLR-PGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQL-KHPHLVNLIGYCCE  153 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~  153 (449)
                      ..++|.+.+.||+|+||.||+|.+....+ .......+|+|.+.... ......+.+|+.++..+ +||||+++++++..
T Consensus        16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (307)
T cd05098          16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   95 (307)
T ss_pred             ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            34679999999999999999997643111 11234579999997542 33456788899999999 79999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEE
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYS--------------STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILL  219 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill  219 (449)
                      .+..|+||||+.+|+|.+++.....              ..+++.+++.++.|++.||+|||  +.|++||||||+|||+
T Consensus        96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~gi~H~dlkp~Nill  173 (307)
T cd05098          96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVLV  173 (307)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH--HCCcccccccHHheEE
Confidence            9999999999999999999976421              34788999999999999999999  7789999999999999


Q ss_pred             cCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchh
Q 013105          220 DSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKD  298 (449)
Q Consensus       220 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~  298 (449)
                      +.++.++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||.......   
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~---  250 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---  250 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---
Confidence            9999999999999876543221111222234578999999988889999999999999999998 888886532111   


Q ss_pred             hHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          299 LVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                      ...              .+........+..++.++.+|+.+||..+|.+|||+.++++.|+.++..
T Consensus       251 ~~~--------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         251 LFK--------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             HHH--------------HHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence            111              0011111122334566799999999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.9e-41  Score=318.62  Aligned_cols=256  Identities=29%  Similarity=0.405  Sum_probs=206.3

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      +..++|++.+.||+|+||.||+|...+       ++.||+|.+.... .....+.+|+.+++.++|+||+++++++. .+
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~-------~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~   73 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYNG-------HTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QE   73 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecCC-------CceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cC
Confidence            345789999999999999999997543       5789999987443 33567889999999999999999999874 56


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..+++|||+.+++|.+++.......+++.+...++.|++.||.|||  +.|++|+||||+||+++.++.++|+|||++..
T Consensus        74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH--~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  151 (260)
T cd05067          74 PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE--RKNYIHRDLRAANILVSETLCCKIADFGLARL  151 (260)
T ss_pred             CcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh--cCCeecccccHHhEEEcCCCCEEEccCcceee
Confidence            7899999999999999987766667899999999999999999999  77899999999999999999999999999976


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchh
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ...... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.+......   ....           
T Consensus       152 ~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~-----------  216 (260)
T cd05067         152 IEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---IQNL-----------  216 (260)
T ss_pred             cCCCCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---HHHH-----------
Confidence            542221 11222345678999999988889999999999999999999 9999975432111   1100           


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEP  360 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  360 (449)
                         ........+...+.++.+++.+||+.+|++||++++++..|+.
T Consensus       217 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         217 ---ERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ---HcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence               0111111223345679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.8e-41  Score=322.01  Aligned_cols=262  Identities=27%  Similarity=0.388  Sum_probs=204.7

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      .++|.+.+.||+|+||.||+|.+... ........||+|.+..... .....+.+|+.+++.++|+||+++++++.+.+.
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~-~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGR-DGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecC-CCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            46789999999999999999988642 1112467899998864432 234568899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC---cEEEe
Q 013105          157 RLLVYEYMALGNLHDQLFKNYS-----STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY---NAKLS  228 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~---~~kl~  228 (449)
                      .++||||+.|++|.+++.....     ..+++..++.++.|++.||.|||  .++++||||||+|||++.++   .+||+
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE--ENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccchheEEEeccCCCcceEec
Confidence            9999999999999999866432     35889999999999999999999  67899999999999998764   59999


Q ss_pred             eeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhh
Q 013105          229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPML  307 (449)
Q Consensus       229 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  307 (449)
                      |||++................++..|+|||++.+..++.++|||||||++|||++ |..||...........        
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~--------  233 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF--------  233 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--------
Confidence            9999986532211111112234568999999988889999999999999999997 9999976432211111        


Q ss_pred             ccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 013105          308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE  359 (449)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  359 (449)
                               +........+..++..+.+++.+||+.+|++|||+.+|+++|+
T Consensus       234 ---------~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         234 ---------VTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             ---------HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                     1111111223445667999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=8.8e-42  Score=331.44  Aligned_cols=238  Identities=28%  Similarity=0.382  Sum_probs=190.4

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHH-HHhcCCCCCcceeeeEEEeCCEEEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVI-FLGQLKHPHLVNLIGYCCEDEHRLLV  160 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~~lv  160 (449)
                      +.||+|+||.||+|.+..      +++.||+|++...   .......+..|.. +++.++||||+++++++.+.+..|+|
T Consensus         1 ~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv   74 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKA------DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFV   74 (323)
T ss_pred             CeeeeCCCeEEEEEEECC------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEE
Confidence            469999999999998765      5889999999643   1223344555554 56789999999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCC
Q 013105          161 YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGE  240 (449)
Q Consensus       161 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~  240 (449)
                      |||+.+|+|..++...  ..+++.....++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  150 (323)
T cd05575          75 LDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLH--SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS  150 (323)
T ss_pred             EcCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC
Confidence            9999999999988764  57889999999999999999999  7889999999999999999999999999987543222


Q ss_pred             CCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhccc
Q 013105          241 DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSR  320 (449)
Q Consensus       241 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (449)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|..||........   .   .          .+... 
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---~---~----------~i~~~-  211 (323)
T cd05575         151 K--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM---Y---D----------NILNK-  211 (323)
T ss_pred             C--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH---H---H----------HHHcC-
Confidence            1  23345699999999999988999999999999999999999999976432111   0   0          01111 


Q ss_pred             ccccCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 013105          321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMT  352 (449)
Q Consensus       321 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  352 (449)
                       ....+...+..+.+++.+||+.||.+||++.
T Consensus       212 -~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         212 -PLRLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             -CCCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence             0112233466789999999999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.4e-41  Score=319.92  Aligned_cols=258  Identities=26%  Similarity=0.429  Sum_probs=199.3

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC----
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED----  154 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~----  154 (449)
                      |.+.+.||+|+||.||+|.+...    .....+|+|.++..  .......+.+|+.+++.++|+||+++++++...    
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~----~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQD----DSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESE   76 (272)
T ss_pred             CccccccCcccCceEEEeEEccC----CCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCccc
Confidence            35678999999999999987652    11236999998754  233456788999999999999999999987532    


Q ss_pred             --CEEEEEEEecCCCChHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEe
Q 013105          155 --EHRLLVYEYMALGNLHDQLFKN----YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLS  228 (449)
Q Consensus       155 --~~~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~  228 (449)
                        ...+++|||+.+|+|.+++...    ....+++.....++.|++.||.|||  +++|+||||||+|||++.++.++|+
T Consensus        77 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~  154 (272)
T cd05075          77 GYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS--SKSFIHRDLAARNCMLNENMNVCVA  154 (272)
T ss_pred             CCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH--HCCeeccccchhheEEcCCCCEEEC
Confidence              3468999999999999887432    2345789999999999999999999  7889999999999999999999999


Q ss_pred             eeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhh
Q 013105          229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPML  307 (449)
Q Consensus       229 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  307 (449)
                      |||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||......   .......   
T Consensus       155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~~---  228 (272)
T cd05075         155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIYDYLR---  228 (272)
T ss_pred             CCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH---
Confidence            9999986543322111122346778999999988889999999999999999999 88998753221   1111110   


Q ss_pred             ccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcc
Q 013105          308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL  361 (449)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  361 (449)
                       .          ......+..++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       229 -~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         229 -Q----------GNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             -c----------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             0          001112234556789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=7.1e-42  Score=344.83  Aligned_cols=264  Identities=21%  Similarity=0.337  Sum_probs=195.6

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC---
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED---  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~---  154 (449)
                      ..+|.+.+.||+|+||.||+|....      +++.||||++....    ....+|+.+|+.++||||+++++++...   
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~  134 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICID------TSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFK  134 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECC------CCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccc
Confidence            4679999999999999999998765      47899999885332    2234699999999999999999887432   


Q ss_pred             -----CEEEEEEEecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC-cEE
Q 013105          155 -----EHRLLVYEYMALGNLHDQLFK--NYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY-NAK  226 (449)
Q Consensus       155 -----~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~-~~k  226 (449)
                           ..+++||||+. ++|.+++..  .....+++..+..++.|++.||.|||  .++|+||||||+|||++.++ .+|
T Consensus       135 ~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH--~~~IiHrDLKp~NILl~~~~~~vk  211 (440)
T PTZ00036        135 KNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH--SKFICHRDLKPQNLLIDPNTHTLK  211 (440)
T ss_pred             cCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCcCHHHEEEcCCCCcee
Confidence                 24679999997 577776643  23467899999999999999999999  77899999999999998665 699


Q ss_pred             EeeeccccCCCCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHH-hh-
Q 013105          227 LSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVE-WA-  303 (449)
Q Consensus       227 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~-~~-  303 (449)
                      |+|||+++.......   .....||+.|+|||++.+ ..|+.++|||||||+||||++|.+||.+.........+. .. 
T Consensus       212 L~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~  288 (440)
T PTZ00036        212 LCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLG  288 (440)
T ss_pred             eeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            999999986543221   223568999999999865 468999999999999999999999998654322111110 00 


Q ss_pred             hhhh-------ccccc--hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          304 RPML-------KDFTK--LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       304 ~~~~-------~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .+..       ..+..  +...........++...+.++.+|+.+||+.||.+|||+.++++|
T Consensus       289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            0000       00000  000000011111233345679999999999999999999999987

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.6e-41  Score=318.97  Aligned_cols=256  Identities=25%  Similarity=0.375  Sum_probs=203.5

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      .++|++.+.||+|+||.||+|....      +++.||+|++..........+.+|+.++..++||||+++++++..++..
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~------~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~   81 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLH------TGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKL   81 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECC------CCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence            3579999999999999999998765      4789999999765444556778899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+.+++|.+++...  ..+++..+..++.|++.||.|||  +.+|+||||||+||+++.++.++|+|||++....
T Consensus        82 ~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  157 (267)
T cd06646          82 WICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLH--SKGKMHRDIKGANILLTDNGDVKLADFGVAAKIT  157 (267)
T ss_pred             EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEECCCCCEEECcCccceeec
Confidence            9999999999999988654  56889999999999999999999  7789999999999999999999999999998653


Q ss_pred             CCCCCceeeecCCCCccccccccc---cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYIN---TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ....  ......|+..|+|||.+.   ...++.++|||||||++|||++|..||............      ...  .  
T Consensus       158 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~------~~~--~--  225 (267)
T cd06646         158 ATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM------SKS--N--  225 (267)
T ss_pred             cccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee------ecC--C--
Confidence            2211  122345889999999884   345788999999999999999999998643211110000      000  0  


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL  358 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  358 (449)
                        .... ........+..+.+++.+||+.||++|||+++++++|
T Consensus       226 --~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         226 --FQPP-KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             --CCCC-CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence              0000 0001123456799999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.8e-41  Score=323.86  Aligned_cols=267  Identities=27%  Similarity=0.403  Sum_probs=206.8

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      ...++|++.+.||+|+||.||+|...+. .....+..||+|.+..... .....+.+|+.+++.++||||+++++++.+.
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDI-IKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEecc-CCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            3467899999999999999999976542 1122356899999864432 2334678899999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEE
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNY--------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAK  226 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~k  226 (449)
                      +..++||||+.+|+|.+++....        ........+..++.|++.||.|||  .++|+||||||+|||++.++.++
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN--AKKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCcCCCCChheEEEcCCCcEE
Confidence            99999999999999999996532        133456778899999999999999  78899999999999999999999


Q ss_pred             EeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhh
Q 013105          227 LSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARP  305 (449)
Q Consensus       227 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~  305 (449)
                      |+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......   .....  
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~~~--  234 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLKFV--  234 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH--
Confidence            999999885433222111222345678999999988889999999999999999998 788886532211   11110  


Q ss_pred             hhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccc
Q 013105          306 MLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL  362 (449)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  362 (449)
                                 ... .....+..++..+.+++.+||+.||++|||+.++++.|+..+
T Consensus       235 -----------~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         235 -----------MDG-GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             -----------HcC-CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence                       000 001112334567999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.4e-41  Score=325.57  Aligned_cols=270  Identities=26%  Similarity=0.371  Sum_probs=210.8

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCC-CCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcC-CCCCcceeeeEEE
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNL-RPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQL-KHPHLVNLIGYCC  152 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~  152 (449)
                      ...++|.+.+.||+|+||.||+|.+.... .....+..||+|.+.... ......+.+|+.++..+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            34567889999999999999999754210 112245689999986432 33456788999999999 7999999999999


Q ss_pred             eCCEEEEEEEecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceE
Q 013105          153 EDEHRLLVYEYMALGNLHDQLFKNY--------------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNIL  218 (449)
Q Consensus       153 ~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nil  218 (449)
                      .....++||||+.+|+|.+++....              ...+++..+..++.|++.||.|||  ++||+||||||+|||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--~~givH~dlkp~Nil  169 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA--SQKCIHRDLAARNVL  169 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH--HCCeeecccccceEE
Confidence            9999999999999999999987642              135778889999999999999999  778999999999999


Q ss_pred             EcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccch
Q 013105          219 LDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREK  297 (449)
Q Consensus       219 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~  297 (449)
                      ++.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~  249 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  249 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence            99999999999999986543322222223346778999999988889999999999999999998 78888654221111


Q ss_pred             hhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          298 DLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                      ..                 +........+..++..+.+++.+||+.+|.+|||+.++++.|+.++..
T Consensus       250 ~~-----------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         250 KL-----------------LKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             HH-----------------HHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence            10                 011111112334566799999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.4e-41  Score=317.25  Aligned_cols=259  Identities=21%  Similarity=0.333  Sum_probs=207.1

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ++|++.+.||+|+||.||+|....      +++.||||.+...   .......+.+|+.+++.++||||+++++++.+.+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLL------DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN   75 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeC------CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC
Confidence            579999999999999999998765      4789999988642   2233456788999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          156 HRLLVYEYMALGNLHDQLFKN--YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      ..++||||+.+|+|.+++...  ....++......++.|++.||.|||  +++++|+||||+||+++.++.++|+|||++
T Consensus        76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~~~nil~~~~~~~~l~d~g~~  153 (267)
T cd08228          76 ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             eEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh--hCCeeCCCCCHHHEEEcCCCCEEECccccc
Confidence            999999999999999888532  2345788999999999999999999  778999999999999999999999999998


Q ss_pred             cCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccch
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      ........  ......|++.|+|||.+.+..++.++|+||||+++|||++|..||....... .......          
T Consensus       154 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~----------  220 (267)
T cd08228         154 RFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQKI----------  220 (267)
T ss_pred             eeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHHHH----------
Confidence            86543221  1223458899999999988889999999999999999999999986432110 0111100          


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcc
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL  361 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  361 (449)
                         .............+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       221 ---~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         221 ---EQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             ---hcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence               000111111234567799999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.6e-41  Score=317.71  Aligned_cols=255  Identities=28%  Similarity=0.398  Sum_probs=204.1

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      ..++|++.+.||+|+||.||+|.+..       +..+|+|.+..... ....+.+|+.++++++|+||+++++++. ...
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~-------~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~   74 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWNG-------NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEP   74 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEecC-------CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCC
Confidence            34678999999999999999997653       46799999875433 3467889999999999999999999875 456


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .+++|||+.+++|.+++.......+++..+..++.+++.||.|||  +++|+||||||+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~  152 (260)
T cd05070          75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE--RMNYIHRDLRSANILVGDGLVCKIADFGLARLI  152 (260)
T ss_pred             cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCccceEEEeCCceEEeCCceeeeec
Confidence            899999999999999987655567899999999999999999999  678999999999999999999999999999765


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ...... ......++..|+|||.+.+..++.++||||||+++|+|++ |.+||.......   .....            
T Consensus       153 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~------------  216 (260)
T cd05070         153 EDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQV------------  216 (260)
T ss_pred             cCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH------------
Confidence            432211 1122335678999999988889999999999999999999 899997542111   11110            


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEP  360 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  360 (449)
                        ........+...+..+.+|+.+||..+|++|||+.++++.|+.
T Consensus       217 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         217 --ERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             --HcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence              1111112233456679999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.7e-41  Score=320.13  Aligned_cols=263  Identities=24%  Similarity=0.344  Sum_probs=204.9

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      .++|++.+.||+|+||.||+|.+..+.  ......||+|++..... .....+.+|+.++..++||||+++++++.. ..
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~--~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~   82 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDG--ENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-ST   82 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCC--CccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CC
Confidence            356888999999999999999876531  11233589999875432 334578899999999999999999999875 45


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .+++|||+++|+|.+++... ...+++...+.++.|++.||.|||  +++|+||||||+|||++.++.+||+|||+++..
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH--~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLE--EVRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence            78999999999999988654 356899999999999999999999  788999999999999999999999999999865


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      .............++..|+|||.+.+..++.++|||||||++|||++ |..||.......   ....             
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~-------------  223 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDL-------------  223 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH-------------
Confidence            43222111222235678999999988889999999999999999998 899986532111   1111             


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                       +........+..++..+.+++.+||+.||++||++.++++.|+.+..
T Consensus       224 -~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         224 -LEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             -HHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence             11111111223455678999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.3e-41  Score=321.62  Aligned_cols=252  Identities=27%  Similarity=0.373  Sum_probs=202.7

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      |+..+.||+|+||+||+|.+..      +++.||+|.+....   ......+.+|+.+++.++|+||+.+++.+..++..
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~   75 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRA------TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDAL   75 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECC------CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEE
Confidence            6778899999999999998765      57899999986432   22234577899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+.+++|.+++.......+++.....++.|++.||.|||  +++|+||||||+||+++.++.++|+|||++....
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH--~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~  153 (285)
T cd05632          76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH--RENTVYRDLKPENILLDDYGHIRISDLGLAVKIP  153 (285)
T ss_pred             EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence            99999999999998887655567999999999999999999999  7889999999999999999999999999987543


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII  317 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (449)
                      ...   ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||..............  ..           
T Consensus       154 ~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~--~~-----------  217 (285)
T cd05632         154 EGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR--RV-----------  217 (285)
T ss_pred             CCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH--hh-----------
Confidence            221   12234689999999999888899999999999999999999999976432211111100  00           


Q ss_pred             cccccccCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 013105          318 DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT-----MTTVVKA  357 (449)
Q Consensus       318 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~  357 (449)
                      .. ....++...+..+.+|+..||+.||++||+     +.+++.+
T Consensus       218 ~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         218 LE-TEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             hc-cccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            00 011223345566899999999999999999     6677765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-43  Score=328.87  Aligned_cols=263  Identities=27%  Similarity=0.384  Sum_probs=218.6

Q ss_pred             CHHHHHHHh-cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcc
Q 013105           70 TLKELQMIT-HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLV  145 (449)
Q Consensus        70 ~~~~~~~~~-~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv  145 (449)
                      ..-|.+.++ +.|+..++||+||||.||-+....      +|+.+|+|.+...   ........++|-++|.+++.+.||
T Consensus       175 K~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvra------TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiV  248 (591)
T KOG0986|consen  175 KWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRA------TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIV  248 (591)
T ss_pred             HHHHhhhccccceeeeEEEecccccceeEEEEec------chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEE
Confidence            334555555 558999999999999999987766      7999999998632   334445678899999999999999


Q ss_pred             eeeeEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcE
Q 013105          146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNA  225 (449)
Q Consensus       146 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~  225 (449)
                      .+-..|++.+.+|+||..|+||+|.-.|++..+..+++..++-++.+|+.||.+||  +.+||+|||||+|||+|+.|++
T Consensus       249 slaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH--~~~iVYRDLKPeNILLDd~Ghv  326 (591)
T KOG0986|consen  249 SLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH--RRRIVYRDLKPENILLDDHGHV  326 (591)
T ss_pred             EEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH--hcceeeccCChhheeeccCCCe
Confidence            99999999999999999999999999999888889999999999999999999999  7889999999999999999999


Q ss_pred             EEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhh
Q 013105          226 KLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARP  305 (449)
Q Consensus       226 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~  305 (449)
                      +|+|+|||.....+..   ....+||.+|||||++.++.|+...|+|||||+||||+.|+.||.........+-+     
T Consensus       327 RISDLGLAvei~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEv-----  398 (591)
T KOG0986|consen  327 RISDLGLAVEIPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEV-----  398 (591)
T ss_pred             EeeccceEEecCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHH-----
Confidence            9999999998766543   33457999999999999999999999999999999999999999865433222111     


Q ss_pred             hhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 013105          306 MLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT-----MTTVVKA  357 (449)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~  357 (449)
                              ++.+. .....++...++++.+|+..+|++||++|.-     +.++-+|
T Consensus       399 --------drr~~-~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H  446 (591)
T KOG0986|consen  399 --------DRRTL-EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH  446 (591)
T ss_pred             --------HHHHh-cchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence                    11111 1133466778888999999999999999954     4566655

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=7.4e-42  Score=336.96  Aligned_cols=254  Identities=21%  Similarity=0.291  Sum_probs=199.2

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ++|++.+.||+|+||.||+|....      +++.||+|++...   .......+.+|+.++..++||||+++++.+.+.+
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   74 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKD------TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR   74 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECC------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            468889999999999999998765      5789999999642   2333456788999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..|+||||++||+|.+++.+.  ..+++.....++.|++.||.|||  ++||+||||||+|||++.++.++|+|||++..
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH--~~givHrDLkp~NIli~~~~~vkL~DfG~~~~  150 (360)
T cd05627          75 NLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIH--QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTG  150 (360)
T ss_pred             EEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEccCCCHHHEEECCCCCEEEeeccCCcc
Confidence            999999999999999998764  56889999999999999999999  78899999999999999999999999999875


Q ss_pred             CCCCCCC---------------------------------ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHH
Q 013105          236 GPQGEDS---------------------------------HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELL  282 (449)
Q Consensus       236 ~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ell  282 (449)
                      .......                                 ......+||+.|+|||++.+..++.++|||||||++|||+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~  230 (360)
T cd05627         151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML  230 (360)
T ss_pred             cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecc
Confidence            4221100                                 0012356999999999999899999999999999999999


Q ss_pred             hCCCcccccccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCC---HHHHHHH
Q 013105          283 TGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT---MTTVVKA  357 (449)
Q Consensus       283 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~eil~~  357 (449)
                      +|..||...........+      .....      ....+..  ...+.++.+++.+|+ .||.+|++   +.++++|
T Consensus       231 tG~~Pf~~~~~~~~~~~i------~~~~~------~~~~p~~--~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         231 IGYPPFCSETPQETYRKV------MNWKE------TLVFPPE--VPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH  293 (360)
T ss_pred             cCCCCCCCCCHHHHHHHH------HcCCC------ceecCCC--CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence            999999765322111100      00000      0000110  123456888888876 49999985   6777776

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.2e-41  Score=336.26  Aligned_cols=261  Identities=21%  Similarity=0.274  Sum_probs=202.6

Q ss_pred             HHHHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceee
Q 013105           72 KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLI  148 (449)
Q Consensus        72 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~  148 (449)
                      .++....++|++.+.||+|+||.||+|.+..      +++.||+|++...   .......+.+|+.+++.++||||++++
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~  109 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS------TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF  109 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECC------CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            3444556899999999999999999997765      5889999998632   222344577899999999999999999


Q ss_pred             eEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEe
Q 013105          149 GYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLS  228 (449)
Q Consensus       149 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~  228 (449)
                      +++.+++..|+||||+.||+|.+++...   .++......++.|++.||.|||  +++|+||||||+|||++.++.+||+
T Consensus       110 ~~~~~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDLkp~NIll~~~~~ikL~  184 (371)
T cd05622         110 YAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIH--SMGFIHRDVKPDNMLLDKSGHLKLA  184 (371)
T ss_pred             EEEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHEEECCCCCEEEE
Confidence            9999999999999999999999988653   5788888999999999999999  7889999999999999999999999


Q ss_pred             eeccccCCCCCCCCceeeecCCCCccccccccccC----CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhh
Q 013105          229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTG----HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR  304 (449)
Q Consensus       229 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~  304 (449)
                      |||++........ .......||+.|+|||++.+.    .++.++|||||||++|||++|..||.........      .
T Consensus       185 DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------~  257 (371)
T cd05622         185 DFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------S  257 (371)
T ss_pred             eCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH------H
Confidence            9999986543221 112345699999999998653    3789999999999999999999999764321110      0


Q ss_pred             hhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHHh
Q 013105          305 PMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKS--RPTMTTVVKAL  358 (449)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~L  358 (449)
                      .......        ...-......+..+.+++..||..++.+  |+++.++++|.
T Consensus       258 ~i~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         258 KIMNHKN--------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             HHHcCCC--------cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            0000000        0000111245567889999999844433  78999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4e-41  Score=315.46  Aligned_cols=251  Identities=25%  Similarity=0.336  Sum_probs=205.5

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      +|++.+.||+|+||.||++.+..      ++..+|+|.++... ......+.+|+.+++.++|+||+++++.+.+.+..|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   74 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVN------SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLY   74 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcC------CCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEE
Confidence            57889999999999999997765      57899999986432 334567788999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCC
Q 013105          159 LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~  238 (449)
                      +||||+++|+|.+++.......++......++.|++.||.|||  ++||+|+||||+||+++.++.++|+|||++.....
T Consensus        75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  152 (255)
T cd08219          75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH--EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS  152 (255)
T ss_pred             EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence            9999999999999887655567889999999999999999999  78899999999999999999999999999875533


Q ss_pred             CCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhc
Q 013105          239 GEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIID  318 (449)
Q Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (449)
                      ...  ......|++.|+|||++.+..++.++|+||||+++|+|++|..||..........      ..           .
T Consensus       153 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~------~~-----------~  213 (255)
T cd08219         153 PGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL------KV-----------C  213 (255)
T ss_pred             ccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHH------HH-----------h
Confidence            221  1223568999999999988889999999999999999999999997542211100      00           0


Q ss_pred             ccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          319 SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       319 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .......+...+..+.+++.+||+.||++||++.+++..
T Consensus       214 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         214 QGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             cCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            011112233455678999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.8e-41  Score=316.92  Aligned_cols=252  Identities=25%  Similarity=0.368  Sum_probs=201.0

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      ++|.+.+.||+|+||.||+|.+..       +..+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+..+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-------~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   75 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-------QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIY   75 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-------CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcE
Confidence            458888999999999999997654       3469999987432 33467899999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCC
Q 013105          159 LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~  238 (449)
                      +||||+.+|+|.+++.... ..+++..++.++.|++.||.|||  +.+++|+||||+||+++.++.+||+|||++.....
T Consensus        76 lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05113          76 IVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLE--SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD  152 (256)
T ss_pred             EEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccCcceEEEcCCCCEEECCCccceecCC
Confidence            9999999999999886643 36899999999999999999999  78899999999999999999999999999875533


Q ss_pred             CCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHhh
Q 013105          239 GEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII  317 (449)
Q Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (449)
                      .... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......   .....             .
T Consensus       153 ~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~-------------~  215 (256)
T cd05113         153 DEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEKV-------------S  215 (256)
T ss_pred             Ccee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHH-------------h
Confidence            2211 1112235678999999988889999999999999999998 999986543211   11100             0


Q ss_pred             cccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 013105          318 DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE  359 (449)
Q Consensus       318 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  359 (449)
                      . ......+...+..+.+++.+||+.||.+||++.+|++.|+
T Consensus       216 ~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         216 Q-GLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             c-CCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            0 0011112223567999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.4e-41  Score=344.32  Aligned_cols=269  Identities=20%  Similarity=0.287  Sum_probs=195.5

Q ss_pred             HHHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC------CCCcce
Q 013105           73 ELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK------HPHLVN  146 (449)
Q Consensus        73 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~nIv~  146 (449)
                      ++....++|++.+.||+|+||.||+|.+..      .++.||||+++... .....+..|+.++..++      |.+|+.
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~------~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~  195 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRK------RKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMK  195 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcC------CCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceee
Confidence            334456789999999999999999998765      47899999996432 22334556777776664      456888


Q ss_pred             eeeEEEeC-CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC--
Q 013105          147 LIGYCCED-EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY--  223 (449)
Q Consensus       147 ~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~--  223 (449)
                      +++++... .++|+|||++ |++|.+++.+.  ..+++..+..++.|++.||.|||+ ..|||||||||+|||++.++  
T Consensus       196 i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~-~~gIiHrDlKP~NILl~~~~~~  271 (467)
T PTZ00284        196 IQRYFQNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHT-ELHLMHTDLKPENILMETSDTV  271 (467)
T ss_pred             eEEEEEcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh-cCCeecCCCCHHHEEEecCCcc
Confidence            99888764 5789999988 68898888765  578999999999999999999993 14899999999999998765  


Q ss_pred             --------------cEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCccc
Q 013105          224 --------------NAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVE  289 (449)
Q Consensus       224 --------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~  289 (449)
                                    .+||+|||++.....     .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.
T Consensus       272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~  346 (467)
T PTZ00284        272 VDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD  346 (467)
T ss_pred             cccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence                          499999998864322     1234679999999999999999999999999999999999999998


Q ss_pred             ccccccchhhHHhhhhhhc-cc------cchhHhhcc------ccc---------c-cC-CHHHHHHHHHHHHHhccCCC
Q 013105          290 KNRCKREKDLVEWARPMLK-DF------TKLDQIIDS------RLE---------D-RY-STEGAKRLAAVAHQCLSHNP  345 (449)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~-~~------~~~~~~~~~------~~~---------~-~~-~~~~~~~l~~li~~cl~~dP  345 (449)
                      +.........+........ .+      .....+...      ...         . .. .....+.+.+||.+||+.||
T Consensus       347 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP  426 (467)
T PTZ00284        347 THDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR  426 (467)
T ss_pred             CCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcCh
Confidence            6543222221111100000 00      000000000      000         0 00 00113567899999999999


Q ss_pred             CCCCCHHHHHHH
Q 013105          346 KSRPTMTTVVKA  357 (449)
Q Consensus       346 ~~RPs~~eil~~  357 (449)
                      ++|||+.|+++|
T Consensus       427 ~~R~ta~e~L~H  438 (467)
T PTZ00284        427 QKRLNARQMTTH  438 (467)
T ss_pred             hhCCCHHHHhcC
Confidence            999999999997

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.5e-42  Score=331.22  Aligned_cols=242  Identities=27%  Similarity=0.341  Sum_probs=195.0

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYE  162 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  162 (449)
                      +.||+|+||.||++....   ...+++.||+|++....  ......+.+|+.++.+++||||+++++++.+++..|+|||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~---~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (318)
T cd05582           2 KVLGQGSFGKVFLVRKIT---GPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD   78 (318)
T ss_pred             ceeeeCCCEEEEEEEEec---cCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence            579999999999986532   12357899999997432  2233456789999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCC
Q 013105          163 YMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS  242 (449)
Q Consensus       163 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~  242 (449)
                      |+.+|+|.+++.+.  ..+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++.......  
T Consensus        79 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--  152 (318)
T cd05582          79 FLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLH--SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--  152 (318)
T ss_pred             CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--
Confidence            99999999998654  56899999999999999999999  7789999999999999999999999999988643321  


Q ss_pred             ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhccccc
Q 013105          243 HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLE  322 (449)
Q Consensus       243 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (449)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........   .             .+...  .
T Consensus       153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~---~-------------~i~~~--~  214 (318)
T cd05582         153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM---T-------------MILKA--K  214 (318)
T ss_pred             CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH---H-------------HHHcC--C
Confidence            1233457999999999998888999999999999999999999999764321111   0             00010  1


Q ss_pred             ccCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 013105          323 DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTT  353 (449)
Q Consensus       323 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  353 (449)
                      ..++...+..+.+++.+||+.||++||++.+
T Consensus       215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            1123345667899999999999999999554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.5e-41  Score=328.14  Aligned_cols=242  Identities=24%  Similarity=0.363  Sum_probs=195.5

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCC-CCCcceeeeEEEeCC
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLK-HPHLVNLIGYCCEDE  155 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~  155 (449)
                      +|...+.||+|+||.||+|....      +++.||+|++...   .......+..|..++..+. |++|+++++++.+.+
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKG------TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD   74 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC
Confidence            47788999999999999998765      5789999999743   2233456778888988885 678888999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..|+||||++||+|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH--~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~  150 (323)
T cd05615          75 RLYFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLH--RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             EEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEEeccccccc
Confidence            999999999999999988654  56899999999999999999999  78899999999999999999999999999875


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ......  ......||+.|+|||++.+..++.++|||||||++|||++|..||.+......   ..             .
T Consensus       151 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~~-------------~  212 (323)
T cd05615         151 HMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL---FQ-------------S  212 (323)
T ss_pred             cCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH---HH-------------H
Confidence            432211  12345699999999999988899999999999999999999999976432111   10             0


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM  351 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  351 (449)
                      +...  ...++...+..+.+++.+||+.||.+|++.
T Consensus       213 i~~~--~~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         213 IMEH--NVSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             HHhC--CCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            1110  112233455678999999999999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=6.6e-41  Score=314.52  Aligned_cols=250  Identities=28%  Similarity=0.385  Sum_probs=198.2

Q ss_pred             cccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEEEe
Q 013105           86 YLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEY  163 (449)
Q Consensus        86 ~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  163 (449)
                      .||+|+||.||+|.+..    ..++..+|+|+++...  ......+.+|+.+++.+.||||+++++++. .+..++||||
T Consensus         2 ~lg~G~~g~v~~~~~~~----~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~   76 (257)
T cd05116           2 ELGSGNFGTVKKGMYKM----KKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMEL   76 (257)
T ss_pred             cCCCcCCcceEEeEEec----CCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEec
Confidence            58999999999997643    1246789999986443  223467889999999999999999999875 4567899999


Q ss_pred             cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCCc
Q 013105          164 MALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSH  243 (449)
Q Consensus       164 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~~  243 (449)
                      +.+|+|.+++...  ..+++.....++.|++.||.|||  ++||+||||||.|||++.++.++|+|||++..........
T Consensus        77 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH--~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~  152 (257)
T cd05116          77 AELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLE--ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY  152 (257)
T ss_pred             CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence            9999999998654  46889999999999999999999  7889999999999999999999999999998654332111


Q ss_pred             -eeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHhhcccc
Q 013105          244 -ITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRL  321 (449)
Q Consensus       244 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (449)
                       ......++..|+|||.+....++.++|||||||++|||++ |..||.......   ....              +....
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~--------------i~~~~  215 (257)
T cd05116         153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VTQM--------------IESGE  215 (257)
T ss_pred             eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH--------------HHCCC
Confidence             1112234578999999988889999999999999999998 999997543211   1111              11111


Q ss_pred             cccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcc
Q 013105          322 EDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL  361 (449)
Q Consensus       322 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  361 (449)
                      ....+..++.++.++|.+||+.||++||++.+|.+.|+.+
T Consensus       216 ~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         216 RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            1223345567799999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4.7e-41  Score=331.16  Aligned_cols=266  Identities=21%  Similarity=0.280  Sum_probs=198.7

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      .+.++|++.+.||+|+||.||+|.+..      ++..||+|++...  .......+.+|+.+++.++||||+++++++..
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   91 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTV------LGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTP   91 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcC------CCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeecc
Confidence            356789999999999999999997755      5789999998643  22334567899999999999999999999865


Q ss_pred             CC------EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEE
Q 013105          154 DE------HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKL  227 (449)
Q Consensus       154 ~~------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl  227 (449)
                      .+      ..|+||||+. ++|.+.+.    ..++...+..++.|++.||.|||  ++||+||||||+|||++.++.+||
T Consensus        92 ~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH--~~~ivHrDlkp~NIl~~~~~~~kl  164 (359)
T cd07876          92 QKSLEEFQDVYLVMELMD-ANLCQVIH----MELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKI  164 (359)
T ss_pred             CCCccccceeEEEEeCCC-cCHHHHHh----ccCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEE
Confidence            43      5799999997 56666653    34788888999999999999999  778999999999999999999999


Q ss_pred             eeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchh-hHHh----
Q 013105          228 SDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKD-LVEW----  302 (449)
Q Consensus       228 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~-~~~~----  302 (449)
                      +|||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+........ ....    
T Consensus       165 ~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  241 (359)
T cd07876         165 LDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTP  241 (359)
T ss_pred             ecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9999997543221   1233568999999999998899999999999999999999999998653211100 0000    


Q ss_pred             -----------hhhhhccccc-----hhHhhcc---cccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          303 -----------ARPMLKDFTK-----LDQIIDS---RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       303 -----------~~~~~~~~~~-----~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                                 ..........     .......   ..........+..+.+|+.+||+.||++|||+.|++.|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         242 SAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             cHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                       0000000000     0000000   00000111234568999999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=9.2e-41  Score=322.11  Aligned_cols=266  Identities=24%  Similarity=0.347  Sum_probs=204.5

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      ++|++.+.||+|+||.||++.+..      ++..+|+|.+..... .....+.+|++++++++||||+++++++.+++..
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   74 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRP------SGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEI   74 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcC------CCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEE
Confidence            468999999999999999997765      477899999875432 2345688999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+++++|.+++...  ..+++.....++.|++.||.|||+ ..+++|+||||+|||++.++.++|+|||++....
T Consensus        75 ~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  151 (308)
T cd06615          75 SICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  151 (308)
T ss_pred             EEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh-hCCEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence            9999999999999998764  568899999999999999999994 2479999999999999999999999999987543


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccc-------
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF-------  310 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-------  310 (449)
                      ...    .....|+..|+|||.+.+..++.++|||||||++|+|++|..||......................       
T Consensus       152 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (308)
T cd06615         152 DSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVS  227 (308)
T ss_pred             ccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCccccc
Confidence            221    233568999999999988889999999999999999999999997543211111110000000000       


Q ss_pred             ---------cchhHhhc---ccccccCC-HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          311 ---------TKLDQIID---SRLEDRYS-TEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       311 ---------~~~~~~~~---~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                               .......+   .......+ ..++.++.+++.+||..||++|||+.+++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         228 GHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                     00000000   00001111 1245679999999999999999999999987

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-41  Score=314.70  Aligned_cols=251  Identities=25%  Similarity=0.378  Sum_probs=200.2

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      .+|++.+.||+|+||.||+|.+..       +..+|+|++.... .....+.+|+.+++.++||||+++++++...+..+
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~-------~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRG-------KIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIF   75 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecC-------CccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceE
Confidence            357888999999999999997643       4579999986332 23456888999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCC
Q 013105          159 LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~  238 (449)
                      +||||+++++|.+++..+. ..+++.....++.|++.||+|||  +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        76 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~  152 (256)
T cd05059          76 IVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLE--SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD  152 (256)
T ss_pred             EEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH--HCCcccccccHhhEEECCCCcEEECCcccceeccc
Confidence            9999999999999987543 46899999999999999999999  77899999999999999999999999999875432


Q ss_pred             CCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHhh
Q 013105          239 GEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII  317 (449)
Q Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (449)
                      .... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||........   ....              
T Consensus       153 ~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~--------------  214 (256)
T cd05059         153 DQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---VESV--------------  214 (256)
T ss_pred             cccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH---HHHH--------------
Confidence            2111 1111123457999999988889999999999999999999 8999875432111   1100              


Q ss_pred             cccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 013105          318 DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL  358 (449)
Q Consensus       318 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  358 (449)
                      ........+..++..+.+++.+||+.+|++|||+.++++.|
T Consensus       215 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         215 SAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            01111122234566799999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5.5e-41  Score=324.60  Aligned_cols=268  Identities=26%  Similarity=0.380  Sum_probs=208.5

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCC-CCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcC-CCCCcceeeeEEEe
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLR-PGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQL-KHPHLVNLIGYCCE  153 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~  153 (449)
                      -.++|.+.+.||+|+||.||+|....... .......+|+|.+.... ......+.+|+.+++.+ +||||+++++++..
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            34678899999999999999997643111 12245679999987442 33456788999999999 69999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEE
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNY--------------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILL  219 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill  219 (449)
                      .+..++||||+.+|+|.+++....              ...+++.....++.|++.||.|||  ++||+||||||+|||+
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~gi~H~dlkp~Nill  167 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE--SRRCIHRDLAARNVLV  167 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH--HCCeeeccccceeEEE
Confidence            999999999999999999996532              235788899999999999999999  7889999999999999


Q ss_pred             cCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchh
Q 013105          220 DSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKD  298 (449)
Q Consensus       220 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~  298 (449)
                      +.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||.......   
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---  244 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE---  244 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence            9999999999999986543221111222234568999999988889999999999999999999 889986542211   


Q ss_pred             hHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          299 LVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                      .....              ........+..++..+.+++.+||+.||++|||+.++++.|..+..
T Consensus       245 ~~~~~--------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         245 LFKLL--------------REGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             HHHHH--------------HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            11110              0111111233445678999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=4e-41  Score=321.21  Aligned_cols=266  Identities=26%  Similarity=0.312  Sum_probs=197.9

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcC---CCCCcceeeeEEEe-
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQL---KHPHLVNLIGYCCE-  153 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~-  153 (449)
                      +|++.+.||+|+||.||+|.+..      +++.||+|.+....  ......+.+|+.+++.+   +||||+++++++.. 
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~   74 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPH------SGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATS   74 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECC------CCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence            48889999999999999998765      58899999987532  12223455677776665   79999999998864 


Q ss_pred             ----CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEee
Q 013105          154 ----DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSD  229 (449)
Q Consensus       154 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~D  229 (449)
                          ....++||||+. ++|.+++.......+++..+..++.|++.||.|||  +.||+||||||+|||++.++.+||+|
T Consensus        75 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dikp~Nili~~~~~~kl~d  151 (288)
T cd07863          75 RTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH--ANCIVHRDLKPENILVTSGGQVKLAD  151 (288)
T ss_pred             cCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCCEEECc
Confidence                356899999997 58988887655556899999999999999999999  77899999999999999999999999


Q ss_pred             eccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhh-HHhhh-hhh
Q 013105          230 FGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDL-VEWAR-PML  307 (449)
Q Consensus       230 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~-~~~~~-~~~  307 (449)
                      ||++........   .....||..|+|||++.+..++.++|||||||++|+|++|.+||........... ..... +..
T Consensus       152 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~  228 (288)
T cd07863         152 FGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE  228 (288)
T ss_pred             cCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCCh
Confidence            999986543221   2234589999999999888899999999999999999999999976432221111 11000 000


Q ss_pred             ccccchh----Hhhcc---cccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          308 KDFTKLD----QIIDS---RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       308 ~~~~~~~----~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ..+....    .....   .......+.++..+.+++.+||+.||++|||+.+++.|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0000000    00000   00011122456678999999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5.7e-41  Score=321.89  Aligned_cols=261  Identities=28%  Similarity=0.426  Sum_probs=204.8

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC-CcchHHHHHHHHHHHhcC-CCCCcceeeeEEEeCCE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~  156 (449)
                      ++|++.+.||+|+||.||+|....+    .....+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~   77 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKD----GLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY   77 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCC----CCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence            5789999999999999999987542    11235788888632 233456788999999999 79999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNY--------------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD  222 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~  222 (449)
                      .++||||+++++|.+++....              ...+++..+..++.|++.||+|||  ++||+||||||+|||++.+
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH--~~~ivH~dlkp~Nill~~~  155 (297)
T cd05089          78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS--EKQFIHRDLAARNVLVGEN  155 (297)
T ss_pred             ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCcCCcceEEECCC
Confidence            999999999999999986532              135788999999999999999999  7889999999999999999


Q ss_pred             CcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHH
Q 013105          223 YNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVE  301 (449)
Q Consensus       223 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~  301 (449)
                      +.+||+|||++........   ......+..|+|||.+.+..++.++|||||||++|||++ |..||........   ..
T Consensus       156 ~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~---~~  229 (297)
T cd05089         156 LASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL---YE  229 (297)
T ss_pred             CeEEECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH
Confidence            9999999999874321110   111123457999999988889999999999999999997 9999975432211   10


Q ss_pred             hhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCC
Q 013105          302 WARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN  365 (449)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  365 (449)
                         .           +........+..++..+.+|+.+||+.+|.+|||+.++++.|+.+....
T Consensus       230 ---~-----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         230 ---K-----------LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             ---H-----------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence               0           0111111123345567999999999999999999999999998887543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.5e-41  Score=328.49  Aligned_cols=242  Identities=25%  Similarity=0.350  Sum_probs=191.2

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHH-HHhcCCCCCcceeeeEEEeCCEEEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVI-FLGQLKHPHLVNLIGYCCEDEHRLLV  160 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~~lv  160 (449)
                      +.||+|+||.||+|.+..      +++.||+|++....   ......+..|.. +++.++||||+++++++...+..|+|
T Consensus         1 ~~lg~G~fg~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv   74 (325)
T cd05602           1 KVIGKGSFGKVLLARHKA------EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV   74 (325)
T ss_pred             CeeeeCCCeEEEEEEECC------CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEE
Confidence            469999999999998765      47889999996431   222334444544 56788999999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCC
Q 013105          161 YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGE  240 (449)
Q Consensus       161 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~  240 (449)
                      |||+.+|+|.+++...  ..+++.....++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH--~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~  150 (325)
T cd05602          75 LDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLH--SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN  150 (325)
T ss_pred             EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC
Confidence            9999999999988664  56778888889999999999999  7789999999999999999999999999987543222


Q ss_pred             CCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhccc
Q 013105          241 DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSR  320 (449)
Q Consensus       241 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (449)
                      .  ......||+.|+|||++.+..++.++|||||||++|+|++|..||........   ..             .+... 
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~-------------~i~~~-  211 (325)
T cd05602         151 G--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YD-------------NILNK-  211 (325)
T ss_pred             C--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH---HH-------------HHHhC-
Confidence            1  23345699999999999988999999999999999999999999975432111   00             00111 


Q ss_pred             ccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013105          321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK  356 (449)
Q Consensus       321 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  356 (449)
                       ........+..+.+++.+||+.||.+||++.+.+.
T Consensus       212 -~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         212 -PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             -CcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence             11123345567899999999999999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=8.7e-41  Score=325.99  Aligned_cols=273  Identities=26%  Similarity=0.377  Sum_probs=211.5

Q ss_pred             HHHhcCCCCcccccccCceEEEEEEEcCCCC-CCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcC-CCCCcceeeeEE
Q 013105           75 QMITHNFSRSDYLGEGGFGKVYKGCVDDNLR-PGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQL-KHPHLVNLIGYC  151 (449)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~  151 (449)
                      +....+|.+.+.||+|+||.||+|.+....+ .......||+|++.... ......+.+|+.++.++ +||||+++++++
T Consensus         8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100           8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            3445679999999999999999997643211 11234579999887432 23456788999999999 799999999999


Q ss_pred             EeCCEEEEEEEecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCce
Q 013105          152 CEDEHRLLVYEYMALGNLHDQLFKNY--------------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNI  217 (449)
Q Consensus       152 ~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Ni  217 (449)
                      ...+..+++|||+.+|+|.+++....              ...+++..++.++.|++.||.|||  ++||+||||||+||
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~givH~dlkp~Ni  165 (334)
T cd05100          88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA--SQKCIHRDLAARNV  165 (334)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH--HCCeeccccccceE
Confidence            99999999999999999999987532              234778889999999999999999  78899999999999


Q ss_pred             EEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccc
Q 013105          218 LLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKRE  296 (449)
Q Consensus       218 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~  296 (449)
                      |++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  245 (334)
T cd05100         166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  245 (334)
T ss_pred             EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            999999999999999986543221111222334568999999988889999999999999999998 8888865422111


Q ss_pred             hhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCCC
Q 013105          297 KDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLND  366 (449)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~  366 (449)
                         ..   .           +........+..++..+.+++.+||+.+|.+|||+.++++.|+.+.....
T Consensus       246 ---~~---~-----------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~  298 (334)
T cd05100         246 ---FK---L-----------LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS  298 (334)
T ss_pred             ---HH---H-----------HHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence               10   0           01111111233445679999999999999999999999999998875543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=9e-41  Score=315.14  Aligned_cols=259  Identities=22%  Similarity=0.357  Sum_probs=207.5

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ++|.+.+.||+|+||.||+|....      ++..+|||.+....   ......+.+|+.+++.++|+||+++++++..++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   75 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLL------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN   75 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecC------CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC
Confidence            468889999999999999997755      47899999886432   233457889999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          156 HRLLVYEYMALGNLHDQLFKN--YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      ..+++|||+.+++|.+++...  ....+++...+.++.+++.||.|||  ++|++|+||||+||+++.++.++|+|||++
T Consensus        76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~p~nili~~~~~~~l~dfg~~  153 (267)
T cd08229          76 ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             eEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCCEEECcchhh
Confidence            999999999999999988642  2356889999999999999999999  788999999999999999999999999998


Q ss_pred             cCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccch
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      ........  ......|+..|+|||.+.+..++.++||||||+++|+|++|..||.+....    ......         
T Consensus       154 ~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~---------  218 (267)
T cd08229         154 RFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCK---------  218 (267)
T ss_pred             hccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhh---------
Confidence            76543221  122346899999999998888999999999999999999999999653211    001000         


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcc
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL  361 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  361 (449)
                       .+.............+..+.+++.+||+.||++|||+.+|++.++.+
T Consensus       219 -~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         219 -KIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             -hhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence             00000111111234567799999999999999999999999988765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=7.3e-41  Score=322.98  Aligned_cols=267  Identities=22%  Similarity=0.319  Sum_probs=202.1

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      ++|.+.+.||+|+||.||+|....      ++..||+|.++... ......+.+|+.+++.++||||+++++++..++..
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKL------TENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSL   79 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecC------CCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeE
Confidence            568999999999999999997654      57889999987543 22334677899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+. ++|.+++... ...+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++....
T Consensus        80 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  155 (309)
T cd07872          80 TLVFEYLD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCH--RRKVLHRDLKPQNLLINERGELKLADFGLARAKS  155 (309)
T ss_pred             EEEEeCCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEECccccceecC
Confidence            99999997 5888877654 345788899999999999999999  7789999999999999999999999999987543


Q ss_pred             CCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhh--hhhccccch-
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR--PMLKDFTKL-  313 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~-  313 (449)
                      ....  ......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||................  +....+..+ 
T Consensus       156 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
T cd07872         156 VPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS  233 (309)
T ss_pred             CCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence            2221  1223457999999998864 468999999999999999999999998654332222111100  000000000 


Q ss_pred             --hHhhcccccc-------cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          314 --DQIIDSRLED-------RYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       314 --~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                        ..........       .....++.++.+++.+||+.||.+|||+.++++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence              0000000000       0112345678999999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-40  Score=312.28  Aligned_cols=253  Identities=34%  Similarity=0.501  Sum_probs=205.7

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc-hHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEEEe
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ-GHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEY  163 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  163 (449)
                      +.||+|+||.||+|.+....   ..+..|++|++...... ....+.+|+.++..++|+||+++++++......++||||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKD---GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCC---CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEe
Confidence            46999999999999886521   24778999999755433 357788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcC-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          164 MALGNLHDQLFKNY-------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       164 ~~~g~L~~~l~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      +.+++|.+++....       ...+++..+..++.|++.||.|||  +++++|+||||+||+++.++.++|+|||.+...
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~  155 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA--SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDV  155 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH--cCCcccCccCcceEEECCCCcEEEccccccccc
Confidence            99999999987642       367899999999999999999999  788999999999999999999999999999876


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      .............++..|+|||.+....++.++|||||||++|+|++ |..||.......   ....             
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~-------------  219 (262)
T cd00192         156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLEY-------------  219 (262)
T ss_pred             ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHHH-------------
Confidence            54332222333457889999999988889999999999999999999 699997652211   1110             


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE  359 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  359 (449)
                       +........+..++.++.+++.+||..+|++|||+.+++++|+
T Consensus       220 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         220 -LRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -HHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence             0111122234455678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=7.5e-41  Score=313.87  Aligned_cols=248  Identities=28%  Similarity=0.422  Sum_probs=201.1

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEE-eCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCC-EDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~-~~~~~  157 (449)
                      .+|.+.+.||+|+||.||+|...        +..||+|.+...  .....+.+|+.+++.++|+||+++++++. .++..
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--------~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--------GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   75 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--------CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence            57889999999999999999653        567999998643  23467889999999999999999999764 45678


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+.+++|.+++.......+++.....++.+++.||.|||  .+||+||||||+||+++.++.+||+|||++....
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  153 (256)
T cd05082          76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  153 (256)
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeccccchheEEEcCCCcEEecCCccceecc
Confidence            99999999999999997765556889999999999999999999  7789999999999999999999999999987543


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI  316 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (449)
                      ...     ....++..|+|||++.+..++.++|||||||++|+|++ |+.||.......   ....              
T Consensus       154 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~--------------  211 (256)
T cd05082         154 STQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR--------------  211 (256)
T ss_pred             ccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH--------------
Confidence            321     12235678999999988889999999999999999997 999986432111   1110              


Q ss_pred             hcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 013105          317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEP  360 (449)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  360 (449)
                      +........+..++..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       212 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         212 VEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             HhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            01111112233456679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.7e-41  Score=334.74  Aligned_cols=268  Identities=22%  Similarity=0.253  Sum_probs=204.1

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      .+..+|.+.+.||+|+||.||+|...+.    ..+..||+|.+...     ....+|+.+|+.++||||+++++++....
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~----~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~  159 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGD----EQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKS  159 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCC----ccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCC
Confidence            3456899999999999999999976432    24678999988532     23457999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..|+|||++. ++|.+++..  ...+++..++.++.|++.||.|||  .+||+||||||+|||++.++.++|+|||++..
T Consensus       160 ~~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH--~~givHrDlkp~Nill~~~~~~~l~DfG~a~~  234 (392)
T PHA03207        160 TVCMVMPKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLH--GRGIIHRDVKTENIFLDEPENAVLGDFGAACK  234 (392)
T ss_pred             EEEEEehhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEcCCCCEEEccCccccc
Confidence            9999999996 788888843  367899999999999999999999  77899999999999999999999999999986


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcc----cc
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKD----FT  311 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----~~  311 (449)
                      ..............||+.|+|||++.+..++.++|||||||++|||++|+.||.+...................    +.
T Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~  314 (392)
T PHA03207        235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP  314 (392)
T ss_pred             cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence            54433322233467999999999999889999999999999999999999999765432211111100000000    00


Q ss_pred             -----chhHh---hcccccccC--C-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          312 -----KLDQI---IDSRLEDRY--S-----TEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       312 -----~~~~~---~~~~~~~~~--~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                           .+...   ........+  +     ...+.++.++|.+||..||++|||+.+++.+
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                 00000   000001111  0     1234568899999999999999999999998

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.2e-40  Score=312.30  Aligned_cols=258  Identities=22%  Similarity=0.368  Sum_probs=208.5

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ++|++.+.||+|+||.||+|....      +++.||+|.++..   .......+.+|++++++++|+||+++++++...+
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~   75 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLL------DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN   75 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcC------CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence            579999999999999999998764      4789999988642   2233567889999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          156 HRLLVYEYMALGNLHDQLFKN--YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      ..++||||+++|+|.+++...  ....+++..+..++.+++.||.|||  +.||+|+||+|+||+++.++.++|+|||++
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~nil~~~~~~~~l~d~~~~  153 (267)
T cd08224          76 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH--SKRIMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             eEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH--hCCEecCCcChhhEEECCCCcEEEecccee
Confidence            999999999999999988642  2356889999999999999999999  778999999999999999999999999998


Q ss_pred             cCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccch
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      .........  .....|+..|+|||.+.+..++.++|||||||++|+|++|..||......    .......        
T Consensus       154 ~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~--------  219 (267)
T cd08224         154 RFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKK--------  219 (267)
T ss_pred             eeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHhh--------
Confidence            755432211  22345889999999998888999999999999999999999998654211    1111000        


Q ss_pred             hHhhcccccccCCH-HHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcc
Q 013105          314 DQIIDSRLEDRYST-EGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL  361 (449)
Q Consensus       314 ~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  361 (449)
                         +........+. ..+..+.+++.+||..+|++|||+.+|++.|+.+
T Consensus       220 ---~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         220 ---IEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             ---hhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence               00111111222 4566799999999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=8.9e-41  Score=320.40  Aligned_cols=252  Identities=22%  Similarity=0.374  Sum_probs=206.1

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      ..+|.+.+.||+|+||.||+|....      .++.|++|.+..........+.+|+.+++.+.|+||+++++.+......
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~   92 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVA------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL   92 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECC------CCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEE
Confidence            3579999999999999999997654      4789999999866555567788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+.+++|.+++..   ..+++.+...++.|++.||.|||  ..||+|+||||+|||++.++.++|+|||++....
T Consensus        93 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH--~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~  167 (296)
T cd06654          93 WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (296)
T ss_pred             EEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence            999999999999998854   35788999999999999999999  7789999999999999999999999999987543


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII  317 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (449)
                      .....  .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||........  ....    ..         
T Consensus       168 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~~----~~---------  230 (296)
T cd06654         168 PEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLI----AT---------  230 (296)
T ss_pred             ccccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHHH----hc---------
Confidence            32211  2234689999999999888889999999999999999999999975432111  0000    00         


Q ss_pred             cccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          318 DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       318 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ........+...+..+.+++.+||..||++||++.+++++
T Consensus       231 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         231 NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            0000111233456678999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.7e-41  Score=333.45  Aligned_cols=266  Identities=22%  Similarity=0.280  Sum_probs=201.0

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC--
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE--  155 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--  155 (449)
                      +|++.+.||+|+||.||+|.+..      +++.||+|.+...  .......+.+|+.+++.++|+||+++++++...+  
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   74 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPR------DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHID   74 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECC------CCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence            47889999999999999997654      5789999998643  2233467889999999999999999999998776  


Q ss_pred             ---EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecc
Q 013105          156 ---HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL  232 (449)
Q Consensus       156 ---~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGl  232 (449)
                         ..|+||||+. ++|.+.+...  ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||+
T Consensus        75 ~~~~~~lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~  149 (372)
T cd07853          75 PFEEIYVVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLH--SAGILHRDIKPGNLLVNSNCVLKICDFGL  149 (372)
T ss_pred             ccceEEEEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChHHEEECCCCCEEeccccc
Confidence               7899999996 6888877543  57899999999999999999999  77899999999999999999999999999


Q ss_pred             ccCCCCCCCCceeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhh--hhcc
Q 013105          233 ATDGPQGEDSHITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARP--MLKD  309 (449)
Q Consensus       233 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~--~~~~  309 (449)
                      +........ .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+.....  ....
T Consensus       150 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~  228 (372)
T cd07853         150 ARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA  228 (372)
T ss_pred             eeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            986543221 122334689999999998764 579999999999999999999999986543322221110000  0000


Q ss_pred             c----cchhHhh-cccccc-------cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          310 F----TKLDQII-DSRLED-------RYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       310 ~----~~~~~~~-~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .    ......+ ......       ......++++.+|+.+||+.||++|||+.+++.|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            0    0000000 000000       1122335678999999999999999999999987

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.8e-41  Score=314.89  Aligned_cols=256  Identities=29%  Similarity=0.424  Sum_probs=207.3

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      ..++|.+.+.||+|+||.||+|.+.+       +..||||.+.... .....+.+|+.+++.++|+||+++++++.....
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~-------~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNG-------TTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEP   75 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcC-------CceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCc
Confidence            45789999999999999999997653       4679999987443 345678899999999999999999999998899


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||+++++|.+++.......+++..+..++.+++.||.|||  +++++|+||||+||+++.++.++|+|||++...
T Consensus        76 ~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh--~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~  153 (261)
T cd05034          76 IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE--SRNYIHRDLAARNILVGENLVCKIADFGLARLI  153 (261)
T ss_pred             eEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcchheEEEcCCCCEEECccccceec
Confidence            999999999999999997765567899999999999999999999  778999999999999999999999999998765


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ..... .......++..|+|||.+.+..++.++|||||||++|+|++ |+.||.+.....   .....            
T Consensus       154 ~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~------------  217 (261)
T cd05034         154 EDDEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLEQV------------  217 (261)
T ss_pred             cchhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH------------
Confidence            43211 11112234678999999988889999999999999999998 999997543211   11100            


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEP  360 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  360 (449)
                        ........+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       218 --~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         218 --ERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             --HcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence              0001111223345679999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=6.2e-41  Score=318.69  Aligned_cols=266  Identities=25%  Similarity=0.357  Sum_probs=209.5

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEe-C
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCE-D  154 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~  154 (449)
                      -.++|.+.+.||+|+||.||+|.+...  ....+..|++|++.... ......+.+|+.+++.++|+||+++++++.. +
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~--~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   81 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDE--KPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG   81 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecC--CCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            356799999999999999999987652  12236789999986432 3335668899999999999999999998766 5


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCC------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEe
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYS------STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLS  228 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~  228 (449)
                      ...+++++|+.+++|.+++.....      ..+++..+..++.+++.||.|||  +.+++||||||+||+++.++.+||+
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH--KRGVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccCHhhEEEcCCCcEEEC
Confidence            778999999999999999865422      46889999999999999999999  7789999999999999999999999


Q ss_pred             eeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhh
Q 013105          229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPML  307 (449)
Q Consensus       229 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  307 (449)
                      |||+++...............++..|+|||++.+..++.++|||||||++||+++ |+.||......   ....+..   
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~---  233 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAAYLK---  233 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHHHHH---
Confidence            9999986543322211222346778999999988889999999999999999999 99999754221   1111110   


Q ss_pred             ccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                                 ..........+++.+.+++.+||..||++|||+.++++.|+.+..
T Consensus       234 -----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         234 -----------DGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             -----------cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                       011111223345679999999999999999999999999987753

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.2e-40  Score=317.43  Aligned_cols=274  Identities=24%  Similarity=0.353  Sum_probs=206.3

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEe--CCE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE--DEH  156 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~  156 (449)
                      ++|++.+.||+|+||.||+|....  .....+..||+|.+..........+.+|++++..++||||+++++++..  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~--~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDP--LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   81 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecC--CcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence            468889999999999999997542  1233578999999976655556788899999999999999999998754  356


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||+.+|+|.+++... ...+++..+..++.|++.||.|||  ++||+||||||+||+++.++.++|+|||++...
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH--~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLG--SKRYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            89999999999999998654 246899999999999999999999  788999999999999999999999999999865


Q ss_pred             CCCCCCce-eeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhc---cccc
Q 013105          237 PQGEDSHI-TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK---DFTK  312 (449)
Q Consensus       237 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~---~~~~  312 (449)
                      ........ .....++..|+|||++.+..++.++|||||||++|||++|..++......    +.........   ....
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~  234 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQMIVYH  234 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhcccccccccchHH
Confidence            43322111 11122345699999998888999999999999999999988775432110    0000000000   0000


Q ss_pred             hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcc
Q 013105          313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL  361 (449)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  361 (449)
                      +...+........+..++..+.+|+.+||+.+|++|||+.+|++.|+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         235 LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            1111121112222344567799999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.2e-42  Score=328.03  Aligned_cols=253  Identities=25%  Similarity=0.351  Sum_probs=201.3

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCC-CCCcceeeeEEEeC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLK-HPHLVNLIGYCCED  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~  154 (449)
                      ...|++.+.||+||.+.||++...+       .+.||+|.+...  +.....-|.+|+.+|.+|+ |.+||++++|-..+
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~-------~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d  432 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSD-------KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD  432 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCC-------CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence            3569999999999999999986543       466788776533  3455677999999999995 99999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +.+||||||-+ .+|..+|.........| .+..+..|++.++.++|  ..||||.||||.|+|+- .|.+||+|||+|.
T Consensus       433 ~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH--~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~  507 (677)
T KOG0596|consen  433 GYLYMVMECGD-IDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIH--QHGIVHSDLKPANFLLV-KGRLKLIDFGIAN  507 (677)
T ss_pred             ceEEEEeeccc-ccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHH--HhceeecCCCcccEEEE-eeeEEeeeechhc
Confidence            99999999865 78988887654333334 77888999999999999  77899999999999984 4699999999999


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccCC-----------CCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhh
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTGH-----------LTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA  303 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~  303 (449)
                      ..............+||+.||+||.+....           .++++||||||||||+|+.|++||....           
T Consensus       508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----------  576 (677)
T KOG0596|consen  508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----------  576 (677)
T ss_pred             ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----------
Confidence            887776666677789999999999984322           5678999999999999999999997421           


Q ss_pred             hhhhccccchhHhhcccccccCCHHHH-HHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          304 RPMLKDFTKLDQIIDSRLEDRYSTEGA-KRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                          ..+.++..+.+....-.|+..-+ .+++++++.||+.||.+||++.++|+|
T Consensus       577 ----n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  577 ----NQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             ----HHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence                11223333334333223332221 239999999999999999999999998

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.3e-40  Score=316.36  Aligned_cols=251  Identities=24%  Similarity=0.359  Sum_probs=199.2

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      ++|++.+.||+|+||.||+|.+..      +++.||+|++.... ......+.+|+.++.+++||||+++++++...+..
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   74 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLL------TRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRI   74 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcC------CCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEE
Confidence            368888999999999999997755      57899999987542 23345688999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+++++|..+      ..+++.....++.|++.||.|||  +.||+|+||||+|||++.++.++|+|||++....
T Consensus        75 ~lv~e~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~  146 (279)
T cd06619          75 SICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLW--SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV  146 (279)
T ss_pred             EEEEecCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHH--HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecc
Confidence            999999999998654      25678888999999999999999  7889999999999999999999999999997543


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchh-hHHhhhhhhccccchhHh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKD-LVEWARPMLKDFTKLDQI  316 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  316 (449)
                      ...    .....||..|+|||.+.+..++.++|||||||++|+|++|..||.......... .....          ...
T Consensus       147 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~----------~~~  212 (279)
T cd06619         147 NSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL----------QCI  212 (279)
T ss_pred             ccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH----------HHH
Confidence            321    233568999999999988889999999999999999999999997532111110 00000          000


Q ss_pred             hcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .............+.++.+++.+||+.||++||++.+++++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         213 VDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             hccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            00000000112244568999999999999999999999987

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-40  Score=312.24  Aligned_cols=250  Identities=30%  Similarity=0.477  Sum_probs=205.8

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      .++|++.+.||.|+||.||+|...        ++.||+|.+..... ....+.+|+.+++.++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   75 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--------GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPL   75 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--------CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCe
Confidence            357889999999999999999653        57899999975543 467789999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+.+++|.+++.......+++..+..++.|++.||.|||  .++++|+||||+||+++.++.++|+|||++....
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh--~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~  153 (256)
T cd05039          76 YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE--EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS  153 (256)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccchhcccceEEEeCCCCEEEcccccccccc
Confidence            99999999999999997765557899999999999999999999  7889999999999999999999999999998653


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI  316 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (449)
                      ....     ...++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   +....             
T Consensus       154 ~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~-------------  212 (256)
T cd05039         154 QGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHV-------------  212 (256)
T ss_pred             cccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH-------------
Confidence            2211     2235678999999988889999999999999999997 999986542211   11100             


Q ss_pred             hcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 013105          317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEP  360 (449)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  360 (449)
                       ........+...++.+.+++.+||..+|++|||+.++++.|+.
T Consensus       213 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         213 -EKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             -hcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence             0001111223445679999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=9.8e-41  Score=319.82  Aligned_cols=270  Identities=26%  Similarity=0.384  Sum_probs=207.8

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCC----------CCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcce
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNL----------RPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVN  146 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~----------~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~  146 (449)
                      .++|++.+.||+|+||.||+|......          ........||+|.+..... .....+.+|++++..++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            457999999999999999999775421          1112346799999875432 34567889999999999999999


Q ss_pred             eeeEEEeCCEEEEEEEecCCCChHHHHhhcC---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCce
Q 013105          147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNY---------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNI  217 (449)
Q Consensus       147 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Ni  217 (449)
                      +++++..++..+++|||+.+++|.+++....         ...+++..++.++.|++.||.|||  +.+|+||||||+||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH--~~~i~H~dlkp~Ni  161 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE--SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH--HcCccccccchhce
Confidence            9999999999999999999999999986642         126889999999999999999999  67899999999999


Q ss_pred             EEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh--CCCccccccccc
Q 013105          218 LLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT--GRRSVEKNRCKR  295 (449)
Q Consensus       218 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt--g~~pf~~~~~~~  295 (449)
                      +++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++  |..||...... 
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~-  240 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ-  240 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH-
Confidence            999999999999999886543332222333456789999999988889999999999999999998  67777643211 


Q ss_pred             chhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 013105          296 EKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE  359 (449)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  359 (449)
                        .............       ........+..++.++.+++.+||+.||++|||+.+|++.|+
T Consensus       241 --~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 --QVIENAGHFFRDD-------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             --HHHHHHHhccccc-------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence              1111111100000       001111122344567999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=8.8e-41  Score=314.21  Aligned_cols=254  Identities=27%  Similarity=0.386  Sum_probs=203.0

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      .++|.+.+.||+|+||.||+|.+..       +..+|+|.+.... .....+.+|+.+++.++|+||+++++++. .+..
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~-------~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~   75 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNG-------TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPI   75 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcC-------CceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCc
Confidence            3568899999999999999997654       3469999886432 33467889999999999999999999875 4568


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+.+++|.+++.......+++..+..++.+++.||.|||  +.|++|+||||+||+++.++.++|+|||++....
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~  153 (260)
T cd05069          76 YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE--RMNYIHRDLRAANILVGDNLVCKIADFGLARLIE  153 (260)
T ss_pred             EEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeecccCcceEEEcCCCeEEECCCccceEcc
Confidence            99999999999999997655556889999999999999999999  7889999999999999999999999999997553


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI  316 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (449)
                      ..... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.....   .....             
T Consensus       154 ~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~-------------  216 (260)
T cd05069         154 DNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQV-------------  216 (260)
T ss_pred             CCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH-------------
Confidence            32211 1122345678999999988889999999999999999999 899997543211   11110             


Q ss_pred             hcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 013105          317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEP  360 (449)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  360 (449)
                       ........+...+..+.+++.+||+.||++||++.++++.|+.
T Consensus       217 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         217 -ERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -HcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence             0011112234456779999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.3e-41  Score=326.33  Aligned_cols=238  Identities=28%  Similarity=0.383  Sum_probs=189.1

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHH-HHhcCCCCCcceeeeEEEeCCEEEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVI-FLGQLKHPHLVNLIGYCCEDEHRLLV  160 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~~lv  160 (449)
                      +.||+|+||.||+|.+..      .++.||+|++....   ......+..|.. +++.++||||+++++++.+.+..|+|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv   74 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKS------DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFV   74 (321)
T ss_pred             CeeeeCCCEEEEEEEECC------CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEE
Confidence            469999999999998765      47899999986431   222344555554 67889999999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCC
Q 013105          161 YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGE  240 (449)
Q Consensus       161 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~  240 (449)
                      |||+++|+|...+...  ..+++.....++.|++.||.|||  .++|+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  150 (321)
T cd05603          75 LDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLH--SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE  150 (321)
T ss_pred             EcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC
Confidence            9999999998888654  56888888999999999999999  7789999999999999999999999999987532221


Q ss_pred             CCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhccc
Q 013105          241 DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSR  320 (449)
Q Consensus       241 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (449)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|..||.......   ...             .+... 
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~-------------~i~~~-  211 (321)
T cd05603         151 E--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ---MYD-------------NILHK-  211 (321)
T ss_pred             C--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH---HHH-------------HHhcC-
Confidence            1  2234569999999999988889999999999999999999999997642111   100             01111 


Q ss_pred             ccccCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 013105          321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMT  352 (449)
Q Consensus       321 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  352 (449)
                       ....+...+..+.+++.+||+.||.+||++.
T Consensus       212 -~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         212 -PLQLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             -CCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence             1122334456689999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-42  Score=310.75  Aligned_cols=251  Identities=24%  Similarity=0.351  Sum_probs=208.6

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      -.++|..+++||+|.||.|.++..+.      +++.+|+|+++..   .......-+.|-++|+..+||.+..+...|+.
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKa------t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt  239 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKA------TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT  239 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecc------cCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc
Confidence            34789999999999999999985544      7999999999754   23344556789999999999999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      .+++|+||||..||.|.-.|.+.  ..+++....-+...|+.||.|||  .++||+||||.+|+|+|.+|++||+||||+
T Consensus       240 ~drlCFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLH--s~~ivYRDlKLENLlLDkDGHIKitDFGLC  315 (516)
T KOG0690|consen  240 QDRLCFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLH--SRNIVYRDLKLENLLLDKDGHIKITDFGLC  315 (516)
T ss_pred             CceEEEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhh--hCCeeeeechhhhheeccCCceEeeecccc
Confidence            99999999999999999888764  67888888888999999999999  677999999999999999999999999999


Q ss_pred             cCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccch
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      +.....  ...+..++|||.|+|||++....|+.++|+|.+||++|||++|+.||...+....-+++             
T Consensus       316 KE~I~~--g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI-------------  380 (516)
T KOG0690|consen  316 KEEIKY--GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI-------------  380 (516)
T ss_pred             hhcccc--cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH-------------
Confidence            865432  33466788999999999999999999999999999999999999999764322111111             


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRP-----TMTTVVKA  357 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  357 (449)
                          .. ..-.+|..++++...|+..+|.+||.+|.     .+.||.++
T Consensus       381 ----l~-ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  381 ----LM-EDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             ----Hh-hhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence                11 01234566677899999999999999993     56677665

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-42  Score=332.17  Aligned_cols=245  Identities=31%  Similarity=0.440  Sum_probs=203.2

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc---hHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ---GHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      |.-.+.||.|+||.||-|.+..      +.+.||||.+...+.+   ..++++.|+..|+++.|||+|.+.|+|..+...
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~------n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~Ta  101 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVR------NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTA  101 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccC------ccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchH
Confidence            5667889999999999996654      5889999999866544   356789999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      |||||||- |+-.|++.-. .+++-+.++..|+.+.+.||+||||  .+.||||||..|||+++.|.|||+|||.|....
T Consensus       102 WLVMEYCl-GSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS--~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~  177 (948)
T KOG0577|consen  102 WLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHS--HNRIHRDIKAGNILLSEPGLVKLADFGSASIMA  177 (948)
T ss_pred             HHHHHHHh-ccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHH--hhHHhhhccccceEecCCCeeeeccccchhhcC
Confidence            99999996 6777766433 3688899999999999999999995  559999999999999999999999999988654


Q ss_pred             CCCCCceeeecCCCCcccccccc---ccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYI---NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      +      ...++|||+|||||++   ..+.|+-++||||||++..||...++|+..+..-.                .+.
T Consensus       178 P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS----------------ALY  235 (948)
T KOG0577|consen  178 P------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----------------ALY  235 (948)
T ss_pred             c------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH----------------HHH
Confidence            3      3457899999999998   35689999999999999999999999987653211                111


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .+.....+.--..+.++.+..++..||++-|.+|||.+++++|
T Consensus       236 HIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  236 HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             HHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            1111111112246788899999999999999999999999987

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-42  Score=334.11  Aligned_cols=246  Identities=24%  Similarity=0.349  Sum_probs=205.7

Q ss_pred             cccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEEEecC
Q 013105           86 YLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMA  165 (449)
Q Consensus        86 ~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~  165 (449)
                      +||+|.||+||.|.+.+      +...+|||-+........+-+..|+.+.+.|+|.|||+++|.+.++++.-|.||-++
T Consensus       582 VLGKGTYG~VYA~RD~~------tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVP  655 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMD------TQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVP  655 (1226)
T ss_pred             EeecCceeEEEeecccc------ceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCC
Confidence            59999999999997765      577899999987777777889999999999999999999999999999999999999


Q ss_pred             CCChHHHHhhcCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEc-CCCcEEEeeeccccCCCCCCCC
Q 013105          166 LGNLHDQLFKNYSSTL--PWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD-SDYNAKLSDFGLATDGPQGEDS  242 (449)
Q Consensus       166 ~g~L~~~l~~~~~~~l--~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~-~~~~~kl~DfGla~~~~~~~~~  242 (449)
                      ||+|.+++.... +++  .+.+.--+..||++||.|||  ++.|||||||-+|||++ -.|.+||+|||-++....-  .
T Consensus       656 GGSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLH--en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--n  730 (1226)
T KOG4279|consen  656 GGSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLH--ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--N  730 (1226)
T ss_pred             CCcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhh--hcceeeccccCCcEEEeeccceEEecccccchhhccC--C
Confidence            999999997764 344  67788889999999999999  67799999999999996 5689999999998865432  2


Q ss_pred             ceeeecCCCCccccccccccC--CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhccc
Q 013105          243 HITTCVMGTEGYAAPEYINTG--HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSR  320 (449)
Q Consensus       243 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (449)
                      ..+.++.||..|||||++..+  .|+.++|||||||++.||.||++||-......   ...+...            --.
T Consensus       731 P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq---AAMFkVG------------myK  795 (1226)
T KOG4279|consen  731 PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ---AAMFKVG------------MYK  795 (1226)
T ss_pred             ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh---Hhhhhhc------------cee
Confidence            345667899999999999644  68999999999999999999999997542111   1111000            112


Q ss_pred             ccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       321 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ..+++|.+.+.+...+|.+|+..||.+||++.++|..
T Consensus       796 vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  796 VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence            3456788999999999999999999999999999974

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=6.2e-41  Score=322.55  Aligned_cols=262  Identities=29%  Similarity=0.431  Sum_probs=203.8

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC-CcchHHHHHHHHHHHhcC-CCCCcceeeeEEEeCC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCEDE  155 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~  155 (449)
                      .++|++.+.||+|+||.||+|.+..+    .....+++|.+... .......+.+|+.++.++ +|+||+++++++...+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~----~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~   81 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKD----GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   81 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccC----CceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence            35788999999999999999987542    11234677776533 233445788899999999 8999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNY--------------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS  221 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~  221 (449)
                      ..++||||+++|+|.+++....              ...+++..++.++.|++.||+|||  ++||+||||||+|||++.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~gi~H~dlkp~Nili~~  159 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGE  159 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH--hCCccccccchheEEecC
Confidence            9999999999999999986532              235788999999999999999999  788999999999999999


Q ss_pred             CCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhH
Q 013105          222 DYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLV  300 (449)
Q Consensus       222 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~  300 (449)
                      ++.++|+|||++.......   ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......   ..
T Consensus       160 ~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~  233 (303)
T cd05088         160 NYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LY  233 (303)
T ss_pred             CCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---HH
Confidence            9999999999986432111   1111224667999999988889999999999999999998 999997543211   11


Q ss_pred             HhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCC
Q 013105          301 EWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN  365 (449)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  365 (449)
                      ..   .           ........+...+..+.+|+.+||+.+|++||++.+++..|+.++...
T Consensus       234 ~~---~-----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         234 EK---L-----------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             HH---H-----------hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            10   0           000011112234567899999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.8e-41  Score=328.15  Aligned_cols=239  Identities=28%  Similarity=0.373  Sum_probs=190.3

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHH-HHhcCCCCCcceeeeEEEeCCEEEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVI-FLGQLKHPHLVNLIGYCCEDEHRLLV  160 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~~lv  160 (449)
                      +.||+|+||.||+|....      +++.||+|++...   .......+..|.. +++.++||||+++++++..++..|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv   74 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKL------DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFV   74 (325)
T ss_pred             CceeeCCCeEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEE
Confidence            469999999999997765      5789999999643   2223345555654 56778999999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCC
Q 013105          161 YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGE  240 (449)
Q Consensus       161 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~  240 (449)
                      |||+.+|+|..++...  ..+++.....++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH--~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~  150 (325)
T cd05604          75 LDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLH--SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS  150 (325)
T ss_pred             EcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC
Confidence            9999999999888654  57899999999999999999999  7889999999999999999999999999987543222


Q ss_pred             CCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhccc
Q 013105          241 DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSR  320 (449)
Q Consensus       241 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (449)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|..||.........      ..          +....
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~------~~----------~~~~~  212 (325)
T cd05604         151 D--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY------DN----------ILHKP  212 (325)
T ss_pred             C--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH------HH----------HHcCC
Confidence            1  123456999999999999889999999999999999999999999764321110      00          00100


Q ss_pred             ccccCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 013105          321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTT  353 (449)
Q Consensus       321 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  353 (449)
                        ....+..+..+.+++.+||+.||.+||++.+
T Consensus       213 --~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         213 --LVLRPGASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             --ccCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence              1112234556889999999999999998863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=9.9e-41  Score=350.63  Aligned_cols=264  Identities=23%  Similarity=0.319  Sum_probs=205.8

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ++|++.+.||+|+||.||+|.+..      +++.||+|++....   .....++.+|+++++.++||||+++++++.+++
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~------tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~   75 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPV------CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD   75 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECC------CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC
Confidence            579999999999999999998765      57899999997432   223457889999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcC---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEE
Q 013105          156 HRLLVYEYMALGNLHDQLFKNY---------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAK  226 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~k  226 (449)
                      ..++||||++||+|.+++....         ....++...+.++.|++.||+|||  ++||+||||||+|||++.++.++
T Consensus        76 ~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH--s~GIIHRDLKPeNILLd~dg~vK  153 (932)
T PRK13184         76 PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH--SKGVLHRDLKPDNILLGLFGEVV  153 (932)
T ss_pred             EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH--HCCccccCCchheEEEcCCCCEE
Confidence            9999999999999999886421         123556778899999999999999  77899999999999999999999


Q ss_pred             EeeeccccCCCCCCC----------------CceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccc
Q 013105          227 LSDFGLATDGPQGED----------------SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEK  290 (449)
Q Consensus       227 l~DfGla~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~  290 (449)
                      |+|||++........                .......+||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus       154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            999999985521110                0111235699999999999988999999999999999999999999975


Q ss_pred             cccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHhhccccCC
Q 013105          291 NRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRP-TMTTVVKALEPLLDLN  365 (449)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~~~~~~  365 (449)
                      .......    .. ..          +...........+++.+.+++.+||+.||++|| +++++++.|+.++...
T Consensus       234 ~~~~ki~----~~-~~----------i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~  294 (932)
T PRK13184        234 KKGRKIS----YR-DV----------ILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGS  294 (932)
T ss_pred             cchhhhh----hh-hh----------ccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcC
Confidence            3211100    00 00          000000000124456789999999999999995 6777888888776543

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=8.1e-41  Score=315.55  Aligned_cols=254  Identities=23%  Similarity=0.364  Sum_probs=202.4

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      ++|.+.+.||+|+||.||+|....      +++.||+|+++.........+.+|+.+++.++||||+++++++...+..+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVN------TGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW   82 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcC------CCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence            568888999999999999997765      47899999997665555566888999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCC
Q 013105          159 LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~  238 (449)
                      +||||+.+++|.+++...  ..+++.+...++.|++.||.|||  +.|++|+||||+||+++.++.++|+|||++.....
T Consensus        83 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06645          83 ICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLH--SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA  158 (267)
T ss_pred             EEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence            999999999999988654  57899999999999999999999  67899999999999999999999999999875433


Q ss_pred             CCCCceeeecCCCCccccccccc---cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          239 GEDSHITTCVMGTEGYAAPEYIN---TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ...  ......|+..|+|||++.   ...++.++|||||||++|+|++|..||.............     ....     
T Consensus       159 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~-----~~~~-----  226 (267)
T cd06645         159 TIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT-----KSNF-----  226 (267)
T ss_pred             ccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh-----ccCC-----
Confidence            211  123356899999999874   4568899999999999999999999986532211110000     0000     


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                        ..... .....++..+.+++.+||+.+|++||++.+|+++
T Consensus       227 --~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         227 --QPPKL-KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             --CCCcc-cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence              00000 0011234568899999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.1e-40  Score=315.43  Aligned_cols=254  Identities=26%  Similarity=0.378  Sum_probs=202.0

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcC-CCCCcceeeeEEEeC-
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCED-  154 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~-  154 (449)
                      ..+.|.+.+.||+|+||.||+|....      +++.||+|++.... .....+.+|+.++..+ +|+||+++++++... 
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~------~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   76 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVK------TGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN   76 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcC------CCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence            45678889999999999999997765      57899999997543 3345778899999998 699999999998753 


Q ss_pred             -----CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEee
Q 013105          155 -----EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSD  229 (449)
Q Consensus       155 -----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~D  229 (449)
                           ...|+||||+.+++|.+++.......+++..+..++.|++.||.|||  +++|+|+||||+||+++.++.++|+|
T Consensus        77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH--~~~ivh~dl~~~nili~~~~~~~l~D  154 (272)
T cd06637          77 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVD  154 (272)
T ss_pred             CCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCCHHHEEECCCCCEEEcc
Confidence                 46899999999999999987755567899999999999999999999  67899999999999999999999999


Q ss_pred             eccccCCCCCCCCceeeecCCCCccccccccc-----cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhh
Q 013105          230 FGLATDGPQGEDSHITTCVMGTEGYAAPEYIN-----TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR  304 (449)
Q Consensus       230 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~  304 (449)
                      ||++........  ......|+..|+|||++.     +..++.++|||||||++|||++|..||............    
T Consensus       155 fg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~----  228 (272)
T cd06637         155 FGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI----  228 (272)
T ss_pred             CCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH----
Confidence            999875433211  123356899999999985     345788999999999999999999999654221111000    


Q ss_pred             hhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          305 PMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                                  ............++..+.+|+.+||..||.+|||+.+++++
T Consensus       229 ------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         229 ------------PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             ------------hcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence                        00001111122345678999999999999999999999986

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=5.7e-41  Score=330.07  Aligned_cols=266  Identities=20%  Similarity=0.260  Sum_probs=199.6

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      .+.++|++.+.||+|+||.||+|.+..      .++.||+|++...  .......+.+|+.+++.++||||+++++++..
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   87 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAV------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP   87 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecC------CCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeec
Confidence            356789999999999999999997654      5788999998743  22334567889999999999999999998864


Q ss_pred             C------CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEE
Q 013105          154 D------EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKL  227 (449)
Q Consensus       154 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl  227 (449)
                      .      ...|+||||+. ++|.+.+..    .++...+..++.|++.||.|||  ++||+||||||+|||++.++.+||
T Consensus        88 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH--~~givHrDikp~Nill~~~~~~kl  160 (355)
T cd07874          88 QKSLEEFQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKI  160 (355)
T ss_pred             cccccccceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChHHEEECCCCCEEE
Confidence            3      35799999997 567666643    4788888999999999999999  788999999999999999999999


Q ss_pred             eeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhH-Hh----
Q 013105          228 SDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV-EW----  302 (449)
Q Consensus       228 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~-~~----  302 (449)
                      +|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.......... ..    
T Consensus       161 ~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (355)
T cd07874         161 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP  237 (355)
T ss_pred             eeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999998643321   123356899999999999889999999999999999999999999765322111100 00    


Q ss_pred             -----------hhhhhccccchh-----Hhhccc---ccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          303 -----------ARPMLKDFTKLD-----QIIDSR---LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       303 -----------~~~~~~~~~~~~-----~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                                 ............     ......   .........+..+.+|+.+||+.||++|||+.++++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             CHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                       000000000000     000000   0001112234578999999999999999999999997

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-41  Score=326.15  Aligned_cols=256  Identities=20%  Similarity=0.257  Sum_probs=198.5

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ++|++.+.||+|+||.||++....      +++.||+|++...   .......+.+|+.++..++|+||+.+++++.+++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKN------TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN   74 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECC------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence            478999999999999999997765      5789999999632   2233456788999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..|+||||+.||+|.+++.+. ...+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  151 (331)
T cd05597          75 NLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVH--QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLR  151 (331)
T ss_pred             eEEEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH--hCCeEECCCCHHHEEECCCCCEEEEECCceee
Confidence            999999999999999998653 356889999999999999999999  78899999999999999999999999999875


Q ss_pred             CCCCCCCceeeecCCCCcccccccccc-----CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccc
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINT-----GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF  310 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  310 (449)
                      ....... ......||+.|+|||++.+     ..++.++|||||||++|||++|+.||..........      ......
T Consensus       152 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~------~i~~~~  224 (331)
T cd05597         152 LLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KIMNHK  224 (331)
T ss_pred             cCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHH------HHHcCC
Confidence            4432211 1222469999999999863     457889999999999999999999997543211110      000000


Q ss_pred             cchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 013105          311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKS--RPTMTTVVKA  357 (449)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~  357 (449)
                      ..      ... .......+..+.+++.+||..++.+  ||++.++++|
T Consensus       225 ~~------~~~-~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         225 EH------FQF-PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             Cc------ccC-CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            00      000 0111235567889999988654443  7899999988

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.1e-41  Score=337.36  Aligned_cols=264  Identities=20%  Similarity=0.238  Sum_probs=198.6

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      ..+|.+.+.||+|+||.||+|.+..      .++.||||...      ...+.+|+++|++++|+||+++++++..++..
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~------~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~  235 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPD------YPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLT  235 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECC------CCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEE
Confidence            4579999999999999999997765      47889999643      23356899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++|||++. ++|.+++... ...+++..++.++.|++.||.|||  .+||+||||||+|||++.++.++|+|||+++...
T Consensus       236 ~lv~e~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH--~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~  311 (461)
T PHA03211        236 CLVLPKYR-SDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIH--GEGIIHRDIKTENVLVNGPEDICLGDFGAACFAR  311 (461)
T ss_pred             EEEEEccC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence            99999995 7888888654 247899999999999999999999  7789999999999999999999999999998654


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccc-----hhh---HHhhhhhhcc
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE-----KDL---VEWARPMLKD  309 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~-----~~~---~~~~~~~~~~  309 (449)
                      ............||+.|+|||++.+..++.++|||||||+||||++|..++........     ..+   +.........
T Consensus       312 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~  391 (461)
T PHA03211        312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE  391 (461)
T ss_pred             cccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence            32222222345699999999999988999999999999999999998876543211100     011   1111100000


Q ss_pred             ccc-----hhHhhcc----cccc-----cCC--HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          310 FTK-----LDQIIDS----RLED-----RYS--TEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       310 ~~~-----~~~~~~~----~~~~-----~~~--~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      +..     +......    ....     .+.  ...+.++.+||.+||+.||.+|||+.|+|+|
T Consensus       392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            000     0000000    0000     000  1234468899999999999999999999997

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-40  Score=319.40  Aligned_cols=270  Identities=23%  Similarity=0.366  Sum_probs=203.0

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCC--------CCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceee
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNL--------RPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLI  148 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~--------~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~  148 (449)
                      .++|++.+.||+|+||.||++......        ........||+|.+.... ......+.+|++++++++|+||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            357999999999999999998664310        011123468999987542 23345688999999999999999999


Q ss_pred             eEEEeCCEEEEEEEecCCCChHHHHhhcC----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceE
Q 013105          149 GYCCEDEHRLLVYEYMALGNLHDQLFKNY----------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNIL  218 (449)
Q Consensus       149 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nil  218 (449)
                      +++...+..++||||+.+++|.+++....          ...+++..++.++.+++.||.|||  +.+++|+||||+|||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~Nil  161 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA--SLNFVHRDLATRNCL  161 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH--hcCeeccccChhhEE
Confidence            99999999999999999999999885431          124678889999999999999999  778999999999999


Q ss_pred             EcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh--CCCcccccccccc
Q 013105          219 LDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT--GRRSVEKNRCKRE  296 (449)
Q Consensus       219 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt--g~~pf~~~~~~~~  296 (449)
                      ++.++.+||+|||++................++..|+|||.+.+..++.++|||||||++|+|++  |..||........
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            99999999999999986543322222223345778999999988889999999999999999988  6677765322111


Q ss_pred             hhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 013105          297 KDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE  359 (449)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  359 (449)
                         ..........       .........+...+..+.+|+.+||+.||++|||+.+|++.|+
T Consensus       242 ---~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         242 ---IENTGEFFRN-------QGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             ---HHHHHHhhhh-------ccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence               1100000000       0000001112234567999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.9e-40  Score=318.02  Aligned_cols=270  Identities=24%  Similarity=0.375  Sum_probs=203.6

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCC----------CCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcce
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNL----------RPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVN  146 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~----------~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~  146 (449)
                      .++|++.+.||+|+||.||++......          ........+|+|++.... ......+.+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            357999999999999999998543210          111234579999997543 233467889999999999999999


Q ss_pred             eeeEEEeCCEEEEEEEecCCCChHHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCce
Q 013105          147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYS---------STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNI  217 (449)
Q Consensus       147 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Ni  217 (449)
                      +++++...+..++||||+.+|+|.+++.....         ..+++.+...++.|++.||.|||  +.|++|+||||+||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dlkp~Ni  161 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS--SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH--HCCeecccCChheE
Confidence            99999999999999999999999999865421         24667889999999999999999  77899999999999


Q ss_pred             EEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh--CCCccccccccc
Q 013105          218 LLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT--GRRSVEKNRCKR  295 (449)
Q Consensus       218 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt--g~~pf~~~~~~~  295 (449)
                      |++.++.++|+|||++................++..|++||...+..++.++|||||||++|||++  |..||.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999886533222111222334678999999888889999999999999999998  778886532211


Q ss_pred             chhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 013105          296 EKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE  359 (449)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  359 (449)
                      ..   ..........       ........+..++..+.+|+.+||+.||.+||++.+|++.|+
T Consensus       242 ~~---~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         242 VI---ENTGEFFRDQ-------GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HH---HHHHHHHhhc-------cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            11   0000000000       000001112334567999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.5e-40  Score=312.55  Aligned_cols=256  Identities=28%  Similarity=0.407  Sum_probs=205.4

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      +..++|++.+.||+|+||.||+|.+..       +..+|+|.+... ......+.+|+.+++.++|+||+++++++.+ .
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~-------~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~   73 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYNK-------HTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-E   73 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEecC-------CccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-C
Confidence            345789999999999999999997543       456999988643 2335678899999999999999999999887 7


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..+++|||+.+++|.+++.......+++..+..++.+++.||.|||  +.|++|+||||+||+++.++.++|+|||++..
T Consensus        74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~  151 (260)
T cd05073          74 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGLARV  151 (260)
T ss_pred             CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH--hCCccccccCcceEEEcCCCcEEECCCcceee
Confidence            7899999999999999997765567888999999999999999999  78899999999999999999999999999876


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchh
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ...... .......++..|+|||++.+..++.++|+|||||++|+|++ |..||........   ....           
T Consensus       152 ~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~-----------  216 (260)
T cd05073         152 IEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IRAL-----------  216 (260)
T ss_pred             ccCCCc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH---HHHH-----------
Confidence            543221 11222345678999999988889999999999999999998 9999975422111   1100           


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEP  360 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  360 (449)
                         ........+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       217 ---~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         217 ---ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ---hCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence               0001111223445679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.2e-40  Score=310.72  Aligned_cols=253  Identities=30%  Similarity=0.415  Sum_probs=202.2

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEEEe
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEY  163 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  163 (449)
                      +.||+|++|.||+|.+...   ......||+|.+..... .....+.+|+.++++++||||+++++++.. ...++||||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTS---GGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecC---CCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEe
Confidence            4689999999999987642   12344799999986554 456788999999999999999999999988 889999999


Q ss_pred             cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCC-
Q 013105          164 MALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS-  242 (449)
Q Consensus       164 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~-  242 (449)
                      +++++|.+++.......+++...+.++.|++.||.|||  +++++|+||||+||+++.++.+||+|||++......... 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE--SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH--hCCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            99999999997754357899999999999999999999  788999999999999999999999999999865432211 


Q ss_pred             ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHhhcccc
Q 013105          243 HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRL  321 (449)
Q Consensus       243 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (449)
                      .......++..|+|||.+.+..++.++|||||||++|||++ |..||............   .   .          ...
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~---~---~----------~~~  218 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI---D---K----------EGE  218 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---H---h----------cCC
Confidence            11123457789999999988889999999999999999998 99999654222111100   0   0          000


Q ss_pred             cccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 013105          322 EDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE  359 (449)
Q Consensus       322 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  359 (449)
                      ....+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            11122344567999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.3e-40  Score=317.74  Aligned_cols=262  Identities=25%  Similarity=0.405  Sum_probs=204.7

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      .++|++.+.||+|+||.||+|..... .+..++..||+|++..... .....+.+|+.+++.++||||+++++++.+++.
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~-~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGL-LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             hHhceecccccccccccEEEEEEccc-CCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            46789999999999999999976431 2233577899999875432 334668899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcC--------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCc
Q 013105          157 RLLVYEYMALGNLHDQLFKNY--------------------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASN  216 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~N  216 (449)
                      .++||||+.+|+|.+++....                    ...+++..++.++.|++.||.|||  .++++||||||+|
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH--~~~i~H~dl~p~n  160 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS--ERKFVHRDLATRN  160 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hCCeecccccHhh
Confidence            999999999999999986432                    124678888999999999999999  7789999999999


Q ss_pred             eEEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCccccccccc
Q 013105          217 ILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKR  295 (449)
Q Consensus       217 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~  295 (449)
                      ||++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||.+.....
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999875433221111122234667999999988889999999999999999997 888886432211


Q ss_pred             chhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 013105          296 EKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE  359 (449)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  359 (449)
                         .....             .... ....+..++..+.+++.+||+.||++|||+.|+++.|+
T Consensus       241 ---~~~~~-------------~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         241 ---VIYYV-------------RDGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             ---HHHHH-------------hcCC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence               11100             0000 01122345567999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.3e-40  Score=314.51  Aligned_cols=260  Identities=25%  Similarity=0.421  Sum_probs=204.6

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC-CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      .+|++.+.||+|+||.||+|.+...   ......||+|++... .......+..|+.+++.++||||+++++++.++...
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLP---GKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecC---CCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence            4578899999999999999987653   112357999998754 233456789999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+.+++|.+++... ...+++..++.++.|++.||.|||  ++|++|+||||+||+++.++.++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH--~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          81 MIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLS--EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccChheEEEcCCCcEEECCCccccccc
Confidence            9999999999999988654 356889999999999999999999  7889999999999999999999999999987543


Q ss_pred             CCCCCceeee-cC--CCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccch
Q 013105          238 QGEDSHITTC-VM--GTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       238 ~~~~~~~~~~-~~--gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      .......... ..  ++..|+|||.+.+..++.++|||||||++|||++ |..||......   +......         
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~---------  225 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIE---------  225 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHH---------
Confidence            3221111111 11  2457999999988889999999999999999886 99998754321   1111110         


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcc
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL  361 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  361 (449)
                           .......+.+++..+.+++..||+.+|.+||++.+|+..|+.+
T Consensus       226 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         226 -----QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             -----cCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                 0011112234556789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.9e-40  Score=313.22  Aligned_cols=261  Identities=24%  Similarity=0.417  Sum_probs=205.7

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      .++|+..+.||+|+||.||+|....+   ......+|+|.++... ......+.+|+.++..++|+||+++++++...+.
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~---~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMP---GRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecC---CCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            35688889999999999999987542   1123479999987542 3335678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||+.+++|.+++... ...+++.....++.+++.||.|||  +.+++|+||||+||+++.++.++|+|||++...
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          81 AMIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLS--DMNYVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccchhhEEEcCCCcEEECCCccceec
Confidence            99999999999999988654 357899999999999999999999  778999999999999999999999999998765


Q ss_pred             CCCCCCcee-eecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchh
Q 013105          237 PQGEDSHIT-TCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       237 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ......... .....+..|+|||++.+..++.++|||||||++|||++ |..||.......   .....           
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~~i-----------  223 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMKAI-----------  223 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHH-----------
Confidence            432211111 11123457999999988889999999999999999997 999996542211   11100           


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcc
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL  361 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  361 (449)
                         ........+..++..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus       224 ---~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         224 ---NDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ---hcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               00111112234556789999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.1e-40  Score=329.21  Aligned_cols=265  Identities=19%  Similarity=0.247  Sum_probs=199.1

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      +.++|.+.+.||+|+||.||+|.+..      .++.||||++...  .......+.+|+.+++.++||||+++++++...
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~   95 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAI------LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQ   95 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECC------CCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccc
Confidence            45789999999999999999997655      5788999998643  233346678899999999999999999987543


Q ss_pred             ------CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEe
Q 013105          155 ------EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLS  228 (449)
Q Consensus       155 ------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~  228 (449)
                            ...|+||||+. ++|.+.+..    .+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+
T Consensus        96 ~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~  168 (364)
T cd07875          96 KSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKIL  168 (364)
T ss_pred             ccccccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHh--hCCeecCCCCHHHEEECCCCcEEEE
Confidence                  45799999997 577777643    4788888999999999999999  7789999999999999999999999


Q ss_pred             eeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHh-h----
Q 013105          229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEW-A----  303 (449)
Q Consensus       229 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~-~----  303 (449)
                      |||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.. .    
T Consensus       169 DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  245 (364)
T cd07875         169 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC  245 (364)
T ss_pred             eCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            999998643321   12335689999999999988999999999999999999999999976543221111000 0    


Q ss_pred             -------h----hhhccccc-----hhHhhccc---ccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          304 -------R----PMLKDFTK-----LDQIIDSR---LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       304 -------~----~~~~~~~~-----~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                             .    ........     ........   .........+..+.+|+.+||+.||.+|||+.++++|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                   0    00000000     00000000   0000111224568899999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-43  Score=314.10  Aligned_cols=248  Identities=26%  Similarity=0.360  Sum_probs=210.1

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLL  159 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  159 (449)
                      -|.+.+.||+|+||.||+|.++.      +|+.+|||.+..+  .+.++++.|+.+++++..|+||++||.+.....++|
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~E------sG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWI  105 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRE------SGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWI  105 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhc------cCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEe
Confidence            36677899999999999997766      6999999998654  457899999999999999999999999999999999


Q ss_pred             EEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCC
Q 013105          160 VYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQG  239 (449)
Q Consensus       160 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~  239 (449)
                      |||||-.|++.+.+..+ ++++.+.++..++...+.||+|||  ...-||||||..|||++.+|..||+|||.|..+.+.
T Consensus       106 VMEYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH--~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT  182 (502)
T KOG0574|consen  106 VMEYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLH--DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT  182 (502)
T ss_pred             ehhhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHH--HHHHHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence            99999999999988654 578999999999999999999999  555899999999999999999999999999876543


Q ss_pred             CCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcc
Q 013105          240 EDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDS  319 (449)
Q Consensus       240 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (449)
                      .  .....+.|||.|||||++..-.|+.++||||||++..||..|++||..-.+-....                - +..
T Consensus       183 M--AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF----------------M-IPT  243 (502)
T KOG0574|consen  183 M--AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF----------------M-IPT  243 (502)
T ss_pred             H--HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE----------------e-ccC
Confidence            2  22445779999999999998899999999999999999999999997532111110                0 011


Q ss_pred             ccccc--CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          320 RLEDR--YSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       320 ~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ..++.  -+...+.++.++++.||-+.|++|.|+.++++|
T Consensus       244 ~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  244 KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            11222  256778899999999999999999999999987

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=5.7e-41  Score=314.89  Aligned_cols=252  Identities=33%  Similarity=0.516  Sum_probs=201.8

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHH--HHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR--EWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      |++.+.||+|+||+||++....      +++.||+|++.........  ...+|+.++++++||||+++++++.+....+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~   74 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKK------NGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLY   74 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETT------TTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECC------CCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccc
Confidence            6778999999999999998776      5779999999866443322  3456999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCC
Q 013105          159 LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~  238 (449)
                      +|||++.+++|.+++...  ..+++..+..++.|++.||.+||  +.+|+|+||||+||+++.++.++|+|||++.... 
T Consensus        75 ~v~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh--~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-  149 (260)
T PF00069_consen   75 IVMEYCPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLH--SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-  149 (260)
T ss_dssp             EEEEEETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHH--HTTEEESSBSGGGEEESTTSEEEESSGTTTEEST-
T ss_pred             cccccccccccccccccc--ccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccc-
Confidence            999999999999999743  57899999999999999999999  6789999999999999999999999999987531 


Q ss_pred             CCCCceeeecCCCCccccccccc-cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhh
Q 013105          239 GEDSHITTCVMGTEGYAAPEYIN-TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII  317 (449)
Q Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (449)
                       ..........++..|+|||++. +..++.++||||||+++|+|++|..||................             
T Consensus       150 -~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~-------------  215 (260)
T PF00069_consen  150 -ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKIL-------------  215 (260)
T ss_dssp             -STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHH-------------
T ss_pred             -ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcc-------------
Confidence             1122344566899999999998 7889999999999999999999999998652111111111000             


Q ss_pred             cccccccC--CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          318 DSRLEDRY--STEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       318 ~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ........  .......+.+++..||+.||++||++.+++++
T Consensus       216 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  216 KRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             HTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             cccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00000000  00112679999999999999999999999976

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.5e-40  Score=313.97  Aligned_cols=256  Identities=28%  Similarity=0.473  Sum_probs=201.4

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEEEe
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEY  163 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  163 (449)
                      +.||+|+||.||+|.+.+.......+..+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            36999999999999876532223345789999886432 23456788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC-----cEEEeeeccc
Q 013105          164 MALGNLHDQLFKNY-----SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY-----NAKLSDFGLA  233 (449)
Q Consensus       164 ~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~-----~~kl~DfGla  233 (449)
                      +++++|.+++....     ...+++..++.++.|++.||.|||  +.+++|+||||+||+++.++     .++|+|||++
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE--QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH--hCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            99999999986532     234788999999999999999999  77899999999999999887     8999999998


Q ss_pred             cCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccc
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTK  312 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  312 (449)
                      ................++..|+|||.+.+..++.++|||||||++|||++ |..||.......   .....         
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~~---------  226 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHV---------  226 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHHH---------
Confidence            75543222222223346788999999988889999999999999999998 999987532111   11100         


Q ss_pred             hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 013105          313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE  359 (449)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  359 (449)
                           ........+...+..+.+++.+||..+|.+||++.+|++.|+
T Consensus       227 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         227 -----TAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             -----hcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                 011111223445677999999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.8e-40  Score=311.83  Aligned_cols=251  Identities=22%  Similarity=0.373  Sum_probs=202.4

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc---------hHHHHHHHHHHHhcCCCCCcceeeeE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ---------GHREWLAEVIFLGQLKHPHLVNLIGY  150 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~nIv~~~~~  150 (449)
                      +|.+.+.||+|+||.||+|....      .++.+|+|.+......         ....+.+|+.+++.++||||++++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   74 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNAS------SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGS   74 (267)
T ss_pred             CccccceeecCCCeEEEEEEecC------CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence            47888999999999999997654      4788999988643221         12457789999999999999999999


Q ss_pred             EEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeee
Q 013105          151 CCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDF  230 (449)
Q Consensus       151 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~Df  230 (449)
                      +.+.+..++||||+++++|.+++...  ..+++.....++.|++.||.|||  +.+++||||+|+||+++.++.++|+||
T Consensus        75 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH--~~~ivH~di~p~nil~~~~~~~~l~df  150 (267)
T cd06628          75 SLDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLH--NRGIIHRDIKGANILVDNKGGIKISDF  150 (267)
T ss_pred             EEeCCccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHH--hcCcccccCCHHHEEEcCCCCEEeccc
Confidence            99999999999999999999998664  56888899999999999999999  778999999999999999999999999


Q ss_pred             ccccCCCCCCCC----ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhh
Q 013105          231 GLATDGPQGEDS----HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPM  306 (449)
Q Consensus       231 Gla~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~  306 (449)
                      |++.........    .......|+..|+|||.+.+..++.++|||||||++|+|++|..||........  ..      
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~------  222 (267)
T cd06628         151 GISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA--IF------  222 (267)
T ss_pred             CCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH--HH------
Confidence            998865422111    111234588999999999888899999999999999999999999975421110  00      


Q ss_pred             hccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          307 LKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                              .. ........+...+..+.+++.+||+.||.+||++.+++++
T Consensus       223 --------~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         223 --------KI-GENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             --------HH-hccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence                    00 0011122334456779999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-42  Score=334.05  Aligned_cols=251  Identities=24%  Similarity=0.388  Sum_probs=207.4

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLL  159 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  159 (449)
                      .|.++..||.|+||.||+|..++      ++-..|-|++.........+++-|+.||..+.||+||++++.|..++.++|
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nke------t~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwi  106 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKE------TKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWI  106 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhccc------chhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEE
Confidence            35666779999999999997765      456678899987777788899999999999999999999999999999999


Q ss_pred             EEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCC
Q 013105          160 VYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQG  239 (449)
Q Consensus       160 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~  239 (449)
                      +.|||.||-+...+..- ...+.+.++.-+++|++.||.|||  +++|||||||..|||++.+|.++|+|||.+......
T Consensus       107 liEFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LH--s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t  183 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLH--SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST  183 (1187)
T ss_pred             EEeecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHh--hcchhhhhccccceEEEecCcEeeecccccccchhH
Confidence            99999999998877654 468999999999999999999999  677999999999999999999999999998754322


Q ss_pred             CCCceeeecCCCCccccccccc-----cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          240 EDSHITTCVMGTEGYAAPEYIN-----TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       240 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                        ......+.|||+|||||++.     ..+|+.++||||||++|.||..+.+|-....+-      .          .+-
T Consensus       184 --~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM------R----------Vll  245 (1187)
T KOG0579|consen  184 --RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM------R----------VLL  245 (1187)
T ss_pred             --HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH------H----------HHH
Confidence              22345678999999999874     457999999999999999999999997643211      1          111


Q ss_pred             Hhhccccc-ccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          315 QIIDSRLE-DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       315 ~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .+..+..+ -..|...+..+.+++..||.+||..||++.++++|
T Consensus       246 KiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  246 KIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             HHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            11111111 12255677789999999999999999999999998

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.7e-41  Score=327.59  Aligned_cols=265  Identities=22%  Similarity=0.291  Sum_probs=197.8

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      .+.++|.+.+.||+|+||.||+|.+..      ++..||||++....  ......+.+|+.+|+.++||||+++++++..
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTR------LRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTP   85 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECC------CCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcc
Confidence            456789999999999999999997765      57899999986432  2234567789999999999999999998754


Q ss_pred             C------CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEE
Q 013105          154 D------EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKL  227 (449)
Q Consensus       154 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl  227 (449)
                      .      ...|++|+++ +++|.+++..   ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||
T Consensus        86 ~~~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH--~~~ivHrdikp~Nil~~~~~~~kl  159 (343)
T cd07878          86 ATSIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIH--SAGIIHRDLKPSNVAVNEDCELRI  159 (343)
T ss_pred             cccccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecccCChhhEEECCCCCEEE
Confidence            3      4578999988 6889877643   46899999999999999999999  778999999999999999999999


Q ss_pred             eeeccccCCCCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhH-Hhhhh
Q 013105          228 SDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV-EWARP  305 (449)
Q Consensus       228 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~-~~~~~  305 (449)
                      +|||++......     .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||............ .....
T Consensus       160 ~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  234 (343)
T cd07878         160 LDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGT  234 (343)
T ss_pred             cCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCC
Confidence            999999865332     223468999999999876 56899999999999999999999999764322111100 00000


Q ss_pred             ----hhccc--cchhHhhccc--ccc----cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          306 ----MLKDF--TKLDQIIDSR--LED----RYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       306 ----~~~~~--~~~~~~~~~~--~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                          .....  ..........  ...    ......++.+.+|+.+||..||.+|||+.+++.|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             CCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                00000  0000000000  000    0001123457899999999999999999999987

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.5e-40  Score=310.20  Aligned_cols=251  Identities=21%  Similarity=0.339  Sum_probs=203.5

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEe-CCE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCE-DEH  156 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~~~  156 (449)
                      +|++.+.||+|++|.||++....      .++.||+|.+....  ......+.+|+.+++.++|+||+++++.+.. +..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRT------DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGL   74 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcC------CCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCE
Confidence            48899999999999999998765      46789999986432  2334568889999999999999999988764 456


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      +|++|||+.+++|.+++.......+++.++..++.+++.||.+||  ++||+|+||||+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH--~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~  152 (257)
T cd08223          75 LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL  152 (257)
T ss_pred             EEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCchhEEEecCCcEEEecccceEEe
Confidence            899999999999999997755567899999999999999999999  788999999999999999999999999998755


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHh
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI  316 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (449)
                      .....  ......|++.|+|||++.+..++.++|||||||++|+|++|+.||........      .....         
T Consensus       153 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~------~~~~~---------  215 (257)
T cd08223         153 ENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL------VYRII---------  215 (257)
T ss_pred             cccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHH---------
Confidence            33221  22335689999999999988899999999999999999999999975321110      00000         


Q ss_pred             hcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       .. .....+...+..+.+++.+||+.||++||++.+++++
T Consensus       216 -~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         216 -EG-KLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             -hc-CCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence             10 1112234566779999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.8e-40  Score=309.48  Aligned_cols=252  Identities=25%  Similarity=0.366  Sum_probs=197.8

Q ss_pred             cccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEEEec
Q 013105           86 YLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYM  164 (449)
Q Consensus        86 ~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  164 (449)
                      .||+|+||.||+|.+...    ..+..||+|++..... .....+.+|+.++++++||||+++++++. ....++||||+
T Consensus         2 ~ig~G~~g~v~~~~~~~~----~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~   76 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMR----KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMA   76 (257)
T ss_pred             ccCCCCcccEEEEEEecC----CCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeC
Confidence            389999999999977531    1355799999875432 33456889999999999999999999885 45789999999


Q ss_pred             CCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCCc-
Q 013105          165 ALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSH-  243 (449)
Q Consensus       165 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~~-  243 (449)
                      .+++|.+++... ...+++..+..++.|++.||.|||  .+|++||||||+|||++.++.+||+|||++.......... 
T Consensus        77 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  153 (257)
T cd05115          77 SGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLE--GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK  153 (257)
T ss_pred             CCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH--hcCeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence            999999988643 357899999999999999999999  7789999999999999999999999999997543322111 


Q ss_pred             eeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHhhccccc
Q 013105          244 ITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLE  322 (449)
Q Consensus       244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (449)
                      ......++..|+|||.+.+..++.++|||||||++|||++ |..||........   ..              .+.....
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~--------------~~~~~~~  216 (257)
T cd05115         154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV---MS--------------FIEQGKR  216 (257)
T ss_pred             ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH---HH--------------HHHCCCC
Confidence            1111223578999999988889999999999999999996 9999975432111   11              1111112


Q ss_pred             ccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccc
Q 013105          323 DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL  362 (449)
Q Consensus       323 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  362 (449)
                      ...+..++.++.+++..||..||++||++.+|++.|+.++
T Consensus       217 ~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~  256 (257)
T cd05115         217 LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY  256 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence            2233455677999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.2e-41  Score=353.52  Aligned_cols=257  Identities=21%  Similarity=0.322  Sum_probs=200.7

Q ss_pred             HHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEE
Q 013105           75 QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCC  152 (449)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~  152 (449)
                      ....++|.+.+.||+|+||.||+|.+..      ++..||+|++....  ......+..|+.+|..|+||||++++++|.
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~------tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~   82 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKR------TQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFL   82 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECC------CCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence            3456789999999999999999998765      57899999987542  233567889999999999999999999886


Q ss_pred             e--CCEEEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCeeeccCCCCceEEcC--
Q 013105          153 E--DEHRLLVYEYMALGNLHDQLFKN--YSSTLPWLTRIKIAIGAARCLAFLHGEE-----KPVIYRDFKASNILLDS--  221 (449)
Q Consensus       153 ~--~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~-----~~ivHrDikp~Nill~~--  221 (449)
                      .  ...+||||||+.+|+|.++|...  ....+++..++.|+.||+.||.|||+..     ++||||||||+||||+.  
T Consensus        83 de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~  162 (1021)
T PTZ00266         83 NKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI  162 (1021)
T ss_pred             ecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence            5  46789999999999999998653  2357999999999999999999999532     56999999999999964  


Q ss_pred             ---------------CCcEEEeeeccccCCCCCCCCceeeecCCCCcccccccccc--CCCCcccchhhhHHHHHHHHhC
Q 013105          222 ---------------DYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT--GHLTTMCDVFSFGVVLLELLTG  284 (449)
Q Consensus       222 ---------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~vl~elltg  284 (449)
                                     .+.+||+|||++.......   ......||+.|+|||++.+  ..++.++||||||||||||++|
T Consensus       163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG  239 (1021)
T PTZ00266        163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG  239 (1021)
T ss_pred             cccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence                           2358999999998653322   1233569999999999854  4588999999999999999999


Q ss_pred             CCcccccccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          285 RRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       285 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ..||.......     .....           +.... .......+.++.+||..||+.+|.+||++.++|.+
T Consensus       240 k~PF~~~~~~~-----qli~~-----------lk~~p-~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        240 KTPFHKANNFS-----QLISE-----------LKRGP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             CCCCCcCCcHH-----HHHHH-----------HhcCC-CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            99997532111     11000           00000 00012235679999999999999999999999964

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-40  Score=309.23  Aligned_cols=252  Identities=31%  Similarity=0.440  Sum_probs=199.0

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEEEe
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEY  163 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  163 (449)
                      +.||+|+||.||+|.+...   ......+|+|.+..... .....+.+|+.+++.+.|+||+++++++. .+..++||||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~---~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMK---SGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeecc---CCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEe
Confidence            4699999999999987542   11347899999975543 24567889999999999999999999876 5568999999


Q ss_pred             cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCCc
Q 013105          164 MALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSH  243 (449)
Q Consensus       164 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~~  243 (449)
                      +.+|+|.+++...  ..+++..+..++.|++.||.|||  ..+++|+||||+|||++.++.+||+|||++..........
T Consensus        77 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh--~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          77 APLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLE--SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHh--hcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            9999999999765  37899999999999999999999  7789999999999999999999999999998654332211


Q ss_pred             e-eeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHhhcccc
Q 013105          244 I-TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRL  321 (449)
Q Consensus       244 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (449)
                      . .....++..|+|||.+.+..++.++|||||||++|+|++ |..||......   .......              ...
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~--------------~~~  215 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLE--------------SGE  215 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHH--------------cCC
Confidence            0 111223567999999988889999999999999999998 99999754321   1111111              111


Q ss_pred             cccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcc
Q 013105          322 EDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL  361 (449)
Q Consensus       322 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  361 (449)
                      ....+..++..+.+++.+||..+|++||++.++++.|+.+
T Consensus       216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            1122334556799999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.8e-40  Score=314.93  Aligned_cols=273  Identities=25%  Similarity=0.372  Sum_probs=205.3

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeC--CE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCED--EH  156 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~  156 (449)
                      .|++.+.||+|+||.||+|.+..  .....+..||+|.++... ......+.+|+.+++.++||||+++++++...  ..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~--~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDP--EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEcc--CCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            47888999999999999997643  223457889999987443 33346788999999999999999999998775  67


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||++|++|.+++.... ..+++..+..++.|++.||+|||  ++||+||||||+||+++.++.++|+|||++...
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH--~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLG--SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence            899999999999999986542 46899999999999999999999  788999999999999999999999999999865


Q ss_pred             CCCCCC-ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcc--ccch
Q 013105          237 PQGEDS-HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKD--FTKL  313 (449)
Q Consensus       237 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~  313 (449)
                      ...... .......|+..|+|||.+.+..++.++|||||||++|||++++.|+.......    .....+....  ....
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~----~~~~~~~~~~~~~~~~  235 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF----LKMIGPTHGQMTVTRL  235 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchh----hhhcccccccccHHHH
Confidence            432221 11223457778999999988889999999999999999999887653221000    0000000000  0000


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcc
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL  361 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  361 (449)
                      ...+........+..++..+.+|+.+||+.||++|||+.++++.|+.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         236 VRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            000111111122334567799999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-40  Score=313.25  Aligned_cols=263  Identities=25%  Similarity=0.367  Sum_probs=207.2

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      .+|++.+.||+|+||.||+|.+..+  .......+|+|.+..... .....+.+|+.++..++||||+++++++.. ...
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~--~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPE--GEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV   83 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecC--CCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence            5688889999999999999987652  112244799998875533 334678899999999999999999999987 789


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+.+|+|.+++... ...+++.....++.|++.||+|||  +.+++||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH--~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLE--EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH--hCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            9999999999999998764 245899999999999999999999  6889999999999999999999999999998655


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI  316 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (449)
                      ............++..|+|||.+....++.++|||||||++|||++ |..||.........   .              .
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~--------------~  223 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP---D--------------L  223 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH---H--------------H
Confidence            3322211112224568999999988889999999999999999998 99999764321111   1              0


Q ss_pred             hcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                      +........+..++..+.+++.+||..||.+||++.++++.|..+...
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         224 LEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             HhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence            111111112223445688999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5.2e-40  Score=314.40  Aligned_cols=253  Identities=23%  Similarity=0.358  Sum_probs=203.1

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      +.|++.+.||.|+||.||+|....      ++..+++|++..........+.+|+.+++.++|+||+++++++..++..+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKE------TGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW   85 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECC------CCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEE
Confidence            568999999999999999997765      47899999997665556677889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCC
Q 013105          159 LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~  238 (449)
                      +||||+.+++|..++.+. ...+++..+..++.|++.+|.|||  ..+++||||||+||+++.++.++|+|||++.....
T Consensus        86 lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          86 IMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLH--SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             EEEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHh--cCCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            999999999998877543 356899999999999999999999  77899999999999999999999999999875322


Q ss_pred             CCCCceeeecCCCCccccccccc-----cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccch
Q 013105          239 GEDSHITTCVMGTEGYAAPEYIN-----TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      ..  .......|++.|+|||++.     ...++.++|||||||++|||++|.+||.......  .....    ...    
T Consensus       163 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~~~----~~~----  230 (292)
T cd06644         163 TL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLKI----AKS----  230 (292)
T ss_pred             cc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH--HHHHH----hcC----
Confidence            21  1122345889999999984     3456889999999999999999999996542111  00000    000    


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                           .......+..++.++.+++.+||..||++||++.+++++
T Consensus       231 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         231 -----EPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             -----CCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                 000111223455678999999999999999999999986

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.3e-40  Score=308.56  Aligned_cols=251  Identities=23%  Similarity=0.355  Sum_probs=206.4

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      +|++.+.||.|+||.||.+....      ++..+++|.+...  .......+.+|+.++++++|+||+++++++.+.+..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   74 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTE------DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTL   74 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcC------CCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeE
Confidence            58889999999999999987655      5788999998754  234456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      +++|||+++++|.+++.......+++..+..++.|++.+|.|||  +.+++|+||+|+||+++.++.+||+|||++....
T Consensus        75 ~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~  152 (256)
T cd08221          75 LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH--KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILG  152 (256)
T ss_pred             EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCChHhEEEeCCCCEEECcCcceEEcc
Confidence            99999999999999997765567899999999999999999999  6789999999999999999999999999987654


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII  317 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (449)
                      ....  ......|++.|+|||.+.+..++.++|||||||++|||++|..||..........                .+.
T Consensus       153 ~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~----------------~~~  214 (256)
T cd08221         153 SEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV----------------KIV  214 (256)
T ss_pred             cccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHH----------------HHH
Confidence            3321  1233568999999999988888999999999999999999999997542211110                000


Q ss_pred             cccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          318 DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       318 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ... ........+.++.+++.+||..+|++||++.+++++
T Consensus       215 ~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         215 QGN-YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             cCC-CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            110 111223456679999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.8e-40  Score=313.64  Aligned_cols=251  Identities=24%  Similarity=0.370  Sum_probs=201.3

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEE
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLV  160 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  160 (449)
                      |++.+.||+|+||.||+|.+..      ++..+++|.+..........+.+|+.+++.++||||+++++++...+..++|
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v   80 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKE------TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL   80 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECC------CCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEE
Confidence            5677889999999999998765      4778999998765555567788999999999999999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCC
Q 013105          161 YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGE  240 (449)
Q Consensus       161 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~  240 (449)
                      |||+.+++|..++... ...+++..+..++.|++.||.|||  +.||+||||||+|||++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH--~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  157 (282)
T cd06643          81 IEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLH--ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI  157 (282)
T ss_pred             EEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence            9999999998877543 357899999999999999999999  6789999999999999999999999999987543321


Q ss_pred             CCceeeecCCCCccccccccc-----cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          241 DSHITTCVMGTEGYAAPEYIN-----TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       241 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      .  ......|+..|+|||++.     +..++.++|||||||++|||++|.+||........  ....    ...      
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~----~~~------  223 (282)
T cd06643         158 Q--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLKI----AKS------  223 (282)
T ss_pred             c--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHHH----hhc------
Confidence            1  123346899999999883     34578899999999999999999999975421110  0000    000      


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                         .......+..++..+.+++.+||+.||.+||++.+++++
T Consensus       224 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         224 ---EPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             ---CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               000111223445679999999999999999999999987

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.3e-40  Score=311.50  Aligned_cols=260  Identities=25%  Similarity=0.418  Sum_probs=205.4

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      ++|++.+.||+|+||.||+|.+...   ......+|+|.++... ......+.+|+.+++.++||||+++++++..++..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~---~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLP---GKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecC---CCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            5688899999999999999977532   1134579999987543 23345788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+++++|.+++... ...+++.+...++.|++.||.|||  +.+++||||||+|||++.++.++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH--~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            9999999999999998754 346889999999999999999999  7889999999999999999999999999998654


Q ss_pred             CCCCCce-eeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          238 QGEDSHI-TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       238 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ....... .....++..|+|||.+.+..++.++|+|||||++||+++ |..||.......   ......           
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~-----------  223 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAIE-----------  223 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHHh-----------
Confidence            3221111 111223568999999988889999999999999999886 999997543211   111110           


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcc
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL  361 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  361 (449)
                        . ......+..++..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       224 --~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         224 --E-GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             --C-CCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence              0 001112234456789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.4e-40  Score=324.14  Aligned_cols=256  Identities=19%  Similarity=0.247  Sum_probs=198.9

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ++|.+.+.||+|+||.||++.+..      +++.+|+|++...   .......+..|+.++..++|+||+++++++.+.+
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKN------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN   74 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECC------CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence            478999999999999999998765      4788999998632   2223345778999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..|+||||+.+|+|.+++.+. ...+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH--~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~  151 (332)
T cd05623          75 NLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVH--QLHYVHRDIKPDNILMDMNGHIRLADFGSCLK  151 (332)
T ss_pred             EEEEEEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHEEECCCCCEEEeecchhee
Confidence            999999999999999998753 246888899999999999999999  78899999999999999999999999999875


Q ss_pred             CCCCCCCceeeecCCCCccccccccc-----cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccc
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYIN-----TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF  310 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  310 (449)
                      ...... .......||+.|+|||++.     ...++.++|||||||++|||++|+.||.........      .......
T Consensus       152 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~------~~i~~~~  224 (332)
T cd05623         152 LMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHK  224 (332)
T ss_pred             cccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHH------HHHhCCC
Confidence            432221 1123356999999999985     346889999999999999999999999754321111      0011000


Q ss_pred             cchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 013105          311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKS--RPTMTTVVKA  357 (449)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~  357 (449)
                      ..      .. .+.....++.++.+|+.+||..++.+  |+++.++++|
T Consensus       225 ~~------~~-~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         225 ER------FQ-FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             cc------cc-CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            00      00 01112245667899999998765554  6899999987

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.3e-40  Score=324.20  Aligned_cols=256  Identities=20%  Similarity=0.258  Sum_probs=198.8

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ++|.+.+.||+|+||.||++....      +++.||+|++...   .......+.+|+.++..++|+||+.+++++.+.+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~   74 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKH------TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN   74 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECC------CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            478999999999999999997765      5788999998642   2223345778999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..|+||||+.||+|.+++... ...+++.....++.|++.||.|||  +++|+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH--~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~  151 (331)
T cd05624          75 YLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIH--QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLK  151 (331)
T ss_pred             EEEEEEeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCchHHEEEcCCCCEEEEeccceee
Confidence            999999999999999998753 246888899999999999999999  78899999999999999999999999999876


Q ss_pred             CCCCCCCceeeecCCCCcccccccccc-----CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccc
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINT-----GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF  310 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  310 (449)
                      ...... .......||+.|+|||++.+     ..++.++|||||||+||||++|+.||..........      ......
T Consensus       152 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~------~i~~~~  224 (331)
T cd05624         152 MNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KIMNHE  224 (331)
T ss_pred             ccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHH------HHHcCC
Confidence            543221 11233569999999999865     467889999999999999999999997543211100      000000


Q ss_pred             cchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 013105          311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKS--RPTMTTVVKA  357 (449)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~  357 (449)
                      ..      ... +.....++.++.+++.+||..++.+  |+++.++++|
T Consensus       225 ~~------~~~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         225 ER------FQF-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             Cc------ccC-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            00      000 1111234567899999999876654  4688888877

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.1e-40  Score=324.85  Aligned_cols=262  Identities=20%  Similarity=0.294  Sum_probs=195.0

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      ...+|.+.+.||+|+||.||+|....      ++..||+|+....      ....|+.+++.++||||+++++++.....
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  131 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPG------QPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAI  131 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECC------CCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCe
Confidence            34579999999999999999998765      4778999985422      23468999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++|||++. ++|.+++... ...+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||++...
T Consensus       132 ~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  207 (357)
T PHA03209        132 TCMVLPHYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLH--AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFP  207 (357)
T ss_pred             eEEEEEccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEEecCcccccc
Confidence            999999996 6888887653 357899999999999999999999  778999999999999999999999999999753


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchh--------hHHhhhhhh-
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKD--------LVEWARPML-  307 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~--------~~~~~~~~~-  307 (449)
                      ....   ......||+.|+|||++.+..++.++|||||||++|||+++..++..........        +........ 
T Consensus       208 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~  284 (357)
T PHA03209        208 VVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKV  284 (357)
T ss_pred             ccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhcc
Confidence            2211   1233569999999999998899999999999999999998655543221111000        000000000 


Q ss_pred             --cccc------chhHhhcc--cccc---cC----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          308 --KDFT------KLDQIIDS--RLED---RY----STEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       308 --~~~~------~~~~~~~~--~~~~---~~----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                        ..+.      .....+..  ....   .+    ....+.++.+||.+||+.||.+|||+.++++|
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        285 HPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             ChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence              0000      00000000  0000   00    01234567789999999999999999999987

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-40  Score=312.31  Aligned_cols=249  Identities=27%  Similarity=0.387  Sum_probs=205.0

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      ++|++.+.||.|+||.||+|.+..      +++.||+|++.... ......+.+|+.+++.++|+||+++++++.++...
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKR------TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKL   74 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECC------CCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeE
Confidence            468888999999999999998765      57899999997553 33456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++|+||+.+++|.+++...   .+++..+..++.|++.||.|||  ..+++|+||+|+||+++.++.++|+|||++....
T Consensus        75 ~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  149 (274)
T cd06609          75 WIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLH--EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLT  149 (274)
T ss_pred             EEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEEcccccceeec
Confidence            9999999999999988653   7899999999999999999999  7789999999999999999999999999998654


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII  317 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (449)
                      ....  ......|++.|+|||.+.+..++.++|||||||++|+|++|..||.........   .              .+
T Consensus       150 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~---~--------------~~  210 (274)
T cd06609         150 STMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL---F--------------LI  210 (274)
T ss_pred             cccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH---H--------------Hh
Confidence            3321  123356889999999998888999999999999999999999999754311100   0              00


Q ss_pred             cccccccCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          318 DSRLEDRYSTE-GAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       318 ~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ........... ++..+.+++.+||..+|++|||+++++++
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         211 PKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             hhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            00111111122 55678999999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.3e-40  Score=316.43  Aligned_cols=251  Identities=22%  Similarity=0.394  Sum_probs=205.9

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      .+|++.+.||.|+||.||+|....      +++.|++|.+..........+.+|+.+++.++||||+++++++...+..+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVA------TGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELF   92 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcC------CCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEE
Confidence            468999999999999999997655      57899999997655555677889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCC
Q 013105          159 LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~  238 (449)
                      +||||+.+++|..++..   ..+++.++..++.+++.||.|||  +.|++|+||||+||+++.++.++|+|||++.....
T Consensus        93 lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH--~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~  167 (296)
T cd06655          93 VVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLH--ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP  167 (296)
T ss_pred             EEEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence            99999999999998854   35899999999999999999999  67899999999999999999999999999876543


Q ss_pred             CCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhc
Q 013105          239 GEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIID  318 (449)
Q Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (449)
                      ....  .....|+..|+|||.+.+..++.++|||||||++|+|++|..||............      ...         
T Consensus       168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~------~~~---------  230 (296)
T cd06655         168 EQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATN---------  230 (296)
T ss_pred             cccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------Hhc---------
Confidence            2211  22345899999999998888999999999999999999999999764322111100      000         


Q ss_pred             ccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          319 SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       319 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .......+..++..+.+++.+||..||.+||++.+++++
T Consensus       231 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         231 GTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             CCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            000011223455678999999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.5e-40  Score=310.94  Aligned_cols=256  Identities=27%  Similarity=0.335  Sum_probs=192.1

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEEEe
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEY  163 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  163 (449)
                      +.||+|+||.||+|.+...    .+...+|+|.++.... .....+.+|+.+++.++||||+++++++.+....++||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~----~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   76 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSG----YTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF   76 (269)
T ss_pred             CcccccCCceEEEEEEcCC----CCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence            3699999999999987532    2456799999875432 2335688899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCC
Q 013105          164 MALGNLHDQLFKNY---SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGE  240 (449)
Q Consensus       164 ~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~  240 (449)
                      +++|+|.+++....   ....++.....++.|++.||.|||  +.+++||||||+||+++.++.++|+|||++.......
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH--HCCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence            99999999986532   234566777889999999999999  7889999999999999999999999999987543222


Q ss_pred             CCceeeecCCCCccccccccccC-------CCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccc
Q 013105          241 DSHITTCVMGTEGYAAPEYINTG-------HLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTK  312 (449)
Q Consensus       241 ~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  312 (449)
                      .........|+..|+|||++.+.       .++.++|||||||++|||++ |..||.........   ....  ....  
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~---~~~~--~~~~--  227 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL---TYTV--REQQ--  227 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH---HHHh--hccc--
Confidence            11112234578889999998532       35789999999999999996 99999754322111   1000  0000  


Q ss_pred             hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 013105          313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE  359 (449)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  359 (449)
                           .....+......++.+.+++..|| .+|++|||+.+|++.|.
T Consensus       228 -----~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         228 -----LKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             -----CCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence                 000011112234456888999999 68999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.3e-40  Score=306.48  Aligned_cols=248  Identities=27%  Similarity=0.447  Sum_probs=198.3

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc-hHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEEEe
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ-GHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEY  163 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  163 (449)
                      +.||+|+||.||+|.+..       ++.||+|.+...... ....+.+|+.+++.++|+||+++++++.+....++||||
T Consensus         1 ~~lg~g~~g~v~~~~~~~-------~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   73 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-------NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMEL   73 (251)
T ss_pred             CccccCCCceEEEEEEeC-------CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEc
Confidence            469999999999997643       678999998754333 456788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCCc
Q 013105          164 MALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSH  243 (449)
Q Consensus       164 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~~  243 (449)
                      +.+++|.+++... ...+++.....++.+++.+|.|||  +++++||||||+|||++.++.++|+|||++..........
T Consensus        74 ~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH--~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  150 (251)
T cd05041          74 VPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLE--SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV  150 (251)
T ss_pred             CCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCccee
Confidence            9999999998654 246788899999999999999999  7789999999999999999999999999998554221111


Q ss_pred             eeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHhhccccc
Q 013105          244 ITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLE  322 (449)
Q Consensus       244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (449)
                      ......++..|+|||.+.+..++.++|||||||++|||++ |..||...........                 +.....
T Consensus       151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~-----------------~~~~~~  213 (251)
T cd05041         151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER-----------------IESGYR  213 (251)
T ss_pred             ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH-----------------HhcCCC
Confidence            1111223567999999988889999999999999999999 8888865432111111                 111111


Q ss_pred             ccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 013105          323 DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE  359 (449)
Q Consensus       323 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  359 (449)
                      ...+...+..+.+++.+||..+|.+|||+.++++.|+
T Consensus       214 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         214 MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            1223345667999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.9e-40  Score=317.03  Aligned_cols=252  Identities=23%  Similarity=0.373  Sum_probs=206.3

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      ..+|.+.+.||+|+||.||+|....      .++.||+|.+..........+.+|+.+++.++|+||+++++++...+..
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIA------TGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL   91 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECC------CCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence            4679999999999999999997655      4789999999765555556788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+++++|.+++.+   ..+++..+..++.+++.||.|||  +.+|+||||||+|||++.++.++|+|||++....
T Consensus        92 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH--~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~  166 (297)
T cd06656          92 WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (297)
T ss_pred             EEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence            999999999999998865   35788899999999999999999  6789999999999999999999999999987543


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII  317 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (449)
                      .....  .....|++.|+|||.+.+..++.++|||||||++|+|++|..||...........      ..         .
T Consensus       167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~---------~  229 (297)
T cd06656         167 PEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IA---------T  229 (297)
T ss_pred             CCccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------ec---------c
Confidence            32211  2234589999999999888899999999999999999999999975432111000      00         0


Q ss_pred             cccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          318 DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       318 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ........+...+..+.+++.+||..||++||++.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         230 NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000111233455678999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-41  Score=326.77  Aligned_cols=242  Identities=25%  Similarity=0.323  Sum_probs=188.4

Q ss_pred             ccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcC---CCCCcceeeeEEEeCCEEEEE
Q 013105           87 LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQL---KHPHLVNLIGYCCEDEHRLLV  160 (449)
Q Consensus        87 lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~~~~~~lv  160 (449)
                      ||+|+||+||+|....      +++.||+|++....   ......+..|..++..+   .||||+.+++++.+.+..|+|
T Consensus         1 lG~G~~g~Vy~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv   74 (330)
T cd05586           1 IGKGTFGQVYQVRKKD------TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLV   74 (330)
T ss_pred             CCCCCceEEEEEEECC------CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEE
Confidence            7999999999997765      57899999986321   22233455667776655   699999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCC
Q 013105          161 YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGE  240 (449)
Q Consensus       161 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~  240 (449)
                      |||+.+|+|.+++...  ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.++|+|||++.......
T Consensus        75 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH--~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~  150 (330)
T cd05586          75 TDYMSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLH--KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN  150 (330)
T ss_pred             EcCCCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC
Confidence            9999999999888654  57899999999999999999999  7789999999999999999999999999987543222


Q ss_pred             CCceeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcc
Q 013105          241 DSHITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDS  319 (449)
Q Consensus       241 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (449)
                      .  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+      ...        ..
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i------~~~--------~~  214 (330)
T cd05586         151 K--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI------AFG--------KV  214 (330)
T ss_pred             C--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH------HcC--------CC
Confidence            1  12345699999999998654 5899999999999999999999999764321110000      000        00


Q ss_pred             cccccCCHHHHHHHHHHHHHhccCCCCCCC----CHHHHHHH
Q 013105          320 RLEDRYSTEGAKRLAAVAHQCLSHNPKSRP----TMTTVVKA  357 (449)
Q Consensus       320 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~eil~~  357 (449)
                      ...   ....++.+.+++.+||+.||.+||    ++.++++|
T Consensus       215 ~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         215 RFP---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             CCC---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence            001   112455688999999999999998    56777665

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-40  Score=313.93  Aligned_cols=253  Identities=25%  Similarity=0.391  Sum_probs=204.4

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      ++|++.+.||.|+||.||+|.+..      ++..+|+|++..........+.+|+.+++.++||||+++++++..+...|
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKE------TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLW   78 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcC------CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEE
Confidence            568899999999999999998764      47899999998665556677889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCC
Q 013105          159 LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~  238 (449)
                      +||||+.+++|.+++... ...+++..+..++.|++.||.|||  +.+|+|+||||+||+++.++.++|+|||++.....
T Consensus        79 lv~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~  155 (280)
T cd06611          79 ILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLH--SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS  155 (280)
T ss_pred             EEeeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence            999999999999888653 346899999999999999999999  77899999999999999999999999999875433


Q ss_pred             CCCCceeeecCCCCccccccccc-----cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccch
Q 013105          239 GEDSHITTCVMGTEGYAAPEYIN-----TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      ...  ......|++.|+|||.+.     ...++.++|||||||++|||++|..||........  ....    ...    
T Consensus       156 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~~~----~~~----  223 (280)
T cd06611         156 TLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LLKI----LKS----  223 (280)
T ss_pred             ccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HHHH----hcC----
Confidence            221  123345899999999874     34467899999999999999999999975422111  0000    000    


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                           .......+..++..+.+++..||+.+|.+||++.+++++
T Consensus       224 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         224 -----EPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             -----CCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                 000001123445678999999999999999999999987

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.2e-40  Score=312.88  Aligned_cols=247  Identities=26%  Similarity=0.428  Sum_probs=193.0

Q ss_pred             ccccccCceEEEEEEEcCCCCC-CCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEEEe
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRP-GLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEY  163 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  163 (449)
                      +.||+|+||.||+|........ ......+|+|.+..........+.+|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            4699999999999987542111 223456899988655444556788899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCc--------EEEeeeccccC
Q 013105          164 MALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYN--------AKLSDFGLATD  235 (449)
Q Consensus       164 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~--------~kl~DfGla~~  235 (449)
                      +.+|+|.+++.... ..+++.....++.|++.||.|||  +++|+||||||+|||++.++.        ++++|||++..
T Consensus        81 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLE--DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            99999999986542 36889999999999999999999  788999999999999987764        69999999875


Q ss_pred             CCCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCC-CcccccccccchhhHHhhhhhhccccch
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGR-RSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      ...      .....++..|+|||++.+ ..++.++|||||||++|||++|. +||...........       .      
T Consensus       158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-------~------  218 (258)
T cd05078         158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-------Y------  218 (258)
T ss_pred             cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-------H------
Confidence            432      122457889999999976 45799999999999999999995 56543321111000       0      


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE  359 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  359 (449)
                          ..  ...++.....++.+++.+||+.||++|||+.++++.|+
T Consensus       219 ----~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         219 ----ED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ----Hc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                00  11122233456899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.6e-40  Score=315.05  Aligned_cols=267  Identities=21%  Similarity=0.281  Sum_probs=200.7

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      +|++.+.||+|+||.||+|....      ++..||+|.+....  ......+.+|+.+++.++||||+++++++.+++..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKK------TGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRL   74 (285)
T ss_pred             CceEeeEecccCceEEEEEEECC------CCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeE
Confidence            57888999999999999998765      47899999986442  22345678899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          158 LLVYEYMALGNLHDQLFKNY-SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      ++||||+. ++|.+++.... ...+++..+..++.|++.||.|||  .++|+|+||||+|||++.++.++|+|||++...
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  151 (285)
T cd07861          75 YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH--SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF  151 (285)
T ss_pred             EEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCCHHHEEEcCCCcEEECcccceeec
Confidence            99999997 68888876533 357899999999999999999999  778999999999999999999999999998754


Q ss_pred             CCCCCCceeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCCcccccccccchhh-HH-hhhh---hhccc
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDL-VE-WARP---MLKDF  310 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~-~~-~~~~---~~~~~  310 (449)
                      ....  .......+++.|+|||++.+. .++.++|||||||++|+|++|++||.+......... .. +..+   .+...
T Consensus       152 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (285)
T cd07861         152 GIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV  229 (285)
T ss_pred             CCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcc
Confidence            3321  112234578999999988653 578899999999999999999999976432211100 00 0000   00000


Q ss_pred             cchhH---hhcc---cccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          311 TKLDQ---IIDS---RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       311 ~~~~~---~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .....   ....   .........++.++.+++.+||+.||++|||+.+|+.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             hhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            00000   0000   00001112345678899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4e-40  Score=320.36  Aligned_cols=265  Identities=19%  Similarity=0.271  Sum_probs=197.8

Q ss_pred             Cccccccc--CceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           83 RSDYLGEG--GFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        83 ~~~~lG~G--~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      +.++||+|  +|++||++....      +++.||+|+++...  ......+.+|+.+++.++||||+++++++..++..+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~   75 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKP------TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW   75 (327)
T ss_pred             hhhhccccccceEEEEEEeecc------cCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEE
Confidence            46789999  789999997765      58999999997542  223355778999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCC
Q 013105          159 LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~  238 (449)
                      +||||+++|+|.+++..+....+++..+..++.|++.||.|||  +++|+||||||+|||++.++.++++||+.+.....
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~  153 (327)
T cd08227          76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH--HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIN  153 (327)
T ss_pred             EEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCChhhEEEecCCcEEEcccchhhcccc
Confidence            9999999999999997655566899999999999999999999  77899999999999999999999999986543221


Q ss_pred             CCC-----CceeeecCCCCcccccccccc--CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccc-
Q 013105          239 GED-----SHITTCVMGTEGYAAPEYINT--GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF-  310 (449)
Q Consensus       239 ~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-  310 (449)
                      ...     ........++..|+|||++.+  ..++.++|||||||++|||++|..||........  ............ 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~  231 (327)
T cd08227         154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLL  231 (327)
T ss_pred             ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCccccc
Confidence            110     001122346788999999965  4689999999999999999999999975322110  000000000000 


Q ss_pred             --c------------------chhH---------hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          311 --T------------------KLDQ---------IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       311 --~------------------~~~~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                        .                  ....         .........+....++.+.+++.+||+.||++|||+.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence              0                  0000         000000011223456679999999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-40  Score=307.14  Aligned_cols=255  Identities=25%  Similarity=0.394  Sum_probs=206.3

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      ++|++.+.||+|+||.||+|....      +++.+++|++..........+.+|+.+++.++||||+++++++.+....|
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   76 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIA------TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLW   76 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecC------CCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEE
Confidence            578899999999999999997765      46789999998665556678899999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCC
Q 013105          159 LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~  238 (449)
                      ++|||+.+++|.+++... ...++...+..++.|++.||.|||  ..+|+|+||+|+||+++.++.++|+|||++.....
T Consensus        77 l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          77 IVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLH--ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             EEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            999999999999887654 256889999999999999999999  77899999999999999999999999999876543


Q ss_pred             CCCCceeeecCCCCccccccccccC---CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          239 GEDSHITTCVMGTEGYAAPEYINTG---HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ...  ......|+..|+|||.+.+.   .++.++|||||||++|+|++|..||.............  .   ...     
T Consensus       154 ~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~--~---~~~-----  221 (262)
T cd06613         154 TIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS--K---SNF-----  221 (262)
T ss_pred             hhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--h---ccC-----
Confidence            211  12334688999999999766   78999999999999999999999997543221111000  0   000     


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                        . ..........+.++.+++.+||..+|.+|||+.+|+.+
T Consensus       222 --~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         222 --P-PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             --C-CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence              0 00011223456779999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=5.1e-40  Score=311.46  Aligned_cols=261  Identities=26%  Similarity=0.372  Sum_probs=206.0

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc-hHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ-GHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      ++|++.+.||+|+||.||+|..... ........|++|.+...... ....+.+|++++++++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~-~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGI-EEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccC-CcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            5788899999999999999987643 22335678999998754333 456789999999999999999999999998999


Q ss_pred             EEEEEecCCCChHHHHhhcCC-------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeee
Q 013105          158 LLVYEYMALGNLHDQLFKNYS-------STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDF  230 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~Df  230 (449)
                      ++||||+++|+|.+++.....       ..+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.++|+||
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH--~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS--NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh--hcCcccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999876531       26899999999999999999999  778999999999999999999999999


Q ss_pred             ccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhcc
Q 013105          231 GLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKD  309 (449)
Q Consensus       231 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  309 (449)
                      |++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......   ......      
T Consensus       162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~~~~------  231 (275)
T cd05046         162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVLNRL------  231 (275)
T ss_pred             ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHHHHH------
Confidence            99875432211 11223346778999999988888999999999999999998 78888643211   111110      


Q ss_pred             ccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 013105          310 FTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE  359 (449)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  359 (449)
                             .........+..++..+.+++.+||+.||++|||+.++++.|.
T Consensus       232 -------~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         232 -------QAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             -------HcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                   0001111112345567999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=9.7e-40  Score=310.08  Aligned_cols=249  Identities=25%  Similarity=0.398  Sum_probs=206.0

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      ..|+..+.||+|+||.||+|.+..      .+..||+|++.... ......+.+|+.+++.+.||||+++++++.++...
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNR------TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKL   77 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEcc------CCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence            357778899999999999998765      47899999987543 33456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+.|++|.+++..   ..+++.....++.+++.||.|||  ..+++|+||+|+||+++.++.++|+|||++....
T Consensus        78 ~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh--~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~  152 (277)
T cd06640          78 WIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLH--SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT  152 (277)
T ss_pred             EEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--hCCccCcCCChhhEEEcCCCCEEEcccccceecc
Confidence            999999999999998864   46888899999999999999999  6789999999999999999999999999997654


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII  317 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (449)
                      ....  ......++..|+|||.+.+..++.++|+|||||++|||++|..||..........                 .+
T Consensus       153 ~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-----------------~~  213 (277)
T cd06640         153 DTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-----------------LI  213 (277)
T ss_pred             CCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh-----------------hh
Confidence            3221  1223458899999999988889999999999999999999999997543211110                 00


Q ss_pred             cccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          318 DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       318 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ...........++..+.+++.+||+.+|++||++.+++.+
T Consensus       214 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         214 PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             hcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            1111233445677889999999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.2e-40  Score=316.47  Aligned_cols=267  Identities=21%  Similarity=0.308  Sum_probs=201.9

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      ++|.+.+.||+|+||.||+|.+..      ++..||+|.+.... ......+.+|+.+++.++||||+++++++...+..
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~   79 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKL------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSL   79 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcC------CCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeE
Confidence            568999999999999999997754      57899999987543 22345677899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+. ++|.+++... ...+++..+..++.|++.||.|||  +.+|+|+||||+|||++.++.++|+|||++....
T Consensus        80 ~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  155 (301)
T cd07873          80 TLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCH--RRKVLHRDLKPQNLLINERGELKLADFGLARAKS  155 (301)
T ss_pred             EEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence            99999997 6898887654 346888999999999999999999  7789999999999999999999999999987543


Q ss_pred             CCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhh--hhhccccch-
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR--PMLKDFTKL-  313 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~-  313 (449)
                      ....  ......+++.|+|||++.+ ..++.++|||||||++|||++|++||................  +....+..+ 
T Consensus       156 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (301)
T cd07873         156 IPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL  233 (301)
T ss_pred             CCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence            2221  1223457899999998865 457889999999999999999999998654322211111000  000000000 


Q ss_pred             --hHhhccccc-------ccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          314 --DQIIDSRLE-------DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       314 --~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                        .........       ......+++.+.+|+.+||+.||.+|||+.++++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence              000000000       01112345678999999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5e-40  Score=312.69  Aligned_cols=276  Identities=25%  Similarity=0.346  Sum_probs=208.9

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc-hHHHHHHHHHHHhcCCCCCcceeeeEEEe--CC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ-GHREWLAEVIFLGQLKHPHLVNLIGYCCE--DE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~  155 (449)
                      .+|++.+.||+|+||.||+|.+...  ....+..+|+|++...... ....+.+|+.+++.++|+||+++++++..  ..
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~--~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPL--GDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCC--CCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            4577889999999999999987542  1335789999999755443 45678999999999999999999999887  56


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..++||||+++++|.+++.... ..+++..+..++.|++.||.|||  .+|++|+||||+||+++.++.++|+|||++..
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLG--SQRYIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            7899999999999999987642 35899999999999999999999  78899999999999999999999999999987


Q ss_pred             CCCCCCCc-eeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          236 GPQGEDSH-ITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       236 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ........ ......++..|+|||.+.+..++.++|||||||++|||++|..|+.............  .........+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~  236 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI--AQGQMIVTRLL  236 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc--ccccccHHHHH
Confidence            65322211 1112235667999999988889999999999999999999999986532111000000  00000001111


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcc
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL  361 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  361 (449)
                      ..+........+..++..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            11111112222334567799999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7e-40  Score=308.57  Aligned_cols=247  Identities=24%  Similarity=0.393  Sum_probs=191.5

Q ss_pred             ccccccCceEEEEEEEcCCCC------CCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLR------PGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      +.||+|+||.||+|.+.....      .......|++|++..........+.+|+.++..++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998643211      01234468999987554445567888999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCc-------EEEeeec
Q 013105          159 LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYN-------AKLSDFG  231 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~-------~kl~DfG  231 (449)
                      +||||+.+|+|..++... ...+++...+.++.|++.||+|||  +++|+||||||+|||++.++.       ++++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLE--DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhh--hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999998877543 356899999999999999999999  788999999999999987664       8999999


Q ss_pred             cccCCCCCCCCceeeecCCCCccccccccc-cCCCCcccchhhhHHHHHHHH-hCCCcccccccccchhhHHhhhhhhcc
Q 013105          232 LATDGPQGEDSHITTCVMGTEGYAAPEYIN-TGHLTTMCDVFSFGVVLLELL-TGRRSVEKNRCKREKDLVEWARPMLKD  309 (449)
Q Consensus       232 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~vl~ell-tg~~pf~~~~~~~~~~~~~~~~~~~~~  309 (449)
                      ++......      ....|+..|+|||.+. +..++.++|||||||++|||+ .|..||..........+          
T Consensus       158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~----------  221 (262)
T cd05077         158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF----------  221 (262)
T ss_pred             CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH----------
Confidence            98754321      2245788999999886 567899999999999999998 58888765321111000          


Q ss_pred             ccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 013105          310 FTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE  359 (449)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  359 (449)
                             .....  ......++++.+|+.+||+.||.+||++.+|++.|+
T Consensus       222 -------~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         222 -------YEGQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             -------HhcCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence                   00000  011122456899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-40  Score=317.75  Aligned_cols=255  Identities=24%  Similarity=0.337  Sum_probs=205.3

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc---hHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ---GHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ++|++.+.||+|+||.||+|....      +++.||+|.+......   ....+..|+++++.++|+||+++++.+...+
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   74 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKG------TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET   74 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcC------CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC
Confidence            368889999999999999997765      5789999999754322   4456888999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..|+||||+.+++|.+++.......+++.....++.|++.||.|||  +.|++|+||||+||+++.++.++|+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  152 (316)
T cd05574          75 YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH--LLGIVYRDLKPENILLHESGHIMLSDFDLSKQ  152 (316)
T ss_pred             EEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH--HCCeeccCCChHHeEEcCCCCEEEeecchhhc
Confidence            9999999999999999987665567899999999999999999999  77899999999999999999999999999875


Q ss_pred             CCCCCCC---------------------------ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcc
Q 013105          236 GPQGEDS---------------------------HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSV  288 (449)
Q Consensus       236 ~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf  288 (449)
                      .......                           .......||..|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf  232 (316)
T cd05574         153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF  232 (316)
T ss_pred             ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCC
Confidence            4321110                           0111246899999999998888999999999999999999999999


Q ss_pred             cccccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCC----HHHHHHH
Q 013105          289 EKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT----MTTVVKA  357 (449)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~eil~~  357 (449)
                      ........  +.              .+.............+..+.+++.+||+.||++||+    +.+++.+
T Consensus       233 ~~~~~~~~--~~--------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         233 KGSNRDET--FS--------------NILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             CCCchHHH--HH--------------HHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            75432111  00              011111111111125677999999999999999999    8888875

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=4e-40  Score=313.42  Aligned_cols=260  Identities=27%  Similarity=0.360  Sum_probs=204.4

Q ss_pred             HHHHHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcC-CCCCcceeee
Q 013105           71 LKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL-KHPHLVNLIG  149 (449)
Q Consensus        71 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~  149 (449)
                      ..+.....+.|++.+.||.|+||.||+|.+..      .++.+|+|++.... .....+..|+.++..+ +|+||+++++
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~------~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~   80 (282)
T cd06636           8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVK------TGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYG   80 (282)
T ss_pred             hhhhcChhhhhhhheeeccCCCeEEEEEEEcC------CCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEee
Confidence            34444456789999999999999999998765      47899999986543 2345678899999998 6999999999


Q ss_pred             EEEe------CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC
Q 013105          150 YCCE------DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY  223 (449)
Q Consensus       150 ~~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~  223 (449)
                      ++..      ....|++|||+.+|+|.+++.......+++..+..++.|++.||.|||  +.+|+|+||+|+||+++.++
T Consensus        81 ~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--~~~ivH~dl~~~nili~~~~  158 (282)
T cd06636          81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH--AHKVIHRDIKGQNVLLTENA  158 (282)
T ss_pred             ehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCC
Confidence            9853      467899999999999999987765567888889999999999999999  67899999999999999999


Q ss_pred             cEEEeeeccccCCCCCCCCceeeecCCCCccccccccc-----cCCCCcccchhhhHHHHHHHHhCCCcccccccccchh
Q 013105          224 NAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN-----TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKD  298 (449)
Q Consensus       224 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~  298 (449)
                      .++|+|||++........  ......|++.|+|||++.     ...++.++|||||||++|||++|..||..........
T Consensus       159 ~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~  236 (282)
T cd06636         159 EVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF  236 (282)
T ss_pred             CEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh
Confidence            999999999875432211  122356899999999875     3467889999999999999999999996542211110


Q ss_pred             hHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          299 LVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .                .............++..+.++|.+||+.||.+|||+.+|+++
T Consensus       237 ~----------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         237 L----------------IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             h----------------HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence            0                000101111122355679999999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=7.1e-40  Score=309.56  Aligned_cols=254  Identities=26%  Similarity=0.356  Sum_probs=190.2

Q ss_pred             cccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEEEec
Q 013105           86 YLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYM  164 (449)
Q Consensus        86 ~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  164 (449)
                      .||+|+||.||+|.....    .....+|+|.+..... .....+.+|+.+++.++|+||+++++.+......++||||+
T Consensus         2 ~lg~G~fg~v~~~~~~~~----~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRG----MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFC   77 (269)
T ss_pred             cCCccCCceEEEEEEecC----CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeC
Confidence            599999999999976432    2456789998764432 23456789999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCC
Q 013105          165 ALGNLHDQLFKNYS---STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGED  241 (449)
Q Consensus       165 ~~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~  241 (449)
                      .+|+|.+++.....   ...++.....++.|++.||+|||  +++|+||||||+|||++.++.+||+|||++........
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~  155 (269)
T cd05042          78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY  155 (269)
T ss_pred             CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH--hcCEecccccHhheEecCCCcEEEeccccccccccchh
Confidence            99999999876432   23467778899999999999999  77899999999999999999999999999875433221


Q ss_pred             CceeeecCCCCcccccccccc-------CCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccch
Q 013105          242 SHITTCVMGTEGYAAPEYINT-------GHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       242 ~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      ........++..|+|||++..       ..++.++|||||||++|||++ |..||.........  .....   ...   
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~--~~~~~---~~~---  227 (269)
T cd05042         156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL--KQVVR---EQD---  227 (269)
T ss_pred             eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH--HHHhh---ccC---
Confidence            111223346778999998742       356889999999999999999 78888654221110  00000   000   


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL  358 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  358 (449)
                          ........+...+..+.+++..|| .||++|||+.+|++.|
T Consensus       228 ----~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         228 ----IKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             ----ccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence                000111223345566788999998 5999999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=9.7e-40  Score=308.18  Aligned_cols=252  Identities=24%  Similarity=0.349  Sum_probs=199.4

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-----cchHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-----SQGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      .+|.+.+.||+|+||.||+|....      ++..||+|.+....     ......+.+|+.+++.++||||+++++++.+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   75 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVD------TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD   75 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcC------CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc
Confidence            478999999999999999997765      47899999986432     1223567889999999999999999998875


Q ss_pred             --CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeec
Q 013105          154 --DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFG  231 (449)
Q Consensus       154 --~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfG  231 (449)
                        ....+++|||+.+++|.+++...  ..+++.....++.|++.||.|||  +.+|+|+||||+||+++.++.++|+|||
T Consensus        76 ~~~~~~~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH--~~~i~H~~l~p~nil~~~~~~~~l~dfg  151 (266)
T cd06651          76 RAEKTLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLH--SNMIVHRDIKGANILRDSAGNVKLGDFG  151 (266)
T ss_pred             CCCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEECCCCCEEEccCC
Confidence              36789999999999999998764  45888899999999999999999  7889999999999999999999999999


Q ss_pred             cccCCCCCC-CCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccc
Q 013105          232 LATDGPQGE-DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF  310 (449)
Q Consensus       232 la~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  310 (449)
                      ++....... .........|+..|+|||.+.+..++.++|||||||++|||++|+.||.........             
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~-------------  218 (266)
T cd06651         152 ASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI-------------  218 (266)
T ss_pred             CccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH-------------
Confidence            987543211 111122345889999999998888999999999999999999999999753211110             


Q ss_pred             cchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                         ...........++...++.+.+++ .||..+|++||++.+|+.|
T Consensus       219 ---~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         219 ---FKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             ---HHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence               011111112233445566678888 6778899999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-40  Score=309.78  Aligned_cols=252  Identities=30%  Similarity=0.454  Sum_probs=196.3

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcC-CCCCcceeeeEEEeCCEEEEEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQL-KHPHLVNLIGYCCEDEHRLLVYE  162 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e  162 (449)
                      +.||+|+||.||+|.+..+    .....+++|.+.... ......+.+|+.++.++ +||||+++++++...+..++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~----~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e   76 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKD----GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE   76 (270)
T ss_pred             CcCCCCCCceEEEEEEcCC----CCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence            3699999999999987652    112357888886432 33456788999999999 79999999999999999999999


Q ss_pred             ecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEe
Q 013105          163 YMALGNLHDQLFKNY--------------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLS  228 (449)
Q Consensus       163 ~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~  228 (449)
                      |+++|+|.+++....              ...+++.+...++.|++.||+|||  +++++||||||+|||++.++.+||+
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH--~~~i~H~dikp~nili~~~~~~kl~  154 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIA  154 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccccceEEEcCCCeEEEC
Confidence            999999999986532              134788999999999999999999  7889999999999999999999999


Q ss_pred             eeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhh
Q 013105          229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPML  307 (449)
Q Consensus       229 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  307 (449)
                      |||++.......   .......+..|+|||++.+..++.++|||||||++|||++ |..||.......   ...   .. 
T Consensus       155 dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~---~~-  224 (270)
T cd05047         155 DFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYE---KL-  224 (270)
T ss_pred             CCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHH---HH-
Confidence            999986322111   0111223567999999988889999999999999999997 999996542211   110   00 


Q ss_pred             ccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccc
Q 013105          308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL  362 (449)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  362 (449)
                                ........+..++..+.+++.+||+.||.+|||+.+++..|..++
T Consensus       225 ----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         225 ----------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             ----------hCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                      000111122234567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7e-40  Score=312.43  Aligned_cols=254  Identities=25%  Similarity=0.394  Sum_probs=203.0

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC-CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      ++|++.+.||+|+||.||+|.+..      .+..||+|.+... .......+.+|+.++++++|+||+++++.+..++..
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRP------TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAV   74 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcC------CCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeE
Confidence            368889999999999999997764      4789999998754 233346788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          158 LLVYEYMALGNLHDQLFKN-YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      ++||||+++++|..++... ....+++..+..++.+++.||.|||+ ..+|+|+||||+||+++.++.++|+|||++...
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  153 (286)
T cd06622          75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE-EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL  153 (286)
T ss_pred             EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCEeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            9999999999998887653 12478999999999999999999993 247999999999999999999999999998754


Q ss_pred             CCCCCCceeeecCCCCccccccccccC------CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccc
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTG------HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF  310 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  310 (449)
                      ....    .....|++.|+|||.+.+.      .++.++|||||||++|+|++|..||..........            
T Consensus       154 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~------------  217 (286)
T cd06622         154 VASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA------------  217 (286)
T ss_pred             cCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH------------
Confidence            3221    2234588899999998543      35889999999999999999999996532111100            


Q ss_pred             cchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       .+..+.. ......+..++.++.+++.+||+.+|++||++.+++.+
T Consensus       218 -~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         218 -QLSAIVD-GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             -HHHHHhh-cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence             0011111 11223444577789999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.5e-40  Score=311.35  Aligned_cols=245  Identities=26%  Similarity=0.397  Sum_probs=190.1

Q ss_pred             cccccCceEEEEEEEcCCC------------------CCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCccee
Q 013105           86 YLGEGGFGKVYKGCVDDNL------------------RPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNL  147 (449)
Q Consensus        86 ~lG~G~~g~V~~~~~~~~~------------------~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~  147 (449)
                      .||+|+||.||+|.+....                  ........|++|++..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            5999999999999764211                  1122335689999875544445678889999999999999999


Q ss_pred             eeEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC----
Q 013105          148 IGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY----  223 (449)
Q Consensus       148 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~----  223 (449)
                      ++++.+....++||||+++|+|..++... ...+++..+..++.|++.||.|||  +++|+||||||+|||++..+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH--~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLE--DKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--cCCccCCCCCcccEEEeccCcccC
Confidence            99999999999999999999998887653 357889999999999999999999  78899999999999997643    


Q ss_pred             ---cEEEeeeccccCCCCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHH-hCCCcccccccccchh
Q 013105          224 ---NAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELL-TGRRSVEKNRCKREKD  298 (449)
Q Consensus       224 ---~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~ell-tg~~pf~~~~~~~~~~  298 (449)
                         .++++|||++......      ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||..........
T Consensus       159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~  232 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER  232 (274)
T ss_pred             ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence               4899999988643221      12347888999998865 56899999999999999984 7999987543221111


Q ss_pred             hHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 013105          299 LVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL  358 (449)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  358 (449)
                      ..                 ..  ....+......+.+++.+||+.+|++|||+.+|++.|
T Consensus       233 ~~-----------------~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         233 FY-----------------EK--KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HH-----------------Hh--ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            00                 00  0011112234588999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=9.4e-40  Score=306.02  Aligned_cols=250  Identities=24%  Similarity=0.337  Sum_probs=204.4

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      +|++.+.||+|+||.||+|....      +++.+|+|.+....  ......+.+|+.+++.++||||+++++.+..++..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKA------DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKAL   74 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcC------CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEE
Confidence            58889999999999999997765      57899999987542  33456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC-cEEEeeeccccCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY-NAKLSDFGLATDG  236 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~-~~kl~DfGla~~~  236 (449)
                      ++||||+.+++|.+++.......+++..+..++.+++.+|.|||  +++++|+||+|+||+++.++ .++|+|||++...
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh--~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (256)
T cd08220          75 MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH--TKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL  152 (256)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence            99999999999999997765567899999999999999999999  77899999999999998654 6899999999865


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHh
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI  316 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (449)
                      .....   .....|+..|+|||.+.+..++.++||||||+++|+|++|..||........   ...             .
T Consensus       153 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~-------------~  213 (256)
T cd08220         153 SSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VLK-------------I  213 (256)
T ss_pred             CCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---HHH-------------H
Confidence            43221   2234588999999999888889999999999999999999999975432111   000             0


Q ss_pred             hcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .. ......+...+..+.+++.+||+.||++|||+.+++.+
T Consensus       214 ~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         214 MS-GTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             Hh-cCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            00 11112233456679999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=6.4e-40  Score=309.05  Aligned_cols=252  Identities=25%  Similarity=0.393  Sum_probs=201.2

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc------chHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS------QGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      +|.+.+.||+|+||.||+|...       +++.+|+|.+.....      .....+.+|+++++.++|+||+++++++.+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   73 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD   73 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec
Confidence            5888999999999999999753       367899999864321      123457889999999999999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      .+..++||||+.+++|.+++.+.  ..+++..+..++.|++.||.|||  +.+|+|+||+|+||+++.++.++|+|||++
T Consensus        74 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  149 (265)
T cd06631          74 DNTISIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLH--NNCVVHRDIKGNNVMLMPNGIIKLIDFGCA  149 (265)
T ss_pred             CCeEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcCHHhEEECCCCeEEeccchhh
Confidence            99999999999999999998764  46788999999999999999999  778999999999999999999999999998


Q ss_pred             cCCCCCC----CCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcc
Q 013105          234 TDGPQGE----DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKD  309 (449)
Q Consensus       234 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  309 (449)
                      .......    .........|+..|+|||.+.+..++.++|||||||++|+|++|..||............       ..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~-------~~  222 (265)
T cd06631         150 RRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI-------GA  222 (265)
T ss_pred             HhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh-------hh
Confidence            7542111    111122356899999999998888999999999999999999999999754221110000       00


Q ss_pred             ccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          310 FTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                              ........+...+..+.+++.+||+.+|++||++.+++.+
T Consensus       223 --------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         223 --------HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             --------ccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                    0001112233456678999999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.2e-39  Score=304.44  Aligned_cols=247  Identities=28%  Similarity=0.455  Sum_probs=196.1

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEEEe
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEY  163 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  163 (449)
                      ++||+|+||.||+|...+       +..+|+|++..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~ig~g~~g~vy~~~~~~-------~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   73 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKD-------KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMEL   73 (250)
T ss_pred             CccCCCCCceEEEEEecC-------CcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEEC
Confidence            469999999999997543       57899999875432 2234688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCCc
Q 013105          164 MALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSH  243 (449)
Q Consensus       164 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~~  243 (449)
                      +.+++|.+++... ...+++.....++.+++.+|.|||  .+|++|+||||+||+++.++.++|+|||++......... 
T Consensus        74 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH--~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-  149 (250)
T cd05085          74 VPGGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLE--SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-  149 (250)
T ss_pred             CCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccChheEEEcCCCeEEECCCccceeccccccc-
Confidence            9999999988654 246789999999999999999999  778999999999999999999999999998754322111 


Q ss_pred             eeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHhhccccc
Q 013105          244 ITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLE  322 (449)
Q Consensus       244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (449)
                      ......++..|+|||++.+..++.++||||||+++|+|++ |..||............                 .....
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~-----------------~~~~~  212 (250)
T cd05085         150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV-----------------EKGYR  212 (250)
T ss_pred             cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-----------------HcCCC
Confidence            1111234667999999988889999999999999999998 99999754221111000                 00011


Q ss_pred             ccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 013105          323 DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE  359 (449)
Q Consensus       323 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  359 (449)
                      ...+..++..+.+++.+||+.+|++||++.++++.|.
T Consensus       213 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         213 MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            1122345567999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=9.8e-40  Score=307.20  Aligned_cols=256  Identities=28%  Similarity=0.411  Sum_probs=195.3

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC-CcchHHHHHHHHHHHhcCCCCCcceeeeEEE-eCCEEEEEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGHREWLAEVIFLGQLKHPHLVNLIGYCC-EDEHRLLVYE  162 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~-~~~~~~lv~e  162 (449)
                      +.||+|+||.||+|.+.+.   ......+|+|.+... .......+.+|+.+++.++||||+++++++. .++..++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDS---DGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecC---CCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEe
Confidence            4689999999999987542   123567999998533 2334567889999999999999999999775 4566899999


Q ss_pred             ecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCC
Q 013105          163 YMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS  242 (449)
Q Consensus       163 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~  242 (449)
                      |+.+|+|.+++... ....++.....++.|++.||.|||  ..+++||||||+|||++.++.+||+|||++.........
T Consensus        78 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          78 YMKHGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLA--SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--hCCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            99999999998654 234677788899999999999999  778999999999999999999999999999754322110


Q ss_pred             --ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhC-CCcccccccccchhhHHhhhhhhccccchhHhhcc
Q 013105          243 --HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG-RRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDS  319 (449)
Q Consensus       243 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (449)
                        .......++..|+|||.+.+..++.++|||||||++|||++| .+||......   ......              ..
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~~--------------~~  217 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVYL--------------LQ  217 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH--------------hc
Confidence              111123457789999999888899999999999999999995 5666543211   111110              00


Q ss_pred             cccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          320 RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       320 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                      ......+...+..+.+++..||+.+|++||++.++++.|+.++.
T Consensus       218 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         218 GRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            00111122345679999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.2e-39  Score=315.55  Aligned_cols=265  Identities=22%  Similarity=0.302  Sum_probs=189.3

Q ss_pred             cccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEe--CCEEEEEE
Q 013105           84 SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE--DEHRLLVY  161 (449)
Q Consensus        84 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~lv~  161 (449)
                      .+.||+|+||.||+|...+.    ..+..||+|.+....  ....+.+|+.+|+.++||||+++++++..  +...++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~----~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDG----KDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   79 (317)
T ss_pred             ccccccCCCeEEEEEEEccC----CCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence            46799999999999986531    246789999986432  23456789999999999999999998854  46789999


Q ss_pred             EecCCCChHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEE----cCCCcEEEeee
Q 013105          162 EYMALGNLHDQLFKN-------YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILL----DSDYNAKLSDF  230 (449)
Q Consensus       162 e~~~~g~L~~~l~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill----~~~~~~kl~Df  230 (449)
                      ||+. ++|.+++...       ....+++..+..++.|++.||.|||  ++||+||||||+|||+    +.++.+||+||
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH--hCCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            9986 6888776432       1235888999999999999999999  7789999999999999    45678999999


Q ss_pred             ccccCCCCCCC-CceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccch------hhHHh
Q 013105          231 GLATDGPQGED-SHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREK------DLVEW  302 (449)
Q Consensus       231 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~------~~~~~  302 (449)
                      |++........ ........||+.|+|||++.+ ..++.++|||||||++|||++|++||.........      .....
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07868         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR  236 (317)
T ss_pred             CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence            99986543221 111234568999999999876 45899999999999999999999999754321110      00000


Q ss_pred             hhhhh-----ccccchhH------hhcc----ccc--------ccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          303 ARPML-----KDFTKLDQ------IIDS----RLE--------DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       303 ~~~~~-----~~~~~~~~------~~~~----~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .....     ..+.....      ....    ...        .......+..+.+|+.+||+.||.+|||++|+++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h  314 (317)
T cd07868         237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  314 (317)
T ss_pred             HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            00000     00000000      0000    000        00000113457899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.4e-40  Score=312.05  Aligned_cols=255  Identities=25%  Similarity=0.393  Sum_probs=204.7

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      ++|++.+.||+|+||.||+|.+..      .+..||+|++.... ......+.+|+++++.++||||+++++++...+.+
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIP------TGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNI   78 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcC------CCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEE
Confidence            568888999999999999998765      47889999986543 33456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+++++|.+++...  +.+++.....++.+++.+|.|||+ ..+++||||+|+||+++.++.++|+|||++....
T Consensus        79 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~-~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~  155 (284)
T cd06620          79 CMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYN-VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI  155 (284)
T ss_pred             EEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHH-hcCeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence            9999999999999888654  568999999999999999999994 2579999999999999999999999999987542


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccch-----hhHHhhhhhhccccc
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREK-----DLVEWARPMLKDFTK  312 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~-----~~~~~~~~~~~~~~~  312 (449)
                      ...    .....|+..|+|||++.+..++.++|||||||++|+|++|..||.........     .......        
T Consensus       156 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------  223 (284)
T cd06620         156 NSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ--------  223 (284)
T ss_pred             hhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHH--------
Confidence            211    22346899999999998888999999999999999999999999854322110     0111111        


Q ss_pred             hhHhhcccccccCC-HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          313 LDQIIDSRLEDRYS-TEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       313 ~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                        .+.... ....+ ..++..+.+++.+||+.||++|||+.+++++
T Consensus       224 --~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         224 --QIVQEP-PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             --HHhhcc-CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence              111111 11111 2356679999999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=322.54  Aligned_cols=263  Identities=29%  Similarity=0.423  Sum_probs=217.6

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC-CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ..+.....+.||.|.||.||+|++.+.  .....-.||||..+.+ .....+.|+.|..+|+.++||||++++|+|.+ .
T Consensus       387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~--~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~  463 (974)
T KOG4257|consen  387 RRELITLKRLIGEGQFGDVYKGVYTDP--EKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q  463 (974)
T ss_pred             ehhhccHHHhhcCCcccceeeeEeccc--ccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence            344455678899999999999999863  2445567999999865 34556789999999999999999999999975 5


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..|||||.+..|.|..++..+ ...++......++.|++.||+|||  ++.+|||||...|||+.....+||+|||+++.
T Consensus       464 P~WivmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLe--SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~  540 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLE--SKRFVHRDIAARNILVSSPQCVKLADFGLSRY  540 (974)
T ss_pred             ceeEEEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHH--hhchhhhhhhhhheeecCcceeeecccchhhh
Confidence            689999999999999999875 357889999999999999999999  67799999999999999999999999999998


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchh
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ..+....... ...-...|||||.+....++.++|||-|||++||++. |..||.+-...+..                 
T Consensus       541 ~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-----------------  602 (974)
T KOG4257|consen  541 LEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-----------------  602 (974)
T ss_pred             ccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-----------------
Confidence            7765543332 1223568999999999999999999999999999876 99999864322211                 


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                      ..+....+.+.|+.||+.|..|+.+||+.+|.+||.+.+|...|.++++
T Consensus       603 ~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  603 GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            1123334556788999999999999999999999999999988887765

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-40  Score=293.10  Aligned_cols=249  Identities=24%  Similarity=0.407  Sum_probs=200.2

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC-CcchHHHHHHHHHHHhcCC-CCCcceeeeEEEeCCEEE
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGHREWLAEVIFLGQLK-HPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~  158 (449)
                      .++...||.|+.|.||++.+..      ++...|||.+... +....++++..+.++...+ +|+||+.+|+|..+...+
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs------~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~  167 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRS------TGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF  167 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcc------cceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH
Confidence            3445679999999999998876      6889999999755 4455677888888776664 899999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCC
Q 013105          159 LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~  238 (449)
                      |.||.|.  +-.+.|.+....++++...-++...++.||.||-. +++|||||+||+|||+|+.|++||||||++-...+
T Consensus       168 IcMelMs--~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe-KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd  244 (391)
T KOG0983|consen  168 ICMELMS--TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD  244 (391)
T ss_pred             HHHHHHH--HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH-hcceeecccCccceEEccCCCEEeecccccceeec
Confidence            9999984  44555555555779998888999999999999975 67899999999999999999999999999987654


Q ss_pred             CCCCceeeecCCCCccccccccc---cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          239 GEDSHITTCVMGTEGYAAPEYIN---TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ..   ..+...|.+.|||||.+.   ...|+..+||||||++|+||.||+.||.+....               +..+..
T Consensus       245 Sk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td---------------Fe~ltk  306 (391)
T KOG0983|consen  245 SK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD---------------FEVLTK  306 (391)
T ss_pred             cc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc---------------HHHHHH
Confidence            32   234456999999999984   346899999999999999999999999875322               122222


Q ss_pred             hhcccccccC--CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          316 IIDSRLEDRY--STEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       316 ~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      +++.. ++.+  ...+++.+++++..||.+|+.+||.+.++++|
T Consensus       307 vln~e-PP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  307 VLNEE-PPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             HHhcC-CCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            22211 1212  22367889999999999999999999999997

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5e-40  Score=312.00  Aligned_cols=248  Identities=26%  Similarity=0.402  Sum_probs=202.1

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      .|+..+.||+|+||.||+|.+..      .+..||+|.+.... ......+.+|+.+++.++||||+++++++..++..+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNR------TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLW   78 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcC------CCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceE
Confidence            46667889999999999998765      47789999987543 333457889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCC
Q 013105          159 LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~  238 (449)
                      +||||+.+++|.+++..   ..+++..+..++.+++.||.|||  .++++|+||+|+||+++.++.++|+|||++.....
T Consensus        79 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06642          79 IIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLH--SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             EEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHh--cCCeeccCCChheEEEeCCCCEEEccccccccccC
Confidence            99999999999988754   46888999999999999999999  78899999999999999999999999999876543


Q ss_pred             CCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhc
Q 013105          239 GEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIID  318 (449)
Q Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (449)
                      ...  ......|+..|+|||.+.+..++.++|||||||++|||++|..||........   ..              .+.
T Consensus       154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~--------------~~~  214 (277)
T cd06642         154 TQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---LF--------------LIP  214 (277)
T ss_pred             cch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---Hh--------------hhh
Confidence            221  12234588999999999888899999999999999999999999864321110   00              001


Q ss_pred             ccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          319 SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       319 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ...........+..+.+++.+||+.+|++||++.+++++
T Consensus       215 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         215 KNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             cCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            111112233456679999999999999999999999987

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.1e-39  Score=308.12  Aligned_cols=255  Identities=21%  Similarity=0.296  Sum_probs=201.9

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      .++++.....||+|+||.||+|.+..      ++..||+|.+..........+.+|+.+++.++|+||+++++++..++.
T Consensus         6 ~~~~~~~~~~lg~g~~g~v~~~~~~~------~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (268)
T cd06624           6 EYDENGERVVLGKGTYGIVYAARDLS------TQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGF   79 (268)
T ss_pred             ccccCCceEEEecCCceEEEEeEecC------CCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCE
Confidence            34455556789999999999997765      477899999876655566788999999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC-CCcEEEeeeccc
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTL--PWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS-DYNAKLSDFGLA  233 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l--~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~-~~~~kl~DfGla  233 (449)
                      .++||||+.+++|.+++.... ..+  +...+..++.|++.||.|||  .++|+||||||+||+++. ++.++|+|||++
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~  156 (268)
T cd06624          80 FKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLH--DNQIVHRDIKGDNVLVNTYSGVVKISDFGTS  156 (268)
T ss_pred             EEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence            999999999999999987542 234  77888889999999999999  788999999999999976 679999999998


Q ss_pred             cCCCCCCCCceeeecCCCCccccccccccC--CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcccc
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINTG--HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFT  311 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  311 (449)
                      ........  ......|++.|+|||.+.+.  .++.++||||||+++|+|++|..||........   ..+...      
T Consensus       157 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~------  225 (268)
T cd06624         157 KRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVG------  225 (268)
T ss_pred             eecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhh------
Confidence            75432221  12234589999999998654  378899999999999999999999965321110   000000      


Q ss_pred             chhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          312 KLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                            .......++..+++++.+++.+||+.+|.+|||+.+++.+
T Consensus       226 ------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         226 ------MFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             ------hhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence                  0011122344566779999999999999999999999986

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=9.1e-40  Score=308.97  Aligned_cols=262  Identities=27%  Similarity=0.378  Sum_probs=206.0

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      .++|.+.+.||+|+||.||+|.+.+.   ......||+|...... ....+.+.+|+.+++.++||||+++++++.+ +.
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~---~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~   80 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSP---ENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP   80 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecC---CCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence            35688899999999999999987542   1234579999987543 3445678899999999999999999998875 55


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||+.+|+|.+++... ...+++..++.++.+++.||.|||  +.+++|+||||+|||++.++.++|+|||++...
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH--~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLE--SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccChheEEEecCCCeEEccCceeeec
Confidence            78999999999999998654 246899999999999999999999  778999999999999999999999999998755


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ...... ......++..|+|||.+.+..++.++|||||||++|||++ |..||........   ....            
T Consensus       158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~~------------  221 (270)
T cd05056         158 EDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGRI------------  221 (270)
T ss_pred             ccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHH------------
Confidence            432111 1112234568999999988889999999999999999986 9999975432111   1100            


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                        ........+..++..+.+++.+||..+|++|||+.++++.|+.+...
T Consensus       222 --~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         222 --ENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             --HcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence              00011122344566799999999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.5e-39  Score=306.59  Aligned_cols=252  Identities=23%  Similarity=0.295  Sum_probs=200.3

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-----cchHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-----SQGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      .+|++.+.||+|+||.||+|.+.+      ++..||+|.+....     ......+.+|+.+++.++||||+++++++.+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   75 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDAD------TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD   75 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcC------CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc
Confidence            578999999999999999998765      57899999986432     1224567889999999999999999998876


Q ss_pred             C--CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeec
Q 013105          154 D--EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFG  231 (449)
Q Consensus       154 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfG  231 (449)
                      .  ...++||||+++++|.+++...  ..+++.....++.|++.||.|||  +.+|+|+||||+||+++.++.++|+|||
T Consensus        76 ~~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~l~Dfg  151 (265)
T cd06652          76 PMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLH--SNMIVHRDIKGANILRDSVGNVKLGDFG  151 (265)
T ss_pred             CCCceEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEecCCCCEEECcCc
Confidence            3  5688999999999999988754  45788889999999999999999  7789999999999999999999999999


Q ss_pred             cccCCCCCCC-CceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccc
Q 013105          232 LATDGPQGED-SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF  310 (449)
Q Consensus       232 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  310 (449)
                      ++........ ........|+..|+|||++.+..++.++|||||||++|+|++|+.||.........             
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-------------  218 (265)
T cd06652         152 ASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI-------------  218 (265)
T ss_pred             cccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH-------------
Confidence            9885432111 11122345899999999998888999999999999999999999999753211110             


Q ss_pred             cchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                         ............+...+..+.+++.+||. +|++||++++|+++
T Consensus       219 ---~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         219 ---FKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             ---HHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence               00111111222345566778899999995 99999999999976

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=7.5e-40  Score=315.02  Aligned_cols=263  Identities=24%  Similarity=0.366  Sum_probs=203.1

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      ++|+..+.||+|+||.||+|.+..+.  ......||+|.+..... .....+.+|+.+++.++||||+++++++... ..
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~   83 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEG--ETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI   83 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCC--CcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence            56888899999999999999876521  11123689998864432 2234688999999999999999999998754 46


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++++||+.+|+|.+++... ...+++..+..++.|++.||.|||  +++|+||||||+|||++.++.+||+|||++....
T Consensus        84 ~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH--~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHh--hcCeeccccccceeeecCCCceEEcccccccccc
Confidence            7999999999999998654 346888999999999999999999  7789999999999999999999999999998654


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI  316 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (449)
                      ............++..|+|||.+.+..++.++|||||||++|||++ |..||.+.......   .+.             
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~---~~~-------------  224 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP---DLL-------------  224 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHH-------------
Confidence            3222211222345778999999988889999999999999999997 89998754221111   111             


Q ss_pred             hcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                       ........+..++..+.+++..||..+|++||++.++++.|..+...
T Consensus       225 -~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         225 -EKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             -HCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence             00001111222345688999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.1e-39  Score=307.71  Aligned_cols=255  Identities=26%  Similarity=0.429  Sum_probs=204.4

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc------chHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS------QGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      +|+..+.||+|+||.||+|....      +++.||+|++.....      .....+.+|+.+++.++|+||+++++++.+
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~------~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   74 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVK------TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE   74 (268)
T ss_pred             CccccceecCcCceEEEEEEEcC------CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc
Confidence            47888999999999999997654      578999999874321      124568899999999999999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC-cEEEeeecc
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY-NAKLSDFGL  232 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~-~~kl~DfGl  232 (449)
                      .+..++||||+.+++|.+++...  ..+++.....++.|++.||.|||  ++|++|+||+|+||+++.++ .++|+|||+
T Consensus        75 ~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH--~~~i~H~~i~~~nil~~~~~~~~~l~dfg~  150 (268)
T cd06630          75 DSHFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLH--ENQIIHRDVKGANLLIDSTGQRLRIADFGA  150 (268)
T ss_pred             CCeEEEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEEccccc
Confidence            99999999999999999988654  56889999999999999999999  77899999999999998776 599999999


Q ss_pred             ccCCCCCCC--CceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccc
Q 013105          233 ATDGPQGED--SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF  310 (449)
Q Consensus       233 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  310 (449)
                      +........  ........|+..|+|||.+.+..++.++|||||||++|+|++|..||............          
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~----------  220 (268)
T cd06630         151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI----------  220 (268)
T ss_pred             ccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH----------
Confidence            876543211  11122346889999999998888999999999999999999999999643221111100          


Q ss_pred             cchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                         ............+...+..+.+++.+||..+|++||++.+++++
T Consensus       221 ---~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         221 ---FKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             ---HHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence               00111111233445667789999999999999999999999976

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.1e-39  Score=305.53  Aligned_cols=251  Identities=26%  Similarity=0.399  Sum_probs=205.6

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      ++|++.+.||+|+||.||+|.+..      .+..+++|.+.....  ...+.+|+++++.++|+||+++++++.+....|
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~------~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~   74 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKE------TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLW   74 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcC------CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEE
Confidence            578999999999999999998765      468899999875432  678899999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCC
Q 013105          159 LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~  238 (449)
                      ++|||+.+++|.+++... ...+++.....++.|++.||.|||  ..+++|+||+|+||+++.++.++|+|||++.....
T Consensus        75 l~~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh--~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~  151 (256)
T cd06612          75 IVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLH--SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD  151 (256)
T ss_pred             EEEecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence            999999999999988643 357899999999999999999999  77899999999999999999999999999886543


Q ss_pred             CCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhc
Q 013105          239 GEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIID  318 (449)
Q Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (449)
                      ...  ......|+..|+|||++.+..++.++|||||||++|+|++|+.||............      ..         .
T Consensus       152 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~------~~---------~  214 (256)
T cd06612         152 TMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI------PN---------K  214 (256)
T ss_pred             Ccc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh------cc---------C
Confidence            321  123345889999999998888999999999999999999999999754221110000      00         0


Q ss_pred             ccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          319 SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       319 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .......+...+..+.+++..||+.||++|||+.+++++
T Consensus       215 ~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         215 PPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             CCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            000111223455679999999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.8e-39  Score=304.24  Aligned_cols=256  Identities=32%  Similarity=0.507  Sum_probs=203.8

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc-hHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEE
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ-GHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLL  159 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  159 (449)
                      +++.+.||.|+||.||+|.+...  ....+..||+|++...... ....+..|+.++..++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGL--SGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCC--CCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            45678999999999999988652  1123588999999755433 46678899999999999999999999999999999


Q ss_pred             EEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCC
Q 013105          160 VYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQG  239 (449)
Q Consensus       160 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~  239 (449)
                      +|||+.+++|.+++.......+++..+..++.|++.||.|||  +.+++|+||||+||+++.++.++|+|||++......
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh--~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh--cCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence            999999999999987654333899999999999999999999  778999999999999999999999999999865443


Q ss_pred             CCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHhhc
Q 013105          240 EDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIID  318 (449)
Q Consensus       240 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (449)
                      ...... ...+++.|+|||.+.+..++.++|||||||++|+|++ |.+||.......   .....              .
T Consensus       157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~--------------~  218 (258)
T smart00219      157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE---VLEYL--------------K  218 (258)
T ss_pred             cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH--------------h
Confidence            221111 2236789999999988889999999999999999998 788886532111   11100              0


Q ss_pred             ccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 013105          319 SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL  358 (449)
Q Consensus       319 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  358 (449)
                      .......+...+.++.+++.+||..||++|||+.++++.|
T Consensus       219 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      219 KGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             cCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            0011112233566799999999999999999999999764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2e-39  Score=305.56  Aligned_cols=258  Identities=26%  Similarity=0.388  Sum_probs=206.8

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      ++|++.+.||.|+||.||+|....      .+..+|+|++.... ......+.+|+.+++.++|+||+++++.+...+..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLP------NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDEL   74 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcC------CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEE
Confidence            478999999999999999997654      47789999997543 23457788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYS-STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      ++|||++.+++|.+++..... ..+++.....++.|++.||.|||  +.||+|+||+|+||++++++.++|+|||++...
T Consensus        75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh--~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~  152 (267)
T cd06610          75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH--SNGQIHRDIKAGNILLGEDGSVKIADFGVSASL  152 (267)
T ss_pred             EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence            999999999999999976533 57899999999999999999999  788999999999999999999999999998765


Q ss_pred             CCCCCCc--eeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccch
Q 013105          237 PQGEDSH--ITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       237 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      .......  ......|+..|+|||.+... .++.++|+|||||++|+|++|+.||........  .......   .    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~~---~----  223 (267)
T cd06610         153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTLQN---D----  223 (267)
T ss_pred             ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHhcC---C----
Confidence            4432221  22334689999999998766 789999999999999999999999975432110  1110000   0    


Q ss_pred             hHhhcccccc-cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          314 DQIIDSRLED-RYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       314 ~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                          ...... ......+..+.+++.+||+.||++||++.++++|
T Consensus       224 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         224 ----PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             ----CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                000000 0012456778999999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.1e-39  Score=305.72  Aligned_cols=251  Identities=24%  Similarity=0.383  Sum_probs=205.0

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      +|++.+.||+|+||.||++....      .++.||+|.+...  .......+.+|+.+++.++||||+++++++...+..
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKE------DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNL   74 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcC------CCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeE
Confidence            58889999999999999997765      4789999998643  223345788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+.+++|.+++.......+++.....++.|++.||.|||  +.+++|+||+|+|||++.++.++|+|||++....
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~  152 (256)
T cd08218          75 YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH--DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN  152 (256)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCCCEEEeeccceeecC
Confidence            99999999999999887655556889999999999999999999  6789999999999999999999999999987553


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII  317 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (449)
                      ....  ......|++.|+|||++.+..++.++|+|||||++|+|++|..||........   .             ..+.
T Consensus       153 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~---~-------------~~~~  214 (256)
T cd08218         153 STVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL---V-------------LKII  214 (256)
T ss_pred             cchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH---H-------------HHHh
Confidence            3221  12234588999999999888899999999999999999999999975321110   0             0000


Q ss_pred             cccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          318 DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       318 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .. .....+...+.++.+++.+||+.+|++||++.+++++
T Consensus       215 ~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         215 RG-SYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             cC-CCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            11 1111233456679999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=8.5e-40  Score=306.36  Aligned_cols=247  Identities=28%  Similarity=0.448  Sum_probs=199.4

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      ++|++.+.||+|+||.||++..        .+..||+|.+....  ....+.+|+.+++.++||||+++++++..+ ..+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--------~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   74 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--------TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLY   74 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--------CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcE
Confidence            4688999999999999999853        35789999986432  345788999999999999999999998754 479


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCC
Q 013105          159 LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~  238 (449)
                      +||||+.+++|.+++.......+++..+..++.|++.||.|||  +.|++||||||+||+++.++.++|+|||++.....
T Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~  152 (254)
T cd05083          75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE--SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM  152 (254)
T ss_pred             EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccCcceEEEcCCCcEEECCCccceeccc
Confidence            9999999999999997765557899999999999999999999  78899999999999999999999999999875432


Q ss_pred             CCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHhh
Q 013105          239 GEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII  317 (449)
Q Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (449)
                      ..     .....+..|+|||.+.+..++.++|+|||||++|+|++ |..||............                 
T Consensus       153 ~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~-----------------  210 (254)
T cd05083         153 GV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV-----------------  210 (254)
T ss_pred             cC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH-----------------
Confidence            21     11234568999999988889999999999999999997 99999754322111100                 


Q ss_pred             cccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 013105          318 DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEP  360 (449)
Q Consensus       318 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  360 (449)
                      ........+..++..+.+++.+||+.+|++||++.++++.|+.
T Consensus       211 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         211 EKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             hCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            1111111223455678999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-41  Score=323.31  Aligned_cols=269  Identities=25%  Similarity=0.417  Sum_probs=224.7

Q ss_pred             HHHHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEE
Q 013105           72 KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYC  151 (449)
Q Consensus        72 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~  151 (449)
                      +.|+.-..+.....+||-|.||.||.|.|+.      ..-.||||.++ .+.....+|+.|+.+|+.++|||+|+++|+|
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKk------yslTvAVKtLK-EDtMeveEFLkEAAvMKeikHpNLVqLLGVC  332 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC  332 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeec------cceeeehhhhh-hcchhHHHHHHHHHHHHhhcCccHHHHhhhh
Confidence            4566666667778899999999999999987      35689999997 4456688999999999999999999999999


Q ss_pred             EeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeec
Q 013105          152 CEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFG  231 (449)
Q Consensus       152 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfG  231 (449)
                      ..+...|||.|||..|+|.++|.+-....++....+.++.||..|+.||.  .+++|||||...|+|+.++..+||+|||
T Consensus       333 T~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE--kknFIHRDLAARNCLVgEnhiVKvADFG  410 (1157)
T KOG4278|consen  333 THEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHIVKVADFG  410 (1157)
T ss_pred             ccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH--HhhhhhhhhhhhhccccccceEEeeccc
Confidence            99999999999999999999998876678888889999999999999999  8889999999999999999999999999


Q ss_pred             cccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccc
Q 013105          232 LATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDF  310 (449)
Q Consensus       232 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  310 (449)
                      |++....+.... .....-...|.|||-+....++.++|||+|||+|||+.| |-.||.+-+......            
T Consensus       411 LsRlMtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~------------  477 (1157)
T KOG4278|consen  411 LSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYG------------  477 (1157)
T ss_pred             hhhhhcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHH------------
Confidence            999765433211 111112467999999999999999999999999999998 778887643322222            


Q ss_pred             cchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCCCC
Q 013105          311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDI  367 (449)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~  367 (449)
                           ++....+-..+..||+.+.+||..||+..|.+||++.|+-+.++.++....+
T Consensus       478 -----LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSi  529 (1157)
T KOG4278|consen  478 -----LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSI  529 (1157)
T ss_pred             -----HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccc
Confidence                 2223333344678888999999999999999999999999999988776543

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.5e-39  Score=304.94  Aligned_cols=249  Identities=25%  Similarity=0.399  Sum_probs=202.6

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-----cchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-----SQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      +|+..+.||+|+||.||+|....      ++..|++|.+....     ......+.+|+.+++.++|+||+++++++...
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   74 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLD------DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE   74 (258)
T ss_pred             CccccceeeecCCceEEEEEEcC------CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC
Confidence            47788999999999999998764      47889999986543     22346788999999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      ...+++|||+++++|.+++...  ..+++.....++.|++.||.|||  ..+|+|+||+|+||+++.++.+||+|||++.
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~  150 (258)
T cd06632          75 DNLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLH--DRNTVHRDIKGANILVDTNGVVKLADFGMAK  150 (258)
T ss_pred             CeEEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEccCccce
Confidence            9999999999999999998764  46889999999999999999999  6789999999999999999999999999987


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccCC-CCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccch
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTGH-LTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      ......   ......|+..|+|||.+.... ++.++|+|||||++|+|++|..||........  ...            
T Consensus       151 ~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~--~~~------------  213 (258)
T cd06632         151 QVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--VFK------------  213 (258)
T ss_pred             eccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH--HHH------------
Confidence            654322   123456899999999987666 89999999999999999999999975431110  000            


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                        ..........+..++..+.+++.+||+.+|.+||++.+++.+
T Consensus       214 --~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         214 --IGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             --HHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence              000001112233456678999999999999999999999976

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=320.55  Aligned_cols=266  Identities=25%  Similarity=0.395  Sum_probs=216.9

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcch-HHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG-HREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ..+...+.+.||+|-||.|.++....       +..||||+++...... ..+|..|+++|.+|+||||++++++|..++
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg-------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De  608 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEG-------PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD  608 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecC-------ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC
Confidence            34567788999999999999987654       5789999998665444 478999999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      .+++|+|||++|+|.+++.++....+.......|+.||+.||+||.  +.++|||||.+.|+|++.++++||+|||+++.
T Consensus       609 PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe--s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~  686 (807)
T KOG1094|consen  609 PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE--SLNFVHRDLATRNCLVDGEFTIKIADFGMSRN  686 (807)
T ss_pred             chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH--hhchhhccccccceeecCcccEEecCcccccc
Confidence            9999999999999999999875455566677889999999999999  56699999999999999999999999999997


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh--CCCcccccccccchhhHHhhhhhhccccch
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT--GRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      +..++........+-...|||+|.+..++++.++|||+||++|||+++  ...||........   ++-...+.....  
T Consensus       687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~--  761 (807)
T KOG1094|consen  687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQG--  761 (807)
T ss_pred             cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCC--
Confidence            776666665655666789999999988999999999999999999765  6778875432211   111111111100  


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcc
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL  361 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  361 (449)
                           ...-...|.-|+..+.++|..||..|-++||+++++..+|++.
T Consensus       762 -----~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  762 -----RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             -----cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence                 0111233567788899999999999999999999999988754

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.2e-39  Score=310.48  Aligned_cols=267  Identities=25%  Similarity=0.313  Sum_probs=201.5

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      ++|++.+.||+|+||.||+|.+..      +++.||+|++....  ....+.+.+|+.+++.++|+||+++++++.....
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   74 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRE------TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRK   74 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECC------CCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCE
Confidence            468899999999999999998765      47899999986432  2223567889999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||++++.|..++...  ..+++..+..++.|++.+|.|||  +.+++|+||||+||+++.++.++|+|||++...
T Consensus        75 ~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (286)
T cd07847          75 LHLVFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCH--KHNCIHRDVKPENILITKQGQIKLCDFGFARIL  150 (286)
T ss_pred             EEEEEeccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCChhhEEEcCCCcEEECccccceec
Confidence            99999999988887665432  46899999999999999999999  678999999999999999999999999999865


Q ss_pred             CCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHH-hhhhhhccccc--
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVE-WARPMLKDFTK--  312 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~-~~~~~~~~~~~--  312 (449)
                      .....  ......++..|+|||.+.+ ..++.++|||||||++|+|++|.+||.+........... ...........  
T Consensus       151 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07847         151 TGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF  228 (286)
T ss_pred             CCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            43321  1223457899999999865 457899999999999999999999998654322111110 00000000000  


Q ss_pred             -----hhHhhccccc-----ccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          313 -----LDQIIDSRLE-----DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       313 -----~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                           ..........     .......+..+.+++.+||+.||++||++.+++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence                 0000000000     00012345678999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-41  Score=335.73  Aligned_cols=263  Identities=25%  Similarity=0.422  Sum_probs=221.6

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      ....+.++||.|.||.|++|.++..   ......||||.++... .....+|+.|+.||.+++||||+++.|+.......
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~p---gkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv  705 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLP---GKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV  705 (996)
T ss_pred             hheEEEEEEecccccceecccccCC---CCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence            4567789999999999999988753   3456789999998654 34456899999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      .||.|||++|+|+.+|..+. +.+.+.+..-++.+|+.|+.||-  +.++|||||...|||++.+..+|++||||++...
T Consensus       706 MIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLs--dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle  782 (996)
T KOG0196|consen  706 MIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLS--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  782 (996)
T ss_pred             EEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHh--hcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence            99999999999999998775 56999999999999999999999  7889999999999999999999999999999765


Q ss_pred             CCCCCceeeecCC--CCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchh
Q 013105          238 QGEDSHITTCVMG--TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       238 ~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ++.. ...++..|  ...|.|||.+....++.++||||+|++|||.++ |..||..+...+....               
T Consensus       783 dd~~-~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIka---------------  846 (996)
T KOG0196|consen  783 DDPE-AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA---------------  846 (996)
T ss_pred             cCCC-ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHH---------------
Confidence            5442 22233333  368999999999999999999999999999776 9999887643332222               


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCC
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN  365 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  365 (449)
                        +....+-+-|.+||..|.+|+..||++|-.+||.+.+|+..|+.++...
T Consensus       847 --Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  847 --IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             --HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence              2223334446788999999999999999999999999999999987653

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2e-39  Score=306.96  Aligned_cols=259  Identities=26%  Similarity=0.406  Sum_probs=200.1

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC---
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE---  155 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~---  155 (449)
                      |.+.+.||+|+||.||+|.+..+   ..++..||||++....  ......+.+|+++++.++||||+++++++....   
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSE---DGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG   77 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeecc---CCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence            56788999999999999987532   2357899999987542  334567889999999999999999999886532   


Q ss_pred             ---EEEEEEEecCCCChHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEe
Q 013105          156 ---HRLLVYEYMALGNLHDQLFKNY----SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLS  228 (449)
Q Consensus       156 ---~~~lv~e~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~  228 (449)
                         ..++++||+.+|+|.+++....    ...+++.....++.|++.||+|||  +++|+||||||+||+++.++.+||+
T Consensus        78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~nili~~~~~~kl~  155 (273)
T cd05074          78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS--SKNFIHRDLAARNCMLNENMTVCVA  155 (273)
T ss_pred             cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeecccchhhEEEcCCCCEEEC
Confidence               3478999999999988875321    235788899999999999999999  7789999999999999999999999


Q ss_pred             eeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhh
Q 013105          229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPML  307 (449)
Q Consensus       229 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  307 (449)
                      |||+++...............+++.|++||.+....++.++|||||||++|+|++ |.+||.......   ...+..   
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~~---  229 (273)
T cd05074         156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYLI---  229 (273)
T ss_pred             cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHHH---
Confidence            9999986543221111222345678999999988889999999999999999999 889987542211   111100   


Q ss_pred             ccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcc
Q 013105          308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL  361 (449)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  361 (449)
                       .          ......+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       230 -~----------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         230 -K----------GNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             -c----------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             0          000111223456799999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2e-39  Score=306.94  Aligned_cols=256  Identities=23%  Similarity=0.375  Sum_probs=200.8

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc----------chHHHHHHHHHHHhcCCCCCcceeee
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS----------QGHREWLAEVIFLGQLKHPHLVNLIG  149 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~nIv~~~~  149 (449)
                      +|.+.+.||+|+||.||+|....      +++.+|+|.+.....          ...+.+.+|+.+++.++||||+++++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~------~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   75 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVT------TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLG   75 (272)
T ss_pred             ceeecceecccCceEEEEEeecC------CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEE
Confidence            47788999999999999997654      478999998863211          01235778999999999999999999


Q ss_pred             EEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEee
Q 013105          150 YCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSD  229 (449)
Q Consensus       150 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~D  229 (449)
                      ++...+..++||||+.+++|.+++...  ..+++..+..++.|++.||.|||  +++++|+||+|+||+++.++.++|+|
T Consensus        76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~~~nil~~~~~~~~l~d  151 (272)
T cd06629          76 FETTEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLH--SKGILHRDLKADNLLVDADGICKISD  151 (272)
T ss_pred             EeccCCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHh--hCCeeecCCChhhEEEcCCCeEEEee
Confidence            999999999999999999999998765  57888999999999999999999  67899999999999999999999999


Q ss_pred             eccccCCCCCCCCceeeecCCCCccccccccccCC--CCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhh
Q 013105          230 FGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGH--LTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML  307 (449)
Q Consensus       230 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~  307 (449)
                      ||++................|+..|+|||.+....  ++.++|+||||+++|+|++|..||........  ....    .
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~----~  225 (272)
T cd06629         152 FGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA--MFKL----G  225 (272)
T ss_pred             ccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH--HHHh----h
Confidence            99987644322111223345889999999987654  78999999999999999999999964321110  0000    0


Q ss_pred             ccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ..      .............++..+.+++.+||+.+|++|||+.+++++
T Consensus       226 ~~------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         226 NK------RSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             cc------ccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            00      001111122223456779999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=326.17  Aligned_cols=313  Identities=22%  Similarity=0.259  Sum_probs=237.9

Q ss_pred             ccccccceeeecccccccCCCCCCcccccccCcccccceeecccCCCCCCCccccccccccCCCccccCHHHH-----HH
Q 013105            2 ALIKSFTWKIILPSCIKATNKPSCMSKVHVSNQVSTQRLLLTDVSNPGSPISLNELSSSLVGSNLHVFTLKEL-----QM   76 (449)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~   76 (449)
                      -||.+++|+.+......++.+|......++.+ .+..++..++..+|..+.+...-.   ....+.+....-+     ..
T Consensus       244 ~f~~~i~~~~l~~r~~~~~fkp~~~~e~~~~~-fd~eft~~~P~dsp~~~~~~s~~~---if~g~sfva~~il~~~~~~~  319 (612)
T KOG0603|consen  244 EFFQSIDWNELEARSRPPPFKPGSITERDVAQ-FDPEFTSQVPADSPLLSASGSDHT---IFSGPSFVAPGVLEDAVTAP  319 (612)
T ss_pred             chheeeeHhhHhhcCCCCCCCCcccchhhhhh-cCchhccCCcccCCCCCCCccccc---hhcCCCccChHHhhccccCC
Confidence            37899999999999999999998877777666 555566666655555444332210   0011111111111     12


Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcC-CCCCcceeeeEEEeCC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCEDE  155 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~  155 (449)
                      +.+.|.+...+|.|+|+.|-.+....      +++..++|++.....    +..+|+.++... +||||+++.+++.++.
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~------t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~  389 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSP------TDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGK  389 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccc------cccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCc
Confidence            45778888899999999999886655      688999999975422    223466555554 7999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEE-cCCCcEEEeeecccc
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILL-DSDYNAKLSDFGLAT  234 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill-~~~~~~kl~DfGla~  234 (449)
                      +.|+|||.+.|+-|.+.+...   .....++..|+.+|+.|+.|||  .+|||||||||+|||+ +..++++|+|||.++
T Consensus       390 ~~~~v~e~l~g~ell~ri~~~---~~~~~e~~~w~~~lv~Av~~LH--~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~  464 (612)
T KOG0603|consen  390 EIYLVMELLDGGELLRRIRSK---PEFCSEASQWAAELVSAVDYLH--EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWS  464 (612)
T ss_pred             eeeeeehhccccHHHHHHHhc---chhHHHHHHHHHHHHHHHHHHH--hcCeeecCCChhheeecCCCCcEEEEEechhh
Confidence            999999999999998888654   2333677789999999999999  7889999999999999 688999999999998


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      .....     ....+-|..|.|||++....|++++||||||++||+||+|+.||......                   .
T Consensus       465 ~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------------------~  520 (612)
T KOG0603|consen  465 ELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------------------I  520 (612)
T ss_pred             hCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------------------H
Confidence            76543     11223588999999999999999999999999999999999999764221                   1


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .+........+...+++...+|+.+||+.||.+||++.++..|
T Consensus       521 ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  521 EIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             HHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence            1111111223336677889999999999999999999999987

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.8e-39  Score=310.08  Aligned_cols=273  Identities=24%  Similarity=0.330  Sum_probs=204.1

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc-----hHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ-----GHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      +|.+.+.||+|+||.||+|.+..      +++.||+|.+......     ....+..|+.+++.++|+||+++++++.+.
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   74 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKE------TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK   74 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECC------CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC
Confidence            47788999999999999998765      4789999999754322     234567899999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +..++||||+ +|+|.+++.... ..+++..+..++.|++.||.|||  .+||+|+||+|+||+++.++.++|+|||++.
T Consensus        75 ~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dl~p~nill~~~~~~~l~dfg~~~  150 (298)
T cd07841          75 SNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLH--SNWILHRDLKPNNLLIASDGVLKLADFGLAR  150 (298)
T ss_pred             CEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCChhhEEEcCCCCEEEccceeee
Confidence            9999999999 899999986543 36899999999999999999999  7789999999999999999999999999998


Q ss_pred             CCCCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhH-Hhh-hhhhccc-
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV-EWA-RPMLKDF-  310 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~-~~~-~~~~~~~-  310 (449)
                      .......  ......+++.|+|||.+.+ ..++.++|||||||++|||++|.+||............ ... .+....+ 
T Consensus       151 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (298)
T cd07841         151 SFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP  228 (298)
T ss_pred             eccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhh
Confidence            6543221  1223356889999998854 46789999999999999999998888754322111110 000 0000000 


Q ss_pred             --cchhHhhcccc-----cccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCCC
Q 013105          311 --TKLDQIIDSRL-----EDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLND  366 (449)
Q Consensus       311 --~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~  366 (449)
                        ...........     ........+..+.+++.+||+.||++|||+.+++.+  .++....
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~--~~~~~~~  289 (298)
T cd07841         229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH--PYFSNDP  289 (298)
T ss_pred             hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC--ccccCCC
Confidence              00000000000     011123446779999999999999999999999996  4444433

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.4e-39  Score=303.49  Aligned_cols=252  Identities=24%  Similarity=0.421  Sum_probs=199.5

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      .+|++.+.||+|+||.||+|.+..       +..+|+|.+.... .....+.+|+++++.++||||+++++++......+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~-------~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLE-------KRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPIC   75 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeC-------CCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceE
Confidence            467888999999999999997753       4679999986432 23457889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCC
Q 013105          159 LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~  238 (449)
                      +||||+.+++|.+++.... ..+++..+..++.+++.+|.|||  +.+++|+||||+||+++.++.++|+|||++.....
T Consensus        76 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH--~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  152 (256)
T cd05112          76 LVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLE--SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD  152 (256)
T ss_pred             EEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH--HCCccccccccceEEEcCCCeEEECCCcceeeccc
Confidence            9999999999999886542 46788999999999999999999  77899999999999999999999999999875433


Q ss_pred             CCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHhh
Q 013105          239 GEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII  317 (449)
Q Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (449)
                      .... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......   .....              
T Consensus       153 ~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~~--------------  214 (256)
T cd05112         153 DQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVETI--------------  214 (256)
T ss_pred             Cccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHH--------------
Confidence            2111 1112234678999999988889999999999999999998 999987532111   11100              


Q ss_pred             cccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 013105          318 DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE  359 (449)
Q Consensus       318 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  359 (449)
                      ........+...++.+.+|+.+||+.+|++|||+.++++.|.
T Consensus       215 ~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         215 NAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             hCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            000000111223467999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.5e-40  Score=320.20  Aligned_cols=251  Identities=26%  Similarity=0.351  Sum_probs=209.5

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      .-...|.+...||+|.|+.|.+|.+..      ++..||||+++...  ....+.+.+|+++|+.|+|||||+++.+...
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~------t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t  126 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHIL------TGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET  126 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecC------CCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee
Confidence            345679999999999999999997665      69999999998653  3334568899999999999999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      ...+|+||||+.+|.+++++.++  +...+.....++.|++.|++|||  .++|+|||||.+||||+.+.++||+|||++
T Consensus       127 ~~~lylV~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH--~k~ivHrdLk~eNilL~~~mnikIaDfgfS  202 (596)
T KOG0586|consen  127 EATLYLVMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCH--SKNIVHRDLKAENILLDENMNIKIADFGFS  202 (596)
T ss_pred             cceeEEEEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHh--hcceeccccchhhcccccccceeeeccccc
Confidence            99999999999999999999876  45556888899999999999999  788999999999999999999999999999


Q ss_pred             cCCCCCCCCceeeecCCCCccccccccccCCC-CcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccc
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINTGHL-TTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK  312 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  312 (449)
                      ..+..+.   .....+|++.|.|||++.+..| ++.+|+||+|++||.|+.|..||++........-+            
T Consensus       203 ~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv------------  267 (596)
T KOG0586|consen  203 TFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV------------  267 (596)
T ss_pred             eeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh------------
Confidence            9876433   3455779999999999988876 78999999999999999999999976432211111            


Q ss_pred             hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                          +....  .++.-.+.++.++|+++|.++|.+|++++++.++
T Consensus       268 ----l~gk~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  268 ----LRGKY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             ----eeeee--cccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence                11111  1122334457889999999999999999999987

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.4e-39  Score=308.67  Aligned_cols=259  Identities=24%  Similarity=0.323  Sum_probs=200.4

Q ss_pred             HHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcC-CCCCcceeeeEEE
Q 013105           74 LQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL-KHPHLVNLIGYCC  152 (449)
Q Consensus        74 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~  152 (449)
                      +....++|++.+.||+|+||.||+|....      .++.+|+|++.... .....+.+|+.++..+ +||||+++++++.
T Consensus        13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~------~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   85 (286)
T cd06638          13 FPDPSDTWEIIETIGKGTYGKVFKVLNKK------NGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYY   85 (286)
T ss_pred             CCCcccceeeeeeeccCCCcEEEEEEECC------CCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence            34467889999999999999999998765      47889999986432 2235677899999999 6999999999874


Q ss_pred             -----eCCEEEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcE
Q 013105          153 -----EDEHRLLVYEYMALGNLHDQLFKN--YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNA  225 (449)
Q Consensus       153 -----~~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~  225 (449)
                           .++..++||||+++++|.+++...  ....+++..+..++.|++.||.|||  ..+|+||||||+||+++.++.+
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH--VNKTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH--hCCccccCCCHHhEEECCCCCE
Confidence                 346789999999999999887532  2356788889999999999999999  6789999999999999999999


Q ss_pred             EEeeeccccCCCCCCCCceeeecCCCCcccccccccc-----CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhH
Q 013105          226 KLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT-----GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV  300 (449)
Q Consensus       226 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~  300 (449)
                      +|+|||++........  ......|++.|+|||++..     ..++.++|||||||++|||++|..||.........  .
T Consensus       164 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~--~  239 (286)
T cd06638         164 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL--F  239 (286)
T ss_pred             EEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH--h
Confidence            9999999876533221  1223458999999998853     45788999999999999999999999754321110  0


Q ss_pred             HhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 013105          301 EWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL  358 (449)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  358 (449)
                      ..    ...         .......+...+..+.+++.+||+.||++|||+.++++++
T Consensus       240 ~~----~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         240 KI----PRN---------PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             hc----ccc---------CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            00    000         0000011222345689999999999999999999999873

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.2e-39  Score=309.71  Aligned_cols=246  Identities=27%  Similarity=0.393  Sum_probs=203.5

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ++|++.+.||+|+||.||++.+..      .++.||+|++....   ......+.+|++++++++||||+++++++.+.+
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   74 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKG------SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS   74 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC
Confidence            468899999999999999998765      47899999986432   233466889999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..++||||+.+++|.+++...  ..++...+..++.|++.||.|||  ..||+|+||+|.|||++.++.+||+|||++..
T Consensus        75 ~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH--~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~  150 (290)
T cd05580          75 NLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLH--SLDIVYRDLKPENLLLDSDGYIKITDFGFAKR  150 (290)
T ss_pred             eEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEECCCCCEEEeeCCCccc
Confidence            999999999999999998765  57899999999999999999999  78899999999999999999999999999886


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ....     .....|++.|+|||.+.+..++.++||||||+++|+|++|..||.......   ...             .
T Consensus       151 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~-------------~  209 (290)
T cd05580         151 VKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ---IYE-------------K  209 (290)
T ss_pred             cCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HHH-------------H
Confidence            5433     223458999999999988888999999999999999999999997543110   000             0


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRP-----TMTTVVKA  357 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  357 (449)
                      +...  ...++...+..+.+++.+||+.||.+|+     ++.+++.+
T Consensus       210 ~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         210 ILEG--KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             HhcC--CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence            0000  1112334466789999999999999998     88888876

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.7e-39  Score=308.06  Aligned_cols=267  Identities=22%  Similarity=0.303  Sum_probs=203.0

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      +|++.+.||+|+||.||+|.+..      .+..||+|++....  ......+.+|+.+++.++||||+++++++......
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRE------TGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGF   74 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECC------CCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCee
Confidence            58889999999999999998765      47899999997543  23346788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+ +++|.+++.... ..+++..+..++.|++.||.|||  +.+++|+||||+||+++.++.++|+|||++....
T Consensus        75 ~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~  150 (286)
T cd07832          75 VLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMH--ANGIMHRDLKPANLLISADGVLKIADFGLARLFS  150 (286)
T ss_pred             EEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCcCHHHEEEcCCCcEEEeeeeeccccc
Confidence            9999999 999999886543 57899999999999999999999  6789999999999999999999999999988654


Q ss_pred             CCCCCceeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCCcccccccccchhhH-Hhh-hhh---hcccc
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV-EWA-RPM---LKDFT  311 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~-~~~-~~~---~~~~~  311 (449)
                      .... .......|+..|+|||.+.+. .++.++|||||||++|||++|.+||............ ... .+.   .....
T Consensus       151 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07832         151 EEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT  229 (286)
T ss_pred             CCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhcc
Confidence            4321 112334689999999998654 4689999999999999999998888654321111100 000 000   00000


Q ss_pred             c---hhHhhcccc----cccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          312 K---LDQIIDSRL----EDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       312 ~---~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .   ...+.....    ......+.+..+.+++.+||+.||.+|||+++++.|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0   000000000    001112345789999999999999999999999987

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.2e-39  Score=310.89  Aligned_cols=256  Identities=22%  Similarity=0.288  Sum_probs=200.9

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ++|.+.+.||+|+||.||++....      .++.|++|.+....   ......+.+|+.+++.++||||+++++.+..++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKE------TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR   74 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECC------CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC
Confidence            468899999999999999997765      57899999987442   223456778999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..++||||+.|++|.+++...  ..+++.....++.+++.||.|||  ..+++||||||+||+++.++.++|+|||+++.
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~  150 (305)
T cd05609          75 HLCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLH--NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI  150 (305)
T ss_pred             EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCchHHEEECCCCCEEEeeCCCccc
Confidence            999999999999999998664  56889999999999999999999  67899999999999999999999999999864


Q ss_pred             CCCCCC-------------CceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHh
Q 013105          236 GPQGED-------------SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEW  302 (449)
Q Consensus       236 ~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~  302 (449)
                      ......             ........|+..|+|||.+.+..++.++|||||||++|||++|..||.+.....   ... 
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~---~~~-  226 (305)
T cd05609         151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFG-  226 (305)
T ss_pred             cCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH-
Confidence            211100             001112457889999999988889999999999999999999999997542211   000 


Q ss_pred             hhhhhccccchhHhhcccc-cccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 013105          303 ARPMLKDFTKLDQIIDSRL-EDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEP  360 (449)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  360 (449)
                        .          ...... .......++..+.+++.+||+.||++||+..++++.|+.
T Consensus       227 --~----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         227 --Q----------VISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             --H----------HHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence              0          000000 001112355678999999999999999996666655554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.6e-39  Score=311.82  Aligned_cols=249  Identities=23%  Similarity=0.335  Sum_probs=200.1

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEE
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLV  160 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  160 (449)
                      |.....||+|+||.||+|....      .+..||+|++..........+.+|+.++..++||||+++++++..++..++|
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv   96 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKH------SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVL   96 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcC------CCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEE
Confidence            4445579999999999997754      4789999999765545556788999999999999999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCC
Q 013105          161 YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGE  240 (449)
Q Consensus       161 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~  240 (449)
                      |||+++++|..++..   ..+++..+..++.|++.||.|||  +.+++||||||+||+++.++.++|+|||++.......
T Consensus        97 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH--~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~  171 (297)
T cd06659          97 MEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLH--SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV  171 (297)
T ss_pred             EecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence            999999999887754   46889999999999999999999  7789999999999999999999999999987543322


Q ss_pred             CCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhccc
Q 013105          241 DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSR  320 (449)
Q Consensus       241 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (449)
                      .  ......|+..|+|||++.+..++.++|||||||++|||++|..||........   ......   ..         .
T Consensus       172 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~~~~~~---~~---------~  234 (297)
T cd06659         172 P--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MKRLRD---SP---------P  234 (297)
T ss_pred             c--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHhc---cC---------C
Confidence            1  12235689999999999888899999999999999999999999975432111   110000   00         0


Q ss_pred             ccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       321 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .........+..+.+++.+||+.+|.+||++.+++++
T Consensus       235 ~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         235 PKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0001112344568899999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.6e-39  Score=307.78  Aligned_cols=251  Identities=26%  Similarity=0.375  Sum_probs=195.5

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHH-HhcCCCCCcceeeeEEEeCCE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIF-LGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      ++|++.+.||+|+||.||+|.+..      ++..||+|.++... ......+..|+.+ ++.++||||+++++++..++.
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~   74 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVP------TGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGD   74 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcC------CCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCc
Confidence            468899999999999999998765      58899999987542 2233455666665 566789999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          157 RLLVYEYMALGNLHDQLFKN--YSSTLPWLTRIKIAIGAARCLAFLHGEEK-PVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      .|+||||++ |+|.+++...  ....+++..++.++.|++.||.|||  ++ +++||||||+|||++.++.+||+|||++
T Consensus        75 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~  151 (283)
T cd06617          75 VWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS  151 (283)
T ss_pred             EEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh--hcCCeecCCCCHHHEEECCCCCEEEeecccc
Confidence            999999997 7888777542  2356899999999999999999999  55 7999999999999999999999999998


Q ss_pred             cCCCCCCCCceeeecCCCCcccccccccc----CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcc
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINT----GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKD  309 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  309 (449)
                      .......   ......|+..|+|||.+.+    ..++.++|+|||||++|+|++|..||........ .           
T Consensus       152 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~-----------  216 (283)
T cd06617         152 GYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ-Q-----------  216 (283)
T ss_pred             ccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH-H-----------
Confidence            8653221   1222458899999998854    4568899999999999999999999964321100 0           


Q ss_pred             ccchhHhhcccccccC-CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          310 FTKLDQIIDSRLEDRY-STEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       310 ~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                         +....... .... ...++.++.+++.+||..+|++||++.+++++
T Consensus       217 ---~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         217 ---LKQVVEEP-SPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             ---HHHHHhcC-CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               00111110 0111 12345679999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.2e-39  Score=311.93  Aligned_cols=249  Identities=24%  Similarity=0.356  Sum_probs=199.5

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEE
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLV  160 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  160 (449)
                      |.....||+|+||.||++....      ++..||||.+..........+.+|+.+++.++|+||+++++.+...+..++|
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv   97 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKH------TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVV   97 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECC------CCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEE
Confidence            4445679999999999997654      4789999998765555556788999999999999999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCC
Q 013105          161 YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGE  240 (449)
Q Consensus       161 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~  240 (449)
                      |||+.+++|.+++..   ..+++.....++.|++.||.|||  +++|+||||||+||+++.++.++|+|||++.......
T Consensus        98 ~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~  172 (292)
T cd06658          98 MEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLH--NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV  172 (292)
T ss_pred             EeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence            999999999988744   35888999999999999999999  6789999999999999999999999999987543222


Q ss_pred             CCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhccc
Q 013105          241 DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSR  320 (449)
Q Consensus       241 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (449)
                      .  ......|+..|+|||.+.+..++.++||||||+++|||++|..||..........   ...          ......
T Consensus       173 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~---~~~----------~~~~~~  237 (292)
T cd06658         173 P--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR---RIR----------DNLPPR  237 (292)
T ss_pred             c--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHH----------hcCCCc
Confidence            1  1223458999999999988889999999999999999999999997542211100   000          000000


Q ss_pred             ccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       321 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ..  .....+..+.+++.+||..||.+|||+.+++++
T Consensus       238 ~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         238 VK--DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cc--cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            01  112344568899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.9e-39  Score=301.68  Aligned_cols=245  Identities=26%  Similarity=0.445  Sum_probs=191.3

Q ss_pred             ccccccCceEEEEEEEcCCCCC----CCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRP----GLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLV  160 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  160 (449)
                      +.||+|+||.||+|.+......    ......+++|++...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            4699999999999988753110    122346888887644333 5778899999999999999999999988 778999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC-------cEEEeeeccc
Q 013105          161 YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY-------NAKLSDFGLA  233 (449)
Q Consensus       161 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~-------~~kl~DfGla  233 (449)
                      |||+.+|+|.+++.... ..+++..+..++.|++.||.|||  +++|+||||||+|||++.++       .++|+|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLE--DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHh--hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            99999999999987653 37889999999999999999999  78899999999999999887       7999999998


Q ss_pred             cCCCCCCCCceeeecCCCCccccccccccC--CCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccc
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINTG--HLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDF  310 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  310 (449)
                      .....      .....++..|+|||++.+.  .++.++|||||||++|+|++ |..||.............       . 
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-------~-  221 (259)
T cd05037         156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-------D-  221 (259)
T ss_pred             ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-------c-
Confidence            86433      1223467889999999766  78999999999999999999 577776543211111000       0 


Q ss_pred             cchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 013105          311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE  359 (449)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  359 (449)
                             ...    .+......+.+++.+||..+|.+|||+.++++.|.
T Consensus       222 -------~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         222 -------QHR----LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             -------CCC----CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                   000    00011156899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2e-39  Score=305.48  Aligned_cols=254  Identities=26%  Similarity=0.390  Sum_probs=205.0

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      ++|++.+.||.|+||.||+|.+..      +++.+|+|.+.... ......+.+|+.+++.++||||+++++++...+..
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRP------TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDI   74 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcC------CCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEE
Confidence            367888999999999999998765      57899999987553 33446788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE-KPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      +++|||+.+++|.+++.... ..++......++.|++.||.|||  + .+++|+||||+||+++.++.++|+|||++...
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH--~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~  151 (265)
T cd06605          75 SICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL  151 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHc--CCCCeecCCCCHHHEEECCCCCEEEeecccchhh
Confidence            99999999999999886543 67889999999999999999999  6 78999999999999999999999999998754


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHh
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI  316 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (449)
                      ....    .....|+..|+|||.+.+..++.++|||||||++|+|++|..||........ .......          ..
T Consensus       152 ~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~----------~~  216 (265)
T cd06605         152 VNSL----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQ----------YI  216 (265)
T ss_pred             HHHH----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHH----------HH
Confidence            3221    1115689999999999888999999999999999999999999975421111 1111111          11


Q ss_pred             hcccccccCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          317 IDSRLEDRYSTE-GAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       317 ~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ... .....+.. .+..+.++|..||..||++|||+.+++.+
T Consensus       217 ~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         217 VNE-PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             hcC-CCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            111 11112222 56779999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=6e-39  Score=301.84  Aligned_cols=253  Identities=27%  Similarity=0.386  Sum_probs=208.2

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      ++|++.+.||+|++|.||+|....      +++.|++|++..... .....+.+|+.++..++|+||+++++++...+..
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~------~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKP------TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEI   74 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcC------CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeE
Confidence            468889999999999999998765      578999999976543 3456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE-KPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      ++||||+.+++|.+++...  ..++......++.|++.||.|||  . .+++|+||+|+||+++.++.++|+|||++...
T Consensus        75 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh--~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~  150 (264)
T cd06623          75 SIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL  150 (264)
T ss_pred             EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHh--ccCCCccCCCCHHHEEECCCCCEEEccCccceec
Confidence            9999999999999999765  67899999999999999999999  7 88999999999999999999999999998865


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHh
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI  316 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (449)
                      ......  .....++..|+|||.+.+..++.++||||||+++|+|++|..||..............             +
T Consensus       151 ~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-------------~  215 (264)
T cd06623         151 ENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA-------------I  215 (264)
T ss_pred             ccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH-------------H
Confidence            433221  1234588999999999888899999999999999999999999976532111111111             0


Q ss_pred             hcccccccCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          317 IDSRLEDRYSTE-GAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       317 ~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      . .......+.. .+..+.+++..||..+|++||++.+++++
T Consensus       216 ~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         216 C-DGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             h-cCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            0 1111122233 56779999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.5e-39  Score=308.43  Aligned_cols=262  Identities=26%  Similarity=0.349  Sum_probs=202.8

Q ss_pred             CHHHHHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcC-CCCCcceee
Q 013105           70 TLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL-KHPHLVNLI  148 (449)
Q Consensus        70 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~  148 (449)
                      ...++....++|.+.+.||+|+||.||+|....      +++.+|+|++.... .....+.+|+.++.++ +||||++++
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~------~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~   85 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKK------DGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFY   85 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECC------CCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence            334445567889999999999999999998765      47899999986432 2345677899999998 799999999


Q ss_pred             eEEEeC-----CEEEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC
Q 013105          149 GYCCED-----EHRLLVYEYMALGNLHDQLFKN--YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS  221 (449)
Q Consensus       149 ~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~  221 (449)
                      +++...     +..++||||+.+++|.+++...  ....+++..+..++.|++.||.|||  ..+++|+||||+||+++.
T Consensus        86 ~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dlkp~nili~~  163 (291)
T cd06639          86 GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH--NNRIIHRDVKGNNILLTT  163 (291)
T ss_pred             EEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEEcC
Confidence            998754     4689999999999999987532  3356889999999999999999999  778999999999999999


Q ss_pred             CCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccC-----CCCcccchhhhHHHHHHHHhCCCcccccccccc
Q 013105          222 DYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTG-----HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE  296 (449)
Q Consensus       222 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~  296 (449)
                      ++.++|+|||++.........  .....|+..|+|||.+...     .++.++|||||||++|||++|+.||........
T Consensus       164 ~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~  241 (291)
T cd06639         164 EGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT  241 (291)
T ss_pred             CCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH
Confidence            999999999998865432211  1224588999999998543     368899999999999999999999975422111


Q ss_pred             hhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          297 KDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                        .....    ..         .......+...+..+.+++.+||+.+|++||++.+++++
T Consensus       242 --~~~~~----~~---------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         242 --LFKIP----RN---------PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             --HHHHh----cC---------CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence              11000    00         000001122344568999999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-39  Score=304.87  Aligned_cols=254  Identities=28%  Similarity=0.376  Sum_probs=201.2

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcC-CCCCcceeeeEEEeCC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCEDE  155 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~  155 (449)
                      ..++|++.+.||+|+||.||+|....      +++.+++|++..... ....+.+|+.+++++ .|+||+++++++....
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   76 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKK------TGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKN   76 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECC------CCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecC
Confidence            35789999999999999999998765      477899999875433 346788999999999 6999999999997644


Q ss_pred             ------EEEEEEEecCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEE
Q 013105          156 ------HRLLVYEYMALGNLHDQLFKNY--SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKL  227 (449)
Q Consensus       156 ------~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl  227 (449)
                            ..++||||+.+++|.+++....  ...+++..+..++.|++.||.|||  +.+++|+||+|+||+++.++.++|
T Consensus        77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH--~~~i~H~~l~p~ni~~~~~~~~~l  154 (275)
T cd06608          77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH--ENKVIHRDIKGQNILLTKNAEVKL  154 (275)
T ss_pred             CCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh--cCCcccCCCCHHHEEEccCCeEEE
Confidence                  4899999999999999886543  467899999999999999999999  678999999999999999999999


Q ss_pred             eeeccccCCCCCCCCceeeecCCCCcccccccccc-----CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHh
Q 013105          228 SDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT-----GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEW  302 (449)
Q Consensus       228 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~  302 (449)
                      +|||++.......  .......|+..|+|||++..     ..++.++|||||||+||+|++|..||........  ... 
T Consensus       155 ~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~-  229 (275)
T cd06608         155 VDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LFK-  229 (275)
T ss_pred             CCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HHH-
Confidence            9999987543322  11233458999999998753     3467899999999999999999999974321111  100 


Q ss_pred             hhhhhccccchhHhhcccc-cccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          303 ARPMLKDFTKLDQIIDSRL-EDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                                   +..... .-..+...+..+.+++.+||..||++|||+.+++++
T Consensus       230 -------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         230 -------------IPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             -------------hhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                         000000 011122356679999999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5.9e-39  Score=301.73  Aligned_cols=253  Identities=24%  Similarity=0.339  Sum_probs=204.6

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEe--CC
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCE--DE  155 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~  155 (449)
                      +|++.+.||.|+||.||+|....      ++..||+|++....  ......+..|+++++.++|+||+++++++..  ..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKS------DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ   74 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecC------CCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC
Confidence            47888999999999999997765      47889999987432  2334568889999999999999999998764  45


Q ss_pred             EEEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcC---CCCeeeccCCCCceEEcCCCcEEEeee
Q 013105          156 HRLLVYEYMALGNLHDQLFKN--YSSTLPWLTRIKIAIGAARCLAFLHGE---EKPVIYRDFKASNILLDSDYNAKLSDF  230 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~---~~~ivHrDikp~Nill~~~~~~kl~Df  230 (449)
                      ..+++|||+.+++|.+++...  ....+++...+.++.+++.||.|||..   +.+++|+||+|+||+++.++.++|+||
T Consensus        75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~  154 (265)
T cd08217          75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDF  154 (265)
T ss_pred             EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecc
Confidence            689999999999999998653  245789999999999999999999944   466999999999999999999999999


Q ss_pred             ccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccc
Q 013105          231 GLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF  310 (449)
Q Consensus       231 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  310 (449)
                      |++........  ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||......   ....         
T Consensus       155 g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~---------  220 (265)
T cd08217         155 GLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLAS---------  220 (265)
T ss_pred             cccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHH---------
Confidence            99986644321  122346899999999998888999999999999999999999999764311   1111         


Q ss_pred             cchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                           .+........+...+..+.+++.+||+.+|++||++.+|+++
T Consensus       221 -----~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         221 -----KIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             -----HHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                 111111223344566789999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.1e-39  Score=310.60  Aligned_cols=266  Identities=21%  Similarity=0.281  Sum_probs=198.1

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      +|++.+.||+|+||.||+|.+..      ++..||+|.+....  ......+.+|+.+++.++||||+++++++.+....
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~------~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   74 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRE------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKL   74 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECC------CCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCce
Confidence            47888999999999999998765      47899999987432  22234577899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+. ++|.+++... ...+++.....++.|++.||.|||  ..+|+||||||+||+++.++.++|+|||++....
T Consensus        75 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH--~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  150 (284)
T cd07839          75 TLVFEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCH--SHNVLHRDLKPQNLLINKNGELKLADFGLARAFG  150 (284)
T ss_pred             EEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence            99999997 6888877653 356899999999999999999999  7789999999999999999999999999988543


Q ss_pred             CCCCCceeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCCcccccccccc-hhhH-Hhhh-hhhccccch
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE-KDLV-EWAR-PMLKDFTKL  313 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~-~~~~-~~~~-~~~~~~~~~  313 (449)
                      ....  ......++..|+|||++.+. .++.++|||||||++|+|++|..||........ ...+ .... +....+...
T Consensus       151 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07839         151 IPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV  228 (284)
T ss_pred             CCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHh
Confidence            3221  12234578999999998664 478999999999999999999988643221110 0000 0000 000000000


Q ss_pred             hHhhccc---------ccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          314 DQIIDSR---------LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       314 ~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .......         ........++.++.+++.+||+.||.+|||+.+++.|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            0000000         0011122356778999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=9e-39  Score=301.99  Aligned_cols=255  Identities=24%  Similarity=0.366  Sum_probs=188.5

Q ss_pred             cccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEEEec
Q 013105           86 YLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYM  164 (449)
Q Consensus        86 ~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  164 (449)
                      .||+|+||.||+|.....    .....+++|.+.... ......+.+|+.+++.++||||+++++.+.+....|+||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~----~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTD----TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC   77 (268)
T ss_pred             cCCCCcCceEEEEEEEcC----CCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence            599999999999975432    123457778776443 234567899999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCC
Q 013105          165 ALGNLHDQLFKNY--SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS  242 (449)
Q Consensus       165 ~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~  242 (449)
                      .+|+|.+++....  ....+......++.|++.||.|||  +.+++||||||+|||++.++.++|+|||++.........
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~  155 (268)
T cd05086          78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH--KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI  155 (268)
T ss_pred             CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH--HCCeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence            9999999987642  234667778899999999999999  678999999999999999999999999998643221111


Q ss_pred             ceeeecCCCCcccccccccc-------CCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchh
Q 013105          243 HITTCVMGTEGYAAPEYINT-------GHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       243 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      .......|+..|+|||++..       ..++.++|||||||++|||++ |..||.......   ....   ....  ...
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~---~~~~--~~~  227 (268)
T cd05086         156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE---VLNH---VIKD--QQV  227 (268)
T ss_pred             hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH---HHhh--ccc
Confidence            11233557899999998743       245789999999999999997 567775432211   1110   0000  000


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE  359 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  359 (449)
                      ..    ..+......++.+.+++..|| .+|++||++.+|++.|.
T Consensus       228 ~~----~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         228 KL----FKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             cc----CCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            00    111222234566888999999 67999999999998763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-39  Score=308.45  Aligned_cols=268  Identities=25%  Similarity=0.319  Sum_probs=203.0

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      ++|++.+.||+|+||.||+|.+..      +++.||+|+++..  .......+.+|+++++.++|+||+++++++..++.
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   74 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKA------TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGR   74 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCC------CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCE
Confidence            368899999999999999998765      4789999998643  23334678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||+.++.+..+...  ...+++.....++.+++.||.|||  ..+++|+||+|+||+++.++.++|+|||++...
T Consensus        75 ~~iv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~  150 (288)
T cd07833          75 LYLVFEYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCH--SHNIIHRDIKPENILVSESGVLKLCDFGFARAL  150 (288)
T ss_pred             EEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCCEEEEeeeccccc
Confidence            9999999997666554433  245889999999999999999999  778999999999999999999999999998865


Q ss_pred             CCCCCCceeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCCcccccccccchhhH-Hhhhhhh-------
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV-EWARPML-------  307 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~-~~~~~~~-------  307 (449)
                      ...... ......|+..|+|||++.+. .++.++||||||+++|+|++|.+||............ .......       
T Consensus       151 ~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (288)
T cd07833         151 RARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF  229 (288)
T ss_pred             CCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhc
Confidence            543321 22335688999999999877 7899999999999999999999999754322111000 0000000       


Q ss_pred             ccccchh-----Hhhc-ccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          308 KDFTKLD-----QIID-SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       308 ~~~~~~~-----~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .......     .... ......++..++.++.+++.+||..+|++||++++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            0000000     0000 000112233346789999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=8.7e-39  Score=302.01  Aligned_cols=255  Identities=23%  Similarity=0.386  Sum_probs=201.2

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC----------cchHHHHHHHHHHHhc-CCCCCcceee
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG----------SQGHREWLAEVIFLGQ-LKHPHLVNLI  148 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~nIv~~~  148 (449)
                      +|++.+.||+|+||.||+|.+..+     .++.+|+|.+....          .....++.+|+.++.+ ++||||++++
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~-----~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~   75 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNN-----GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYY   75 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCC-----CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEE
Confidence            478889999999999999987652     46789999885321          2233557788888865 7999999999


Q ss_pred             eEEEeCCEEEEEEEecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEE
Q 013105          149 GYCCEDEHRLLVYEYMALGNLHDQLFK--NYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAK  226 (449)
Q Consensus       149 ~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~k  226 (449)
                      +++..++..++||||+.+++|.+++..  .....+++..++.++.|++.+|.|||+ ..+++|+||+|+|||++.++.++
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~i~H~dl~~~nil~~~~~~~~  154 (269)
T cd08528          76 KTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK-EKRIVHRDLTPNNIMLGEDDKVT  154 (269)
T ss_pred             eeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc-CCceeecCCCHHHEEECCCCcEE
Confidence            999999999999999999999988754  234568899999999999999999994 25799999999999999999999


Q ss_pred             EeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhh
Q 013105          227 LSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPM  306 (449)
Q Consensus       227 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~  306 (449)
                      |+|||++.......   ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.........   .     
T Consensus       155 l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~---~-----  223 (269)
T cd08528         155 ITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA---T-----  223 (269)
T ss_pred             Eecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH---H-----
Confidence            99999998654332   233456899999999998888999999999999999999999998653211110   0     


Q ss_pred             hccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 013105          307 LKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE  359 (449)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  359 (449)
                              .+......+......+..+.+++.+||+.||++||++.++..++.
T Consensus       224 --------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         224 --------KIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             --------HHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                    000110011011134466899999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.7e-39  Score=313.05  Aligned_cols=265  Identities=22%  Similarity=0.282  Sum_probs=188.8

Q ss_pred             cccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEe--CCEEEEEE
Q 013105           84 SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE--DEHRLLVY  161 (449)
Q Consensus        84 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~lv~  161 (449)
                      ...||+|+||.||+|...+.    .++..||+|.+....  ....+.+|+.+++.++||||+++++++..  +...++||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~----~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDG----KDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF   79 (317)
T ss_pred             ceEeccCCCeeEEEEEecCC----CccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence            35799999999999986542    246789999986432  23457789999999999999999998854  56789999


Q ss_pred             EecCCCChHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEE----cCCCcEEEeee
Q 013105          162 EYMALGNLHDQLFKN-------YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILL----DSDYNAKLSDF  230 (449)
Q Consensus       162 e~~~~g~L~~~l~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill----~~~~~~kl~Df  230 (449)
                      ||+. ++|.+++...       ....+++..+..++.|++.||.|||  +.+|+||||||+|||+    +.++.+||+||
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          80 DYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH--hCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            9987 5777776422       1235788899999999999999999  7789999999999999    56678999999


Q ss_pred             ccccCCCCCCCC-ceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccch-------hhHH
Q 013105          231 GLATDGPQGEDS-HITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREK-------DLVE  301 (449)
Q Consensus       231 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~-------~~~~  301 (449)
                      |+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|.+||.........       ....
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07867         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR  236 (317)
T ss_pred             cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence            999865432211 11233568999999999876 45899999999999999999999999754321110       0000


Q ss_pred             hhhh----hhcccc---------chhHhhccc-c--------cccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          302 WARP----MLKDFT---------KLDQIIDSR-L--------EDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       302 ~~~~----~~~~~~---------~~~~~~~~~-~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ....    ....+.         ......... .        ...........+.+|+.+||+.||.+|||+.|+++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h  314 (317)
T cd07867         237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD  314 (317)
T ss_pred             HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence            0000    000000         000000000 0        000011123458889999999999999999999986

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.3e-39  Score=310.28  Aligned_cols=267  Identities=23%  Similarity=0.312  Sum_probs=200.7

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc--chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      ++|++.+.||+|+||.||+|.+..      .++.||+|++.....  .....+.+|+++++.++||||+++++++..++.
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   74 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKE------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKR   74 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECC------CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCe
Confidence            468889999999999999998765      478999999864322  234567889999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||+.+++|..+....  ..+++.....++.|++.||.|||  ..+++|+||+|+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH--~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~  150 (286)
T cd07846          75 LYLVFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCH--SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL  150 (286)
T ss_pred             EEEEEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEECCCCcEEEEeeeeeeec
Confidence            99999999988887765433  45899999999999999999999  678999999999999999999999999998765


Q ss_pred             CCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhh-HHhhhhhh-------
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDL-VEWARPML-------  307 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~-~~~~~~~~-------  307 (449)
                      .....  ......|+..|+|||.+.+ ..++.++|||||||++|||++|.+||..........- ........       
T Consensus       151 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07846         151 AAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF  228 (286)
T ss_pred             cCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence            33221  1233458899999999865 4578899999999999999999999975432111000 00000000       


Q ss_pred             ccccchhHhhcccc-----cccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          308 KDFTKLDQIIDSRL-----EDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       308 ~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ..............     .....+.++..+.+++.+||+.+|++||++.+++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            00000000000000     001122456779999999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-40  Score=322.10  Aligned_cols=254  Identities=28%  Similarity=0.420  Sum_probs=211.8

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc-hHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEE
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ-GHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLL  159 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  159 (449)
                      ..+.++||+|.||.|++|.|..   ...+.-.||||.+..+... ...+|++|+.+|.+|+|+|++++||+..+ ....+
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~---psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM  187 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQ---PSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM  187 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccC---CCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence            4456889999999999999975   3445668999999866433 66889999999999999999999999987 67889


Q ss_pred             EEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCC
Q 013105          160 VYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQG  239 (449)
Q Consensus       160 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~  239 (449)
                      |||++.+|+|.+.|.+.....+.......++.||+.||.||.  .+++|||||...|+||.....+|||||||.+.+..+
T Consensus       188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe--skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE--SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh--hhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            999999999999998866678888899999999999999999  678999999999999999999999999999987665


Q ss_pred             CCCceee-ecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHhh
Q 013105          240 EDSHITT-CVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII  317 (449)
Q Consensus       240 ~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (449)
                      .....+. ...-...|+|||.+....++.++|||+|||+||||++ |..||.+......                 -+.+
T Consensus       266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI-----------------L~~i  328 (1039)
T KOG0199|consen  266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI-----------------LKNI  328 (1039)
T ss_pred             CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH-----------------HHhc
Confidence            5433222 1223457999999999999999999999999999998 7789877532211                 2223


Q ss_pred             cccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          318 DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       318 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      +....-.-+..|++++.+++..||..+|++|||+..|.+.
T Consensus       329 D~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  329 DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence            3333444567889999999999999999999999999743

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-40  Score=323.35  Aligned_cols=246  Identities=22%  Similarity=0.384  Sum_probs=197.2

Q ss_pred             CcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEec---c-CCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE--
Q 013105           83 RSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---V-NGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH--  156 (449)
Q Consensus        83 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~---~-~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~--  156 (449)
                      ...+||+|+|-+||+|.+..      +|..||=-.++   . ......++|..|+.+|+.|+||||+++|+++.+...  
T Consensus        44 ~~evLGrGafKtVYka~De~------~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~  117 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEE------EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT  117 (632)
T ss_pred             hhhhcccccceeeeeccccc------cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence            35679999999999997654      56666643332   2 234456889999999999999999999999987655  


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC-CcEEEeeeccccC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD-YNAKLSDFGLATD  235 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~-~~~kl~DfGla~~  235 (449)
                      ..+|+|.+..|+|..|+.+.  +......+..|+.||++||.|||++..+|||||||-+||+|+.+ |.|||+|+|||..
T Consensus       118 in~iTEL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  118 INFITELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL  195 (632)
T ss_pred             eeeeeecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence            78999999999999999876  67888899999999999999999999999999999999999765 8999999999986


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      .....    ...+.|||.|||||+.. ..|+..+||||||++|+||+|+..||..-......               +.+
T Consensus       196 ~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQI---------------YKK  255 (632)
T KOG0584|consen  196 LRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQI---------------YKK  255 (632)
T ss_pred             hhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHH---------------HHH
Confidence            54432    33467999999999997 78999999999999999999999999754321111               111


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      +.....+..+..--.++++++|.+||.. .++|||+.|+|.+
T Consensus       256 V~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  256 VTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             HHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence            1111112222222245699999999999 9999999999986

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=9.9e-39  Score=300.47  Aligned_cols=252  Identities=28%  Similarity=0.419  Sum_probs=202.7

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc--hHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ--GHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      +|.+.+.||+|+||.||+|....      +++.|++|.+......  ....+.+|+.+++.++|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~   74 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLD------TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKV   74 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECC------CCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEE
Confidence            58889999999999999997765      4789999999765432  567789999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++|+||+.+++|.+++...  ..+++.....++.+++.||.|||  +.+|+|+||+|+||+++.++.+||+|||++....
T Consensus        75 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh--~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~  150 (264)
T cd06626          75 YIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLH--SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK  150 (264)
T ss_pred             EEEEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEcccccccccC
Confidence            9999999999999998764  45788899999999999999999  7789999999999999999999999999988654


Q ss_pred             CCCCCce--eeecCCCCccccccccccCC---CCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccc
Q 013105          238 QGEDSHI--TTCVMGTEGYAAPEYINTGH---LTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK  312 (449)
Q Consensus       238 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  312 (449)
                      .......  .....++..|+|||++.+..   ++.++||||||+++|+|++|..||.........   .+.         
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~---~~~---------  218 (264)
T cd06626         151 NNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI---MFH---------  218 (264)
T ss_pred             CCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH---HHH---------
Confidence            3322111  11345789999999997665   889999999999999999999999754211100   000         


Q ss_pred             hhHhhcccccccCCH--HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          313 LDQIIDSRLEDRYST--EGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       313 ~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                          +........+.  .++..+.+++.+||+.+|.+|||+.+++.+
T Consensus       219 ----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         219 ----VGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             ----HhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                00001111111  235678899999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4.9e-39  Score=307.84  Aligned_cols=251  Identities=23%  Similarity=0.382  Sum_probs=204.6

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      ++|.+.+.||+|+||.||+|....      ++..||+|.+..........+.+|+.+++.++||||+++++++...+..|
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~   92 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVA------TGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELW   92 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcC------CCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence            678999999999999999997654      46789999987555555567889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCC
Q 013105          159 LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~  238 (449)
                      +||||+++++|.+++.+.   .+++..+..++.+++.||.|||  ++|++|+||||+||+++.++.++|+|||++.....
T Consensus        93 lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH--~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647          93 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             EEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH--hCCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence            999999999999988653   5788899999999999999999  77899999999999999999999999998875543


Q ss_pred             CCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhc
Q 013105          239 GEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIID  318 (449)
Q Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (449)
                      ...  ......|++.|+|||.+.+..++.++|||||||++|+|++|..||............      ..         .
T Consensus       168 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~~---------~  230 (293)
T cd06647         168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------AT---------N  230 (293)
T ss_pred             ccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------hc---------C
Confidence            221  122346889999999998888999999999999999999999999754321110000      00         0


Q ss_pred             ccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          319 SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       319 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .......+...+..+.+++.+||+.+|++||++.+++.|
T Consensus       231 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         231 GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000111123345678999999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=9.8e-39  Score=303.18  Aligned_cols=248  Identities=26%  Similarity=0.396  Sum_probs=202.2

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      -|++.+.||+|+||.||+|.+..      .+..||+|++.... ......+.+|+.++..++||||+++++++..++..+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   78 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNR------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW   78 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECC------CCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEE
Confidence            47778899999999999997765      47899999986443 233456888999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCC
Q 013105          159 LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~  238 (449)
                      +||||+.+++|.+++..   ..+++.....++.+++.+|.|||  ..+++|+||+|+||+++.++.++|+|||++.....
T Consensus        79 lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06641          79 IIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLH--SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  153 (277)
T ss_pred             EEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHc--cCCeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence            99999999999988854   46889999999999999999999  78899999999999999999999999999875533


Q ss_pred             CCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhc
Q 013105          239 GEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIID  318 (449)
Q Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (449)
                      ...  ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||..........                 .+.
T Consensus       154 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-----------------~~~  214 (277)
T cd06641         154 TQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF-----------------LIP  214 (277)
T ss_pred             chh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHH-----------------HHh
Confidence            211  1223468899999999988888999999999999999999999996532111000                 001


Q ss_pred             ccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          319 SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       319 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ..........++..+.+++.+||+.+|.+||++.+++.+
T Consensus       215 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         215 KNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             cCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            111122334456678999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.1e-39  Score=307.58  Aligned_cols=265  Identities=24%  Similarity=0.316  Sum_probs=201.0

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      +|++.+.||.|+||.||+|....      ++..||||.+....  ......+.+|++++++++||||+++++++.+.+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   74 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKL------TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL   74 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECC------CCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcE
Confidence            48889999999999999998765      47899999987442  22335688899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+. ++|..++.......+++..+..++.|++.||+|||  ..+++|+||+|+||+++.++.++|+|||++....
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh--~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~  151 (284)
T cd07860          75 YLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG  151 (284)
T ss_pred             EEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence            99999996 68988887665677899999999999999999999  7789999999999999999999999999987543


Q ss_pred             CCCCCceeeecCCCCccccccccccCC-CCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhc-------c
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGH-LTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK-------D  309 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~-------~  309 (449)
                      ....  ......++..|+|||.+.+.. ++.++|||||||++|+|+||+.||........  ..........       .
T Consensus       152 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~  227 (284)
T cd07860         152 VPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPG  227 (284)
T ss_pred             cCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhh
Confidence            3221  122345788999999886543 68899999999999999999999975432211  1111000000       0


Q ss_pred             ccchhHh---hccc---ccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          310 FTKLDQI---IDSR---LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       310 ~~~~~~~---~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ...+...   ....   ........++..+.+++.+||+.||++|||+.+++.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         228 VTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             hhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            0000000   0000   0001112345668899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-39  Score=306.24  Aligned_cols=265  Identities=23%  Similarity=0.297  Sum_probs=197.1

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      ++|++.+.||+|+||.||+|....      .++.||+|.+..... .....+.+|+.+++.++|+||+++++++.+++..
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKL------TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTL   78 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcC------CCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeE
Confidence            678999999999999999998754      478899999875432 2234567899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+. ++|.+++.... ..+++.....++.|++.||.|||  +.+|+||||||+||+++.++.++|+|||+++...
T Consensus        79 ~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH--~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  154 (291)
T cd07844          79 TLVFEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCH--QRRVLHRDLKPQNLLISERGELKLADFGLARAKS  154 (291)
T ss_pred             EEEEecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--hCCeecccCCHHHEEEcCCCCEEECccccccccC
Confidence            99999998 58988886543 47889999999999999999999  7789999999999999999999999999987543


Q ss_pred             CCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcc-----cc
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKD-----FT  311 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-----~~  311 (449)
                      .....  .....++..|+|||++.+ ..++.++|||||||++|+|++|..||........  ...........     +.
T Consensus       155 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  230 (291)
T cd07844         155 VPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETWP  230 (291)
T ss_pred             CCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhhh
Confidence            21111  122346889999999865 4588999999999999999999999965431111  00000000000     00


Q ss_pred             chhH---hhc-------ccccccCCHHH--HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          312 KLDQ---IID-------SRLEDRYSTEG--AKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       312 ~~~~---~~~-------~~~~~~~~~~~--~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ....   ...       ...........  ...+.+++.+||+.+|++|||+.+++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             hhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence            0000   000       00000000011  2567899999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.8e-38  Score=303.06  Aligned_cols=259  Identities=25%  Similarity=0.322  Sum_probs=202.2

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEe--CC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCE--DE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~  155 (449)
                      ++|...+.||.|++|.||+|.+..      +++.+|+|.+..... .....+.+|+++++.++||||+++++++.+  .+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   74 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKN------TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSS   74 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECC------CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCC
Confidence            468888999999999999998765      478999999975433 345678899999999999999999998865  34


Q ss_pred             EEEEEEEecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          156 HRLLVYEYMALGNLHDQLFK--NYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      .+++||||+++++|.+++..  .....++......++.|++.||.|||  ..+++|+||+|+||+++.++.++|+|||++
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH--~~~i~H~dl~~~nil~~~~~~~~l~dfg~~  152 (287)
T cd06621          75 SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH--SRKIIHRDIKPSNILLTRKGQVKLCDFGVS  152 (287)
T ss_pred             eEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEecCCeEEEeecccc
Confidence            78999999999999888753  23456888999999999999999999  778999999999999999999999999998


Q ss_pred             cCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccc--cchhhHHhhhhhhcccc
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCK--REKDLVEWARPMLKDFT  311 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~  311 (449)
                      .......    .....++..|+|||.+.+..++.++|||||||++|+|++|..||......  ...+...+...   . .
T Consensus       153 ~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~-~  224 (287)
T cd06621         153 GELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN---M-P  224 (287)
T ss_pred             ccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc---C-C
Confidence            7543322    12345788999999998889999999999999999999999999765321  11111111110   0 0


Q ss_pred             chhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          312 KLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       .... ..  ........++.+.+++.+||..+|++|||+.+++++
T Consensus       225 -~~~~-~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         225 -NPEL-KD--EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             -chhh-cc--CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence             0000 00  000012345679999999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.2e-39  Score=303.05  Aligned_cols=250  Identities=26%  Similarity=0.346  Sum_probs=205.1

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      +|++.+.||.|+||.||+|.+..      ++..||+|++....   ......+.+|++++++++||||+++++++.++..
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   74 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRD------TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEEN   74 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEcc------CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCe
Confidence            58889999999999999997764      57899999997432   2345678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||+.|++|.+++...  ..+++.....++.|+++||.|||  .++++|+||+|+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh--~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~  150 (258)
T cd05578          75 MYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLH--SKGIIHRDIKPDNILLDEQGHVHITDFNIATKV  150 (258)
T ss_pred             EEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeEEcCCCCEEEeeccccccc
Confidence            99999999999999998765  57889999999999999999999  778999999999999999999999999998865


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHh
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI  316 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (449)
                      ....   ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||..........+...              
T Consensus       151 ~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--------------  213 (258)
T cd05578         151 TPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK--------------  213 (258)
T ss_pred             CCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH--------------
Confidence            4332   12334588999999999888899999999999999999999999986542211111100              


Q ss_pred             hcccccccCCHHHHHHHHHHHHHhccCCCCCCCCH--HHHHHH
Q 013105          317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM--TTVVKA  357 (449)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~eil~~  357 (449)
                      ... .....+...+..+.+++.+||+.||.+||++  .+++.+
T Consensus       214 ~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~  255 (258)
T cd05578         214 QET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH  255 (258)
T ss_pred             hcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence            000 1222344556789999999999999999999  776654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-39  Score=302.96  Aligned_cols=248  Identities=25%  Similarity=0.389  Sum_probs=200.2

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC-CcchHHHHHHHHHHHhcCC---CCCcceeeeEEEeCC
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGHREWLAEVIFLGQLK---HPHLVNLIGYCCEDE  155 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~  155 (449)
                      .|++.+.||+|+||.||+|.+..      ++..||+|.+... .......+.+|+.+++.++   ||||+++++++..+.
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~   75 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVP------TGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP   75 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcC------CCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC
Confidence            47788899999999999998765      4789999998754 2334567888999999986   999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..++||||+.+++|.+++..   ..+++.....++.+++.||.|||  ..||+|+||+|+||+++.++.++|+|||++..
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh--~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  150 (277)
T cd06917          76 RLWIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIH--KVGVIHRDIKAANILVTNTGNVKLCDFGVAAL  150 (277)
T ss_pred             EEEEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcCHHHEEEcCCCCEEEccCCceee
Confidence            99999999999999998754   37889999999999999999999  78899999999999999999999999999886


Q ss_pred             CCCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ......  ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||..........   .    .       
T Consensus       151 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~---~----~-------  214 (277)
T cd06917         151 LNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM---L----I-------  214 (277)
T ss_pred             cCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh---c----c-------
Confidence            544321  1233468999999998864 457899999999999999999999997542211100   0    0       


Q ss_pred             HhhcccccccCCH-HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          315 QIIDSRLEDRYST-EGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       315 ~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                         ........+. ..+.++.+++.+||+.||++||++.+++.+
T Consensus       215 ---~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         215 ---PKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             ---ccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence               0000111111 245679999999999999999999999985

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.4e-38  Score=303.41  Aligned_cols=250  Identities=24%  Similarity=0.360  Sum_probs=201.2

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLL  159 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  159 (449)
                      +|...+.||+|++|.||+|....      .+..+++|.++.........+.+|+.+++.++||||+++++++...+..++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~   93 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKS------TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWV   93 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECC------CCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEE
Confidence            34556789999999999997654      478899999875554455668899999999999999999999999999999


Q ss_pred             EEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCC
Q 013105          160 VYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQG  239 (449)
Q Consensus       160 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~  239 (449)
                      |+||+.+++|.+++..   ..+++..+..++.|++.||.|||  +++|+||||+|+||+++.++.++|+|||++......
T Consensus        94 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~  168 (285)
T cd06648          94 VMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLH--AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE  168 (285)
T ss_pred             EEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence            9999999999998865   46888999999999999999999  678999999999999999999999999988754332


Q ss_pred             CCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcc
Q 013105          240 EDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDS  319 (449)
Q Consensus       240 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (449)
                      ..  ......|+..|+|||.+.+..++.++|||||||++|+|++|..||...........      .....       . 
T Consensus       169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~------~~~~~-------~-  232 (285)
T cd06648         169 VP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR------IRDNL-------P-  232 (285)
T ss_pred             Cc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHH------HHhcC-------C-
Confidence            11  12334589999999999888899999999999999999999999975422111100      00000       0 


Q ss_pred             cccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          320 RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       320 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       ........++..+.+++.+||+.+|++||++.+++++
T Consensus       233 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         233 -PKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             -CCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence             0001112245679999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=6.2e-39  Score=300.62  Aligned_cols=251  Identities=24%  Similarity=0.402  Sum_probs=203.3

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      +|.+.+.||+|+||.||+|....      .+..+|+|.+....  ......+.+|+.+++.++|+||+++++.+...+..
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~   74 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKS------DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRL   74 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcC------CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeE
Confidence            47888999999999999998866      47789999986532  23345678999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC-cEEEeeeccccCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY-NAKLSDFGLATDG  236 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~-~~kl~DfGla~~~  236 (449)
                      ++||||+.+++|.+++.......+++..+..++.+++.||.|||  ..+++|+||||+||+++.++ .++|+|||.+...
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (257)
T cd08225          75 FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH--DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL  152 (257)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence            99999999999999997765556899999999999999999999  67899999999999999886 4699999998765


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHh
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI  316 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (449)
                      .....  ......|++.|+|||.+.+..++.++|+|||||++|+|++|..||.......      ......         
T Consensus       153 ~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~---------  215 (257)
T cd08225         153 NDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKIC---------  215 (257)
T ss_pred             cCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHh---------
Confidence            43221  1223458999999999988889999999999999999999999997542111      110000         


Q ss_pred             hcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       ... ........+..+.+++.+||..+|++|||+.+++++
T Consensus       216 -~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         216 -QGY-FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             -ccc-CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence             000 111223445679999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.6e-40  Score=297.13  Aligned_cols=285  Identities=23%  Similarity=0.321  Sum_probs=206.8

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEe-C
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCE-D  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~  154 (449)
                      ...|+....||+|.||.||+|...+. . ......+|||.++...  ........+|+.+++.++||||+.+..++.+ +
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~-n-~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNT-N-DKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccC-C-cccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence            45699999999999999999966542 1 1124579999997442  2223567789999999999999999999877 7


Q ss_pred             CEEEEEEEecCCCChHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC----CcEEE
Q 013105          155 EHRLLVYEYMALGNLHDQLFKN---YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD----YNAKL  227 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~----~~~kl  227 (449)
                      ...++++||.+ -+|...|..+   ....++...+..|+.||+.|+.|||  ++-|+||||||.|||+..+    |.+||
T Consensus       101 ~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH--~NWvlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  101 KKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH--SNWVLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             ceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh--hhheeeccCCcceEEEeccCCccCeeEe
Confidence            88999999998 5887777432   3357899999999999999999999  6669999999999999887    89999


Q ss_pred             eeeccccCCCCCCCCc-eeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchh------h
Q 013105          228 SDFGLATDGPQGEDSH-ITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKD------L  299 (449)
Q Consensus       228 ~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~------~  299 (449)
                      +|||+++.+...-... ....++-|.+|+|||++.| ..|+.++||||+|||+.||++-.+.|.+........      .
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ  257 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ  257 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence            9999999764432211 1223456999999999865 479999999999999999999999998764432221      0


Q ss_pred             HHhh-----hhhhccccchhHh------hcccccccC-CHH----------HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          300 VEWA-----RPMLKDFTKLDQI------IDSRLEDRY-STE----------GAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       300 ~~~~-----~~~~~~~~~~~~~------~~~~~~~~~-~~~----------~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ....     .+....++.+...      +.......+ +..          -++...+|+.++|..||.+|.|+++.+++
T Consensus       258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            1111     1111122211111      111100011 100          12337789999999999999999999997


Q ss_pred             hhccccCCCCCC
Q 013105          358 LEPLLDLNDIPI  369 (449)
Q Consensus       358 L~~~~~~~~~~~  369 (449)
                        .++...+.|.
T Consensus       338 --~yF~~d~lpp  347 (438)
T KOG0666|consen  338 --PYFTEDPLPP  347 (438)
T ss_pred             --cccccCCCCC
Confidence              5555555553

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=9.4e-39  Score=305.77  Aligned_cols=267  Identities=22%  Similarity=0.292  Sum_probs=200.8

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc--chHHHHHHHHHHHhcCCCCCcceeeeEEEeC--
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLKHPHLVNLIGYCCED--  154 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--  154 (449)
                      ++|++.+.||.|+||.||+|.+..      +++.+|+|.++....  .....+.+|+.++.+++||||+++++++...  
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   78 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKK------TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNL   78 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECC------CCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC
Confidence            468889999999999999998765      478899999975432  2233567899999999999999999998877  


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +..|+||||+. ++|.+++.... ..+++.....++.|++.||.|||  .++++|+||||+|||++.++.++|+|||++.
T Consensus        79 ~~~~lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH--~~~i~H~dl~p~nili~~~~~~~l~d~g~~~  154 (293)
T cd07843          79 DKIYMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLH--DNWILHRDLKTSNLLLNNRGILKICDFGLAR  154 (293)
T ss_pred             CcEEEEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCCHHHEEECCCCcEEEeecCcee
Confidence            89999999997 58988886543 46899999999999999999999  7789999999999999999999999999988


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCCcccccccccchhhH-Hhh-hhh---hc
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV-EWA-RPM---LK  308 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~-~~~-~~~---~~  308 (449)
                      .......  ......+++.|+|||.+.+. .++.++|||||||++|+|++|.+||...........+ ... .+.   +.
T Consensus       155 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
T cd07843         155 EYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP  232 (293)
T ss_pred             eccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence            6544321  12234578999999998654 4689999999999999999999999765332211111 000 000   00


Q ss_pred             cccchhH--------hhcccccccCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          309 DFTKLDQ--------IIDSRLEDRYSTE-GAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       309 ~~~~~~~--------~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ....+..        .........++.. .++.+.+++.+||+.||++|||+.|++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence            0000000        0000111122222 46678999999999999999999999976

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.3e-38  Score=302.24  Aligned_cols=246  Identities=27%  Similarity=0.383  Sum_probs=196.9

Q ss_pred             ccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEEEe
Q 013105           87 LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEY  163 (449)
Q Consensus        87 lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  163 (449)
                      ||+|+||+||+|....      +++.||+|++....   ......+..|+.+++.++||||+++++++...+..|+||||
T Consensus         1 lg~g~~g~vy~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   74 (277)
T cd05577           1 LGKGGFGEVCACQVKA------TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTL   74 (277)
T ss_pred             CCCCCceeEEEEEEcC------CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEec
Confidence            6999999999997665      47899999986432   22344567899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCCc
Q 013105          164 MALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSH  243 (449)
Q Consensus       164 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~~  243 (449)
                      +++++|.+++.......+++..+..++.|++.||.|||  ..|++|+||+|+||+++.++.++|+|||++.......   
T Consensus        75 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH--~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---  149 (277)
T cd05577          75 MNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH--QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---  149 (277)
T ss_pred             CCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---
Confidence            99999999997765557899999999999999999999  7789999999999999999999999999987543321   


Q ss_pred             eeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccccc
Q 013105          244 ITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLED  323 (449)
Q Consensus       244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (449)
                      ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||..............             ... ....
T Consensus       150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------~~~-~~~~  215 (277)
T cd05577         150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR-------------RTL-EMAV  215 (277)
T ss_pred             ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh-------------ccc-cccc
Confidence            12234578899999999888899999999999999999999999975432111111000             000 0111


Q ss_pred             cCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013105          324 RYSTEGAKRLAAVAHQCLSHNPKSRP-----TMTTVVKA  357 (449)
Q Consensus       324 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  357 (449)
                      .++...++.+.+++.+||+.||++||     ++.+++.|
T Consensus       216 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         216 EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence            22334566799999999999999999     77777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8e-39  Score=327.45  Aligned_cols=278  Identities=19%  Similarity=0.271  Sum_probs=191.6

Q ss_pred             HHHhcCCCCcccccccCceEEEEEEEcCCCCC---------CCCCcEE----EEEEeccCCcchHHHHHHHHHHHhcCCC
Q 013105           75 QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRP---------GLKAQTV----AVKVLDVNGSQGHREWLAEVIFLGQLKH  141 (449)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~---------~~~~~~v----avK~~~~~~~~~~~~~~~E~~~l~~l~h  141 (449)
                      ..+.++|++.+.||+|+||+||+|.+......         ...+...    +.|.+. ........+.+|+.+|..++|
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~H  222 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNH  222 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCC
Confidence            34567899999999999999999876432000         0000111    111111 112234567899999999999


Q ss_pred             CCcceeeeEEEeCCEEEEEEEecCCCChHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceE
Q 013105          142 PHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNY---SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNIL  218 (449)
Q Consensus       142 ~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nil  218 (449)
                      |||+++++++...+..|+||+++. ++|.+++....   ...........++.|++.||.|||  ++||+||||||+|||
T Consensus       223 pnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH--~~gIiHrDLKP~NIL  299 (501)
T PHA03210        223 ENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH--DKKLIHRDIKLENIF  299 (501)
T ss_pred             CCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEE
Confidence            999999999999999999999985 67777775431   122335567789999999999999  778999999999999


Q ss_pred             EcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCc-ccccccccch
Q 013105          219 LDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS-VEKNRCKREK  297 (449)
Q Consensus       219 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p-f~~~~~~~~~  297 (449)
                      ++.++.+||+|||++........ .......||..|+|||++.+..++.++|||||||+||||++|..+ |.........
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             ECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            99999999999999986543221 112335699999999999988999999999999999999998854 4332211111


Q ss_pred             hhHHhhhhh---hcccc----chhHhhccccc----ccCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          298 DLVEWARPM---LKDFT----KLDQIIDSRLE----DRYS-----TEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       298 ~~~~~~~~~---~~~~~----~~~~~~~~~~~----~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .+.......   ...+.    .+...+.....    ...+     ...+.++.+++.+||+.||.+|||+.|++.|
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            111111100   00000    01111110000    0000     1134567888999999999999999999986

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.8e-38  Score=303.51  Aligned_cols=267  Identities=22%  Similarity=0.306  Sum_probs=197.4

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      .++|.+.+.||+|+||.||+|....      ++..||+|++..... .....+.+|+.+++.++|+||+++++++..++.
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   77 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRI------NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKET   77 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcC------CCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCe
Confidence            3679999999999999999997765      478999999875432 223456789999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .|+||||+. ++|.+++... ...+++.....++.|++.||.|||  ..+|+|+||||+|||++.++.++|+|||++...
T Consensus        78 ~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  153 (291)
T cd07870          78 LTFVFEYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIH--GQHILHRDLKPQNLLISYLGELKLADFGLARAK  153 (291)
T ss_pred             EEEEEeccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChHHEEEcCCCcEEEecccccccc
Confidence            999999996 7787776543 246788888899999999999999  678999999999999999999999999998754


Q ss_pred             CCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhh----hh-----
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR----PM-----  306 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~----~~-----  306 (449)
                      ......  .....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.......+ .+.....    +.     
T Consensus       154 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~  230 (291)
T cd07870         154 SIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEKIWTVLGVPTEDTWP  230 (291)
T ss_pred             CCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHHHHHHcCCCChhhhh
Confidence            322111  223457899999999865 3578899999999999999999999975432111 0000000    00     


Q ss_pred             -hccccchh-HhhcccccccC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          307 -LKDFTKLD-QIIDSRLEDRY-----STEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       307 -~~~~~~~~-~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       ........ ...........     ....+..+.+++.+||+.||++|||+.+++.|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence             00000000 00000000000     00114568899999999999999999999876

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-41  Score=347.79  Aligned_cols=257  Identities=28%  Similarity=0.397  Sum_probs=210.4

Q ss_pred             HHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEE
Q 013105           75 QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCC  152 (449)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~  152 (449)
                      ..++-+|.....||.|.||.||-|...+      +|...|+|-+....  ......+.+|..+|..|+|||+|++||+-.
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~------tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv 1304 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLD------TGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEV 1304 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEeecCC------ccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceee
Confidence            3445678888999999999999998877      68899999887543  233456778999999999999999999999


Q ss_pred             eCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecc
Q 013105          153 EDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL  232 (449)
Q Consensus       153 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGl  232 (449)
                      +.+..+|.||||++|+|.+.+...  ...++.....+..|++.|+.|||  +.|||||||||+||+|+.+|.+|++|||.
T Consensus      1305 HRekv~IFMEyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH--~~gIVHRDIK~aNI~Ld~~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1305 HREKVYIFMEYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLH--EHGIVHRDIKPANILLDFNGLIKYGDFGS 1380 (1509)
T ss_pred             cHHHHHHHHHHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHH--hcCceecCCCccceeeecCCcEEeecccc
Confidence            999999999999999999988653  56677777788899999999999  78899999999999999999999999999


Q ss_pred             ccCCCCCCC--CceeeecCCCCccccccccccC---CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhh
Q 013105          233 ATDGPQGED--SHITTCVMGTEGYAAPEYINTG---HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML  307 (449)
Q Consensus       233 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~  307 (449)
                      |........  .......+||+.|||||++.+.   ....+.||||||||+.||+||+.||...+.       +|+    
T Consensus      1381 a~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~a---- 1449 (1509)
T KOG4645|consen 1381 AVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWA---- 1449 (1509)
T ss_pred             eeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhH----
Confidence            987654321  1112346799999999999643   467899999999999999999999975421       111    


Q ss_pred             ccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                          .+. .+.....+.+|..++.+-.+++.+||..||++|.++.+++++
T Consensus      1450 ----IMy-~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1450 ----IMY-HVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ----HHh-HHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                111 122334456677788889999999999999999999999987

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.8e-38  Score=301.79  Aligned_cols=243  Identities=26%  Similarity=0.380  Sum_probs=189.4

Q ss_pred             cccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHH---HhcCCCCCcceeeeEEEeCCEEEE
Q 013105           86 YLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIF---LGQLKHPHLVNLIGYCCEDEHRLL  159 (449)
Q Consensus        86 ~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~---l~~l~h~nIv~~~~~~~~~~~~~l  159 (449)
                      .||+|+||.||++....      +++.+|+|.+....   ......+.+|..+   +....||||+.+++++..++..++
T Consensus         1 ~lg~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l   74 (279)
T cd05633           1 IIGRGGFGEVYGCRKAD------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCF   74 (279)
T ss_pred             CcccCCCeEEEEEEECC------CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEE
Confidence            48999999999997765      57899999986432   1112233444433   334479999999999999999999


Q ss_pred             EEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCC
Q 013105          160 VYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQG  239 (449)
Q Consensus       160 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~  239 (449)
                      ||||+.+|+|.+++..+  ..+++.....++.|++.||.|||  ..+|+||||||+|||++.++.++|+|||++......
T Consensus        75 v~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH--~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~  150 (279)
T cd05633          75 ILDLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  150 (279)
T ss_pred             EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc
Confidence            99999999999888654  56899999999999999999999  678999999999999999999999999998754322


Q ss_pred             CCCceeeecCCCCccccccccc-cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhc
Q 013105          240 EDSHITTCVMGTEGYAAPEYIN-TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIID  318 (449)
Q Consensus       240 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (449)
                      .    .....|+..|+|||.+. +..++.++|||||||++|+|++|..||..............               .
T Consensus       151 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---------------~  211 (279)
T cd05633         151 K----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---------------T  211 (279)
T ss_pred             C----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH---------------h
Confidence            1    12245899999999986 45689999999999999999999999975432211111000               0


Q ss_pred             ccccccCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013105          319 SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRP-----TMTTVVKA  357 (449)
Q Consensus       319 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  357 (449)
                      .......+...+.++.+++.+||..||++||     ++.++++|
T Consensus       212 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         212 LTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             hcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            0011223445567799999999999999999     69999987

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.3e-38  Score=296.40  Aligned_cols=251  Identities=24%  Similarity=0.381  Sum_probs=207.2

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc--chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      +|.+.+.||.|+||.||++.+..      ++..|++|++.....  .....+.+|+++++.++|+|++++++.+...+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~   74 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKS------DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKL   74 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcC------CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEE
Confidence            57888999999999999998765      478999999975533  4456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          158 LLVYEYMALGNLHDQLFKNY--SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ++||||+++++|.+++....  ...+++.....++.+++.||.|||  +.|++|+||+|+||+++.++.++|+|||++..
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh--~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~  152 (258)
T cd08215          75 CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH--SRKILHRDIKPQNIFLTSNGLVKLGDFGISKV  152 (258)
T ss_pred             EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH--hCCEecccCChHHeEEcCCCcEEECCccceee
Confidence            99999999999999887643  467899999999999999999999  67899999999999999999999999999986


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      .....  .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.......   ...   .          
T Consensus       153 ~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~---~----------  214 (258)
T cd08215         153 LSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LAL---K----------  214 (258)
T ss_pred             cccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---HHH---H----------
Confidence            54432  12233468999999999988889999999999999999999999996543111   000   0          


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      . ........+..++..+.+++.+||..+|++|||+.+++++
T Consensus       215 ~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         215 I-LKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             H-hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0 0111222333556679999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.9e-38  Score=304.55  Aligned_cols=248  Identities=29%  Similarity=0.406  Sum_probs=198.2

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc---chHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS---QGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      .+.|.+.+.||+|+||.||+|....      .++.||+|.+.....   .....+.+|+.+++.++||||+++++++.+.
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~   87 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVR------TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE   87 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcC------CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC
Confidence            3568888999999999999998765      478999999864322   2335688999999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +..++||||+. |+|.+.+... ...+++..+..++.|++.||.|||  ..+|+|+||+|+||+++.++.++|+|||++.
T Consensus        88 ~~~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH--~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~  163 (307)
T cd06607          88 HTAWLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLH--SHERIHRDIKAGNILLTEPGTVKLADFGSAS  163 (307)
T ss_pred             CeEEEEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCcccEEECCCCCEEEeecCcce
Confidence            99999999997 6777776543 246899999999999999999999  6789999999999999999999999999987


Q ss_pred             CCCCCCCCceeeecCCCCccccccccc---cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcccc
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYIN---TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFT  311 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  311 (449)
                      .....      ....|+..|+|||++.   ...++.++||||||+++|||++|..||...........            
T Consensus       164 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~------------  225 (307)
T cd06607         164 LVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH------------  225 (307)
T ss_pred             ecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH------------
Confidence            54322      2245888999999874   35688999999999999999999999875421111000            


Q ss_pred             chhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          312 KLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                          +............++..+.+++.+||+.||++||++.+++.+
T Consensus       226 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         226 ----IAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             ----HhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                000000111123456679999999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=5.6e-39  Score=306.48  Aligned_cols=255  Identities=25%  Similarity=0.345  Sum_probs=196.2

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCC-CCCcceeeeEEEeCCEE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLK-HPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~  157 (449)
                      +|...+.||+|+||.||++.+..      +++.||+|.+.... ......+.+|+.++.++. |+||+++++++..++..
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~   78 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKP------SGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDC   78 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECC------CCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcE
Confidence            45567789999999999998765      57899999987543 234557889999999996 99999999999999999


Q ss_pred             EEEEEecCCCChHHH---HhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          158 LLVYEYMALGNLHDQ---LFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~---l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +++|||+. +++.++   +.......+++.....++.+++.||+|||+ ..+|+||||||+||+++.++.++|+|||++.
T Consensus        79 ~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  156 (288)
T cd06616          79 WICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFGISG  156 (288)
T ss_pred             EEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-cCCeeccCCCHHHEEEccCCcEEEeecchhH
Confidence            99999986 455443   333334678999999999999999999993 2479999999999999999999999999987


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccC---CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcccc
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTG---HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFT  311 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  311 (449)
                      .......   .....|+..|+|||++.+.   .++.++|||||||++|+|++|+.||.....     ............ 
T Consensus       157 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~-  227 (288)
T cd06616         157 QLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVKGD-  227 (288)
T ss_pred             HhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcCCC-
Confidence            5433221   1223589999999999765   689999999999999999999999975421     111000000000 


Q ss_pred             chhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          312 KLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                            ...........++..+.+|+.+||+.||++|||+.+|+.+
T Consensus       228 ------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         228 ------PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             ------CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  0011111223456679999999999999999999999987

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-38  Score=297.29  Aligned_cols=252  Identities=24%  Similarity=0.312  Sum_probs=202.1

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC-----CcchHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-----GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      .+|.+.+.||+|+||.||+|.+..      ++..||+|.+...     .......+.+|+.+++.++|+||+++++++.+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   75 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDAD------TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD   75 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcC------CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc
Confidence            478999999999999999998765      5789999987532     12334578889999999999999999999876


Q ss_pred             C--CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeec
Q 013105          154 D--EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFG  231 (449)
Q Consensus       154 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfG  231 (449)
                      .  ..++++|||+.+++|.+++...  ..+++.....++.|++.||.|||  +.+++|+||||+||+++.++.++|+|||
T Consensus        76 ~~~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH--~~~i~H~dl~p~ni~i~~~~~~~l~dfg  151 (264)
T cd06653          76 PEEKKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLH--SNMIVHRDIKGANILRDSAGNVKLGDFG  151 (264)
T ss_pred             CCCCEEEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCCCEEECccc
Confidence            4  5688999999999999998754  45788899999999999999999  7789999999999999999999999999


Q ss_pred             cccCCCCCCC-CceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccc
Q 013105          232 LATDGPQGED-SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF  310 (449)
Q Consensus       232 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  310 (449)
                      ++........ ........|+..|+|||.+.+..++.++|+|||||++|+|++|+.||.......               
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------------  216 (264)
T cd06653         152 ASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA---------------  216 (264)
T ss_pred             cccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH---------------
Confidence            9986432111 111223568999999999988888999999999999999999999997532111               


Q ss_pred             cchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       ...+..........+...++.+.+++.+||. +|..||++.+++.|
T Consensus       217 -~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         217 -AIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             -HHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence             0111111222233456677789999999999 57999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3e-38  Score=301.23  Aligned_cols=254  Identities=24%  Similarity=0.397  Sum_probs=206.5

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      ..+.|++.+.||+|+||.||+|.+..      .+..|++|++..... ....+.+|+++++.++|+||+++++++...+.
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   89 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRA------TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDE   89 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEcc------CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCE
Confidence            45678888999999999999998764      478899999975544 45678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||+.+++|.+++.... ..+++..+..++.+++.||.|||  ..|++|+||+|+||+++.++.++|+|||++...
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH--~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  166 (286)
T cd06614          90 LWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLH--SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL  166 (286)
T ss_pred             EEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence            999999999999999997653 47899999999999999999999  788999999999999999999999999998754


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHh
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI  316 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (449)
                      .....  ......++..|+|||.+.+..++.++|||||||++|+|++|..||............  .    .        
T Consensus       167 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~--~----~--------  230 (286)
T cd06614         167 TKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI--T----T--------  230 (286)
T ss_pred             ccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--H----h--------
Confidence            33221  122345789999999998888999999999999999999999998754321111000  0    0        


Q ss_pred             hcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       ...........++..+.+++.+||+.+|.+||++.+++.+
T Consensus       231 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         231 -KGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             -cCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence             0000011122356679999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=4.3e-38  Score=293.29  Aligned_cols=251  Identities=28%  Similarity=0.429  Sum_probs=205.2

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLL  159 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  159 (449)
                      +|.+.+.||+|++|.||++.+..      .+..+++|++..........+.+|+.+++.++|+||+++++++......++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   74 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKR------TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWI   74 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECC------CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence            47788999999999999998765      478899999976554456788999999999999999999999999999999


Q ss_pred             EEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCC
Q 013105          160 VYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQG  239 (449)
Q Consensus       160 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~  239 (449)
                      ++||+.+++|.+++.... ..+++..+..++.+++.+|.+||  ..+++|+||+|+||+++.++.++|+|||.+......
T Consensus        75 ~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh--~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  151 (253)
T cd05122          75 VMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLH--SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT  151 (253)
T ss_pred             EEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhh--cCCEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence            999999999999886643 57899999999999999999999  688999999999999999999999999998866543


Q ss_pred             CCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcc
Q 013105          240 EDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDS  319 (449)
Q Consensus       240 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (449)
                      ..   .....|+..|+|||.+.+..++.++||||||+++|+|++|..||.............   .  ...         
T Consensus       152 ~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~--~~~---------  214 (253)
T cd05122         152 KA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA---T--NGP---------  214 (253)
T ss_pred             cc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH---h--cCC---------
Confidence            21   233568999999999988888999999999999999999999997542111111000   0  000         


Q ss_pred             cccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          320 RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       320 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       .........+..+.+++..||+.||++|||+.+++++
T Consensus       215 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         215 -PGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             -CCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             0000111225679999999999999999999999976

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-39  Score=312.16  Aligned_cols=266  Identities=23%  Similarity=0.336  Sum_probs=198.5

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC-CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC-
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED-  154 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-  154 (449)
                      +.++|++.+.||+|+||.||+|.+..      +++.||+|.+... .......+.+|+.+++.++|+||+++++++... 
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   76 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKP------TGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPS   76 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcC------CCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeeccc
Confidence            35789999999999999999998765      5789999998643 233445678899999999999999999987654 


Q ss_pred             ----CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeee
Q 013105          155 ----EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDF  230 (449)
Q Consensus       155 ----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~Df  230 (449)
                          ...|+||||+. ++|.+.+..   ..+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.++|+||
T Consensus        77 ~~~~~~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH--~~~ivH~dlkp~Nill~~~~~~kl~df  150 (336)
T cd07849          77 FESFNDVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTNCDLKICDF  150 (336)
T ss_pred             ccccceEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEECCCCCEEECcc
Confidence                35799999997 588777743   46899999999999999999999  678999999999999999999999999


Q ss_pred             ccccCCCCCCC-CceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhc
Q 013105          231 GLATDGPQGED-SHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK  308 (449)
Q Consensus       231 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  308 (449)
                      |++........ ........||+.|+|||.+.+ ..++.++|||||||++|+|++|++||.+.........   ......
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~---~~~~~~  227 (336)
T cd07849         151 GLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNL---ILGVLG  227 (336)
T ss_pred             cceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcC
Confidence            99876433221 111223568999999998754 5689999999999999999999999975432111100   000000


Q ss_pred             c--ccchhHhhc--------c-cccc-----cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          309 D--FTKLDQIID--------S-RLED-----RYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       309 ~--~~~~~~~~~--------~-~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .  ...+..+..        . ....     ...+..+..+.+++.+||+.||++|||+.+++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         228 TPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             CCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0  000000000        0 0000     0112235678999999999999999999999998

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.4e-38  Score=295.21  Aligned_cols=253  Identities=28%  Similarity=0.406  Sum_probs=207.6

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc--chHHHHHHHHHHHhcCCCCCcceeeeEEEeC--C
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLKHPHLVNLIGYCCED--E  155 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~  155 (449)
                      +|.+.+.||+|++|.||+|....      ++..|++|++.....  .....+.+|+.++++++|+||+++++.+...  .
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKD------TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKN   74 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECC------CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCC
Confidence            47788999999999999998765      478999999975542  4457788999999999999999999999988  8


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..++||||+.+++|.+++...  ..+++..+..++.+++.+|.|||  +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh--~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~  150 (260)
T cd06606          75 TLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLH--SNGIVHRDIKGANILVDSDGVVKLADFGCAKR  150 (260)
T ss_pred             eEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEcCCCCEEEcccccEEe
Confidence            999999999999999998765  38899999999999999999999  68899999999999999999999999999886


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ..............++..|+|||.+.+..++.++||||||+++|+|++|..||.....     ......          .
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~----------~  215 (260)
T cd06606         151 LGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALY----------K  215 (260)
T ss_pred             cccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHH----------h
Confidence            6543321112335688999999999888899999999999999999999999976530     000000          0


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ..........+...+..+.+++.+||+.||++||++.+++.+
T Consensus       216 ~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         216 IGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             ccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            001111223344557789999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.1e-38  Score=303.62  Aligned_cols=264  Identities=16%  Similarity=0.186  Sum_probs=188.5

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHH-----------HHHHHHHHHhcCCCCCcc
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-----------EWLAEVIFLGQLKHPHLV  145 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~-----------~~~~E~~~l~~l~h~nIv  145 (449)
                      ..++|.+.+.||+|+||.||+|.+.++   ......+|+|+..........           ....+...+..+.|+||+
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~---~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~   86 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASD---HCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP   86 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCC---cccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence            446899999999999999999987652   112456777775433322111           122344456677899999


Q ss_pred             eeeeEEEeCC----EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC
Q 013105          146 NLIGYCCEDE----HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS  221 (449)
Q Consensus       146 ~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~  221 (449)
                      ++++++....    ..+++|+++. .++.+.+...  ...++..+..++.|++.||.|||  +++|+||||||+|||++.
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH--~~~iiHrDiKp~Nill~~  161 (294)
T PHA02882         87 KYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIH--EHGISHGDIKPENIMVDG  161 (294)
T ss_pred             cEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcC
Confidence            9999776543    4477888774 4666665443  34577888899999999999999  778999999999999999


Q ss_pred             CCcEEEeeeccccCCCCCCCC-----ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccc
Q 013105          222 DYNAKLSDFGLATDGPQGEDS-----HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE  296 (449)
Q Consensus       222 ~~~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~  296 (449)
                      ++.++|+|||+|+........     .......||+.|+|||++.+..++.++|||||||++|||++|..||........
T Consensus       162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~  241 (294)
T PHA02882        162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN  241 (294)
T ss_pred             CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence            999999999999865322110     112234699999999999999999999999999999999999999986522111


Q ss_pred             hhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 013105          297 KDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL  358 (449)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  358 (449)
                        .......   +  .+..+.....   ....+++.+.+++..||..+|++||++.++++.|
T Consensus       242 --~~~~~~~---~--~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        242 --LIHAAKC---D--FIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             --HHHHhHH---H--HHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence              0000000   0  0000000000   1123457799999999999999999999999875

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.6e-38  Score=310.48  Aligned_cols=269  Identities=27%  Similarity=0.384  Sum_probs=200.1

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcC-CCCCcceeeeEEEe
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCE  153 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~  153 (449)
                      +.++|.+.+.||+|+||.||+|.+..      ++..+|+|.+...  .......+.+|+.++.++ +||||+++++++..
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~   78 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRR------TKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA   78 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcC------CCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc
Confidence            56789999999999999999998764      4788999988532  223345677899999999 99999999998865


Q ss_pred             C--CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeec
Q 013105          154 D--EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFG  231 (449)
Q Consensus       154 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfG  231 (449)
                      .  ...++||||+. ++|..++...   .+++.....++.|++.||.|||  ++||+||||||+||+++.++.++|+|||
T Consensus        79 ~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH--~~~i~H~dl~p~nill~~~~~~kl~d~g  152 (337)
T cd07852          79 ENDKDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIH--SGNVIHRDLKPSNILLNSDCRVKLADFG  152 (337)
T ss_pred             CCCceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCcEEEeecc
Confidence            3  46899999997 6998887553   6788888999999999999999  7889999999999999999999999999


Q ss_pred             cccCCCCCCCC---ceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhh
Q 013105          232 LATDGPQGEDS---HITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML  307 (449)
Q Consensus       232 la~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~  307 (449)
                      ++.........   .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.................
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~  232 (337)
T cd07852         153 LARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP  232 (337)
T ss_pred             chhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99865433221   12234568999999998754 467899999999999999999999997543322111110000000


Q ss_pred             c--cc-----cchhHhhcc------cccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          308 K--DF-----TKLDQIIDS------RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       308 ~--~~-----~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .  ..     .....++..      ..........+..+.+++.+||+.||++|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            0  00     000000000      00001112246779999999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-38  Score=302.60  Aligned_cols=264  Identities=22%  Similarity=0.285  Sum_probs=200.3

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      |++.+.||.|++|.||+|.+..      ++..||+|++....  ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~   74 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKL------TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLY   74 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcC------CCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEE
Confidence            6778899999999999998765      47899999987543  223356788999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCC
Q 013105          159 LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~  238 (449)
                      ++|||+. ++|.+++.......+++..+..++.|++.||.|||  .++++|+||+|+||+++.++.++|+|||++.....
T Consensus        75 iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH--~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~  151 (283)
T cd07835          75 LVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH--SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGV  151 (283)
T ss_pred             EEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCC
Confidence            9999995 78999887654457899999999999999999999  67899999999999999999999999999975433


Q ss_pred             CCCCceeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhc-------cc
Q 013105          239 GEDSHITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK-------DF  310 (449)
Q Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~-------~~  310 (449)
                      ...  ......++..|+|||++.+. .++.++|||||||++|+|++|.+||........  ..........       ..
T Consensus       152 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~  227 (283)
T cd07835         152 PVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGV  227 (283)
T ss_pred             Ccc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhh
Confidence            211  12223468899999988654 578899999999999999999999976532211  1110000000       00


Q ss_pred             cchhHhhcc------cccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          311 TKLDQIIDS------RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       311 ~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ..+......      ..........+..+.+++.+||+.||++|||+.+++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         228 TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            000000000      00011122344678999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.6e-38  Score=297.58  Aligned_cols=244  Identities=29%  Similarity=0.388  Sum_probs=198.8

Q ss_pred             ccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEEEe
Q 013105           87 LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEY  163 (449)
Q Consensus        87 lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  163 (449)
                      ||.|+||.||+|.+..      .++.||+|++....   ......+.+|+.+++.++||||+++++++.++...++||||
T Consensus         1 lg~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   74 (262)
T cd05572           1 LGVGGFGRVELVKVKS------KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEY   74 (262)
T ss_pred             CCCCCceEEEEEEECC------CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEec
Confidence            7999999999998765      47899999996432   23346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCCc
Q 013105          164 MALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSH  243 (449)
Q Consensus       164 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~~  243 (449)
                      +.+++|.+++...  ..++...+..++.|++.||.|||  +.+++|+||+|+||+++.++.++|+|||++.......   
T Consensus        75 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH--~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---  147 (262)
T cd05572          75 CLGGELWTILRDR--GLFDEYTARFYIACVVLAFEYLH--NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---  147 (262)
T ss_pred             CCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---
Confidence            9999999999764  45889999999999999999999  6889999999999999999999999999998654432   


Q ss_pred             eeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccccc
Q 013105          244 ITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLED  323 (449)
Q Consensus       244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (449)
                      ......|+..|++||.+.+..++.++|+||||+++|+|++|..||.......    ....          ..........
T Consensus       148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~----------~~~~~~~~~~  213 (262)
T cd05572         148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIY----------NDILKGNGKL  213 (262)
T ss_pred             ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHH----------HHHhccCCCC
Confidence            1233468999999999988889999999999999999999999997653210    0000          1111111122


Q ss_pred             cCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 013105          324 RYSTEGAKRLAAVAHQCLSHNPKSRPT-----MTTVVKA  357 (449)
Q Consensus       324 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~  357 (449)
                      .++...++.+.+++.+||+.||++||+     +.+++++
T Consensus       214 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         214 EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence            233444678999999999999999999     8888876

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.1e-38  Score=311.51  Aligned_cols=266  Identities=20%  Similarity=0.266  Sum_probs=200.0

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      .+.++|++.+.||+|+||.||+|....      +++.||+|++...  .......+.+|+.+++.++||||+++++++..
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   86 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTV------TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTP   86 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECC------CCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeecc
Confidence            356789999999999999999997765      5789999998643  23334567789999999999999999998864


Q ss_pred             C------CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEE
Q 013105          154 D------EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKL  227 (449)
Q Consensus       154 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl  227 (449)
                      .      ...|+||||+. ++|.+.+..    .++......++.|++.||.|||  ..||+||||||+||+++.++.+||
T Consensus        87 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH--~~gi~H~dlkp~Nil~~~~~~~kL  159 (353)
T cd07850          87 QKSLEEFQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKI  159 (353)
T ss_pred             CCCccccCcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEECCCCCEEE
Confidence            3      35799999996 688887753    2888889999999999999999  678999999999999999999999


Q ss_pred             eeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhH-H-----
Q 013105          228 SDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV-E-----  301 (449)
Q Consensus       228 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~-~-----  301 (449)
                      +|||++........   .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...........+ .     
T Consensus       160 ~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  236 (353)
T cd07850         160 LDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTP  236 (353)
T ss_pred             ccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99999986533211   22345889999999999889999999999999999999999999754321111000 0     


Q ss_pred             ---hhh-------hhhccc-----cchhHhhccccc----ccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          302 ---WAR-------PMLKDF-----TKLDQIIDSRLE----DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       302 ---~~~-------~~~~~~-----~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                         +..       ......     ..+.........    .......+..+.+++.+||+.||++|||+.+++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         237 SDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             CHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence               000       000000     000000000000    00012346678999999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=291.37  Aligned_cols=253  Identities=24%  Similarity=0.301  Sum_probs=201.7

Q ss_pred             HHhcCCCCc-ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcC-CCCCcceeeeEEEe
Q 013105           76 MITHNFSRS-DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCE  153 (449)
Q Consensus        76 ~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~  153 (449)
                      .++++|.+. ++||-|-.|.|-.+..+.      +++.+|+|++..     .....+|+++.-.. .|||||.++++|.+
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~------T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeN  126 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKR------TQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYEN  126 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEecc------chhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence            467788875 679999999998886654      789999999852     24556788876655 59999999999864


Q ss_pred             ----CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC---CCcEE
Q 013105          154 ----DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS---DYNAK  226 (449)
Q Consensus       154 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~---~~~~k  226 (449)
                          ...+.+|||+|+||.|+..+..+....+++.++..|+.||..|+.|||  ..+|.||||||+|+|...   |..+|
T Consensus       127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH--~~nIAHRDlKpENLLyt~t~~na~lK  204 (400)
T KOG0604|consen  127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH--SMNIAHRDLKPENLLYTTTSPNAPLK  204 (400)
T ss_pred             hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH--hcchhhccCChhheeeecCCCCcceE
Confidence                466789999999999999999998888999999999999999999999  566999999999999965   44799


Q ss_pred             EeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhh
Q 013105          227 LSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPM  306 (449)
Q Consensus       227 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~  306 (449)
                      |+|||+|+......   ...+.+-||+|.|||++....|+..+|+||+||++|-||+|-+||....-.. ..        
T Consensus       205 LtDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-is--------  272 (400)
T KOG0604|consen  205 LTDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-IS--------  272 (400)
T ss_pred             ecccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-CC--------
Confidence            99999998654322   1333456999999999999999999999999999999999999997542110 00        


Q ss_pred             hccccchh-Hhhcc--cccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          307 LKDFTKLD-QIIDS--RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       307 ~~~~~~~~-~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                          +.+. .+...  .++.+--..+++...++|+.+|..+|.+|.|+.+++.|
T Consensus       273 ----pgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  273 ----PGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             ----hhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence                0000 11111  11222234678889999999999999999999999987

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4e-38  Score=303.80  Aligned_cols=268  Identities=25%  Similarity=0.297  Sum_probs=198.8

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc--chHHHHHHHHHHHhcCCCCCcceeeeEEEeC-
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLKHPHLVNLIGYCCED-  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-  154 (449)
                      .++|++.+.||+|+||.||+|.+..      +++.||+|++.....  .....+.+|+.++++++|+||+++++++... 
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTT------SGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH   79 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECC------CCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC
Confidence            3679999999999999999998765      578999999874422  1223466899999999999999999998764 


Q ss_pred             -CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          155 -EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       155 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                       +..++||||+. ++|.+++... ...+++..+..++.|++.||.|||  ..|++||||||+||+++.++.++|+|||++
T Consensus        80 ~~~~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~kL~dfg~~  155 (309)
T cd07845          80 LDSIFLVMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLH--ENFIIHRDLKVSNLLLTDKGCLKIADFGLA  155 (309)
T ss_pred             CCeEEEEEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCCEEECcccee
Confidence             56899999997 5888887653 357899999999999999999999  778999999999999999999999999999


Q ss_pred             cCCCCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhh-h-hhhccc
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA-R-PMLKDF  310 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~-~-~~~~~~  310 (449)
                      .........  .....+++.|+|||.+.+ ..++.++|||||||++|||++|.+||...........+... . +....+
T Consensus       156 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
T cd07845         156 RTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW  233 (309)
T ss_pred             eecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence            865432211  122345788999999865 46799999999999999999999999765432221111100 0 000000


Q ss_pred             cchhHhh---ccccc-cc------CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          311 TKLDQII---DSRLE-DR------YSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       311 ~~~~~~~---~~~~~-~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .......   ..... ..      .....++.+.++|.+||+.||++|||+.+++.|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0000000   00000 00      001235678899999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4.6e-38  Score=306.01  Aligned_cols=263  Identities=20%  Similarity=0.308  Sum_probs=195.4

Q ss_pred             cccccc--CceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc--chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEE
Q 013105           85 DYLGEG--GFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLV  160 (449)
Q Consensus        85 ~~lG~G--~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  160 (449)
                      ..||+|  +||+||+|.+..      +++.||+|++.....  ...+.+.+|+.+++.++||||+++++++..++..++|
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v   77 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTP------TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVI   77 (328)
T ss_pred             HHhCCcccCceeEEEEEEcC------CCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEE
Confidence            457776  999999997755      589999999875432  2346678899999999999999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCC
Q 013105          161 YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGE  240 (449)
Q Consensus       161 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~  240 (449)
                      |||+.+++|.+++.......+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.++++||+.+.......
T Consensus        78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH--~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~  155 (328)
T cd08226          78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH--QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG  155 (328)
T ss_pred             EecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccC
Confidence            99999999999987765567899999999999999999999  7889999999999999999999999998654321111


Q ss_pred             CC-c----eeeecCCCCccccccccccC--CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhh-hhcc---
Q 013105          241 DS-H----ITTCVMGTEGYAAPEYINTG--HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARP-MLKD---  309 (449)
Q Consensus       241 ~~-~----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~---  309 (449)
                      .. .    ......++..|+|||++.+.  .++.++|||||||++|||++|..||.........  ...... ....   
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~  233 (328)
T cd08226         156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSPLDI  233 (328)
T ss_pred             ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCCCCccc
Confidence            00 0    00112356679999999753  4789999999999999999999999764321111  000000 0000   


Q ss_pred             --c-----------cchh--------------HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          310 --F-----------TKLD--------------QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       310 --~-----------~~~~--------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                        .           ....              ..............++..+.+|+.+||+.||++|||+.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence              0           0000              0000011112234567789999999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-38  Score=305.65  Aligned_cols=271  Identities=21%  Similarity=0.278  Sum_probs=199.0

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceeeeEEEeC--
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLIGYCCED--  154 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--  154 (449)
                      +|.+.+.||+|+||.||+|.....    ..+..||+|.+....   ......+.+|+.++..++||||+++++++.+.  
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~----~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   76 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNG----KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHAD   76 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCC----CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCC
Confidence            478889999999999999987541    247899999997532   33345678899999999999999999999988  


Q ss_pred             CEEEEEEEecCCCChHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC----CCcEEE
Q 013105          155 EHRLLVYEYMALGNLHDQLFKN---YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS----DYNAKL  227 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~----~~~~kl  227 (449)
                      ...++||||+. ++|.+.+...   ....++...+..++.|++.||.|||  .++|+||||||+|||++.    ++.+||
T Consensus        77 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~h~dlkp~Nil~~~~~~~~~~~kl  153 (316)
T cd07842          77 KSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH--SNWVLHRDLKPANILVMGEGPERGVVKI  153 (316)
T ss_pred             ceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH--hCCEeeCCCCHHHEEEcCCCCccceEEE
Confidence            88999999997 5777766432   2236889999999999999999999  778999999999999999    899999


Q ss_pred             eeeccccCCCCCCC-CceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccch-------h
Q 013105          228 SDFGLATDGPQGED-SHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREK-------D  298 (449)
Q Consensus       228 ~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~-------~  298 (449)
                      +|||++........ ........++..|+|||++.+ ..++.++|||||||++|+|++|.+||.........       .
T Consensus       154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
T cd07842         154 GDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ  233 (316)
T ss_pred             CCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence            99999986543222 111223457899999998865 45789999999999999999999999865432200       0


Q ss_pred             hHHhhhhhh----------ccccchhHhhcccccccCC---------H--HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          299 LVEWARPML----------KDFTKLDQIIDSRLEDRYS---------T--EGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       299 ~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~---------~--~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      +......+.          .................++         .  ..+..+.+++.+||+.||++|||+.+++.+
T Consensus       234 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         234 LERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            000000000          0000000000000000111         0  234568899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.8e-38  Score=295.91  Aligned_cols=249  Identities=24%  Similarity=0.356  Sum_probs=205.3

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      +|++.+.||+|+||.||++....      +++.+|+|.+....  ......+.+|+.+++.++|+||+++++++.+....
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLS------DNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKL   74 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECC------CCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEE
Confidence            47888999999999999997765      47899999987532  23345678899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          158 LLVYEYMALGNLHDQLFKN--YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ++||||+++++|.+++...  ....+++..+..++.+++.||.|||  +.|++|+||+|+||+++.++.++|+|||++..
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh--~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~  152 (256)
T cd08530          75 CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH--EQKILHRDLKSANILLVANDLVKIGDLGISKV  152 (256)
T ss_pred             EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCcceEEEecCCcEEEeeccchhh
Confidence            9999999999999988652  2356888999999999999999999  78899999999999999999999999999986


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ....    ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.......   +.              .
T Consensus       153 ~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~--------------~  211 (256)
T cd08530         153 LKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LR--------------Y  211 (256)
T ss_pred             hccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH--------------H
Confidence            5443    1223458899999999988889999999999999999999999997543211   00              0


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .+........+...+.++.+++.+||+.+|++||++.+++++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         212 KVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             HHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            011111222334567789999999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=8.6e-38  Score=302.66  Aligned_cols=252  Identities=29%  Similarity=0.413  Sum_probs=199.7

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc---chHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS---QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      +.|...+.||+|+||.||+|.+..      ++..||+|.+.....   .....+.+|+.+++.++|||++++++++.+++
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   98 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVR------TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH   98 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcC------CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence            347778899999999999998765      478999999864322   23456888999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..++||||+. |+|.+.+... ...+++..+..++.+++.||.|||  +.+|+||||+|+||+++.++.++|+|||++..
T Consensus        99 ~~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH--~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~  174 (317)
T cd06635          99 TAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLADFGSASI  174 (317)
T ss_pred             eEEEEEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcccEEECCCCCEEEecCCCccc
Confidence            9999999997 5787776543 356899999999999999999999  77899999999999999999999999999875


Q ss_pred             CCCCCCCceeeecCCCCccccccccc---cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccc
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYIN---TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK  312 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  312 (449)
                      ...      .....|+..|+|||.+.   ...++.++|||||||++|||++|..||..........              
T Consensus       175 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~--------------  234 (317)
T cd06635         175 ASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--------------  234 (317)
T ss_pred             cCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH--------------
Confidence            432      22345889999999873   4568899999999999999999999986532111100              


Q ss_pred             hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccc
Q 013105          313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL  362 (449)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  362 (449)
                        .+.............+..+.+++.+||+.+|.+||++.++++++..+.
T Consensus       235 --~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         235 --HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             --HHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence              000111111112345567899999999999999999999999855443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.7e-38  Score=302.77  Aligned_cols=268  Identities=21%  Similarity=0.274  Sum_probs=199.6

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc--chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      ++|++.+.||+|++|.||+|.+..      +++.||+|.+.....  .....+.+|+.+++.++||||+++++++.+...
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRV------TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKR   75 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecC------CCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCe
Confidence            578899999999999999998765      478999999864422  233567889999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC-CCcEEEeeeccccC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS-DYNAKLSDFGLATD  235 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~-~~~~kl~DfGla~~  235 (449)
                      .++||||+. ++|.+.+.......+++.....++.|++.||.|||  +++++|+||+|+||+++. ++.+||+|||++..
T Consensus        76 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH--~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~  152 (294)
T PLN00009         76 LYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH--SHRVLHRDLKPQNLLIDRRTNALKLADFGLARA  152 (294)
T ss_pred             EEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCcceEEEECCCCEEEEcccccccc
Confidence            999999996 68888876654455678888899999999999999  778999999999999985 45799999999975


Q ss_pred             CCCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhH-Hh-hhh---hhcc
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV-EW-ARP---MLKD  309 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~-~~-~~~---~~~~  309 (449)
                      .....  .......|++.|+|||.+.+ ..++.++|||||||++|+|++|.+||............ .. ..+   .+..
T Consensus       153 ~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (294)
T PLN00009        153 FGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG  230 (294)
T ss_pred             cCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence            43321  11233457899999998865 45789999999999999999999999764322111100 00 000   0000


Q ss_pred             ccchhHhhcc--ccc----ccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          310 FTKLDQIIDS--RLE----DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       310 ~~~~~~~~~~--~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ...+......  ...    .......++.+.+++.+||+.+|++||++.+++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000000000  000    00122345668999999999999999999999986

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=6.1e-38  Score=298.15  Aligned_cols=260  Identities=21%  Similarity=0.254  Sum_probs=195.5

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCC-CCCcceeeeEEEeC--CE
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLK-HPHLVNLIGYCCED--EH  156 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~--~~  156 (449)
                      |++.+.||+|+||.||+|....      ++..||+|.+.... ........+|+.++.++. |+||+++++++.+.  +.
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~------~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   74 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRK------TGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGR   74 (282)
T ss_pred             CceEeeccccccceEEEEEEcC------CCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCc
Confidence            6778899999999999998765      47889999987432 222334567899999885 99999999999987  89


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||+. ++|.+.+... ...+++..+..++.|++.||.|||  ..+++||||+|+||+++. +.+||+|||++...
T Consensus        75 ~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH--~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~  149 (282)
T cd07831          75 LALVFELMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMH--RNGIFHRDIKPENILIKD-DILKLADFGSCRGI  149 (282)
T ss_pred             EEEEEecCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH--HCCceecccCHHHEEEcC-CCeEEEeccccccc
Confidence            999999997 6888877653 257899999999999999999999  778999999999999999 99999999999865


Q ss_pred             CCCCCCceeeecCCCCccccccccc-cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccc-cchh
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYIN-TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF-TKLD  314 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~  314 (449)
                      .....   .....++..|+|||.+. +..++.++|||||||++|||++|.+||.+.......   .......... ..+.
T Consensus       150 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~  223 (282)
T cd07831         150 YSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQI---AKIHDVLGTPDAEVL  223 (282)
T ss_pred             ccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHH---HHHHHHcCCCCHHHH
Confidence            43221   12345789999999764 455788999999999999999999999765332111   1110000000 0000


Q ss_pred             Hhhc------cccc-------ccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          315 QIID------SRLE-------DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       315 ~~~~------~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ....      ....       .......+..+.+++.+||+.||++||++.+++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         224 KKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             HhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            0000      0000       01122456789999999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=6.1e-38  Score=298.54  Aligned_cols=267  Identities=23%  Similarity=0.320  Sum_probs=201.1

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      +|++.+.||.|++|.||+|.+..      ++..||||++..... .....+.+|+.+++.++|+||+++++++.+.+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   74 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRT------TGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLM   74 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECC------CCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEE
Confidence            58889999999999999998765      478999999975532 23456778999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          159 LVYEYMALGNLHDQLFKNY-SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      +||||+. ++|.+++.... ...+++..+..++.|++.||.|||  ..+++|+||||+||+++.++.++|+|||++....
T Consensus        75 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~  151 (284)
T cd07836          75 LVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH--ENRVLHRDLKPQNLLINKRGELKLADFGLARAFG  151 (284)
T ss_pred             EEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence            9999998 58888876542 246899999999999999999999  6789999999999999999999999999997543


Q ss_pred             CCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhh-HHhh-hhhhccccch-
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDL-VEWA-RPMLKDFTKL-  313 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~-~~~~-~~~~~~~~~~-  313 (449)
                      ....  ......++..|++||.+.+ ..++.++|||||||++|+|++|..||.+......... .... .+....+..+ 
T Consensus       152 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07836         152 IPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS  229 (284)
T ss_pred             CCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence            3211  1223457889999998865 3578899999999999999999999976532211111 0000 0000000000 


Q ss_pred             --hHhhcc------cccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          314 --DQIIDS------RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       314 --~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                        ......      .....+.+..+..+.+++.+||+.||.+||++.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence              000000      00011122346678999999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=334.65  Aligned_cols=258  Identities=22%  Similarity=0.280  Sum_probs=210.6

Q ss_pred             HHHHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEecc---CCcchHHHHHHHHHHHhcCCCCCcceee
Q 013105           72 KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDV---NGSQGHREWLAEVIFLGQLKHPHLVNLI  148 (449)
Q Consensus        72 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~~~  148 (449)
                      .++..-.++|.+.++||+|+||.|.++..+.      +++.||+|+++.   -......-|..|-.+|..-+.+=|+.++
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~------t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lh  141 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKS------TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLH  141 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeec------cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHH
Confidence            4555567899999999999999999997665      689999999975   2344456688888999988899999999


Q ss_pred             eEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEe
Q 013105          149 GYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLS  228 (449)
Q Consensus       149 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~  228 (449)
                      ..|+++.++|+|||||+||+|..++.+..  .+|+..+.-++..|+.||.-||  ..|+|||||||+|||||..|++||+
T Consensus       142 yAFQD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH--~mgyVHRDiKPDNvLld~~GHikLA  217 (1317)
T KOG0612|consen  142 YAFQDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLH--SMGYVHRDIKPDNVLLDKSGHIKLA  217 (1317)
T ss_pred             HHhcCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHH--hccceeccCCcceeEecccCcEeec
Confidence            99999999999999999999999997752  7999999999999999999999  7889999999999999999999999


Q ss_pred             eeccccCCCCCCCCceeeecCCCCccccccccc----c-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhh
Q 013105          229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN----T-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA  303 (449)
Q Consensus       229 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~  303 (449)
                      |||.+...... ........+|||.|.+||++.    + +.|++.+|+||+||++|||+.|..||..........     
T Consensus       218 DFGsClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~-----  291 (1317)
T KOG0612|consen  218 DFGSCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYG-----  291 (1317)
T ss_pred             cchhHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHH-----
Confidence            99998876532 233345578999999999983    3 579999999999999999999999998653222211     


Q ss_pred             hhhhccccchhHhhcccccccCC--HHHHHHHHHHHHHhccCCCCCCCC---HHHHHHH
Q 013105          304 RPMLKDFTKLDQIIDSRLEDRYS--TEGAKRLAAVAHQCLSHNPKSRPT---MTTVVKA  357 (449)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs---~~eil~~  357 (449)
                       ..+          +-.-.-.+|  ..++.+..+||...+. +|+.|..   ++++-.|
T Consensus       292 -KIm----------~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  292 -KIM----------NHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             -HHh----------chhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence             111          111111122  3467789999999876 6888887   9999887

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4e-38  Score=301.57  Aligned_cols=268  Identities=21%  Similarity=0.252  Sum_probs=197.7

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCC-CCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLK-HPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~  155 (449)
                      ++|++.+.||+|+||.||+|.+..      +++.||+|.+....  ......+.+|+.+++.+. ||||+++++++...+
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~------~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   74 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKN------TGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEE   74 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECC------CCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence            468899999999999999998765      47899999986542  223356788999999995 699999999998766


Q ss_pred             E-----EEEEEEecCCCChHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC-CCcEE
Q 013105          156 H-----RLLVYEYMALGNLHDQLFKNY---SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS-DYNAK  226 (449)
Q Consensus       156 ~-----~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~-~~~~k  226 (449)
                      .     .|+||||+.+ +|.+++....   ...+++..+..++.|++.||.|||  .++|+||||||+||+++. ++.++
T Consensus        75 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH--~~~i~H~dl~~~nil~~~~~~~~k  151 (295)
T cd07837          75 KNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH--KHGVMHRDLKPQNLLVDKQKGLLK  151 (295)
T ss_pred             CCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCChHHEEEecCCCeEE
Confidence            5     8999999984 8888876532   246799999999999999999999  778999999999999998 88999


Q ss_pred             EeeeccccCCCCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchh-hHHhhh
Q 013105          227 LSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKD-LVEWAR  304 (449)
Q Consensus       227 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~-~~~~~~  304 (449)
                      |+|||++........  ......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+........ ......
T Consensus       152 l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~  229 (295)
T cd07837         152 IADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG  229 (295)
T ss_pred             EeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence            999999875432211  1122347889999998854 457899999999999999999999997643221110 000000


Q ss_pred             -hhhccccch---hHhhc-c----cccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          305 -PMLKDFTKL---DQIID-S----RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       305 -~~~~~~~~~---~~~~~-~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       +....+...   ..... .    .......+..+..+.++|.+||+.||.+||++.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence             000000000   00000 0    00001112356678999999999999999999999976

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=9.5e-38  Score=300.93  Aligned_cols=270  Identities=23%  Similarity=0.292  Sum_probs=197.5

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      .++|++.+.||+|+||.||+|....      +++.||||.+....  ......+.+|+.++++++||||+++++++....
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   84 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKK------TKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA   84 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECC------CCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence            3579999999999999999997765      57899999986432  222345678999999999999999999987653


Q ss_pred             --------EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEE
Q 013105          156 --------HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKL  227 (449)
Q Consensus       156 --------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl  227 (449)
                              ..++||||+. ++|.+.+... ...+++.++..++.|++.||.|||  +++++|+||||+||+++.++.+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH--~~~i~H~dl~p~nil~~~~~~~kl  160 (310)
T cd07865          85 TPYNRYKGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIH--RNKILHRDMKAANILITKDGILKL  160 (310)
T ss_pred             ccccCCCceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEECCCCcEEE
Confidence                    4599999996 5887777543 346899999999999999999999  678999999999999999999999


Q ss_pred             eeeccccCCCCCCCC--ceeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhh
Q 013105          228 SDFGLATDGPQGEDS--HITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR  304 (449)
Q Consensus       228 ~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~  304 (449)
                      +|||++.........  .......++..|+|||.+.+. .++.++||||||+++|||++|.+||...........+....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~  240 (310)
T cd07865         161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC  240 (310)
T ss_pred             CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            999999755332211  112234578899999988654 47889999999999999999999997654332222211111


Q ss_pred             h-----hhccccchhHhhcccccccC---------CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          305 P-----MLKDFTKLDQIIDSRLEDRY---------STEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       305 ~-----~~~~~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .     ...........-........         ....+..+.++|.+||..||.+|||+.++++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            0     00000000000000000000         00123457899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-38  Score=291.74  Aligned_cols=249  Identities=31%  Similarity=0.450  Sum_probs=205.4

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc--chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      +|++.+.||+|++|.||+|....      .++.|++|.+.....  .....+.+|++++.+++|+|++++++++.+.+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLE------TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSL   74 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcC------CCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Confidence            47888999999999999998765      468899999975543  3456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      +++|||+.+++|.+++...  ..+++..+..++.|++.+|.|||  +.||+|+||+|+||+++.++.++|+|||++....
T Consensus        75 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  150 (254)
T cd06627          75 YIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLH--EQGVIHRDIKAANILTTKDGVVKLADFGVATKLN  150 (254)
T ss_pred             EEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCHHHEEECCCCCEEEeccccceecC
Confidence            9999999999999998765  57899999999999999999999  7789999999999999999999999999998665


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII  317 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (449)
                      .....  .....|+..|+|||.+.+..++.++||||||+++|+|++|..||........  ...              ..
T Consensus       151 ~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~--~~~--------------~~  212 (254)
T cd06627         151 DVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA--LFR--------------IV  212 (254)
T ss_pred             CCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH--HHH--------------Hh
Confidence            43321  2334589999999999877789999999999999999999999975321100  000              00


Q ss_pred             cccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          318 DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       318 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       .......+...+..+.+++.+||..+|++|||+.+++.+
T Consensus       213 -~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         213 -QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             -ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence             011122333456679999999999999999999999865

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=6.9e-38  Score=299.74  Aligned_cols=246  Identities=24%  Similarity=0.372  Sum_probs=197.8

Q ss_pred             cccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEEEe
Q 013105           84 SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEY  163 (449)
Q Consensus        84 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  163 (449)
                      ...||+|+||.||++....      ++..||+|.+..........+.+|+.+++.++|+||+++++.+...+..++||||
T Consensus        25 ~~~lg~g~~g~v~~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   98 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKS------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF   98 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcC------CCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence            3579999999999997765      5789999998755444556788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCCc
Q 013105          164 MALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSH  243 (449)
Q Consensus       164 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~~  243 (449)
                      +++++|.+++..   ..+++.....++.|++.+|+|||  +.|++|+||+|+||+++.++.++|+|||++........  
T Consensus        99 ~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH--~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--  171 (292)
T cd06657          99 LEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--  171 (292)
T ss_pred             CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--
Confidence            999999987743   35788999999999999999999  67899999999999999999999999999875433211  


Q ss_pred             eeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccccc
Q 013105          244 ITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLED  323 (449)
Q Consensus       244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (449)
                      ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||............   ..   .       .....  
T Consensus       172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~---~~---~-------~~~~~--  236 (292)
T cd06657         172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RD---N-------LPPKL--  236 (292)
T ss_pred             cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hh---h-------CCccc--
Confidence            123345899999999998888899999999999999999999999754221111100   00   0       00000  


Q ss_pred             cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          324 RYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       324 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ......+..+.+++.+||+.||.+||++.+++.+
T Consensus       237 ~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         237 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            0112345568899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.6e-37  Score=293.31  Aligned_cols=250  Identities=24%  Similarity=0.293  Sum_probs=194.8

Q ss_pred             HHHHHhcCCCCcccc--cccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcC-CCCCcceeee
Q 013105           73 ELQMITHNFSRSDYL--GEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL-KHPHLVNLIG  149 (449)
Q Consensus        73 ~~~~~~~~y~~~~~l--G~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~  149 (449)
                      +.....++|.+.+.+  |+|+||.||++....      ++..+|+|++........     |+.....+ +||||+++++
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~------~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~   76 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKP------TQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYY   76 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEEcC------CCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEE
Confidence            334455678887776  999999999997655      578899999864322111     22222222 6999999999


Q ss_pred             EEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC-cEEEe
Q 013105          150 YCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY-NAKLS  228 (449)
Q Consensus       150 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~-~~kl~  228 (449)
                      .+...+..++||||+++++|.+++...  ..+++..+..++.|++.||.|||  +.|++||||||+||+++.++ .++|+
T Consensus        77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~~l~  152 (267)
T PHA03390         77 SVTTLKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLH--KHNIIHNDIKLENVLYDRAKDRIYLC  152 (267)
T ss_pred             EEecCCeeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEEeCCCCeEEEe
Confidence            999999999999999999999998765  38899999999999999999999  77899999999999999998 99999


Q ss_pred             eeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhc
Q 013105          229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK  308 (449)
Q Consensus       229 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  308 (449)
                      |||++......      ....|+..|+|||++.+..++.++|||||||++|+|++|..||...... ......+...   
T Consensus       153 dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~---  222 (267)
T PHA03390        153 DYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKR---  222 (267)
T ss_pred             cCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHh---
Confidence            99998754322      2245899999999998888999999999999999999999999743221 1111111110   


Q ss_pred             cccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHH
Q 013105          309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT-MTTVVKA  357 (449)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~~  357 (449)
                              ..  .........+..+.+++.+||+.||.+||+ ++++++|
T Consensus       223 --------~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        223 --------QQ--KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             --------hc--ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence                    00  111223356677999999999999999996 6999976

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.2e-37  Score=295.86  Aligned_cols=243  Identities=26%  Similarity=0.367  Sum_probs=189.1

Q ss_pred             cccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc---chHHHHHHHH---HHHhcCCCCCcceeeeEEEeCCEEEE
Q 013105           86 YLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS---QGHREWLAEV---IFLGQLKHPHLVNLIGYCCEDEHRLL  159 (449)
Q Consensus        86 ~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~h~nIv~~~~~~~~~~~~~l  159 (449)
                      .||+|+||.||+|....      +++.||+|.+.....   .....+..|.   ..+....||||+.+++++...+..++
T Consensus         1 ~ig~g~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~   74 (278)
T cd05606           1 IIGRGGFGEVYGCRKAD------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF   74 (278)
T ss_pred             CcccCCCeEEEEEEEec------CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEE
Confidence            48999999999997654      578999999864321   1112233343   34455679999999999999999999


Q ss_pred             EEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCC
Q 013105          160 VYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQG  239 (449)
Q Consensus       160 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~  239 (449)
                      ||||+.||+|.+++...  ..+++..+..++.|++.||.|||  +.+|+||||||+||+++.++.++|+|||++......
T Consensus        75 v~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~  150 (278)
T cd05606          75 ILDLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  150 (278)
T ss_pred             EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc
Confidence            99999999999888654  57899999999999999999999  678999999999999999999999999998754332


Q ss_pred             CCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhc
Q 013105          240 EDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIID  318 (449)
Q Consensus       240 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (449)
                      .    .....|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||..............              . 
T Consensus       151 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~--------------~-  211 (278)
T cd05606         151 K----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM--------------T-  211 (278)
T ss_pred             C----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH--------------h-
Confidence            1    223468999999999864 4689999999999999999999999976422111111000              0 


Q ss_pred             ccccccCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013105          319 SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRP-----TMTTVVKA  357 (449)
Q Consensus       319 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  357 (449)
                      .......+...+..+.+++.+||..+|.+||     ++.+++++
T Consensus       212 ~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         212 LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             hccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            0011122333466799999999999999999     99999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=265.32  Aligned_cols=266  Identities=22%  Similarity=0.311  Sum_probs=205.3

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc--chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      +|...+.||+|.||+||+|...+      +++.||+|.++.++.  ......++|+-+|+.++|.|||+++++...+..+
T Consensus         3 ~ydkmekigegtygtvfkarn~~------t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkl   76 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRE------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKL   76 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCC------ccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCcee
Confidence            45667889999999999996655      689999999976532  2345688999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      -+|+|||. -+|..++.. .++.+.......++.|+++||.++|  .++++|||+||.|+||+.+|.+||+|||+++.+.
T Consensus        77 tlvfe~cd-qdlkkyfds-lng~~d~~~~rsfmlqllrgl~fch--shnvlhrdlkpqnllin~ngelkladfglarafg  152 (292)
T KOG0662|consen   77 TLVFEFCD-QDLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCH--SHNVLHRDLKPQNLLINRNGELKLADFGLARAFG  152 (292)
T ss_pred             EEeHHHhh-HHHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhh--hhhhhhccCCcceEEeccCCcEEecccchhhhcC
Confidence            99999996 677776643 4578899999999999999999999  4559999999999999999999999999999765


Q ss_pred             CCCCCceeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhh--hhhhccccch
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWA--RPMLKDFTKL  313 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~  313 (449)
                      ...  ......+-|.+|++|.++.|. -|+...|+||.||++.|+.. |++.|.+.+..+....+-+.  .+....++.+
T Consensus       153 ipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~  230 (292)
T KOG0662|consen  153 IPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSM  230 (292)
T ss_pred             Cce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcc
Confidence            432  123334579999999998765 58999999999999999986 77778776554443333222  1222233333


Q ss_pred             hHhhcccccccC---------CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          314 DQIIDSRLEDRY---------STEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       314 ~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .++.+-...+-+         .+.....-+++++++|.-+|..|.++++.+++
T Consensus       231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            333222221212         12333345789999999999999999999987

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.1e-38  Score=308.40  Aligned_cols=268  Identities=23%  Similarity=0.313  Sum_probs=200.9

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      +.++|.+.+.||+|+||.||+|....      ++..||||.+...  .......+.+|+.+++.++|+||+++++++...
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~   76 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSE------TNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPP   76 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecC------CCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecc
Confidence            34679999999999999999997754      5889999998643  233345677899999999999999999987654


Q ss_pred             -----CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEee
Q 013105          155 -----EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSD  229 (449)
Q Consensus       155 -----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~D  229 (449)
                           ...|+||||+. ++|.+++...  ..+++.....++.|++.||.|||  .++++||||||+||+++.++.+||+|
T Consensus        77 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH--~~~i~H~dlkp~Nil~~~~~~~kL~D  151 (337)
T cd07858          77 HREAFNDVYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIH--SANVLHRDLKPSNLLLNANCDLKICD  151 (337)
T ss_pred             cccccCcEEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCCCEEECc
Confidence                 35799999996 7898888654  57899999999999999999999  77899999999999999999999999


Q ss_pred             eccccCCCCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhh-hhhh
Q 013105          230 FGLATDGPQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA-RPML  307 (449)
Q Consensus       230 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~-~~~~  307 (449)
                      ||++.......  .......|+..|+|||.+.. ..++.++|||||||++|+|++|++||.+............. ....
T Consensus       152 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  229 (337)
T cd07858         152 FGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPS  229 (337)
T ss_pred             CccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            99998654321  11233457899999998854 46899999999999999999999999764322111111000 0000


Q ss_pred             -cc-----ccchhHhhcc---ccc---ccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          308 -KD-----FTKLDQIIDS---RLE---DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       308 -~~-----~~~~~~~~~~---~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       ..     .......+..   ...   ......++..+.+++.+||+.||++|||+.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         230 EEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence             00     0000000000   000   01122456778999999999999999999999998

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=4.6e-38  Score=306.78  Aligned_cols=269  Identities=20%  Similarity=0.304  Sum_probs=201.2

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEe--
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCE--  153 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--  153 (449)
                      .++|++.+.||.|+||.||+|....      ++..||+|++....  ......+.+|+.+|+.++||||+++++++..  
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   77 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTR------SGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG   77 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcC------CCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC
Confidence            4789999999999999999997765      57899999987432  2344667889999999999999999998753  


Q ss_pred             --CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeec
Q 013105          154 --DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFG  231 (449)
Q Consensus       154 --~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfG  231 (449)
                        ....++||||+. ++|.+++...  ..+++.....++.|++.||.|||  .++|+||||||+||+++.++.+||+|||
T Consensus        78 ~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~Nil~~~~~~~kl~dfg  152 (334)
T cd07855          78 ADFKDVYVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIH--SANVIHRDLKPSNLLVNEDCELRIGDFG  152 (334)
T ss_pred             CCCceEEEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCcEEecccc
Confidence              357899999996 6888887654  45899999999999999999999  6789999999999999999999999999


Q ss_pred             cccCCCCCCC--CceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhh---
Q 013105          232 LATDGPQGED--SHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARP---  305 (449)
Q Consensus       232 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~---  305 (449)
                      ++........  ........|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.....   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~  232 (334)
T cd07855         153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS  232 (334)
T ss_pred             cceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCCh
Confidence            9875433221  111223468999999999855 4689999999999999999999999976533221111100000   


Q ss_pred             --hhccc--cchhHhhcc-ccc-----ccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          306 --MLKDF--TKLDQIIDS-RLE-----DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       306 --~~~~~--~~~~~~~~~-~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                        .....  ..+...... ...     .......+.++.+++..||+.+|.+||++.+++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence              00000  000000000 000     01123346779999999999999999999999987

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-39  Score=297.21  Aligned_cols=242  Identities=28%  Similarity=0.388  Sum_probs=200.7

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcC-CCCCcceeeeEEEe
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCE  153 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~  153 (449)
                      ..+|..+.+||+|+||.|.+|..+.      +.+.+|||+++.+   ...+.+--+.|-++|... +-|.+++++.+|++
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkg------tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT  421 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKG------TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT  421 (683)
T ss_pred             ecccceEEEeccCccceeeeecccC------cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh
Confidence            4578899999999999999996554      6889999999754   223333345677888776 57899999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      -+.+|+||||+.||+|--.++.-  +.+.+..+.-++..|+.||-+||  ++|||+||||.+|||++.+|++||+|||++
T Consensus       422 mDRLyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh--~kgIiYRDLKLDNvmLd~eGHiKi~DFGmc  497 (683)
T KOG0696|consen  422 MDRLYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDSEGHIKIADFGMC  497 (683)
T ss_pred             hhheeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhh--cCCeeeeeccccceEeccCCceEeeecccc
Confidence            99999999999999998877664  56667778888999999999999  889999999999999999999999999999


Q ss_pred             cCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccch
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      .......  ..+.+++|||.|+|||++...+|+.++|+||+||+|||||.|++||++.+...   +..            
T Consensus       498 KEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e---lF~------------  560 (683)
T KOG0696|consen  498 KENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQ------------  560 (683)
T ss_pred             cccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHH------------
Confidence            8655433  33566789999999999999999999999999999999999999999864321   111            


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCC
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRP  349 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  349 (449)
                       .+.+  ..-.|+..++.+..+++...|.+.|.+|.
T Consensus       561 -aI~e--hnvsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  561 -AIME--HNVSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             -HHHH--ccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence             1111  12346778888999999999999999994

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-38  Score=297.35  Aligned_cols=269  Identities=27%  Similarity=0.421  Sum_probs=203.9

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhc--CCCCCcceeeeEEEeCC---
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ--LKHPHLVNLIGYCCEDE---  155 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~~~~~~~~~~---  155 (449)
                      ..+.++||+|.||.||+|.+.        ++.||||++..   ...+.|.+|-.|...  ++|+||++++++-....   
T Consensus       212 l~l~eli~~Grfg~V~KaqL~--------~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~  280 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLD--------NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR  280 (534)
T ss_pred             hhhHHHhhcCccceeehhhcc--------CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence            445678999999999999775        47999999963   345677788777766  47999999999876555   


Q ss_pred             -EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-------CCCCeeeccCCCCceEEcCCCcEEE
Q 013105          156 -HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG-------EEKPVIYRDFKASNILLDSDYNAKL  227 (449)
Q Consensus       156 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-------~~~~ivHrDikp~Nill~~~~~~kl  227 (449)
                       .++||++|.+.|+|.++|..+   .++|....+++..+++||+|||.       ++.+|+|||||..||||..|+++.|
T Consensus       281 ~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI  357 (534)
T KOG3653|consen  281 MEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI  357 (534)
T ss_pred             cceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence             899999999999999999875   89999999999999999999996       3568999999999999999999999


Q ss_pred             eeeccccCCCCCCCCceeeecCCCCccccccccccCC-CC-----cccchhhhHHHHHHHHhCCCcccc-cccccchhhH
Q 013105          228 SDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGH-LT-----TMCDVFSFGVVLLELLTGRRSVEK-NRCKREKDLV  300 (449)
Q Consensus       228 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwslG~vl~elltg~~pf~~-~~~~~~~~~~  300 (449)
                      +|||||..+..+.........+||..|||||++.+.- +.     .+.||||+|.|||||++...-+.. .......-+.
T Consensus       358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe  437 (534)
T KOG3653|consen  358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE  437 (534)
T ss_pred             eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence            9999999887766555555688999999999997642 22     368999999999999996654432 1100000000


Q ss_pred             HhhhhhhccccchhH----hhcccccccCCHH-----HHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCCCC
Q 013105          301 EWARPMLKDFTKLDQ----IIDSRLEDRYSTE-----GAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDI  367 (449)
Q Consensus       301 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~-----~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~  367 (449)
                          ..+...+.+++    .+....++.++..     ...-+.+.+..||+.||+.|.|+.=+-+.+..+....+.
T Consensus       438 ----~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~  509 (534)
T KOG3653|consen  438 ----AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED  509 (534)
T ss_pred             ----HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence                01111122221    1222223333322     245688999999999999999999888888777655443

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=292.30  Aligned_cols=242  Identities=24%  Similarity=0.275  Sum_probs=187.6

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc---chHHHHHHHHHHH-hcCCCCCcceeeeEEEeCCEEEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS---QGHREWLAEVIFL-GQLKHPHLVNLIGYCCEDEHRLLV  160 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~nIv~~~~~~~~~~~~~lv  160 (449)
                      +.||+|+||.||+|....      .++.||+|++.....   .....+..|..++ ...+|+||+++++++..++..|+|
T Consensus         2 ~~l~~g~~~~v~~a~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   75 (260)
T cd05611           2 KPISKGAFGSVYLAKKRS------TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLV   75 (260)
T ss_pred             ccCCcCCCeeEEEEEecC------CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEE
Confidence            569999999999997765      478999999864321   1223344555444 455899999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCC
Q 013105          161 YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGE  240 (449)
Q Consensus       161 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~  240 (449)
                      |||+.+++|.+++...  ..+++..+..++.|++.||.|||  ..+++|+||+|+||+++.++.++|+|||++.....  
T Consensus        76 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--  149 (260)
T cd05611          76 MEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLH--QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--  149 (260)
T ss_pred             EeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCcEEEeecccceeccc--
Confidence            9999999999988654  56889999999999999999999  67899999999999999999999999999875432  


Q ss_pred             CCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhccc
Q 013105          241 DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSR  320 (449)
Q Consensus       241 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (449)
                          .....|+..|+|||.+.+..++.++||||||+++|+|++|..||..........      .....        ...
T Consensus       150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~--------~~~  211 (260)
T cd05611         150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFD------NILSR--------RIN  211 (260)
T ss_pred             ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHH------HHHhc--------ccC
Confidence                223458899999999988888999999999999999999999997543211100      00000        000


Q ss_pred             ccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013105          321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK  356 (449)
Q Consensus       321 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  356 (449)
                      ........++..+.+++.+||+.||++||++.++.+
T Consensus       212 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~  247 (260)
T cd05611         212 WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE  247 (260)
T ss_pred             CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence            111122245677999999999999999997654433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-39  Score=288.66  Aligned_cols=258  Identities=23%  Similarity=0.344  Sum_probs=200.0

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC-CCCcceeeeEEEeCCEEEEEEEe
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-HPHLVNLIGYCCEDEHRLLVYEY  163 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e~  163 (449)
                      +.||+|+|+.|-.+....      ++..||||+++....-...++.+|++++.+.+ |+||+.++++|++++..|||||-
T Consensus        84 e~LGeGAyasVqtcv~i~------t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEK  157 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQ------TGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEK  157 (463)
T ss_pred             HHhcCccceeeeeeeeec------cchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEec
Confidence            679999999998886554      68999999998776556678999999999996 99999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC---cEEEeeeccccCCCCCC
Q 013105          164 MALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY---NAKLSDFGLATDGPQGE  240 (449)
Q Consensus       164 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~---~~kl~DfGla~~~~~~~  240 (449)
                      |.||.|...|.++  ..+++.+...+...|+.||.|||  .+||.||||||+|||-..-.   -+|||||.|..-.....
T Consensus       158 m~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH--~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~  233 (463)
T KOG0607|consen  158 MRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLH--TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN  233 (463)
T ss_pred             ccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHh--hcCcccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence            9999999999876  68999999999999999999999  89999999999999996544   48999998876432222


Q ss_pred             C-----CceeeecCCCCccccccccc-----cCCCCcccchhhhHHHHHHHHhCCCccccccccc----chhhHHhhhhh
Q 013105          241 D-----SHITTCVMGTEGYAAPEYIN-----TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKR----EKDLVEWARPM  306 (449)
Q Consensus       241 ~-----~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~----~~~~~~~~~~~  306 (449)
                      .     .....+.+|+..|||||+..     ...|+.++|.||||+|||-||+|.+||.+.-..+    ..+.....+..
T Consensus       234 ~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~  313 (463)
T KOG0607|consen  234 DCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNK  313 (463)
T ss_pred             CCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHH
Confidence            1     11233467999999999862     3468999999999999999999999998652211    00000000000


Q ss_pred             hccccchhHhhcc--cccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          307 LKDFTKLDQIIDS--RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       307 ~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                           -++.+-+.  .+++.--..++.+..+++..+|..|+.+|.++..++.|
T Consensus       314 -----LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh  361 (463)
T KOG0607|consen  314 -----LFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH  361 (463)
T ss_pred             -----HHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence                 00000010  01111123567788999999999999999999999875

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-37  Score=294.87  Aligned_cols=266  Identities=23%  Similarity=0.330  Sum_probs=199.8

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeC--CE
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCED--EH  156 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~  156 (449)
                      |.+.+.||.|+||.||+|....      .++.+|+|++....  ......+.+|+.+++.++|+||+++++++...  +.
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKK------TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS   74 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECC------CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCc
Confidence            6678899999999999998765      47899999997552  33345688899999999999999999999888  89


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||+. ++|.+++... ...+++..+..++.|++.||.|||  ..+++|+||+|+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH--~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~  150 (287)
T cd07840          75 IYMVFEYMD-HDLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLH--SNGILHRDIKGSNILINNDGVLKLADFGLARPY  150 (287)
T ss_pred             EEEEecccc-ccHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCcHHHeEEcCCCCEEEccccceeec
Confidence            999999997 5888877553 257899999999999999999999  678999999999999999999999999999865


Q ss_pred             CCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhH-Hhhh-hhhccccch
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV-EWAR-PMLKDFTKL  313 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~-~~~~-~~~~~~~~~  313 (449)
                      ...... ......++..|+|||.+.+ ..++.++|||||||++|||++|..||............ .... +....+...
T Consensus       151 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07840         151 TKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV  229 (287)
T ss_pred             cCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccc
Confidence            443211 1223457889999998764 45789999999999999999999999765432211111 0000 000000000


Q ss_pred             hHh---hc--------ccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          314 DQI---ID--------SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       314 ~~~---~~--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ...   ..        ......+...++..+.+++.+||+.+|.+||++.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            000   00        000001111136678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.5e-37  Score=300.49  Aligned_cols=263  Identities=21%  Similarity=0.295  Sum_probs=195.3

Q ss_pred             CcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEE
Q 013105           83 RSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLV  160 (449)
Q Consensus        83 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  160 (449)
                      +.+.+|.|+++.|+++  ..      +++.||+|++...  .......+.+|+.+++.++|+||+++++++.+.+..+++
T Consensus         6 i~~~~~~~~~v~~~~~--~~------~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   77 (314)
T cd08216           6 IGKCFEDLMIVHLAKH--KP------TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVV   77 (314)
T ss_pred             hhHhhcCCceEEEEEe--cC------CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEE
Confidence            3444555555555554  22      5789999999754  334456788999999999999999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCC
Q 013105          161 YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGE  240 (449)
Q Consensus       161 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~  240 (449)
                      |||+.+|+|.+++.......+++.....++.|++.||.|||  +++|+||||||+||+++.++.++|+|||.+.......
T Consensus        78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH--~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~  155 (314)
T cd08216          78 SPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH--SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHG  155 (314)
T ss_pred             EeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCcceEEEecCCceEEecCccceeecccc
Confidence            99999999999998765667899999999999999999999  7789999999999999999999999999887443211


Q ss_pred             C-----CceeeecCCCCcccccccccc--CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhh----cc
Q 013105          241 D-----SHITTCVMGTEGYAAPEYINT--GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML----KD  309 (449)
Q Consensus       241 ~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~----~~  309 (449)
                      .     ........++..|+|||++.+  ..++.++|||||||++|||++|..||........  ..+......    ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~  233 (314)
T cd08216         156 KRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDK  233 (314)
T ss_pred             ccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCcccccc
Confidence            1     111223457889999999865  3588999999999999999999999975432111  111000000    00


Q ss_pred             ------ccchh--------HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          310 ------FTKLD--------QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       310 ------~~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                            .....        ...............+.++.+++..||+.||++|||+.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence                  00000        0000011122334556789999999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=7.5e-38  Score=294.23  Aligned_cols=243  Identities=23%  Similarity=0.334  Sum_probs=194.2

Q ss_pred             ccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc---chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEEEe
Q 013105           87 LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS---QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEY  163 (449)
Q Consensus        87 lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  163 (449)
                      ||+|+||.||++.+..      +++.+++|++.....   .....+.+|+++++.++||||+++++.+..+...|++|||
T Consensus         1 lg~g~~~~vy~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   74 (265)
T cd05579           1 ISKGAYGRVFLAKKKS------TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEY   74 (265)
T ss_pred             CCCCCceEEEEEEECC------CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEec
Confidence            6899999999998765      478999999864432   3456788899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCC--
Q 013105          164 MALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGED--  241 (449)
Q Consensus       164 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~--  241 (449)
                      +.+++|.+++.+.  ..+++..+..++.|++.||.|||  ..+++|+||+|+||+++.++.++|+|||++........  
T Consensus        75 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH--~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  150 (265)
T cd05579          75 LPGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLH--SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQIN  150 (265)
T ss_pred             CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccc
Confidence            9999999998764  37899999999999999999999  78899999999999999999999999999875433211  


Q ss_pred             ----CceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhh
Q 013105          242 ----SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII  317 (449)
Q Consensus       242 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (449)
                          ........++..|+|||.+....++.++||||||+++|+|++|..||........   ...   .          .
T Consensus       151 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~~---~----------~  214 (265)
T cd05579         151 LNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI---FQN---I----------L  214 (265)
T ss_pred             cccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHH---H----------h
Confidence                1122335588899999999888889999999999999999999999975432111   100   0          0


Q ss_pred             cccccccCCHH--HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          318 DSRLEDRYSTE--GAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       318 ~~~~~~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ...  ...+..  .+..+.+++.+||+.+|++|||+.++.+.
T Consensus       215 ~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~  254 (265)
T cd05579         215 NGK--IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEI  254 (265)
T ss_pred             cCC--cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHH
Confidence            000  011112  36678999999999999999999444443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=5.3e-38  Score=298.01  Aligned_cols=251  Identities=24%  Similarity=0.361  Sum_probs=205.1

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCC-CCCcceeeeEEEeC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLK-HPHLVNLIGYCCED  154 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~  154 (449)
                      ++|.+.+.||+|+||.||+|....      +++.||+|++...   .......+.+|+.+++++. ||||+++++++...
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~   74 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKE------TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE   74 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcC------CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC
Confidence            478899999999999999998765      5789999998643   2233456788999999998 99999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +..++||||+.+++|.+++...  ..+++..+..++.|++.||.|||  +.|++|+||+|+||+++.++.++|+|||++.
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh--~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~  150 (280)
T cd05581          75 ENLYFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLH--SKGIIHRDLKPENILLDKDMHIKITDFGTAK  150 (280)
T ss_pred             ceEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHeEECCCCCEEecCCcccc
Confidence            9999999999999999998765  47999999999999999999999  7789999999999999999999999999988


Q ss_pred             CCCCCCCC------------------ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccc
Q 013105          235 DGPQGEDS------------------HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE  296 (449)
Q Consensus       235 ~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~  296 (449)
                      ........                  .......|+..|+|||.+.+..++.++||||||+++++|++|..||........
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  230 (280)
T cd05581         151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT  230 (280)
T ss_pred             ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence            55432210                  122345688999999999888899999999999999999999999986531110


Q ss_pred             hhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCH----HHHHHH
Q 013105          297 KDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM----TTVVKA  357 (449)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~eil~~  357 (449)
                         .             ....  .....++...++.+.+++..||+.||.+||++    ++++.|
T Consensus       231 ---~-------------~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         231 ---F-------------QKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             ---H-------------HHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence               0             0000  01112334446679999999999999999999    888875

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=313.52  Aligned_cols=269  Identities=27%  Similarity=0.400  Sum_probs=199.7

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeC-----
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCED-----  154 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-----  154 (449)
                      |...+.||+|+||.||+|.++.      +|+.||||.++... ....+...+|+++|++|+|+|||+++++-.+.     
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnke------tG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~   88 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKE------TGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV   88 (732)
T ss_pred             eeehhhhcCCccceeeeecccc------cccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence            5556789999999999996554      79999999997543 34456788999999999999999999986544     


Q ss_pred             -CEEEEEEEecCCCChHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEc--CCC--cEEEe
Q 013105          155 -EHRLLVYEYMALGNLHDQLFK-NYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD--SDY--NAKLS  228 (449)
Q Consensus       155 -~~~~lv~e~~~~g~L~~~l~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~--~~~--~~kl~  228 (449)
                       ....+|||||.||+|...+.+ .....+++.+.+.++..++.||.|||  ++||+||||||.||++-  .+|  .-||+
T Consensus        89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr--En~IvHRDlKP~NIvl~~Gedgq~IyKLt  166 (732)
T KOG4250|consen   89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR--ENGIVHRDLKPGNIVLQIGEDGQSIYKLT  166 (732)
T ss_pred             cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH--HcCceeccCCCCcEEEeecCCCceEEeee
Confidence             356899999999999999965 24568999999999999999999999  88899999999999983  334  46999


Q ss_pred             eeccccCCCCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhh
Q 013105          229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML  307 (449)
Q Consensus       229 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~  307 (449)
                      |||.|+...++.   ....++||+.|++||++.. ..|+..+|.|||||++|+++||..||..........-+.|....-
T Consensus       167 DfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tk  243 (732)
T KOG4250|consen  167 DFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITK  243 (732)
T ss_pred             cccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhcc
Confidence            999999876544   4677899999999999984 789999999999999999999999997554332111111110000


Q ss_pred             ccccchhHh--------h----cccccccCCHHHHHHHHHHHHHhccCCCCCCC--CHHHHHHHhhcc
Q 013105          308 KDFTKLDQI--------I----DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRP--TMTTVVKALEPL  361 (449)
Q Consensus       308 ~~~~~~~~~--------~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP--s~~eil~~L~~~  361 (449)
                      +. ......        +    .-+.+..........+..++..+|..+|.+|-  ...+....+..+
T Consensus       244 kp-~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI  310 (732)
T KOG4250|consen  244 KP-SGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI  310 (732)
T ss_pred             CC-CceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence            00 000000        0    00112223344455567778888888999887  555544444443

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.4e-37  Score=298.76  Aligned_cols=271  Identities=25%  Similarity=0.276  Sum_probs=200.1

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      ...++|++.+.||+|+||.||+|....      +++.||+|+++...  ......+.+|+++++.++||||+++++++.+
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~   77 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKD------TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTD   77 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECC------CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecC
Confidence            456789999999999999999998865      47899999997542  2233467789999999999999999999876


Q ss_pred             CC----------EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC
Q 013105          154 DE----------HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY  223 (449)
Q Consensus       154 ~~----------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~  223 (449)
                      ..          ..++||||+.+ +|.+.+... ...+++..+..++.|++.||+|||  ..+|+|+||||+||+++.++
T Consensus        78 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH--~~~i~H~dl~p~nili~~~~  153 (302)
T cd07864          78 KQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCH--KKNFLHRDIKCSNILLNNKG  153 (302)
T ss_pred             cchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCC
Confidence            54          78999999985 777776543 357899999999999999999999  77899999999999999999


Q ss_pred             cEEEeeeccccCCCCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHh
Q 013105          224 NAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEW  302 (449)
Q Consensus       224 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~  302 (449)
                      .+||+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++|++||...........+..
T Consensus       154 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~  232 (302)
T cd07864         154 QIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR  232 (302)
T ss_pred             cEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence            999999999986543321 11222346788999998864 3578999999999999999999999975432211111110


Q ss_pred             h--hhhhccccchhHhhc-----c-----cccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          303 A--RPMLKDFTKLDQIID-----S-----RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       303 ~--~~~~~~~~~~~~~~~-----~-----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .  .+....+..+.....     .     ..........+..+.+++..||+.||.+||++.+++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0  000000000000000     0     00000111246679999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.6e-37  Score=296.98  Aligned_cols=245  Identities=29%  Similarity=0.438  Sum_probs=195.0

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc---chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS---QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      |...+.||+|+||.||+|....      ++..|++|++.....   .....+.+|+.+++.++|||++++++++.+....
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   96 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSH------TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTA   96 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECC------CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence            6667789999999999997654      578999999874322   2335678899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      |+||||+. |+|.+++... ...+++.++..++.|++.+|.|||  ..|++|+||+|+||+++.++.++|+|||++....
T Consensus        97 ~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH--~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~  172 (313)
T cd06633          97 WLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS  172 (313)
T ss_pred             EEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCChhhEEECCCCCEEEeecCCCcccC
Confidence            99999996 6787777543 356899999999999999999999  7789999999999999999999999999986432


Q ss_pred             CCCCCceeeecCCCCccccccccc---cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYIN---TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      .      .....|+..|+|||++.   ...++.++|||||||++|+|++|..||............              
T Consensus       173 ~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~--------------  232 (313)
T cd06633         173 P------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--------------  232 (313)
T ss_pred             C------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--------------
Confidence            2      22346899999999984   456888999999999999999999998754321111000              


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                        .............+..+.+++.+||+.+|.+||++.+++.+
T Consensus       233 --~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         233 --AQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             --HhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              00001111122344568999999999999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=295.65  Aligned_cols=265  Identities=23%  Similarity=0.287  Sum_probs=202.0

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc--chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      |.+.+.||.|++|.||+|....      .++.+++|.+.....  .....+.+|+.+++.++|+||+++++++..++..+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKL------TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLY   74 (283)
T ss_pred             CccceeeecCCCceEEEEEcCC------CCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEE
Confidence            5677899999999999997754      478899999875432  23467788999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCC
Q 013105          159 LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~  238 (449)
                      +||||+. ++|.+.+.... ..+++..+..++.+++.||.|||  ..+|+|+||||+||+++.++.++|+|||.+.....
T Consensus        75 ~v~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~  150 (283)
T cd05118          75 LVFEFMD-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCH--SHGILHRDLKPENLLINTEGVLKLADFGLARSFGS  150 (283)
T ss_pred             EEEeccC-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHH--HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCC
Confidence            9999997 58888776542 57899999999999999999999  77899999999999999999999999999876544


Q ss_pred             CCCCceeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHH-hh-hhhhccccchhH
Q 013105          239 GEDSHITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVE-WA-RPMLKDFTKLDQ  315 (449)
Q Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~-~~-~~~~~~~~~~~~  315 (449)
                      ..  .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||............. .. .+....+.....
T Consensus       151 ~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd05118         151 PV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS  228 (283)
T ss_pred             Cc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchh
Confidence            32  112234588899999998766 78999999999999999999999997654322111110 00 000000000000


Q ss_pred             --------hhcc--cccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          316 --------IIDS--RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       316 --------~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                              ....  ..........+.++.+++.+||+.||.+||++.+++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                    0000  00011223467789999999999999999999999976

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.4e-38  Score=329.40  Aligned_cols=255  Identities=28%  Similarity=0.420  Sum_probs=189.6

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      ....+|+..++||+||||.||++..+      ..|+.||||.+.... ......+.+|+..|.+|+|||||+++..+.+.
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNK------lDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs  549 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNK------LDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVES  549 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeec------ccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhcc
Confidence            34567888999999999999999554      469999999998653 33456788999999999999999998753100


Q ss_pred             --------------------------------------------------------------------------------
Q 013105          155 --------------------------------------------------------------------------------  154 (449)
Q Consensus       155 --------------------------------------------------------------------------------  154 (449)
                                                                                                      
T Consensus       550 ~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~  629 (1351)
T KOG1035|consen  550 TAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRN  629 (1351)
T ss_pred             CCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------------------CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHH
Q 013105          155 ---------------------------------------EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR  195 (449)
Q Consensus       155 ---------------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~  195 (449)
                                                             -.+||-||||+..+|.+++.++... -.....++++.+|++
T Consensus       630 ~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlE  708 (1351)
T KOG1035|consen  630 LSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILE  708 (1351)
T ss_pred             cccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHH
Confidence                                                   1258899999977777777654211 146778999999999


Q ss_pred             HHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC----------------CCCCCceeeecCCCCccccccc
Q 013105          196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP----------------QGEDSHITTCVMGTEGYAAPEY  259 (449)
Q Consensus       196 ~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~  259 (449)
                      ||.|+|  +.|||||||||.||++++++.|||+|||+|....                .+......+..+||.-|+|||+
T Consensus       709 GLaYIH--~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl  786 (1351)
T KOG1035|consen  709 GLAYIH--DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL  786 (1351)
T ss_pred             HHHHHH--hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence            999999  8889999999999999999999999999998621                0111113455789999999999


Q ss_pred             cccC---CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccccc--cCCHHHHHHHH
Q 013105          260 INTG---HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLED--RYSTEGAKRLA  334 (449)
Q Consensus       260 ~~~~---~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~  334 (449)
                      +.+.   .|+.|+|+||||+||+||+.   ||.......  ..             +..+-+..++.  .+....-+.-.
T Consensus       787 l~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa--~i-------------L~~LR~g~iP~~~~f~~~~~~~e~  848 (1351)
T KOG1035|consen  787 LSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERA--SI-------------LTNLRKGSIPEPADFFDPEHPEEA  848 (1351)
T ss_pred             hcccccccccchhhhHHHHHHHHHHhc---cCCchHHHH--HH-------------HHhcccCCCCCCcccccccchHHH
Confidence            9654   49999999999999999986   465332110  00             11111111111  11122222356


Q ss_pred             HHHHHhccCCCCCCCCHHHHHHH
Q 013105          335 AVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       335 ~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .+|++|++.||.+|||+.|+|..
T Consensus       849 slI~~Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  849 SLIRWLLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             HHHHHHhcCCCccCCCHHHHhhc
Confidence            79999999999999999999975

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-37  Score=293.42  Aligned_cols=265  Identities=26%  Similarity=0.319  Sum_probs=197.7

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc--chHHHHHHHHHHHhcC---CCCCcceeeeEEEeCC
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQL---KHPHLVNLIGYCCEDE  155 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~~~  155 (449)
                      |++.+.||+|+||.||+|.+..      ++..||+|++.....  .....+.+|+.+++.+   .|+||+++++++...+
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   74 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLN------TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR   74 (287)
T ss_pred             CeEEEEecccCceEEEEEEECC------CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence            6778899999999999998765      478999999974322  2234466777777665   5999999999998877


Q ss_pred             E-----EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeee
Q 013105          156 H-----RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDF  230 (449)
Q Consensus       156 ~-----~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~Df  230 (449)
                      .     .+++|||+. ++|.+++.......+++..+..++.|++.||.|||  ..+++|+||+|+||+++.++.++|+||
T Consensus        75 ~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH--~~~i~h~~l~~~nili~~~~~~~l~df  151 (287)
T cd07838          75 TDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH--SHRIVHRDLKPQNILVTSDGQVKIADF  151 (287)
T ss_pred             CCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCChhhEEEccCCCEEEecc
Confidence            6     999999997 58988887654456899999999999999999999  678999999999999999999999999


Q ss_pred             ccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhH-Hhhhh-hhc
Q 013105          231 GLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV-EWARP-MLK  308 (449)
Q Consensus       231 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~-~~~~~-~~~  308 (449)
                      |++........   .....++..|+|||.+.+..++.++|||||||++|+|++|.+||...........+ ..... ...
T Consensus       152 g~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (287)
T cd07838         152 GLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEE  228 (287)
T ss_pred             CcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChH
Confidence            99876543221   12234788999999998888999999999999999999999999764322111100 00000 000


Q ss_pred             cccch----hHhhccc---ccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          309 DFTKL----DQIIDSR---LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       309 ~~~~~----~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .+...    .......   .........+..+.+++.+||+.||++||++.+++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            00000    0000000   0011123456778999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.3e-37  Score=293.84  Aligned_cols=256  Identities=28%  Similarity=0.351  Sum_probs=198.9

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC----cchHHHHHHHHHHHhcC-CCCCcceeeeEEEeC
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG----SQGHREWLAEVIFLGQL-KHPHLVNLIGYCCED  154 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~  154 (449)
                      +|++.+.||+|+||.||+|.....   ..++..||+|++....    ......+.+|+.++..+ +|+||+.+++++..+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~---~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSG---HDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD   77 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccC---CCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC
Confidence            478889999999999999976432   1257889999986431    22345678899999999 599999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      ...++||||+++++|.+++...  ..+++..+..++.|++.||.|||  ..+++||||+|+|||++.++.++|+|||++.
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH--~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          78 TKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             CeEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence            9999999999999999998764  56888899999999999999999  7889999999999999999999999999998


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccC--CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccc
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTG--HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK  312 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  312 (449)
                      ........ ......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||........  .........     
T Consensus       154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~-----  225 (290)
T cd05613         154 EFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRIL-----  225 (290)
T ss_pred             eccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhh-----
Confidence            65432211 12235689999999998653  468899999999999999999999864321111  011100000     


Q ss_pred             hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013105          313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRP-----TMTTVVKA  357 (449)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  357 (449)
                           .  ....++..++..+.+++.+||+.||++||     ++.+++.+
T Consensus       226 -----~--~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         226 -----K--SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             -----c--cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence                 0  01123344566789999999999999997     77777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.1e-37  Score=297.51  Aligned_cols=247  Identities=28%  Similarity=0.400  Sum_probs=196.1

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ..|...+.||+|+||.||+|....      .+..+|+|.+...   .......+.+|+.+++.++|+|++++++++....
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   88 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVR------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH   88 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcC------CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC
Confidence            346677889999999999998765      4788999998643   2233456788999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..++||||+. |+|.+.+... ...+++..+..++.+++.||.|||  ..+++||||+|+|||++.++.++|+|||++..
T Consensus        89 ~~~lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH--~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  164 (308)
T cd06634          89 TAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI  164 (308)
T ss_pred             eeEEEEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHhEEECCCCcEEECCccccee
Confidence            9999999996 6887776543 346889999999999999999999  77899999999999999999999999999875


Q ss_pred             CCCCCCCceeeecCCCCccccccccc---cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccc
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYIN---TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK  312 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  312 (449)
                      ...      .....|+..|+|||.+.   ...++.++|||||||++|+|++|..||..........  .           
T Consensus       165 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~-----------  225 (308)
T cd06634         165 MAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--H-----------  225 (308)
T ss_pred             ecC------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH--H-----------
Confidence            432      12345889999999874   3467889999999999999999999986532111100  0           


Q ss_pred             hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                         ..............+..+.++|.+||+.+|++||++.+++.+
T Consensus       226 ---~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         226 ---IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             ---HhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence               000111111123455678999999999999999999999987

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-37  Score=303.04  Aligned_cols=267  Identities=24%  Similarity=0.295  Sum_probs=203.1

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC--
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE--  155 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--  155 (449)
                      +|.+.+.||.|+||.||+|....      +++.||+|.+....  ....+.+.+|+.+++.++|+||+++++++....  
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKR------TGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPE   74 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCC------CCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence            58889999999999999998755      47899999987543  334567889999999999999999999988775  


Q ss_pred             ---EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecc
Q 013105          156 ---HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL  232 (449)
Q Consensus       156 ---~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGl  232 (449)
                         ..|+||||+. ++|.+++...  ..+++..+..++.+++.||.|||  .+||+|+||||+|||++.++.++|+|||+
T Consensus        75 ~~~~~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH--~~gi~H~dlkp~nili~~~~~~~L~dfg~  149 (330)
T cd07834          75 DFNDVYIVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLH--SANVIHRDLKPSNILVNSNCDLKICDFGL  149 (330)
T ss_pred             cccceEEEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEcccCc
Confidence               7899999997 5888888654  47899999999999999999999  67899999999999999999999999999


Q ss_pred             ccCCCCCCCC-ceeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhh--h--
Q 013105          233 ATDGPQGEDS-HITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARP--M--  306 (449)
Q Consensus       233 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~--~--  306 (449)
                      +......... .......++..|+|||++.+. .++.++|||||||++|+|++|.+||...........+.....  .  
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  229 (330)
T cd07834         150 ARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE  229 (330)
T ss_pred             eEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChh
Confidence            9865443210 112334578999999999877 789999999999999999999999976543221111100000  0  


Q ss_pred             -h--ccccchhHhhccc------ccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          307 -L--KDFTKLDQIIDSR------LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       307 -~--~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       .  .........+...      .........+..+.+++.+||+.+|.+||++.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence             0  0000000000100      0001122356778999999999999999999999987

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-37  Score=293.77  Aligned_cols=265  Identities=24%  Similarity=0.302  Sum_probs=198.7

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCC-CCCcceeeeEEEeCCEEE
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLK-HPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~  158 (449)
                      |.+.+.||.|+||.||+|....      +++.|+||.+..... .......+|+..+.+++ |+||+++++++..++..+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   74 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKE------TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELY   74 (283)
T ss_pred             CeeheeeccCCceEEEEEEECC------CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEE
Confidence            6678899999999999998765      478899999864322 22334567999999999 999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCC
Q 013105          159 LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~  238 (449)
                      +||||+ +|+|.+.+.......+++..+..++.|++.+|.|||  +++++|+||+|+||+++.++.++|+|||++.....
T Consensus        75 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh--~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~  151 (283)
T cd07830          75 FVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH--KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS  151 (283)
T ss_pred             EEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence            999999 789999887765567899999999999999999999  67899999999999999999999999999875533


Q ss_pred             CCCCceeeecCCCCccccccccc-cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhh-HHhhhhhh----ccccc
Q 013105          239 GEDSHITTCVMGTEGYAAPEYIN-TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDL-VEWARPML----KDFTK  312 (449)
Q Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~-~~~~~~~~----~~~~~  312 (449)
                      ...   .....|+..|+|||++. +..++.++|+||||+++|||++|.+||........... ........    .....
T Consensus       152 ~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd07830         152 RPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK  228 (283)
T ss_pred             CCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence            221   22345889999999884 45578999999999999999999999976533221110 00000000    00000


Q ss_pred             hhHhhccccc-------ccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          313 LDQIIDSRLE-------DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       313 ~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      +.........       .......+..+.+++.+||+.||++|||+.+++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            0000000000       00111124679999999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=9.5e-37  Score=337.19  Aligned_cols=265  Identities=29%  Similarity=0.479  Sum_probs=205.5

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      +...|...+.||+|+||.||+|.+..      .+..||||.+......    ...|++++++++||||+++++++.+.+.
T Consensus       688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~  757 (968)
T PLN00113        688 ILSSLKEENVISRGKKGASYKGKSIK------NGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKG  757 (968)
T ss_pred             HHhhCCcccEEccCCCeeEEEEEECC------CCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence            34567888899999999999998754      4789999998643221    1246889999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE-EKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      .|+||||+++|+|.+++.     .+++..+..++.|++.||+|||.. ..+|+||||||+||+++.++..++. ||.+..
T Consensus       758 ~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~  831 (968)
T PLN00113        758 AYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL  831 (968)
T ss_pred             CEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence            999999999999999984     478999999999999999999965 5689999999999999999888775 665543


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ...      .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......|....... .....
T Consensus       832 ~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~-~~~~~  903 (968)
T PLN00113        832 LCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSD-CHLDM  903 (968)
T ss_pred             ccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCc-cchhh
Confidence            221      1123589999999999988999999999999999999999999954321 122334444322211 11222


Q ss_pred             hhcccccc--cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCC
Q 013105          316 IIDSRLED--RYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN  365 (449)
Q Consensus       316 ~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  365 (449)
                      .++.....  ........++.+++.+||+.||++|||+.++++.|+.+....
T Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  955 (968)
T PLN00113        904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS  955 (968)
T ss_pred             eeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence            22322221  223455667889999999999999999999999999876533

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.6e-37  Score=304.04  Aligned_cols=268  Identities=21%  Similarity=0.279  Sum_probs=197.7

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC---
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED---  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~---  154 (449)
                      ..+|.+.+.||.|+||.||+|....      ++..||+|.+..........+.+|+.+++.++||||+++++++...   
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~------~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~   77 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSD------CDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSD   77 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECC------CCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccc
Confidence            4679999999999999999998765      5789999999766555567788999999999999999999876543   


Q ss_pred             -----------CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC-C
Q 013105          155 -----------EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS-D  222 (449)
Q Consensus       155 -----------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~-~  222 (449)
                                 ...|+||||+. ++|.+++..   ..+++.....++.|++.||.|||  +.||+||||||+||+++. +
T Consensus        78 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH--~~givH~dikp~Nili~~~~  151 (342)
T cd07854          78 LTEDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIH--SANVLHRDLKPANVFINTED  151 (342)
T ss_pred             cccccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEcCCC
Confidence                       35799999997 688887753   36889999999999999999999  778999999999999974 5


Q ss_pred             CcEEEeeeccccCCCCCCCC-ceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhH
Q 013105          223 YNAKLSDFGLATDGPQGEDS-HITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV  300 (449)
Q Consensus       223 ~~~kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~  300 (449)
                      +.++|+|||++......... .......|+..|+|||.+.. ..++.++|||||||++|+|++|+.||............
T Consensus       152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~  231 (342)
T cd07854         152 LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI  231 (342)
T ss_pred             ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            57899999998754321111 11122357889999998743 56888999999999999999999999755332211111


Q ss_pred             Hhhhhhhcc--c----cchhHhhc-cccc-----ccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          301 EWARPMLKD--F----TKLDQIID-SRLE-----DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       301 ~~~~~~~~~--~----~~~~~~~~-~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ....+....  .    ........ ....     .......+.++.+++.+||+.||.+|||+.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            000000000  0    00000000 0000     00112345678999999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.5e-37  Score=301.78  Aligned_cols=269  Identities=23%  Similarity=0.290  Sum_probs=197.8

Q ss_pred             hcCCC-CcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcch--------------HHHHHHHHHHHhcCCCC
Q 013105           78 THNFS-RSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG--------------HREWLAEVIFLGQLKHP  142 (449)
Q Consensus        78 ~~~y~-~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~  142 (449)
                      .++|. +.+.||.|+||.||+|.+..      .++.||+|++.......              ...+.+|+.+++.++|+
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   80 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTL------TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHE   80 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECC------CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCc
Confidence            45565 45779999999999997664      47899999986432211              12467899999999999


Q ss_pred             CcceeeeEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC
Q 013105          143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD  222 (449)
Q Consensus       143 nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~  222 (449)
                      ||+++++++...+..++||||+. |+|.+++...  ..+++.....++.|++.||.|||  ..||+|+||+|+||+++.+
T Consensus        81 ~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH--~~~i~H~dl~~~nill~~~  155 (335)
T PTZ00024         81 NIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLH--KWYFMHRDLSPANIFINSK  155 (335)
T ss_pred             ceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeecccccHHHeEECCC
Confidence            99999999999999999999997 6898888654  56889999999999999999999  7889999999999999999


Q ss_pred             CcEEEeeeccccCCCCCC------------CCceeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCCccc
Q 013105          223 YNAKLSDFGLATDGPQGE------------DSHITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVE  289 (449)
Q Consensus       223 ~~~kl~DfGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~  289 (449)
                      +.++|+|||++.......            .........++..|+|||.+.+. .++.++|||||||++|+|++|.+||.
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~  235 (335)
T PTZ00024        156 GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP  235 (335)
T ss_pred             CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            999999999987543110            01111223468899999998654 46899999999999999999999997


Q ss_pred             ccccccchhhH-Hhhh-hhhccccchhHhh-----ccccc---ccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          290 KNRCKREKDLV-EWAR-PMLKDFTKLDQII-----DSRLE---DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       290 ~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~-----~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ..........+ .... +....+.......     .....   .......+..+.+++.+||+.+|++|||+.+++.+
T Consensus       236 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        236 GENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             CCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            65432211110 0000 0000000000000     00000   00112335678999999999999999999999986

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.1e-37  Score=293.72  Aligned_cols=259  Identities=26%  Similarity=0.339  Sum_probs=200.6

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC----cchHHHHHHHHHHHhcC-CCCCcceeeeEEEeC
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG----SQGHREWLAEVIFLGQL-KHPHLVNLIGYCCED  154 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~  154 (449)
                      +|++.+.||+|+||.||++....+   ...+..||||++....    ......+.+|+.++.++ +||||+++++.+..+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~---~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~   77 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGG---HDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD   77 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEecc---ccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC
Confidence            478889999999999999976432   1246789999986321    22335678899999999 599999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      ...++||||+.+|+|.+++...  ..+++.....++.|++.+|.|||  ..+++|+||+|.||+++.++.++|+|||++.
T Consensus        78 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH--~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          78 TKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLH--QLGIIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             CEEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence            9999999999999999998654  46888999999999999999999  7889999999999999999999999999987


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccCC--CCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccc
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTGH--LTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK  312 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  312 (449)
                      ....... .......|+..|+|||.+.+..  .+.++||||||+++|||++|..||.........  .......      
T Consensus       154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~~------  224 (288)
T cd05583         154 EFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ--SEISRRI------  224 (288)
T ss_pred             ccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH--HHHHHHH------
Confidence            6543321 1122346899999999987654  788999999999999999999999643211110  0000000      


Q ss_pred             hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 013105          313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEP  360 (449)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  360 (449)
                          ...  ....+..++..+.+++.+||+.||++|||+.++.+.|+.
T Consensus       225 ----~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         225 ----LKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             ----Hcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                000  112233455678999999999999999998877766553

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4.1e-37  Score=294.97  Aligned_cols=253  Identities=25%  Similarity=0.389  Sum_probs=194.7

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCC-CCCcceeeeEEEeCC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLK-HPHLVNLIGYCCEDE  155 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~  155 (449)
                      .++|.+.+.||+|+||.||+|.+..      +++.||||.+.... ......+..|+.++..+. |+||+++++++.+..
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~   87 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKK------TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS   87 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECC------CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence            3678899999999999999998765      47899999997543 233455677787776664 999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..|+||||+. ++|.+++... ...+++..+..++.+++.||.|||+ ..+|+||||+|+||+++.++.++|+|||++..
T Consensus        88 ~~~~v~e~~~-~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~-~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~  164 (296)
T cd06618          88 DVFICMELMS-TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKE-KHGVIHRDVKPSNILLDASGNVKLCDFGISGR  164 (296)
T ss_pred             eEEEEeeccC-cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-hCCEecCCCcHHHEEEcCCCCEEECccccchh
Confidence            9999999985 5776666543 3478999999999999999999994 24799999999999999999999999999875


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCC----CCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcccc
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGH----LTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFT  311 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  311 (449)
                      ......   .....|+..|+|||.+.+..    ++.++||||||+++|+|++|+.||......  .+...          
T Consensus       165 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~----------  229 (296)
T cd06618         165 LVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLT----------  229 (296)
T ss_pred             ccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHH----------
Confidence            533221   12234788999999986543    788999999999999999999999653211  00000          


Q ss_pred             chhHhhcccc-cccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          312 KLDQIIDSRL-EDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       312 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                         ....... .......++.++.+++.+||+.||.+||++.+++.+
T Consensus       230 ---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         230 ---KILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             ---HHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence               0000000 000111245678999999999999999999999987

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=4e-37  Score=296.76  Aligned_cols=270  Identities=25%  Similarity=0.290  Sum_probs=196.5

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc--chHHHHHHHHHHHhcCCCCCcceeeeEEEeC-
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLKHPHLVNLIGYCCED-  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-  154 (449)
                      .++|.+.+.||+|+||.||+|.+..      +++.+|+|++.....  .....+.+|+++++.++||||+++++++.+. 
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIK------TGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERP   80 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECC------CCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccc
Confidence            4789999999999999999998765      478899999864322  2234567899999999999999999987543 


Q ss_pred             -------CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEE
Q 013105          155 -------EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKL  227 (449)
Q Consensus       155 -------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl  227 (449)
                             ...++||||+. ++|...+... ...+++..+..++.|++.||.|||  ..||+|+||||+||+++.++.++|
T Consensus        81 ~~~~~~~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH--~~~i~H~dl~p~nil~~~~~~~~l  156 (311)
T cd07866          81 DKSKRKRGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLH--ENHILHRDIKAANILIDNQGILKI  156 (311)
T ss_pred             ccccccCceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCCEEE
Confidence                   34699999997 5777766543 357899999999999999999999  778999999999999999999999


Q ss_pred             eeeccccCCCCCCCC---------ceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccch
Q 013105          228 SDFGLATDGPQGEDS---------HITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREK  297 (449)
Q Consensus       228 ~DfGla~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~  297 (449)
                      +|||++.........         .......|++.|+|||.+.+ ..++.++|||||||++|||++|++||.+.......
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~  236 (311)
T cd07866         157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL  236 (311)
T ss_pred             CcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            999999754332111         11123457889999998764 45789999999999999999999999765432221


Q ss_pred             hhHHhh-hh----hhccccchhHhhcccccccC-------CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          298 DLVEWA-RP----MLKDFTKLDQIIDSRLEDRY-------STEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       298 ~~~~~~-~~----~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ..+... ..    .+..+..+............       .......+.+++.+||+.||++|||+.+++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            111100 00    00000000000000000000       11223568899999999999999999999876

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.9e-37  Score=301.50  Aligned_cols=271  Identities=22%  Similarity=0.261  Sum_probs=200.8

Q ss_pred             CHHHHHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCccee
Q 013105           70 TLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNL  147 (449)
Q Consensus        70 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~  147 (449)
                      ...++..+.++|.+.+.||+|+||.||+|....      +++.||+|++....  ......+.+|+.++++++||||+++
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~   81 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL   81 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcC------CCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccce
Confidence            345566778999999999999999999997654      57899999986432  2234567789999999999999999


Q ss_pred             eeEEEeC------CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC
Q 013105          148 IGYCCED------EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS  221 (449)
Q Consensus       148 ~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~  221 (449)
                      ++++...      ...|++++++ +++|.+++..   ..+++..+..++.|++.||.|||  +.+|+||||||+||+++.
T Consensus        82 ~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIll~~  155 (345)
T cd07877          82 LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNE  155 (345)
T ss_pred             eeeeeecccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCChHHEEEcC
Confidence            9988643      3468888887 6899887754   35889999999999999999999  778999999999999999


Q ss_pred             CCcEEEeeeccccCCCCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhH
Q 013105          222 DYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV  300 (449)
Q Consensus       222 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~  300 (449)
                      ++.++|+|||++......     .....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+
T Consensus       156 ~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~  230 (345)
T cd07877         156 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI  230 (345)
T ss_pred             CCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999998854321     223458899999998865 56889999999999999999999999754322111110


Q ss_pred             Hhhhh-----hhcccc--chhHhh---cccccc---cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          301 EWARP-----MLKDFT--KLDQII---DSRLED---RYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       301 ~~~~~-----~~~~~~--~~~~~~---~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .....     ......  .....+   ......   ......+..+.+++..||+.||.+||++.+++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            00000     000000  000000   000000   0001235568999999999999999999999987

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4.4e-37  Score=288.90  Aligned_cols=250  Identities=22%  Similarity=0.319  Sum_probs=196.7

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC-----CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-----GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      +|.+.+.||+|+||.||++.+..      .+..+++|+++..     .......+..|+.+++.++||||+++++++.+.
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   74 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKK------AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER   74 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecC------CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC
Confidence            48888999999999999997654      2444556655421     122334567799999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecc
Q 013105          155 EHRLLVYEYMALGNLHDQLFK--NYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL  232 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGl  232 (449)
                      ...++||||+.+++|.+++..  .....+++.....++.|++.||.|||  +.|++|+||+|+||+++. +.++|+|||+
T Consensus        75 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~h~~l~~~nili~~-~~~~l~d~g~  151 (260)
T cd08222          75 DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH--QRRILHRDLKAKNIFLKN-NLLKIGDFGV  151 (260)
T ss_pred             CceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH--HcCccccCCChhheEeec-CCEeecccCc
Confidence            999999999999999988864  23457899999999999999999999  788999999999999975 5799999999


Q ss_pred             ccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccc
Q 013105          233 ATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK  312 (449)
Q Consensus       233 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  312 (449)
                      +........  ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.........      .        
T Consensus       152 ~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~------~--------  215 (260)
T cd08222         152 SRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVV------L--------  215 (260)
T ss_pred             eeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH------H--------
Confidence            876533221  223355889999999998888899999999999999999999999653211100      0        


Q ss_pred             hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                        .... ......+..++.++.+++.+||..||++||++.+++++
T Consensus       216 --~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         216 --RIVE-GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             --HHHc-CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence              0001 11222344566789999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=286.73  Aligned_cols=263  Identities=27%  Similarity=0.331  Sum_probs=199.2

Q ss_pred             CccccCHHHHHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcC-CCC
Q 013105           65 NLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQL-KHP  142 (449)
Q Consensus        65 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~  142 (449)
                      ..+.|+...++.       ...||.|+||+|++-.++.      .++..|||.++.... ..+++++.|.....+- +.|
T Consensus        57 ~~~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~------sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp  123 (361)
T KOG1006|consen   57 HLHTFTSDNLQD-------LGEIGNGAFGTVNKMLHKP------SGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCP  123 (361)
T ss_pred             cccccccchHHH-------HHHhcCCcchhhhhhhcCc------cCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCc
Confidence            445555544443       4569999999999986554      799999999986543 5667888898865554 699


Q ss_pred             CcceeeeEEEeCCEEEEEEEecCCCChHHHH---hhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEE
Q 013105          143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQL---FKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILL  219 (449)
Q Consensus       143 nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l---~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill  219 (449)
                      |||++||.+..++..||.||.|. -+|..+.   .......+++.-.-.|....+.||.||-. ...||||||||+|||+
T Consensus       124 ~IVkfyGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~-~lkiIHRDvKPSNILl  201 (361)
T KOG1006|consen  124 NIVKFYGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE-ELKIIHRDVKPSNILL  201 (361)
T ss_pred             HHHHHhhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH-HhhhhhccCChhheEE
Confidence            99999999999999999999997 5664433   22344678888888899999999999974 4569999999999999


Q ss_pred             cCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccc--cCCCCcccchhhhHHHHHHHHhCCCcccccccccch
Q 013105          220 DSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN--TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREK  297 (449)
Q Consensus       220 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~  297 (449)
                      +..|.+||||||++..+...   ...+.-.|...|||||.+.  +..|+-++||||||++|||+.||..|+..+...   
T Consensus       202 dr~G~vKLCDFGIcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv---  275 (361)
T KOG1006|consen  202 DRHGDVKLCDFGICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV---  275 (361)
T ss_pred             ecCCCEeeecccchHhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH---
Confidence            99999999999998765332   2233456899999999984  346899999999999999999999999876431   


Q ss_pred             hhHHhhhhhh-ccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          298 DLVEWARPML-KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       298 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                        .+...... .+.+.+.       .+.-..+.+..+..+|..||.+|-..||.+.+++++
T Consensus       276 --feql~~Vv~gdpp~l~-------~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  276 --FEQLCQVVIGDPPILL-------FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             --HHHHHHHHcCCCCeec-------CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence              11111111 1111110       011122356679999999999999999999999876

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-39  Score=282.45  Aligned_cols=278  Identities=22%  Similarity=0.300  Sum_probs=206.2

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEe---
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCE---  153 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~---  153 (449)
                      ..|....+||+|.||.||+|..      ..+++.||+|++-..+  ...-...++|+.+|..|+|+|++.++++|..   
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~------~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~T   90 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARS------KNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT   90 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhh------cCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence            3466677899999999999944      4478889998765432  2233567899999999999999999988753   


Q ss_pred             -----CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEe
Q 013105          154 -----DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLS  228 (449)
Q Consensus       154 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~  228 (449)
                           ...+|+||++|+ -+|..++... ...++..++.+++.++..||.|+|  ...|+|||+|++|+||+.+|.+||+
T Consensus        91 p~~r~r~t~ylVf~~ce-hDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iH--r~kilHRDmKaaNvLIt~dgilklA  166 (376)
T KOG0669|consen   91 PTNRDRATFYLVFDFCE-HDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIH--RNKILHRDMKAANVLITKDGILKLA  166 (376)
T ss_pred             CcccccceeeeeHHHhh-hhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHH--HhhHHhhcccHhhEEEcCCceEEee
Confidence                 245899999998 6888777543 357888999999999999999999  5569999999999999999999999


Q ss_pred             eeccccCCCCCCC--CceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhh--
Q 013105          229 DFGLATDGPQGED--SHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA--  303 (449)
Q Consensus       229 DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~--  303 (449)
                      |||+++.+.....  ....+..+-|.+|++||.+.| ..|+++.|||+.|||+.||.++.+.+.+........++...  
T Consensus       167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG  246 (376)
T KOG0669|consen  167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG  246 (376)
T ss_pred             ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence            9999976543222  122344556999999998865 57999999999999999999999999988766666555332  


Q ss_pred             ------hhhhccccchhHhhcccccccCCH---------HHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCCCCC
Q 013105          304 ------RPMLKDFTKLDQIIDSRLEDRYST---------EGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDIP  368 (449)
Q Consensus       304 ------~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~  368 (449)
                            +|...+.+-+..+-..++....-.         .-.++..+|+..+|..||.+|+++++++.|  +++..++.|
T Consensus       247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh--~~F~kdp~p  324 (376)
T KOG0669|consen  247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH--DFFWKDPMP  324 (376)
T ss_pred             cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch--hhhhcCCcc
Confidence                  111111111111111111111000         112467899999999999999999999998  444444433

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.7e-37  Score=301.38  Aligned_cols=262  Identities=21%  Similarity=0.304  Sum_probs=194.7

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      +.++|.+.+.||+|+||.||+|.+..      +++.||+|++....  ......+.+|+.+++.++||||+++++++...
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~   86 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDKR------TGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSA   86 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeCC------CCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheeccc
Confidence            35789999999999999999998754      57899999986432  22335678899999999999999999998654


Q ss_pred             ------CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEe
Q 013105          155 ------EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLS  228 (449)
Q Consensus       155 ------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~  228 (449)
                            ..+++||||+. .+|..++    ...+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.++|+
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH--~~~i~H~dlkp~NIll~~~~~~kL~  159 (342)
T cd07879          87 VSGDEFQDFYLVMPYMQ-TDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIH--SAGIIHRDLKPGNLAVNEDCELKIL  159 (342)
T ss_pred             ccCCCCceEEEEecccc-cCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEe
Confidence                  35699999996 4676554    246889999999999999999999  6789999999999999999999999


Q ss_pred             eeccccCCCCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhh--
Q 013105          229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARP--  305 (449)
Q Consensus       229 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~--  305 (449)
                      |||++......     .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.+...............  
T Consensus       160 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  234 (342)
T cd07879         160 DFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP  234 (342)
T ss_pred             eCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99998754321     123457889999999865 4688999999999999999999999986532211111000000  


Q ss_pred             ------hhccccchhHhhcc---cccccC---CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          306 ------MLKDFTKLDQIIDS---RLEDRY---STEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       306 ------~~~~~~~~~~~~~~---~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                            .... .........   ......   .+..+..+.+++.+||+.||++||++.+++.|
T Consensus       235 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         235 GPEFVQKLED-KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             CHHHHHHhcc-cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                  0000 000000000   000000   11234568899999999999999999999987

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.6e-37  Score=300.17  Aligned_cols=264  Identities=20%  Similarity=0.272  Sum_probs=198.2

Q ss_pred             HHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEE
Q 013105           75 QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCC  152 (449)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~  152 (449)
                      ..+.++|++.+.||+|+||.||+|....      ++..||||++....  ......+.+|+.+++.++||||+++++++.
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   84 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRR------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFT   84 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECC------CCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeec
Confidence            3456789999999999999999997765      47899999986432  223356789999999999999999999987


Q ss_pred             eCC------EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEE
Q 013105          153 EDE------HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAK  226 (449)
Q Consensus       153 ~~~------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~k  226 (449)
                      ...      ..++||||+ +++|.+++..   ..+++..+..++.|++.||.|||  ..||+||||||+||+++.++.++
T Consensus        85 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH--~~gi~H~dlkp~Nill~~~~~~k  158 (343)
T cd07880          85 PDLSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIH--AAGIIHRDLKPGNLAVNEDCELK  158 (343)
T ss_pred             CCccccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEE
Confidence            653      458999998 6888877753   46899999999999999999999  78899999999999999999999


Q ss_pred             EeeeccccCCCCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchh-hHH---
Q 013105          227 LSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKD-LVE---  301 (449)
Q Consensus       227 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~-~~~---  301 (449)
                      |+|||++......     .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.......... ...   
T Consensus       159 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~  233 (343)
T cd07880         159 ILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTG  233 (343)
T ss_pred             EeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            9999999854322     123457899999999865 458899999999999999999999997543211100 000   


Q ss_pred             -----hhhhhhccccchhHhhcc---ccc---ccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          302 -----WARPMLKDFTKLDQIIDS---RLE---DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       302 -----~~~~~~~~~~~~~~~~~~---~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                           +.......  ........   ...   ......++..+.+++.+||+.||++|||+.+++.+
T Consensus       234 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         234 TPSKEFVQKLQSE--DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             CCCHHHHHhhcch--hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                 00000000  00000000   000   01112345568899999999999999999999976

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=6.9e-37  Score=298.28  Aligned_cols=269  Identities=20%  Similarity=0.246  Sum_probs=194.3

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcC-CCCCcceeeeEEEeC--
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCED--  154 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~--  154 (449)
                      +|.+.+.||+|+||.||++.....    ..+..||+|.+...  .......+.+|+.+++++ +||||+++++.+...  
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~   76 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAET----SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPG   76 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCC----CcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccc
Confidence            478889999999999999987541    12678999998643  222345678899999999 599999999875432  


Q ss_pred             --CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecc
Q 013105          155 --EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL  232 (449)
Q Consensus       155 --~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGl  232 (449)
                        ...+++|+|+. ++|.+++...  ..+++..+..++.|++.||.|||  .+||+||||||+|||++.++.++|+|||+
T Consensus        77 ~~~~~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~givH~dlkp~Nili~~~~~~kl~Dfg~  151 (332)
T cd07857          77 NFNELYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIH--SANVLHRDLKPGNLLVNADCELKICDFGL  151 (332)
T ss_pred             cCCcEEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence              45789999986 7898888643  57889999999999999999999  78899999999999999999999999999


Q ss_pred             ccCCCCCCCC--ceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhH-Hhh-----
Q 013105          233 ATDGPQGEDS--HITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV-EWA-----  303 (449)
Q Consensus       233 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~-~~~-----  303 (449)
                      +.........  .......||..|+|||.+.+ ..++.++|||||||++|+|++|.+||............ ...     
T Consensus       152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (332)
T cd07857         152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE  231 (332)
T ss_pred             ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence            9865432211  11233568999999998765 46899999999999999999999999764321111000 000     


Q ss_pred             ---hhhhccc-cchhHhhccccc---ccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          304 ---RPMLKDF-TKLDQIIDSRLE---DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       304 ---~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                         ....... ............   .......+..+.+++.+||+.||.+|||+.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence               0000000 000000000000   00111235678999999999999999999999876

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.3e-36  Score=295.71  Aligned_cols=265  Identities=22%  Similarity=0.257  Sum_probs=198.3

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      .+.++|++.+.||.|+||.||+|....      ++..||+|.+....  ......+.+|+.+++.++||||+++++++..
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   80 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQL------TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS   80 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECC------CCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec
Confidence            467889999999999999999997665      58899999886432  2234567789999999999999999999875


Q ss_pred             -CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecc
Q 013105          154 -DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL  232 (449)
Q Consensus       154 -~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGl  232 (449)
                       ....++||||+ +++|.+++..   ..++......++.|++.||.|||  .++|+||||+|.|||++.++.++|+|||+
T Consensus        81 ~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH--~~~iiH~dl~p~Nili~~~~~~~l~dfg~  154 (328)
T cd07856          81 PLEDIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVH--SAGVVHRDLKPSNILINENCDLKICDFGL  154 (328)
T ss_pred             CCCcEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEeECCCCCEEeCcccc
Confidence             56789999998 5788877753   35788888899999999999999  77899999999999999999999999999


Q ss_pred             ccCCCCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhH-Hhhhhh----
Q 013105          233 ATDGPQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV-EWARPM----  306 (449)
Q Consensus       233 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~-~~~~~~----  306 (449)
                      +......     .....++..|+|||.+.+ ..++.++|||||||++|+|++|.+||............ ......    
T Consensus       155 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  229 (328)
T cd07856         155 ARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV  229 (328)
T ss_pred             ccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            8754321     122457889999998765 56899999999999999999999999764321111100 000000    


Q ss_pred             h---ccccchhHhhccccccc-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          307 L---KDFTKLDQIIDSRLEDR-----YSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       307 ~---~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .   .................     ....++..+.++|.+||+.+|++||++.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         230 INTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0   00000000000000011     112345679999999999999999999999987

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-38  Score=299.70  Aligned_cols=246  Identities=25%  Similarity=0.352  Sum_probs=201.5

Q ss_pred             cccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEE
Q 013105           84 SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVY  161 (449)
Q Consensus        84 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  161 (449)
                      .++||+|.||+||-|.++.      +|+.||||+++..  .......+.+|+.||..+.||.||.+-..|++.+..++||
T Consensus       569 devLGSGQFG~VYgg~hRk------tGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM  642 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRK------TGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM  642 (888)
T ss_pred             HhhccCCcceeeecceecc------cCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence            4789999999999997665      7999999999753  2333467889999999999999999999999999999999


Q ss_pred             EecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC---CcEEEeeeccccCCCC
Q 013105          162 EYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD---YNAKLSDFGLATDGPQ  238 (449)
Q Consensus       162 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~---~~~kl~DfGla~~~~~  238 (449)
                      |-+. |+..+.|.....+.+++....-++.||+.||.|||  .++|+|+||||+|||+...   -++||||||.|+....
T Consensus       643 EKl~-GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH--~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE  719 (888)
T KOG4236|consen  643 EKLH-GDMLEMILSSEKGRLPERITKFLVTQILVALRYLH--FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE  719 (888)
T ss_pred             hhhc-chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh--hcceeeccCCchheeeccCCCCCceeeccccceeecch
Confidence            9996 67777776666688999888889999999999999  8889999999999999654   4799999999997754


Q ss_pred             CCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhc
Q 013105          239 GEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIID  318 (449)
Q Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (449)
                      ..   .....+|||.|+|||++....|...-|+||.|||+|.-|+|..||.......+.  +.-+.          -.  
T Consensus       720 ks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ--IQNAa----------FM--  782 (888)
T KOG4236|consen  720 KS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ--IQNAA----------FM--  782 (888)
T ss_pred             hh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH--hhccc----------cc--
Confidence            32   345678999999999999999999999999999999999999999764321111  10000          00  


Q ss_pred             ccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          319 SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       319 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                        .+..--.+++...++||..+|+..-.+|.|....+.|
T Consensus       783 --yPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  783 --YPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             --cCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence              0111123566678999999999999999999888876

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-38  Score=289.30  Aligned_cols=265  Identities=25%  Similarity=0.327  Sum_probs=203.8

Q ss_pred             HHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC-C-C----Ccceee
Q 013105           75 QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-H-P----HLVNLI  148 (449)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----nIv~~~  148 (449)
                      ..+.++|.+...+|+|.||.|-.+.++.      ++..||||+++.-. ...+..+-|+++|.++. + |    -++.+.
T Consensus        85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~------~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~  157 (415)
T KOG0671|consen   85 DILTNRYEIVDLLGEGTFGKVVECWDRE------TKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMR  157 (415)
T ss_pred             cccccceehhhhhcCCcccceEEEeecC------CCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence            4458899999999999999999987765      47899999997332 22344567999999993 2 2    267788


Q ss_pred             eEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC-------
Q 013105          149 GYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS-------  221 (449)
Q Consensus       149 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~-------  221 (449)
                      ++|.-.++.|||+|.+ |-++.+++.++.-.+++...+..++.|++++++|||  +.+++|-||||+|||+-.       
T Consensus       158 ~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh--~~kl~HTDLKPENILfvss~~~~~~  234 (415)
T KOG0671|consen  158 DWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH--DLKLTHTDLKPENILFVSSEYFKTY  234 (415)
T ss_pred             hhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH--hcceeecCCChheEEEeccceEEEe
Confidence            8899999999999988 569999999887788999999999999999999999  677999999999999832       


Q ss_pred             -------------CCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcc
Q 013105          222 -------------DYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSV  288 (449)
Q Consensus       222 -------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf  288 (449)
                                   +..++|+|||.|+......     ..++.|..|+|||++.+-.++..+||||+||||+|+++|...|
T Consensus       235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF  309 (415)
T KOG0671|consen  235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF  309 (415)
T ss_pred             ccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence                         2358999999998654432     4466899999999999999999999999999999999999999


Q ss_pred             cccccccchhhHHhhhhhhccccc----------------h-----------hHhhcccccc----cCCHHHHHHHHHHH
Q 013105          289 EKNRCKREKDLVEWARPMLKDFTK----------------L-----------DQIIDSRLED----RYSTEGAKRLAAVA  337 (449)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~----------------~-----------~~~~~~~~~~----~~~~~~~~~l~~li  337 (449)
                      ......+.....+.+   +...+.                +           ....+.+.+.    .........|.+|+
T Consensus       310 qtHen~EHLaMMerI---lGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl  386 (415)
T KOG0671|consen  310 QTHENLEHLAMMERI---LGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL  386 (415)
T ss_pred             ccCCcHHHHHHHHHh---hCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence            876533322111111   110000                0           0000000000    01123445699999


Q ss_pred             HHhccCCCCCCCCHHHHHHH
Q 013105          338 HQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       338 ~~cl~~dP~~RPs~~eil~~  357 (449)
                      ++||..||.+|+|+.|++.|
T Consensus       387 ~~mL~fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  387 RRMLEFDPARRITLREALSH  406 (415)
T ss_pred             HHHHccCccccccHHHHhcC
Confidence            99999999999999999987

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-37  Score=289.84  Aligned_cols=265  Identities=26%  Similarity=0.333  Sum_probs=200.4

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      |++.+.||+|+||.||+|....      +++.||+|++....  ......+..|+.+++.++|+||+++++++.+.+..+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   74 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKK------TGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLY   74 (282)
T ss_pred             CeeehcccccCcceEEEeeecC------CCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceE
Confidence            5667889999999999997765      47899999997542  333466788999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCC
Q 013105          159 LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~  238 (449)
                      +||||+. ++|.+++.... ..+++..+..++.+++.||.|||  ..+|+|+||+|+||+++.++.++|+|||++.....
T Consensus        75 ~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~  150 (282)
T cd07829          75 LVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCH--SHRILHRDLKPQNILINRDGVLKLADFGLARAFGI  150 (282)
T ss_pred             EEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence            9999997 68999887642 46899999999999999999999  67899999999999999999999999999886543


Q ss_pred             CCCCceeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCCcccccccccchhhH-Hhhh-h---hhccccc
Q 013105          239 GEDSHITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV-EWAR-P---MLKDFTK  312 (449)
Q Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~-~~~~-~---~~~~~~~  312 (449)
                      ...  ......++..|+|||.+.+. .++.++|||||||++|||++|.+||............ .... +   .+.....
T Consensus       151 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07829         151 PLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK  228 (282)
T ss_pred             Ccc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence            221  12234467889999998766 7899999999999999999999999765422111100 0000 0   0000000


Q ss_pred             h---hHhhcc---cccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          313 L---DQIIDS---RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       313 ~---~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      +   ......   .......+..+..+.+++..||..||++||++.+++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            0   000000   00001112235679999999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.5e-36  Score=320.06  Aligned_cols=146  Identities=29%  Similarity=0.380  Sum_probs=130.4

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ++|.+.+.||+|+||.||+|.+..      .++.||||++....   ......+..|+.++..++||||+++++++...+
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~------~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~   77 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKN------NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN   77 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECC------CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC
Confidence            679999999999999999998765      47899999996432   223456788999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      ..||||||+.|++|.+++...  ..+++...+.++.||+.||.|||  .++|+||||||+|||++.++.+||+|||+++
T Consensus        78 ~~~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH--~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          78 NVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLH--RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999999998654  46888899999999999999999  6789999999999999999999999999975

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-36  Score=298.29  Aligned_cols=265  Identities=21%  Similarity=0.296  Sum_probs=199.4

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      .+.++|.+.+.||+|+||.||+|.+..      +++.||+|++...  .......+.+|+.+++.+.||||+++++++..
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTK------TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTP   85 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECC------CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhc
Confidence            356789999999999999999998765      4789999998643  22234567789999999999999999998766


Q ss_pred             CCE------EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEE
Q 013105          154 DEH------RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKL  227 (449)
Q Consensus       154 ~~~------~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl  227 (449)
                      .+.      .++|+||+ +++|.+++..   ..+++..+..++.|++.||.|||  +.||+||||||+||+++.++.++|
T Consensus        86 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH--~~gi~H~dlkp~Nill~~~~~~kL  159 (343)
T cd07851          86 ASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIH--SAGIIHRDLKPSNIAVNEDCELKI  159 (343)
T ss_pred             cccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCCEEE
Confidence            554      89999998 5799888864   46899999999999999999999  778999999999999999999999


Q ss_pred             eeeccccCCCCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhH-Hhhhh
Q 013105          228 SDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV-EWARP  305 (449)
Q Consensus       228 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~-~~~~~  305 (449)
                      +|||++......     .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+ .....
T Consensus       160 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~  234 (343)
T cd07851         160 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT  234 (343)
T ss_pred             cccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Confidence            999999865332     223457899999998854 36789999999999999999999999754322111100 00000


Q ss_pred             ----hhccc--cchhHhhcc---ccccc---CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          306 ----MLKDF--TKLDQIIDS---RLEDR---YSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       306 ----~~~~~--~~~~~~~~~---~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                          .....  ......+..   .....   .....+..+.+++.+||+.||++|||+.+|+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence                00000  000000000   00000   011235679999999999999999999999987

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-36  Score=281.35  Aligned_cols=241  Identities=30%  Similarity=0.382  Sum_probs=196.2

Q ss_pred             ccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc---chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEEEe
Q 013105           87 LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS---QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEY  163 (449)
Q Consensus        87 lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  163 (449)
                      ||.|+||.||++....      .++.+|+|++.....   .....+..|+.+++.++|+||+++++.+..++..++||||
T Consensus         1 lg~G~~~~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   74 (250)
T cd05123           1 LGKGSFGKVLLVRKKD------TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEY   74 (250)
T ss_pred             CCCCCceEEEEEEECC------CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEec
Confidence            6999999999998765      478999999875422   2345788899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCCc
Q 013105          164 MALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSH  243 (449)
Q Consensus       164 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~~  243 (449)
                      +.+++|.+++...  ..+++.....++.|++.||.|||  ..+++|+||+|+||+++.++.++|+|||++........  
T Consensus        75 ~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh--~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--  148 (250)
T cd05123          75 APGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLH--SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--  148 (250)
T ss_pred             CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--
Confidence            9999999998765  46899999999999999999999  68899999999999999999999999999886543221  


Q ss_pred             eeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccccc
Q 013105          244 ITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLED  323 (449)
Q Consensus       244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (449)
                      ......|+..|+|||.+.+...+.++|+||||+++|+|++|..||......   .....             +..  ...
T Consensus       149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~~-------------~~~--~~~  210 (250)
T cd05123         149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---EIYEK-------------ILK--DPL  210 (250)
T ss_pred             cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHH-------------Hhc--CCC
Confidence            123456889999999998888899999999999999999999999754321   10100             001  111


Q ss_pred             cCCHHHHHHHHHHHHHhccCCCCCCCCH---HHHHHH
Q 013105          324 RYSTEGAKRLAAVAHQCLSHNPKSRPTM---TTVVKA  357 (449)
Q Consensus       324 ~~~~~~~~~l~~li~~cl~~dP~~RPs~---~eil~~  357 (449)
                      .++...+..+.+++.+||..||++||++   .+++.+
T Consensus       211 ~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~  247 (250)
T cd05123         211 RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH  247 (250)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence            2333446778999999999999999999   666654

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-36  Score=284.32  Aligned_cols=274  Identities=27%  Similarity=0.435  Sum_probs=204.8

Q ss_pred             cccccCCCccccCHHHHHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHh
Q 013105           58 SSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLG  137 (449)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~  137 (449)
                      ..|.+++.++.+-.   ..+..+..+.+.||+|.||.||+|.|+        |+.||||++...+   ...+.+|.+|.+
T Consensus       193 ~tSGSGSGlplLVQ---RTiarqI~L~e~IGkGRyGEVwrG~wr--------Ge~VAVKiF~srd---E~SWfrEtEIYq  258 (513)
T KOG2052|consen  193 ETSGSGSGLPLLVQ---RTIARQIVLQEIIGKGRFGEVWRGRWR--------GEDVAVKIFSSRD---ERSWFRETEIYQ  258 (513)
T ss_pred             ccCCCCCCchhHhH---HhhhheeEEEEEecCccccceeecccc--------CCceEEEEecccc---hhhhhhHHHHHH
Confidence            34555555554433   345678889999999999999999886        5789999996433   345566776665


Q ss_pred             c--CCCCCcceeeeEEEeC----CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC------CC
Q 013105          138 Q--LKHPHLVNLIGYCCED----EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE------EK  205 (449)
Q Consensus       138 ~--l~h~nIv~~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~------~~  205 (449)
                      .  |+|+||+.+++.-..+    .+++||.+|-+.|+|+|+|.++   .++....++++..++.||++||..      +.
T Consensus       259 TvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKP  335 (513)
T KOG2052|consen  259 TVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKP  335 (513)
T ss_pred             HHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCc
Confidence            5  5999999998875433    4689999999999999999874   899999999999999999999952      44


Q ss_pred             CeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCC--CceeeecCCCCccccccccccC----CC--CcccchhhhHHH
Q 013105          206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGED--SHITTCVMGTEGYAAPEYINTG----HL--TTMCDVFSFGVV  277 (449)
Q Consensus       206 ~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~----~~--~~~~DvwslG~v  277 (449)
                      .|.|||||+.|||+..+|.+.|+|+|||........  ....+..+||..|||||++...    .+  -..+||||||.|
T Consensus       336 aIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLV  415 (513)
T KOG2052|consen  336 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLV  415 (513)
T ss_pred             hhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHH
Confidence            699999999999999999999999999986544321  1223457899999999998532    12  235899999999


Q ss_pred             HHHHHhC----------CCcccccccccchhhHHhhhhhhccccchhHhhcc----cccccC-----CHHHHHHHHHHHH
Q 013105          278 LLELLTG----------RRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDS----RLEDRY-----STEGAKRLAAVAH  338 (449)
Q Consensus       278 l~elltg----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~-----~~~~~~~l~~li~  338 (449)
                      +||++..          ++||.+.               .+..+.+++..+-    +.++..     ...+-..+.+||+
T Consensus       416 lWEiarRc~~ggi~eey~~Pyyd~---------------Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMk  480 (513)
T KOG2052|consen  416 LWEIARRCESGGIVEEYQLPYYDV---------------VPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMK  480 (513)
T ss_pred             HHHHHHHhhcCCEehhhcCCcccC---------------CCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHH
Confidence            9999863          2444322               1222222222111    111111     2355667899999


Q ss_pred             HhccCCCCCCCCHHHHHHHhhcccc
Q 013105          339 QCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       339 ~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                      .||..||.-|-|+-.|-+.|..+.+
T Consensus       481 eCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  481 ECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             HhhcCCchhhhHHHHHHHHHHHHhc
Confidence            9999999999999999999888764

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-36  Score=303.66  Aligned_cols=253  Identities=25%  Similarity=0.349  Sum_probs=208.6

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcC-CCCCcceeeeEEEe---
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCE---  153 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~---  153 (449)
                      ++-|++.+.||.|.+|.||++....      .++..|+|+...... ...++..|.++|+.+ .|||++.+++++..   
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~------~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~   90 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVK------TGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP   90 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeee------cCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence            4668999999999999999997765      588999999975533 345667789999988 59999999999864   


Q ss_pred             --CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeec
Q 013105          154 --DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFG  231 (449)
Q Consensus       154 --~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfG  231 (449)
                        ++.+|||||||.||+.-|++....+..+.+..+..|++.++.||.+||  .+.++|||||-.|||++.++.|||+|||
T Consensus        91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH--~nkviHRDikG~NiLLT~e~~VKLvDFG  168 (953)
T KOG0587|consen   91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH--NNKVIHRDIKGQNVLLTENAEVKLVDFG  168 (953)
T ss_pred             CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh--hcceeeecccCceEEEeccCcEEEeeee
Confidence              578999999999999999998777788999999999999999999999  6669999999999999999999999999


Q ss_pred             cccCCCCCCCCceeeecCCCCccccccccccC-----CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhh
Q 013105          232 LATDGPQGEDSHITTCVMGTEGYAAPEYINTG-----HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPM  306 (449)
Q Consensus       232 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~  306 (449)
                      ++........  ...+.+|||.|||||++...     .|+..+|+||||++..||.-|.+|+....+.....        
T Consensus       169 vSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF--------  238 (953)
T KOG0587|consen  169 VSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF--------  238 (953)
T ss_pred             eeeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc--------
Confidence            9987654332  24456799999999999543     46788999999999999999999987653221111        


Q ss_pred             hccccchhHhh-cccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          307 LKDFTKLDQII-DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       307 ~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                              .+. .++....-+....+++.++|..||.+|.++||++.++++|
T Consensus       239 --------~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  239 --------LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             --------cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence                    111 1111122356778899999999999999999999999987

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.6e-36  Score=279.03  Aligned_cols=226  Identities=24%  Similarity=0.273  Sum_probs=180.6

Q ss_pred             cCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEEEecCCCCh
Q 013105           90 GGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNL  169 (449)
Q Consensus        90 G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L  169 (449)
                      |.||.||++.+..      +++.||+|.+....     .+.+|...+....||||+++++++.+.+..++||||+.||+|
T Consensus         4 g~~~~v~~~~~~~------~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   72 (237)
T cd05576           4 GVIDKVLLVMDTR------TQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKL   72 (237)
T ss_pred             cccceEEEEEEcc------CCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCH
Confidence            8999999997765      58899999996542     223455555566799999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCCceeeecC
Q 013105          170 HDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM  249 (449)
Q Consensus       170 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  249 (449)
                      .+++...  ..+++.....++.|++.||.|||  +++|+||||||+||+++.++.++|+|||++......     .....
T Consensus        73 ~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~  143 (237)
T cd05576          73 WSHISKF--LNIPEECVKRWAAEMVVALDALH--REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEA  143 (237)
T ss_pred             HHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCC
Confidence            9998765  45899999999999999999999  788999999999999999999999999987654332     12234


Q ss_pred             CCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccccccCCHHH
Q 013105          250 GTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEG  329 (449)
Q Consensus       250 gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (449)
                      ++..|+|||.+.+..++.++||||+||++|||++|..|+......            .          ........+..+
T Consensus       144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------~----------~~~~~~~~~~~~  201 (237)
T cd05576         144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------------I----------NTHTTLNIPEWV  201 (237)
T ss_pred             cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------c----------ccccccCCcccC
Confidence            677899999998888999999999999999999999887532100            0          000001122334


Q ss_pred             HHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 013105          330 AKRLAAVAHQCLSHNPKSRPTM-----TTVVKA  357 (449)
Q Consensus       330 ~~~l~~li~~cl~~dP~~RPs~-----~eil~~  357 (449)
                      +..+.+++.+||+.||++||++     ++++.|
T Consensus       202 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  234 (237)
T cd05576         202 SEEARSLLQQLLQFNPTERLGAGVAGVEDIKSH  234 (237)
T ss_pred             CHHHHHHHHHHccCCHHHhcCCCccchHHHHcC
Confidence            5678999999999999999996     555544

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-36  Score=310.33  Aligned_cols=272  Identities=28%  Similarity=0.444  Sum_probs=214.9

Q ss_pred             HHHHHhcCCCCcccccccCceEEEEEEEcCCCCC-CCCCcEEEEEEeccC-CcchHHHHHHHHHHHhcC-CCCCcceeee
Q 013105           73 ELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRP-GLKAQTVAVKVLDVN-GSQGHREWLAEVIFLGQL-KHPHLVNLIG  149 (449)
Q Consensus        73 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~  149 (449)
                      .++...++..+.+.||+|.||.|++|....-... ......||||.++.. .....+.+..|+.+|+.+ .|+||+.+++
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            3445556667777999999999999987653222 123678999999744 334567889999999999 5999999999


Q ss_pred             EEEeCCEEEEEEEecCCCChHHHHhhcC------C--------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCC
Q 013105          150 YCCEDEHRLLVYEYMALGNLHDQLFKNY------S--------STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKAS  215 (449)
Q Consensus       150 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~------~--------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~  215 (449)
                      ++...+..++|+||+..|+|.+++....      .        ..+.....+.++.||+.|++||+  +.++|||||-..
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~--~~~~vHRDLAaR  447 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA--SVPCVHRDLAAR  447 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh--hCCccchhhhhh
Confidence            9999999999999999999999997754      0        13888999999999999999999  677999999999


Q ss_pred             ceEEcCCCcEEEeeeccccCCCCCCCCceeeecCC--CCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccc
Q 013105          216 NILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG--TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNR  292 (449)
Q Consensus       216 Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~  292 (449)
                      |||+..+..+||+|||+|+.......... ..-.|  ...|||||.+....|+.++||||||++||||++ |..||.+..
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            99999999999999999996544333221 11123  335999999999999999999999999999998 778887521


Q ss_pred             cccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          293 CKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                      .  ..++.+              .+....+...|..+++++.++|+.||+.+|++||++.++.+.|+..+.
T Consensus       527 ~--~~~l~~--------------~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  527 P--TEELLE--------------FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             c--HHHHHH--------------HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            1  111111              222223334466678889999999999999999999999999988654

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=296.23  Aligned_cols=250  Identities=24%  Similarity=0.319  Sum_probs=209.8

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      .++++...||-||||.|=++..+..      ...+|+|+++..   +....+.+..|-+||...+.|.||++|-.|.+..
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~------~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k  493 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQ------KATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK  493 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEeccc------chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch
Confidence            4566778899999999999887652      335889988643   3444566788999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..|+.||-|-||.|...+..+  +.+...+..-++..+++|++|||  .+|||+|||||+|++++.+|-+||.|||+|+.
T Consensus       494 yvYmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH--~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKk  569 (732)
T KOG0614|consen  494 YVYMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLH--RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKK  569 (732)
T ss_pred             hhhhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHH--hcCceeccCChhheeeccCCceEEeehhhHHH
Confidence            999999999999999998776  67888888889999999999999  78899999999999999999999999999998


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ...+.   .+.+++|||.|.|||++.+...+.++|.||||+++||||+|.+||.+.++....+++....           
T Consensus       570 i~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi-----------  635 (732)
T KOG0614|consen  570 IGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI-----------  635 (732)
T ss_pred             hccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh-----------
Confidence            76544   3677899999999999999999999999999999999999999999875544443332111           


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT-----MTTVVKA  357 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~  357 (449)
                           -.-.+|..++....+||+++...+|.+|.-     +.+|-+|
T Consensus       636 -----d~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  636 -----DKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH  677 (732)
T ss_pred             -----hhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence                 112345566677889999999999999964     6777777

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=285.37  Aligned_cols=260  Identities=24%  Similarity=0.359  Sum_probs=202.0

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-------chHHHHHHHHHHHhcCCCCCcceeee
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-------QGHREWLAEVIFLGQLKHPHLVNLIG  149 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~nIv~~~~  149 (449)
                      +.++|-++.+||+|||+.||+|.+..      ..+.||||+-..+..       ...+...+|.+|.+.|.||-||++|+
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~------EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD  534 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLT------EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD  534 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccc------hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence            44568888999999999999997654      578999999764421       22345678999999999999999999


Q ss_pred             EEE-eCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEc---CCCcE
Q 013105          150 YCC-EDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD---SDYNA  225 (449)
Q Consensus       150 ~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~---~~~~~  225 (449)
                      +|. +.+..|-|+|||+|.+|.-+|..+  ..+++.+...|+.||+.||.||.....+|||-||||.|||+-   ..|.+
T Consensus       535 yfslDtdsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeI  612 (775)
T KOG1151|consen  535 YFSLDTDSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEI  612 (775)
T ss_pred             eeeeccccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCccccee
Confidence            986 457788999999999998888765  678999999999999999999998888999999999999993   45789


Q ss_pred             EEeeeccccCCCCCCCC-----ceeeecCCCCcccccccccc----CCCCcccchhhhHHHHHHHHhCCCcccccccccc
Q 013105          226 KLSDFGLATDGPQGEDS-----HITTCVMGTEGYAAPEYINT----GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE  296 (449)
Q Consensus       226 kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~  296 (449)
                      ||.||||+.........     ..+....||.||++||.+.-    ...+.++||||+|||+|.++.|+.||.......+
T Consensus       613 KITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd  692 (775)
T KOG1151|consen  613 KITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD  692 (775)
T ss_pred             EeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH
Confidence            99999999976554332     33556779999999998842    3578999999999999999999999976532211


Q ss_pred             hhhHHhhhhhhccccchhHhhccc-ccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          297 KDLVEWARPMLKDFTKLDQIIDSR-LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                        .+.       ...    ++... ..-+..+.++.+..++|++||+.--++|....++..+
T Consensus       693 --ILq-------eNT----IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  693 --ILQ-------ENT----ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             --HHh-------hhc----hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence              111       000    00100 0001112345568899999999999999988887654

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-36  Score=273.14  Aligned_cols=249  Identities=24%  Similarity=0.386  Sum_probs=199.9

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcC-CCCCcceeeeEEEe
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCE  153 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~  153 (449)
                      .++|.+.++||+|+|+.|.++.+..      +.+.+|+|+++..   ...+..-...|-.+..+- +||.+|.+..+|++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~------t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt  322 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKK------TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT  322 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcc------cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence            4689999999999999999986665      6899999999743   344555667787777776 69999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      +..+++|.||++||+|--.++++  ..+++....-+...|+.||.|||  +.|||+||||.+|+|+|.+|++||.|+|++
T Consensus       323 esrlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh--~rgiiyrdlkldnvlldaeghikltdygmc  398 (593)
T KOG0695|consen  323 ESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLH--ERGIIYRDLKLDNVLLDAEGHIKLTDYGMC  398 (593)
T ss_pred             cceEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHh--hcCeeeeeccccceEEccCCceeecccchh
Confidence            99999999999999998777665  68999999999999999999999  889999999999999999999999999999


Q ss_pred             cCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccc-cchhhHHhhhhhhccccc
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCK-REKDLVEWARPMLKDFTK  312 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~  312 (449)
                      +.....  ...+.+++|||.|.|||++.+..|+..+|+|+||++++||+.|+.||+--... .+.+-.++....      
T Consensus       399 ke~l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv------  470 (593)
T KOG0695|consen  399 KEGLGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV------  470 (593)
T ss_pred             hcCCCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH------
Confidence            865432  23466688999999999999999999999999999999999999999732111 111111111110      


Q ss_pred             hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCC
Q 013105          313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRP  349 (449)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  349 (449)
                         ++...  -.++...+-....+++..|++||.+|.
T Consensus       471 ---ilekq--iriprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  471 ---ILEKQ--IRIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ---Hhhhc--ccccceeehhhHHHHHHhhcCCcHHhc
Confidence               11111  123444555577889999999999994

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-36  Score=299.47  Aligned_cols=260  Identities=26%  Similarity=0.365  Sum_probs=214.2

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC-CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEE
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLL  159 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  159 (449)
                      .+..++||+|+||+||+|.|-..  ...-+.+||+|++... ......+++.|+.+|.++.|||++++++++.... +-|
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pe--ge~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql  774 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPE--GENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL  774 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecC--CceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence            34457899999999999999763  3344678999998644 4445678999999999999999999999998665 889


Q ss_pred             EEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCC
Q 013105          160 VYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQG  239 (449)
Q Consensus       160 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~  239 (449)
                      |++|+++|.|.+++..+ ...+.....+.|+.||++||.|||  ++.++||||-..|||+..-..+||.|||+++.....
T Consensus       775 vtq~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe--~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLE--EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HHHhcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHH--hcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            99999999999999875 467888899999999999999999  788999999999999999999999999999977655


Q ss_pred             CCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHhhc
Q 013105          240 EDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIID  318 (449)
Q Consensus       240 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (449)
                      ..........-.+.|||-|.+....|+.++|||||||++||++| |..|+.+....+..+                 ++.
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~d-----------------lle  914 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPD-----------------LLE  914 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhH-----------------HHh
Confidence            44333333223568999999999999999999999999999998 889988764333322                 233


Q ss_pred             ccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          319 SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       319 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                      ...+-..|+.++.++..++.+||..|+..||+++++...+.....
T Consensus       915 ~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  915 KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence            333344577888899999999999999999999999987665543

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-35  Score=287.39  Aligned_cols=205  Identities=26%  Similarity=0.344  Sum_probs=174.6

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      |..++.||-|+||.|.+++-.+      +...||+|.++..+   .........|-.||..-..+-||++|-.|++++.+
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvD------T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL  704 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVD------TRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL  704 (1034)
T ss_pred             eEEEeeecccccceeEEEeecc------hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence            6667889999999999997766      46789999987432   33345567899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      |+||+|++||++-.+|.+.  +.+++....-++..+.+|+++.|  +.|+|||||||+|||||.+|++||.||||+.-+.
T Consensus       705 YFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVH--kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR  780 (1034)
T KOG0608|consen  705 YFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVH--KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  780 (1034)
T ss_pred             EEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHH--hccceecccCccceEEccCCceeeeeccccccce
Confidence            9999999999999999876  68888888889999999999999  8999999999999999999999999999986331


Q ss_pred             CCCCC----------------------------------------ceeeecCCCCccccccccccCCCCcccchhhhHHH
Q 013105          238 QGEDS----------------------------------------HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVV  277 (449)
Q Consensus       238 ~~~~~----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~v  277 (449)
                      -..++                                        ......+||+.|+|||++....|+..+|+||.|||
T Consensus       781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi  860 (1034)
T KOG0608|consen  781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI  860 (1034)
T ss_pred             eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence            11000                                        00113579999999999999999999999999999


Q ss_pred             HHHHHhCCCccccccccc
Q 013105          278 LLELLTGRRSVEKNRCKR  295 (449)
Q Consensus       278 l~elltg~~pf~~~~~~~  295 (449)
                      ||||+.|++||-......
T Consensus       861 l~em~~g~~pf~~~tp~~  878 (1034)
T KOG0608|consen  861 LYEMLVGQPPFLADTPGE  878 (1034)
T ss_pred             HHHHhhCCCCccCCCCCc
Confidence            999999999998765443

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-35  Score=272.13  Aligned_cols=272  Identities=25%  Similarity=0.364  Sum_probs=222.2

Q ss_pred             HHHHHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeee
Q 013105           71 LKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIG  149 (449)
Q Consensus        71 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~  149 (449)
                      .+++..-..+++...++-+|.||.||.|.|.+. ..-...+.|-+|.++... ......++.|.-.+..+.|||+..+.+
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eE-dt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREE-DTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeeccc-CCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            456666678899999999999999999988863 333445667788886543 334567889999999999999999999


Q ss_pred             EEEe-CCEEEEEEEecCCCChHHHHhh------cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC
Q 013105          150 YCCE-DEHRLLVYEYMALGNLHDQLFK------NYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD  222 (449)
Q Consensus       150 ~~~~-~~~~~lv~e~~~~g~L~~~l~~------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~  222 (449)
                      ++.+ ....++++.++.-|+|+.++..      +....+...+...++.|++.|++|||  +.+|||.||...|++||+.
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh--~~~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH--NHGVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH--hcCcccchhhhhcceehhh
Confidence            9865 4678899999999999999862      34456778888999999999999999  7779999999999999999


Q ss_pred             CcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHH
Q 013105          223 YNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVE  301 (449)
Q Consensus       223 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~  301 (449)
                      .++||+|=.+++...+.+.............||+||.+.+..|+.++||||||++||||+| |+.|+..-++.      +
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf------E  506 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF------E  506 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH------H
Confidence            9999999999998877666555555556789999999999999999999999999999998 78887543221      1


Q ss_pred             hhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccc
Q 013105          302 WARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL  362 (449)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  362 (449)
                                 +...+....+-..|-+||+++..++..||+.+|++||+++++..-|.++.
T Consensus       507 -----------m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  507 -----------MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             -----------HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence                       11222222333446788999999999999999999999999999887764

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.1e-34  Score=298.99  Aligned_cols=268  Identities=19%  Similarity=0.220  Sum_probs=170.7

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeE------
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGY------  150 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~------  150 (449)
                      ..++|.+.+.||+|+||.||+|.+..+.  ...+..||+|.+......  .....|  .+....+.++..++..      
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~--~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~  203 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQ--SKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVS  203 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCc--cccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence            3578999999999999999999886521  123789999988633221  111111  1122222222222211      


Q ss_pred             EEeCCEEEEEEEecCCCChHHHHhhcCCC------------------CCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccC
Q 013105          151 CCEDEHRLLVYEYMALGNLHDQLFKNYSS------------------TLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDF  212 (449)
Q Consensus       151 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------------~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDi  212 (449)
                      .......+|||||+.+++|.+++......                  ......+..++.|++.||.|||  +++|+||||
T Consensus       204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH--~~gIiHRDL  281 (566)
T PLN03225        204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH--STGIVHRDV  281 (566)
T ss_pred             cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH--HCCEEeCcC
Confidence            24567899999999999999988653210                  1112345578999999999999  678999999


Q ss_pred             CCCceEEcC-CCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccC----------------------CCCccc
Q 013105          213 KASNILLDS-DYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTG----------------------HLTTMC  269 (449)
Q Consensus       213 kp~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~  269 (449)
                      ||+|||++. ++.+||+|||+|........ .......||+.|+|||.+...                      .++.++
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            999999986 57999999999986543222 123446789999999976322                      234567


Q ss_pred             chhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccccccC------CHHHHHHHHHHHHHhccC
Q 013105          270 DVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRY------STEGAKRLAAVAHQCLSH  343 (449)
Q Consensus       270 DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~  343 (449)
                      |||||||+||||+++..++.....    .+.............+...+........      .........+|+.+||+.
T Consensus       361 DVwSlGviL~el~~~~~~~~~~~~----~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSNLI----QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchHHH----HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence            999999999999997766543210    0000000000000011111111100000      001122356899999999


Q ss_pred             CCCCCCCHHHHHHH
Q 013105          344 NPKSRPTMTTVVKA  357 (449)
Q Consensus       344 dP~~RPs~~eil~~  357 (449)
                      ||++|||+.++++|
T Consensus       437 dP~kR~ta~e~L~H  450 (566)
T PLN03225        437 KGRQRISAKAALAH  450 (566)
T ss_pred             CcccCCCHHHHhCC
Confidence            99999999999997

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1e-33  Score=261.85  Aligned_cols=238  Identities=31%  Similarity=0.401  Sum_probs=192.7

Q ss_pred             CceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcch-HHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEEEecCCCCh
Q 013105           91 GFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG-HREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNL  169 (449)
Q Consensus        91 ~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L  169 (449)
                      +||.||+|.+..      +++.+|+|++....... ...+.+|++.+++++|+||+++++++......+++|||+.+++|
T Consensus         1 ~~g~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L   74 (244)
T smart00220        1 SFGKVYLARDKK------TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDL   74 (244)
T ss_pred             CceEEEEEEECC------CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCH
Confidence            589999998865      47899999997654443 67889999999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCCceeeecC
Q 013105          170 HDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM  249 (449)
Q Consensus       170 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  249 (449)
                      .+++....  .+++.....++.+++.++.+||  ..+++|+||+|.||+++.++.++|+|||.+.......   ......
T Consensus        75 ~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~  147 (244)
T smart00220       75 FDLLKKRG--RLSEDEARFYARQILSALEYLH--SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFV  147 (244)
T ss_pred             HHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH--HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---cccccc
Confidence            99886642  3889999999999999999999  6789999999999999999999999999998654432   223355


Q ss_pred             CCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccccccCCH--
Q 013105          250 GTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYST--  327 (449)
Q Consensus       250 gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  327 (449)
                      |+..|++||.+.+..++.++||||||+++|+|++|..||......  .......              ..........  
T Consensus       148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~--------------~~~~~~~~~~~~  211 (244)
T smart00220      148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKI--------------GKPKPPFPPPEW  211 (244)
T ss_pred             CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHH--------------hccCCCCccccc
Confidence            889999999998888899999999999999999999999752111  1111110              0000000000  


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          328 EGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       328 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .++.++.+++.+||..+|++||++.+++++
T Consensus       212 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      212 KISPEAKDLIRKLLVKDPEKRLTAEEALQH  241 (244)
T ss_pred             cCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence            145679999999999999999999999974

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.4e-33  Score=283.85  Aligned_cols=272  Identities=18%  Similarity=0.273  Sum_probs=182.6

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCC----------CCCCCCcEEEEEEeccCCcchHHHH--------------HHHH
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNL----------RPGLKAQTVAVKVLDVNGSQGHREW--------------LAEV  133 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~----------~~~~~~~~vavK~~~~~~~~~~~~~--------------~~E~  133 (449)
                      .++|.+.++||+|+||.||+|.+....          .....++.||||.+.........+|              ..|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            568999999999999999999763211          1123456899999875433222233              3466


Q ss_pred             HHHhcCCCCCc-----ceeeeEEEe--------CCEEEEEEEecCCCChHHHHhhcCC----------------------
Q 013105          134 IFLGQLKHPHL-----VNLIGYCCE--------DEHRLLVYEYMALGNLHDQLFKNYS----------------------  178 (449)
Q Consensus       134 ~~l~~l~h~nI-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~----------------------  178 (449)
                      .++.+++|.++     ++++++|..        .+..+|||||+.+++|.+++.....                      
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77777766554     566676643        3568999999999999998864211                      


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCcccccc
Q 013105          179 STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPE  258 (449)
Q Consensus       179 ~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE  258 (449)
                      ..+++..+..++.|++.+|.|||  ..+|+||||||+|||++.++.+||+|||++.......... .....+|+.|+|||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH--~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~aPE  380 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLH--RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSPPE  380 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeChh
Confidence            12356678889999999999999  6789999999999999999999999999997543322111 12233589999999


Q ss_pred             ccccCC--------------------CC--cccchhhhHHHHHHHHhCCC-cccccccccchhhHHhhhhhhccccchhH
Q 013105          259 YINTGH--------------------LT--TMCDVFSFGVVLLELLTGRR-SVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       259 ~~~~~~--------------------~~--~~~DvwslG~vl~elltg~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ++....                    |+  .+.||||+||++|+|++|.. ||........ +...+    ......+..
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~-~~~~~----~~~~~~~r~  455 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT-ELRQY----DNDLNRWRM  455 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh-HHhhc----cchHHHHHh
Confidence            875322                    11  34799999999999999885 6643211100 00000    000000000


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCC---CCCCCHHHHHHH
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNP---KSRPTMTTVVKA  357 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~eil~~  357 (449)
                      .......-......++...+|+.+||..+|   .+|+|+.++|+|
T Consensus       456 ~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        456 YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            000011111122345678999999999866   689999999998

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=246.08  Aligned_cols=202  Identities=28%  Similarity=0.358  Sum_probs=166.6

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC-CcchHHHHHHHHHHHhcC-CCCCcceeeeEEEeCCE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~  156 (449)
                      ++......||+|+||.|=+-.      +..+|+..|+|.+... +.+...++++|+.+..+. .+|++|.+||.......
T Consensus        46 d~L~~i~elGrGayG~vekmr------h~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd  119 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMR------HIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD  119 (282)
T ss_pred             hhhhhhhhhcCCccchhhhee------eccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence            344455679999999997764      4447999999999755 455567788999877665 69999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          157 RLLVYEYMALGNLHDQLFK--NYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      .+|.||.|. .+|..+..+  ..+..+++...-+|+..++.||.|||+ ...|||||+||+||||+.+|++|+||||++-
T Consensus       120 vwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~-kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  120 VWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS-KLSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH-HhhhhhccCCcceEEEccCCcEEEcccccce
Confidence            999999997 566554432  246789999999999999999999997 5679999999999999999999999999998


Q ss_pred             CCCCCCCCceeeecCCCCcccccccccc----CCCCcccchhhhHHHHHHHHhCCCccccc
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINT----GHLTTMCDVFSFGVVLLELLTGRRSVEKN  291 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~vl~elltg~~pf~~~  291 (449)
                      .+.+..   ..+...|...|||||.+..    ..|+-++||||||+++.||.+++.||+.+
T Consensus       198 ~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  198 YLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             eehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            664322   2222458899999998843    36899999999999999999999999865

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-34  Score=288.41  Aligned_cols=246  Identities=27%  Similarity=0.383  Sum_probs=186.1

Q ss_pred             CCCcccccccCceE-EEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcC-CCCCcceeeeEEEeCCEEE
Q 013105           81 FSRSDYLGEGGFGK-VYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        81 y~~~~~lG~G~~g~-V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~  158 (449)
                      |.-.+++|.|+-|+ ||+|.+.        ++.||||.+-.   .......+|+..|+.- .|||||++|+.-.+....|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye--------~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~Y  579 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE--------GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLY  579 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC--------CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEE
Confidence            44457799998765 7999774        67999998842   2234567899999988 5999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC---C--CcEEEeeec
Q 013105          159 LVYEYMALGNLHDQLFKN--YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS---D--YNAKLSDFG  231 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~---~--~~~kl~DfG  231 (449)
                      |..|.|. .+|.+++...  ..........+.+..|++.||++||  ..+||||||||+||||+.   +  ..++|+|||
T Consensus       580 IalELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH--sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfg  656 (903)
T KOG1027|consen  580 IALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH--SLKIVHRDLKPQNILISVPSADGTLRAKISDFG  656 (903)
T ss_pred             EEehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH--hcccccccCCCceEEEEccCCCcceeEEecccc
Confidence            9999997 8999999763  1111111445778899999999999  567999999999999976   3  468999999


Q ss_pred             cccCCCCCCCC-ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhC-CCcccccccccchhhHHhhhhhhcc
Q 013105          232 LATDGPQGEDS-HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG-RRSVEKNRCKREKDLVEWARPMLKD  309 (449)
Q Consensus       232 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~  309 (449)
                      +++....+..+ .......||-+|+|||++....-+.++|||||||++|+.++| ..||...-.. +.+.       +..
T Consensus       657 lsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-~~NI-------l~~  728 (903)
T KOG1027|consen  657 LSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-QANI-------LTG  728 (903)
T ss_pred             cccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-hhhh-------hcC
Confidence            99987655432 223456799999999999888888899999999999999997 8999754211 1111       111


Q ss_pred             ccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          310 FTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ...+..+      .. ..++  +..+||.+|++.+|..||++.+|+.|
T Consensus       729 ~~~L~~L------~~-~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  729 NYTLVHL------EP-LPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             ccceeee------cc-CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence            1111000      00 1111  68899999999999999999999988

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=2.2e-34  Score=274.44  Aligned_cols=274  Identities=25%  Similarity=0.280  Sum_probs=208.4

Q ss_pred             CHHHHHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC------CCC
Q 013105           70 TLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK------HPH  143 (449)
Q Consensus        70 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~n  143 (449)
                      .+.-.+.+..+|.+....|+|-|++|.+|.+..      .+..||||+|..+ ...++.=+.|+++|++|+      --|
T Consensus       423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~------r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~H  495 (752)
T KOG0670|consen  423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQA------RGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFH  495 (752)
T ss_pred             EEehhhhhcceeEEEeccccceeeeeeeccccC------CCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhH
Confidence            344556778899999999999999999996654      5779999999744 333455678999999995      358


Q ss_pred             cceeeeEEEeCCEEEEEEEecCCCChHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC
Q 013105          144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKN-YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD  222 (449)
Q Consensus       144 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~  222 (449)
                      +++++..|...+++|||+|-+. -+|.+.|.+- .+-.|....+..++.|+.-||..|-  .-||+|.||||.|||+++.
T Consensus       496 clrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK--~c~vlHaDIKPDNiLVNE~  572 (752)
T KOG0670|consen  496 CLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK--KCGVLHADIKPDNILVNES  572 (752)
T ss_pred             HHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH--hcCeeecccCccceEeccC
Confidence            9999999999999999999885 7888888653 3456788899999999999999999  7789999999999999876


Q ss_pred             C-cEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHH
Q 013105          223 Y-NAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVE  301 (449)
Q Consensus       223 ~-~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~  301 (449)
                      . .+||||||.|..........    +.-+..|.|||++.|..|+...|+||.||+||||.||+..|.+........+..
T Consensus       573 k~iLKLCDfGSA~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m  648 (752)
T KOG0670|consen  573 KNILKLCDFGSASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM  648 (752)
T ss_pred             cceeeeccCccccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence            4 67999999998765544222    234678999999999999999999999999999999999999875544433321


Q ss_pred             hhhh-----hhccccchhHhhcc--------------------------------cc--cccCCH---HHHHHHHHHHHH
Q 013105          302 WARP-----MLKDFTKLDQIIDS--------------------------------RL--EDRYST---EGAKRLAAVAHQ  339 (449)
Q Consensus       302 ~~~~-----~~~~~~~~~~~~~~--------------------------------~~--~~~~~~---~~~~~l~~li~~  339 (449)
                      -+..     ++....-.++.++.                                .+  .+.++.   ..-..|.+|+..
T Consensus       649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk  728 (752)
T KOG0670|consen  649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK  728 (752)
T ss_pred             HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH
Confidence            1100     00000000000000                                00  011222   234568899999


Q ss_pred             hccCCCCCCCCHHHHHHH
Q 013105          340 CLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       340 cl~~dP~~RPs~~eil~~  357 (449)
                      ||..||++|.|+.+.|+|
T Consensus       729 ml~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  729 MLILDPEKRITVNQALKH  746 (752)
T ss_pred             HhccChhhcCCHHHHhcC
Confidence            999999999999999988

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=3.6e-34  Score=247.46  Aligned_cols=261  Identities=16%  Similarity=0.297  Sum_probs=196.9

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC-CCCcceeeeEEEeC--
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-HPHLVNLIGYCCED--  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~--  154 (449)
                      .++|++.+.+|+|.|+.||-|....      +.+.++||+++.-   ..+.+.+|+.||..|. ||||+.++++..+.  
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~------~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S  107 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINIT------NNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPES  107 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccC------CCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence            4679999999999999999996554      4788999999732   3467889999999997 99999999998765  


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC-CcEEEeeeccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD-YNAKLSDFGLA  233 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~-~~~kl~DfGla  233 (449)
                      ..+.||+||+++.+...+.     ..++...+..++.+++.||.|||  +.||+|||+||.|++||.. ..++|+|+|+|
T Consensus       108 ktpaLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCH--S~GImHRDVKPhNvmIdh~~rkLrlIDWGLA  180 (338)
T KOG0668|consen  108 KTPSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCH--SMGIMHRDVKPHNVMIDHELRKLRLIDWGLA  180 (338)
T ss_pred             cCchhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHH--hcCcccccCCcceeeechhhceeeeeecchH
Confidence            5678999999987776554     45777788899999999999999  7889999999999999865 47999999999


Q ss_pred             cCCCCCCCCceeeecCCCCccccccccc-cCCCCcccchhhhHHHHHHHHhCCCcccccccccch-----------hhHH
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYIN-TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREK-----------DLVE  301 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~-----------~~~~  301 (449)
                      ....++...   ...+.+..|--||++. ...|+.+-|+|||||+|..|+..+.||.......++           ++..
T Consensus       181 EFYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~  257 (338)
T KOG0668|consen  181 EFYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYA  257 (338)
T ss_pred             hhcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHH
Confidence            987765543   3345688899999984 467899999999999999999999998654322211           1111


Q ss_pred             hhhhh-hccccchhHhhcccccc---cC----CHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          302 WARPM-LKDFTKLDQIIDSRLED---RY----STE-GAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       302 ~~~~~-~~~~~~~~~~~~~~~~~---~~----~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      +.... +.-.+.+..++......   .+    ... ..++..+++.++|..|-.+|+|+.|.+.|
T Consensus       258 Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  258 YLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence            11110 00111122221111111   11    111 24678999999999999999999999987

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-35  Score=258.67  Aligned_cols=267  Identities=19%  Similarity=0.287  Sum_probs=198.1

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC---
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED---  154 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~---  154 (449)
                      +.+-.+.||-|+||.||.+++..      .++.||+|.+..-  +-...+.+.+|+.+|..++|.|++..+++.+-.   
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPR------dgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~d  127 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPR------SGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPS  127 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCC------CccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCch
Confidence            45567889999999999987654      5888999987521  223346788999999999999999999887643   


Q ss_pred             --CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecc
Q 013105          155 --EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL  232 (449)
Q Consensus       155 --~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGl  232 (449)
                        ..+|++.|.|. .+|...|..  ...++...+.-+.+||++||.|||  ..+|+||||||.|+|++.|..+||||||+
T Consensus       128 fFqEiYV~TELmQ-SDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLH--sA~ILHRDIKPGNLLVNSNCvLKICDFGL  202 (449)
T KOG0664|consen  128 FFQELYVLTELMQ-SDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLH--TANILHRDIKPGNLLVNSNCILKICDFGL  202 (449)
T ss_pred             HHHHHHHHHHHHH-hhhhheecc--CCCCCcchhhhhHHHHHhhhHHHh--hcchhhccCCCccEEeccCceEEeccccc
Confidence              24577888886 677776643  367888888889999999999999  67799999999999999999999999999


Q ss_pred             ccCCCCCCCCceeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhh--hhhcc
Q 013105          233 ATDGPQGEDSHITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR--PMLKD  309 (449)
Q Consensus       233 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~  309 (449)
                      ++........ .++..+-|-+|+|||++.|. .|+.++||||.|||+.||+..+..|....+....+++.-..  +.+..
T Consensus       203 ARvee~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~Ea  281 (449)
T KOG0664|consen  203 ARTWDQRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEA  281 (449)
T ss_pred             ccccchhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHH
Confidence            9976554433 34455678999999999764 69999999999999999999999998776666555543221  11111


Q ss_pred             ccc-----hhHhhccccc-ccC--------CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 013105          310 FTK-----LDQIIDSRLE-DRY--------STEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL  358 (449)
Q Consensus       310 ~~~-----~~~~~~~~~~-~~~--------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  358 (449)
                      ...     -..++..... +.+        +..-..+...++..+|..||++|.+..+.+.++
T Consensus       282 Mr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  282 MKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             HHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            000     0001111110 000        112234567788899999999999999998874

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-32  Score=260.51  Aligned_cols=132  Identities=25%  Similarity=0.310  Sum_probs=114.3

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC-----C---CCcceeeeE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-----H---PHLVNLIGY  150 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~nIv~~~~~  150 (449)
                      .+|.+.++||.|.|++||+|.+..      ..+.||+|+.+.. ....+..+.||.+|++++     |   .+||++++.
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq------~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~  150 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQ------NKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH  150 (590)
T ss_pred             ceEEEEEeccccccceeEEEeecc------CCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence            789999999999999999998776      4789999999733 233456788999999883     3   469999999


Q ss_pred             EEe----CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEE
Q 013105          151 CCE----DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILL  219 (449)
Q Consensus       151 ~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill  219 (449)
                      |..    +.+.|+|+|++ |.+|..+|....-+.++...+..|+.|++.||.|||. .-||||-||||+|||+
T Consensus       151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~-ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR-ECGIIHTDLKPENVLL  221 (590)
T ss_pred             ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH-hcCccccCCCcceeee
Confidence            864    57899999998 6899999987777889999999999999999999996 5689999999999998

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1e-32  Score=244.03  Aligned_cols=266  Identities=22%  Similarity=0.342  Sum_probs=195.4

Q ss_pred             ccccCHHHHH--HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcC-CCC
Q 013105           66 LHVFTLKELQ--MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL-KHP  142 (449)
Q Consensus        66 ~~~~~~~~~~--~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~  142 (449)
                      .|.+...+++  .+.+.|.+.+.||+|.||.+-++.++.      +.+.+++|.+... .....+|.+|...--.| .|.
T Consensus         9 ih~I~~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~------s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~   81 (378)
T KOG1345|consen    9 IHLIPMEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQ------SKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQ   81 (378)
T ss_pred             ccccccccccccchhhhhhHHHHhcccceeeEEeeeccC------CceEEEeeccCcc-hhhHHHHHHHhccceeeccch
Confidence            3444444443  345789999999999999999996654      6889999998744 34467899998876666 499


Q ss_pred             CcceeeeE-EEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEc-
Q 013105          143 HLVNLIGY-CCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD-  220 (449)
Q Consensus       143 nIv~~~~~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~-  220 (449)
                      ||+.-|++ |+..+.++++|||++.|+|..-+..   ..+.+.....++.|++.|+.|+|  ++++||||||.+||||- 
T Consensus        82 hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMH--sknlVHRdlK~eNiLif~  156 (378)
T KOG1345|consen   82 HIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMH--SKNLVHRDLKAENILIFD  156 (378)
T ss_pred             hhhHHHHHHhhcCceEEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhh--ccchhhcccccceEEEec
Confidence            99998875 5677889999999999999887754   46778888899999999999999  78899999999999993 


Q ss_pred             C-CCcEEEeeeccccCCCCCCCCceeeecCCCCcccccccccc---C--CCCcccchhhhHHHHHHHHhCCCcccccccc
Q 013105          221 S-DYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT---G--HLTTMCDVFSFGVVLLELLTGRRSVEKNRCK  294 (449)
Q Consensus       221 ~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DvwslG~vl~elltg~~pf~~~~~~  294 (449)
                      . .-.+||||||+.+.....     .....-+..|.+||++..   +  ...+.+|||.||+++|.+|||++||.. ...
T Consensus       157 ~df~rvKlcDFG~t~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk-a~~  230 (378)
T KOG1345|consen  157 ADFYRVKLCDFGLTRKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK-ASI  230 (378)
T ss_pred             CCccEEEeeecccccccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh-hhc
Confidence            3 347999999998854322     222234677999998632   2  347889999999999999999999983 333


Q ss_pred             cchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 013105          295 REKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL  358 (449)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  358 (449)
                      .+..+.+|..-.......        .+.. -..+++.+..+.++-|..+|++|--..++.++-
T Consensus       231 ~d~~Y~~~~~w~~rk~~~--------~P~~-F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  231 MDKPYWEWEQWLKRKNPA--------LPKK-FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             cCchHHHHHHHhcccCcc--------Cchh-hcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            344444443221111111        1111 122345678889999999999996655555543

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.98  E-value=6.3e-33  Score=250.88  Aligned_cols=263  Identities=21%  Similarity=0.265  Sum_probs=196.3

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC-
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED-  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-  154 (449)
                      ..+|...+.+|.|.- .|..|      .+...++.||+|.+...  .....++..+|..++..+.|+||++++.+|.-. 
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a------~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~   88 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAA------FDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQK   88 (369)
T ss_pred             eeeeeeecccCCCCc-eEEec------chhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccc
Confidence            456778888999987 56665      33457889999987532  344556788999999999999999999998543 


Q ss_pred             -----CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEee
Q 013105          155 -----EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSD  229 (449)
Q Consensus       155 -----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~D  229 (449)
                           ...|+|||+|. ++|...+.-    .++-.++..+++|++.|+.|||  +.||+||||||+||++..+..+||+|
T Consensus        89 ~l~~~~e~y~v~e~m~-~nl~~vi~~----elDH~tis~i~yq~~~~ik~lh--s~~IihRdLkPsnivv~~~~~lKi~d  161 (369)
T KOG0665|consen   89 TLEEFQEVYLVMELMD-ANLCQVILM----ELDHETISYILYQMLCGIKHLH--SAGIIHRDLKPSNIVVNSDCTLKILD  161 (369)
T ss_pred             cHHHHHhHHHHHHhhh-hHHHHHHHH----hcchHHHHHHHHHHHHHHHHHH--hcceeecccCcccceecchhheeecc
Confidence                 45699999997 789888762    4666788899999999999999  78899999999999999999999999


Q ss_pred             eccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchh-----------
Q 013105          230 FGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKD-----------  298 (449)
Q Consensus       230 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~-----------  298 (449)
                      ||+|+.....   -..+.++.|..|.|||++.+..|.+.+||||+||++.||++|+..|.+....+.-.           
T Consensus       162 fg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~  238 (369)
T KOG0665|consen  162 FGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDP  238 (369)
T ss_pred             chhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCH
Confidence            9999965443   23555778999999999988889999999999999999999999998653221111           


Q ss_pred             -hHH----hhhhhhccccc-----hhHh-hccccccc--CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          299 -LVE----WARPMLKDFTK-----LDQI-IDSRLEDR--YSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       299 -~~~----~~~~~~~~~~~-----~~~~-~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       +..    .++.+..+.+.     .... .+..++..  .+..-...+.+++.+||..||++|.|+.++|.|
T Consensus       239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence             000    00111110000     0000 01111110  111223457899999999999999999999998

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.98  E-value=1.2e-32  Score=265.68  Aligned_cols=197  Identities=23%  Similarity=0.331  Sum_probs=168.4

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc--------chHHHHHHHHHHHhcCC---CCCccee
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--------QGHREWLAEVIFLGQLK---HPHLVNL  147 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---h~nIv~~  147 (449)
                      .+|...+.||+|+||.|++|+++.+      ...|+||.+.+..-        ...-.+-.|++||..|+   |+||+++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n------~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKl  634 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKEN------NYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKL  634 (772)
T ss_pred             ccceeeeeccccccceEEEeeeccc------ceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhh
Confidence            3588899999999999999998873      67899999864311        01112345999999997   9999999


Q ss_pred             eeEEEeCCEEEEEEEec-CCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEE
Q 013105          148 IGYCCEDEHRLLVYEYM-ALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAK  226 (449)
Q Consensus       148 ~~~~~~~~~~~lv~e~~-~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~k  226 (449)
                      +++|++++.+||+||-- +|-+|+++|..+  ..+.+.+...|+.|++.|+++||  +.||||||||-+|+.++.+|.+|
T Consensus       635 LdfFEddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh--~~~ivhrdikdenvivd~~g~~k  710 (772)
T KOG1152|consen  635 LDFFEDDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLH--DQGIVHRDIKDENVIVDSNGFVK  710 (772)
T ss_pred             hheeecCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhcccccc--ccCceecccccccEEEecCCeEE
Confidence            99999999999999964 456889998765  67889999999999999999999  78899999999999999999999


Q ss_pred             EeeeccccCCCCCCCCceeeecCCCCccccccccccCCC-CcccchhhhHHHHHHHHhCCCccc
Q 013105          227 LSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL-TTMCDVFSFGVVLLELLTGRRSVE  289 (449)
Q Consensus       227 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~pf~  289 (449)
                      |+|||.|.....+.    ...++||..|.|||++.|..| +..-|||+||++||.++....||.
T Consensus       711 lidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  711 LIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99999988654432    456789999999999999887 667899999999999999888874

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=5e-33  Score=272.37  Aligned_cols=255  Identities=24%  Similarity=0.365  Sum_probs=205.8

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      .++|.....+|+|.||.||+|.+.      .+++..|+|+++........-+.+|+-+++..+||||+.+++.+...+.+
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~------~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dkl   87 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDK------RSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKL   87 (829)
T ss_pred             ccchhheeeecCCcccchhhhccc------ccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCc
Confidence            467888999999999999999554      47899999999988777788888999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      +++||||.||+|.+...  ..+.+++.++...+...+.||+|||  +.|=+|||||-.|||+++.|.+|++|||.+-...
T Consensus        88 wicMEycgggslQdiy~--~TgplselqiayvcRetl~gl~ylh--s~gk~hRdiKGanilltd~gDvklaDfgvsaqit  163 (829)
T KOG0576|consen   88 WICMEYCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLH--SQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT  163 (829)
T ss_pred             EEEEEecCCCcccceee--ecccchhHHHHHHHhhhhccchhhh--cCCcccccccccceeecccCceeecccCchhhhh
Confidence            99999999999988664  3478999999999999999999999  7778999999999999999999999999987554


Q ss_pred             CCCCCceeeecCCCCcccccccc---ccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYI---NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ..  ......+.||++|||||+-   ..+.|...+|||++|+...|+-.-++|.....+.....+.      -..     
T Consensus       164 at--i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm------TkS-----  230 (829)
T KOG0576|consen  164 AT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM------TKS-----  230 (829)
T ss_pred             hh--hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh------hcc-----
Confidence            32  2224557899999999986   4567999999999999999998888886543221111100      000     


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       ..++. ...-.....+.+.++++.||.++|++||+++.+|.|
T Consensus       231 -~~qpp-~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  231 -GFQPP-TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             -CCCCC-cccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence             00110 001123445668999999999999999999988864

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=3.3e-30  Score=232.54  Aligned_cols=212  Identities=34%  Similarity=0.555  Sum_probs=182.2

Q ss_pred             ccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc-hHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEEEecC
Q 013105           87 LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ-GHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMA  165 (449)
Q Consensus        87 lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~  165 (449)
                      ||+|++|.||++....      .++.+++|++...... ....+.+|++.++.++|++|+++++++......+++||++.
T Consensus         1 l~~g~~~~v~~~~~~~------~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~   74 (215)
T cd00180           1 LGEGGFGTVYLARDKK------TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCE   74 (215)
T ss_pred             CCcCCceEEEEEEecC------CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCC
Confidence            6899999999997764      4789999999754332 34678899999999999999999999999999999999999


Q ss_pred             CCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC-CCcEEEeeeccccCCCCCCCCce
Q 013105          166 LGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS-DYNAKLSDFGLATDGPQGEDSHI  244 (449)
Q Consensus       166 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~-~~~~kl~DfGla~~~~~~~~~~~  244 (449)
                      +++|.+++.... ..++...+..++.+++.+|.+||  ..+++|+||+|.||+++. ++.++|+|||.+........  .
T Consensus        75 ~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh--~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~  149 (215)
T cd00180          75 GGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLH--SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--L  149 (215)
T ss_pred             CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--h
Confidence            999999886532 46889999999999999999999  678999999999999999 89999999999986544321  1


Q ss_pred             eeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccccc
Q 013105          245 TTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLED  323 (449)
Q Consensus       245 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (449)
                      .....+...|++||.+... .++.+.|+|+||+++++|                                          
T Consensus       150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------  187 (215)
T cd00180         150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------  187 (215)
T ss_pred             hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------
Confidence            2234578899999999776 788999999999999998                                          


Q ss_pred             cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 013105          324 RYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL  358 (449)
Q Consensus       324 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  358 (449)
                             ..+.+++..|++.||++||++.++++++
T Consensus       188 -------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                   2378899999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=5.9e-31  Score=246.54  Aligned_cols=272  Identities=27%  Similarity=0.375  Sum_probs=199.8

Q ss_pred             HHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC-CCCcceeeeEEE
Q 013105           74 LQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-HPHLVNLIGYCC  152 (449)
Q Consensus        74 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~  152 (449)
                      +..+.+.|.+.++||+|.|++||+|++...   ......||+|.+...+.  ..++.+|+++|..+. +.||+++.+++.
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~---~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~r  105 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQ---DTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFR  105 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhh---ccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhc
Confidence            445667899999999999999999977651   33578999999975543  356889999999995 999999999999


Q ss_pred             eCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC-CcEEEeeec
Q 013105          153 EDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD-YNAKLSDFG  231 (449)
Q Consensus       153 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~-~~~kl~DfG  231 (449)
                      .++...+||||++..+..+++.     .++...+..++..++.||.++|  .+|||||||||.|+|.+.. +.-.|+|||
T Consensus       106 nnd~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h--~~GIvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  106 NNDQVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLH--KNGIVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             cCCeeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhh--ccCccccCCCccccccccccCCceEEech
Confidence            9999999999999888877763     5668889999999999999999  8889999999999999754 678999999


Q ss_pred             cccCCC-----------------C--CCC-----------------------CceeeecCCCCccccccccc-cCCCCcc
Q 013105          232 LATDGP-----------------Q--GED-----------------------SHITTCVMGTEGYAAPEYIN-TGHLTTM  268 (449)
Q Consensus       232 la~~~~-----------------~--~~~-----------------------~~~~~~~~gt~~y~aPE~~~-~~~~~~~  268 (449)
                      +|....                 .  +..                       ........||++|+|||++. ....+++
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            997110                 0  000                       00011246999999999985 4567899


Q ss_pred             cchhhhHHHHHHHHhCCCcccccccccc--hhhHHhh--------h----h--hhc------------cccch--hHhhc
Q 013105          269 CDVFSFGVVLLELLTGRRSVEKNRCKRE--KDLVEWA--------R----P--MLK------------DFTKL--DQIID  318 (449)
Q Consensus       269 ~DvwslG~vl~elltg~~pf~~~~~~~~--~~~~~~~--------~----~--~~~------------~~~~~--~~~~~  318 (449)
                      +||||.|+|+.-+++++.||.....+.+  .++....        .    .  ++.            .+..+  ..+..
T Consensus       259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~  338 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK  338 (418)
T ss_pred             cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence            9999999999999999999964422111  1111000        0    0  000            01111  00000


Q ss_pred             cc----ccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          319 SR----LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       319 ~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ..    .........+..+.+++.+||..||.+|.|+++.|+|
T Consensus       339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence            00    0111122334578999999999999999999999998

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=3.1e-29  Score=229.55  Aligned_cols=200  Identities=36%  Similarity=0.461  Sum_probs=171.9

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc-hHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEE
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ-GHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLL  159 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  159 (449)
                      |.+.+.||.|++|.||+|....      +++.+|+|.+...... ....+.+|+..+..++|+|++++++++......++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   74 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKG------TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYL   74 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcC------CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEE
Confidence            5677899999999999998765      4688999999865444 56788899999999999999999999999999999


Q ss_pred             EEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCC
Q 013105          160 VYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQG  239 (449)
Q Consensus       160 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~  239 (449)
                      ++|++.+++|.+++..... .+++.....++.+++.+|.+||  ..+++|+||+|.||+++.++.++|+|||++......
T Consensus        75 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~  151 (225)
T smart00221       75 VMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLH--SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRD  151 (225)
T ss_pred             EEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence            9999999999999876421 2788999999999999999999  678999999999999999999999999998866443


Q ss_pred             CCCceeeecCCCCcccccccc-ccCCCCcccchhhhHHHHHHHHhCCCcccc
Q 013105          240 EDSHITTCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGRRSVEK  290 (449)
Q Consensus       240 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~vl~elltg~~pf~~  290 (449)
                      .. .......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus       152 ~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      152 LA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cc-ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            20 012334578899999998 666788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=3.7e-29  Score=270.11  Aligned_cols=197  Identities=17%  Similarity=0.205  Sum_probs=139.2

Q ss_pred             cCCC-CCcceeeeEE-------EeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 013105          138 QLKH-PHLVNLIGYC-------CEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIY  209 (449)
Q Consensus       138 ~l~h-~nIv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH  209 (449)
                      .++| .||.++++++       ......+++|||+ +++|.+++... ...+++..+..++.||+.||.|||  .+||+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH--~~gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAH--SQGIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHH--hCCeee
Confidence            3445 5777788876       2334667888987 57999998643 356899999999999999999999  788999


Q ss_pred             ccCCCCceEEcCCC-------------------cEEEeeeccccCCCCCCC--------------CceeeecCCCCcccc
Q 013105          210 RDFKASNILLDSDY-------------------NAKLSDFGLATDGPQGED--------------SHITTCVMGTEGYAA  256 (449)
Q Consensus       210 rDikp~Nill~~~~-------------------~~kl~DfGla~~~~~~~~--------------~~~~~~~~gt~~y~a  256 (449)
                      |||||+||||+..+                   .+||+|||+++.......              .......+||++|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            99999999996544                   455666666543211000              000112458999999


Q ss_pred             ccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHH
Q 013105          257 PEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAV  336 (449)
Q Consensus       257 PE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  336 (449)
                      ||++.+..|+.++|||||||+||||++|.+|+......    .......              ..+.... ........+
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~----~~~~~~~--------------~~~~~~~-~~~~~~~~~  244 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT----MSSLRHR--------------VLPPQIL-LNWPKEASF  244 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH----HHHHHHh--------------hcChhhh-hcCHHHHHH
Confidence            99999889999999999999999999999887532110    0000000              0000000 112235678


Q ss_pred             HHHhccCCCCCCCCHHHHHHH
Q 013105          337 AHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       337 i~~cl~~dP~~RPs~~eil~~  357 (449)
                      +.+||+.||.+||++.+++++
T Consensus       245 ~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        245 CLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHhCCCChhhCcChHHHhhc
Confidence            899999999999999999986

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=2.2e-27  Score=229.81  Aligned_cols=275  Identities=23%  Similarity=0.246  Sum_probs=207.0

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCC----CCcceeeeEE-EeC
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKH----PHLVNLIGYC-CED  154 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~nIv~~~~~~-~~~  154 (449)
                      +|.+.+.||+|+||.||++.....     ....+|+|+...........+..|..++..+..    +++..+++.+ ..+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~-----~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~   93 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSE-----KNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE   93 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCC-----CCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence            799999999999999999987652     145799999875433322366778888888863    6899999999 578


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC-----CcEEEee
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD-----YNAKLSD  229 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~-----~~~kl~D  229 (449)
                      ...|+||+.+ |.+|.++........++..+.+.++.|++.+|.+||  +.|++||||||+|+++...     ..+.|.|
T Consensus        94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH--~~G~iHRDiKp~N~~~g~~~~~~~~~~~llD  170 (322)
T KOG1164|consen   94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH--SKGFIHRDIKPENFVVGQSSRSEVRTLYLLD  170 (322)
T ss_pred             ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH--hcCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence            8899999987 789999776655688999999999999999999999  8889999999999999765     4699999


Q ss_pred             ecccc--CCCCCCCC---c--e-eeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHH
Q 013105          230 FGLAT--DGPQGEDS---H--I-TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVE  301 (449)
Q Consensus       230 fGla~--~~~~~~~~---~--~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~  301 (449)
                      ||+++  ........   .  . .....||..|+++..+.+.+.+++.|+||++.++.||+.|..||.............
T Consensus       171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence            99999  32221111   0  1 223569999999999999999999999999999999999999997653222211110


Q ss_pred             hhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCCCCC-CCCceee
Q 013105          302 WARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDIP-IGPFVYT  375 (449)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~-~~~~~~~  375 (449)
                      .             ..............+..+.++...+-..+...+|.+..+...|.......... ..|+.|.
T Consensus       251 ~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~  312 (322)
T KOG1164|consen  251 K-------------DPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWE  312 (322)
T ss_pred             H-------------HhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCccc
Confidence            0             00000000022234456777888888899999999999999988877665333 3455544

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1.3e-27  Score=217.45  Aligned_cols=283  Identities=18%  Similarity=0.200  Sum_probs=220.2

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC-CCCcceeeeEEEeCC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-HPHLVNLIGYCCEDE  155 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~  155 (449)
                      +.-+|++++.||+|+||+++.|+..-      .++.||||.-...+  ...++..|.+..+.|. .++|..+|-+..++-
T Consensus        26 VG~hyrVGkKIGeGsFG~lf~G~Nl~------nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~   97 (449)
T KOG1165|consen   26 VGPHYRVGKKIGEGSFGVLFLGKNLY------NNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGK   97 (449)
T ss_pred             ecccceeccccccCcceeeecccccc------cCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccc
Confidence            44579999999999999999996543      58999999875432  2345667888888884 799999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC-----CcEEEeee
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD-----YNAKLSDF  230 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~-----~~~kl~Df  230 (449)
                      +-.||||++ |.+|.|++ ...+..++..++..++.|++.-++|+|  .+.+|+|||||+|+||..-     ..+.|+||
T Consensus        98 ~NiLVidLL-GPSLEDLF-D~CgR~FSvKTV~miA~Qmi~rie~vH--~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDF  173 (449)
T KOG1165|consen   98 YNILVIDLL-GPSLEDLF-DLCGRRFSVKTVAMIAKQMITRIEYVH--EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDF  173 (449)
T ss_pred             hhhhhhhhh-CcCHHHHH-HHhcCcccHHhHHHHHHHHHHHHHHHH--hcceeecccCccceeecCCCCCCCceEEEEec
Confidence            999999988 67887754 455678999999999999999999999  6779999999999999643     36899999


Q ss_pred             ccccCCCCCCCC-----ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhh
Q 013105          231 GLATDGPQGEDS-----HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARP  305 (449)
Q Consensus       231 Gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~  305 (449)
                      |+|+...+....     .-.....||..||+-..+.|.+.+...|+-|||-++.+.|-|..||.+..........+.+  
T Consensus       174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI--  251 (449)
T KOG1165|consen  174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI--  251 (449)
T ss_pred             cchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh--
Confidence            999977554321     1234567999999999999999999999999999999999999999986544332222111  


Q ss_pred             hhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCCCCC-CCCceeeecCCCC
Q 013105          306 MLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDIP-IGPFVYTVVPPGD  381 (449)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~-~~~~~~~~~~~~~  381 (449)
                              ..-........+...+|.++...+...-..+..+-|.++-+...+.++++..... .+.++|.....+.
T Consensus       252 --------Ge~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln~g~  320 (449)
T KOG1165|consen  252 --------GETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLNNGK  320 (449)
T ss_pred             --------ccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccCCCC
Confidence                    1111111122234556778889999999999999999999999988888665443 4567777666443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=4.3e-28  Score=211.39  Aligned_cols=281  Identities=19%  Similarity=0.214  Sum_probs=218.9

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC-CCCcceeeeEEEeC
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-HPHLVNLIGYCCED  154 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~  154 (449)
                      +..+.|.+.+.||+|+||.+|.|....      .|..||||+-...  .....+..|..+.+.|+ ...|..+..++.+.
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~------~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~   83 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISIT------SGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEK   83 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeecc------CCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhcccc
Confidence            456789999999999999999997765      5899999997543  23456778999999997 47888888889899


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC---CcEEEeeec
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD---YNAKLSDFG  231 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~---~~~kl~DfG  231 (449)
                      ..-.+||+.+ |.+|.+++. -....++..+++.++-|++.-++|+|  .+++|||||||+|+|..-+   ..+.|+|||
T Consensus        84 ~ynvlVMdLL-GPsLEdLfn-fC~R~ftmkTvLMLaDQml~RiEyvH--~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFG  159 (341)
T KOG1163|consen   84 DYNVLVMDLL-GPSLEDLFN-FCSRRFTMKTVLMLADQMLSRIEYVH--LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFG  159 (341)
T ss_pred             ccceeeeecc-CccHHHHHH-HHhhhhhHHhHHHHHHHHHHHHHHHH--hhccccccCCccceeeccccccceEEEEecc
Confidence            9999999988 688877653 33467889999999999999999999  7889999999999999644   468999999


Q ss_pred             cccCCCCCCCC-----ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhh
Q 013105          232 LATDGPQGEDS-----HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPM  306 (449)
Q Consensus       232 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~  306 (449)
                      +|+...+....     .......||..|.+--.+.+.+.+...|+-|+|.+|.++.-|..||.+..........+     
T Consensus       160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE-----  234 (341)
T KOG1163|consen  160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE-----  234 (341)
T ss_pred             chhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH-----
Confidence            99976543221     12334679999999988888888999999999999999999999999865433322221     


Q ss_pred             hccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCCCCCCC-CceeeecC
Q 013105          307 LKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDIPIG-PFVYTVVP  378 (449)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~~-~~~~~~~~  378 (449)
                           .+.+...+..........|.++.-.+..|-..-.++-|++.-+.+.+..++.......+ -++|+...
T Consensus       235 -----kI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lk  302 (341)
T KOG1163|consen  235 -----KISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLK  302 (341)
T ss_pred             -----HHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHH
Confidence                 11111112222333445667788899999999999999999999998888877766554 45666554

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=6.5e-27  Score=206.53  Aligned_cols=167  Identities=23%  Similarity=0.203  Sum_probs=125.2

Q ss_pred             CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCCceee
Q 013105          167 GNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITT  246 (449)
Q Consensus       167 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  246 (449)
                      |+|.+++... ...+++..++.++.|++.||.|||  ..+      ||+|||++.++.+++  ||++.......      
T Consensus         1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH--~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELH--RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHH--hcC------CcccEeEcCccceee--ccceEeecccc------
Confidence            6899988653 356999999999999999999999  544      999999999999999  99987643321      


Q ss_pred             ecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccccccCC
Q 013105          247 CVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYS  326 (449)
Q Consensus       247 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (449)
                       ..||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+..........        . .......
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~--------~-~~~~~~~  132 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILLNGMPAD--------D-PRDRSNL  132 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHHHHhccC--------C-ccccccH
Confidence             2589999999999999999999999999999999999999965321110 000110000000        0 0000112


Q ss_pred             HHHHH--HHHHHHHHhccCCCCCCCCHHHHHHHhhcc
Q 013105          327 TEGAK--RLAAVAHQCLSHNPKSRPTMTTVVKALEPL  361 (449)
Q Consensus       327 ~~~~~--~l~~li~~cl~~dP~~RPs~~eil~~L~~~  361 (449)
                      .....  .+.+++.+||+.||.+||++.++++++...
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            23333  699999999999999999999999997654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=5.7e-26  Score=219.74  Aligned_cols=178  Identities=18%  Similarity=0.134  Sum_probs=133.8

Q ss_pred             HHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC-----CcchHHHHHHHHHHHhcCCCCCcce-ee
Q 013105           75 QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-----GSQGHREWLAEVIFLGQLKHPHLVN-LI  148 (449)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~-~~  148 (449)
                      ..+.++|.+.+.||+|+||+||+|.+...     +++.||||++...     .......+.+|+++|+.++|+||+. ++
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~   88 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGD-----PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLL   88 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCC-----CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEE
Confidence            34667899999999999999999976542     3567899987532     1122456889999999999999985 44


Q ss_pred             eEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccC-CCCceEEcCCCcEEE
Q 013105          149 GYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDF-KASNILLDSDYNAKL  227 (449)
Q Consensus       149 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDi-kp~Nill~~~~~~kl  227 (449)
                      +    .+..||||||+.|++|.. +..     ..   ...++.+++.+|.|||  .+||+|||| ||+|||++.++.++|
T Consensus        89 ~----~~~~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH--~~gIiHrDL~KP~NILv~~~~~ikL  153 (365)
T PRK09188         89 A----TGKDGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLH--RAGITHNDLAKPQNWLMGPDGEAAV  153 (365)
T ss_pred             E----cCCcEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHH--HCCCeeCCCCCcceEEEcCCCCEEE
Confidence            3    245899999999999963 211     11   1467889999999999  788999999 999999999999999


Q ss_pred             eeeccccCCCCCCCCce------eeecCCCCccccccccccCC------CCcccchh
Q 013105          228 SDFGLATDGPQGEDSHI------TTCVMGTEGYAAPEYINTGH------LTTMCDVF  272 (449)
Q Consensus       228 ~DfGla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~------~~~~~Dvw  272 (449)
                      +|||+|+..........      .....|++.|+|||.+....      .+...|-|
T Consensus       154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            99999986544321111      13467899999999985432      23446666

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=9.2e-24  Score=203.41  Aligned_cols=260  Identities=30%  Similarity=0.419  Sum_probs=195.4

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc---hHHHHHHHHHHHhcCCCC-CcceeeeEEEeCCE
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ---GHREWLAEVIFLGQLKHP-HLVNLIGYCCEDEH  156 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-nIv~~~~~~~~~~~  156 (449)
                      |.+.+.||.|+||.||++.+.         ..+++|.+......   ....+.+|+.++..+.|+ +|+.+++++.....
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   72 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGS   72 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCE
Confidence            667788999999999999764         57899999754322   367789999999999988 79999999988888


Q ss_pred             EEEEEEecCCCChHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC-cEEEeeecccc
Q 013105          157 RLLVYEYMALGNLHDQLFKNYS-STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY-NAKLSDFGLAT  234 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~-~~kl~DfGla~  234 (449)
                      .+++++++.++++.+++..... ..+.......+..|++.++.|+|  ..+++||||||+||+++..+ .++++|||++.
T Consensus        73 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H--~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~  150 (384)
T COG0515          73 LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH--SKGIIHRDIKPENILLDRDGRVVKLIDFGLAK  150 (384)
T ss_pred             EEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeeecCCCCeEEEeccCcce
Confidence            8999999999999966644321 26888999999999999999999  77799999999999999998 79999999998


Q ss_pred             CCCCCCCCc----eeeecCCCCcccccccccc---CCCCcccchhhhHHHHHHHHhCCCcccccccc-cchhhHHhhhhh
Q 013105          235 DGPQGEDSH----ITTCVMGTEGYAAPEYINT---GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCK-REKDLVEWARPM  306 (449)
Q Consensus       235 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~vl~elltg~~pf~~~~~~-~~~~~~~~~~~~  306 (449)
                      .........    ......||..|++||.+.+   ..++...|+||+|++++++++|..||...... ............
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  230 (384)
T COG0515         151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL  230 (384)
T ss_pred             ecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc
Confidence            544332221    2355679999999999987   57899999999999999999999997654321 000111110000


Q ss_pred             hccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          307 LKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .   ..   .................+.+++..|+..+|..|.+..+....
T Consensus       231 ~---~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         231 P---TP---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             C---Cc---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            0   00   000000000001223568899999999999999998887765

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=4.3e-26  Score=234.61  Aligned_cols=260  Identities=19%  Similarity=0.273  Sum_probs=189.5

Q ss_pred             CCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEe-ccCCcchH-HHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEE
Q 013105           82 SRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL-DVNGSQGH-REWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLL  159 (449)
Q Consensus        82 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~-~~~~~~~~-~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  159 (449)
                      ....++|.|++|.|+.+....... ....+.+++| . ........ ..+..|+.+-..++|||++..+..+.+....+-
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~-~~~~~~~r~~-~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~  398 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLK-SFPEKEFRVR-VKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQ  398 (601)
T ss_pred             CccceeeecccCceEEEEecCCCc-cchhhhhhcc-cCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchh
Confidence            456789999999777765543211 1112222332 1 11111111 125668888888999999988887777666666


Q ss_pred             EEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCC
Q 013105          160 VYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQG  239 (449)
Q Consensus       160 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~  239 (449)
                      +||||++ +|..++...  ..+....+..++.|++.|+.|+|  ..||.|||||++|++++.+|.+||+|||.+..+...
T Consensus       399 ~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h--~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  399 SMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLH--SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHH--hcCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            6999998 999988664  46788888999999999999999  788999999999999999999999999999866554


Q ss_pred             CCC--ceeeecCCCCccccccccccCCCCc-ccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHh
Q 013105          240 EDS--HITTCVMGTEGYAAPEYINTGHLTT-MCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI  316 (449)
Q Consensus       240 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (449)
                      ...  .....++|+..|+|||++.+..|.+ .+||||.|+++..|.+|+.||......+......       ....  ..
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~-------~~~~--~~  544 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN-------NYSD--QR  544 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh-------cccc--cc
Confidence            433  4556678999999999999998876 5899999999999999999998654332211000       0000  00


Q ss_pred             hcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      -...-.......++.+.+.+|.+||+.||.+|.|+++|++.
T Consensus       545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            00001122234567778999999999999999999999975

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.91  E-value=2.1e-25  Score=197.86  Aligned_cols=245  Identities=21%  Similarity=0.354  Sum_probs=193.5

Q ss_pred             cccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEE
Q 013105           84 SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVY  161 (449)
Q Consensus        84 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  161 (449)
                      ..+|.+...|..|+|.|..        ..++.|++....  ....++|..|.-.|+-+.||||+.+++.|....++.++.
T Consensus       195 ~tkl~e~hsgelwrgrwqg--------ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is  266 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQG--------NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS  266 (448)
T ss_pred             hhhhccCCCcccccccccC--------cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence            4458888999999998865        357788886543  223357888999999999999999999999999999999


Q ss_pred             EecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEe--eeccccCCCCC
Q 013105          162 EYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLS--DFGLATDGPQG  239 (449)
Q Consensus       162 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~--DfGla~~~~~~  239 (449)
                      .||+.|+|+..+....+-..+..+..+++.++++|++|||+.+.-|.---|....+++|++.+.+|.  |--++..    
T Consensus       267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq----  342 (448)
T KOG0195|consen  267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ----  342 (448)
T ss_pred             eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee----
Confidence            9999999999998877677788899999999999999999877656666889999999999877664  3222111    


Q ss_pred             CCCceeeecCCCCccccccccccCCC---CcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHh
Q 013105          240 EDSHITTCVMGTEGYAAPEYINTGHL---TTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI  316 (449)
Q Consensus       240 ~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (449)
                           .....-.|.||+||.++..+-   -.++|+|||+++||||.|...||.....-+                ---++
T Consensus       343 -----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme----------------cgmki  401 (448)
T KOG0195|consen  343 -----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME----------------CGMKI  401 (448)
T ss_pred             -----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh----------------hhhhh
Confidence                 111224789999999976543   357999999999999999999997643211                11112


Q ss_pred             hcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcc
Q 013105          317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL  361 (449)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  361 (449)
                      ....++..+++..+..+..|+.-|++.||.+||.+..|+-.|+..
T Consensus       402 aleglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  402 ALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             hhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            233455667788888999999999999999999999999888764

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=1.1e-23  Score=189.99  Aligned_cols=174  Identities=13%  Similarity=0.125  Sum_probs=132.9

Q ss_pred             HHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHH---H------HHHHHHHHhcCCCCCcc
Q 013105           75 QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR---E------WLAEVIFLGQLKHPHLV  145 (449)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~h~nIv  145 (449)
                      ..+.++|++.++||.|+||.||++.. .       +..+|+|++.........   .      +.+|++.+.++.|++|.
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~-------~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~   98 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT-D-------YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLA   98 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec-C-------CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCC
Confidence            45678999999999999999999643 2       457999999743222222   2      57899999999999999


Q ss_pred             eeeeEEEeC--------CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCce
Q 013105          146 NLIGYCCED--------EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNI  217 (449)
Q Consensus       146 ~~~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Ni  217 (449)
                      .+.+++...        +..+|||||++|.+|.++.      .++.    ....+++.+|..+|  ..|++||||||+||
T Consensus        99 ~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH--~~gi~H~Dikp~Ni  166 (232)
T PRK10359         99 SLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLH--QHGMVSGDPHKGNF  166 (232)
T ss_pred             cceEeeeecccccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHH--HcCCccCCCChHHE
Confidence            999986643        3578999999999998763      1222    24558899999999  78899999999999


Q ss_pred             EEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh
Q 013105          218 LLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT  283 (449)
Q Consensus       218 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt  283 (449)
                      +++.+| ++|+|||............              ..+....|+.++|+||||+++..+..
T Consensus       167 li~~~g-i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        167 IVSKNG-LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             EEeCCC-EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHHH
Confidence            999998 9999999887543211110              02333457789999999999876643

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.88  E-value=1.5e-22  Score=187.85  Aligned_cols=232  Identities=21%  Similarity=0.300  Sum_probs=150.6

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCC----------CCccee
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKH----------PHLVNL  147 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~nIv~~  147 (449)
                      +...+.||.|+++.||.+++..      +++.+|+|+.....   ....+.+.+|......+.+          -.++-.
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~------t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P   87 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVE------TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP   87 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETT------TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred             EEEccccccCCceEEEEEEEcc------CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence            4456789999999999998876      68999999986443   2345666666655554322          223333


Q ss_pred             eeEEE---------eC---C-----EEEEEEEecCCCChHHHHhh---cCC--CCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 013105          148 IGYCC---------ED---E-----HRLLVYEYMALGNLHDQLFK---NYS--STLPWLTRIKIAIGAARCLAFLHGEEK  205 (449)
Q Consensus       148 ~~~~~---------~~---~-----~~~lv~e~~~~g~L~~~l~~---~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~  205 (449)
                      ++...         ..   .     +.+++|+-+. ++|.+.+..   ...  ..+....++.+..|+++.+++||  ..
T Consensus        88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh--~~  164 (288)
T PF14531_consen   88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH--SY  164 (288)
T ss_dssp             SEEEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH--HT
T ss_pred             eEEEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh--hc
Confidence            33322         11   1     2367888886 788877532   211  22445566778899999999999  67


Q ss_pred             CeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCcccccccccc--------CCCCcccchhhhHHH
Q 013105          206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT--------GHLTTMCDVFSFGVV  277 (449)
Q Consensus       206 ~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~v  277 (449)
                      |++|+||+|+|++++.+|.+.|+||+.......     .......+..|.+||....        ..++.+.|.|+||++
T Consensus       165 GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~-----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~  239 (288)
T PF14531_consen  165 GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGT-----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT  239 (288)
T ss_dssp             TEEEST-SGGGEEE-TTS-EEE--GGGEEETTE-----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred             ceEecccceeeEEEcCCCCEEEcChHHHeecCc-----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence            899999999999999999999999998774332     1222345678999997743        247889999999999


Q ss_pred             HHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCC
Q 013105          278 LLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSR  348 (449)
Q Consensus       278 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  348 (449)
                      +|.|.+|..||...........                     ....+. +.|+.+..||..+|+.||.+|
T Consensus       240 ly~lWC~~lPf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  240 LYSLWCGRLPFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHSS-STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHccCCCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999999999986432211110                     112233 778889999999999999987

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=1.8e-22  Score=179.79  Aligned_cols=139  Identities=14%  Similarity=0.144  Sum_probs=106.8

Q ss_pred             cccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc--h-------H-----------------HHHHHHHHHHh
Q 013105           84 SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ--G-------H-----------------REWLAEVIFLG  137 (449)
Q Consensus        84 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~  137 (449)
                      ...||+|+||.||+|...       +|+.||||+++.....  .       .                 .....|++++.
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   74 (190)
T cd05147           2 NGCISTGKEANVYHATTA-------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLK   74 (190)
T ss_pred             CCccccccceEEEEEECC-------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHH
Confidence            467999999999999653       4789999999743211  0       0                 12235999999


Q ss_pred             cCCCCCcceeeeEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCeeeccCCCCc
Q 013105          138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFL-HGEEKPVIYRDFKASN  216 (449)
Q Consensus       138 ~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~l-H~~~~~ivHrDikp~N  216 (449)
                      .+.++++.....+...  ..+|||||+.|+++...+...  ..++......++.|++.+|.++ |  ..||+||||||+|
T Consensus        75 ~l~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDlkP~N  148 (190)
T cd05147          75 RLVTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQ--DCRLVHADLSEYN  148 (190)
T ss_pred             HHHHCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHH
Confidence            9988877544333222  238999999988776554332  5688889999999999999999 7  6789999999999


Q ss_pred             eEEcCCCcEEEeeeccccCC
Q 013105          217 ILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       217 ill~~~~~~kl~DfGla~~~  236 (449)
                      ||++ ++.++|+|||+|...
T Consensus       149 Ili~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         149 LLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             EEEE-CCcEEEEEccccccC
Confidence            9998 478999999999743

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.87  E-value=3.7e-23  Score=213.44  Aligned_cols=247  Identities=24%  Similarity=0.299  Sum_probs=178.6

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHH---HHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREW---LAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~---~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      +|...+.||++.|=+|.+|.+.+       | .|+||++-... ....+.+   +.|++ ...++|||.+++.-+-..+.
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-------G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~k   94 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-------G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDK   94 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-------c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhH
Confidence            56778899999999999997764       3 49999985443 3333333   44555 55668999999988887888


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..|||-+|.. -+|+|.+..+  ..+...+...|+.|++.||..+|  +.||+|+|||.+||||+.-+-+.|+||..-+.
T Consensus        95 AAylvRqyvk-hnLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH--~~gVcHGDIKsENILiTSWNW~~LtDFAsFKP  169 (1431)
T KOG1240|consen   95 AAYLVRQYVK-HNLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCH--KLGVCHGDIKSENILITSWNWLYLTDFASFKP  169 (1431)
T ss_pred             HHHHHHHHHh-hhhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHH--HcCccccccccceEEEeeechhhhhcccccCC
Confidence            8899999987 6899999665  56777888899999999999999  88999999999999999999999999976542


Q ss_pred             C--CCCCCCce---eeecCCCCccccccccccC----------C-CCcccchhhhHHHHHHHHh-CCCcccccccccchh
Q 013105          236 G--PQGEDSHI---TTCVMGTEGYAAPEYINTG----------H-LTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKD  298 (449)
Q Consensus       236 ~--~~~~~~~~---~~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~  298 (449)
                      .  +.++....   ..+-..-.+|.|||.+...          . .+++.||||+||+++||++ |++||.-.+      
T Consensus       170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------  243 (1431)
T KOG1240|consen  170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------  243 (1431)
T ss_pred             ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------
Confidence            2  22221111   1111233579999987321          1 5678999999999999988 688886431      


Q ss_pred             hHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          299 LVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      +..+-...    ....+.+...+++       ..++.++..|++.||++|.++++.|+.
T Consensus       244 L~aYr~~~----~~~~e~~Le~Ied-------~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  244 LLAYRSGN----ADDPEQLLEKIED-------VSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHhHhccC----ccCHHHHHHhCcC-------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence            22111110    0111111111111       148899999999999999999999987

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=2.2e-21  Score=173.33  Aligned_cols=140  Identities=16%  Similarity=0.107  Sum_probs=109.0

Q ss_pred             cccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc---------------------h-----HHHHHHHHHHHh
Q 013105           84 SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ---------------------G-----HREWLAEVIFLG  137 (449)
Q Consensus        84 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~  137 (449)
                      ...||+|+||.||+|...       +|+.||||+++.....                     .     ...+..|+..+.
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   74 (190)
T cd05145           2 NGCISTGKEANVYHARTG-------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLK   74 (190)
T ss_pred             CceeecCCCcEEEEEEcC-------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHH
Confidence            568999999999999654       4789999999754211                     0     112357899999


Q ss_pred             cCCCCCcceeeeEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCeeeccCCCCc
Q 013105          138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE-KPVIYRDFKASN  216 (449)
Q Consensus       138 ~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-~~ivHrDikp~N  216 (449)
                      ++.|++|.....+....  .+|||||+.|+++.......  ..++......++.+++.+|.++|  . .||+||||||+|
T Consensus        75 ~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH--~~~givHrDlkP~N  148 (190)
T cd05145          75 RLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLY--QEAGLVHGDLSEYN  148 (190)
T ss_pred             HHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHH--HhCCEecCCCChhh
Confidence            99999875554444332  48999999988654443222  45778888999999999999999  5 789999999999


Q ss_pred             eEEcCCCcEEEeeeccccCCC
Q 013105          217 ILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       217 ill~~~~~~kl~DfGla~~~~  237 (449)
                      ||++ ++.++|+|||++....
T Consensus       149 Ill~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         149 ILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             EEEE-CCCEEEEEcccceecC
Confidence            9999 7899999999998543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.87  E-value=3.3e-23  Score=204.13  Aligned_cols=229  Identities=29%  Similarity=0.376  Sum_probs=178.8

Q ss_pred             cccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc--chHHHHHHHHHHHhcCC-CCCcceeeeEEEeCCEEEEEEE
Q 013105           86 YLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLK-HPHLVNLIGYCCEDEHRLLVYE  162 (449)
Q Consensus        86 ~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e  162 (449)
                      .+|+|+||.|+++.--.   ....+.-+|+|++.....  ........|..++...+ ||.++++...++.+...+++++
T Consensus         1 vlg~g~~gkvfLvrk~~---g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld   77 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAG---GADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD   77 (612)
T ss_pred             CCCcCCCcchHHHHHhc---cccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence            37999999999853222   122467789998864311  11114456788888886 9999999999999999999999


Q ss_pred             ecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCC
Q 013105          163 YMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS  242 (449)
Q Consensus       163 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~  242 (449)
                      +..||+|...+...  ..+.......+...++-++.++|  ..+|+|||+|++||+++.+|++++.|||+++..-.....
T Consensus        78 ~~rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh--~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~  153 (612)
T KOG0603|consen   78 FLRGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLH--KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA  153 (612)
T ss_pred             hcccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcc--hhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence            99999998877654  45556666667778888999999  788999999999999999999999999999865443321


Q ss_pred             ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhccccc
Q 013105          243 HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLE  322 (449)
Q Consensus       243 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (449)
                            +||..|||||++.  ....++|.||||++++||++|..||....                    ...++.  ..
T Consensus       154 ------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~--------------------~~~Il~--~~  203 (612)
T KOG0603|consen  154 ------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDT--------------------MKRILK--AE  203 (612)
T ss_pred             ------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHH--------------------HHHHhh--hc
Confidence                  6999999999998  56889999999999999999999997610                    011111  12


Q ss_pred             ccCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 013105          323 DRYSTEGAKRLAAVAHQCLSHNPKSRPTM  351 (449)
Q Consensus       323 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~  351 (449)
                      ..++......+.+++..++..+|..|.-.
T Consensus       204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  204 LEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            34567777889999999999999999544

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=2.9e-21  Score=170.53  Aligned_cols=187  Identities=19%  Similarity=0.136  Sum_probs=138.1

Q ss_pred             CCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc----hHHHHHHHHHHHhcCC-CCCcceeeeEEEeCCE
Q 013105           82 SRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ----GHREWLAEVIFLGQLK-HPHLVNLIGYCCEDEH  156 (449)
Q Consensus        82 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~  156 (449)
                      .+...|++|+||+||.+..        .+..++.+.+.....-    ....+.+|+++|++|. |++|++++++    +.
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~   72 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DG   72 (218)
T ss_pred             ccceeecCCCcceEEEeec--------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cC
Confidence            3567899999999997643        3567777777543221    1225788999999995 5889999886    44


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccC-CCCceEEcCCCcEEEeeeccccC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDF-KASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDi-kp~Nill~~~~~~kl~DfGla~~  235 (449)
                      .+++|||+.|.+|...+..         ....++.+++.+|.++|  ..||+|||| ||+|||++.++.++|+|||+|..
T Consensus        73 ~~lvmeyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH--~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~  141 (218)
T PRK12274         73 RHLDRSYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLH--RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVR  141 (218)
T ss_pred             EEEEEeeecCccHHhhhhh---------hhHHHHHHHHHHHHHHH--HCcCccCCCCCcceEEEcCCCCEEEEECCCcee
Confidence            7999999999888654321         11356788999999999  788999999 79999999999999999999985


Q ss_pred             CCCCCCC----c-------eeeecCCCCccccccccccC-CCC-cccchhhhHHHHHHHHhCCCccccc
Q 013105          236 GPQGEDS----H-------ITTCVMGTEGYAAPEYINTG-HLT-TMCDVFSFGVVLLELLTGRRSVEKN  291 (449)
Q Consensus       236 ~~~~~~~----~-------~~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslG~vl~elltg~~pf~~~  291 (449)
                      .......    .       .......++.|+.|+...-. ..+ ...++++.|+-+|.++|+..++...
T Consensus       142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            4432210    0       01112368888888865322 233 5678899999999999999887544

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=1.4e-21  Score=182.06  Aligned_cols=198  Identities=19%  Similarity=0.213  Sum_probs=143.6

Q ss_pred             CCCCcceeeeEEEe---------------------------CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHH
Q 013105          140 KHPHLVNLIGYCCE---------------------------DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIG  192 (449)
Q Consensus       140 ~h~nIv~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~  192 (449)
                      +|||||++..+|.+                           +..+|+||..++ .+|..++..+   ..+.....-++.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~---~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR---HRSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC---CCchHHHHHHHHH
Confidence            59999999988742                           245799999886 7999998654   5666777888999


Q ss_pred             HHHHHHHhhcCCCCeeeccCCCCceEE--cCCC--cEEEeeeccccCCCCC----CCCceeeecCCCCccccccccccCC
Q 013105          193 AARCLAFLHGEEKPVIYRDFKASNILL--DSDY--NAKLSDFGLATDGPQG----EDSHITTCVMGTEGYAAPEYINTGH  264 (449)
Q Consensus       193 i~~~l~~lH~~~~~ivHrDikp~Nill--~~~~--~~kl~DfGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~  264 (449)
                      +++|+.|||  .+||.|||+|++|||+  |+++  .+.|+|||++......    ..........|...-||||+.....
T Consensus       350 lLEav~hL~--~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  350 LLEAVTHLH--KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHH--HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            999999999  7889999999999999  3443  5899999987532210    0111122345788899999885321


Q ss_pred             ------CCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHH
Q 013105          265 ------LTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAH  338 (449)
Q Consensus       265 ------~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  338 (449)
                            --.++|.|+.|.+.||++....||..... ...+...               ......+..+..+++.+++++.
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~r~---------------Yqe~qLPalp~~vpp~~rqlV~  491 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDTRT---------------YQESQLPALPSRVPPVARQLVF  491 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccch-heechhh---------------hhhhhCCCCcccCChHHHHHHH
Confidence                  12489999999999999999999975211 0000000               1111233456677888999999


Q ss_pred             HhccCCCCCCCCHHHHHHHhh
Q 013105          339 QCLSHNPKSRPTMTTVVKALE  359 (449)
Q Consensus       339 ~cl~~dP~~RPs~~eil~~L~  359 (449)
                      .+|+.||++|++..-....|+
T Consensus       492 ~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  492 DLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHhcCCccccCCccHHHhHHH
Confidence            999999999998876665554

>PRK10345 hypothetical protein; Provisional

Probab=99.84  E-value=4.8e-20  Score=165.80  Aligned_cols=135  Identities=17%  Similarity=0.188  Sum_probs=104.1

Q ss_pred             CcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcC-----CCCCcceeeeEEEeCC--
Q 013105           83 RSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL-----KHPHLVNLIGYCCEDE--  155 (449)
Q Consensus        83 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~~~~~~~~~~--  155 (449)
                      -.+.||+|+||.||.  +..      ... .+||++..........+.+|+.+++.+     .||||+++++++.++.  
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~------~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~   76 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPE------DAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT   76 (210)
T ss_pred             CcceecCCCceEEEE--CCC------CcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCC
Confidence            356899999999995  322      233 379988765444567789999999999     5799999999998873  


Q ss_pred             -EEE-EEEEe--cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHH-HHhhcCCCCeeeccCCCCceEEcC----CCcEE
Q 013105          156 -HRL-LVYEY--MALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL-AFLHGEEKPVIYRDFKASNILLDS----DYNAK  226 (449)
Q Consensus       156 -~~~-lv~e~--~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l-~~lH~~~~~ivHrDikp~Nill~~----~~~~k  226 (449)
                       ..+ +||||  +.+|+|.+++.+.   .+++.  ..++.+++.++ .|||  +++|+||||||+|||++.    ++.++
T Consensus        77 g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh--~~~IvhrDlKp~NILl~~~~~~~~~~~  149 (210)
T PRK10345         77 GYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLL--DNRIVTMELKPQNILCQRISESEVIPV  149 (210)
T ss_pred             eEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEeccCCCCCcEE
Confidence             433 78999  5579999999653   34444  35577778777 9999  677999999999999974    34799


Q ss_pred             Eeeeccc
Q 013105          227 LSDFGLA  233 (449)
Q Consensus       227 l~DfGla  233 (449)
                      |+||+.+
T Consensus       150 LiDg~G~  156 (210)
T PRK10345        150 VCDNIGE  156 (210)
T ss_pred             EEECCCC
Confidence            9995433

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=1.8e-20  Score=197.09  Aligned_cols=199  Identities=23%  Similarity=0.282  Sum_probs=160.6

Q ss_pred             HHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC---CCCcceeeeE
Q 013105           74 LQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK---HPHLVNLIGY  150 (449)
Q Consensus        74 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~  150 (449)
                      .+.-...|.|.+.||+|+||.||+|...+       ++.||+|+-+....-   +|.--.+++.+|+   -+.|..+...
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-------~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a  762 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-------GKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSA  762 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCC-------CcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHH
Confidence            34445678889999999999999997654       789999998754332   1111233444444   3455666666


Q ss_pred             EEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC-------CC
Q 013105          151 CCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS-------DY  223 (449)
Q Consensus       151 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~-------~~  223 (449)
                      ..-.+.-+||+||.+.|+|.+++.  ..+..++...+.+..|++..+..||  ..+|||+||||+|+||..       ..
T Consensus       763 ~~~~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH--~~~IIHgDiKPDNfll~~~~~~~~~~~  838 (974)
T KOG1166|consen  763 HVFQNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLH--AMGIIHGDIKPDNFLLRREICADSDSK  838 (974)
T ss_pred             HccCCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHH--hcceecccCCcceeEeecccCCCCccc
Confidence            666778899999999999999997  4578999999999999999999999  777999999999999942       34


Q ss_pred             cEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCC
Q 013105          224 NAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRR  286 (449)
Q Consensus       224 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~  286 (449)
                      .++|+|||.+.....-.........++|-.+-.+|+..|..++..+|.|.|+.+++.||.|+.
T Consensus       839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            699999999987665555556677889999999999999999999999999999999999874

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.81  E-value=1.3e-20  Score=194.61  Aligned_cols=210  Identities=25%  Similarity=0.315  Sum_probs=145.9

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      ...+|..+++|-.|+||.||.+.++      .+.+.+|+|+-+.+      .+++-  ++.....|.+|           
T Consensus        81 ~e~df~~IklisngAygavylvrh~------~trqrfa~kiNkq~------lilRn--ilt~a~npfvv-----------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHK------ETRQRFAMKINKQN------LILRN--ILTFAGNPFVV-----------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeecc------ccccchhhcccccc------hhhhc--cccccCCccee-----------
Confidence            3468999999999999999998554      46788999553211      11111  33333344444           


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                                |+-...+..  .+.++...        +.+++|||  +.||+|||+||+|+||+.-|++|+.|||++...
T Consensus       136 ----------gDc~tllk~--~g~lPvdm--------vla~Eylh--~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~G  193 (1205)
T KOG0606|consen  136 ----------GDCATLLKN--IGPLPVDM--------VLAVEYLH--SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKG  193 (1205)
T ss_pred             ----------chhhhhccc--CCCCcchh--------hHHhHhhc--cCCeecCCCCCCcceeeecccccccchhhhhhh
Confidence                      444444432  24454433        66799999  788999999999999999999999999998743


Q ss_pred             CCCCCC-------------ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhh
Q 013105          237 PQGEDS-------------HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA  303 (449)
Q Consensus       237 ~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~  303 (449)
                      ......             -.....+||+.|.|||++....|+..+|+|++|+|+||.+-|+.||.+..+.+....    
T Consensus       194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~----  269 (1205)
T KOG0606|consen  194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ----  269 (1205)
T ss_pred             hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhh----
Confidence            221110             112345899999999999989999999999999999999999999998744322111    


Q ss_pred             hhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCC
Q 013105          304 RPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSR  348 (449)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  348 (449)
                        ++.+...         ...-....+.++++++.++|+.+|..|
T Consensus       270 --visd~i~---------wpE~dea~p~Ea~dli~~LL~qnp~~R  303 (1205)
T KOG0606|consen  270 --VISDDIE---------WPEEDEALPPEAQDLIEQLLRQNPLCR  303 (1205)
T ss_pred             --hhhhhcc---------ccccCcCCCHHHHHHHHHHHHhChHhh
Confidence              1111000         111123445678999999999999999

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.81  E-value=7.9e-21  Score=183.96  Aligned_cols=175  Identities=26%  Similarity=0.341  Sum_probs=129.0

Q ss_pred             CEEEEEEEecCCCChHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKN-YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      ..+||.|++|.-++|.++|... .....++.....++.|++.++.|     ++.+|||+||.||+...+..+||+|||+.
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y-----k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY-----KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh-----ccchhhhccccccccccchhhhhhhhhhe
Confidence            3578999999999999999743 44567788889999999999998     66999999999999999999999999998


Q ss_pred             cCCCCCC----CCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhc
Q 013105          234 TDGPQGE----DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLK  308 (449)
Q Consensus       234 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  308 (449)
                      .......    .....+...||.+||+||++.+..|+.++||||||++|+||+. -...|+...                
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~----------------  467 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA----------------  467 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----------------
Confidence            8654433    1122345679999999999999999999999999999999998 222222110                


Q ss_pred             cccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 013105          309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTV  354 (449)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei  354 (449)
                         .+..+-+..+++.+..+.| .-..|+.+++...|.+||++.+.
T Consensus       468 ---t~~d~r~g~ip~~~~~d~p-~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  468 ---TLTDIRDGIIPPEFLQDYP-EEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             ---hhhhhhcCCCChHHhhcCc-HHHHHHHHhcCCCcccCchHHHH
Confidence               0001111111111111111 23579999999999999954443

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.81  E-value=1.1e-19  Score=179.34  Aligned_cols=217  Identities=22%  Similarity=0.357  Sum_probs=162.2

Q ss_pred             HhcCCCCCcceeeeEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCC
Q 013105          136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKAS  215 (449)
Q Consensus       136 l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~  215 (449)
                      |+.+.|.|+.+++|.+.+....++|.+||..|+|.|.+... ...+++.....+..+++.||.|||.... ..|+.+++.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i-~~hg~l~s~   78 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPI-GYHGALKSS   78 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcc-eeeeeeccc
Confidence            45788999999999999999999999999999999998763 4678888999999999999999995332 289999999


Q ss_pred             ceEEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCC-------CCcccchhhhHHHHHHHHhCCCcc
Q 013105          216 NILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGH-------LTTMCDVFSFGVVLLELLTGRRSV  288 (449)
Q Consensus       216 Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslG~vl~elltg~~pf  288 (449)
                      |++++....+||+|||+.................-..-|.|||.+.+..       .+.+.||||||++++|+++...||
T Consensus        79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            9999999999999999987653211111111111245699999996531       466799999999999999999999


Q ss_pred             cccccccch-hhHHhhhhhhccccchhHhhcccccccCC--HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          289 EKNRCKREK-DLVEWARPMLKDFTKLDQIIDSRLEDRYS--TEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       289 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                      ......... +.+..+..   .       ......+...  .+.++++..++..||..+|.+||++..+-..++.+...
T Consensus       159 ~~~~~~~~~~eii~~~~~---~-------~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  159 DLRNLVEDPDEIILRVKK---G-------GSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             ccccccCChHHHHHHHHh---c-------CCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            864332221 22222111   0       0111111111  14455799999999999999999999999988877654

>smart00090 RIO RIO-like kinase

Probab=99.81  E-value=2.4e-19  Score=165.14  Aligned_cols=142  Identities=16%  Similarity=0.134  Sum_probs=109.2

Q ss_pred             CCCCcccccccCceEEEEEE-EcCCCCCCCCCcEEEEEEeccCCcc------------------------hHHHHHHHHH
Q 013105           80 NFSRSDYLGEGGFGKVYKGC-VDDNLRPGLKAQTVAVKVLDVNGSQ------------------------GHREWLAEVI  134 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~-~~~~~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~  134 (449)
                      .|.+.+.||+|+||.||+|. ...      +++.||+|+++.....                        ....+..|+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~------~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  102 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDG------SGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR  102 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCC------CCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence            38899999999999999997 322      4789999998743210                        0123567999


Q ss_pred             HHhcCCCC--CcceeeeEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-eeecc
Q 013105          135 FLGQLKHP--HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP-VIYRD  211 (449)
Q Consensus       135 ~l~~l~h~--nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-ivHrD  211 (449)
                      ++.++.+.  .+++++++    ...++||||+.|++|.......  ..........++.|++.+|.+||  ..| |+|||
T Consensus       103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH--~~g~iiH~D  174 (237)
T smart00090      103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLY--KEGELVHGD  174 (237)
T ss_pred             HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHH--hcCCEEeCC
Confidence            99999753  34444443    2358999999988886654332  34555667789999999999999  788 99999


Q ss_pred             CCCCceEEcCCCcEEEeeeccccCC
Q 013105          212 FKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       212 ikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      |||+||+++ ++.++|+|||.+...
T Consensus       175 ikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      175 LSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             CChhhEEEE-CCCEEEEEChhhhcc
Confidence            999999999 889999999998743

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=1.7e-18  Score=157.43  Aligned_cols=134  Identities=20%  Similarity=0.238  Sum_probs=111.1

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc--------hHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ--------GHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      +.||+|++|.||+|.+.        +..+++|+.......        ....+.+|+.++..+.|++|.....++...+.
T Consensus         2 ~~l~~G~~~~vy~~~~~--------~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~   73 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFL--------GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPEN   73 (211)
T ss_pred             cccccCceEEEEEEeeC--------CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCC
Confidence            57999999999999762        567999986532211        12357789999999999998887777777888


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      .+++|||++|++|.+.+....     . ....++.+++.+|.++|  ..+++|+|++|.|||++ ++.++|+|||++..
T Consensus        74 ~~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH--~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         74 FIIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLH--SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CEEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHH--hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999999999885431     1 77889999999999999  78899999999999999 78999999998874

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.77  E-value=1.8e-18  Score=155.76  Aligned_cols=130  Identities=19%  Similarity=0.269  Sum_probs=104.8

Q ss_pred             cccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc--c------hHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           86 YLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--Q------GHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        86 ~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      .||+|+||.||+|.+        .+..+++|.......  .      ...++.+|++++..+.|+++.....++...+..
T Consensus         1 ~ig~G~~~~vy~~~~--------~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~   72 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--------LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNK   72 (199)
T ss_pred             CCCCCceEEEEEeec--------CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCC
Confidence            489999999999974        256799998643211  1      124567899999999988766655566667778


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ++||||++|++|.+.+.....         .++.+++.+|.+||  ..|++|+|++|.||+++ ++.++++|||++..
T Consensus        73 ~lv~e~~~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH--~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        73 TIVMEYIEGKPLKDVIEEGND---------ELLREIGRLVGKLH--KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EEEEEEECCccHHHHHhhcHH---------HHHHHHHHHHHHHH--HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999999999988754210         77899999999999  78899999999999999 78999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.76  E-value=5.6e-18  Score=152.47  Aligned_cols=138  Identities=17%  Similarity=0.102  Sum_probs=106.5

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc----------------------hHHHHHHHHHHHh
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ----------------------GHREWLAEVIFLG  137 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~  137 (449)
                      .|.+.+.||+|+||.||+|...       +++.||||++......                      ....+..|+.++.
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            3888899999999999999653       3789999997643210                      0112567888999


Q ss_pred             cCCCCC--cceeeeEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCC
Q 013105          138 QLKHPH--LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKAS  215 (449)
Q Consensus       138 ~l~h~n--Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~  215 (449)
                      .+.|++  ++.+++    ....++||||+.|++|......        .....++.+++.++.++|  ..||+|+||||+
T Consensus        89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh--~~gi~H~Dl~p~  154 (198)
T cd05144          89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAY--KHGIIHGDLSEF  154 (198)
T ss_pred             HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHH--HCCCCcCCCCcc
Confidence            887774  444443    2456899999999998765321        234567889999999999  688999999999


Q ss_pred             ceEEcCCCcEEEeeeccccCCCC
Q 013105          216 NILLDSDYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       216 Nill~~~~~~kl~DfGla~~~~~  238 (449)
                      ||+++.++.++|+|||++.....
T Consensus       155 Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         155 NILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             cEEEcCCCcEEEEECCccccCCC
Confidence            99999999999999999975443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.76  E-value=7.3e-18  Score=174.19  Aligned_cols=136  Identities=21%  Similarity=0.250  Sum_probs=109.7

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--C------cchHHHHHHHHHHHhcCCCCCcceeeeE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--G------SQGHREWLAEVIFLGQLKHPHLVNLIGY  150 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~------~~~~~~~~~E~~~l~~l~h~nIv~~~~~  150 (449)
                      ..|...+.||+|+||.||+|.+..        ..+++|+....  .      ......+.+|++++..++|++|+....+
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~--------~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~  404 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLG--------RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIY  404 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecC--------ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEE
Confidence            445678899999999999997654        23444432111  1      1123457889999999999999988888


Q ss_pred             EEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeee
Q 013105          151 CCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDF  230 (449)
Q Consensus       151 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~Df  230 (449)
                      +......++||||++|++|.+++.          ....++.+++.+|.+||  ..+++||||||+|||+ .++.++|+||
T Consensus       405 ~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH--~~giiHrDlkp~NILl-~~~~~~liDF  471 (535)
T PRK09605        405 DVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLH--KAGIVHGDLTTSNFIV-RDDRLYLIDF  471 (535)
T ss_pred             EEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHH--hCCCccCCCChHHEEE-ECCcEEEEeC
Confidence            777778899999999999998874          34678899999999999  7889999999999999 5779999999


Q ss_pred             ccccC
Q 013105          231 GLATD  235 (449)
Q Consensus       231 Gla~~  235 (449)
                      |+++.
T Consensus       472 Gla~~  476 (535)
T PRK09605        472 GLGKY  476 (535)
T ss_pred             ccccc
Confidence            99874

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=3.8e-19  Score=183.40  Aligned_cols=259  Identities=23%  Similarity=0.287  Sum_probs=191.7

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCC-CCCcceeeeEEEeCCE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLK-HPHLVNLIGYCCEDEH  156 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~  156 (449)
                      .|.+.+.||+|+|+.|-......+     ....+|+|.+....  .........|..+-..+. |+|++.+++...+.+.
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~-----~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~   95 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRD-----PESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS   95 (601)
T ss_pred             cccccccccccccchhhhhhhcCC-----CcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcc
Confidence            466677799999999987654332     34567777765443  222334445777777776 9999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC-cEEEeeeccccC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY-NAKLSDFGLATD  235 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~-~~kl~DfGla~~  235 (449)
                      .+++++|..|+++.+.+........+....-.++.|+..++.|+|. ..++.||||||+|.+++..+ .++++|||+|..
T Consensus        96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~-~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen   96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP-ENGVTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc-ccccccCCCCCccchhccCCCcccCCCchhhcc
Confidence            9999999999999988843222245556667789999999999995 56799999999999999999 999999999997


Q ss_pred             CCC-CCCCceeeecCC-CCccccccccccC-CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccc
Q 013105          236 GPQ-GEDSHITTCVMG-TEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK  312 (449)
Q Consensus       236 ~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  312 (449)
                      ... ..........+| ++.|+|||...+. ...+..|+||+|+++..+++|..||......... +..|...       
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~-------  246 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSN-------  246 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeeccc-------
Confidence            766 444444555678 9999999999874 5588999999999999999999999765333211 1111100       


Q ss_pred             hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       .    ................+++.+++..+|..|.+.+++-..
T Consensus       247 -~----~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  247 -K----GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD  286 (601)
T ss_pred             -c----cccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence             0    000011122344457889999999999999999888654

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.69  E-value=1.7e-16  Score=141.43  Aligned_cols=137  Identities=19%  Similarity=0.185  Sum_probs=95.6

Q ss_pred             cccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc--hHHH----------------------HHHHHHHHhcC
Q 013105           84 SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ--GHRE----------------------WLAEVIFLGQL  139 (449)
Q Consensus        84 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l  139 (449)
                      .+.||+|+||.||+|...       .++.||||++......  ....                      ...|...+..+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l   74 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRL   74 (187)
T ss_pred             CcccccccceeEEEEECC-------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHH
Confidence            467999999999999654       3789999998643211  1111                      12456666665


Q ss_pred             CCC--CcceeeeEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCeeeccCCCCc
Q 013105          140 KHP--HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE-KPVIYRDFKASN  216 (449)
Q Consensus       140 ~h~--nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-~~ivHrDikp~N  216 (449)
                      .+.  .+.+++++    ...++||||+.|+++........  ... .....++.+++.++.++|  . .+|+|+||||+|
T Consensus        75 ~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~--~~~-~~~~~~~~~~~~~l~~lh--~~~~ivH~Dl~p~N  145 (187)
T cd05119          75 YEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV--RLL-EDPEELYDQILELMRKLY--REAGLVHGDLSEYN  145 (187)
T ss_pred             HHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhh--hhc-ccHHHHHHHHHHHHHHHh--hccCcCcCCCChhh
Confidence            433  34445443    24689999999854422111110  011 556788999999999999  5 789999999999


Q ss_pred             eEEcCCCcEEEeeeccccCCC
Q 013105          217 ILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       217 ill~~~~~~kl~DfGla~~~~  237 (449)
                      |+++ ++.++|+|||.+....
T Consensus       146 ili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         146 ILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             EEEE-CCcEEEEECccccccc
Confidence            9999 8899999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.67  E-value=6.9e-16  Score=131.79  Aligned_cols=135  Identities=21%  Similarity=0.166  Sum_probs=111.3

Q ss_pred             CcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCC--CCcceeeeEEEeCCEEEEE
Q 013105           83 RSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKH--PHLVNLIGYCCEDEHRLLV  160 (449)
Q Consensus        83 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~~~~~lv  160 (449)
                      +.+.||+|.++.||++...        +..+++|.......  ...+.+|+.++..++|  .++++++.+....+..+++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--------~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v   71 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--------DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLL   71 (155)
T ss_pred             cceecccccccceEEEEec--------CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEE
Confidence            4567999999999999763        25799999864433  4568889999999976  5899999988888889999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          161 YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE-KPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       161 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      |||+.|+.+..+         +......++.+++.+|+++|... .+++|+|++|+||+++..+.++++|||++...
T Consensus        72 ~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          72 MEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             EEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            999998777543         45566778899999999999432 47999999999999999899999999988743

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.67  E-value=7.5e-16  Score=142.21  Aligned_cols=134  Identities=22%  Similarity=0.162  Sum_probs=101.2

Q ss_pred             cccc-ccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-------------cchHHHHHHHHHHHhcCCCCCc--ceee
Q 013105           85 DYLG-EGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-------------SQGHREWLAEVIFLGQLKHPHL--VNLI  148 (449)
Q Consensus        85 ~~lG-~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~nI--v~~~  148 (449)
                      ..|| .||.|+||.+...        +..++||.+...+             ......+.+|+.++..|.|++|  +..+
T Consensus        37 ~~lg~~~g~gtv~~v~~~--------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl  108 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPI  108 (239)
T ss_pred             ceeecCCCCccEEEEEeC--------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeE
Confidence            4577 7888888887553        5678998874211             1123467889999999998775  6777


Q ss_pred             eEEEeCC----EEEEEEEecCC-CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC
Q 013105          149 GYCCEDE----HRLLVYEYMAL-GNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY  223 (449)
Q Consensus       149 ~~~~~~~----~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~  223 (449)
                      ++.....    ..++|||+++| .+|.+++..   ..++..    .+.+++.+|.+||  ..||+||||||+|||++.++
T Consensus       109 ~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH--~~GI~HrDlkp~NILv~~~~  179 (239)
T PRK01723        109 AARVVRHGLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFH--DAGVYHADLNAHNILLDPDG  179 (239)
T ss_pred             eeeeeecCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHH--HCCCCCCCCCchhEEEcCCC
Confidence            7654322    23599999997 688887754   234443    3567899999999  78899999999999999999


Q ss_pred             cEEEeeeccccC
Q 013105          224 NAKLSDFGLATD  235 (449)
Q Consensus       224 ~~kl~DfGla~~  235 (449)
                      .++|+|||.+..
T Consensus       180 ~v~LIDfg~~~~  191 (239)
T PRK01723        180 KFWLIDFDRGEL  191 (239)
T ss_pred             CEEEEECCCccc
Confidence            999999998874

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.56  E-value=5.4e-15  Score=146.31  Aligned_cols=255  Identities=24%  Similarity=0.291  Sum_probs=188.0

Q ss_pred             HhcCCCCcccccc--cCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc--chHHHHHHHHHHHhcCC-CCCcceeeeEE
Q 013105           77 ITHNFSRSDYLGE--GGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLK-HPHLVNLIGYC  151 (449)
Q Consensus        77 ~~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~nIv~~~~~~  151 (449)
                      ....|.+...+|.  |.+|.||.+....    ......+|+|.-+....  .....-.+|+...+.+. |+|.++.+..+
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~----~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~  187 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTN----SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW  187 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCc----ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc
Confidence            4456778889999  9999999985411    33578899998543322  22333456777777774 99999999999


Q ss_pred             EeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHH----HHHHhhcCCCCeeeccCCCCceEEcCC-CcEE
Q 013105          152 CEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR----CLAFLHGEEKPVIYRDFKASNILLDSD-YNAK  226 (449)
Q Consensus       152 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~----~l~~lH~~~~~ivHrDikp~Nill~~~-~~~k  226 (449)
                      ...+..|+-+|++. .+|..+.... ...++....+..+.+...    ||.++|  ..+++|-|+||.||++..+ ..++
T Consensus       188 e~~~~lfiqtE~~~-~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~h--s~~~~~~~~kp~~i~~~~~~~s~~  263 (524)
T KOG0601|consen  188 EGSGILFIQTELCG-ESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLH--SNNIVHDDLKPANIFTTSDWTSCK  263 (524)
T ss_pred             ccCCcceeeecccc-chhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccC--CCcccccccchhheecccccceee
Confidence            99999999999985 7777766443 345788888888888888    999999  6779999999999999999 8899


Q ss_pred             EeeeccccCCCCCCCCcee---eecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhh
Q 013105          227 LSDFGLATDGPQGEDSHIT---TCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA  303 (449)
Q Consensus       227 l~DfGla~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~  303 (449)
                      ++|||+.............   ....|...|++||.+. .-++...|||+||.++.+..++..+.....           
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~-----------  331 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGK-----------  331 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCC-----------
Confidence            9999999876654422211   2235788999999887 467999999999999999998876654321           


Q ss_pred             hhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          304 RPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                         ...|..++.   ..+...+.......+...+..|++.+|-.|+++..+..+
T Consensus       332 ---~~~W~~~r~---~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  332 ---NSSWSQLRQ---GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             ---CCCcccccc---ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence               111111111   112333333344456668999999999999998887754

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.53  E-value=3.8e-14  Score=142.04  Aligned_cols=141  Identities=22%  Similarity=0.172  Sum_probs=94.9

Q ss_pred             cccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchH-------------------------------------
Q 013105           84 SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGH-------------------------------------  126 (449)
Q Consensus        84 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-------------------------------------  126 (449)
                      .+.||+|++|.||+|+..+       |+.||||+.+.......                                     
T Consensus       122 ~~plasaSigQVh~A~l~~-------G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l  194 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVD-------GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTL  194 (437)
T ss_pred             CcceeeeehhheEEEEecC-------CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHH
Confidence            3679999999999998764       78999999864311100                                     


Q ss_pred             ---HHHHHHHHHHhcC----CCCCcceeeeEE-EeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHH-HH
Q 013105          127 ---REWLAEVIFLGQL----KHPHLVNLIGYC-CEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR-CL  197 (449)
Q Consensus       127 ---~~~~~E~~~l~~l----~h~nIv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~-~l  197 (449)
                         -++.+|+..+.++    +|.+-+.+-.++ ...+..+|||||++|++|.+...... ....   ...++..++. .+
T Consensus       195 ~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-~~~~---~~~ia~~~~~~~l  270 (437)
T TIGR01982       195 RRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-AGLD---RKALAENLARSFL  270 (437)
T ss_pred             HHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-cCCC---HHHHHHHHHHHHH
Confidence               0134455555554    222222222222 22345799999999999988764321 1122   2345555554 46


Q ss_pred             HHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       198 ~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ..+|  ..|++|+|++|.||+++.++.++|+|||++....
T Consensus       271 ~ql~--~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       271 NQVL--RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHH--hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            7788  6789999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.45  E-value=1.2e-13  Score=140.09  Aligned_cols=145  Identities=17%  Similarity=0.122  Sum_probs=91.8

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc---------------------------------
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ---------------------------------  124 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---------------------------------  124 (449)
                      ...|.. +.||+|++|.||+|..++      +|+.||||+++..-..                                 
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~------~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~  191 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKD------NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVA  191 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECC------CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHH
Confidence            345776 789999999999998875      4789999999643110                                 


Q ss_pred             -hHH------HHHHHHHHHhcC----CCCCcceeeeEEEe-CCEEEEEEEecCCCChHHHHhhcCCC----CCCHHHHHH
Q 013105          125 -GHR------EWLAEVIFLGQL----KHPHLVNLIGYCCE-DEHRLLVYEYMALGNLHDQLFKNYSS----TLPWLTRIK  188 (449)
Q Consensus       125 -~~~------~~~~E~~~l~~l----~h~nIv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~----~l~~~~~~~  188 (449)
                       ...      ++.+|+..+.++    .+.+.+.+-.++.+ ....+|||||+.|+.+.+.-.-...+    .+.......
T Consensus       192 e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~  271 (537)
T PRK04750        192 EFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEV  271 (537)
T ss_pred             HHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHH
Confidence             001      133444444444    23333333233322 34568999999999997742211111    122222222


Q ss_pred             HHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC----cEEEeeeccccCCCC
Q 013105          189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY----NAKLSDFGLATDGPQ  238 (449)
Q Consensus       189 i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~----~~kl~DfGla~~~~~  238 (449)
                      ++.|       +.  ..|++|+|+||.||+++.++    .++++|||++.....
T Consensus       272 ~~~Q-------if--~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        272 FFTQ-------VF--RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHH-------HH--hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            2233       33  46799999999999999888    999999999886543

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.41  E-value=3.6e-12  Score=127.65  Aligned_cols=164  Identities=18%  Similarity=0.192  Sum_probs=125.1

Q ss_pred             CCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHH
Q 013105          109 KAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIK  188 (449)
Q Consensus       109 ~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~  188 (449)
                      .+.+|.|...+...........+-++.|+.++||||+++++.++..+..|||+|.+.  .|..++.+.     .......
T Consensus        36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-----~~~~v~~  108 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-----GKEEVCL  108 (690)
T ss_pred             cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-----HHHHHHH
Confidence            577888888875554334556677889999999999999999999999999999985  566666543     2556667


Q ss_pred             HHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcc
Q 013105          189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTM  268 (449)
Q Consensus       189 i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  268 (449)
                      .+.||+.||.|||. +.+++|++|....|+++..|..||++|.++........  ......---.|..|+.+...  ...
T Consensus       109 Gl~qIl~AL~FL~~-d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s--~~s  183 (690)
T KOG1243|consen  109 GLFQILAALSFLND-DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS--EWS  183 (690)
T ss_pred             HHHHHHHHHHHHhc-cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc--ccc
Confidence            78999999999984 66799999999999999999999999998875433221  01111112245666655322  256


Q ss_pred             cchhhhHHHHHHHHhC
Q 013105          269 CDVFSFGVVLLELLTG  284 (449)
Q Consensus       269 ~DvwslG~vl~elltg  284 (449)
                      .|.|.|||+++|++.|
T Consensus       184 ~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  184 IDSWGLGCLIEELFNG  199 (690)
T ss_pred             hhhhhHHHHHHHHhCc
Confidence            7999999999999998

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.41  E-value=2.8e-13  Score=124.34  Aligned_cols=204  Identities=22%  Similarity=0.319  Sum_probs=140.3

Q ss_pred             HHHhcCCCCCcceeeeEEEeC-----CEEEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 013105          134 IFLGQLKHPHLVNLIGYCCED-----EHRLLVYEYMALGNLHDQLFKN--YSSTLPWLTRIKIAIGAARCLAFLHGEEKP  206 (449)
Q Consensus       134 ~~l~~l~h~nIv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~  206 (449)
                      .-|-++-|.||++++.++.+.     ....++.|||..|+|..+|.+.  ....+......+|+-||+.||.|||+....
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            344455799999999988654     3468899999999999999763  345677788889999999999999999999


Q ss_pred             eeeccCCCCceEEcCCCcEEEeeeccccCCCCCC--CCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhC
Q 013105          207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGE--DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG  284 (449)
Q Consensus       207 ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg  284 (449)
                      |+|+++..+-|++..+|-+|++----......-.  .........|-++|.+||.=...+.+.++|||+||.+..||..+
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            9999999999999999888875211100000000  00001123467899999977666778899999999999999887


Q ss_pred             CCcccccccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          285 RRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       285 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ..--.........+            ..+...+.. ...       ..-..++.+|++..|..||++.+++-|
T Consensus       279 Eiq~tnseS~~~~e------------e~ia~~i~~-len-------~lqr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  279 EIQSTNSESKVEVE------------ENIANVIIG-LEN-------GLQRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             eeccCCCcceeehh------------hhhhhheee-ccC-------ccccCcCcccccCCCCCCcchhhhhcC
Confidence            64422111110000            000000000 000       012357899999999999999999876

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.39  E-value=1.5e-12  Score=113.97  Aligned_cols=130  Identities=19%  Similarity=0.093  Sum_probs=93.1

Q ss_pred             cccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCc-ceeeeEEEeCCEEEEEEE
Q 013105           84 SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHL-VNLIGYCCEDEHRLLVYE  162 (449)
Q Consensus        84 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv~e  162 (449)
                      .+.|+.|.++.||++...        +..|++|+...... ....+..|+.++..+.+.++ .+++.+.  ....++|||
T Consensus         3 ~~~l~~G~~~~vy~~~~~--------~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e   71 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--------NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITE   71 (170)
T ss_pred             eeecCCcccCceEEEEEC--------CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEE
Confidence            356889999999998653        56899999754321 12345678999988865554 4455443  334589999


Q ss_pred             ecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC---CCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          163 YMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE---KPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       163 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      |++|.++...-          .....+..+++.+|+.||...   .+++|+|++|.||+++ ++.++++|||.+..
T Consensus        72 ~i~G~~l~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          72 FIEGSELLTED----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ecCCCcccccc----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            99998875430          111345678899999999432   1259999999999999 66899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.39  E-value=1e-11  Score=109.94  Aligned_cols=144  Identities=13%  Similarity=0.101  Sum_probs=99.0

Q ss_pred             cccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC----------------------cchHHHH----HHHHHHHh
Q 013105           84 SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG----------------------SQGHREW----LAEVIFLG  137 (449)
Q Consensus        84 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~----~~E~~~l~  137 (449)
                      ...||.|.-+.||.|...++......+..+|||+.+...                      ......+    .+|++.|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            356899999999999643210001135789999974210                      0011122    37999999


Q ss_pred             cCC--CCCcceeeeEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCeeeccCCC
Q 013105          138 QLK--HPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFL-HGEEKPVIYRDFKA  214 (449)
Q Consensus       138 ~l~--h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~l-H~~~~~ivHrDikp  214 (449)
                      ++.  .-+++.++++    ...+|||||+.++.+.....+.  ..++......+..+++.+|..| |  ..||+|+||++
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H--~~glVHGDLs~  153 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYK--ECNLVHADLSE  153 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHH--hCCeecCCCCH
Confidence            985  3567777765    4578999999765442221111  2344455667788999999988 8  67899999999


Q ss_pred             CceEEcCCCcEEEeeeccccCC
Q 013105          215 SNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       215 ~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .|||++ ++.+.|+|||.+...
T Consensus       154 ~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         154 YNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             HHEEEE-CCcEEEEECCCceeC
Confidence            999997 468999999988754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.35  E-value=8.7e-13  Score=130.78  Aligned_cols=248  Identities=21%  Similarity=0.170  Sum_probs=176.3

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHH--HHHHHHHHHhcC-CCCCcceeeeEEEeC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR--EWLAEVIFLGQL-KHPHLVNLIGYCCED  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~h~nIv~~~~~~~~~  154 (449)
                      ..+|..+..||.|.|+.|+......     ..+..|++|.+...-.....  .-+.|+.+...+ .|.+++..+..+...
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~-----~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~  338 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRP-----EGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL  338 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecC-----CCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc
Confidence            4568888999999999999875432     24678898887533222222  234577766666 499999988888888


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC-CcEEEeeeccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD-YNAKLSDFGLA  233 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~-~~~kl~DfGla  233 (449)
                      .+.|+-.|||+++++...+.  ....+.....+.+..|++.++.++|  .+.++|+|+||+||++..+ +..+++|||+.
T Consensus       339 r~~~ip~e~~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~--s~~~~~~d~~psni~i~~~~~~~~~~~~~~~  414 (524)
T KOG0601|consen  339 RQGYIPLEFCEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIH--SKLFVHLDVKPSNILISNDGFFSKLGDFGCW  414 (524)
T ss_pred             ccccCchhhhcCcchhhhhH--HHHhcCcchhhhhHHHHHhcccccc--chhhhcccccccceeeccchhhhhccccccc
Confidence            88889999999998876652  2346677788999999999999999  7889999999999999876 78899999998


Q ss_pred             cCCCCCCCCceeeecCCCCccc--cccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcccc
Q 013105          234 TDGPQGEDSHITTCVMGTEGYA--APEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFT  311 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  311 (449)
                      ..+....    .. ..++-+++  +++......+..+.|++|||..+.+.+++.+.-+....        |.        
T Consensus       415 t~~~~~~----~~-~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------~~--------  473 (524)
T KOG0601|consen  415 TRLAFSS----GV-FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------SL--------  473 (524)
T ss_pred             cccceec----cc-ccccccccccchhhccccccccccccccccccccccccCcccCccccc--------ce--------
Confidence            6432211    11 12233344  55555666789999999999999999998754332110        00        


Q ss_pred             chhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 013105          312 KLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEP  360 (449)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  360 (449)
                         . +........ ......+..+.+.++..++..||.+.++..+.+.
T Consensus       474 ---~-i~~~~~p~~-~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  474 ---T-IRSGDTPNL-PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             ---e-eecccccCC-CchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence               0 000111111 2222668888999999999999999988776443

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.31  E-value=1.8e-11  Score=104.69  Aligned_cols=131  Identities=22%  Similarity=0.242  Sum_probs=97.7

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--------cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--------SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      ..+++|+-+.+|.+.+.        +..+++|.-....        .-...+..+|++++.++.--.|.-.+=+..+.+.
T Consensus         2 ~~i~~GAEa~i~~~~~~--------g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~   73 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--------GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN   73 (204)
T ss_pred             chhhCCcceeEEeeecc--------CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC
Confidence            35889999999998664        3456666542211        1112345679999999875555555555667788


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..|+|||++|..|.+.+...         ...++..+-..+.-||  ..||+|+||.++||++..++ +.++||||+..
T Consensus        74 ~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH--~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          74 GLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLH--KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHH--hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            89999999998888888654         2445666666788899  88899999999999998774 99999999873

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.30  E-value=6.5e-13  Score=138.33  Aligned_cols=249  Identities=20%  Similarity=0.222  Sum_probs=170.3

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      .+.+.+.+-+-+|.++.++.+      .....+...++|+....   .....+....+-.++-...+|.++...--+...
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~------~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r  876 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPA------SPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCR  876 (1205)
T ss_pred             CccceecccccCCCCcccccC------CccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCC
Confidence            356677778889999999886      33335555666655422   122223333333333334456666554444456


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      ...+|+|+|+.+++|...+..-  ...+..........+..++++||  ...+.|||++|.|+|+..+++.+++|||...
T Consensus       877 sP~~L~~~~~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~--s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~  952 (1205)
T KOG0606|consen  877 SPLPLVGHYLNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLH--SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLS  952 (1205)
T ss_pred             CCcchhhHHhccCCchhhhhcC--CCcccccccchhHHHHhhhhccc--cchhhcccccccchhhcccCCcccCcccccc
Confidence            7889999999999999888654  34555555566667788899999  4458999999999999999999999998433


Q ss_pred             CCCCC--------C---------------------CCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCC
Q 013105          235 DGPQG--------E---------------------DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR  285 (449)
Q Consensus       235 ~~~~~--------~---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~  285 (449)
                      ....-        .                     .........||+.|.+||.+.+...+..+|+|++|++++|.++|.
T Consensus       953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen  953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred             ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence            11000        0                     001122356999999999999999999999999999999999999


Q ss_pred             CcccccccccchhhHHhhhhhhccccchhHhhccc-ccccCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 013105          286 RSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSR-LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMT  352 (449)
Q Consensus       286 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  352 (449)
                      +||........-                ..++... .+...+...+....+++...+..+|.+|-.+.
T Consensus      1033 pp~na~tpq~~f----------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETPQQIF----------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCcchhhhh----------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            999865432211                1111111 12223445566788999999999999997665

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.30  E-value=3e-11  Score=102.82  Aligned_cols=143  Identities=17%  Similarity=0.186  Sum_probs=106.7

Q ss_pred             CcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--------CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           83 RSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--------GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        83 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      ...+|-+|+-+.|+++.+.        |+..+||.-...        ..-...+..+|+++|.++.--.|.-..-++.+.
T Consensus        11 ~l~likQGAEArv~~~~~~--------Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~   82 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--------GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT   82 (229)
T ss_pred             cceeeeccceeeEeeeccC--------CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec
Confidence            4567889999999998764        567777764211        112234577899999998655555555567777


Q ss_pred             CEEEEEEEecCC-CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC---cEEEeee
Q 013105          155 EHRLLVYEYMAL-GNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY---NAKLSDF  230 (449)
Q Consensus       155 ~~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~---~~kl~Df  230 (449)
                      ..-.|+|||++| .++.+++...............++..+-+.+.-||  .++|+|+||..+||++..++   .+.++||
T Consensus        83 ~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH--~ndiiHGDLTTSNill~~~~~~~~~~lIdf  160 (229)
T KOG3087|consen   83 YGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH--DNDIIHGDLTTSNILLRSDGNQITPILIDF  160 (229)
T ss_pred             CCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh--hCCeecccccccceEEecCCCcCceEEEee
Confidence            778899999986 37888887654444444444678888888999999  77799999999999996654   4589999


Q ss_pred             ccccC
Q 013105          231 GLATD  235 (449)
Q Consensus       231 Gla~~  235 (449)
                      |++..
T Consensus       161 gls~~  165 (229)
T KOG3087|consen  161 GLSSV  165 (229)
T ss_pred             cchhc
Confidence            99864

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.20  E-value=1.4e-10  Score=105.81  Aligned_cols=142  Identities=20%  Similarity=0.221  Sum_probs=104.3

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCC--CCcceeeeEEEeC---CEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKH--PHLVNLIGYCCED---EHRL  158 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~---~~~~  158 (449)
                      +.|+.|..+.||++...+       +..+++|+...... .....+..|+.++..+.+  .++.+++.+....   +..+
T Consensus         4 ~~l~~G~~n~~~~v~~~~-------g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~   76 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-------GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPF   76 (223)
T ss_pred             eecCCCccceEEEEEecC-------CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCce
Confidence            568999999999986532       46899999864322 134567889999999965  4567777776654   3678


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC-----------------------------------
Q 013105          159 LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE-----------------------------------  203 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-----------------------------------  203 (449)
                      +||||++|.++.+.+..   ..++......++.+++.+|..||+.                                   
T Consensus        77 ~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (223)
T cd05154          77 YVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE  153 (223)
T ss_pred             EEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence            99999998887665421   2455556666677777777777631                                   


Q ss_pred             -------------------CCCeeeccCCCCceEEcC--CCcEEEeeeccccCC
Q 013105          204 -------------------EKPVIYRDFKASNILLDS--DYNAKLSDFGLATDG  236 (449)
Q Consensus       204 -------------------~~~ivHrDikp~Nill~~--~~~~kl~DfGla~~~  236 (449)
                                         ...++|+|+.|.||+++.  ++.+.|+||+.+...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                               245799999999999998  667899999987743

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.08  E-value=2.9e-09  Score=103.99  Aligned_cols=216  Identities=18%  Similarity=0.184  Sum_probs=149.6

Q ss_pred             ceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEe----CCEEEEEEEecCC-
Q 013105           92 FGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE----DEHRLLVYEYMAL-  166 (449)
Q Consensus        92 ~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~----~~~~~lv~e~~~~-  166 (449)
                      -.+.|++...-      +|..|++|+++............-+++++++.|+|||++.+++..    +..+++|++|.++ 
T Consensus       289 ~~Ttyk~~s~~------DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s  362 (655)
T KOG3741|consen  289 SITTYKATSNV------DGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSS  362 (655)
T ss_pred             cceeEeeeecc------CCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCC
Confidence            35678885543      688999999954433333233445789999999999999998863    4678999999875 


Q ss_pred             CChHHHHhhcC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          167 GNLHDQLFKNY-------------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       167 g~L~~~l~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      ++|.++.....             +...++...|.++.|+..||.++|  +.|+.-+-|.|.+||++.+..++|...|+.
T Consensus       363 ~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH--ssGLAck~L~~~kIlv~G~~RIriS~C~i~  440 (655)
T KOG3741|consen  363 PTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH--SSGLACKTLDLKKILVTGKMRIRISGCGIM  440 (655)
T ss_pred             chHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH--hcCceeecccHhHeEeeCcceEEEecccce
Confidence            47777664432             234678899999999999999999  677888999999999999999999888776


Q ss_pred             cCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccch
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      .....+.         +       |-+   +-..+-|.=.||.+++.|.||..--...+  .....              
T Consensus       441 Dvl~~d~---------~-------~~l---e~~Qq~D~~~lG~ll~aLAt~~~ns~~~d--~~~~s--------------  485 (655)
T KOG3741|consen  441 DVLQEDP---------T-------EPL---ESQQQNDLRDLGLLLLALATGTENSNRTD--STQSS--------------  485 (655)
T ss_pred             eeecCCC---------C-------cch---hHHhhhhHHHHHHHHHHHhhccccccccc--chHHH--------------
Confidence            5433221         0       111   12346788899999999999964321110  00000              


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL  358 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  358 (449)
                             ....+....+.++.+++......++.+ -++.+++.++
T Consensus       486 -------~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  486 -------HLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             -------HHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence                   001122345556777787777777776 5777777653

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.04  E-value=1.3e-08  Score=97.17  Aligned_cols=263  Identities=17%  Similarity=0.184  Sum_probs=161.7

Q ss_pred             CcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcC-CCCCcceeeeEE-------EeC
Q 013105           83 RSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL-KHPHLVNLIGYC-------CED  154 (449)
Q Consensus        83 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~-------~~~  154 (449)
                      ..+.||+|+-+.+|-.-.         -...+-|+..........+.   +..|... .||-+-.-+.+=       ...
T Consensus        15 ~gr~LgqGgea~ly~l~e---------~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~   82 (637)
T COG4248          15 PGRPLGQGGEADLYTLGE---------VRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRG   82 (637)
T ss_pred             CCccccCCccceeeecch---------hhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCcc
Confidence            457799999999996411         12245577765443333332   2223332 466443312221       112


Q ss_pred             CEEEEEEEecCCCC-hHHHHh----hcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEee
Q 013105          155 EHRLLVYEYMALGN-LHDQLF----KNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSD  229 (449)
Q Consensus       155 ~~~~lv~e~~~~g~-L~~~l~----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~D  229 (449)
                      ...-++|+.+.|.. +.+++.    ++.-....|...+..+..++.+.+.||  ..|.+-+|+.++|+|+.+++.+.|.|
T Consensus        83 ~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH--~~Gh~vGDVn~~~~lVsd~~~V~LVd  160 (637)
T COG4248          83 KVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH--EHGHVVGDVNQNSFLVSDDSKVVLVD  160 (637)
T ss_pred             ceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH--hcCCcccccCccceeeecCceEEEEc
Confidence            23667888887652 223321    122345678999999999999999999  77799999999999999999999997


Q ss_pred             eccccCCCCCCCCceeeecCCCCccccccccc-----cCCCCcccchhhhHHHHHHHHhC-CCcccccccccc-hhhHH-
Q 013105          230 FGLATDGPQGEDSHITTCVMGTEGYAAPEYIN-----TGHLTTMCDVFSFGVVLLELLTG-RRSVEKNRCKRE-KDLVE-  301 (449)
Q Consensus       230 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg-~~pf~~~~~~~~-~~~~~-  301 (449)
                      -..-...   .......+.+|...|.+||.-.     +..-+...|.|.||+++++++.| +.||.+-..... ....+ 
T Consensus       161 sDsfqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~  237 (637)
T COG4248         161 SDSFQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET  237 (637)
T ss_pred             ccceeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence            4432222   2334466788999999999754     34567789999999999999987 999976421110 00000 


Q ss_pred             h-hhhhhccccchhHhhcccccccCC-HHHHHHHHHHHHHhccC--CCCCCCCHHHHHHHhhcccc
Q 013105          302 W-ARPMLKDFTKLDQIIDSRLEDRYS-TEGAKRLAAVAHQCLSH--NPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       302 ~-~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~--dP~~RPs~~eil~~L~~~~~  363 (449)
                      . ....+.. ......-....+...+ .-+++.+..|..+|+..  ++.-|||++..+..|..+.+
T Consensus       238 ~Ia~g~f~y-a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~  302 (637)
T COG4248         238 DIAHGRFAY-ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ  302 (637)
T ss_pred             hhhcceeee-chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence            0 0000000 0000000000011111 23467789999999874  46789999999988877654

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.04  E-value=7.1e-09  Score=96.94  Aligned_cols=138  Identities=13%  Similarity=0.012  Sum_probs=96.5

Q ss_pred             ccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-----------chHHHHHHHHHHHhcCCC--CCcceeeeEEEe
Q 013105           87 LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-----------QGHREWLAEVIFLGQLKH--PHLVNLIGYCCE  153 (449)
Q Consensus        87 lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~  153 (449)
                      +-......|++..+        .|+.|.||.......           .....+.+|...+..|..  -.++.+++++..
T Consensus        30 v~~~~~rrvvr~~~--------~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~  101 (268)
T PRK15123         30 FRELEGRRTLRFEL--------AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGER  101 (268)
T ss_pred             EecCCCceEEEEEE--------CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEe
Confidence            33333344666544        256899997643221           111236789988888843  334455555543


Q ss_pred             -----CCEEEEEEEecCCC-ChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC------
Q 013105          154 -----DEHRLLVYEYMALG-NLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS------  221 (449)
Q Consensus       154 -----~~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~------  221 (449)
                           ....+||||++.+. +|.+++........+......++.+++..+.-||  ..||+|+|+++.|||++.      
T Consensus       102 ~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH--~~Gi~HgDL~~~NiLl~~~~~~~~  179 (268)
T PRK15123        102 GSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH--AAGINHRDCYICHFLLHLPFPGRE  179 (268)
T ss_pred             cCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH--HCcCccCCCChhhEEEeccccCCC
Confidence                 23578999999876 7888875432344556677789999999999999  788999999999999975      


Q ss_pred             -CCcEEEeeecccc
Q 013105          222 -DYNAKLSDFGLAT  234 (449)
Q Consensus       222 -~~~~kl~DfGla~  234 (449)
                       +..+.|+||+.+.
T Consensus       180 ~~~~~~LIDl~r~~  193 (268)
T PRK15123        180 EDLKLSVIDLHRAQ  193 (268)
T ss_pred             CCceEEEEECCccc
Confidence             4689999999875

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.92  E-value=1e-08  Score=90.43  Aligned_cols=125  Identities=22%  Similarity=0.215  Sum_probs=77.3

Q ss_pred             EEEEEEEcCCCCCCCCCcEEEEEEeccCC--------------c--------c----hHHHHHHHHHHHhcCCCC--Ccc
Q 013105           94 KVYKGCVDDNLRPGLKAQTVAVKVLDVNG--------------S--------Q----GHREWLAEVIFLGQLKHP--HLV  145 (449)
Q Consensus        94 ~V~~~~~~~~~~~~~~~~~vavK~~~~~~--------------~--------~----~~~~~~~E~~~l~~l~h~--nIv  145 (449)
                      .||.|...+       +..+|+|+.....              .        .    ......+|++.|.++..-  +++
T Consensus         1 ~Vy~~~~~~-------~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP   73 (188)
T PF01163_consen    1 DVYHAIDPD-------GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVP   73 (188)
T ss_dssp             EEEEEEECT-------TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS-
T ss_pred             CEEEEECCC-------CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence            388886644       6799999974210              0        0    012356799999999755  567


Q ss_pred             eeeeEEEeCCEEEEEEEecC--CCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHH-hhcCCCCeeeccCCCCceEEcCC
Q 013105          146 NLIGYCCEDEHRLLVYEYMA--LGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAF-LHGEEKPVIYRDFKASNILLDSD  222 (449)
Q Consensus       146 ~~~~~~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~-lH~~~~~ivHrDikp~Nill~~~  222 (449)
                      +++++.    ..+|||||+.  |..+..+....    +.......++.+++..+.. +|  ..||+|+||.+.|||++.+
T Consensus        74 ~p~~~~----~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~--~~givHGDLs~~NIlv~~~  143 (188)
T PF01163_consen   74 KPYDYN----RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLH--KAGIVHGDLSEYNILVDDG  143 (188)
T ss_dssp             -EEEEE----TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHH--CTTEEESS-STTSEEEETT
T ss_pred             cEEEEe----CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHH--hcCceecCCChhhEEeecc
Confidence            777553    2469999998  55554332211    1122344556666664444 57  7889999999999999888


Q ss_pred             CcEEEeeeccccCC
Q 013105          223 YNAKLSDFGLATDG  236 (449)
Q Consensus       223 ~~~kl~DfGla~~~  236 (449)
                       .+.|+|||.+...
T Consensus       144 -~~~iIDf~qav~~  156 (188)
T PF01163_consen  144 -KVYIIDFGQAVDS  156 (188)
T ss_dssp             -CEEE--GTTEEET
T ss_pred             -eEEEEecCcceec
Confidence             9999999988743

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.88  E-value=6.8e-10  Score=111.99  Aligned_cols=151  Identities=21%  Similarity=0.302  Sum_probs=106.3

Q ss_pred             HHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCC-------CceeeecCCCCccccccccccC
Q 013105          191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGED-------SHITTCVMGTEGYAAPEYINTG  263 (449)
Q Consensus       191 ~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~  263 (449)
                      .+++.||.|+|. ..++||+.|.|++|.++.++..||+.|+.+........       ........-...|.|||.+.+.
T Consensus       106 ~~v~dgl~flh~-sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  106 GNVADGLAFLHR-SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             hcccchhhhhcc-CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            344589999996 45799999999999999999999999998764433111       1111123346789999999888


Q ss_pred             CCCcccchhhhHHHHHHHH-hCCCcccccccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhcc
Q 013105          264 HLTTMCDVFSFGVVLLELL-TGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLS  342 (449)
Q Consensus       264 ~~~~~~DvwslG~vl~ell-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  342 (449)
                      ..+.++|+|||||++|.+. .|+..+.........              ......+......+..++|.++.+=+.+++.
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~--------------~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY--------------SFSRNLLNAGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchh--------------hhhhcccccccccccccCcHHHHHHHHHHhc
Confidence            8899999999999999999 555554433111111              1111111112223446778889999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 013105          343 HNPKSRPTMTTVVK  356 (449)
Q Consensus       343 ~dP~~RPs~~eil~  356 (449)
                      .++.-||++.++..
T Consensus       251 ~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  251 GDSAVRPTLDLLLS  264 (700)
T ss_pred             CCcccCcchhhhhc
Confidence            99999998777664

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.85  E-value=2.4e-08  Score=90.73  Aligned_cols=134  Identities=19%  Similarity=0.124  Sum_probs=94.3

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc----------------------chHHHHHHHHHHHhc
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS----------------------QGHREWLAEVIFLGQ  138 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~  138 (449)
                      +.++..||-|.-+.||.|...+       +.++|||.-+....                      .......+|.++|..
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~-------g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~  165 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPK-------GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQR  165 (304)
T ss_pred             HhhccccccCccceEEEEECCC-------CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHH
Confidence            5667899999999999997653       78999998632100                      011235679999999


Q ss_pred             CCCC--CcceeeeEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCc
Q 013105          139 LKHP--HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASN  216 (449)
Q Consensus       139 l~h~--nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~N  216 (449)
                      |...  .|.+.+++    +...+|||+++|-.|...-       +.....-.++..|++-+.-+-  ..||||+|+.+-|
T Consensus       166 L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~--~~GiVHGDlSefN  232 (304)
T COG0478         166 LYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAY--RRGIVHGDLSEFN  232 (304)
T ss_pred             hhhcCCCCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHH--HcCccccCCchhe
Confidence            9654  77777764    4678999999986664322       112223333444444444333  4679999999999


Q ss_pred             eEEcCCCcEEEeeecccc
Q 013105          217 ILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       217 ill~~~~~~kl~DfGla~  234 (449)
                      |+++++|.+.++||--+.
T Consensus       233 IlV~~dg~~~vIDwPQ~v  250 (304)
T COG0478         233 ILVTEDGDIVVIDWPQAV  250 (304)
T ss_pred             EEEecCCCEEEEeCcccc
Confidence            999999999999996554

>PRK09902 hypothetical protein; Provisional

Probab=98.74  E-value=3.1e-07  Score=81.63  Aligned_cols=138  Identities=16%  Similarity=0.060  Sum_probs=101.1

Q ss_pred             ccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC------cchHHHHHHHHHHHhcCCC--CCcceeeeEEEe----C
Q 013105           87 LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG------SQGHREWLAEVIFLGQLKH--PHLVNLIGYCCE----D  154 (449)
Q Consensus        87 lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~----~  154 (449)
                      -|.||.+.|++..+.        |..+-+|.-...-      ......|.+|+..|..|..  -.+.++......    .
T Consensus        26 ~~rgG~SgV~r~~~~--------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~   97 (216)
T PRK09902         26 YRRNGMSGVQCVERN--------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGE   97 (216)
T ss_pred             cCCCCcceEEEEEeC--------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCc
Confidence            567999999987553        3467888764110      2245678999999998853  335555522222    1


Q ss_pred             CEEEEEEEecCC-CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCc--EEEeeec
Q 013105          155 EHRLLVYEYMAL-GNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYN--AKLSDFG  231 (449)
Q Consensus       155 ~~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~--~kl~DfG  231 (449)
                      -..+||+|-+.| -+|.+++........+......+..+++..+.-||  ..|+.|+|+.+.|||++.++.  +.++||.
T Consensus        98 ~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH--~~Gv~Hgdly~khIll~~~g~~~v~lIDlE  175 (216)
T PRK09902         98 WRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH--SVNRQHGCCYVRHIYVKTEGKAEAGFLDLE  175 (216)
T ss_pred             eEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHhheeecCCCCeeEEEEEhh
Confidence            335899997754 47877776654445677778899999999999999  788999999999999987777  9999998


Q ss_pred             ccc
Q 013105          232 LAT  234 (449)
Q Consensus       232 la~  234 (449)
                      -++
T Consensus       176 k~r  178 (216)
T PRK09902        176 KSR  178 (216)
T ss_pred             ccc
Confidence            665

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.70  E-value=1.5e-07  Score=85.10  Aligned_cols=106  Identities=24%  Similarity=0.164  Sum_probs=83.2

Q ss_pred             HHHHHHHHHHHhcCC--CCCcceeeeEEEeC----CEEEEEEEecCCC-ChHHHHhhcCCCCCCHHHHHHHHHHHHHHHH
Q 013105          126 HREWLAEVIFLGQLK--HPHLVNLIGYCCED----EHRLLVYEYMALG-NLHDQLFKNYSSTLPWLTRIKIAIGAARCLA  198 (449)
Q Consensus       126 ~~~~~~E~~~l~~l~--h~nIv~~~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~  198 (449)
                      .....+|...+..|.  .-.++..+++....    ...+||+|++++. +|.+++....  ..+......++.+++..++
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIA  132 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHH
Confidence            346778888887774  34456677776653    2458999999874 7888886532  2566677889999999999


Q ss_pred             HhhcCCCCeeeccCCCCceEEcCCC---cEEEeeeccccC
Q 013105          199 FLHGEEKPVIYRDFKASNILLDSDY---NAKLSDFGLATD  235 (449)
Q Consensus       199 ~lH~~~~~ivHrDikp~Nill~~~~---~~kl~DfGla~~  235 (449)
                      -||  ..||+|+|+++.|||++.++   .+.|+||+-++.
T Consensus       133 ~lH--~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  133 KLH--DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHH--HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999  78899999999999999887   899999987764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.69  E-value=3.8e-07  Score=83.52  Aligned_cols=138  Identities=16%  Similarity=0.121  Sum_probs=85.7

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCC--CcceeeeEEEeCCEEEEEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHP--HLVNLIGYCCEDEHRLLVYE  162 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~~~~~~~~~~~~~lv~e  162 (449)
                      ..||+|..+.||+.          .+..+++|+.....  ......+|.+++..+..-  .+.+++++....+...+|||
T Consensus         7 ~~i~~G~t~~~y~~----------~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e   74 (226)
T TIGR02172         7 TQTGEGGNGESYTH----------KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYE   74 (226)
T ss_pred             eeecCCCCcceeEe----------cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeee
Confidence            46899999999984          13457889876432  334568899999888633  35778888888888899999


Q ss_pred             ecCCCC-hH--------------HHHhh----cCC---CCCCHHHHHH-HHHH----------HHH-HHHHhh--cCCCC
Q 013105          163 YMALGN-LH--------------DQLFK----NYS---STLPWLTRIK-IAIG----------AAR-CLAFLH--GEEKP  206 (449)
Q Consensus       163 ~~~~g~-L~--------------~~l~~----~~~---~~l~~~~~~~-i~~~----------i~~-~l~~lH--~~~~~  206 (449)
                      +++|.+ +.              ..+.+    -..   ...+...... +..+          +.. ...+|.  .....
T Consensus        75 ~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~  154 (226)
T TIGR02172        75 LIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST  154 (226)
T ss_pred             ecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence            999863 11              11100    000   1111111100 0000          001 112222  22345


Q ss_pred             eeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          207 VIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       207 ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ++|+|+.|.||++++++ +.|+||+.+..
T Consensus       155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       155 CLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             eEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            78999999999999888 99999998763

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.60  E-value=2.2e-07  Score=94.07  Aligned_cols=142  Identities=18%  Similarity=0.179  Sum_probs=90.7

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcch------------------------------HH-------
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG------------------------------HR-------  127 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~------------------------------~~-------  127 (449)
                      +.|+.++-|.||+|++++       |+.||||+.+..-...                              .+       
T Consensus       131 ~PiAsASIaQVH~A~L~s-------G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~  203 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-------GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR  203 (517)
T ss_pred             CchhhhhHhhheeEEecC-------CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence            679999999999999875       7999999974221100                              00       


Q ss_pred             ---HHHHHHHHHhcCC-----CCCcceeeeEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 013105          128 ---EWLAEVIFLGQLK-----HPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAF  199 (449)
Q Consensus       128 ---~~~~E~~~l~~l~-----h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~  199 (449)
                         ++.+|...+.++.     .++|.=..=+.+-.+...|+|||++|-.+.+...-.. ...+...+.....++.  +..
T Consensus       204 ~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q  280 (517)
T COG0661         204 EELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQ  280 (517)
T ss_pred             HHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHH
Confidence               1334555555542     3333222222233456789999999988877743222 3444333333222222  222


Q ss_pred             hhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCC
Q 013105          200 LHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       200 lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~  238 (449)
                      +-  ..|++|.|..|.||+++.+|.+.+.|||+......
T Consensus       281 ~~--~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         281 LL--RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HH--hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            22  35699999999999999999999999999886543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.52  E-value=1.9e-06  Score=77.02  Aligned_cols=139  Identities=12%  Similarity=0.083  Sum_probs=90.7

Q ss_pred             HHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHH---------HHHHHHHhcCC---CC
Q 013105           75 QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREW---------LAEVIFLGQLK---HP  142 (449)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~---h~  142 (449)
                      ..+.++|...+++-......|.+-..        .++.+++|..........+.|         .+++..+..+.   --
T Consensus        27 ~i~~~~~~~~kv~k~~~r~~ValIei--------~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~   98 (229)
T PF06176_consen   27 KILDNNYKIIKVFKNTKRNYVALIEI--------DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFT   98 (229)
T ss_pred             HHHhCCceEEEeecCCCccEEEEEEE--------CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcc
Confidence            34567888888888887777776543        468899999865433333322         22333333332   22


Q ss_pred             CcceeeeEEEe-----CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCce
Q 013105          143 HLVNLIGYCCE-----DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNI  217 (449)
Q Consensus       143 nIv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Ni  217 (449)
                      ....++.+...     ....+|+|||++|..|.+...      ++.    .+...+.+++.-||  ..|++|+|..|.|+
T Consensus        99 ~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH--~~G~~HGD~hpgNF  166 (229)
T PF06176_consen   99 EPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLH--KHGFYHGDPHPGNF  166 (229)
T ss_pred             ccccceeeeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHH--HcCCccCCCCcCcE
Confidence            33333333322     244568999999988866431      222    23455667789999  78899999999999


Q ss_pred             EEcCCCcEEEeeecccc
Q 013105          218 LLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       218 ll~~~~~~kl~DfGla~  234 (449)
                      +++.+ .++++||+..+
T Consensus       167 lv~~~-~i~iID~~~k~  182 (229)
T PF06176_consen  167 LVSNN-GIRIIDTQGKR  182 (229)
T ss_pred             EEECC-cEEEEECcccc
Confidence            99866 59999997655

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.35  E-value=6.9e-06  Score=76.25  Aligned_cols=137  Identities=20%  Similarity=0.100  Sum_probs=82.1

Q ss_pred             ccccCc-eEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC-CCCcceeeeEEEeCCEEEEEEEec
Q 013105           87 LGEGGF-GKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-HPHLVNLIGYCCEDEHRLLVYEYM  164 (449)
Q Consensus        87 lG~G~~-g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e~~  164 (449)
                      |-.|.. ..||+...        .+..+.+|+.....   ...+.+|+++++.+. +--+.+++++....+..++|||++
T Consensus         6 ~~~g~~~~~v~~~~~--------~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i   74 (244)
T cd05150           6 VTEGQSGATVYRLDG--------KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAV   74 (244)
T ss_pred             cCCCCCcCeEEEEcC--------CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEee
Confidence            444544 78898742        13578888875332   335667888888874 444667888877777789999999


Q ss_pred             CCCChHHHHh----------------hcCCC-----CCCH--HHHHHHHHH--------------------HHHHHHHhh
Q 013105          165 ALGNLHDQLF----------------KNYSS-----TLPW--LTRIKIAIG--------------------AARCLAFLH  201 (449)
Q Consensus       165 ~~g~L~~~l~----------------~~~~~-----~l~~--~~~~~i~~~--------------------i~~~l~~lH  201 (449)
                      +|.+|.....                +-...     ....  .........                    +...+..|-
T Consensus        75 ~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  154 (244)
T cd05150          75 PGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELE  154 (244)
T ss_pred             CCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHH
Confidence            9877653310                00000     1110  000000000                    111112221


Q ss_pred             -----cCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          202 -----GEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       202 -----~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                           .....++|+|+.|.|||++.++.+.|+||+.+.
T Consensus       155 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         155 ATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             hhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence                 013458999999999999998778899998775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.34  E-value=5.4e-06  Score=76.04  Aligned_cols=140  Identities=22%  Similarity=0.190  Sum_probs=80.9

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCC--CcceeeeEEE---eCCEEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHP--HLVNLIGYCC---EDEHRLL  159 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~~~~~~~---~~~~~~l  159 (449)
                      +.|+.|..+.||+....+        ..+++|.....  .....+.+|..+++.+...  .+..++....   .....++
T Consensus         3 ~~l~~G~~n~~~~v~~~~--------~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~   72 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD--------GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYL   72 (239)
T ss_dssp             EEEEESSSSEEEEEEETT--------SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEE
T ss_pred             ccCCCCCeeeEEEEEECC--------cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceE
Confidence            568999999999986542        48999997533  3456677888888887422  3566776443   3456799


Q ss_pred             EEEecCCCChHH----------------HHhh--cC---CCCCCHHH---------HHHH------------HHHHHH-H
Q 013105          160 VYEYMALGNLHD----------------QLFK--NY---SSTLPWLT---------RIKI------------AIGAAR-C  196 (449)
Q Consensus       160 v~e~~~~g~L~~----------------~l~~--~~---~~~l~~~~---------~~~i------------~~~i~~-~  196 (449)
                      +|++++|..+..                .+..  ..   ........         ....            ...+.. .
T Consensus        73 ~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (239)
T PF01636_consen   73 LMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERL  152 (239)
T ss_dssp             EEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHH
T ss_pred             EEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHH
Confidence            999999887766                1111  00   01111100         0000            001111 2


Q ss_pred             HHHhhc-----CCCCeeeccCCCCceEEc-CCCcEEEeeecccc
Q 013105          197 LAFLHG-----EEKPVIYRDFKASNILLD-SDYNAKLSDFGLAT  234 (449)
Q Consensus       197 l~~lH~-----~~~~ivHrDikp~Nill~-~~~~~kl~DfGla~  234 (449)
                      +..++.     ....++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus       153 ~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  153 LQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            222221     345699999999999999 66667899998654

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.30  E-value=1.6e-07  Score=94.27  Aligned_cols=183  Identities=18%  Similarity=0.140  Sum_probs=125.7

Q ss_pred             cccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCC-cceeeeEEEeCCEEEEEEE
Q 013105           84 SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPH-LVNLIGYCCEDEHRLLVYE  162 (449)
Q Consensus        84 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~lv~e  162 (449)
                      ..-+++|+++.++|..      +..+... ..+.+...     ....-++++|.+++||| .+..++-++.++..+++|+
T Consensus       247 fh~fvK~altknpKkR------ptaeklL-~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~  314 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKR------PTAEKLL-QHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR  314 (829)
T ss_pred             HHHHHHHHhcCCCccC------CChhhhe-eceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence            3458899999999963      2222222 25554322     23344788999999999 7777777777888899999


Q ss_pred             ecCCC-ChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCC
Q 013105          163 YMALG-NLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGED  241 (449)
Q Consensus       163 ~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~  241 (449)
                      ++.++ +....... ..-.+..-+...+...-+++|+++|+.  .=+|+|    ||+..+ +..+.+||+....+.... 
T Consensus       315 i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~--~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-  385 (829)
T KOG0576|consen  315 ICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSS--YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-  385 (829)
T ss_pred             hhcCCccccccCCh-hhHhhhhhhhhhhhhhhcccccccccc--cccCcc----cccccc-cccccccccCCcccCccc-
Confidence            99877 22211110 001122233344555567789999942  248888    877765 588999999988665443 


Q ss_pred             CceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCccc
Q 013105          242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVE  289 (449)
Q Consensus       242 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~  289 (449)
                        ......+|+.++|||+.....+....|+|++|.--.+|.-|.+|-.
T Consensus       386 --~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  386 --KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             --ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence              2344669999999999998999999999999987777777776643

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.27  E-value=1.3e-05  Score=72.53  Aligned_cols=151  Identities=21%  Similarity=0.189  Sum_probs=96.4

Q ss_pred             CHHHHHHHhcCCCCccccc---ccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc-------------------hHH
Q 013105           70 TLKELQMITHNFSRSDYLG---EGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ-------------------GHR  127 (449)
Q Consensus        70 ~~~~~~~~~~~y~~~~~lG---~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-------------------~~~  127 (449)
                      +...+..+..+..+..+.|   .|.-+.||+|...       .+..+|+|+.......                   ...
T Consensus        36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~-------~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr  108 (268)
T COG1718          36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETG-------DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRR  108 (268)
T ss_pred             HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC-------CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHH
Confidence            4555556666666666654   6777889998543       3688999998532111                   011


Q ss_pred             -----HHHHHHHHHhcCC--CCCcceeeeEEEeCCEEEEEEEecCCCCh-HHHHhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 013105          128 -----EWLAEVIFLGQLK--HPHLVNLIGYCCEDEHRLLVYEYMALGNL-HDQLFKNYSSTLPWLTRIKIAIGAARCLAF  199 (449)
Q Consensus       128 -----~~~~E~~~l~~l~--h~nIv~~~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~  199 (449)
                           ....|+.-|.++.  +-.+.+.+.+.    ...|||||+....+ .=.|..   -.+.......+..++++.+.-
T Consensus       109 ~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~  181 (268)
T COG1718         109 KLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRR  181 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHH
Confidence                 1245777777773  45556666554    34799999853211 000111   122222455666677777766


Q ss_pred             hhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          200 LHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       200 lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      |-. ..++||+||..-|||+. ++.+.|+|||-|...
T Consensus       182 l~~-~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         182 LYK-EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             HHH-hcCcccccchhhheEEE-CCeEEEEECcccccc
Confidence            652 36799999999999999 779999999988754

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.25  E-value=2.6e-05  Score=69.44  Aligned_cols=131  Identities=21%  Similarity=0.273  Sum_probs=90.9

Q ss_pred             cccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC----------------cchHHHHHHHHHHHhcCC------C
Q 013105           84 SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG----------------SQGHREWLAEVIFLGQLK------H  141 (449)
Q Consensus        84 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h  141 (449)
                      ...||+|+.-.||.-  .       .....+||+.....                .....+..+|+.....+.      +
T Consensus         6 ~~~i~~G~~R~cy~H--P-------~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~   76 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH--P-------DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDW   76 (199)
T ss_pred             CcccccCCCceEEEC--C-------CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcc
Confidence            457999999999973  1       24457899987554                122455666776655554      8


Q ss_pred             CCcceeeeEEEeCCEEEEEEEecCC------CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCC
Q 013105          142 PHLVNLIGYCCEDEHRLLVYEYMAL------GNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKAS  215 (449)
Q Consensus       142 ~nIv~~~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~  215 (449)
                      .+|.+++|+.+++-..-+|+|.+..      -+|.+++.+.   .++. .....+.+.   ..||-  ..+|+.+|++|.
T Consensus        77 ~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~L~~f---~~~l~--~~~Iv~~dl~~~  147 (199)
T PF10707_consen   77 SHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQALDEF---KRYLL--DHHIVIRDLNPH  147 (199)
T ss_pred             cccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHHHHHH---HHHHH--HcCCeecCCCcc
Confidence            8999999999999999999998753      2677777443   4444 444444443   34555  455999999999


Q ss_pred             ceEEcCC--C--cEEEee-ecc
Q 013105          216 NILLDSD--Y--NAKLSD-FGL  232 (449)
Q Consensus       216 Nill~~~--~--~~kl~D-fGl  232 (449)
                      ||++...  +  .+.|+| ||-
T Consensus       148 NIv~~~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  148 NIVVQRRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             cEEEEecCCCceEEEEEeCCCC
Confidence            9999543  2  588888 443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.24  E-value=7.1e-06  Score=83.05  Aligned_cols=141  Identities=17%  Similarity=0.131  Sum_probs=88.3

Q ss_pred             cccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcch-------------------------------------H
Q 013105           84 SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG-------------------------------------H  126 (449)
Q Consensus        84 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------------------------------~  126 (449)
                      .+.||..+.|.||+|..++       |+.||||+-+..-...                                     .
T Consensus       166 ~~piaaASlaQVhrA~L~~-------G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~E  238 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKN-------GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQE  238 (538)
T ss_pred             cchhhhcchhheEEEEecC-------CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhh
Confidence            3679999999999998875       7899999964221100                                     0


Q ss_pred             HHHHHHHHHHhc----CCCCC------cceeeeEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHH
Q 013105          127 REWLAEVIFLGQ----LKHPH------LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC  196 (449)
Q Consensus       127 ~~~~~E~~~l~~----l~h~n------Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~  196 (449)
                      -+|.+|++-..+    +.|-+      |.++|-.+  .....|+||||+|..+.|.-.-. ...++...+..-+.++..-
T Consensus       239 LDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~-~~gi~~~~i~~~l~~~~~~  315 (538)
T KOG1235|consen  239 LDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAID-KRGISPHDILNKLVEAYLE  315 (538)
T ss_pred             cchHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHH-HcCCCHHHHHHHHHHHHHH
Confidence            013344443333    23444      44454333  34678999999998776543211 1244444444333332222


Q ss_pred             HHHhhcCCCCeeeccCCCCceEEcC----CCcEEEeeeccccCCCC
Q 013105          197 LAFLHGEEKPVIYRDFKASNILLDS----DYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       197 l~~lH~~~~~ivHrDikp~Nill~~----~~~~kl~DfGla~~~~~  238 (449)
                      +-+    ..|++|.|-.|.||+++.    ++.+.+.|||+......
T Consensus       316 qIf----~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  316 QIF----KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHH----hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            222    356999999999999984    56899999999886543

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.22  E-value=4.5e-05  Score=67.60  Aligned_cols=99  Identities=27%  Similarity=0.322  Sum_probs=77.9

Q ss_pred             HHHHHHhcCCC-CCcceeeeEEEeCCEEEEEEEecCCCChHHH---HhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC-C
Q 013105          131 AEVIFLGQLKH-PHLVNLIGYCCEDEHRLLVYEYMALGNLHDQ---LFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE-K  205 (449)
Q Consensus       131 ~E~~~l~~l~h-~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~---l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-~  205 (449)
                      .|.-+++.+++ +++++++|+|-    .++|.||...+++...   +..  -...+|..+.+|+.++++.+.+++... .
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~--~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQ--FLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccccc--ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            47888888875 69999999983    4678999987655421   111  135789999999999999999998432 3


Q ss_pred             CeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          206 PVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       206 ~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      .+.-.|++++|+-+++++.+|++|...+..
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence            477789999999999999999999987653

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.18  E-value=1.6e-05  Score=73.42  Aligned_cols=73  Identities=12%  Similarity=0.143  Sum_probs=46.4

Q ss_pred             ccccccCce-EEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCC---CcceeeeEEEeC---CEE
Q 013105           85 DYLGEGGFG-KVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHP---HLVNLIGYCCED---EHR  157 (449)
Q Consensus        85 ~~lG~G~~g-~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~~~~~~~~~---~~~  157 (449)
                      +.|+.||.. .||+.           +..+++|+....  .....+.+|.++|..+...   -+..+++.....   ...
T Consensus         3 ~~~~~gG~~n~vy~~-----------~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~   69 (235)
T cd05155           3 EPVDSGGTDNATFRL-----------GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWP   69 (235)
T ss_pred             eeccCCCcccceEEc-----------CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcc
Confidence            457777766 48875           235778876432  2345688899999887532   345555544332   245


Q ss_pred             EEEEEecCCCChH
Q 013105          158 LLVYEYMALGNLH  170 (449)
Q Consensus       158 ~lv~e~~~~g~L~  170 (449)
                      +++|++++|.++.
T Consensus        70 ~~l~~~i~G~~l~   82 (235)
T cd05155          70 WSVYRWLEGETAT   82 (235)
T ss_pred             eEEEEeecCCCCC
Confidence            8899999987663

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PLN02876 acyl-CoA dehydrogenase

Probab=98.15  E-value=4e-05  Score=83.62  Aligned_cols=81  Identities=14%  Similarity=0.146  Sum_probs=56.4

Q ss_pred             cccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCC-CCCc--ceeeeEEEeC---CE
Q 013105           84 SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLK-HPHL--VNLIGYCCED---EH  156 (449)
Q Consensus        84 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nI--v~~~~~~~~~---~~  156 (449)
                      .+.|+.|.+..+|+.....+    .....+++|+..... ......+.+|+++|+.+. |.+|  .+++.++.+.   +.
T Consensus        43 v~~l~gG~sn~ty~l~~~~~----~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~  118 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNG----GSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT  118 (822)
T ss_pred             EEEeCCCCcCceEEEEECCC----CcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence            46688999999999765431    112467888764322 122356789999999995 6665  7788887664   46


Q ss_pred             EEEEEEecCCCC
Q 013105          157 RLLVYEYMALGN  168 (449)
Q Consensus       157 ~~lv~e~~~~g~  168 (449)
                      .|+||||++|..
T Consensus       119 ~flVME~v~G~~  130 (822)
T PLN02876        119 AFYIMEYLEGRI  130 (822)
T ss_pred             ceEEEEecCCcc
Confidence            799999998754

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.14  E-value=1.8e-05  Score=67.72  Aligned_cols=126  Identities=19%  Similarity=0.155  Sum_probs=86.7

Q ss_pred             CcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcce-eeeEEEeCCEEEEEE
Q 013105           83 RSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN-LIGYCCEDEHRLLVY  161 (449)
Q Consensus        83 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~-~~~~~~~~~~~~lv~  161 (449)
                      +.+.||+|++|.||+|.+.        +..+|+|+-..+..  ...+..|+++|..+.-.++-+ +|.+..    .++.|
T Consensus        26 v~~~L~KG~~s~Vyl~~~~--------~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~m   91 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR--------GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRM   91 (201)
T ss_pred             hhhhhhcccccEEEEeecc--------CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech----hhhhh
Confidence            4567999999999999875        45899999865433  467788999999998766554 554443    34559


Q ss_pred             EecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCC--CceEEcCCCcEEEeeecccc
Q 013105          162 EYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKA--SNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       162 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp--~Nill~~~~~~kl~DfGla~  234 (449)
                      ||+.|-.|.+.....     ....    ...+++.-.-|-  ..||-|..|.-  .||++.. +.+.|+||.-|+
T Consensus        92 e~i~G~~L~~~~~~~-----~rk~----l~~vlE~a~~LD--~~GI~H~El~~~~k~vlv~~-~~~~iIDFd~At  154 (201)
T COG2112          92 EYIDGRPLGKLEIGG-----DRKH----LLRVLEKAYKLD--RLGIEHGELSRPWKNVLVND-RDVYIIDFDSAT  154 (201)
T ss_pred             hhhcCcchhhhhhcc-----cHHH----HHHHHHHHHHHH--HhccchhhhcCCceeEEecC-CcEEEEEccchh
Confidence            999988887655321     1122    333444433344  56788888864  4555554 499999999887

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.89  E-value=0.00011  Score=65.04  Aligned_cols=125  Identities=26%  Similarity=0.366  Sum_probs=87.5

Q ss_pred             cCCCCcccccccCc-eEEEEEEEcCCCCCCCCCcEEEEEEecc---CCc------------------chHHHHHHHHHHH
Q 013105           79 HNFSRSDYLGEGGF-GKVYKGCVDDNLRPGLKAQTVAVKVLDV---NGS------------------QGHREWLAEVIFL  136 (449)
Q Consensus        79 ~~y~~~~~lG~G~~-g~V~~~~~~~~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l  136 (449)
                      .+++..+.||.|.- |.||++...        +..+|+|+...   ...                  .....|..|.+..
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--------g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAf  108 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--------GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAF  108 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--------CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhh
Confidence            67888999999999 999999764        57999999321   100                  1112467788887


Q ss_pred             hcCC---CCCc--ceeeeEEEeC------------------CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHH
Q 013105          137 GQLK---HPHL--VNLIGYCCED------------------EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGA  193 (449)
Q Consensus       137 ~~l~---h~nI--v~~~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i  193 (449)
                      .+|+   +.++  ++++||..-.                  ....||.||+....           .+.    ..-+.+|
T Consensus       109 gRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~  173 (207)
T PF13095_consen  109 GRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQM  173 (207)
T ss_pred             HHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHH
Confidence            7774   4566  8899987322                  12357888776433           111    2234556


Q ss_pred             HHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          194 ARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       194 ~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      .+-|..+|  ..||+-+|+++.|..     .-+|+|||.+
T Consensus       174 ~~dl~~~~--k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  174 LRDLKILH--KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHHH--HCCeeeccCcccccc-----CCEEEecccC
Confidence            67788899  788999999999986     4578999864

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.87  E-value=4.6e-05  Score=81.99  Aligned_cols=195  Identities=21%  Similarity=0.233  Sum_probs=131.0

Q ss_pred             HHHHHHHhcCCCCCcceeeeEEEeCCEEE----EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 013105          130 LAEVIFLGQLKHPHLVNLIGYCCEDEHRL----LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK  205 (449)
Q Consensus       130 ~~E~~~l~~l~h~nIv~~~~~~~~~~~~~----lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~  205 (449)
                      ..|...+..+.|+|++.++.|.......-    +..+++..-++...+..-  ...+..+.+.+..+..+||.|+|++. 
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~~~-  306 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHSLS-  306 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHHhc-
Confidence            34667778889999999999876543332    334677777777777554  67888888999999999999999653 


Q ss_pred             CeeeccCCCC---ceEEcCCCcEEEe--eeccccCCCCCCCCceeeecCCCCccccccccccCCCCc--ccchhhhHHHH
Q 013105          206 PVIYRDFKAS---NILLDSDYNAKLS--DFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTT--MCDVFSFGVVL  278 (449)
Q Consensus       206 ~ivHrDikp~---Nill~~~~~~kl~--DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~DvwslG~vl  278 (449)
                       ..|.-+...   +-..+.++.+.++  ||+.+..........   ...-+..|.++|......+..  ..|+|.+|..+
T Consensus       307 -l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  307 -LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             -cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence             444433333   3334556667766  888887665433221   122355678888876555544  47999999999


Q ss_pred             HHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 013105          279 LELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL  358 (449)
Q Consensus       279 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  358 (449)
                      ..+..|..+-....                   ....++.        ......+.+...+|+.-++++|+++.+++.+.
T Consensus       383 ~~~~~~~~i~~~~~-------------------~~~~~l~--------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  383 LQLSQGEDISEKSA-------------------VPVSLLD--------VLSTSELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             hhhhhcCccccccc-------------------chhhhhc--------cccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence            99998775532210                   0000001        11111467788999999999999999999873

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.82  E-value=0.00013  Score=68.14  Aligned_cols=136  Identities=15%  Similarity=0.060  Sum_probs=75.7

Q ss_pred             ccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCc-ceeeeEEEeCCEEEEEEEecC
Q 013105           87 LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHL-VNLIGYCCEDEHRLLVYEYMA  165 (449)
Q Consensus        87 lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv~e~~~  165 (449)
                      +..|-...+|+...        .+..+++|+.............+|..+++.+....+ .+++...  .  .++||||++
T Consensus         4 ~~~G~tn~~y~~~~--------~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~   71 (256)
T TIGR02721         4 LSGGLTNRSWRIEH--------PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLE   71 (256)
T ss_pred             CCCcCcCCeEEEEe--------CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEecc
Confidence            45677788998752        255788887653322211234678888888864333 4444443  2  368999999


Q ss_pred             CCChHH--------------HHhhcC-----CCCCCHHHH-HHHHHHH---------HHHHHHhhc------CCCCeeec
Q 013105          166 LGNLHD--------------QLFKNY-----SSTLPWLTR-IKIAIGA---------ARCLAFLHG------EEKPVIYR  210 (449)
Q Consensus       166 ~g~L~~--------------~l~~~~-----~~~l~~~~~-~~i~~~i---------~~~l~~lH~------~~~~ivHr  210 (449)
                      |..+..              .+.+-.     ...+..... ..+..++         ...+..+-.      ....++|+
T Consensus        72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~  151 (256)
T TIGR02721        72 GEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM  151 (256)
T ss_pred             CcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence            866531              111101     111121111 1111111         111111111      12358999


Q ss_pred             cCCCCceEEcCCCcEEEeeeccccC
Q 013105          211 DFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       211 Dikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      |+.|.||+++.++ +.|+||+.+..
T Consensus       152 Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       152 DVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CCCcCcEEEeCCC-CEEEeccccCc
Confidence            9999999999887 78999988764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.81  E-value=0.0002  Score=68.51  Aligned_cols=140  Identities=19%  Similarity=0.183  Sum_probs=81.1

Q ss_pred             cccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCC--Ccceeee------EEEeCC
Q 013105           84 SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHP--HLVNLIG------YCCEDE  155 (449)
Q Consensus        84 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~~~~------~~~~~~  155 (449)
                      .+.|..|....+|+....        +..+++|+...   .....+..|+.++..+.+.  .+.+++.      +...++
T Consensus        19 i~~i~~G~~n~~y~v~~~--------~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~   87 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--------SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG   87 (296)
T ss_pred             eecccCccccceEEEEeC--------CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence            345777777889987432        34689998753   2234566678777777432  2444443      223345


Q ss_pred             EEEEEEEecCCCChHH----H-------H---hh---cCCC------CCCHHHHH----------HHHHHHHHHHHHhhc
Q 013105          156 HRLLVYEYMALGNLHD----Q-------L---FK---NYSS------TLPWLTRI----------KIAIGAARCLAFLHG  202 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~----~-------l---~~---~~~~------~l~~~~~~----------~i~~~i~~~l~~lH~  202 (449)
                      ..++||+|++|..+..    .       +   ..   ....      ...+....          .....+..++.++..
T Consensus        88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  167 (296)
T cd05153          88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA  167 (296)
T ss_pred             ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence            6789999999866421    0       1   00   0000      01111110          001112223333331


Q ss_pred             -----CCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          203 -----EEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       203 -----~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                           ...+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus       168 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         168 FDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             hhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence                 13579999999999999998777899998776

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK10593 hypothetical protein; Provisional

Probab=97.74  E-value=0.00053  Score=65.59  Aligned_cols=76  Identities=9%  Similarity=0.023  Sum_probs=55.0

Q ss_pred             cccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCC---CCcceeeeEEEe---CCEE
Q 013105           84 SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKH---PHLVNLIGYCCE---DEHR  157 (449)
Q Consensus        84 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~nIv~~~~~~~~---~~~~  157 (449)
                      .+.||.|..+.||.....+        ..+.+|..+.  ......+..|...|+.|.-   -.+.++++++..   .+..
T Consensus        19 ~~~i~~G~~~~vy~~~~~~--------~~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~   88 (297)
T PRK10593         19 VECISEQPYAALWALYDSQ--------GNPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPD   88 (297)
T ss_pred             eeecCCccceeEEEEEcCC--------CCEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCe
Confidence            4579999999999974322        3477787542  1123577889999988852   468888888754   3668


Q ss_pred             EEEEEecCCCCh
Q 013105          158 LLVYEYMALGNL  169 (449)
Q Consensus       158 ~lv~e~~~~g~L  169 (449)
                      +||||+++|+++
T Consensus        89 ~LVmE~i~G~~~  100 (297)
T PRK10593         89 VLLLERLRGVSV  100 (297)
T ss_pred             EEEEeccCCEec
Confidence            999999998754

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.71  E-value=0.0014  Score=64.74  Aligned_cols=76  Identities=16%  Similarity=0.121  Sum_probs=53.3

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC-----C--cchHHHHHHHHHHHhcCC---CCCcceeeeEEEeC
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-----G--SQGHREWLAEVIFLGQLK---HPHLVNLIGYCCED  154 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~  154 (449)
                      +.||.|.+..||++...+      .++.++||.-...     .  .....+...|.+.|..+.   ..++++++.+  +.
T Consensus        32 ~elggGn~N~VyrV~~~~------g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~  103 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTE------GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DE  103 (401)
T ss_pred             eEcCCCceEEEEEEEeCC------CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CC
Confidence            569999999999997653      1247999985411     1  124566777888888763   3467778776  44


Q ss_pred             CEEEEEEEecCCCC
Q 013105          155 EHRLLVYEYMALGN  168 (449)
Q Consensus       155 ~~~~lv~e~~~~g~  168 (449)
                      +..++||||+++..
T Consensus       104 ~~~~lVME~L~~~~  117 (401)
T PRK09550        104 ELAVTVMEDLSDHK  117 (401)
T ss_pred             CCCEEEEecCCCcc
Confidence            66889999997643

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.69  E-value=0.00061  Score=62.73  Aligned_cols=75  Identities=17%  Similarity=0.125  Sum_probs=45.9

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCC-CcceeeeEEEeCCEEEEEEEe
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHP-HLVNLIGYCCEDEHRLLVYEY  163 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~-nIv~~~~~~~~~~~~~lv~e~  163 (449)
                      +.|..|-...+|+....++     .+..|++|+..... .......+|+.++..+... -.++++..+.  +  .++|||
T Consensus         4 ~~l~gG~tN~~~~v~~~~~-----~~~~~vlR~~~~~~-~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~   73 (235)
T cd05157           4 KRFTGGITNKLVKVSNKED-----NQDAVLVRVYGNKT-ELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEF   73 (235)
T ss_pred             EEcCCcccceEEEEEcCCC-----CCCeEEEEEccCCc-cceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEe
Confidence            4577787889998754310     14578899775332 1112334688888888533 3445554332  2  479999


Q ss_pred             cCCCCh
Q 013105          164 MALGNL  169 (449)
Q Consensus       164 ~~~g~L  169 (449)
                      ++|.++
T Consensus        74 i~G~~l   79 (235)
T cd05157          74 IPGRTL   79 (235)
T ss_pred             eCCCcC
Confidence            998765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.67  E-value=0.00056  Score=65.81  Aligned_cols=153  Identities=14%  Similarity=0.141  Sum_probs=84.4

Q ss_pred             HHHHHHhcCCCC-----cccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCC--Cc
Q 013105           72 KELQMITHNFSR-----SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHP--HL  144 (449)
Q Consensus        72 ~~~~~~~~~y~~-----~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nI  144 (449)
                      +++..+.+.|.+     .+.++.|....+|+....        +..+++|+.....  ....+..|+.++..|...  .+
T Consensus        10 ~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~--------~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pv   79 (307)
T TIGR00938        10 EEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTD--------VGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPV   79 (307)
T ss_pred             HHHHHHHHhcCCCCceeccccCCccccceEEEEeC--------CCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCC
Confidence            444444445544     345777777889987432        3368889875422  123445567777666322  24


Q ss_pred             ceeeeE------EEeCCEEEEEEEecCCCChH----H-------HH---hh---cCCCC-------CCHHHHHH------
Q 013105          145 VNLIGY------CCEDEHRLLVYEYMALGNLH----D-------QL---FK---NYSST-------LPWLTRIK------  188 (449)
Q Consensus       145 v~~~~~------~~~~~~~~lv~e~~~~g~L~----~-------~l---~~---~~~~~-------l~~~~~~~------  188 (449)
                      ++++..      ....+..+++|+|++|..+.    .       .+   ..   .....       ..|.....      
T Consensus        80 p~~i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~  159 (307)
T TIGR00938        80 PKPVKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAA  159 (307)
T ss_pred             CccccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcc
Confidence            444432      12346678999999875431    1       11   10   00000       01111000      


Q ss_pred             ------HHHHHHHHHHHhhc-----CCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          189 ------IAIGAARCLAFLHG-----EEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       189 ------i~~~i~~~l~~lH~-----~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                            ....+...+.++..     ...+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       160 ~~l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       160 PQLEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cccCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence                  01112233444431     24689999999999999998777899998765

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=97.59  E-value=0.0024  Score=61.77  Aligned_cols=31  Identities=29%  Similarity=0.390  Sum_probs=26.7

Q ss_pred             CCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          204 EKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       204 ~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      ..+++|+|+.|.|||++.+...-|+||+.+.
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            4589999999999999977556899999876

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.50  E-value=0.001  Score=63.87  Aligned_cols=80  Identities=16%  Similarity=0.142  Sum_probs=47.4

Q ss_pred             cccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCC-cceeeeEEEeCCEEEEEEEec
Q 013105           86 YLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPH-LVNLIGYCCEDEHRLLVYEYM  164 (449)
Q Consensus        86 ~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~lv~e~~  164 (449)
                      .|..|--..+|+.....+......++.+++|+..... .......+|..++..+...+ ..++++++. +   .+|+||+
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~i   79 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEFI   79 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhee
Confidence            4555666788987643211112235789999976432 22234567888888875333 345555553 2   3689999


Q ss_pred             CCCChH
Q 013105          165 ALGNLH  170 (449)
Q Consensus       165 ~~g~L~  170 (449)
                      +|..+.
T Consensus        80 ~G~~l~   85 (302)
T cd05156          80 PSRTLT   85 (302)
T ss_pred             CCCcCC
Confidence            887653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.49  E-value=0.00012  Score=68.60  Aligned_cols=133  Identities=17%  Similarity=0.146  Sum_probs=89.9

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---------Cc--------ch-----HHHHHHHHHHHhc
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---------GS--------QG-----HREWLAEVIFLGQ  138 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---------~~--------~~-----~~~~~~E~~~l~~  138 (449)
                      +.+++.||-|.-+.||.+.+..       |.+.++|+-+..         ..        ..     .-...+|+..|+.
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~-------G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmka  166 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEE-------GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKA  166 (465)
T ss_pred             hhhccccccccccceEEEecCC-------CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHH
Confidence            6788999999999999987654       678888875321         00        00     0124568888888


Q ss_pred             CC-C-CCcceeeeEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCc
Q 013105          139 LK-H-PHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASN  216 (449)
Q Consensus       139 l~-h-~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~N  216 (449)
                      |. | --|++.+++    +..++|||++.|-.|...-     ......++..-+..+   +.-|.  ++|+||+|..-=|
T Consensus       167 L~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~-----~v~d~~~ly~~lm~~---Iv~la--~~GlIHgDFNEFN  232 (465)
T KOG2268|consen  167 LYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVR-----HVEDPPTLYDDLMGL---IVRLA--NHGLIHGDFNEFN  232 (465)
T ss_pred             HHHcCCCCCCcccc----cceeeHHHhhcccceeeee-----ecCChHHHHHHHHHH---HHHHH--HcCceecccchhe
Confidence            84 3 234555543    5678999999987775432     122333333333333   34444  6789999999999


Q ss_pred             eEEcCCCcEEEeeecccc
Q 013105          217 ILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       217 ill~~~~~~kl~DfGla~  234 (449)
                      |++++++.++++||--..
T Consensus       233 imv~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  233 IMVKDDDKIVVIDFPQMV  250 (465)
T ss_pred             eEEecCCCEEEeechHhh
Confidence            999999999999996543

>PLN02236 choline kinase

Probab=97.20  E-value=0.0044  Score=60.55  Aligned_cols=144  Identities=16%  Similarity=0.113  Sum_probs=79.1

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCc-ceeeeEEEeCCEEEEEEEe
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHL-VNLIGYCCEDEHRLLVYEY  163 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv~e~  163 (449)
                      +.|-.|-.-.+|++.+..+  ....+..|++|+......... ...+|..+++.+..-++ .++++.+.. +   .|++|
T Consensus        42 ~~l~gGlTN~~y~v~~~~~--~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~ef  114 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTK--EGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEF  114 (344)
T ss_pred             EEcCCcccceeEEEEeCCC--CCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEe
Confidence            3454577788999765431  111346799998764432222 23668888888854333 345565532 2   58999


Q ss_pred             cCCCChHHH----------H----hhcCC-----C--CCCHHHHHHHHHHH-----------------HHHHHH----hh
Q 013105          164 MALGNLHDQ----------L----FKNYS-----S--TLPWLTRIKIAIGA-----------------ARCLAF----LH  201 (449)
Q Consensus       164 ~~~g~L~~~----------l----~~~~~-----~--~l~~~~~~~i~~~i-----------------~~~l~~----lH  201 (449)
                      +++.+|...          +    .+-..     .  ...+.....+..++                 ...+..    +.
T Consensus       115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~  194 (344)
T PLN02236        115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS  194 (344)
T ss_pred             eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence            987665321          1    10000     0  11122222222111                 111111    12


Q ss_pred             --cCCCCeeeccCCCCceEEcC-CCcEEEeeeccccC
Q 013105          202 --GEEKPVIYRDFKASNILLDS-DYNAKLSDFGLATD  235 (449)
Q Consensus       202 --~~~~~ivHrDikp~Nill~~-~~~~kl~DfGla~~  235 (449)
                        .....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus       195 ~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        195 GDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             ccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence              11346899999999999986 46899999987763

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.15  E-value=2.9e-05  Score=85.35  Aligned_cols=159  Identities=15%  Similarity=0.033  Sum_probs=112.2

Q ss_pred             HHHHHHHHhcCCCCCcceeeeEEE--eCCEEEEEEEecCCCChHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhcC-
Q 013105          129 WLAEVIFLGQLKHPHLVNLIGYCC--EDEHRLLVYEYMALGNLHDQLFKNYS--STLPWLTRIKIAIGAARCLAFLHGE-  203 (449)
Q Consensus       129 ~~~E~~~l~~l~h~nIv~~~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~-  203 (449)
                      .+.|...++...|+++.....=..  +....+..++|+.+|.+.+.|.+...  ..+..........+.+.+..-+|+. 
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            344555566678988876655432  23456889999999999999876422  2222222222222224455555543 


Q ss_pred             --CCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHH
Q 013105          204 --EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLEL  281 (449)
Q Consensus       204 --~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~el  281 (449)
                        +.-.+|+++|+-|.+|..+.+++++++|+.+....  .........+++.|+.|++...-.++.++|+|..|+.+|+.
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence              33478999999999999999999999999983322  12234446688899999999888889899999999999999


Q ss_pred             HhCCCccc
Q 013105          282 LTGRRSVE  289 (449)
Q Consensus       282 ltg~~pf~  289 (449)
                      ..|..+|-
T Consensus      1434 s~~n~~fi 1441 (2724)
T KOG1826|consen 1434 SDGNAYFI 1441 (2724)
T ss_pred             hcccHHHH
Confidence            98887764

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.12  E-value=0.0059  Score=58.36  Aligned_cols=121  Identities=20%  Similarity=0.240  Sum_probs=73.5

Q ss_pred             CcEEEEEEec--cCCcchHHHHHHHHHHHhcCCC--CCcceeeeEEEeCC--EEEEEEEecCCCChHHHHhhcCCCCCCH
Q 013105          110 AQTVAVKVLD--VNGSQGHREWLAEVIFLGQLKH--PHLVNLIGYCCEDE--HRLLVYEYMALGNLHDQLFKNYSSTLPW  183 (449)
Q Consensus       110 ~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~l~~  183 (449)
                      ++.+++. ..  ...........+|+.+++.+.-  --+...+++|.++.  ..|.||+|++|..+.+.+...   ... 
T Consensus        48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~---~~~-  122 (321)
T COG3173          48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPE---SLG-  122 (321)
T ss_pred             CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcc---cch-
Confidence            5678887 32  1223344566778888887743  23445566666655  679999999974332211100   000 


Q ss_pred             HHHHHHH-HHHHHHHHHhhc--------------------------------------------------C------CCC
Q 013105          184 LTRIKIA-IGAARCLAFLHG--------------------------------------------------E------EKP  206 (449)
Q Consensus       184 ~~~~~i~-~~i~~~l~~lH~--------------------------------------------------~------~~~  206 (449)
                         ..++ ..++..|+-||+                                                  +      ...
T Consensus       123 ---~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~  199 (321)
T COG3173         123 ---RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPV  199 (321)
T ss_pred             ---HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCce
Confidence               0111 133333333332                                                  2      335


Q ss_pred             eeeccCCCCceEEcCCCcEEEeeeccccCCCC
Q 013105          207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       207 ivHrDikp~Nill~~~~~~kl~DfGla~~~~~  238 (449)
                      ++|+|+.+.||+++.++-+=|.||+++....+
T Consensus       200 lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         200 LVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             eeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence            89999999999999998899999999986544

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.78  E-value=0.022  Score=55.25  Aligned_cols=73  Identities=16%  Similarity=0.159  Sum_probs=47.6

Q ss_pred             cccccCceEEEEEEEcCCCCCCCCCcEEEEEEec----c-C-C-cchHHHHHHHHHHHhcCC--CC-CcceeeeEEEeCC
Q 013105           86 YLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD----V-N-G-SQGHREWLAEVIFLGQLK--HP-HLVNLIGYCCEDE  155 (449)
Q Consensus        86 ~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~----~-~-~-~~~~~~~~~E~~~l~~l~--h~-nIv~~~~~~~~~~  155 (449)
                      .||.|....||++....      .++.|+||.-.    . . + .....+..-|...|+...  -| .++++|.+  +.+
T Consensus         2 EigdGnlN~VfrV~~~~------g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e   73 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQE------GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTE   73 (370)
T ss_pred             cCCCCceEEEEEEEcCC------CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccc
Confidence            47999999999997532      23579999753    1 1 1 233455667888887663  34 45555443  566


Q ss_pred             EEEEEEEecCC
Q 013105          156 HRLLVYEYMAL  166 (449)
Q Consensus       156 ~~~lv~e~~~~  166 (449)
                      ...+|||+++.
T Consensus        74 ~~~~vMEdL~~   84 (370)
T TIGR01767        74 MAVTVMEDLSH   84 (370)
T ss_pred             cceehHhhCcc
Confidence            67799999854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.69  E-value=0.028  Score=55.55  Aligned_cols=73  Identities=15%  Similarity=0.157  Sum_probs=49.4

Q ss_pred             cccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC----Cc---chHHHHHHHHHHHhcCC---CCCcceeeeEEEe
Q 013105           84 SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN----GS---QGHREWLAEVIFLGQLK---HPHLVNLIGYCCE  153 (449)
Q Consensus        84 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~----~~---~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~  153 (449)
                      .+.||.|....||+....        +..++||.-...    +.   -...+...|+..|+.+.   ..++++++.++. 
T Consensus        37 ~~eiggGn~N~VyrV~~~--------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de-  107 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR-  107 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC-
Confidence            457899999999997542        346899986511    11   13344455677776653   357888888876 


Q ss_pred             CCEEEEEEEecCC
Q 013105          154 DEHRLLVYEYMAL  166 (449)
Q Consensus       154 ~~~~~lv~e~~~~  166 (449)
                       +..+++||++++
T Consensus       108 -d~~vlvME~L~~  119 (418)
T PLN02756        108 -TMALIGMRYLEP  119 (418)
T ss_pred             -CCCEEEEeecCC
Confidence             556889999976

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.68  E-value=0.0044  Score=61.81  Aligned_cols=167  Identities=23%  Similarity=0.276  Sum_probs=95.8

Q ss_pred             HHHHHHHHHHHhcCCCCCcceeeeEEEeC-CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 013105          126 HREWLAEVIFLGQLKHPHLVNLIGYCCED-EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE  204 (449)
Q Consensus       126 ~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~  204 (449)
                      ...++...++++.+.|+|...++++.... ....+|||++. .+|.+.+..+.   +....          ++  .|   
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~---l~~~s----------~~--~~---   86 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN---LKDES----------LL--AH---   86 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc---cchhh----------hc--cc---
Confidence            35667778999999999999999887643 45788999985 78988876542   11100          01  12   


Q ss_pred             CCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhC
Q 013105          205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG  284 (449)
Q Consensus       205 ~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg  284 (449)
                       ++.|-     |       .++++| -++..                  |  |     ....+++|||++|.++.++.-|
T Consensus        87 -~~~~~-----~-------~~~~td-~~~t~------------------~--~-----~~~~pKsdVwsl~~i~~el~L~  127 (725)
T KOG1093|consen   87 -GVLHL-----N-------IIYITD-HFLTK------------------Y--P-----SPIGPKSDVWSLGFIILELYLG  127 (725)
T ss_pred             -cccee-----h-------hhhccc-ccccc------------------C--C-----CCCCcchhhhhHHHHHHHHHHh
Confidence             23332     1       223333 01100                  0  0     0112599999999999999998


Q ss_pred             CCcccccccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013105          285 RRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK  356 (449)
Q Consensus       285 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  356 (449)
                      ...+......+...   ....+.........  .. ....+.-.++..+.++...|+-..|..||...++.+
T Consensus       128 ~~l~~~~~~s~~l~---~i~k~~~~d~~~~~--~a-~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k  193 (725)
T KOG1093|consen  128 ISLEAELTESEYLE---ILLKYYTDDQELLS--TA-MEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK  193 (725)
T ss_pred             hHHHHHHHHHHHHH---HHHHhccCchhHHH--HH-HHHHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence            87665432222211   11111111111000  00 011223456677888999999999999986655543

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.66  E-value=0.015  Score=54.89  Aligned_cols=32  Identities=28%  Similarity=0.418  Sum_probs=26.2

Q ss_pred             CCeeeccCCCCceEEcCCCc-EEEeeeccccCC
Q 013105          205 KPVIYRDFKASNILLDSDYN-AKLSDFGLATDG  236 (449)
Q Consensus       205 ~~ivHrDikp~Nill~~~~~-~kl~DfGla~~~  236 (449)
                      ..++|+|+.|.|||++.++. .-|+||+.+...
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            35899999999999997555 569999988743

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.38  E-value=0.0098  Score=53.75  Aligned_cols=29  Identities=34%  Similarity=0.457  Sum_probs=20.5

Q ss_pred             CeeeccCCCCceEE-cCCCcEEEeeecccc
Q 013105          206 PVIYRDFKASNILL-DSDYNAKLSDFGLAT  234 (449)
Q Consensus       206 ~ivHrDikp~Nill-~~~~~~kl~DfGla~  234 (449)
                      .+.|.|+.+.|||+ +.++.++|+||..|.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            47799999999999 888999999998765

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.37  E-value=0.045  Score=52.63  Aligned_cols=32  Identities=16%  Similarity=0.189  Sum_probs=28.6

Q ss_pred             CCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       204 ~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..+++|+|+.++|+|++.++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            44799999999999999999999999988764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.25  E-value=0.025  Score=50.61  Aligned_cols=103  Identities=13%  Similarity=0.059  Sum_probs=67.9

Q ss_pred             EEEEEEeccCCcc-hHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHH
Q 013105          112 TVAVKVLDVNGSQ-GHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA  190 (449)
Q Consensus       112 ~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~  190 (449)
                      +..+|.+..-.-. ...-+..+.+++.+++  .|+++..=  ..-.+-+++|+|.....           .    ...++
T Consensus        87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-----------~----~~N~i  147 (308)
T PF07387_consen   87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-----------N----FSNFI  147 (308)
T ss_pred             hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-----------c----hhHHH
Confidence            4455555422222 3345677888888774  46666521  34456689999853211           1    11122


Q ss_pred             HHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       191 ~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      ..-+.+|.-.|+...+.+|+|-.|+||+-|..|.+||.|=+..
T Consensus       148 ~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  148 TAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             HHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence            2225678889988889999999999999999999999997643

The function of this family is unknown.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.24  E-value=0.097  Score=50.23  Aligned_cols=30  Identities=27%  Similarity=0.366  Sum_probs=26.0

Q ss_pred             CCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          204 EKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       204 ~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      ..+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            357999999999999987 678999998665

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.09  E-value=0.021  Score=54.83  Aligned_cols=74  Identities=19%  Similarity=0.163  Sum_probs=54.8

Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      ....|++|++- |+.|. .+     ....+.+...++.+.+..++-+.. +-..-|||+...||||+ +|++.|+||-++
T Consensus       298 ~~y~yl~~kdh-gt~is-~i-----k~~~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLId-~GnvtLIDfkls  368 (488)
T COG5072         298 TLYLYLHFKDH-GTPIS-II-----KADRSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILID-EGNVTLIDFKLS  368 (488)
T ss_pred             ceEEEEEEecC-Cceee-ee-----ecccHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceeee-cCceEEEEeeee
Confidence            34556777764 45543 22     345678888999888776666652 34578999999999999 999999999999


Q ss_pred             cCC
Q 013105          234 TDG  236 (449)
Q Consensus       234 ~~~  236 (449)
                      +..
T Consensus       369 Rl~  371 (488)
T COG5072         369 RLS  371 (488)
T ss_pred             ecc
Confidence            943

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.08  E-value=0.03  Score=53.13  Aligned_cols=73  Identities=19%  Similarity=0.281  Sum_probs=46.1

Q ss_pred             cccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcC---CCCCcceeeeEEEeCCEEEEE
Q 013105           84 SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL---KHPHLVNLIGYCCEDEHRLLV  160 (449)
Q Consensus        84 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~~~~~~lv  160 (449)
                      .+.|+.|....+|+..  .      .++.+.||+-..   .....|..|..-|+.|   ..-.+++++++....+..|||
T Consensus        22 ~~~v~GG~i~~a~~~~--~------~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl   90 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD--T------DGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL   90 (288)
T ss_dssp             EEEE--SSSSEEEEEE--T------TS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred             eEecCCCChhheEEEE--C------CCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence            4568888899999865  2      467899999862   2234566788777777   355688899999888888999


Q ss_pred             EEecCCC
Q 013105          161 YEYMALG  167 (449)
Q Consensus       161 ~e~~~~g  167 (449)
                      |||++.+
T Consensus        91 le~l~~~   97 (288)
T PF03881_consen   91 LEFLEMG   97 (288)
T ss_dssp             EE-----
T ss_pred             EEeecCC
Confidence            9999866

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.01  E-value=0.067  Score=51.61  Aligned_cols=138  Identities=15%  Similarity=0.158  Sum_probs=85.2

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC-----Cc-------------------c-hH-HHHHHHHHHHhc
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-----GS-------------------Q-GH-REWLAEVIFLGQ  138 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-----~~-------------------~-~~-~~~~~E~~~l~~  138 (449)
                      ..|..|.-+.||.|+-.+       |..+|||+.+..     ..                   . .. -....|++-|.+
T Consensus       150 GCiSTGKEANVYHat~~d-------G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkR  222 (520)
T KOG2270|consen  150 GCISTGKEANVYHATEED-------GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKR  222 (520)
T ss_pred             cccccCccceeEeeecCC-------CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHH
Confidence            447778899999986654       677999997421     00                   0 00 113458888888


Q ss_pred             CCCCCcceeeeEEEeCCEEEEEEEecCCCChH-HHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCce
Q 013105          139 LKHPHLVNLIGYCCEDEHRLLVYEYMALGNLH-DQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNI  217 (449)
Q Consensus       139 l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~-~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Ni  217 (449)
                      |+...|.-.--+..  ....|||+|+-..... -.|   ....++...+..+-.+++.-+.-|.. .-++||.||.--|+
T Consensus       223 l~~aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~-~c~LVHADLSEfN~  296 (520)
T KOG2270|consen  223 LNNAGIPCPEPILL--KNHVLVMEFLGRDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQ-KCRLVHADLSEFNL  296 (520)
T ss_pred             HHhcCCCCCCceee--ecceEeeeeccCCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHH-Hhceeccchhhhhh
Confidence            86555432221111  2346999998422111 111   12345555566666666666665542 44599999999999


Q ss_pred             EEcCCCcEEEeeeccccCC
Q 013105          218 LLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       218 ll~~~~~~kl~DfGla~~~  236 (449)
                      |+- +|.+.|+|.+-+...
T Consensus       297 Lyh-dG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  297 LYH-DGKLYIIDVSQSVEH  314 (520)
T ss_pred             eEE-CCEEEEEEccccccC
Confidence            985 559999999877644

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.94  E-value=0.05  Score=53.56  Aligned_cols=75  Identities=16%  Similarity=0.176  Sum_probs=49.9

Q ss_pred             cccccccCceEEEEEEEcCCCCCCCCCcEEEEEEec----cC-C-cchHHHHHHHHHHHhcCC--CC-CcceeeeEEEeC
Q 013105           84 SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD----VN-G-SQGHREWLAEVIFLGQLK--HP-HLVNLIGYCCED  154 (449)
Q Consensus        84 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~----~~-~-~~~~~~~~~E~~~l~~l~--h~-nIv~~~~~~~~~  154 (449)
                      .+.||.|.-..||++.+..      .++.|+||.-.    .. + .....+..-|..+|+.+.  .| +++++|.+  +.
T Consensus        34 ~~eigdGnlN~VfrV~~~~------~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~  105 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQ------KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DS  105 (409)
T ss_pred             eeEcCCCceEEEEEEeeCC------CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--Cc
Confidence            4578999999999997632      13579998753    11 1 234566677888887763  34 45556543  56


Q ss_pred             CEEEEEEEecCC
Q 013105          155 EHRLLVYEYMAL  166 (449)
Q Consensus       155 ~~~~lv~e~~~~  166 (449)
                      +...+|||+++.
T Consensus       106 e~~~~vMEdL~~  117 (409)
T PRK12396        106 VMNCCVMEDLSD  117 (409)
T ss_pred             HHhhHHHHhCcc
Confidence            677889998853

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.90  E-value=0.072  Score=51.75  Aligned_cols=76  Identities=14%  Similarity=0.191  Sum_probs=44.0

Q ss_pred             cccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCc-ceeeeEEEeCCEEEEEEEec
Q 013105           86 YLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHL-VNLIGYCCEDEHRLLVYEYM  164 (449)
Q Consensus        86 ~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv~e~~  164 (449)
                      .|..|=-..+|+....+.   ......|++++....... .-.-.+|..+++.+..-++ .++++++. ++   +|.+|+
T Consensus        21 ~l~gGlTN~~~~v~~~~~---~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi   92 (330)
T PLN02421         21 RISGGITNLLLKVSVKEE---NGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFI   92 (330)
T ss_pred             EeCCcccceEEEEEecCC---CCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehhh
Confidence            344466677888754331   011347889987543222 2233568888888865444 35565552 22   588999


Q ss_pred             CCCCh
Q 013105          165 ALGNL  169 (449)
Q Consensus       165 ~~g~L  169 (449)
                      +|.+|
T Consensus        93 ~g~~l   97 (330)
T PLN02421         93 NARTL   97 (330)
T ss_pred             cCCCC
Confidence            87655

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=95.49  E-value=0.11  Score=49.46  Aligned_cols=77  Identities=17%  Similarity=0.151  Sum_probs=46.0

Q ss_pred             cccCceEEEEEEEcC--CCCCCCCCcEEEEEEeccCCc-----chHHHHHHHHHHHhcCC-------------CCCccee
Q 013105           88 GEGGFGKVYKGCVDD--NLRPGLKAQTVAVKVLDVNGS-----QGHREWLAEVIFLGQLK-------------HPHLVNL  147 (449)
Q Consensus        88 G~G~~g~V~~~~~~~--~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~-------------h~nIv~~  147 (449)
                      |.|-.|.+|++...-  ..........++||.......     .....|.+|+.+...+-             ...+.++
T Consensus         2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~   81 (294)
T PF02958_consen    2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC   81 (294)
T ss_pred             CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence            678889999987743  112233456789999862211     11234667776665441             1234566


Q ss_pred             eeEEEeCCEEEEEEEec
Q 013105          148 IGYCCEDEHRLLVYEYM  164 (449)
Q Consensus       148 ~~~~~~~~~~~lv~e~~  164 (449)
                      +....+....+||||-+
T Consensus        82 ~~~~~~~~~~~lvlEDL   98 (294)
T PF02958_consen   82 YYADEDPGDEVLVLEDL   98 (294)
T ss_pred             EEeccCCCceeeehhhh
Confidence            66655555678999865

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PTZ00384 choline kinase; Provisional

Probab=95.49  E-value=0.21  Score=49.45  Aligned_cols=81  Identities=12%  Similarity=0.111  Sum_probs=44.6

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCc-ceeeeEEEeCCEEEEEEEe
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHL-VNLIGYCCEDEHRLLVYEY  163 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv~e~  163 (449)
                      +.|..|--..+|++...+........+.|.+.+.. ......-.-.+|+++++.+...++ .++++.+.    .++|.||
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g-~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~ef  130 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS-TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEW  130 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEecc-CCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEE
Confidence            44555778889998654321001111224444432 111111223568899998865444 45666553    2589999


Q ss_pred             cCCCChH
Q 013105          164 MALGNLH  170 (449)
Q Consensus       164 ~~~g~L~  170 (449)
                      ++|.+|.
T Consensus       131 IeGr~l~  137 (383)
T PTZ00384        131 VEGNTMG  137 (383)
T ss_pred             eccccCC
Confidence            9987653

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.23  E-value=0.16  Score=45.88  Aligned_cols=74  Identities=20%  Similarity=0.231  Sum_probs=51.4

Q ss_pred             cccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcC---CCCCcceeeeEEEeCCEEEEEEE
Q 013105           86 YLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL---KHPHLVNLIGYCCEDEHRLLVYE  162 (449)
Q Consensus        86 ~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~~~~~~lv~e  162 (449)
                      .+--|..-..|...+        ...++-||+-.   ......|..|+.-|..|   +.-+|.+++.+..+.++.|+|||
T Consensus        23 ~v~gG~inea~~v~d--------g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle   91 (286)
T COG3001          23 EVSGGDINEAWRLRD--------GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLE   91 (286)
T ss_pred             ccCCccccceeEeec--------CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEe
Confidence            344455555555433        24578888743   34456677788766666   44678899999999999999999


Q ss_pred             ecCCCChH
Q 013105          163 YMALGNLH  170 (449)
Q Consensus       163 ~~~~g~L~  170 (449)
                      |++-|.+.
T Consensus        92 ~L~~~~~d   99 (286)
T COG3001          92 YLPTGPLD   99 (286)
T ss_pred             eccCCCCC
Confidence            99876554

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=94.79  E-value=0.29  Score=47.30  Aligned_cols=28  Identities=32%  Similarity=0.529  Sum_probs=25.4

Q ss_pred             eeeccCCCCceEEcCCCc-EEEeeecccc
Q 013105          207 VIYRDFKASNILLDSDYN-AKLSDFGLAT  234 (449)
Q Consensus       207 ivHrDikp~Nill~~~~~-~kl~DfGla~  234 (449)
                      +||+|+.|.||+++.+.. +.++|||-+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            999999999999999874 8999998765

>PRK06148 hypothetical protein; Provisional

Probab=94.54  E-value=0.54  Score=52.75  Aligned_cols=32  Identities=41%  Similarity=0.476  Sum_probs=26.8

Q ss_pred             CCCeeeccCCCCceEEcCCC--cEE-EeeeccccC
Q 013105          204 EKPVIYRDFKASNILLDSDY--NAK-LSDFGLATD  235 (449)
Q Consensus       204 ~~~ivHrDikp~Nill~~~~--~~k-l~DfGla~~  235 (449)
                      ..++||.|+.+.|||++.++  .+. |+|||-+..
T Consensus       202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            46799999999999999875  454 999998764

>PRK11768 serine/threonine protein kinase; Provisional

Probab=94.43  E-value=1.9  Score=41.79  Aligned_cols=29  Identities=24%  Similarity=0.250  Sum_probs=24.5

Q ss_pred             CCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          204 EKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       204 ~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      ..+++|+|+.+.|||++ + .+.|+||+-+.
T Consensus       195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             CccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            45789999999999995 4 57899998766

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	449
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		8e-52
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-51
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-50
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-49
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		7e-39
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-38
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-38
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		8e-36
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-22
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-21
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-20
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-19
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-19
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-19
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-19
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-19
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		6e-19
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		7e-19
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-19
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-19
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-18
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-18
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-18
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-18
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-18
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		5e-18
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		6e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-18
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		6e-18
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-18
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		6e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-18
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		7e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-18
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		7e-18
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-18
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-18
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		8e-18
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		8e-18
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-18
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-18
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		9e-18
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		9e-18
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		9e-18
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		9e-18
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		9e-18
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		9e-18
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-17
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-17
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-17
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-17
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-17
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-17
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-17
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-17
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-17
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-17
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-17
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-17
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-17
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-17
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-17
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-17
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-17
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-17
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-17
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-17
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-17
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-17
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-17
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-17
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-17
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-17
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-17
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-17
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-17
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-17
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-17
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-17
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-17
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-17
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-17
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-17
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-17
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-17
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-17
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-17
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-17
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-17
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-17
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-17
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-17
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-17
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-17
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-17
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-17
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		5e-17
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		5e-17
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		5e-17
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-17
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-17
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		5e-17
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-17
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-17
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-17
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-17
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		7e-17
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		7e-17
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		7e-17
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		7e-17
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		7e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-17
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		8e-17
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		8e-17
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-17
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		8e-17
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		8e-17
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		8e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-17
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-17
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		8e-17
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		9e-17
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-17
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-16
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-16
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-16
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-16
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-16
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-16
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-16
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-16
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-16
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-16
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-16
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-16
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-16
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-16
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-16
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-16
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-16
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-16
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-16
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-16
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-16
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-16
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-16
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-16
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-16
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-16
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-16
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-16
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-16
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-16
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-16
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-16
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-16
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-16
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-16
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-16
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-16
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-16
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-16
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-16
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-16
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-16
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-16
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-16
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-16
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-16
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-16
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-16
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-16
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-16
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		6e-16
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		7e-16
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		8e-16
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-16
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		9e-16
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-15
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-15
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-15
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-15
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-15
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-15
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-15
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-15
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-15
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-15
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-15
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-15
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-15
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-15
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-15
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-15
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-15
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-15
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-15
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-15
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-15
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-15
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-15
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-15
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-15
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-15
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-15
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-15
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-15
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-15
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-15
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-15
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-15
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-15
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-15
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-15
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-15
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		6e-15
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		6e-15
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-15
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		7e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-15
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		7e-15
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		7e-15
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		9e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		9e-15
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-14
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-14
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-14
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-14
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-14
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-14
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-14
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-14
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-14
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-14
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-14
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		5e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		5e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		6e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-14
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		6e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		7e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		7e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		7e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		7e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		7e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		7e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		7e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		7e-14
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		8e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		8e-14
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		8e-14
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		9e-14
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		9e-14
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-13
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-13
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-13
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-13
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-13
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-13
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-13
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-13
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-13
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-13
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-13
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-13
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-13
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-13
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-13
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-13
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-13
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-13
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-13
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-13
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-13
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-13
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-13
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-13
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-13
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-13
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-13
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-13
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-13
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-13
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-13
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-13
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-13
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-13
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-13
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-13
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-13
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-13
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-13
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-13
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-13
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-13
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		5e-13
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		6e-13
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-13
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-13
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		6e-13
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-13
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		6e-13
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		6e-13
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		6e-13
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-13
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		7e-13
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-13
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-13
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-13
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		7e-13
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		8e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		8e-13
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-13
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-13
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-13
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		8e-13
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-13
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-13
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		8e-13
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		9e-13
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		9e-13
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		9e-13
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-13
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		9e-13
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		9e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-12
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-12
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-12
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-12
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-12
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-12
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-12
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-12
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-12
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-12
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-12
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-12
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-12
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-12
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-12
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-12
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-12
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-12
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-12
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		4e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-12
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-12
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-12
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		5e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		6e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		7e-12
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		8e-12
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		9e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		9e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		9e-12
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-11
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-11
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-11
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-11
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-11
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-11
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-11
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-11
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-11
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-11
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-11
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-11
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		7e-11
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		7e-11
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		8e-11
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		8e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-11
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		9e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		9e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		9e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		9e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-10
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-10
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-10
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-10
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-10
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-10
3soa_A	444	Full-Length Human Camkii Length = 444		3e-10
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-10
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-10
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-10
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-10
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-10
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		5e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-10
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-10
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		9e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		9e-10
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		9e-10
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-09
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-09
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-09
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-09
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-09
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-09
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-09
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-09
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-09
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-09
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-09
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-09
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		6e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-08
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-08
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-08
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-08
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-08
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-08
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-08
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-08
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-08
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-08
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-08
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-08
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		5e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		6e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		6e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		8e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		9e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		9e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		9e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		9e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		9e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		9e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-07
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-07
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-07
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-07
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-07
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-07
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-07
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-07
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		4e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-07
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		5e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		6e-07
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		6e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		6e-07
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		7e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		7e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		7e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		7e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		7e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		7e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		7e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		7e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		7e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		7e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		7e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		7e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		7e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		7e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		7e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		8e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		8e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		8e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		9e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		9e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-06
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-06
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-06
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-06
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-06
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-06
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-06
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		3e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-06
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		5e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		6e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		6e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		6e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		7e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		9e-06
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		9e-06
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		9e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-05
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-05
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-05
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-05
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-05
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-05
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-05
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-05
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		4e-05
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		5e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-05
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		6e-05
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		7e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		8e-05
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		9e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		9e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		9e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-04
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-04
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-04
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-04
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-04
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-04
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-04
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-04
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-04
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-04
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-04
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-04
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-04
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-04
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-04
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-04
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-04
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-04
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-04
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-04
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-04
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		3e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  201 bits (511), Expect = 8e-52,   Method: Compositional matrix adjust.
 Identities = 123/301 (40%), Positives = 175/301 (58%), Gaps = 15/301 (4%)
Query: 65  NLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ 124
            L  F+L+ELQ+ + NFS  + LG GGFGKVYKG + D          VAVK L     Q
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-------GTLVAVKRLKEERXQ 76
Query: 125 GHR-EWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLP- 182
           G   ++  EV  +    H +L+ L G+C     RLLVY YMA G++   L +   S  P 
Sbjct: 77  GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPL 136
Query: 183 -WLTRIKIAIGAARCLAFLHGEEKP-VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGE 240
            W  R +IA+G+AR LA+LH    P +I+RD KA+NILLD ++ A + DFGLA      +
Sbjct: 137 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYK 195
Query: 241 DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKD-- 298
           D H+   V GT G+ APEY++TG  +   DVF +GV+LLEL+TG+R+ +  R   + D  
Sbjct: 196 DXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 255
Query: 299 LVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL 358
           L++W + +LK+  KL+ ++D  L+  Y  E  ++L  VA  C   +P  RP M+ VV+ L
Sbjct: 256 LLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 314
Query: 359 E 359
           E
Sbjct: 315 E 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  198 bits (503), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 121/301 (40%), Positives = 174/301 (57%), Gaps = 15/301 (4%)
Query: 65  NLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ 124
            L  F+L+ELQ+ + NF   + LG GGFGKVYKG + D          VAVK L    +Q
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLAD-------GXLVAVKRLKEERTQ 68
Query: 125 GHR-EWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLP- 182
           G   ++  EV  +    H +L+ L G+C     RLLVY YMA G++   L +   S  P 
Sbjct: 69  GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPL 128
Query: 183 -WLTRIKIAIGAARCLAFLHGEEKP-VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGE 240
            W  R +IA+G+AR LA+LH    P +I+RD KA+NILLD ++ A + DFGLA      +
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYK 187
Query: 241 DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKD-- 298
           D H+   V G  G+ APEY++TG  +   DVF +GV+LLEL+TG+R+ +  R   + D  
Sbjct: 188 DXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247
Query: 299 LVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL 358
           L++W + +LK+  KL+ ++D  L+  Y  E  ++L  VA  C   +P  RP M+ VV+ L
Sbjct: 248 LLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
Query: 359 E 359
           E
Sbjct: 307 E 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  194 bits (494), Expect = 6e-50,   Method: Compositional matrix adjust.
 Identities = 120/314 (38%), Positives = 175/314 (55%), Gaps = 18/314 (5%)
Query: 58  SSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV 117
           SS LV    +   L +L+  T+NF     +G G FGKVYKG + D  +  LK +T     
Sbjct: 18  SSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP---- 73
Query: 118 LDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNY 177
                SQG  E+  E+  L   +HPHLV+LIG+C E    +L+Y+YM  GNL   L   Y
Sbjct: 74  ---ESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL---Y 127
Query: 178 SSTLP-----WLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL 232
            S LP     W  R++I IGAAR L +LH   + +I+RD K+ NILLD ++  K++DFG+
Sbjct: 128 GSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDFGI 185
Query: 233 ATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNR 292
           +  G + + +H+   V GT GY  PEY   G LT   DV+SFGVVL E+L  R ++ ++ 
Sbjct: 186 SKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245
Query: 293 CKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMT 352
            +   +L EWA     +  +L+QI+D  L D+   E  ++    A +CL+ + + RP+M 
Sbjct: 246 PREMVNLAEWAVESHNN-GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMG 304
Query: 353 TVVKALEPLLDLND 366
            V+  LE  L L +
Sbjct: 305 DVLWKLEYALRLQE 318

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  193 bits (490), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 120/314 (38%), Positives = 174/314 (55%), Gaps = 18/314 (5%)
Query: 58  SSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV 117
           SS LV    +   L +L+  T+NF     +G G FGKVYKG + D  +  LK +T     
Sbjct: 18  SSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP---- 73
Query: 118 LDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNY 177
                SQG  E+  E+  L   +HPHLV+LIG+C E    +L+Y+YM  GNL   L   Y
Sbjct: 74  ---ESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL---Y 127
Query: 178 SSTLP-----WLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL 232
            S LP     W  R++I IGAAR L +LH   + +I+RD K+ NILLD ++  K++DFG+
Sbjct: 128 GSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDFGI 185
Query: 233 ATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNR 292
           +  G +   +H+   V GT GY  PEY   G LT   DV+SFGVVL E+L  R ++ ++ 
Sbjct: 186 SKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245
Query: 293 CKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMT 352
            +   +L EWA     +  +L+QI+D  L D+   E  ++    A +CL+ + + RP+M 
Sbjct: 246 PREMVNLAEWAVESHNN-GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMG 304
Query: 353 TVVKALEPLLDLND 366
            V+  LE  L L +
Sbjct: 305 DVLWKLEYALRLQE 318

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  158 bits (399), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 105/309 (33%), Positives = 172/309 (55%), Gaps = 25/309 (8%)
Query: 64  SNLHVFTLKELQMITHNFSR------SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVK- 116
           +  H F+  EL+ +T+NF         + +GEGGFG VYKG V++         TVAVK 
Sbjct: 10  TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT--------TVAVKK 61
Query: 117 ---VLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQL 173
              ++D+   +  +++  E+  + + +H +LV L+G+  + +   LVY YM  G+L D+L
Sbjct: 62  LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121
Query: 174 F-KNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL 232
              + +  L W  R KIA GAA  + FLH  E   I+RD K++NILLD  + AK+SDFGL
Sbjct: 122 SCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGL 179
Query: 233 ATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNR 292
           A    +   + + + ++GT  Y APE +  G +T   D++SFGVVLLE++TG  +V+++R
Sbjct: 180 ARASEKFAQTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHR 238
Query: 293 CKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMT 352
               + L++    +  +   ++  ID ++ D  ST   + + +VA QCL      RP + 
Sbjct: 239 --EPQLLLDIKEEIEDEEKTIEDYIDKKMNDADST-SVEAMYSVASQCLHEKKNKRPDIK 295
Query: 353 TVVKALEPL 361
            V + L+ +
Sbjct: 296 KVQQLLQEM 304

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 105/309 (33%), Positives = 171/309 (55%), Gaps = 25/309 (8%)
Query: 64  SNLHVFTLKELQMITHNFSR------SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVK- 116
           +  H F+  EL+ +T+NF         + +GEGGFG VYKG V++         TVAVK 
Sbjct: 10  TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT--------TVAVKK 61
Query: 117 ---VLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQL 173
              ++D+   +  +++  E+  + + +H +LV L+G+  + +   LVY YM  G+L D+L
Sbjct: 62  LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121
Query: 174 F-KNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL 232
              + +  L W  R KIA GAA  + FLH  E   I+RD K++NILLD  + AK+SDFGL
Sbjct: 122 SCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGL 179
Query: 233 ATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNR 292
           A    +   + +   ++GT  Y APE +  G +T   D++SFGVVLLE++TG  +V+++R
Sbjct: 180 ARASEKFAQTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHR 238
Query: 293 CKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMT 352
               + L++    +  +   ++  ID ++ D  ST   + + +VA QCL      RP + 
Sbjct: 239 --EPQLLLDIKEEIEDEEKTIEDYIDKKMNDADST-SVEAMYSVASQCLHEKKNKRPDIK 295
Query: 353 TVVKALEPL 361
            V + L+ +
Sbjct: 296 KVQQLLQEM 304

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 105/309 (33%), Positives = 170/309 (55%), Gaps = 25/309 (8%)
Query: 64  SNLHVFTLKELQMITHNFSR------SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVK- 116
           +  H F+  EL+ +T+NF         + +GEGGFG VYKG V++         TVAVK 
Sbjct: 4   TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT--------TVAVKK 55
Query: 117 ---VLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQL 173
              ++D+   +  +++  E+  + + +H +LV L+G+  + +   LVY YM  G+L D+L
Sbjct: 56  LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 115
Query: 174 F-KNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL 232
              + +  L W  R KIA GAA  + FLH  E   I+RD K++NILLD  + AK+SDFGL
Sbjct: 116 SCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGL 173
Query: 233 ATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNR 292
           A    +     +   ++GT  Y APE +  G +T   D++SFGVVLLE++TG  +V+++R
Sbjct: 174 ARASEKFAQXVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHR 232
Query: 293 CKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMT 352
               + L++    +  +   ++  ID ++ D  ST   + + +VA QCL      RP + 
Sbjct: 233 --EPQLLLDIKEEIEDEEKTIEDYIDKKMNDADST-SVEAMYSVASQCLHEKKNKRPDIK 289
Query: 353 TVVKALEPL 361
            V + L+ +
Sbjct: 290 KVQQLLQEM 298

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  147 bits (372), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 104/307 (33%), Positives = 164/307 (53%), Gaps = 25/307 (8%)
Query: 64  SNLHVFTLKELQMITHNFSR------SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVK- 116
           +  H F+  EL+ +T+NF         +  GEGGFG VYKG V++         TVAVK 
Sbjct: 1   TRFHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNT--------TVAVKK 52
Query: 117 ---VLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQL 173
              ++D+   +  +++  E+    + +H +LV L+G+  + +   LVY Y   G+L D+L
Sbjct: 53  LAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRL 112
Query: 174 F-KNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL 232
              + +  L W  R KIA GAA  + FLH  E   I+RD K++NILLD  + AK+SDFGL
Sbjct: 113 SCLDGTPPLSWHXRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGL 170
Query: 233 ATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNR 292
           A    +       + ++GT  Y APE +  G +T   D++SFGVVLLE++TG  +V+++R
Sbjct: 171 ARASEKFAQXVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHR 229
Query: 293 CKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMT 352
               + L++    +  +   ++  ID +  D  ST   +   +VA QCL      RP + 
Sbjct: 230 --EPQLLLDIKEEIEDEEKTIEDYIDKKXNDADST-SVEAXYSVASQCLHEKKNKRPDIK 286
Query: 353 TVVKALE 359
            V + L+
Sbjct: 287 KVQQLLQ 293

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 125/279 (44%), Gaps = 29/279 (10%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR--EWLAEVIFLGQLKHPHL 144
           +G G FG V+        R       VAVK+L        R  E+L EV  + +L+HP++
Sbjct: 45  IGAGSFGTVH--------RAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYS-STLPWLTRIKIAIGAARCLAFLHGE 203
           V  +G   +  +  +V EY++ G+L+  L K+ +   L    R+ +A   A+ + +LH  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTG 263
             P+++RD K+ N+L+D  Y  K+ DFGL+    +      +    GT  + APE +   
Sbjct: 157 NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEVLRDE 214
Query: 264 HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLED 323
                 DV+SFGV+L EL T ++               W                 RLE 
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQP--------------WGNLNPAQVVAAVGFKCKRLE- 259
Query: 324 RYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
                   ++AA+   C ++ P  RP+  T++  L PL+
Sbjct: 260 -IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 126/279 (45%), Gaps = 29/279 (10%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR--EWLAEVIFLGQLKHPHL 144
           +G G FG V+        R       VAVK+L        R  E+L EV  + +L+HP++
Sbjct: 45  IGAGSFGTVH--------RAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYS-STLPWLTRIKIAIGAARCLAFLHGE 203
           V  +G   +  +  +V EY++ G+L+  L K+ +   L    R+ +A   A+ + +LH  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTG 263
             P+++R+ K+ N+L+D  Y  K+ DFGL+    +      +    GT  + APE +   
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 264 HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLED 323
                 DV+SFGV+L EL T ++               W                 RLE 
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQP--------------WGNLNPAQVVAAVGFKCKRLEI 260
Query: 324 RYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
             +     ++AA+   C ++ P  RP+  T++  L PL+
Sbjct: 261 PRNLN--PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 135/290 (46%), Gaps = 44/290 (15%)
Query: 87  LGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGSQGH-------REWLAEVIFLGQ 138
           +G+GGFG V+KG  V D          VA+K L +  S+G        +E+  EV  +  
Sbjct: 27  IGKGGFGLVHKGRLVKDK-------SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 139 LKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLA 198
           L HP++V L G         +V E++  G+L+ +L  + +  + W  ++++ +  A  + 
Sbjct: 80  LNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL-DKAHPIKWSVKLRLMLDIALGIE 136
Query: 199 FLHGEEKPVIYRDFKASNILLDS-DYN----AKLSDFGLATDGPQGEDSHITTCVMGTEG 253
           ++  +  P+++RD ++ NI L S D N    AK++DFGL+      +  H  + ++G   
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQ 191
Query: 254 YAAPEYINTGH--LTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFT 311
           + APE I       T   D +SF ++L  +LTG           E    E++   +K   
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTG-----------EGPFDEYSYGKIK--- 237
Query: 312 KLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL 361
            ++ I +  L      +   RL  V   C S +PK RP  + +VK L  L
Sbjct: 238 FINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 134/290 (46%), Gaps = 44/290 (15%)
Query: 87  LGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGSQGH-------REWLAEVIFLGQ 138
           +G+GGFG V+KG  V D          VA+K L +  S+G        +E+  EV  +  
Sbjct: 27  IGKGGFGLVHKGRLVKDK-------SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 139 LKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLA 198
           L HP++V L G         +V E++  G+L+ +L  + +  + W  ++++ +  A  + 
Sbjct: 80  LNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL-DKAHPIKWSVKLRLMLDIALGIE 136
Query: 199 FLHGEEKPVIYRDFKASNILLDS-DYN----AKLSDFGLATDGPQGEDSHITTCVMGTEG 253
           ++  +  P+++RD ++ NI L S D N    AK++DFG +      +  H  + ++G   
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVSGLLGNFQ 191
Query: 254 YAAPEYINTGH--LTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFT 311
           + APE I       T   D +SF ++L  +LTG           E    E++   +K   
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTG-----------EGPFDEYSYGKIK--- 237
Query: 312 KLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL 361
            ++ I +  L      +   RL  V   C S +PK RP  + +VK L  L
Sbjct: 238 FINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 134/290 (46%), Gaps = 44/290 (15%)
Query: 87  LGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGSQGH-------REWLAEVIFLGQ 138
           +G+GGFG V+KG  V D          VA+K L +  S+G        +E+  EV  +  
Sbjct: 27  IGKGGFGLVHKGRLVKDK-------SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 139 LKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLA 198
           L HP++V L G         +V E++  G+L+ +L  + +  + W  ++++ +  A  + 
Sbjct: 80  LNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL-DKAHPIKWSVKLRLMLDIALGIE 136
Query: 199 FLHGEEKPVIYRDFKASNILLDS-DYN----AKLSDFGLATDGPQGEDSHITTCVMGTEG 253
           ++  +  P+++RD ++ NI L S D N    AK++DF L+      +  H  + ++G   
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVSGLLGNFQ 191
Query: 254 YAAPEYINTGH--LTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFT 311
           + APE I       T   D +SF ++L  +LTG           E    E++   +K   
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTG-----------EGPFDEYSYGKIK--- 237
Query: 312 KLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL 361
            ++ I +  L      +   RL  V   C S +PK RP  + +VK L  L
Sbjct: 238 FINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/202 (37%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFLGQLKHPHLV 145
           LGEG FGKV   C D         + VAVK L  +    HR  W  E+  L  L H H++
Sbjct: 39  LGEGHFGKVSLYCYDPT--NDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 146 NLIGYCCEDEHRL---LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
              G CCED       LV EY+ LG+L D L   +S  L  L  +  A      +A+LH 
Sbjct: 97  KYKG-CCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQL--LLFAQQICEGMAYLHA 152
Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSH-ITTCVMGTEGYAAPEYIN 261
           +    I+RD  A N+LLD+D   K+ DFGLA   P+G + + +         + APE + 
Sbjct: 153 QH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLK 210
Query: 262 TGHLTTMCDVFSFGVVLLELLT 283
                   DV+SFGV L ELLT
Sbjct: 211 EYKFYYASDVWSFGVTLYELLT 232

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 87/333 (26%), Positives = 152/333 (45%), Gaps = 61/333 (18%)
Query: 65  NLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ 124
           +LH+   KE+++        + +G G FG V K           +A+ VA+K ++    +
Sbjct: 2   SLHMIDYKEIEV-------EEVVGRGAFGVVCKA--------KWRAKDVAIKQIESESER 46
Query: 125 GHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWL 184
             + ++ E+  L ++ HP++V L G C       LV EY   G+L++ L  + +  LP+ 
Sbjct: 47  --KAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVL--HGAEPLPYY 100
Query: 185 TRIKIAIGAARC---LAFLHG-EEKPVIYRDFKASNILLDSDYNA-KLSDFGLATDGPQG 239
           T         +C   +A+LH  + K +I+RD K  N+LL +     K+ DFG A D    
Sbjct: 101 TAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD---- 156
Query: 240 EDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDL 299
             +H+T    G+  + APE     + +  CDVFS+G++L E++T R+  ++      +  
Sbjct: 157 IQTHMTN-NKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-- 213
Query: 300 VEWA------RPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTT 353
           + WA       P++K+  K  + + +R                   C S +P  RP+M  
Sbjct: 214 IMWAVHNGTRPPLIKNLPKPIESLMTR-------------------CWSKDPSQRPSMEE 254
Query: 354 VVKALEPLLDLNDIPIGPFVYTV---VPPGDHG 383
           +VK +  L+        P  Y     +PPG+ G
Sbjct: 255 IVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDG 287

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 87/333 (26%), Positives = 152/333 (45%), Gaps = 61/333 (18%)
Query: 65  NLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ 124
           +LH+   KE+++        + +G G FG V K           +A+ VA+K ++    +
Sbjct: 1   SLHMIDYKEIEV-------EEVVGRGAFGVVCKA--------KWRAKDVAIKQIESESER 45
Query: 125 GHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWL 184
             + ++ E+  L ++ HP++V L G C       LV EY   G+L++ L  + +  LP+ 
Sbjct: 46  --KAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVL--HGAEPLPYY 99
Query: 185 TRIKIAIGAARC---LAFLHG-EEKPVIYRDFKASNILLDSDYNA-KLSDFGLATDGPQG 239
           T         +C   +A+LH  + K +I+RD K  N+LL +     K+ DFG A D    
Sbjct: 100 TAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD---- 155
Query: 240 EDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDL 299
             +H+T    G+  + APE     + +  CDVFS+G++L E++T R+  ++      +  
Sbjct: 156 IQTHMTN-NKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-- 212
Query: 300 VEWA------RPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTT 353
           + WA       P++K+  K  + + +R                   C S +P  RP+M  
Sbjct: 213 IMWAVHNGTRPPLIKNLPKPIESLMTR-------------------CWSKDPSQRPSMEE 253
Query: 354 VVKALEPLLDLNDIPIGPFVYTV---VPPGDHG 383
           +VK +  L+        P  Y     +PPG+ G
Sbjct: 254 IVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDG 286

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 130/302 (43%), Gaps = 40/302 (13%)
Query: 85  DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHL 144
           + LG+G FG+  K    +        + + +K L     +  R +L EV  +  L+HP++
Sbjct: 16  EVLGKGCFGQAIKVTHRET------GEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           +  IG   +D+    + EY+  G L   + K+  S  PW  R+  A   A  +A+LH   
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRG-IIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN 128
Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLA------TDGPQG------EDSHITTCVMGTE 252
             +I+RD  + N L+  + N  ++DFGLA         P+G       D      V+G  
Sbjct: 129 --IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK 312
            + APE IN        DVFSFG+VL E++ GR + + +   R  D     R  L     
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNADPDYLPRTMDFGLNVRGFL----- 240
Query: 313 LDQIIDSRLEDRYSTEGA-KRLAAVAHQCLSHNPKSRPTMTTVVKALEPL-LDL-NDIPI 369
                     DRY           +  +C   +P+ RP+   +   LE L + L   +P+
Sbjct: 241 ----------DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPL 290
Query: 370 GP 371
           GP
Sbjct: 291 GP 292

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/202 (36%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFLGQLKHPHLV 145
           LGEG FGKV   C D         + VAVK L  +    HR  W  E+  L  L H H++
Sbjct: 22  LGEGHFGKVSLYCYDPT--NDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 146 NLIGYCCEDEHR---LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
              G CCED+      LV EY+ LG+L D L   +S  L  L  +  A      +A+LH 
Sbjct: 80  KYKG-CCEDQGEKSLQLVMEYVPLGSLRDYL-PRHSIGLAQL--LLFAQQICEGMAYLHA 135
Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSH-ITTCVMGTEGYAAPEYIN 261
           +    I+R+  A N+LLD+D   K+ DFGLA   P+G + + +         + APE + 
Sbjct: 136 QH--YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 193
Query: 262 TGHLTTMCDVFSFGVVLLELLT 283
                   DV+SFGV L ELLT
Sbjct: 194 EYKFYYASDVWSFGVTLYELLT 215

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 74/202 (36%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFLGQLKHPHLV 145
           LGEG FGKV   C D         + VAVK L  +    HR  W  E+  L  L H H++
Sbjct: 22  LGEGHFGKVSLYCYDPT--NDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 146 NLIGYCCEDEHR---LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
              G CCED+      LV EY+ LG+L D L   +S  L  L  +  A      +A+LH 
Sbjct: 80  KYKG-CCEDQGEKSLQLVMEYVPLGSLRDYL-PRHSIGLAQL--LLFAQQICEGMAYLHS 135
Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSH-ITTCVMGTEGYAAPEYIN 261
           +    I+R+  A N+LLD+D   K+ DFGLA   P+G + + +         + APE + 
Sbjct: 136 QH--YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 193
Query: 262 TGHLTTMCDVFSFGVVLLELLT 283
                   DV+SFGV L ELLT
Sbjct: 194 EYKFYYASDVWSFGVTLYELLT 215

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 131/301 (43%), Gaps = 28/301 (9%)
Query: 68  VFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR 127
           VF   E ++     +    LG+G FG VY+G   D ++ G     VAVK ++ + S   R
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRER 64
Query: 128 -EWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLF-------KNYSS 179
            E+L E   +      H+V L+G   + +  L+V E MA G+L   L         N   
Sbjct: 65  IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 124
Query: 180 TLPWLTR-IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ 238
             P L   I++A   A  +A+L+   K  ++RD  A N ++  D+  K+ DFG+  D  +
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE 182
Query: 239 GEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKD 298
            +        +    + APE +  G  TT  D++SFGVVL E+ +               
Sbjct: 183 TDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS--------------- 227
Query: 299 LVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL 358
           L E     L +   L  ++D    D+      +R+  +   C   NPK RPT   +V  L
Sbjct: 228 LAEQPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286
Query: 359 E 359
           +
Sbjct: 287 K 287

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 131/301 (43%), Gaps = 28/301 (9%)
Query: 68  VFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR 127
           VF   E ++     +    LG+G FG VY+G   D ++ G     VAVK ++ + S   R
Sbjct: 3   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRER 61
Query: 128 -EWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLF-------KNYSS 179
            E+L E   +      H+V L+G   + +  L+V E MA G+L   L         N   
Sbjct: 62  IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 121
Query: 180 TLPWLTR-IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ 238
             P L   I++A   A  +A+L+   K  ++RD  A N ++  D+  K+ DFG+  D  +
Sbjct: 122 PPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE 179
Query: 239 GEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKD 298
            +        +    + APE +  G  TT  D++SFGVVL E+ +               
Sbjct: 180 TDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS--------------- 224
Query: 299 LVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL 358
           L E     L +   L  ++D    D+      +R+  +   C   NPK RPT   +V  L
Sbjct: 225 LAEQPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 283
Query: 359 E 359
           +
Sbjct: 284 K 284

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 11/206 (5%)
Query: 82  SRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLK 140
           +R   +G G FG+VYKG +  +   G K   VA+K L    ++  R ++L E   +GQ  
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTS--SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 104
Query: 141 HPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFL 200
           H +++ L G   + +  +++ EYM  G L D+  +        L  + +  G A  + +L
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGAL-DKFLREKDGEFSVLQLVGMLRGIAAGMKYL 163
Query: 201 HGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGEDSHITTCVMGTEGYAAP 257
                  ++RD  A NIL++S+   K+SDFGL+    D P  E ++ T+       + AP
Sbjct: 164 ANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP--EATYTTSGGKIPIRWTAP 219
Query: 258 EYINTGHLTTMCDVFSFGVVLLELLT 283
           E I+    T+  DV+SFG+V+ E++T
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 131/301 (43%), Gaps = 28/301 (9%)
Query: 68  VFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR 127
           VF   E ++     +    LG+G FG VY+G   D ++ G     VAVK ++ + S   R
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRER 64
Query: 128 -EWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLF-------KNYSS 179
            E+L E   +      H+V L+G   + +  L+V E MA G+L   L         N   
Sbjct: 65  IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 124
Query: 180 TLPWLTR-IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ 238
             P L   I++A   A  +A+L+   K  ++RD  A N ++  D+  K+ DFG+  D  +
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE 182
Query: 239 GEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKD 298
            +        +    + APE +  G  TT  D++SFGVVL E+ +               
Sbjct: 183 TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS--------------- 227
Query: 299 LVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL 358
           L E     L +   L  ++D    D+      +R+  +   C   NPK RPT   +V  L
Sbjct: 228 LAEQPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286
Query: 359 E 359
           +
Sbjct: 287 K 287

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 113/222 (50%), Gaps = 15/222 (6%)
Query: 66  LHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG 125
           +H F  KEL     N S    +G G FG+V  G +     P  K  +VA+K L V  ++ 
Sbjct: 35  VHEFA-KELD--ATNISIDKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEK 88
Query: 126 HR-EWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWL 184
            R ++L E   +GQ  HP+++ L G   + +  ++V EYM  G+L D   + + +    +
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVI 147
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGED 241
             + +  G A  + +L   +   ++RD  A NIL++S+   K+SDFGLA    D P  E 
Sbjct: 148 QLVGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDP--EA 203
Query: 242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           ++ T        + +PE I     T+  DV+S+G+VL E+++
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 122/292 (41%), Gaps = 43/292 (14%)
Query: 72  KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHRE 128
           K+ Q    +F     LG+G FG VY        R       +A+KVL    +  +    +
Sbjct: 27  KKRQWALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQ 80
Query: 129 WLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK----NYSSTLPWL 184
              EV     L+HP+++ L GY  +     L+ EY  LG ++ +L K    +   T  ++
Sbjct: 81  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 140
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI 244
           T +      A  L++ H   K VI+RD K  N+LL S    K++DFG +   P    S  
Sbjct: 141 TEL------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSR 188
Query: 245 TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR 304
            T + GT  Y  PE I         D++S GV+  E L G+   E N  +     +    
Sbjct: 189 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 248
Query: 305 PMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
               DF                TEGA+ L +   + L HNP  RP +  V++
Sbjct: 249 FTFPDFV---------------TEGARDLIS---RLLKHNPSQRPMLREVLE 282

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 133/281 (47%), Gaps = 32/281 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLKHPHL 144
           +G G FG VYKG    +         VAVK+L+V     Q  + +  EV  L + +H ++
Sbjct: 32  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           +  +GY  + +   +V ++    +L+  L  +  +       I IA   AR + +LH   
Sbjct: 83  LLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHA-- 138
Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI---N 261
           K +I+RD K++NI L  D   K+ DFGLAT+  +   SH    + G+  + APE I   +
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 262 TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK-DFTKLDQIIDSR 320
           +   +   DV++FG+VL EL+TG+     N   R++ +    R  L  D +K+      R
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257
Query: 321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL 361
           +         KRL A   +CL      RP+   ++  +E L
Sbjct: 258 M---------KRLMA---ECLKKKRDERPSFPRILAEIEEL 286

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 122/292 (41%), Gaps = 43/292 (14%)
Query: 72  KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHRE 128
           K+ Q    +F     LG+G FG VY        R       +A+KVL    +  +    +
Sbjct: 18  KKRQWALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQ 71
Query: 129 WLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK----NYSSTLPWL 184
              EV     L+HP+++ L GY  +     L+ EY  LG ++ +L K    +   T  ++
Sbjct: 72  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 131
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI 244
           T +      A  L++ H   K VI+RD K  N+LL S    K++DFG +   P    S  
Sbjct: 132 TEL------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSR 179
Query: 245 TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR 304
            T + GT  Y  PE I         D++S GV+  E L G+   E N  +     +    
Sbjct: 180 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 239
Query: 305 PMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
               DF                TEGA+ L +   + L HNP  RP +  V++
Sbjct: 240 FTFPDFV---------------TEGARDLIS---RLLKHNPSQRPMLREVLE 273

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 113/222 (50%), Gaps = 15/222 (6%)
Query: 66  LHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG 125
           +H F  KEL     N S    +G G FG+V  G +     P  K  +VA+K L V  ++ 
Sbjct: 23  VHEFA-KELD--ATNISIDKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEK 76
Query: 126 HR-EWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWL 184
            R ++L E   +GQ  HP+++ L G   + +  ++V EYM  G+L D   + + +    +
Sbjct: 77  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVI 135
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGED 241
             + +  G A  + +L   +   ++RD  A NIL++S+   K+SDFGL+    D P  E 
Sbjct: 136 QLVGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EA 191
Query: 242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           ++ T        + +PE I     T+  DV+S+G+VL E+++
Sbjct: 192 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 130/301 (43%), Gaps = 28/301 (9%)
Query: 68  VFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR 127
           VF   E ++     +    LG+G FG VY+G   D ++ G     VAVK ++ + S   R
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRER 64
Query: 128 -EWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLF-------KNYSS 179
            E+L E   +      H+V L+G   + +  L+V E MA G+L   L         N   
Sbjct: 65  IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 124
Query: 180 TLPWLTR-IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ 238
             P L   I++A   A  +A+L+   K  ++RD  A N ++  D+  K+ DFG+  D  +
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE 182
Query: 239 GEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKD 298
                     +    + APE +  G  TT  D++SFGVVL E+ +               
Sbjct: 183 TAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS--------------- 227
Query: 299 LVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL 358
           L E     L +   L  ++D    D+      +R+  +   C   NPK RPT   +V  L
Sbjct: 228 LAEQPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286
Query: 359 E 359
           +
Sbjct: 287 K 287

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 122/292 (41%), Gaps = 43/292 (14%)
Query: 72  KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHRE 128
           K+ Q    +F     LG+G FG VY        R       +A+KVL    +  +    +
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQ 59
Query: 129 WLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK----NYSSTLPWL 184
              EV     L+HP+++ L GY  +     L+ EY  LG ++ +L K    +   T  ++
Sbjct: 60  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 119
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI 244
           T +      A  L++ H   K VI+RD K  N+LL S    K++DFG +   P    S  
Sbjct: 120 TEL------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSR 167
Query: 245 TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR 304
            T + GT  Y  PE I         D++S GV+  E L G+   E N  +     +    
Sbjct: 168 RTTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 227
Query: 305 PMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
               DF                TEGA+ L +   + L HNP  RP +  V++
Sbjct: 228 FTFPDFV---------------TEGARDLIS---RLLKHNPSQRPXLREVLE 261

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 113/222 (50%), Gaps = 15/222 (6%)
Query: 66  LHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG 125
           +H F  KEL     N S    +G G FG+V  G +     P  K  +VA+K L V  ++ 
Sbjct: 35  VHEFA-KELD--ATNISIDKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEK 88
Query: 126 HR-EWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWL 184
            R ++L E   +GQ  HP+++ L G   + +  ++V EYM  G+L D   + + +    +
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVI 147
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGED 241
             + +  G A  + +L   +   ++RD  A NIL++S+   K+SDFGL+    D P  E 
Sbjct: 148 QLVGMLRGIASGMKYL--SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EA 203
Query: 242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           ++ T        + +PE I     T+  DV+S+G+VL E+++
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 113/222 (50%), Gaps = 15/222 (6%)
Query: 66  LHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG 125
           +H F  KEL     N S    +G G FG+V  G +     P  K  +VA+K L V  ++ 
Sbjct: 6   VHEFA-KELD--ATNISIDKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEK 59
Query: 126 HR-EWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWL 184
            R ++L E   +GQ  HP+++ L G   + +  ++V EYM  G+L D   + + +    +
Sbjct: 60  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVI 118
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGED 241
             + +  G A  + +L   +   ++RD  A NIL++S+   K+SDFGL+    D P  E 
Sbjct: 119 QLVGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EA 174
Query: 242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           ++ T        + +PE I     T+  DV+S+G+VL E+++
Sbjct: 175 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 113/222 (50%), Gaps = 15/222 (6%)
Query: 66  LHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG 125
           +H F  KEL     N S    +G G FG+V  G +     P  K  +VA+K L V  ++ 
Sbjct: 33  VHEFA-KELD--ATNISIDKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEK 86
Query: 126 HR-EWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWL 184
            R ++L E   +GQ  HP+++ L G   + +  ++V EYM  G+L D   + + +    +
Sbjct: 87  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVI 145
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGED 241
             + +  G A  + +L   +   ++RD  A NIL++S+   K+SDFGL+    D P  E 
Sbjct: 146 QLVGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EA 201
Query: 242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           ++ T        + +PE I     T+  DV+S+G+VL E+++
Sbjct: 202 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 113/222 (50%), Gaps = 15/222 (6%)
Query: 66  LHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG 125
           +H F  KEL     N S    +G G FG+V  G +     P  K  +VA+K L V  ++ 
Sbjct: 35  VHEFA-KELDAT--NISIDKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEK 88
Query: 126 HR-EWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWL 184
            R ++L E   +GQ  HP+++ L G   + +  ++V EYM  G+L D   + + +    +
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVI 147
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGED 241
             + +  G A  + +L   +   ++RD  A NIL++S+   K+SDFGL+    D P  E 
Sbjct: 148 QLVGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EA 203
Query: 242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           ++ T        + +PE I     T+  DV+S+G+VL E+++
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 113/222 (50%), Gaps = 15/222 (6%)
Query: 66  LHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG 125
           +H F  KEL     N S    +G G FG+V  G +     P  K  +VA+K L V  ++ 
Sbjct: 35  VHEFA-KELDAT--NISIDKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEK 88
Query: 126 HR-EWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWL 184
            R ++L E   +GQ  HP+++ L G   + +  ++V EYM  G+L D   + + +    +
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVI 147
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGED 241
             + +  G A  + +L   +   ++RD  A NIL++S+   K+SDFGL+    D P  E 
Sbjct: 148 QLVGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EA 203
Query: 242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           ++ T        + +PE I     T+  DV+S+G+VL E+++
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 124/282 (43%), Gaps = 28/282 (9%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLV 145
           LG+G FG VY+G   D ++ G     VAVK ++ + S   R E+L E   +      H+V
Sbjct: 25  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLF-------KNYSSTLPWLTR-IKIAIGAARCL 197
            L+G   + +  L+V E MA G+L   L         N     P L   I++A   A  +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAP 257
           A+L+   K  ++RD  A N ++  D+  K+ DFG+  D  + +        +    + AP
Sbjct: 144 AYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 258 EYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII 317
           E +  G  TT  D++SFGVVL E+ +               L E     L +   L  ++
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVLKFVM 246
Query: 318 DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
           D    D+      +R+  +   C   NP  RPT   +V  L+
Sbjct: 247 DGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 122/292 (41%), Gaps = 43/292 (14%)
Query: 72  KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHRE 128
           K+ Q    +F     LG+G FG VY        R       +A+KVL    +  +    +
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQ 57
Query: 129 WLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK----NYSSTLPWL 184
              EV     L+HP+++ L GY  +     L+ EY  LG ++ +L K    +   T  ++
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI 244
           T +      A  L++ H   K VI+RD K  N+LL S    K++DFG +   P    S  
Sbjct: 118 TEL------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSR 165
Query: 245 TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR 304
            T + GT  Y  PE I         D++S GV+  E L G+   E N  +     +    
Sbjct: 166 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 225
Query: 305 PMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
               DF                TEGA+ L +   + L HNP  RP +  V++
Sbjct: 226 FTFPDFV---------------TEGARDLIS---RLLKHNPSQRPMLREVLE 259

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 122/292 (41%), Gaps = 43/292 (14%)
Query: 72  KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHRE 128
           K+ Q    +F     LG+G FG VY        R       +A+KVL    +  +    +
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQ 59
Query: 129 WLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK----NYSSTLPWL 184
              EV     L+HP+++ L GY  +     L+ EY  LG ++ +L K    +   T  ++
Sbjct: 60  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 119
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI 244
           T +      A  L++ H   K VI+RD K  N+LL S    K++DFG +   P    S  
Sbjct: 120 TEL------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSR 167
Query: 245 TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR 304
            T + GT  Y  PE I         D++S GV+  E L G+   E N  +     +    
Sbjct: 168 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 227
Query: 305 PMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
               DF                TEGA+ L +   + L HNP  RP +  V++
Sbjct: 228 FTFPDFV---------------TEGARDLIS---RLLKHNPSQRPMLREVLE 261

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 113/222 (50%), Gaps = 15/222 (6%)
Query: 66  LHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG 125
           +H F  KEL     N S    +G G FG+V  G +     P  K  +VA+K L V  ++ 
Sbjct: 35  VHEFA-KELDAT--NISIDKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEK 88
Query: 126 HR-EWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWL 184
            R ++L E   +GQ  HP+++ L G   + +  ++V EYM  G+L D   + + +    +
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVI 147
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGED 241
             + +  G A  + +L   +   ++RD  A NIL++S+   K+SDFGL+    D P  E 
Sbjct: 148 QLVGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EA 203
Query: 242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           ++ T        + +PE I     T+  DV+S+G+VL E+++
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 81/241 (33%), Positives = 119/241 (49%), Gaps = 15/241 (6%)
Query: 48  PGSP-ISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRP 106
           PG+  I L+ L+  LV +  HV  +    +I H    ++ +G G FG VY G + DN   
Sbjct: 2   PGTVHIDLSALNPELVQAVQHV-VIGPSSLIVH---FNEVIGRGHFGCVYHGTLLDN--D 55
Query: 107 GLKAQTVAVKVLDVNGSQGH-REWLAEVIFLGQLKHPHLVNLIGYCCEDEHR-LLVYEYM 164
           G K    AVK L+     G   ++L E I +    HP++++L+G C   E   L+V  YM
Sbjct: 56  GKKIHC-AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 114
Query: 165 ALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYN 224
             G+L +   +N +        I   +  A+ + FL    K  ++RD  A N +LD  + 
Sbjct: 115 KHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFT 171
Query: 225 AKLSDFGLATDGPQGE-DS-HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELL 282
            K++DFGLA D    E DS H  T       + A E + T   TT  DV+SFGV+L EL+
Sbjct: 172 VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 231
Query: 283 T 283
           T
Sbjct: 232 T 232

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 113/222 (50%), Gaps = 15/222 (6%)
Query: 66  LHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG 125
           +H F  KEL     N S    +G G FG+V  G +     P  K  +VA+K L V  ++ 
Sbjct: 35  VHEFA-KELD--ATNISIDKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEK 88
Query: 126 HR-EWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWL 184
            R ++L E   +GQ  HP+++ L G   + +  ++V EYM  G+L D   + + +    +
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVI 147
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGED 241
             + +  G A  + +L   +   ++RD  A NIL++S+   K+SDFGL+    D P  E 
Sbjct: 148 QLVGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EA 203
Query: 242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           ++ T        + +PE I     T+  DV+S+G+VL E+++
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 125/282 (44%), Gaps = 28/282 (9%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLV 145
           LG+G FG VY+G   D ++ G     VAVK ++ + S   R E+L E   +      H+V
Sbjct: 24  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLF-------KNYSSTLPWLTR-IKIAIGAARCL 197
            L+G   + +  L+V E MA G+L   L         N     P L   I++A   A  +
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAP 257
           A+L+   K  ++RD  A N ++  D+  K+ DFG+  D  + +        +    + AP
Sbjct: 143 AYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 258 EYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII 317
           E +  G  TT  D++SFGVVL E+ +               L E     L +   L  ++
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVLKFVM 245
Query: 318 DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
           D    D+      +R+  +   C   NPK RPT   +V  L+
Sbjct: 246 DGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 286

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 116/236 (49%), Gaps = 14/236 (5%)
Query: 52  ISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQ 111
           I L+ L+  LV +  HV  +    +I H    ++ +G G FG VY G + DN   G K  
Sbjct: 5   IDLSALNPELVQAVQHV-VIGPSSLIVH---FNEVIGRGHFGCVYHGTLLDN--DGKKIH 58
Query: 112 TVAVKVLDVNGSQGH-REWLAEVIFLGQLKHPHLVNLIGYCCEDEHR-LLVYEYMALGNL 169
             AVK L+     G   ++L E I +    HP++++L+G C   E   L+V  YM  G+L
Sbjct: 59  C-AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 117
Query: 170 HDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSD 229
            +   +N +        I   +  A+ + FL    K  ++RD  A N +LD  +  K++D
Sbjct: 118 RN-FIRNETHNPTVKDLIGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVAD 174
Query: 230 FGLATDGPQGE-DS-HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           FGLA D    E DS H  T       + A E + T   TT  DV+SFGV+L EL+T
Sbjct: 175 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 116/236 (49%), Gaps = 14/236 (5%)
Query: 52  ISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQ 111
           I L+ L+  LV +  HV  +    +I H    ++ +G G FG VY G + DN   G K  
Sbjct: 7   IDLSALNPELVQAVQHV-VIGPSSLIVH---FNEVIGRGHFGCVYHGTLLDN--DGKKIH 60
Query: 112 TVAVKVLDVNGSQGH-REWLAEVIFLGQLKHPHLVNLIGYCCEDEHR-LLVYEYMALGNL 169
             AVK L+     G   ++L E I +    HP++++L+G C   E   L+V  YM  G+L
Sbjct: 61  C-AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 119
Query: 170 HDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSD 229
            +   +N +        I   +  A+ + FL    K  ++RD  A N +LD  +  K++D
Sbjct: 120 RN-FIRNETHNPTVKDLIGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVAD 176
Query: 230 FGLATDGPQGE-DS-HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           FGLA D    E DS H  T       + A E + T   TT  DV+SFGV+L EL+T
Sbjct: 177 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 122/292 (41%), Gaps = 43/292 (14%)
Query: 72  KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHRE 128
           K+ Q    +F     LG+G FG VY        R       +A+KVL    +  +    +
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQ 57
Query: 129 WLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK----NYSSTLPWL 184
              EV     L+HP+++ L GY  +     L+ EY  LG ++ +L K    +   T  ++
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI 244
           T +      A  L++ H   K VI+RD K  N+LL S    K++DFG +   P    S  
Sbjct: 118 TEL------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSR 165
Query: 245 TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR 304
            T + GT  Y  PE I         D++S GV+  E L G+   E N  +     +    
Sbjct: 166 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 225
Query: 305 PMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
               DF                TEGA+ L +   + L HNP  RP +  V++
Sbjct: 226 FTFPDFV---------------TEGARDLIS---RLLKHNPSQRPMLREVLE 259

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 121/289 (41%), Gaps = 43/289 (14%)
Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHREWLA 131
           Q    +F     LG+G FG VY        R   +   +A+KVL    +  +    +   
Sbjct: 1   QWALEDFEIGRPLGKGKFGNVYLA------REKQRKFILALKVLFKAQLEKAGVEHQLRR 54
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK----NYSSTLPWLTRI 187
           EV     L+HP+++ L GY  +     L+ EY  LG ++ +L K    +   T  ++T +
Sbjct: 55  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 114
Query: 188 KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC 247
                 A  L++ H   K VI+RD K  N+LL S    K++DFG +   P    S   T 
Sbjct: 115 ------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTT 162
Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML 307
           + GT  Y  PE I         D++S GV+  E L G+   E N  +     +       
Sbjct: 163 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF 222
Query: 308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
            DF                TEGA+ L +   + L HNP  RP +  V++
Sbjct: 223 PDFV---------------TEGARDLIS---RLLKHNPSQRPMLREVLE 253

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 116/236 (49%), Gaps = 14/236 (5%)
Query: 52  ISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQ 111
           I L+ L+  LV +  HV  +    +I H    ++ +G G FG VY G + DN   G K  
Sbjct: 66  IDLSALNPELVQAVQHV-VIGPSSLIVH---FNEVIGRGHFGCVYHGTLLDN--DGKKIH 119
Query: 112 TVAVKVLDVNGSQGH-REWLAEVIFLGQLKHPHLVNLIGYCCEDEHR-LLVYEYMALGNL 169
             AVK L+     G   ++L E I +    HP++++L+G C   E   L+V  YM  G+L
Sbjct: 120 C-AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 178
Query: 170 HDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSD 229
            +   +N +        I   +  A+ + FL    K  ++RD  A N +LD  +  K++D
Sbjct: 179 RN-FIRNETHNPTVKDLIGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVAD 235
Query: 230 FGLATDGPQGE-DS-HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           FGLA D    E DS H  T       + A E + T   TT  DV+SFGV+L EL+T
Sbjct: 236 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 132/281 (46%), Gaps = 32/281 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLKHPHL 144
           +G G FG VYKG    +         VAVK+L+V     Q  + +  EV  L + +H ++
Sbjct: 32  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           +  +GY    +   +V ++    +L+  L  +  +       I IA   AR + +LH   
Sbjct: 83  LLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHA-- 138
Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI---N 261
           K +I+RD K++NI L  D   K+ DFGLAT+  +   SH    + G+  + APE I   +
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 262 TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK-DFTKLDQIIDSR 320
           +   +   DV++FG+VL EL+TG+     N   R++ +    R  L  D +K+      R
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257
Query: 321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL 361
           +         KRL A   +CL      RP+   ++  +E L
Sbjct: 258 M---------KRLMA---ECLKKKRDERPSFPRILAEIEEL 286

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 116/236 (49%), Gaps = 14/236 (5%)
Query: 52  ISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQ 111
           I L+ L+  LV +  HV  +    +I H    ++ +G G FG VY G + DN   G K  
Sbjct: 12  IDLSALNPELVQAVQHV-VIGPSSLIVH---FNEVIGRGHFGCVYHGTLLDN--DGKKIH 65
Query: 112 TVAVKVLDVNGSQGH-REWLAEVIFLGQLKHPHLVNLIGYCCEDEHR-LLVYEYMALGNL 169
             AVK L+     G   ++L E I +    HP++++L+G C   E   L+V  YM  G+L
Sbjct: 66  C-AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 124
Query: 170 HDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSD 229
            +   +N +        I   +  A+ + FL    K  ++RD  A N +LD  +  K++D
Sbjct: 125 RN-FIRNETHNPTVKDLIGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVAD 181
Query: 230 FGLATDGPQGE-DS-HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           FGLA D    E DS H  T       + A E + T   TT  DV+SFGV+L EL+T
Sbjct: 182 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 112/222 (50%), Gaps = 15/222 (6%)
Query: 66  LHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG 125
           +H F  KEL     N S    +G G FG+V  G +     P  K  +VA+K L V  ++ 
Sbjct: 35  VHEFA-KELD--ATNISIDKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEK 88
Query: 126 HR-EWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWL 184
            R ++L E   +GQ  HP+++ L G   + +  ++V EYM  G+L D   + + +    +
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVI 147
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGED 241
             + +  G A  + +L   +   ++RD  A NIL++S+   K+SDFGL     D P  E 
Sbjct: 148 QLVGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP--EA 203
Query: 242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           ++ T        + +PE I     T+  DV+S+G+VL E+++
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 116/236 (49%), Gaps = 14/236 (5%)
Query: 52  ISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQ 111
           I L+ L+  LV +  HV  +    +I H    ++ +G G FG VY G + DN   G K  
Sbjct: 8   IDLSALNPELVQAVQHV-VIGPSSLIVH---FNEVIGRGHFGCVYHGTLLDN--DGKKIH 61
Query: 112 TVAVKVLDVNGSQGH-REWLAEVIFLGQLKHPHLVNLIGYCCEDEHR-LLVYEYMALGNL 169
             AVK L+     G   ++L E I +    HP++++L+G C   E   L+V  YM  G+L
Sbjct: 62  C-AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 120
Query: 170 HDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSD 229
            +   +N +        I   +  A+ + FL    K  ++RD  A N +LD  +  K++D
Sbjct: 121 RN-FIRNETHNPTVKDLIGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVAD 177
Query: 230 FGLATDGPQGE-DS-HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           FGLA D    E DS H  T       + A E + T   TT  DV+SFGV+L EL+T
Sbjct: 178 FGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 122/292 (41%), Gaps = 43/292 (14%)
Query: 72  KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHRE 128
           K+ Q    +F     LG+G FG VY        R       +A+KVL    +  +    +
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQ 55
Query: 129 WLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK----NYSSTLPWL 184
              EV     L+HP+++ L GY  +     L+ EY  LG ++ +L K    +   T  ++
Sbjct: 56  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 115
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI 244
           T +      A  L++ H   K VI+RD K  N+LL S    K++DFG +   P    S  
Sbjct: 116 TEL------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSCHAP----SSR 163
Query: 245 TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR 304
            T + GT  Y  PE I         D++S GV+  E L G+   E N  +     +    
Sbjct: 164 RTTLSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 223
Query: 305 PMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
               DF                TEGA+ L +   + L HNP  RP +  V++
Sbjct: 224 FTFPDFV---------------TEGARDLIS---RLLKHNPSQRPMLREVLE 257

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 136/301 (45%), Gaps = 51/301 (16%)
Query: 84  SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL-KHP 142
            D +GEG FG+V K  +    + GL+      ++ +      HR++  E+  L +L  HP
Sbjct: 20  QDVIGEGNFGQVLKARIK---KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 76
Query: 143 HLVNLIGYCCEDEHRLLVY---EYMALGNLHDQLFKNY--------------SSTLPWLT 185
           +++NL+G C   EHR  +Y   EY   GNL D L K+               +STL    
Sbjct: 77  NIINLLGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 133
Query: 186 RIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHIT 245
            +  A   AR + +L   +K  I+RD  A NIL+  +Y AK++DFGL+    +G++ ++ 
Sbjct: 134 LLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVYVK 187
Query: 246 TCVMGT--EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEW 302
              MG     + A E +N    TT  DV+S+GV+L E+++ G        C    + +  
Sbjct: 188 K-TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 246
Query: 303 ARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
              + K     D++ D                 +  QC    P  RP+   ++ +L  +L
Sbjct: 247 GYRLEKPLNCDDEVYD-----------------LMRQCWREKPYERPSFAQILVSLNRML 289
Query: 363 D 363
           +
Sbjct: 290 E 290

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 116/236 (49%), Gaps = 14/236 (5%)
Query: 52  ISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQ 111
           I L+ L+  LV +  HV  +    +I H    ++ +G G FG VY G + DN   G K  
Sbjct: 8   IDLSALNPELVQAVQHV-VIGPSSLIVH---FNEVIGRGHFGCVYHGTLLDN--DGKKIH 61
Query: 112 TVAVKVLDVNGSQGH-REWLAEVIFLGQLKHPHLVNLIGYCCEDEHR-LLVYEYMALGNL 169
             AVK L+     G   ++L E I +    HP++++L+G C   E   L+V  YM  G+L
Sbjct: 62  C-AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 120
Query: 170 HDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSD 229
            +   +N +        I   +  A+ + FL    K  ++RD  A N +LD  +  K++D
Sbjct: 121 RN-FIRNETHNPTVKDLIGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVAD 177
Query: 230 FGLATDGPQGE-DS-HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           FGLA D    E DS H  T       + A E + T   TT  DV+SFGV+L EL+T
Sbjct: 178 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 136/301 (45%), Gaps = 51/301 (16%)
Query: 84  SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL-KHP 142
            D +GEG FG+V K  +    + GL+      ++ +      HR++  E+  L +L  HP
Sbjct: 30  QDVIGEGNFGQVLKARIK---KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 86
Query: 143 HLVNLIGYCCEDEHRLLVY---EYMALGNLHDQLFKNY--------------SSTLPWLT 185
           +++NL+G C   EHR  +Y   EY   GNL D L K+               +STL    
Sbjct: 87  NIINLLGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 186 RIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHIT 245
            +  A   AR + +L   +K  I+RD  A NIL+  +Y AK++DFGL+    +G++ ++ 
Sbjct: 144 LLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVYVK 197
Query: 246 TCVMGT--EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEW 302
              MG     + A E +N    TT  DV+S+GV+L E+++ G        C    + +  
Sbjct: 198 K-TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 256
Query: 303 ARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
              + K     D++ D                 +  QC    P  RP+   ++ +L  +L
Sbjct: 257 GYRLEKPLNCDDEVYD-----------------LMRQCWREKPYERPSFAQILVSLNRML 299
Query: 363 D 363
           +
Sbjct: 300 E 300

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/309 (24%), Positives = 138/309 (44%), Gaps = 28/309 (9%)
Query: 64  SNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS 123
           S   V+   E ++     + S  LG+G FG VY+G     ++   + + VA+K ++   S
Sbjct: 4   SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAAS 62
Query: 124 QGHR-EWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHD-------QLFK 175
              R E+L E   + +    H+V L+G   + +  L++ E M  G+L         ++  
Sbjct: 63  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMEN 122
Query: 176 NYSSTLPWLTR-IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT 234
           N     P L++ I++A   A  +A+L+  +   ++RD  A N ++  D+  K+ DFG+  
Sbjct: 123 NPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTR 180
Query: 235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCK 294
           D  + +        +    + +PE +  G  TT  DV+SFGVVL E+ T           
Sbjct: 181 DIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------- 229
Query: 295 REKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTV 354
               L E     L +   L  +++  L D+        L  +   C  +NPK RP+   +
Sbjct: 230 ----LAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEI 284
Query: 355 VKALEPLLD 363
           + +++  ++
Sbjct: 285 ISSIKEEME 293

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 122/292 (41%), Gaps = 43/292 (14%)
Query: 72  KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHRE 128
           K+ Q    +F     LG+G FG VY        R       +A+KVL    +  +    +
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQ 59
Query: 129 WLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK----NYSSTLPWL 184
              EV     L+HP+++ L GY  +     L+ EY  LG ++ +L K    +   T  ++
Sbjct: 60  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 119
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI 244
           T +      A  L++ H   K VI+RD K  N+LL S    K++DFG +   P    S  
Sbjct: 120 TEL------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSR 167
Query: 245 TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR 304
            T + GT  Y  PE I         D++S GV+  E L G+   E N  +     +    
Sbjct: 168 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 227
Query: 305 PMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
               DF                TEGA+ L +   + L HNP  RP +  V++
Sbjct: 228 FTFPDFV---------------TEGARDLIS---RLLKHNPSQRPMLREVLE 261

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 122/292 (41%), Gaps = 43/292 (14%)
Query: 72  KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHRE 128
           K+ Q    +F     LG+G FG VY        R       +A+KVL    +  +    +
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQ 55
Query: 129 WLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK----NYSSTLPWL 184
              EV     L+HP+++ L GY  +     L+ EY  LG ++ +L K    +   T  ++
Sbjct: 56  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 115
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI 244
           T +      A  L++ H   K VI+RD K  N+LL S    K++DFG +   P    S  
Sbjct: 116 TEL------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSR 163
Query: 245 TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR 304
            T + GT  Y  PE I         D++S GV+  E L G+   E N  +     +    
Sbjct: 164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 223
Query: 305 PMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
               DF                TEGA+ L +   + L HNP  RP +  V++
Sbjct: 224 FTFPDFV---------------TEGARDLIS---RLLKHNPSQRPMLREVLE 257

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 130/303 (42%), Gaps = 54/303 (17%)
Query: 74  LQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL----DVNGSQGHREW 129
           L++     +  + +G GGFGKVY        R       VAVK      D + SQ     
Sbjct: 2   LEIDFAELTLEEIIGIGGFGKVY--------RAFWIGDEVAVKAARHDPDEDISQTIENV 53
Query: 130 LAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKI 189
             E      LKHP+++ L G C ++ +  LV E+   G L+  L       +P    +  
Sbjct: 54  RQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNW 110
Query: 190 AIGAARCLAFLHGEE-KPVIYRDFKASNILLD--------SDYNAKLSDFGLATDGPQGE 240
           A+  AR + +LH E   P+I+RD K+SNIL+         S+   K++DFGLA       
Sbjct: 111 AVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA------R 164
Query: 241 DSHITTCVMGTEGYA--APEYINTGHLTTMCDVFSFGVVLLELLTGR---RSVEKNRCKR 295
           + H TT +     YA  APE I     +   DV+S+GV+L ELLTG    R ++      
Sbjct: 165 EWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY 224
Query: 296 EKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVV 355
              + + A P+                    +   +  A +   C + +P SRP+ T ++
Sbjct: 225 GVAMNKLALPI-------------------PSTCPEPFAKLMEDCWNPDPHSRPSFTNIL 265
Query: 356 KAL 358
             L
Sbjct: 266 DQL 268

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 120/289 (41%), Gaps = 43/289 (14%)
Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHREWLA 131
           Q    +F     LG+G FG VY        R       +A+KVL    +  +    +   
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRR 57
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK----NYSSTLPWLTRI 187
           EV     L+HP+++ L GY  +     L+ EY  LG ++ +L K    +   T  ++T +
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 188 KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC 247
                 A  L++ H   K VI+RD K  N+LL S    K++DFG +   P    S   T 
Sbjct: 118 ------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTT 165
Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML 307
           + GT  Y  PE I         D++S GV+  E L G+   E N  +     +       
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF 225
Query: 308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
            DF                TEGA+ L +   + L HNP  RP +  V++
Sbjct: 226 PDFV---------------TEGARDLIS---RLLKHNPSQRPMLREVLE 256

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 122/292 (41%), Gaps = 43/292 (14%)
Query: 72  KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHRE 128
           K+ Q    +F     LG+G FG VY        R       +A+KVL    +  +    +
Sbjct: 1   KKRQWALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQ 54
Query: 129 WLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK----NYSSTLPWL 184
              EV     L+HP+++ L GY  +     L+ EY  LG ++ +L K    +   T  ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI 244
           T +      A  L++ H   K VI+RD K  N+LL S    K++DFG +   P    S  
Sbjct: 115 TEL------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSR 162
Query: 245 TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR 304
            T + GT  Y  PE I         D++S GV+  E L G+   E N  +     +    
Sbjct: 163 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 222
Query: 305 PMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
               DF                TEGA+ L +   + L HNP  RP +  V++
Sbjct: 223 FTFPDFV---------------TEGARDLIS---RLLKHNPSQRPMLREVLE 256

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG+V+    +       K   VAVK +   GS     +LAE   +  L+H  LV 
Sbjct: 23  LGAGQFGEVWMATYN-------KHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVK 74
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     + E   ++ E+MA G+L D L  +  S  P    I  +   A  +AF+  E++ 
Sbjct: 75  LHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI--EQRN 131
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG------YAAPEYI 260
            I+RD +A+NIL+ +    K++DFGLA      ED+  T      EG      + APE I
Sbjct: 132 YIHRDLRAANILVSASLVCKIADFGLAR---VIEDNEYT----AREGAKFPIKWTAPEAI 184
Query: 261 NTGHLTTMCDVFSFGVVLLELLTGRR 286
           N G  T   DV+SFG++L+E++T  R
Sbjct: 185 NFGSFTIKSDVWSFGILLMEIVTYGR 210

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 132/291 (45%), Gaps = 46/291 (15%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G +G+VY+G           + TVAVK L  +  +   E+L E   + ++KHP+LV 
Sbjct: 23  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 75
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L+G C  +    ++ E+M  GNL D L +     +  +  + +A   +  + +L  E+K 
Sbjct: 76  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL--EKKN 133
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLAT-------DGPQGEDSHITTCVMGTEGYAAPEY 259
            I+RD  A N L+  ++  K++DFGL+          P G    I         + APE 
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK--------WTAPES 185
Query: 260 INTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII-- 317
           +     +   DV++FGV+L E+ T   S                 P + D +++ +++  
Sbjct: 186 LAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEK 229
Query: 318 DSRLEDRYSTEGA-KRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDI 367
           D R+E     EG  +++  +   C   NP  RP+   + +A E +   + I
Sbjct: 230 DYRME---RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 277

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 132/291 (45%), Gaps = 46/291 (15%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G +G+VY+G           + TVAVK L  +  +   E+L E   + ++KHP+LV 
Sbjct: 22  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 74
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L+G C  +    ++ E+M  GNL D L +     +  +  + +A   +  + +L  E+K 
Sbjct: 75  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL--EKKN 132
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLAT-------DGPQGEDSHITTCVMGTEGYAAPEY 259
            I+RD  A N L+  ++  K++DFGL+          P G    I         + APE 
Sbjct: 133 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK--------WTAPES 184
Query: 260 INTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII-- 317
           +     +   DV++FGV+L E+ T   S                 P + D +++ +++  
Sbjct: 185 LAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEK 228
Query: 318 DSRLEDRYSTEGA-KRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDI 367
           D R+E     EG  +++  +   C   NP  RP+   + +A E +   + I
Sbjct: 229 DYRME---RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 276

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 95/202 (47%), Gaps = 13/202 (6%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGHREWLAEVIFLGQLKHPHLV 145
           LGEG FGKV   C D         + VAVK L    G Q    W  E+  L  L H H+V
Sbjct: 17  LGEGHFGKVSLYCYDPT--NDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIV 74
Query: 146 NLIGYCCEDEHR---LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
              G CCED+      LV EY+ LG+L D L ++       L     A      +A+LH 
Sbjct: 75  KYKG-CCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL---FAQQICEGMAYLHA 130
Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSH-ITTCVMGTEGYAAPEYIN 261
           +    I+R   A N+LLD+D   K+ DFGLA   P+G + + +         + APE + 
Sbjct: 131 QH--YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 188
Query: 262 TGHLTTMCDVFSFGVVLLELLT 283
                   DV+SFGV L ELLT
Sbjct: 189 ECKFYYASDVWSFGVTLYELLT 210

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 121/292 (41%), Gaps = 43/292 (14%)
Query: 72  KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHRE 128
           K+ Q    +F     LG+G FG VY        R       +A+KVL    +  +    +
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQ 55
Query: 129 WLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK----NYSSTLPWL 184
              EV     L+HP+++ L GY  +     L+ EY  LG ++ +L K    +   T  ++
Sbjct: 56  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 115
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI 244
           T +      A  L++ H   K VI+RD K  N+LL S    K++DFG +   P       
Sbjct: 116 TEL------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD-- 165
Query: 245 TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR 304
           T C  GT  Y  PE I         D++S GV+  E L G+   E N  +     +    
Sbjct: 166 TLC--GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 223
Query: 305 PMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
               DF                TEGA+ L +   + L HNP  RP +  V++
Sbjct: 224 FTFPDFV---------------TEGARDLIS---RLLKHNPSQRPMLREVLE 257

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG+V+ G  + + +       VAVK L   GS     +LAE   + QL+H  LV 
Sbjct: 29  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 80
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     + E   ++ EYM  G+L D L       L     + +A   A  +AF+  EE+ 
Sbjct: 81  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERN 137
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG------YAAPEYI 260
            I+RD +A+NIL+    + K++DFGLA      ED+  T      EG      + APE I
Sbjct: 138 YIHRDLRAANILVSDTLSCKIADFGLAR---LIEDNEXT----AREGAKFPIKWTAPEAI 190
Query: 261 NTGHLTTMCDVFSFGVVLLELLTGRR 286
           N G  T   DV+SFG++L E++T  R
Sbjct: 191 NYGTFTIKSDVWSFGILLTEIVTHGR 216

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 95/202 (47%), Gaps = 13/202 (6%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGHREWLAEVIFLGQLKHPHLV 145
           LGEG FGKV   C D         + VAVK L    G Q    W  E+  L  L H H+V
Sbjct: 16  LGEGHFGKVSLYCYDPT--NDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIV 73
Query: 146 NLIGYCCEDEHR---LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
              G CCED+      LV EY+ LG+L D L ++       L     A      +A+LH 
Sbjct: 74  KYKG-CCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL---FAQQICEGMAYLHA 129
Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSH-ITTCVMGTEGYAAPEYIN 261
           +    I+R   A N+LLD+D   K+ DFGLA   P+G + + +         + APE + 
Sbjct: 130 QH--YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 187
Query: 262 TGHLTTMCDVFSFGVVLLELLT 283
                   DV+SFGV L ELLT
Sbjct: 188 ECKFYYASDVWSFGVTLYELLT 209

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG+V+ G  + + +       VAVK L   GS     +LAE   + QL+H  LV 
Sbjct: 27  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 78
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     + E   ++ EYM  G+L D L       L     + +A   A  +AF+  EE+ 
Sbjct: 79  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERN 135
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG------YAAPEYI 260
            I+RD +A+NIL+    + K++DFGLA      ED+  T      EG      + APE I
Sbjct: 136 YIHRDLRAANILVSDTLSCKIADFGLAR---LIEDNEXT----AREGAKFPIKWTAPEAI 188
Query: 261 NTGHLTTMCDVFSFGVVLLELLTGRR 286
           N G  T   DV+SFG++L E++T  R
Sbjct: 189 NYGTFTIKSDVWSFGILLTEIVTHGR 214

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 120/289 (41%), Gaps = 43/289 (14%)
Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHREWLA 131
           Q    +F     LG+G FG VY        R       +A+KVL    +  +    +   
Sbjct: 3   QWALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRR 56
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK----NYSSTLPWLTRI 187
           EV     L+HP+++ L GY  +     L+ EY  LG ++ +L K    +   T  ++T +
Sbjct: 57  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 116
Query: 188 KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC 247
                 A  L++ H   K VI+RD K  N+LL S    K++DFG +   P    S   T 
Sbjct: 117 ------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTT 164
Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML 307
           + GT  Y  PE I         D++S GV+  E L G+   E N  +     +       
Sbjct: 165 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF 224
Query: 308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
            DF                TEGA+ L +   + L HNP  RP +  V++
Sbjct: 225 PDFV---------------TEGARDLIS---RLLKHNPSQRPMLREVLE 255

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 120/289 (41%), Gaps = 43/289 (14%)
Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHREWLA 131
           Q    +F     LG+G FG VY        R       +A+KVL    +  +    +   
Sbjct: 8   QWALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRR 61
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK----NYSSTLPWLTRI 187
           EV     L+HP+++ L GY  +     L+ EY  LG ++ +L K    +   T  ++T +
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 121
Query: 188 KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC 247
                 A  L++ H   K VI+RD K  N+LL S    K++DFG +   P    S   T 
Sbjct: 122 ------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTT 169
Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML 307
           + GT  Y  PE I         D++S GV+  E L G+   E N  +     +       
Sbjct: 170 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF 229
Query: 308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
            DF                TEGA+ L +   + L HNP  RP +  V++
Sbjct: 230 PDFV---------------TEGARDLIS---RLLKHNPSQRPMLREVLE 260

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/249 (31%), Positives = 120/249 (48%), Gaps = 18/249 (7%)
Query: 43  TDVSNP----GSPISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKG 98
           +D+S+P       I L+ L+  LV +  HV  +    +I H    ++ +G G FG VY G
Sbjct: 12  SDISSPLLQNTVHIDLSALNPELVQAVQHV-VIGPSSLIVH---FNEVIGRGHFGCVYHG 67
Query: 99  CVDDNLRPGLKAQTVAVKVLDVNGSQGH-REWLAEVIFLGQLKHPHLVNLIGYCCEDEHR 157
            + DN   G K    AVK L+     G   ++L E I +    HP++++L+G C   E  
Sbjct: 68  TLLDN--DGKKIHC-AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 124
Query: 158 -LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASN 216
            L+V  YM  G+L +   +N +        I   +  A+ + +L    K  ++RD  A N
Sbjct: 125 PLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARN 181
Query: 217 ILLDSDYNAKLSDFGLATDGPQGE--DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSF 274
            +LD  +  K++DFGLA D    E    H  T       + A E + T   TT  DV+SF
Sbjct: 182 CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 241
Query: 275 GVVLLELLT 283
           GV+L EL+T
Sbjct: 242 GVLLWELMT 250

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 132/281 (46%), Gaps = 32/281 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLKHPHL 144
           +G G FG VYKG    +         VAVK+L+V     Q  + +  EV  L + +H ++
Sbjct: 20  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 70
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           +  +GY  + +   +V ++    +L+  L  +  +       I IA   AR + +LH   
Sbjct: 71  LLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHA-- 126
Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI---N 261
           K +I+RD K++NI L  D   K+ DFGLAT   +   SH    + G+  + APE I   +
Sbjct: 127 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 186
Query: 262 TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK-DFTKLDQIIDSR 320
           +   +   DV++FG+VL EL+TG+     N   R++ +    R  L  D +K+      R
Sbjct: 187 SNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 245
Query: 321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL 361
           +         KRL A   +CL      RP+   ++  +E L
Sbjct: 246 M---------KRLMA---ECLKKKRDERPSFPRILAEIEEL 274

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG+V+ G  + + +       VAVK L   GS     +LAE   + QL+H  LV 
Sbjct: 31  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 82
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     + E   ++ EYM  G+L D L       L     + +A   A  +AF+  EE+ 
Sbjct: 83  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERN 139
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG------YAAPEYI 260
            I+RD +A+NIL+    + K++DFGLA      ED+  T      EG      + APE I
Sbjct: 140 YIHRDLRAANILVSDTLSCKIADFGLAR---LIEDNEYT----AREGAKFPIKWTAPEAI 192
Query: 261 NTGHLTTMCDVFSFGVVLLELLTGRR 286
           N G  T   DV+SFG++L E++T  R
Sbjct: 193 NYGTFTIKSDVWSFGILLTEIVTHGR 218

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG+V+    +       K   VAVK +   GS     +LAE   +  L+H  LV 
Sbjct: 196 LGAGQFGEVWMATYN-------KHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVK 247
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     + E   ++ E+MA G+L D L  +  S  P    I  +   A  +AF+  E++ 
Sbjct: 248 LHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI--EQRN 304
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG------YAAPEYI 260
            I+RD +A+NIL+ +    K++DFGLA      ED+  T      EG      + APE I
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLAR---VIEDNEYT----AREGAKFPIKWTAPEAI 357
Query: 261 NTGHLTTMCDVFSFGVVLLELLTGRR 286
           N G  T   DV+SFG++L+E++T  R
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIVTYGR 383

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/309 (24%), Positives = 138/309 (44%), Gaps = 28/309 (9%)
Query: 64  SNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS 123
           S   VF   E ++     + S  LG+G FG VY+G     ++   + + VA+K ++   S
Sbjct: 1   SAADVFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAAS 59
Query: 124 QGHR-EWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHD-------QLFK 175
              R E+L E   + +    H+V L+G   + +  L++ E M  G+L         ++  
Sbjct: 60  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMEN 119
Query: 176 NYSSTLPWLTR-IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT 234
           N     P L++ I++A   A  +A+L+  +   ++RD  A N ++  D+  K+ DFG+  
Sbjct: 120 NPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTR 177
Query: 235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCK 294
           D  + +        +    + +PE +  G  TT  DV+SFGVVL E+ T           
Sbjct: 178 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------- 226
Query: 295 REKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTV 354
               L E     L +   L  +++  L D+        L  +   C  +NPK RP+   +
Sbjct: 227 ----LAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEI 281
Query: 355 VKALEPLLD 363
           + +++  ++
Sbjct: 282 ISSIKEEME 290

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG+V+ G  + + +       VAVK L   GS     +LAE   + QL+H  LV 
Sbjct: 27  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 78
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     + E   ++ EYM  G+L D L       L     + +A   A  +AF+  EE+ 
Sbjct: 79  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERN 135
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG------YAAPEYI 260
            I+RD +A+NIL+    + K++DFGLA      ED+  T      EG      + APE I
Sbjct: 136 YIHRDLRAANILVSDTLSCKIADFGLAR---LIEDNEYT----AREGAKFPIKWTAPEAI 188
Query: 261 NTGHLTTMCDVFSFGVVLLELLTGRR 286
           N G  T   DV+SFG++L E++T  R
Sbjct: 189 NYGTFTIKSDVWSFGILLTEIVTHGR 214

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG+V+ G  + + +       VAVK L   GS     +LAE   + QL+H  LV 
Sbjct: 30  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 81
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     + E   ++ EYM  G+L D L       L     + +A   A  +AF+  EE+ 
Sbjct: 82  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERN 138
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG------YAAPEYI 260
            I+RD +A+NIL+    + K++DFGLA      ED+  T      EG      + APE I
Sbjct: 139 YIHRDLRAANILVSDTLSCKIADFGLAR---LIEDNEXT----AREGAKFPIKWTAPEAI 191
Query: 261 NTGHLTTMCDVFSFGVVLLELLTGRR 286
           N G  T   DV+SFG++L E++T  R
Sbjct: 192 NYGTFTIKSDVWSFGILLTEIVTHGR 217

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG+V+ G  + + +       VAVK L   GS     +LAE   + QL+H  LV 
Sbjct: 21  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     + E   ++ EYM  G+L D L       L     + +A   A  +AF+  EE+ 
Sbjct: 73  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERN 129
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG------YAAPEYI 260
            I+RD +A+NIL+    + K++DFGLA      ED+  T      EG      + APE I
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLAR---LIEDNEXT----AREGAKFPIKWTAPEAI 182
Query: 261 NTGHLTTMCDVFSFGVVLLELLTGRR 286
           N G  T   DV+SFG++L E++T  R
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG+V+ G  + + +       VAVK L   GS     +LAE   + QL+H  LV 
Sbjct: 23  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 74
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     + E   ++ EYM  G+L D L       L     + +A   A  +AF+  EE+ 
Sbjct: 75  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERN 131
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG------YAAPEYI 260
            I+RD +A+NIL+    + K++DFGLA      ED+  T      EG      + APE I
Sbjct: 132 YIHRDLRAANILVSDTLSCKIADFGLAR---LIEDNEXT----AREGAKFPIKWTAPEAI 184
Query: 261 NTGHLTTMCDVFSFGVVLLELLTGRR 286
           N G  T   DV+SFG++L E++T  R
Sbjct: 185 NYGTFTIKSDVWSFGILLTEIVTHGR 210

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/236 (32%), Positives = 114/236 (48%), Gaps = 14/236 (5%)
Query: 52  ISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQ 111
           I L+ L+  LV +  HV  +    +I H    ++ +G G FG VY G + DN   G K  
Sbjct: 26  IDLSALNPELVQAVQHV-VIGPSSLIVH---FNEVIGRGHFGCVYHGTLLDN--DGKKIH 79
Query: 112 TVAVKVLDVNGSQGH-REWLAEVIFLGQLKHPHLVNLIGYCCEDEHR-LLVYEYMALGNL 169
             AVK L+     G   ++L E I +    HP++++L+G C   E   L+V  YM  G+L
Sbjct: 80  C-AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 138
Query: 170 HDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSD 229
            +   +N +        I   +  A+ + +L    K  ++RD  A N +LD  +  K++D
Sbjct: 139 RN-FIRNETHNPTVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVAD 195
Query: 230 FGLATDGPQGE--DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           FGLA D    E    H  T       + A E + T   TT  DV+SFGV+L EL+T
Sbjct: 196 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/236 (32%), Positives = 114/236 (48%), Gaps = 14/236 (5%)
Query: 52  ISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQ 111
           I L+ L+  LV +  HV  +    +I H    ++ +G G FG VY G + DN   G K  
Sbjct: 6   IDLSALNPELVQAVQHV-VIGPSSLIVH---FNEVIGRGHFGCVYHGTLLDN--DGKKIH 59
Query: 112 TVAVKVLDVNGSQGH-REWLAEVIFLGQLKHPHLVNLIGYCCEDEHR-LLVYEYMALGNL 169
             AVK L+     G   ++L E I +    HP++++L+G C   E   L+V  YM  G+L
Sbjct: 60  C-AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 118
Query: 170 HDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSD 229
            +   +N +        I   +  A+ + +L    K  ++RD  A N +LD  +  K++D
Sbjct: 119 RN-FIRNETHNPTVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVAD 175
Query: 230 FGLATDGPQGEDS--HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           FGLA D    E    H  T       + A E + T   TT  DV+SFGV+L EL+T
Sbjct: 176 FGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG+V+ G  + + +       VAVK L   GS     +LAE   + QL+H  LV 
Sbjct: 26  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 77
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     + E   ++ EYM  G+L D L       L     + +A   A  +AF+  EE+ 
Sbjct: 78  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERN 134
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG------YAAPEYI 260
            I+RD +A+NIL+    + K++DFGLA      ED+  T      EG      + APE I
Sbjct: 135 YIHRDLRAANILVSDTLSCKIADFGLAR---LIEDNEYT----AREGAKFPIKWTAPEAI 187
Query: 261 NTGHLTTMCDVFSFGVVLLELLTGRR 286
           N G  T   DV+SFG++L E++T  R
Sbjct: 188 NYGTFTIKSDVWSFGILLTEIVTHGR 213

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 120/289 (41%), Gaps = 43/289 (14%)
Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHREWLA 131
           Q    +F     LG+G FG VY        R       +A+KVL    +  +    +   
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRR 57
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK----NYSSTLPWLTRI 187
           EV     L+HP+++ L GY  +     L+ EY  LG ++ +L K    +   T  ++T +
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 188 KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC 247
                 A  L++ H   K VI+RD K  N+LL S    K++DFG +   P    S   T 
Sbjct: 118 ------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTX 165
Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML 307
           + GT  Y  PE I         D++S GV+  E L G+   E N  +     +       
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF 225
Query: 308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
            DF                TEGA+ L +   + L HNP  RP +  V++
Sbjct: 226 PDFV---------------TEGARDLIS---RLLKHNPSQRPMLREVLE 256

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/236 (32%), Positives = 114/236 (48%), Gaps = 14/236 (5%)
Query: 52  ISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQ 111
           I L+ L+  LV +  HV  +    +I H    ++ +G G FG VY G + DN   G K  
Sbjct: 7   IDLSALNPELVQAVQHV-VIGPSSLIVH---FNEVIGRGHFGCVYHGTLLDN--DGKKIH 60
Query: 112 TVAVKVLDVNGSQGH-REWLAEVIFLGQLKHPHLVNLIGYCCEDEHR-LLVYEYMALGNL 169
             AVK L+     G   ++L E I +    HP++++L+G C   E   L+V  YM  G+L
Sbjct: 61  C-AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 119
Query: 170 HDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSD 229
            +   +N +        I   +  A+ + +L    K  ++RD  A N +LD  +  K++D
Sbjct: 120 RN-FIRNETHNPTVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVAD 176
Query: 230 FGLATDGPQGE--DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           FGLA D    E    H  T       + A E + T   TT  DV+SFGV+L EL+T
Sbjct: 177 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG+V+ G  + + +       VAVK L   GS     +LAE   + QL+H  LV 
Sbjct: 21  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     + E   ++ EYM  G+L D L       L     + +A   A  +AF+  EE+ 
Sbjct: 73  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERN 129
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG------YAAPEYI 260
            I+RD +A+NIL+    + K++DFGLA      ED+  T      EG      + APE I
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLAR---LIEDNEXT----AREGAKFPIKWTAPEAI 182
Query: 261 NTGHLTTMCDVFSFGVVLLELLTGRR 286
           N G  T   DV+SFG++L E++T  R
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 22/200 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG+V+    + + +       VAVK +   GS     +LAE   +  L+H  LV 
Sbjct: 190 LGAGQFGEVWMATYNKHTK-------VAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVK 241
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     + E   ++ E+MA G+L D L  +  S  P    I  +   A  +AF+  E++ 
Sbjct: 242 LHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI--EQRN 298
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
            I+RD +A+NIL+ +    K++DFGLA  G +               + APE IN G  T
Sbjct: 299 YIHRDLRAANILVSASLVCKIADFGLARVGAKFPIK-----------WTAPEAINFGSFT 347
Query: 267 TMCDVFSFGVVLLELLTGRR 286
              DV+SFG++L+E++T  R
Sbjct: 348 IKSDVWSFGILLMEIVTYGR 367

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/296 (27%), Positives = 130/296 (43%), Gaps = 49/296 (16%)
Query: 69  FTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE 128
             +KEL+++         +G+G FG V  G          +   VAVK +  + +   + 
Sbjct: 190 LNMKELKLL-------QTIGKGEFGDVMLG--------DYRGNKVAVKCIKNDATA--QA 232
Query: 129 WLAEVIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRI 187
           +LAE   + QL+H +LV L+G   E++  L +V EYMA G+L D L     S L     +
Sbjct: 233 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 292
Query: 188 KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC 247
           K ++     + +L G     ++RD  A N+L+  D  AK+SDFGL  +    +D+     
Sbjct: 293 KFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV 350
Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML 307
                 + APE +     +T  DV+SFG++L E+ +  R             V + R  L
Sbjct: 351 -----KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR-------------VPYPRIPL 392
Query: 308 KDFTKLDQIIDSRLEDRYSTEGAK----RLAAVAHQCLSHNPKSRPTMTTVVKALE 359
           KD       +  R+E  Y  +        +  V   C   +  +RPT   + + LE
Sbjct: 393 KD-------VVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLE 441

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG+V+ G  + + +       VAVK L   GS     +LAE   + QL+H  LV 
Sbjct: 22  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 73
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     + E   ++ EYM  G+L D L       L     + +A   A  +AF+  EE+ 
Sbjct: 74  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERN 130
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG------YAAPEYI 260
            I+RD +A+NIL+    + K++DFGLA      ED+  T      EG      + APE I
Sbjct: 131 YIHRDLRAANILVSDTLSCKIADFGLAR---LIEDNEXT----AREGAKFPIKWTAPEAI 183
Query: 261 NTGHLTTMCDVFSFGVVLLELLTGRR 286
           N G  T   DV+SFG++L E++T  R
Sbjct: 184 NYGTFTIKSDVWSFGILLTEIVTHGR 209

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 138/301 (45%), Gaps = 32/301 (10%)
Query: 70  TLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREW 129
           +L + +M   + +    LG G FG+VY+G           + TVAVK L  +  +   E+
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQFGEVYEGVWKKY------SLTVAVKTLKEDTMEVE-EF 54
Query: 130 LAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKI 189
           L E   + ++KHP+LV L+G C  +    ++ E+M  GNL D L +     +  +  + +
Sbjct: 55  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 114
Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM 249
           A   +  + +L  E+K  I+RD  A N L+  ++  K++DFGL+     G+         
Sbjct: 115 ATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTXTAHAGAK 171
Query: 250 GTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKD 309
               + APE +     +   DV++FGV+L E+ T   S                 P + D
Sbjct: 172 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGI-D 215
Query: 310 FTKLDQII--DSRLEDRYSTEGA-KRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLND 366
            +++ +++  D R+E     EG  +++  +   C   NP  RP+   + +A E +   + 
Sbjct: 216 PSQVYELLEKDYRME---RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 272
Query: 367 I 367
           I
Sbjct: 273 I 273

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG+V+ G  + + +       VAVK L   GS     +LAE   + QL+H  LV 
Sbjct: 16  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 67
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     + E   ++ EYM  G+L D L       L     + +A   A  +AF+  EE+ 
Sbjct: 68  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERN 124
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG------YAAPEYI 260
            I+RD +A+NIL+    + K++DFGLA      ED+  T      EG      + APE I
Sbjct: 125 YIHRDLRAANILVSDTLSCKIADFGLAR---LIEDNEYT----AREGAKFPIKWTAPEAI 177
Query: 261 NTGHLTTMCDVFSFGVVLLELLTGRR 286
           N G  T   DV+SFG++L E++T  R
Sbjct: 178 NYGTFTIKSDVWSFGILLTEIVTHGR 203

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 122/292 (41%), Gaps = 43/292 (14%)
Query: 72  KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHRE 128
           K+ Q    +F     LG+G FG VY        R       +A+KVL    +  +    +
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQ 57
Query: 129 WLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK----NYSSTLPWL 184
              EV     L+HP+++ L GY  +     L+ EY  LG ++ +L K    +   T  ++
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI 244
           T +      A  L++ H   K VI+RD K  N+LL S    K+++FG +   P    S  
Sbjct: 118 TEL------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIANFGWSVHAP----SSR 165
Query: 245 TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR 304
            T + GT  Y  PE I         D++S GV+  E L G+   E N  +     +    
Sbjct: 166 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 225
Query: 305 PMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
               DF                TEGA+ L +   + L HNP  RP +  V++
Sbjct: 226 FTFPDFV---------------TEGARDLIS---RLLKHNPSQRPMLREVLE 259

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG+V+ G  + + +       VAVK L   GS     +LAE   + QL+H  LV 
Sbjct: 21  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     + E   ++ EYM  G+L D L       L     + +A   A  +AF+  EE+ 
Sbjct: 73  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERN 129
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG------YAAPEYI 260
            I+RD +A+NIL+    + K++DFGLA      ED+  T      EG      + APE I
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLAR---LIEDNEYT----AREGAKFPIKWTAPEAI 182
Query: 261 NTGHLTTMCDVFSFGVVLLELLTGRR 286
           N G  T   DV+SFG++L E++T  R
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 120/289 (41%), Gaps = 43/289 (14%)
Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHREWLA 131
           Q    +F     LG+G FG VY        R       +A+KVL    +  +    +   
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRR 57
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK----NYSSTLPWLTRI 187
           EV     L+HP+++ L GY  +     L+ EY  LG ++ +L K    +   T  ++T +
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 188 KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC 247
                 A  L++ H   K VI+RD K  N+LL S    K++DFG +   P    S   T 
Sbjct: 118 ------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTE 165
Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML 307
           + GT  Y  PE I         D++S GV+  E L G+   E N  +     +       
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF 225
Query: 308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
            DF                TEGA+ L +   + L HNP  RP +  V++
Sbjct: 226 PDFV---------------TEGARDLIS---RLLKHNPSQRPMLREVLE 256

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/296 (24%), Positives = 133/296 (44%), Gaps = 28/296 (9%)
Query: 73  ELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLA 131
           E ++     + S  LG+G FG VY+G     ++   + + VA+K ++   S   R E+L 
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLN 62
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHD-------QLFKNYSSTLPWL 184
           E   + +    H+V L+G   + +  L++ E M  G+L         ++  N     P L
Sbjct: 63  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 122
Query: 185 TR-IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSH 243
           ++ I++A   A  +A+L+  +   ++RD  A N ++  D+  K+ DFG+  D  + +   
Sbjct: 123 SKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXR 180
Query: 244 ITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA 303
                +    + +PE +  G  TT  DV+SFGVVL E+ T               L E  
Sbjct: 181 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQP 225
Query: 304 RPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
              L +   L  +++  L D+        L  +   C  +NPK RP+   ++ +++
Sbjct: 226 YQGLSNEQVLRFVMEGGLLDK-PDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIK 280

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/236 (32%), Positives = 114/236 (48%), Gaps = 14/236 (5%)
Query: 52  ISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQ 111
           I L+ L+  LV +  HV  +    +I H    ++ +G G FG VY G + DN   G K  
Sbjct: 4   IDLSALNPELVQAVQHV-VIGPSSLIVH---FNEVIGRGHFGCVYHGTLLDN--DGKKIH 57
Query: 112 TVAVKVLDVNGSQGH-REWLAEVIFLGQLKHPHLVNLIGYCCEDEHR-LLVYEYMALGNL 169
             AVK L+     G   ++L E I +    HP++++L+G C   E   L+V  YM  G+L
Sbjct: 58  C-AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 116
Query: 170 HDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSD 229
            +   +N +        I   +  A+ + +L    K  ++RD  A N +LD  +  K++D
Sbjct: 117 RN-FIRNETHNPTVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVAD 173
Query: 230 FGLATDGPQGE--DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           FGLA D    E    H  T       + A E + T   TT  DV+SFGV+L EL+T
Sbjct: 174 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 122/292 (41%), Gaps = 43/292 (14%)
Query: 72  KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHRE 128
           K+ Q    +F     LG+G FG VY        R       +A+KVL    +  +    +
Sbjct: 3   KKRQWALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQ 56
Query: 129 WLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK----NYSSTLPWL 184
              EV     L+HP+++ L GY  +     L+ EY  LG ++ +L K    +   T  ++
Sbjct: 57  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 116
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI 244
           T +      A  L++ H   K VI+RD K  N+LL S    K+++FG +   P    S  
Sbjct: 117 TEL------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIANFGWSVHAP----SSR 164
Query: 245 TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR 304
            T + GT  Y  PE I         D++S GV+  E L G+   E N  +     +    
Sbjct: 165 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 224
Query: 305 PMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
               DF                TEGA+ L +   + L HNP  RP +  V++
Sbjct: 225 FTFPDFV---------------TEGARDLIS---RLLKHNPSQRPMLREVLE 258

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/236 (32%), Positives = 114/236 (48%), Gaps = 14/236 (5%)
Query: 52  ISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQ 111
           I L+ L+  LV +  HV  +    +I H    ++ +G G FG VY G + DN   G K  
Sbjct: 5   IDLSALNPELVQAVQHV-VIGPSSLIVH---FNEVIGRGHFGCVYHGTLLDN--DGKKIH 58
Query: 112 TVAVKVLDVNGSQGH-REWLAEVIFLGQLKHPHLVNLIGYCCEDEHR-LLVYEYMALGNL 169
             AVK L+     G   ++L E I +    HP++++L+G C   E   L+V  YM  G+L
Sbjct: 59  C-AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 117
Query: 170 HDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSD 229
            +   +N +        I   +  A+ + +L    K  ++RD  A N +LD  +  K++D
Sbjct: 118 RN-FIRNETHNPTVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVAD 174
Query: 230 FGLATDGPQGE--DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           FGLA D    E    H  T       + A E + T   TT  DV+SFGV+L EL+T
Sbjct: 175 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/236 (32%), Positives = 114/236 (48%), Gaps = 14/236 (5%)
Query: 52  ISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQ 111
           I L+ L+  LV +  HV  +    +I H    ++ +G G FG VY G + DN   G K  
Sbjct: 6   IDLSALNPELVQAVQHV-VIGPSSLIVH---FNEVIGRGHFGCVYHGTLLDN--DGKKIH 59
Query: 112 TVAVKVLDVNGSQGH-REWLAEVIFLGQLKHPHLVNLIGYCCEDEHR-LLVYEYMALGNL 169
             AVK L+     G   ++L E I +    HP++++L+G C   E   L+V  YM  G+L
Sbjct: 60  C-AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 118
Query: 170 HDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSD 229
            +   +N +        I   +  A+ + +L    K  ++RD  A N +LD  +  K++D
Sbjct: 119 RN-FIRNETHNPTVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVAD 175
Query: 230 FGLATDGPQGE--DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           FGLA D    E    H  T       + A E + T   TT  DV+SFGV+L EL+T
Sbjct: 176 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 121/292 (41%), Gaps = 43/292 (14%)
Query: 72  KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHRE 128
           K+ Q    +F     LG+G FG VY        R       +A+KVL    +  +    +
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQ 59
Query: 129 WLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK----NYSSTLPWL 184
              EV     L+HP+++ L GY  +     L+ EY   G ++ +L K    +   T  ++
Sbjct: 60  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYI 119
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI 244
           T +      A  L++ H   K VI+RD K  N+LL S    K++DFG +   P    S  
Sbjct: 120 TEL------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSR 167
Query: 245 TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR 304
            T + GT  Y  PE I         D++S GV+  E L G+   E N  +     +    
Sbjct: 168 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 227
Query: 305 PMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
               DF                TEGA+ L +   + L HNP  RP +  V++
Sbjct: 228 FTFPDFV---------------TEGARDLIS---RLLKHNPSQRPMLREVLE 261

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/236 (32%), Positives = 114/236 (48%), Gaps = 14/236 (5%)
Query: 52  ISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQ 111
           I L+ L+  LV +  HV  +    +I H    ++ +G G FG VY G + DN   G K  
Sbjct: 2   IDLSALNPELVQAVQHV-VIGPSSLIVH---FNEVIGRGHFGCVYHGTLLDN--DGKKIH 55
Query: 112 TVAVKVLDVNGSQGH-REWLAEVIFLGQLKHPHLVNLIGYCCEDEHR-LLVYEYMALGNL 169
             AVK L+     G   ++L E I +    HP++++L+G C   E   L+V  YM  G+L
Sbjct: 56  C-AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 114
Query: 170 HDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSD 229
            +   +N +        I   +  A+ + +L    K  ++RD  A N +LD  +  K++D
Sbjct: 115 RN-FIRNETHNPTVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVAD 171
Query: 230 FGLATDGPQGE--DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           FGLA D    E    H  T       + A E + T   TT  DV+SFGV+L EL+T
Sbjct: 172 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/236 (32%), Positives = 114/236 (48%), Gaps = 14/236 (5%)
Query: 52  ISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQ 111
           I L+ L+  LV +  HV  +    +I H    ++ +G G FG VY G + DN   G K  
Sbjct: 7   IDLSALNPELVQAVQHV-VIGPSSLIVH---FNEVIGRGHFGCVYHGTLLDN--DGKKIH 60
Query: 112 TVAVKVLDVNGSQGH-REWLAEVIFLGQLKHPHLVNLIGYCCEDEHR-LLVYEYMALGNL 169
             AVK L+     G   ++L E I +    HP++++L+G C   E   L+V  YM  G+L
Sbjct: 61  C-AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 119
Query: 170 HDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSD 229
            +   +N +        I   +  A+ + +L    K  ++RD  A N +LD  +  K++D
Sbjct: 120 RN-FIRNETHNPTVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVAD 176
Query: 230 FGLATDGPQGE--DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           FGLA D    E    H  T       + A E + T   TT  DV+SFGV+L EL+T
Sbjct: 177 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 106/219 (48%), Gaps = 25/219 (11%)
Query: 69  FTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE 128
             +KEL+++         +G+G FG V  G          +   VAVK +  + +   + 
Sbjct: 9   LNMKELKLLQT-------IGKGEFGDVMLG--------DYRGNKVAVKCIKNDATA--QA 51
Query: 129 WLAEVIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRI 187
           +LAE   + QL+H +LV L+G   E++  L +V EYMA G+L D L     S L     +
Sbjct: 52  FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 111
Query: 188 KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC 247
           K ++     + +L G     ++RD  A N+L+  D  AK+SDFGL  +    +D+     
Sbjct: 112 KFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV 169
Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRR 286
                 + APE +     +T  DV+SFG++L E+ +  R
Sbjct: 170 -----KWTAPEALREAAFSTKSDVWSFGILLWEIYSFGR 203

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 120/292 (41%), Gaps = 43/292 (14%)
Query: 72  KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHRE 128
           K+ Q    +F     LG+G FG VY        R       +A+KVL    +  +    +
Sbjct: 27  KKRQWALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQ 80
Query: 129 WLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK----NYSSTLPWL 184
              EV     L+HP+++ L GY  +     L+ EY  LG ++ +L K    +   T  ++
Sbjct: 81  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 140
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI 244
           T +      A  L++ H   K VI+RD K  N+LL S    K++DFG +   P      +
Sbjct: 141 TEL------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDL 192
Query: 245 TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR 304
                GT  Y  PE I         D++S GV+  E L G+   E N  +     +    
Sbjct: 193 C----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 248
Query: 305 PMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
               DF                TEGA+ L +   + L HNP  RP +  V++
Sbjct: 249 FTFPDFV---------------TEGARDLIS---RLLKHNPSQRPMLREVLE 282

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 121/292 (41%), Gaps = 43/292 (14%)
Query: 72  KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHRE 128
           K+ Q    +F     LG+G FG VY        R       +A+KVL    +  +    +
Sbjct: 3   KKRQWALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQ 56
Query: 129 WLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK----NYSSTLPWL 184
              EV     L+HP+++ L GY  +     L+ EY  LG ++ +L K    +   T  ++
Sbjct: 57  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 116
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI 244
           T +      A  L++ H   K VI+RD K  N+LL S    K++DFG +   P    S  
Sbjct: 117 TEL------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSR 164
Query: 245 TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR 304
              + GT  Y  PE I         D++S GV+  E L G+   E N  +     +    
Sbjct: 165 RXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 224
Query: 305 PMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
               DF                TEGA+ L +   + L HNP  RP +  V++
Sbjct: 225 FTFPDFV---------------TEGARDLIS---RLLKHNPSQRPMLREVLE 258

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 120/289 (41%), Gaps = 43/289 (14%)
Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHREWLA 131
           Q    +F     LG+G FG VY        R       +A+KVL    +  +    +   
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRR 57
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK----NYSSTLPWLTRI 187
           EV     L+HP+++ L GY  +     L+ EY  LG ++ +L K    +   T  ++T +
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 188 KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC 247
                 A  L++ H   K VI+RD K  N+LL S    K++DFG +   P    S   T 
Sbjct: 118 ------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTD 165
Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML 307
           + GT  Y  PE I         D++S GV+  E L G+   E N  +     +       
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF 225
Query: 308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
            DF                TEGA+ L +   + L HNP  RP +  V++
Sbjct: 226 PDFV---------------TEGARDLIS---RLLKHNPSQRPMLREVLE 256

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 113/239 (47%), Gaps = 30/239 (12%)
Query: 49  GSPISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGL 108
           GS  + +E   S  G  L++  LK LQ I          G+G FG V  G          
Sbjct: 3   GSVAAQDEFYRS--GWALNMKELKLLQTI----------GKGEFGDVMLG--------DY 42
Query: 109 KAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALG 167
           +   VAVK +  + +   + +LAE   + QL+H +LV L+G   E++  L +V EYMA G
Sbjct: 43  RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 100
Query: 168 NLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKL 227
           +L D L     S L     +K ++     + +L G     ++RD  A N+L+  D  AK+
Sbjct: 101 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKV 158
Query: 228 SDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRR 286
           SDFGL  +    +D+           + APE +     +T  DV+SFG++L E+ +  R
Sbjct: 159 SDFGLTKEASSTQDTGKLPV-----KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 212

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 106/219 (48%), Gaps = 25/219 (11%)
Query: 69  FTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE 128
             +KEL+++         +G+G FG V  G          +   VAVK +  + +   + 
Sbjct: 3   LNMKELKLLQT-------IGKGEFGDVMLG--------DYRGNKVAVKCIKNDATA--QA 45
Query: 129 WLAEVIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRI 187
           +LAE   + QL+H +LV L+G   E++  L +V EYMA G+L D L     S L     +
Sbjct: 46  FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 105
Query: 188 KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC 247
           K ++     + +L G     ++RD  A N+L+  D  AK+SDFGL  +    +D+     
Sbjct: 106 KFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV 163
Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRR 286
                 + APE +     +T  DV+SFG++L E+ +  R
Sbjct: 164 -----KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 112/222 (50%), Gaps = 15/222 (6%)
Query: 66  LHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG 125
           +H F  KEL     N S    +G G FG+V  G +     P  K  +VA+K L V  ++ 
Sbjct: 35  VHEFA-KELD--ATNISIDKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEK 88
Query: 126 HR-EWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWL 184
            R ++L E   +GQ  HP+++ L G   + +  ++V E M  G+L D   + + +    +
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVI 147
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGED 241
             + +  G A  + +L   +   ++RD  A NIL++S+   K+SDFGL+    D P  E 
Sbjct: 148 QLVGMLRGIASGMKYL--SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EA 203
Query: 242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           ++ T        + +PE I     T+  DV+S+G+VL E+++
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 121/292 (41%), Gaps = 43/292 (14%)
Query: 72  KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHRE 128
           K+ Q    +F     LG+G FG VY        R       +A+KVL    +  +    +
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQ 57
Query: 129 WLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK----NYSSTLPWL 184
              EV     L+HP+++ L GY  +     L+ EY  LG ++ +L K    +   T  ++
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI 244
           T +      A  L++ H   K VI+RD K  N+LL S    K++DFG +   P    S  
Sbjct: 118 TEL------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSR 165
Query: 245 TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR 304
              + GT  Y  PE I         D++S GV+  E L G+   E N  +     +    
Sbjct: 166 RXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 225
Query: 305 PMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
               DF                TEGA+ L +   + L HNP  RP +  V++
Sbjct: 226 FTFPDFV---------------TEGARDLIS---RLLKHNPSQRPMLREVLE 259

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 136/301 (45%), Gaps = 51/301 (16%)
Query: 84  SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL-KHP 142
            D +GEG FG+V K  +    + GL+      ++ +      HR++  E+  L +L  HP
Sbjct: 27  QDVIGEGNFGQVLKARIK---KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 83
Query: 143 HLVNLIGYCCEDEHRLLVY---EYMALGNLHDQLFKNY--------------SSTLPWLT 185
           +++NL+G C   EHR  +Y   EY   GNL D L K+               +STL    
Sbjct: 84  NIINLLGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 140
Query: 186 RIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHIT 245
            +  A   AR + +L   +K  I+R+  A NIL+  +Y AK++DFGL+    +G++ ++ 
Sbjct: 141 LLHFAADVARGMDYL--SQKQFIHRNLAARNILVGENYVAKIADFGLS----RGQEVYVK 194
Query: 246 TCVMGT--EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEW 302
              MG     + A E +N    TT  DV+S+GV+L E+++ G        C    + +  
Sbjct: 195 K-TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 253
Query: 303 ARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
              + K     D++ D                 +  QC    P  RP+   ++ +L  +L
Sbjct: 254 GYRLEKPLNCDDEVYD-----------------LMRQCWREKPYERPSFAQILVSLNRML 296
Query: 363 D 363
           +
Sbjct: 297 E 297

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 131/284 (46%), Gaps = 32/284 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G +G+VY+G           + TVAVK L  +  +   E+L E   + ++KHP+LV 
Sbjct: 22  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 74
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L+G C  +    ++ E+M  GNL D L +     +  +  + +A   +  + +L  E+K 
Sbjct: 75  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL--EKKN 132
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
            I+RD  A N L+  ++  K++DFGL+     G+             + APE +     +
Sbjct: 133 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNKFS 191
Query: 267 TMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII--DSRLEDR 324
              DV++FGV+L E+ T   S                 P + D +++ +++  D R+E  
Sbjct: 192 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRME-- 233
Query: 325 YSTEGA-KRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDI 367
              EG  +++  +   C   NP  RP+   + +A E +   + I
Sbjct: 234 -RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 276

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 131/284 (46%), Gaps = 32/284 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G +G+VY+G           + TVAVK L  +  +   E+L E   + ++KHP+LV 
Sbjct: 21  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 73
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L+G C  +    ++ E+M  GNL D L +     +  +  + +A   +  + +L  E+K 
Sbjct: 74  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKKN 131
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
            I+RD  A N L+  ++  K++DFGL+     G+             + APE +     +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 267 TMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII--DSRLEDR 324
              DV++FGV+L E+ T   S                 P + D +++ +++  D R+E  
Sbjct: 191 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRME-- 232
Query: 325 YSTEGA-KRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDI 367
              EG  +++  +   C   NP  RP+   + +A E +   + I
Sbjct: 233 -RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 275

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 138/301 (45%), Gaps = 32/301 (10%)
Query: 70  TLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREW 129
           +L + +M   + +    LG G +G+VY+G           + TVAVK L  +  +   E+
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEVE-EF 54
Query: 130 LAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKI 189
           L E   + ++KHP+LV L+G C  +    ++ E+M  GNL D L +     +  +  + +
Sbjct: 55  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYM 114
Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM 249
           A   +  + +L  E+K  I+RD  A N L+  ++  K++DFGL+     G+         
Sbjct: 115 ATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTXTAHAGAK 171
Query: 250 GTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKD 309
               + APE +     +   DV++FGV+L E+ T   S                 P + D
Sbjct: 172 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGI-D 215
Query: 310 FTKLDQII--DSRLEDRYSTEGA-KRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLND 366
            +++ +++  D R+E     EG  +++  +   C   NP  RP+   + +A E +   + 
Sbjct: 216 PSQVYELLEKDYRME---RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 272
Query: 367 I 367
           I
Sbjct: 273 I 273

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 119/289 (41%), Gaps = 43/289 (14%)
Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHREWLA 131
           Q    +F     LG+G FG VY        R       +A+KVL    +  +    +   
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK----NYSSTLPWLTRI 187
           EV     L+HP+++ L GY  +     L+ EY  LG ++ +L K    +   T  ++T +
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 188 KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC 247
                 A  L++ H   K VI+RD K  N+LL S    K++DFG +   P    S     
Sbjct: 121 ------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAA 168
Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML 307
           + GT  Y  PE I         D++S GV+  E L G+   E N  +     +       
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF 228
Query: 308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
            DF                TEGA+ L +   + L HNP  RP +  V++
Sbjct: 229 PDFV---------------TEGARDLIS---RLLKHNPSQRPMLREVLE 259

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 119/289 (41%), Gaps = 43/289 (14%)
Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHREWLA 131
           Q    +F     LG+G FG VY        R       +A+KVL    +  +    +   
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRR 57
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK----NYSSTLPWLTRI 187
           EV     L+HP+++ L GY  +     L+ EY  LG ++ +L K    +   T  ++T +
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 188 KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC 247
                 A  L++ H   K VI+RD K  N+LL S    K++DFG +   P    S     
Sbjct: 118 ------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAA 165
Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML 307
           + GT  Y  PE I         D++S GV+  E L G+   E N  +     +       
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF 225
Query: 308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
            DF                TEGA+ L +   + L HNP  RP +  V++
Sbjct: 226 PDFV---------------TEGARDLIS---RLLKHNPSQRPMLREVLE 256

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 136/305 (44%), Gaps = 28/305 (9%)
Query: 64  SNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS 123
           S   V+   E ++     + S  LG+G FG VY+G     ++   + + VA+K ++   S
Sbjct: 10  SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAAS 68
Query: 124 QGHR-EWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHD-------QLFK 175
              R E+L E   + +    H+V L+G   + +  L++ E M  G+L         ++  
Sbjct: 69  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMEN 128
Query: 176 NYSSTLPWLTR-IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT 234
           N     P L++ I++A   A  +A+L+  +   ++RD  A N ++  D+  K+ DFG+  
Sbjct: 129 NPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTR 186
Query: 235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCK 294
           D  + +        +    + +PE +  G  TT  DV+SFGVVL E+ T           
Sbjct: 187 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------- 235
Query: 295 REKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTV 354
               L E     L +   L  +++  L D+        L  +   C  +NPK RP+   +
Sbjct: 236 ----LAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEI 290
Query: 355 VKALE 359
           + +++
Sbjct: 291 ISSIK 295

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 131/284 (46%), Gaps = 32/284 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G +G+VY+G           + TVAVK L  +  +   E+L E   + ++KHP+LV 
Sbjct: 21  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 73
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L+G C  +    ++ E+M  GNL D L +     +  +  + +A   +  + +L  E+K 
Sbjct: 74  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKKN 131
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
            I+RD  A N L+  ++  K++DFGL+     G+             + APE +     +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 267 TMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII--DSRLEDR 324
              DV++FGV+L E+ T   S                 P + D +++ +++  D R+E  
Sbjct: 191 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRME-- 232
Query: 325 YSTEGA-KRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDI 367
              EG  +++  +   C   NP  RP+   + +A E +   + I
Sbjct: 233 -RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 275

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 133/287 (46%), Gaps = 38/287 (13%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G +G+VY+G           + TVAVK L  +  +   E+L E   + ++KHP+LV 
Sbjct: 21  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 73
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L+G C  +    ++ E+M  GNL D L +     +  +  + +A   +  + +L  E+K 
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKKN 131
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINTG 263
            I+RD  A N L+  ++  K++DFGL+    +       T   G +    + APE +   
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLS----RLMTGDTYTAHAGAKFPIKWTAPESLAYN 187
Query: 264 HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII--DSRL 321
             +   DV++FGV+L E+ T   S                 P + D +++ +++  D R+
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRM 231
Query: 322 EDRYSTEGA-KRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDI 367
           E     EG  +++  +   C   NP  RP+   + +A E +   + I
Sbjct: 232 E---RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 275

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 133/287 (46%), Gaps = 38/287 (13%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G +G+VY+G           + TVAVK L  +  +   E+L E   + ++KHP+LV 
Sbjct: 26  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 78
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L+G C  +    ++ E+M  GNL D L +     +  +  + +A   +  + +L  E+K 
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKKN 136
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINTG 263
            I+RD  A N L+  ++  K++DFGL+    +       T   G +    + APE +   
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLS----RLMTGDTYTAHAGAKFPIKWTAPESLAYN 192
Query: 264 HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII--DSRL 321
             +   DV++FGV+L E+ T   S                 P + D +++ +++  D R+
Sbjct: 193 KFSIKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRM 236
Query: 322 EDRYSTEGA-KRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDI 367
           E     EG  +++  +   C   NP  RP+   + +A E +   + I
Sbjct: 237 E---RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 280

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 131/284 (46%), Gaps = 32/284 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G +G+VY+G           + TVAVK L  +  +   E+L E   + ++KHP+LV 
Sbjct: 21  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 73
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L+G C  +    ++ E+M  GNL D L +     +  +  + +A   +  + +L  E+K 
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKKN 131
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
            I+RD  A N L+  ++  K++DFGL+     G+             + APE +     +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 267 TMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII--DSRLEDR 324
              DV++FGV+L E+ T   S                 P + D +++ +++  D R+E  
Sbjct: 191 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRME-- 232
Query: 325 YSTEGA-KRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDI 367
              EG  +++  +   C   NP  RP+   + +A E +   + I
Sbjct: 233 -RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 275

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 112/222 (50%), Gaps = 15/222 (6%)
Query: 66  LHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG 125
           +H F  KEL     N S    +G G FG+V  G +     P  K  +VA+K L V  ++ 
Sbjct: 6   VHEFA-KELD--ATNISIDKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEK 59
Query: 126 HR-EWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWL 184
            R ++L E   +GQ  HP+++ L G   + +  ++V E M  G+L D   + + +    +
Sbjct: 60  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVI 118
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGED 241
             + +  G A  + +L   +   ++RD  A NIL++S+   K+SDFGL+    D P  E 
Sbjct: 119 QLVGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EA 174
Query: 242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           ++ T        + +PE I     T+  DV+S+G+VL E+++
Sbjct: 175 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 75/309 (24%), Positives = 138/309 (44%), Gaps = 28/309 (9%)
Query: 64  SNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS 123
           S   V+   E ++     + S  LG+G FG VY+G     ++   + + VA+K ++   S
Sbjct: 4   SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAAS 62
Query: 124 QGHR-EWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHD-------QLFK 175
              R E+L E   + +    H+V L+G   + +  L++ E M  G+L         ++  
Sbjct: 63  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMEN 122
Query: 176 NYSSTLPWLTR-IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT 234
           N     P L++ I++A   A  +A+L+  +   ++RD  A N ++  D+  K+ DFG+  
Sbjct: 123 NPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTR 180
Query: 235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCK 294
           D  + +        +    + +PE +  G  TT  DV+SFGVVL E+ T           
Sbjct: 181 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------- 229
Query: 295 REKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTV 354
               L E     L +   L  +++  L D+        L  +   C  +NPK RP+   +
Sbjct: 230 ----LAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEI 284
Query: 355 VKALEPLLD 363
           + +++  ++
Sbjct: 285 ISSIKEEME 293

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 136/305 (44%), Gaps = 28/305 (9%)
Query: 64  SNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS 123
           S   V+   E ++     + S  LG+G FG VY+G     ++   + + VA+K ++   S
Sbjct: 3   SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAAS 61
Query: 124 QGHR-EWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHD-------QLFK 175
              R E+L E   + +    H+V L+G   + +  L++ E M  G+L         ++  
Sbjct: 62  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMEN 121
Query: 176 NYSSTLPWLTR-IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT 234
           N     P L++ I++A   A  +A+L+  +   ++RD  A N ++  D+  K+ DFG+  
Sbjct: 122 NPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTR 179
Query: 235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCK 294
           D  + +        +    + +PE +  G  TT  DV+SFGVVL E+ T           
Sbjct: 180 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------- 228
Query: 295 REKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTV 354
               L E     L +   L  +++  L D+        L  +   C  +NPK RP+   +
Sbjct: 229 ----LAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEI 283
Query: 355 VKALE 359
           + +++
Sbjct: 284 ISSIK 288

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 75/309 (24%), Positives = 138/309 (44%), Gaps = 28/309 (9%)
Query: 64  SNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS 123
           S   V+   E ++     + S  LG+G FG VY+G     ++   + + VA+K ++   S
Sbjct: 3   SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAAS 61
Query: 124 QGHR-EWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHD-------QLFK 175
              R E+L E   + +    H+V L+G   + +  L++ E M  G+L         ++  
Sbjct: 62  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMEN 121
Query: 176 NYSSTLPWLTR-IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT 234
           N     P L++ I++A   A  +A+L+  +   ++RD  A N ++  D+  K+ DFG+  
Sbjct: 122 NPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTR 179
Query: 235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCK 294
           D  + +        +    + +PE +  G  TT  DV+SFGVVL E+ T           
Sbjct: 180 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------- 228
Query: 295 REKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTV 354
               L E     L +   L  +++  L D+        L  +   C  +NPK RP+   +
Sbjct: 229 ----LAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEI 283
Query: 355 VKALEPLLD 363
           + +++  ++
Sbjct: 284 ISSIKEEME 292

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 119/289 (41%), Gaps = 43/289 (14%)
Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHREWLA 131
           Q    +F     LG+G FG VY        R       +A+KVL    +  +    +   
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLA------REKNSKFILALKVLFKAQLEKAGVEHQLRR 57
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK----NYSSTLPWLTRI 187
           EV     L+HP+++ L GY  +     L+ EY  LG ++ +L K    +   T  ++T +
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 188 KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC 247
                 A  L++ H   K VI+RD K  N+LL S    K++DFG +   P    +     
Sbjct: 118 ------ANALSYCHS--KKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRA----A 165
Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML 307
           + GT  Y  PE I         D++S GV+  E L G+   E N  +     +       
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTF 225
Query: 308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
            DF                TEGA+ L +   + L HNP  RP +  V++
Sbjct: 226 PDFV---------------TEGARDLIS---RLLKHNPSQRPMLREVLE 256

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/305 (24%), Positives = 135/305 (44%), Gaps = 28/305 (9%)
Query: 64  SNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS 123
           S   V+   E ++     + S  LG+G FG VY+G     ++   + + VA+K ++   S
Sbjct: 10  SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAAS 68
Query: 124 QGHR-EWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQL-------FK 175
              R E+L E   + +    H+V L+G   + +  L++ E M  G+L   L         
Sbjct: 69  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN 128
Query: 176 NYSSTLPWLTR-IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT 234
           N     P L++ I++A   A  +A+L+  +   ++RD  A N ++  D+  K+ DFG+  
Sbjct: 129 NPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTR 186
Query: 235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCK 294
           D  + +        +    + +PE +  G  TT  DV+SFGVVL E+ T           
Sbjct: 187 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------- 235
Query: 295 REKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTV 354
               L E     L +   L  +++  L D+        L  +   C  +NPK RP+   +
Sbjct: 236 ----LAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEI 290
Query: 355 VKALE 359
           + +++
Sbjct: 291 ISSIK 295

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 112/222 (50%), Gaps = 15/222 (6%)
Query: 66  LHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG 125
           +H F  KEL     N S    +G G FG+V  G +     P  K  +VA+K L V  ++ 
Sbjct: 35  VHEFA-KELDAT--NISIDKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEK 88
Query: 126 HR-EWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWL 184
            R ++L E   +GQ  HP+++ L G   + +  ++V E M  G+L D   + + +    +
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVI 147
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGED 241
             + +  G A  + +L   +   ++RD  A NIL++S+   K+SDFGL+    D P  E 
Sbjct: 148 QLVGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EA 203
Query: 242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           ++ T        + +PE I     T+  DV+S+G+VL E+++
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 75/309 (24%), Positives = 138/309 (44%), Gaps = 28/309 (9%)
Query: 64  SNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS 123
           S   V+   E ++     + S  LG+G FG VY+G     ++   + + VA+K ++   S
Sbjct: 32  SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAAS 90
Query: 124 QGHR-EWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHD-------QLFK 175
              R E+L E   + +    H+V L+G   + +  L++ E M  G+L         ++  
Sbjct: 91  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMEN 150
Query: 176 NYSSTLPWLTR-IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT 234
           N     P L++ I++A   A  +A+L+  +   ++RD  A N ++  D+  K+ DFG+  
Sbjct: 151 NPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTR 208
Query: 235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCK 294
           D  + +        +    + +PE +  G  TT  DV+SFGVVL E+ T           
Sbjct: 209 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------- 257
Query: 295 REKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTV 354
               L E     L +   L  +++  L D+        L  +   C  +NPK RP+   +
Sbjct: 258 ----LAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEI 312
Query: 355 VKALEPLLD 363
           + +++  ++
Sbjct: 313 ISSIKEEME 321

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 131/281 (46%), Gaps = 32/281 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLKHPHL 144
           +G G FG VYKG    +         VAVK+L+V     Q  + +  EV  L + +H ++
Sbjct: 36  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 86
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           +  +GY  + +   +V ++    +L+  L     +    +  I IA   A+ + +LH   
Sbjct: 87  LLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLHA-- 142
Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI---N 261
           K +I+RD K++NI L  D   K+ DFGLAT+  +   SH    + G+  + APE I   +
Sbjct: 143 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 202
Query: 262 TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK-DFTKLDQIIDSR 320
               +   DV++FG+VL EL+TG+     N   R++ +    R  L  D +K+       
Sbjct: 203 KNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKVRS----- 256
Query: 321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL 361
                  +  KRL A   +CL      RP    ++ ++E L
Sbjct: 257 ----NCPKAMKRLMA---ECLKKKRDERPLFPQILASIELL 290

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 101/203 (49%), Gaps = 23/203 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG+V+ G  +++ +       VAVK L   G+   + +L E   +  L+H  LV 
Sbjct: 21  LGAGQFGEVWMGYYNNSTK-------VAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVR 72
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L      +E   ++ EYMA G+L D L  +    +     I  +   A  +A++  E K 
Sbjct: 73  LYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI--ERKN 130
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG------YAAPEYI 260
            I+RD +A+N+L+      K++DFGLA      ED+  T      EG      + APE I
Sbjct: 131 YIHRDLRAANVLVSESLMCKIADFGLAR---VIEDNEYT----AREGAKFPIKWTAPEAI 183
Query: 261 NTGHLTTMCDVFSFGVVLLELLT 283
           N G  T   DV+SFG++L E++T
Sbjct: 184 NFGCFTIKSDVWSFGILLYEIVT 206

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 131/284 (46%), Gaps = 32/284 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G +G+VY+G           + TVAVK L  +  +   E+L E   + ++KHP+LV 
Sbjct: 23  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 75
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L+G C  +    ++ E+M  GNL D L +     +  +  + +A   +  + +L  E+K 
Sbjct: 76  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL--EKKN 133
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
            I+RD  A N L+  ++  K++DFGL+     G+             + APE +     +
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 192
Query: 267 TMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII--DSRLEDR 324
              DV++FGV+L E+ T   S                 P + D +++ +++  D R+E  
Sbjct: 193 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRME-- 234
Query: 325 YSTEGA-KRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDI 367
              EG  +++  +   C   NP  RP+   + +A E +   + I
Sbjct: 235 -RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 277

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 116/240 (48%), Gaps = 15/240 (6%)
Query: 48  PGSPISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPG 107
           PG+   ++  +       +H F  KEL        R   +G G FG+V  G +     PG
Sbjct: 15  PGTKTYIDPETYEDPNRAVHQFA-KELDASCIKIER--VIGAGEFGEVCSGRLK---LPG 68
Query: 108 LKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMAL 166
            +   VA+K L V  ++  R ++L E   +GQ  HP++V+L G     +  ++V E+M  
Sbjct: 69  KRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMEN 128
Query: 167 GNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAK 226
           G L D   + +      +  + +  G A  + +L   +   ++RD  A NIL++S+   K
Sbjct: 129 GAL-DAFLRKHDGQFTVIQLVGMLRGIAAGMRYL--ADMGYVHRDLAARNILVNSNLVCK 185
Query: 227 LSDFGLA---TDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           +SDFGL+    D P  E  + TT       + APE I     T+  DV+S+G+V+ E+++
Sbjct: 186 VSDFGLSRVIEDDP--EAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 134/301 (44%), Gaps = 28/301 (9%)
Query: 68  VFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR 127
           V+   E ++     + S  LG+G FG VY+G     ++   + + VA+K ++   S   R
Sbjct: 4   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRER 62
Query: 128 -EWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQL-------FKNYSS 179
            E+L E   + +    H+V L+G   + +  L++ E M  G+L   L         N   
Sbjct: 63  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 122
Query: 180 TLPWLTR-IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ 238
             P L++ I++A   A  +A+L+  +   ++RD  A N ++  D+  K+ DFG+  D  +
Sbjct: 123 APPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 180
Query: 239 GEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKD 298
            +        +    + +PE +  G  TT  DV+SFGVVL E+ T               
Sbjct: 181 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT--------------- 225
Query: 299 LVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL 358
           L E     L +   L  +++  L D+        L  +   C  +NPK RP+   ++ ++
Sbjct: 226 LAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 284
Query: 359 E 359
           +
Sbjct: 285 K 285

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 131/284 (46%), Gaps = 32/284 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G +G+VY+G           + TVAVK L  +  +   E+L E   + ++KHP+LV 
Sbjct: 34  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 86
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L+G C  +    ++ E+M  GNL D L +     +  +  + +A   +  + +L  E+K 
Sbjct: 87  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL--EKKN 144
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
            I+RD  A N L+  ++  K++DFGL+     G+             + APE +     +
Sbjct: 145 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 203
Query: 267 TMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII--DSRLEDR 324
              DV++FGV+L E+ T   S                 P + D +++ +++  D R+E  
Sbjct: 204 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRME-- 245
Query: 325 YSTEGA-KRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDI 367
              EG  +++  +   C   NP  RP+   + +A E +   + I
Sbjct: 246 -RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 288

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 133/287 (46%), Gaps = 38/287 (13%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G +G+VY+G           + TVAVK L  +  +   E+L E   + ++KHP+LV 
Sbjct: 26  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 78
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L+G C  +    ++ E+M  GNL D L +     +  +  + +A   +  + +L  E+K 
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL--EKKN 136
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINTG 263
            I+RD  A N L+  ++  K++DFGL+    +       T   G +    + APE +   
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLS----RLMTGDTYTAHAGAKFPIKWTAPESLAYN 192
Query: 264 HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII--DSRL 321
             +   DV++FGV+L E+ T   S                 P + D +++ +++  D R+
Sbjct: 193 KFSIKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRM 236
Query: 322 EDRYSTEGA-KRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDI 367
           E     EG  +++  +   C   NP  RP+   + +A E +   + I
Sbjct: 237 E---RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 280

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 131/281 (46%), Gaps = 32/281 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLKHPHL 144
           +G G FG VYKG    +         VAVK+L+V     Q  + +  EV  L + +H ++
Sbjct: 16  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           +  +GY  + +   +V ++    +L+  L     +    +  I IA   A+ + +LH   
Sbjct: 67  LLFMGYSTKPQ-LAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHA-- 122
Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI---N 261
           K +I+RD K++NI L  D   K+ DFGLAT+  +   SH    + G+  + APE I   +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 262 TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK-DFTKLDQIIDSR 320
               +   DV++FG+VL EL+TG+     N   R++ +    R  L  D +K+       
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKVRS----- 236
Query: 321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL 361
                  +  KRL A   +CL      RP    ++ ++E L
Sbjct: 237 ----NCPKAMKRLMA---ECLKKKRDERPLFPQILASIELL 270

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 133/287 (46%), Gaps = 38/287 (13%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G +G+VY+G           + TVAVK L  +  +   E+L E   + ++KHP+LV 
Sbjct: 23  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 75
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L+G C  +    ++ E+M  GNL D L +     +  +  + +A   +  + +L  E+K 
Sbjct: 76  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL--EKKN 133
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINTG 263
            I+RD  A N L+  ++  K++DFGL+    +       T   G +    + APE +   
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLS----RLMTGDTYTAHAGAKFPIKWTAPESLAYN 189
Query: 264 HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII--DSRL 321
             +   DV++FGV+L E+ T   S                 P + D +++ +++  D R+
Sbjct: 190 KFSIKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRM 233
Query: 322 EDRYSTEGA-KRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDI 367
           E     EG  +++  +   C   NP  RP+   + +A E +   + I
Sbjct: 234 E---RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 277

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 113/234 (48%), Gaps = 14/234 (5%)
Query: 54  LNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTV 113
           L+ L+  LV +  HV  +    +I H    ++ +G G FG VY G + DN   G K    
Sbjct: 1   LSALNPELVQAVQHV-VIGPSSLIVH---FNEVIGRGHFGCVYHGTLLDN--DGKKIHC- 53
Query: 114 AVKVLDVNGSQGH-REWLAEVIFLGQLKHPHLVNLIGYCCEDEHR-LLVYEYMALGNLHD 171
           AVK L+     G   ++L E I +    HP++++L+G C   E   L+V  YM  G+L +
Sbjct: 54  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 113
Query: 172 QLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFG 231
              +N +        I   +  A+ + +L    K  ++RD  A N +LD  +  K++DFG
Sbjct: 114 -FIRNETHNPTVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFG 170
Query: 232 LATDGPQGE--DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           LA D    E    H  T       + A E + T   TT  DV+SFGV+L EL+T
Sbjct: 171 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 129/279 (46%), Gaps = 32/279 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G +G+VY+G           + TVAVK L  +  +   E+L E   + ++KHP+LV 
Sbjct: 26  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 78
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L+G C  +    ++ E+M  GNL D L +     +  +  + +A   +  + +L  E+K 
Sbjct: 79  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL--EKKN 136
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
            I+RD  A N L+  ++  K++DFGL+     G+             + APE +     +
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 267 TMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII--DSRLEDR 324
              DV++FGV+L E+ T   S                 P + D +++ +++  D R+E  
Sbjct: 196 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRME-- 237
Query: 325 YSTEGA-KRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
              EG  +++  +   C   NP  RP+   + +A E + 
Sbjct: 238 -RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 275

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 124/282 (43%), Gaps = 28/282 (9%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLV 145
           LG+G FG VY+G   D ++ G     VAVK ++ + S   R E+L E   +      H+V
Sbjct: 26  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLF-------KNYSSTLPWLTR-IKIAIGAARCL 197
            L+G   + +  L+V E MA G+L   L         N     P L   I++A   A  +
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAP 257
           A+L+   K  ++R+  A N ++  D+  K+ DFG+  D  + +        +    + AP
Sbjct: 145 AYLNA--KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 258 EYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII 317
           E +  G  TT  D++SFGVVL E+ +               L E     L +   L  ++
Sbjct: 203 ESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVLKFVM 247
Query: 318 DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
           D    D+      +R+  +   C   NP  RPT   +V  L+
Sbjct: 248 DGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 288

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 119/289 (41%), Gaps = 43/289 (14%)
Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHREWLA 131
           Q    +F     LG+G FG VY        R       +A+KVL    +  +    +   
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRR 57
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK----NYSSTLPWLTRI 187
           EV     L+HP+++ L GY  +     L+ EY  LG ++ +L K    +   T  ++T +
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 188 KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC 247
                 A  L++ H   K VI+RD K  N+LL S    K++DFG +   P    S     
Sbjct: 118 ------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRXX 165
Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML 307
           + GT  Y  PE I         D++S GV+  E L G+   E N  +     +       
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF 225
Query: 308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
            DF                TEGA+ L +   + L HNP  RP +  V++
Sbjct: 226 PDFV---------------TEGARDLIS---RLLKHNPSQRPMLREVLE 256

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 124/282 (43%), Gaps = 28/282 (9%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLV 145
           LG+G FG VY+G   D ++ G     VAVK ++ + S   R E+L E   +      H+V
Sbjct: 25  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLF-------KNYSSTLPWLTR-IKIAIGAARCL 197
            L+G   + +  L+V E MA G+L   L         N     P L   I++A   A  +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAP 257
           A+L+   K  ++R+  A N ++  D+  K+ DFG+  D  + +        +    + AP
Sbjct: 144 AYLNA--KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 258 EYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII 317
           E +  G  TT  D++SFGVVL E+ +               L E     L +   L  ++
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVLKFVM 246
Query: 318 DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
           D    D+      +R+  +   C   NP  RPT   +V  L+
Sbjct: 247 DGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG+V+ G  + + +       VAVK L   GS     +LAE   + QL+H  LV 
Sbjct: 17  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 68
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     + E   ++ EYM  G+L D L       L     + +A   A  +AF+  EE+ 
Sbjct: 69  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERN 125
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG------YAAPEYI 260
            I+R+ +A+NIL+    + K++DFGLA      ED+  T      EG      + APE I
Sbjct: 126 YIHRNLRAANILVSDTLSCKIADFGLAR---LIEDNEYT----AREGAKFPIKWTAPEAI 178
Query: 261 NTGHLTTMCDVFSFGVVLLELLTGRR 286
           N G  T   DV+SFG++L E++T  R
Sbjct: 179 NYGTFTIKSDVWSFGILLTEIVTHGR 204

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 120/292 (41%), Gaps = 43/292 (14%)
Query: 72  KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHRE 128
           K+ Q    +F     LG+G FG VY        R       +A+KVL    +  +    +
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQ 59
Query: 129 WLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK----NYSSTLPWL 184
              EV     L+HP+++ L GY  +     L+ EY   G ++ +L K    +   T  ++
Sbjct: 60  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYI 119
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI 244
           T +      A  L++ H   K VI+RD K  N+LL S    K++DFG +   P    S  
Sbjct: 120 TEL------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSR 167
Query: 245 TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR 304
              + GT  Y  PE I         D++S GV+  E L G+   E N  +     +    
Sbjct: 168 RXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 227
Query: 305 PMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
               DF                TEGA+ L +   + L HNP  RP +  V++
Sbjct: 228 FTFPDFV---------------TEGARDLIS---RLLKHNPSQRPMLREVLE 261

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 140/304 (46%), Gaps = 38/304 (12%)
Query: 70  TLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREW 129
           +L + +M   + +    LG G +G+VY+G           + TVAVK L  +  +   E+
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEVE-EF 54
Query: 130 LAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKI 189
           L E   + ++KHP+LV L+G C  +    ++ E+M  GNL D L +     +  +  + +
Sbjct: 55  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 114
Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM 249
           A   +  + +L  E+K  I+RD  A N L+  ++  K++DFGL+    +       T   
Sbjct: 115 ATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLS----RLMTGDTFTAHA 168
Query: 250 GTE---GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPM 306
           G +    + APE +     +   DV++FGV+L E+ T   S                 P 
Sbjct: 169 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PYPG 213
Query: 307 LKDFTKLDQII--DSRLEDRYSTEGA-KRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD 363
           + D +++ +++  D R+E     EG  +++  +   C   NP  RP+   + +A E +  
Sbjct: 214 I-DPSQVYELLEKDYRME---RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 269
Query: 364 LNDI 367
            + I
Sbjct: 270 ESSI 273

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 118/289 (40%), Gaps = 43/289 (14%)
Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHREWLA 131
           Q    +F     LG+G FG VY        R       +A+KVL    +  +    +   
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK----NYSSTLPWLTRI 187
           EV     L+HP+++ L GY  +     L+ EY  LG ++ +L K    +   T  ++T +
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 188 KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC 247
                 A  L++ H   K VI+RD K  N+LL S    K++DFG +   P      +   
Sbjct: 121 ------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC-- 170
Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML 307
             GT  Y  PE I         D++S GV+  E L G+   E N  +     +       
Sbjct: 171 --GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF 228
Query: 308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
            DF                TEGA+ L +   + L HNP  RP +  V++
Sbjct: 229 PDFV---------------TEGARDLIS---RLLKHNPSQRPMLREVLE 259

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 129/279 (46%), Gaps = 32/279 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G +G+VY+G           + TVAVK L  +  +   E+L E   + ++KHP+LV 
Sbjct: 26  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 78
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L+G C  +    ++ E+M  GNL D L +     +  +  + +A   +  + +L  E+K 
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL--EKKN 136
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
            I+RD  A N L+  ++  K++DFGL+     G+             + APE +     +
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 267 TMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII--DSRLEDR 324
              DV++FGV+L E+ T   S                 P + D +++ +++  D R+E  
Sbjct: 196 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRME-- 237
Query: 325 YSTEGA-KRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
              EG  +++  +   C   NP  RP+   + +A E + 
Sbjct: 238 -RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 275

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 131/281 (46%), Gaps = 32/281 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLKHPHL 144
           +G G FG VYKG    +         VAVK+L+V     Q  + +  EV  L + +H ++
Sbjct: 44  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 94
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           +  +GY  + +   +V ++    +L+  L     +    +  I IA   A+ + +LH   
Sbjct: 95  LLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLHA-- 150
Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI---N 261
           K +I+RD K++NI L  D   K+ DFGLAT+  +   SH    + G+  + APE I   +
Sbjct: 151 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 262 TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK-DFTKLDQIIDSR 320
               +   DV++FG+VL EL+TG+     N   R++ +    R  L  D +K+       
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKVRS----- 264
Query: 321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL 361
                  +  KRL A   +CL      RP    ++ ++E L
Sbjct: 265 ----NCPKAMKRLMA---ECLKKKRDERPLFPQILASIELL 298

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 133/287 (46%), Gaps = 38/287 (13%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G +G+VY+G           + TVAVK L  +  +   E+L E   + ++KHP+LV 
Sbjct: 228 LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 280
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L+G C  +    ++ E+M  GNL D L +     +  +  + +A   +  + +L  E+K 
Sbjct: 281 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKKN 338
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINTG 263
            I+R+  A N L+  ++  K++DFGL+    +       T   G +    + APE +   
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLS----RLMTGDTYTAHAGAKFPIKWTAPESLAYN 394
Query: 264 HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII--DSRL 321
             +   DV++FGV+L E+ T   S                 P + D +++ +++  D R+
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRM 438
Query: 322 EDRYSTEG-AKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDI 367
           E     EG  +++  +   C   NP  RP+   + +A E +   + I
Sbjct: 439 E---RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 482

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 129/279 (46%), Gaps = 32/279 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G +G+VY+G           + TVAVK L  +  +   E+L E   + ++KHP+LV 
Sbjct: 26  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 78
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L+G C  +    ++ E+M  GNL D L +     +  +  + +A   +  + +L  E+K 
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL--EKKN 136
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
            I+RD  A N L+  ++  K++DFGL+     G+             + APE +     +
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 267 TMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII--DSRLEDR 324
              DV++FGV+L E+ T   S                 P + D +++ +++  D R+E  
Sbjct: 196 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRME-- 237
Query: 325 YSTEGA-KRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
              EG  +++  +   C   NP  RP+   + +A E + 
Sbjct: 238 -RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 275

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/305 (24%), Positives = 136/305 (44%), Gaps = 28/305 (9%)
Query: 68  VFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR 127
           V+   E ++     + S  LG+G FG VY+G     ++   + + VA+K ++   S   R
Sbjct: 1   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRER 59
Query: 128 -EWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHD-------QLFKNYSS 179
            E+L E   + +    H+V L+G   + +  L++ E M  G+L         ++  N   
Sbjct: 60  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 119
Query: 180 TLPWLTR-IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ 238
             P L++ I++A   A  +A+L+  +   ++RD  A N  +  D+  K+ DFG+  D  +
Sbjct: 120 APPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCXVAEDFTVKIGDFGMTRDIYE 177
Query: 239 GEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKD 298
            +        +    + +PE +  G  TT  DV+SFGVVL E+ T               
Sbjct: 178 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT--------------- 222
Query: 299 LVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL 358
           L E     L +   L  +++  L D+        L  +   C  +NPK RP+   ++ ++
Sbjct: 223 LAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLLELMRMCWQYNPKMRPSFLEIISSI 281
Query: 359 EPLLD 363
           +  ++
Sbjct: 282 KEEME 286

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 104/201 (51%), Gaps = 12/201 (5%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLV 145
           +G G FG+V  G +     PG +   VA+K L V  ++  R ++L E   +GQ  HP+++
Sbjct: 30  IGAGEFGEVCSGRLK---LPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
           +L G   + +  ++V EYM  G+L D   K        +  + +  G +  + +L   + 
Sbjct: 87  HLEGVVTKSKPVMIVTEYMENGSL-DTFLKKNDGQFTVIQLVGMLRGISAGMKYL--SDM 143
Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGEDSHITTCVMGTEGYAAPEYINT 262
             ++RD  A NIL++S+   K+SDFGL+    D P  E ++ T        + APE I  
Sbjct: 144 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EAAYTTRGGKIPIRWTAPEAIAF 201
Query: 263 GHLTTMCDVFSFGVVLLELLT 283
              T+  DV+S+G+V+ E+++
Sbjct: 202 RKFTSASDVWSYGIVMWEVVS 222

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 129/279 (46%), Gaps = 32/279 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G +G+VY+G           + TVAVK L  +  +   E+L E   + ++KHP+LV 
Sbjct: 21  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 73
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L+G C  +    ++ E+M  GNL D L +     +  +  + +A   +  + +L  E+K 
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL--EKKN 131
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
            I+RD  A N L+  ++  K++DFGL+     G+             + APE +     +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 267 TMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII--DSRLEDR 324
              DV++FGV+L E+ T   S                 P + D +++ +++  D R+E  
Sbjct: 191 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRME-- 232
Query: 325 YSTEGA-KRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
              EG  +++  +   C   NP  RP+   + +A E + 
Sbjct: 233 -RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 135/300 (45%), Gaps = 28/300 (9%)
Query: 73  ELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLA 131
           E ++     + S  LG+G FG VY+G     ++   + + VA+K ++   S   R E+L 
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLN 64
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHD-------QLFKNYSSTLPWL 184
           E   + +    H+V L+G   + +  L++ E M  G+L         ++  N     P L
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 185 TR-IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSH 243
           ++ I++A   A  +A+L+  +   ++RD  A N ++  D+  K+ DFG+  D  + +   
Sbjct: 125 SKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 182
Query: 244 ITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA 303
                +    + +PE +  G  TT  DV+SFGVVL E+ T               L E  
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQP 227
Query: 304 RPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD 363
              L +   L  +++  L D+        L  +   C  +NPK RP+   ++ +++  ++
Sbjct: 228 YQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 286

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 129/281 (45%), Gaps = 39/281 (13%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA-EVIFLGQL 139
           F++ + +G+G FG+V+KG +D+  +     Q VA+K++D+  ++   E +  E+  L Q 
Sbjct: 25  FTKLERIGKGSFGEVFKG-IDNRTQ-----QVVAIKIIDLEEAEDEIEDIQQEITVLSQC 78
Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAF 199
              ++    G   +     ++ EY+  G+  D L           T +K  +   + L +
Sbjct: 79  DSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDY 135
Query: 200 LHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHIT-TCVMGTEGYAAPE 258
           LH E+K  I+RD KA+N+LL    + KL+DFG+A    Q  D+ I     +GT  + APE
Sbjct: 136 LHSEKK--IHRDIKAANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPE 190
Query: 259 YINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARP--MLKDFTK-LDQ 315
            I      +  D++S G+  +EL  G          R   L+    P  ++ DFTK   +
Sbjct: 191 VIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGDFTKSFKE 250
Query: 316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
            ID+                    CL+ +P  RPT   ++K
Sbjct: 251 FIDA--------------------CLNKDPSFRPTAKELLK 271

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 129/279 (46%), Gaps = 32/279 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G +G+VY+G           + TVAVK L  +  +   E+L E   + ++KHP+LV 
Sbjct: 21  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 73
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L+G C  +    ++ E+M  GNL D L +     +  +  + +A   +  + +L  E+K 
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL--EKKN 131
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
            I+RD  A N L+  ++  K++DFGL+     G+             + APE +     +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 267 TMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII--DSRLEDR 324
              DV++FGV+L E+ T   S                 P + D +++ +++  D R+E  
Sbjct: 191 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRME-- 232
Query: 325 YSTEGA-KRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
              EG  +++  +   C   NP  RP+   + +A E + 
Sbjct: 233 -RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 129/279 (46%), Gaps = 32/279 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G +G+VY+G           + TVAVK L  +  +   E+L E   + ++KHP+LV 
Sbjct: 25  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 77
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L+G C  +    ++ E+M  GNL D L +     +  +  + +A   +  + +L  E+K 
Sbjct: 78  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL--EKKN 135
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
            I+RD  A N L+  ++  K++DFGL+     G+             + APE +     +
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 267 TMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII--DSRLEDR 324
              DV++FGV+L E+ T   S                 P + D +++ +++  D R+E  
Sbjct: 195 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRME-- 236
Query: 325 YSTEGA-KRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
              EG  +++  +   C   NP  RP+   + +A E + 
Sbjct: 237 -RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/200 (35%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFLGQLKHPHLV 145
           +GEG FG V++G     + P   A  VA+K      S   RE +L E + + Q  HPH+V
Sbjct: 18  IGEGQFGDVHQGIY---MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQL-FKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
            LIG   E+    ++ E   LG L   L  + YS  L  L  I  A   +  LA+L  E 
Sbjct: 75  KLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASL--ILYAYQLSTALAYL--ES 129
Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE--GYAAPEYINT 262
           K  ++RD  A N+L+ S+   KL DFGL+      EDS       G     + APE IN 
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSR---YMEDSTYYKASKGKLPIKWMAPESINF 186
Query: 263 GHLTTMCDVFSFGVVLLELL 282
              T+  DV+ FGV + E+L
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 87  LGEGGFGKVY-----KGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKH 141
           LG+G FGKV+      G     L      +   +KV D   ++  R+ L EV       H
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV------NH 85
Query: 142 PHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFL 200
           P +V L  Y  + E +L L+ +++  G+L  +L K    T      +K  + A   LA  
Sbjct: 86  PFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE---EDVKFYL-AELALALD 140
Query: 201 HGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI 260
           H     +IYRD K  NILLD + + KL+DFGL+ +    E    + C  GT  Y APE +
Sbjct: 141 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC--GTVEYMAPEVV 198
Query: 261 NTGHLTTMCDVFSFGVVLLELLTG 284
           N    T   D +SFGV++ E+LTG
Sbjct: 199 NRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 80  NFSRSDYLGEGGFGKVY-----KGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVI 134
            F     LG+G FGKV+      G     L      +   +KV D   ++  R+ L EV 
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV- 83
Query: 135 FLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGA 193
                 HP +V L  Y  + E +L L+ +++  G+L  +L K    T      +K  + A
Sbjct: 84  -----NHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE---EDVKFYL-A 133
Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
              LA  H     +IYRD K  NILLD + + KL+DFGL+ +    E    + C  GT  
Sbjct: 134 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC--GTVE 191
Query: 254 YAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           Y APE +N    T   D +SFGV++ E+LTG
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 80  NFSRSDYLGEGGFGKVY-----KGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVI 134
            F     LG+G FGKV+      G     L      +   +KV D   ++  R+ L EV 
Sbjct: 26  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV- 84
Query: 135 FLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGA 193
                 HP +V L  Y  + E +L L+ +++  G+L  +L K    T      +K  + A
Sbjct: 85  -----NHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE---EDVKFYL-A 134
Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
              LA  H     +IYRD K  NILLD + + KL+DFGL+ +    E    + C  GT  
Sbjct: 135 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC--GTVE 192
Query: 254 YAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           Y APE +N    T   D +SFGV++ E+LTG
Sbjct: 193 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 126/287 (43%), Gaps = 36/287 (12%)
Query: 85  DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPH 143
           + +G G FG+V +G +     PG K   VA+K L    ++  R E+L+E   +GQ +HP+
Sbjct: 22  EVIGAGEFGEVCRGRLKA---PGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPN 78
Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE 203
           ++ L G        +++ E+M  G L D   +        +  + +  G A  + +L   
Sbjct: 79  IIRLEGVVTNSMPVMILTEFMENGAL-DSFLRLNDGQFTVIQLVGMLRGIASGMRYLA-- 135
Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYI 260
           E   ++RD  A NIL++S+   K+SDFGL+    +       T  +G +    + APE I
Sbjct: 136 EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAI 195
Query: 261 NTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDS 319
                T+  D +S+G+V+ E+++ G R               W      D +  D I  +
Sbjct: 196 AFRKFTSASDAWSYGIVMWEVMSFGERPY-------------W------DMSNQDVI--N 234
Query: 320 RLEDRYSTEGAKRLAAVAHQ----CLSHNPKSRPTMTTVVKALEPLL 362
            +E  Y            HQ    C   +  +RP    VV AL+ ++
Sbjct: 235 AIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMI 281

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 102/206 (49%), Gaps = 24/206 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G  G+V+ G  + + +       VAVK L   GS     +LAE   + QL+H  LV 
Sbjct: 21  LGAGQAGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     + E   ++ EYM  G+L D L       L     + +A   A  +AF+  EE+ 
Sbjct: 73  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERN 129
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG------YAAPEYI 260
            I+RD +A+NIL+    + K++DFGLA      ED+  T      EG      + APE I
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLAR---LIEDAEXT----AREGAKFPIKWTAPEAI 182
Query: 261 NTGHLTTMCDVFSFGVVLLELLTGRR 286
           N G  T   DV+SFG++L E++T  R
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 133/287 (46%), Gaps = 38/287 (13%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G +G+VY+G           + TVAVK L  +  +   E+L E   + ++KHP+LV 
Sbjct: 267 LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 319
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L+G C  +    ++ E+M  GNL D L +     +  +  + +A   +  + +L  E+K 
Sbjct: 320 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL--EKKN 377
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINTG 263
            I+R+  A N L+  ++  K++DFGL+    +       T   G +    + APE +   
Sbjct: 378 FIHRNLAARNCLVGENHLVKVADFGLS----RLMTGDTYTAHAGAKFPIKWTAPESLAYN 433
Query: 264 HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII--DSRL 321
             +   DV++FGV+L E+ T   S                 P + D +++ +++  D R+
Sbjct: 434 KFSIKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRM 477
Query: 322 EDRYSTEG-AKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDI 367
           E     EG  +++  +   C   NP  RP+   + +A E +   + I
Sbjct: 478 E---RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 521

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/200 (35%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFLGQLKHPHLV 145
           +GEG FG V++G     + P   A  VA+K      S   RE +L E + + Q  HPH+V
Sbjct: 18  IGEGQFGDVHQGIY---MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQL-FKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
            LIG   E+    ++ E   LG L   L  + +S  L  L  I  A   +  LA+L  E 
Sbjct: 75  KLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASL--ILYAYQLSTALAYL--ES 129
Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE--GYAAPEYINT 262
           K  ++RD  A N+L+ S+   KL DFGL+      EDS       G     + APE IN 
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSR---YMEDSTXXKASKGKLPIKWMAPESINF 186
Query: 263 GHLTTMCDVFSFGVVLLELL 282
              T+  DV+ FGV + E+L
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/309 (26%), Positives = 131/309 (42%), Gaps = 30/309 (9%)
Query: 60  SLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL- 118
           S  G    +  LKE+     N +    LG G FG+VY+G V          Q VAVK L 
Sbjct: 14  SFAGKTSSISDLKEVP--RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQ-VAVKTLP 70
Query: 119 DVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK--- 175
           +V   Q   ++L E + + +L H ++V  IG   +   R ++ E MA G+L   L +   
Sbjct: 71  EVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP 130
Query: 176 --NYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD---SDYNAKLSDF 230
             +  S+L  L  + +A   A    +L  EE   I+RD  A N LL        AK+ DF
Sbjct: 131 RPSQPSSLAMLDLLHVARDIACGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDF 188
Query: 231 GLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEK 290
           G+A D  +        C M    +  PE    G  T+  D +SFGV+L E+ +       
Sbjct: 189 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMP 246
Query: 291 NRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT 350
              K  ++++E+                 R++   +  G   +  +  QC  H P+ RP 
Sbjct: 247 YPSKSNQEVLEFV------------TSGGRMDPPKNCPGP--VYRIMTQCWQHQPEDRPN 292
Query: 351 MTTVVKALE 359
              +++ +E
Sbjct: 293 FAIILERIE 301

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK 140
           F   + LGEG +G VYK    +        Q VA+K + V      +E + E+  + Q  
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKET------GQIVAIKQVPVESD--LQEIIKEISIMQQCD 82
Query: 141 HPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFL 200
            PH+V   G   ++    +V EY   G++ D + +  + TL       I     + L +L
Sbjct: 83  SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYL 141
Query: 201 HGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI 260
           H   K  I+RD KA NILL+++ +AKL+DFG+A  G   +       V+GT  + APE I
Sbjct: 142 HFMRK--IHRDIKAGNILLNTEGHAKLADFGVA--GQLTDXMAKRNXVIGTPFWMAPEVI 197
Query: 261 NTGHLTTMCDVFSFGVVLLELLTGR 285
                  + D++S G+  +E+  G+
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFLGQLKHPHLV 145
           LGEG FG+VY+G   ++   G K   VAVK    + +  ++E +++E + +  L HPH+V
Sbjct: 32  LGEGFFGEVYEGVYTNH--KGEKIN-VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            LIG   E+E   ++ E    G L   L +N +S L  LT +  ++   + +A+L  E  
Sbjct: 89  KLIG-IIEEEPTWIIMELYPYGELGHYLERNKNS-LKVLTLVLYSLQICKAMAYL--ESI 144
Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
             ++RD    NIL+ S    KL DFGL+    + ED +  +       + +PE IN    
Sbjct: 145 NCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESINFRRF 203
Query: 266 TTMCDVFSFGVVLLELLT 283
           TT  DV+ F V + E+L+
Sbjct: 204 TTASDVWMFAVCMWEILS 221

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/200 (35%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFLGQLKHPHLV 145
           +GEG FG V++G     + P   A  VA+K      S   RE +L E + + Q  HPH+V
Sbjct: 46  IGEGQFGDVHQGIY---MSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 102
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQL-FKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
            LIG   E+    ++ E   LG L   L  + YS  L  L  I  A   +  LA+L  E 
Sbjct: 103 KLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASL--ILYAYQLSTALAYL--ES 157
Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE--GYAAPEYINT 262
           K  ++RD  A N+L+ S+   KL DFGL+      EDS       G     + APE IN 
Sbjct: 158 KRFVHRDIAARNVLVSSNDCVKLGDFGLSR---YMEDSTYYKASKGKLPIKWMAPESINF 214
Query: 263 GHLTTMCDVFSFGVVLLELL 282
              T+  DV+ FGV + E+L
Sbjct: 215 RRFTSASDVWMFGVCMWEIL 234

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 126/287 (43%), Gaps = 36/287 (12%)
Query: 85  DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPH 143
           + +G G FG+V +G +     PG K   VA+K L    ++  R E+L+E   +GQ +HP+
Sbjct: 20  EVIGAGEFGEVCRGRLKA---PGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPN 76
Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE 203
           ++ L G        +++ E+M  G L D   +        +  + +  G A  + +L   
Sbjct: 77  IIRLEGVVTNSMPVMILTEFMENGAL-DSFLRLNDGQFTVIQLVGMLRGIASGMRYLA-- 133
Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYI 260
           E   ++RD  A NIL++S+   K+SDFGL+    +       T  +G +    + APE I
Sbjct: 134 EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAI 193
Query: 261 NTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDS 319
                T+  D +S+G+V+ E+++ G R               W      D +  D I  +
Sbjct: 194 AFRKFTSASDAWSYGIVMWEVMSFGERPY-------------W------DMSNQDVI--N 232
Query: 320 RLEDRYSTEGAKRLAAVAHQ----CLSHNPKSRPTMTTVVKALEPLL 362
            +E  Y            HQ    C   +  +RP    VV AL+ ++
Sbjct: 233 AIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMI 279

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/200 (35%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFLGQLKHPHLV 145
           +GEG FG V++G     + P   A  VA+K      S   RE +L E + + Q  HPH+V
Sbjct: 23  IGEGQFGDVHQGIY---MSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQL-FKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
            LIG   E+    ++ E   LG L   L  + YS  L  L  I  A   +  LA+L  E 
Sbjct: 80  KLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASL--ILYAYQLSTALAYL--ES 134
Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE--GYAAPEYINT 262
           K  ++RD  A N+L+ S+   KL DFGL+      EDS       G     + APE IN 
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSR---YMEDSTYYKASKGKLPIKWMAPESINF 191
Query: 263 GHLTTMCDVFSFGVVLLELL 282
              T+  DV+ FGV + E+L
Sbjct: 192 RRFTSASDVWMFGVCMWEIL 211

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/200 (35%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFLGQLKHPHLV 145
           +GEG FG V++G     + P   A  VA+K      S   RE +L E + + Q  HPH+V
Sbjct: 18  IGEGQFGDVHQGIY---MSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQL-FKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
            LIG   E+    ++ E   LG L   L  + YS  L  L  I  A   +  LA+L  E 
Sbjct: 75  KLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASL--ILYAYQLSTALAYL--ES 129
Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE--GYAAPEYINT 262
           K  ++RD  A N+L+ S+   KL DFGL+      EDS       G     + APE IN 
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSR---YMEDSTYYKASKGKLPIKWMAPESINF 186
Query: 263 GHLTTMCDVFSFGVVLLELL 282
              T+  DV+ FGV + E+L
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFLGQLKHPHLV 145
           LGEG FG+VY+G   ++   G K   VAVK    + +  ++E +++E + +  L HPH+V
Sbjct: 16  LGEGFFGEVYEGVYTNH--KGEKIN-VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            LIG   E+E   ++ E    G L   L +N +S L  LT +  ++   + +A+L  E  
Sbjct: 73  KLIG-IIEEEPTWIIMELYPYGELGHYLERNKNS-LKVLTLVLYSLQICKAMAYL--ESI 128
Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
             ++RD    NIL+ S    KL DFGL+    + ED +  +       + +PE IN    
Sbjct: 129 NCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESINFRRF 187
Query: 266 TTMCDVFSFGVVLLELLT 283
           TT  DV+ F V + E+L+
Sbjct: 188 TTASDVWMFAVCMWEILS 205

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 130/281 (46%), Gaps = 32/281 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLKHPHL 144
           +G G FG VYKG    +         VAVK+L+V     Q  + +  EV  L + +H ++
Sbjct: 18  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 68
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           +  +GY  + +   +V ++    +L+  L     +    +  I IA   A+ + +LH   
Sbjct: 69  LLFMGYSTKPQ-LAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHA-- 124
Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI---N 261
           K +I+RD K++NI L  D   K+ DFGLAT   +   SH    + G+  + APE I   +
Sbjct: 125 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 184
Query: 262 TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK-DFTKLDQIIDSR 320
               +   DV++FG+VL EL+TG+     N   R++ +    R  L  D +K+       
Sbjct: 185 KNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKVRS----- 238
Query: 321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL 361
                  +  KRL A   +CL      RP    ++ ++E L
Sbjct: 239 ----NCPKAMKRLMA---ECLKKKRDERPLFPQILASIELL 272

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/200 (35%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFLGQLKHPHLV 145
           +GEG FG V++G     + P   A  VA+K      S   RE +L E + + Q  HPH+V
Sbjct: 20  IGEGQFGDVHQGIY---MSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 76
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQL-FKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
            LIG   E+    ++ E   LG L   L  + YS  L  L  I  A   +  LA+L  E 
Sbjct: 77  KLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASL--ILYAYQLSTALAYL--ES 131
Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE--GYAAPEYINT 262
           K  ++RD  A N+L+ S+   KL DFGL+      EDS       G     + APE IN 
Sbjct: 132 KRFVHRDIAARNVLVSSNDCVKLGDFGLSR---YMEDSTYYKASKGKLPIKWMAPESINF 188
Query: 263 GHLTTMCDVFSFGVVLLELL 282
              T+  DV+ FGV + E+L
Sbjct: 189 RRFTSASDVWMFGVCMWEIL 208

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 130/281 (46%), Gaps = 32/281 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLKHPHL 144
           +G G FG VYKG    +         VAVK+L+V     Q  + +  EV  L + +H ++
Sbjct: 21  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 71
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           +  +GY  + +   +V ++    +L+  L     +    +  I IA   A+ + +LH   
Sbjct: 72  LLFMGYSTKPQ-LAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHA-- 127
Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI---N 261
           K +I+RD K++NI L  D   K+ DFGLAT   +   SH    + G+  + APE I   +
Sbjct: 128 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 262 TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK-DFTKLDQIIDSR 320
               +   DV++FG+VL EL+TG+     N   R++ +    R  L  D +K+       
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKVRS----- 241
Query: 321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL 361
                  +  KRL A   +CL      RP    ++ ++E L
Sbjct: 242 ----NCPKAMKRLMA---ECLKKKRDERPLFPQILASIELL 275

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/200 (35%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFLGQLKHPHLV 145
           +GEG FG V++G     + P   A  VA+K      S   RE +L E + + Q  HPH+V
Sbjct: 21  IGEGQFGDVHQGIY---MSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 77
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQL-FKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
            LIG   E+    ++ E   LG L   L  + YS  L  L  I  A   +  LA+L  E 
Sbjct: 78  KLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASL--ILYAYQLSTALAYL--ES 132
Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE--GYAAPEYINT 262
           K  ++RD  A N+L+ S+   KL DFGL+      EDS       G     + APE IN 
Sbjct: 133 KRFVHRDIAARNVLVSSNDCVKLGDFGLSR---YMEDSTYYKASKGKLPIKWMAPESINF 189
Query: 263 GHLTTMCDVFSFGVVLLELL 282
              T+  DV+ FGV + E+L
Sbjct: 190 RRFTSASDVWMFGVCMWEIL 209

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFLGQLKHPHLV 145
           LGEG FG+VY+G   ++   G K   VAVK    + +  ++E +++E + +  L HPH+V
Sbjct: 20  LGEGFFGEVYEGVYTNH--KGEKIN-VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            LIG   E+E   ++ E    G L   L +N +S L  LT +  ++   + +A+L  E  
Sbjct: 77  KLIG-IIEEEPTWIIMELYPYGELGHYLERNKNS-LKVLTLVLYSLQICKAMAYL--ESI 132
Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
             ++RD    NIL+ S    KL DFGL+    + ED +  +       + +PE IN    
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESINFRRF 191
Query: 266 TTMCDVFSFGVVLLELLT 283
           TT  DV+ F V + E+L+
Sbjct: 192 TTASDVWMFAVCMWEILS 209

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 127/278 (45%), Gaps = 33/278 (11%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA-EVIFLGQL 139
           F++ D +G+G FG+VYKG +D++ +     + VA+K++D+  ++   E +  E+  L Q 
Sbjct: 21  FTKLDRIGKGSFGEVYKG-IDNHTK-----EVVAIKIIDLEEAEDEIEDIQQEITVLSQC 74
Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAF 199
             P++    G   +     ++ EY+  G+  D L K       ++  I   I   + L +
Sbjct: 75  DSPYITRYFGSYLKSTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREI--LKGLDY 131
Query: 200 LHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHIT-TCVMGTEGYAAPE 258
           LH E K  I+RD KA+N+LL    + KL+DFG+A    Q  D+ I     +GT  + APE
Sbjct: 132 LHSERK--IHRDIKAANVLLSEQGDVKLADFGVAG---QLTDTQIKRNXFVGTPFWMAPE 186
Query: 259 YINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIID 318
            I         D++S G+  +EL  G          R   L+    P             
Sbjct: 187 VIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP------------- 233
Query: 319 SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
             LE ++S    K        CL+ +P+ RPT   ++K
Sbjct: 234 PTLEGQHS----KPFKEFVEACLNKDPRFRPTAKELLK 267

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 130/281 (46%), Gaps = 32/281 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLKHPHL 144
           +G G FG VYKG    +         VAVK+L+V     Q  + +  EV  L + +H ++
Sbjct: 43  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 93
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           +  +GY  + +   +V ++    +L+  L     +    +  I IA   A+ + +LH   
Sbjct: 94  LLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLHA-- 149
Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI---N 261
           K +I+RD K++NI L  D   K+ DFGLAT   +   SH    + G+  + APE I   +
Sbjct: 150 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 209
Query: 262 TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK-DFTKLDQIIDSR 320
               +   DV++FG+VL EL+TG+     N   R++ +    R  L  D +K+       
Sbjct: 210 KNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKVRS----- 263
Query: 321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL 361
                  +  KRL A   +CL      RP    ++ ++E L
Sbjct: 264 ----NCPKAMKRLMA---ECLKKKRDERPLFPQILASIELL 297

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 132/306 (43%), Gaps = 40/306 (13%)
Query: 64  SNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS 123
            NL+  ++ + +M   + +    LG G +G+VY G           + TVAVK L  +  
Sbjct: 17  ENLYFQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKY------SLTVAVKTLKEDTM 70
Query: 124 QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPW 183
           +   E+L E   + ++KHP+LV L+G C  +    +V EYM  GNL D L +     +  
Sbjct: 71  EV-EEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTA 129
Query: 184 LTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSH 243
           +  + +A   +  + +L  E+K  I+RD  A N L+  ++  K++DFGL+    +     
Sbjct: 130 VVLLYMATQISSAMEYL--EKKNFIHRDLAARNCLVGENHVVKVADFGLS----RLMTGD 183
Query: 244 ITTCVMGTE---GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV 300
             T   G +    + APE +     +   DV++FGV+L E+ T   S             
Sbjct: 184 TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG--------- 234
Query: 301 EWARPMLKDFTKLDQIIDSRLEDRYSTEGAK----RLAAVAHQCLSHNPKSRPTMTTVVK 356
                       L Q+ D  LE  Y  E  +    ++  +   C   +P  RP+     +
Sbjct: 235 ----------IDLSQVYD-LLEKGYRMEQPEGCPPKVYELMRACWKWSPADRPSFAETHQ 283
Query: 357 ALEPLL 362
           A E + 
Sbjct: 284 AFETMF 289

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 130/281 (46%), Gaps = 32/281 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLKHPHL 144
           +G G FG VYKG    +         VAVK+L+V     Q  + +  EV  L + +H ++
Sbjct: 21  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 71
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           +  +GY  + +   +V ++    +L+  L     +    +  I IA   A+ + +LH   
Sbjct: 72  LLFMGYSTKPQ-LAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHA-- 127
Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI---N 261
           K +I+RD K++NI L  D   K+ DFGLAT   +   SH    + G+  + APE I   +
Sbjct: 128 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 262 TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK-DFTKLDQIIDSR 320
               +   DV++FG+VL EL+TG+     N   R++ +    R  L  D +K+       
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKVRS----- 241
Query: 321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL 361
                  +  KRL A   +CL      RP    ++ ++E L
Sbjct: 242 ----NCPKAMKRLMA---ECLKKKRDERPLFPQILASIELL 275

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 130/281 (46%), Gaps = 32/281 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLKHPHL 144
           +G G FG VYKG    +         VAVK+L+V     Q  + +  EV  L + +H ++
Sbjct: 44  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 94
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           +  +GY  + +   +V ++    +L+  L     +    +  I IA   A+ + +LH   
Sbjct: 95  LLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLHA-- 150
Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI---N 261
           K +I+RD K++NI L  D   K+ DFGLAT   +   SH    + G+  + APE I   +
Sbjct: 151 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 262 TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK-DFTKLDQIIDSR 320
               +   DV++FG+VL EL+TG+     N   R++ +    R  L  D +K+       
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKVRS----- 264
Query: 321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL 361
                  +  KRL A   +CL      RP    ++ ++E L
Sbjct: 265 ----NCPKAMKRLMA---ECLKKKRDERPLFPQILASIELL 298

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/200 (35%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFLGQLKHPHLV 145
           +GEG FG V++G     + P   A  VA+K      S   RE +L E + + Q  HPH+V
Sbjct: 15  IGEGQFGDVHQGIY---MSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQL-FKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
            LIG   E+    ++ E   LG L   L  + YS  L  L  I  A   +  LA+L  E 
Sbjct: 72  KLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASL--ILYAYQLSTALAYL--ES 126
Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE--GYAAPEYINT 262
           K  ++RD  A N+L+ S+   KL DFGL+      EDS       G     + APE IN 
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSR---YMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 263 GHLTTMCDVFSFGVVLLELL 282
              T+  DV+ FGV + E+L
Sbjct: 184 RRFTSASDVWMFGVCMWEIL 203

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/252 (30%), Positives = 116/252 (46%), Gaps = 41/252 (16%)
Query: 65  NLHVFTLKELQMITHNFSRSDY-----LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD 119
           +L V   K L+     F R +      LGEG FGKV K     +L+      TVAVK+L 
Sbjct: 4   SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAF-HLKGRAGYTTVAVKMLK 62
Query: 120 VNGSQGH-REWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYS 178
            N S    R+ L+E   L Q+ HPH++ L G C +D   LL+ EY   G+L   L ++  
Sbjct: 63  ENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRK 122
Query: 179 STLPWLTR----------------------IKIAIGAARCLAFLHGEEKPVIYRDFKASN 216
               +L                        I  A   ++ + +L   E  +++RD  A N
Sbjct: 123 VGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARN 180
Query: 217 ILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG-----YAAPEYINTGHLTTMCDV 271
           IL+      K+SDFGL+ D  + EDS++      ++G     + A E +     TT  DV
Sbjct: 181 ILVAEGRKMKISDFGLSRDVYE-EDSYVKR----SQGRIPVKWMAIESLFDHIYTTQSDV 235
Query: 272 FSFGVVLLELLT 283
           +SFGV+L E++T
Sbjct: 236 WSFGVLLWEIVT 247

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 130/281 (46%), Gaps = 32/281 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLKHPHL 144
           +G G FG VYKG    +         VAVK+L+V     Q  + +  EV  L + +H ++
Sbjct: 16  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           +  +GY  + +   +V ++    +L+  L     +    +  I IA   A+ + +LH   
Sbjct: 67  LLFMGYSTKPQ-LAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHA-- 122
Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI---N 261
           K +I+RD K++NI L  D   K+ DFGLAT   +   SH    + G+  + APE I   +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 262 TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK-DFTKLDQIIDSR 320
               +   DV++FG+VL EL+TG+     N   R++ +    R  L  D +K+       
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKVRS----- 236
Query: 321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL 361
                  +  KRL A   +CL      RP    ++ ++E L
Sbjct: 237 ----NCPKAMKRLMA---ECLKKKRDERPLFPQILASIELL 270

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/200 (35%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFLGQLKHPHLV 145
           +GEG FG V++G     + P   A  VA+K      S   RE +L E + + Q  HPH+V
Sbjct: 398 IGEGQFGDVHQGIY---MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQL-FKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
            LIG   E+    ++ E   LG L   L  + +S  L  L  I  A   +  LA+L  E 
Sbjct: 455 KLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASL--ILYAYQLSTALAYL--ES 509
Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE--GYAAPEYINT 262
           K  ++RD  A N+L+ S+   KL DFGL+      EDS       G     + APE IN 
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSR---YMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 263 GHLTTMCDVFSFGVVLLELL 282
              T+  DV+ FGV + E+L
Sbjct: 567 RRFTSASDVWMFGVCMWEIL 586

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 123/277 (44%), Gaps = 28/277 (10%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           +G G FG V+ G         L    VA+K +   GS    +++ E   + +L HP LV 
Sbjct: 35  IGSGQFGLVHLGY-------WLNKDKVAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQ 86
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L G C E     LV+E+M  G L D L +         T + + +     +A+L  EE  
Sbjct: 87  LYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYL--EEAC 143
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
           VI+RD  A N L+  +   K+SDFG+ T     +    +T       +A+PE  +    +
Sbjct: 144 VIHRDLAARNCLVGENQVIKVSDFGM-TRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 202
Query: 267 TMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYS 326
           +  DV+SFGV++ E+ +  +   +NR   E         +++D +   ++   RL     
Sbjct: 203 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRL----- 248
Query: 327 TEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD 363
              +  +  + + C    P+ RP  + +++ L  + +
Sbjct: 249 --ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 283

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 122/275 (44%), Gaps = 28/275 (10%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           +G G FG V+ G         L    VA+K +   G+    +++ E   + +L HP LV 
Sbjct: 15  IGSGQFGLVHLGY-------WLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ 66
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L G C E     LV+E+M  G L D L +         T + + +     +A+L  EE  
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYL--EEAS 123
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
           VI+RD  A N L+  +   K+SDFG+ T     +    +T       +A+PE  +    +
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGM-TRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 182
Query: 267 TMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYS 326
           +  DV+SFGV++ E+ +  +   +NR   E         +++D +   ++   RL     
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRL----- 228
Query: 327 TEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL 361
              +  +  + + C    P+ RP  + +++ L  +
Sbjct: 229 --ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAAI 261

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 129/281 (45%), Gaps = 32/281 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLKHPHL 144
           +G G FG VYKG    +         VAVK+L+V     Q  + +  EV  L + +H ++
Sbjct: 16  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           +  +GY    +   +V ++    +L+  L     +    +  I IA   A+ + +LH   
Sbjct: 67  LLFMGYSTAPQ-LAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHA-- 122
Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI---N 261
           K +I+RD K++NI L  D   K+ DFGLAT   +   SH    + G+  + APE I   +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 262 TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK-DFTKLDQIIDSR 320
               +   DV++FG+VL EL+TG+     N   R++ +    R  L  D +K+       
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKVRS----- 236
Query: 321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL 361
                  +  KRL A   +CL      RP    ++ ++E L
Sbjct: 237 ----NCPKAMKRLMA---ECLKKKRDERPLFPQILASIELL 270

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 126/278 (45%), Gaps = 33/278 (11%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA-EVIFLGQL 139
           F++ + +G+G FG+V+KG +D+  +     + VA+K++D+  ++   E +  E+  L Q 
Sbjct: 29  FTKLEKIGKGSFGEVFKG-IDNRTQ-----KVVAIKIIDLEEAEDEIEDIQQEITVLSQC 82
Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAF 199
             P++    G   +D    ++ EY+  G+  D L           T ++  +   + L +
Sbjct: 83  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDY 139
Query: 200 LHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHIT-TCVMGTEGYAAPE 258
           LH E+K  I+RD KA+N+LL      KL+DFG+A    Q  D+ I     +GT  + APE
Sbjct: 140 LHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPE 194
Query: 259 YINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIID 318
            I      +  D++S G+  +EL  G     +    +   L+    P             
Sbjct: 195 VIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP------------- 241
Query: 319 SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
             LE  YS    K L      CL+  P  RPT   ++K
Sbjct: 242 PTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLK 275

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 129/309 (41%), Gaps = 30/309 (9%)
Query: 60  SLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL- 118
           S  G    +  LKE+        R   LG G FG+VY+G V          Q VAVK L 
Sbjct: 14  SFAGKTSSISDLKEVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQ-VAVKTLP 70
Query: 119 DVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK--- 175
           +V   Q   ++L E + + +  H ++V  IG   +   R ++ E MA G+L   L +   
Sbjct: 71  EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP 130
Query: 176 --NYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD---SDYNAKLSDF 230
             +  S+L  L  + +A   A    +L  EE   I+RD  A N LL        AK+ DF
Sbjct: 131 RPSQPSSLAMLDLLHVARDIACGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDF 188
Query: 231 GLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEK 290
           G+A D  +        C M    +  PE    G  T+  D +SFGV+L E+ +       
Sbjct: 189 GMAQDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMP 246
Query: 291 NRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT 350
              K  ++++E+                 R++   +  G   +  +  QC  H P+ RP 
Sbjct: 247 YPSKSNQEVLEFV------------TSGGRMDPPKNCPGP--VYRIMTQCWQHQPEDRPN 292
Query: 351 MTTVVKALE 359
              +++ +E
Sbjct: 293 FAIILERIE 301

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 130/309 (42%), Gaps = 30/309 (9%)
Query: 60  SLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL- 118
           S  G    +  LKE+     N +    LG G FG+VY+G V          Q VAVK L 
Sbjct: 14  SFAGKTSSISDLKEVP--RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQ-VAVKTLP 70
Query: 119 DVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK--- 175
           +V   Q   ++L E + + +  H ++V  IG   +   R ++ E MA G+L   L +   
Sbjct: 71  EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP 130
Query: 176 --NYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD---SDYNAKLSDF 230
             +  S+L  L  + +A   A    +L  EE   I+RD  A N LL        AK+ DF
Sbjct: 131 RPSQPSSLAMLDLLHVARDIACGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDF 188
Query: 231 GLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEK 290
           G+A D  +        C M    +  PE    G  T+  D +SFGV+L E+ +       
Sbjct: 189 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMP 246
Query: 291 NRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT 350
              K  ++++E+                 R++   +  G   +  +  QC  H P+ RP 
Sbjct: 247 YPSKSNQEVLEFV------------TSGGRMDPPKNCPGP--VYRIMTQCWQHQPEDRPN 292
Query: 351 MTTVVKALE 359
              +++ +E
Sbjct: 293 FAIILERIE 301

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 123/277 (44%), Gaps = 28/277 (10%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           +G G FG V+ G         L    VA+K +   G+    +++ E   + +L HP LV 
Sbjct: 15  IGSGQFGLVHLG-------YWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ 66
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L G C E     LV+E+M  G L D L +         T + + +     +A+L  EE  
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYL--EEAC 123
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
           VI+RD  A N L+  +   K+SDFG+ T     +    +T       +A+PE  +    +
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGM-TRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 182
Query: 267 TMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYS 326
           +  DV+SFGV++ E+ +  +   +NR   E         +++D +   ++   RL     
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRL----- 228
Query: 327 TEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD 363
              +  +  + + C    P+ RP  + +++ L  + +
Sbjct: 229 --ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 263

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 123/277 (44%), Gaps = 28/277 (10%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           +G G FG V+ G         L    VA+K +   G+    +++ E   + +L HP LV 
Sbjct: 13  IGSGQFGLVHLG-------YWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L G C E     LV+E+M  G L D L +         T + + +     +A+L  EE  
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYL--EEAC 121
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
           VI+RD  A N L+  +   K+SDFG+ T     +    +T       +A+PE  +    +
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGM-TRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 267 TMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYS 326
           +  DV+SFGV++ E+ +  +   +NR   E         +++D +   ++   RL     
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRL----- 226
Query: 327 TEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD 363
              +  +  + + C    P+ RP  + +++ L  + +
Sbjct: 227 --ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 23/203 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG+V+ G  +++ +       VAVK L   G+   + +L E   +  L+H  LV 
Sbjct: 20  LGAGQFGEVWMGYYNNSTK-------VAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVR 71
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     ++E   ++ E+MA G+L D L  +    +     I  +   A  +A++  E K 
Sbjct: 72  LYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI--ERKN 129
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG------YAAPEYI 260
            I+RD +A+N+L+      K++DFGLA      ED+  T      EG      + APE I
Sbjct: 130 YIHRDLRAANVLVSESLMCKIADFGLAR---VIEDNEYT----AREGAKFPIKWTAPEAI 182
Query: 261 NTGHLTTMCDVFSFGVVLLELLT 283
           N G  T   +V+SFG++L E++T
Sbjct: 183 NFGCFTIKSNVWSFGILLYEIVT 205

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/252 (30%), Positives = 115/252 (45%), Gaps = 41/252 (16%)
Query: 65  NLHVFTLKELQMITHNFSRSDY-----LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD 119
           +L V   K L+     F R +      LGEG FGKV K     +L+      TVAVK+L 
Sbjct: 4   SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAF-HLKGRAGYTTVAVKMLK 62
Query: 120 VNGSQGH-REWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYS 178
            N S    R+ L+E   L Q+ HPH++ L G C +D   LL+ EY   G+L   L ++  
Sbjct: 63  ENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRK 122
Query: 179 STLPWLTR----------------------IKIAIGAARCLAFLHGEEKPVIYRDFKASN 216
               +L                        I  A   ++ + +L   E  +++RD  A N
Sbjct: 123 VGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL--AEMSLVHRDLAARN 180
Query: 217 ILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL-----TTMCDV 271
           IL+      K+SDFGL+ D  + EDS +      ++G    +++    L     TT  DV
Sbjct: 181 ILVAEGRKMKISDFGLSRDVYE-EDSXVKR----SQGRIPVKWMAIESLFDHIYTTQSDV 235
Query: 272 FSFGVVLLELLT 283
           +SFGV+L E++T
Sbjct: 236 WSFGVLLWEIVT 247

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/252 (30%), Positives = 115/252 (45%), Gaps = 41/252 (16%)
Query: 65  NLHVFTLKELQMITHNFSRSDY-----LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD 119
           +L V   K L+     F R +      LGEG FGKV K     +L+      TVAVK+L 
Sbjct: 4   SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAF-HLKGRAGYTTVAVKMLK 62
Query: 120 VNGSQGH-REWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYS 178
            N S    R+ L+E   L Q+ HPH++ L G C +D   LL+ EY   G+L   L ++  
Sbjct: 63  ENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRK 122
Query: 179 STLPWLTR----------------------IKIAIGAARCLAFLHGEEKPVIYRDFKASN 216
               +L                        I  A   ++ + +L   E  +++RD  A N
Sbjct: 123 VGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARN 180
Query: 217 ILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL-----TTMCDV 271
           IL+      K+SDFGL+ D  + EDS +      ++G    +++    L     TT  DV
Sbjct: 181 ILVAEGRKMKISDFGLSRDVYE-EDSXVKR----SQGRIPVKWMAIESLFDHIYTTQSDV 235
Query: 272 FSFGVVLLELLT 283
           +SFGV+L E++T
Sbjct: 236 WSFGVLLWEIVT 247

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 126/278 (45%), Gaps = 33/278 (11%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA-EVIFLGQL 139
           F++ + +G+G FG+V+KG +D+  +     + VA+K++D+  ++   E +  E+  L Q 
Sbjct: 24  FTKLEKIGKGSFGEVFKG-IDNRTQ-----KVVAIKIIDLEEAEDEIEDIQQEITVLSQC 77
Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAF 199
             P++    G   +D    ++ EY+  G+  D L           T ++  +   + L +
Sbjct: 78  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDY 134
Query: 200 LHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHIT-TCVMGTEGYAAPE 258
           LH E+K  I+RD KA+N+LL      KL+DFG+A    Q  D+ I     +GT  + APE
Sbjct: 135 LHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAG---QLTDTQIKRNXFVGTPFWMAPE 189
Query: 259 YINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIID 318
            I      +  D++S G+  +EL  G     +    +   L+    P             
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP------------- 236
Query: 319 SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
             LE  YS    K L      CL+  P  RPT   ++K
Sbjct: 237 PTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLK 270

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 130/309 (42%), Gaps = 30/309 (9%)
Query: 60  SLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL- 118
           S  G    +  LKE+     N +    LG G FG+VY+G V          Q VAVK L 
Sbjct: 20  SFAGKTSSISDLKEVP--RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQ-VAVKTLP 76
Query: 119 DVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK--- 175
           +V   Q   ++L E + + +  H ++V  IG   +   R ++ E MA G+L   L +   
Sbjct: 77  EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP 136
Query: 176 --NYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD---SDYNAKLSDF 230
             +  S+L  L  + +A   A    +L  EE   I+RD  A N LL        AK+ DF
Sbjct: 137 RPSQPSSLAMLDLLHVARDIACGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDF 194
Query: 231 GLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEK 290
           G+A D  +        C M    +  PE    G  T+  D +SFGV+L E+ +       
Sbjct: 195 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMP 252
Query: 291 NRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT 350
              K  ++++E+                 R++   +  G   +  +  QC  H P+ RP 
Sbjct: 253 YPSKSNQEVLEFV------------TSGGRMDPPKNCPGP--VYRIMTQCWQHQPEDRPN 298
Query: 351 MTTVVKALE 359
              +++ +E
Sbjct: 299 FAIILERIE 307

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 14/202 (6%)
Query: 87  LGEGGFGKVYKGCVDDNLR-PGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHL 144
           +G G  G+V  G     LR PG +   VA+K L    ++  R ++L+E   +GQ  HP++
Sbjct: 57  IGSGDSGEVCYG----RLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           + L G        ++V EYM  G+L D   + +      +  + +  G    + +L   +
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQFTIMQLVGMLRGVGAGMRYL--SD 169
Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGEDSHITTCVMGTEGYAAPEYIN 261
              ++RD  A N+L+DS+   K+SDFGL+    D P  + ++ TT       + APE I 
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP--DAAYTTTGGKIPIRWTAPEAIA 227
Query: 262 TGHLTTMCDVFSFGVVLLELLT 283
               ++  DV+SFGVV+ E+L 
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLA 249

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 100/204 (49%), Gaps = 18/204 (8%)
Query: 87  LGEGGFGKVYKGCVDDNLR-PGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHL 144
           +G G  G+V  G     LR PG +   VA+K L    ++  R ++L+E   +GQ  HP++
Sbjct: 57  IGSGDSGEVCYG----RLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           + L G        ++V EYM  G+L D   + +      +  + +  G    + +L   +
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQFTIMQLVGMLRGVGAGMRYL--SD 169
Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG-----YAAPEY 259
              ++RD  A N+L+DS+   K+SDFGL+       D+  TT    T G     + APE 
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTT----TGGKIPIRWTAPEA 225
Query: 260 INTGHLTTMCDVFSFGVVLLELLT 283
           I     ++  DV+SFGVV+ E+L 
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 123/277 (44%), Gaps = 28/277 (10%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           +G G FG V+ G         L    VA+K +   G+    +++ E   + +L HP LV 
Sbjct: 18  IGSGQFGLVHLG-------YWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ 69
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L G C E     LV+E+M  G L D L +         T + + +     +A+L  EE  
Sbjct: 70  LYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYL--EEAC 126
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
           VI+RD  A N L+  +   K+SDFG+ T     +    +T       +A+PE  +    +
Sbjct: 127 VIHRDLAARNCLVGENQVIKVSDFGM-TRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 185
Query: 267 TMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYS 326
           +  DV+SFGV++ E+ +  +   +NR   E         +++D +   ++   RL     
Sbjct: 186 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRL----- 231
Query: 327 TEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD 363
              +  +  + + C    P+ RP  + +++ L  + +
Sbjct: 232 --ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 130/309 (42%), Gaps = 30/309 (9%)
Query: 60  SLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL- 118
           S  G    +  LKE+     N +    LG G FG+VY+G V          Q VAVK L 
Sbjct: 40  SFAGKTSSISDLKEVP--RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQ-VAVKTLP 96
Query: 119 DVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK--- 175
           +V   Q   ++L E + + +  H ++V  IG   +   R ++ E MA G+L   L +   
Sbjct: 97  EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP 156
Query: 176 --NYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD---SDYNAKLSDF 230
             +  S+L  L  + +A   A    +L  EE   I+RD  A N LL        AK+ DF
Sbjct: 157 RPSQPSSLAMLDLLHVARDIACGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDF 214
Query: 231 GLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEK 290
           G+A D  +        C M    +  PE    G  T+  D +SFGV+L E+ +       
Sbjct: 215 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMP 272
Query: 291 NRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT 350
              K  ++++E+                 R++   +  G   +  +  QC  H P+ RP 
Sbjct: 273 YPSKSNQEVLEFV------------TSGGRMDPPKNCPGP--VYRIMTQCWQHQPEDRPN 318
Query: 351 MTTVVKALE 359
              +++ +E
Sbjct: 319 FAIILERIE 327

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 94/217 (43%), Gaps = 16/217 (7%)
Query: 79  HNFSRSDYLGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLG 137
           HN      LGEG FGKV+   C   NL P      VAVK L        +++  E   L 
Sbjct: 13  HNIVLKRELGEGAFGKVFLAECY--NLCPEQDKILVAVKTLKDASDNARKDFHREAELLT 70
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK-----------NYSSTLPWLTR 186
            L+H H+V   G C E +  ++V+EYM  G+L+  L             N  + L     
Sbjct: 71  NLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQM 130
Query: 187 IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITT 246
           + IA   A  + +L  +    ++RD    N L+  +   K+ DFG++ D    +   +  
Sbjct: 131 LHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG 188
Query: 247 CVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
             M    +  PE I     TT  DV+S GVVL E+ T
Sbjct: 189 HTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 82/308 (26%), Positives = 130/308 (42%), Gaps = 30/308 (9%)
Query: 61  LVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL-D 119
             G    +  LKE+     N +    LG G FG+VY+G V          Q VAVK L +
Sbjct: 29  FAGKTSSISDLKEVP--RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQ-VAVKTLPE 85
Query: 120 VNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK---- 175
           V   Q   ++L E + + +L H ++V  IG   +   R ++ E MA G+L   L +    
Sbjct: 86  VCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPR 145
Query: 176 -NYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD---SDYNAKLSDFG 231
            +  S+L  L  + +A   A    +L  EE   I+RD  A N LL        AK+ DFG
Sbjct: 146 PSQPSSLAMLDLLHVARDIACGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 203
Query: 232 LATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKN 291
           +A D  +        C M    +  PE    G  T+  D +SFGV+L E+ +        
Sbjct: 204 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPY 261
Query: 292 RCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM 351
             K  ++++E+                 R++   +  G   +  +  QC  H P+ RP  
Sbjct: 262 PSKSNQEVLEFV------------TSGGRMDPPKNCPGP--VYRIMTQCWQHQPEDRPNF 307
Query: 352 TTVVKALE 359
             +++ +E
Sbjct: 308 AIILERIE 315

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 126/278 (45%), Gaps = 33/278 (11%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA-EVIFLGQL 139
           F++ + +G+G FG+V+KG +D+  +     + VA+K++D+  ++   E +  E+  L Q 
Sbjct: 9   FTKLEKIGKGSFGEVFKG-IDNRTQ-----KVVAIKIIDLEEAEDEIEDIQQEITVLSQC 62
Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAF 199
             P++    G   +D    ++ EY+  G+  D L           T ++  +   + L +
Sbjct: 63  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDY 119
Query: 200 LHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHIT-TCVMGTEGYAAPE 258
           LH E+K  I+RD KA+N+LL      KL+DFG+A    Q  D+ I     +GT  + APE
Sbjct: 120 LHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPE 174
Query: 259 YINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIID 318
            I      +  D++S G+  +EL  G     +    +   L+    P             
Sbjct: 175 VIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP------------- 221
Query: 319 SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
             LE  YS    K L      CL+  P  RPT   ++K
Sbjct: 222 PTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLK 255

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 125/285 (43%), Gaps = 36/285 (12%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLV 145
           +G G FG+V  G +     PG +   VA+K L    ++  R ++L+E   +GQ  HP+++
Sbjct: 41  IGAGEFGEVCSGHLK---LPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
           +L G   +    +++ E+M  G+L D   +        +  + +  G A  + +L   + 
Sbjct: 98  HLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYL--ADM 154
Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINT 262
             ++RD  A NIL++S+   K+SDFGL+            T  +G +    + APE I  
Sbjct: 155 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 214
Query: 263 GHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRL 321
              T+  DV+S+G+V+ E+++ G R               W      D T  D I  + +
Sbjct: 215 RKFTSASDVWSYGIVMWEVMSYGERPY-------------W------DMTNQDVI--NAI 253
Query: 322 EDRYSTEGAKRLAAVAHQ----CLSHNPKSRPTMTTVVKALEPLL 362
           E  Y         +  HQ    C   +   RP    +V  L+ ++
Sbjct: 254 EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 298

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 126/278 (45%), Gaps = 33/278 (11%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA-EVIFLGQL 139
           F++ + +G+G FG+V+KG +D+  +     + VA+K++D+  ++   E +  E+  L Q 
Sbjct: 9   FTKLEKIGKGSFGEVFKG-IDNRTQ-----KVVAIKIIDLEEAEDEIEDIQQEITVLSQC 62
Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAF 199
             P++    G   +D    ++ EY+  G+  D L           T ++  +   + L +
Sbjct: 63  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDY 119
Query: 200 LHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHIT-TCVMGTEGYAAPE 258
           LH E+K  I+RD KA+N+LL      KL+DFG+A    Q  D+ I     +GT  + APE
Sbjct: 120 LHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAG---QLTDTQIKRNXFVGTPFWMAPE 174
Query: 259 YINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIID 318
            I      +  D++S G+  +EL  G     +    +   L+    P             
Sbjct: 175 VIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP------------- 221
Query: 319 SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
             LE  YS    K L      CL+  P  RPT   ++K
Sbjct: 222 PTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLK 255

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 96/226 (42%), Gaps = 25/226 (11%)
Query: 78  THNFSRSDY-----LGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA 131
            H+  R D      LGEG FGKV+   C   NL P      VAVK L        +++  
Sbjct: 12  VHHIKRRDIVLKWELGEGAFGKVFLAEC--HNLLPEQDKMLVAVKALKEASESARQDFQR 69
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLT------ 185
           E   L  L+H H+V   G C E    L+V+EYM  G+L ++  +++      L       
Sbjct: 70  EAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVA 128
Query: 186 --------RIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP 237
                    + +A   A  + +L G     ++RD    N L+      K+ DFG++ D  
Sbjct: 129 PGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIY 186
Query: 238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
             +   +    M    +  PE I     TT  DV+SFGVVL E+ T
Sbjct: 187 STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 130/283 (45%), Gaps = 20/283 (7%)
Query: 74  LQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAE 132
           +++   +F +   LG G  G V+K     + +P      +A K++ +      R + + E
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK----VSHKP--SGLVMARKLIHLEIKPAIRNQIIRE 54
Query: 133 VIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIG 192
           +  L +   P++V   G    D    +  E+M  G+L DQ+ K  +  +P     K++I 
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKK-AGRIPEQILGKVSIA 112
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE 252
             + L +L  E+  +++RD K SNIL++S    KL DFG++    Q  DS   + V GT 
Sbjct: 113 VIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV-GTR 167
Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK 312
            Y +PE +   H +   D++S G+ L+E+  GR  +     K      E +RP +  F  
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK------EDSRPPMAIFEL 221
Query: 313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVV 355
           LD I++       S   +       ++CL  NP  R  +  ++
Sbjct: 222 LDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 264

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFLGQLKHPHLV 145
           +GEG FG V++G     + P   A  VA+K      S   RE +L E + + Q  HPH+V
Sbjct: 18  IGEGQFGDVHQGIY---MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQL-FKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
            LIG   E+    ++ E   LG L   L  + +S  L  L  I  A   +  LA+L  E 
Sbjct: 75  KLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASL--ILYAYQLSTALAYL--ES 129
Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE--GYAAPEYINT 262
           K  ++RD  A N+L+ +    KL DFGL+      EDS       G     + APE IN 
Sbjct: 130 KRFVHRDIAARNVLVSATDCVKLGDFGLSR---YMEDSTYYKASKGKLPIKWMAPESINF 186
Query: 263 GHLTTMCDVFSFGVVLLELL 282
              T+  DV+ FGV + E+L
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFLGQLKHPHLV 145
           +GEG FG V++G     + P   A  VA+K      S   RE +L E + + Q  HPH+V
Sbjct: 398 IGEGQFGDVHQGIY---MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQL-FKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
            LIG   E+    ++ E   LG L   L  + +S  L  L  I  A   +  LA+L  E 
Sbjct: 455 KLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASL--ILYAYQLSTALAYL--ES 509
Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE--GYAAPEYINT 262
           K  ++RD  A N+L+ +    KL DFGL+      EDS       G     + APE IN 
Sbjct: 510 KRFVHRDIAARNVLVSATDCVKLGDFGLSR---YMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 263 GHLTTMCDVFSFGVVLLELL 282
              T+  DV+ FGV + E+L
Sbjct: 567 RRFTSASDVWMFGVCMWEIL 586

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 96/226 (42%), Gaps = 25/226 (11%)
Query: 78  THNFSRSDY-----LGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA 131
            H+  R D      LGEG FGKV+   C   NL P      VAVK L        +++  
Sbjct: 6   VHHIKRRDIVLKWELGEGAFGKVFLAEC--HNLLPEQDKMLVAVKALKEASESARQDFQR 63
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLT------ 185
           E   L  L+H H+V   G C E    L+V+EYM  G+L ++  +++      L       
Sbjct: 64  EAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVA 122
Query: 186 --------RIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP 237
                    + +A   A  + +L G     ++RD    N L+      K+ DFG++ D  
Sbjct: 123 PGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIY 180
Query: 238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
             +   +    M    +  PE I     TT  DV+SFGVVL E+ T
Sbjct: 181 STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 128/308 (41%), Gaps = 30/308 (9%)
Query: 61  LVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL-D 119
             G    +  LKE+        R   LG G FG+VY+G V          Q VAVK L +
Sbjct: 29  FAGKTSSISDLKEVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQ-VAVKTLPE 85
Query: 120 VNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK---- 175
           V   Q   ++L E + + +  H ++V  IG   +   R ++ E MA G+L   L +    
Sbjct: 86  VYSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPR 145
Query: 176 -NYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD---SDYNAKLSDFG 231
            +  S+L  L  + +A   A    +L  EE   I+RD  A N LL        AK+ DFG
Sbjct: 146 PSQPSSLAMLDLLHVARDIACGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 203
Query: 232 LATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKN 291
           +A D  +        C M    +  PE    G  T+  D +SFGV+L E+ +        
Sbjct: 204 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPY 261
Query: 292 RCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM 351
             K  ++++E+                 R++   +  G   +  +  QC  H P+ RP  
Sbjct: 262 PSKSNQEVLEFV------------TSGGRMDPPKNCPGP--VYRIMTQCWQHQPEDRPNF 307
Query: 352 TTVVKALE 359
             +++ +E
Sbjct: 308 AIILERIE 315

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 96/226 (42%), Gaps = 25/226 (11%)
Query: 78  THNFSRSDY-----LGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA 131
            H+  R D      LGEG FGKV+   C   NL P      VAVK L        +++  
Sbjct: 35  VHHIKRRDIVLKWELGEGAFGKVFLAEC--HNLLPEQDKMLVAVKALKEASESARQDFQR 92
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTR----- 186
           E   L  L+H H+V   G C E    L+V+EYM  G+L ++  +++      L       
Sbjct: 93  EAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVA 151
Query: 187 ---------IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP 237
                    + +A   A  + +L G     ++RD    N L+      K+ DFG++ D  
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIY 209
Query: 238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
             +   +    M    +  PE I     TT  DV+SFGVVL E+ T
Sbjct: 210 STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 129/308 (41%), Gaps = 30/308 (9%)
Query: 61  LVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL-D 119
             G    +  LKE+     N +    LG G FG+VY+G V          Q VAVK L +
Sbjct: 6   FAGKTSSISDLKEVP--RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQ-VAVKTLPE 62
Query: 120 VNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK---- 175
           V   Q   ++L E + + +  H ++V  IG   +   R ++ E MA G+L   L +    
Sbjct: 63  VCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPR 122
Query: 176 -NYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILL---DSDYNAKLSDFG 231
            +  S+L  L  + +A   A    +L  EE   I+RD  A N LL        AK+ DFG
Sbjct: 123 PSQPSSLAMLDLLHVARDIACGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 180
Query: 232 LATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKN 291
           +A D  +        C M    +  PE    G  T+  D +SFGV+L E+ +        
Sbjct: 181 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPY 238
Query: 292 RCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM 351
             K  ++++E+                 R++   +  G   +  +  QC  H P+ RP  
Sbjct: 239 PSKSNQEVLEFV------------TSGGRMDPPKNCPGP--VYRIMTQCWQHQPEDRPNF 284
Query: 352 TTVVKALE 359
             +++ +E
Sbjct: 285 AIILERIE 292

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 129/308 (41%), Gaps = 30/308 (9%)
Query: 61  LVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL-D 119
             G    +  LKE+     N +    LG G FG+VY+G V          Q VAVK L +
Sbjct: 29  FAGKTSSISDLKEVP--RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQ-VAVKTLPE 85
Query: 120 VNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK---- 175
           V   Q   ++L E + + +  H ++V  IG   +   R ++ E MA G+L   L +    
Sbjct: 86  VCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPR 145
Query: 176 -NYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD---SDYNAKLSDFG 231
            +  S+L  L  + +A   A    +L  EE   I+RD  A N LL        AK+ DFG
Sbjct: 146 PSQPSSLAMLDLLHVARDIACGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 203
Query: 232 LATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKN 291
           +A D  +        C M    +  PE    G  T+  D +SFGV+L E+ +        
Sbjct: 204 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPY 261
Query: 292 RCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM 351
             K  ++++E+                 R++   +  G   +  +  QC  H P+ RP  
Sbjct: 262 PSKSNQEVLEFV------------TSGGRMDPPKNCPGP--VYRIMTQCWQHQPEDRPNF 307
Query: 352 TTVVKALE 359
             +++ +E
Sbjct: 308 AIILERIE 315

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 129/308 (41%), Gaps = 30/308 (9%)
Query: 61  LVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL-D 119
             G    +  LKE+     N +    LG G FG+VY+G V          Q VAVK L +
Sbjct: 14  FAGKTSSISDLKEVP--RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQ-VAVKTLPE 70
Query: 120 VNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK---- 175
           V   Q   ++L E + + +  H ++V  IG   +   R ++ E MA G+L   L +    
Sbjct: 71  VCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPR 130
Query: 176 -NYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD---SDYNAKLSDFG 231
            +  S+L  L  + +A   A    +L  EE   I+RD  A N LL        AK+ DFG
Sbjct: 131 PSQPSSLAMLDLLHVARDIACGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188
Query: 232 LATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKN 291
           +A D  +        C M    +  PE    G  T+  D +SFGV+L E+ +        
Sbjct: 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPY 246
Query: 292 RCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM 351
             K  ++++E+                 R++   +  G   +  +  QC  H P+ RP  
Sbjct: 247 PSKSNQEVLEFV------------TSGGRMDPPKNCPGP--VYRIMTQCWQHQPEDRPNF 292
Query: 352 TTVVKALE 359
             +++ +E
Sbjct: 293 AIILERIE 300

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 129/308 (41%), Gaps = 30/308 (9%)
Query: 61  LVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL-D 119
             G    +  LKE+     N +    LG G FG+VY+G V          Q VAVK L +
Sbjct: 31  FAGKTSSISDLKEVP--RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQ-VAVKTLPE 87
Query: 120 VNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK---- 175
           V   Q   ++L E + + +  H ++V  IG   +   R ++ E MA G+L   L +    
Sbjct: 88  VCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPR 147
Query: 176 -NYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD---SDYNAKLSDFG 231
            +  S+L  L  + +A   A    +L  EE   I+RD  A N LL        AK+ DFG
Sbjct: 148 PSQPSSLAMLDLLHVARDIACGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 205
Query: 232 LATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKN 291
           +A D  +        C M    +  PE    G  T+  D +SFGV+L E+ +        
Sbjct: 206 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPY 263
Query: 292 RCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM 351
             K  ++++E+                 R++   +  G   +  +  QC  H P+ RP  
Sbjct: 264 PSKSNQEVLEFV------------TSGGRMDPPKNCPGP--VYRIMTQCWQHQPEDRPNF 309
Query: 352 TTVVKALE 359
             +++ +E
Sbjct: 310 AIILERIE 317

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 129/308 (41%), Gaps = 30/308 (9%)
Query: 61  LVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL-D 119
             G    +  LKE+     N +    LG G FG+VY+G V          Q VAVK L +
Sbjct: 14  FAGKTSSISDLKEVP--RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQ-VAVKTLPE 70
Query: 120 VNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK---- 175
           V   Q   ++L E + + +  H ++V  IG   +   R ++ E MA G+L   L +    
Sbjct: 71  VCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPR 130
Query: 176 -NYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD---SDYNAKLSDFG 231
            +  S+L  L  + +A   A    +L  EE   I+RD  A N LL        AK+ DFG
Sbjct: 131 PSQPSSLAMLDLLHVARDIACGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188
Query: 232 LATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKN 291
           +A D  +        C M    +  PE    G  T+  D +SFGV+L E+ +        
Sbjct: 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPY 246
Query: 292 RCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM 351
             K  ++++E+                 R++   +  G   +  +  QC  H P+ RP  
Sbjct: 247 PSKSNQEVLEFV------------TSGGRMDPPKNCPGP--VYRIMTQCWQHQPEDRPNF 292
Query: 352 TTVVKALE 359
             +++ +E
Sbjct: 293 AIILERIE 300

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 118/277 (42%), Gaps = 36/277 (12%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG+V+ G  +   R       VA+K L   G+     +L E   + +L+H  LV 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     E E   +V EYM+ G+L D L       L     + +A   A  +A++  E   
Sbjct: 78  LYAVVSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV--ERMN 134
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
            ++RD +A+NIL+  +   K++DFGLA      E +         + + APE    G  T
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIK-WTAPEAALYGRFT 193
Query: 267 TMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYS 326
              DV+SFG++L EL T  R        RE                LDQ+     E  Y 
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNRE---------------VLDQV-----ERGYR 233
Query: 327 T----EGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
                E  + L  +  QC   +P+ RPT   +   LE
Sbjct: 234 MPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 29/216 (13%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLG 137
              R   LG G FG VYKG     +  G   +  VA+K+L +  G + + E++ E + + 
Sbjct: 39  ELKRVKVLGSGAFGTVYKGIW---VPEGETVKIPVAIKILNETTGPKANVEFMDEALIMA 95
Query: 138 QLKHPHLVNLIGYCCEDEHRL----------LVYEYMALGNLHDQLFKNYSSTLPWLTRI 187
            + HPHLV L+G C     +L          L Y +    N+  QL  N+         +
Sbjct: 96  SMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWC--------V 147
Query: 188 KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC 247
           +IA G       ++ EE+ +++RD  A N+L+ S  + K++DFGLA      E  +    
Sbjct: 148 QIAKG------MMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG 201
Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
                 + A E I+    T   DV+S+GV + EL+T
Sbjct: 202 GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 129/308 (41%), Gaps = 30/308 (9%)
Query: 61  LVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL-D 119
             G    +  LKE+     N +    LG G FG+VY+G V          Q VAVK L +
Sbjct: 55  FAGKTSSISDLKEVP--RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQ-VAVKTLPE 111
Query: 120 VNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK---- 175
           V   Q   ++L E + + +  H ++V  IG   +   R ++ E MA G+L   L +    
Sbjct: 112 VCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPR 171
Query: 176 -NYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD---SDYNAKLSDFG 231
            +  S+L  L  + +A   A    +L  EE   I+RD  A N LL        AK+ DFG
Sbjct: 172 PSQPSSLAMLDLLHVARDIACGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 229
Query: 232 LATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKN 291
           +A D  +        C M    +  PE    G  T+  D +SFGV+L E+ +        
Sbjct: 230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPY 287
Query: 292 RCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM 351
             K  ++++E+                 R++   +  G   +  +  QC  H P+ RP  
Sbjct: 288 PSKSNQEVLEFV------------TSGGRMDPPKNCPGP--VYRIMTQCWQHQPEDRPNF 333
Query: 352 TTVVKALE 359
             +++ +E
Sbjct: 334 AIILERIE 341

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 129/308 (41%), Gaps = 30/308 (9%)
Query: 61  LVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL-D 119
             G    +  LKE+     N +    LG G FG+VY+G V          Q VAVK L +
Sbjct: 32  FAGKTSSISDLKEVP--RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQ-VAVKTLPE 88
Query: 120 VNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK---- 175
           V   Q   ++L E + + +  H ++V  IG   +   R ++ E MA G+L   L +    
Sbjct: 89  VCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPR 148
Query: 176 -NYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILL---DSDYNAKLSDFG 231
            +  S+L  L  + +A   A    +L  EE   I+RD  A N LL        AK+ DFG
Sbjct: 149 PSQPSSLAMLDLLHVARDIACGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 206
Query: 232 LATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKN 291
           +A D  +        C M    +  PE    G  T+  D +SFGV+L E+ +        
Sbjct: 207 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPY 264
Query: 292 RCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM 351
             K  ++++E+                 R++   +  G   +  +  QC  H P+ RP  
Sbjct: 265 PSKSNQEVLEFV------------TSGGRMDPPKNCPGP--VYRIMTQCWQHQPEDRPNF 310
Query: 352 TTVVKALE 359
             +++ +E
Sbjct: 311 AIILERIE 318

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 100/204 (49%), Gaps = 17/204 (8%)
Query: 87  LGEGGFGKVYKGCVDDNLRPG-LKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLV 145
           LG+GG+GKV++         G + A  V  K + V  ++      AE   L ++KHP +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 146 NLIGYCCEDEHRL-LVYEYMALGNLHDQLFKN----YSSTLPWLTRIKIAIGAARCLAFL 200
           +LI Y  +   +L L+ EY++ G L  QL +       +   +L  I +A+G        
Sbjct: 85  DLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG-------- 135
Query: 201 HGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI 260
           H  +K +IYRD K  NI+L+   + KL+DFGL  +     D  +T    GT  Y APE +
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH--DGTVTHTFCGTIEYMAPEIL 193
Query: 261 NTGHLTTMCDVFSFGVVLLELLTG 284
                    D +S G ++ ++LTG
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 122/277 (44%), Gaps = 28/277 (10%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           +G G FG V+ G         L    VA+K +   G+    +++ E   + +L HP LV 
Sbjct: 16  IGSGQFGLVHLG-------YWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ 67
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L G C E     LV E+M  G L D L +         T + + +     +A+L  EE  
Sbjct: 68  LYGVCLEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYL--EEAC 124
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
           VI+RD  A N L+  +   K+SDFG+ T     +    +T       +A+PE  +    +
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGM-TRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 267 TMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYS 326
           +  DV+SFGV++ E+ +  +   +NR   E         +++D +   ++   RL     
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRL----- 229
Query: 327 TEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD 363
              +  +  + + C    P+ RP  + +++ L  + +
Sbjct: 230 --ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 102/206 (49%), Gaps = 23/206 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPG---LKAQTV----AVKVLDVNGSQGHREWLAEVIFLGQL 139
           LG+G FGKV+   V    RP    L A  V     +KV D   ++  R+ LA+V      
Sbjct: 36  LGQGSFGKVF--LVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADV------ 87
Query: 140 KHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLA 198
            HP +V L  Y  + E +L L+ +++  G+L  +L K    T      +K  + A   L 
Sbjct: 88  NHPFVVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE---EDVKFYL-AELALG 142
Query: 199 FLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPE 258
             H     +IYRD K  NILLD + + KL+DFGL+ +    E    + C  GT  Y APE
Sbjct: 143 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFC--GTVEYMAPE 200
Query: 259 YINTGHLTTMCDVFSFGVVLLELLTG 284
            +N    +   D +S+GV++ E+LTG
Sbjct: 201 VVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 103/201 (51%), Gaps = 12/201 (5%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLV 145
           +G G FG+V  G +     PG +   VA+K L    + +  R++L+E   +GQ  HP+++
Sbjct: 37  IGVGEFGEVCSGRLK---VPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
           +L G   + +  +++ EYM  G+L D   +        +  + +  G    + +L   + 
Sbjct: 94  HLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS--DM 150
Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGEDSHITTCVMGTEGYAAPEYINT 262
             ++RD  A NIL++S+   K+SDFG++    D P  E ++ T        + APE I  
Sbjct: 151 SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDP--EAAYTTRGGKIPIRWTAPEAIAY 208
Query: 263 GHLTTMCDVFSFGVVLLELLT 283
              T+  DV+S+G+V+ E+++
Sbjct: 209 RKFTSASDVWSYGIVMWEVMS 229

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 121/280 (43%), Gaps = 42/280 (15%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG+V+ G  +   R       VA+K L   G+     +L E   + +L+H  LV 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     E E   +V EYM+ G+L D L       L     + +A   A  +A++  E   
Sbjct: 78  LYAVVSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV--ERMN 134
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINTG 263
            ++RD +A+NIL+  +   K++DFGLA      ED+  T    G +    + APE    G
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTA-RQGAKFPIKWTAPEAALYG 190
Query: 264 HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLED 323
             T   DV+SFG++L EL T  R        RE                LDQ+     E 
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------------VLDQV-----ER 230
Query: 324 RYST----EGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
            Y      E  + L  +  QC   +P+ RPT   +   LE
Sbjct: 231 GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 119/283 (42%), Gaps = 40/283 (14%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREW---LAEVIFLG 137
           FS    +G G FG VY        R    ++ VA+K +  +G Q + +W   + EV FL 
Sbjct: 56  FSDLREIGHGSFGAVYFA------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +L+HP+ +   G    +    LV EY  LG+  D L + +   L  +    +  GA + L
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEY-CLGSASD-LLEVHKKPLQEVEIAAVTHGALQGL 167
Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT-DGPQGEDSHITTCVMGTEGYAA 256
           A+LH     +I+RD KA NILL      KL DFG A+   P           +GT  + A
Sbjct: 168 AYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMA 218
Query: 257 PEYI---NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKL 313
           PE I   + G      DV+S G+  +EL            +R+  L       +   + L
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIEL-----------AERKPPLFN-----MNAMSAL 262
Query: 314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
             I  +      S   ++        CL   P+ RPT   ++K
Sbjct: 263 YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 120/276 (43%), Gaps = 34/276 (12%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG+V+ G  +   R       VA+K L   G+     +L E   + +L+H  LV 
Sbjct: 15  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 66
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     E E   +V EYM+ G+L D L       L     + +A   A  +A++  E   
Sbjct: 67  LYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV--ERMN 123
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINTG 263
            ++RD +A+NIL+  +   K++DFGLA      ED+  T    G +    + APE    G
Sbjct: 124 YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTA-RQGAKFPIKWTAPEAALYG 179
Query: 264 HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLED 323
             T   DV+SFG++L EL T  R        RE                LDQ ++     
Sbjct: 180 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------------VLDQ-VERGYRM 223
Query: 324 RYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
               E  + L  +  QC   +P+ RPT   +   LE
Sbjct: 224 PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 259

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 121/280 (43%), Gaps = 42/280 (15%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG+V+ G  +   R       VA+K L   G+     +L E   + +L+H  LV 
Sbjct: 193 LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGNMSPEAFLQEAQVMKKLRHEKLVQ 244
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     E E   +V EYM+ G+L D L       L     + +A   A  +A++  E   
Sbjct: 245 LYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV--ERMN 301
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINTG 263
            ++RD +A+NIL+  +   K++DFGL   G   ED+  T    G +    + APE    G
Sbjct: 302 YVHRDLRAANILVGENLVCKVADFGL---GRLIEDNEYT-ARQGAKFPIKWTAPEAALYG 357
Query: 264 HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLED 323
             T   DV+SFG++L EL T  R        RE                LDQ+     E 
Sbjct: 358 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------------VLDQV-----ER 397
Query: 324 RYST----EGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
            Y      E  + L  +  QC   +P+ RPT   +   LE
Sbjct: 398 GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 437

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 121/280 (43%), Gaps = 42/280 (15%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG+V+ G  +   R       VA+K L   G+     +L E   + +L+H  LV 
Sbjct: 17  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 68
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     E E   +V EYM+ G+L D L       L     + +A   A  +A++  E   
Sbjct: 69  LYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV--ERMN 125
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINTG 263
            ++RD +A+NIL+  +   K++DFGLA      ED+  T    G +    + APE    G
Sbjct: 126 YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTA-RQGAKFPIKWTAPEAALYG 181
Query: 264 HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLED 323
             T   DV+SFG++L EL T  R        RE                LDQ+     E 
Sbjct: 182 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------------VLDQV-----ER 221
Query: 324 RYST----EGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
            Y      E  + L  +  QC   +P+ RPT   +   LE
Sbjct: 222 GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 261

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 100/204 (49%), Gaps = 17/204 (8%)
Query: 87  LGEGGFGKVYKGCVDDNLRPG-LKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLV 145
           LG+GG+GKV++         G + A  V  K + V  ++      AE   L ++KHP +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 146 NLIGYCCEDEHRL-LVYEYMALGNLHDQLFKN----YSSTLPWLTRIKIAIGAARCLAFL 200
           +LI Y  +   +L L+ EY++ G L  QL +       +   +L  I +A+G        
Sbjct: 85  DLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG-------- 135
Query: 201 HGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI 260
           H  +K +IYRD K  NI+L+   + KL+DFGL  +     D  +T    GT  Y APE +
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH--DGTVTHXFCGTIEYMAPEIL 193
Query: 261 NTGHLTTMCDVFSFGVVLLELLTG 284
                    D +S G ++ ++LTG
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 87  LGEGGFGKVYKGCVDDNLR---PGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPH 143
           LG G FG+V+      N R     +  + + V++  V  +   R      + L  + HP 
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDER------LMLSIVTHPF 67
Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE 203
           ++ + G   + +   ++ +Y+  G L   L K+     P    +     A  CLA  +  
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP----VAKFYAAEVCLALEYLH 123
Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTG 263
            K +IYRD K  NILLD + + K++DFG A   P      +T  + GT  Y APE ++T 
Sbjct: 124 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXLCGTPDYIAPEVVSTK 178
Query: 264 HLTTMCDVFSFGVVLLELLTG 284
                 D +SFG+++ E+L G
Sbjct: 179 PYNKSIDWWSFGILIYEMLAG 199

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 121/280 (43%), Gaps = 42/280 (15%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG+V+ G  +   R       VA+K L   G+     +L E   + +L+H  LV 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     E E   +V EYM+ G+L D L       L     + +A   A  +A++  E   
Sbjct: 78  LYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV--ERMN 134
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINTG 263
            ++RD +A+NIL+  +   K++DFGLA      ED+   T   G +    + APE    G
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEY-TARQGAKFPIKWTAPEAALYG 190
Query: 264 HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLED 323
             T   DV+SFG++L EL T  R        RE                LDQ+     E 
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------------VLDQV-----ER 230
Query: 324 RYST----EGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
            Y      E  + L  +  QC   +P+ RPT   +   LE
Sbjct: 231 GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 15/209 (7%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLG 137
              R   LG G FG VYKG     +  G   +  VA+K+L +  G + + E++ E + + 
Sbjct: 16  ELKRVKVLGSGAFGTVYKGIW---VPEGETVKIPVAIKILNETTGPKANVEFMDEALIMA 72
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK---NYSSTLPWLTRIKIAIGAA 194
            + HPHLV L+G C     +L V + M  G L + + +   N  S L     ++IA G  
Sbjct: 73  SMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKG-- 129
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
                ++ EE+ +++RD  A N+L+ S  + K++DFGLA      E  +          +
Sbjct: 130 ----MMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW 185
Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLELLT 283
            A E I+    T   DV+S+GV + EL+T
Sbjct: 186 MALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 120/276 (43%), Gaps = 34/276 (12%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG+V+ G  +   R       VA+K L   G+     +L E   + +L+H  LV 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     E E   +V EYM+ G+L D L       L     + +A   A  +A++  E   
Sbjct: 78  LYAVVSE-EPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV--ERMN 134
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINTG 263
            ++RD +A+NIL+  +   K++DFGLA      ED+  T    G +    + APE    G
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTA-RQGAKFPIKWTAPEAALYG 190
Query: 264 HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLED 323
             T   DV+SFG++L EL T  R        RE                LDQ ++     
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------------VLDQ-VERGYRM 234
Query: 324 RYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
               E  + L  +  QC   +P+ RPT   +   LE
Sbjct: 235 PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/273 (28%), Positives = 116/273 (42%), Gaps = 28/273 (10%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG+V+ G  +   R       VA+K L   G+     +L E   + +L+H  LV 
Sbjct: 16  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 67
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     E E   +V EYM+ G+L D L       L     + +A   A  +A++  E   
Sbjct: 68  LYAVVSE-EPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERMN 124
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
            ++RD +A+NIL+  +   K++DFGLA      E +         + + APE    G  T
Sbjct: 125 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIK-WTAPEAALYGRFT 183
Query: 267 TMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYS 326
              DV+SFG++L EL T  R        RE                LDQ ++        
Sbjct: 184 IKSDVWSFGILLTELTTKGRVPYPGMVNRE---------------VLDQ-VERGYRMPCP 227
Query: 327 TEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
            E  + L  +  QC    P+ RPT   +   LE
Sbjct: 228 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 260

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 103/201 (51%), Gaps = 12/201 (5%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLV 145
           +G G FG+V  G +     PG +   VA+K L    + +  R++L+E   +GQ  HP+++
Sbjct: 22  IGVGEFGEVCSGRLK---VPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
           +L G   + +  +++ EYM  G+L D   +        +  + +  G    + +L   + 
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYL--SDM 135
Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGEDSHITTCVMGTEGYAAPEYINT 262
             ++RD  A NIL++S+   K+SDFG++    D P  E ++ T        + APE I  
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDP--EAAYTTRGGKIPIRWTAPEAIAY 193
Query: 263 GHLTTMCDVFSFGVVLLELLT 283
              T+  DV+S+G+V+ E+++
Sbjct: 194 RKFTSASDVWSYGIVMWEVMS 214

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 118/282 (41%), Gaps = 38/282 (13%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREW---LAEVIFLG 137
           FS    +G G FG VY        R    ++ VA+K +  +G Q + +W   + EV FL 
Sbjct: 17  FSDLREIGHGSFGAVYFA------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +L+HP+ +   G    +    LV EY  LG+  D L + +   L  +    +  GA + L
Sbjct: 71  KLRHPNTIQYRGCYLREHTAWLVMEY-CLGSASD-LLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAP 257
           A+LH     +I+RD KA NILL      KL DFG A+              +GT  + AP
Sbjct: 129 AYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAP 180
Query: 258 EYI---NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD 314
           E I   + G      DV+S G+  +EL            +R+  L       +   + L 
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIEL-----------AERKPPLFN-----MNAMSALY 224
Query: 315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
            I  +      S   ++        CL   P+ RPT   ++K
Sbjct: 225 HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 120/280 (42%), Gaps = 42/280 (15%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG+V+ G  +   R       VA+K L   G+     +L E   + +L+H  LV 
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     E E   +V EYM+ G+L D L       L     + +A   A  +A++  E   
Sbjct: 244 LYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERMN 300
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINTG 263
            ++RD +A+NIL+  +   K++DFGLA      ED+   T   G +    + APE    G
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEY-TARQGAKFPIKWTAPEAALYG 356
Query: 264 HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLED 323
             T   DV+SFG++L EL T  R        RE                LDQ+     E 
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------------VLDQV-----ER 396
Query: 324 RYST----EGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
            Y      E  + L  +  QC    P+ RPT   +   LE
Sbjct: 397 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 119/289 (41%), Gaps = 43/289 (14%)
Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHREWLA 131
           Q    +F     LG+G FG VY        R       +A+KVL    +  +    +   
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLA------RERQSKFILALKVLFKTQLEKAGVEHQLRR 61
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK----NYSSTLPWLTRI 187
           EV     L+HP+++ L GY  +     L+ EY  LG ++ +L K    +   T  ++T +
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL 121
Query: 188 KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC 247
                 A  L++ H   K VI+RD K  N+LL S+   K++DFG +   P    S   T 
Sbjct: 122 ------ANALSYCHS--KRVIHRDIKPENLLLGSNGELKIADFGWSVHAP----SSRRTT 169
Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML 307
           + GT  Y  PE I         D++S GV+  E L G    E +  +     +       
Sbjct: 170 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTF 229
Query: 308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
            DF                TEGA+ L +   + L HN   R T+  V++
Sbjct: 230 PDFV---------------TEGARDLIS---RLLKHNASQRLTLAEVLE 260

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 120/280 (42%), Gaps = 42/280 (15%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG+V+ G  +   R       VA+K L   G+     +L E   + +L+H  LV 
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     E E   +V EYM+ G+L D L       L     + +A   A  +A++  E   
Sbjct: 244 LYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERMN 300
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINTG 263
            ++RD +A+NIL+  +   K++DFGLA      ED+   T   G +    + APE    G
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEY-TARQGAKFPIKWTAPEAALYG 356
Query: 264 HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLED 323
             T   DV+SFG++L EL T  R        RE                LDQ+     E 
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------------VLDQV-----ER 396
Query: 324 RYST----EGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
            Y      E  + L  +  QC    P+ RPT   +   LE
Sbjct: 397 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 108/224 (48%), Gaps = 13/224 (5%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGH-REWLAEVIFLGQLKHPHLV 145
           LG G FG V +G      R   K   VA+KVL     +    E + E   + QL +P++V
Sbjct: 18  LGCGNFGSVRQGV----YRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            LIG  C+ E  +LV E    G LH  L       +P     ++    +  + +L  EEK
Sbjct: 74  RLIG-VCQAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYL--EEK 129
Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE--GYAAPEYINTG 263
             ++RD  A N+LL + + AK+SDFGL +     +DS+ T    G     + APE IN  
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGL-SKALGADDSYYTARSAGKWPLKWYAPECINFR 188
Query: 264 HLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPM 306
             ++  DV+S+GV + E L+ G++  +K +       +E  + M
Sbjct: 189 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM 232

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 120/280 (42%), Gaps = 42/280 (15%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG+V+ G  +   R       VA+K L   G+     +L E   + +L+H  LV 
Sbjct: 275 LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 326
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     E E   +V EYM+ G+L D L       L     + +A   A  +A++  E   
Sbjct: 327 LYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERMN 383
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINTG 263
            ++RD +A+NIL+  +   K++DFGLA      ED+   T   G +    + APE    G
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEY-TARQGAKFPIKWTAPEAALYG 439
Query: 264 HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLED 323
             T   DV+SFG++L EL T  R        RE                LDQ+     E 
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------------VLDQV-----ER 479
Query: 324 RYST----EGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
            Y      E  + L  +  QC    P+ RPT   +   LE
Sbjct: 480 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 103/201 (51%), Gaps = 12/201 (5%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLV 145
           +G G FG+V  G +     PG +   VA+K L    + +  R++L+E   +GQ  HP+++
Sbjct: 16  IGVGEFGEVCSGRLK---VPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
           +L G   + +  +++ EYM  G+L D   +        +  + +  G    + +L   + 
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYL--SDM 129
Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGEDSHITTCVMGTEGYAAPEYINT 262
             ++RD  A NIL++S+   K+SDFG++    D P  E ++ T        + APE I  
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDP--EAAYTTRGGKIPIRWTAPEAIAY 187
Query: 263 GHLTTMCDVFSFGVVLLELLT 283
              T+  DV+S+G+V+ E+++
Sbjct: 188 RKFTSASDVWSYGIVMWEVMS 208

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 95/200 (47%), Gaps = 12/200 (6%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG+V+ G  + N +       VA+K L   G+     +L E   + +LKH  LV 
Sbjct: 17  LGNGQFGEVWMGTWNGNTK-------VAIKTLK-PGTMSPESFLEEAQIMKKLKHDKLVQ 68
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     E E   +V EYM  G+L D L       L     + +A   A  +A++  E   
Sbjct: 69  LYAVVSE-EPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI--ERMN 125
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
            I+RD +++NIL+ +    K++DFGLA      E +         + + APE    G  T
Sbjct: 126 YIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIK-WTAPEAALYGRFT 184
Query: 267 TMCDVFSFGVVLLELLTGRR 286
              DV+SFG++L EL+T  R
Sbjct: 185 IKSDVWSFGILLTELVTKGR 204

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 121/280 (43%), Gaps = 42/280 (15%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG+V+ G  +   R       VA+K L   G+     +L E   + +++H  LV 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKIRHEKLVQ 77
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     E E   +V EYM+ G+L D L       L     + +A   A  +A++  E   
Sbjct: 78  LYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV--ERMN 134
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINTG 263
            ++RD +A+NIL+  +   K++DFGLA      ED+   T   G +    + APE    G
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEY-TARQGAKFPIKWTAPEAALYG 190
Query: 264 HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLED 323
             T   DV+SFG++L EL T  R        RE                LDQ+     E 
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------------VLDQV-----ER 230
Query: 324 RYST----EGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
            Y      E  + L  +  QC   +P+ RPT   +   LE
Sbjct: 231 GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 119/276 (43%), Gaps = 34/276 (12%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG+V+ G  +   R       VA+K L   G+     +L E   + +L+H  LV 
Sbjct: 19  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 70
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     E E   +V EYM+ G+L D L       L     + +A   A  +A++  E   
Sbjct: 71  LYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERMN 127
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINTG 263
            ++RD +A+NIL+  +   K++DFGLA      ED+  T    G +    + APE    G
Sbjct: 128 YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTA-RQGAKFPIKWTAPEAALYG 183
Query: 264 HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLED 323
             T   DV+SFG++L EL T  R        RE                LDQ ++     
Sbjct: 184 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------------VLDQ-VERGYRM 227
Query: 324 RYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
               E  + L  +  QC    P+ RPT   +   LE
Sbjct: 228 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 263

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 119/276 (43%), Gaps = 34/276 (12%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG+V+ G  +   R       VA+K L   G+     +L E   + +L+H  LV 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     E E   +V EYM+ G L D L       L     + +A   A  +A++  E   
Sbjct: 78  LYAVVSE-EPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV--ERMN 134
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINTG 263
            ++RD +A+NIL+  +   K++DFGLA      ED+  T    G +    + APE    G
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTA-RQGAKFPIKWTAPEAALYG 190
Query: 264 HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLED 323
             T   DV+SFG++L EL T  R        RE                LDQ ++     
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------------VLDQ-VERGYRM 234
Query: 324 RYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
               E  + L  +  QC   +P+ RPT   +   LE
Sbjct: 235 PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 84  SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDV--NGSQGHREWLAEVIFLGQLKH 141
           S  +G G FG VYKG    +         VAVK+L V     +  + +  EV  L + +H
Sbjct: 41  STRIGSGSFGTVYKGKWHGD---------VAVKILKVVDPTPEQFQAFRNEVAVLRKTRH 91
Query: 142 PHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLH 201
            +++  +GY  +D +  +V ++    +L+  L     +       I IA   A+ + +LH
Sbjct: 92  VNILLFMGYMTKD-NLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLH 149
Query: 202 GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI- 260
              K +I+RD K++NI L      K+ DFGLAT   +   S       G+  + APE I 
Sbjct: 150 A--KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIR 207
Query: 261 --NTGHLTTMCDVFSFGVVLLELLTG 284
             +    +   DV+S+G+VL EL+TG
Sbjct: 208 MQDNNPFSFQSDVYSYGIVLYELMTG 233

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 123/282 (43%), Gaps = 38/282 (13%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLA-EVIFL 136
           +F   + LG+G F  VY+    +++  GL+   VA+K++D       G  + +  EV   
Sbjct: 12  DFKVGNLLGKGSFAGVYRA---ESIHTGLE---VAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQL---FKNYSSTLPWLTRIKIAIGA 193
            QLKHP ++ L  Y  +  +  LV E    G ++  L    K +S         +I  G 
Sbjct: 66  CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITG- 124
Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
              + +LH     +++RD   SN+LL  + N K++DFGLAT      + H T C  GT  
Sbjct: 125 ---MLYLHSH--GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--GTPN 177
Query: 254 YAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKL 313
           Y +PE           DV+S G +   LL GR   + +  K   + V  A   +  F  +
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSI 237
Query: 314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVV 355
           +               AK L    HQ L  NP  R ++++V+
Sbjct: 238 E---------------AKDL---IHQLLRRNPADRLSLSSVL 261

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 119/276 (43%), Gaps = 34/276 (12%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG+V+ G  +   R       VA+K L   G+     +L E   + +L+H  LV 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     E E   +V EYM+ G+L D L       L     + +A   A  +A++  E   
Sbjct: 78  LYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV--ERMN 134
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINTG 263
            ++RD  A+NIL+  +   K++DFGLA      ED+  T    G +    + APE    G
Sbjct: 135 YVHRDLAAANILVGENLVCKVADFGLAR---LIEDNEYTA-RQGAKFPIKWTAPEAALYG 190
Query: 264 HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLED 323
             T   DV+SFG++L EL T  R        RE                LDQ ++     
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------------VLDQ-VERGYRM 234
Query: 324 RYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
               E  + L  +  QC   +P+ RPT   +   LE
Sbjct: 235 PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 120/280 (42%), Gaps = 42/280 (15%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG+V+ G  +   R       VA+K L   G+     +L E   + +L+H  LV 
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     E E   +V EYM+ G+L D L       L     + +A   A  +A++  E   
Sbjct: 244 LYAVVSE-EPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERMN 300
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINTG 263
            ++RD +A+NIL+  +   K++DFGLA      ED+   T   G +    + APE    G
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEY-TARQGAKFPIKWTAPEAALYG 356
Query: 264 HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLED 323
             T   DV+SFG++L EL T  R        RE                LDQ+     E 
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------------VLDQV-----ER 396
Query: 324 RYST----EGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
            Y      E  + L  +  QC    P+ RPT   +   LE
Sbjct: 397 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 119/276 (43%), Gaps = 34/276 (12%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG+V+ G  +   R       VA+K L   G+     +L E   + +L+H  LV 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     E E   +V EYM+ G L D L       L     + +A   A  +A++  E   
Sbjct: 78  LYAVVSE-EPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV--ERMN 134
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINTG 263
            ++RD +A+NIL+  +   K++DFGLA      ED+  T    G +    + APE    G
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTA-RQGAKFPIKWTAPEAALYG 190
Query: 264 HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLED 323
             T   DV+SFG++L EL T  R        RE                LDQ ++     
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------------VLDQ-VERGYRM 234
Query: 324 RYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
               E  + L  +  QC   +P+ RPT   +   LE
Sbjct: 235 PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 124/285 (43%), Gaps = 36/285 (12%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLV 145
           +G G FG+V  G +     PG +   VA+K L    ++  R ++L+E   +GQ  HP+++
Sbjct: 15  IGAGEFGEVCSGHLK---LPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
           +L G   +    +++ E+M  G+L D   +        +  + +  G A  + +L   + 
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYL--ADM 128
Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINT 262
             ++R   A NIL++S+   K+SDFGL+            T  +G +    + APE I  
Sbjct: 129 NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 188
Query: 263 GHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRL 321
              T+  DV+S+G+V+ E+++ G R               W      D T  D I  + +
Sbjct: 189 RKFTSASDVWSYGIVMWEVMSYGERPY-------------W------DMTNQDVI--NAI 227
Query: 322 EDRYSTEGAKRLAAVAHQ----CLSHNPKSRPTMTTVVKALEPLL 362
           E  Y         +  HQ    C   +   RP    +V  L+ ++
Sbjct: 228 EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 272

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 10/218 (4%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLGQLKHPHL 144
           LG G FG V+KG     +  G   +  V +KV+ D +G Q  +     ++ +G L H H+
Sbjct: 39  LGSGVFGTVHKGVW---IPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 95
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           V L+G C     +L V +Y+ LG+L D + ++  +  P L  +   +  A+ + +L  EE
Sbjct: 96  VRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLL-LNWGVQIAKGMYYL--EE 151
Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGH 264
             +++R+  A N+LL S    +++DFG+A   P  +   + +       + A E I+ G 
Sbjct: 152 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 211
Query: 265 LTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVE 301
            T   DV+S+GV + EL+T G       R     DL+E
Sbjct: 212 YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 249

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 87  LGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLV 145
           LGEG FGKV+   C   NL P      VAVK L        +++  E   L  L+H H+V
Sbjct: 23  LGEGAFGKVFLAECY--NLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLH--------------DQLFKNYSSTLPWLTRIKIAI 191
              G C + +  ++V+EYM  G+L+              D   +     L     + IA 
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
             A  + +L  +    ++RD    N L+ ++   K+ DFG++ D    +   +    M  
Sbjct: 141 QIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198
Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
             +  PE I     TT  DV+SFGV+L E+ T
Sbjct: 199 IRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 10/218 (4%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLGQLKHPHL 144
           LG G FG V+KG     +  G   +  V +KV+ D +G Q  +     ++ +G L H H+
Sbjct: 21  LGSGVFGTVHKGVW---IPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           V L+G C     +L V +Y+ LG+L D + ++  +  P L  +   +  A+ + +L  EE
Sbjct: 78  VRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLL-LNWGVQIAKGMYYL--EE 133
Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGH 264
             +++R+  A N+LL S    +++DFG+A   P  +   + +       + A E I+ G 
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193
Query: 265 LTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVE 301
            T   DV+S+GV + EL+T G       R     DL+E
Sbjct: 194 YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 118/289 (40%), Gaps = 43/289 (14%)
Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHREWLA 131
           Q    +F     LG+G FG VY        R       +A+KVL    +  +    +   
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLA------RERQSKFILALKVLFKTQLEKAGVEHQLRR 61
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK----NYSSTLPWLTRI 187
           EV     L+HP+++ L GY  +     L+ EY  LG ++ +L K    +   T  ++T +
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL 121
Query: 188 KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC 247
                 A  L++ H   K VI+RD K  N+LL S+   K++DFG +   P       T C
Sbjct: 122 ------ANALSYCHS--KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRD--TLC 171
Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML 307
             GT  Y  PE I         D++S GV+  E L G    E +  +     +       
Sbjct: 172 --GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTF 229
Query: 308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
            DF                TEGA+ L +   + L HN   R T+  V++
Sbjct: 230 PDFV---------------TEGARDLIS---RLLKHNASQRLTLAEVLE 260

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 89/314 (28%), Positives = 135/314 (42%), Gaps = 34/314 (10%)
Query: 55  NELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVA 114
            +L S+L+     V    E +++TH+      +G+G FG VY G   D  +  ++    A
Sbjct: 1   RDLDSALLAEVKDVLIPHE-RVVTHS---DRVIGKGHFGVVYHGEYIDQAQNRIQC---A 53
Query: 115 VKVLD-VNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE---HRLLVYEYMALGNLH 170
           +K L  +   Q    +L E + +  L HP+++ LIG     E   H LL   YM  G+L 
Sbjct: 54  IKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL--PYMCHGDLL 111
Query: 171 DQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDF 230
            Q  ++          I   +  AR + +L   E+  ++RD  A N +LD  +  K++DF
Sbjct: 112 -QFIRSPQRNPTVKDLISFGLQVARGMEYL--AEQKFVHRDLAARNCMLDESFTVKVADF 168
Query: 231 GLATDGPQGEDSHITTCVMGT--EGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSV 288
           GLA D    E   +           + A E + T   TT  DV+SFGV+L ELLT  R  
Sbjct: 169 GLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT--RGA 226
Query: 289 EKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSR 348
              R     DL  +    L    +L Q         Y  +    L  V  QC   +P  R
Sbjct: 227 PPYRHIDPFDLTHF----LAQGRRLPQ-------PEYCPDS---LYQVMQQCWEADPAVR 272
Query: 349 PTMTTVVKALEPLL 362
           PT   +V  +E ++
Sbjct: 273 PTFRVLVGEVEQIV 286

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 107/229 (46%), Gaps = 22/229 (9%)
Query: 71  LKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG--HRE 128
           LKE+ +    F     LGE  FGKVYKG +     PG + Q VA+K L  + ++G    E
Sbjct: 20  LKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPA-PGEQTQAVAIKTLK-DKAEGPLREE 75
Query: 129 WLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLF-------------- 174
           +  E +   +L+HP++V L+G   +D+   +++ Y + G+LH+ L               
Sbjct: 76  FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 135
Query: 175 KNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT 234
           +   S L     + +    A  + +L      V+++D    N+L+    N K+SD GL  
Sbjct: 136 RTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLFR 193
Query: 235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           +    +   +    +    + APE I  G  +   D++S+GVVL E+ +
Sbjct: 194 EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 108/224 (48%), Gaps = 13/224 (5%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGH-REWLAEVIFLGQLKHPHLV 145
           LG G FG V +G      R   K   VA+KVL     +    E + E   + QL +P++V
Sbjct: 344 LGCGNFGSVRQGVY----RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            LIG  C+ E  +LV E    G LH  L       +P     ++    +  + +L  EEK
Sbjct: 400 RLIG-VCQAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYL--EEK 455
Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE--GYAAPEYINTG 263
             ++R+  A N+LL + + AK+SDFGL +     +DS+ T    G     + APE IN  
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGL-SKALGADDSYYTARSAGKWPLKWYAPECINFR 514
Query: 264 HLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPM 306
             ++  DV+S+GV + E L+ G++  +K +       +E  + M
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM 558

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 107/229 (46%), Gaps = 22/229 (9%)
Query: 71  LKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG--HRE 128
           LKE+ +    F     LGE  FGKVYKG +     PG + Q VA+K L  + ++G    E
Sbjct: 3   LKEISLSAVRFMEE--LGEDRFGKVYKGHLF-GPAPGEQTQAVAIKTLK-DKAEGPLREE 58
Query: 129 WLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLF-------------- 174
           +  E +   +L+HP++V L+G   +D+   +++ Y + G+LH+ L               
Sbjct: 59  FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 175 KNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT 234
           +   S L     + +    A  + +L      V+++D    N+L+    N K+SD GL  
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLFR 176
Query: 235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           +    +   +    +    + APE I  G  +   D++S+GVVL E+ +
Sbjct: 177 EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/208 (34%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVLD---VNGSQGHREWLAEVIFLGQLKHP 142
           LGEG FGKV        L    K Q  VA+K +    +  S  H     E+ +L  L+HP
Sbjct: 17  LGEGSFGKV-------KLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
           H++ L          ++V EY A G L D + +    T     R    I  A  + + H 
Sbjct: 70  HIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICA--IEYCHR 126
Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGEDSHITTCVMGTEGYAAPEY 259
            +  +++RD K  N+LLD + N K++DFGL+   TDG    +   T+C  G+  YAAPE 
Sbjct: 127 HK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG----NFLKTSC--GSPNYAAPEV 178
Query: 260 INTGHLTT--MCDVFSFGVVLLELLTGR 285
           IN G L      DV+S G+VL  +L GR
Sbjct: 179 IN-GKLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 119/280 (42%), Gaps = 42/280 (15%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG+V+ G  +   R       VA+K L   G+     +L E   + +L+H  LV 
Sbjct: 23  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 74
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     E E   +V EYM  G+L D L       L     + ++   A  +A++  E   
Sbjct: 75  LYAVVSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYV--ERMN 131
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINTG 263
            ++RD +A+NIL+  +   K++DFGLA      ED+   T   G +    + APE    G
Sbjct: 132 YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEY-TARQGAKFPIKWTAPEAALYG 187
Query: 264 HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLED 323
             T   DV+SFG++L EL T  R        RE                LDQ+     E 
Sbjct: 188 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------------VLDQV-----ER 227
Query: 324 RYST----EGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
            Y      E  + L  +  QC    P+ RPT   +   LE
Sbjct: 228 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 96/212 (45%), Gaps = 33/212 (15%)
Query: 85  DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL--------DVNGSQGHREWLAEVIFL 136
           D LG G FGKV  G      +  L    VAVK+L        DV G     +   E+  L
Sbjct: 22  DTLGVGTFGKVKVG------KHELTGHKVAVKILNRQKIRSLDVVG-----KIRREIQNL 70
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRI--KIAIGAA 194
              +HPH++ L           +V EY++ G L D + KN         R+  +I  G  
Sbjct: 71  KLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD 130
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
            C   +      V++RD K  N+LLD+  NAK++DFGL+     GE         G+  Y
Sbjct: 131 YCHRHM------VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRXSCGSPNY 181
Query: 255 AAPEYINTGHLTT--MCDVFSFGVVLLELLTG 284
           AAPE I +G L      D++S GV+L  LL G
Sbjct: 182 AAPEVI-SGRLYAGPEVDIWSSGVILYALLCG 212

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 128/296 (43%), Gaps = 37/296 (12%)
Query: 87  LGEGGFGKVY--KGCVDDNLRPGLKAQTVAVKVLDVNGSQGH-REWLAEVIFLGQL-KHP 142
           LGEG FG+V   +    D  +P  +   VAVK+L  + ++    + ++E+  +  + KH 
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPN-RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 94
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQL--------------FKNYSSTLPWLTRIK 188
           +++NL+G C +D    ++ EY + GNL + L                N    L     + 
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVS 154
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
            A   AR + +L    K  I+RD  A N+L+  D   K++DFGLA D    +    TT  
Sbjct: 155 CAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
                + APE +     T   DV+SFGV+L E+ T   S            VE    +LK
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------VEELFKLLK 266
Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL 364
           +  ++D+           +     L  +   C    P  RPT   +V+ L+ ++ L
Sbjct: 267 EGHRMDK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 312

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 119/280 (42%), Gaps = 42/280 (15%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG+V+ G  +   R       VA+K L   G+     +L E   + +L+H  LV 
Sbjct: 23  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 74
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     E E   +V EYM  G+L D L       L     + ++   A  +A++  E   
Sbjct: 75  LYAVVSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYV--ERMN 131
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINTG 263
            ++RD +A+NIL+  +   K++DFGLA      ED+   T   G +    + APE    G
Sbjct: 132 YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEW-TARQGAKFPIKWTAPEAALYG 187
Query: 264 HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLED 323
             T   DV+SFG++L EL T  R        RE                LDQ+     E 
Sbjct: 188 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------------VLDQV-----ER 227
Query: 324 RYST----EGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
            Y      E  + L  +  QC    P+ RPT   +   LE
Sbjct: 228 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 21/209 (10%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK 140
           ++R + +G+G  G VY      ++  G   Q VA++ +++         + E++ + + K
Sbjct: 22  YTRFEKIGQGASGTVYTAM---DVATG---QEVAIRQMNLQQQPKKELIINEILVMRENK 75
Query: 141 HPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLA-- 198
           +P++VN +      +   +V EY+A G+L D +      T   +   +IA     CL   
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQAL 129
Query: 199 -FLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL-ATDGPQGEDSHITTCVMGTEGYAA 256
            FLH  +  VI+RD K+ NILL  D + KL+DFG  A   P  E S  +T V GT  + A
Sbjct: 130 EFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMA 184
Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           PE +         D++S G++ +E++ G 
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 10/201 (4%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG V + C  D L+     + VAVK L  +  +  R++  E+  L  L+H ++V 
Sbjct: 17  LGKGNFGSV-EMCRYDPLQDNT-GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 147 LIGYCCEDEHR--LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR-CLAFLHGE 203
             G C     R   L+ EY+  G+L D L K+       +  IK+    ++ C    +  
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYLG 130
Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQG-EDSHITTCVMGTEGYAAPEYINT 262
            K  I+RD    NIL++++   K+ DFGL    PQ  E   +         + APE +  
Sbjct: 131 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 190
Query: 263 GHLTTMCDVFSFGVVLLELLT 283
              +   DV+SFGVVL EL T
Sbjct: 191 SKFSVASDVWSFGVVLYELFT 211

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 112/242 (46%), Gaps = 48/242 (19%)
Query: 64  SNLHVFTLKELQMITHNFSRSDY------LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV 117
            NL+  ++K+ + +T + +  D+      LG+G FGKVYK     N    + A   A KV
Sbjct: 16  ENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKA---QNKETSVLA---AAKV 69
Query: 118 LDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNY 177
           +D    +   +++ E+  L    HP++V L+     + +  ++ E+ A G +   + +  
Sbjct: 70  IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE 129
Query: 178 SSTLPWLTRIKIAIGAAR---CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA- 233
                 LT  +I +   +    L +LH  +  +I+RD KA NIL   D + KL+DFG++ 
Sbjct: 130 RP----LTESQIQVVCKQTLDALNYLH--DNKIIHRDLKAGNILFTLDGDIKLADFGVSA 183
Query: 234 --TDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMC------------DVFSFGVVLL 279
             T   Q  DS I     GT  + APE +       MC            DV+S G+ L+
Sbjct: 184 KNTRTIQRRDSFI-----GTPYWMAPEVV-------MCETSKDRPYDYKADVWSLGITLI 231
Query: 280 EL 281
           E+
Sbjct: 232 EM 233

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 112/242 (46%), Gaps = 48/242 (19%)
Query: 64  SNLHVFTLKELQMITHNFSRSDY------LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV 117
            NL+  ++K+ + +T + +  D+      LG+G FGKVYK     N    + A   A KV
Sbjct: 16  ENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKA---QNKETSVLA---AAKV 69
Query: 118 LDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNY 177
           +D    +   +++ E+  L    HP++V L+     + +  ++ E+ A G +   + +  
Sbjct: 70  IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE 129
Query: 178 SSTLPWLTRIKIAIGAAR---CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA- 233
                 LT  +I +   +    L +LH  +  +I+RD KA NIL   D + KL+DFG++ 
Sbjct: 130 RP----LTESQIQVVCKQTLDALNYLH--DNKIIHRDLKAGNILFTLDGDIKLADFGVSA 183
Query: 234 --TDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMC------------DVFSFGVVLL 279
             T   Q  DS I     GT  + APE +       MC            DV+S G+ L+
Sbjct: 184 KNTRXIQRRDSFI-----GTPYWMAPEVV-------MCETSKDRPYDYKADVWSLGITLI 231
Query: 280 EL 281
           E+
Sbjct: 232 EM 233

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 119/274 (43%), Gaps = 31/274 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ-LKHPHLV 145
           LGEG +G+V            +  + VAVK++D+  +    E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 67
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
              G+  E   + L  EY + G L D++  +     P   R    + A   + +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG--VVYLHG--I 123
Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
            + +RD K  N+LLD   N K+SDFGLAT         +   + GT  Y APE +     
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 266 -TTMCDVFSFGVVLLELLTGRRSVEK--NRCKREKDLVEWARPMLKDFTKLDQIIDSRLE 322
                DV+S G+VL  +L G    ++  + C+   D  E  +  L  + K+D        
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-KKTYLNPWKKIDSAP----- 237
Query: 323 DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                       A+ H+ L  NP +R T+  + K
Sbjct: 238 -----------LALLHKILVENPSARITIPDIKK 260

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 119/274 (43%), Gaps = 31/274 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ-LKHPHLV 145
           LGEG +G+V            +  + VAVK++D+  +    E + + I + + L H ++V
Sbjct: 15  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 68
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
              G+  E   + L  EY + G L D++  +     P   R    + A   + +LHG   
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG--VVYLHG--I 124
Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
            + +RD K  N+LLD   N K+SDFGLAT         +   + GT  Y APE +     
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 184
Query: 266 -TTMCDVFSFGVVLLELLTGRRSVEK--NRCKREKDLVEWARPMLKDFTKLDQIIDSRLE 322
                DV+S G+VL  +L G    ++  + C+   D  E  +  L  + K+D        
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-KKTYLNPWKKIDSAP----- 238
Query: 323 DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                       A+ H+ L  NP +R T+  + K
Sbjct: 239 -----------LALLHKILVENPSARITIPDIKK 261

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 10/201 (4%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG V + C  D L+     + VAVK L  +  +  R++  E+  L  L+H ++V 
Sbjct: 22  LGKGNFGSV-EMCRYDPLQDN-TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 147 LIGYCCEDEHR--LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR-CLAFLHGE 203
             G C     R   L+ EY+  G+L D L K+       +  IK+    ++ C    +  
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYLG 135
Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQG-EDSHITTCVMGTEGYAAPEYINT 262
            K  I+RD    NIL++++   K+ DFGL    PQ  E   +         + APE +  
Sbjct: 136 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 195
Query: 263 GHLTTMCDVFSFGVVLLELLT 283
              +   DV+SFGVVL EL T
Sbjct: 196 SKFSVASDVWSFGVVLYELFT 216

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 10/201 (4%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG V + C  D L+     + VAVK L  +  +  R++  E+  L  L+H ++V 
Sbjct: 18  LGKGNFGSV-EMCRYDPLQDNT-GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 147 LIGYCCEDEHR--LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR-CLAFLHGE 203
             G C     R   L+ EY+  G+L D L K+       +  IK+    ++ C    +  
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYLG 131
Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQG-EDSHITTCVMGTEGYAAPEYINT 262
            K  I+RD    NIL++++   K+ DFGL    PQ  E   +         + APE +  
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 263 GHLTTMCDVFSFGVVLLELLT 283
              +   DV+SFGVVL EL T
Sbjct: 192 SKFSVASDVWSFGVVLYELFT 212

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 10/201 (4%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG V + C  D L+     + VAVK L  +  +  R++  E+  L  L+H ++V 
Sbjct: 21  LGKGNFGSV-EMCRYDPLQDNT-GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 147 LIGYCCEDEHR--LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR-CLAFLHGE 203
             G C     R   L+ EY+  G+L D L K+       +  IK+    ++ C    +  
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYLG 134
Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQG-EDSHITTCVMGTEGYAAPEYINT 262
            K  I+RD    NIL++++   K+ DFGL    PQ  E   +         + APE +  
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 263 GHLTTMCDVFSFGVVLLELLT 283
              +   DV+SFGVVL EL T
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 10/201 (4%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG V + C  D L+     + VAVK L  +  +  R++  E+  L  L+H ++V 
Sbjct: 16  LGKGNFGSV-EMCRYDPLQDNT-GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 147 LIGYCCEDEHR--LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR-CLAFLHGE 203
             G C     R   L+ EY+  G+L D L K+       +  IK+    ++ C    +  
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYLG 129
Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQG-EDSHITTCVMGTEGYAAPEYINT 262
            K  I+RD    NIL++++   K+ DFGL    PQ  E   +         + APE +  
Sbjct: 130 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 189
Query: 263 GHLTTMCDVFSFGVVLLELLT 283
              +   DV+SFGVVL EL T
Sbjct: 190 SKFSVASDVWSFGVVLYELFT 210

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 10/201 (4%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG V + C  D L+     + VAVK L  +  +  R++  E+  L  L+H ++V 
Sbjct: 18  LGKGNFGSV-EMCRYDPLQDNT-GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 147 LIGYCCEDEHR--LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR-CLAFLHGE 203
             G C     R   L+ EY+  G+L D L K+       +  IK+    ++ C    +  
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYLG 131
Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQG-EDSHITTCVMGTEGYAAPEYINT 262
            K  I+RD    NIL++++   K+ DFGL    PQ  E   +         + APE +  
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 263 GHLTTMCDVFSFGVVLLELLT 283
              +   DV+SFGVVL EL T
Sbjct: 192 SKFSVASDVWSFGVVLYELFT 212

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 10/201 (4%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG V + C  D L+     + VAVK L  +  +  R++  E+  L  L+H ++V 
Sbjct: 36  LGKGNFGSV-EMCRYDPLQDN-TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 147 LIGYCCEDEHR--LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR-CLAFLHGE 203
             G C     R   L+ EY+  G+L D L K+       +  IK+    ++ C    +  
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYLG 149
Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQG-EDSHITTCVMGTEGYAAPEYINT 262
            K  I+RD    NIL++++   K+ DFGL    PQ  E   +         + APE +  
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 263 GHLTTMCDVFSFGVVLLELLT 283
              +   DV+SFGVVL EL T
Sbjct: 210 SKFSVASDVWSFGVVLYELFT 230

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 10/201 (4%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG V + C  D L+     + VAVK L  +  +  R++  E+  L  L+H ++V 
Sbjct: 23  LGKGNFGSV-EMCRYDPLQDNT-GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 147 LIGYCCEDEHR--LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR-CLAFLHGE 203
             G C     R   L+ EY+  G+L D L K+       +  IK+    ++ C    +  
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYLG 136
Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQG-EDSHITTCVMGTEGYAAPEYINT 262
            K  I+RD    NIL++++   K+ DFGL    PQ  E   +         + APE +  
Sbjct: 137 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 196
Query: 263 GHLTTMCDVFSFGVVLLELLT 283
              +   DV+SFGVVL EL T
Sbjct: 197 SKFSVASDVWSFGVVLYELFT 217

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 10/201 (4%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG V + C  D L+     + VAVK L  +  +  R++  E+  L  L+H ++V 
Sbjct: 49  LGKGNFGSV-EMCRYDPLQDN-TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 147 LIGYCCEDEHR--LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR-CLAFLHGE 203
             G C     R   L+ EY+  G+L D L K+       +  IK+    ++ C    +  
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYLG 162
Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQG-EDSHITTCVMGTEGYAAPEYINT 262
            K  I+RD    NIL++++   K+ DFGL    PQ  E   +         + APE +  
Sbjct: 163 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 222
Query: 263 GHLTTMCDVFSFGVVLLELLT 283
              +   DV+SFGVVL EL T
Sbjct: 223 SKFSVASDVWSFGVVLYELFT 243

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 10/201 (4%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG V + C  D L+     + VAVK L  +  +  R++  E+  L  L+H ++V 
Sbjct: 25  LGKGNFGSV-EMCRYDPLQDNT-GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 147 LIGYCCEDEHR--LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR-CLAFLHGE 203
             G C     R   L+ EY+  G+L D L K+       +  IK+    ++ C    +  
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYLG 138
Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQG-EDSHITTCVMGTEGYAAPEYINT 262
            K  I+RD    NIL++++   K+ DFGL    PQ  E   +         + APE +  
Sbjct: 139 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 198
Query: 263 GHLTTMCDVFSFGVVLLELLT 283
              +   DV+SFGVVL EL T
Sbjct: 199 SKFSVASDVWSFGVVLYELFT 219

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 119/274 (43%), Gaps = 31/274 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ-LKHPHLV 145
           LGEG +G+V            +  + VAVK++D+  +    E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 67
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
              G+  E   + L  EY + G L D++  +     P   R    + A   + +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG--VVYLHG--I 123
Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
            + +RD K  N+LLD   N K+SDFGLAT         +   + GT  Y APE +     
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 266 -TTMCDVFSFGVVLLELLTGRRSVEK--NRCKREKDLVEWARPMLKDFTKLDQIIDSRLE 322
                DV+S G+VL  +L G    ++  + C+   D  E  +  L  + K+D        
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-KKTYLNPWKKIDSAP----- 237
Query: 323 DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                       A+ H+ L  NP +R T+  + K
Sbjct: 238 -----------LALLHKILVENPSARITIPDIKK 260

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 119/274 (43%), Gaps = 31/274 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ-LKHPHLV 145
           LGEG +G+V            +  + VAVK++D+  +    E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
              G+  E   + L  EY + G L D++  +     P   R    + A   + +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG--VVYLHG--I 123
Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
            + +RD K  N+LLD   N K+SDFGLAT         +   + GT  Y APE +     
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 266 -TTMCDVFSFGVVLLELLTGRRSVEK--NRCKREKDLVEWARPMLKDFTKLDQIIDSRLE 322
                DV+S G+VL  +L G    ++  + C+   D  E  +  L  + K+D        
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-KKTYLNPWKKIDSAP----- 237
Query: 323 DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                       A+ H+ L  NP +R T+  + K
Sbjct: 238 -----------LALLHKILVENPSARITIPDIKK 260

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 10/201 (4%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG V + C  D L+     + VAVK L  +  +  R++  E+  L  L+H ++V 
Sbjct: 24  LGKGNFGSV-EMCRYDPLQDNT-GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 147 LIGYCCEDEHR--LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR-CLAFLHGE 203
             G C     R   L+ EY+  G+L D L K+       +  IK+    ++ C    +  
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYLG 137
Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQG-EDSHITTCVMGTEGYAAPEYINT 262
            K  I+RD    NIL++++   K+ DFGL    PQ  E   +         + APE +  
Sbjct: 138 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 197
Query: 263 GHLTTMCDVFSFGVVLLELLT 283
              +   DV+SFGVVL EL T
Sbjct: 198 SKFSVASDVWSFGVVLYELFT 218

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 119/274 (43%), Gaps = 31/274 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ-LKHPHLV 145
           LGEG +G+V            +  + VAVK++D+  +    E + + I + + L H ++V
Sbjct: 15  LGEGAYGEVQLAVNR------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
              G+  E   + L  EY + G L D++  +     P   R    + A   + +LHG   
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG--VVYLHG--I 124
Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
            + +RD K  N+LLD   N K+SDFGLAT         +   + GT  Y APE +     
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 266 -TTMCDVFSFGVVLLELLTGRRSVEK--NRCKREKDLVEWARPMLKDFTKLDQIIDSRLE 322
                DV+S G+VL  +L G    ++  + C+   D  E  +  L  + K+D        
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-KKTYLNPWKKIDSAP----- 238
Query: 323 DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                       A+ H+ L  NP +R T+  + K
Sbjct: 239 -----------LALLHKILVENPSARITIPDIKK 261

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 119/274 (43%), Gaps = 31/274 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ-LKHPHLV 145
           LGEG +G+V            +  + VAVK++D+  +    E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
              G+  E   + L  EY + G L D++  +     P   R    + A   + +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG--VVYLHG--I 123
Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
            + +RD K  N+LLD   N K+SDFGLAT         +   + GT  Y APE +     
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 266 -TTMCDVFSFGVVLLELLTGRRSVEK--NRCKREKDLVEWARPMLKDFTKLDQIIDSRLE 322
                DV+S G+VL  +L G    ++  + C+   D  E  +  L  + K+D        
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-KKTYLNPWKKIDSAP----- 237
Query: 323 DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                       A+ H+ L  NP +R T+  + K
Sbjct: 238 -----------LALLHKILVENPSARITIPDIKK 260

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 119/284 (41%), Gaps = 37/284 (13%)
Query: 80  NFSRSDYLGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ 138
           NF     +G G F +VY+  C+ D +   LK     V++ D+  ++   + + E+  L Q
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKK----VQIFDLMDAKARADCIKEIDLLKQ 88
Query: 139 LKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQL--FKNYSSTLPWLTRIKIAIGAARC 196
           L HP+++       ED    +V E    G+L   +  FK     +P  T  K  +    C
Sbjct: 89  LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL--C 146
Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
            A  H   + V++RD K +N+ + +    KL D GL         +     ++GT  Y +
Sbjct: 147 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMS 204
Query: 257 PEYINTGHLTTMCDVFSFGVVLLEL------LTGRRSVEKNRCKREKDLVEWARPMLKDF 310
           PE I+        D++S G +L E+        G +    + CK+ +           D+
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC---------DY 255
Query: 311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTV 354
             L         D YS E    L  + + C++ +P+ RP +T V
Sbjct: 256 PPLP-------SDHYSEE----LRQLVNMCINPDPEKRPDVTYV 288

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 119/274 (43%), Gaps = 31/274 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ-LKHPHLV 145
           LGEG +G+V            +  + VAVK++D+  +    E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAVNR------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
              G+  E   + L  EY + G L D++  +     P   R    + A   + +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG--VVYLHG--I 123
Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
            + +RD K  N+LLD   N K+SDFGLAT         +   + GT  Y APE +     
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 266 -TTMCDVFSFGVVLLELLTGRRSVEK--NRCKREKDLVEWARPMLKDFTKLDQIIDSRLE 322
                DV+S G+VL  +L G    ++  + C+   D  E  +  L  + K+D        
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-KKTYLNPWKKIDSAP----- 237
Query: 323 DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                       A+ H+ L  NP +R T+  + K
Sbjct: 238 -----------LALLHKILVENPSARITIPDIKK 260

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 10/201 (4%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG V + C  D L+     + VAVK L  +  +  R++  E+  L  L+H ++V 
Sbjct: 36  LGKGNFGSV-EMCRYDPLQDN-TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 147 LIGYCCEDEHR--LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR-CLAFLHGE 203
             G C     R   L+ EY+  G+L D L K+       +  IK+    ++ C    +  
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYLG 149
Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQG-EDSHITTCVMGTEGYAAPEYINT 262
            K  I+RD    NIL++++   K+ DFGL    PQ  E   +         + APE +  
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 263 GHLTTMCDVFSFGVVLLELLT 283
              +   DV+SFGVVL EL T
Sbjct: 210 SKFSVASDVWSFGVVLYELFT 230

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 128/296 (43%), Gaps = 37/296 (12%)
Query: 87  LGEGGFGKVY--KGCVDDNLRPGLKAQTVAVKVLDVNGSQGH-REWLAEVIFLGQL-KHP 142
           LGEG FG+V   +    D  +P  +   VAVK+L  + ++    + ++E+  +  + KH 
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPN-RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQL--------------FKNYSSTLPWLTRIK 188
           +++NL+G C +D    ++ EY + GNL + L                N    L     + 
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVS 139
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
            A   AR + +L    K  I+RD  A N+L+  D   K++DFGLA D    +    TT  
Sbjct: 140 CAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
                + APE +     T   DV+SFGV+L E+ T   S            VE    +LK
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------VEELFKLLK 251
Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL 364
           +  ++D+           +     L  +   C    P  RPT   +V+ L+ ++ L
Sbjct: 252 EGHRMDK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 87/326 (26%), Positives = 144/326 (44%), Gaps = 53/326 (16%)
Query: 72  KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA 131
           K++QM+         +G+G +G+V+ G          + + VAVKV     +     W  
Sbjct: 37  KQIQMVKQ-------IGKGRYGEVWMG--------KWRGEKVAVKVF---FTTEEASWFR 78
Query: 132 EVIFLGQLKHPHLVNLIGYCCED-------EHRLLVYEYMALGNLHDQLFKNYSSTLPWL 184
           E      +   H  N++G+   D           L+ +Y   G+L+D L    S+TL   
Sbjct: 79  ETEIYQTVLMRH-ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAK 134
Query: 185 TRIKIAIGAARCLAFLHGE-----EKPVI-YRDFKASNILLDSDYNAKLSDFGLATD--G 236
           + +K+A  +   L  LH E      KP I +RD K+ NIL+  +    ++D GLA     
Sbjct: 135 SMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFIS 194
Query: 237 PQGEDSHITTCVMGTEGYAAPEY----INTGHLTT--MCDVFSFGVVLLELLTGRRSVEK 290
              E        +GT+ Y  PE     +N  H  +  M D++SFG++L E+   RR V  
Sbjct: 195 DTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV--ARRCVSG 252
Query: 291 NRCKREK----DLVEWARPMLKDFTKLDQIIDSR--LEDRYST-EGAKRLAAVAHQCLSH 343
              +  +    DLV  + P  +D  ++  I   R    +R+S+ E  +++  +  +C +H
Sbjct: 253 GIVEEYQLPYHDLVP-SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAH 311
Query: 344 NPKSRPTMTTVVKALEPLLDLNDIPI 369
           NP SR T   V K L  + +  DI +
Sbjct: 312 NPASRLTALRVKKTLAKMSESQDIKL 337

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 119/274 (43%), Gaps = 31/274 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ-LKHPHLV 145
           LGEG +G+V            +  + VAVK++D+  +    E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
              G+  E   + L  EY + G L D++  +     P   R    + A   + +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG--VVYLHG--I 123
Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
            + +RD K  N+LLD   N K+SDFGLAT         +   + GT  Y APE +     
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 266 -TTMCDVFSFGVVLLELLTGRRSVEK--NRCKREKDLVEWARPMLKDFTKLDQIIDSRLE 322
                DV+S G+VL  +L G    ++  + C+   D  E  +  L  + K+D        
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-KKTYLNPWKKIDSAP----- 237
Query: 323 DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                       A+ H+ L  NP +R T+  + K
Sbjct: 238 -----------LALLHKILVENPSARITIPDIKK 260

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 128/296 (43%), Gaps = 37/296 (12%)
Query: 87  LGEGGFGKVY--KGCVDDNLRPGLKAQTVAVKVLDVNGSQGH-REWLAEVIFLGQL-KHP 142
           LGEG FG+V   +    D  +P  +   VAVK+L  + ++    + ++E+  +  + KH 
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPN-RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 86
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQL--------------FKNYSSTLPWLTRIK 188
           +++NL+G C +D    ++ EY + GNL + L                N    L     + 
Sbjct: 87  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 146
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
            A   AR + +L    K  I+RD  A N+L+  D   K++DFGLA D    +    TT  
Sbjct: 147 CAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
                + APE +     T   DV+SFGV+L E+ T   S            VE    +LK
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------VEELFKLLK 258
Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL 364
           +  ++D+           +     L  +   C    P  RPT   +V+ L+ ++ L
Sbjct: 259 EGHRMDK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 304

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 128/296 (43%), Gaps = 37/296 (12%)
Query: 87  LGEGGFGKVY--KGCVDDNLRPGLKAQTVAVKVLDVNGSQGH-REWLAEVIFLGQL-KHP 142
           LGEG FG+V   +    D  +P  +   VAVK+L  + ++    + ++E+  +  + KH 
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPN-RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 87
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQL--------------FKNYSSTLPWLTRIK 188
           +++NL+G C +D    ++ EY + GNL + L                N    L     + 
Sbjct: 88  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 147
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
            A   AR + +L    K  I+RD  A N+L+  D   K++DFGLA D    +    TT  
Sbjct: 148 CAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
                + APE +     T   DV+SFGV+L E+ T   S            VE    +LK
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------VEELFKLLK 259
Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL 364
           +  ++D+           +     L  +   C    P  RPT   +V+ L+ ++ L
Sbjct: 260 EGHRMDK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 305

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 128/296 (43%), Gaps = 37/296 (12%)
Query: 87  LGEGGFGKVY--KGCVDDNLRPGLKAQTVAVKVLDVNGSQGH-REWLAEVIFLGQL-KHP 142
           LGEG FG+V   +    D  +P  +   VAVK+L  + ++    + ++E+  +  + KH 
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPN-RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 83
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQL--------------FKNYSSTLPWLTRIK 188
           +++NL+G C +D    ++ EY + GNL + L                N    L     + 
Sbjct: 84  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 143
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
            A   AR + +L    K  I+RD  A N+L+  D   K++DFGLA D    +    TT  
Sbjct: 144 CAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
                + APE +     T   DV+SFGV+L E+ T   S            VE    +LK
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------VEELFKLLK 255
Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL 364
           +  ++D+           +     L  +   C    P  RPT   +V+ L+ ++ L
Sbjct: 256 EGHRMDK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 301

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 110/229 (48%), Gaps = 16/229 (6%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQ 138
           +F R   LG G  G V K       RP      +A K++ +      R + + E+  L +
Sbjct: 17  DFERISELGAGNGGVVTK----VQHRP--SGLIMARKLIHLEIKPAIRNQIIRELQVLHE 70
Query: 139 LKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLA 198
              P++V   G    D    +  E+M  G+L DQ+ K  +  +P     K++I   R LA
Sbjct: 71  CNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKE-AKRIPEEILGKVSIAVLRGLA 128
Query: 199 FLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPE 258
           +L  E+  +++RD K SNIL++S    KL DFG++    Q  DS +    +GT  Y APE
Sbjct: 129 YLR-EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDS-MANSFVGTRSYMAPE 183
Query: 259 YINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML 307
            +   H +   D++S G+ L+EL  GR  +     K  + +  + RP++
Sbjct: 184 RLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAI--FGRPVV 230

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 119/274 (43%), Gaps = 31/274 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ-LKHPHLV 145
           LGEG +G+V            +  + VAVK++D+  +    E + + I + + L H ++V
Sbjct: 15  LGEGAYGEVQLAVNR------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
              G+  E   + L  EY + G L D++  +     P   R    + A   + +LHG   
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG--VVYLHG--I 124
Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
            + +RD K  N+LLD   N K+SDFGLAT         +   + GT  Y APE +     
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 266 -TTMCDVFSFGVVLLELLTGRRSVEK--NRCKREKDLVEWARPMLKDFTKLDQIIDSRLE 322
                DV+S G+VL  +L G    ++  + C+   D  E  +  L  + K+D        
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-KKTYLNPWKKIDSAP----- 238
Query: 323 DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                       A+ H+ L  NP +R T+  + K
Sbjct: 239 -----------LALLHKILVENPSARITIPDIKK 261

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 119/274 (43%), Gaps = 31/274 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ-LKHPHLV 145
           LGEG +G+V            +  + VAVK++D+  +    E + + I + + L H ++V
Sbjct: 15  LGEGAYGEVQLAVNR------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
              G+  E   + L  EY + G L D++  +     P   R    + A   + +LHG   
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG--VVYLHG--I 124
Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
            + +RD K  N+LLD   N K+SDFGLAT         +   + GT  Y APE +     
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 266 -TTMCDVFSFGVVLLELLTGRRSVEK--NRCKREKDLVEWARPMLKDFTKLDQIIDSRLE 322
                DV+S G+VL  +L G    ++  + C+   D  E  +  L  + K+D        
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-KKTYLNPWKKIDSAP----- 238
Query: 323 DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                       A+ H+ L  NP +R T+  + K
Sbjct: 239 -----------LALLHKILVENPSARITIPDIKK 261

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 119/274 (43%), Gaps = 31/274 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ-LKHPHLV 145
           LGEG +G+V            +  + VAVK++D+  +    E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
              G+  E   + L  EY + G L D++  +     P   R    + A   + +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG--VVYLHG--I 123
Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
            + +RD K  N+LLD   N K+SDFGLAT         +   + GT  Y APE +     
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 266 -TTMCDVFSFGVVLLELLTGRRSVEK--NRCKREKDLVEWARPMLKDFTKLDQIIDSRLE 322
                DV+S G+VL  +L G    ++  + C+   D  E  +  L  + K+D        
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-KKTYLNPWKKIDSAP----- 237
Query: 323 DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                       A+ H+ L  NP +R T+  + K
Sbjct: 238 -----------LALLHKILVENPSARITIPDIKK 260

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 119/274 (43%), Gaps = 31/274 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ-LKHPHLV 145
           LGEG +G+V            +  + VAVK++D+  +    E + + I + + L H ++V
Sbjct: 15  LGEGAYGEVQLAVNR------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
              G+  E   + L  EY + G L D++  +     P   R    + A   + +LHG   
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG--VVYLHG--I 124
Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
            + +RD K  N+LLD   N K+SDFGLAT         +   + GT  Y APE +     
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 266 -TTMCDVFSFGVVLLELLTGRRSVEK--NRCKREKDLVEWARPMLKDFTKLDQIIDSRLE 322
                DV+S G+VL  +L G    ++  + C+   D  E  +  L  + K+D        
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-KKTYLNPWKKIDSAP----- 238
Query: 323 DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                       A+ H+ L  NP +R T+  + K
Sbjct: 239 -----------LALLHKILVENPSARITIPDIKK 261

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 119/274 (43%), Gaps = 31/274 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ-LKHPHLV 145
           LGEG +G+V            +  + VAVK++D+  +    E + + I + + L H ++V
Sbjct: 13  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
              G+  E   + L  EY + G L D++  +     P   R    + A   + +LHG   
Sbjct: 67  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG--VVYLHG--I 122
Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
            + +RD K  N+LLD   N K+SDFGLAT         +   + GT  Y APE +     
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 266 -TTMCDVFSFGVVLLELLTGRRSVEK--NRCKREKDLVEWARPMLKDFTKLDQIIDSRLE 322
                DV+S G+VL  +L G    ++  + C+   D  E  +  L  + K+D        
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-KKTYLNPWKKIDSAP----- 236
Query: 323 DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                       A+ H+ L  NP +R T+  + K
Sbjct: 237 -----------LALLHKILVENPSARITIPDIKK 259

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 128/296 (43%), Gaps = 37/296 (12%)
Query: 87  LGEGGFGKVY--KGCVDDNLRPGLKAQTVAVKVLDVNGSQGH-REWLAEVIFLGQL-KHP 142
           LGEG FG+V   +    D  +P  +   VAVK+L  + ++    + ++E+  +  + KH 
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPN-RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 94
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQL--------------FKNYSSTLPWLTRIK 188
           +++NL+G C +D    ++ EY + GNL + L                N    L     + 
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVS 154
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
            A   AR + +L    K  I+RD  A N+L+  D   K++DFGLA D    +    TT  
Sbjct: 155 CAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
                + APE +     T   DV+SFGV+L E+ T   S            VE    +LK
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------VEELFKLLK 266
Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL 364
           +  ++D+           +     L  +   C    P  RPT   +V+ L+ ++ L
Sbjct: 267 EGHRMDK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 312

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 119/274 (43%), Gaps = 31/274 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ-LKHPHLV 145
           LGEG +G+V            +  + VAVK++D+  +    E + + I + + L H ++V
Sbjct: 15  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
              G+  E   + L  EY + G L D++  +     P   R    + A   + +LHG   
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG--VVYLHG--I 124
Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
            + +RD K  N+LLD   N K+SDFGLAT         +   + GT  Y APE +     
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 266 -TTMCDVFSFGVVLLELLTGRRSVEK--NRCKREKDLVEWARPMLKDFTKLDQIIDSRLE 322
                DV+S G+VL  +L G    ++  + C+   D  E  +  L  + K+D        
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-KKTYLNPWKKIDSAP----- 238
Query: 323 DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                       A+ H+ L  NP +R T+  + K
Sbjct: 239 -----------LALLHKILVENPSARITIPDIKK 261

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 119/274 (43%), Gaps = 31/274 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ-LKHPHLV 145
           LGEG +G+V            +  + VAVK++D+  +    E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
              G+  E   + L  EY + G L D++  +     P   R    + A   + +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG--VVYLHG--I 123
Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
            + +RD K  N+LLD   N K+SDFGLAT         +   + GT  Y APE +     
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 266 -TTMCDVFSFGVVLLELLTGRRSVEK--NRCKREKDLVEWARPMLKDFTKLDQIIDSRLE 322
                DV+S G+VL  +L G    ++  + C+   D  E  +  L  + K+D        
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-KKTYLNPWKKIDSAP----- 237
Query: 323 DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                       A+ H+ L  NP +R T+  + K
Sbjct: 238 -----------LALLHKILVENPSARITIPDIKK 260

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 119/274 (43%), Gaps = 31/274 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ-LKHPHLV 145
           LGEG +G+V            +  + VAVK++D+  +    E + + I + + L H ++V
Sbjct: 15  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
              G+  E   + L  EY + G L D++  +     P   R    + A   + +LHG   
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG--VVYLHG--I 124
Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
            + +RD K  N+LLD   N K+SDFGLAT         +   + GT  Y APE +     
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 266 -TTMCDVFSFGVVLLELLTGRRSVEK--NRCKREKDLVEWARPMLKDFTKLDQIIDSRLE 322
                DV+S G+VL  +L G    ++  + C+   D  E  +  L  + K+D        
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-KKTYLNPWKKIDSAP----- 238
Query: 323 DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                       A+ H+ L  NP +R T+  + K
Sbjct: 239 -----------LALLHKILVENPSARITIPDIKK 261

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 117/274 (42%), Gaps = 31/274 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA-EVIFLGQLKHPHLV 145
           LGEG +G+V            +  + VAVK++D+  +    E +  E+     L H ++V
Sbjct: 15  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVV 68
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
              G+  E   + L  EY + G L D++  +     P   R    + A   + +LHG   
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG--VVYLHG--I 124
Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
            + +RD K  N+LLD   N K+SDFGLAT         +   + GT  Y APE +     
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 266 -TTMCDVFSFGVVLLELLTGRRSVEK--NRCKREKDLVEWARPMLKDFTKLDQIIDSRLE 322
                DV+S G+VL  +L G    ++  + C+   D  E  +  L  + K+D        
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-KKTYLNPWKKIDSAP----- 238
Query: 323 DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                       A+ H+ L  NP +R T+  + K
Sbjct: 239 -----------LALLHKILVENPSARITIPDIKK 261

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 128/296 (43%), Gaps = 37/296 (12%)
Query: 87  LGEGGFGKVY--KGCVDDNLRPGLKAQTVAVKVLDVNGSQGH-REWLAEVIFLGQL-KHP 142
           LGEG FG+V   +    D  +P  +   VAVK+L  + ++    + ++E+  +  + KH 
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPN-RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 94
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQL--------------FKNYSSTLPWLTRIK 188
           +++NL+G C +D    ++ EY + GNL + L                N    L     + 
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 154
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
            A   AR + +L    K  I+RD  A N+L+  D   K++DFGLA D    +    TT  
Sbjct: 155 CAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
                + APE +     T   DV+SFGV+L E+ T   S            VE    +LK
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------VEELFKLLK 266
Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL 364
           +  ++D+           +     L  +   C    P  RPT   +V+ L+ ++ L
Sbjct: 267 EGHRMDK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 312

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 119/274 (43%), Gaps = 31/274 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ-LKHPHLV 145
           LGEG +G+V            +  + VAVK++D+  +    E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
              G+  E   + L  EY + G L D++  +     P   R    + A   + +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG--VVYLHG--I 123
Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
            + +RD K  N+LLD   N K+SDFGLAT         +   + GT  Y APE +     
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 266 -TTMCDVFSFGVVLLELLTGRRSVEK--NRCKREKDLVEWARPMLKDFTKLDQIIDSRLE 322
                DV+S G+VL  +L G    ++  + C+   D  E  +  L  + K+D        
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-KKTYLNPWKKIDSAP----- 237
Query: 323 DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                       A+ H+ L  NP +R T+  + K
Sbjct: 238 -----------LALLHKILVENPSARITIPDIKK 260

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG V + C  D L+     + VAVK L  +  +  R++  E+  L  L+H ++V 
Sbjct: 18  LGKGNFGSV-EMCRYDPLQDN-TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 147 LIGYCCEDEHR--LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR-CLAFLHGE 203
             G C     R   L+ EY+  G+L D L K+       +  IK+    ++ C    +  
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYLG 131
Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG---YAAPEYI 260
            K  I+RD    NIL++++   K+ DFGL    PQ  D          E    + APE +
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ--DKEFFKVKEPGESPIFWYAPESL 189
Query: 261 NTGHLTTMCDVFSFGVVLLELLT 283
                +   DV+SFGVVL EL T
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT 212

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 119/274 (43%), Gaps = 31/274 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ-LKHPHLV 145
           LGEG +G+V            +  + VAVK++D+  +    E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
              G+  E   + L  EY + G L D++  +     P   R    + A   + +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG--VVYLHG--I 123
Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
            + +RD K  N+LLD   N K+SDFGLAT         +   + GT  Y APE +     
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 266 -TTMCDVFSFGVVLLELLTGRRSVEK--NRCKREKDLVEWARPMLKDFTKLDQIIDSRLE 322
                DV+S G+VL  +L G    ++  + C+   D  E  +  L  + K+D        
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-KKTYLNPWKKIDSAP----- 237
Query: 323 DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                       A+ H+ L  NP +R T+  + K
Sbjct: 238 -----------LALLHKILVENPSARITIPDIKK 260

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 8/200 (4%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG V + C  D L+     + VAVK L  +  +  R++  E+  L  L+H ++V 
Sbjct: 21  LGKGNFGSV-EMCRYDPLQDN-TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 147 LIGYCCEDEHR--LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
             G C     R   L+ EY+  G+L D L + ++  +  +  ++      + + +L    
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QAHAERIDHIKLLQYTSQICKGMEYLGT-- 135
Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQG-EDSHITTCVMGTEGYAAPEYINTG 263
           K  I+RD    NIL++++   K+ DFGL    PQ  E   +         + APE +   
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 264 HLTTMCDVFSFGVVLLELLT 283
             +   DV+SFGVVL EL T
Sbjct: 196 KFSVASDVWSFGVVLYELFT 215

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 128/296 (43%), Gaps = 37/296 (12%)
Query: 87  LGEGGFGKVY--KGCVDDNLRPGLKAQTVAVKVLDVNGSQGH-REWLAEVIFLGQL-KHP 142
           LGEG FG+V   +    D  +P  +   VAVK+L  + ++    + ++E+  +  + KH 
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPN-RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 94
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQL--------------FKNYSSTLPWLTRIK 188
           +++NL+G C +D    ++ EY + GNL + L                N    L     + 
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVS 154
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
            A   AR + +L    K  I+RD  A N+L+  D   K++DFGLA D    +    TT  
Sbjct: 155 CAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
                + APE +     T   DV+SFGV+L E+ T   S            VE    +LK
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------VEELFKLLK 266
Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL 364
           +  ++D+           +     L  +   C    P  RPT   +V+ L+ ++ L
Sbjct: 267 EGHRMDK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 312

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLG 137
           N+     +G+G F KV         R  L  + VAVK++D     S   ++   EV  + 
Sbjct: 8   NYRLLKTIGKGNFAKVKLA------RHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMK 61
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
            L HP++V L      ++   LV EY + G + D L  +      W+   K A    R +
Sbjct: 62  VLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH-----GWMKE-KEARAKFRQI 115
Query: 198 --AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
             A  +  +K +++RD KA N+LLD+D N K++DFG + +   G +   T C  G+  YA
Sbjct: 116 VSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDTFC--GSPPYA 172
Query: 256 APE-YINTGHLTTMCDVFSFGVVLLELLTG 284
           APE +    +     DV+S GV+L  L++G
Sbjct: 173 APELFQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 128/296 (43%), Gaps = 37/296 (12%)
Query: 87  LGEGGFGKVY--KGCVDDNLRPGLKAQTVAVKVLDVNGSQGH-REWLAEVIFLGQL-KHP 142
           LGEG FG+V   +    D  +P  +   VAVK+L  + ++    + ++E+  +  + KH 
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPN-RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQL--------------FKNYSSTLPWLTRIK 188
           +++NL+G C +D    ++ EY + GNL + L                N    L     + 
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
            A   AR + +L    K  I+RD  A N+L+  D   K++DFGLA D    +    TT  
Sbjct: 196 CAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
                + APE +     T   DV+SFGV+L E+ T   S            VE    +LK
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------VEELFKLLK 307
Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL 364
           +  ++D+           +     L  +   C    P  RPT   +V+ L+ ++ L
Sbjct: 308 EGHRMDK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 88/333 (26%), Positives = 151/333 (45%), Gaps = 47/333 (14%)
Query: 56  ELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAV 115
           ++++S  GS L +   +    I       + +G+G FG+V++G          + + VAV
Sbjct: 22  DMTTSGSGSGLPLLVQR---TIARTIVLQESIGKGRFGEVWRG--------KWRGEEVAV 70
Query: 116 KVLDVNGSQGHREWL--AEVIFLGQLKHPHLVNLIGYCCEDE----HRLLVYEYMALGNL 169
           K+     S+  R W   AE+     L+H +++  I    +D        LV +Y   G+L
Sbjct: 71  KIF---SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL 127
Query: 170 HDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE-----EKPVI-YRDFKASNILLDSDY 223
            D L   Y+ T+  +  IK+A+  A  LA LH E      KP I +RD K+ NIL+  + 
Sbjct: 128 FDYL-NRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 184
Query: 224 NAKLSDFGLATDGPQGEDS--HITTCVMGTEGYAAPEY----INTGHLTTM--CDVFSFG 275
              ++D GLA       D+        +GT+ Y APE     IN  H  +    D+++ G
Sbjct: 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 244
Query: 276 VVLLELLTGRR----SVEKNRCKREKDLVEWARPMLKDFTKL--DQIIDSRLEDRY-STE 328
           +V  E+   RR     + ++      DLV  + P +++  K+  +Q +   + +R+ S E
Sbjct: 245 LVFWEI--ARRCSIGGIHEDYQLPYYDLVP-SDPSVEEMRKVVCEQKLRPNIPNRWQSCE 301
Query: 329 GAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL 361
             + +A +  +C   N  +R T   + K L  L
Sbjct: 302 ALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK 140
           ++R + +G+G  G VY      ++  G   Q VA++ +++         + E++ + + K
Sbjct: 22  YTRFEKIGQGASGTVYTAM---DVATG---QEVAIRQMNLQQQPKKELIINEILVMRENK 75
Query: 141 HPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLA-- 198
           +P++VN +      +   +V EY+A G+L D +      T   +   +IA     CL   
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQAL 129
Query: 199 -FLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAP 257
            FLH  +  VI+RD K+ NILL  D + KL+DFG        +     + ++GT  + AP
Sbjct: 130 EFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWMAP 185
Query: 258 EYINTGHLTTMCDVFSFGVVLLELLTGR 285
           E +         D++S G++ +E++ G 
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 88/333 (26%), Positives = 151/333 (45%), Gaps = 47/333 (14%)
Query: 56  ELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAV 115
           ++++S  GS L +   +    I       + +G+G FG+V++G          + + VAV
Sbjct: 9   DMTTSGSGSGLPLLVQR---TIARTIVLQESIGKGRFGEVWRG--------KWRGEEVAV 57
Query: 116 KVLDVNGSQGHREWL--AEVIFLGQLKHPHLVNLIGYCCEDE----HRLLVYEYMALGNL 169
           K+     S+  R W   AE+     L+H +++  I    +D        LV +Y   G+L
Sbjct: 58  KIFS---SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL 114
Query: 170 HDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE-----EKPVI-YRDFKASNILLDSDY 223
            D L   Y+ T+  +  IK+A+  A  LA LH E      KP I +RD K+ NIL+  + 
Sbjct: 115 FDYL-NRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 171
Query: 224 NAKLSDFGLATDGPQGEDS--HITTCVMGTEGYAAPEY----INTGHLTTM--CDVFSFG 275
              ++D GLA       D+        +GT+ Y APE     IN  H  +    D+++ G
Sbjct: 172 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 231
Query: 276 VVLLELLTGRR----SVEKNRCKREKDLVEWARPMLKDFTKL--DQIIDSRLEDRY-STE 328
           +V  E+   RR     + ++      DLV  + P +++  K+  +Q +   + +R+ S E
Sbjct: 232 LVFWEI--ARRCSIGGIHEDYQLPYYDLVP-SDPSVEEMRKVVCEQKLRPNIPNRWQSCE 288
Query: 329 GAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL 361
             + +A +  +C   N  +R T   + K L  L
Sbjct: 289 ALRVMAKIMRECWYANGAARLTALRIKKTLSQL 321

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK 140
           ++R + +G+G  G VY      ++  G   Q VA++ +++         + E++ + + K
Sbjct: 23  YTRFEKIGQGASGTVYTAM---DVATG---QEVAIRQMNLQQQPKKELIINEILVMRENK 76
Query: 141 HPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLA-- 198
           +P++VN +      +   +V EY+A G+L D +      T   +   +IA     CL   
Sbjct: 77  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQAL 130
Query: 199 -FLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAP 257
            FLH  +  VI+RD K+ NILL  D + KL+DFG        +     + ++GT  + AP
Sbjct: 131 EFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWMAP 186
Query: 258 EYINTGHLTTMCDVFSFGVVLLELLTGR 285
           E +         D++S G++ +E++ G 
Sbjct: 187 EVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 48/242 (19%)
Query: 64  SNLHVFTLKELQMITHNFSRSDY------LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV 117
            NL+  ++K+ + +T + +  D+      LG+G FGKVYK     N    + A   A KV
Sbjct: 16  ENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKA---QNKETSVLA---AAKV 69
Query: 118 LDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNY 177
           +D    +   +++ E+  L    HP++V L+     + +  ++ E+ A G +   + +  
Sbjct: 70  IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE 129
Query: 178 SSTLPWLTRIKIAIGAAR---CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA- 233
                 LT  +I +   +    L +LH  +  +I+RD KA NIL   D + KL+DFG++ 
Sbjct: 130 RP----LTESQIQVVCKQTLDALNYLH--DNKIIHRDLKAGNILFTLDGDIKLADFGVSA 183
Query: 234 --TDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMC------------DVFSFGVVLL 279
             T   Q  D  I     GT  + APE +       MC            DV+S G+ L+
Sbjct: 184 KNTRXIQRRDXFI-----GTPYWMAPEVV-------MCETSKDRPYDYKADVWSLGITLI 231
Query: 280 EL 281
           E+
Sbjct: 232 EM 233

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 14/209 (6%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 7   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +L HP++V L+     +    LV+E++++ +L D +  +  + +P            + L
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAP 257
           AF H     V++RD K  N+L++++   KL+DFGLA        ++    V  T  Y AP
Sbjct: 120 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 258 E-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           E  +   + +T  D++S G +  E++T R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 120/274 (43%), Gaps = 30/274 (10%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFLGQLKHPH 143
           LG+G FG V +G  D    P  K  +VAVK L    ++  +   +++ EV  +  L H +
Sbjct: 20  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 76
Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE 203
           L+ L G       ++ V E   LG+L D+L K+    L   T  + A+  A  + +L  E
Sbjct: 77  LIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYL--E 132
Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE-GYAAPEYINT 262
            K  I+RD  A N+LL +    K+ DFGL    PQ +D ++          + APE + T
Sbjct: 133 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 263 GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK-DFTKLDQIIDSRL 321
              +   D + FGV L E+ T  +                  P +  + +++   ID   
Sbjct: 193 RTFSHASDTWMFGVTLWEMFTYGQE-----------------PWIGLNGSQILHKIDKEG 235
Query: 322 EDRYSTEGAKR-LAAVAHQCLSHNPKSRPTMTTV 354
           E     E   + +  V  QC +H P+ RPT   +
Sbjct: 236 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 269

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 104/209 (49%), Gaps = 21/209 (10%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK 140
           ++R + +G+G  G VY      ++  G   Q VA++ +++         + E++ + + K
Sbjct: 23  YTRFEKIGQGASGTVYTAM---DVATG---QEVAIRQMNLQQQPKKELIINEILVMRENK 76
Query: 141 HPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLA-- 198
           +P++VN +      +   +V EY+A G+L D +      T   +   +IA     CL   
Sbjct: 77  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQAL 130
Query: 199 -FLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL-ATDGPQGEDSHITTCVMGTEGYAA 256
            FLH  +  VI+R+ K+ NILL  D + KL+DFG  A   P  E S  +T V GT  + A
Sbjct: 131 EFLHSNQ--VIHRNIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMA 185
Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           PE +         D++S G++ +E++ G 
Sbjct: 186 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 100/216 (46%), Gaps = 14/216 (6%)
Query: 73  ELQMITHNFSRSDYLGEGGFGKVYKGCVDD-NLRPGLKAQTVAVKVLDVNGSQGHREWLA 131
           ++++   +F     LG+G FGKV+       N    +KA    V ++D +      E   
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE--K 69
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNL--HDQLFKNYSSTLPWLTRIKI 189
            V+ L   +HP L ++       E+   V EY+  G+L  H Q    +  +       +I
Sbjct: 70  RVLSLA-WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 128
Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM 249
            +G    L FLH   K ++YRD K  NILLD D + K++DFG+  +   G+      C  
Sbjct: 129 ILG----LQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFC-- 180
Query: 250 GTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           GT  Y APE +         D +SFGV+L E+L G+
Sbjct: 181 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 14/209 (6%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 6   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 59
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +L HP++V L+     +    LV+E++++ +L D +  +  + +P            + L
Sbjct: 60  ELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAP 257
           AF H     V++RD K  N+L++++   KL+DFGLA        ++    V  T  Y AP
Sbjct: 119 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 174
Query: 258 E-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           E  +   + +T  D++S G +  E++T R
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 129/305 (42%), Gaps = 35/305 (11%)
Query: 63  GSNLHVFTLKELQMITH-NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN 121
           G  LH    K+  ++ H +    + +G G FG+V+ G         L+A    V V    
Sbjct: 97  GVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSG--------RLRADNTLVAVKSCR 148
Query: 122 GS---QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYS 178
            +       ++L E   L Q  HP++V LIG C + +   +V E +  G+      +   
Sbjct: 149 ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT-FLRTEG 207
Query: 179 STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ 238
           + L   T +++   AA  + +L  E K  I+RD  A N L+      K+SDFG++ +   
Sbjct: 208 ARLRVKTLLQMVGDAAAGMEYL--ESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265
Query: 239 GEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE-K 297
           G  +           + APE +N G  ++  DV+SFG++L E  +   S   N   ++ +
Sbjct: 266 GVXAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR 325
Query: 298 DLVEWARPMLKDFTKLDQIIDSRLE-DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
           + VE                  RL       +   RL     QC ++ P  RP+ +T+ +
Sbjct: 326 EFVE---------------KGGRLPCPELCPDAVFRL---MEQCWAYEPGQRPSFSTIYQ 367
Query: 357 ALEPL 361
            L+ +
Sbjct: 368 ELQSI 372

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 21/209 (10%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK 140
           ++R + +G+G  G VY      ++  G   Q VA++ +++         + E++ + + K
Sbjct: 22  YTRFEKIGQGASGTVYTAM---DVATG---QEVAIRQMNLQQQPKKELIINEILVMRENK 75
Query: 141 HPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLA-- 198
           +P++VN +      +   +V EY+A G+L D +      T   +   +IA     CL   
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQAL 129
Query: 199 -FLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL-ATDGPQGEDSHITTCVMGTEGYAA 256
            FLH  +  VI+RD K+ NILL  D + KL+DFG  A   P  E S  +  V GT  + A
Sbjct: 130 EFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSEMV-GTPYWMA 184
Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           PE +         D++S G++ +E++ G 
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 122/277 (44%), Gaps = 30/277 (10%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQ 138
           +F +   LG G  G V+K     + +P      +A K++ +      R + + E+  L +
Sbjct: 10  DFEKISELGAGNGGVVFK----VSHKP--SGLVMARKLIHLEIKPAIRNQIIRELQVLHE 63
Query: 139 LKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLA 198
              P++V   G    D    +  E+M  G+L DQ+ K  +  +P     K++I   + L 
Sbjct: 64  CNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKK-AGRIPEQILGKVSIAVIKGLT 121
Query: 199 FLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPE 258
           +L  E+  +++RD K SNIL++S    KL DFG++    Q  D      V GT  Y +PE
Sbjct: 122 YLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDEMANEFV-GTRSYMSPE 176
Query: 259 YINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIID 318
            +   H +   D++S G+ L+E+  GR                + RP +  F  LD I++
Sbjct: 177 RLQGTHYSVQSDIWSMGLSLVEMAVGR----------------YPRPPMAIFELLDYIVN 220
Query: 319 SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVV 355
                  S   +       ++CL  NP  R  +  ++
Sbjct: 221 EPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLM 257

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 10/201 (4%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG V + C  D L+     + VAVK L  +  +  R++  E+  L  L+H ++V 
Sbjct: 19  LGKGNFGSV-EMCRYDPLQDNT-GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 147 LIGYCCEDEHR--LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR-CLAFLHGE 203
             G C     R   L+ EY+  G+L D L K+       +  IK+    ++ C    +  
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYLG 132
Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSH-ITTCVMGTEGYAAPEYINT 262
            K  I+R+    NIL++++   K+ DFGL    PQ ++ + +         + APE +  
Sbjct: 133 TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 192
Query: 263 GHLTTMCDVFSFGVVLLELLT 283
              +   DV+SFGVVL EL T
Sbjct: 193 SKFSVASDVWSFGVVLYELFT 213

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 120/274 (43%), Gaps = 30/274 (10%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFLGQLKHPH 143
           LG+G FG V +G  D    P  K  +VAVK L    ++  +   +++ EV  +  L H +
Sbjct: 16  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE 203
           L+ L G       ++ V E   LG+L D+L K+    L   T  + A+  A  + +L  E
Sbjct: 73  LIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYL--E 128
Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE-GYAAPEYINT 262
            K  I+RD  A N+LL +    K+ DFGL    PQ +D ++          + APE + T
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 263 GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK-DFTKLDQIIDSRL 321
              +   D + FGV L E+ T  +                  P +  + +++   ID   
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQE-----------------PWIGLNGSQILHKIDKEG 231
Query: 322 EDRYSTEGAKR-LAAVAHQCLSHNPKSRPTMTTV 354
           E     E   + +  V  QC +H P+ RPT   +
Sbjct: 232 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 265

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 120/274 (43%), Gaps = 30/274 (10%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFLGQLKHPH 143
           LG+G FG V +G  D    P  K  +VAVK L    ++  +   +++ EV  +  L H +
Sbjct: 26  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE 203
           L+ L G       ++ V E   LG+L D+L K+    L   T  + A+  A  + +L  E
Sbjct: 83  LIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYL--E 138
Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE-GYAAPEYINT 262
            K  I+RD  A N+LL +    K+ DFGL    PQ +D ++          + APE + T
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 263 GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK-DFTKLDQIIDSRL 321
              +   D + FGV L E+ T  +                  P +  + +++   ID   
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQE-----------------PWIGLNGSQILHKIDKEG 241
Query: 322 EDRYSTEGAKR-LAAVAHQCLSHNPKSRPTMTTV 354
           E     E   + +  V  QC +H P+ RPT   +
Sbjct: 242 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 275

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/303 (25%), Positives = 130/303 (42%), Gaps = 40/303 (13%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQ 138
           +F +   LG G  G V+K     +   GL    +A K++ +      R + + E+  L +
Sbjct: 69  DFEKISELGAGNGGVVFKVSHKPS---GL---VMARKLIHLEIKPAIRNQIIRELQVLHE 122
Query: 139 LKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLA 198
              P++V   G    D    +  E+M  G+L DQ+ K  +  +P     K++I   + L 
Sbjct: 123 CNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKK-AGRIPEQILGKVSIAVIKGLT 180
Query: 199 FLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPE 258
           +L  E+  +++RD K SNIL++S    KL DFG++    Q  DS   + V GT  Y +PE
Sbjct: 181 YLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV-GTRSYMSPE 235
Query: 259 YINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNR---------CKREKDLVEW------- 302
            +   H +   D++S G+ L+E+  GR  +             C+ E D  E        
Sbjct: 236 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 295
Query: 303 ----------ARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMT 352
                     +RP +  F  LD I++       S   +       ++CL  NP  R  + 
Sbjct: 296 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLK 355
Query: 353 TVV 355
            ++
Sbjct: 356 QLM 358

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 84/301 (27%), Positives = 126/301 (41%), Gaps = 47/301 (15%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG-HREWLAEVIFLGQLKHPHL- 144
           LG G FG+V +      +      +TVAVK+L    +   HR  ++E+  L  + H HL 
Sbjct: 37  LGRGAFGQVIEADAF-GIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH-HLN 94
Query: 145 -VNLIGYCCEDEHRLLV-YEYMALGNLHDQLFKNYSSTLPWLTR------------IKIA 190
            VNL+G C +    L+V  E+   GNL   L    +  +P+               I  +
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYS 154
Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG 250
              A+ + FL    +  I+RD  A NILL      K+ DFGLA D  +  D         
Sbjct: 155 FQVAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 251 TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS------VEKNRCKREKDLVEWAR 304
              + APE I     T   DV+SFGV+L E+ +   S      +++  C+R         
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR--------- 263
Query: 305 PMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL 364
             LK+ T++      R  D  + E  + +      C    P  RPT + +V+ L  LL  
Sbjct: 264 --LKEGTRM------RAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLGNLLQA 311
Query: 365 N 365
           N
Sbjct: 312 N 312

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/309 (24%), Positives = 133/309 (43%), Gaps = 40/309 (12%)
Query: 74  LQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAE 132
           +++   +F +   LG G  G V+K     + +P      +A K++ +      R + + E
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK----VSHKP--SGLVMARKLIHLEIKPAIRNQIIRE 54
Query: 133 VIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIG 192
           +  L +   P++V   G    D    +  E+M  G+L DQ+ K  +  +P     K++I 
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKK-AGRIPEQILGKVSIA 112
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE 252
             + L +L  E+  +++RD K SNIL++S    KL DFG++    Q  DS   + V GT 
Sbjct: 113 VIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV-GTR 167
Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNR---------CKREKDLVEW- 302
            Y +PE +   H +   D++S G+ L+E+  GR  +             C+ E D  E  
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227
Query: 303 ----------------ARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPK 346
                           +RP +  F  LD I++       S   +       ++CL  NP 
Sbjct: 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 287
Query: 347 SRPTMTTVV 355
            R  +  ++
Sbjct: 288 ERADLKQLM 296

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 120/274 (43%), Gaps = 30/274 (10%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFLGQLKHPH 143
           LG+G FG V +G  D    P  K  +VAVK L    ++  +   +++ EV  +  L H +
Sbjct: 20  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 76
Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE 203
           L+ L G       ++ V E   LG+L D+L K+    L   T  + A+  A  + +L  E
Sbjct: 77  LIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYL--E 132
Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE-GYAAPEYINT 262
            K  I+RD  A N+LL +    K+ DFGL    PQ +D ++          + APE + T
Sbjct: 133 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 263 GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK-DFTKLDQIIDSRL 321
              +   D + FGV L E+ T  +                  P +  + +++   ID   
Sbjct: 193 RTFSHASDTWMFGVTLWEMFTYGQE-----------------PWIGLNGSQILHKIDKEG 235
Query: 322 EDRYSTEGAKR-LAAVAHQCLSHNPKSRPTMTTV 354
           E     E   + +  V  QC +H P+ RPT   +
Sbjct: 236 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 269

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 120/274 (43%), Gaps = 30/274 (10%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFLGQLKHPH 143
           LG+G FG V +G  D    P  K  +VAVK L    ++  +   +++ EV  +  L H +
Sbjct: 16  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE 203
           L+ L G       ++ V E   LG+L D+L K+    L   T  + A+  A  + +L  E
Sbjct: 73  LIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYL--E 128
Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE-GYAAPEYINT 262
            K  I+RD  A N+LL +    K+ DFGL    PQ +D ++          + APE + T
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 263 GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK-DFTKLDQIIDSRL 321
              +   D + FGV L E+ T  +                  P +  + +++   ID   
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQE-----------------PWIGLNGSQILHKIDKEG 231
Query: 322 EDRYSTEGAKR-LAAVAHQCLSHNPKSRPTMTTV 354
           E     E   + +  V  QC +H P+ RPT   +
Sbjct: 232 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 265

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 108/234 (46%), Gaps = 28/234 (11%)
Query: 63  GSNLH----VFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL 118
           G +LH    +F      + +  +     LG+G FG+V   C D      +  Q  AVKV+
Sbjct: 30  GDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVIL-CKDK-----ITGQECAVKVI 83
Query: 119 ---DVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLF- 174
               V         L EV  L QL HP+++ L  +  +  +  LV E    G L D++  
Sbjct: 84  SKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS 143
Query: 175 -KNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS---DYNAKLSDF 230
            K +S     +   +I       + ++H  +  +++RD K  N+LL+S   D N ++ DF
Sbjct: 144 RKRFSE----VDAARIIRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDF 197
Query: 231 GLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           GL+T     E S      +GT  Y APE ++ G     CDV+S GV+L  LL+G
Sbjct: 198 GLST---HFEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 247

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 131/296 (44%), Gaps = 37/296 (12%)
Query: 87  LGEGGFGKVY--KGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL--KHP 142
           LGEG FG+V   +    D  +P  +A TVAVK+L  + ++     L   + + ++  KH 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK------NYS--------STLPWLTRIK 188
           +++NL+G C +D    ++ EY + GNL + L         YS          + +   + 
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
                AR + +L  ++   I+RD  A N+L+  +   K++DFGLA D    +    TT  
Sbjct: 162 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
                + APE +     T   DV+SFGV++ E+ T   S            VE    +LK
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------VEELFKLLK 273
Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL 364
           +  ++D+  +   E          L  +   C    P  RPT   +V+ L+ +L L
Sbjct: 274 EGHRMDKPANCTNE----------LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 108/234 (46%), Gaps = 28/234 (11%)
Query: 63  GSNLH----VFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL 118
           G +LH    +F      + +  +     LG+G FG+V   C D      +  Q  AVKV+
Sbjct: 29  GDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVIL-CKDK-----ITGQECAVKVI 82
Query: 119 ---DVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLF- 174
               V         L EV  L QL HP+++ L  +  +  +  LV E    G L D++  
Sbjct: 83  SKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS 142
Query: 175 -KNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS---DYNAKLSDF 230
            K +S     +   +I       + ++H  +  +++RD K  N+LL+S   D N ++ DF
Sbjct: 143 RKRFSE----VDAARIIRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDF 196
Query: 231 GLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           GL+T     E S      +GT  Y APE ++ G     CDV+S GV+L  LL+G
Sbjct: 197 GLST---HFEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 246

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/309 (24%), Positives = 133/309 (43%), Gaps = 40/309 (12%)
Query: 74  LQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAE 132
           +++   +F +   LG G  G V+K     + +P      +A K++ +      R + + E
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK----VSHKP--SGLVMARKLIHLEIKPAIRNQIIRE 54
Query: 133 VIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIG 192
           +  L +   P++V   G    D    +  E+M  G+L DQ+ K  +  +P     K++I 
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKK-AGRIPEQILGKVSIA 112
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE 252
             + L +L  E+  +++RD K SNIL++S    KL DFG++    Q  DS   + V GT 
Sbjct: 113 VIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV-GTR 167
Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNR---------CKREKDLVEW- 302
            Y +PE +   H +   D++S G+ L+E+  GR  +             C+ E D  E  
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227
Query: 303 ----------------ARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPK 346
                           +RP +  F  LD I++       S   +       ++CL  NP 
Sbjct: 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 287
Query: 347 SRPTMTTVV 355
            R  +  ++
Sbjct: 288 ERADLKQLM 296

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 85/302 (28%), Positives = 127/302 (42%), Gaps = 48/302 (15%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG-HREWLAEVIFLGQLKHPHL- 144
           LG G FG+V +      +      +TVAVK+L    +   HR  ++E+  L  + H HL 
Sbjct: 36  LGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH-HLN 93
Query: 145 -VNLIGYCCEDEHRLLV-YEYMALGNLHDQLFKNYSSTLPWLTR-------------IKI 189
            VNL+G C +    L+V  E+   GNL   L    +  +P+ T              I  
Sbjct: 94  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICY 153
Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM 249
           +   A+ + FL    +  I+RD  A NILL      K+ DFGLA D  +  D        
Sbjct: 154 SFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 250 GTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS------VEKNRCKREKDLVEWA 303
               + APE I     T   DV+SFGV+L E+ +   S      +++  C+R        
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-------- 263
Query: 304 RPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD 363
              LK+ T++      R  D  + E  + +      C    P  RPT + +V+ L  LL 
Sbjct: 264 ---LKEGTRM------RAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLGNLLQ 310
Query: 364 LN 365
            N
Sbjct: 311 AN 312

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 118/258 (45%), Gaps = 16/258 (6%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           +GEG  G V   C+      G   + VAVK +D+   Q       EV+ +    H ++V+
Sbjct: 53  IGEGSTGIV---CIATEKHTG---KQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVD 106
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           +       +   +V E++  G L D +     +     T   + +   R L++LH +   
Sbjct: 107 MYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT---VCLSVLRALSYLHNQG-- 161
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
           VI+RD K+ +ILL SD   KLSDFG        ++      ++GT  + APE I+     
Sbjct: 162 VIHRDIKSDSILLTSDGRIKLSDFGFCAQ--VSKEVPKRKXLVGTPYWMAPEVISRLPYG 219
Query: 267 TMCDVFSFGVVLLELLTGRRS-VEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRY 325
           T  D++S G++++E++ G      +   +  + + +   P +KD  K+  ++   L+   
Sbjct: 220 TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKDLHKVSSVLRGFLDLML 279
Query: 326 STEGAKRLAAVAHQCLSH 343
             E ++R  A A + L H
Sbjct: 280 VREPSQR--ATAQELLGH 295

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 100/216 (46%), Gaps = 14/216 (6%)
Query: 73  ELQMITHNFSRSDYLGEGGFGKVYKGCVDD-NLRPGLKAQTVAVKVLDVNGSQGHREWLA 131
           ++++   +F     LG+G FGKV+       N    +KA    V ++D +      E   
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE--K 68
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNL--HDQLFKNYSSTLPWLTRIKI 189
            V+ L   +HP L ++       E+   V EY+  G+L  H Q    +  +       +I
Sbjct: 69  RVLSLA-WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 127
Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM 249
            +G    L FLH   K ++YRD K  NILLD D + K++DFG+  +   G+      C  
Sbjct: 128 ILG----LQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFC-- 179
Query: 250 GTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           GT  Y APE +         D +SFGV+L E+L G+
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 140/302 (46%), Gaps = 44/302 (14%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWL--AEVIFLGQLKHPHL 144
           +G+G FG+V++G          + + VAVK+     S+  R W   AE+     L+H ++
Sbjct: 12  IGKGRFGEVWRG--------KWRGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENI 60
Query: 145 VNLIGYCCEDE----HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFL 200
           +  I    +D        LV +Y   G+L D L + Y+ T+  +  IK+A+  A  LA L
Sbjct: 61  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGM--IKLALSTASGLAHL 117
Query: 201 HGE-----EKPVI-YRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS--HITTCVMGTE 252
           H E      KP I +RD K+ NIL+  +    ++D GLA       D+        +GT+
Sbjct: 118 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 177
Query: 253 GYAAPEY----INTGHLTTM--CDVFSFGVVLLELLTGRR----SVEKNRCKREKDLVEW 302
            Y APE     IN  H  +    D+++ G+V  E+   RR     + ++      DLV  
Sbjct: 178 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI--ARRCSIGGIHEDYQLPYYDLVP- 234
Query: 303 ARPMLKDFTKL--DQIIDSRLEDRY-STEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
           + P +++  K+  +Q +   + +R+ S E  + +A +  +C   N  +R T   + K L 
Sbjct: 235 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 294
Query: 360 PL 361
            L
Sbjct: 295 QL 296

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 130/282 (46%), Gaps = 42/282 (14%)
Query: 87  LGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHP 142
           LG G FG V    +KG  D           VAVK++   GS    E+  E   + +L HP
Sbjct: 16  LGSGQFGVVKLGKWKGQYD-----------VAVKMIK-EGSMSEDEFFQEAQTMMKLSHP 63
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
            LV   G C ++    +V EY++ G L + L +++   L     +++       +AFL  
Sbjct: 64  KLVKFYGVCSKEYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFL-- 120
Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEY 259
           E    I+RD  A N L+D D   K+SDFG+       +D ++++  +GT+    ++APE 
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL--DDQYVSS--VGTKFPVKWSAPEV 176
Query: 260 INTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDS 319
            +    ++  DV++FG+++ E+ +          K   DL   +  +LK  ++  ++   
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFS--------LGKMPYDLYTNSEVVLK-VSQGHRLYRP 227
Query: 320 RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL 361
            L        +  +  + + C    P+ RPT   ++ ++EPL
Sbjct: 228 HL-------ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 129/305 (42%), Gaps = 35/305 (11%)
Query: 63  GSNLHVFTLKELQMITH-NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN 121
           G  LH    K+  ++ H +    + +G G FG+V+ G         L+A    V V    
Sbjct: 97  GVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSG--------RLRADNTLVAVKSCR 148
Query: 122 GS---QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYS 178
            +       ++L E   L Q  HP++V LIG C + +   +V E +  G+      +   
Sbjct: 149 ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT-FLRTEG 207
Query: 179 STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ 238
           + L   T +++   AA  + +L  E K  I+RD  A N L+      K+SDFG++ +   
Sbjct: 208 ARLRVKTLLQMVGDAAAGMEYL--ESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265
Query: 239 GEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE-K 297
           G  +           + APE +N G  ++  DV+SFG++L E  +   S   N   ++ +
Sbjct: 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR 325
Query: 298 DLVEWARPMLKDFTKLDQIIDSRLE-DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
           + VE                  RL       +   RL     QC ++ P  RP+ +T+ +
Sbjct: 326 EFVE---------------KGGRLPCPELCPDAVFRL---MEQCWAYEPGQRPSFSTIYQ 367
Query: 357 ALEPL 361
            L+ +
Sbjct: 368 ELQSI 372

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 83/310 (26%), Positives = 136/310 (43%), Gaps = 60/310 (19%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           +G+G +G+V++G            ++VAVK+     S+  + W  E      +   H  N
Sbjct: 16  VGKGRYGEVWRGL--------WHGESVAVKIF---SSRDEQSWFRETEIYNTVLLRH-DN 63
Query: 147 LIGYCCED-------EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAF 199
           ++G+   D           L+  Y   G+L+D L +    TL     +++A+ AA  LA 
Sbjct: 64  ILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQ---TLEPHLALRLAVSAACGLAH 120
Query: 200 LHGE-----EKPVI-YRDFKASNILLDSDYNAKLSDFGLATDGPQGED--SHITTCVMGT 251
           LH E      KP I +RDFK+ N+L+ S+    ++D GLA    QG D         +GT
Sbjct: 121 LHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGT 180
Query: 252 EGYAAPEYINTGHLTTMC-------DVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR 304
           + Y APE ++   + T C       D+++FG+VL E+   RR++          +VE  R
Sbjct: 181 KRYMAPEVLDE-QIRTDCFESYKWTDIWAFGLVLWEI--ARRTIVNG-------IVEDYR 230
Query: 305 PMLKDFTKLDQIIDSRLE----DRYSTEGAKRLAA---------VAHQCLSHNPKSRPTM 351
           P   D    D   +   +    D+ +     RLAA         +  +C   NP +R T 
Sbjct: 231 PPFYDVVPNDPSFEDMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTA 290
Query: 352 TTVVKALEPL 361
             + K L+ +
Sbjct: 291 LRIKKTLQKI 300

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/309 (24%), Positives = 133/309 (43%), Gaps = 40/309 (12%)
Query: 74  LQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAE 132
           +++   +F +   LG G  G V+K     + +P      +A K++ +      R + + E
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK----VSHKP--SGLVMARKLIHLEIKPAIRNQIIRE 54
Query: 133 VIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIG 192
           +  L +   P++V   G    D    +  E+M  G+L DQ+ K  +  +P     K++I 
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKK-AGRIPEQILGKVSIA 112
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE 252
             + L +L  E+  +++RD K SNIL++S    KL DFG++    Q  DS   + V GT 
Sbjct: 113 VIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV-GTR 167
Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNR---------CKREKDLVEW- 302
            Y +PE +   H +   D++S G+ L+E+  GR  +             C+ E D  E  
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227
Query: 303 ----------------ARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPK 346
                           +RP +  F  LD I++       S   +       ++CL  NP 
Sbjct: 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 287
Query: 347 SRPTMTTVV 355
            R  +  ++
Sbjct: 288 ERADLKQLM 296

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/309 (24%), Positives = 133/309 (43%), Gaps = 40/309 (12%)
Query: 74  LQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAE 132
           +++   +F +   LG G  G V+K     + +P      +A K++ +      R + + E
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK----VSHKP--SGLVMARKLIHLEIKPAIRNQIIRE 54
Query: 133 VIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIG 192
           +  L +   P++V   G    D    +  E+M  G+L DQ+ K  +  +P     K++I 
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKK-AGRIPEQILGKVSIA 112
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE 252
             + L +L  E+  +++RD K SNIL++S    KL DFG++    Q  DS   + V GT 
Sbjct: 113 VIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV-GTR 167
Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNR---------CKREKDLVEW- 302
            Y +PE +   H +   D++S G+ L+E+  GR  +             C+ E D  E  
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227
Query: 303 ----------------ARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPK 346
                           +RP +  F  LD I++       S   +       ++CL  NP 
Sbjct: 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 287
Query: 347 SRPTMTTVV 355
            R  +  ++
Sbjct: 288 ERADLKQLM 296

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 139/302 (46%), Gaps = 44/302 (14%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWL--AEVIFLGQLKHPHL 144
           +G+G FG+V++G          + + VAVK+     S+  R W   AE+     L+H ++
Sbjct: 11  IGKGRFGEVWRG--------KWRGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENI 59
Query: 145 VNLIGYCCEDE----HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFL 200
           +  I    +D        LV +Y   G+L D L   Y+ T+  +  IK+A+  A  LA L
Sbjct: 60  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGM--IKLALSTASGLAHL 116
Query: 201 HGE-----EKPVI-YRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS--HITTCVMGTE 252
           H E      KP I +RD K+ NIL+  +    ++D GLA       D+        +GT+
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 253 GYAAPEY----INTGHLTTM--CDVFSFGVVLLELLTGRR----SVEKNRCKREKDLVEW 302
            Y APE     IN  H  +    D+++ G+V  E+   RR     + ++      DLV  
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI--ARRCSIGGIHEDYQLPYYDLVP- 233
Query: 303 ARPMLKDFTKL--DQIIDSRLEDRY-STEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
           + P +++  K+  +Q +   + +R+ S E  + +A +  +C   N  +R T   + K L 
Sbjct: 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
Query: 360 PL 361
            L
Sbjct: 294 QL 295

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 97/199 (48%), Gaps = 10/199 (5%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG V KG     ++  +K   V +   + N      E LAE   + QL +P++V 
Sbjct: 35  LGSGNFGTVKKGYY--QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           +IG  CE E  +LV E   LG L+  L +N         +  I +     +   + EE  
Sbjct: 93  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVK----DKNIIELVHQVSMGMKYLEESN 147
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE--GYAAPEYINTGH 264
            ++RD  A N+LL + + AK+SDFGL +   + ++++      G     + APE IN   
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGL-SKALRADENYYKAQTHGKWPVKWYAPECINYYK 206
Query: 265 LTTMCDVFSFGVVLLELLT 283
            ++  DV+SFGV++ E  +
Sbjct: 207 FSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 97/199 (48%), Gaps = 10/199 (5%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG V KG     ++  +K   V +   + N      E LAE   + QL +P++V 
Sbjct: 35  LGSGNFGTVKKGYY--QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           +IG  CE E  +LV E   LG L+  L +N         +  I +     +   + EE  
Sbjct: 93  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVK----DKNIIELVHQVSMGMKYLEESN 147
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE--GYAAPEYINTGH 264
            ++RD  A N+LL + + AK+SDFGL +   + ++++      G     + APE IN   
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGL-SKALRADENYYKAQTHGKWPVKWYAPECINYYK 206
Query: 265 LTTMCDVFSFGVVLLELLT 283
            ++  DV+SFGV++ E  +
Sbjct: 207 FSSKSDVWSFGVLMWEAFS 225

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 97/199 (48%), Gaps = 10/199 (5%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG V KG     ++  +K   V +   + N      E LAE   + QL +P++V 
Sbjct: 33  LGSGNFGTVKKGYY--QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 90
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           +IG  CE E  +LV E   LG L+  L +N         +  I +     +   + EE  
Sbjct: 91  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVK----DKNIIELVHQVSMGMKYLEESN 145
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE--GYAAPEYINTGH 264
            ++RD  A N+LL + + AK+SDFGL +   + ++++      G     + APE IN   
Sbjct: 146 FVHRDLAARNVLLVTQHYAKISDFGL-SKALRADENYYKAQTHGKWPVKWYAPECINYYK 204
Query: 265 LTTMCDVFSFGVVLLELLT 283
            ++  DV+SFGV++ E  +
Sbjct: 205 FSSKSDVWSFGVLMWEAFS 223

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 139/302 (46%), Gaps = 44/302 (14%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWL--AEVIFLGQLKHPHL 144
           +G+G FG+V++G          + + VAVK+     S+  R W   AE+     L+H ++
Sbjct: 17  IGKGRFGEVWRG--------KWRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENI 65
Query: 145 VNLIGYCCEDE----HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFL 200
           +  I    +D        LV +Y   G+L D L   Y+ T+  +  IK+A+  A  LA L
Sbjct: 66  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGM--IKLALSTASGLAHL 122
Query: 201 HGE-----EKPVI-YRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS--HITTCVMGTE 252
           H E      KP I +RD K+ NIL+  +    ++D GLA       D+        +GT+
Sbjct: 123 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 182
Query: 253 GYAAPEY----INTGHLTTM--CDVFSFGVVLLELLTGRR----SVEKNRCKREKDLVEW 302
            Y APE     IN  H  +    D+++ G+V  E+   RR     + ++      DLV  
Sbjct: 183 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI--ARRCSIGGIHEDYQLPYYDLVP- 239
Query: 303 ARPMLKDFTKL--DQIIDSRLEDRY-STEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
           + P +++  K+  +Q +   + +R+ S E  + +A +  +C   N  +R T   + K L 
Sbjct: 240 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 299
Query: 360 PL 361
            L
Sbjct: 300 QL 301

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 24/212 (11%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLG 137
           N+     +G+G F KV         R  L  + VAVK++D     S   ++   EV  + 
Sbjct: 15  NYRLLKTIGKGNFAKVKLA------RHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMK 68
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR-- 195
            L HP++V L      ++   LV EY + G + D L  +         R+K     A+  
Sbjct: 69  VLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--------GRMKEKEARAKFR 120
Query: 196 --CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
               A  +  +K +++RD KA N+LLD+D N K++DFG + +   G +   T C  G+  
Sbjct: 121 QIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDTFC--GSPP 177
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTG 284
           YAAPE +    +     DV+S GV+L  L++G
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 139/302 (46%), Gaps = 44/302 (14%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWL--AEVIFLGQLKHPHL 144
           +G+G FG+V++G          + + VAVK+     S+  R W   AE+     L+H ++
Sbjct: 14  IGKGRFGEVWRG--------KWRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENI 62
Query: 145 VNLIGYCCEDE----HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFL 200
           +  I    +D        LV +Y   G+L D L   Y+ T+  +  IK+A+  A  LA L
Sbjct: 63  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGM--IKLALSTASGLAHL 119
Query: 201 HGE-----EKPVI-YRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS--HITTCVMGTE 252
           H E      KP I +RD K+ NIL+  +    ++D GLA       D+        +GT+
Sbjct: 120 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 179
Query: 253 GYAAPEY----INTGHLTTM--CDVFSFGVVLLELLTGRR----SVEKNRCKREKDLVEW 302
            Y APE     IN  H  +    D+++ G+V  E+   RR     + ++      DLV  
Sbjct: 180 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI--ARRCSIGGIHEDYQLPYYDLVP- 236
Query: 303 ARPMLKDFTKL--DQIIDSRLEDRY-STEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
           + P +++  K+  +Q +   + +R+ S E  + +A +  +C   N  +R T   + K L 
Sbjct: 237 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 296
Query: 360 PL 361
            L
Sbjct: 297 QL 298

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 129/296 (43%), Gaps = 37/296 (12%)
Query: 87  LGEGGFGKVY--KGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL--KHP 142
           LGEG FG+V   +    D  +P  +A TVAVK+L  + ++     L   + + ++  KH 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNY--------------SSTLPWLTRIK 188
           +++NL+G C +D    ++ EY + GNL + L                     + +   + 
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVS 161
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
                AR + +L  ++   I+RD  A N+L+  +   K++DFGLA D    +    TT  
Sbjct: 162 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
                + APE +     T   DV+SFGV++ E+ T   S            VE    +LK
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------VEELFKLLK 273
Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL 364
           +  ++D+  +   E          L  +   C    P  RPT   +V+ L+ +L L
Sbjct: 274 EGHRMDKPANCTNE----------LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 24/212 (11%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLG 137
           N+     +G+G F KV         R  L  + VAVK++D     S   ++   EV  + 
Sbjct: 15  NYRLLKTIGKGNFAKVKLA------RHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMK 68
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR-- 195
            L HP++V L      ++   LV EY + G + D L  +         R+K     A+  
Sbjct: 69  VLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--------GRMKEKEARAKFR 120
Query: 196 --CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
               A  +  +K +++RD KA N+LLD+D N K++DFG + +   G +   T C  G+  
Sbjct: 121 QIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDTFC--GSPP 177
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTG 284
           YAAPE +    +     DV+S GV+L  L++G
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 100/199 (50%), Gaps = 10/199 (5%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG V KG     ++  +K   V +   + N      E LAE   + QL +P++V 
Sbjct: 377 LGSGNFGTVKKGYY--QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 434
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           +IG  CE E  +LV E   LG L+  L +N       +  I++    +  + +L  EE  
Sbjct: 435 MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI--IELVHQVSMGMKYL--EESN 489
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE--GYAAPEYINTGH 264
            ++RD  A N+LL + + AK+SDFGL +   + ++++      G     + APE IN   
Sbjct: 490 FVHRDLAARNVLLVTQHYAKISDFGL-SKALRADENYYKAQTHGKWPVKWYAPECINYYK 548
Query: 265 LTTMCDVFSFGVVLLELLT 283
            ++  DV+SFGV++ E  +
Sbjct: 549 FSSKSDVWSFGVLMWEAFS 567

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHREWLAEVIFLGQLKHPH 143
           LG+G FG+V   C D      +  Q  AVKV+    V         L EV  L QL HP+
Sbjct: 34  LGKGSFGEVIL-CKD-----KITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQLF--KNYSSTLPWLTRIKIAIGAARCLAFLH 201
           ++ L  +  +  +  LV E    G L D++   K +S     +   +I       + ++H
Sbjct: 88  IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE----VDAARIIRQVLSGITYMH 143
Query: 202 GEEKPVIYRDFKASNILLDS---DYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPE 258
             +  +++RD K  N+LL+S   D N ++ DFGL+T     E S      +GT  Y APE
Sbjct: 144 --KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKMKDKIGTAYYIAPE 198
Query: 259 YINTGHLTTMCDVFSFGVVLLELLTG 284
            ++ G     CDV+S GV+L  LL+G
Sbjct: 199 VLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 100/199 (50%), Gaps = 10/199 (5%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG V KG     ++  +K   V +   + N      E LAE   + QL +P++V 
Sbjct: 378 LGSGNFGTVKKGYY--QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 435
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           +IG  CE E  +LV E   LG L+  L +N       +  I++    +  + +L  EE  
Sbjct: 436 MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI--IELVHQVSMGMKYL--EESN 490
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE--GYAAPEYINTGH 264
            ++RD  A N+LL + + AK+SDFGL +   + ++++      G     + APE IN   
Sbjct: 491 FVHRDLAARNVLLVTQHYAKISDFGL-SKALRADENYYKAQTHGKWPVKWYAPECINYYK 549
Query: 265 LTTMCDVFSFGVVLLELLT 283
            ++  DV+SFGV++ E  +
Sbjct: 550 FSSKSDVWSFGVLMWEAFS 568

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 119/274 (43%), Gaps = 30/274 (10%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFLGQLKHPH 143
           LG+G FG V +G  D    P  K  +VAVK L    ++  +   +++ EV  +  L H +
Sbjct: 16  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE 203
           L+ L G       ++ V E   LG+L D+L K+    L   T  + A+  A  + +L  E
Sbjct: 73  LIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYL--E 128
Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE-GYAAPEYINT 262
            K  I+RD  A N+LL +    K+ DFGL    PQ +D  +          + APE + T
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 188
Query: 263 GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK-DFTKLDQIIDSRL 321
              +   D + FGV L E+ T  +                  P +  + +++   ID   
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQE-----------------PWIGLNGSQILHKIDKEG 231
Query: 322 EDRYSTEGAKR-LAAVAHQCLSHNPKSRPTMTTV 354
           E     E   + +  V  QC +H P+ RPT   +
Sbjct: 232 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 265

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 118/274 (43%), Gaps = 31/274 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ-LKHPHLV 145
           LGEG  G+V            +  + VAVK++D+  +    E + + I + + L H ++V
Sbjct: 14  LGEGAAGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
              G+  E   + L  EY + G L D++  +     P   R    + A   + +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG--VVYLHG--I 123
Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
            + +RD K  N+LLD   N K+SDFGLAT         +   + GT  Y APE +     
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 266 -TTMCDVFSFGVVLLELLTGRRSVEK--NRCKREKDLVEWARPMLKDFTKLDQIIDSRLE 322
                DV+S G+VL  +L G    ++  + C+   D  E  +  L  + K+D        
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-KKTYLNPWKKIDSAP----- 237
Query: 323 DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                       A+ H+ L  NP +R T+  + K
Sbjct: 238 -----------LALLHKILVENPSARITIPDIKK 260

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +L HP++V L+     +    LV+E+     LH  L K   ++   LT I + +  +   
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASA--LTGIPLPLIKSYLF 110
Query: 198 AFLHG----EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
             L G        V++RD K  N+L++++   KL+DFGLA     G      T  + T  
Sbjct: 111 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLW 168
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +   + +T  D++S G +  E++T R
Sbjct: 169 YRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 123/289 (42%), Gaps = 34/289 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR--EWLAEVIFLGQLKHPHL 144
           LGEG FG V +G +       LK   VAVK + ++ S      E+L+E   +    HP++
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLK---VAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 145 VNLIGYCCEDEHR-----LLVYEYMALGNLHDQLFKNYSST----LPWLTRIKIAIGAAR 195
           + L+G C E   +     +++  +M  G+LH  L  +   T    +P  T +K  +  A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            + +L    +  ++RD  A N +L  D    ++DFGL+     G+             + 
Sbjct: 159 GMEYLSN--RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ 315
           A E +     T+  DV++FGV + E+ T   +                 P +++    D 
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATRGMT---------------PYPGVQNHEMYDY 261
Query: 316 IIDS-RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD 363
           ++   RL  +   +    L  + + C   +P  RPT + +   LE LL+
Sbjct: 262 LLHGHRL--KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 97/199 (48%), Gaps = 10/199 (5%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG V KG     ++  +K   V +   + N      E LAE   + QL +P++V 
Sbjct: 25  LGSGNFGTVKKGYY--QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           +IG  CE E  +LV E   LG L+  L +N         +  I +     +   + EE  
Sbjct: 83  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVK----DKNIIELVHQVSMGMKYLEESN 137
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE--GYAAPEYINTGH 264
            ++RD  A N+LL + + AK+SDFGL +   + ++++      G     + APE IN   
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGL-SKALRADENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 265 LTTMCDVFSFGVVLLELLT 283
            ++  DV+SFGV++ E  +
Sbjct: 197 FSSKSDVWSFGVLMWEAFS 215

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 10/201 (4%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG V + C  D L+     + VAVK L  +  +  R++  E+  L  L+H ++V 
Sbjct: 21  LGKGNFGSV-EMCRYDPLQDNT-GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 147 LIGYCCEDEHR--LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR-CLAFLHGE 203
             G C     R   L+ E++  G+L + L K+       +  IK+    ++ C    +  
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKER----IDHIKLLQYTSQICKGMEYLG 134
Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQG-EDSHITTCVMGTEGYAAPEYINT 262
            K  I+RD    NIL++++   K+ DFGL    PQ  E   +         + APE +  
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 263 GHLTTMCDVFSFGVVLLELLT 283
              +   DV+SFGVVL EL T
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHREWLAEVIFLGQLKHPH 143
           LG+G FG+V   C D      +  Q  AVKV+    V         L EV  L QL HP+
Sbjct: 40  LGKGSFGEVIL-CKDK-----ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 93
Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQLF--KNYSSTLPWLTRIKIAIGAARCLAFLH 201
           ++ L  +  +  +  LV E    G L D++   K +S     +   +I       + ++H
Sbjct: 94  IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE----VDAARIIRQVLSGITYMH 149
Query: 202 GEEKPVIYRDFKASNILLDS---DYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPE 258
             +  +++RD K  N+LL+S   D N ++ DFGL+T     E S      +GT  Y APE
Sbjct: 150 --KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKMKDKIGTAYYIAPE 204
Query: 259 YINTGHLTTMCDVFSFGVVLLELLTG 284
            ++ G     CDV+S GV+L  LL+G
Sbjct: 205 VLH-GTYDEKCDVWSTGVILYILLSG 229

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           ++   D LG G FGKV  G         L    VAVK+L+       R+ +  +  +G++
Sbjct: 12  HYVLGDTLGVGTFGKVKIG------EHQLTGHKVAVKILN-------RQKIRSLDVVGKI 58
Query: 140 K----------HPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKI 189
           K          HPH++ L           +V EY++ G L D + K+         R+  
Sbjct: 59  KREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ 118
Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM 249
            I +A      H     V++RD K  N+LLD+  NAK++DFGL+     GE    T+C  
Sbjct: 119 QILSAVDYCHRH----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR-TSC-- 171
Query: 250 GTEGYAAPEYINTGHLTT--MCDVFSFGVVLLELLTG 284
           G+  YAAPE I +G L      D++S GV+L  LL G
Sbjct: 172 GSPNYAAPEVI-SGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 119/274 (43%), Gaps = 30/274 (10%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFLGQLKHPH 143
           LG+G FG V +G  D    P  K  +VAVK L    ++  +   +++ EV  +  L H +
Sbjct: 26  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE 203
           L+ L G       ++ V E   LG+L D+L K+    L   T  + A+  A  + +L  E
Sbjct: 83  LIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYL--E 138
Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE-GYAAPEYINT 262
            K  I+RD  A N+LL +    K+ DFGL    PQ +D  +          + APE + T
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 198
Query: 263 GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK-DFTKLDQIIDSRL 321
              +   D + FGV L E+ T  +                  P +  + +++   ID   
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQE-----------------PWIGLNGSQILHKIDKEG 241
Query: 322 EDRYSTEGAKR-LAAVAHQCLSHNPKSRPTMTTV 354
           E     E   + +  V  QC +H P+ RPT   +
Sbjct: 242 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 275

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 8   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 61
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA--- 194
           +L HP++V L+     +    LV+E+     LH  L K   ++   LT I + +  +   
Sbjct: 62  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASA--LTGIPLPLIKSYLF 114
Query: 195 ---RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
              + LAF H     V++RD K  N+L++++   KL+DFGLA     G      T  + T
Sbjct: 115 QLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 170
Query: 252 EGYAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE  +   + +T  D++S G +  E++T R
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 97/199 (48%), Gaps = 10/199 (5%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG V KG     ++  +K   V +   + N      E LAE   + QL +P++V 
Sbjct: 15  LGSGNFGTVKKGYY--QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           +IG  CE E  +LV E   LG L+  L +N         +  I +     +   + EE  
Sbjct: 73  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVK----DKNIIELVHQVSMGMKYLEESN 127
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE--GYAAPEYINTGH 264
            ++RD  A N+LL + + AK+SDFGL +   + ++++      G     + APE IN   
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGL-SKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 265 LTTMCDVFSFGVVLLELLT 283
            ++  DV+SFGV++ E  +
Sbjct: 187 FSSKSDVWSFGVLMWEAFS 205

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 97/199 (48%), Gaps = 10/199 (5%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG V KG     ++  +K   V +   + N      E LAE   + QL +P++V 
Sbjct: 19  LGSGNFGTVKKGYY--QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           +IG  CE E  +LV E   LG L+  L +N         +  I +     +   + EE  
Sbjct: 77  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVK----DKNIIELVHQVSMGMKYLEESN 131
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE--GYAAPEYINTGH 264
            ++RD  A N+LL + + AK+SDFGL +   + ++++      G     + APE IN   
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGL-SKALRADENYYKAQTHGKWPVKWYAPECINYYK 190
Query: 265 LTTMCDVFSFGVVLLELLT 283
            ++  DV+SFGV++ E  +
Sbjct: 191 FSSKSDVWSFGVLMWEAFS 209

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 97/199 (48%), Gaps = 10/199 (5%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG V KG     ++  +K   V +   + N      E LAE   + QL +P++V 
Sbjct: 13  LGSGNFGTVKKGYY--QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 70
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           +IG  CE E  +LV E   LG L+  L +N         +  I +     +   + EE  
Sbjct: 71  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVK----DKNIIELVHQVSMGMKYLEESN 125
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE--GYAAPEYINTGH 264
            ++RD  A N+LL + + AK+SDFGL +   + ++++      G     + APE IN   
Sbjct: 126 FVHRDLAARNVLLVTQHYAKISDFGL-SKALRADENYYKAQTHGKWPVKWYAPECINYYK 184
Query: 265 LTTMCDVFSFGVVLLELLT 283
            ++  DV+SFGV++ E  +
Sbjct: 185 FSSKSDVWSFGVLMWEAFS 203

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 11  NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 64
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA--- 194
           +L HP++V L+     +    LV+E+     LH  L K   ++   LT I + +  +   
Sbjct: 65  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASA--LTGIPLPLIKSYLF 117
Query: 195 ---RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
              + LAF H     V++RD K  N+L++++   KL+DFGLA     G      T  + T
Sbjct: 118 QLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 173
Query: 252 EGYAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE  +   + +T  D++S G +  E++T R
Sbjct: 174 LWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +L HP++V L+     +    LV+E+     LH  L K   ++   LT I + +  +   
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASA--LTGIPLPLIKSYLF 110
Query: 198 AFLHG----EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
             L G        V++RD K  N+L++++   KL+DFGLA     G      T  + T  
Sbjct: 111 QLLQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLW 168
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +   + +T  D++S G +  E++T R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 56
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA--- 194
           +L HP++V L+     +    LV+E+     LH  L K   ++   LT I + +  +   
Sbjct: 57  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASA--LTGIPLPLIKSYLF 109
Query: 195 ---RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
              + LAF H     V++RD K  N+L++++   KL+DFGLA     G      T  + T
Sbjct: 110 QLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 165
Query: 252 EGYAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE  +   + +T  D++S G +  E++T R
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 95/198 (47%), Gaps = 8/198 (4%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG V KG     ++  +K   V +   + N      E LAE   + QL +P++V 
Sbjct: 19  LGSGNFGTVKKGYY--QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           +IG  CE E  +LV E   LG L+  L +N         +  I +     +   + EE  
Sbjct: 77  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVK----DKNIIELVHQVSMGMKYLEESN 131
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSH-ITTCVMGTEGYAAPEYINTGHL 265
            ++RD  A N+LL + + AK+SDFGL+      E+ +   T       + APE IN    
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKF 191
Query: 266 TTMCDVFSFGVVLLELLT 283
           ++  DV+SFGV++ E  +
Sbjct: 192 SSKSDVWSFGVLMWEAFS 209

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +L HP++V L+     +    LV+E+     LH  L K   ++   LT I + +  +   
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASA--LTGIPLPLIKSYLF 110
Query: 198 AFLHG----EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
             L G        V++RD K  N+L++++   KL+DFGLA     G      T  + T  
Sbjct: 111 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLW 168
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +   + +T  D++S G +  E++T R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 5   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 58
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +L HP++V L+     +    LV+E+     LH  L K   ++   LT I + +  +   
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASA--LTGIPLPLIKSYLF 111
Query: 198 AFLHG----EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
             L G        V++RD K  N+L++++   KL+DFGLA     G      T  + T  
Sbjct: 112 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLW 169
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +   + +T  D++S G +  E++T R
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 56
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +L HP++V L+     +    LV+E+     LH  L K   ++   LT I + +  +   
Sbjct: 57  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASA--LTGIPLPLIKSYLF 109
Query: 198 AFLHG----EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
             L G        V++RD K  N+L++++   KL+DFGLA     G      T  + T  
Sbjct: 110 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLW 167
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +   + +T  D++S G +  E++T R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 120/301 (39%), Gaps = 44/301 (14%)
Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWL-AEVIFLG 137
           +N      LG G FGKV +      L        VAVK+L        +E L +E+  + 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAF-GLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 138 QL-KHPHLVNLIGYCCEDEHRLLVYEYMALGNL------------HDQLFKNYSSTLPWL 184
            L +H ++VNL+G C      L++ EY   G+L             D  F   +STL   
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTR 164
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI 244
             +  +   A+ +AFL    K  I+RD  A N+LL + + AK+ DFGLA D     +  +
Sbjct: 165 DLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 245 TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS------VEKNRCKREKD 298
                    + APE I     T   DV+S+G++L E+ +   +      V     K  KD
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282
Query: 299 LVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL 358
             + A+P                         K + ++   C +  P  RPT   +   L
Sbjct: 283 GYQMAQPAF---------------------APKNIYSIMQACWALEPTHRPTFQQICSFL 321
Query: 359 E 359
           +
Sbjct: 322 Q 322

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +L HP++V L+     +    LV+E+     LH  L K   ++   LT I + +  +   
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASA--LTGIPLPLIKSYLF 110
Query: 198 AFLHG----EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
             L G        V++RD K  N+L++++   KL+DFGLA     G      T  + T  
Sbjct: 111 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLW 168
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +   + +T  D++S G +  E++T R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 108/235 (45%), Gaps = 25/235 (10%)
Query: 74  LQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWL 130
           + +  ++FS    +G GGFG+VY GC     R     +  A+K LD   +   QG    L
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVY-GC-----RKADTGKMYAMKCLDKKRIKMKQGETLAL 237
Query: 131 AEVIFLGQLKH---PHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTR 186
            E I L  +     P +V  + Y      +L  + + M  G+LH  L     S     + 
Sbjct: 238 NERIMLSLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGVFSE 291
Query: 187 IKIAIGAARC-LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHIT 245
             +   AA   L   H   + V+YRD K +NILLD   + ++SD GLA D  + +  H +
Sbjct: 292 ADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS 350
Query: 246 TCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDL 299
              +GT GY APE +  G    +  D FS G +L +LL G     +++ K + ++
Sbjct: 351 ---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 108/235 (45%), Gaps = 25/235 (10%)
Query: 74  LQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWL 130
           + +  ++FS    +G GGFG+VY GC     R     +  A+K LD   +   QG    L
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVY-GC-----RKADTGKMYAMKCLDKKRIKMKQGETLAL 237
Query: 131 AEVIFLGQLKH---PHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTR 186
            E I L  +     P +V  + Y      +L  + + M  G+LH  L     S     + 
Sbjct: 238 NERIMLSLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGVFSE 291
Query: 187 IKIAIGAARC-LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHIT 245
             +   AA   L   H   + V+YRD K +NILLD   + ++SD GLA D  + +  H +
Sbjct: 292 ADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS 350
Query: 246 TCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDL 299
              +GT GY APE +  G    +  D FS G +L +LL G     +++ K + ++
Sbjct: 351 ---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 108/235 (45%), Gaps = 25/235 (10%)
Query: 74  LQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWL 130
           + +  ++FS    +G GGFG+VY GC     R     +  A+K LD   +   QG    L
Sbjct: 183 IHLTMNDFSVHRIIGRGGFGEVY-GC-----RKADTGKMYAMKCLDKKRIKMKQGETLAL 236
Query: 131 AEVIFLGQLKH---PHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTR 186
            E I L  +     P +V  + Y      +L  + + M  G+LH  L     S     + 
Sbjct: 237 NERIMLSLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGVFSE 290
Query: 187 IKIAIGAARC-LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHIT 245
             +   AA   L   H   + V+YRD K +NILLD   + ++SD GLA D  + +  H +
Sbjct: 291 ADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS 349
Query: 246 TCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDL 299
              +GT GY APE +  G    +  D FS G +L +LL G     +++ K + ++
Sbjct: 350 ---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 401

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 108/235 (45%), Gaps = 25/235 (10%)
Query: 74  LQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWL 130
           + +  ++FS    +G GGFG+VY GC     R     +  A+K LD   +   QG    L
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVY-GC-----RKADTGKMYAMKCLDKKRIKMKQGETLAL 237
Query: 131 AEVIFLGQLKH---PHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTR 186
            E I L  +     P +V  + Y      +L  + + M  G+LH  L     S     + 
Sbjct: 238 NERIMLSLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGVFSE 291
Query: 187 IKIAIGAARC-LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHIT 245
             +   AA   L   H   + V+YRD K +NILLD   + ++SD GLA D  + +  H +
Sbjct: 292 ADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS 350
Query: 246 TCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDL 299
              +GT GY APE +  G    +  D FS G +L +LL G     +++ K + ++
Sbjct: 351 ---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 126/298 (42%), Gaps = 43/298 (14%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG-HREWLAEVIFLGQL-KHPHL 144
           LG G FG+V +      +      +TVAVK+L    +   HR  ++E+  L  +  H ++
Sbjct: 35  LGRGAFGQVIEADAF-GIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 145 VNLIGYCCEDEHRLLV-YEYMALGNLHDQLFKNYSSTLPWLTRIK----------IAIGA 193
           VNL+G C +    L+V  E+   GNL   L    +  +P+    K           +   
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQV 153
Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
           A+ + FL    +  I+RD  A NILL      K+ DFGLA D  +  D            
Sbjct: 154 AKGMEFL--ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 254 YAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS------VEKNRCKREKDLVEWARPML 307
           + APE I     T   DV+SFGV+L E+ +   S      +++  C+R           L
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-----------L 260
Query: 308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN 365
           K+ T++      R  D  + E  + +      C    P  RPT + +V+ L  LL  N
Sbjct: 261 KEGTRM------RAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLGNLLQAN 308

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 11  NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 64
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA--- 194
           +L HP++V L+     +    LV+E+     LH  L K   ++   LT I + +  +   
Sbjct: 65  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASA--LTGIPLPLIKSYLF 117
Query: 195 ---RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
              + LAF H     V++RD K  N+L++++   KL+DFGLA     G      T  + T
Sbjct: 118 QLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 173
Query: 252 EGYAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE  +   + +T  D++S G +  E++T R
Sbjct: 174 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 24/212 (11%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLG 137
           N+     +G+G F KV         R  L  + VAV+++D     S   ++   EV  + 
Sbjct: 15  NYRLLKTIGKGNFAKVKLA------RHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMK 68
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR-- 195
            L HP++V L      ++   LV EY + G + D L  +         R+K     A+  
Sbjct: 69  VLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--------GRMKEKEARAKFR 120
Query: 196 --CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
               A  +  +K +++RD KA N+LLD+D N K++DFG + +   G +   T C  G+  
Sbjct: 121 QIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDTFC--GSPP 177
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTG 284
           YAAPE +    +     DV+S GV+L  L++G
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 131/296 (44%), Gaps = 37/296 (12%)
Query: 87  LGEGGFGKVY--KGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL--KHP 142
           LGEG FG+V   +    D  +P  +A TVAVK+L  + ++     L   + + ++  KH 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK------NYS--------STLPWLTRIK 188
           +++NL+G C +D    ++ EY + GNL + L         YS          + +   + 
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
                AR + +L  ++   I+RD  A N+L+  +   K++DFGLA D    +    TT  
Sbjct: 162 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
                + APE +     T   DV+SFGV++ E+ T   S            VE    +LK
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------VEELFKLLK 273
Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL 364
           +  ++D+  +   E          L  +   C    P  RPT   +V+ L+ +L L
Sbjct: 274 EGHRMDKPANCTNE----------LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 118/274 (43%), Gaps = 31/274 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ-LKHPHLV 145
           LGEG +G+V            +  + VAVK++D+  +    E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
              G+  E   + L  EY + G L D++  +     P   R    + A   + +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG--VVYLHG--I 123
Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
            + +RD K  N+LLD   N K+SDFGLAT         +   + GT  Y APE +     
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 266 -TTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEW--ARPMLKDFTKLDQIIDSRLE 322
                DV+S G+VL  +L G    ++      ++  +W   +  L  + K+D        
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQP-SDSXQEYSDWKEKKTYLNPWKKIDSAP----- 237
Query: 323 DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                       A+ H+ L  NP +R T+  + K
Sbjct: 238 -----------LALLHKILVENPSARITIPDIKK 260

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 131/296 (44%), Gaps = 37/296 (12%)
Query: 87  LGEGGFGKVY--KGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL--KHP 142
           LGEG FG+V   +    D  +P  +A TVAVK+L  + ++     L   + + ++  KH 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHK 101
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK------NYS--------STLPWLTRIK 188
           +++NL+G C +D    ++ EY + GNL + L         YS          + +   + 
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
                AR + +L  ++   I+RD  A N+L+  +   K++DFGLA D    +    TT  
Sbjct: 162 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
                + APE +     T   DV+SFGV++ E+ T   S            VE    +LK
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------VEELFKLLK 273
Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL 364
           +  ++D+  +   E          L  +   C    P  RPT   +V+ L+ +L L
Sbjct: 274 EGHRMDKPANCTNE----------LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/303 (25%), Positives = 130/303 (42%), Gaps = 40/303 (13%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQ 138
           +F +   LG G  G V+K     + +P      +A K++ +      R + + E+  L +
Sbjct: 34  DFEKISELGAGNGGVVFK----VSHKPS--GLVMARKLIHLEIKPAIRNQIIRELQVLHE 87
Query: 139 LKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLA 198
              P++V   G    D    +  E+M  G+L DQ+ K  +  +P     K++I   + L 
Sbjct: 88  CNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKK-AGRIPEQILGKVSIAVIKGLT 145
Query: 199 FLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPE 258
           +L  E+  +++RD K SNIL++S    KL DFG++    Q  DS   + V GT  Y +PE
Sbjct: 146 YLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV-GTRSYMSPE 200
Query: 259 YINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNR---------CKREKDLVEW------- 302
            +   H +   D++S G+ L+E+  GR  +             C+ E D  E        
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260
Query: 303 ----------ARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMT 352
                     +RP +  F  LD I++       S   +       ++CL  NP  R  + 
Sbjct: 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 320
Query: 353 TVV 355
            ++
Sbjct: 321 QLM 323

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 116/291 (39%), Gaps = 36/291 (12%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWL-AEVIFLGQL-KHPHL 144
           LG G FGKV +      ++    A TVAVK+L  +     RE L +E+  L  L  H ++
Sbjct: 54  LGAGAFGKVVEATAYGLIKSD-AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 112
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKI--------------- 189
           VNL+G C      L++ EY   G+L + L +   S +   T   I               
Sbjct: 113 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 172
Query: 190 -AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
            +   A+ +AFL    K  I+RD  A NILL      K+ DFGLA D     +  +    
Sbjct: 173 FSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 230
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
                + APE I     T   DV+S+G+ L EL +   S                 P + 
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS---------------PYPGMP 275
Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
             +K  ++I               +  +   C   +P  RPT   +V+ +E
Sbjct: 276 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 116/291 (39%), Gaps = 36/291 (12%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWL-AEVIFLGQL-KHPHL 144
           LG G FGKV +      ++    A TVAVK+L  +     RE L +E+  L  L  H ++
Sbjct: 47  LGAGAFGKVVEATAYGLIKSD-AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 105
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKI--------------- 189
           VNL+G C      L++ EY   G+L + L +   S +   T   I               
Sbjct: 106 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 165
Query: 190 -AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
            +   A+ +AFL    K  I+RD  A NILL      K+ DFGLA D     +  +    
Sbjct: 166 FSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 223
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
                + APE I     T   DV+S+G+ L EL +   S                 P + 
Sbjct: 224 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS---------------PYPGMP 268
Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
             +K  ++I               +  +   C   +P  RPT   +V+ +E
Sbjct: 269 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 319

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHREWLAEVIFLGQLKHPH 143
           LG+G FG+V   C D      +  Q  AVKV+    V         L EV  L QL HP+
Sbjct: 34  LGKGSFGEVIL-CKD-----KITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA-IGAARCL----- 197
           +  L  +  +  +  LV E    G L D++          ++R + + + AAR +     
Sbjct: 88  IXKLYEFFEDKGYFYLVGEVYTGGELFDEI----------ISRKRFSEVDAARIIRQVLS 137
Query: 198 AFLHGEEKPVIYRDFKASNILLDS---DYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
              +  +  +++RD K  N+LL+S   D N ++ DFGL+T     E S      +GT  Y
Sbjct: 138 GITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKXKDKIGTAYY 194
Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            APE ++ G     CDV+S GV+L  LL+G
Sbjct: 195 IAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +L HP++V L+     +    LV+E++   +L D +  +  + +P            + L
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKDFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAP 257
           AF H     V++RD K  N+L++++   KL+DFGLA        ++    V  T  Y AP
Sbjct: 117 AFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 258 E-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           E  +   + +T  D++S G +  E++T R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 80/315 (25%), Positives = 139/315 (44%), Gaps = 46/315 (14%)
Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVI 134
           + + H  +  + +G+G +G+V++G          + + VAVK+     S+  + W  E  
Sbjct: 4   RTVAHQITLLECVGKGRYGEVWRG--------SWQGENVAVKIF---SSRDEKSWFRETE 52
Query: 135 FLG--QLKHPHLVNLIGYCCEDEHR----LLVYEYMALGNLHDQLFKNYSSTLPWLTRIK 188
                 L+H +++  I       H      L+  Y  +G+L+D L     +TL  ++ ++
Sbjct: 53  LYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLR 109
Query: 189 IAIGAARCLAFLHGE-----EKPVI-YRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS 242
           I +  A  LA LH E      KP I +RD K+ NIL+  +    ++D GLA    Q  + 
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169
Query: 243 HIT--TCVMGTEGYAAPEYINTGHLTTMC-------DVFSFGVVLLELLTGRRSVEKNRC 293
                   +GT+ Y APE ++   +   C       D+++FG+VL E+   RR V     
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDET-IQVDCFDSYKRVDIWAFGLVLWEV--ARRMVSNGIV 226
Query: 294 KREK----DLVEWARPMLKDFTKLDQIIDSR--LEDR-YSTEGAKRLAAVAHQCLSHNPK 346
           +  K    D+V    P  +D  K+  +   R  + +R +S      LA +  +C   NP 
Sbjct: 227 EDYKPPFYDVVP-NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPS 285
Query: 347 SRPTMTTVVKALEPL 361
           +R T   + K L  +
Sbjct: 286 ARLTALRIKKTLTKI 300

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLG 137
           N+     +G+G F KV         R  L  + VAVK++D         ++   EV  + 
Sbjct: 16  NYRLQKTIGKGNFAKVKLA------RHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMK 69
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR-- 195
            L HP++V L      ++   LV EY + G + D L  +         R+K     A+  
Sbjct: 70  ILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--------GRMKEKEARAKFR 121
Query: 196 --CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
               A  +  +K +++RD KA N+LLD D N K++DFG + +   G +   T C  G+  
Sbjct: 122 QIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVG-NKLDTFC--GSPP 178
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTG 284
           YAAPE +    +     DV+S GV+L  L++G
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 116/291 (39%), Gaps = 36/291 (12%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWL-AEVIFLGQL-KHPHL 144
           LG G FGKV +      ++    A TVAVK+L  +     RE L +E+  L  L  H ++
Sbjct: 31  LGAGAFGKVVEATAYGLIKSD-AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKI--------------- 189
           VNL+G C      L++ EY   G+L + L +   S +   T   I               
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 190 -AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
            +   A+ +AFL    K  I+RD  A NILL      K+ DFGLA D     +  +    
Sbjct: 150 FSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
                + APE I     T   DV+S+G+ L EL +   S                 P + 
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS---------------PYPGMP 252
Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
             +K  ++I               +  +   C   +P  RPT   +V+ +E
Sbjct: 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 16/220 (7%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
            + R  +LG+GGF K Y+  + D     + A  V  K + +   Q  +    E+     L
Sbjct: 43  RYMRGRFLGKGGFAKCYE--ITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSL 99
Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLP---WLTRIKIAIGAARC 196
            +PH+V   G+  +D+   +V E     +L +   +  + T P   +  R  I     + 
Sbjct: 100 DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QG 154
Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           + +LH     VI+RD K  N+ L+ D + K+ DFGLAT      +   T C  GT  Y A
Sbjct: 155 VQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLC--GTPNYIA 210
Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE 296
           PE +     +   D++S G +L  LL G+   E + C +E
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS-CLKE 249

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 131/296 (44%), Gaps = 37/296 (12%)
Query: 87  LGEGGFGKVY--KGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL--KHP 142
           LGEG FG+V   +    D  +P  +A TVAVK+L  + ++     L   + + ++  KH 
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK------NYS--------STLPWLTRIK 188
           +++NL+G C +D    ++ EY + GNL + L         YS          + +   + 
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
                AR + +L  ++   I+RD  A N+L+  +   K++DFGLA D    +    TT  
Sbjct: 208 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
                + APE +     T   DV+SFGV++ E+ T   S            VE    +LK
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------VEELFKLLK 319
Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL 364
           +  ++D+  +   E          L  +   C    P  RPT   +V+ L+ +L L
Sbjct: 320 EGHRMDKPANCTNE----------LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 126/303 (41%), Gaps = 49/303 (16%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG-HREWLAEVIFLGQLKHPHL- 144
           LG G FG+V +      +      +TVAVK+L    +   HR  ++E+  L  + H HL 
Sbjct: 35  LGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH-HLN 92
Query: 145 -VNLIGYCCEDEHRLLV-YEYMALGNLHDQLFKNYSSTLPWLTR--------------IK 188
            VNL+G C +    L+V  E+   GNL   L    +  +P+                 I 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
            +   A+ + FL    +  I+RD  A NILL      K+ DFGLA D  +  D       
Sbjct: 153 YSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS------VEKNRCKREKDLVEW 302
                + APE I     T   DV+SFGV+L E+ +   S      +++  C+R       
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR------- 263
Query: 303 ARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
               LK+ T++      R  D  + E  + +      C    P  RPT + +V+ L  LL
Sbjct: 264 ----LKEGTRM------RAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLGNLL 309
Query: 363 DLN 365
             N
Sbjct: 310 QAN 312

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 7   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +L HP++V L+     +    LV+E++++ +L   +  +  + +P            + L
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAP 257
           AF H     V++RD K  N+L++++   KL+DFGLA        ++    V  T  Y AP
Sbjct: 120 AFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 258 E-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           E  +   + +T  D++S G +  E++T R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 116/291 (39%), Gaps = 36/291 (12%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWL-AEVIFLGQL-KHPHL 144
           LG G FGKV +      ++    A TVAVK+L  +     RE L +E+  L  L  H ++
Sbjct: 49  LGAGAFGKVVEATAYGLIKSD-AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 107
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKI--------------- 189
           VNL+G C      L++ EY   G+L + L +   S +   T   I               
Sbjct: 108 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 167
Query: 190 -AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
            +   A+ +AFL    K  I+RD  A NILL      K+ DFGLA D     +  +    
Sbjct: 168 FSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 225
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
                + APE I     T   DV+S+G+ L EL +   S                 P + 
Sbjct: 226 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS---------------PYPGMP 270
Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
             +K  ++I               +  +   C   +P  RPT   +V+ +E
Sbjct: 271 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 321

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 126/302 (41%), Gaps = 47/302 (15%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG-HREWLAEVIFLGQL-KHPHL 144
           LG G FG+V +      +      +TVAVK+L    +   HR  ++E+  L  +  H ++
Sbjct: 26  LGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 84
Query: 145 VNLIGYCCEDEHRLLV-YEYMALGNLHDQLFKNYSSTLPWLTR--------------IKI 189
           VNL+G C +    L+V  E+   GNL   L    +  +P+                 I  
Sbjct: 85  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM 249
           +   A+ + FL    +  I+RD  A NILL      K+ DFGLA D  +  D        
Sbjct: 145 SFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 250 GTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS------VEKNRCKREKDLVEWA 303
               + APE I     T   DV+SFGV+L E+ +   S      +++  C+R        
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-------- 254
Query: 304 RPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD 363
              LK+ T++      R  D  + E  + +      C    P  RPT + +V+ L  LL 
Sbjct: 255 ---LKEGTRM------RAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLGNLLQ 301
Query: 364 LN 365
            N
Sbjct: 302 AN 303

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLG 137
           N+     +G+G F KV         R  L  + VAVK++D     S   ++   EV  + 
Sbjct: 15  NYRLLKTIGKGNFAKVKLA------RHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMK 68
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR-- 195
            L HP++V L      ++   LV EY + G + D L  +         R+K     A+  
Sbjct: 69  VLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--------GRMKEKEARAKFR 120
Query: 196 --CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
               A  +  +K +++RD KA N+LLD+D N K++DFG + +   G          G   
Sbjct: 121 QIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDAFCGAPP 177
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTG 284
           YAAPE +    +     DV+S GV+L  L++G
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 126/302 (41%), Gaps = 47/302 (15%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG-HREWLAEVIFLGQL-KHPHL 144
           LG G FG+V +      +      +TVAVK+L    +   HR  ++E+  L  +  H ++
Sbjct: 26  LGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 84
Query: 145 VNLIGYCCEDEHRLLVY-EYMALGNLHDQLFKNYSSTLPWLTR--------------IKI 189
           VNL+G C +    L+V  E+   GNL   L    +  +P+                 I  
Sbjct: 85  VNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM 249
           +   A+ + FL    +  I+RD  A NILL      K+ DFGLA D  +  D        
Sbjct: 145 SFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 250 GTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS------VEKNRCKREKDLVEWA 303
               + APE I     T   DV+SFGV+L E+ +   S      +++  C+R        
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-------- 254
Query: 304 RPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD 363
              LK+ T++      R  D  + E  + +      C    P  RPT + +V+ L  LL 
Sbjct: 255 ---LKEGTRM------RAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLGNLLQ 301
Query: 364 LN 365
            N
Sbjct: 302 AN 303

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 5   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 58
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +L HP++V L+     +    LV+E++++ +L   +  +  + +P            + L
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAP 257
           AF H     V++RD K  N+L++++   KL+DFGLA        ++    V  T  Y AP
Sbjct: 118 AFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 173
Query: 258 E-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           E  +   + +T  D++S G +  E++T R
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA--- 194
           +L HP++V L+     +    LV+E+     LH  L K   ++   LT I + +  +   
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASA--LTGIPLPLIKSYLF 110
Query: 195 ---RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
              + LAF H     V++RD K  N+L++++   KL+DFGLA        ++    V  T
Sbjct: 111 QLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 166
Query: 252 EGYAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE  +   + +T  D++S G +  E++T R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA--- 194
           +L HP++V L+     +    LV+E+     LH  L K   ++   LT I + +  +   
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASA--LTGIPLPLIKSYLF 110
Query: 195 ---RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
              + LAF H     V++RD K  N+L++++   KL+DFGLA        ++    V  T
Sbjct: 111 QLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 166
Query: 252 EGYAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE  +   + +T  D++S G +  E++T R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 118/288 (40%), Gaps = 45/288 (15%)
Query: 79  HNFSRSDYLGEGGFGK-VYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIF 135
             + R   +GEG FGK +     +D        +   +K ++++   S+   E   EV  
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTED-------GRQYVIKEINISRMSSKEREESRREVAV 76
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQ-------LFKNYSSTLPWLTRIK 188
           L  +KHP++V       E+    +V +Y   G+L  +       LF+     L W  +I 
Sbjct: 77  LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE-DQILDWFVQI- 134
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
                  CLA  H  ++ +++RD K+ NI L  D   +L DFG+A          +    
Sbjct: 135 -------CLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIAR--VLNSTVELARAC 185
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
           +GT  Y +PE           D+++ G VL EL T + + E       K+LV        
Sbjct: 186 IGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM---KNLVL------- 235
Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                 +II        S   +  L ++  Q    NP+ RP++ ++++
Sbjct: 236 ------KIISGSFPP-VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 69/258 (26%), Positives = 118/258 (45%), Gaps = 16/258 (6%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           +GEG  G V   C+      G   + VAVK++D+   Q       EV+ +   +H ++V 
Sbjct: 53  IGEGSTGIV---CLAREKHSG---RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           +       E   ++ E++  G L D + +   +     T  +  + A   LA+LH +   
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQA---LAYLHAQ--G 161
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
           VI+RD K+ +ILL  D   KLSDFG        +D      ++GT  + APE I+     
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQ--ISKDVPKRKXLVGTPYWMAPEVISRSLYA 219
Query: 267 TMCDVFSFGVVLLELLTGRRS-VEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRY 325
           T  D++S G++++E++ G       +  +  K L +   P LK+  K+  ++   LE   
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279
Query: 326 STEGAKRLAAVAHQCLSH 343
             +  +R  A A + L H
Sbjct: 280 VRDPQER--ATAQELLDH 295

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 131/296 (44%), Gaps = 37/296 (12%)
Query: 87  LGEGGFGKVY--KGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL--KHP 142
           LGEG FG+V   +    D  +P  +A TVAVK+L  + ++     L   + + ++  KH 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK------NYS--------STLPWLTRIK 188
           +++NL+G C +D    ++ EY + GNL + L         YS          + +   + 
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
                AR + +L  ++   I+RD  A N+L+  +   +++DFGLA D    +    TT  
Sbjct: 162 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
                + APE +     T   DV+SFGV++ E+ T   S            VE    +LK
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------VEELFKLLK 273
Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL 364
           +  ++D+  +   E          L  +   C    P  RPT   +V+ L+ +L L
Sbjct: 274 EGHRMDKPANCTNE----------LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 6   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 59
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA--- 194
           +L HP++V L+     +    LV+E+     LH  L K   ++   LT I + +  +   
Sbjct: 60  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASA--LTGIPLPLIKSYLF 112
Query: 195 ---RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
              + LAF H     V++RD K  N+L++++   KL+DFGLA        ++    V  T
Sbjct: 113 QLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 168
Query: 252 EGYAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE  +   + +T  D++S G +  E++T R
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 56
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +L HP++V L+     +    LV+E+     LH  L K   ++   LT I + +  +   
Sbjct: 57  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASA--LTGIPLPLIKSYLF 109
Query: 198 AFLHG----EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
             L G        V++RD K  N+L++++   KL+DFGLA        ++    V  T  
Sbjct: 110 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLW 167
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +   + +T  D++S G +  E++T R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 6   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 59
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA--- 194
           +L HP++V L+     +    LV+E+     LH  L K   ++   LT I + +  +   
Sbjct: 60  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASA--LTGIPLPLIKSYLF 112
Query: 195 ---RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
              + LAF H     V++RD K  N+L++++   KL+DFGLA        ++    V  T
Sbjct: 113 QLLQGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 168
Query: 252 EGYAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE  +   + +T  D++S G +  E++T R
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 131/296 (44%), Gaps = 37/296 (12%)
Query: 87  LGEGGFGKVY--KGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL--KHP 142
           LGEG FG+V   +    D  +P  +A TVAVK+L  + ++     L   + + ++  KH 
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 90
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK------NYS--------STLPWLTRIK 188
           +++NL+G C +D    ++ EY + GNL + L         YS          + +   + 
Sbjct: 91  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 150
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
                AR + +L  ++   I+RD  A N+L+  +   K++DFGLA D    +    TT  
Sbjct: 151 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
                + APE +     T   DV+SFGV++ E+ T   S            VE    +LK
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------VEELFKLLK 262
Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL 364
           +  ++D+  +   E          L  +   C    P  RPT   +V+ L+ +L L
Sbjct: 263 EGHRMDKPANCTNE----------LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 308

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 7   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA--- 194
           +L HP++V L+     +    LV+E+     LH  L K   ++   LT I + +  +   
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASA--LTGIPLPLIKSYLF 113
Query: 195 ---RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
              + LAF H     V++RD K  N+L++++   KL+DFGLA        ++    V  T
Sbjct: 114 QLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 169
Query: 252 EGYAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE  +   + +T  D++S G +  E++T R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 6   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 59
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA--- 194
           +L HP++V L+     +    LV+E+     LH  L K   ++   LT I + +  +   
Sbjct: 60  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASA--LTGIPLPLIKSYLF 112
Query: 195 ---RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
              + LAF H     V++RD K  N+L++++   KL+DFGLA        ++    V  T
Sbjct: 113 QLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 168
Query: 252 EGYAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE  +   + +T  D++S G +  E++T R
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 103/224 (45%), Gaps = 24/224 (10%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
            + R  +LG+GGF K Y+  + D     + A  V  K + +   Q  +    E+     L
Sbjct: 43  RYMRGRFLGKGGFAKCYE--ITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSL 99
Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLP---WLTRIKIAIGAARC 196
            +PH+V   G+  +D+   +V E     +L +   +  + T P   +  R  I     + 
Sbjct: 100 DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QG 154
Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT----DGPQGEDSHITTCVMGTE 252
           + +LH     VI+RD K  N+ L+ D + K+ DFGLAT    DG + +D      + GT 
Sbjct: 155 VQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD------LCGTP 206
Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE 296
            Y APE +     +   D++S G +L  LL G+   E + C +E
Sbjct: 207 NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS-CLKE 249

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 131/296 (44%), Gaps = 37/296 (12%)
Query: 87  LGEGGFGKVY--KGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL--KHP 142
           LGEG FG+V   +    D  +P  +A TVAVK+L  + ++     L   + + ++  KH 
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 88
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK------NYS--------STLPWLTRIK 188
           +++NL+G C +D    ++ EY + GNL + L         YS          + +   + 
Sbjct: 89  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 148
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
                AR + +L  ++   I+RD  A N+L+  +   K++DFGLA D    +    TT  
Sbjct: 149 CTYQLARGMEYLASQK--CIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
                + APE +     T   DV+SFGV++ E+ T   S            VE    +LK
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------VEELFKLLK 260
Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL 364
           +  ++D+  +   E          L  +   C    P  RPT   +V+ L+ +L L
Sbjct: 261 EGHRMDKPANCTNE----------LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 306

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 5   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 58
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +L HP++V L+     +    LV+E+     LH  L K   ++   LT I + +  +   
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASA--LTGIPLPLIKSYLF 111
Query: 198 AFLHG----EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
             L G        V++RD K  N+L++++   KL+DFGLA        ++    V  T  
Sbjct: 112 QLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLW 169
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +   + +T  D++S G +  E++T R
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 102/211 (48%), Gaps = 20/211 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           N+     LGEG FGKV K          +  + +  KVL  +  QG  E   E+ +L  L
Sbjct: 5   NYQIVKTLGEGSFGKV-KLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLL 61
Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAF 199
           +HPH++ L       +  ++V EY A   L D + +    +     R    I +A  + +
Sbjct: 62  RHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISA--VEY 118
Query: 200 LHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGEDSHITTCVMGTEGYAA 256
            H  +  +++RD K  N+LLD   N K++DFGL+   TDG    +   T+C  G+  YAA
Sbjct: 119 CHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG----NFLKTSC--GSPNYAA 170
Query: 257 PEYINTGHLTT--MCDVFSFGVVLLELLTGR 285
           PE I +G L      DV+S GV+L  +L  R
Sbjct: 171 PEVI-SGKLYAGPEVDVWSCGVILYVMLCRR 200

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA--- 194
           +L HP++V L+     +    LV+E+     LH  L K   ++   LT I + +  +   
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASA--LTGIPLPLIKSYLF 110
Query: 195 ---RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
              + LAF H     V++RD K  N+L++++   KL+DFGLA        ++    V  T
Sbjct: 111 QLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 166
Query: 252 EGYAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE  +   + +T  D++S G +  E++T R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 134 IFLGQLKHPHLVNLIGYCCEDEHRLL-VYEYMALGNL--HDQLFKNYSSTLPWLTRIKIA 190
           +F     HP LV L   C + E RL  V EY+  G+L  H Q  +            +I+
Sbjct: 105 VFEQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 163
Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG 250
           +     L +LH  E+ +IYRD K  N+LLDS+ + KL+D+G+  +G +  D+  T C  G
Sbjct: 164 L----ALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC--G 215
Query: 251 TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           T  Y APE +         D ++ GV++ E++ GR
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 56
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA--- 194
           +L HP++V L+     +    LV+E+     LH  L K   ++   LT I + +  +   
Sbjct: 57  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASA--LTGIPLPLIKSYLF 109
Query: 195 ---RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
              + LAF H     V++RD K  N+L++++   KL+DFGLA        ++    V  T
Sbjct: 110 QLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 165
Query: 252 EGYAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE  +   + +T  D++S G +  E++T R
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 5   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 58
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +L HP++V L+     +    LV+E+     LH  L K   ++   LT I + +  +   
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASA--LTGIPLPLIKSYLF 111
Query: 198 AFLHG----EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
             L G        V++RD K  N+L++++   KL+DFGLA        ++    V  T  
Sbjct: 112 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLW 169
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +   + +T  D++S G +  E++T R
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 5   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 58
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +L HP++V L+     +    LV+E+     LH  L K   ++   LT I + +  +   
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASA--LTGIPLPLIKSYLF 111
Query: 198 AFLHG----EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
             L G        V++RD K  N+L++++   KL+DFGLA        ++    V  T  
Sbjct: 112 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLW 169
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +   + +T  D++S G +  E++T R
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 131/296 (44%), Gaps = 37/296 (12%)
Query: 87  LGEGGFGKVY--KGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL--KHP 142
           LGEG FG+V   +    D  +P  +A TVAVK+L  + ++     L   + + ++  KH 
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 93
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK------NYS--------STLPWLTRIK 188
           +++NL+G C +D    ++ EY + GNL + L         YS          + +   + 
Sbjct: 94  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 153
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
                AR + +L  ++   I+RD  A N+L+  +   K++DFGLA D    +    TT  
Sbjct: 154 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
                + APE +     T   DV+SFGV++ E+ T   S            VE    +LK
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------VEELFKLLK 265
Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL 364
           +  ++D+  +   E          L  +   C    P  RPT   +V+ L+ +L L
Sbjct: 266 EGHRMDKPANCTNE----------LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 311

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 126/303 (41%), Gaps = 49/303 (16%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG-HREWLAEVIFLGQLKHPHL- 144
           LG G FG+V +      +      +TVAVK+L    +   HR  ++E+  L  + H HL 
Sbjct: 35  LGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH-HLN 92
Query: 145 -VNLIGYCCEDEHRLLV-YEYMALGNLHDQLFKNYSSTLPWLTR--------------IK 188
            VNL+G C +    L+V  E+   GNL   L    +  +P+                 I 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
            +   A+ + FL    +  I+RD  A NILL      K+ DFGLA D  +  D       
Sbjct: 153 YSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDA 210
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS------VEKNRCKREKDLVEW 302
                + APE I     T   DV+SFGV+L E+ +   S      +++  C+R       
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR------- 263
Query: 303 ARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
               LK+ T++      R  D  + E  + +      C    P  RPT + +V+ L  LL
Sbjct: 264 ----LKEGTRM------RAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLGNLL 309
Query: 363 DLN 365
             N
Sbjct: 310 QAN 312

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 8   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 61
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA--- 194
           +L HP++V L+     +    LV+E+     LH  L K   ++   LT I + +  +   
Sbjct: 62  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASA--LTGIPLPLIKSYLF 114
Query: 195 ---RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
              + LAF H     V++RD K  N+L++++   KL+DFGLA        ++    V  T
Sbjct: 115 QLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 170
Query: 252 EGYAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE  +   + +T  D++S G +  E++T R
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 7   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA--- 194
           +L HP++V L+     +    LV+E+     LH  L K   ++   LT I + +  +   
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASA--LTGIPLPLIKSYLF 113
Query: 195 ---RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
              + LAF H     V++RD K  N+L++++   KL+DFGLA        ++    V  T
Sbjct: 114 QLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 169
Query: 252 EGYAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE  +   + +T  D++S G +  E++T R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 102/211 (48%), Gaps = 20/211 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           N+     LGEG FGKV K          +  + +  KVL  +  QG  E   E+ +L  L
Sbjct: 14  NYQIVKTLGEGSFGKV-KLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLL 70
Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAF 199
           +HPH++ L       +  ++V EY A   L D + +    +     R    I +A  + +
Sbjct: 71  RHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISA--VEY 127
Query: 200 LHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGEDSHITTCVMGTEGYAA 256
            H  +  +++RD K  N+LLD   N K++DFGL+   TDG    +   T+C  G+  YAA
Sbjct: 128 CHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG----NFLKTSC--GSPNYAA 179
Query: 257 PEYINTGHLTT--MCDVFSFGVVLLELLTGR 285
           PE I +G L      DV+S GV+L  +L  R
Sbjct: 180 PEVI-SGKLYAGPEVDVWSCGVILYVMLCRR 209

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 103/224 (45%), Gaps = 24/224 (10%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
            + R  +LG+GGF K Y+  + D     + A  V  K + +   Q  +    E+     L
Sbjct: 27  RYMRGRFLGKGGFAKCYE--ITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSL 83
Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLP---WLTRIKIAIGAARC 196
            +PH+V   G+  +D+   +V E     +L +   +  + T P   +  R  I     + 
Sbjct: 84  DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QG 138
Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT----DGPQGEDSHITTCVMGTE 252
           + +LH     VI+RD K  N+ L+ D + K+ DFGLAT    DG + +D      + GT 
Sbjct: 139 VQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD------LCGTP 190
Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE 296
            Y APE +     +   D++S G +L  LL G+   E + C +E
Sbjct: 191 NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS-CLKE 233

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 121/278 (43%), Gaps = 25/278 (8%)
Query: 73  ELQMITHN-FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA 131
           E Q +T N F +   LG+GGFG+V   C       G       ++   +   +G    L 
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEV---CACQVRATGKMYACKKLEKKRIKKRKGEAMALN 233
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA 190
           E   L ++    +V+L  Y  E +  L LV   M  G+L   ++    +  P    +  A
Sbjct: 234 EKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA 292
Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG 250
                 L  LH E   ++YRD K  NILLD   + ++SD GLA   P+G+        +G
Sbjct: 293 AEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVG 347
Query: 251 TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF 310
           T GY APE +     T   D ++ G +L E++ G+   ++ + K +++ VE         
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE--------- 398
Query: 311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSR 348
            +L + +     +R+S +      ++  Q L  +P  R
Sbjct: 399 -RLVKEVPEEYSERFSPQA----RSLCSQLLCKDPAER 431

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +L HP++V L+     +    LV+E+     LH  L K   ++   LT I + +  +   
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASA--LTGIPLPLIKSYLF 110
Query: 198 AFLHG----EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
             L G        V++RD K  N+L++++   KL+DFGLA        ++    V  T  
Sbjct: 111 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLW 168
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +   + +T  D++S G +  E++T R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 102/211 (48%), Gaps = 20/211 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           N+     LGEG FGKV K          +  + +  KVL  +  QG  E   E+ +L  L
Sbjct: 15  NYQIVKTLGEGSFGKV-KLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLL 71
Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAF 199
           +HPH++ L       +  ++V EY A   L D + +    +     R    I +A  + +
Sbjct: 72  RHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISA--VEY 128
Query: 200 LHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGEDSHITTCVMGTEGYAA 256
            H  +  +++RD K  N+LLD   N K++DFGL+   TDG    +   T+C  G+  YAA
Sbjct: 129 CHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG----NFLKTSC--GSPNYAA 180
Query: 257 PEYINTGHLTT--MCDVFSFGVVLLELLTGR 285
           PE I +G L      DV+S GV+L  +L  R
Sbjct: 181 PEVI-SGKLYAGPEVDVWSCGVILYVMLCRR 210

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 120/297 (40%), Gaps = 41/297 (13%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG-HREWLAEVIFLGQLKHPHL- 144
           LG G FG+V +      +      +TVAVK+L    +   HR  ++E+  L  + H HL 
Sbjct: 35  LGRGAFGQVIEADAF-GIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH-HLN 92
Query: 145 -VNLIGYCCEDEHRLLV-YEYMALGNLHDQLFKNYSSTLPW-------LTR---IKIAIG 192
            VNL+G C +    L+V  E+   GNL   L    +  +P+       LT    I  +  
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQ 152
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE 252
            A+ + FL    +  I+RD  A NILL      K+ DFGLA D  +  D           
Sbjct: 153 VAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPL 210
Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK 312
            + APE I     T   DV+SFGV+L E+ +   S                        K
Sbjct: 211 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG-------------------VK 251
Query: 313 LDQIIDSRLEDRYSTEGAKRLAAVAHQ----CLSHNPKSRPTMTTVVKALEPLLDLN 365
           +D+    RL++              +Q    C    P  RPT + +V+ L  LL  N
Sbjct: 252 IDEEFXRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 308

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 126/303 (41%), Gaps = 49/303 (16%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG-HREWLAEVIFLGQLKHPHL- 144
           LG G FG+V +      +      +TVAVK+L    +   HR  ++E+  L  + H HL 
Sbjct: 35  LGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH-HLN 92
Query: 145 -VNLIGYCCEDEHRLLV-YEYMALGNLHDQLFKNYSSTLPWLTR--------------IK 188
            VNL+G C +    L+V  E+   GNL   L    +  +P+                 I 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
            +   A+ + FL    +  I+RD  A NILL      K+ DFGLA D  +  D       
Sbjct: 153 YSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS------VEKNRCKREKDLVEW 302
                + APE I     T   DV+SFGV+L E+ +   S      +++  C+R       
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR------- 263
Query: 303 ARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
               LK+ T++      R  D  + E  + +      C    P  RPT + +V+ L  LL
Sbjct: 264 ----LKEGTRM------RAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLGNLL 309
Query: 363 DLN 365
             N
Sbjct: 310 QAN 312

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 102/211 (48%), Gaps = 20/211 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           N+     LGEG FGKV K          +  + +  KVL  +  QG  E   E+ +L  L
Sbjct: 9   NYQIVKTLGEGSFGKV-KLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLL 65
Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAF 199
           +HPH++ L       +  ++V EY A   L D + +    +     R    I +A  + +
Sbjct: 66  RHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISA--VEY 122
Query: 200 LHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGEDSHITTCVMGTEGYAA 256
            H  +  +++RD K  N+LLD   N K++DFGL+   TDG    +   T+C  G+  YAA
Sbjct: 123 CHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG----NFLKTSC--GSPNYAA 174
Query: 257 PEYINTGHLTT--MCDVFSFGVVLLELLTGR 285
           PE I +G L      DV+S GV+L  +L  R
Sbjct: 175 PEVI-SGKLYAGPEVDVWSCGVILYVMLCRR 204

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 121/278 (43%), Gaps = 25/278 (8%)
Query: 73  ELQMITHN-FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA 131
           E Q +T N F +   LG+GGFG+V   C       G       ++   +   +G    L 
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEV---CACQVRATGKMYACKKLEKKRIKKRKGEAMALN 233
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA 190
           E   L ++    +V+L  Y  E +  L LV   M  G+L   ++    +  P    +  A
Sbjct: 234 EKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA 292
Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG 250
                 L  LH E   ++YRD K  NILLD   + ++SD GLA   P+G+        +G
Sbjct: 293 AEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVG 347
Query: 251 TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF 310
           T GY APE +     T   D ++ G +L E++ G+   ++ + K +++ VE         
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE--------- 398
Query: 311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSR 348
            +L + +     +R+S +      ++  Q L  +P  R
Sbjct: 399 -RLVKEVPEEYSERFSPQA----RSLCSQLLCKDPAER 431

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 126/302 (41%), Gaps = 47/302 (15%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG-HREWLAEVIFLGQL-KHPHL 144
           LG G FG+V +      +      +TVAVK+L    +   HR  ++E+  L  +  H ++
Sbjct: 26  LGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 84
Query: 145 VNLIGYCCEDEHRLLVY-EYMALGNLHDQLFKNYSSTLPWLTR--------------IKI 189
           VNL+G C +    L+V  E+   GNL   L    +  +P+                 I  
Sbjct: 85  VNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM 249
           +   A+ + FL    +  I+RD  A NILL      K+ DFGLA D  +  D        
Sbjct: 145 SFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 250 GTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS------VEKNRCKREKDLVEWA 303
               + APE I     T   DV+SFGV+L E+ +   S      +++  C+R        
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-------- 254
Query: 304 RPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD 363
              LK+ T++      R  D  + E  + +      C    P  RPT + +V+ L  LL 
Sbjct: 255 ---LKEGTRM------RAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLGNLLQ 301
Query: 364 LN 365
            N
Sbjct: 302 AN 303

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 126/302 (41%), Gaps = 47/302 (15%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG-HREWLAEVIFLGQL-KHPHL 144
           LG G FG+V +      +      +TVAVK+L    +   HR  ++E+  L  +  H ++
Sbjct: 72  LGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 130
Query: 145 VNLIGYCCEDEHRLLV-YEYMALGNLHDQLFKNYSSTLPWLTR--------------IKI 189
           VNL+G C +    L+V  E+   GNL   L    +  +P+                 I  
Sbjct: 131 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 190
Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM 249
           +   A+ + FL    +  I+RD  A NILL      K+ DFGLA D  +  D        
Sbjct: 191 SFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 250 GTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS------VEKNRCKREKDLVEWA 303
               + APE I     T   DV+SFGV+L E+ +   S      +++  C+R        
Sbjct: 249 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-------- 300
Query: 304 RPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD 363
              LK+ T++      R  D  + E  + +      C    P  RPT + +V+ L  LL 
Sbjct: 301 ---LKEGTRM------RAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLGNLLQ 347
Query: 364 LN 365
            N
Sbjct: 348 AN 349

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 126/302 (41%), Gaps = 47/302 (15%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG-HREWLAEVIFLGQL-KHPHL 144
           LG G FG+V +      +      +TVAVK+L    +   HR  ++E+  L  +  H ++
Sbjct: 26  LGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 84
Query: 145 VNLIGYCCEDEHRLLVY-EYMALGNLHDQLFKNYSSTLPWLTR--------------IKI 189
           VNL+G C +    L+V  E+   GNL   L    +  +P+                 I  
Sbjct: 85  VNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM 249
           +   A+ + FL    +  I+RD  A NILL      K+ DFGLA D  +  D        
Sbjct: 145 SFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 250 GTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS------VEKNRCKREKDLVEWA 303
               + APE I     T   DV+SFGV+L E+ +   S      +++  C+R        
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-------- 254
Query: 304 RPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD 363
              LK+ T++      R  D  + E  + +      C    P  RPT + +V+ L  LL 
Sbjct: 255 ---LKEGTRM------RAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLGNLLQ 301
Query: 364 LN 365
            N
Sbjct: 302 AN 303

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 102/220 (46%), Gaps = 39/220 (17%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           ++   D LG G FGKV  G         L    VAVK+L+       R+ +  +  +G++
Sbjct: 12  HYVLGDTLGVGTFGKVKIG------EHQLTGHKVAVKILN-------RQKIRSLDVVGKI 58
Query: 140 K----------HPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKI 189
           K          HPH++ L           +V EY++ G L D + K+         R+  
Sbjct: 59  KREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ 118
Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGEDSHITT 246
            I +A      H     V++RD K  N+LLD+  NAK++DFGL+   +DG    DS    
Sbjct: 119 QILSAVDYCHRH----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS---- 170
Query: 247 CVMGTEGYAAPEYINTGHLTT--MCDVFSFGVVLLELLTG 284
           C  G+  YAAPE I +G L      D++S GV+L  LL G
Sbjct: 171 C--GSPNYAAPEVI-SGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 119/301 (39%), Gaps = 44/301 (14%)
Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWL-AEVIFLG 137
           +N      LG G FGKV +      L        VAVK+L        +E L +E+  + 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAF-GLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 138 QL-KHPHLVNLIGYCCEDEHRLLVYEYMALGNL------------HDQLFKNYSSTLPWL 184
            L +H ++VNL+G C      L++ EY   G+L             D  F   +ST    
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTR 164
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI 244
             +  +   A+ +AFL    K  I+RD  A N+LL + + AK+ DFGLA D     +  +
Sbjct: 165 DLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 245 TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS------VEKNRCKREKD 298
                    + APE I     T   DV+S+G++L E+ +   +      V     K  KD
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282
Query: 299 LVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL 358
             + A+P                         K + ++   C +  P  RPT   +   L
Sbjct: 283 GYQMAQPAF---------------------APKNIYSIMQACWALEPTHRPTFQQICSFL 321
Query: 359 E 359
           +
Sbjct: 322 Q 322

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+    LD          + E+  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALXKIRLDTETEGVPSTAIREISLLK 57
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +L HP++V L+     +    LV+E+     LH  L K   ++   LT I + +  +   
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASA--LTGIPLPLIKSYLF 110
Query: 198 AFLHG----EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
             L G        V++RD K  N+L++++   KL+DFGLA     G      T  + T  
Sbjct: 111 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLW 168
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +   + +T  D++S G +  E++T R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+    LD          + E+  L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALXKIRLDTETEGVPSTAIREISLLK 56
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +L HP++V L+     +    LV+E+     LH  L K   ++   LT I + +  +   
Sbjct: 57  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASA--LTGIPLPLIKSYLF 109
Query: 198 AFLHG----EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
             L G        V++RD K  N+L++++   KL+DFGLA     G      T  + T  
Sbjct: 110 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLW 167
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +   + +T  D++S G +  E++T R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 121/297 (40%), Gaps = 40/297 (13%)
Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWL-AEVIFLG 137
           +N      LG G FGKV +      L        VAVK+L        +E L +E+  + 
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAF-GLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 96
Query: 138 QL-KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTL------PWLTR--IK 188
            L +H ++VNL+G C      L++ EY   G+L + L +   + L      P   R  + 
Sbjct: 97  HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLH 156
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
            +   A+ +AFL    K  I+RD  A N+LL + + AK+ DFGLA D     +  +    
Sbjct: 157 FSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 214
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS------VEKNRCKREKDLVEW 302
                + APE I     T   DV+S+G++L E+ +   +      V     K  KD  + 
Sbjct: 215 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM 274
Query: 303 ARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
           A+P                         K + ++   C +  P  RPT   +   L+
Sbjct: 275 AQPAF---------------------APKNIYSIMQACWALEPTHRPTFQQICSFLQ 310

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLG 137
            F +   LG G FG VYKG     +  G K +  VA+K L +    + ++E L E   + 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 73
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST-----LPWLTRIKIAIG 192
            + +PH+  L+G C     +L++ + M  G L D + ++  +      L W  +I     
Sbjct: 74  SVDNPHVCRLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYLLNWCVQI----- 127
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT-DGPQGEDSHITTCVMGT 251
            A+ + +L  E++ +++RD  A N+L+ +  + K++DFGLA   G + ++ H     +  
Sbjct: 128 -AKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           + + A E I     T   DV+S+GV + EL+T
Sbjct: 185 K-WMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 19/203 (9%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGH--REWLAEVIFLGQLKHPHL 144
           LG+G FG+V K C D      +  Q  AVKV++   ++       L EV  L +L HP++
Sbjct: 30  LGKGSFGEVLK-CKD-----RITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           + L     +     +V E    G L D++ K    +     RI   + +   + ++H  +
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG--ITYMH--K 139
Query: 205 KPVIYRDFKASNILLDS---DYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN 261
             +++RD K  NILL+S   D + K+ DFGL+T   Q          +GT  Y APE + 
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLR 196
Query: 262 TGHLTTMCDVFSFGVVLLELLTG 284
            G     CDV+S GV+L  LL+G
Sbjct: 197 -GTYDEKCDVWSAGVILYILLSG 218

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 112/272 (41%), Gaps = 34/272 (12%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHREWLAEVIFLGQLKHPHL 144
           LG G +G V K      +R     Q +AVK +   VN  +  R  +   I +  +  P  
Sbjct: 59  LGRGAYGVVEK------MRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 112
Query: 145 VNLIGYCCEDEHRLLVYEYM--ALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
           V   G    +    +  E M  +L   + Q+  +   T+P     KIA+   + L  LH 
Sbjct: 113 VTFYGALFREGDVWICMELMDTSLDKFYKQVI-DKGQTIPEDILGKIAVSIVKALEHLHS 171
Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI-- 260
           +   VI+RD K SN+L+++    K+ DFG++       DS   T   G + Y APE I  
Sbjct: 172 KLS-VIHRDVKPSNVLINALGQVKMCDFGISG---YLVDSVAKTIDAGCKPYMAPERINP 227
Query: 261 --NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIID 318
             N    +   D++S G+ ++EL   R   +            W  P    F +L Q+++
Sbjct: 228 ELNQKGYSVKSDIWSLGITMIELAILRFPYD-----------SWGTP----FQQLKQVVE 272
Query: 319 SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT 350
                  + + +        QCL  N K RPT
Sbjct: 273 EPSPQLPADKFSAEFVDFTSQCLKKNSKERPT 304

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLG 137
           N+     +G+G F KV         R  L  + VAV+++D     S   ++   EV  + 
Sbjct: 15  NYRLLKTIGKGNFAKVKLA------RHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMK 68
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR-- 195
            L HP++V L      ++   LV EY + G + D L  +         R+K     A+  
Sbjct: 69  VLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--------GRMKEKEARAKFR 120
Query: 196 --CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
               A  +  +K +++RD KA N+LLD+D N K++DFG + +   G +     C  G+  
Sbjct: 121 QIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDEFC--GSPP 177
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTG 284
           YAAPE +    +     DV+S GV+L  L++G
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 10/212 (4%)
Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVI 134
           ++I   +   D LG GG   VY    +D +   +K    A+ +      +  + +  EV 
Sbjct: 7   KIINERYKIVDKLGGGGMSTVY--LAEDTIL-NIKVAIKAIFIPPREKEETLKRFEREVH 63
Query: 135 FLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA 194
              QL H ++V++I    ED+   LV EY+    L + +     S  P      I     
Sbjct: 64  NSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI----ESHGPLSVDTAINFTNQ 119
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
                 H  +  +++RD K  NIL+DS+   K+ DFG+A    +   +  T  V+GT  Y
Sbjct: 120 ILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQY 178
Query: 255 AAPEYINTGHLTTMC-DVFSFGVVLLELLTGR 285
            +PE    G  T  C D++S G+VL E+L G 
Sbjct: 179 FSPEQAK-GEATDECTDIYSIGIVLYEMLVGE 209

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 130/296 (43%), Gaps = 37/296 (12%)
Query: 87  LGEGGFGKVY--KGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL--KHP 142
           LGEG FG+V   +    D  +P  +A TVAVK+L  + ++     L   + + ++  KH 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK------NYS--------STLPWLTRIK 188
           +++NL+G C +D    ++  Y + GNL + L         YS          + +   + 
Sbjct: 102 NIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
                AR + +L  ++   I+RD  A N+L+  +   K++DFGLA D    +    TT  
Sbjct: 162 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
                + APE +     T   DV+SFGV++ E+ T   S            VE    +LK
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------VEELFKLLK 273
Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL 364
           +  ++D+  +   E          L  +   C    P  RPT   +V+ L+ +L L
Sbjct: 274 EGHRMDKPANCTNE----------LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 126/303 (41%), Gaps = 49/303 (16%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG-HREWLAEVIFLGQLKHPHL- 144
           LG G FG+V +      +      +TVAVK+L    +   HR  ++E+  L  + H HL 
Sbjct: 37  LGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH-HLN 94
Query: 145 -VNLIGYCCEDEHRLLV-YEYMALGNLHDQLFKNYSSTLPWLTR--------------IK 188
            VNL+G C +    L+V  E+   GNL   L    +  +P+                 I 
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLIC 154
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
            +   A+ + FL    +  I+RD  A NILL      K+ DFGLA D  +  D       
Sbjct: 155 YSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 212
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS------VEKNRCKREKDLVEW 302
                + APE I     T   DV+SFGV+L E+ +   S      +++  C+R       
Sbjct: 213 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR------- 265
Query: 303 ARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
               LK+ T++      R  D  + E  + +      C    P  RPT + +V+ L  LL
Sbjct: 266 ----LKEGTRM------RAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLGNLL 311
Query: 363 DLN 365
             N
Sbjct: 312 QAN 314

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 121/297 (40%), Gaps = 40/297 (13%)
Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWL-AEVIFLG 137
           +N      LG G FGKV +      L        VAVK+L        +E L +E+  + 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAF-GLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 138 QL-KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTL------PWLTR--IK 188
            L +H ++VNL+G C      L++ EY   G+L + L +   + L      P   R  + 
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLH 164
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
            +   A+ +AFL    K  I+RD  A N+LL + + AK+ DFGLA D     +  +    
Sbjct: 165 FSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 222
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS------VEKNRCKREKDLVEW 302
                + APE I     T   DV+S+G++L E+ +   +      V     K  KD  + 
Sbjct: 223 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM 282
Query: 303 ARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
           A+P                         K + ++   C +  P  RPT   +   L+
Sbjct: 283 AQPAF---------------------APKNIYSIMQACWALEPTHRPTFQQICSFLQ 318

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 131/296 (44%), Gaps = 37/296 (12%)
Query: 87  LGEGGFGKVY--KGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL--KHP 142
           LGEG FG+V   +    D  +P  +A TVAVK+L  + ++     L   + + ++  KH 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK------NYS--------STLPWLTRIK 188
           ++++L+G C +D    ++ EY + GNL + L         YS          + +   + 
Sbjct: 102 NIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
                AR + +L  ++   I+RD  A N+L+  +   K++DFGLA D    +    TT  
Sbjct: 162 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
                + APE +     T   DV+SFGV++ E+ T   S            VE    +LK
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------VEELFKLLK 273
Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL 364
           +  ++D+  +   E          L  +   C    P  RPT   +V+ L+ +L L
Sbjct: 274 EGHRMDKPANCTNE----------LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 130/296 (43%), Gaps = 37/296 (12%)
Query: 87  LGEGGFGKVY--KGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL--KHP 142
           LGEG FG+V   +    D  +P  +A TVAVK+L  + ++     L   + + ++  KH 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK------NYS--------STLPWLTRIK 188
           +++ L+G C +D    ++ EY + GNL + L         YS          + +   + 
Sbjct: 102 NIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
                AR + +L  ++   I+RD  A N+L+  +   K++DFGLA D    +    TT  
Sbjct: 162 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
                + APE +     T   DV+SFGV++ E+ T   S            VE    +LK
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------VEELFKLLK 273
Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL 364
           +  ++D+  +   E          L  +   C    P  RPT   +V+ L+ +L L
Sbjct: 274 EGHRMDKPANCTNE----------LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 99/220 (45%), Gaps = 36/220 (16%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 56
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYM-----------ALGNLHDQLFKNYSSTLPWLTR 186
           +L HP++V L+     +    LV+E++           AL  +   L K+Y   L     
Sbjct: 57  ELNHPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQL----- 111
Query: 187 IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITT 246
                   + LAF H     V++RD K  N+L++++   KL+DFGLA     G      T
Sbjct: 112 -------LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYT 160
Query: 247 CVMGTEGYAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
             + T  Y APE  +   + +T  D++S G +  E++T R
Sbjct: 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 30/217 (13%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 7   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQL--FKNYSSTLPWLTRIKIAIGAA- 194
           +L HP++V L+     +    LV+E+     LH  L  F + S+    LT I + +  + 
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKTFMDASA----LTGIPLPLIKSY 111
Query: 195 -----RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM 249
                + LAF H     V++RD K  N+L++++   KL+DFGLA        ++    V 
Sbjct: 112 LFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 168
Query: 250 GTEGYAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            T  Y APE  +   + +T  D++S G +  E++T R
Sbjct: 169 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLG 137
            F +   LG G FG VYKG     +  G K +  VA+K L +    + ++E L E   + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 72
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST-----LPWLTRIKIAIG 192
            + +PH+  L+G C     +L+  + M  G L D + ++  +      L W  +I     
Sbjct: 73  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQYLLNWCVQI----- 126
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT-DGPQGEDSHITTCVMGT 251
            A+ + +L  E++ +++RD  A N+L+ +  + K++DFGLA   G + ++ H     +  
Sbjct: 127 -AKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           + + A E I     T   DV+S+GV + EL+T
Sbjct: 184 K-WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGH--REWLAEVIFLGQLKHPHL 144
           LG+G FG+V K C D      +  Q  AVKV++   ++       L EV  L +L HP++
Sbjct: 30  LGKGSFGEVLK-CKD-----RITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           + L     +     +V E    G L D++ K    +     RI   + +   + ++H   
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG--ITYMHKHN 141
Query: 205 KPVIYRDFKASNILLDS---DYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN 261
             +++RD K  NILL+S   D + K+ DFGL+T   Q          +GT  Y APE + 
Sbjct: 142 --IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAPEVLR 196
Query: 262 TGHLTTMCDVFSFGVVLLELLTG 284
            G     CDV+S GV+L  LL+G
Sbjct: 197 -GTYDEKCDVWSAGVILYILLSG 218

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 101/235 (42%), Gaps = 37/235 (15%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---------DVNGSQGHREWL 130
           NF     LG+G FGKV    V +           AVKVL         DV  +   +  L
Sbjct: 24  NFEFIRVLGKGSFGKVMLARVKET------GDLYAVKVLKKDVILQDDDVECTMTEKRIL 77
Query: 131 AEVIFLGQLKHPHLVNLIGYCC--EDEHRLLVYEYMALGNL--HDQLFKNYSSTLPWLTR 186
           +    L +  HP L  L  +CC    +    V E++  G+L  H Q  + +         
Sbjct: 78  S----LAR-NHPFLTQL--FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYA 130
Query: 187 IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITT 246
            +I       L FLH  +K +IYRD K  N+LLD + + KL+DFG+  +G     +  T 
Sbjct: 131 AEII----SALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF 184
Query: 247 CVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVE 301
           C  GT  Y APE +         D ++ GV+L E+L G    E    + E DL E
Sbjct: 185 C--GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE---AENEDDLFE 234

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 99/231 (42%), Gaps = 40/231 (17%)
Query: 80  NFSRSDYLGEGGFGKVY--KGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFL 136
           +F     LG GGFG V+  K  VDD           A+K + +   +  RE  + EV  L
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDC--------NYAIKRIRLPNRELAREKVMREVKAL 57
Query: 137 GQLKHPHLVNLIGYCCEDEH---------RLLVYEYMAL---GNLHDQLFKNYSSTLPWL 184
            +L+HP +V       E            ++ +Y  M L    NL D +  N   T+   
Sbjct: 58  AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM--NGRCTIEER 115
Query: 185 TR---IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGED 241
            R   + I +  A  + FLH   K +++RD K SNI    D   K+ DFGL T   Q E+
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 173
Query: 242 SHITTCVM----------GTEGYAAPEYINTGHLTTMCDVFSFGVVLLELL 282
                  M          GT+ Y +PE I+    +   D+FS G++L ELL
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 16/220 (7%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
            + R  +LG+GGF K Y+  + D     + A  V  K + +   Q  +    E+     L
Sbjct: 43  RYMRGRFLGKGGFAKCYE--ITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSL 99
Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLP---WLTRIKIAIGAARC 196
            +PH+V   G+  +D+   +V E     +L +   +  + T P   +  R  I     + 
Sbjct: 100 DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QG 154
Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           + +LH     VI+RD K  N+ L+ D + K+ DFGLAT      +     C  GT  Y A
Sbjct: 155 VQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLC--GTPNYIA 210
Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE 296
           PE +     +   D++S G +L  LL G+   E + C +E
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS-CLKE 249

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 134/303 (44%), Gaps = 46/303 (15%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLG--QLKHPHL 144
           +G+G +G+V++G          + + VAVK+     S+  + W  E        L+H ++
Sbjct: 45  VGKGRYGEVWRG--------SWQGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENI 93
Query: 145 VNLIGYCCEDEHR----LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFL 200
           +  I       H      L+  Y  +G+L+D L     +TL  ++ ++I +  A  LA L
Sbjct: 94  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHL 150
Query: 201 HGE-----EKPVI-YRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHIT--TCVMGTE 252
           H E      KP I +RD K+ NIL+  +    ++D GLA    Q  +         +GT+
Sbjct: 151 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 210
Query: 253 GYAAPEYINTGHLTTMC-------DVFSFGVVLLELLTGRRSVEKNRCKREK----DLVE 301
            Y APE ++   +   C       D+++FG+VL E+   RR V     +  K    D+V 
Sbjct: 211 RYMAPEVLDET-IQVDCFDSYKRVDIWAFGLVLWEV--ARRMVSNGIVEDYKPPFYDVVP 267
Query: 302 WARPMLKDFTKLDQIIDSR--LEDR-YSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL 358
              P  +D  K+  +   R  + +R +S      LA +  +C   NP +R T   + K L
Sbjct: 268 -NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 326
Query: 359 EPL 361
             +
Sbjct: 327 TKI 329

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGH--REWLAEVIFLGQLKHPHL 144
           LG+G FG+V K C D      +  Q  AVKV++   ++       L EV  L +L HP++
Sbjct: 30  LGKGSFGEVLK-CKDR-----ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           + L     +     +V E    G L D++ K    +     RI   + +   + ++H   
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG--ITYMHKHN 141
Query: 205 KPVIYRDFKASNILLDS---DYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN 261
             +++RD K  NILL+S   D + K+ DFGL+T   Q          +GT  Y APE + 
Sbjct: 142 --IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAPEVLR 196
Query: 262 TGHLTTMCDVFSFGVVLLELLTG 284
            G     CDV+S GV+L  LL+G
Sbjct: 197 -GTYDEKCDVWSAGVILYILLSG 218

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 68  VFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR 127
           +F  + L+ I+        LG+G FG V + C  D L     A  VAVK L  +G    R
Sbjct: 6   IFEERHLKYISQ-------LGKGNFGSV-ELCRYDPLGDNTGA-LVAVKQLQHSGPDQQR 56
Query: 128 EWLAEVIFLGQLKHPHLVNLIG--YCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLT 185
           ++  E+  L  L    +V   G  Y    +   LV EY+  G L D           +L 
Sbjct: 57  DFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD-----------FLQ 105
Query: 186 RIKIAIGAARCLAF----LHGEE----KPVIYRDFKASNILLDSDYNAKLSDFGLATDGP 237
           R +  + A+R L +      G E    +  ++RD  A NIL++S+ + K++DFGLA   P
Sbjct: 106 RHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 165
Query: 238 QGEDSHITTCVMGTE-GYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
             +D ++      +   + APE ++    +   DV+SFGVVL EL T
Sbjct: 166 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 130/296 (43%), Gaps = 37/296 (12%)
Query: 87  LGEGGFGKVY--KGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL--KHP 142
           LGEG FG+V   +    D  +P  +A TVAVK+L  + ++     L   + + ++  KH 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK------NYS--------STLPWLTRIK 188
           +++NL+G C +D    ++  Y + GNL + L         YS          + +   + 
Sbjct: 102 NIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
                AR + +L  ++   I+RD  A N+L+  +   K++DFGLA D    +    TT  
Sbjct: 162 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
                + APE +     T   DV+SFGV++ E+ T   S            VE    +LK
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------VEELFKLLK 273
Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL 364
           +  ++D+  +   E          L  +   C    P  RPT   +V+ L+ +L L
Sbjct: 274 EGHRMDKPANCTNE----------LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLG 137
            F +   LG G FG VYKG     +  G K +  VA+K L +    + ++E L E   + 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 73
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST-----LPWLTRIKIAIG 192
            + +PH+  L+G C     +L++ + M  G L D + ++  +      L W  +I     
Sbjct: 74  SVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 127
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT-DGPQGEDSHITTCVMGT 251
            A+ + +L  E++ +++RD  A N+L+ +  + K++DFGLA   G + ++ H     +  
Sbjct: 128 -AKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           + + A E I     T   DV+S+GV + EL+T
Sbjct: 185 K-WMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFLGQL 139
           +   + LG GGFG V +    D        + VA+K      S  +RE W  E+  + +L
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDT------GEQVAIKQCRQELSPKNRERWCLEIQIMKKL 70
Query: 140 KHPHLVNL------IGYCCEDEHRLLVYEYMALGNLHDQL--FKNYSSTLPWLTRIKIAI 191
            HP++V+       +     ++  LL  EY   G+L   L  F+N         R  ++ 
Sbjct: 71  NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS- 129
Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNA---KLSDFGLATDGPQGEDSHITTCV 248
             +  L +LH  E  +I+RD K  NI+L         K+ D G A +  QGE   + T  
Sbjct: 130 DISSALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEF 184
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRR 286
           +GT  Y APE +     T   D +SFG +  E +TG R
Sbjct: 185 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 222

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 134/303 (44%), Gaps = 46/303 (15%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLG--QLKHPHL 144
           +G+G +G+V++G          + + VAVK+     S+  + W  E        L+H ++
Sbjct: 16  VGKGRYGEVWRG--------SWQGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENI 64
Query: 145 VNLIGYCCEDEHR----LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFL 200
           +  I       H      L+  Y  +G+L+D L     +TL  ++ ++I +  A  LA L
Sbjct: 65  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHL 121
Query: 201 HGE-----EKPVI-YRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHIT--TCVMGTE 252
           H E      KP I +RD K+ NIL+  +    ++D GLA    Q  +         +GT+
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 253 GYAAPEYINTGHLTTMC-------DVFSFGVVLLELLTGRRSVEKNRCKREK----DLVE 301
            Y APE ++   +   C       D+++FG+VL E+   RR V     +  K    D+V 
Sbjct: 182 RYMAPEVLDET-IQVDCFDSYKRVDIWAFGLVLWEV--ARRMVSNGIVEDYKPPFYDVVP 238
Query: 302 WARPMLKDFTKLDQIIDSR--LEDR-YSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL 358
              P  +D  K+  +   R  + +R +S      LA +  +C   NP +R T   + K L
Sbjct: 239 -NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297
Query: 359 EPL 361
             +
Sbjct: 298 TKI 300

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLG 137
            F +   LG G FG VYKG     +  G K +  VA+K L +    + ++E L E   + 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 76
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST-----LPWLTRIKIAIG 192
            + +PH+  L+G C     +L++ + M  G L D + ++  +      L W  +I     
Sbjct: 77  SVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 130
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT-DGPQGEDSHITTCVMGT 251
            A+ + +L  E++ +++RD  A N+L+ +  + K++DFGLA   G + ++ H     +  
Sbjct: 131 -AKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 187
Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           + + A E I     T   DV+S+GV + EL+T
Sbjct: 188 K-WMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 28/206 (13%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FGKVYK     N   G  A   A KV++    +   +++ E+  L    HP++V 
Sbjct: 27  LGDGAFGKVYKA---KNKETGALA---AAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI---GAARCLAFLHGE 203
           L+G    D    ++ E+   G +   + +        LT  +I +        L FLH  
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVVCRQMLEALNFLHS- 135
Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDG---PQGEDSHITTCVMGTEGYAAPEYI 260
            K +I+RD KA N+L+  + + +L+DFG++       Q  DS I     GT  + APE +
Sbjct: 136 -KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEVV 189
Query: 261 NTGHLTTM-----CDVFSFGVVLLEL 281
               +         D++S G+ L+E+
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLG 137
           N+     +G+G F KV         R  L  + VAVK++D     S   ++   EV    
Sbjct: 15  NYRLLKTIGKGNFAKVKLA------RHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXK 68
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
            L HP++V L      ++   LV EY + G + D L  +         + K A    R +
Sbjct: 69  VLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAH------GRXKEKEARAKFRQI 122
Query: 198 --AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
             A  +  +K +++RD KA N+LLD+D N K++DFG + +   G          G   YA
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNK---LDAFCGAPPYA 179
Query: 256 APE-YINTGHLTTMCDVFSFGVVLLELLTG 284
           APE +    +     DV+S GV+L  L++G
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 133/305 (43%), Gaps = 35/305 (11%)
Query: 71  LKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHRE 128
           L+++ +    F+    LG+G FG V +  +       +K   VAVK+L  D+  S    E
Sbjct: 15  LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVK---VAVKMLKADIIASSDIEE 71
Query: 129 WLAEVIFLGQLKHPHLVNLIGYCCEDEHR------LLVYEYMALGNLHDQLFKNYSS--- 179
           +L E   + +  HPH+  L+G       +      +++  +M  G+LH  L  +      
Sbjct: 72  FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP 131
Query: 180 -TLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ 238
             LP  T ++  +  A  + +L    +  I+RD  A N +L  D    ++DFGL+     
Sbjct: 132 FNLPLQTLVRFMVDIACGMEYLSS--RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS 189
Query: 239 GEDSHITTCVMGTE-GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREK 297
           G D +   C       + A E +     T   DV++FGV + E++T        R +   
Sbjct: 190 G-DYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT--------RGQTPY 240
Query: 298 DLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA 357
             +E A    + +  L  I  +RL  +   E  + +  + +QC S +PK RP+ T +   
Sbjct: 241 AGIENA----EIYNYL--IGGNRL--KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRME 292
Query: 358 LEPLL 362
           LE +L
Sbjct: 293 LENIL 297

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 68  VFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR 127
           +F  + L+ I+        LG+G FG V + C  D L     A  VAVK L  +G    R
Sbjct: 7   IFEERHLKYISQ-------LGKGNFGSV-ELCRYDPLGDNTGA-LVAVKQLQHSGPDQQR 57
Query: 128 EWLAEVIFLGQLKHPHLVNLIG--YCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLT 185
           ++  E+  L  L    +V   G  Y    +   LV EY+  G L D           +L 
Sbjct: 58  DFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD-----------FLQ 106
Query: 186 RIKIAIGAARCLAF----LHGEE----KPVIYRDFKASNILLDSDYNAKLSDFGLATDGP 237
           R +  + A+R L +      G E    +  ++RD  A NIL++S+ + K++DFGLA   P
Sbjct: 107 RHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 166
Query: 238 QGEDSHITTCVMGTE-GYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
             +D ++      +   + APE ++    +   DV+SFGVVL EL T
Sbjct: 167 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLG 137
            F +   LG G FG VYKG     +  G K +  VA+K L +    + ++E L E   + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 74
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST-----LPWLTRIKIAIG 192
            + +PH+  L+G C     +L++ + M  G L D + ++  +      L W  +I     
Sbjct: 75  SVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 128
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT-DGPQGEDSHITTCVMGT 251
            A+ + +L  E++ +++RD  A N+L+ +  + K++DFGLA   G + ++ H     +  
Sbjct: 129 -AKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           + + A E I     T   DV+S+GV + EL+T
Sbjct: 186 K-WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLG 137
            F +   LG G FG VYKG     +  G K +  VA+K L +    + ++E L E   + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 75
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST-----LPWLTRIKIAIG 192
            + +PH+  L+G C     +L++ + M  G L D + ++  +      L W  +I     
Sbjct: 76  SVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 129
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT-DGPQGEDSHITTCVMGT 251
            A+ + +L  E++ +++RD  A N+L+ +  + K++DFGLA   G + ++ H     +  
Sbjct: 130 -AKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           + + A E I     T   DV+S+GV + EL+T
Sbjct: 187 K-WMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLG 137
            F +   LG G FG VYKG     +  G K +  VA+K L +    + ++E L E   + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 72
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST-----LPWLTRIKIAIG 192
            + +PH+  L+G C     +L++ + M  G L D + ++  +      L W  +I     
Sbjct: 73  SVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 126
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT-DGPQGEDSHITTCVMGT 251
            A+ + +L  E++ +++RD  A N+L+ +  + K++DFGLA   G + ++ H     +  
Sbjct: 127 -AKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           + + A E I     T   DV+S+GV + EL+T
Sbjct: 184 K-WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK       R  L  + VA+K   LD          + E+  L 
Sbjct: 7   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA--- 194
           +L HP++V L+     +    LV+E++      DQ  K +      LT I + +  +   
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEHV------DQDLKKFMDASA-LTGIPLPLIKSYLF 113
Query: 195 ---RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
              + LAF H     V++RD K  N+L++++   KL+DFGLA        ++    V  T
Sbjct: 114 QLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 169
Query: 252 EGYAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE  +   + +T  D++S G +  E++T R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFLGQL 139
           +   + LG GGFG V +    D        + VA+K      S  +RE W  E+  + +L
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDT------GEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 140 KHPHLVNL------IGYCCEDEHRLLVYEYMALGNLHDQL--FKNYSSTLPWLTRIKIAI 191
            HP++V+       +     ++  LL  EY   G+L   L  F+N         R  ++ 
Sbjct: 70  NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS- 128
Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNA---KLSDFGLATDGPQGEDSHITTCV 248
             +  L +LH  E  +I+RD K  NI+L         K+ D G A +  QGE   + T  
Sbjct: 129 DISSALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEF 183
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRR 286
           +GT  Y APE +     T   D +SFG +  E +TG R
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 99/228 (43%), Gaps = 26/228 (11%)
Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWL-AEVIFLG 137
            N      LG G FGKV         + G+  Q VAVK+L        RE L +E+  + 
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQ-VAVKMLKEKADSSEREALMSELKMMT 103
Query: 138 QL-KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQL-------------FKNYS----- 178
           QL  H ++VNL+G C       L++EY   G+L + L             ++N       
Sbjct: 104 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163
Query: 179 ---STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD 235
              + L +   +  A   A+ + FL  E K  ++RD  A N+L+      K+ DFGLA D
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFL--EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
                +  +         + APE +  G  T   DV+S+G++L E+ +
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 28/206 (13%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FGKVYK     N   G  A   A KV++    +   +++ E+  L    HP++V 
Sbjct: 19  LGDGAFGKVYKA---KNKETGALA---AAKVIETKSEEELEDYIVEIEILATCDHPYIVK 72
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI---GAARCLAFLHGE 203
           L+G    D    ++ E+   G +   + +        LT  +I +        L FLH  
Sbjct: 73  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVVCRQMLEALNFLHS- 127
Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDG---PQGEDSHITTCVMGTEGYAAPEYI 260
            K +I+RD KA N+L+  + + +L+DFG++       Q  DS I     GT  + APE +
Sbjct: 128 -KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEVV 181
Query: 261 NTGHLTTM-----CDVFSFGVVLLEL 281
               +         D++S G+ L+E+
Sbjct: 182 MCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLG 137
            F +   LG G FG VYKG     +  G K +  VA+K L +    + ++E L E   + 
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 82
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST-----LPWLTRIKIAIG 192
            + +PH+  L+G C     +L+  + M  G L D + ++  +      L W  +I     
Sbjct: 83  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 136
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT-DGPQGEDSHITTCVMGT 251
            A+ + +L  E++ +++RD  A N+L+ +  + K++DFGLA   G + ++ H     +  
Sbjct: 137 -AKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 193
Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           + + A E I     T   DV+S+GV + EL+T
Sbjct: 194 K-WMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/155 (32%), Positives = 78/155 (50%), Gaps = 12/155 (7%)
Query: 134 IFLGQLKHPHLVNLIGYCCEDEHRLL-VYEYMALGNL--HDQLFKNYSSTLPWLTRIKIA 190
           +F     HP LV L   C + E RL  V EY+  G+L  H Q  +            +I+
Sbjct: 73  VFEQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 131
Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG 250
           +     L +LH  E+ +IYRD K  N+LLDS+ + KL+D+G+  +G +  D+    C  G
Sbjct: 132 L----ALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC--G 183
Query: 251 TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           T  Y APE +         D ++ GV++ E++ GR
Sbjct: 184 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 218

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 68  VFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR 127
           +F  + L+ I+        LG+G FG V + C  D L     A  VAVK L  +G    R
Sbjct: 19  IFEERHLKYISQ-------LGKGNFGSV-ELCRYDPLGDNTGA-LVAVKQLQHSGPDQQR 69
Query: 128 EWLAEVIFLGQLKHPHLVNLIG--YCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLT 185
           ++  E+  L  L    +V   G  Y    +   LV EY+  G L D           +L 
Sbjct: 70  DFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD-----------FLQ 118
Query: 186 RIKIAIGAARCLAF----LHGEE----KPVIYRDFKASNILLDSDYNAKLSDFGLATDGP 237
           R +  + A+R L +      G E    +  ++RD  A NIL++S+ + K++DFGLA   P
Sbjct: 119 RHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178
Query: 238 QGEDSHITTCVMGTE-GYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
             +D ++      +   + APE ++    +   DV+SFGVVL EL T
Sbjct: 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLG 137
            F +   LG G FG VYKG     +  G K +  VA+K L +    + ++E L E   + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 72
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST-----LPWLTRIKIAIG 192
            + +PH+  L+G C     +L+  + M  G L D + ++  +      L W  +I     
Sbjct: 73  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 126
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT-DGPQGEDSHITTCVMGT 251
            A+ + +L  E++ +++RD  A N+L+ +  + K++DFGLA   G + ++ H     +  
Sbjct: 127 -AKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           + + A E I     T   DV+S+GV + EL+T
Sbjct: 184 K-WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 125/298 (41%), Gaps = 39/298 (13%)
Query: 84  SDYLGEGGFGKVYKGCVDDNLRPG-LKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHP 142
           ++ LG+G F K++KG   +    G L    V +KVLD         +      + +L H 
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
           HLV   G C   +  +LV E++  G+L   L KN  + +  L ++++A   A  + FL  
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFL-- 129
Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE------GYAA 256
           EE  +I+ +  A NILL  + + K  +        +  D  I+  V+  +       +  
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFI----KLSDPGISITVLPKDILQERIPWVP 185
Query: 257 PEYI-NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ 315
           PE I N  +L    D +SFG  L E+ +G                       K  + LD 
Sbjct: 186 PECIENPKNLNLATDKWSFGTTLWEICSGGD---------------------KPLSALDS 224
Query: 316 IIDSRL-EDRYSTEGAK--RLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDIPIG 370
               +  EDR+     K   LA + + C+ + P  RP+   +++ L  L   + +P G
Sbjct: 225 QRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRG 282

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 26/277 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQ 138
           +F +   LG G  G V+K     + +P      +A K++ +      R + + E+  L +
Sbjct: 26  DFEKISELGAGNGGVVFK----VSHKP--SGLVMARKLIHLEIKPAIRNQIIRELQVLHE 79
Query: 139 LKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLA 198
              P++V   G    D    +  E+M  G+L DQ+ K  +  +P     K++I   + L 
Sbjct: 80  CNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKK-AGRIPEQILGKVSIAVIKGLT 137
Query: 199 FLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPE 258
           +L  E+  +++RD K SNIL++S    KL DFG++    Q  DS   + V GT  Y +PE
Sbjct: 138 YLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV-GTRSYMSPE 192
Query: 259 YINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIID 318
            +   H +   D++S G+ L+E+  GR  +                  +  F  LD I++
Sbjct: 193 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGS------------MAIFELLDYIVN 240
Query: 319 SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVV 355
                  S   +       ++CL  NP  R  +  ++
Sbjct: 241 EPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 277

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 128/299 (42%), Gaps = 41/299 (13%)
Query: 84  SDYLGEGGFGKVYKGCVDDNLRPG-LKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHP 142
           ++ LG+G F K++KG   +    G L    V +KVLD         +      + +L H 
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 143 HLVNLIGYC-CEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLH 201
           HLV   G C C DE+ +LV E++  G+L   L KN  + +  L ++++A   A  + FL 
Sbjct: 73  HLVLNYGVCFCGDEN-ILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAWAMHFL- 129
Query: 202 GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE------GYA 255
            EE  +I+ +  A NILL  + + K  +        +  D  I+  V+  +       + 
Sbjct: 130 -EENTLIHGNVCAKNILLIREEDRKTGNPPFI----KLSDPGISITVLPKDILQERIPWV 184
Query: 256 APEYI-NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD 314
            PE I N  +L    D +SFG  L E+ +G                       K  + LD
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSGGD---------------------KPLSALD 223
Query: 315 QIIDSRL-EDRYSTEGAK--RLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDIPIG 370
                +  EDR+     K   LA + + C+ + P  RP+   +++ L  L   + +P G
Sbjct: 224 SQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRG 282

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 115/291 (39%), Gaps = 36/291 (12%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWL-AEVIFLGQL-KHPHL 144
           LG G FGKV +      ++    A TVAVK+L  +     RE L +E+  L  L  H ++
Sbjct: 54  LGAGAFGKVVEATAYGLIKSD-AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 112
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKI--------------- 189
           VNL+G C      L++ EY   G+L + L +   S +   T   I               
Sbjct: 113 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 172
Query: 190 -AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
            +   A+ +AFL    K  I+RD  A NILL      K+ DFGLA       +  +    
Sbjct: 173 FSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNA 230
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
                + APE I     T   DV+S+G+ L EL +   S                 P + 
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS---------------PYPGMP 275
Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
             +K  ++I               +  +   C   +P  RPT   +V+ +E
Sbjct: 276 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLG 137
            F +   LG G FG VYKG     +  G K +  VA+K L +    + ++E L E   + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 75
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST-----LPWLTRIKIAIG 192
            + +PH+  L+G C     +L+  + M  G L D + ++  +      L W  +I     
Sbjct: 76  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 129
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT-DGPQGEDSHITTCVMGT 251
            A+ + +L  E++ +++RD  A N+L+ +  + K++DFGLA   G + ++ H     +  
Sbjct: 130 -AKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           + + A E I     T   DV+S+GV + EL+T
Sbjct: 187 K-WMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLG 137
            F +   LG G FG VYKG     +  G K +  VA+K L +    + ++E L E   + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 75
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST-----LPWLTRIKIAIG 192
            + +PH+  L+G C     +L+  + M  G L D + ++  +      L W  +I     
Sbjct: 76  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 129
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT-DGPQGEDSHITTCVMGT 251
            A+ + +L  E++ +++RD  A N+L+ +  + K++DFGLA   G + ++ H     +  
Sbjct: 130 -AKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           + + A E I     T   DV+S+GV + EL+T
Sbjct: 187 K-WMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLG 137
            F +   LG G FG VYKG     +  G K +  VA+K L +    + ++E L E   + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 74
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST-----LPWLTRIKIAIG 192
            + +PH+  L+G C     +L+  + M  G L D + ++  +      L W  +I     
Sbjct: 75  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 128
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT-DGPQGEDSHITTCVMGT 251
            A+ + +L  E++ +++RD  A N+L+ +  + K++DFGLA   G + ++ H     +  
Sbjct: 129 -AKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           + + A E I     T   DV+S+GV + EL+T
Sbjct: 186 K-WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLG 137
            F +   LG G FG VYKG     +  G K +  VA+K L +    + ++E L E   + 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 79
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST-----LPWLTRIKIAIG 192
            + +PH+  L+G C     +L+  + M  G L D + ++  +      L W  +I     
Sbjct: 80  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 133
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT-DGPQGEDSHITTCVMGT 251
            A+ + +L  E++ +++RD  A N+L+ +  + K++DFGLA   G + ++ H     +  
Sbjct: 134 -AKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           + + A E I     T   DV+S+GV + EL+T
Sbjct: 191 K-WMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLG 137
            F +   LG G FG VYKG     +  G K +  VA+K L +    + ++E L E   + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 72
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST-----LPWLTRIKIAIG 192
            + +PH+  L+G C     +L+  + M  G L D + ++  +      L W  +I     
Sbjct: 73  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 126
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT-DGPQGEDSHITTCVMGT 251
            A+ + +L  E++ +++RD  A N+L+ +  + K++DFGLA   G + ++ H     +  
Sbjct: 127 -AKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           + + A E I     T   DV+S+GV + EL+T
Sbjct: 184 K-WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLG 137
            F +   LG G FG VYKG     +  G K +  VA+K L +    + ++E L E   + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 75
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST-----LPWLTRIKIAIG 192
            + +PH+  L+G C     +L+  + M  G L D + ++  +      L W  +I     
Sbjct: 76  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 129
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT-DGPQGEDSHITTCVMGT 251
            A+ + +L  E++ +++RD  A N+L+ +  + K++DFGLA   G + ++ H     +  
Sbjct: 130 -AKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           + + A E I     T   DV+S+GV + EL+T
Sbjct: 187 K-WMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLG 137
            F +   LG G FG VYKG     +  G K +  VA+K L +    + ++E L E   + 
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 78
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST-----LPWLTRIKIAIG 192
            + +PH+  L+G C     +L+  + M  G L D + ++  +      L W  +I     
Sbjct: 79  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 132
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT-DGPQGEDSHITTCVMGT 251
            A+ + +L  E++ +++RD  A N+L+ +  + K++DFGLA   G + ++ H     +  
Sbjct: 133 -AKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 189
Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           + + A E I     T   DV+S+GV + EL+T
Sbjct: 190 K-WMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 116/283 (40%), Gaps = 51/283 (18%)
Query: 36  STQRLLLTDVSNPGSPISLNELS---SSLV----------GSNLHVF---------TLKE 73
           S QR L   + +P SPI++  L    +SLV            N+  F          ++ 
Sbjct: 10  SRQRKLEALIRDPRSPINVESLLDGLNSLVLDLDFPALRKNKNIDNFLNRYEKIVKKIRG 69
Query: 74  LQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD----VNGSQGHREW 129
           LQM   ++     +G G FG+V        +R     +  A+K+L     +  S     W
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQL------VRHKASQKVYAMKLLSKFEMIKRSDSAFFW 123
Query: 130 LAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWL----T 185
             E   +     P +V L     +D++  +V EYM  G+L + L  NY     W      
Sbjct: 124 -EERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTA 181
Query: 186 RIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHIT 245
            + +A+ A   +  +H        RD K  N+LLD   + KL+DFG      +    H  
Sbjct: 182 EVVLALDAIHSMGLIH--------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCD 233
Query: 246 TCVMGTEGYAAPEYINT----GHLTTMCDVFSFGVVLLELLTG 284
           T V GT  Y +PE + +    G+    CD +S GV L E+L G
Sbjct: 234 TAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 20/210 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLG 137
           N+     +G+G F KV         R  L  + VA+K++D         ++   EV  + 
Sbjct: 13  NYRLLKTIGKGNFAKVKLA------RHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMK 66
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
            L HP++V L      ++   L+ EY + G + D L  +         + K A    R +
Sbjct: 67  ILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR------MKEKEARSKFRQI 120
Query: 198 --AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
             A  +  +K +++RD KA N+LLD+D N K++DFG + +   G     T C  G+  YA
Sbjct: 121 VSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD-TFC--GSPPYA 177
Query: 256 APE-YINTGHLTTMCDVFSFGVVLLELLTG 284
           APE +    +     DV+S GV+L  L++G
Sbjct: 178 APELFQGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/155 (32%), Positives = 78/155 (50%), Gaps = 12/155 (7%)
Query: 134 IFLGQLKHPHLVNLIGYCCEDEHRLL-VYEYMALGNL--HDQLFKNYSSTLPWLTRIKIA 190
           +F     HP LV L   C + E RL  V EY+  G+L  H Q  +            +I+
Sbjct: 58  VFEQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 116
Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG 250
           +     L +LH  E+ +IYRD K  N+LLDS+ + KL+D+G+  +G +  D+    C  G
Sbjct: 117 L----ALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC--G 168
Query: 251 TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           T  Y APE +         D ++ GV++ E++ GR
Sbjct: 169 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 203

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLG 137
            F +   LG G FG VYKG     +  G K +  VA+K L +    + ++E L E   + 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST-----LPWLTRIKIAIG 192
            + +PH+  L+G C     +L+  + M  G L D + ++  +      L W  +I     
Sbjct: 67  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 120
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT-DGPQGEDSHITTCVMGT 251
            A+ + +L  E++ +++RD  A N+L+ +  + K++DFGLA   G + ++ H     +  
Sbjct: 121 -AKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           + + A E I     T   DV+S+GV + EL+T
Sbjct: 178 K-WMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/155 (32%), Positives = 78/155 (50%), Gaps = 12/155 (7%)
Query: 134 IFLGQLKHPHLVNLIGYCCEDEHRLL-VYEYMALGNL--HDQLFKNYSSTLPWLTRIKIA 190
           +F     HP LV L   C + E RL  V EY+  G+L  H Q  +            +I+
Sbjct: 62  VFEQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 120
Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG 250
           +     L +LH  E+ +IYRD K  N+LLDS+ + KL+D+G+  +G +  D+    C  G
Sbjct: 121 L----ALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC--G 172
Query: 251 TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           T  Y APE +         D ++ GV++ E++ GR
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLG 137
            F +   LG G FG VYKG     +  G K +  VA+K L +    + ++E L E   + 
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 97
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST-----LPWLTRIKIAIG 192
            + +PH+  L+G C     +L+  + M  G L D + ++  +      L W  +I     
Sbjct: 98  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 151
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT-DGPQGEDSHITTCVMGT 251
            A+ + +L  E++ +++RD  A N+L+ +  + K++DFGLA   G + ++ H     +  
Sbjct: 152 -AKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 208
Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           + + A E I     T   DV+S+GV + EL+T
Sbjct: 209 K-WMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 92/221 (41%), Gaps = 28/221 (12%)
Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEV----- 133
             +   D +G G    V + CV             AVK+++V   +   E L EV     
Sbjct: 94  QKYDPKDVIGRG-VSSVVRRCVH-----RATGHEFAVKIMEVTAERLSPEQLEEVREATR 147
Query: 134 ----IFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKI 189
               I      HPH++ LI          LV++ M  G L D L +  + +      I  
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMR 207
Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM 249
           ++  A  ++FLH     +++RD K  NILLD +   +LSDFG +     GE       + 
Sbjct: 208 SLLEA--VSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELC 260
Query: 250 GTEGYAAPEYINTGHLTTM------CDVFSFGVVLLELLTG 284
           GT GY APE +      T        D+++ GV+L  LL G
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLV 145
           +GEG FG+V++      L P      VAVK+L    S   + ++  E   + +  +P++V
Sbjct: 55  IGEGAFGRVFQARAP-GLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLT-------------------- 185
            L+G C   +   L++EYMA G+L++ L      T+  L+                    
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 186 --RIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSH 243
             ++ IA   A  +A+L   E+  ++RD    N L+  +   K++DFGL+ +    +   
Sbjct: 174 AEQLCIARQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 244 ITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
                     +  PE I     TT  DV+++GVVL E+ +
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 103/227 (45%), Gaps = 31/227 (13%)
Query: 68  VFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR 127
           +F  + L+ I+        LG+G FG V + C  D L     A  VAVK L  +G    R
Sbjct: 3   IFEERHLKYISQ-------LGKGNFGSV-ELCRYDPLGDNTGA-LVAVKQLQHSGPDQQR 53
Query: 128 EWLAEVIFLGQLKHPHLVNLIG--YCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLT 185
           ++  E+  L  L    +V   G  Y        LV EY+  G L D           +L 
Sbjct: 54  DFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRD-----------FLQ 102
Query: 186 RIKIAIGAARCLAF----LHGEE----KPVIYRDFKASNILLDSDYNAKLSDFGLATDGP 237
           R +  + A+R L +      G E    +  ++RD  A NIL++S+ + K++DFGLA   P
Sbjct: 103 RHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 162
Query: 238 QGEDSHITTCVMGTE-GYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
             +D  +      +   + APE ++    +   DV+SFGVVL EL T
Sbjct: 163 LDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 87  LGEGGFGKVY---KGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPH 143
           LG+G FGKV    +   D+     +  + V ++  DV  +      + E   L     P 
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT------MVEKRVLALPGKPP 402
Query: 144 LVNLIGYCCEDEHRL-LVYEYMALGNL--HDQLFKNYSSTLPWLTRIKIAIGAARCLAFL 200
            +  +  C +   RL  V EY+  G+L  H Q    +          +IAIG    L FL
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----LFFL 458
Query: 201 HGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI 260
             + K +IYRD K  N++LDS+ + K++DFG+  +     D   T    GT  Y APE I
Sbjct: 459 --QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW--DGVTTKXFCGTPDYIAPEII 514
Query: 261 NTGHLTTMCDVFSFGVVLLELLTGRRSVE 289
                    D ++FGV+L E+L G+   E
Sbjct: 515 AYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 21/212 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLG 137
            F +   LG G FG VYKG     +  G K +  VA+K L +    + ++E L E   + 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 69
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST-----LPWLTRIKIAIG 192
            + +PH+  L+G C     +L+  + M  G L D + ++  +      L W  +I     
Sbjct: 70  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 123
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT-DGPQGEDSHITTCVMGT 251
            A  + +L  E++ +++RD  A N+L+ +  + K++DFGLA   G + ++ H     +  
Sbjct: 124 -AEGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 180
Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           + + A E I     T   DV+S+GV + EL+T
Sbjct: 181 K-WMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 87  LGEGGFGKVYKGCVD---DNLRPGLKAQTVAVKVLDVNGSQGH-REWLAEVIFLGQLKHP 142
           LGEG FGKV     D   DN       + VAVK L       H  +   E+  L  L H 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNT-----GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83
Query: 143 HLVNLIGYCCEDEHR--LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFL 200
           ++V   G C ED      L+ E++  G+L + L KN  + +    ++K A+   + + +L
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYL 142
Query: 201 HGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG---YAAP 257
              +   ++RD  A N+L++S++  K+ DFGL        D    T     +    + AP
Sbjct: 143 GSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTK--AIETDKEXXTVKDDRDSPVFWYAP 198
Query: 258 EYINTGHLTTMCDVFSFGVVLLELLT 283
           E +         DV+SFGV L ELLT
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 113/262 (43%), Gaps = 24/262 (9%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           +GEG  G V    V  +       + VAVK +D+   Q       EV+ +   +H ++V 
Sbjct: 159 IGEGSTGIVCIATVRSS------GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 212
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG---- 202
           +       +   +V E++  G L D +           TR+     AA CLA L      
Sbjct: 213 MYNSYLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCLAVLQALSVL 263
Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT 262
             + VI+RD K+ +ILL  D   KLSDFG        ++      ++GT  + APE I+ 
Sbjct: 264 HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISR 321
Query: 263 GHLTTMCDVFSFGVVLLELLTGRRS-VEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRL 321
                  D++S G++++E++ G      +   K  K + +   P LK+  K+   +   L
Sbjct: 322 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL 381
Query: 322 EDRYSTEGAKRLAAVAHQCLSH 343
           +     + A+R  A A + L H
Sbjct: 382 DRLLVRDPAQR--ATAAELLKH 401

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGC-VDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ 138
            F +   LG G FG VYKG  + +  +  +K     +++ +    + ++E L E   +  
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEK--VKIPVAIMELREATSPKANKEILDEAYVMAS 107
Query: 139 LKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST-----LPWLTRIKIAIGA 193
           + +PH+  L+G C     +L+  + M  G L D + ++  +      L W  +I      
Sbjct: 108 VDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------ 160
Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT-DGPQGEDSHITTCVMGTE 252
           A+ + +L  E++ +++RD  A N+L+ +  + K++DFGLA   G + ++ H     +  +
Sbjct: 161 AKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 218
Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
            + A E I     T   DV+S+GV + EL+T
Sbjct: 219 -WMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 101/241 (41%), Gaps = 20/241 (8%)
Query: 47  NPGSPISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRP 106
           +P       E+  SL     H  T+ E + +         LG+G FGKV    V +    
Sbjct: 127 SPSDNSGAEEMEVSLAKPK-HRVTMNEFEYLK-------LLGKGTFGKVI--LVKEKATG 176
Query: 107 GLKAQTVAVK-VLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYM 164
              A  +  K V+       H   L E   L   +HP L  L  Y  +   RL  V EY 
Sbjct: 177 RYYAMKILKKEVIVAKDEVAHT--LTENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYA 233
Query: 165 ALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYN 224
             G L   L +    +          I +A  L +LH E K V+YRD K  N++LD D +
Sbjct: 234 NGGELFFHLSRERVFSEDRARFYGAEIVSA--LDYLHSE-KNVVYRDLKLENLMLDKDGH 290
Query: 225 AKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            K++DFGL  +G +   +  T C  GT  Y APE +         D +  GVV+ E++ G
Sbjct: 291 IKITDFGLCKEGIKDGATMKTFC--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 348
Query: 285 R 285
           R
Sbjct: 349 R 349

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 113/262 (43%), Gaps = 24/262 (9%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           +GEG  G V    V  +       + VAVK +D+   Q       EV+ +   +H ++V 
Sbjct: 39  IGEGSTGIVCIATVRSS------GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 92
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG---- 202
           +       +   +V E++  G L D +           TR+     AA CLA L      
Sbjct: 93  MYNSYLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCLAVLQALSVL 143
Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT 262
             + VI+RD K+ +ILL  D   KLSDFG        ++      ++GT  + APE I+ 
Sbjct: 144 HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISR 201
Query: 263 GHLTTMCDVFSFGVVLLELLTGRRS-VEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRL 321
                  D++S G++++E++ G      +   K  K + +   P LK+  K+   +   L
Sbjct: 202 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL 261
Query: 322 EDRYSTEGAKRLAAVAHQCLSH 343
           +     + A+R  A A + L H
Sbjct: 262 DRLLVRDPAQR--ATAAELLKH 281

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 101/241 (41%), Gaps = 20/241 (8%)
Query: 47  NPGSPISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRP 106
           +P       E+  SL     H  T+ E + +         LG+G FGKV    V +    
Sbjct: 124 SPSDNSGAEEMEVSLAKPK-HRVTMNEFEYLK-------LLGKGTFGKVI--LVKEKATG 173
Query: 107 GLKAQTVAVK-VLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYM 164
              A  +  K V+       H   L E   L   +HP L  L  Y  +   RL  V EY 
Sbjct: 174 RYYAMKILKKEVIVAKDEVAHT--LTENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYA 230
Query: 165 ALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYN 224
             G L   L +    +          I +A  L +LH E K V+YRD K  N++LD D +
Sbjct: 231 NGGELFFHLSRERVFSEDRARFYGAEIVSA--LDYLHSE-KNVVYRDLKLENLMLDKDGH 287
Query: 225 AKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            K++DFGL  +G +   +  T C  GT  Y APE +         D +  GVV+ E++ G
Sbjct: 288 IKITDFGLCKEGIKDGATMKTFC--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 345
Query: 285 R 285
           R
Sbjct: 346 R 346

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 100/221 (45%), Gaps = 29/221 (13%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--------QGHREW-L 130
           N+   + LG G    V + C+    +P  K    AVK++DV G         Q  RE  L
Sbjct: 18  NYEPKEILGRG-VSSVVRRCIH---KPTCKE--YAVKIIDVTGGGSFSAEEVQELREATL 71
Query: 131 AEVIFLGQLK-HPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKI 189
            EV  L ++  HP+++ L      +    LV++ M  G L D L +  + +     +I  
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR 131
Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM 249
           A+    C   LH  +  +++RD K  NILLD D N KL+DFG +     GE       V 
Sbjct: 132 ALLEVICA--LH--KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LRSVC 184
Query: 250 GTEGYAAPEYI----NTGH--LTTMCDVFSFGVVLLELLTG 284
           GT  Y APE I    N  H       D++S GV++  LL G
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 105/223 (47%), Gaps = 20/223 (8%)
Query: 87  LGEGGFGKVYKGC-VDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHL 144
           LG G FG VYKG  + D     +    VA+KVL  N S + ++E L E   +  +  P++
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKI---PVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV 81
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNY-----SSTLPWLTRIKIAIGAARCLAF 199
             L+G C     +L V + M  G L D + +N         L W  +I      A+ +++
Sbjct: 82  SRLLGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQI------AKGMSY 134
Query: 200 LHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEY 259
           L  E+  +++RD  A N+L+ S  + K++DFGLA      E  +          + A E 
Sbjct: 135 L--EDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 192
Query: 260 INTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVE 301
           I     T   DV+S+GV + EL+T G +  +    +   DL+E
Sbjct: 193 ILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE 235

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 113/262 (43%), Gaps = 24/262 (9%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           +GEG  G V    V  +       + VAVK +D+   Q       EV+ +   +H ++V 
Sbjct: 82  IGEGSTGIVCIATVRSS------GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 135
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG---- 202
           +       +   +V E++  G L D +           TR+     AA CLA L      
Sbjct: 136 MYNSYLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCLAVLQALSVL 186
Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT 262
             + VI+RD K+ +ILL  D   KLSDFG        ++      ++GT  + APE I+ 
Sbjct: 187 HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISR 244
Query: 263 GHLTTMCDVFSFGVVLLELLTGRRS-VEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRL 321
                  D++S G++++E++ G      +   K  K + +   P LK+  K+   +   L
Sbjct: 245 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL 304
Query: 322 EDRYSTEGAKRLAAVAHQCLSH 343
           +     + A+R  A A + L H
Sbjct: 305 DRLLVRDPAQR--ATAAELLKH 324

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 113/262 (43%), Gaps = 24/262 (9%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           +GEG  G V    V  +       + VAVK +D+   Q       EV+ +   +H ++V 
Sbjct: 37  IGEGSTGIVCIATVRSS------GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 90
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG---- 202
           +       +   +V E++  G L D +           TR+     AA CLA L      
Sbjct: 91  MYNSYLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCLAVLQALSVL 141
Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT 262
             + VI+RD K+ +ILL  D   KLSDFG        ++      ++GT  + APE I+ 
Sbjct: 142 HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISR 199
Query: 263 GHLTTMCDVFSFGVVLLELLTGRRS-VEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRL 321
                  D++S G++++E++ G      +   K  K + +   P LK+  K+   +   L
Sbjct: 200 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL 259
Query: 322 EDRYSTEGAKRLAAVAHQCLSH 343
           +     + A+R  A A + L H
Sbjct: 260 DRLLVRDPAQR--ATAAELLKH 279

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLG 137
           N+     +G+G F KV         R  L  + VA+K++D         ++   EV  + 
Sbjct: 16  NYRLLKTIGKGNFAKVKLA------RHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMK 69
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
            L HP++V L      ++   L+ EY + G + D L  +         + K A    R +
Sbjct: 70  ILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR------MKEKEARSKFRQI 123
Query: 198 --AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
             A  +  +K +++RD KA N+LLD+D N K++DFG + +   G          G   YA
Sbjct: 124 VSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYA 180
Query: 256 APE-YINTGHLTTMCDVFSFGVVLLELLTG 284
           APE +    +     DV+S GV+L  L++G
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 87  LGEGGFGKVYKGCVD---DNLRPGLKAQTVAVKVLDVNGSQGH-REWLAEVIFLGQLKHP 142
           LGEG FGKV     D   DN       + VAVK L       H  +   E+  L  L H 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNT-----GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 71
Query: 143 HLVNLIGYCCEDEHR--LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFL 200
           ++V   G C ED      L+ E++  G+L + L KN  + +    ++K A+   + + +L
Sbjct: 72  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYL 130
Query: 201 HGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG---YAAP 257
              +   ++RD  A N+L++S++  K+ DFGL        D    T     +    + AP
Sbjct: 131 GSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTK--AIETDKEXXTVKDDRDSPVFWYAP 186
Query: 258 EYINTGHLTTMCDVFSFGVVLLELLT 283
           E +         DV+SFGV L ELLT
Sbjct: 187 ECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 113/262 (43%), Gaps = 24/262 (9%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           +GEG  G V    V  +       + VAVK +D+   Q       EV+ +   +H ++V 
Sbjct: 28  IGEGSTGIVCIATVRSS------GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG---- 202
           +       +   +V E++  G L D +           TR+     AA CLA L      
Sbjct: 82  MYNSYLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCLAVLQALSVL 132
Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT 262
             + VI+RD K+ +ILL  D   KLSDFG        ++      ++GT  + APE I+ 
Sbjct: 133 HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISR 190
Query: 263 GHLTTMCDVFSFGVVLLELLTGRRS-VEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRL 321
                  D++S G++++E++ G      +   K  K + +   P LK+  K+   +   L
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL 250
Query: 322 EDRYSTEGAKRLAAVAHQCLSH 343
           +     + A+R  A A + L H
Sbjct: 251 DRLLVRDPAQR--ATAAELLKH 270

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLG 137
            F +   LG G FG VYKG     +  G K +  VA+K L +    + ++E L E   + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 74
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST-----LPWLTRIKIAIG 192
            + +PH+  L+G C     +L++ + M  G L D + ++  +      L W  +I     
Sbjct: 75  SVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 128
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT-DGPQGEDSHITTCVMGT 251
            A+ + +L  E++ +++RD  A N+L+ +  + K++DFG A   G + ++ H     +  
Sbjct: 129 -AKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           + + A E I     T   DV+S+GV + EL+T
Sbjct: 186 K-WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 113/262 (43%), Gaps = 24/262 (9%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           +GEG  G V    V  +       + VAVK +D+   Q       EV+ +   +H ++V 
Sbjct: 32  IGEGSTGIVCIATVRSS------GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 85
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG---- 202
           +       +   +V E++  G L D +           TR+     AA CLA L      
Sbjct: 86  MYNSYLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCLAVLQALSVL 136
Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT 262
             + VI+RD K+ +ILL  D   KLSDFG        ++      ++GT  + APE I+ 
Sbjct: 137 HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISR 194
Query: 263 GHLTTMCDVFSFGVVLLELLTGRRS-VEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRL 321
                  D++S G++++E++ G      +   K  K + +   P LK+  K+   +   L
Sbjct: 195 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL 254
Query: 322 EDRYSTEGAKRLAAVAHQCLSH 343
           +     + A+R  A A + L H
Sbjct: 255 DRLLVRDPAQR--ATAAELLKH 274

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLG 137
            F +   LG G FG VYKG     +  G K +  VA+K L +    + ++E L E   + 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 76
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST-----LPWLTRIKIAIG 192
            + +PH+  L+G C     +L++ + M  G L D + ++  +      L W  +I     
Sbjct: 77  SVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 130
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT-DGPQGEDSHITTCVMGT 251
            A+ + +L  E++ +++RD  A N+L+ +  + K++DFG A   G + ++ H     +  
Sbjct: 131 -AKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 187
Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           + + A E I     T   DV+S+GV + EL+T
Sbjct: 188 K-WMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLG 137
            F +   LG G FG VYKG     +  G K +  VA+K L +    + ++E L E   + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 74
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST-----LPWLTRIKIAIG 192
            + +PH+  L+G C     +L++ + M  G L D + ++  +      L W  +I     
Sbjct: 75  SVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 128
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT-DGPQGEDSHITTCVMGT 251
            A+ + +L  E++ +++RD  A N+L+ +  + K++DFG A   G + ++ H     +  
Sbjct: 129 -AKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           + + A E I     T   DV+S+GV + EL+T
Sbjct: 186 K-WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHREW-LAEVIFLGQLKHPH 143
           LG+G FGKV         R G + +  A+K+L  DV       E  + E   L  L  P 
Sbjct: 27  LGKGSFGKVMLAD-----RKGTE-ELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPP 80
Query: 144 LVNLIGYCCEDEHRL-LVYEYMALGNL--HDQLFKNYSSTLPWLTRIKIAIGAARCLAFL 200
            +  +  C +   RL  V EY+  G+L  H Q    +          +I+IG    L FL
Sbjct: 81  FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIG----LFFL 136
Query: 201 HGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI 260
           H  ++ +IYRD K  N++LDS+ + K++DFG+  +     D   T    GT  Y APE I
Sbjct: 137 H--KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--HMMDGVTTREFCGTPDYIAPEII 192
Query: 261 NTGHLTTMCDVFSFGVVLLELLTGR 285
                    D +++GV+L E+L G+
Sbjct: 193 AYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 76/303 (25%), Positives = 119/303 (39%), Gaps = 46/303 (15%)
Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWL-AEVIFLG 137
           +N      LG G FGKV +      L        VAVK+L        +E L +E+  + 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAF-GLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 138 QL-KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK--------------NYSSTLP 182
            L +H ++VNL+G C      L++ EY   G+L + L +              N    L 
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLS 164
Query: 183 WLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS 242
               +  +   A+ +AFL    K  I+RD  A N+LL + + AK+ DFGLA D     + 
Sbjct: 165 SRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 222
Query: 243 HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS------VEKNRCKRE 296
            +         + APE I     T   DV+S+G++L E+ +   +      V     K  
Sbjct: 223 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 282
Query: 297 KDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
           KD  + A+P                         K + ++   C +  P  RPT   +  
Sbjct: 283 KDGYQMAQPAF---------------------APKNIYSIMQACWALEPTHRPTFQQICS 321
Query: 357 ALE 359
            L+
Sbjct: 322 FLQ 324

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 87  LGEGGFGKVY---KGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPH 143
           LG+G FGKV    +   D+     +  + V ++  DV  +      + E   L     P 
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT------MVEKRVLALPGKPP 81
Query: 144 LVNLIGYCCEDEHRL-LVYEYMALGNL--HDQLFKNYSSTLPWLTRIKIAIGAARCLAFL 200
            +  +  C +   RL  V EY+  G+L  H Q    +          +IAIG    L FL
Sbjct: 82  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----LFFL 137
Query: 201 HGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI 260
             + K +IYRD K  N++LDS+ + K++DFG+  +     D   T    GT  Y APE I
Sbjct: 138 --QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW--DGVTTKXFCGTPDYIAPEII 193
Query: 261 NTGHLTTMCDVFSFGVVLLELLTGRRSVE 289
                    D ++FGV+L E+L G+   E
Sbjct: 194 AYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLG 137
            F +   L  G FG VYKG     +  G K +  VA+K L +    + ++E L E   + 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 79
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST-----LPWLTRIKIAIG 192
            + +PH+  L+G C     +L++ + M  G L D + ++  +      L W  +I     
Sbjct: 80  SVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 133
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT-DGPQGEDSHITTCVMGT 251
            A+ + +L  E++ +++RD  A N+L+ +  + K++DFGLA   G + ++ H     +  
Sbjct: 134 -AKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           + + A E I     T   DV+S+GV + EL+T
Sbjct: 191 K-WMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 26/220 (11%)
Query: 74  LQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLA 131
            Q +   + + + +GEG +G VYK    D+     + + VA+K   LD          + 
Sbjct: 16  FQGLMEKYQKLEKVGEGTYGVVYKA--KDS-----QGRIVALKRIRLDAEDEGIPSTAIR 68
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI 191
           E+  L +L HP++V+LI     +    LV+E+M   +L   L +N +      ++IKI +
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGLQD--SQIKIYL 125
Query: 192 -----GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITT 246
                G A C       +  +++RD K  N+L++SD   KL+DFGLA        S+   
Sbjct: 126 YQLLRGVAHC------HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE 179
Query: 247 CVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
            V  T  Y AP+ +  +   +T  D++S G +  E++TG+
Sbjct: 180 VV--TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 26/220 (11%)
Query: 74  LQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLA 131
            Q +   + + + +GEG +G VYK    D+     + + VA+K   LD          + 
Sbjct: 16  FQGLMEKYQKLEKVGEGTYGVVYKA--KDS-----QGRIVALKRIRLDAEDEGIPSTAIR 68
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI 191
           E+  L +L HP++V+LI     +    LV+E+M   +L   L +N +      ++IKI +
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGLQD--SQIKIYL 125
Query: 192 -----GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITT 246
                G A C       +  +++RD K  N+L++SD   KL+DFGLA        S+   
Sbjct: 126 YQLLRGVAHC------HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE 179
Query: 247 CVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
            V  T  Y AP+ +  +   +T  D++S G +  E++TG+
Sbjct: 180 VV--TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 21/212 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLG 137
            F +   LG G FG VYKG     +  G K +  VA+K L +    + ++E L E   + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 74
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST-----LPWLTRIKIAIG 192
            + +PH+  L+G C     +L+  + M  G L D + ++  +      L W  +I     
Sbjct: 75  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 128
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT-DGPQGEDSHITTCVMGT 251
            A+ + +L  E++ +++RD  A N+L+ +  + K++DFG A   G + ++ H     +  
Sbjct: 129 -AKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           + + A E I     T   DV+S+GV + EL+T
Sbjct: 186 K-WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 93/215 (43%), Gaps = 17/215 (7%)
Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE---WLA 131
           ++  ++F     LG+G FGKV        +R     +  A+K+L         E    + 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVT 54
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA 190
           E   L   +HP L  L  Y  +   RL  V EY   G L   L +    T          
Sbjct: 55  ESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG 250
           I +A  L +LH  +  V+YRD K  N++LD D + K++DFGL  +G     +  T C  G
Sbjct: 114 IVSA--LEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC--G 167
Query: 251 TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           T  Y APE +         D +  GVV+ E++ GR
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 21/212 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLG 137
            F +   L  G FG VYKG     +  G K +  VA+K L +    + ++E L E   + 
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 72
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST-----LPWLTRIKIAIG 192
            + +PH+  L+G C     +L+  + M  G L D + ++  +      L W  +I     
Sbjct: 73  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 126
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT-DGPQGEDSHITTCVMGT 251
            A+ + +L  E++ +++RD  A N+L+ +  + K++DFGLA   G + ++ H     +  
Sbjct: 127 -AKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           + + A E I     T   DV+S+GV + EL+T
Sbjct: 184 K-WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 18/215 (8%)
Query: 86  YLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA-EVIFLGQLKHPHL 144
           +LG+GGF K ++  + D     + A  +  K L +   Q  RE ++ E+     L H H+
Sbjct: 24  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQ--REKMSMEISIHRSLAHQHV 79
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLP---WLTRIKIAIGAARCLAFLH 201
           V   G+  +++   +V E     +L +   +  + T P   +  R +I +G      +LH
Sbjct: 80  VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----YLH 134
Query: 202 GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN 261
                VI+RD K  N+ L+ D   K+ DFGLAT      +   T C  GT  Y APE ++
Sbjct: 135 RNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC--GTPNYIAPEVLS 190
Query: 262 TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE 296
               +   DV+S G ++  LL G+   E + C +E
Sbjct: 191 KKGHSFEVDVWSIGCIMYTLLVGKPPFETS-CLKE 224

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 18/215 (8%)
Query: 86  YLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA-EVIFLGQLKHPHL 144
           +LG+GGF K ++  + D     + A  +  K L +   Q  RE ++ E+     L H H+
Sbjct: 28  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQ--REKMSMEISIHRSLAHQHV 83
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLP---WLTRIKIAIGAARCLAFLH 201
           V   G+  +++   +V E     +L +   +  + T P   +  R +I +G      +LH
Sbjct: 84  VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----YLH 138
Query: 202 GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN 261
                VI+RD K  N+ L+ D   K+ DFGLAT      +   T C  GT  Y APE ++
Sbjct: 139 RNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC--GTPNYIAPEVLS 194
Query: 262 TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE 296
               +   DV+S G ++  LL G+   E + C +E
Sbjct: 195 KKGHSFEVDVWSIGCIMYTLLVGKPPFETS-CLKE 228

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 21/212 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLG 137
            F +   LG G FG VYKG     +  G K +  VA+K L +    + ++E L E   + 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 79
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST-----LPWLTRIKIAIG 192
            + +PH+  L+G C     +L+  + M  G L D + ++  +      L W  +I     
Sbjct: 80  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 133
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT-DGPQGEDSHITTCVMGT 251
            A+ + +L  E++ +++RD  A N+L+ +  + K++DFG A   G + ++ H     +  
Sbjct: 134 -AKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 190
Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           + + A E I     T   DV+S+GV + EL+T
Sbjct: 191 K-WMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 93/215 (43%), Gaps = 17/215 (7%)
Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE---WLA 131
           ++  ++F     LG+G FGKV        +R     +  A+K+L         E    + 
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVT 57
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA 190
           E   L   +HP L  L  Y  +   RL  V EY   G L   L +    T          
Sbjct: 58  ESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 116
Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG 250
           I +A  L +LH  +  V+YRD K  N++LD D + K++DFGL  +G     +  T C  G
Sbjct: 117 IVSA--LEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC--G 170
Query: 251 TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           T  Y APE +         D +  GVV+ E++ GR
Sbjct: 171 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 93/215 (43%), Gaps = 17/215 (7%)
Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE---WLA 131
           ++  ++F     LG+G FGKV        +R     +  A+K+L         E    + 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVT 54
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA 190
           E   L   +HP L  L  Y  +   RL  V EY   G L   L +    T          
Sbjct: 55  ESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG 250
           I +A  L +LH  +  V+YRD K  N++LD D + K++DFGL  +G     +  T C  G
Sbjct: 114 IVSA--LEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC--G 167
Query: 251 TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           T  Y APE +         D +  GVV+ E++ GR
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 21/212 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLG 137
            F +   LG G FG VYKG     +  G K +  VA+K L +    + ++E L E   + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 72
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST-----LPWLTRIKIAIG 192
            + +PH+  L+G C     +L+  + M  G L D + ++  +      L W  +I     
Sbjct: 73  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 126
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT-DGPQGEDSHITTCVMGT 251
            A+ + +L  E++ +++RD  A N+L+ +  + K++DFG A   G + ++ H     +  
Sbjct: 127 -AKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 183
Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           + + A E I     T   DV+S+GV + EL+T
Sbjct: 184 K-WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 21/212 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVL-DVNGSQGHREWLAEVIFLG 137
            F +   L  G FG VYKG     +  G K +  VA+K L +    + ++E L E   + 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 79
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST-----LPWLTRIKIAIG 192
            + +PH+  L+G C     +L+  + M  G L D + ++  +      L W  +I     
Sbjct: 80  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 133
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT-DGPQGEDSHITTCVMGT 251
            A+ + +L  E++ +++RD  A N+L+ +  + K++DFGLA   G + ++ H     +  
Sbjct: 134 -AKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           + + A E I     T   DV+S+GV + EL+T
Sbjct: 191 K-WMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 100/221 (45%), Gaps = 29/221 (13%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--------QGHREW-L 130
           N+   + LG G    V + C+    +P  K    AVK++DV G         Q  RE  L
Sbjct: 18  NYEPKEILGRG-VSSVVRRCIH---KPTCKE--YAVKIIDVTGGGSFSAEEVQELREATL 71
Query: 131 AEVIFLGQLK-HPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKI 189
            EV  L ++  HP+++ L      +    LV++ M  G L D L +  + +     +I  
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR 131
Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM 249
           A+    C   LH  +  +++RD K  NILLD D N KL+DFG +     GE       V 
Sbjct: 132 ALLEVICA--LH--KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVC 184
Query: 250 GTEGYAAPEYI----NTGH--LTTMCDVFSFGVVLLELLTG 284
           GT  Y APE I    N  H       D++S GV++  LL G
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 100/222 (45%), Gaps = 29/222 (13%)
Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--------QGHREW- 129
            N+   + LG G    V + C+    +P  K    AVK++DV G         Q  RE  
Sbjct: 4   ENYEPKEILGRG-VSSVVRRCIH---KPTCKE--YAVKIIDVTGGGSFSAEEVQELREAT 57
Query: 130 LAEVIFLGQLK-HPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIK 188
           L EV  L ++  HP+++ L      +    LV++ M  G L D L +  + +     +I 
Sbjct: 58  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM 117
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
            A+    C   LH  +  +++RD K  NILLD D N KL+DFG +     GE       V
Sbjct: 118 RALLEVICA--LH--KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREV 170
Query: 249 MGTEGYAAPEYI----NTGH--LTTMCDVFSFGVVLLELLTG 284
            GT  Y APE I    N  H       D++S GV++  LL G
Sbjct: 171 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 18/215 (8%)
Query: 86  YLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA-EVIFLGQLKHPHL 144
           +LG+GGF K ++  + D     + A  +  K L +   Q  RE ++ E+     L H H+
Sbjct: 24  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQ--REKMSMEISIHRSLAHQHV 79
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLP---WLTRIKIAIGAARCLAFLH 201
           V   G+  +++   +V E     +L +   +  + T P   +  R +I +G      +LH
Sbjct: 80  VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----YLH 134
Query: 202 GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN 261
                VI+RD K  N+ L+ D   K+ DFGLAT      +   T C  GT  Y APE ++
Sbjct: 135 RNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC--GTPNYIAPEVLS 190
Query: 262 TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE 296
               +   DV+S G ++  LL G+   E + C +E
Sbjct: 191 KKGHSFEVDVWSIGCIMYTLLVGKPPFETS-CLKE 224

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 112/276 (40%), Gaps = 42/276 (15%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHREWLAEVIFLGQLKHPHL 144
           LG G +G V K      +R     Q +AVK +   VN  +  R  +   I +  +  P  
Sbjct: 15  LGRGAYGVVEK------MRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 145 VNLIGYCCEDEHRLLVYEYM--ALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
           V   G    +    +  E M  +L   + Q+  +   T+P     KIA+   + L  LH 
Sbjct: 69  VTFYGALFREGDVWICMELMDTSLDKFYKQVI-DKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFG----LATDGPQGEDSHITTCVMGTEGYAAPE 258
           +   VI+RD K SN+L+++    K+ DFG    L  D  +  D+       G + Y APE
Sbjct: 128 KLS-VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA-------GCKPYMAPE 179
Query: 259 YI----NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD 314
            I    N    +   D++S G+ ++EL   R   +            W  P    F +L 
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYD-----------SWGTP----FQQLK 224
Query: 315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT 350
           Q+++       + + +        QCL  N K RPT
Sbjct: 225 QVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPT 260

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 92/222 (41%), Gaps = 22/222 (9%)
Query: 76  MITHNFSRSDY-----LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHR 127
           ++T +F+  D+     LG+G FG VY        R       VA+KVL    +       
Sbjct: 15  ILTRHFTIDDFEIGRPLGKGKFGNVYLA------REKKSHFIVALKVLFKSQIEKEGVEH 68
Query: 128 EWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRI 187
           +   E+     L HP+++ L  Y  +     L+ EY   G L+ +L K  S T       
Sbjct: 69  QLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQK--SCTFDEQRTA 126
Query: 188 KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC 247
            I    A  L + HG  K VI+RD K  N+LL      K++DFG +   P       T C
Sbjct: 127 TIMEELADALMYCHG--KKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRK--TMC 182
Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVE 289
             GT  Y  PE I         D++  GV+  ELL G    E
Sbjct: 183 --GTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFE 222

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 122/282 (43%), Gaps = 28/282 (9%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           +G+G FGKV    V  N    + A     K   V  ++  R    E+  +  L+HP LVN
Sbjct: 23  IGKGSFGKV--CIVQKNDTKKMYAMKYMNKQKCVERNEV-RNVFKELQIMQGLEHPFLVN 79
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     ++E   +V + +  G+L   L +N          +K+ I     +A  + + + 
Sbjct: 80  LWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKE---ETVKLFI-CELVMALDYLQNQR 135
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT---G 263
           +I+RD K  NILLD   +  ++DF +A   P+  ++ ITT + GT+ Y APE  ++    
Sbjct: 136 IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--ETQITT-MAGTKPYMAPEMFSSRKGA 192
Query: 264 HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLED 323
             +   D +S GV   ELL GRR          K++V      +                
Sbjct: 193 GYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV--------------- 237
Query: 324 RYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN 365
            Y +  ++ + ++  + L  NP  R +  + V+    + D+N
Sbjct: 238 TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ 138
           +  S+++ LG G FG+V+K C  +    GLK   +A K++   G +   E   E+  + Q
Sbjct: 89  YTVSKTEILGGGRFGQVHK-C--EETATGLK---LAAKIIKTRGMKDKEEVKNEISVMNQ 142
Query: 139 LKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLA 198
           L H +L+ L          +LV EY+  G L D++  + S  L  L    I      C  
Sbjct: 143 LDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII-DESYNLTELD--TILFMKQICEG 199
Query: 199 FLHGEEKPVIYRDFKASNIL-LDSDYNA-KLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
             H  +  +++ D K  NIL ++ D    K+ DFGLA      E   +     GT  + A
Sbjct: 200 IRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN---FGTPEFLA 256
Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTG 284
           PE +N   ++   D++S GV+   LL+G
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 100/232 (43%), Gaps = 42/232 (18%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           +F     LG+G FG+V K       R  L ++  A+K +  +  +     L+EV+ L  L
Sbjct: 7   DFEEIAVLGQGAFGQVVKA------RNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASL 59
Query: 140 KHPHLVNLIGYCCEDEHRLLV---------------YEYMALGNLHDQLF-KNYSSTLPW 183
            H ++V    Y    E R  V                EY   G L+D +  +N +     
Sbjct: 60  NHQYVVRY--YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE 117
Query: 184 LTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGED-- 241
             R+   I  A  L+++H +   +I+RD K  NI +D   N K+ DFGLA +  +  D  
Sbjct: 118 YWRLFRQILEA--LSYIHSQ--GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 242 ----------SHITTCVMGTEGYAAPEYIN-TGHLTTMCDVFSFGVVLLELL 282
                     S   T  +GT  Y A E ++ TGH     D++S G++  E++
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 85  DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDV---NGSQG--HREWLAEVIFLGQL 139
           + +G+G F  V + C++         Q  AVK++DV     S G    +   E      L
Sbjct: 30  EVIGKGAFS-VVRRCINRE-----TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAF 199
           KHPH+V L+     D    +V+E+M   +L  ++ K   +   +   +          A 
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 200 LHGEEKPVIYRDFKASNILLDSDYNA---KLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
            +  +  +I+RD K  N+LL S  N+   KL DFG+A     GE   +    +GT  + A
Sbjct: 144 RYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQ--LGESGLVAGGRVGTPHFMA 201
Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTG 284
           PE +         DV+  GV+L  LL+G
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 75/304 (24%), Positives = 122/304 (40%), Gaps = 41/304 (13%)
Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWL-AEVIFLG 137
           +N      LG G FGKV +      L        VAVK+L        +E L +E+  + 
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAF-GLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 89
Query: 138 QL-KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTL--------------- 181
            L +H ++VNL+G C      L++ EY   G+L + L +   + L               
Sbjct: 90  HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDK 149
Query: 182 ----PWLTR--IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD 235
               P   R  +  +   A+ +AFL    K  I+RD  A N+LL + + AK+ DFGLA D
Sbjct: 150 EDGRPLELRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 207
Query: 236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKR 295
                +  +         + APE I     T   DV+S+G++L E+     S+  N    
Sbjct: 208 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN---- 259
Query: 296 EKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVV 355
                    P +   +K  +++    +        K + ++   C +  P  RPT   + 
Sbjct: 260 -------PYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQIC 312
Query: 356 KALE 359
             L+
Sbjct: 313 SFLQ 316

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 90/204 (44%), Gaps = 20/204 (9%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTV--AVKVLDVNG---SQGHREWLAEV-IFLGQLK 140
           +G+G FGKV        L    KA+ V  AVKVL        +  +  ++E  + L  +K
Sbjct: 46  IGKGSFGKV--------LLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 141 HPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFL 200
           HP LV L       +    V +Y+  G L   L +      P        I +A  L +L
Sbjct: 98  HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASA--LGYL 155
Query: 201 HGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI 260
           H     ++YRD K  NILLDS  +  L+DFGL  +  +   +  T C  GT  Y APE +
Sbjct: 156 HSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC--GTPEYLAPEVL 211
Query: 261 NTGHLTTMCDVFSFGVVLLELLTG 284
           +        D +  G VL E+L G
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 29/209 (13%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHL 144
           LG+G F  V + CV       L  Q  A K+++     ++ H++   E      LKHP++
Sbjct: 30  LGKGAFS-VVRRCVK-----VLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNI 83
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNL-HDQLFKNYSSTLPWLTRIKIAIGAARCL-----A 198
           V L     E+ H  L+++ +  G L  D + + Y S             A+ C+     A
Sbjct: 84  VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSE----------ADASHCIQQILEA 133
Query: 199 FLHGEEKPVIYRDFKASNILLDSDYNA---KLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            LH  +  V++RD K  N+LL S       KL+DFGLA +  +GE         GT GY 
Sbjct: 134 VLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIE-VEGE-QQAWFGFAGTPGYL 191
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           +PE +         D+++ GV+L  LL G
Sbjct: 192 SPEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 127/294 (43%), Gaps = 33/294 (11%)
Query: 98  GCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGY----CCE 153
           GCV    +  L  + VAVK+  +   Q  +    EV  L  +KH +++  IG        
Sbjct: 38  GCV---WKAQLLNEYVAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKRGTSV 93
Query: 154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE-------EKP 206
           D    L+  +   G+L D L  N  S   W     IA   AR LA+LH +        KP
Sbjct: 94  DVDLWLITAFHEKGSLSDFLKANVVS---WNELCHIAETMARGLAYLHEDIPGLKDGHKP 150
Query: 207 VI-YRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTG-- 263
            I +RD K+ N+LL ++  A ++DFGLA     G+ +  T   +GT  Y APE +     
Sbjct: 151 AISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAIN 210
Query: 264 ---HLTTMCDVFSFGVVLLELLT----GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI 316
                    D+++ G+VL EL +        V++     E+++ +   P L+D  ++   
Sbjct: 211 FQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ--HPSLEDMQEVVVH 268
Query: 317 IDSR--LEDRYSTE-GAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDI 367
              R  L D +    G   L     +C  H+ ++R +   V + +  +  L +I
Sbjct: 269 KKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLTNI 322

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 15/204 (7%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG---HREWLAEVIFLGQLKHPH 143
           LG GGFG+V+   +    +     +    ++    G QG    ++ LA+V       H  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HSR 245
Query: 144 LVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFL-H 201
            +  + Y  E +  L LV   M  G++   ++ N     P     +     A+ ++ L H
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY-NVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 202 GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN 261
             ++ +IYRD K  N+LLD D N ++SD GLA +   G+    T    GT G+ APE + 
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLL 362
Query: 262 TGHLTTMCDVFSFGVVLLELLTGR 285
                   D F+ GV L E++  R
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 15/204 (7%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG---HREWLAEVIFLGQLKHPH 143
           LG GGFG+V+   +    +     +    ++    G QG    ++ LA+V       H  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HSR 245
Query: 144 LVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFL-H 201
            +  + Y  E +  L LV   M  G++   ++ N     P     +     A+ ++ L H
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY-NVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 202 GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN 261
             ++ +IYRD K  N+LLD D N ++SD GLA +   G+    T    GT G+ APE + 
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLL 362
Query: 262 TGHLTTMCDVFSFGVVLLELLTGR 285
                   D F+ GV L E++  R
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 15/204 (7%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG---HREWLAEVIFLGQLKHPH 143
           LG GGFG+V+   +    +     +    ++    G QG    ++ LA+V       H  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HSR 245
Query: 144 LVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFL-H 201
            +  + Y  E +  L LV   M  G++   ++ N     P     +     A+ ++ L H
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY-NVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 202 GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN 261
             ++ +IYRD K  N+LLD D N ++SD GLA +   G+    T    GT G+ APE + 
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLL 362
Query: 262 TGHLTTMCDVFSFGVVLLELLTGR 285
                   D F+ GV L E++  R
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 18/215 (8%)
Query: 86  YLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA-EVIFLGQLKHPHL 144
           +LG+GGF K ++  + D     + A  +  K L +   Q  RE ++ E+     L H H+
Sbjct: 48  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQ--REKMSMEISIHRSLAHQHV 103
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLP---WLTRIKIAIGAARCLAFLH 201
           V   G+  +++   +V E     +L +   +  + T P   +  R +I +G      +LH
Sbjct: 104 VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----YLH 158
Query: 202 GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN 261
                VI+RD K  N+ L+ D   K+ DFGLAT      +     C  GT  Y APE ++
Sbjct: 159 RNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPEVLS 214
Query: 262 TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE 296
               +   DV+S G ++  LL G+   E + C +E
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGKPPFETS-CLKE 248

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 18/215 (8%)
Query: 86  YLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA-EVIFLGQLKHPHL 144
           +LG+GGF K ++  + D     + A  +  K L +   Q  RE ++ E+     L H H+
Sbjct: 46  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQ--REKMSMEISIHRSLAHQHV 101
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLP---WLTRIKIAIGAARCLAFLH 201
           V   G+  +++   +V E     +L +   +  + T P   +  R +I +G      +LH
Sbjct: 102 VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----YLH 156
Query: 202 GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN 261
                VI+RD K  N+ L+ D   K+ DFGLAT      +     C  GT  Y APE ++
Sbjct: 157 RNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPEVLS 212
Query: 262 TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE 296
               +   DV+S G ++  LL G+   E + C +E
Sbjct: 213 KKGHSFEVDVWSIGCIMYTLLVGKPPFETS-CLKE 246

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 15/204 (7%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG---HREWLAEVIFLGQLKHPH 143
           LG GGFG+V+   +    +     +    ++    G QG    ++ LA+V       H  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HSR 245
Query: 144 LVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFL-H 201
            +  + Y  E +  L LV   M  G++   ++ N     P     +     A+ ++ L H
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY-NVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 202 GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN 261
             ++ +IYRD K  N+LLD D N ++SD GLA +   G+    T    GT G+ APE + 
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLL 362
Query: 262 TGHLTTMCDVFSFGVVLLELLTGR 285
                   D F+ GV L E++  R
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 92/215 (42%), Gaps = 16/215 (7%)
Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE---WLA 131
           ++  + F     LG+G FGKV        ++     +  A+K+L         E    L 
Sbjct: 6   RVTMNEFEYLKLLGKGTFGKVIL------VKEKATGRYYAMKILKKEVIVAKDEVAHTLT 59
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA 190
           E   L   +HP L  L  Y  +   RL  V EY   G L   L +    +          
Sbjct: 60  ENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 118
Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG 250
           I +A  L +LH E K V+YRD K  N++LD D + K++DFGL  +G +  D        G
Sbjct: 119 IVSA--LDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKXFCG 173
Query: 251 TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           T  Y APE +         D +  GVV+ E++ GR
Sbjct: 174 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 92/215 (42%), Gaps = 16/215 (7%)
Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE---WLA 131
           ++  + F     LG+G FGKV        ++     +  A+K+L         E    L 
Sbjct: 5   RVTMNEFEYLKLLGKGTFGKVIL------VKEKATGRYYAMKILKKEVIVAKDEVAHTLT 58
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA 190
           E   L   +HP L  L  Y  +   RL  V EY   G L   L +    +          
Sbjct: 59  ENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 117
Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG 250
           I +A  L +LH E K V+YRD K  N++LD D + K++DFGL  +G +  D        G
Sbjct: 118 IVSA--LDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKXFCG 172
Query: 251 TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           T  Y APE +         D +  GVV+ E++ GR
Sbjct: 173 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 92/215 (42%), Gaps = 16/215 (7%)
Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE---WLA 131
           ++  + F     LG+G FGKV        ++     +  A+K+L         E    L 
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVIL------VKEKATGRYYAMKILKKEVIVAKDEVAHTLT 57
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA 190
           E   L   +HP L  L  Y  +   RL  V EY   G L   L +    +          
Sbjct: 58  ENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 116
Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG 250
           I +A  L +LH E K V+YRD K  N++LD D + K++DFGL  +G +  D        G
Sbjct: 117 IVSA--LDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKXFCG 171
Query: 251 TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           T  Y APE +         D +  GVV+ E++ GR
Sbjct: 172 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 15/216 (6%)
Query: 72  KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA 131
           K+ + I   +   D LG G F +V     D   +  +  + +A K L+  G +G  E   
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVIL-AEDKRTQKLVAIKCIAKKALE--GKEGSME--N 65
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI 191
           E+  L ++KHP++V L        H  L+ + ++ G L D++ +    T    +R+   +
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQV 125
Query: 192 GAARCLAFLHGEEKPVIYRDFKASNIL---LDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
             A  + +LH  +  +++RD K  N+L   LD D    +SDFGL+     G    + +  
Sbjct: 126 LDA--VKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTA 178
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            GT GY APE +     +   D +S GV+   LL G
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 120/299 (40%), Gaps = 61/299 (20%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           +F   + +G GGFG+V+K       +  +  +T  +K +  N  +  RE    V  L +L
Sbjct: 12  DFKEIELIGSGGFGQVFKA------KHRIDGKTYVIKRVKYNNEKAERE----VKALAKL 61
Query: 140 KHPHLVNLIG------YCCEDEHR----------LLVYEYMALGNLHDQLFKNYSSTLPW 183
            H ++V+  G      Y  E   +           +  E+   G L   + K     L  
Sbjct: 62  DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121
Query: 184 LTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT----DGPQG 239
           +  +++     + + ++H   K +I RD K SNI L      K+ DFGL T    DG + 
Sbjct: 122 VLALELFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRX 179
Query: 240 EDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDL 299
                     GT  Y +PE I++       D+++ G++L ELL                +
Sbjct: 180 RSK-------GTLRYMSPEQISSQDYGKEVDLYALGLILAELL---------------HV 217
Query: 300 VEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL 358
            + A    K FT L   I S + D       K+   +  + LS  P+ RP  + +++ L
Sbjct: 218 CDTAFETSKFFTDLRDGIISDIFD-------KKEKTLLQKLLSKKPEDRPNTSEILRTL 269

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 92/215 (42%), Gaps = 17/215 (7%)
Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE---WLA 131
           ++  ++F     LG+G FGKV        +R     +  A+K+L         E    + 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVT 54
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA 190
           E   L   +HP L  L  Y  +   RL  V EY   G L   L +    T          
Sbjct: 55  ESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG 250
           I +A  L +LH  +  V+YRD K  N++LD D + K++DFGL  +G     +    C  G
Sbjct: 114 IVSA--LEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC--G 167
Query: 251 TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           T  Y APE +         D +  GVV+ E++ GR
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 92/215 (42%), Gaps = 17/215 (7%)
Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE---WLA 131
           ++  ++F     LG+G FGKV        +R     +  A+K+L         E    + 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVT 54
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA 190
           E   L   +HP L  L  Y  +   RL  V EY   G L   L +    T          
Sbjct: 55  ESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG 250
           I +A  L +LH  +  V+YRD K  N++LD D + K++DFGL  +G     +    C  G
Sbjct: 114 IVSA--LEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC--G 167
Query: 251 TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           T  Y APE +         D +  GVV+ E++ GR
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 18/215 (8%)
Query: 86  YLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA-EVIFLGQLKHPHL 144
           +LG+GGF K ++  + D     + A  +  K L +   Q  RE ++ E+     L H H+
Sbjct: 22  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQ--REKMSMEISIHRSLAHQHV 77
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLP---WLTRIKIAIGAARCLAFLH 201
           V   G+  +++   +V E     +L +   +  + T P   +  R +I +G      +LH
Sbjct: 78  VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----YLH 132
Query: 202 GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN 261
                VI+RD K  N+ L+ D   K+ DFGLAT      +     C  GT  Y APE ++
Sbjct: 133 RNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPEVLS 188
Query: 262 TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE 296
               +   DV+S G ++  LL G+   E + C +E
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPPFETS-CLKE 222

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 92/215 (42%), Gaps = 17/215 (7%)
Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE---WLA 131
           ++  ++F     LG+G FGKV        +R     +  A+K+L         E    + 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVT 54
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA 190
           E   L   +HP L  L  Y  +   RL  V EY   G L   L +    T          
Sbjct: 55  ESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG 250
           I +A  L +LH   + V+YRD K  N++LD D + K++DFGL  +G     +    C  G
Sbjct: 114 IVSA--LEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC--G 167
Query: 251 TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           T  Y APE +         D +  GVV+ E++ GR
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 92/215 (42%), Gaps = 17/215 (7%)
Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE---WLA 131
           ++  ++F     LG+G FGKV        +R     +  A+K+L         E    + 
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVT 59
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA 190
           E   L   +HP L  L  Y  +   RL  V EY   G L   L +    T          
Sbjct: 60  ESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 118
Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG 250
           I +A  L +LH   + V+YRD K  N++LD D + K++DFGL  +G     +    C  G
Sbjct: 119 IVSA--LEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC--G 172
Query: 251 TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           T  Y APE +         D +  GVV+ E++ GR
Sbjct: 173 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 96/226 (42%), Gaps = 29/226 (12%)
Query: 71  LKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD----VNGSQGH 126
           +++L+M   ++     +G G FG+V        +R     +  A+K+L     +  S   
Sbjct: 61  IRDLRMKAEDYEVVKVIGRGAFGEVQL------VRHKSTRKVYAMKLLSKFEMIKRSDSA 114
Query: 127 REWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPW--- 183
             W  E   +     P +V L     +D +  +V EYM  G+L + L  NY     W   
Sbjct: 115 FFW-EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF 172
Query: 184 -LTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS 242
               + +A+ A   + F+H        RD K  N+LLD   + KL+DFG      +    
Sbjct: 173 YTAEVVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224
Query: 243 HITTCVMGTEGYAAPEYINT----GHLTTMCDVFSFGVVLLELLTG 284
              T V GT  Y +PE + +    G+    CD +S GV L E+L G
Sbjct: 225 RCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 96/226 (42%), Gaps = 29/226 (12%)
Query: 71  LKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD----VNGSQGH 126
           +++L+M   ++     +G G FG+V        +R     +  A+K+L     +  S   
Sbjct: 66  IRDLRMKAEDYEVVKVIGRGAFGEVQL------VRHKSTRKVYAMKLLSKFEMIKRSDSA 119
Query: 127 REWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPW--- 183
             W  E   +     P +V L     +D +  +V EYM  G+L + L  NY     W   
Sbjct: 120 FFW-EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF 177
Query: 184 -LTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS 242
               + +A+ A   + F+H        RD K  N+LLD   + KL+DFG      +    
Sbjct: 178 YTAEVVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 229
Query: 243 HITTCVMGTEGYAAPEYINT----GHLTTMCDVFSFGVVLLELLTG 284
              T V GT  Y +PE + +    G+    CD +S GV L E+L G
Sbjct: 230 RCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 96/226 (42%), Gaps = 29/226 (12%)
Query: 71  LKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD----VNGSQGH 126
           +++L+M   ++     +G G FG+V        +R     +  A+K+L     +  S   
Sbjct: 66  IRDLRMKAEDYEVVKVIGRGAFGEVQL------VRHKSTRKVYAMKLLSKFEMIKRSDSA 119
Query: 127 REWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPW--- 183
             W  E   +     P +V L     +D +  +V EYM  G+L + L  NY     W   
Sbjct: 120 FFW-EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF 177
Query: 184 -LTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS 242
               + +A+ A   + F+H        RD K  N+LLD   + KL+DFG      +    
Sbjct: 178 YTAEVVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 229
Query: 243 HITTCVMGTEGYAAPEYINT----GHLTTMCDVFSFGVVLLELLTG 284
              T V GT  Y +PE + +    G+    CD +S GV L E+L G
Sbjct: 230 RCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDV----NGSQG-HREWLAEVIF 135
           + + D+LGEG F  VYK       R     Q VA+K + +        G +R  L E+  
Sbjct: 12  YEKLDFLGEGQFATVYKA------RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL 65
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
           L +L HP+++ L+       +  LV+++M      + + K+ S  L         +   +
Sbjct: 66  LQELSHPNIIGLLDAFGHKSNISLVFDFMETD--LEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L +LH  +  +++RD K +N+LLD +   KL+DFGLA        ++    V  T  Y 
Sbjct: 124 GLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV--TRWYR 179
Query: 256 APEYINTGHLTTM-CDVFSFGVVLLELL 282
           APE +    +  +  D+++ G +L ELL
Sbjct: 180 APELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 105/250 (42%), Gaps = 47/250 (18%)
Query: 53  SLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT 112
           SL+E+  S +     +F L EL            +G G +G+VYKG      R     Q 
Sbjct: 10  SLDEIDLSALRDPAGIFELVEL------------VGNGTYGQVYKG------RHVKTGQL 51
Query: 113 VAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE---------DEHRLLVYEY 163
            A+KV+DV G +   E   E+  L   K+ H  N+  Y            D+   LV E+
Sbjct: 52  AAIKVMDVTGDE-EEEIKQEINMLK--KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 108
Query: 164 MALGNLHDQLFKNYSSTLP--WLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS 221
              G++ D +     +TL   W+  I   I   R L+ LH  +  VI+RD K  N+LL  
Sbjct: 109 CGAGSVTDLIKNTKGNTLKEEWIAYICREI--LRGLSHLH--QHKVIHRDIKGQNVLLTE 164
Query: 222 DYNAKLSDFGLAT--DGPQGEDSHITTCVMGTEGYAAPEYINTGH-----LTTMCDVFSF 274
           +   KL DFG++   D   G         +GT  + APE I              D++S 
Sbjct: 165 NAEVKLVDFGVSAQLDRTVGR----RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSL 220
Query: 275 GVVLLELLTG 284
           G+  +E+  G
Sbjct: 221 GITAIEMAEG 230

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 20/217 (9%)
Query: 74  LQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEV 133
            Q ++  + R   LG G +G+V      D L    +A  + +K   V  +      L EV
Sbjct: 16  FQGLSDRYQRVKKLGSGAYGEVL--LCKDKLTGAERAIKI-IKKSSVTTTSNSGALLDEV 72
Query: 134 IFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGA 193
             L QL HP+++ L  +  +  +  LV E    G L D++           + +  A+  
Sbjct: 73  AVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQK-----FSEVDAAVIM 127
Query: 194 ARCLA---FLHGEEKPVIYRDFKASNILLDS---DYNAKLSDFGLATDGPQGEDSHITTC 247
            + L+   +LH  +  +++RD K  N+LL+S   D   K+ DFGL+     G        
Sbjct: 128 KQVLSGTTYLH--KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER-- 183
Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            +GT  Y APE +   +    CDV+S GV+L  LL G
Sbjct: 184 -LGTAYYIAPEVLRKKY-DEKCDVWSCGVILYILLCG 218

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 40/224 (17%)
Query: 90  GGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAE--VIFLGQLKHPHLVNL 147
           G FG V+K  + ++         VAVK+  +   Q    W +E  +     +KH +L+  
Sbjct: 26  GRFGCVWKAQLMNDF--------VAVKIFPLQDKQS---WQSEREIFSTPGMKHENLLQF 74
Query: 148 IGYCCEDEHRLLVYEYMALGNLHDQ-LFKNY--SSTLPWLTRIKIAIGAARCLAFLH--- 201
           I    E     L  E   +   HD+    +Y   + + W     +A   +R L++LH   
Sbjct: 75  IA--AEKRGSNLEVELWLITAFHDKGSLTDYLKGNIITWNELCHVAETMSRGLSYLHEDV 132
Query: 202 ------GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
                 G +  + +RDFK+ N+LL SD  A L+DFGLA     G+    T   +GT  Y 
Sbjct: 133 PWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYM 192
Query: 256 APEYINTG-----HLTTMCDVFSFGVVLLELLTGRRSVEKNRCK 294
           APE +              D+++ G+VL EL++        RCK
Sbjct: 193 APEVLEGAINFQRDAFLRIDMYAMGLVLWELVS--------RCK 228

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 78/180 (43%), Gaps = 31/180 (17%)
Query: 187 IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITT 246
           + I I  A  + FLH   K +++RD K SNI    D   K+ DFGL T   Q E+     
Sbjct: 167 LHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
Query: 247 CVM----------GTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE 296
             M          GT+ Y +PE I+  + +   D+FS G++L ELL    S +  R +  
Sbjct: 225 TPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS-FSTQMERVRII 283
Query: 297 KDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
            D+     P+L  FT+           +Y  E       +    LS +P  RP  T +++
Sbjct: 284 TDVRNLKFPLL--FTQ-----------KYPQEH-----MMVQDMLSPSPTERPEATDIIE 325

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 99/232 (42%), Gaps = 42/232 (18%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           +F     LG+G FG+V K       R  L ++  A+K +  +  +     L+EV+ L  L
Sbjct: 7   DFEEIAVLGQGAFGQVVKA------RNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASL 59
Query: 140 KHPHLVNLIGYCCEDEHRLLV---------------YEYMALGNLHDQLF-KNYSSTLPW 183
            H ++V    Y    E R  V                EY     L+D +  +N +     
Sbjct: 60  NHQYVVRY--YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDE 117
Query: 184 LTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGED-- 241
             R+   I  A  L+++H +   +I+RD K  NI +D   N K+ DFGLA +  +  D  
Sbjct: 118 YWRLFRQILEA--LSYIHSQ--GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 242 ----------SHITTCVMGTEGYAAPEYIN-TGHLTTMCDVFSFGVVLLELL 282
                     S   T  +GT  Y A E ++ TGH     D++S G++  E++
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 15/216 (6%)
Query: 72  KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA 131
           K+ + I   +   D LG G F +V     D   +  +  + +A + L+  G +G  E   
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVILA-EDKRTQKLVAIKCIAKEALE--GKEGSME--N 65
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI 191
           E+  L ++KHP++V L        H  L+ + ++ G L D++ +    T    +R+   +
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQV 125
Query: 192 GAARCLAFLHGEEKPVIYRDFKASNIL---LDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
             A  + +LH  +  +++RD K  N+L   LD D    +SDFGL+     G    + +  
Sbjct: 126 LDA--VKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTA 178
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            GT GY APE +     +   D +S GV+   LL G
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 15/216 (6%)
Query: 72  KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA 131
           K+ + I   +   D LG G F +V     D   +  +  + +A + L+  G +G  E   
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVILA-EDKRTQKLVAIKCIAKEALE--GKEGSME--N 65
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI 191
           E+  L ++KHP++V L        H  L+ + ++ G L D++ +    T    +R+   +
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQV 125
Query: 192 GAARCLAFLHGEEKPVIYRDFKASNIL---LDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
             A  + +LH  +  +++RD K  N+L   LD D    +SDFGL+     G    + +  
Sbjct: 126 LDA--VKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTA 178
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            GT GY APE +     +   D +S GV+   LL G
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 29/219 (13%)
Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVI 134
            T  +   + LG+G F  V + CV       L  Q  A  +++     ++ H++   E  
Sbjct: 9   FTEEYQLFEELGKGAFS-VVRRCVK-----VLAGQEYAAMIINTKKLSARDHQKLEREAR 62
Query: 135 FLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNL-HDQLFKNYSSTLPWLTRIKIAIGA 193
               LKHP++V L     E+ H  L+++ +  G L  D + + Y S             A
Sbjct: 63  ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSE----------ADA 112
Query: 194 ARCL-----AFLHGEEKPVIYRDFKASNILLDSDYNA---KLSDFGLATDGPQGEDSHIT 245
           + C+     A LH  +  V++R+ K  N+LL S       KL+DFGLA +  +GE     
Sbjct: 113 SHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE-VEGE-QQAW 170
Query: 246 TCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
               GT GY +PE +         D+++ GV+L  LL G
Sbjct: 171 FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 98/207 (47%), Gaps = 23/207 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGH-----REWLAEVIFLGQLK 140
           +GEG +GKV+K     +L+ G   + VA+K + V  G +G      RE +A +  L   +
Sbjct: 19  IGEGAYGKVFKA---RDLKNG--GRFVALKRVRVQTGEEGMPLSTIRE-VAVLRHLETFE 72
Query: 141 HPHLVNLIGYCC----EDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
           HP++V L   C     + E +L LV+E++   +L   L K     +P  T   +     R
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLR 131
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L FLH     V++RD K  NIL+ S    KL+DFGLA            T V+ T  Y 
Sbjct: 132 GLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWYR 186
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELL 282
           APE +      T  D++S G +  E+ 
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 15/216 (6%)
Query: 72  KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA 131
           K+ + I   +   D LG G F +V     D   +  +  + +A + L+  G +G  E   
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVILA-EDKRTQKLVAIKCIAKEALE--GKEGSME--N 65
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI 191
           E+  L ++KHP++V L        H  L+ + ++ G L D++ +    T    +R+   +
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQV 125
Query: 192 GAARCLAFLHGEEKPVIYRDFKASNIL---LDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
             A  + +LH  +  +++RD K  N+L   LD D    +SDFGL+     G    + +  
Sbjct: 126 LDA--VKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTA 178
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            GT GY APE +     +   D +S GV+   LL G
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 25/230 (10%)
Query: 64  SNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS 123
            NL+   +      T ++   + LG+G F  V + CV         A+ +  K L    +
Sbjct: 16  ENLYFQXMATCTRFTDDYQLFEELGKGAFS-VVRRCVKKTPTQEYAAKIINTKKL---SA 71
Query: 124 QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNL-HDQLFKNYSSTLP 182
           + H++   E      LKHP++V L     E+    LV++ +  G L  D + + Y S   
Sbjct: 72  RDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSE-- 129
Query: 183 WLTRIKIAIGAARCLAFL-----HGEEKPVIYRDFKASNILLDSDYNA---KLSDFGLAT 234
                     A+ C+  +     H  +  +++RD K  N+LL S       KL+DFGLA 
Sbjct: 130 --------ADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAI 181
Query: 235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           +  QGE         GT GY +PE +         D+++ GV+L  LL G
Sbjct: 182 E-VQGE-QQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 101/216 (46%), Gaps = 23/216 (10%)
Query: 80  NFSRSDYLGEGGFGKVY---KGCVDDNLR----PGLKAQTVAVKVLDVNGSQGHREWLAE 132
           NF     LG G +GKV+   K    D  +      LK  T+  K      ++  R+ L  
Sbjct: 55  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114
Query: 133 VIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI 191
           +      + P LV L  Y  + E +L L+ +Y+  G L   L +    T      ++I +
Sbjct: 115 I-----RQSPFLVTL-HYAFQTETKLHLILDYINGGELFTHLSQRERFTE---HEVQIYV 165
Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
           G    LA  H  +  +IYRD K  NILLDS+ +  L+DFGL+ +    +++       GT
Sbjct: 166 GEI-VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV-ADETERAYDFCGT 223
Query: 252 EGYAAPEYI---NTGHLTTMCDVFSFGVVLLELLTG 284
             Y AP+ +   ++GH     D +S GV++ ELLTG
Sbjct: 224 IEYMAPDIVRGGDSGH-DKAVDWWSLGVLMYELLTG 258

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 26/204 (12%)
Query: 87  LGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHP 142
           LG G FG V    ++G  D           VA+K++   GS    E++ E   +  L H 
Sbjct: 32  LGTGQFGVVKYGKWRGQYD-----------VAIKMIK-EGSMSEDEFIEEAKVMMNLSHE 79
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
            LV L G C +     ++ EYMA G L + L +       + T+  + +    C A  + 
Sbjct: 80  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYL 136
Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEY 259
           E K  ++RD  A N L++     K+SDFGL+      E+    T  +G++    ++ PE 
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEE----TSSVGSKFPVRWSPPEV 192
Query: 260 INTGHLTTMCDVFSFGVVLLELLT 283
           +     ++  D+++FGV++ E+ +
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 98/207 (47%), Gaps = 23/207 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGH-----REWLAEVIFLGQLK 140
           +GEG +GKV+K     +L+ G   + VA+K + V  G +G      RE +A +  L   +
Sbjct: 19  IGEGAYGKVFKA---RDLKNG--GRFVALKRVRVQTGEEGMPLSTIRE-VAVLRHLETFE 72
Query: 141 HPHLVNLIGYCC----EDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
           HP++V L   C     + E +L LV+E++   +L   L K     +P  T   +     R
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLR 131
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L FLH     V++RD K  NIL+ S    KL+DFGLA            T V+ T  Y 
Sbjct: 132 GLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWYR 186
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELL 282
           APE +      T  D++S G +  E+ 
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 98/207 (47%), Gaps = 23/207 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGH-----REWLAEVIFLGQLK 140
           +GEG +GKV+K     +L+ G   + VA+K + V  G +G      RE +A +  L   +
Sbjct: 19  IGEGAYGKVFKA---RDLKNG--GRFVALKRVRVQTGEEGMPLSTIRE-VAVLRHLETFE 72
Query: 141 HPHLVNLIGYCC----EDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
           HP++V L   C     + E +L LV+E++   +L   L K     +P  T   +     R
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLR 131
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L FLH     V++RD K  NIL+ S    KL+DFGLA            T V+ T  Y 
Sbjct: 132 GLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWYR 186
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELL 282
           APE +      T  D++S G +  E+ 
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 87/213 (40%), Gaps = 19/213 (8%)
Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHREWLAEVI 134
           +   + +   +GEG +G V+K    D        Q VA+K      +     +  L E+ 
Sbjct: 1   MMEKYEKIGKIGEGSYGVVFKCRNRDT------GQIVAIKKFLESEDDPVIKKIALREIR 54
Query: 135 FLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA 194
            L QLKHP+LVNL+          LV+EY     LH+     Y   +P      I     
Sbjct: 55  MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHE--LDRYQRGVPEHLVKSITWQTL 112
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT--DGPQGEDSHITTCVMGTE 252
           + + F H      I+RD K  NIL+      KL DFG A    GP    S      + T 
Sbjct: 113 QAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGP----SDYYDDEVATR 166
Query: 253 GYAAPE-YINTGHLTTMCDVFSFGVVLLELLTG 284
            Y +PE  +         DV++ G V  ELL+G
Sbjct: 167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 71/312 (22%), Positives = 122/312 (39%), Gaps = 74/312 (23%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           +F   + +G GGFG+V+K       +  +  +T  ++ +  N  +  RE  A    L +L
Sbjct: 13  DFKEIELIGSGGFGQVFKA------KHRIDGKTYVIRRVKYNNEKAEREVKA----LAKL 62
Query: 140 KHPHLVNLIG--------------------YCCEDEHR---------LLVYEYMALGNLH 170
            H ++V+  G                    Y  E+             +  E+   G L 
Sbjct: 63  DHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLE 122
Query: 171 DQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDF 230
             + K     L  +  +++     + + ++H   K +I+RD K SNI L      K+ DF
Sbjct: 123 QWIEKRRGEKLDKVLALELFEQITKGVDYIHS--KKLIHRDLKPSNIFLVDTKQVKIGDF 180
Query: 231 GLAT----DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRR 286
           GL T    DG +       T   GT  Y +PE I++       D+++ G++L ELL    
Sbjct: 181 GLVTSLKNDGKR-------TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH--- 230
Query: 287 SVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPK 346
                       + + A    K FT L   I S + D       K+   +  + LS  P+
Sbjct: 231 ------------VCDTAFETSKFFTDLRDGIISDIFD-------KKEKTLLQKLLSKKPE 271
Query: 347 SRPTMTTVVKAL 358
            RP  + +++ L
Sbjct: 272 DRPNTSEILRTL 283

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/289 (22%), Positives = 118/289 (40%), Gaps = 48/289 (16%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHL 144
           L E   G+++KG    N         + VKVL V    ++  R++  E   L    HP++
Sbjct: 18  LNENHSGELWKGRWQGN--------DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 145 VNLIGYCCEDE--HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
           + ++G C      H  L+  +M  G+L++ L +  +  +     +K A+  AR +AFLH 
Sbjct: 70  LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129
Query: 203 EEKPVIYRDFKASNILLDSDYNAKLS--DFGLATDGPQGEDSHITTCVMGTEGYAAPEYI 260
            E  +      + ++++D D  A++S  D   +   P           M    + APE +
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR---------MYAPAWVAPEAL 180
Query: 261 NTGHLTT---MCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII 317
                 T     D++SF V+L EL+T  R V                    D + ++  +
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVT--REVP-----------------FADLSNMEIGM 221
Query: 318 DSRLEDRYSTEG---AKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD 363
              LE    T     +  ++ +   C++ +P  RP    +V  LE + D
Sbjct: 222 KVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLKHPHL 144
           +G G  G+V+K      +R       +AVK +  +G+  +  R  +   + L     P++
Sbjct: 33  MGSGTCGQVWK------MRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           V   G    +    +  E M  G   ++L K     +P     K+ +   + L +L  E+
Sbjct: 87  VQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK-EK 143
Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGH 264
             VI+RD K SNILLD     KL DFG++    +  D        G   Y APE I+   
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPD 200
Query: 265 LTT-----MCDVFSFGVVLLELLTGR 285
            T        DV+S G+ L+EL TG+
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 26/204 (12%)
Query: 87  LGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHP 142
           LG G FG V    ++G  D           VA+K++   GS    E++ E   +  L H 
Sbjct: 12  LGTGQFGVVKYGKWRGQYD-----------VAIKMIK-EGSMSEDEFIEEAKVMMNLSHE 59
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
            LV L G C +     ++ EYMA G L + L +       + T+  + +    C A  + 
Sbjct: 60  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYL 116
Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEY 259
           E K  ++RD  A N L++     K+SDFGL+      E     T  +G++    ++ PE 
Sbjct: 117 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPPEV 172
Query: 260 INTGHLTTMCDVFSFGVVLLELLT 283
           +     ++  D+++FGV++ E+ +
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYS 196

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 26/204 (12%)
Query: 87  LGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHP 142
           LG G FG V    ++G  D           VA+K++   GS    E++ E   +  L H 
Sbjct: 16  LGTGQFGVVKYGKWRGQYD-----------VAIKMIK-EGSMSEDEFIEEAKVMMNLSHE 63
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
            LV L G C +     ++ EYMA G L + L +       + T+  + +    C A  + 
Sbjct: 64  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYL 120
Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEY 259
           E K  ++RD  A N L++     K+SDFGL+      E     T  +G++    ++ PE 
Sbjct: 121 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPPEV 176
Query: 260 INTGHLTTMCDVFSFGVVLLELLT 283
           +     ++  D+++FGV++ E+ +
Sbjct: 177 LMYSKFSSKSDIWAFGVLMWEIYS 200

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 20/214 (9%)
Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFL 136
           ++  + R   LG G +G+V      D L    +A  + +K   V  +      L EV  L
Sbjct: 2   LSDRYQRVKKLGSGAYGEVL--LCKDKLTGAERAIKI-IKKSSVTTTSNSGALLDEVAVL 58
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
            QL HP+++ L  +  +  +  LV E    G L D++           + +  A+   + 
Sbjct: 59  KQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQK-----FSEVDAAVIMKQV 113
Query: 197 LA---FLHGEEKPVIYRDFKASNILLDS---DYNAKLSDFGLATDGPQGEDSHITTCVMG 250
           L+   +LH  +  +++RD K  N+LL+S   D   K+ DFGL+     G         +G
Sbjct: 114 LSGTTYLH--KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER---LG 168
Query: 251 TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           T  Y APE +   +    CDV+S GV+L  LL G
Sbjct: 169 TAYYIAPEVLRKKY-DEKCDVWSCGVILYILLCG 201

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 26/204 (12%)
Query: 87  LGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHP 142
           LG G FG V    ++G  D           VA+K++   GS    E++ E   +  L H 
Sbjct: 32  LGTGQFGVVKYGKWRGQYD-----------VAIKMIK-EGSMSEDEFIEEAKVMMNLSHE 79
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
            LV L G C +     ++ EYMA G L + L +       + T+  + +    C A  + 
Sbjct: 80  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYL 136
Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEY 259
           E K  ++RD  A N L++     K+SDFGL+      E     T  +G++    ++ PE 
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPPEV 192
Query: 260 INTGHLTTMCDVFSFGVVLLELLT 283
           +     ++  D+++FGV++ E+ +
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 39/225 (17%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVK-VLDV--NGSQGHREWLAEVIFLGQLK-HP 142
           LG+G +G V+K     + R G   + VAVK + D   N +   R +  E++ L +L  H 
Sbjct: 17  LGKGAYGIVWKSI---DRRTG---EVVAVKKIFDAFQNSTDAQRTF-REIMILTELSGHE 69
Query: 143 HLVNLIGYCCEDEHR--LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFL 200
           ++VNL+     D  R   LV++YM   +LH  +  N    L  + +  +     + + +L
Sbjct: 70  NIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYL 125
Query: 201 HGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ-------------------GED 241
           H     +++RD K SNILL+++ + K++DFGL+                         +D
Sbjct: 126 HS--GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 242 SHITTCVMGTEGYAAPEY-INTGHLTTMCDVFSFGVVLLELLTGR 285
             I T  + T  Y APE  + +   T   D++S G +L E+L G+
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 18/216 (8%)
Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA---EV 133
           ++  +   + LG GG  +V+   +  +LR     + VAVKVL  + ++    +L    E 
Sbjct: 10  LSDRYELGEILGFGGMSEVH---LARDLR---DHRDVAVKVLRADLARDPSFYLRFRREA 63
Query: 134 IFLGQLKHPHLVNL--IGYCCEDEHRL--LVYEYMALGNLHDQLFKNYSSTLPWLTRIKI 189
                L HP +V +   G        L  +V EY+    L D +     +  P   +  I
Sbjct: 64  QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAI 119
Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD-GPQGEDSHITTCV 248
            + A  C A     +  +I+RD K +NIL+ +    K+ DFG+A      G     T  V
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAV 179
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           +GT  Y +PE      +    DV+S G VL E+LTG
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 26/204 (12%)
Query: 87  LGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHP 142
           LG G FG V    ++G  D           VA+K++   GS    E++ E   +  L H 
Sbjct: 17  LGTGQFGVVKYGKWRGQYD-----------VAIKMIK-EGSMSEDEFIEEAKVMMNLSHE 64
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
            LV L G C +     ++ EYMA G L + L +       + T+  + +    C A  + 
Sbjct: 65  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYL 121
Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEY 259
           E K  ++RD  A N L++     K+SDFGL+      E     T  +G++    ++ PE 
Sbjct: 122 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPPEV 177
Query: 260 INTGHLTTMCDVFSFGVVLLELLT 283
           +     ++  D+++FGV++ E+ +
Sbjct: 178 LMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 80/327 (24%), Positives = 133/327 (40%), Gaps = 79/327 (24%)
Query: 72  KELQMITHNFSRSDYLGEGGFGKVYKGC-VDDNLRPGLKAQTVAVKVLDVNGSQGHREWL 130
           K+ +     +     LG+GGFG V+ G  + D L+       VA+KV+  N   G   W 
Sbjct: 24  KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQ-------VAIKVIPRNRVLG---WS 73
Query: 131 A---------EVIFLGQLK----HPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNY 177
                     EV  L ++     HP ++ L+ +    E  +LV E          LF   
Sbjct: 74  PLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQ---DLFDYI 130
Query: 178 SSTLPWLTRIKIAIGAARCL------AFLHGEEKPVIYRDFKASNILLDSDYN-AKLSDF 230
           +   P      +  G +RC       A  H   + V++RD K  NIL+D     AKL DF
Sbjct: 131 TEKGP------LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184
Query: 231 G---LATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTM-CDVFSFGVVLLELLTGRR 286
           G   L  D P        T   GT  Y+ PE+I+      +   V+S G++L +++ G  
Sbjct: 185 GSGALLHDEP-------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDI 237
Query: 287 SVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPK 346
             E+++                      +I+++ L   +    +    A+  +CL+  P 
Sbjct: 238 PFERDQ----------------------EILEAELH--FPAHVSPDCCALIRRCLAPKPS 273
Query: 347 SRPTMTTVVKALEPLLD--LNDIPIGP 371
           SRP++  ++  L+P +     D+P+ P
Sbjct: 274 SRPSLEEIL--LDPWMQTPAEDVPLNP 298

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 103/236 (43%), Gaps = 22/236 (9%)
Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD-VNGSQGHREWLAEVIF 135
           I+ +F     LGEG +G V   C   +   G   + VA+K ++  +        L E+  
Sbjct: 9   ISSDFQLKSLLGEGAYGVV---CSATHKPTG---EIVAIKKIEPFDKPLFALRTLREIKI 62
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI-GAA 194
           L   KH +++ +      D        Y+    +   L +  S+ +     I+  I    
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA---------TDGPQGEDSHIT 245
           R +  LHG    VI+RD K SN+L++S+ + K+ DFGLA            P G+ S +T
Sbjct: 123 RAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMT 180
Query: 246 TCVMGTEGYAAPE-YINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV 300
             V  T  Y APE  + +   +   DV+S G +L EL   RR +   R  R + L+
Sbjct: 181 EXV-ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQLLL 234

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 26/204 (12%)
Query: 87  LGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHP 142
           LG G FG V    ++G  D           VA+K++   GS    E++ E   +  L H 
Sbjct: 23  LGTGQFGVVKYGKWRGQYD-----------VAIKMIK-EGSMSEDEFIEEAKVMMNLSHE 70
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
            LV L G C +     ++ EYMA G L + L +       + T+  + +    C A  + 
Sbjct: 71  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYL 127
Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEY 259
           E K  ++RD  A N L++     K+SDFGL+      E     T  +G++    ++ PE 
Sbjct: 128 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPPEV 183
Query: 260 INTGHLTTMCDVFSFGVVLLELLT 283
           +     ++  D+++FGV++ E+ +
Sbjct: 184 LMYSKFSSKSDIWAFGVLMWEIYS 207

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 31/218 (14%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGH-REWLAEVIFLGQL 139
           F + + LG G +  VYKG    N   G+    VA+K + ++  +G     + E+  + +L
Sbjct: 7   FKQLEKLGNGTYATVYKGL---NKTTGV---YVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYM-----------ALGNLHDQLFKNYSSTLPWLTRIK 188
           KH ++V L      +    LV+E+M            +GN    L  N      W     
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW----- 115
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
                 + LAF H  E  +++RD K  N+L++     KL DFGLA     G   +  +  
Sbjct: 116 ---QLLQGLAFCH--ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF--GIPVNTFSSE 168
Query: 249 MGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
           + T  Y AP+ +  +   +T  D++S G +L E++TG+
Sbjct: 169 VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 103/236 (43%), Gaps = 22/236 (9%)
Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD-VNGSQGHREWLAEVIF 135
           I+ +F     LGEG +G V   C   +   G   + VA+K ++  +        L E+  
Sbjct: 9   ISSDFQLKSLLGEGAYGVV---CSATHKPTG---EIVAIKKIEPFDKPLFALRTLREIKI 62
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI-GAA 194
           L   KH +++ +      D        Y+    +   L +  S+ +     I+  I    
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA---------TDGPQGEDSHIT 245
           R +  LHG    VI+RD K SN+L++S+ + K+ DFGLA            P G+ S +T
Sbjct: 123 RAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMT 180
Query: 246 TCVMGTEGYAAPE-YINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV 300
             V  T  Y APE  + +   +   DV+S G +L EL   RR +   R  R + L+
Sbjct: 181 EYV-ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQLLL 234

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 23/205 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGHREWLAEVIFLGQLKHPHLV 145
           LGEG F  + + CV          Q  AVK++     +   +E  A  +  G   HP++V
Sbjct: 19  LGEGSFS-ICRKCVHKK-----SNQAFAVKIISKRMEANTQKEITALKLCEG---HPNIV 69
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFK--NYSSTLPWLTRIKIAIGAARCLAFLHGE 203
            L     +  H  LV E +  G L +++ K  ++S T       K+    +      H  
Sbjct: 70  KLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVS------HMH 123
Query: 204 EKPVIYRDFKASNILL---DSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI 260
           +  V++RD K  N+L    + +   K+ DFG A   P       T C   T  YAAPE +
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF--TLHYAAPELL 181
Query: 261 NTGHLTTMCDVFSFGVVLLELLTGR 285
           N       CD++S GV+L  +L+G+
Sbjct: 182 NQNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 26/204 (12%)
Query: 87  LGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHP 142
           LG G FG V    ++G  D           VA+K++   GS    E++ E   +  L H 
Sbjct: 17  LGTGQFGVVKYGKWRGQYD-----------VAIKMIK-EGSMSEDEFIEEAKVMMNLSHE 64
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
            LV L G C +     ++ EYMA G L + L +       + T+  + +    C A  + 
Sbjct: 65  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYL 121
Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEY 259
           E K  ++RD  A N L++     K+SDFGL+      E     T   G++    ++ PE 
Sbjct: 122 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE----YTSSRGSKFPVRWSPPEV 177
Query: 260 INTGHLTTMCDVFSFGVVLLELLT 283
           +     ++  D+++FGV++ E+ +
Sbjct: 178 LMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 114/262 (43%), Gaps = 41/262 (15%)
Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVI 134
           ++  + R   LG G +G+V   C     R  +     A+K++      +  + + L EV 
Sbjct: 35  LSEMYQRVKKLGSGAYGEVLL-C-----RDKVTHVERAIKIIRKTSVSTSSNSKLLEEVA 88
Query: 135 FLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA 194
            L  L HP+++ L  +  +  +  LV E    G L D++             +  A+   
Sbjct: 89  VLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK-----FNEVDAAVIIK 143
Query: 195 RCLA---FLHGEEKPVIYRDFKASNILLDS---DYNAKLSDFGLATDGPQGEDSHITTCV 248
           + L+   +LH  +  +++RD K  N+LL+S   D   K+ DFGL+      E+       
Sbjct: 144 QVLSGVTYLH--KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA---VFENQKKMKER 198
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR------------RSVEKNRCKRE 296
           +GT  Y APE +   +    CDV+S GV+L  LL G             R VEK +   +
Sbjct: 199 LGTAYYIAPEVLRKKY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD 257
Query: 297 ----KDLVEWARPMLKDFTKLD 314
               K++ E A+ ++K   + D
Sbjct: 258 SPEWKNVSEGAKDLIKQMLQFD 279

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 18/216 (8%)
Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA---EV 133
           ++  +   + LG GG  +V+   +  +LR     + VAVKVL  + ++    +L    E 
Sbjct: 10  LSDRYELGEILGFGGMSEVH---LARDLR---DHRDVAVKVLRADLARDPSFYLRFRREA 63
Query: 134 IFLGQLKHPHLVNL--IGYCCEDEHRL--LVYEYMALGNLHDQLFKNYSSTLPWLTRIKI 189
                L HP +V +   G        L  +V EY+    L D +     +  P   +  I
Sbjct: 64  QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAI 119
Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD-GPQGEDSHITTCV 248
            + A  C A     +  +I+RD K +NI++ +    K+ DFG+A      G     T  V
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           +GT  Y +PE      +    DV+S G VL E+LTG
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 18/216 (8%)
Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA---EV 133
           ++  +   + LG GG  +V+   +  +LR     + VAVKVL  + ++    +L    E 
Sbjct: 10  LSDRYELGEILGFGGMSEVH---LARDLR---DHRDVAVKVLRADLARDPSFYLRFRREA 63
Query: 134 IFLGQLKHPHLVNL--IGYCCEDEHRL--LVYEYMALGNLHDQLFKNYSSTLPWLTRIKI 189
                L HP +V +   G        L  +V EY+    L D +     +  P   +  I
Sbjct: 64  QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAI 119
Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD-GPQGEDSHITTCV 248
            + A  C A     +  +I+RD K +NI++ +    K+ DFG+A      G     T  V
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           +GT  Y +PE      +    DV+S G VL E+LTG
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 16/220 (7%)
Query: 69  FTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE 128
           F +      + N+   + LG+G F  V + CV         A+ +  K L     Q    
Sbjct: 19  FMMNASTKFSDNYDVKEELGKGAFS-VVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77
Query: 129 WLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNL-HDQLFKNYSSTLPWLTRI 187
              E     +L+HP++V L     E+    LV++ +  G L  D + + + S       I
Sbjct: 78  ---EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI 134
Query: 188 KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNA---KLSDFGLATDGPQGEDSHI 244
           +  +     +A+ H     +++R+ K  N+LL S       KL+DFGLA +    E  H 
Sbjct: 135 QQIL---ESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH- 188
Query: 245 TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
                GT GY +PE +     +   D+++ GV+L  LL G
Sbjct: 189 --GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 22/218 (10%)
Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA---EV 133
           ++  +   + LG GG  +V+   +  +LR     + VAVKVL  + ++    +L    E 
Sbjct: 10  LSDRYELGEILGFGGMSEVH---LARDLR---LHRDVAVKVLRADLARDPSFYLRFRREA 63
Query: 134 IFLGQLKHPHLVNLIGYCCEDEHR------LLVYEYMALGNLHDQLFKNYSSTLPWLTRI 187
                L HP +V +  Y   +          +V EY+    L D +     +  P   + 
Sbjct: 64  QNAAALNHPAIVAV--YATGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKR 117
Query: 188 KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD-GPQGEDSHITT 246
            I + A  C A     +  +I+RD K +NI++ +    K+ DFG+A      G     T 
Sbjct: 118 AIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 247 CVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            V+GT  Y +PE      +    DV+S G VL E+LTG
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 113/283 (39%), Gaps = 40/283 (14%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVK-VLDVNGSQGHREWLAEV-IFLGQLKHPHL 144
           +G G +G V K       +P    Q +AVK +      +  ++ L ++ + +     P++
Sbjct: 30  IGRGAYGSVNKMV----HKPS--GQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTL----PWLTRIKIAIGAARCLAFL 200
           V   G    +    +  E M+     D+ +K   S L    P     KI +   + L  L
Sbjct: 84  VQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 201 HGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI 260
             E   +I+RD K SNILLD   N KL DFG++    Q  DS   T   G   Y APE I
Sbjct: 142 K-ENLKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERI 197
Query: 261 NTGH----LTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI 316
           +            DV+S G+ L EL TGR    K           W       F +L Q+
Sbjct: 198 DPSASRQGYDVRSDVWSLGITLYELATGRFPYPK-----------WNSV----FDQLTQV 242
Query: 317 IDS---RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
           +     +L +    E +       + CL+ +   RP    ++K
Sbjct: 243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQL 139
           + + D LGEG +  VYKG      +  L    VA+K + +   +G     + EV  L  L
Sbjct: 4   YIKLDKLGEGTYATVYKG------KSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL 57
Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNY---SSTLPWLTRIKIAI-GAAR 195
           KH ++V L      ++   LV+EY+      D+  K Y      +  +  +K+ +    R
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYL------DKDLKQYLDDCGNIINMHNVKLFLFQLLR 111
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            LA+ H ++  V++RD K  N+L++     KL+DFGLA        ++    V  T  Y 
Sbjct: 112 GLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYR 167
Query: 256 APE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            P+  + +   +T  D++  G +  E+ TGR
Sbjct: 168 PPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 106/233 (45%), Gaps = 18/233 (7%)
Query: 62  VGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVY-----KGCVDDNLRPGLKAQTVAVK 116
           +  N  ++  K+   I  ++ +   LG G +G+V       G  +  ++   K+Q    +
Sbjct: 19  IAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGR 78
Query: 117 VLDVNGS--QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLF 174
             D N +  + H E   E+  L  L HP+++ L     + ++  LV E+   G L +Q+ 
Sbjct: 79  YSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII 138
Query: 175 KNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD---YNAKLSDFG 231
             +         I   I +  C  +LH  +  +++RD K  NILL++     N K+ DFG
Sbjct: 139 NRHKFDECDAANIMKQILSGIC--YLH--KHNIVHRDIKPENILLENKNSLLNIKIVDFG 194
Query: 232 LATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           L++   +    +     +GT  Y APE +   +    CDV+S GV++  LL G
Sbjct: 195 LSSFFSK---DYKLRDRLGTAYYIAPEVLKKKY-NEKCDVWSCGVIMYILLCG 243

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWL-AEVIFLGQLKHPHL 144
           +G G +G+  K      +R     + +  K LD    ++  ++ L +EV  L +LKHP++
Sbjct: 14  IGTGSYGRCQK------IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 145 VNLIGYCCEDEHRLL--VYEYMALGNL--------HDQLFKNYSSTLPWLTRIKIAIGAA 194
           V       +  +  L  V EY   G+L         ++ + +    L  +T++ +A+   
Sbjct: 68  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL--K 125
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
            C     G    V++RD K +N+ LD   N KL DFGLA       D+      +GT  Y
Sbjct: 126 ECHRRSDGGH-TVLHRDLKPANVFLDGKQNVKLGDFGLAR--ILNHDTSFAKAFVGTPYY 182
Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLEL 281
            +PE +N        D++S G +L EL
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 18/216 (8%)
Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA---EV 133
           ++  +   + LG GG  +V+   +  +LR     + VAVKVL  + ++    +L    E 
Sbjct: 10  LSDRYELGEILGFGGMSEVH---LARDLR---LHRDVAVKVLRADLARDPSFYLRFRREA 63
Query: 134 IFLGQLKHPHLVNL--IGYCCEDEHRL--LVYEYMALGNLHDQLFKNYSSTLPWLTRIKI 189
                L HP +V +   G        L  +V EY+    L D +     +  P   +  I
Sbjct: 64  QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAI 119
Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD-GPQGEDSHITTCV 248
            + A  C A     +  +I+RD K +NI++ +    K+ DFG+A      G     T  V
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           +GT  Y +PE      +    DV+S G VL E+LTG
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWL-AEVIFLGQLKHPHL 144
           +G G +G+  K      +R     + +  K LD    ++  ++ L +EV  L +LKHP++
Sbjct: 14  IGTGSYGRCQK------IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 145 VNLIGYCCEDEHRLL--VYEYMALGNL--------HDQLFKNYSSTLPWLTRIKIAIGAA 194
           V       +  +  L  V EY   G+L         ++ + +    L  +T++ +A+   
Sbjct: 68  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL--K 125
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
            C     G    V++RD K +N+ LD   N KL DFGLA       D+      +GT  Y
Sbjct: 126 ECHRRSDGGH-TVLHRDLKPANVFLDGKQNVKLGDFGLAR--ILNHDTSFAKTFVGTPYY 182
Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLEL 281
            +PE +N        D++S G +L EL
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 103/233 (44%), Gaps = 47/233 (20%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAE--VIFLG 137
           N    + +G G +G VYKG +D+  RP      VAVKV      Q    ++ E  +  + 
Sbjct: 14  NLKLLELIGRGRYGAVYKGSLDE--RP------VAVKVFSFANRQN---FINEKNIYRVP 62
Query: 138 QLKHPHLVNLIGYCCEDE--------HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKI 189
            ++H    N+  +   DE          LLV EY   G+L   L  + S    W++  ++
Sbjct: 63  LMEHD---NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD---WVSSCRL 116
Query: 190 AIGAARCLAFLHGE------EKPVI-YRDFKASNILLDSDYNAKLSDFGLAT--DGPQ-- 238
           A    R LA+LH E       KP I +RD  + N+L+ +D    +SDFGL+    G +  
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 239 --GEDSHITTCVMGTEGYAAPEYI-------NTGHLTTMCDVFSFGVVLLELL 282
             GE+ +     +GT  Y APE +       +        D+++ G++  E+ 
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVK-VLDVNGSQGHREW-LAEVIFLGQLKHPHL 144
           +GEG +G V K    D  R       VA+K  L+ +  +  ++  + E+  L QL+H +L
Sbjct: 33  VGEGSYGMVMKCRNKDTGR------IVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENL 86
Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHD-QLFKN---YSSTLPWLTRIKIAIGAARCLAFL 200
           VNL+  C + +   LV+E++    L D +LF N   Y     +L +I   IG      F 
Sbjct: 87  VNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIG------FC 140
Query: 201 HGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYAAPE- 258
           H     +I+RD K  NIL+      KL DFG A T    GE   +    + T  Y APE 
Sbjct: 141 HSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYDDEVATRWYRAPEL 195
Query: 259 YINTGHLTTMCDVFSFGVVLLELLTG 284
            +         DV++ G ++ E+  G
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMG 221

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           +++ +  +G G FG VY+  + D+       + VA+K +     Q  R    E+  + +L
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKL 70
Query: 140 KHPHLVNL-IGYCCEDEHRLLVYEYMALGNLHDQLFK---NYS---STLPWLTRIKIAIG 192
            H ++V L   +    E + +VY  + L  + + +++   +YS    TLP +        
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNA-KLSDFGLATDGPQGEDSHITTCVMGT 251
             R LA++H     + +RD K  N+LLD D    KL DFG A    +GE +    C   +
Sbjct: 131 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---S 185
Query: 252 EGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE I      T+  DV+S G VL ELL G+
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 102/236 (43%), Gaps = 22/236 (9%)
Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD-VNGSQGHREWLAEVIF 135
           I+ +F     LGEG +G V   C   +   G   + VA+K ++  +        L E+  
Sbjct: 9   ISSDFQLKSLLGEGAYGVV---CSATHKPTG---EIVAIKKIEPFDKPLFALRTLREIKI 62
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI-GAA 194
           L   KH +++ +      D        Y+    +   L +  S+ +     I+  I    
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA---------TDGPQGEDSHIT 245
           R +  LHG    VI+RD K SN+L++S+ + K+ DFGLA            P G+ S + 
Sbjct: 123 RAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 246 TCVMGTEGYAAPE-YINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV 300
             V  T  Y APE  + +   +   DV+S G +L EL   RR +   R  R + L+
Sbjct: 181 EFV-ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQLLL 234

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 16/212 (7%)
Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFL 136
            + N+   + LG+G F  V + CV         A+ +  K L     Q       E    
Sbjct: 4   FSDNYDVKEELGKGAFS-VVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARIC 59
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNL-HDQLFKNYSSTLPWLTRIKIAIGAAR 195
            +L+HP++V L     E+    LV++ +  G L  D + + + S       I+  + +  
Sbjct: 60  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES-- 117
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNA---KLSDFGLATDGPQGEDSHITTCVMGTE 252
            +A+ H     +++R+ K  N+LL S       KL+DFGLA +    E  H      GT 
Sbjct: 118 -IAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTP 171
Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           GY +PE +     +   D+++ GV+L  LL G
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 16/212 (7%)
Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFL 136
            + N+   + LG+G F  V + CV         A+ +  K L     Q       E    
Sbjct: 3   FSDNYDVKEELGKGAFS-VVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARIC 58
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNL-HDQLFKNYSSTLPWLTRIKIAIGAAR 195
            +L+HP++V L     E+    LV++ +  G L  D + + + S       I+  + +  
Sbjct: 59  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES-- 116
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNA---KLSDFGLATDGPQGEDSHITTCVMGTE 252
            +A+ H     +++R+ K  N+LL S       KL+DFGLA +    E  H      GT 
Sbjct: 117 -IAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTP 170
Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           GY +PE +     +   D+++ GV+L  LL G
Sbjct: 171 GYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 102/241 (42%), Gaps = 28/241 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG V++ CV+         +    K ++            E+  + QL HP L+N
Sbjct: 59  LGSGAFGVVHR-CVE-----KATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQL-FKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
           L     +    +L+ E+++ G L D++  ++Y  +   +    I      C    H  E 
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV----INYMRQACEGLKHMHEH 168
Query: 206 PVIYRDFKASNILLDSDY--NAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN-- 261
            +++ D K  NI+ ++    + K+ DFGLAT     E   +TT    T  +AAPE ++  
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA---TAEFAAPEIVDRE 225
Query: 262 -TGHLTTMCDVFSFGVVLLELLT---GRRSVEK----NRCKRE--KDLVEWARPMLKDFT 311
             G  T M  +   G VLL  L+   G   +E      RC  E  +D      P  KDF 
Sbjct: 226 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 285
Query: 312 K 312
           K
Sbjct: 286 K 286

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 16/208 (7%)
Query: 85  DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDV---NGSQG--HREWLAEVIFLGQL 139
           + +G+G F  V + C++         Q  AVK++DV     S G    +   E      L
Sbjct: 32  EVIGKGPFS-VVRRCINRE-----TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 85
Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAF 199
           KHPH+V L+     D    +V+E+M   +L  ++ K   +   +   +          A 
Sbjct: 86  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 145
Query: 200 LHGEEKPVIYRDFKASNILLDSDYNA---KLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
            +  +  +I+RD K   +LL S  N+   KL  FG+A     GE   +    +GT  + A
Sbjct: 146 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGTPHFMA 203
Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTG 284
           PE +         DV+  GV+L  LL+G
Sbjct: 204 PEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 96/232 (41%), Gaps = 42/232 (18%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           +F     LG+G FG+V K       R  L ++  A+K +  +  +     L+EV  L  L
Sbjct: 7   DFEEIAVLGQGAFGQVVKA------RNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASL 59
Query: 140 KHPHLVNLIGYCCEDEHRLLV---------------YEYMALGNLHDQLF-KNYSSTLPW 183
            H ++V    Y    E R  V                EY     L+D +  +N +     
Sbjct: 60  NHQYVVRY--YAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDE 117
Query: 184 LTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGED-- 241
             R+   I  A  L+++H +   +I+R+ K  NI +D   N K+ DFGLA +  +  D  
Sbjct: 118 YWRLFRQILEA--LSYIHSQ--GIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 242 ----------SHITTCVMGTEGYAAPEYIN-TGHLTTMCDVFSFGVVLLELL 282
                     S   T  +GT  Y A E ++ TGH     D +S G++  E +
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 114/260 (43%), Gaps = 23/260 (8%)
Query: 109 KAQTVAVKVLDVNGSQ-GHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALG 167
           K + VA+K +++   Q    E L E+  + Q  HP++V+        +   LV + ++ G
Sbjct: 34  KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGG 93
Query: 168 NLHDQLF------KNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS 221
           ++ D +       ++ S  L   T   I       L +LH   +  I+RD KA NILL  
Sbjct: 94  SVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ--IHRDVKAGNILLGE 151
Query: 222 DYNAKLSDFGLATDGPQGED---SHITTCVMGTEGYAAPEYINTGH-LTTMCDVFSFGVV 277
           D + +++DFG++     G D   + +    +GT  + APE +          D++SFG+ 
Sbjct: 152 DGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGIT 211
Query: 278 LLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ-IIDSRLEDRYSTEGAKRLAAV 336
            +EL TG     K    +   L      +  D   L+  + D  +  +Y     K ++  
Sbjct: 212 AIELATGAAPYHKYPPMKVLMLT-----LQNDPPSLETGVQDKEMLKKYGKSFRKMISL- 265
Query: 337 AHQCLSHNPKSRPTMTTVVK 356
              CL  +P+ RPT   +++
Sbjct: 266 ---CLQKDPEKRPTAAELLR 282

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 91/220 (41%), Gaps = 32/220 (14%)
Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFL 136
            + N+   + LG+G F  V + CV         A+ +  K L     Q       E    
Sbjct: 4   FSDNYDVKEELGKGAFS-VVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARIC 59
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKN--YSSTLPWLTRIKIAIGAA 194
            +L+HP++V L     E+    LV++ +  G L + +     YS              A+
Sbjct: 60  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA-----------DAS 108
Query: 195 RCL-------AFLHGEEKPVIYRDFKASNILLDSDYNA---KLSDFGLATDGPQGEDSHI 244
            C+       A+ H     +++R+ K  N+LL S       KL+DFGLA +    E  H 
Sbjct: 109 HCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH- 165
Query: 245 TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
                GT GY +PE +     +   D+++ GV+L  LL G
Sbjct: 166 --GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 18/216 (8%)
Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA---EV 133
           ++  +   + LG GG  +V+   +  +LR     + VAVKVL  + ++    +L    E 
Sbjct: 27  LSDRYELGEILGFGGMSEVH---LARDLR---LHRDVAVKVLRADLARDPSFYLRFRREA 80
Query: 134 IFLGQLKHPHLVNL--IGYCCEDEHRL--LVYEYMALGNLHDQLFKNYSSTLPWLTRIKI 189
                L HP +V +   G        L  +V EY+    L D +     +  P   +  I
Sbjct: 81  QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAI 136
Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD-GPQGEDSHITTCV 248
            + A  C A     +  +I+RD K +NI++ +    K+ DFG+A      G     T  V
Sbjct: 137 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 196
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           +GT  Y +PE      +    DV+S G VL E+LTG
Sbjct: 197 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 232

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 114/260 (43%), Gaps = 23/260 (8%)
Query: 109 KAQTVAVKVLDVNGSQ-GHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALG 167
           K + VA+K +++   Q    E L E+  + Q  HP++V+        +   LV + ++ G
Sbjct: 39  KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGG 98
Query: 168 NLHDQLF------KNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS 221
           ++ D +       ++ S  L   T   I       L +LH   +  I+RD KA NILL  
Sbjct: 99  SVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ--IHRDVKAGNILLGE 156
Query: 222 DYNAKLSDFGLATDGPQGED---SHITTCVMGTEGYAAPEYINTGH-LTTMCDVFSFGVV 277
           D + +++DFG++     G D   + +    +GT  + APE +          D++SFG+ 
Sbjct: 157 DGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGIT 216
Query: 278 LLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ-IIDSRLEDRYSTEGAKRLAAV 336
            +EL TG     K    +   L      +  D   L+  + D  +  +Y     K ++  
Sbjct: 217 AIELATGAAPYHKYPPMKVLMLT-----LQNDPPSLETGVQDKEMLKKYGKSFRKMISL- 270
Query: 337 AHQCLSHNPKSRPTMTTVVK 356
              CL  +P+ RPT   +++
Sbjct: 271 ---CLQKDPEKRPTAAELLR 287

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 120/269 (44%), Gaps = 31/269 (11%)
Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFL 136
           I   F   + LG G F +V+       ++  L  +  A+K +  + +        E+  L
Sbjct: 7   IRKTFIFMEVLGSGAFSEVFL------VKQRLTGKLFALKCIKKSPAFRDSSLENEIAVL 60
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKN--YSSTLPWLTRIKIAIGAA 194
            ++KH ++V L        H  LV + ++ G L D++ +   Y+     L  I+  + A 
Sbjct: 61  KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV-IQQVLSAV 119
Query: 195 RCLAFLHGEEKPVIYRDFKASNIL-LDSDYNAKL--SDFGLATDGPQGEDSHITTCVMGT 251
           +   +LH  E  +++RD K  N+L L  + N+K+  +DFGL+    + E + I +   GT
Sbjct: 120 K---YLH--ENGIVHRDLKPENLLYLTPEENSKIMITDFGLS----KMEQNGIMSTACGT 170
Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG-----RRSVEKNRCKREKDLVEWARPM 306
            GY APE +     +   D +S GV+   LL G       +  K   K ++   E+  P 
Sbjct: 171 PGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPF 230
Query: 307 LKDFTK-----LDQIIDSRLEDRYSTEGA 330
             D ++     +  +++    +RY+ E A
Sbjct: 231 WDDISESAKDFICHLLEKDPNERYTCEKA 259

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWL-AEVIFLGQLKHPHL 144
           +G G +G+  K      +R     + +  K LD    ++  ++ L +EV  L +LKHP++
Sbjct: 14  IGTGSYGRCQK------IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 145 VNLIGYCCEDEHRLL--VYEYMALGNL--------HDQLFKNYSSTLPWLTRIKIAIGAA 194
           V       +  +  L  V EY   G+L         ++ + +    L  +T++ +A+   
Sbjct: 68  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL--K 125
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
            C     G    V++RD K +N+ LD   N KL DFGLA      ED       +GT  Y
Sbjct: 126 ECHRRSDGGH-TVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED--FAKEFVGTPYY 182
Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLEL 281
            +PE +N        D++S G +L EL
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 16/208 (7%)
Query: 85  DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDV---NGSQG--HREWLAEVIFLGQL 139
           + +G+G F  V + C++         Q  AVK++DV     S G    +   E      L
Sbjct: 30  EVIGKGPFS-VVRRCINRE-----TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAF 199
           KHPH+V L+     D    +V+E+M   +L  ++ K   +   +   +          A 
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 200 LHGEEKPVIYRDFKASNILLDSDYNA---KLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
            +  +  +I+RD K   +LL S  N+   KL  FG+A     GE   +    +GT  + A
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGTPHFMA 201
Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTG 284
           PE +         DV+  GV+L  LL+G
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 25/217 (11%)
Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFL 136
           +T  +   + +G+G F  V + CV         A+ +  K L    ++ H++   E    
Sbjct: 2   MTDEYQLYEDIGKGAFS-VVRRCVKLCTGHEYAAKIINTKKL---SARDHQKLEREARIC 57
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNL-HDQLFKNYSSTLPWLTRIKIAIGAAR 195
             LKH ++V L     E+    LV++ +  G L  D + + Y S             A+ 
Sbjct: 58  RLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSE----------ADASH 107
Query: 196 CL-----AFLHGEEKPVIYRDFKASNILLDSDYNA---KLSDFGLATDGPQGEDSHITTC 247
           C+     A LH  +  V++RD K  N+LL S       KL+DFGLA +  QG D      
Sbjct: 108 CIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIE-VQG-DQQAWFG 165
Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
             GT GY +PE +         D+++ GV+L  LL G
Sbjct: 166 FAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 25/217 (11%)
Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFL 136
           +T  +   + LG+G F  V + C+         A+ +  K L    ++ H++   E    
Sbjct: 2   MTDEYQLFEELGKGAFS-VVRRCMKIPTGQEYAAKIINTKKL---SARDHQKLEREARIC 57
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNL-HDQLFKNYSSTLPWLTRIKIAIGAAR 195
             LKHP++V L     E+    LV++ +  G L  D + + Y S             A+ 
Sbjct: 58  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSE----------ADASH 107
Query: 196 CLAFL-----HGEEKPVIYRDFKASNILLDSDYNA---KLSDFGLATDGPQGEDSHITTC 247
           C+  +     H     +++RD K  N+LL S       KL+DFGLA +  QG D      
Sbjct: 108 CIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIE-VQG-DQQAWFG 165
Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
             GT GY +PE +         D+++ GV+L  LL G
Sbjct: 166 FAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 76  MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDV-NGSQGHR-EWLAEV 133
           M T  +     +G G +G VYK       R       VA+K + V NG +G     + EV
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKA------RDPHSGHFVALKSVRVPNGEEGLPISTVREV 54
Query: 134 IFLGQLK---HPHLVNLIGYCC----EDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLT 185
             L +L+   HP++V L+  C     + E ++ LV+E++   +L   L K     LP  T
Sbjct: 55  ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAET 113
Query: 186 RIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHIT 245
              +     R L FLH     +++RD K  NIL+ S    KL+DFGLA            
Sbjct: 114 IKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMAL 168
Query: 246 TCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELL 282
             V+ T  Y APE +      T  D++S G +  E+ 
Sbjct: 169 APVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           +++ +  +G G FG VY+  + D+       + VA+K +     Q  R    E+  + +L
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKL 82
Query: 140 KHPHLVNL-IGYCCEDEHRLLVYEYMALGNLHDQLFK---NYS---STLPWLTRIKIAIG 192
            H ++V L   +    E +  VY  + L  + + +++   +YS    TLP +        
Sbjct: 83  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 142
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNA-KLSDFGLATDGPQGEDSHITTCVMGT 251
             R LA++H     + +RD K  N+LLD D    KL DFG A    +GE +    C   +
Sbjct: 143 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---S 197
Query: 252 EGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE I      T+  DV+S G VL ELL G+
Sbjct: 198 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           +++ +  +G G FG VY+  + D+       + VA+K +     Q  R    E+  + +L
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKL 78
Query: 140 KHPHLVNL-IGYCCEDEHRLLVYEYMALGNLHDQLFK---NYS---STLPWLTRIKIAIG 192
            H ++V L   +    E +  VY  + L  + + +++   +YS    TLP +        
Sbjct: 79  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 138
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNA-KLSDFGLATDGPQGEDSHITTCVMGT 251
             R LA++H     + +RD K  N+LLD D    KL DFG A    +GE +    C   +
Sbjct: 139 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---S 193
Query: 252 EGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE I      T+  DV+S G VL ELL G+
Sbjct: 194 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 15/176 (8%)
Query: 114 AVKVLDVNGSQGHREWLAEV-IFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQ 172
           AVKV+D    +  R+   E+ I L   +HP+++ L     + +H  LV E M  G L D+
Sbjct: 56  AVKVID----KSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDK 111
Query: 173 LFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNIL-LDSDYNA---KLS 228
           + +    +    + +   IG  + + +LH +   V++RD K SNIL +D   N    ++ 
Sbjct: 112 ILRQKFFSEREASFVLHTIG--KTVEYLHSQG--VVHRDLKPSNILYVDESGNPECLRIC 167
Query: 229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           DFG A          +T C   T  + APE +        CD++S G++L  +L G
Sbjct: 168 DFGFAKQLRAENGLLMTPCY--TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           +++ +  +G G FG VY+  + D+       + VA+K +     Q  R    E+  + +L
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKL 89
Query: 140 KHPHLVNL-IGYCCEDEHRLLVYEYMALGNLHDQLFK---NYS---STLPWLTRIKIAIG 192
            H ++V L   +    E +  VY  + L  + + +++   +YS    TLP +        
Sbjct: 90  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 149
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNA-KLSDFGLATDGPQGEDSHITTCVMGT 251
             R LA++H     + +RD K  N+LLD D    KL DFG A    +GE +    C   +
Sbjct: 150 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---S 204
Query: 252 EGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE I      T+  DV+S G VL ELL G+
Sbjct: 205 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           +++ +  +G G FG VY+  + D+       + VA+K +     Q  R    E+  + +L
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKL 70
Query: 140 KHPHLVNL-IGYCCEDEHRLLVYEYMALGNLHDQLFK---NYS---STLPWLTRIKIAIG 192
            H ++V L   +    E +  VY  + L  + + +++   +YS    TLP +        
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNA-KLSDFGLATDGPQGEDSHITTCVMGT 251
             R LA++H     + +RD K  N+LLD D    KL DFG A    +GE +    C   +
Sbjct: 131 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---S 185
Query: 252 EGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE I      T+  DV+S G VL ELL G+
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           +++ +  +G G FG VY+  + D+       + VA+K +     Q  R    E+  + +L
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKL 70
Query: 140 KHPHLVNL-IGYCCEDEHRLLVYEYMALGNLHDQLFK---NYS---STLPWLTRIKIAIG 192
            H ++V L   +    E +  VY  + L  + + +++   +YS    TLP +        
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNA-KLSDFGLATDGPQGEDSHITTCVMGT 251
             R LA++H     + +RD K  N+LLD D    KL DFG A    +GE +    C   +
Sbjct: 131 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---S 185
Query: 252 EGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE I      T+  DV+S G VL ELL G+
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           +++ +  +G G FG VY+  + D+       + VA+K +     Q  R    E+  + +L
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKL 82
Query: 140 KHPHLVNL-IGYCCEDEHRLLVYEYMALGNLHDQLFK---NYS---STLPWLTRIKIAIG 192
            H ++V L   +    E +  VY  + L  + + +++   +YS    TLP +        
Sbjct: 83  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 142
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNA-KLSDFGLATDGPQGEDSHITTCVMGT 251
             R LA++H     + +RD K  N+LLD D    KL DFG A    +GE +    C   +
Sbjct: 143 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---S 197
Query: 252 EGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE I      T+  DV+S G VL ELL G+
Sbjct: 198 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           +++ +  +G G FG VY+  + D+       + VA+K +     Q  R    E+  + +L
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKL 71
Query: 140 KHPHLVNL-IGYCCEDEHRLLVYEYMALGNLHDQLFK---NYS---STLPWLTRIKIAIG 192
            H ++V L   +    E +  VY  + L  + + +++   +YS    TLP +        
Sbjct: 72  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 131
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNA-KLSDFGLATDGPQGEDSHITTCVMGT 251
             R LA++H     + +RD K  N+LLD D    KL DFG A    +GE +    C   +
Sbjct: 132 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---S 186
Query: 252 EGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE I      T+  DV+S G VL ELL G+
Sbjct: 187 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 32/211 (15%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD------VNGSQGHREWLAEVIFLGQLK 140
           +G G +G V   C   + + GL+   VAVK L       ++  + +RE    +  L  +K
Sbjct: 30  VGSGAYGSV---CAAFDTKTGLR---VAVKKLSRPFQSIIHAKRTYRE----LRLLKHMK 79
Query: 141 HPHLVNLI-----GYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
           H +++ L+         E+ + + +  ++   +L++ + K    T   +  +   I   R
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN-IVKXQKLTDDHVQFLIYQI--LR 136
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y 
Sbjct: 137 GLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLA----RHTDDEMTGYV-ATRWYR 189
Query: 256 APE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           APE  +N  H     D++S G ++ ELLTGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           +++ +  +G G FG VY+  + D+       + VA+K +     Q  R    E+  + +L
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKL 104
Query: 140 KHPHLVNL-IGYCCEDEHRLLVYEYMALGNLHDQLFK---NYS---STLPWLTRIKIAIG 192
            H ++V L   +    E +  VY  + L  + + +++   +YS    TLP +        
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 164
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNA-KLSDFGLATDGPQGEDSHITTCVMGT 251
             R LA++H     + +RD K  N+LLD D    KL DFG A    +GE +    C   +
Sbjct: 165 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---S 219
Query: 252 EGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE I      T+  DV+S G VL ELL G+
Sbjct: 220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 17/211 (8%)
Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLA-EVIF 135
            +F     LGEG F  V         R    ++  A+K+L+      +    ++  E   
Sbjct: 37  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 90
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLV-YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA 194
           + +L HP  V L  +C +D+ +L     Y   G L   + +   S     TR   A    
Sbjct: 91  MSRLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIV 147
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEG 253
             L +LHG  K +I+RD K  NILL+ D + +++DFG A    P+ + +     V GT  
Sbjct: 148 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQ 204
Query: 254 YAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           Y +PE +         D+++ G ++ +L+ G
Sbjct: 205 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           +++ +  +G G FG VY+  + D+       + VA+K +     Q  R    E+  + +L
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKL 74
Query: 140 KHPHLVNL-IGYCCEDEHRLLVYEYMALGNLHDQLFK---NYS---STLPWLTRIKIAIG 192
            H ++V L   +    E +  VY  + L  + + +++   +YS    TLP +        
Sbjct: 75  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 134
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNA-KLSDFGLATDGPQGEDSHITTCVMGT 251
             R LA++H     + +RD K  N+LLD D    KL DFG A    +GE +    C   +
Sbjct: 135 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---S 189
Query: 252 EGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE I      T+  DV+S G VL ELL G+
Sbjct: 190 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 25/217 (11%)
Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFL 136
           +T  +   + LG+G F  V + C+         A+ +  K L    ++ H++   E    
Sbjct: 2   MTDEYQLFEELGKGAFS-VVRRCMKIPTGQEYAAKIINTKKL---SARDHQKLEREARIC 57
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNL-HDQLFKNYSSTLPWLTRIKIAIGAAR 195
             LKHP++V L     E+    LV++ +  G L  D + + Y S             A+ 
Sbjct: 58  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSE----------ADASH 107
Query: 196 CLAFL-----HGEEKPVIYRDFKASNILLDSDYNA---KLSDFGLATDGPQGEDSHITTC 247
           C+  +     H     +++RD K  N+LL S       KL+DFGLA +  QG D      
Sbjct: 108 CIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIE-VQG-DQQAWFG 165
Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
             GT GY +PE +         D+++ GV+L  LL G
Sbjct: 166 FAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 91/220 (41%), Gaps = 26/220 (11%)
Query: 75  QMITHNFSRSDY-----LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREW 129
           +M    F+  D+     LG+G FG VY      N         +A+KVL    SQ  +E 
Sbjct: 5   EMPKRKFTIDDFDIVRPLGKGKFGNVYLAREKQN------KFIMALKVL--FKSQLEKEG 56
Query: 130 LA-----EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWL 184
           +      E+     L+HP+++ +  Y  + +   L+ E+   G L+ +L K+        
Sbjct: 57  VEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQ 114
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI 244
                    A  L + H  E+ VI+RD K  N+L+      K++DFG +   P    S  
Sbjct: 115 RSATFMEELADALHYCH--ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP----SLR 168
Query: 245 TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
              + GT  Y  PE I         D++  GV+  E L G
Sbjct: 169 RRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 91/220 (41%), Gaps = 26/220 (11%)
Query: 75  QMITHNFSRSDY-----LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREW 129
           +M    F+  D+     LG+G FG VY      N         +A+KVL    SQ  +E 
Sbjct: 6   EMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQN------KFIMALKVL--FKSQLEKEG 57
Query: 130 LA-----EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWL 184
           +      E+     L+HP+++ +  Y  + +   L+ E+   G L+ +L K+        
Sbjct: 58  VEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQ 115
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI 244
                    A  L + H  E+ VI+RD K  N+L+      K++DFG +   P    S  
Sbjct: 116 RSATFMEELADALHYCH--ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP----SLR 169
Query: 245 TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
              + GT  Y  PE I         D++  GV+  E L G
Sbjct: 170 RRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 76  MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDV-NGSQGHR-EWLAEV 133
           M T  +     +G G +G VYK       R       VA+K + V NG +G     + EV
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKA------RDPHSGHFVALKSVRVPNGEEGLPISTVREV 54
Query: 134 IFLGQLK---HPHLVNLIGYCC----EDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLT 185
             L +L+   HP++V L+  C     + E ++ LV+E++   +L   L K     LP  T
Sbjct: 55  ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAET 113
Query: 186 RIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHIT 245
              +     R L FLH     +++RD K  NIL+ S    KL+DFGLA            
Sbjct: 114 IKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMAL 168
Query: 246 TCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELL 282
             V+ T  Y APE +      T  D++S G +  E+ 
Sbjct: 169 DPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 32/211 (15%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD------VNGSQGHREWLAEVIFLGQLK 140
           +G G +G V   C   +++ GLK   +AVK L       ++  + +RE    +  L  +K
Sbjct: 59  VGSGAYGSV---CSSYDVKSGLK---IAVKKLSRPFQSIIHAKRTYRE----LRLLKHMK 108
Query: 141 HPHLVNLI-----GYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
           H +++ L+         E+ + + +  ++   +L++ + K    T   +  +   I   R
Sbjct: 109 HENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNN-IVKCQKLTDDHVQFLIYQI--LR 165
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y 
Sbjct: 166 GLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWYR 218
Query: 256 APE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           APE  +N  H     D++S G ++ ELLTGR
Sbjct: 219 APEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           +++ +  +G G FG VY+  + D+       + VA+K +     Q  R    E+  + +L
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKL 83
Query: 140 KHPHLVNL-IGYCCEDEHRLLVYEYMALGNLHDQLFK---NYS---STLPWLTRIKIAIG 192
            H ++V L   +    E +  VY  + L  + + +++   +YS    TLP +        
Sbjct: 84  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 143
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNA-KLSDFGLATDGPQGEDSHITTCVMGT 251
             R LA++H     + +RD K  N+LLD D    KL DFG A    +GE +    C   +
Sbjct: 144 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---S 198
Query: 252 EGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE I      T+  DV+S G VL ELL G+
Sbjct: 199 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 141 RGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLA----RHTDDEMTGYV-ATRWY 193
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 147 RGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLA----RHTDDEMTGYV-ATRWY 199
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 200 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 141 RGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLA----RHTDDEMTGYV-ATRWY 193
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           +++ +  +G G FG VY+  + D+       + VA+K +     Q  R    E+  + +L
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKL 70
Query: 140 KHPHLVNL-IGYCCEDEHRLLVYEYMALGNLHDQLFK---NYS---STLPWLTRIKIAIG 192
            H ++V L   +    E +  VY  + L  + + +++   +YS    TLP +        
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNA-KLSDFGLATDGPQGEDSHITTCVMGT 251
             R LA++H     + +RD K  N+LLD D    KL DFG A    +GE +    C   +
Sbjct: 131 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---S 185
Query: 252 EGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE I      T+  DV+S G VL ELL G+
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           +++ +  +G G FG VY+  + D+       + VA+K +     Q  R    E+  + +L
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKL 106
Query: 140 KHPHLVNL-IGYCCEDEHRLLVYEYMALGNLHDQLFK---NYS---STLPWLTRIKIAIG 192
            H ++V L   +    E +  VY  + L  + + +++   +YS    TLP +        
Sbjct: 107 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 166
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNA-KLSDFGLATDGPQGEDSHITTCVMGT 251
             R LA++H     + +RD K  N+LLD D    KL DFG A    +GE +    C   +
Sbjct: 167 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---S 221
Query: 252 EGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE I      T+  DV+S G VL ELL G+
Sbjct: 222 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 15/176 (8%)
Query: 114 AVKVLDVNGSQGHREWLAEV-IFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQ 172
           AVKV+D    +  R+   E+ I L   +HP+++ L     + +H  LV E M  G L D+
Sbjct: 56  AVKVID----KSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDK 111
Query: 173 LFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNIL-LDSDYNA---KLS 228
           + +    +    + +   IG  + + +LH +   V++RD K SNIL +D   N    ++ 
Sbjct: 112 ILRQKFFSEREASFVLHTIG--KTVEYLHSQ--GVVHRDLKPSNILYVDESGNPECLRIC 167
Query: 229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           DFG A          +T C   T  + APE +        CD++S G++L  +L G
Sbjct: 168 DFGFAKQLRAENGLLMTPCY--TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           +++ +  +G G FG VY+  + D+       + VA+K +     QG      E+  + +L
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIKKV----LQGKAFKNRELQIMRKL 70
Query: 140 KHPHLVNL-IGYCCEDEHRLLVYEYMALGNLHDQLFK---NYS---STLPWLTRIKIAIG 192
            H ++V L   +    E +  VY  + L  + + +++   +YS    TLP +        
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNA-KLSDFGLATDGPQGEDSHITTCVMGT 251
             R LA++H     + +RD K  N+LLD D    KL DFG A    +GE +    C   +
Sbjct: 131 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---S 185
Query: 252 EGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE I      T+  DV+S G VL ELL G+
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           +++ +  +G G FG VY+  + D+       + VA+K +     Q  R    E+  + +L
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKL 104
Query: 140 KHPHLVNL-IGYCCEDEHRLLVYEYMALGNLHDQLFK---NYS---STLPWLTRIKIAIG 192
            H ++V L   +    E +  VY  + L  + + +++   +YS    TLP +        
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 164
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNA-KLSDFGLATDGPQGEDSHITTCVMGT 251
             R LA++H     + +RD K  N+LLD D    KL DFG A    +GE +    C   +
Sbjct: 165 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---S 219
Query: 252 EGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE I      T+  DV+S G VL ELL G+
Sbjct: 220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           +++ +  +G G FG VY+  + D+       + VA+K +     Q  R    E+  + +L
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKL 108
Query: 140 KHPHLVNL-IGYCCEDEHRLLVYEYMALGNLHDQLFK---NYS---STLPWLTRIKIAIG 192
            H ++V L   +    E +  VY  + L  + + +++   +YS    TLP +        
Sbjct: 109 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 168
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNA-KLSDFGLATDGPQGEDSHITTCVMGT 251
             R LA++H     + +RD K  N+LLD D    KL DFG A    +GE +    C   +
Sbjct: 169 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---S 223
Query: 252 EGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE I      T+  DV+S G VL ELL G+
Sbjct: 224 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           +++ +  +G G FG VY+  + D+       + VA+K +     Q  R    E+  + +L
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKL 98
Query: 140 KHPHLVNL-IGYCCEDEHRLLVYEYMALGNLHDQLFK---NYS---STLPWLTRIKIAIG 192
            H ++V L   +    E +  VY  + L  + + +++   +YS    TLP +        
Sbjct: 99  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 158
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNA-KLSDFGLATDGPQGEDSHITTCVMGT 251
             R LA++H     + +RD K  N+LLD D    KL DFG A    +GE +    C   +
Sbjct: 159 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---S 213
Query: 252 EGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE I      T+  DV+S G VL ELL G+
Sbjct: 214 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 15/210 (7%)
Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLA-EVIF 135
            +F     LGEG F  V         R    ++  A+K+L+      +    ++  E   
Sbjct: 7   EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 60
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
           + +L HP  V L     +DE       Y   G L   + +   S     TR   A     
Sbjct: 61  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 118
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGY 254
            L +LHG  K +I+RD K  NILL+ D + +++DFG A    P+ + +     V GT  Y
Sbjct: 119 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQY 175
Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            +PE +         D+++ G ++ +L+ G
Sbjct: 176 VSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 84/176 (47%), Gaps = 15/176 (8%)
Query: 114 AVKVLDVNGSQGHREWLAEV-IFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQ 172
           AVK++D    +  R+   E+ I L   +HP+++ L     + ++  +V E M  G L D+
Sbjct: 51  AVKIID----KSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDK 106
Query: 173 LFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNIL-LDSDYNA---KLS 228
           + +    +    + +   I   + + +LH +   V++RD K SNIL +D   N    ++ 
Sbjct: 107 ILRQKFFSEREASAVLFTI--TKTVEYLHAQ--GVVHRDLKPSNILYVDESGNPESIRIC 162
Query: 229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           DFG A          +T C   T  + APE +        CD++S GV+L  +LTG
Sbjct: 163 DFGFAKQLRAENGLLMTPCY--TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 15/210 (7%)
Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLA-EVIF 135
            +F     LGEG F  V         R    ++  A+K+L+      +    ++  E   
Sbjct: 9   EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 62
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
           + +L HP  V L     +DE       Y   G L   + +   S     TR   A     
Sbjct: 63  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 120
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD-GPQGEDSHITTCVMGTEGY 254
            L +LHG  K +I+RD K  NILL+ D + +++DFG A    P+ + +     V GT  Y
Sbjct: 121 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQY 177
Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            +PE +         D+++ G ++ +L+ G
Sbjct: 178 VSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 19/218 (8%)
Query: 72  KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA 131
           K+ + I   F   + LG G F +V               +  AVK +     +G    + 
Sbjct: 15  KQAEDIKKIFEFKETLGTGAFSEVVLA------EEKATGKLFAVKCIPKKALKGKESSIE 68
Query: 132 -EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLF-KNYSSTLPWLTRIKI 189
            E+  L ++KH ++V L        H  LV + ++ G L D++  K + +     T I+ 
Sbjct: 69  NEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQ 128
Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILL---DSDYNAKLSDFGLATDGPQGEDSHITT 246
            + A   + +LH     +++RD K  N+L    D +    +SDFGL+    +G D   T 
Sbjct: 129 VLDA---VYYLH--RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKG-DVMSTA 182
Query: 247 CVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           C  GT GY APE +     +   D +S GV+   LL G
Sbjct: 183 C--GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           +++ +  +G G FG VY+  + D+       + VA+K +     Q  R    E+  + +L
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKL 75
Query: 140 KHPHLVNL-IGYCCEDEHRLLVYEYMALGNLHDQLFK---NYS---STLPWLTRIKIAIG 192
            H ++V L   +    E +  VY  + L  + + +++   +YS    TLP +        
Sbjct: 76  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 135
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNA-KLSDFGLATDGPQGEDSHITTCVMGT 251
             R LA++H     + +RD K  N+LLD D    KL DFG A    +GE +    C   +
Sbjct: 136 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---S 190
Query: 252 EGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE I      T+  DV+S G VL ELL G+
Sbjct: 191 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 142 RGLKYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLA----RHTDDEMTGYV-ATRWY 194
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           +++ +  +G G FG VY+  + D+       + VA+K +     QG      E+  + +L
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIKKV----LQGKAFKNRELQIMRKL 70
Query: 140 KHPHLVNL-IGYCCEDEHRLLVYEYMALGNLHDQLFK---NYS---STLPWLTRIKIAIG 192
            H ++V L   +    E +  VY  + L  + + +++   +YS    TLP +        
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNA-KLSDFGLATDGPQGEDSHITTCVMGT 251
             R LA++H     + +RD K  N+LLD D    KL DFG A    +GE +    C   +
Sbjct: 131 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---S 185
Query: 252 EGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE I      T+  DV+S G VL ELL G+
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 188
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 76  MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDV-NGSQGHR-EWLAEV 133
           M T  +     +G G +G VYK       R       VA+K + V NG +G     + EV
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKA------RDPHSGHFVALKSVRVPNGEEGLPISTVREV 54
Query: 134 IFLGQLK---HPHLVNLIGYCC----EDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLT 185
             L +L+   HP++V L+  C     + E ++ LV+E++   +L   L K     LP  T
Sbjct: 55  ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAET 113
Query: 186 RIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHIT 245
              +     R L FLH     +++RD K  NIL+ S    KL+DFGLA            
Sbjct: 114 IKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMAL 168
Query: 246 TCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELL 282
             V+ T  Y APE +      T  D++S G +  E+ 
Sbjct: 169 FPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           +++ +  +G G FG VY+  + D+       + VA+K +     Q  R    E+  + +L
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKL 149
Query: 140 KHPHLVNL-IGYCCEDEHRLLVYEYMALGNLHDQLFK---NYS---STLPWLTRIKIAIG 192
            H ++V L   +    E +  VY  + L  + + +++   +YS    TLP +        
Sbjct: 150 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 209
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNA-KLSDFGLATDGPQGEDSHITTCVMGT 251
             R LA++H     + +RD K  N+LLD D    KL DFG A    +GE +    C   +
Sbjct: 210 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---S 264
Query: 252 EGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE I      T+  DV+S G VL ELL G+
Sbjct: 265 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 15/210 (7%)
Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLA-EVIF 135
            +F     LGEG F  V         R    ++  A+K+L+      +    ++  E   
Sbjct: 33  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 86
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
           + +L HP  V L     +DE       Y   G L  +  +   S     TR   A     
Sbjct: 87  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTA-EIVS 144
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGY 254
            L +LHG  K +I+RD K  NILL+ D + +++DFG A    P+ + +   + V GT  Y
Sbjct: 145 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQY 201
Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            +PE +         D+++ G ++ +L+ G
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 19/212 (8%)
Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLA-EVIF 135
            +F     LGEG F  V         R    ++  A+K+L+      +    ++  E   
Sbjct: 10  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 63
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK--NYSSTLPWLTRIKIAIGA 193
           + +L HP  V L     +DE       Y   G L   + K  ++  T    TR   A   
Sbjct: 64  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTA-EI 119
Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTE 252
              L +LHG  K +I+RD K  NILL+ D + +++DFG A    P+ + +     V GT 
Sbjct: 120 VSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTA 176
Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            Y +PE +         D+++ G ++ +L+ G
Sbjct: 177 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 138 RGLKYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLA----RHTDDEMTGYV-ATRWY 190
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 15/210 (7%)
Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLA-EVIF 135
            +F     LGEG F  V         R    ++  A+K+L+      +    ++  E   
Sbjct: 8   EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 61
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
           + +L HP  V L     +DE       Y   G L   + +   S     TR   A     
Sbjct: 62  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 119
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGY 254
            L +LHG  K +I+RD K  NILL+ D + +++DFG A    P+ + +     V GT  Y
Sbjct: 120 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQY 176
Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            +PE +         D+++ G ++ +L+ G
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 86/205 (41%), Gaps = 24/205 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG V++      +         A K +             E+  +  L+HP LVN
Sbjct: 59  LGTGAFGVVHR------VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 112
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYS-----STLPWLTRIKIAIGAARCLAFLH 201
           L     +D   +++YE+M+ G L +++   ++       + ++ ++        C    H
Sbjct: 113 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQV--------CKGLCH 164
Query: 202 GEEKPVIYRDFKASNILLDSDYNA--KLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEY 259
             E   ++ D K  NI+  +  +   KL DFGL       +   +TT   GT  +AAPE 
Sbjct: 165 MHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEV 221
Query: 260 INTGHLTTMCDVFSFGVVLLELLTG 284
                +    D++S GV+   LL+G
Sbjct: 222 AEGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWL-AEVIFLGQLKHPHLV 145
           LG G FG V+   + +    GL+     +K ++ + SQ   E + AE+  L  L HP+++
Sbjct: 30  LGSGAFGDVH---LVEERSSGLER---VIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 146 NLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYS--STLPWLTRIKIAIGAARCLAFLHG 202
            +     ED H + +V E    G L +++    +    L      ++       LA+ H 
Sbjct: 84  KIFE-VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS 142
Query: 203 EEKPVIYRDFKASNILL-DSDYNA--KLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEY 259
           +   V+++D K  NIL  D+  ++  K+ DFGLA      E S   T   GT  Y APE 
Sbjct: 143 QH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTALYMAPEV 197
Query: 260 INTGHLTTMCDVFSFGVVLLELLTG 284
                +T  CD++S GVV+  LLTG
Sbjct: 198 FKRD-VTFKCDIWSAGVVMYFLLTG 221

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 86/205 (41%), Gaps = 24/205 (11%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG V++      +         A K +             E+  +  L+HP LVN
Sbjct: 165 LGTGAFGVVHR------VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218
Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYS-----STLPWLTRIKIAIGAARCLAFLH 201
           L     +D   +++YE+M+ G L +++   ++       + ++ ++        C    H
Sbjct: 219 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQV--------CKGLCH 270
Query: 202 GEEKPVIYRDFKASNILLDSDYNA--KLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEY 259
             E   ++ D K  NI+  +  +   KL DFGL       +   +TT   GT  +AAPE 
Sbjct: 271 MHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEV 327
Query: 260 INTGHLTTMCDVFSFGVVLLELLTG 284
                +    D++S GV+   LL+G
Sbjct: 328 AEGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 16/211 (7%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGH-REWLAEVIFLGQL 139
           +++  Y+GEG +G V      D++R       VA+K +     Q + +  L E+  L + 
Sbjct: 45  YTQLQYIGEGAYGMV--SSAYDHVR----KTRVAIKKISPFEHQTYCQRTLREIQILLRF 98
Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI---GAARC 196
           +H +++ +           +   Y+    +   L+K   S    L+   I        R 
Sbjct: 99  RHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQ--QLSNDHICYFLYQILRG 156
Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYA 255
           L ++H     V++RD K SN+L+++  + K+ DFGLA    P+ + +   T  + T  Y 
Sbjct: 157 LKYIHSAN--VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYR 214
Query: 256 APE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           APE  +N+   T   D++S G +L E+L+ R
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 32/211 (15%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD------VNGSQGHREWLAEVIFLGQLK 140
           +G G +G V   C   + + GL+   VAVK L       ++  + +RE    +  L  +K
Sbjct: 30  VGSGAYGSV---CAAFDTKTGLR---VAVKKLSRPFQSIIHAKRTYRE----LRLLKHMK 79
Query: 141 HPHLVNLI-----GYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
           H +++ L+         E+ + + +  ++   +L++ + K    T   +  +   I   R
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN-IVKXQKLTDDHVQFLIYQI--LR 136
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y 
Sbjct: 137 GLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWYR 189
Query: 256 APE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           APE  +N  H     D++S G ++ ELLTGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLA-EVIF 135
            +F     LGEG F  V         R    ++  A+K+L+      +    ++  E   
Sbjct: 32  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 85
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
           + +L HP  V L     +DE       Y   G L  +  +   S     TR   A     
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLL-KYIRKIGSFDETCTRFYTA-EIVS 143
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGY 254
            L +LHG  K +I+RD K  NILL+ D + +++DFG A    P+ + +   + V GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQY 200
Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            +PE +     +   D+++ G ++ +L+ G
Sbjct: 201 VSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 15/209 (7%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLA-EVIFL 136
           +F     LGEG F  V         R    ++  A+K+L+      +    ++  E   +
Sbjct: 30  DFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDVM 83
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
            +L HP  V L     +DE       Y   G L   + +   S     TR   A      
Sbjct: 84  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVSA 141
Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYA 255
           L +LHG  K +I+RD K  NILL+ D + +++DFG A    P+ + +   + V GT  Y 
Sbjct: 142 LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYV 198
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           +PE +         D+++ G ++ +L+ G
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGXV-ATRWY 188
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 107/276 (38%), Gaps = 42/276 (15%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGHREWLAEV-IFLGQLKHPHL 144
           LG G +G V K       R     Q  AVK +     SQ  +  L ++ I    +  P  
Sbjct: 42  LGRGAYGVVEK------XRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFT 95
Query: 145 VNLIGYCCEDEHRLLVYEYM--ALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
           V   G    +    +  E    +L   + Q+  +   T+P     KIA+   + L  LH 
Sbjct: 96  VTFYGALFREGDVWICXELXDTSLDKFYKQVI-DKGQTIPEDILGKIAVSIVKALEHLHS 154
Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFG----LATDGPQGEDSHITTCVMGTEGYAAPE 258
           +   VI+RD K SN+L+++    K  DFG    L  D  +  D+       G + Y APE
Sbjct: 155 KLS-VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA-------GCKPYXAPE 206
Query: 259 YI----NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD 314
            I    N    +   D++S G+  +EL   R   +            W  P    F +L 
Sbjct: 207 RINPELNQKGYSVKSDIWSLGITXIELAILRFPYDS-----------WGTP----FQQLK 251
Query: 315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT 350
           Q+++       + + +        QCL  N K RPT
Sbjct: 252 QVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPT 287

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 188
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 188
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 147 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 199
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 200 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 15/210 (7%)
Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLA-EVIF 135
            +F     LGEG F  V         R    ++  A+K+L+      +    ++  E   
Sbjct: 30  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 83
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
           + +L HP  V L     +DE       Y   G L   + +   S     TR   A     
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 141
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGY 254
            L +LHG  K +I+RD K  NILL+ D + +++DFG A    P+ + +     V GT  Y
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFV-GTAQY 198
Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            +PE +         D+++ G ++ +L+ G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 188
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 138 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 190
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 146 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 198
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 199 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 142 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 194
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 142 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 194
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 6/150 (4%)
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
           + +L HP  V L     +DE       Y   G L  +  +   S     TR   A     
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTA-EIVS 143
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGY 254
            L +LHG  K +I+RD K  NILL+ D + +++DFG A    P+ + +     V GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQY 200
Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            +PE +         D+++ G ++ +L+ G
Sbjct: 201 VSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 143 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 195
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 132 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 184
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 155 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 207
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 141 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 193
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 148 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 200
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 156 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 208
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 148 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 200
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 138 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 190
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 135 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 187
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 188 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 148 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 200
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 155 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 207
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 142 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 194
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 156 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 208
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 132 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 184
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 188
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 188
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 188
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 133 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 185
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 186 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 188
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 132 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 184
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 188
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 15/210 (7%)
Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLA-EVIF 135
            +F     LGEG F  V         R    ++  A+K+L+      +    ++  E   
Sbjct: 32  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 85
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
           + +L HP  V L     +DE       Y   G L   + +   S     TR   A     
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 143
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGY 254
            L +LHG  K +I+RD K  NILL+ D + +++DFG A    P+ + +     V GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQY 200
Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            +PE +         D+++ G ++ +L+ G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 141 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 193
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 133 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 185
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 186 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 15/209 (7%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLA-EVIFL 136
           +F     LGEG F  V         R    ++  A+K+L+      +    ++  E   +
Sbjct: 15  DFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDVM 68
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
            +L HP  V L     +DE       Y   G L   + +   S     TR   A      
Sbjct: 69  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVSA 126
Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYA 255
           L +LHG  K +I+RD K  NILL+ D + +++DFG A    P+ + +     V GT  Y 
Sbjct: 127 LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYV 183
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           +PE +         D+++ G ++ +L+ G
Sbjct: 184 SPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           +++ +  +G G FG VY+  + D+       + VA+K +     QG      E+  + +L
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIKKV----LQGKAFKNRELQIMRKL 70
Query: 140 KHPHLVNL-IGYCCEDEHRLLVYEYMALGNLHDQLFK---NYS---STLPWLTRIKIAIG 192
            H ++V L   +    E +  VY  + L  +   +++   +YS    TLP +        
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNA-KLSDFGLATDGPQGEDSHITTCVMGT 251
             R LA++H     + +RD K  N+LLD D    KL DFG A    +GE +    C   +
Sbjct: 131 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---S 185
Query: 252 EGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE I      T+  DV+S G VL ELL G+
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 138 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 190
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 134 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 186
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +T  V  T  Y
Sbjct: 159 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYV-ATRWY 211
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 212 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 15/210 (7%)
Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLA-EVIF 135
            +F     LGEG F  V         R    ++  A+K+L+      +    ++  E   
Sbjct: 30  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 83
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
           + +L HP  V L     +DE       Y   G L  +  +   S     TR   A     
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTA-EIVS 141
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGY 254
            L +LHG  K +I+RD K  NILL+ D + +++DFG A    P+ + +     V GT  Y
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQY 198
Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            +PE +         D+++ G ++ +L+ G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 15/210 (7%)
Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLA-EVIF 135
            +F     LGEG F  V         R    ++  A+K+L+      +    ++  E   
Sbjct: 30  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 83
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
           + +L HP  V L     +DE       Y   G L  +  +   S     TR   A     
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTA-EIVS 141
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGY 254
            L +LHG  K +I+RD K  NILL+ D + +++DFG A    P+ + +     V GT  Y
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQY 198
Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            +PE +         D+++ G ++ +L+ G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 15/210 (7%)
Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLA-EVIF 135
            +F     LGEG F  V         R    ++  A+K+L+      +    ++  E   
Sbjct: 33  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 86
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
           + +L HP  V L     +DE       Y   G L  +  +   S     TR   A     
Sbjct: 87  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTA-EIVS 144
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGY 254
            L +LHG  K +I+RD K  NILL+ D + +++DFG A    P+ + +     V GT  Y
Sbjct: 145 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQY 201
Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            +PE +         D+++ G ++ +L+ G
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 15/210 (7%)
Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLA-EVIF 135
            +F     LGEG F  V         R    ++  A+K+L+      +    ++  E   
Sbjct: 32  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 85
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
           + +L HP  V L     +DE       Y   G L  +  +   S     TR   A     
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTA-EIVS 143
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGY 254
            L +LHG  K +I+RD K  NILL+ D + +++DFG A    P+ + +     V GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQY 200
Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            +PE +         D+++ G ++ +L+ G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 94/220 (42%), Gaps = 25/220 (11%)
Query: 76  MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA---- 131
           M T  +     +G G +G VYK       R       VA+K + V    G    L     
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKA------RDPHSGHFVALKSVRVPNGGGGGGGLPISTV 59
Query: 132 -EVIFLGQLK---HPHLVNLIGYCC----EDEHRL-LVYEYMALGNLHDQLFKNYSSTLP 182
            EV  L +L+   HP++V L+  C     + E ++ LV+E++   +L   L K     LP
Sbjct: 60  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLP 118
Query: 183 WLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS 242
             T   +     R L FLH     +++RD K  NIL+ S    KL+DFGLA         
Sbjct: 119 AETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQ 173
Query: 243 HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELL 282
              T V+ T  Y APE +      T  D++S G +  E+ 
Sbjct: 174 MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 15/210 (7%)
Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLA-EVIF 135
            +F     LGEG F  V         R    ++  A+K+L+      +    ++  E   
Sbjct: 32  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 85
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
           + +L HP  V L     +DE       Y   G L   + +   S     TR   A     
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 143
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGY 254
            L +LHG  K +I+RD K  NILL+ D + +++DFG A    P+ + +     V GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQY 200
Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            +PE +         D+++ G ++ +L+ G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 15/209 (7%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLA-EVIFL 136
           +F     LGEG F  V         R    ++  A+K+L+      +    ++  E   +
Sbjct: 30  DFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDVM 83
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
            +L HP  V L     +DE       Y   G L   + +   S     TR   A      
Sbjct: 84  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVSA 141
Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYA 255
           L +LHG  K +I+RD K  NILL+ D + +++DFG A    P+ + +     V GT  Y 
Sbjct: 142 LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYV 198
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           +PE +         D+++ G ++ +L+ G
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 15/210 (7%)
Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLA-EVIF 135
            +F     LGEG F  V         R    ++  A+K+L+      +    ++  E   
Sbjct: 32  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 85
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
           + +L HP  V L     +DE       Y   G L  +  +   S     TR   A     
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTA-EIVS 143
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGY 254
            L +LHG  K +I+RD K  NILL+ D + +++DFG A    P+ + +     V GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQY 200
Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            +PE +         D+++ G ++ +L+ G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 4/93 (4%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEG 253
           R L ++H     V++RD K SN+LL++  + K+ DFGLA    P  + +   T  + T  
Sbjct: 135 RGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +N+   T   D++S G +L E+L+ R
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 6/150 (4%)
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
           + +L HP  V L     +DE       Y   G L  +  +   S     TR   A     
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTA-EIVS 141
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD-GPQGEDSHITTCVMGTEGY 254
            L +LHG  K +I+RD K  NILL+ D + +++DFG A    P+ + +     V GT  Y
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQY 198
Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            +PE +         D+++ G ++ +L+ G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 15/210 (7%)
Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLA-EVIF 135
            +F     LGEG F  V         R    ++  A+K+L+      +    ++  E   
Sbjct: 35  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 88
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
           + +L HP  V L     +DE       Y   G L  +  +   S     TR   A     
Sbjct: 89  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTA-EIVS 146
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGY 254
            L +LHG  K +I+RD K  NILL+ D + +++DFG A    P+ + +     V GT  Y
Sbjct: 147 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQY 203
Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            +PE +         D+++ G ++ +L+ G
Sbjct: 204 VSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 32/211 (15%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD------VNGSQGHREWLAEVIFLGQLK 140
           +G G +G V   C   + + GL+   VAVK L       ++  + +RE    +  L  +K
Sbjct: 30  VGSGAYGSV---CAAFDTKTGLR---VAVKKLSRPFQSIIHAKRTYRE----LRLLKHMK 79
Query: 141 HPHLVNLI-----GYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
           H +++ L+         E+ + + +  ++   +L++ + K+   T   +  +   I   R
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN-IVKSQKLTDDHVQFLIYQI--LR 136
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L ++H  +  +I+RD K SN+ ++ D   K+ DFGL     +  D  +T  V  T  Y 
Sbjct: 137 GLKYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLC----RHTDDEMTGYV-ATRWYR 189
Query: 256 APE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           APE  +N  H     D++S G ++ ELLTGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 14/210 (6%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK 140
           ++   Y+GEG +G V      DNL    K +    K+         +  L E+  L + +
Sbjct: 29  YTNLSYIGEGAYGMVCSAY--DNLN---KVRVAIKKISPFEHQTYXQRTLREIKILLRFR 83
Query: 141 HPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI---GAARCL 197
           H +++ +           +   Y+    +   L+K   +    L+   I        R L
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHICYFLYQILRGL 141
Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYAA 256
            ++H     V++RD K SN+LL++  + K+ DFGLA    P  + +   T  + T  Y A
Sbjct: 142 KYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 257 PE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           PE  +N+   T   D++S G +L E+L+ R
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 4/93 (4%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEG 253
           R L ++H     V++RD K SN+LL++  + K+ DFGLA    P  + +   T  + T  
Sbjct: 135 RGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +N+   T   D++S G +L E+L+ R
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 4/93 (4%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEG 253
           R L ++H     V++RD K SN+LL++  + K+ DFGLA    P  + +   T  + T  
Sbjct: 135 RGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +N+   T   D++S G +L E+L+ R
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 4/93 (4%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEG 253
           R L ++H     V++RD K SN+LL++  + K+ DFGLA    P  + +   T  + T  
Sbjct: 155 RGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +N+   T   D++S G +L E+L+ R
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 75/157 (47%), Gaps = 15/157 (9%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-HPHLV 145
           L EGGF  VY+     ++  G   +  A+K L  N  + +R  + EV F+ +L  HP++V
Sbjct: 36  LAEGGFAFVYEA---QDVGSG---REYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 146 NL-----IGYCCED--EHRLLVYEYMALGNLHDQLFKNYS-STLPWLTRIKIAIGAARCL 197
                  IG    D  +   L+   +  G L + L K  S   L   T +KI     R +
Sbjct: 90  QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT 234
             +H ++ P+I+RD K  N+LL +    KL DFG AT
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT 186

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 4/93 (4%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEG 253
           R L ++H     V++RD K SN+LL++  + K+ DFGLA    P  + +   T  + T  
Sbjct: 139 RGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +N+   T   D++S G +L E+L+ R
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 36/214 (16%)
Query: 87  LGEGGFGKVYKGC-VDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLV 145
           LG+G +G VY G  + + +R       +A+K +    S+  +    E+     LKH ++V
Sbjct: 30  LGKGTYGIVYAGRDLSNQVR-------IAIKEIPERDSRYSQPLHEEIALHKHLKHKNIV 82
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQL------FKNYSSTLPWLTRIKIAIGAARCLAF 199
             +G   E+    +  E +  G+L   L       K+   T+ + T+ +I  G    L +
Sbjct: 83  QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-QILEG----LKY 137
Query: 200 LHGEEKPVIYRDFKASNILLDSDYNA--KLSDFG----LATDGPQGEDSHITTCVMGTEG 253
           LH  +  +++RD K  N+L+++ Y+   K+SDFG    LA   P       T    GT  
Sbjct: 138 LHDNQ--IVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGINP------CTETFTGTLQ 188
Query: 254 YAAPEYINTG--HLTTMCDVFSFGVVLLELLTGR 285
           Y APE I+ G        D++S G  ++E+ TG+
Sbjct: 189 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ D+GLA    +  D  +T  V  T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDYGLA----RHTDDEMTGYV-ATRWY 188
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 4/93 (4%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEG 253
           R L ++H     V++RD K SN+LL++  + K+ DFGLA    P  + +   T  + T  
Sbjct: 137 RGLKYIHSAN--VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +N+   T   D++S G +L E+L+ R
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 13/214 (6%)
Query: 76  MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA-EVI 134
           M+  ++   + LG G F  V K C          A+ +  + L  +     RE +  EV 
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRK-CRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 135 FLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA 194
            L +++HP+++ L          +L+ E ++ G L D L +  S T    T+    I   
Sbjct: 61  ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI--L 118
Query: 195 RCLAFLHGEEKPVIYRDFKASNI-LLDSDY---NAKLSDFGLATDGPQGEDSHITTCVMG 250
             + +LH   K + + D K  NI LLD +      KL DFG+A     G +      + G
Sbjct: 119 DGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFG 173
Query: 251 TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           T  + APE +N   L    D++S GV+   LL+G
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA        +   T  + T  Y
Sbjct: 143 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGYVATRWY 195
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 110/278 (39%), Gaps = 41/278 (14%)
Query: 84  SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKH 141
           S  LG G F  V + C+  +       Q  A K L     G     E L E+  L   K 
Sbjct: 34  SKELGRGKFA-VVRQCISKS-----TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 142 -PHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFL 200
            P ++NL          +L+ EY A G +        +  +     I++       + +L
Sbjct: 88  CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 201 HGEEKPVIYRDFKASNILLDSDY---NAKLSDFGLATD-GPQGEDSHITTCVMGTEGYAA 256
           H  +  +++ D K  NILL S Y   + K+ DFG++   G   E   I    MGT  Y A
Sbjct: 148 H--QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREI----MGTPEYLA 201
Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI 316
           PE +N   +TT  D+++ G++   LLT                     P + +  +   +
Sbjct: 202 PEILNYDPITTATDMWNIGIIAYMLLTH------------------TSPFVGEDNQETYL 243
Query: 317 IDSRLEDRYSTEGAKRLAAVA----HQCLSHNPKSRPT 350
             S++   YS E    ++ +A       L  NP+ RPT
Sbjct: 244 NISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPT 281

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 99/217 (45%), Gaps = 28/217 (12%)
Query: 84  SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-HP 142
           S+ LGEG + KV +G V  +L+ G   +  AVK+++            EV  L Q + + 
Sbjct: 18  SELLGEGAYAKV-QGAV--SLQNG---KEYAVKIIEKQAGHSRSRVFREVETLYQCQGNK 71
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
           +++ LI +  +D    LV+E +  G++   + K         +R+   + AA  L FLH 
Sbjct: 72  NILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAA--LDFLH- 128
Query: 203 EEKPVIYRDFKASNILLDSDYNA---KLSDFGLATD-------GPQGEDSHITTCVMGTE 252
             K + +RD K  NIL +S       K+ DF L +         P       T C  G+ 
Sbjct: 129 -TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPC--GSA 185
Query: 253 GYAAPEYIN--TGHLT---TMCDVFSFGVVLLELLTG 284
            Y APE +   T   T     CD++S GVVL  +L+G
Sbjct: 186 EYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA        +   T  + T  Y
Sbjct: 143 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGYVATRWY 195
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA        +   T  + T  Y
Sbjct: 143 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGYVATRWY 195
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 4/93 (4%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEG 253
           R L ++H     V++RD K SN+LL++  + K+ DFGLA    P  + +   T  + T  
Sbjct: 135 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +N+   T   D++S G +L E+L+ R
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 4/93 (4%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEG 253
           R L ++H     V++RD K SN+LL++  + K+ DFGLA    P  + +   T  + T  
Sbjct: 137 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +N+   T   D++S G +L E+L+ R
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +   V  T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMAGFV-ATRWY 188
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +   V  T  Y
Sbjct: 132 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMAGFV-ATRWY 184
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +   V  T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMAGFV-ATRWY 188
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 4/93 (4%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEG 253
           R L ++H     V++RD K SN+LL++  + K+ DFGLA    P  + +   T  + T  
Sbjct: 137 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +N+   T   D++S G +L E+L+ R
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 4/93 (4%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEG 253
           R L ++H     V++RD K SN+LL++  + K+ DFGLA    P  + +   T  + T  
Sbjct: 140 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 197
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +N+   T   D++S G +L E+L+ R
Sbjct: 198 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 4/93 (4%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEG 253
           R L ++H     V++RD K SN+LL++  + K+ DFGLA    P  + +   T  + T  
Sbjct: 141 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 198
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +N+   T   D++S G +L E+L+ R
Sbjct: 199 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 4/93 (4%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEG 253
           R L ++H     V++RD K SN+LL++  + K+ DFGLA    P  + +   T  + T  
Sbjct: 132 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 189
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +N+   T   D++S G +L E+L+ R
Sbjct: 190 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 4/93 (4%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEG 253
           R L ++H     V++RD K SN+LL++  + K+ DFGLA    P  + +   T  + T  
Sbjct: 155 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +N+   T   D++S G +L E+L+ R
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 4/93 (4%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEG 253
           R L ++H     V++RD K SN+LL++  + K+ DFGLA    P  + +   T  + T  
Sbjct: 139 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +N+   T   D++S G +L E+L+ R
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 4/93 (4%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEG 253
           R L ++H     V++RD K SN+LL++  + K+ DFGLA    P  + +   T  + T  
Sbjct: 139 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +N+   T   D++S G +L E+L+ R
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 4/93 (4%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEG 253
           R L ++H     V++RD K SN+LL++  + K+ DFGLA    P  + +   T  + T  
Sbjct: 139 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +N+   T   D++S G +L E+L+ R
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 4/93 (4%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEG 253
           R L ++H     V++RD K SN+LL++  + K+ DFGLA    P  + +   T  + T  
Sbjct: 133 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 190
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +N+   T   D++S G +L E+L+ R
Sbjct: 191 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +   V  T  Y
Sbjct: 156 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMXGXV-ATRWY 208
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 4/93 (4%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEG 253
           R L ++H     V++RD K SN+LL++  + K+ DFGLA    P  + +   T  + T  
Sbjct: 133 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 190
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +N+   T   D++S G +L E+L+ R
Sbjct: 191 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 4/93 (4%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEG 253
           R L ++H     V++RD K SN+LL++  + K+ DFGLA    P  + +   T  + T  
Sbjct: 143 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 200
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +N+   T   D++S G +L E+L+ R
Sbjct: 201 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 4/93 (4%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEG 253
           R L ++H     V++RD K SN+LL++  + K+ DFGLA    P  + +   T  + T  
Sbjct: 135 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +N+   T   D++S G +L E+L+ R
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 13/214 (6%)
Query: 76  MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA-EVI 134
           M+  ++   + LG G F  V K C          A+ +  + L  +     RE +  EV 
Sbjct: 23  MVEDHYEMGEELGSGQFAIVRK-CRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVN 81
Query: 135 FLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA 194
            L +++HP+++ L          +L+ E ++ G L D L +  S T    T+    I   
Sbjct: 82  ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI--L 139
Query: 195 RCLAFLHGEEKPVIYRDFKASNI-LLDSDY---NAKLSDFGLATDGPQGEDSHITTCVMG 250
             + +LH   K + + D K  NI LLD +      KL DFG+A     G +      + G
Sbjct: 140 DGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFG 194
Query: 251 TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           T  + APE +N   L    D++S GV+   LL+G
Sbjct: 195 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 44/217 (20%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL------DVNGSQGHREWLAEVIFLGQLK 140
           +G G +G V   C   + R G K   VA+K L      ++   + +RE    +  L  ++
Sbjct: 33  VGSGAYGAV---CSAVDGRTGAK---VAIKKLYRPFQSELFAKRAYRE----LRLLKHMR 82
Query: 141 HPHLVNLIGYCCEDE------HRLLVYEYMA--LGNL--HDQLFKNYSSTLPWLTRIKIA 190
           H +++ L+     DE         LV  +M   LG L  H++L ++         RI+  
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED---------RIQFL 133
Query: 191 I-GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM 249
           +    + L ++H     +I+RD K  N+ ++ D   K+ DFGLA       DS +   V+
Sbjct: 134 VYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMXGXVV 187
Query: 250 GTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
            T  Y APE I N    T   D++S G ++ E++TG+
Sbjct: 188 -TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    +  D  +   V  T  Y
Sbjct: 159 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMXGYV-ATRWY 211
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 212 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 36/214 (16%)
Query: 87  LGEGGFGKVYKGC-VDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLV 145
           LG+G +G VY G  + + +R       +A+K +    S+  +    E+     LKH ++V
Sbjct: 16  LGKGTYGIVYAGRDLSNQVR-------IAIKEIPERDSRYSQPLHEEIALHKHLKHKNIV 68
Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQL------FKNYSSTLPWLTRIKIAIGAARCLAF 199
             +G   E+    +  E +  G+L   L       K+   T+ + T+ +I  G    L +
Sbjct: 69  QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-QILEG----LKY 123
Query: 200 LHGEEKPVIYRDFKASNILLDSDYNA--KLSDFG----LATDGPQGEDSHITTCVMGTEG 253
           LH  +  +++RD K  N+L+++ Y+   K+SDFG    LA   P       T    GT  
Sbjct: 124 LHDNQ--IVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGINP------CTETFTGTLQ 174
Query: 254 YAAPEYINTG--HLTTMCDVFSFGVVLLELLTGR 285
           Y APE I+ G        D++S G  ++E+ TG+
Sbjct: 175 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 105/247 (42%), Gaps = 30/247 (12%)
Query: 48  PGSPISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPG 107
           PGS +SLN  +++   S       KE+      F      G+G FG V  G      +  
Sbjct: 2   PGSMMSLNAAAAADERSR------KEMD----RFQVERMAGQGTFGTVQLG------KEK 45
Query: 108 LKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGY--CCEDEHRLLVYEYMA 165
               +VA+K +  +    +RE L  +  L  L HP++V L  Y     +  R  +Y  + 
Sbjct: 46  STGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVV 104
Query: 166 LGNLHDQLFK---NY--SSTLPWLTRIKIAI-GAARCLAFLHGEEKPVIYRDFKASNILL 219
           +  + D L +   NY      P    IK+ +    R +  LH     V +RD K  N+L+
Sbjct: 105 MEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV 164
Query: 220 -DSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVV 277
            ++D   KL DFG A      E +    C   +  Y APE I    H TT  D++S G +
Sbjct: 165 NEADGTLKLCDFGSAKKLSPSEPNVAYIC---SRYYRAPELIFGNQHYTTAVDIWSVGCI 221
Query: 278 LLELLTG 284
             E++ G
Sbjct: 222 FAEMMLG 228

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 109/278 (39%), Gaps = 45/278 (16%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKH--P 142
           +G GG  KV++   +       K Q  A+K +++    +Q    +  E+ +L +L+    
Sbjct: 20  IGSGGSSKVFQVLNE-------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 72
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLH-DQLFKNYSSTLPWLTRIKIAIGAARCLAFLH 201
            ++ L  Y   D++   +Y  M  GN+  +   K   S  PW  R          +  +H
Sbjct: 73  KIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLEAVHTIH 128
Query: 202 GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN 261
             +  +++ D K +N L+  D   KL DFG+A        S +    +GT  Y  PE I 
Sbjct: 129 --QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 185
Query: 262 -----------TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF 310
                         ++   DV+S G +L  +  G+   ++               ++   
Sbjct: 186 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---------------IINQI 230
Query: 311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSR 348
           +KL  IID   E  +     K L  V   CL  +PK R
Sbjct: 231 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 268

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 109/278 (39%), Gaps = 45/278 (16%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKH--P 142
           +G GG  KV++   +       K Q  A+K +++    +Q    +  E+ +L +L+    
Sbjct: 36  IGSGGSSKVFQVLNE-------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLH-DQLFKNYSSTLPWLTRIKIAIGAARCLAFLH 201
            ++ L  Y   D++   +Y  M  GN+  +   K   S  PW  R          +  +H
Sbjct: 89  KIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLEAVHTIH 144
Query: 202 GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN 261
             +  +++ D K +N L+  D   KL DFG+A        S +    +GT  Y  PE I 
Sbjct: 145 --QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201
Query: 262 -----------TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF 310
                         ++   DV+S G +L  +  G+   ++               ++   
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---------------IINQI 246
Query: 311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSR 348
           +KL  IID   E  +     K L  V   CL  +PK R
Sbjct: 247 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 284

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 25/214 (11%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK 140
           ++    +G G FG V++  +       +++  VA+K +     Q  R    E+  +  +K
Sbjct: 42  YTNCKVIGNGSFGVVFQAKL-------VESDEVAIKKV----LQDKRFKNRELQIMRIVK 90
Query: 141 HPHLVNLIGYCC-----EDEHRL-LVYEYMALGNLH-DQLFKNYSSTLPWLTRIKIAIGA 193
           HP++V+L  +       +DE  L LV EY+        + +     T+P L         
Sbjct: 91  HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQL 150
Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDSDYNA-KLSDFGLATDGPQGEDSHITTCVMGTE 252
            R LA++H     + +RD K  N+LLD      KL DFG A     GE +    C   + 
Sbjct: 151 LRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXIC---SR 205
Query: 253 GYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
            Y APE I    + TT  D++S G V+ EL+ G+
Sbjct: 206 YYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFL 136
            F R   +G G FG+V    +  ++  G      A+K+LD   V   +     L E   L
Sbjct: 42  QFERIKTIGTGSFGRV---MLVKHMETG---NHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
             +  P LV L     ++ +  +V EYM  G++   L +    + P   R      A   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEP-HARF---YAAQIV 151
Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L F +     +IYRD K  N+L+D     K++DFG A    +G     T  + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKR-VKGR----TWXLCGTPEYLA 206
Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTG 284
           PE I +       D ++ GV++ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFL 136
            F R   +G G FG+V    +  ++  G      A+K+LD   V   +     L E   L
Sbjct: 42  QFERIKTIGTGSFGRV---MLVKHMETG---NHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
             +  P LV L     ++ +  +V EYM  G++   L +    + P   R      A   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEP-HARF---YAAQIV 151
Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L F +     +IYRD K  N+L+D     K++DFG A    +G     T  + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKR-VKGR----TWXLCGTPEYLA 206
Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTG 284
           PE I +       D ++ GV++ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 109/278 (39%), Gaps = 45/278 (16%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKH--P 142
           +G GG  KV++   +       K Q  A+K +++    +Q    +  E+ +L +L+    
Sbjct: 16  IGSGGSSKVFQVLNE-------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 68
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLH-DQLFKNYSSTLPWLTRIKIAIGAARCLAFLH 201
            ++ L  Y   D++   +Y  M  GN+  +   K   S  PW  R          +  +H
Sbjct: 69  KIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLEAVHTIH 124
Query: 202 GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN 261
             +  +++ D K +N L+  D   KL DFG+A        S +    +GT  Y  PE I 
Sbjct: 125 --QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 181
Query: 262 -----------TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF 310
                         ++   DV+S G +L  +  G+   ++               ++   
Sbjct: 182 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---------------IINQI 226
Query: 311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSR 348
           +KL  IID   E  +     K L  V   CL  +PK R
Sbjct: 227 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 264

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H     +I+RD K SN+ ++ D   ++ DFGLA       D  +T  V  T  Y
Sbjct: 142 RGLKYIHS--AGIIHRDLKPSNVAVNEDSELRILDFGLARQA----DEEMTGYV-ATRWY 194
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELL G+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 99/228 (43%), Gaps = 28/228 (12%)
Query: 71  LKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWL 130
           +KE+Q+   +F     +G G FG+V    + +  R          ++L    +   RE  
Sbjct: 66  VKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFRE-E 124
Query: 131 AEVIFLGQLKHPHLVNLIGYCCEDE-HRLLVYEYMALGNLHDQLFKNYSSTLP------W 183
            +V+  G  +    +  + Y  +DE H  LV +Y   G+L   L   +   LP      +
Sbjct: 125 RDVLVNGDCQ---WITALHYAFQDENHLYLVMDYYVGGDLL-TLLSKFEDKLPEDMARFY 180
Query: 184 LTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSH 243
           +  + +AI +   L ++H        RD K  N+LLD + + +L+DFG        +D  
Sbjct: 181 IGEMVLAIDSIHQLHYVH--------RDIKPDNVLLDVNGHIRLADFGSCL--KMNDDGT 230
Query: 244 ITTCV-MGTEGYAAPEYINT-----GHLTTMCDVFSFGVVLLELLTGR 285
           + + V +GT  Y +PE +       G     CD +S GV + E+L G 
Sbjct: 231 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 278

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+  FGLA    +  D  +T  V  T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILGFGLA----RHTDDEMTGYV-ATRWY 188
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 89/209 (42%), Gaps = 20/209 (9%)
Query: 80  NFSRSDYLGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
            F R   LG G FG+V    +K   +      L  Q V VK+  +  +   +  L  V F
Sbjct: 63  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF 121
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
                 P LV L     ++ +  +V EY+A G +   L +    + P   R      A  
Sbjct: 122 ------PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARF---YAAQI 171
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L F +     +IYRD K  N+L+D     +++DFG A    + + +  T C  GT  Y 
Sbjct: 172 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGATWTLC--GTPEYL 226
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           APE I +       D ++ GV++ E+  G
Sbjct: 227 APEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 109/278 (39%), Gaps = 45/278 (16%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKH--P 142
           +G GG  KV++   +       K Q  A+K +++    +Q    +  E+ +L +L+    
Sbjct: 64  IGSGGSSKVFQVLNE-------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLH-DQLFKNYSSTLPWLTRIKIAIGAARCLAFLH 201
            ++ L  Y   D++   +Y  M  GN+  +   K   S  PW  R          +  +H
Sbjct: 117 KIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLEAVHTIH 172
Query: 202 GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN 261
             +  +++ D K +N L+  D   KL DFG+A        S +    +GT  Y  PE I 
Sbjct: 173 --QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 229
Query: 262 -----------TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF 310
                         ++   DV+S G +L  +  G+   ++               ++   
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---------------IINQI 274
Query: 311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSR 348
           +KL  IID   E  +     K L  V   CL  +PK R
Sbjct: 275 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 312

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 99/228 (43%), Gaps = 28/228 (12%)
Query: 71  LKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWL 130
           +KE+Q+   +F     +G G FG+V    + +  R          ++L    +   RE  
Sbjct: 82  VKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFRE-E 140
Query: 131 AEVIFLGQLKHPHLVNLIGYCCEDE-HRLLVYEYMALGNLHDQLFKNYSSTLP------W 183
            +V+  G  +    +  + Y  +DE H  LV +Y   G+L   L   +   LP      +
Sbjct: 141 RDVLVNGDCQ---WITALHYAFQDENHLYLVMDYYVGGDLL-TLLSKFEDKLPEDMARFY 196
Query: 184 LTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSH 243
           +  + +AI +   L ++H        RD K  N+LLD + + +L+DFG        +D  
Sbjct: 197 IGEMVLAIDSIHQLHYVH--------RDIKPDNVLLDVNGHIRLADFGSCL--KMNDDGT 246
Query: 244 ITTCV-MGTEGYAAPEYINT-----GHLTTMCDVFSFGVVLLELLTGR 285
           + + V +GT  Y +PE +       G     CD +S GV + E+L G 
Sbjct: 247 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 294

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 43/278 (15%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ---GHREWLAEVIFLGQLKHPH 143
           LG G F  V K C + +   GL+     +K      S+      +   EV  L +++HP+
Sbjct: 19  LGSGQFA-VVKKCREKS--TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE 203
           ++ L          +L+ E +A G L D L +  S T    T     I     + +LH  
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLHSL 133
Query: 204 EKPVIYRDFKASNILLDSDYNA-----KLSDFGLATDGPQGEDSHITTCVMGTEGYAAPE 258
           +  + + D K  NI+L  D N      K+ DFGLA     G +      + GT  + APE
Sbjct: 134 Q--IAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPAFVAPE 187
Query: 259 YINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI-- 316
            +N   L    D++S GV+   LL+G                  A P L D TK + +  
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGD-TKQETLAN 228
Query: 317 ---IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM 351
              ++   ED Y +  +        + L  +PK R T+
Sbjct: 229 VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H     +I+RD K SN+ ++ D   ++ DFGLA       D  +T  V  T  Y
Sbjct: 142 RGLKYIHS--AGIIHRDLKPSNVAVNEDSELRILDFGLARQA----DEEMTGYV-ATRWY 194
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELL G+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 93/228 (40%), Gaps = 24/228 (10%)
Query: 77  ITHNFSRSDY---LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEV 133
           I H+  R D+   +G G FG      V   +R  L  + VAVK ++  G+        E+
Sbjct: 15  IMHDSDRYDFVKDIGSGNFG------VARLMRDKLTKELVAVKYIE-RGAAIDENVQREI 67
Query: 134 IFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK--NYSSTLPWLTRIKIAI 191
           I    L+HP++V          H  ++ EY + G L++++     +S         ++  
Sbjct: 68  INHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS 127
Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLS--DFGLATDGPQGEDSHITTCVM 249
           G + C +        + +RD K  N LLD     +L   DFG +           T   +
Sbjct: 128 GVSYCHSM------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---V 178
Query: 250 GTEGYAAPEY-INTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE 296
           GT  Y APE  +   +   + DV+S GV L  +L G    E     R+
Sbjct: 179 GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD 226

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ DF LA    +  D  +T  V  T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFYLA----RHTDDEMTGYV-ATRWY 188
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 109/278 (39%), Gaps = 45/278 (16%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKH--P 142
           +G GG  KV++   +       K Q  A+K +++    +Q    +  E+ +L +L+    
Sbjct: 17  IGSGGSSKVFQVLNE-------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLH-DQLFKNYSSTLPWLTRIKIAIGAARCLAFLH 201
            ++ L  Y   D++   +Y  M  GN+  +   K   S  PW  R          +  +H
Sbjct: 70  KIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLEAVHTIH 125
Query: 202 GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN 261
             +  +++ D K +N L+  D   KL DFG+A        S +    +GT  Y  PE I 
Sbjct: 126 --QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 262 -----------TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF 310
                         ++   DV+S G +L  +  G+   ++               ++   
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---------------IINQI 227
Query: 311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSR 348
           +KL  IID   E  +     K L  V   CL  +PK R
Sbjct: 228 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 265

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 25/218 (11%)
Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFL 136
             + + + +GEG +G V+K    +        + VA+K   LD +        L E+  L
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRET------HEIVALKRVRLDDDDEGVPSSALREICLL 55
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTL-----PWLTRIKIAI 191
            +LKH ++V L      D+   LV+E+       DQ  K Y  +      P + +     
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFC------DQDLKKYFDSCNGDLDPEIVK-SFLF 108
Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
              + L F H     V++RD K  N+L++ +   KL+DFGLA     G      +  + T
Sbjct: 109 QLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLADFGLARAF--GIPVRCYSAEVVT 164
Query: 252 EGYAAPEYINTGHL-TTMCDVFSFGVVLLELLTGRRSV 288
             Y  P+ +    L +T  D++S G +  EL    R +
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ D GLA    +  D  +T  V  T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDAGLA----RHTDDEMTGYV-ATRWY 188
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ D GLA    +  D  +T  V  T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDRGLA----RHTDDEMTGYV-ATRWY 188
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 86  YLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL------DVNGSQGHREWLAEVIFLGQL 139
           ++G G +G V   C   + R G K   VA+K L      ++   + +RE    ++ L  +
Sbjct: 49  HVGSGAYGSV---CSAIDKRSGEK---VAIKKLSRPFQSEIFAKRAYRE----LLLLKHM 98
Query: 140 KHPHLVNLIGYCCEDEHRLLVYE-YMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLA 198
           +H +++ L+            Y+ Y+ +  +   L K             +     + L 
Sbjct: 99  QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLK 158
Query: 199 FLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPE 258
           ++H     V++RD K  N+ ++ D   K+ DFGLA       D+ +T  V+ T  Y APE
Sbjct: 159 YIHS--AGVVHRDLKPGNLAVNEDCELKILDFGLARHA----DAEMTGYVV-TRWYRAPE 211
Query: 259 YI-NTGHLTTMCDVFSFGVVLLELLTGR 285
            I +  H     D++S G ++ E+LTG+
Sbjct: 212 VILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 18/208 (8%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREW---LAEVIFL 136
            F R   LG G FG+V    +  ++  G      A+K+LD       +E    L E   L
Sbjct: 42  QFERIKTLGTGSFGRV---MLVKHMETG---NHYAMKILDKQKVVKLKEIEHTLNEKRIL 95
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
             +  P LV L     ++ +  +V EY   G +   L +    + P   R      A   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-HARF---YAAQIV 151
Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L F +     +IYRD K  N+++D     K++DFGLA    +G     T  + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKR-VKGR----TWXLCGTPEYLA 206
Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTG 284
           PE I +       D ++ GV++ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 4/93 (4%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEG 253
           R L ++H     V++RD K SN+LL++  + K+ DFGLA    P  + +      + T  
Sbjct: 139 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRW 196
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +N+   T   D++S G +L E+L+ R
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H     +I+RD K SN+ ++ D   ++ DFGLA       D  +T  V  T  Y
Sbjct: 134 RGLKYIHS--AGIIHRDLKPSNVAVNEDCELRILDFGLARQA----DEEMTGYV-ATRWY 186
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELL G+
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 4/93 (4%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEG 253
           R L ++H     V++RD K SN+LL++  + K+ DFGLA    P  + +      + T  
Sbjct: 140 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRW 197
Query: 254 YAAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE  +N+   T   D++S G +L E+L+ R
Sbjct: 198 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 109/278 (39%), Gaps = 45/278 (16%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKH--P 142
           +G GG  KV++   +       K Q  A+K +++    +Q    +  E+ +L +L+    
Sbjct: 64  IGSGGSSKVFQVLNE-------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLH-DQLFKNYSSTLPWLTRIKIAIGAARCLAFLH 201
            ++ L  Y   D++   +Y  M  GN+  +   K   S  PW  R          +  +H
Sbjct: 117 KIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLEAVHTIH 172
Query: 202 GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN 261
             +  +++ D K +N L+  D   KL DFG+A        S +    +GT  Y  PE I 
Sbjct: 173 --QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 229
Query: 262 -----------TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF 310
                         ++   DV+S G +L  +  G+   ++               ++   
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---------------IINQI 274
Query: 311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSR 348
           +KL  IID   E  +     K L  V   CL  +PK R
Sbjct: 275 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 312

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 107/262 (40%), Gaps = 51/262 (19%)
Query: 141 HPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLF---KNYSSTLPWLTRIKIAIGAARCL 197
           HP+++    YC E   R L Y  + L NL+ Q     KN S     L +    I   R +
Sbjct: 68  HPNVIRY--YCSETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 198 A--FLHGEEKPVIYRDFKASNILL--DSDYNAK-----------LSDFGLATDGPQGEDS 242
           A    H     +I+RD K  NIL+   S + A            +SDFGL      G+ S
Sbjct: 125 ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 243 HITTC--VMGTEGYAAPEYINTGH-------LTTMCDVFSFGVVLLELLTGRRSVEKNRC 293
             T      GT G+ APE +   +       LT   D+FS G V   +L+  +    ++ 
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244
Query: 294 KREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTT 353
            RE +++       +    LD++    L DR     A  L +   Q + H+P  RPT   
Sbjct: 245 SRESNII-------RGIFSLDEM--KCLHDRSLIAEATDLIS---QMIDHDPLKRPTAMK 292
Query: 354 VV---------KALEPLLDLND 366
           V+         K LE LL ++D
Sbjct: 293 VLRHPLFWPKSKKLEFLLKVSD 314

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 75/182 (41%), Gaps = 29/182 (15%)
Query: 187 IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITT 246
           I  +   AR + FL    +  I+RD  A NILL  +   K+ DFGLA D  +  D     
Sbjct: 202 ISYSFQVARGMEFLSS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKG 259
Query: 247 CVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS------VEKNRCKREKDLV 300
                  + APE I     +T  DV+S+GV+L E+ +   S      ++++ C R ++ +
Sbjct: 260 DTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLREGM 319
Query: 301 EWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEP 360
               P                   YST     +  +   C   +PK RP    +V+ L  
Sbjct: 320 RMRAP------------------EYST---PEIYQIMLDCWHRDPKERPRFAELVEKLGD 358
Query: 361 LL 362
           LL
Sbjct: 359 LL 360

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 80  NFSRSDYLGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
            F R   LG G FG+V    +K   +      L  Q V VK+  +  +   +  L  V F
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF 100
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
                 P LV L     ++ +  +V EY+A G +   L +    + P   R      A  
Sbjct: 101 ------PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARF---YAAQI 150
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y 
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLAGTPEYL 205
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           APE I +       D ++ GV++ E+  G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 80  NFSRSDYLGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
            F R   LG G FG+V    +K   +      L  Q V VK+  +  +   +  L  V F
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF 100
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
                 P LV L     ++ +  +V EY+A G +   L +    + P   R      A  
Sbjct: 101 ------PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARF---YAAQI 150
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y 
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLXGTPEYL 205
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           APE I +       D ++ GV++ E+  G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 26/211 (12%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKA--QTVAVKVLDVNGSQGHR--------EWLAEVIFL 136
           L +G F K+   C  DN    LK   +++  K  D   S   +        ++  E+  +
Sbjct: 39  LNQGKFNKII-LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNL--HDQLF----KNYSSTLPWLTRIKIA 190
             +K+ + +   G     +   ++YEYM   ++   D+ F    KNY+  +P +  IK  
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP-IQVIKCI 156
Query: 191 IGAA-RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM 249
           I +     +++H E K + +RD K SNIL+D +   KLSDFG   +     D  I     
Sbjct: 157 IKSVLNSFSYIHNE-KNICHRDVKPSNILMDKNGRVKLSDFG---ESEYMVDKKIKGS-R 211
Query: 250 GTEGYAAPEYIN--TGHLTTMCDVFSFGVVL 278
           GT  +  PE+ +  + +     D++S G+ L
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           R L ++H  +  +I+RD K SN+ ++ D   K+ D GLA    +  D  +T  V  T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDGGLA----RHTDDEMTGYV-ATRWY 188
Query: 255 AAPE-YINTGHLTTMCDVFSFGVVLLELLTGR 285
            APE  +N  H     D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFL 136
            F R   LG G FG+V    +  ++  G      A+K+LD   V   +     L E   L
Sbjct: 42  QFERIKTLGTGSFGRV---MLVKHMETG---NHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
             +  P LV L     ++ +  +V EY+A G +   L +    + P   R      A   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARF---YAAQIV 151
Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLA 206
Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTG 284
           PE I +       D ++ GV++ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 43/278 (15%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ---GHREWLAEVIFLGQLKHPH 143
           LG G F  V K C + +   GL+     +K      S+      +   EV  L +++HP+
Sbjct: 19  LGSGQFA-VVKKCREKS--TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE 203
           ++ L          +L+ E +A G L D L +  S T    T     I     + +LH  
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLHSL 133
Query: 204 EKPVIYRDFKASNILLDSDYNA-----KLSDFGLATDGPQGEDSHITTCVMGTEGYAAPE 258
           +  + + D K  NI+L  D N      K+ DFGLA     G +      + GT  + APE
Sbjct: 134 Q--IAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPE 187
Query: 259 YINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI-- 316
            +N   L    D++S GV+   LL+G                  A P L D TK + +  
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGD-TKQETLAN 228
Query: 317 ---IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM 351
              ++   ED Y +  +        + L  +PK R T+
Sbjct: 229 VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 13/213 (6%)
Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA-EVIF 135
           +  ++   + LG G F  V K C          A+ +  + L  +     RE +  EV  
Sbjct: 10  VEDHYEMGEELGSGQFAIVRK-CRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 68
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
           L +++HP+++ L          +L+ E ++ G L D L +  S T    T+    I    
Sbjct: 69  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI--LD 126
Query: 196 CLAFLHGEEKPVIYRDFKASNI-LLDSDY---NAKLSDFGLATDGPQGEDSHITTCVMGT 251
            + +LH   K + + D K  NI LLD +      KL DFG+A     G +      + GT
Sbjct: 127 GVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGT 181
Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
             + APE +N   L    D++S GV+   LL+G
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 86/206 (41%), Gaps = 26/206 (12%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHL 144
           L E   G+++KG    N         + VKVL V    ++  R++  E   L    HP++
Sbjct: 18  LNENHSGELWKGRWQGN--------DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 145 VNLIGYCCEDE--HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
           + ++G C      H  L+  +   G+L++ L +  +  +     +K A+  AR  AFLH 
Sbjct: 70  LPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHT 129
Query: 203 EEKPVIYRDFKASNILLDSDYNAKLS--DFGLATDGPQGEDSHITTCVMGTEGYAAPEYI 260
            E  +      + ++ +D D  A++S  D   +   P                + APE +
Sbjct: 130 LEPLIPRHALNSRSVXIDEDXTARISXADVKFSFQSPGR---------XYAPAWVAPEAL 180
Query: 261 NTGHLTT---MCDVFSFGVVLLELLT 283
                 T     D +SF V+L EL+T
Sbjct: 181 QKKPEDTNRRSADXWSFAVLLWELVT 206

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 86  YLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL------DVNGSQGHREWLAEVIFLGQL 139
           ++G G +G V   C   + R G K   VA+K L      ++   + +RE    ++ L  +
Sbjct: 31  HVGSGAYGSV---CSAIDKRSGEK---VAIKKLSRPFQSEIFAKRAYRE----LLLLKHM 80
Query: 140 KHPHLVNLIGYCCEDEHRLLVYE-YMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLA 198
           +H +++ L+            Y+ Y+ +  +   L K             +     + L 
Sbjct: 81  QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLK 140
Query: 199 FLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPE 258
           ++H     V++RD K  N+ ++ D   K+ DFGLA       D+ +T  V+ T  Y APE
Sbjct: 141 YIHS--AGVVHRDLKPGNLAVNEDCELKILDFGLARHA----DAEMTGYVV-TRWYRAPE 193
Query: 259 YI-NTGHLTTMCDVFSFGVVLLELLTGR 285
            I +  H     D++S G ++ E+LTG+
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 81/176 (46%), Gaps = 15/176 (8%)
Query: 114 AVKVLDVNGSQGHREWLAEV-IFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQ 172
           AVK++D    +  R+   E+ I L   +HP+++ L     + ++  +V E    G L D+
Sbjct: 51  AVKIID----KSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDK 106
Query: 173 LFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNIL-LDSDYNA---KLS 228
           + +    +    + +   I   + + +LH +   V++RD K SNIL +D   N    ++ 
Sbjct: 107 ILRQKFFSEREASAVLFTI--TKTVEYLHAQ--GVVHRDLKPSNILYVDESGNPESIRIC 162
Query: 229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           DFG A           T C   T  + APE +        CD++S GV+L   LTG
Sbjct: 163 DFGFAKQLRAENGLLXTPCY--TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 86/333 (25%), Positives = 133/333 (39%), Gaps = 71/333 (21%)
Query: 85  DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHP-- 142
           D LGEG FGKV + C+D   + G   + VAVK++  N  +      +E+  L  L     
Sbjct: 20  DTLGEGAFGKVVE-CIDH--KAG--GRHVAVKIVK-NVDRYCEAARSEIQVLEHLNTTDP 73
Query: 143 ----HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPW-LTRI-KIAIGAARC 196
                 V ++ +     H  +V+E + L       F   +  LP+ L  I K+A    + 
Sbjct: 74  NSTFRCVQMLEWFEHHGHICIVFELLGLSTYD---FIKENGFLPFRLDHIRKMAYQICKS 130
Query: 197 LAFLHGEEKPVIYRDFKASNILL-DSDY------------------NAKLSDFGLATDGP 237
           + FLH  +  + + D K  NIL   SDY                  + K+ DFG AT   
Sbjct: 131 VNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT--- 185
Query: 238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREK 297
             +D H +T V  T  Y APE I     +  CDV+S G +L+E   G      +  K   
Sbjct: 186 -YDDEHHSTLV-STRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243
Query: 298 DLVE-----WARPMLKDFTKLDQIIDSRLE-DRYSTEGA--------------------K 331
            ++E       + M++   K       RL+ D +S+ G                     +
Sbjct: 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHE 303
Query: 332 RLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL 364
           RL  +  + L ++P  R T+   +K   P  DL
Sbjct: 304 RLFDLIQKMLEYDPAKRITLREALK--HPFFDL 334

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 114/284 (40%), Gaps = 43/284 (15%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ---GHREWLAEVIFLG 137
           +   + LG G F  V K C + +   GL+     +K      S+      +   EV  L 
Sbjct: 13  YDTGEELGSGKFA-VVKKCREKS--TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +++HP+++ L          +L+ E +A G L D L +  S T    T     I     +
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--LNGV 127
Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNA-----KLSDFGLATDGPQGEDSHITTCVMGTE 252
            +LH  +  + + D K  NI+L  D N      K+ DFGLA     G +      + GT 
Sbjct: 128 YYLHSLQ--IAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 181
Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK 312
            + APE +N   L    D++S GV+   LL+G                  A P L D TK
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGD-TK 222
Query: 313 LDQI-----IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM 351
            + +     ++   ED Y +  +        + L  +PK R T+
Sbjct: 223 QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 63/278 (22%), Positives = 108/278 (38%), Gaps = 45/278 (16%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKH--P 142
           +G GG  KV++   +       K Q  A+K +++    +Q    +  E+ +L +L+    
Sbjct: 36  IGSGGSSKVFQVLNE-------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLH-DQLFKNYSSTLPWLTRIKIAIGAARCLAFLH 201
            ++ L  Y   D++   +Y  M  GN+  +   K   S  PW  R          +  +H
Sbjct: 89  KIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLEAVHTIH 144
Query: 202 GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN 261
             +  +++ D K +N L+  D   KL DFG+A          +    +GT  Y  PE I 
Sbjct: 145 --QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIK 201
Query: 262 -----------TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF 310
                         ++   DV+S G +L  +  G+   ++               ++   
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---------------IINQI 246
Query: 311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSR 348
           +KL  IID   E  +     K L  V   CL  +PK R
Sbjct: 247 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 284

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 80  NFSRSDYLGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
            F R   LG G FG+V    +K   +      L  Q V VK+  +  +   +  L  V F
Sbjct: 43  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF 101
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
                 P LV L     ++ +  +V EY+A G +   L +    + P   R      A  
Sbjct: 102 ------PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARF---YAAQI 151
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y 
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYL 206
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           APE I +       D ++ GV++ E+  G
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 80  NFSRSDYLGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
            F R   LG G FG+V    +K   +      L  Q V VK+  +  +   +  L  V F
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF 100
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
                 P LV L     ++ +  +V EY+A G +   L +    + P   R      A  
Sbjct: 101 ------PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARF---YAAQI 150
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y 
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYL 205
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           APE I +       D ++ GV++ E+  G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 114/284 (40%), Gaps = 43/284 (15%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ---GHREWLAEVIFLG 137
           +   + LG G F  V K C + +   GL+     +K      S+      +   EV  L 
Sbjct: 13  YDTGEELGSGQFA-VVKKCREKS--TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +++HP+++ L          +L+ E +A G L D L +  S T    T     I     +
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--LNGV 127
Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNA-----KLSDFGLATDGPQGEDSHITTCVMGTE 252
            +LH  +  + + D K  NI+L  D N      K+ DFGLA     G +      + GT 
Sbjct: 128 YYLHSLQ--IAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 181
Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK 312
            + APE +N   L    D++S GV+   LL+G                  A P L D TK
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGD-TK 222
Query: 313 LDQI-----IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM 351
            + +     ++   ED Y +  +        + L  +PK R T+
Sbjct: 223 QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 87/213 (40%), Gaps = 38/213 (17%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFLGQLKHPHLV 145
           +G G F  VYKG     L      +    ++ D   ++  R+ +  E   L  L+HP++V
Sbjct: 34  IGRGSFKTVYKG-----LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIV 88
Query: 146 NLI--------GYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC- 196
                      G  C     +LV E    G L     K Y   L      KI +  + C 
Sbjct: 89  RFYDSWESTVKGKKC----IVLVTELXTSGTL-----KTY---LKRFKVXKIKVLRSWCR 136
Query: 197 -----LAFLHGEEKPVIYRDFKASNILLDSDYNA-KLSDFGLATDGPQGEDSHITTCVMG 250
                L FLH    P+I+RD K  NI +     + K+ D GLAT     + +     V+G
Sbjct: 137 QILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIG 192
Query: 251 TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           T  + APE     +  ++ DV++FG   LE  T
Sbjct: 193 TPEFXAPEXYEEKYDESV-DVYAFGXCXLEXAT 224

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 114/284 (40%), Gaps = 43/284 (15%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ---GHREWLAEVIFLG 137
           +   + LG G F  V K C + +   GL+     +K      S+      +   EV  L 
Sbjct: 13  YDTGEELGSGQFA-VVKKCREKS--TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +++HP+++ L          +L+ E +A G L D L +  S T    T     I     +
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--LNGV 127
Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNA-----KLSDFGLATDGPQGEDSHITTCVMGTE 252
            +LH  +  + + D K  NI+L  D N      K+ DFGLA     G +      + GT 
Sbjct: 128 YYLHSLQ--IAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 181
Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK 312
            + APE +N   L    D++S GV+   LL+G                  A P L D TK
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGD-TK 222
Query: 313 LDQI-----IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM 351
            + +     ++   ED Y +  +        + L  +PK R T+
Sbjct: 223 QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 114/284 (40%), Gaps = 43/284 (15%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ---GHREWLAEVIFLG 137
           +   + LG G F  V K C + +   GL+     +K      S+      +   EV  L 
Sbjct: 13  YDTGEELGSGQFA-VVKKCREKS--TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +++HP+++ L          +L+ E +A G L D L +  S T    T     I     +
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--LNGV 127
Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNA-----KLSDFGLATDGPQGEDSHITTCVMGTE 252
            +LH  +  + + D K  NI+L  D N      K+ DFGLA     G +      + GT 
Sbjct: 128 YYLHSLQ--IAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 181
Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK 312
            + APE +N   L    D++S GV+   LL+G                  A P L D TK
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGD-TK 222
Query: 313 LDQI-----IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM 351
            + +     ++   ED Y +  +        + L  +PK R T+
Sbjct: 223 QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 80  NFSRSDYLGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
            F R   LG G FG+V    +K   +      L  Q V VK+  +  +   +  L  V F
Sbjct: 29  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF 87
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
                 P LV L     ++ +  +V EY+A G +   L +    + P   R      A  
Sbjct: 88  ------PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARF---YAAQI 137
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y 
Sbjct: 138 VLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYL 192
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           APE I +       D ++ GV++ E+  G
Sbjct: 193 APEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 114/284 (40%), Gaps = 43/284 (15%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ---GHREWLAEVIFLG 137
           +   + LG G F  V K C + +   GL+     +K      S+      +   EV  L 
Sbjct: 12  YDTGEELGSGQFA-VVKKCREKS--TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +++HP+++ L          +L+ E +A G L D L +  S T    T     I     +
Sbjct: 69  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--LNGV 126
Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNA-----KLSDFGLATDGPQGEDSHITTCVMGTE 252
            +LH  +  + + D K  NI+L  D N      K+ DFGLA     G +      + GT 
Sbjct: 127 YYLHSLQ--IAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 180
Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK 312
            + APE +N   L    D++S GV+   LL+G                  A P L D TK
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGD-TK 221
Query: 313 LDQI-----IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM 351
            + +     ++   ED Y +  +        + L  +PK R T+
Sbjct: 222 QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 265

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 80  NFSRSDYLGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
            F R   LG G FG+V    +K   +      L  Q V VK+  +  +   +  L  V F
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF 100
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
                 P LV L     ++ +  +V EY+A G +   L +    + P   R      A  
Sbjct: 101 ------PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARF---YAAQI 150
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y 
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYL 205
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           APE I +       D ++ GV++ E+  G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 114/284 (40%), Gaps = 43/284 (15%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ---GHREWLAEVIFLG 137
           +   + LG G F  V K C + +   GL+     +K      S+      +   EV  L 
Sbjct: 13  YDTGEELGSGQFA-VVKKCREKS--TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +++HP+++ L          +L+ E +A G L D L +  S T    T     I     +
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--LNGV 127
Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNA-----KLSDFGLATDGPQGEDSHITTCVMGTE 252
            +LH  +  + + D K  NI+L  D N      K+ DFGLA     G +      + GT 
Sbjct: 128 YYLHSLQ--IAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 181
Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK 312
            + APE +N   L    D++S GV+   LL+G                  A P L D TK
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGD-TK 222
Query: 313 LDQI-----IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM 351
            + +     ++   ED Y +  +        + L  +PK R T+
Sbjct: 223 QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 114/284 (40%), Gaps = 43/284 (15%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ---GHREWLAEVIFLG 137
           +   + LG G F  V K C + +   GL+     +K      S+      +   EV  L 
Sbjct: 12  YDTGEELGSGQFA-VVKKCREKS--TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +++HP+++ L          +L+ E +A G L D L +  S T    T     I     +
Sbjct: 69  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--LNGV 126
Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNA-----KLSDFGLATDGPQGEDSHITTCVMGTE 252
            +LH  +  + + D K  NI+L  D N      K+ DFGLA     G +      + GT 
Sbjct: 127 YYLHSLQ--IAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 180
Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK 312
            + APE +N   L    D++S GV+   LL+G                  A P L D TK
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGD-TK 221
Query: 313 LDQI-----IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM 351
            + +     ++   ED Y +  +        + L  +PK R T+
Sbjct: 222 QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 265

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 80  NFSRSDYLGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
            F R   LG G FG+V    +K   +      L  Q V VK+  +  +   +  L  V F
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF 100
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
                 P LV L     ++ +  +V EY+A G +   L +    + P   R      A  
Sbjct: 101 ------PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARF---YAAQI 150
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y 
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYL 205
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           APE I +       D ++ GV++ E+  G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 43/278 (15%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ---GHREWLAEVIFLGQLKHPH 143
           LG G F  V K C + +   GL+     +K      S+      +   EV  L +++HP+
Sbjct: 19  LGSGQFA-VVKKCREKS--TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE 203
           ++ L          +L+ E +A G L D L +  S T    T     I     + +LH  
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLHSL 133
Query: 204 EKPVIYRDFKASNILLDSDYNA-----KLSDFGLATDGPQGEDSHITTCVMGTEGYAAPE 258
           +  + + D K  NI+L  D N      K+ DFGLA     G +      + GT  + APE
Sbjct: 134 Q--IAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPE 187
Query: 259 YINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI-- 316
            +N   L    D++S GV+   LL+G                  A P L D TK + +  
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGD-TKQETLAN 228
Query: 317 ---IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM 351
              ++   ED Y +  +        + L  +PK R T+
Sbjct: 229 VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 72/157 (45%), Gaps = 30/157 (19%)
Query: 145 VNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLP------WLTRIKIAIGAARCL 197
           +  + Y  +D++ L LV +Y   G+L   L   +   LP      +L  + IAI +   L
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLL-TLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL 194
Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFG----LATDGPQGEDSHITTCVMGTEG 253
            ++H        RD K  NIL+D + + +L+DFG    L  DG     +  ++  +GT  
Sbjct: 195 HYVH--------RDIKPDNILMDMNGHIRLADFGSCLKLMEDG-----TVQSSVAVGTPD 241
Query: 254 YAAPEYINT-----GHLTTMCDVFSFGVVLLELLTGR 285
           Y +PE +       G     CD +S GV + E+L G 
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 73/157 (46%), Gaps = 12/157 (7%)
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLF-KNYSSTLPWLTRIKIA 190
           E+  L +L HP+++ L           LV E +  G L D++  K Y S       +K  
Sbjct: 98  EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI 157
Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDS---DYNAKLSDFGLATDGPQGEDSHITTC 247
           + A   +A+LH  E  +++RD K  N+L  +   D   K++DFGL+      E   +   
Sbjct: 158 LEA---VAYLH--ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK---IVEHQVLMKT 209
Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           V GT GY APE +         D++S G++   LL G
Sbjct: 210 VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 80  NFSRSDYLGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
            F R   LG G FG+V    +K   +      L  Q V VK+  +  +   +  L  V F
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF 100
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
                 P LV L     ++ +  +V EY+A G +   L +    + P   R      A  
Sbjct: 101 ------PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARF---YAAQI 150
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y 
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYL 205
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           APE I +       D ++ GV++ E+  G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 80  NFSRSDYLGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
            F R   LG G FG+V    +K   +      L  Q V VK+  +  +   +  L  V F
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF 100
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
                 P LV L     ++ +  +V EY+A G +   L +    + P   R      A  
Sbjct: 101 ------PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARF---YAAQI 150
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y 
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYL 205
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           APE I +       D ++ GV++ E+  G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 114/284 (40%), Gaps = 43/284 (15%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ---GHREWLAEVIFLG 137
           +   + LG G F  V K C + +   GL+     +K      S+      +   EV  L 
Sbjct: 13  YDTGEELGSGQFA-VVKKCREKS--TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +++HP+++ L          +L+ E +A G L D L +  S T    T     I     +
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--LNGV 127
Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNA-----KLSDFGLATDGPQGEDSHITTCVMGTE 252
            +LH  +  + + D K  NI+L  D N      K+ DFGLA     G +      + GT 
Sbjct: 128 YYLHSLQ--IAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 181
Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK 312
            + APE +N   L    D++S GV+   LL+G                  A P L D TK
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGD-TK 222
Query: 313 LDQI-----IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM 351
            + +     ++   ED Y +  +        + L  +PK R T+
Sbjct: 223 QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 114/284 (40%), Gaps = 43/284 (15%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ---GHREWLAEVIFLG 137
           +   + LG G F  V K C + +   GL+     +K      S+      +   EV  L 
Sbjct: 13  YDTGEELGSGVFA-VVKKCREKS--TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +++HP+++ L          +L+ E +A G L D L +  S T    T     I     +
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--LNGV 127
Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNA-----KLSDFGLATDGPQGEDSHITTCVMGTE 252
            +LH  +  + + D K  NI+L  D N      K+ DFGLA     G +      + GT 
Sbjct: 128 YYLHSLQ--IAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 181
Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK 312
            + APE +N   L    D++S GV+   LL+G                  A P L D TK
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGD-TK 222
Query: 313 LDQI-----IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM 351
            + +     ++   ED Y +  +        + L  +PK R T+
Sbjct: 223 QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 18/208 (8%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFL 136
            F R   LG G FG+V    +  ++  G      A+K+LD   V   +     L E   L
Sbjct: 28  QFERIKTLGTGSFGRV---MLVKHMETG---NHYAMKILDKQKVVKLKQIEHTLNEKRIL 81
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
             +  P LV L     ++ +  +V EY+  G +   L +    + P   R      A   
Sbjct: 82  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARF---YAAQIV 137
Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L F +     +IYRD K  N+L+D     +++DFG A    + +    T C  GT  Y A
Sbjct: 138 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWTLC--GTPEYLA 192
Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTG 284
           PE I +       D ++ GV++ E+  G
Sbjct: 193 PEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 18/208 (8%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREW---LAEVIFL 136
            F R   LG G FG+V    +  ++  G      A+K+LD       +E    L E   L
Sbjct: 42  QFERIKTLGTGSFGRV---MLVKHMETG---NHYAMKILDKQKVVKLKEIEHTLNEKRIL 95
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
             +  P LV L     ++ +  +V EY   G +   L +    + P   R      A   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-HARF---YAAQIV 151
Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L F +     +IYRD K  N+++D     +++DFGLA    +G     T  + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKR-VKGR----TWXLCGTPEYLA 206
Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTG 284
           PE I +       D ++ GV++ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 96/220 (43%), Gaps = 23/220 (10%)
Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR------E 128
           Q +   +   + LG G F  + K C + +   GL+    A K +    S+  R      E
Sbjct: 8   QKVEDFYDIGEELGSGQFA-IVKKCREKS--TGLE---YAAKFIKKRQSRASRRGVCREE 61
Query: 129 WLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIK 188
              EV  L Q+ HP+++ L          +L+ E ++ G L D L +  S +    T   
Sbjct: 62  IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNI-LLDSDY---NAKLSDFGLATDGPQGEDSHI 244
             I     + +LH   K + + D K  NI LLD +    + KL DFGLA +   G +   
Sbjct: 122 KQILDG--VNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--- 174
Query: 245 TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
              + GT  + APE +N   L    D++S GV+   LL+G
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 23/216 (10%)
Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFL 136
           + + +     +G+G FG+V K   D  +      Q VA+K++  N  + HR+   E+  L
Sbjct: 95  VAYRYEVLKVIGKGSFGQVVKA-YDHKVH-----QHVALKMVR-NEKRFHRQAAEEIRIL 147
Query: 137 GQLKHP------HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA 190
             L+        ++++++       H  + +E +++ NL++ + KN           K A
Sbjct: 148 EHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFA 206
Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNA--KLSDFGLATDGPQGEDSHITTCV 248
               +CL  LH     +I+ D K  NILL     +  K+ DFG +      E   + T +
Sbjct: 207 HSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCY----EHQRVYTXI 260
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
             +  Y APE I         D++S G +L ELLTG
Sbjct: 261 Q-SRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 87/209 (41%), Gaps = 20/209 (9%)
Query: 80  NFSRSDYLGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
            F R   LG G FG+V    +K   +      L  Q V VK+  +  +   +  L  V F
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF 100
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
                 P LV L     ++ +  +V EY+A G +   L +      P   R      A  
Sbjct: 101 ------PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEP-HARF---YAAQI 150
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y 
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYL 205
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           APE I +       D ++ GV++ E+  G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 18/208 (8%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFL 136
            F R   LG G FG+V    +  ++  G      A+K+LD   V   +     L E   L
Sbjct: 43  QFERIKTLGTGSFGRV---MLVKHMETG---NHYAMKILDKQKVVKLKQIEHTLNEKRIL 96
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
             +  P LV L     ++ +  +V EY+  G +   L +    + P   R      A   
Sbjct: 97  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARF---YAAQIV 152
Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L F +     +IYRD K  N+L+D     +++DFG A    + +    T C  GT  Y A
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWTLC--GTPEYLA 207
Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTG 284
           PE I +       D ++ GV++ E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 80  NFSRSDYLGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
            F R   LG G FG+V    +K   +      L  Q V VK+  +  +   +  L  V F
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF 100
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
                 P LV L     ++ +  +V EY+A G +   L +    + P   R      A  
Sbjct: 101 ------PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARF---YAAQI 150
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L F +     +IYRD K  N+++D     +++DFG A    +G     T  + GT  Y 
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYL 205
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           APE I +       D ++ GV++ E+  G
Sbjct: 206 APEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 114/284 (40%), Gaps = 43/284 (15%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ---GHREWLAEVIFLG 137
           +   + LG G F  V K C + +   GL+     +K      S+      +   EV  L 
Sbjct: 13  YDTGEELGSGQFA-VVKKCREKS--TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +++HP+++ L          +L+ E +A G L D L +  S T    T     I     +
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--LNGV 127
Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNA-----KLSDFGLATDGPQGEDSHITTCVMGTE 252
            +LH  +  + + D K  NI+L  D N      K+ DFGLA     G +      + GT 
Sbjct: 128 YYLHSLQ--IAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 181
Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK 312
            + APE +N   L    D++S GV+   LL+G                  A P L D TK
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGD-TK 222
Query: 313 LDQI-----IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM 351
            + +     ++   ED Y +  +        + L  +PK R T+
Sbjct: 223 QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 87/209 (41%), Gaps = 20/209 (9%)
Query: 80  NFSRSDYLGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
            F R   LG G FG+V    +K   +      L  Q V VK+  +  +   +  L  V F
Sbjct: 63  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF 121
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
                 P LV L     ++ +  +V EY+A G +   L +      P   R      A  
Sbjct: 122 ------PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP-HARF---YAAQI 171
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y 
Sbjct: 172 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYL 226
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           APE I +       D ++ GV++ E+  G
Sbjct: 227 APEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 87/209 (41%), Gaps = 20/209 (9%)
Query: 80  NFSRSDYLGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
            F R   LG G FG+V    +K   +      L  Q V VK+  +  +   +  L  V F
Sbjct: 37  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF 95
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
                 P LV L     ++ +  +V EY+A G +   L +      P   R      A  
Sbjct: 96  ------PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP-HARF---YAAQI 145
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y 
Sbjct: 146 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYL 200
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           APE I +       D ++ GV++ E+  G
Sbjct: 201 APEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 87/209 (41%), Gaps = 20/209 (9%)
Query: 80  NFSRSDYLGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
            F R   LG G FG+V    +K   +      L  Q V VK+  +  +   +  L  V F
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF 100
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
                 P LV L     ++ +  +V EY+A G +   L +      P   R      A  
Sbjct: 101 ------PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP-HARF---YAAQI 150
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y 
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYL 205
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           APE I +       D ++ GV++ E+  G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 114/284 (40%), Gaps = 43/284 (15%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ---GHREWLAEVIFLG 137
           +   + LG G F  V K C + +   GL+     +K      S+      +   EV  L 
Sbjct: 13  YDTGEELGSGQFA-VVKKCREKS--TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +++HP+++ L          +L+ E +A G L D L +  S T    T     I     +
Sbjct: 70  EIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQI--LNGV 127
Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNA-----KLSDFGLATDGPQGEDSHITTCVMGTE 252
            +LH  +  + + D K  NI+L  D N      K+ DFGLA     G +      + GT 
Sbjct: 128 YYLHSLQ--IAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 181
Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK 312
            + APE +N   L    D++S GV+   LL+G                  A P L D TK
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGD-TK 222
Query: 313 LDQI-----IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM 351
            + +     ++   ED Y +  +        + L  +PK R T+
Sbjct: 223 QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 18/208 (8%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFL 136
            F R   +G G FG+V    +  ++  G      A+K+LD   V   +     L E   L
Sbjct: 42  QFERIKTIGTGSFGRV---MLVKHMETG---NHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
             +  P LV L     ++ +  +V EY+  G +   L +    + P   R      A   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARF---YAAQIV 151
Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L F +     +IYRD K  N+L+D     K++DFG A    +G     T  + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKR-VKGR----TWXLCGTPEYLA 206
Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTG 284
           PE I +       D ++ GV++ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 87/209 (41%), Gaps = 20/209 (9%)
Query: 80  NFSRSDYLGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
            F R   LG G FG+V    +K   +      L  Q V VK+  +  +   +  L  V F
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF 100
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
                 P LV L     ++ +  +V EY+A G +   L +      P   R      A  
Sbjct: 101 ------PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP-HARF---YAAQI 150
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y 
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYL 205
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           APE I +       D ++ GV++ E+  G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 23/216 (10%)
Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFL 136
           + + +     +G+G FG+V K   D  +      Q VA+K++  N  + HR+   E+  L
Sbjct: 95  VAYRYEVLKVIGKGSFGQVVKA-YDHKVH-----QHVALKMVR-NEKRFHRQAAEEIRIL 147
Query: 137 GQLKHP------HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA 190
             L+        ++++++       H  + +E +++ NL++ + KN           K A
Sbjct: 148 EHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFA 206
Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNA--KLSDFGLATDGPQGEDSHITTCV 248
               +CL  LH  +  +I+ D K  NILL     +  K+ DFG +      E   + T +
Sbjct: 207 HSILQCLDALH--KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY----EHQRVYTXI 260
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
             +  Y APE I         D++S G +L ELLTG
Sbjct: 261 Q-SRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 87/209 (41%), Gaps = 20/209 (9%)
Query: 80  NFSRSDYLGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
            F R   LG G FG+V    +K   +      L  Q V VK+  +  +   +  L  V F
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF 100
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
                 P LV L     ++ +  +V EY+A G +   L +      P   R      A  
Sbjct: 101 ------PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP-HARF---YAAQI 150
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y 
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYL 205
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           APE I +       D ++ GV++ E+  G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 80  NFSRSDYLGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
            F R   LG G FG+V    +K   +      L  Q V VK+  +  +   +  L  V F
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF 100
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
                 P LV L     ++ +  +V EY+A G +   L +    + P   R      A  
Sbjct: 101 ------PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARF---YAAQI 150
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y 
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYL 205
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           APE I +       D ++ GV++ ++  G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 25/218 (11%)
Query: 72  KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA 131
           +E+   TH       LG G FG+V++  ++D  + G +     V+ L+V  ++       
Sbjct: 71  EEVHWATHQLR----LGRGSFGEVHR--MEDK-QTGFQCAVKKVR-LEVFRAE------- 115
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI 191
           E++    L  P +V L G   E     +  E +  G+L  QL K     LP    +    
Sbjct: 116 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLVKE-QGCLPEDRALYYLG 173
Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSD-YNAKLSDFG----LATDGPQGEDSHITT 246
            A   L +LH   + +++ D KA N+LL SD  +A L DFG    L  DG  G+D     
Sbjct: 174 QALEGLEYLH--SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDG-LGKDLLTGD 230
Query: 247 CVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            + GTE + APE +         DV+S   ++L +L G
Sbjct: 231 YIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 76/185 (41%), Gaps = 29/185 (15%)
Query: 187 IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITT 246
           I  +   A+ + FL    +  I+RD  A NILL      K+ DFGLA D  +  D     
Sbjct: 203 ICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 260
Query: 247 CVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS------VEKNRCKREKDLV 300
                  + APE I     T   DV+SFGV+L E+ +   S      +++  C+R     
Sbjct: 261 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR----- 315
Query: 301 EWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEP 360
                 LK+ T++      R  D  + E    +      C    P  RPT + +V+ L  
Sbjct: 316 ------LKEGTRM------RAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHLGN 359
Query: 361 LLDLN 365
           LL  N
Sbjct: 360 LLQAN 364

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/278 (22%), Positives = 108/278 (38%), Gaps = 45/278 (16%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKH--P 142
           +G GG  KV++   +       K Q  A+K +++    +Q    +  E+ +L +L+    
Sbjct: 64  IGSGGSSKVFQVLNE-------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLH-DQLFKNYSSTLPWLTRIKIAIGAARCLAFLH 201
            ++ L  Y   D++   +Y  M  GN+  +   K   S  PW  R          +  +H
Sbjct: 117 KIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLEAVHTIH 172
Query: 202 GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN 261
             +  +++ D K +N L+  D   KL DFG+A        S +    +G   Y  PE I 
Sbjct: 173 --QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229
Query: 262 -----------TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF 310
                         ++   DV+S G +L  +  G+   ++               ++   
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---------------IINQI 274
Query: 311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSR 348
           +KL  IID   E  +     K L  V   CL  +PK R
Sbjct: 275 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 312

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 76/185 (41%), Gaps = 29/185 (15%)
Query: 187 IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITT 246
           I  +   A+ + FL    +  I+RD  A NILL      K+ DFGLA D  +  D     
Sbjct: 196 ICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253
Query: 247 CVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS------VEKNRCKREKDLV 300
                  + APE I     T   DV+SFGV+L E+ +   S      +++  C+R     
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR----- 308
Query: 301 EWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEP 360
                 LK+ T++      R  D  + E    +      C    P  RPT + +V+ L  
Sbjct: 309 ------LKEGTRM------RAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHLGN 352
Query: 361 LLDLN 365
           LL  N
Sbjct: 353 LLQAN 357

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 76/185 (41%), Gaps = 29/185 (15%)
Query: 187 IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITT 246
           I  +   A+ + FL    +  I+RD  A NILL      K+ DFGLA D  +  D     
Sbjct: 201 ICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 258
Query: 247 CVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS------VEKNRCKREKDLV 300
                  + APE I     T   DV+SFGV+L E+ +   S      +++  C+R     
Sbjct: 259 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR----- 313
Query: 301 EWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEP 360
                 LK+ T++      R  D  + E    +      C    P  RPT + +V+ L  
Sbjct: 314 ------LKEGTRM------RAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHLGN 357
Query: 361 LLDLN 365
           LL  N
Sbjct: 358 LLQAN 362

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 76/185 (41%), Gaps = 29/185 (15%)
Query: 187 IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITT 246
           I  +   A+ + FL    +  I+RD  A NILL      K+ DFGLA D  +  D     
Sbjct: 194 ICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 251
Query: 247 CVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS------VEKNRCKREKDLV 300
                  + APE I     T   DV+SFGV+L E+ +   S      +++  C+R     
Sbjct: 252 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR----- 306
Query: 301 EWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEP 360
                 LK+ T++      R  D  + E    +      C    P  RPT + +V+ L  
Sbjct: 307 ------LKEGTRM------RAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHLGN 350
Query: 361 LLDLN 365
           LL  N
Sbjct: 351 LLQAN 355

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 25/218 (11%)
Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFL 136
             + + + +GEG +G V+K    +        + VA+K   LD +        L E+  L
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRET------HEIVALKRVRLDDDDEGVPSSALREICLL 55
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTL-----PWLTRIKIAI 191
            +LKH ++V L      D+   LV+E+       DQ  K Y  +      P + +     
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFC------DQDLKKYFDSCNGDLDPEIVK-SFLF 108
Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
              + L F H     V++RD K  N+L++ +   KL++FGLA     G      +  + T
Sbjct: 109 QLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAF--GIPVRCYSAEVVT 164
Query: 252 EGYAAPEYINTGHL-TTMCDVFSFGVVLLELLTGRRSV 288
             Y  P+ +    L +T  D++S G +  EL    R +
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 87/208 (41%), Gaps = 18/208 (8%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFL 136
            F R   LG G FG+V    +  ++  G      A+K+LD   V   +     L E   L
Sbjct: 42  QFERIKTLGTGSFGRV---MLVKHMETG---NHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
             +  P LV L     ++ +  +V EY   G +   L +    + P   R      A   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-HARF---YAAQIV 151
Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L F +     +IYRD K  N+++D     K++DFG A    +G     T  + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR-VKGR----TWXLCGTPEYLA 206
Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTG 284
           PE I +       D ++ GV++ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 18/208 (8%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFL 136
            F R   LG G FG+V    +  ++  G      A+K+LD   V   +     L E   L
Sbjct: 43  QFERIKTLGTGSFGRV---MLVKHMETG---NHYAMKILDKQKVVKLKQIEHTLNEKRIL 96
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
             +  P LV L     ++ +  +V EY+  G +   L +    + P   R      A   
Sbjct: 97  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARF---YAAQIV 152
Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y A
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLA 207
Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTG 284
           PE I +       D ++ GV++ E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 33/222 (14%)
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI 191
           E+  L +L HP ++ +  +  + E   +V E M  G L D++  N         R+K A 
Sbjct: 71  EIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGN--------KRLKEAT 121
Query: 192 GA----ARCLAFLHGEEKPVIYRDFKASNILLDS---DYNAKLSDFGLATDGPQGEDSHI 244
                    LA  +  E  +I+RD K  N+LL S   D   K++DFG +     GE S +
Sbjct: 122 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLM 179
Query: 245 TTCVMGTEGYAAPEY---INTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE-KDLV 300
            T + GT  Y APE    + T       D +S GV+L   L+G     ++R +   KD +
Sbjct: 180 RT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI 238
Query: 301 E----------WARPMLKDFTKLDQIIDSRLEDRYSTEGAKR 332
                      WA    K    + +++    + R++TE A R
Sbjct: 239 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 280

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 18/208 (8%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFL 136
            F R   LG G FG+V    +  ++  G      A+K+LD   V   +     L E   L
Sbjct: 42  QFERIKTLGTGSFGRV---MLVKHMETG---NHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
             +  P LV L     ++ +  +V EY+  G +   L +    + P   R      A   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARF---YAAQIV 151
Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLA 206
Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTG 284
           PE I +       D ++ GV++ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 18/208 (8%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFL 136
            F R   LG G FG+V    +  ++  G      A+K+LD   V   +     L E   L
Sbjct: 42  QFERIKTLGTGSFGRV---MLVKHMETG---NHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
             +  P LV L     ++ +  +V EY+  G +   L +    + P   R      A   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARF---YAAQIV 151
Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLA 206
Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTG 284
           PE I +       D ++ GV++ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 18/208 (8%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFL 136
            F R   LG G FG+V    +  ++  G      A+K+LD   V   +     L E   L
Sbjct: 42  QFERIKTLGTGSFGRV---MLVKHMETG---NHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
             +  P LV L     ++ +  +V EY+  G +   L +    + P   R      A   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARF---YAAQIV 151
Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLA 206
Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTG 284
           PE I +       D ++ GV++ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 33/222 (14%)
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI 191
           E+  L +L HP ++ +  +  + E   +V E M  G L D++  N         R+K A 
Sbjct: 65  EIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGN--------KRLKEAT 115
Query: 192 GA----ARCLAFLHGEEKPVIYRDFKASNILLDS---DYNAKLSDFGLATDGPQGEDSHI 244
                    LA  +  E  +I+RD K  N+LL S   D   K++DFG +     GE S +
Sbjct: 116 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLM 173
Query: 245 TTCVMGTEGYAAPEY---INTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE-KDLV 300
            T + GT  Y APE    + T       D +S GV+L   L+G     ++R +   KD +
Sbjct: 174 RT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI 232
Query: 301 E----------WARPMLKDFTKLDQIIDSRLEDRYSTEGAKR 332
                      WA    K    + +++    + R++TE A R
Sbjct: 233 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 5/95 (5%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD--GPQGEDSHITTCVMGTE 252
           R L ++H  +  VI+RD K SN+L++ +   K+ DFG+A        E  +  T  + T 
Sbjct: 170 RGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 227
Query: 253 GYAAPEYINTGH-LTTMCDVFSFGVVLLELLTGRR 286
            Y APE + + H  T   D++S G +  E+L  R+
Sbjct: 228 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 20/209 (9%)
Query: 80  NFSRSDYLGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
            F R   LG G FG+V    +K   +      L  Q V VK+  +  +   +  L  V F
Sbjct: 35  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF 93
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
                 P LV L     ++ +  +V EY+  G +   L +    + P   R      A  
Sbjct: 94  ------PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARF---YAAQI 143
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y 
Sbjct: 144 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYL 198
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           APE I +       D ++ GV++ E+  G
Sbjct: 199 APEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGH--REWLAEVIFLGQLKHPHL 144
           +GEG +G VYK    +N       +T A+K + +           + E+  L +LKH ++
Sbjct: 10  IGEGTYGVVYKA--QNNY-----GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 145 VNLIGYCCEDEHRLLVYEYMA--LGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
           V L       +  +LV+E++   L  L D       S       +++  G A C      
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC------ 116
Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI-N 261
            ++ V++RD K  N+L++ +   K++DFGLA     G      T  + T  Y AP+ +  
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLAR--AFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 262 TGHLTTMCDVFSFGVVLLELLTG 284
           +   +T  D++S G +  E++ G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 33/222 (14%)
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI 191
           E+  L +L HP ++ +  +  + E   +V E M  G L D++  N         R+K A 
Sbjct: 65  EIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGN--------KRLKEAT 115
Query: 192 GA----ARCLAFLHGEEKPVIYRDFKASNILLDS---DYNAKLSDFGLATDGPQGEDSHI 244
                    LA  +  E  +I+RD K  N+LL S   D   K++DFG +     GE S +
Sbjct: 116 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLM 173
Query: 245 TTCVMGTEGYAAPEY---INTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE-KDLV 300
            T + GT  Y APE    + T       D +S GV+L   L+G     ++R +   KD +
Sbjct: 174 RT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI 232
Query: 301 E----------WARPMLKDFTKLDQIIDSRLEDRYSTEGAKR 332
                      WA    K    + +++    + R++TE A R
Sbjct: 233 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 5/95 (5%)
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD--GPQGEDSHITTCVMGTE 252
           R L ++H  +  VI+RD K SN+L++ +   K+ DFG+A        E  +  T  + T 
Sbjct: 169 RGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 226
Query: 253 GYAAPEYINTGH-LTTMCDVFSFGVVLLELLTGRR 286
            Y APE + + H  T   D++S G +  E+L  R+
Sbjct: 227 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGH--REWLAEVIFLGQLKHPHL 144
           +GEG +G VYK    +N       +T A+K + +           + E+  L +LKH ++
Sbjct: 10  IGEGTYGVVYKA--QNNY-----GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 145 VNLIGYCCEDEHRLLVYEYMA--LGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
           V L       +  +LV+E++   L  L D       S       +++  G A C      
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC------ 116
Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI-N 261
            ++ V++RD K  N+L++ +   K++DFGLA     G      T  + T  Y AP+ +  
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLAR--AFGIPVRKYTHEVVTLWYRAPDVLMG 174
Query: 262 TGHLTTMCDVFSFGVVLLELLTG 284
           +   +T  D++S G +  E++ G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 33/222 (14%)
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI 191
           E+  L +L HP ++ +  +  + E   +V E M  G L D++  N         R+K A 
Sbjct: 64  EIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGN--------KRLKEAT 114
Query: 192 GA----ARCLAFLHGEEKPVIYRDFKASNILLDS---DYNAKLSDFGLATDGPQGEDSHI 244
                    LA  +  E  +I+RD K  N+LL S   D   K++DFG +     GE S +
Sbjct: 115 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLM 172
Query: 245 TTCVMGTEGYAAPEY---INTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE-KDLV 300
            T + GT  Y APE    + T       D +S GV+L   L+G     ++R +   KD +
Sbjct: 173 RT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI 231
Query: 301 E----------WARPMLKDFTKLDQIIDSRLEDRYSTEGAKR 332
                      WA    K    + +++    + R++TE A R
Sbjct: 232 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 273

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 20/209 (9%)
Query: 80  NFSRSDYLGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
            F R   LG G FG+V    +K   +      L  Q V VK+  +  +   +  L  V F
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF 101
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
                 P LV L     ++ +  +V EY+  G +   L +    + P   R      A  
Sbjct: 102 ------PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARF---YAAQI 151
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y 
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYL 206
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           APE I +       D ++ GV++ E+  G
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 33/222 (14%)
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI 191
           E+  L +L HP ++ +  +  + E   +V E M  G L D++  N         R+K A 
Sbjct: 65  EIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGN--------KRLKEAT 115
Query: 192 GA----ARCLAFLHGEEKPVIYRDFKASNILLDS---DYNAKLSDFGLATDGPQGEDSHI 244
                    LA  +  E  +I+RD K  N+LL S   D   K++DFG +     GE S +
Sbjct: 116 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLM 173
Query: 245 TTCVMGTEGYAAPEY---INTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE-KDLV 300
            T + GT  Y APE    + T       D +S GV+L   L+G     ++R +   KD +
Sbjct: 174 RT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI 232
Query: 301 E----------WARPMLKDFTKLDQIIDSRLEDRYSTEGAKR 332
                      WA    K    + +++    + R++TE A R
Sbjct: 233 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 87/209 (41%), Gaps = 20/209 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFL 136
            F R   LG G FG+V        ++        A+K+LD   V   +     L E   L
Sbjct: 42  QFERIKTLGTGSFGRVML------VKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 137 GQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
             +  P LV L  Y  +D   L +V EY+  G +   L +    + P   R      A  
Sbjct: 96  QAVNFPFLVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARF---YAAQI 150
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y 
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYL 205
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           APE I +       D ++ GV++ E+  G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 20/209 (9%)
Query: 80  NFSRSDYLGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
            F R   LG G FG+V    +K   +      L  Q V VK+  +  +   +  L  V F
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF 101
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
                 P LV L     ++ +  +V EY+  G +   L +    + P   R      A  
Sbjct: 102 ------PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARF---YAAQI 151
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y 
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYL 206
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           APE I +       D ++ GV++ E+  G
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGH--REWLAEVIFLGQLKHPHL 144
           +GEG +G VYK    +N       +T A+K + +           + E+  L +LKH ++
Sbjct: 10  IGEGTYGVVYKA--QNNY-----GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 145 VNLIGYCCEDEHRLLVYEYMA--LGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
           V L       +  +LV+E++   L  L D       S       +++  G A C      
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC------ 116
Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI-N 261
            ++ V++RD K  N+L++ +   K++DFGLA     G      T  + T  Y AP+ +  
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLAR--AFGIPVRKYTHEVVTLWYRAPDVLMG 174
Query: 262 TGHLTTMCDVFSFGVVLLELLTG 284
           +   +T  D++S G +  E++ G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 83/162 (51%), Gaps = 18/162 (11%)
Query: 132 EVIFLGQLKHPHLVNLIGYCCE--DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKI 189
           E+  L +L HP++V L+    +  ++H  +V+E +  G + +        TL  L+  + 
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME------VPTLKPLSEDQA 139
Query: 190 AI---GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITT 246
                   + + +LH ++  +I+RD K SN+L+  D + K++DFG++ +  +G D+ ++ 
Sbjct: 140 RFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEF-KGSDALLSN 196
Query: 247 CVMGTEGYAAPEYINTGHLT---TMCDVFSFGVVLLELLTGR 285
            V GT  + APE ++           DV++ GV L   + G+
Sbjct: 197 TV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 20/209 (9%)
Query: 80  NFSRSDYLGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
            F R   LG G FG+V    +K   +      L  Q V VK+  +  +   +  L  V F
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF 101
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
                 P LV L     ++ +  +V EY+  G +   L +    + P   R      A  
Sbjct: 102 ------PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARF---YAAQI 151
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y 
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYL 206
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           APE I +       D ++ GV++ E+  G
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 87/209 (41%), Gaps = 20/209 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFL 136
            F R   LG G FG+V        ++        A+K+LD   V   +     L E   L
Sbjct: 42  QFERIKTLGTGSFGRVML------VKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 137 GQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
             +  P LV L  Y  +D   L +V EY+  G +   L +    + P   R      A  
Sbjct: 96  QAVNFPFLVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARF---YAAQI 150
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y 
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYL 205
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           APE I +       D ++ GV++ E+  G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 24/211 (11%)
Query: 80  NFSRSDYLGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
            F R   LG G FG+V    +K   +      L  Q V VK+  +  +   +  L  V F
Sbjct: 63  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF 121
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK--NYSSTLPWLTRIKIAIGA 193
                 P LV L     ++ +  +V EY+  G +   L +   +S         +I +  
Sbjct: 122 ------PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL-- 173
Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
                +LH  +  +IYRD K  N+L+D     +++DFG A    +G     T  + GT  
Sbjct: 174 --TFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPE 224
Query: 254 YAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           Y APE I +       D ++ GV++ E+  G
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 86/209 (41%), Gaps = 20/209 (9%)
Query: 80  NFSRSDYLGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
            F R   LG G FG+V    +K   +      L  Q V VK+  +  +   +  L  V F
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF 101
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
                 P LV L     ++ +  +V EY   G +   L +    + P   R      A  
Sbjct: 102 ------PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-HARF---YAAQI 151
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L F +     +IYRD K  N+++D     K++DFG A    +G     T  + GT  Y 
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR-VKGR----TWXLCGTPEYL 206
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           APE I +       D ++ GV++ E+  G
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 33/222 (14%)
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI 191
           E+  L +L HP ++ +  +  + E   +V E M  G L D++  N         R+K A 
Sbjct: 204 EIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGN--------KRLKEAT 254
Query: 192 GA----ARCLAFLHGEEKPVIYRDFKASNILLDS---DYNAKLSDFGLATDGPQGEDSHI 244
                    LA  +  E  +I+RD K  N+LL S   D   K++DFG +     GE S +
Sbjct: 255 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLM 312
Query: 245 TTCVMGTEGYAAPEY---INTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE-KDLV 300
            T + GT  Y APE    + T       D +S GV+L   L+G     ++R +   KD +
Sbjct: 313 RT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI 371
Query: 301 E----------WARPMLKDFTKLDQIIDSRLEDRYSTEGAKR 332
                      WA    K    + +++    + R++TE A R
Sbjct: 372 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 413

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 87/209 (41%), Gaps = 20/209 (9%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFL 136
            F R   LG G FG+V        ++        A+K+LD   V   +     L E   L
Sbjct: 42  QFERIKTLGTGSFGRVML------VKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 137 GQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
             +  P LV L  Y  +D   L +V EY+  G +   L +    + P   R      A  
Sbjct: 96  QAVNFPFLVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARF---YAAQI 150
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y 
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYL 205
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           APE I +       D ++ GV++ E+  G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 78/173 (45%), Gaps = 22/173 (12%)
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI 191
           E+  L +L HP ++ +  +  + E   +V E M  G L D++  N         R+K A 
Sbjct: 190 EIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGN--------KRLKEAT 240
Query: 192 GA----ARCLAFLHGEEKPVIYRDFKASNILLDS---DYNAKLSDFGLATDGPQGEDSHI 244
                    LA  +  E  +I+RD K  N+LL S   D   K++DFG +     GE S +
Sbjct: 241 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLM 298
Query: 245 TTCVMGTEGYAAPEY---INTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCK 294
            T + GT  Y APE    + T       D +S GV+L   L+G     ++R +
Sbjct: 299 RT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 350

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 104/258 (40%), Gaps = 47/258 (18%)
Query: 141 HPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLF---KNYSSTLPWLTRIKIAIGAARCL 197
           HP+++    YC E   R L Y  + L NL+ Q     KN S     L +    I   R +
Sbjct: 86  HPNVIRY--YCSETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 142
Query: 198 A--FLHGEEKPVIYRDFKASNILL--DSDYNAK-----------LSDFGLATDGPQGEDS 242
           A    H     +I+RD K  NIL+   S + A            +SDFGL      G+  
Sbjct: 143 ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 202
Query: 243 HITTC--VMGTEGYAAPEYINTG---HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREK 297
                    GT G+ APE +       LT   D+FS G V   +L+  +    ++  RE 
Sbjct: 203 FRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 262
Query: 298 DLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVV-- 355
           +++       +    LD++    L DR     A  L +   Q + H+P  RPT   V+  
Sbjct: 263 NII-------RGIFSLDEM--KCLHDRSLIAEATDLIS---QMIDHDPLKRPTAMKVLRH 310
Query: 356 -------KALEPLLDLND 366
                  K LE LL ++D
Sbjct: 311 PLFWPKSKKLEFLLKVSD 328

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 104/258 (40%), Gaps = 47/258 (18%)
Query: 141 HPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLF---KNYSSTLPWLTRIKIAIGAARCL 197
           HP+++    YC E   R L Y  + L NL+ Q     KN S     L +    I   R +
Sbjct: 86  HPNVIRY--YCSETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 142
Query: 198 A--FLHGEEKPVIYRDFKASNILL--DSDYNAK-----------LSDFGLATDGPQGEDS 242
           A    H     +I+RD K  NIL+   S + A            +SDFGL      G+  
Sbjct: 143 ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 202
Query: 243 HITTC--VMGTEGYAAPEYINTG---HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREK 297
                    GT G+ APE +       LT   D+FS G V   +L+  +    ++  RE 
Sbjct: 203 FRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 262
Query: 298 DLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVV-- 355
           +++       +    LD++    L DR     A  L +   Q + H+P  RPT   V+  
Sbjct: 263 NII-------RGIFSLDEM--KCLHDRSLIAEATDLIS---QMIDHDPLKRPTAMKVLRH 310
Query: 356 -------KALEPLLDLND 366
                  K LE LL ++D
Sbjct: 311 PLFWPKSKKLEFLLKVSD 328

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 87/208 (41%), Gaps = 18/208 (8%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFL 136
            F R   LG G FG+V    +  ++  G      A+K+LD   V   +     L E   L
Sbjct: 43  QFERIKTLGTGSFGRV---MLVKHMETG---NHYAMKILDKQKVVKLKQIEHTLNEKRIL 96
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
             +  P LV L     ++ +  +V EY+  G +   L +      P   R      A   
Sbjct: 97  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP-HARF---YAAQIV 152
Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y A
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLA 207
Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTG 284
           PE I +       D ++ GV++ E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 97/245 (39%), Gaps = 38/245 (15%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           N+     +G G +G VY    D N    +  + V     D+      +  L E+  L +L
Sbjct: 29  NYEIKHLIGRGSYGYVYLA-YDKNANKNVAIKKVNRMFEDLIDC---KRILREITILNRL 84
Query: 140 KHPHLVNLIGYCCEDEHRLLVYE--YMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           K  +++ L      ++  LL ++  Y+ L  + D   K    T  +LT   +       L
Sbjct: 85  KSDYIIRLHDLIIPED--LLKFDELYIVL-EIADSDLKKLFKTPIFLTEQHVKTILYNLL 141
Query: 198 ---AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHIT--------- 245
               F+H  E  +I+RD K +N LL+ D + K+ DFGLA      +D HI          
Sbjct: 142 LGEKFIH--ESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEEN 199
Query: 246 --------------TCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGRRSVEK 290
                         T  + T  Y APE I    + T   D++S G +  ELL   +S   
Sbjct: 200 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHIN 259
Query: 291 NRCKR 295
           N   R
Sbjct: 260 NPTNR 264

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 87/208 (41%), Gaps = 18/208 (8%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFL 136
            F R   LG G FG+V    +  ++  G      A+K+LD   V   +     L E   L
Sbjct: 42  QFERIKTLGTGSFGRV---MLVKHMETG---NHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
             +  P LV L     ++ +  +V EY+  G +   L +      P   R      A   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP-HARF---YAAQIV 151
Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLA 206
Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTG 284
           PE I +       D ++ GV++ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 87/208 (41%), Gaps = 18/208 (8%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFL 136
            F R   LG G FG+V    +  ++  G      A+K+LD   V   +     L E   L
Sbjct: 42  QFERIKTLGTGSFGRV---MLVKHMETG---NHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
             +  P LV L     ++ +  +V EY+  G +   L +      P   R      A   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP-HARF---YAAQIV 151
Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLA 206
Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTG 284
           PE I +       D ++ GV++ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 85/333 (25%), Positives = 132/333 (39%), Gaps = 71/333 (21%)
Query: 85  DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHP-- 142
           D LGEG FGKV + C+D   + G   + VAVK++  N  +      +E+  L  L     
Sbjct: 20  DTLGEGAFGKVVE-CIDH--KAG--GRHVAVKIVK-NVDRYCEAARSEIQVLEHLNTTDP 73
Query: 143 ----HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPW-LTRI-KIAIGAARC 196
                 V ++ +     H  +V+E + L       F   +  LP+ L  I K+A    + 
Sbjct: 74  NSTFRCVQMLEWFEHHGHICIVFELLGLSTYD---FIKENGFLPFRLDHIRKMAYQICKS 130
Query: 197 LAFLHGEEKPVIYRDFKASNILL-DSDY------------------NAKLSDFGLATDGP 237
           + FLH  +  + + D K  NIL   SDY                  + K+ DFG AT   
Sbjct: 131 VNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT--- 185
Query: 238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREK 297
             +D H +T V     Y APE I     +  CDV+S G +L+E   G      +  K   
Sbjct: 186 -YDDEHHSTLVX-XRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243
Query: 298 DLVE-----WARPMLKDFTKLDQIIDSRLE-DRYSTEGA--------------------K 331
            ++E       + M++   K       RL+ D +S+ G                     +
Sbjct: 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHE 303
Query: 332 RLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL 364
           RL  +  + L ++P  R T+   +K   P  DL
Sbjct: 304 RLFDLIQKMLEYDPAKRITLREALK--HPFFDL 334

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 86/208 (41%), Gaps = 18/208 (8%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFL 136
            F R   LG G FG+V    +  ++  G      A+K+LD   V   +     L E   L
Sbjct: 42  QFERIKTLGTGSFGRV---MLVKHMETG---NHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
             +  P LV L     ++ +  +V EY   G +   L +      P   R      A   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEP-HARF---YAAQIV 151
Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L F +     +IYRD K  N+++D     K++DFG A    +G     T  + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR-VKGR----TWXLCGTPEYLA 206
Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTG 284
           PE I +       D ++ GV++ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/79 (39%), Positives = 44/79 (55%), Gaps = 5/79 (6%)
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
           +I+RD K SNI++ SD   K+ DFGLA T G     S + T  + T  Y APE I     
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAG----TSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 266 TTMCDVFSFGVVLLELLTG 284
               D++S GV++ E++ G
Sbjct: 203 KENVDIWSVGVIMGEMIKG 221

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/79 (39%), Positives = 44/79 (55%), Gaps = 5/79 (6%)
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
           +I+RD K SNI++ SD   K+ DFGLA T G     S + T  + T  Y APE I     
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAG----TSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 266 TTMCDVFSFGVVLLELLTG 284
               D++S GV++ E++ G
Sbjct: 203 KENVDIWSVGVIMGEMIKG 221

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 28/218 (12%)
Query: 83  RSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-H 141
           + D LGEG   +V + C+  NL   + +Q  AVK+++            EV  L Q + H
Sbjct: 17  QEDVLGEGAHARV-QTCI--NL---ITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 142 PHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLH 201
            +++ LI +  E++   LV+E M  G++   + K        L    +    A  L FLH
Sbjct: 71  RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLH 128
Query: 202 GEEKPVIYRDFKASNILLDSDYNA---KLSDFGLATD-------GPQGEDSHITTCVMGT 251
              K + +RD K  NIL +        K+ DFGL +         P      +T C  G+
Sbjct: 129 N--KGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPC--GS 184
Query: 252 EGYAAPEYINT-----GHLTTMCDVFSFGVVLLELLTG 284
             Y APE +             CD++S GV+L  LL+G
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 86/209 (41%), Gaps = 20/209 (9%)
Query: 80  NFSRSDYLGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
            F R   LG G FG+V    +K   +      L  Q V VK+  +  +   +  L  V F
Sbjct: 35  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF 93
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
                 P LV L     ++ +  +V EY+  G +   L +      P   R      A  
Sbjct: 94  ------PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP-HARF---YAAQI 143
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y 
Sbjct: 144 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYL 198
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           APE I +       D ++ GV++ E+  G
Sbjct: 199 APEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 97/237 (40%), Gaps = 35/237 (14%)
Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFL 136
           +  N+     +G G +G VY    D N    +  + V     D+      +  L E+  L
Sbjct: 24  VPDNYIIKHLIGRGSYGYVYLA-YDKNTEKNVAIKKVNRMFEDLIDC---KRILREITIL 79
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYE--YMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA 194
            +LK  +++ L      D+  LL ++  Y+ L  + D   K    T  +LT   I     
Sbjct: 80  NRLKSDYIIRLYDLIIPDD--LLKFDELYIVL-EIADSDLKKLFKTPIFLTEEHIKTILY 136
Query: 195 RCL---AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHIT------ 245
             L    F+H  E  +I+RD K +N LL+ D + K+ DFGLA      +D++I       
Sbjct: 137 NLLLGENFIH--ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 246 --------------TCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGRRS 287
                         T  + T  Y APE I    + T   D++S G +  ELL   +S
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 20/209 (9%)
Query: 80  NFSRSDYLGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
            F R   LG G FG+V    +K   +      L  Q V VK+  +  +   +  L  V F
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF 100
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
                 P LV L     ++ +  +V EY+A G +   L +    + P   R      A  
Sbjct: 101 ------PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARF---YAAQI 150
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT  Y 
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYL 205
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           AP  I +       D ++ GV++ E+  G
Sbjct: 206 APAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 87/208 (41%), Gaps = 18/208 (8%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFL 136
            F R   LG G FG+V    +  ++  G      A+K+LD   V   +     L E   L
Sbjct: 42  QFERIKTLGTGSFGRV---MLVKHMETG---NHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
             +  P LV L     ++ +  +V EY   G +   L +    + P   R      A   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-HARF---YAAQIV 151
Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L F +     +IYRD K  N+++D     +++DFG A    +G     T  + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLA 206
Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTG 284
           PE I +       D ++ GV++ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 23/216 (10%)
Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFL 136
           + + +     +G+G FG+V K   D  +      Q VA+K++  N  + HR+   E+  L
Sbjct: 95  VAYRYEVLKVIGKGXFGQVVKA-YDHKVH-----QHVALKMVR-NEKRFHRQAAEEIRIL 147
Query: 137 GQLKHP------HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA 190
             L+        ++++++       H  + +E +++ NL++ + KN           K A
Sbjct: 148 EHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFA 206
Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNA--KLSDFGLATDGPQGEDSHITTCV 248
               +CL  LH     +I+ D K  NILL     +  K+ DFG +       +       
Sbjct: 207 HSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSC-----YEHQRVYXX 259
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           + +  Y APE I         D++S G +L ELLTG
Sbjct: 260 IQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 23/217 (10%)
Query: 72  KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA 131
           +E+   TH       LG G FG+V++  ++D  + G +     V+ L+V  ++       
Sbjct: 90  EEVHWATHQLR----LGRGSFGEVHR--MEDK-QTGFQCAVKKVR-LEVFRAE------- 134
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI 191
           E++    L  P +V L G   E     +  E +  G+L  QL K     LP    +    
Sbjct: 135 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLVKE-QGCLPEDRALYYLG 192
Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSD-YNAKLSDFGLATD-GPQGEDSHITTC-- 247
            A   L +LH   + +++ D KA N+LL SD  +A L DFG A    P G    + T   
Sbjct: 193 QALEGLEYLH--SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDY 250
Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           + GTE + APE +         DV+S   ++L +L G
Sbjct: 251 IPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 87/218 (39%), Gaps = 38/218 (17%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
            F R   LG G FG+V        ++        A+K+LD            +V+ L Q+
Sbjct: 43  QFERIRTLGTGSFGRVML------VKHKETGNHYAMKILDKQ----------KVVKLKQI 86
Query: 140 KH-------------PHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTR 186
           +H             P LV L     ++ +  +V EY   G +   L +    + P   R
Sbjct: 87  EHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEP-HAR 145
Query: 187 IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITT 246
                 A   L F +     +IYRD K  N+L+D     K++DFG A    +G     T 
Sbjct: 146 F---YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKR-VKGR----TW 197
Query: 247 CVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            + GT  Y APE I +       D ++ GV++ E+  G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 86/208 (41%), Gaps = 18/208 (8%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFL 136
            F R   LG G FG+V    +  ++  G      A+K+LD   V   +     L E   L
Sbjct: 43  QFERIKTLGTGSFGRV---MLVKHMETG---NHYAMKILDKQKVVKLKQIEHTLNEKRIL 96
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
             +  P L  L     ++ +  +V EY   G +   L +    + P   R      A   
Sbjct: 97  QAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-HARF---YAAQIV 152
Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L F +     +IYRD K  N+++D     K++DFG A    +G     T  + GT  Y A
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR-VKGR----TWXLCGTPEYLA 207
Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTG 284
           PE I +       D ++ GV++ E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 104/262 (39%), Gaps = 51/262 (19%)
Query: 141 HPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLF---KNYSSTLPWLTRIKIAIGAARCL 197
           HP   N+I Y C +     +Y  + L NL+ Q     KN S     L +    I   R +
Sbjct: 68  HP---NVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 198 A--FLHGEEKPVIYRDFKASNILL--DSDYNAK-----------LSDFGLATDGPQGEDS 242
           A    H     +I+RD K  NIL+   S + A            +SDFGL      G+  
Sbjct: 125 ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 184
Query: 243 HITTC--VMGTEGYAAPEYINTGH-------LTTMCDVFSFGVVLLELLTGRRSVEKNRC 293
                    GT G+ APE +   +       LT   D+FS G V   +L+  +    ++ 
Sbjct: 185 FRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244
Query: 294 KREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTT 353
            RE +++       +    LD++    L DR     A  L +   Q + H+P  RPT   
Sbjct: 245 SRESNII-------RGIFSLDEM--KCLHDRSLIAEATDLIS---QMIDHDPLKRPTAMK 292
Query: 354 VV---------KALEPLLDLND 366
           V+         K LE LL ++D
Sbjct: 293 VLRHPLFWPKSKKLEFLLKVSD 314

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 86/208 (41%), Gaps = 18/208 (8%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFL 136
            F R   LG G FG+V    +  ++  G      A+K+LD   V   +     L E   L
Sbjct: 43  QFERIKTLGTGSFGRV---MLVKHMETG---NHYAMKILDKQKVVKLKQIEHTLNEKRIL 96
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
             +  P L  L     ++ +  +V EY   G +   L +    + P   R      A   
Sbjct: 97  QAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-HARF---YAAQIV 152
Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L F +     +IYRD K  N+++D     K++DFG A    +G     T  + GT  Y A
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR-VKGR----TWXLCGTPEYLA 207
Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTG 284
           PE I +       D ++ GV++ E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/76 (38%), Positives = 41/76 (53%), Gaps = 1/76 (1%)
Query: 209 YRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTM 268
           +RD K  NIL+ +D  A L DFG+A+     + + +   V GT  Y APE  +  H T  
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYXAPERFSESHATYR 215
Query: 269 CDVFSFGVVLLELLTG 284
            D+++   VL E LTG
Sbjct: 216 ADIYALTCVLYECLTG 231

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 20/209 (9%)
Query: 80  NFSRSDYLGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
            F R   LG G FG+V    +K   +      L  Q V VK+  +  +   +  L  V F
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF 100
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
                 P LV L     ++ +  +V EY+A G +   L +    + P   R      A  
Sbjct: 101 ------PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARF---YAAQI 150
Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L F +     +IYRD K  N+L+D     +++DFG A    +G     T  + GT    
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEAL 205
Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTG 284
           APE I +       D ++ GV++ E+  G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 124/291 (42%), Gaps = 46/291 (15%)
Query: 80  NFSRSDYLGEGGFGK-VYKGCVDDNLRPGLKAQTVAVK-VLDVNGSQGHREWLAEVIFLG 137
           +F   D LG G  G  VY+G  D+        + VAVK +L    S   RE    V  L 
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDN--------RDVAVKRILPECFSFADRE----VQLLR 72
Query: 138 QL-KHPHLVNLIGYCCEDEHRLLVYEYMAL--GNLHDQLFKNYSSTLPWLTRIKIAIGAA 194
           +  +HP   N+I Y C ++ R   Y  + L    L + + +   + L  L  I +     
Sbjct: 73  ESDEHP---NVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHL-GLEPITLLQQTT 128
Query: 195 RCLAFLHGEEKPVIYRDFKASNILLD-----SDYNAKLSDFGLATDGPQGEDSHIT-TCV 248
             LA LH     +++RD K  NIL+          A +SDFGL      G  S    + V
Sbjct: 129 SGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186
Query: 249 MGTEGYAAPEYINTG---HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARP 305
            GTEG+ APE ++     + T   D+FS G V   +++          +R+ +++  A  
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGA-- 244
Query: 306 MLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                  LD +   + ED  + E  +++ A+       +P+ RP+   V+K
Sbjct: 245 -----CSLDCLHPEKHEDVIARELIEKMIAM-------DPQKRPSAKHVLK 283

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 66/151 (43%), Gaps = 15/151 (9%)
Query: 142 PHLVNLIGYCCEDEHR-----LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
           PH+V ++    E+ H      L++ E M  G L  ++ +            +I       
Sbjct: 82  PHIVCILD-VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 197 LAFLHGEEKPVIYRDFKASNILLDS---DYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
           + FLH     + +RD K  N+L  S   D   KL+DFG A +  Q  ++  T C   T  
Sbjct: 141 IQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ--NALQTPCY--TPY 194
Query: 254 YAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           Y APE +        CD++S GV++  LL G
Sbjct: 195 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 66/151 (43%), Gaps = 15/151 (9%)
Query: 142 PHLVNLIGYCCEDEHR-----LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
           PH+V ++    E+ H      L++ E M  G L  ++ +            +I       
Sbjct: 63  PHIVCILD-VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 121
Query: 197 LAFLHGEEKPVIYRDFKASNILLDS---DYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
           + FLH     + +RD K  N+L  S   D   KL+DFG A +  Q  ++  T C   T  
Sbjct: 122 IQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ--NALQTPCY--TPY 175
Query: 254 YAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           Y APE +        CD++S GV++  LL G
Sbjct: 176 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 206

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 85/208 (40%), Gaps = 18/208 (8%)
Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFL 136
            F R   LG G FG+V    +  ++  G      A+K+LD   V   +     L E   L
Sbjct: 43  QFERIKTLGTGSFGRV---MLVKHMETG---NHYAMKILDKQKVVKLKQIEHTLNEKRIL 96
Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
             +  P L  L     ++ +  +V EY   G +   L +      P   R      A   
Sbjct: 97  QAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEP-HARF---YAAQIV 152
Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L F +     +IYRD K  N+++D     K++DFG A    +G     T  + GT  Y A
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR-VKGR----TWXLCGTPEYLA 207
Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTG 284
           PE I +       D ++ GV++ E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 101/238 (42%), Gaps = 32/238 (13%)
Query: 127 REWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQ-LFKNYSSTLPWLT 185
           R++LAEV+      HP +V +  +    +       Y+ +  +  Q L ++    LP   
Sbjct: 130 RQFLAEVV------HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAE 183
Query: 186 RIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHIT 245
            I   +     L++LH     ++Y D K  NI+L ++   KL D G          S I 
Sbjct: 184 AIAYLLEILPALSYLH--SIGLVYNDLKPENIML-TEEQLKLIDLGAV--------SRIN 232
Query: 246 TC--VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA 303
           +   + GT G+ APE + TG  T   D+++ G  L  L          R  R  D +   
Sbjct: 233 SFGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDL----PTRNGRYVDGLPED 287
Query: 304 RPMLKDFTK----LDQIIDSRLEDRYST--EGAKRLAAVAHQCLSHNPK-SRPTMTTV 354
            P+LK +      L + ID     R++T  E + +L  V  + ++ +    RP ++T+
Sbjct: 288 DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLSTI 345

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 78/160 (48%), Gaps = 26/160 (16%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVK-VLDVNGSQGHR-EWLAEVIFLGQLKHPHL 144
           +G+G FG+V+K       R     Q VA+K VL  N  +G     L E+  L  LKH ++
Sbjct: 26  IGQGTFGEVFKA------RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 145 VNLIGYC---------CEDEHRLLV--YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGA 193
           VNLI  C         C+    L+    E+   G L + L K    TL  + R+   +  
Sbjct: 80  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML-- 134
Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA 233
              L ++H  +  +++RD KA+N+L+  D   KL+DFGLA
Sbjct: 135 LNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLA 172

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 89/216 (41%), Gaps = 19/216 (8%)
Query: 73  ELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAE 132
           E +   H  +    LG G FG+V++   D         + V ++V  V           E
Sbjct: 66  EYREEVHWMTHQPRLGRGSFGEVHR-MKDKQTGFQCAVKKVRLEVFRVE----------E 114
Query: 133 VIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIG 192
           ++    L  P +V L G   E     +  E +  G+L  QL K     LP    +     
Sbjct: 115 LVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLIKQMG-CLPEDRALYYLGQ 172
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSD-YNAKLSDFGLA-TDGPQGEDSHITTC--V 248
           A   L +LH   + +++ D KA N+LL SD   A L DFG A    P G    + T   +
Sbjct: 173 ALEGLEYLH--TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 230
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            GTE + APE +         D++S   ++L +L G
Sbjct: 231 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 70/153 (45%), Gaps = 12/153 (7%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVK-VLDVNGSQGHR-EWLAEVIFLGQLKHPHL 144
           +G+G FG+V+K       R     Q VA+K VL  N  +G     L E+  L  LKH ++
Sbjct: 26  IGQGTFGEVFKA------RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 145 VNLIGYC---CEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLH 201
           VNLI  C       +R     Y+        L    S+ L   T  +I       L  L+
Sbjct: 80  VNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 139
Query: 202 G-EEKPVIYRDFKASNILLDSDYNAKLSDFGLA 233
                 +++RD KA+N+L+  D   KL+DFGLA
Sbjct: 140 YIHRNKILHRDMKAANVLITRDGVLKLADFGLA 172

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 88/221 (39%), Gaps = 24/221 (10%)
Query: 77  ITHNFSRSDY---LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEV 133
           I H+  R +    +G G FG      V   +R     + VAVK ++  G +       E+
Sbjct: 13  IMHDSDRYELVKDIGSGNFG------VARLMRDKQSNELVAVKYIE-RGEKIDENVKREI 65
Query: 134 IFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK--NYSSTLPWLTRIKIAI 191
           I    L+HP++V          H  +V EY + G L +++     +S         ++  
Sbjct: 66  INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 125
Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLS--DFGLATDGPQGEDSHITTCVM 249
           G + C A        V +RD K  N LLD     +L   DFG +           T   +
Sbjct: 126 GVSYCHAM------QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---V 176
Query: 250 GTEGYAAPEY-INTGHLTTMCDVFSFGVVLLELLTGRRSVE 289
           GT  Y APE  +   +   + DV+S GV L  +L G    E
Sbjct: 177 GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 217

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 78/160 (48%), Gaps = 26/160 (16%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVK-VLDVNGSQGHR-EWLAEVIFLGQLKHPHL 144
           +G+G FG+V+K       R     Q VA+K VL  N  +G     L E+  L  LKH ++
Sbjct: 26  IGQGTFGEVFKA------RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 145 VNLIGYC---------CEDEHRLLV--YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGA 193
           VNLI  C         C+    L+    E+   G L + L K    TL  + R+   +  
Sbjct: 80  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML-- 134
Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA 233
              L ++H  +  +++RD KA+N+L+  D   KL+DFGLA
Sbjct: 135 LNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLA 172

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 78/160 (48%), Gaps = 26/160 (16%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVK-VLDVNGSQGHR-EWLAEVIFLGQLKHPHL 144
           +G+G FG+V+K       R     Q VA+K VL  N  +G     L E+  L  LKH ++
Sbjct: 25  IGQGTFGEVFKA------RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 78
Query: 145 VNLIGYC---------CEDEHRLLV--YEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGA 193
           VNLI  C         C+    L+    E+   G L + L K    TL  + R+   +  
Sbjct: 79  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLN 135
Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA 233
              L ++H  +  +++RD KA+N+L+  D   KL+DFGLA
Sbjct: 136 G--LYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLA 171

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 43/79 (54%), Gaps = 5/79 (6%)
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
           +I+RD K SNI++ SD   K+ DFGLA T G     S + T  + T  Y APE I     
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAG----TSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 266 TTMCDVFSFGVVLLELLTG 284
               D++S G ++ E++ G
Sbjct: 203 KENVDIWSVGCIMGEMIKG 221

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 43/79 (54%), Gaps = 5/79 (6%)
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
           +I+RD K SNI++ SD   K+ DFGLA T G     S + T  + T  Y APE I     
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAG----TSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 266 TTMCDVFSFGVVLLELLTG 284
               D++S G ++ E++ G
Sbjct: 203 KENVDIWSVGCIMGEMIKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 43/79 (54%), Gaps = 5/79 (6%)
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
           +I+RD K SNI++ SD   K+ DFGLA T G     S + T  + T  Y APE I     
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAG----TSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 266 TTMCDVFSFGVVLLELLTG 284
               D++S G ++ E++ G
Sbjct: 203 KENVDIWSVGCIMGEMIKG 221

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 89/216 (41%), Gaps = 19/216 (8%)
Query: 73  ELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAE 132
           E +   H  +    +G G FG+V++   D         + V ++V  V           E
Sbjct: 52  EYREEVHWMTHQPRVGRGSFGEVHR-MKDKQTGFQCAVKKVRLEVFRVE----------E 100
Query: 133 VIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIG 192
           ++    L  P +V L G   E     +  E +  G+L  QL K     LP    +     
Sbjct: 101 LVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLIKQMG-CLPEDRALYYLGQ 158
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSD-YNAKLSDFGLA-TDGPQGEDSHITTC--V 248
           A   L +LH   + +++ D KA N+LL SD   A L DFG A    P G    + T   +
Sbjct: 159 ALEGLEYLH--TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            GTE + APE +         D++S   ++L +L G
Sbjct: 217 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 94/218 (43%), Gaps = 28/218 (12%)
Query: 83  RSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-H 141
           + D LGEG   +V + C+  NL   + +Q  AVK+++            EV  L Q + H
Sbjct: 17  QEDVLGEGAHARV-QTCI--NL---ITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 142 PHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLH 201
            +++ LI +  E++   LV+E M  G++   + K        L    +    A  L FLH
Sbjct: 71  RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLH 128
Query: 202 GEEKPVIYRDFKASNILLDSDYNA---KLSDFGLATD-------GPQGEDSHITTCVMGT 251
              K + +RD K  NIL +        K+ DF L +         P      +T C  G+
Sbjct: 129 N--KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC--GS 184
Query: 252 EGYAAPEYINT-----GHLTTMCDVFSFGVVLLELLTG 284
             Y APE +             CD++S GV+L  LL+G
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 89/216 (41%), Gaps = 19/216 (8%)
Query: 73  ELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAE 132
           E +   H  +    +G G FG+V++   D         + V ++V  V           E
Sbjct: 68  EYREEVHWMTHQPRVGRGSFGEVHR-MKDKQTGFQCAVKKVRLEVFRVE----------E 116
Query: 133 VIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIG 192
           ++    L  P +V L G   E     +  E +  G+L  QL K     LP    +     
Sbjct: 117 LVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLIKQMG-CLPEDRALYYLGQ 174
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSD-YNAKLSDFGLA-TDGPQGEDSHITTC--V 248
           A   L +LH   + +++ D KA N+LL SD   A L DFG A    P G    + T   +
Sbjct: 175 ALEGLEYLH--TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 232
Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            GTE + APE +         D++S   ++L +L G
Sbjct: 233 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 43/79 (54%), Gaps = 5/79 (6%)
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
           +I+RD K SNI++ SD   K+ DFGLA T G     S + T  + T  Y APE I     
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG----TSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 266 TTMCDVFSFGVVLLELLTG 284
               D++S G ++ E++ G
Sbjct: 203 KENVDIWSVGCIMGEMIKG 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 43/79 (54%), Gaps = 5/79 (6%)
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
           +I+RD K SNI++ SD   K+ DFGLA T G     S + T  + T  Y APE I     
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG----TSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 266 TTMCDVFSFGVVLLELLTG 284
               D++S G ++ E++ G
Sbjct: 203 KENVDIWSVGCIMGEMIKG 221

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 88/221 (39%), Gaps = 24/221 (10%)
Query: 77  ITHNFSRSDY---LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEV 133
           I H+  R +    +G G FG      V   +R     + VAVK ++  G +       E+
Sbjct: 14  IMHDSDRYELVKDIGSGNFG------VARLMRDKQSNELVAVKYIE-RGEKIAANVKREI 66
Query: 134 IFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK--NYSSTLPWLTRIKIAI 191
           I    L+HP++V          H  +V EY + G L +++     +S         ++  
Sbjct: 67  INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 126
Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLS--DFGLATDGPQGEDSHITTCVM 249
           G + C A        V +RD K  N LLD     +L   DFG +           T   +
Sbjct: 127 GVSYCHAM------QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---V 177
Query: 250 GTEGYAAPEY-INTGHLTTMCDVFSFGVVLLELLTGRRSVE 289
           GT  Y APE  +   +   + DV+S GV L  +L G    E
Sbjct: 178 GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 43/79 (54%), Gaps = 5/79 (6%)
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
           +I+RD K SNI++ SD   K+ DFGLA T G     S + T  + T  Y APE I     
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG----TSFMMTPYVVTRYYRAPEVILGMGY 203
Query: 266 TTMCDVFSFGVVLLELLTG 284
               D++S G ++ E++ G
Sbjct: 204 KENVDIWSVGCIMGEMIKG 222

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 17/217 (7%)
Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ---GHREWLA 131
           Q +   +   + LG G F  + K C + +   GL+     +K      S+      E   
Sbjct: 8   QKVEDFYDIGEELGSGQFA-IVKKCREKS--TGLEYAAKFIKKRQSRASRRGVSREEIER 64
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI 191
           EV  L Q+ H +++ L          +L+ E ++ G L D L +  S +    T     I
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 192 GAARCLAFLHGEEKPVIYRDFKASNI-LLDSDY---NAKLSDFGLATDGPQGEDSHITTC 247
                + +LH   K + + D K  NI LLD +    + KL DFGLA +   G +      
Sbjct: 125 LDG--VNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKN 177
Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           + GT  + APE +N   L    D++S GV+   LL+G
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 93/217 (42%), Gaps = 17/217 (7%)
Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ---GHREWLA 131
           Q +   +   + LG G F  + K C + +   GL+     +K      S+      E   
Sbjct: 8   QKVEDFYDIGEELGSGQFA-IVKKCREKS--TGLEYAAKFIKKRQSRASRRGVSREEIER 64
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI 191
           EV  L Q+ H +++ L          +L+ E ++ G L D L +  S +    T     I
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 192 GAARCLAFLHGEEKPVIYRDFKASNI-LLDSDY---NAKLSDFGLATDGPQGEDSHITTC 247
                + +LH   K + + D K  NI LLD +    + KL DFGLA    + ED      
Sbjct: 125 LDG--VNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKN 177
Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           + GT  + APE +N   L    D++S GV+   LL+G
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 93/217 (42%), Gaps = 17/217 (7%)
Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ---GHREWLA 131
           Q +   +   + LG G F  + K C + +   GL+     +K      S+      E   
Sbjct: 8   QKVEDFYDIGEELGSGQFA-IVKKCREKS--TGLEYAAKFIKKRQSRASRRGVSREEIER 64
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI 191
           EV  L Q+ H +++ L          +L+ E ++ G L D L +  S +    T     I
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 192 GAARCLAFLHGEEKPVIYRDFKASNI-LLDSDY---NAKLSDFGLATDGPQGEDSHITTC 247
                + +LH   K + + D K  NI LLD +    + KL DFGLA    + ED      
Sbjct: 125 LDG--VNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKN 177
Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           + GT  + APE +N   L    D++S GV+   LL+G
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 17/217 (7%)
Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ---GHREWLA 131
           Q +   +   + LG G F  + K C + +   GL+     +K      S+      E   
Sbjct: 8   QKVEDFYDIGEELGSGQFA-IVKKCREKS--TGLEYAAKFIKKRQSRASRRGVSREEIER 64
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI 191
           EV  L Q+ H +++ L          +L+ E ++ G L D L +  S +    T     I
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 192 GAARCLAFLHGEEKPVIYRDFKASNI-LLDSDY---NAKLSDFGLATDGPQGEDSHITTC 247
                + +LH   K + + D K  NI LLD +    + KL DFGLA +   G +      
Sbjct: 125 LDG--VNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKN 177
Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           + GT  + APE +N   L    D++S GV+   LL+G
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 43/79 (54%), Gaps = 5/79 (6%)
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
           +I+RD K SNI++ SD   K+ DFGLA T G     S + T  + T  Y APE I     
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG----TSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 266 TTMCDVFSFGVVLLELLTG 284
               D++S G ++ E++ G
Sbjct: 203 KENVDIWSVGCIMGEMIKG 221

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 99/221 (44%), Gaps = 39/221 (17%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG GG G V+    +D        + VA+K + +   Q  +  L E+  + +L H ++V 
Sbjct: 19  LGCGGNGLVFSAVDNDC------DKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 147 L--------------IGYCCEDEHRLLVYEYMA--LGNLHDQ--LFKNYSSTLPWLTRIK 188
           +              +G   E     +V EYM   L N+ +Q  L + ++    +     
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMY----- 127
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDS-DYNAKLSDFGLA--TDGPQGEDSHIT 245
                 R L ++H     V++RD K +N+ +++ D   K+ DFGLA   D       H++
Sbjct: 128 ---QLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 246 TCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
             ++ T+ Y +P  + +  + T   D+++ G +  E+LTG+
Sbjct: 183 EGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 93/217 (42%), Gaps = 17/217 (7%)
Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ---GHREWLA 131
           Q +   +   + LG G F  + K C + +   GL+     +K      S+      E   
Sbjct: 8   QKVEDFYDIGEELGSGQFA-IVKKCREKS--TGLEYAAKFIKKRQSRASRRGVSREEIER 64
Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI 191
           EV  L Q+ H +++ L          +L+ E ++ G L D L +  S +    T     I
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 192 GAARCLAFLHGEEKPVIYRDFKASNI-LLDSDY---NAKLSDFGLATDGPQGEDSHITTC 247
                + +LH   K + + D K  NI LLD +    + KL DFGLA    + ED      
Sbjct: 125 --LDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKN 177
Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           + GT  + APE +N   L    D++S GV+   LL+G
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 43/79 (54%), Gaps = 5/79 (6%)
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
           +I+RD K SNI++ SD   K+ DFGLA T G     S + T  + T  Y APE I     
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG----TSFMMTPEVVTRYYRAPEVILGMGY 202
Query: 266 TTMCDVFSFGVVLLELLTG 284
               D++S G ++ E++ G
Sbjct: 203 KENVDIWSVGCIMGEMIKG 221

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 41/78 (52%), Gaps = 3/78 (3%)
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
           +I+RD K SNI++ SD   K+ DFGLA        + + T  + T  Y APE I      
Sbjct: 145 IIHRDLKPSNIVVKSDCTLKILDFGLAR---TASTNFMMTPYVVTRYYRAPEVILGMGYK 201
Query: 267 TMCDVFSFGVVLLELLTG 284
              D++S G ++ EL+ G
Sbjct: 202 ENVDIWSVGCIMGELVKG 219

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 75/183 (40%), Gaps = 32/183 (17%)
Query: 130 LAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKI 189
           L E+  L +L H H+V ++      +       Y+ L  + D  FK    T  +LT + I
Sbjct: 100 LREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL-EIADSDFKKLFRTPVYLTELHI 158
Query: 190 AIGAARCLA---FLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA--TDGPQGEDSHI 244
                  L    ++H     +++RD K +N L++ D + K+ DFGLA   D P+  +S +
Sbjct: 159 KTLLYNLLVGVKYVHS--AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216
Query: 245 T-----------------------TCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLE 280
                                   T  + T  Y APE I    + T   DV+S G +  E
Sbjct: 217 PISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAE 276
Query: 281 LLT 283
           LL 
Sbjct: 277 LLN 279

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 85/209 (40%), Gaps = 17/209 (8%)
Query: 76  MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVK--VLDVNGSQGHREWLAEV 133
               +F R   LG G +G+V+K      +R     +  AVK  +    G +     LAEV
Sbjct: 54  FFQQSFQRLSRLGHGSYGEVFK------VRSKEDGRLYAVKRSMSPFRGPKDRARKLAEV 107
Query: 134 IFLGQL-KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIG 192
               ++ +HP  V L      +E  +L  +    G    Q  + + ++LP          
Sbjct: 108 GSHEKVGQHPCCVRL--EQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRD 165
Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE 252
               LA LH +   +++ D K +NI L      KL DFGL  +        +     G  
Sbjct: 166 TLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDP 220
Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLEL 281
            Y APE +  G   T  DVFS G+ +LE+
Sbjct: 221 RYMAPELLQ-GSYGTAADVFSLGLTILEV 248

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 41/78 (52%), Gaps = 3/78 (3%)
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
           +I+RD K SNI++ SD   K+ DFGLA        + + T  + T  Y APE I      
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTACT---NFMMTPYVVTRYYRAPEVILGMGYA 203
Query: 267 TMCDVFSFGVVLLELLTG 284
              D++S G ++ EL+ G
Sbjct: 204 ANVDIWSVGCIMGELVKG 221

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 98/249 (39%), Gaps = 62/249 (24%)
Query: 68  VFTLKELQMITHNFSRSDYLGEGGF-----------GKVYKGCVD---DNLRPGLKAQTV 113
           V  LKE+++   +F     +G G F           G+VY   +    D L+ G  +   
Sbjct: 50  VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFR 109
Query: 114 AVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQL 173
             + + VNG    R W+ ++ F  Q              ++ +  LV EY   G+L   L
Sbjct: 110 EERDVLVNGD---RRWITQLHFAFQ--------------DENYLYLVMEYYVGGDLL-TL 151
Query: 174 FKNYSSTLP------WLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKL 227
              +   +P      +L  I +AI +   L ++H        RD K  NILLD   + +L
Sbjct: 152 LSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVH--------RDIKPDNILLDRCGHIRL 203
Query: 228 SDFG----LATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTM-------CDVFSFGV 276
           +DFG    L  DG     +  +   +GT  Y +PE +               CD ++ GV
Sbjct: 204 ADFGSCLKLRADG-----TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGV 258
Query: 277 VLLELLTGR 285
              E+  G+
Sbjct: 259 FAYEMFYGQ 267

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/79 (36%), Positives = 42/79 (53%), Gaps = 5/79 (6%)
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
           +I+RD K SNI++ SD   K+ DFGLA T G     S +    + T  Y APE I     
Sbjct: 149 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG----TSFMMVPFVVTRYYRAPEVILGMGY 204
Query: 266 TTMCDVFSFGVVLLELLTG 284
               D++S G ++ E++ G
Sbjct: 205 KENVDIWSVGCIMGEMIKG 223

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA--EVIFLGQ 138
           + R   LGEG +G+VYK  +D      +  +TVA+K + +   +      A  EV  L +
Sbjct: 36  YRRITKLGEGTYGEVYK-AIDT-----VTNETVAIKRIRLEHEEEGVPGTAIREVSLLKE 89
Query: 139 LKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           L+H +++ L        HRL L++EY A  +L   + KN   ++  +      +     +
Sbjct: 90  LQHRNIIELKS-VIHHNHRLHLIFEY-AENDLKKYMDKNPDVSMRVIKSFLYQL--INGV 145
Query: 198 AFLHGEEKPVIYRDFKASNILLD-SDYNA----KLSDFGLATDGPQGEDSHITTCVMGTE 252
            F H   +  ++RD K  N+LL  SD +     K+ DFGLA     G      T  + T 
Sbjct: 146 NFCHS--RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEIITL 201
Query: 253 GYAAPE-YINTGHLTTMCDVFSFGVVLLELL 282
            Y  PE  + + H +T  D++S   +  E+L
Sbjct: 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 99/237 (41%), Gaps = 40/237 (16%)
Query: 84  SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL-DVNGSQGHREWLAEVIFLGQLKHP 142
           SD LG+G    V++G      R        A+KV  +++  +     + E   L +L H 
Sbjct: 14  SDILGQGATANVFRG------RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67
Query: 143 HLVNLIGYCCEDE----HRLLVYEYMALGNLHDQLFK-NYSSTLP---WLTRIKIAIGAA 194
           ++V L  +  E+E    H++L+ E+   G+L+  L + + +  LP   +L  ++  +G  
Sbjct: 68  NIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 195 RCLAFLHGEEKPVIYRDFKASNILL----DSDYNAKLSDFGLATDGPQGEDSHITTCVMG 250
                 H  E  +++R+ K  NI+     D     KL+DFG A +    ED      + G
Sbjct: 126 N-----HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---LEDDEQFVSLYG 177
Query: 251 TEGYAAPEYINTGHLT--------TMCDVFSFGVVLLELLTGR---RSVEKNRCKRE 296
           TE Y  P+      L            D++S GV      TG    R  E  R  +E
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 42/77 (54%), Gaps = 5/77 (6%)
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
           +I+RD K SNI++ SD   K+ DFGLA T G     S + T  + T  Y APE I     
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAG----TSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 266 TTMCDVFSFGVVLLELL 282
               D++S G ++ E++
Sbjct: 203 KENVDIWSVGCIMGEMV 219

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 101/243 (41%), Gaps = 40/243 (16%)
Query: 78  THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL-DVNGSQGHREWLAEVIFL 136
            H +  SD LG+G    V++G      R        A+KV  +++  +     + E   L
Sbjct: 8   NHLWLLSDILGQGATANVFRG------RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVL 61
Query: 137 GQLKHPHLVNLIGYCCEDE----HRLLVYEYMALGNLHDQLFK-NYSSTLP---WLTRIK 188
            +L H ++V L  +  E+E    H++L+ E+   G+L+  L + + +  LP   +L  ++
Sbjct: 62  KKLNHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILL----DSDYNAKLSDFGLATDGPQGEDSHI 244
             +G        H  E  +++R+ K  NI+     D     KL+DFG A    + ED   
Sbjct: 120 DVVGGMN-----HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQ 171
Query: 245 TTCVMGTEGYAAPEYINTGHLT--------TMCDVFSFGVVLLELLTGR---RSVEKNRC 293
              + GTE Y  P+      L            D++S GV      TG    R  E  R 
Sbjct: 172 FVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231
Query: 294 KRE 296
            +E
Sbjct: 232 NKE 234

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 42/77 (54%), Gaps = 5/77 (6%)
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
           +I+RD K SNI++ SD   K+ DFGLA T G     S + T  + T  Y APE I     
Sbjct: 140 IIHRDLKPSNIVVKSDXTLKILDFGLARTAG----TSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 266 TTMCDVFSFGVVLLELL 282
               D++S G ++ E++
Sbjct: 196 KENVDIWSVGCIMGEMV 212

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 42/77 (54%), Gaps = 5/77 (6%)
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
           +I+RD K SNI++ SD   K+ DFGLA T G     S + T  + T  Y APE I     
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAG----TSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 266 TTMCDVFSFGVVLLELL 282
               D++S G ++ E++
Sbjct: 203 KENVDIWSVGCIMGEMV 219

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 90/224 (40%), Gaps = 30/224 (13%)
Query: 77  ITHNFSRSDY---LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEV 133
           I H+  R +    +G G FG      V   +R     + VAVK ++  G +       E+
Sbjct: 14  IMHDSDRYELVKDIGSGNFG------VARLMRDKQSNELVAVKYIE-RGEKIDENVKREI 66
Query: 134 IFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK--NYSSTLPWLTRIKIAI 191
           I    L+HP++V          H  +V EY + G L +++     +S         ++  
Sbjct: 67  INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 126
Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLS--DFGLATDG---PQGEDSHITT 246
           G + C A        V +RD K  N LLD     +L    FG +       Q +D+    
Sbjct: 127 GVSYCHAM------QVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDT---- 176
Query: 247 CVMGTEGYAAPEY-INTGHLTTMCDVFSFGVVLLELLTGRRSVE 289
             +GT  Y APE  +   +   + DV+S GV L  +L G    E
Sbjct: 177 --VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 85/219 (38%), Gaps = 20/219 (9%)
Query: 77  ITHNFSRSDY---LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEV 133
           I H+  R +    +G G FG      V   +R     + VAVK ++  G +       E+
Sbjct: 14  IMHDSDRYELVKDIGSGNFG------VARLMRDKQSNELVAVKYIE-RGEKIDENVKREI 66
Query: 134 IFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK--NYSSTLPWLTRIKIAI 191
           I    L+HP++V          H  +V EY + G L +++     +S         ++  
Sbjct: 67  INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 126
Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
           G + C A        V +RD K  N LLD     +L              S   + V GT
Sbjct: 127 GVSYCHAM------QVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTV-GT 179
Query: 252 EGYAAPEY-INTGHLTTMCDVFSFGVVLLELLTGRRSVE 289
             Y APE  +   +   + DV+S GV L  +L G    E
Sbjct: 180 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 42/77 (54%), Gaps = 5/77 (6%)
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
           +I+RD K SNI++ SD   K+ DFGLA T G     S + T  + T  Y APE I     
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAG----TSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 266 TTMCDVFSFGVVLLELL 282
               D++S G ++ E++
Sbjct: 203 KENVDIWSVGCIMGEMV 219

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 42/77 (54%), Gaps = 5/77 (6%)
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
           +I+RD K SNI++ SD   K+ DFGLA T G     S + T  + T  Y APE I     
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAG----TSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 266 TTMCDVFSFGVVLLELL 282
               D++S G ++ E++
Sbjct: 203 KENVDIWSVGCIMGEMV 219

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY-NA--KLSDFGLATDGPQGED 241
           + I  +IG A  + +LH     + +RD K  N+L  S   NA  KL+DFG A +     +
Sbjct: 164 SEIMKSIGEA--IQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHN 218
Query: 242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           S  T C   T  Y APE +        CD++S GV++  LL G
Sbjct: 219 SLTTPCY--TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY-NA--KLSDFGLATDGPQGED 241
           + I  +IG A  + +LH     + +RD K  N+L  S   NA  KL+DFG A +     +
Sbjct: 120 SEIMKSIGEA--IQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHN 174
Query: 242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           S  T C   T  Y APE +        CD++S GV++  LL G
Sbjct: 175 SLTTPCY--TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 215

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY-NA--KLSDFGLATDGPQGED 241
           + I  +IG A  + +LH     + +RD K  N+L  S   NA  KL+DFG A +     +
Sbjct: 170 SEIMKSIGEA--IQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHN 224
Query: 242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           S  T C   T  Y APE +        CD++S GV++  LL G
Sbjct: 225 SLTTPCY--TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 265

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY-NA--KLSDFGLATDGPQGED 241
           + I  +IG A  + +LH     + +RD K  N+L  S   NA  KL+DFG A +     +
Sbjct: 125 SEIMKSIGEA--IQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHN 179
Query: 242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           S  T C   T  Y APE +        CD++S GV++  LL G
Sbjct: 180 SLTTPCY--TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 220

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY-NA--KLSDFGLATDGPQGED 241
           + I  +IG A  + +LH     + +RD K  N+L  S   NA  KL+DFG A +     +
Sbjct: 120 SEIMKSIGEA--IQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHN 174
Query: 242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           S  T C   T  Y APE +        CD++S GV++  LL G
Sbjct: 175 SLTTPCY--TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 215

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY-NA--KLSDFGLATDGPQGED 241
           + I  +IG A  + +LH     + +RD K  N+L  S   NA  KL+DFG A +     +
Sbjct: 124 SEIMKSIGEA--IQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHN 178
Query: 242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           S  T C   T  Y APE +        CD++S GV++  LL G
Sbjct: 179 SLTTPCY--TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 219

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY-NA--KLSDFGLATDGPQGED 241
           + I  +IG A  + +LH     + +RD K  N+L  S   NA  KL+DFG A +     +
Sbjct: 126 SEIMKSIGEA--IQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHN 180
Query: 242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           S  T C   T  Y APE +        CD++S GV++  LL G
Sbjct: 181 SLTTPCY--TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 221

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY-NA--KLSDFGLATDGPQGED 241
           + I  +IG A  + +LH     + +RD K  N+L  S   NA  KL+DFG A +     +
Sbjct: 118 SEIMKSIGEA--IQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHN 172
Query: 242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           S  T C   T  Y APE +        CD++S GV++  LL G
Sbjct: 173 SLTTPCY--TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 213

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY-NA--KLSDFGLATDGPQGED 241
           + I  +IG A  + +LH     + +RD K  N+L  S   NA  KL+DFG A +     +
Sbjct: 119 SEIMKSIGEA--IQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHN 173
Query: 242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           S  T C   T  Y APE +        CD++S GV++  LL G
Sbjct: 174 SLTTPCY--TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 214

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 42/77 (54%), Gaps = 5/77 (6%)
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
           +I+RD K SNI++ SD   K+ DFGLA T G     S + T  + T  Y APE I     
Sbjct: 146 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG----TSFMMTPYVVTRYYRAPEVILGMGY 201
Query: 266 TTMCDVFSFGVVLLELL 282
               D++S G ++ E++
Sbjct: 202 KENVDIWSVGCIMGEMV 218

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 42/77 (54%), Gaps = 5/77 (6%)
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
           +I+RD K SNI++ SD   K+ DFGLA T G     S + T  + T  Y APE I     
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG----TSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 266 TTMCDVFSFGVVLLELL 282
               D++S G ++ E++
Sbjct: 203 KENVDIWSVGCIMGEMV 219

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 42/77 (54%), Gaps = 5/77 (6%)
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
           +I+RD K SNI++ SD   K+ DFGLA T G     S + T  + T  Y APE I     
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG----TSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 266 TTMCDVFSFGVVLLELL 282
               D++S G ++ E++
Sbjct: 196 KENVDIWSVGCIMGEMV 212

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 42/77 (54%), Gaps = 5/77 (6%)
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
           +I+RD K SNI++ SD   K+ DFGLA T G     S + T  + T  Y APE I     
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG----TSFMMTPYVVTRYYRAPEVILGMGY 203
Query: 266 TTMCDVFSFGVVLLELL 282
               D++S G ++ E++
Sbjct: 204 KENVDIWSVGCIMGEMV 220

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 42/77 (54%), Gaps = 5/77 (6%)
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
           +I+RD K SNI++ SD   K+ DFGLA T G     S + T  + T  Y APE I     
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG----TSFMMTPYVVTRYYRAPEVILGMGY 196
Query: 266 TTMCDVFSFGVVLLELL 282
               D++S G ++ E++
Sbjct: 197 KENVDIWSVGCIMGEMV 213

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 42/77 (54%), Gaps = 5/77 (6%)
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
           +I+RD K SNI++ SD   K+ DFGLA T G     S + T  + T  Y APE I     
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG----TSFMMTPYVVTRYYRAPEVILGMGY 203
Query: 266 TTMCDVFSFGVVLLELL 282
               D++S G ++ E++
Sbjct: 204 KENVDIWSVGCIMGEMV 220

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 42/77 (54%), Gaps = 5/77 (6%)
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
           +I+RD K SNI++ SD   K+ DFGLA T G     S + T  + T  Y APE I     
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG----TSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 266 TTMCDVFSFGVVLLELL 282
               D++S G ++ E++
Sbjct: 203 KENVDIWSVGCIMGEMV 219

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 115/298 (38%), Gaps = 53/298 (17%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLK-AQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLV 145
           LGEGGF  V       +L  GL      A+K +  +  Q   E   E        HP+++
Sbjct: 37  LGEGGFSYV-------DLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 146 NLIGYCCEDE----HRLLVYEYMALGNLHDQL--FKNYSSTLPWLTRIKIAIGAARCLAF 199
            L+ YC  +        L+  +   G L +++   K+  + L     + + +G  R L  
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 200 LHGEEKPVIYRDFKASNILLDSDYNAKLSDFG------LATDGPQG----EDSHITTCVM 249
           +H   K   +RD K +NILL  +    L D G      +  +G +     +D     C  
Sbjct: 150 IHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC-- 205
Query: 250 GTEGYAAPEYINTGH---LTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPM 306
            T  Y APE  +      +    DV+S G VL  ++ G             D+V      
Sbjct: 206 -TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY---------DMV------ 249
Query: 307 LKDFTKLDQI---IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL 361
              F K D +   + ++L    S   +  L  + +  ++ +P  RP +  ++  LE L
Sbjct: 250 ---FQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY-NA--KLSDFGLATDGPQGED 241
           + I  +IG A  + +LH     + +RD K  N+L  S   NA  KL+DFG A +     +
Sbjct: 134 SEIMKSIGEA--IQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHN 188
Query: 242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           S  T C   T  Y APE +        CD++S GV++  LL G
Sbjct: 189 SLTTPCY--TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 229

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 42/77 (54%), Gaps = 5/77 (6%)
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
           +I+RD K SNI++ SD   K+ DFGLA T G     S + T  + T  Y APE I     
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG----TSFMMTPYVVTRYYRAPEVILGMGY 196
Query: 266 TTMCDVFSFGVVLLELL 282
               D++S G ++ E++
Sbjct: 197 KENVDIWSVGCIMGEMV 213

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 89/216 (41%), Gaps = 24/216 (11%)
Query: 77  ITHNFSRSDY---LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEV 133
           I H+  R +    +G G FG      V   +R     + VAVK ++  G +       E+
Sbjct: 14  IMHDSDRYELVKDIGAGNFG------VARLMRDKQANELVAVKYIE-RGEKIDENVKREI 66
Query: 134 IFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK--NYSSTLPWLTRIKIAI 191
           I    L+HP++V          H  +V EY + G L +++     +S         ++  
Sbjct: 67  INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 126
Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSD--YNAKLSDFGLATDGPQGEDSHITTCVM 249
           G    +++ H  +  V +RD K  N LLD       K++DFG +               +
Sbjct: 127 G----VSYAHAMQ--VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQP---KSAV 177
Query: 250 GTEGYAAPEY-INTGHLTTMCDVFSFGVVLLELLTG 284
           GT  Y APE  +   +   + DV+S GV L  +L G
Sbjct: 178 GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 42/77 (54%), Gaps = 5/77 (6%)
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
           +I+RD K SNI++ SD   K+ DFGLA T G     S + T  + T  Y APE I     
Sbjct: 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG----TSFMMTPYVVTRYYRAPEVILGMGY 240
Query: 266 TTMCDVFSFGVVLLELL 282
               D++S G ++ E++
Sbjct: 241 KENVDIWSVGCIMGEMV 257

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/76 (35%), Positives = 40/76 (52%), Gaps = 3/76 (3%)
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
           +I+RD K SNI++ SD   K+ DFGLA        S + T  + T  Y APE I      
Sbjct: 185 IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYK 241
Query: 267 TMCDVFSFGVVLLELL 282
              D++S G ++ E++
Sbjct: 242 ENVDIWSVGCIMGEMV 257

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 88/215 (40%), Gaps = 17/215 (7%)
Query: 85  DYLGEGGFGKVYKGCVDDNL-RPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPH 143
           D LGEG +GKV +    + L R  +K           NG    ++   E+  L +L+H +
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKK---EIQLLRRLRHKN 67
Query: 144 LVNLIG--YCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLH 201
           ++ L+   Y  E +   +V EY   G + + L        P              L +LH
Sbjct: 68  VIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH 126
Query: 202 GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD-GPQGEDSHITTCVMGTEGYAAPEYI 260
            +   ++++D K  N+LL +    K+S  G+A    P   D    T   G+  +  PE  
Sbjct: 127 SQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPAFQPPEIA 183
Query: 261 NTGHLTTM----CDVFSFGVVLLELLTGRRSVEKN 291
           N   L T      D++S GV L  + TG    E +
Sbjct: 184 NG--LDTFSGFKVDIWSAGVTLYNITTGLYPFEGD 216

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 65/146 (44%), Gaps = 11/146 (7%)
Query: 78  THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHREWLAEVIF 135
           T  F   + +G G FG V+K CV   L   + A   + K L   V+     RE  A  + 
Sbjct: 8   TTEFHELEKIGSGEFGSVFK-CVK-RLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV- 64
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYS--STLPWLTRIKIAIGA 193
           LGQ  H H+V       ED+H L+  EY   G+L D + +NY   S         + +  
Sbjct: 65  LGQ--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 122
Query: 194 ARCLAFLHGEEKPVIYRDFKASNILL 219
            R L ++H     +++ D K SNI +
Sbjct: 123 GRGLRYIHS--MSLVHMDIKPSNIFI 146

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 65/146 (44%), Gaps = 11/146 (7%)
Query: 78  THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHREWLAEVIF 135
           T  F   + +G G FG V+K CV   L   + A   + K L   V+     RE  A  + 
Sbjct: 8   TTEFHELEKIGSGEFGSVFK-CVK-RLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV- 64
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYS--STLPWLTRIKIAIGA 193
           LGQ  H H+V       ED+H L+  EY   G+L D + +NY   S         + +  
Sbjct: 65  LGQ--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 122
Query: 194 ARCLAFLHGEEKPVIYRDFKASNILL 219
            R L ++H     +++ D K SNI +
Sbjct: 123 GRGLRYIHS--MSLVHMDIKPSNIFI 146

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 65/146 (44%), Gaps = 11/146 (7%)
Query: 78  THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHREWLAEVIF 135
           T  F   + +G G FG V+K CV   L   + A   + K L   V+     RE  A  + 
Sbjct: 6   TTEFHELEKIGSGEFGSVFK-CVK-RLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV- 62
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYS--STLPWLTRIKIAIGA 193
           LGQ  H H+V       ED+H L+  EY   G+L D + +NY   S         + +  
Sbjct: 63  LGQ--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 120
Query: 194 ARCLAFLHGEEKPVIYRDFKASNILL 219
            R L ++H     +++ D K SNI +
Sbjct: 121 GRGLRYIHS--MSLVHMDIKPSNIFI 144

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 65/146 (44%), Gaps = 11/146 (7%)
Query: 78  THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHREWLAEVIF 135
           T  F   + +G G FG V+K CV   L   + A   + K L   V+     RE  A  + 
Sbjct: 10  TTEFHELEKIGSGEFGSVFK-CVK-RLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV- 66
Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYS--STLPWLTRIKIAIGA 193
           LGQ  H H+V       ED+H L+  EY   G+L D + +NY   S         + +  
Sbjct: 67  LGQ--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124
Query: 194 ARCLAFLHGEEKPVIYRDFKASNILL 219
            R L ++H     +++ D K SNI +
Sbjct: 125 GRGLRYIHS--MSLVHMDIKPSNIFI 148

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 42/77 (54%), Gaps = 5/77 (6%)
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
           +I+RD K SNI++ SD   K+ DFGLA T G     S + T  + T  Y APE I     
Sbjct: 152 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG----TSFMMTPYVVTRYYRAPEVILGMGY 207
Query: 266 TTMCDVFSFGVVLLELL 282
               D++S G ++ E++
Sbjct: 208 KENVDLWSVGCIMGEMV 224

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 42/77 (54%), Gaps = 5/77 (6%)
Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
           +I+RD K SNI++ SD   K+ DFGLA T G     S + T  + T  Y APE I     
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG----TSFMMTPYVVTRYYRAPEVILGMGY 196
Query: 266 TTMCDVFSFGVVLLELL 282
               D++S G ++ E++
Sbjct: 197 KENVDLWSVGCIMGEMV 213

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 91/223 (40%), Gaps = 39/223 (17%)
Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL--KHPH- 143
           LGEG FG+V + CVD + R G +   VA+K++  N  +       E+  L ++  K P  
Sbjct: 41  LGEGTFGRVVQ-CVD-HRRGGAR---VALKIIK-NVEKYKEAARLEINVLEKINEKDPDN 94
Query: 144 ---LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFL 200
               V +  +     H  + +E + L    D L  N     P      +A    + + FL
Sbjct: 95  KNLCVQMFDWFDYHGHMCISFELLGLSTF-DFLKDNNYLPYPIHQVRHMAFQLCQAVKFL 153
Query: 201 HGEEKPVIYRDFKASNILL-DSDYN------------------AKLSDFGLATDGPQGED 241
           H  +  + + D K  NIL  +SDY                    ++ DFG AT      D
Sbjct: 154 H--DNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSAT-----FD 206
Query: 242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
               + ++ T  Y APE I     +  CDV+S G ++ E   G
Sbjct: 207 HEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVG 249
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	449
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-171
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-165
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-142
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-83
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-64
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-58
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-56
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-56
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	7e-56
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	8e-56
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-55
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-55
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-55
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-54
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-53
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-53
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-53
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-50
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	6e-46
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-44
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-44
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-44
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-43
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-41
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-40
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-40
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	7e-40
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-40
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-39
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-39
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-39
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-39
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-39
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-38
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-38
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-38
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-38
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-38
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-38
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-37
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-37
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-37
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-37
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-37
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-37
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-37
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-37
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-37
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-37
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	7e-37
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	7e-37
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-37
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-36
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-36
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-36
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-36
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-36
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-36
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-36
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-36
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-36
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	8e-36
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-35
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-35
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-35
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-34
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-34
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-34
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	7e-34
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	9e-34
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-33
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-33
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-33
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-33
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-33
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	7e-33
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-32
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-32
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-32
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-31
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-31
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-31
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-30
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-30
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-30
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-30
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-30
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-29
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-29
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-29
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-29
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-29
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-29
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-29
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-29
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-29
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	6e-29
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	7e-29
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	8e-29
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-28
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-27
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-27
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-27
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-27
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-27
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	8e-27
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-26
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-26
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-26
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-26
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-25
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-25
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-25
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-25
3ork_A	311	Serine/threonine protein kinase; structural genomi	7e-25
3fme_A	290	Dual specificity mitogen-activated protein kinase;	7e-25
3an0_A	340	Dual specificity mitogen-activated protein kinase;	8e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-24
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-24
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-24
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-24
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-24
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-24
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	9e-24
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-23
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-23
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-23
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-23
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-23
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-23
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-23
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-23
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	9e-23
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-22
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-22
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-22
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-04
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-22
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-22
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-22
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-22
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-22
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-22
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	8e-22
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	8e-22
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	9e-22
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	9e-22
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-21
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-21
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-21
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-21
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-21
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-21
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-21
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	6e-21
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	6e-21
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	6e-21
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-21
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-20
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-20
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-20
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-20
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-20
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-20
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-20
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-20
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-20
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-20
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-20
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-20
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-20
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-20
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-20
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-20
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-20
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-20
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	7e-20
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	8e-20
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-19
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-19
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-19
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-18
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-18
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-18
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-18
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-18
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-17
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-17
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-17
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	9e-17
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-16
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-16
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-16
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-16
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-16
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-16
3niz_A	311	Rhodanese family protein; structural genomics, str	7e-16
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	7e-16
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-15
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-15
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-15
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-11
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-14
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-14
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	9e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-13
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-13
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	7e-13
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-12
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-12
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-12
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-12
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-12
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-12
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-12
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	8e-12
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-11
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-11
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	7e-11
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-10
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-09
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	7e-08

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  482 bits (1243), Expect = e-171
 Identities = 106/319 (33%), Positives = 172/319 (53%), Gaps = 25/319 (7%)

Query: 56  ELSSSLVGSNLHVFTLKELQMITHNFSRSDY------LGEGGFGKVYKGCVDDNLRPGLK 109
             S  +  +  H F+  EL+ +T+NF           +GEGGFG VYKG V++       
Sbjct: 2   NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN------- 54

Query: 110 AQTVAVKVL----DVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMA 165
             TVAVK L    D+   +  +++  E+  + + +H +LV L+G+  + +   LVY YM 
Sbjct: 55  -TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMP 113

Query: 166 LGNLHDQLF-KNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYN 224
            G+L D+L   + +  L W  R KIA GAA  + FLH  E   I+RD K++NILLD  + 
Sbjct: 114 NGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFT 171

Query: 225 AKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           AK+SDFGLA    +   + +T+ ++GT  Y APE +  G +T   D++SFGVVLLE++TG
Sbjct: 172 AKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITG 230

Query: 285 RRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHN 344
             +V+++R    + L++    +  +   ++  ID ++ D   +   + + +VA QCL   
Sbjct: 231 LPAVDEHR--EPQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEK 287

Query: 345 PKSRPTMTTVVKALEPLLD 363
              RP +  V + L+ +  
Sbjct: 288 KNKRPDIKKVQQLLQEMTA 306

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  467 bits (1205), Expect = e-165
 Identities = 119/326 (36%), Positives = 181/326 (55%), Gaps = 12/326 (3%)

Query: 43  TDVSNPGSPISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDD 102
           +  S   + I+    SS LV    +   L +L+  T+NF     +G G FGKVYKG + D
Sbjct: 3   SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62

Query: 103 NLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYE 162
                     VA+K      SQG  E+  E+  L   +HPHLV+LIG+C E    +L+Y+
Sbjct: 63  G-------AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK 115

Query: 163 YMALGNLHDQLFK--NYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD 220
           YM  GNL   L+     + ++ W  R++I IGAAR L +LH   + +I+RD K+ NILLD
Sbjct: 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINILLD 173

Query: 221 SDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLE 280
            ++  K++DFG++  G + + +H++T V GT GY  PEY   G LT   DV+SFGVVL E
Sbjct: 174 ENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFE 233

Query: 281 LLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQC 340
           +L  R ++ ++  +   +L EWA     +  +L+QI+D  L D+   E  ++    A +C
Sbjct: 234 VLCARSAIVQSLPREMVNLAEWAVESHNN-GQLEQIVDPNLADKIRPESLRKFGDTAVKC 292

Query: 341 LSHNPKSRPTMTTVVKALEPLLDLND 366
           L+ + + RP+M  V+  LE  L L +
Sbjct: 293 LALSSEDRPSMGDVLWKLEYALRLQE 318

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  407 bits (1049), Expect = e-142
 Identities = 124/301 (41%), Positives = 176/301 (58%), Gaps = 15/301 (4%)

Query: 65  NLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ 124
            L  F+L+ELQ+ + NFS  + LG GGFGKVYKG + D          VAVK L    +Q
Sbjct: 16  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADG-------TLVAVKRLKEERTQ 68

Query: 125 GH-REWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLF--KNYSSTL 181
           G   ++  EV  +    H +L+ L G+C     RLLVY YMA G++   L         L
Sbjct: 69  GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPL 128

Query: 182 PWLTRIKIAIGAARCLAFLHGEEKP-VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGE 240
            W  R +IA+G+AR LA+LH    P +I+RD KA+NILLD ++ A + DFGLA       
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK- 187

Query: 241 DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKD-- 298
           D+H+TT V GT G+ APEY++TG  +   DVF +GV+LLEL+TG+R+ +  R   + D  
Sbjct: 188 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247

Query: 299 LVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL 358
           L++W + +LK+  KL+ ++D  L+  Y  E  ++L  VA  C   +P  RP M+ VV+ L
Sbjct: 248 LLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

Query: 359 E 359
           E
Sbjct: 307 E 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  257 bits (659), Expect = 4e-83
 Identities = 76/323 (23%), Positives = 128/323 (39%), Gaps = 38/323 (11%)

Query: 69  FTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE 128
              + L   +      +    G FG V+K  + +        + VAVK+      Q  + 
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN--------EYVAVKIFP---IQDKQS 62

Query: 129 WLAE--VIFLGQLKHPHLVNLIGYCCEDEH----RLLVYEYMALGNLHDQLFKNYSSTLP 182
           W  E  V  L  +KH +++  IG             L+  +   G+L D L  N    + 
Sbjct: 63  WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVS 119

Query: 183 WLTRIKIAIGAARCLAFLH-------GEEKP-VIYRDFKASNILLDSDYNAKLSDFGLAT 234
           W     IA   AR LA+LH          KP + +RD K+ N+LL ++  A ++DFGLA 
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179

Query: 235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTT-----MCDVFSFGVVLLELLTGRRSVE 289
               G+ +  T   +GT  Y APE +              D+++ G+VL EL +   + +
Sbjct: 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

Query: 290 KNRCKREKDLVE--WARPMLKDFTKL--DQIIDSRLEDRY-STEGAKRLAAVAHQCLSHN 344
               +      E     P L+D  ++   +     L D +    G   L     +C  H+
Sbjct: 240 GPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHD 299

Query: 345 PKSRPTMTTVVKALEPLLDLNDI 367
            ++R +   V + +  +  L +I
Sbjct: 300 AEARLSAGCVGERITQMQRLTNI 322

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  208 bits (532), Expect = 4e-64
 Identities = 71/354 (20%), Positives = 128/354 (36%), Gaps = 57/354 (16%)

Query: 69  FTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE 128
               E  +   N    + +G G +G VYKG         L  + VAVKV         + 
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGS--------LDERPVAVKVFS---FANRQN 51

Query: 129 WLAE--VIFLGQLKHPHLVNLIGYCCEDE-----HRLLVYEYMALGNLHDQLFKNYSSTL 181
           ++ E  +  +  ++H ++   I              LLV EY   G+L   L  +   T 
Sbjct: 52  FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TS 108

Query: 182 PWLTRIKIAIGAARCLAFLHGE-------EKPVIYRDFKASNILLDSDYNAKLSDFGLA- 233
            W++  ++A    R LA+LH E       +  + +RD  + N+L+ +D    +SDFGL+ 
Sbjct: 109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168

Query: 234 -----TDGPQGEDSHITTCVMGTEGYAAPEYI-------NTGHLTTMCDVFSFGVVLLEL 281
                     GE+ +     +GT  Y APE +       +        D+++ G++  E+
Sbjct: 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

Query: 282 LTGRRSVEKNRCKRE-----KDLVEWARPMLKDFTKLDQIIDSRLE--DRYS--TEGAKR 332
                 +       E     +  V    P  +D   L      R +  + +   +   + 
Sbjct: 229 FMRCTDLFPGESVPEYQMAFQTEV-GNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287

Query: 333 LAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDIPIGPFVYTVVPPGDHGHGQ 386
           L      C   + ++R T     + +  L+ + +          V P  H H  
Sbjct: 288 LKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN------KSVSPTAHHHHH 335

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  193 bits (492), Expect = 2e-58
 Identities = 76/287 (26%), Positives = 131/287 (45%), Gaps = 45/287 (15%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGH--REWLAEVIFLGQLKHPHL 144
           +G G FG V++               VAVK+L           E+L EV  + +L+HP++
Sbjct: 45  IGAGSFGTVHRAE--------WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96

Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSS-TLPWLTRIKIAIGAARCLAFLHGE 203
           V  +G   +  +  +V EY++ G+L+  L K+ +   L    R+ +A   A+ + +LH  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156

Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTG 263
             P+++R+ K+ N+L+D  Y  K+ DFGL+        S  +    GT  + APE +   
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDE 214

Query: 264 HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD--QII---- 317
                 DV+SFGV+L EL T +                  +P    +  L+  Q++    
Sbjct: 215 PSNEKSDVYSFGVILWELATLQ------------------QP----WGNLNPAQVVAAVG 252

Query: 318 --DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
               RLE   +     ++AA+   C ++ P  RP+  T++  L PL+
Sbjct: 253 FKCKRLEIPRNLN--PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  188 bits (478), Expect = 4e-56
 Identities = 71/313 (22%), Positives = 125/313 (39%), Gaps = 54/313 (17%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWL--AEVIFLGQLKHPHL 144
           +G+G +G+V+ G          + + VAVKV     +     W    E+     ++H ++
Sbjct: 45  IGKGRYGEVWMGK--------WRGEKVAVKVFF---TTEEASWFRETEIYQTVLMRHENI 93

Query: 145 VNLIGYCCEDEHR----LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFL 200
           +  I    +         L+ +Y   G+L+D L      TL   + +K+A  +   L  L
Sbjct: 94  LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHL 150

Query: 201 HGEEK------PVIYRDFKASNILLDSDYNAKLSDFGLAT--DGPQGEDSHITTCVMGTE 252
           H E         + +RD K+ NIL+  +    ++D GLA        E        +GT+
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210

Query: 253 GYAAPE----YINTGHL--TTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARP- 305
            Y  PE     +N  H     M D++SFG++L E+          RC     + E+  P 
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR--------RCVSGGIVEEYQLPY 262

Query: 306 --MLKDFTKLDQIIDSRLEDRY---------STEGAKRLAAVAHQCLSHNPKSRPTMTTV 354
             ++      + + +     +          S E  +++  +  +C +HNP SR T   V
Sbjct: 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322

Query: 355 VKALEPLLDLNDI 367
            K L  + +  DI
Sbjct: 323 KKTLAKMSESQDI 335

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  186 bits (475), Expect = 7e-56
 Identities = 71/292 (24%), Positives = 113/292 (38%), Gaps = 44/292 (15%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG+  K       R     + + +K L     +  R +L EV  +  L+HP+++ 
Sbjct: 18  LGKGCFGQAIKV----THRE--TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK 71

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
            IG   +D+    + EY+  G L   + K+  S  PW  R+  A   A  +A+LH     
Sbjct: 72  FIGVLYKDKRLNFITEYIKGGTLRGII-KSMDSQYPWSQRVSFAKDIASGMAYLH--SMN 128

Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLA------------TDGPQGEDSHITTCVMGTEGY 254
           +I+RD  + N L+  + N  ++DFGLA                +  D      V+G   +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188

Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD 314
            APE IN        DVFSFG+VL E++                    A P   D+    
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN----------------ADP---DYLPRT 229

Query: 315 QIIDSRLEDRYSTEGAK----RLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
                 +                  +  +C   +P+ RP+   +   LE L 
Sbjct: 230 MDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  187 bits (477), Expect = 8e-56
 Identities = 84/366 (22%), Positives = 143/366 (39%), Gaps = 69/366 (18%)

Query: 36  STQRLLLTDVSNPGSPISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKV 95
           +T + L+ D++  GS   L  L    +         + + +          +G+G FG+V
Sbjct: 14  TTLKDLIYDMTTSGSGSGLPLLVQRTI--------ARTIVLQES-------IGKGRFGEV 58

Query: 96  YKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAE--VIFLGQLKHPHLVNLIGYCCE 153
           ++G          + + VAVK+     S+  R W  E  +     L+H +++  I    +
Sbjct: 59  WRGK--------WRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAADNK 107

Query: 154 DE----HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE----- 204
           D        LV +Y   G+L D L +    T+     IK+A+  A  LA LH E      
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQG 164

Query: 205 KPVI-YRDFKASNILLDSDYNAKLSDFGLAT--DGPQGEDSHITTCVMGTEGYAAPE--- 258
           KP I +RD K+ NIL+  +    ++D GLA   D             +GT+ Y APE   
Sbjct: 165 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 224

Query: 259 -YINTGHL--TTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARP---MLKDFTK 312
             IN  H       D+++ G+V  E+          RC       ++  P   ++     
Sbjct: 225 DSINMKHFESFKRADIYAMGLVFWEIAR--------RCSIGGIHEDYQLPYYDLVPSDPS 276

Query: 313 LDQIIDSRLEDRY---------STEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD 363
           ++++     E +          S E  + +A +  +C   N  +R T   + K L  L  
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336

Query: 364 LNDIPI 369
              I +
Sbjct: 337 QEGIKM 342

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  185 bits (473), Expect = 1e-55
 Identities = 77/314 (24%), Positives = 133/314 (42%), Gaps = 50/314 (15%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           +G G FG V K           +A+ VA+K +        + ++ E+  L ++ HP++V 
Sbjct: 16  VGRGAFGVVCKAK--------WRAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVK 65

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFK-NYSSTLPWLTRIKIAIGAARCLAFLHGEE- 204
           L G C       LV EY   G+L++ L              +   +  ++ +A+LH  + 
Sbjct: 66  LYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123

Query: 205 KPVIYRDFKASNILLDSDYN-AKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTG 263
           K +I+RD K  N+LL +     K+ DFG A D      +H+T    G+  + APE     
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNK-GSAAWMAPEVFEGS 178

Query: 264 HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII------ 317
           + +  CDVFS+G++L E++T R                  +P   +       I      
Sbjct: 179 NYSEKCDVFSWGIILWEVITRR------------------KP-FDEIGGPAFRIMWAVHN 219

Query: 318 DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL---NDIPIGPFVY 374
            +R     +    K + ++  +C S +P  RP+M  +VK +  L+      D P+     
Sbjct: 220 GTRPPLIKNLP--KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQ 277

Query: 375 TVVPPGDHGHGQKS 388
             +PPG+ G  +  
Sbjct: 278 HSLPPGEDGRVEPY 291

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  184 bits (469), Expect = 3e-55
 Identities = 68/308 (22%), Positives = 124/308 (40%), Gaps = 56/308 (18%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEV-IF-LGQLKHPHL 144
           +G+G +G+V++G          + + VAVK+     S+  + W  E  ++    L+H ++
Sbjct: 16  VGKGRYGEVWRGS--------WQGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENI 64

Query: 145 VNLIGYCCEDEHR----LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFL 200
           +  I       H      L+  Y  +G+L+D L      TL  ++ ++I +  A  LA L
Sbjct: 65  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHL 121

Query: 201 HGEEK------PVIYRDFKASNILLDSDYNAKLSDFGLA---TDGPQGEDSHITTCVMGT 251
           H E         + +RD K+ NIL+  +    ++D GLA   +      D      V GT
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GT 180

Query: 252 EGYAAPE------YINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARP 305
           + Y APE       ++        D+++FG+VL E+          R      + ++  P
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR--------RMVSNGIVEDYKPP 232

Query: 306 ---MLKDFTKLDQIIDSRLEDRY---------STEGAKRLAAVAHQCLSHNPKSRPTMTT 353
              ++ +    + +      D+          S      LA +  +C   NP +R T   
Sbjct: 233 FYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALR 292

Query: 354 VVKALEPL 361
           + K L  +
Sbjct: 293 IKKTLTKI 300

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  183 bits (467), Expect = 3e-55
 Identities = 61/290 (21%), Positives = 113/290 (38%), Gaps = 50/290 (17%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHL 144
           L E   G+++KG          +   + VKVL V    ++  R++  E   L    HP++
Sbjct: 18  LNENHSGELWKGR--------WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69

Query: 145 VNLIGYCCE--DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
           + ++G C      H  L+  +M  G+L++ L +  +  +     +K A+  AR +AFLH 
Sbjct: 70  LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129

Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN- 261
            E  +      + ++++D D  A++S   +         S  +   M    + APE +  
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQK 182

Query: 262 --TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD--QII 317
                     D++SF V+L EL+T                     P    F  L   +I 
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTRE------------------VP----FADLSNMEIG 220

Query: 318 DSRLEDRY----STEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD 363
                +          +  ++ +   C++ +P  RP    +V  LE + D
Sbjct: 221 MKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  182 bits (463), Expect = 2e-54
 Identities = 75/297 (25%), Positives = 130/297 (43%), Gaps = 58/297 (19%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGH-------REWLAEVIFLGQL 139
           +G+GGFG V+KG +  +         VA+K L +  S+G        +E+  EV  +  L
Sbjct: 27  IGKGGFGLVHKGRLVKD------KSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80

Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAF 199
            HP++V L G         +V E++  G+L+ +L    +  + W  ++++ +  A  + +
Sbjct: 81  NHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEY 137

Query: 200 LHGEEKPVIYRDFKASNILLDS-----DYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           +  +  P+++RD ++ NI L S        AK++DFGL+      +  H  + ++G   +
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQW 192

Query: 255 AAPEYINTGHL--TTMCDVFSFGVVLLELLTGRR--------SVEKNRCKREKDLVEWAR 304
            APE I       T   D +SF ++L  +LTG           ++     RE+ L    R
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL----R 248

Query: 305 PMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL 361
           P + +                      RL  V   C S +PK RP  + +VK L  L
Sbjct: 249 PTIPEDCP------------------PRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  178 bits (453), Expect = 3e-53
 Identities = 79/294 (26%), Positives = 121/294 (41%), Gaps = 56/294 (19%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL----DVNGSQGHREWLAEVIFLGQLKHP 142
           +G GGFGKVY+               VAVK      D + SQ       E      LKHP
Sbjct: 15  IGIGGFGKVYRAF--------WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66

Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
           +++ L G C ++ +  LV E+   G L+  L       +P    +  A+  AR + +LH 
Sbjct: 67  NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHD 123

Query: 203 E-EKPVIYRDFKASNILLD--------SDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
           E   P+I+RD K+SNIL+         S+   K++DFGLA +              G   
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKMSAAGAYA 179

Query: 254 YAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKL 313
           + APE I     +   DV+S+GV+L ELLTG                    P    F  +
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGE------------------VP----FRGI 217

Query: 314 D--QIIDSRLEDRY----STEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL 361
           D   +      ++      +   +  A +   C + +P SRP+ T ++  L  +
Sbjct: 218 DGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  179 bits (455), Expect = 4e-53
 Identities = 75/288 (26%), Positives = 122/288 (42%), Gaps = 44/288 (15%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGH--REWLAEVIFLGQLKHPHL 144
           +G G FG VYKG              VAVK+L+V        + +  EV  L + +H ++
Sbjct: 32  IGSGSFGTVYKGKWHG---------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82

Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           +  +G         +V ++    +L+  L     +       I IA   AR + +LH   
Sbjct: 83  LLFMG-YSTAPQLAIVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMDYLH--A 138

Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI---N 261
           K +I+RD K++NI L  D   K+ DFGLAT+  +   SH    + G+  + APE I   +
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198

Query: 262 TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDS-- 319
           +   +   DV++FG+VL EL+TG+                   P   +    DQII+   
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQ------------------LP-YSNINNRDQIIEMVG 239

Query: 320 ----RLEDRYSTEGA-KRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
                 +         KR+  +  +CL      RP+   ++  +E L 
Sbjct: 240 RGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  171 bits (435), Expect = 7e-50
 Identities = 61/306 (19%), Positives = 108/306 (35%), Gaps = 57/306 (18%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGH--REWLAEVIFLGQLKHPHL 144
           +G+G FG+VY G              VA++++D+        + +  EV+   Q +H ++
Sbjct: 41  IGKGRFGQVYHGRWH---------GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENV 91

Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           V  +G C    H  ++        L+  + ++    L      +IA    + + +LH   
Sbjct: 92  VLFMGACMSPPHLAIITSLCKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVKGMGYLHA-- 148

Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLAT---DGPQGEDSHITTCVMGTEGYAAPEYIN 261
           K ++++D K+ N+  D +    ++DFGL +       G          G   + APE I 
Sbjct: 149 KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207

Query: 262 TG---------HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK 312
                        +   DVF+ G +  EL                       P    F  
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHARE------------------WP----FKT 245

Query: 313 LD--QII-----DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN 365
                II       +        G K ++ +   C +   + RPT T ++  LE L   N
Sbjct: 246 QPAEAIIWQMGTGMKPNLSQIGMG-KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304

Query: 366 DIPIGP 371
                P
Sbjct: 305 RRLSHP 310

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  160 bits (408), Expect = 6e-46
 Identities = 80/314 (25%), Positives = 126/314 (40%), Gaps = 41/314 (13%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG V     D           VAVK L  +G    R++  E+  L  L    +V 
Sbjct: 31  LGKGNFGSVELCRYDP--LGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 147 LIGYCCEDEHR--LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
             G       +   LV EY+  G L D L + + + L     +  +    + + +L    
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYL--GS 145

Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG-----YAAPEY 259
           +  ++RD  A NIL++S+ + K++DFGLA   P  +D +    V+   G     + APE 
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYAPES 201

Query: 260 INTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIID 318
           ++    +   DV+SFGVVL EL T   +S   +         E   P L    +L     
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL----- 256

Query: 319 SRLEDRYSTEGAKRLAA----------VAHQCLSHNPKSRPTMTTVVKALEPLLDLNDIP 368
             LE+        RL A          +   C + +P+ RP+ + +   L+ L       
Sbjct: 257 --LEEGQ------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS-GSRG 307

Query: 369 IGPFVYTVVPPGDH 382
                +T  P G H
Sbjct: 308 CETHAFTAHPEGKH 321

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  157 bits (398), Expect = 1e-44
 Identities = 84/296 (28%), Positives = 118/296 (39%), Gaps = 43/296 (14%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL-DVNGSQGHREWLAEVIFLGQLKHPHLV 145
           LGEG FGKV   C   +       + VAVK L    G Q    W  E+  L  L H H++
Sbjct: 39  LGEGHFGKVSLYCY--DPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 146 NLIGYCCEDEHR--LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE 203
              G C +       LV EY+ LG+L D L   +S  L  L  +  A      +A+L   
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQL--LLFAQQICEGMAYL--H 151

Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG-----YAAPE 258
            +  I+RD  A N+LLD+D   K+ DFGLA   P+G + +     +  +G     + APE
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFWYAPE 207

Query: 259 YINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII 317
            +         DV+SFGV L ELLT    S        E   +   +  +   T+L    
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL---- 263

Query: 318 DSRLEDRYSTEGAKRLAAVAH----------QCLSHNPKSRPTMTTVVKALEPLLD 363
              LE         RL                C       RPT   ++  L+ + +
Sbjct: 264 ---LERGE------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  155 bits (393), Expect = 5e-44
 Identities = 68/294 (23%), Positives = 121/294 (41%), Gaps = 37/294 (12%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG V     D         + VAVK L  +  +  R++  E+  L  L+H ++V 
Sbjct: 18  LGKGNFGSVEMCRYDP--LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 147 LIGYCCEDEHR--LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
             G C     R   L+ EY+  G+L D L + +   +  +  ++      + + +L    
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL--GT 132

Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG-----YAAPEY 259
           K  I+RD    NIL++++   K+ DFGL    PQ ++           G     + APE 
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK----EPGESPIFWYAPES 188

Query: 260 INTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDS 319
           +     +   DV+SFGVVL EL T     +    +  + +    +  +  F     +I+ 
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF----HLIE- 243

Query: 320 RLEDRYSTEGAKRLAA----------VAHQCLSHNPKSRPTMTTVVKALEPLLD 363
            L++        RL            +  +C ++N   RP+   +   ++ + D
Sbjct: 244 LLKNNG------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  155 bits (393), Expect = 5e-44
 Identities = 66/295 (22%), Positives = 113/295 (38%), Gaps = 41/295 (13%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL-DVNGSQGHREWLAEVIFLGQLKHPHLV 145
           LGEG FGKV     D         + VAVK L   +G     +   E+  L  L H ++V
Sbjct: 29  LGEGHFGKVELCRYD--PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 146 NLIGYCCEDEHR--LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE 203
              G C ED      L+ E++  G+L + L     + +    ++K A+   + + +L   
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYL--G 143

Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG-----YAAPE 258
            +  ++RD  A N+L++S++  K+ DFGL       ++ +        +      + APE
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK----DDRDSPVFWYAPE 199

Query: 259 YINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII 317
            +         DV+SFGV L ELLT             +       +  +          
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT---- 255

Query: 318 DSRLEDRYSTEGAKRLAA----------VAHQCLSHNPKSRPTMTTVVKALEPLL 362
              L++        RL            +  +C    P +R +   +++  E LL
Sbjct: 256 ---LKEGK------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  155 bits (393), Expect = 1e-43
 Identities = 67/294 (22%), Positives = 121/294 (41%), Gaps = 37/294 (12%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG V     D         + VAVK L  +  +  R++  E+  L  L+H ++V 
Sbjct: 49  LGKGNFGSVEMCRYD--PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 147 LIGYCCEDEHR--LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
             G C     R   L+ EY+  G+L D L + +   +  +  ++      + + +L    
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL--GT 163

Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG-----YAAPEY 259
           K  I+RD    NIL++++   K+ DFGL    PQ ++ +     +   G     + APE 
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYAPES 219

Query: 260 INTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDS 319
           +     +   DV+SFGVVL EL T     +    +  + +    +  +        +I+ 
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV----FHLIE- 274

Query: 320 RLEDRYSTEGAKRLAAVAH----------QCLSHNPKSRPTMTTVVKALEPLLD 363
            L++        RL               +C ++N   RP+   +   ++ + D
Sbjct: 275 LLKNNG------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  150 bits (380), Expect = 2e-41
 Identities = 71/290 (24%), Positives = 116/290 (40%), Gaps = 52/290 (17%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL-DVNGSQGHREWLAEVIFLGQLKHPHLV 145
           +G G FG+V+ G     LR       VAVK   +        ++L E   L Q  HP++V
Sbjct: 122 IGRGNFGEVFSG----RLRA--DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIV 175

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            LIG C + +   +V E +  G+    L     + L   T +++   AA  + +L  E K
Sbjct: 176 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYL--ESK 232

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY-----AAPEYI 260
             I+RD  A N L+      K+SDFG++ +   G          G          APE +
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV-----YAASGGLRQVPVKWTAPEAL 287

Query: 261 NTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARP---MLKDFTKLDQI 316
           N G  ++  DV+SFG++L E  + G                    P   +        Q 
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGA------------------SPYPNL-----SNQQT 324

Query: 317 IDSRLEDRY---STEGA-KRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
            +  +E        E     +  +  QC ++ P  RP+ +T+ + L+ + 
Sbjct: 325 RE-FVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  146 bits (370), Expect = 2e-40
 Identities = 65/296 (21%), Positives = 111/296 (37%), Gaps = 61/296 (20%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL-DVNGSQGHREWLAEVIFLGQLKHPHLV 145
           LG G FG VYKG              VA+K L +    + ++E L E   +  + +PH+ 
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            L+G  C      L+ + M  G L D + + +   +     +   +  A+ + +L  E++
Sbjct: 81  RLLG-ICLTSTVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL--EDR 136

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG-----YAAPEYI 260
            +++RD  A N+L+ +  + K++DFGLA      E            G     + A E I
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK-----EYHAEGGKVPIKWMALESI 191

Query: 261 NTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARP---MLKDFTKLDQI 316
                T   DV+S+GV + EL+T G                   +P   +        +I
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGS------------------KPYDGI-----PASEI 228

Query: 317 IDSRLEDRYSTEGAKRLAA----------VAHQCLSHNPKSRPTMTTVVKALEPLL 362
               LE         RL            +  +C   +  SRP    ++     + 
Sbjct: 229 SS-ILEKGE------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  144 bits (365), Expect = 4e-40
 Identities = 74/301 (24%), Positives = 120/301 (39%), Gaps = 55/301 (18%)

Query: 87  LGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLV 145
           LG+G F K++KG   +      L    V +KVLD         +      + +L H HLV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSS-TLPWLTRIKIAIGAARCLAFLHGEE 204
              G C   +  +LV E++  G+L   L KN +   + W   +++A   A  + FL  EE
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAAAMHFL--EE 131

Query: 205 KPVIYRDFKASNILLDSDYN--------AKLSDFGLATDGPQGEDSHITTCVMGTEGY-- 254
             +I+ +  A NILL  + +         KLSD G++              V+  +    
Sbjct: 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPKDILQE 179

Query: 255 ----AAPEYI-NTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLK 308
                 PE I N  +L    D +SFG  L E+ + G + +                  L 
Sbjct: 180 RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL----------------SALD 223

Query: 309 DFTKLDQIID-SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDI 367
              KL    D  +L    + E    LA + + C+ + P  RP+   +++ L  L   + +
Sbjct: 224 SQRKLQFYEDRHQLPAPKAAE----LANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279

Query: 368 P 368
           P
Sbjct: 280 P 280

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  145 bits (367), Expect = 7e-40
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 18/208 (8%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLV 145
           +G G FG+VYKG +      G K   VA+K L    ++  R ++L E   +GQ  H +++
Sbjct: 52  IGAGEFGEVYKGML--KTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            L G   + +  +++ EYM  G L   L +        L  + +  G A  + +L     
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFL-REKDGEFSVLQLVGMLRGIAAGMKYL--ANM 166

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG------YAAPEY 259
             ++RD  A NIL++S+   K+SDFGL+       ++  T     T G      + APE 
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT-----TSGGKIPIRWTAPEA 221

Query: 260 INTGHLTTMCDVFSFGVVLLELLT-GRR 286
           I+    T+  DV+SFG+V+ E++T G R
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGER 249

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  144 bits (366), Expect = 7e-40
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 19/208 (9%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLV 145
           +G G  G+V  G +     PG +   VA+K L    ++  R ++L+E   +GQ  HP+++
Sbjct: 57  IGSGDSGEVCYGRL---RVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            L G        ++V EYM  G+L   L + +      +  + +  G    + +L   + 
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL-RTHDGQFTIMQLVGMLRGVGAGMRYL--SDL 170

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG------YAAPEY 259
             ++RD  A N+L+DS+   K+SDFGL+       D+  T     T G      + APE 
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT-----TTGGKIPIRWTAPEA 225

Query: 260 INTGHLTTMCDVFSFGVVLLELLT-GRR 286
           I     ++  DV+SFGVV+ E+L  G R
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGER 253

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  147 bits (372), Expect = 1e-39
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 25/205 (12%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           +G+G FG V  G          +   VAVK +  + +   + +LAE   + QL+H +LV 
Sbjct: 201 IGKGEFGDVMLGD--------YRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 250

Query: 147 LIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
           L+G   E++  L +V EYMA G+L D L     S L     +K ++     + +L  E  
Sbjct: 251 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGN 308

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINT 262
             ++RD  A N+L+  D  AK+SDFGL  +         ++     +    + APE +  
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTKE--------ASSTQDTGKLPVKWTAPEALRE 360

Query: 263 GHLTTMCDVFSFGVVLLELLT-GRR 286
              +T  DV+SFG++L E+ + GR 
Sbjct: 361 KKFSTKSDVWSFGILLWEIYSFGRV 385

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  143 bits (362), Expect = 1e-39
 Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 23/209 (11%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHREWLAEVIFLGQLKHPHL 144
           LG G FG V KG      +     +TVAVK+L  + N      E LAE   + QL +P++
Sbjct: 25  LGSGNFGTVKKG----YYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80

Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           V +IG  CE E  +LV E   LG L+  L +N       +  I++    +  + +L  EE
Sbjct: 81  VRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI--IELVHQVSMGMKYL--EE 135

Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG------YAAPE 258
              ++RD  A N+LL + + AK+SDFGL+      E+ +                + APE
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA-----QTHGKWPVKWYAPE 190

Query: 259 YINTGHLTTMCDVFSFGVVLLELLT-GRR 286
            IN    ++  DV+SFGV++ E  + G++
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQK 219

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  142 bits (360), Expect = 2e-39
 Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 21/208 (10%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLV 145
           LG G FG V +G      R   K   VA+KVL     +    E + E   + QL +P++V
Sbjct: 18  LGCGNFGSVRQGV----YRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            LIG  C+ E  +LV E    G LH  L       +P     ++    +  + +L  EEK
Sbjct: 74  RLIG-VCQAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYL--EEK 129

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG------YAAPEY 259
             ++RD  A N+LL + + AK+SDFGL+      +  +                + APE 
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA-----RSAGKWPLKWYAPEC 184

Query: 260 INTGHLTTMCDVFSFGVVLLELLT-GRR 286
           IN    ++  DV+S+GV + E L+ G++
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQK 212

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  143 bits (362), Expect = 2e-39
 Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 36/218 (16%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLV 145
           LG+G FG VY+G     +        VA+K ++   S   R E+L E   + +    H+V
Sbjct: 33  LGQGSFGMVYEGVAK-GVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKN-----YSSTLPWLTR---IKIAIGAARCL 197
            L+G   + +  L++ E M  G+L   L         +  L   +    I++A   A  +
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA-- 255
           A+L       ++RD  A N ++  D+  K+ DFG+  D            +  T+ Y   
Sbjct: 152 AYL--NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD------------IYETDYYRKG 197

Query: 256 ----------APEYINTGHLTTMCDVFSFGVVLLELLT 283
                     +PE +  G  TT  DV+SFGVVL E+ T
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  141 bits (357), Expect = 4e-39
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 25/205 (12%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           +G+G FG V  G          +   VAVK +  + +   + +LAE   + QL+H +LV 
Sbjct: 29  IGKGEFGDVMLGD--------YRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 78

Query: 147 LIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
           L+G   E++  L +V EYMA G+L D L     S L     +K ++     + +L  E  
Sbjct: 79  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGN 136

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINT 262
             ++RD  A N+L+  D  AK+SDFGL  +         ++     +    + APE +  
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTKE--------ASSTQDTGKLPVKWTAPEALRE 188

Query: 263 GHLTTMCDVFSFGVVLLELLT-GRR 286
              +T  DV+SFG++L E+ + GR 
Sbjct: 189 KKFSTKSDVWSFGILLWEIYSFGRV 213

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  139 bits (352), Expect = 3e-38
 Identities = 66/208 (31%), Positives = 96/208 (46%), Gaps = 22/208 (10%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLV 145
           +GEG FG V++G     + P   A  VA+K      S   R ++L E + + Q  HPH+V
Sbjct: 23  IGEGQFGDVHQGIY---MSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            LIG    +    ++ E   LG L   L +    +L   + I  A   +  LA+L  E K
Sbjct: 80  KLIG-VITENPVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYL--ESK 135

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG------YAAPEY 259
             ++RD  A N+L+ S+   KL DFGL+      EDS                 + APE 
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYK----ASKGKLPIKWMAPES 188

Query: 260 INTGHLTTMCDVFSFGVVLLELLT-GRR 286
           IN    T+  DV+ FGV + E+L  G +
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILMHGVK 216

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  141 bits (358), Expect = 3e-38
 Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 19/208 (9%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLV 145
           +G G FG+V  G +     P  K  +VA+K L V  ++  R ++L E   +GQ  HP+++
Sbjct: 53  VGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            L G   + +  ++V EYM  G+L   L + + +    +  + +  G A  + +L   + 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIASGMKYL--SDM 166

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG------YAAPEY 259
             ++RD  A NIL++S+   K+SDFGL        ++  T     T G      + +PE 
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT-----TRGGKIPIRWTSPEA 221

Query: 260 INTGHLTTMCDVFSFGVVLLELLT-GRR 286
           I     T+  DV+S+G+VL E+++ G R
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGER 249

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  140 bits (355), Expect = 3e-38
 Identities = 71/306 (23%), Positives = 113/306 (36%), Gaps = 56/306 (18%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LGEG FGKV+      NL P      VAVK L        +++  E   L  L+H H+V 
Sbjct: 49  LGEGAFGKVFLAECH-NLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTR-------------IKIAIGA 193
             G C E    L+V+EYM  G+L+  L  +                       + +A   
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167

Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
           A  + +L       ++RD    N L+      K+ DFG++ D    +        +G   
Sbjct: 168 AAGMVYL--AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD-----YYRVGGRT 220

Query: 254 -----YAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRR-----SVEKNRCKREKDLVEW 302
                +  PE I     TT  DV+SFGVVL E+ T G++     S          + ++ 
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT--------EAID- 271

Query: 303 ARPMLKDFTKLDQIIDSRLEDRYSTEGA-KRLAAVAHQCLSHNPKSRPTMTTVVKALEPL 361
               +    +L++                  + A+   C    P+ R ++  V   L+ L
Sbjct: 272 ---CITQGRELER-----------PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317

Query: 362 LDLNDI 367
                +
Sbjct: 318 AQAPPV 323

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  140 bits (354), Expect = 4e-38
 Identities = 81/343 (23%), Positives = 132/343 (38%), Gaps = 65/343 (18%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL-DVNGSQGHREWLAEVIFLGQLKHPHLV 145
           LG G FG V+KG              V +KV+ D +G Q  +     ++ +G L H H+V
Sbjct: 21  LGSGVFGTVHKGVWIPEGESI--KIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            L+G  C      LV +Y+ LG+L D + + +   L     +   +  A+ + +L  EE 
Sbjct: 79  RLLG-LCPGSSLQLVTQYLPLGSLLDHV-RQHRGALGPQLLLNWGVQIAKGMYYL--EEH 134

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG-----YAAPEYI 260
            +++R+  A N+LL S    +++DFG+A   P  +       ++ +E      + A E I
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ-----LLYSEAKTPIKWMALESI 189

Query: 261 NTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARP---MLKDFTKLDQI 316
           + G  T   DV+S+GV + EL+T G                    P   +     +L ++
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMTFGA------------------EPYAGL-----RLAEV 226

Query: 317 IDSRLEDRYSTEGAKRLAA----------VAHQCLSHNPKSRPTMTTVVKALEPLL---- 362
            D  LE         RLA           V  +C   +   RPT   +      +     
Sbjct: 227 PD-LLEKGE------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPP 279

Query: 363 DLNDIPIGPFVYTVVPPGDHGHGQKSCGQKKNEKRGDGGKEKE 405
               I           P  HG   K   + + E   D   + E
Sbjct: 280 RYLVIKRESGPGIAPGPEPHGLTNKKLEEVELEPELDLDLDLE 322

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  139 bits (352), Expect = 5e-38
 Identities = 59/204 (28%), Positives = 89/204 (43%), Gaps = 16/204 (7%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLV 145
           +G+G FG VY G   D           A+K L           +L E + +  L HP+++
Sbjct: 29  IGKGHFGVVYHGEYID---QAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 146 NLIGYCCEDE-HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
            LIG     E    ++  YM  G+L   + ++          I   +  AR + +L   E
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFI-RSPQRNPTVKDLISFGLQVARGMEYL--AE 142

Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG-----YAAPEY 259
           +  ++RD  A N +LD  +  K++DFGLA D     D    +            + A E 
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARD---ILDREYYSVQQHRHARLPVKWTALES 199

Query: 260 INTGHLTTMCDVFSFGVVLLELLT 283
           + T   TT  DV+SFGV+L ELLT
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLT 223

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  139 bits (353), Expect = 5e-38
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 18/207 (8%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL-DVNGSQGHREWLAEVIFLGQLKHPHLV 145
           LG G FG VYKG              VA+K L +    + ++E L E   +  + +PH+ 
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            L+G  C      L+ + M  G L D + ++    +     +   +  A+ + +L  E++
Sbjct: 81  RLLG-ICLTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYL--EDR 136

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG-----YAAPEYI 260
            +++RD  A N+L+ +  + K++DFGLA      E            G     + A E I
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK-----EYHAEGGKVPIKWMALESI 191

Query: 261 NTGHLTTMCDVFSFGVVLLELLT-GRR 286
                T   DV+S+GV + EL+T G +
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSK 218

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  137 bits (347), Expect = 2e-37
 Identities = 70/212 (33%), Positives = 99/212 (46%), Gaps = 35/212 (16%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG+V+ G  + + +       VAVK L   GS     +LAE   + QL+H  LV 
Sbjct: 21  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 72

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L       E   ++ EYM  G+L D L       L     + +A   A  +AF+  EE+ 
Sbjct: 73  LYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERN 129

Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA----------- 255
            I+RD +A+NIL+    + K++DFGLA              +   E  A           
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARL------------IEDNEYTAREGAKFPIKWT 177

Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLT-GRR 286
           APE IN G  T   DV+SFG++L E++T GR 
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRI 209

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  136 bits (346), Expect = 2e-37
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 22/208 (10%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLV 145
           LGEG FG+VY+G   +      +   VAVK    + +  ++ ++++E + +  L HPH+V
Sbjct: 20  LGEGFFGEVYEGVYTN---HKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            LIG   E+E   ++ E    G L   L +   ++L  LT +  ++   + +A+L  E  
Sbjct: 77  KLIG-IIEEEPTWIIMELYPYGELGHYL-ERNKNSLKVLTLVLYSLQICKAMAYL--ESI 132

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG------YAAPEY 259
             ++RD    NIL+ S    KL DFGL+      ED                  + +PE 
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYI---EDEDYYK----ASVTRLPIKWMSPES 185

Query: 260 INTGHLTTMCDVFSFGVVLLELLT-GRR 286
           IN    TT  DV+ F V + E+L+ G++
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQ 213

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  136 bits (346), Expect = 2e-37
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 35/213 (16%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G +G+VY+G           + TVAVK L    +    E+L E   + ++KHP+LV 
Sbjct: 21  LGGGQYGEVYEGVWKK------YSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQ 73

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L+G C  +    ++ E+M  GNL D L +     +  +  + +A   +  + +L  E+K 
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKKN 131

Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA----------- 255
            I+RD  A N L+  ++  K++DFGL+              +M  + Y            
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSR-------------LMTGDTYTAHAGAKFPIKW 178

Query: 256 -APEYINTGHLTTMCDVFSFGVVLLELLT-GRR 286
            APE +     +   DV++FGV+L E+ T G  
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 211

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  141 bits (357), Expect = 3e-37
 Identities = 74/281 (26%), Positives = 129/281 (45%), Gaps = 36/281 (12%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G +G+VY+G      +    + TVAVK L    +    E+L E   + ++KHP+LV 
Sbjct: 228 LGGGQYGEVYEG----VWKK--YSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQ 280

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L+G C  +    ++ E+M  GNL D L +     +  +  + +A   +  + +L  E+K 
Sbjct: 281 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKKN 338

Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE---GYAAPEYINTG 263
            I+R+  A N L+  ++  K++DFGL+    +       T   G +    + APE +   
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLS----RLMTGDTYTAHAGAKFPIKWTAPESLAYN 394

Query: 264 HLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLE 322
             +   DV++FGV+L E+ T G          +  +L+E      KD+         R+E
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE------KDY---------RME 439

Query: 323 DRYSTEGA-KRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
                EG  +++  +   C   NP  RP+   + +A E + 
Sbjct: 440 ---RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  136 bits (346), Expect = 3e-37
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 22/210 (10%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHREWLAEVIFLGQLKHPH 143
           LG+G FG V +G  D    P  K  +VAVK L    ++  +   +++ EV  +  L H +
Sbjct: 26  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE 203
           L+ L G         +V E   LG+L D+L + +       T  + A+  A  + +L  E
Sbjct: 83  LIRLYG-VVLTPPMKMVTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYL--E 138

Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG------YAAP 257
            K  I+RD  A N+LL +    K+ DFGL    PQ +D ++       E       + AP
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM-----QEHRKVPFAWCAP 193

Query: 258 EYINTGHLTTMCDVFSFGVVLLELLT-GRR 286
           E + T   +   D + FGV L E+ T G+ 
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  136 bits (344), Expect = 3e-37
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 25/207 (12%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG V  G              VAVK++   GS    E+  E   + +L HP LV 
Sbjct: 16  LGSGQFGVVKLGKWKGQYD-------VAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVK 67

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
             G C ++    +V EY++ G L + L +++   L     +++       +AFL  E   
Sbjct: 68  FYGVCSKEYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFL--ESHQ 124

Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG------YAAPEYI 260
            I+RD  A N L+D D   K+SDFG+        D    +    + G      ++APE  
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRY---VLDDQYVS----SVGTKFPVKWSAPEVF 177

Query: 261 NTGHLTTMCDVFSFGVVLLELLT-GRR 286
           +    ++  DV++FG+++ E+ + G+ 
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFSLGKM 204

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  135 bits (343), Expect = 4e-37
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 27/208 (12%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQT-VAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLV 145
           +G G FG V+ G            +  VA+K +   G+    +++ E   + +L HP LV
Sbjct: 16  IGSGQFGLVHLGY--------WLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 66

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            L G C E     LV E+M  G L D L +         T + + +     +A+L  EE 
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYL--EEA 123

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG------YAAPEY 259
            VI+RD  A N L+  +   K+SDFG+        D   T+    + G      +A+PE 
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTRF---VLDDQYTS----STGTKFPVKWASPEV 176

Query: 260 INTGHLTTMCDVFSFGVVLLELLT-GRR 286
            +    ++  DV+SFGV++ E+ + G+ 
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVFSEGKI 204

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  139 bits (353), Expect = 5e-37
 Identities = 67/204 (32%), Positives = 104/204 (50%), Gaps = 19/204 (9%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG+V+    + + +       VAVK +   GS     +LAE   +  L+H  LV 
Sbjct: 196 LGAGQFGEVWMATYNKHTK-------VAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVK 247

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L       E   ++ E+MA G+L D L  +  S  P    I  +   A  +AF+  E++ 
Sbjct: 248 LHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI--EQRN 304

Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG---YAAPEYINTG 263
            I+RD +A+NIL+ +    K++DFGLA    +  + +  T   G +    + APE IN G
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLA----RVIEDNEYTAREGAKFPIKWTAPEAINFG 360

Query: 264 HLTTMCDVFSFGVVLLELLT-GRR 286
             T   DV+SFG++L+E++T GR 
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGRI 384

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  136 bits (344), Expect = 6e-37
 Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 34/213 (15%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLV 145
           +G G FG VY G + D      K    AVK L+     G   ++L E I +    HP+++
Sbjct: 33  IGRGHFGCVYHGTLLD---NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 146 NLIGYCCEDEH-RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           +L+G C   E   L+V  YM  G+L + +    +        I   +  A+ + +L    
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYL--AS 146

Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA--------- 255
           K  ++RD  A N +LD  +  K++DFGLA D            +   E Y+         
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARD------------MYDKEYYSVHNKTGAKL 194

Query: 256 -----APEYINTGHLTTMCDVFSFGVVLLELLT 283
                A E + T   TT  DV+SFGV+L EL+T
Sbjct: 195 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  139 bits (352), Expect = 7e-37
 Identities = 75/278 (26%), Positives = 114/278 (41%), Gaps = 32/278 (11%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG+V+ G          +   VA+K L   G+     +L E   + +L+H  LV 
Sbjct: 192 LGQGCFGEVWMG----TWNGTTR---VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQ 243

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L      +E   +V EYM+ G+L D L       L     + +A   A  +A++  E   
Sbjct: 244 LYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERMN 300

Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
            ++RD +A+NIL+  +   K++DFGLA      E +         + + APE    G  T
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFT 359

Query: 267 TMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRY 325
              DV+SFG++L EL T GR        +   D VE                  R+    
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---------------GYRMP--- 401

Query: 326 STEGA-KRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
                 + L  +  QC    P+ RPT   +   LE   
Sbjct: 402 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  136 bits (344), Expect = 7e-37
 Identities = 68/306 (22%), Positives = 112/306 (36%), Gaps = 64/306 (20%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFL 136
              +F     LG+G FG+V K       R  L ++  A+K +     +     L+EV+ L
Sbjct: 4   YASDFEEIAVLGQGAFGQVVKA------RNALDSRYYAIKKIRHTEEK-LSTILSEVMLL 56

Query: 137 GQLKHPHLVNLIGYCCEDEHRL-------------LVYEYMALGNLHD-----QLFKNYS 178
             L H ++V       E  + +             +  EY   G L+D      L +   
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116

Query: 179 STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT---- 234
                  +I  A      L+++H   + +I+RD K  NI +D   N K+ DFGLA     
Sbjct: 117 EYWRLFRQILEA------LSYIH--SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHR 168

Query: 235 ---------DGPQGEDSHITTCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTG 284
                        G   ++T+ + GT  Y A E +  TGH     D++S G++  E++  
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

Query: 285 RRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHN 344
             S    R             +LK    +        +D       K++       + H+
Sbjct: 228 -FSTGMERVN-----------ILKKLRSVSIEFPPDFDDNKMKV-EKKI---IRLLIDHD 271

Query: 345 PKSRPT 350
           P  RP 
Sbjct: 272 PNKRPG 277

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  142 bits (359), Expect = 7e-37
 Identities = 66/203 (32%), Positives = 97/203 (47%), Gaps = 19/203 (9%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLV 145
           +GEG FG V++G     + P   A  VA+K      S   R ++L E + + Q  HPH+V
Sbjct: 398 IGEGQFGDVHQGIY---MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            LIG    +    ++ E   LG L   L +    +L   + I  A   +  LA+L  E K
Sbjct: 455 KLIG-VITENPVWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYL--ESK 510

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG-----YAAPEYI 260
             ++RD  A N+L+ S+   KL DFGL+      EDS        ++G     + APE I
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYK---ASKGKLPIKWMAPESI 564

Query: 261 NTGHLTTMCDVFSFGVVLLELLT 283
           N    T+  DV+ FGV + E+L 
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILM 587

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  137 bits (348), Expect = 8e-37
 Identities = 76/281 (27%), Positives = 121/281 (43%), Gaps = 20/281 (7%)

Query: 10  KIILPSCIKATNKPSCMSKVHVSNQVSTQRLLLTDVSNPGSPISLNELSSSLVGSNLHVF 69
            I++P      +    + ++  S         L         I L+ L+  LV +  HV 
Sbjct: 24  GILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVV 83

Query: 70  TLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-E 128
                 ++      ++ +G G FG VY G + D      K    AVK L+     G   +
Sbjct: 84  IGPSSLIVH----FNEVIGRGHFGCVYHGTLLD---NDGKKIHCAVKSLNRITDIGEVSQ 136

Query: 129 WLAEVIFLGQLKHPHLVNLIGYCCEDEH-RLLVYEYMALGNLHDQLFKNYSSTLPWLTRI 187
           +L E I +    HP++++L+G C   E   L+V  YM  G+L + + +N +        I
Sbjct: 137 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLI 195

Query: 188 KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC 247
              +  A+ + FL    K  ++RD  A N +LD  +  K++DFGLA D    E   +   
Sbjct: 196 GFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN- 252

Query: 248 VMGTEG-----YAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
              T       + A E + T   TT  DV+SFGV+L EL+T
Sbjct: 253 --KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  135 bits (341), Expect = 1e-36
 Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 25/207 (12%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG V  G              VA+K++   GS    E++ E   +  L H  LV 
Sbjct: 32  LGTGQFGVVKYGKWRGQYD-------VAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQ 83

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L G C +     ++ EYMA G L + L +           +++       + +L  E K 
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYL--ESKQ 140

Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG------YAAPEYI 260
            ++RD  A N L++     K+SDFGL+       D   T+    + G      ++ PE +
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRY---VLDDEYTS----SVGSKFPVRWSPPEVL 193

Query: 261 NTGHLTTMCDVFSFGVVLLELLT-GRR 286
                ++  D+++FGV++ E+ + G+ 
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYSLGKM 220

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  135 bits (343), Expect = 1e-36
 Identities = 62/211 (29%), Positives = 91/211 (43%), Gaps = 22/211 (10%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLV 145
           LG G FG+VY+G V   +        VAVK L    S+    ++L E + + +  H ++V
Sbjct: 38  LGHGAFGEVYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKN-----YSSTLPWLTRIKIAIGAARCLAFL 200
             IG   +   R ++ E MA G+L   L +        S+L  L  + +A   A    +L
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156

Query: 201 HGEEKPVIYRDFKASNILLD---SDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY--- 254
             EE   I+RD  A N LL        AK+ DFG+A D  +           G       
Sbjct: 157 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS-----YYRKGGCAMLPV 209

Query: 255 --AAPEYINTGHLTTMCDVFSFGVVLLELLT 283
               PE    G  T+  D +SFGV+L E+ +
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  134 bits (340), Expect = 2e-36
 Identities = 72/316 (22%), Positives = 116/316 (36%), Gaps = 90/316 (28%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLV 145
           LGE  FGKVYKG +     PG + Q VA+K L        R E+  E +   +L+HP++V
Sbjct: 17  LGEDRFGKVYKGHLF-GPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKN--------------YSSTLPWLTRIKIAI 191
            L+G   +D+   +++ Y + G+LH+ L                   S L     + +  
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135

Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
             A  + +L      V+++D    N+L+    N K+SD GL  +            V   
Sbjct: 136 QIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE------------VYAA 181

Query: 252 EGYA------------APEYINTGHLTTMCDVFSFGVVLLELLT-GRR-----SVEKNRC 293
           + Y             APE I  G  +   D++S+GVVL E+ + G +     S +    
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---- 237

Query: 294 KREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAH----------QCLSH 343
               D+VE                   + +R        L               +C + 
Sbjct: 238 ----DVVE------------------MIRNRQ------VLPCPDDCPAWVYALMIECWNE 269

Query: 344 NPKSRPTMTTVVKALE 359
            P  RP    +   L 
Sbjct: 270 FPSRRPRFKDIHSRLR 285

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  139 bits (352), Expect = 2e-36
 Identities = 76/278 (27%), Positives = 115/278 (41%), Gaps = 32/278 (11%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FG+V+ G  +   R       VA+K L   G+     +L E   + +L+H  LV 
Sbjct: 275 LGQGCFGEVWMGTWNGTTR-------VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQ 326

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L      +E   +V EYM+ G+L D L       L     + +A   A  +A++  E   
Sbjct: 327 LYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERMN 383

Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLT 266
            ++RD +A+NIL+  +   K++DFGLA      E +         + + APE    G  T
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFT 442

Query: 267 TMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRY 325
              DV+SFG++L EL T GR        +   D VE                  R+    
Sbjct: 443 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---------------GYRMP--- 484

Query: 326 STEGA-KRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
                 + L  +  QC    P+ RPT   +   LE   
Sbjct: 485 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  135 bits (342), Expect = 2e-36
 Identities = 79/314 (25%), Positives = 129/314 (41%), Gaps = 83/314 (26%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG-HREWLAEVIFLGQL-KHPHL 144
           +GEG FG+V K      ++        A+K +    S+  HR++  E+  L +L  HP++
Sbjct: 33  IGEGNFGQVLKA----RIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88

Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQL--------------FKNYSSTLPWLTRIKIA 190
           +NL+G C    +  L  EY   GNL D L                + +STL     +  A
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148

Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG 250
              AR + +L   +K  I+RD  A NIL+  +Y AK++DFGL+      ++ ++      
Sbjct: 149 ADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSRG----QEVYVKK---- 198

Query: 251 TEG-----YAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRR-----SVEKNRCKREKDL 299
           T G     + A E +N    TT  DV+S+GV+L E+++ G       +          +L
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------EL 250

Query: 300 VEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAH----------QCLSHNPKSRP 349
            E                  +L   Y      RL    +          QC    P  RP
Sbjct: 251 YE------------------KLPQGY------RLEKPLNCDDEVYDLMRQCWREKPYERP 286

Query: 350 TMTTVVKALEPLLD 363
           +   ++ +L  +L+
Sbjct: 287 SFAQILVSLNRMLE 300

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  135 bits (343), Expect = 3e-36
 Identities = 62/211 (29%), Positives = 91/211 (43%), Gaps = 22/211 (10%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLV 145
           LG G FG+VY+G V   +        VAVK L    S+    ++L E + + +  H ++V
Sbjct: 79  LGHGAFGEVYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKN-----YSSTLPWLTRIKIAIGAARCLAFL 200
             IG   +   R ++ E MA G+L   L +        S+L  L  + +A   A    +L
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197

Query: 201 HGEEKPVIYRDFKASNILLD---SDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY--- 254
             EE   I+RD  A N LL        AK+ DFG+A D  +           G       
Sbjct: 198 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG-----YYRKGGCAMLPV 250

Query: 255 --AAPEYINTGHLTTMCDVFSFGVVLLELLT 283
               PE    G  T+  D +SFGV+L E+ +
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  133 bits (338), Expect = 4e-36
 Identities = 62/223 (27%), Positives = 92/223 (41%), Gaps = 41/223 (18%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LGEG FGKV+      NL P      VAVK L        +++  E   L  L+H H+V 
Sbjct: 23  LGEGAFGKVFLAECY-NLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQL--------------FKNYSSTLPWLTRIKIAIG 192
             G C + +  ++V+EYM  G+L+  L               +     L     + IA  
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141

Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE 252
            A  + +L    +  ++RD    N L+ ++   K+ DFG++ D            V  T+
Sbjct: 142 IASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD------------VYSTD 187

Query: 253 GYA------------APEYINTGHLTTMCDVFSFGVVLLELLT 283
            Y              PE I     TT  DV+SFGV+L E+ T
Sbjct: 188 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  133 bits (336), Expect = 5e-36
 Identities = 59/276 (21%), Positives = 103/276 (37%), Gaps = 45/276 (16%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVK-VLDVNGSQGHREWL-AEVIFLGQLKHPHL 144
           +G G F  VYKG    +         VA   + D   ++  R+    E   L  L+HP++
Sbjct: 34  IGRGSFKTVYKGL---DTETT---VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87

Query: 145 VNLIGYC---CEDEHRLLVY-EYMALGNLHDQLFKNYSSTLPWLTRI--KIAIGAARCLA 198
           V          + +  +++  E M  G L   L +     +  L     +I  G    L 
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKG----LQ 143

Query: 199 FLHGEEKPVIYRDFKASNILLDSDY-NAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAP 257
           FLH    P+I+RD K  NI +     + K+ D GLAT       S     + GT  + AP
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASFAKAVI-GTPEFMAP 199

Query: 258 EYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA--RPMLKDFTKL-D 314
           E     +     DV++FG+ +LE+ T                  ++  +   + + ++  
Sbjct: 200 EMYEEKY-DESVDVYAFGMCMLEMATSEYP--------------YSECQNAAQIYRRVTS 244

Query: 315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT 350
            +  +  +     E  + +      C+  N   R +
Sbjct: 245 GVKPASFDKVAIPEVKEII----EGCIRQNKDERYS 276

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  139 bits (351), Expect = 5e-36
 Identities = 66/208 (31%), Positives = 100/208 (48%), Gaps = 21/208 (10%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLV 145
           LG G FG V +G      R   K   VA+KVL     +    E + E   + QL +P++V
Sbjct: 344 LGCGNFGSVRQGV----YRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            LIG  C+ E  +LV E    G LH  L       +P     ++    +  + +L  EEK
Sbjct: 400 RLIG-VCQAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYL--EEK 455

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG------TEGYAAPEY 259
             ++R+  A N+LL + + AK+SDFGL+      +DS+ T    G           APE 
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA-DDSYYTARSAGKWPLKWY----APEC 510

Query: 260 INTGHLTTMCDVFSFGVVLLELLT-GRR 286
           IN    ++  DV+S+GV + E L+ G++
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALSYGQK 538

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  133 bits (337), Expect = 8e-36
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 40/220 (18%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLKHPHL 144
           LGEG FG V +G +         +  VAVK + ++ S  +   E+L+E   +    HP++
Sbjct: 42  LGEGEFGSVMEGNLKQ---EDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 145 VNLIGYCCEDE-----HRLLVYEYMALGNLHDQL----FKNYSSTLPWLTRIKIAIGAAR 195
           + L+G C E         +++  +M  G+LH  L     +     +P  T +K  +  A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            + +L    +  ++RD  A N +L  D    ++DFGL+              +   + Y 
Sbjct: 159 GMEYL--SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK------------IYSGDYYR 204

Query: 256 ------------APEYINTGHLTTMCDVFSFGVVLLELLT 283
                       A E +     T+  DV++FGV + E+ T
Sbjct: 205 QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  133 bits (336), Expect = 1e-35
 Identities = 53/221 (23%), Positives = 88/221 (39%), Gaps = 41/221 (18%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHREWLAEVIFLGQLKHPHL 144
           LG+G FG V +  +            VAVK+L  D+  S    E+L E   + +  HPH+
Sbjct: 31  LGKGEFGSVREAQLKQ---EDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 145 VNLIGYCCEDEHR------LLVYEYMALGNLHDQL----FKNYSSTLPWLTRIKIAIGAA 194
             L+G       +      +++  +M  G+LH  L           LP  T ++  +  A
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
             + +L    +  I+RD  A N +L  D    ++DFGL+              +   + Y
Sbjct: 148 CGMEYL--SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK------------IYSGDYY 193

Query: 255 A------------APEYINTGHLTTMCDVFSFGVVLLELLT 283
                        A E +     T   DV++FGV + E++T
Sbjct: 194 RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  133 bits (337), Expect = 1e-35
 Identities = 75/313 (23%), Positives = 119/313 (38%), Gaps = 72/313 (23%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL-DVNGSQGHREWLAEVIFLGQL-KHPHL 144
           LG G FGKV +      L        VAVK+L     +      ++E+  +  L +H ++
Sbjct: 54  LGAGAFGKVVEATAFG-LGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112

Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQL------------FKNYSSTLPWLTRIKIAIG 192
           VNL+G C      L++ EY   G+L + L            F   +ST      +  +  
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172

Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE 252
            A+ +AFL    K  I+RD  A N+LL + + AK+ DFGLA D            +M   
Sbjct: 173 VAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD------------IMNDS 218

Query: 253 GYA------------APEYINTGHLTTMCDVFSFGVVLLELLT-------GRRSVEKNRC 293
            Y             APE I     T   DV+S+G++L E+ +       G         
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS---- 274

Query: 294 KREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGA-KRLAAVAHQCLSHNPKSRPTMT 352
                  +    ++KD  ++ Q              A K + ++   C +  P  RPT  
Sbjct: 275 ----KFYK----LVKDGYQMAQ-----------PAFAPKNIYSIMQACWALEPTHRPTFQ 315

Query: 353 TVVKALEPLLDLN 365
            +   L+     +
Sbjct: 316 QICSFLQEQAQED 328

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  131 bits (331), Expect = 5e-35
 Identities = 68/287 (23%), Positives = 104/287 (36%), Gaps = 50/287 (17%)

Query: 80  NFSRSDYLGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFL 136
           +F R   LG G +G+V+K    +D        +  AVK       G +     LAEV   
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDG-------RLYAVKRSMSPFRGPKDRARKLAEVGSH 110

Query: 137 GQL-KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLP------WLTRIKI 189
            ++ +HP  V L     E     L  E     +L     + + ++LP      +L    +
Sbjct: 111 EKVGQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQHC-EAWGASLPEAQVWGYLRDTLL 168

Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM 249
           A      LA LH   + +++ D K +NI L      KL DFGL  +   G          
Sbjct: 169 A------LAHLH--SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE--LGTAGAGEVQE- 217

Query: 250 GTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKD 309
           G   Y APE +   +  T  DVFS G+ +LE+                +L        + 
Sbjct: 218 GDPRYMAPELLQGSY-GTAADVFSLGLTILEVACN------------MELPHGGEGWQQL 264

Query: 310 FTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                  +        S+E    L +V    L  +PK R T   ++ 
Sbjct: 265 RQG---YLPPEFTAGLSSE----LRSVLVMMLEPDPKLRATAEALLA 304

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  130 bits (328), Expect = 2e-34
 Identities = 77/312 (24%), Positives = 117/312 (37%), Gaps = 70/312 (22%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQL-KHPHL 144
           LG G FGKV +      L     A TVAVK+L  +     R   ++E+  L  L  H ++
Sbjct: 31  LGAGAFGKVVEATAY-GLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQL----------------FKNYSSTLPWLTRIK 188
           VNL+G C      L++ EY   G+L + L                 ++    L     + 
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
            +   A+ +AFL    K  I+RD  A NILL      K+ DFGLA D            +
Sbjct: 150 FSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARD------------I 195

Query: 249 MGTEGYA------------APEYINTGHLTTMCDVFSFGVVLLELLT-GRR---SVEKNR 292
                Y             APE I     T   DV+S+G+ L EL + G      +  + 
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255

Query: 293 CKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGA-KRLAAVAHQCLSHNPKSRPTM 351
                   +    M+K+  ++              E A   +  +   C   +P  RPT 
Sbjct: 256 -----KFYK----MIKEGFRMLS-----------PEHAPAEMYDIMKTCWDADPLKRPTF 295

Query: 352 TTVVKALEPLLD 363
             +V+ +E  + 
Sbjct: 296 KQIVQLIEKQIS 307

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  130 bits (328), Expect = 2e-34
 Identities = 61/304 (20%), Positives = 109/304 (35%), Gaps = 49/304 (16%)

Query: 79  HNFSRSDYLGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLG 137
            ++     LGEGGF  V     + D           A+K +  +  Q   E   E     
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDG-------HFYALKRILCHEQQDREEAQREADMHR 81

Query: 138 QLKHPHLVNLIGYCCEDEHR----LLVYEYMALGNLHDQL--FKNYSSTLPWLTRIKIAI 191
              HP+++ L+ YC  +        L+  +   G L +++   K+  + L     + + +
Sbjct: 82  LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141

Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM-- 249
           G  R L  +H   K   +RD K +NILL  +    L D G         +       +  
Sbjct: 142 GICRGLEAIH--AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199

Query: 250 -----GTEGYAAPEYINT---GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVE 301
                 T  Y APE  +      +    DV+S G VL  ++ G    +    K +     
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD----- 254

Query: 302 WARPMLKDFTKLDQIIDSRLE----DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA 357
                      +   + ++L      R+S+     L  + +  ++ +P  RP +  ++  
Sbjct: 255 ----------SVALAVQNQLSIPQSPRHSSA----LWQLLNSMMTVDPHQRPHIPLLLSQ 300

Query: 358 LEPL 361
           LE L
Sbjct: 301 LEAL 304

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  130 bits (330), Expect = 3e-34
 Identities = 75/315 (23%), Positives = 129/315 (40%), Gaps = 73/315 (23%)

Query: 87  LGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGSQG-HREWLAEVIFLGQL-KHPH 143
           LGEG FG+V     V  +     +A TVAVK+L  + ++    + ++E+  +  + KH +
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148

Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQL--------------FKNYSSTLPWLTRIKI 189
           ++NL+G C +D    ++ EY + GNL + L               +     + +   +  
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208

Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM 249
               AR + +L    +  I+RD  A N+L+  +   K++DFGLA D            + 
Sbjct: 209 TYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARD------------IN 254

Query: 250 GTEGYA------------APEYINTGHLTTMCDVFSFGVVLLELLT-GR-----RSVEKN 291
             + Y             APE +     T   DV+SFGV++ E+ T G        VE  
Sbjct: 255 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-- 312

Query: 292 RCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGA-KRLAAVAHQCLSHNPKSRPT 350
                 +L +    +LK+  ++D+                  L  +   C    P  RPT
Sbjct: 313 ------ELFK----LLKEGHRMDK-----------PANCTNELYMMMRDCWHAVPSQRPT 351

Query: 351 MTTVVKALEPLLDLN 365
              +V+ L+ +L L 
Sbjct: 352 FKQLVEDLDRILTLT 366

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  128 bits (323), Expect = 7e-34
 Identities = 70/232 (30%), Positives = 96/232 (41%), Gaps = 50/232 (21%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG-HREWLAEVIFLGQLKHPHLV 145
           LGEG FGKV K      L+      TVAVK+L  N S    R+ L+E   L Q+ HPH++
Sbjct: 31  LGEGEFGKVVKATAFH-LKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQL----------------------FKNYSSTLPW 183
            L G C +D   LL+ EY   G+L   L                             L  
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149

Query: 184 LTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSH 243
              I  A   ++ + +L   E  +++RD  A NIL+      K+SDFGL+ D        
Sbjct: 150 GDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD-------- 199

Query: 244 ITTCVMGTEGYA------------APEYINTGHLTTMCDVFSFGVVLLELLT 283
               V   + Y             A E +     TT  DV+SFGV+L E++T
Sbjct: 200 ----VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  128 bits (324), Expect = 9e-34
 Identities = 57/228 (25%), Positives = 96/228 (42%), Gaps = 42/228 (18%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLGQLKHPHLV 145
           +GEG FG+V++      L P      VAVK+L    S   + ++  E   + +  +P++V
Sbjct: 55  IGEGAFGRVFQARAP-GLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQL----------------------FKNYSSTLPW 183
            L+G C   +   L++EYMA G+L++ L                             L  
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173

Query: 184 LTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSH 243
             ++ IA   A  +A+L   E+  ++RD    N L+  +   K++DFGL+ +        
Sbjct: 174 AEQLCIARQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRN-------- 223

Query: 244 ITTC---VMGTEGY-----AAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           I +                  PE I     TT  DV+++GVVL E+ +
Sbjct: 224 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  128 bits (323), Expect = 1e-33
 Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 43/226 (19%)

Query: 87  LGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVL-DVNGSQGHREWLAEVIFLGQL-KHPH 143
           LGEG FG+V     V  +     +A TVAVK+L D    +   + ++E+  +  + KH +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102

Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQL--------------FKNYSSTLPWLTRIKI 189
           ++NL+G C +D    ++ EY + GNL + L               +     + +   +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162

Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM 249
               AR + +L    +  I+RD  A N+L+  +   K++DFGLA D            + 
Sbjct: 163 TYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARD------------IN 208

Query: 250 GTEGYA------------APEYINTGHLTTMCDVFSFGVVLLELLT 283
             + Y             APE +     T   DV+SFGV++ E+ T
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  128 bits (323), Expect = 1e-33
 Identities = 80/373 (21%), Positives = 131/373 (35%), Gaps = 70/373 (18%)

Query: 46  SNPGS-PISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNL 104
           + PGS   +     S  VG  + +                  L EGGF  VY+       
Sbjct: 2   AGPGSLGGASGRDQSDFVGQTVELGE--------LRLRVRRVLAEGGFAFVYEA------ 47

Query: 105 RPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-HPHLVNLIGYCCEDEHR------ 157
           +     +  A+K L  N  + +R  + EV F+ +L  HP++V         +        
Sbjct: 48  QDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107

Query: 158 -LLVYEYMALGNLHDQLFKNYSSTLPWLTRI-KIAIGAARCLAFLHGEEKPVIYRDFKAS 215
             L+   +  G L + L K  S        + KI     R +  +H ++ P+I+RD K  
Sbjct: 108 EFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVE 167

Query: 216 NILLDSDYNAKLSDFGLAT---DGPQGEDSH---------ITTCVMGTEGYAAPEYINT- 262
           N+LL +    KL DFG AT     P    S          IT     T  Y  PE I+  
Sbjct: 168 NLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN--TTPMYRTPEIIDLY 225

Query: 263 --GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSR 320
               +    D+++ G +L  L                      +   +D  KL +I++ +
Sbjct: 226 SNFPIGEKQDIWALGCILYLLCFR-------------------QHPFEDGAKL-RIVNGK 265

Query: 321 LE----DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDIPI-GPFVYT 375
                 D   T       ++    L  NP+ R ++  VV  L+ +    ++    P    
Sbjct: 266 YSIPPHDTQYTV----FHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITEL 321

Query: 376 VVPPGDHGHGQKS 388
           +   G +G    S
Sbjct: 322 LEQNGGYGSATLS 334

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  127 bits (321), Expect = 1e-33
 Identities = 77/313 (24%), Positives = 116/313 (37%), Gaps = 69/313 (22%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG-HREWLAEVIFLGQL-KHPHL 144
           LG G FG+V +      +      +TVAVK+L    +   HR  ++E+  L  +  H ++
Sbjct: 35  LGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93

Query: 145 VNLIGYCC-EDEHRLLVYEYMALGNLHDQL--------------FKNYSSTLPWLTRIKI 189
           VNL+G C       +++ E+   GNL   L                 Y   L     I  
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153

Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM 249
           +   A+ + FL    +  I+RD  A NILL      K+ DFGLA D            + 
Sbjct: 154 SFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARD------------IY 199

Query: 250 GTEGYA------------APEYINTGHLTTMCDVFSFGVVLLELLT-GRR---SVEKNRC 293
               Y             APE I     T   DV+SFGV+L E+ + G      V+ +  
Sbjct: 200 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE- 258

Query: 294 KREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGA-KRLAAVAHQCLSHNPKSRPTMT 352
               +        LK+ T++              +     +      C    P  RPT +
Sbjct: 259 ----EFCR----RLKEGTRMRA-----------PDYTTPEMYQTMLDCWHGEPSQRPTFS 299

Query: 353 TVVKALEPLLDLN 365
            +V+ L  LL  N
Sbjct: 300 ELVEHLGNLLQAN 312

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  125 bits (317), Expect = 4e-33
 Identities = 64/288 (22%), Positives = 111/288 (38%), Gaps = 45/288 (15%)

Query: 80  NFSRSDYLGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGSQGHRE---WLAEVIF 135
           NF     +G G F +VY+  C+ D          VA+K + +      +     + E+  
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDG-------VPVALKKVQIFDLMDAKARADCIKEIDL 85

Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQL--FKNYSSTLP------WLTRI 187
           L QL HP+++       ED    +V E    G+L   +  FK     +P      +  ++
Sbjct: 86  LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145

Query: 188 KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC 247
             A      L  +H   + V++RD K +N+ + +    KL D GL       + +   + 
Sbjct: 146 CSA------LEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSL 196

Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML 307
           V GT  Y +PE I+        D++S G +L E+   +     +              + 
Sbjct: 197 V-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD-----------KMNLY 244

Query: 308 KDFTK-LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTV 354
               K           D YS E    L  + + C++ +P+ RP +T V
Sbjct: 245 SLCKKIEQCDYPPLPSDHYSEE----LRQLVNMCINPDPEKRPDVTYV 288

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  125 bits (315), Expect = 5e-33
 Identities = 61/300 (20%), Positives = 108/300 (36%), Gaps = 67/300 (22%)

Query: 80  NFSRSDYLGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ 138
           +F   + +G GGFG+V+K     D        +T  +K +  N  +  RE    V  L +
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDG-------KTYVIKRVKYNNEKAERE----VKALAK 60

Query: 139 LKHPHLVNLIGYCCEDEHRL----------------LVYEYMALGNLHDQLFKNYSSTLP 182
           L H ++V+  G     ++                  +  E+   G L   + K     L 
Sbjct: 61  LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 120

Query: 183 ------WLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG 236
                    +I         + ++H   K +I RD K SNI L      K+ DFGL T  
Sbjct: 121 KVLALELFEQITKG------VDYIH--SKKLINRDLKPSNIFLVDTKQVKIGDFGLVT-S 171

Query: 237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE 296
            + +     +   GT  Y +PE I++       D+++ G++L ELL              
Sbjct: 172 LKNDGKRTRSK--GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV------------ 217

Query: 297 KDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                      +       + D  + D +  +       +  + LS  P+ RP  + +++
Sbjct: 218 ------CDTAFETSKFFTDLRDGIISDIFDKK----EKTLLQKLLSKKPEDRPNTSEILR 267

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  127 bits (320), Expect = 7e-33
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 43/226 (19%)

Query: 87  LGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGSQG-HREWLAEVIFLGQL-KHPH 143
           LGEG FG+V     +  +     +   VAVK+L  + ++    + ++E+  +  + KH +
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTR--------------IKI 189
           ++NL+G C +D    ++ EY + GNL + L       L +                 +  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM 249
           A   AR + +L    K  I+RD  A N+L+  D   K++DFGLA D            + 
Sbjct: 197 AYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD------------IH 242

Query: 250 GTEGYA------------APEYINTGHLTTMCDVFSFGVVLLELLT 283
             + Y             APE +     T   DV+SFGV+L E+ T
Sbjct: 243 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  125 bits (317), Expect = 1e-32
 Identities = 66/284 (23%), Positives = 112/284 (39%), Gaps = 43/284 (15%)

Query: 80  NFSRSDYLGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNG-SQGHREW-LAEVIFL 136
            + R   +GEG FGK       +D        +   +K ++++  S   RE    EV  L
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDG-------RQYVIKEINISRMSSKEREESRREVAVL 77

Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLP------WLTRIKIA 190
             +KHP++V       E+    +V +Y   G+L  ++               W  +I +A
Sbjct: 78  ANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLA 137

Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG 250
                 L  +H  ++ +++RD K+ NI L  D   +L DFG+A             C+ G
Sbjct: 138 ------LKHVH--DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACI-G 187

Query: 251 TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF 310
           T  Y +PE           D+++ G VL EL T + + E             A  M    
Sbjct: 188 TPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE-------------AGSMKNLV 234

Query: 311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTV 354
            K+       +   YS +    L ++  Q    NP+ RP++ ++
Sbjct: 235 LKIISGSFPPVSLHYSYD----LRSLVSQLFKRNPRDRPSVNSI 274

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  125 bits (315), Expect = 2e-32
 Identities = 72/316 (22%), Positives = 120/316 (37%), Gaps = 75/316 (23%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL-DVNGSQGHREWLAEVIFLGQL-KHPHL 144
           LG G FGKV        +     +  VAVK+L +   S      ++E+  + QL  H ++
Sbjct: 53  LGSGAFGKVMNATAYG-ISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111

Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQL------------------FKNYSSTLPWLTR 186
           VNL+G C       L++EY   G+L + L                         L  LT 
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171

Query: 187 ---IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSH 243
              +  A   A+ + FL  E K  ++RD  A N+L+      K+ DFGLA D        
Sbjct: 172 EDLLCFAYQVAKGMEFL--EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD-------- 221

Query: 244 ITTCVMGTEGYA------------APEYINTGHLTTMCDVFSFGVVLLELLT-GRR---S 287
               +M    Y             APE +  G  T   DV+S+G++L E+ + G      
Sbjct: 222 ----IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277

Query: 288 VEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGA-KRLAAVAHQCLSHNPK 346
           +  +      +  +    ++++  K+DQ              A + +  +   C + + +
Sbjct: 278 IPVDA-----NFYK----LIQNGFKMDQ-----------PFYATEEIYIIMQSCWAFDSR 317

Query: 347 SRPTMTTVVKALEPLL 362
            RP+   +   L   L
Sbjct: 318 KRPSFPNLTSFLGCQL 333

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  124 bits (312), Expect = 2e-32
 Identities = 70/315 (22%), Positives = 116/315 (36%), Gaps = 57/315 (18%)

Query: 80  NFSRSDYLGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFLG 137
           +F     LG GGFG V++     D+          A+K + +   +  RE  + EV  L 
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDD-------CNYAIKRIRLPNRELAREKVMREVKALA 58

Query: 138 QLKHPHLVNLIGYCCEDE---------HRLLVY---EYMALGNLHDQLFKNYSSTLPWLT 185
           +L+HP +V       E            ++ +Y   +     NL D +    +      +
Sbjct: 59  KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118

Query: 186 RI-KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA----------- 233
               I +  A  + FLH   K +++RD K SNI    D   K+ DFGL            
Sbjct: 119 VCLHIFLQIAEAVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176

Query: 234 TDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRC 293
              P    +  T  V GT+ Y +PE I+    +   D+FS G++L ELL    +      
Sbjct: 177 VLTPMPAYARHTGQV-GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFST------ 229

Query: 294 KREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTT 353
           + E+             T +  +    L  +           +    LS +P  RP    
Sbjct: 230 QMERVRT---------LTDVRNLKFPPLFTQKYPC----EYVMVQDMLSPSPMERPEAIN 276

Query: 354 VVKALEPLLDLNDIP 368
           +++    + +  D P
Sbjct: 277 IIE--NAVFEDLDFP 289

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  120 bits (303), Expect = 2e-31
 Identities = 78/285 (27%), Positives = 118/285 (41%), Gaps = 42/285 (14%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD----VNGSQGHREWLAEVIF 135
           +F   + LG+G F  VY+    +++  G     VA+K++D           R    EV  
Sbjct: 12  DFKVGNLLGKGSFAGVYRA---ESIHTG---LEVAIKMIDKKAMYKAGMVQR-VQNEVKI 64

Query: 136 LGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA--IG 192
             QLKHP ++ L  Y  ED + + LV E    G ++  L            R  +   I 
Sbjct: 65  HCQLKHPSILELYNYF-EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT 123

Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE 252
               + +LH     +++RD   SN+LL  + N K++DFGLAT      + H T C  GT 
Sbjct: 124 G---MLYLH--SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--GTP 176

Query: 253 GYAAPEYIN-TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFT 311
            Y +PE    + H     DV+S G +   LL GR   +         +       L    
Sbjct: 177 NYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFD------TDTVKN----TLNKVV 225

Query: 312 KLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
             D  + S L     +  AK L    HQ L  NP  R ++++V+ 
Sbjct: 226 LADYEMPSFL-----SIEAKDL---IHQLLRRNPADRLSLSSVLD 262

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  122 bits (306), Expect = 4e-31
 Identities = 45/228 (19%), Positives = 71/228 (31%), Gaps = 17/228 (7%)

Query: 72  KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA 131
            E Q+ +        LGEG F +VY+     +L      Q   +KV              
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEA-TQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQ 116

Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHD--QLFKNYSS-TLPWLTRIK 188
            +  L        +            +LV E  + G L +   L+KN     +P    I 
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176

Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILL-----------DSDYNAKLSDFGLATDGP 237
            A+     +  +H  +  +I+ D K  N +L           D      L D G + D  
Sbjct: 177 FAMRMLYMIEQVH--DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234

Query: 238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
                 I T    T G+   E ++        D F     +  +L G 
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  119 bits (300), Expect = 7e-31
 Identities = 69/293 (23%), Positives = 113/293 (38%), Gaps = 48/293 (16%)

Query: 80  NFSRSDYLGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWL-AEVIFL 136
           ++     +G G +G+  K     D        + +  K LD    ++  ++ L +EV  L
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDG-------KILVWKELDYGSMTEAEKQMLVSEVNLL 59

Query: 137 GQLKHPHLVNLIG-YCCEDEHRL-LVYEYMALGNLHDQL--FKNYSSTLP------WLTR 186
            +LKHP++V             L +V EY   G+L   +         L        +T+
Sbjct: 60  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119

Query: 187 IKIAIGAARCLAFLH---GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSH 243
           + +A      L   H        V++RD K +N+ LD   N KL DFGLA      + S 
Sbjct: 120 LTLA------LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSF 172

Query: 244 ITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA 303
             T V GT  Y +PE +N        D++S G +L EL                     A
Sbjct: 173 AKTFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-------------A 218

Query: 304 RPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
               +   K+ +    R+  RYS E    L  +  + L+     RP++  +++
Sbjct: 219 FSQKELAGKIREGKFRRIPYRYSDE----LNEIITRMLNLKDYHRPSVEEILE 267

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  119 bits (301), Expect = 1e-30
 Identities = 52/224 (23%), Positives = 88/224 (39%), Gaps = 29/224 (12%)

Query: 72  KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA 131
            E +   H  +    +G G FG+V++     + + G      AVK + +   +     + 
Sbjct: 51  YEYREEVHWMTHQPRVGRGSFGEVHRMK---DKQTG---FQCAVKKVRLEVFR-----VE 99

Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYS----STLPWLTRI 187
           E++    L  P +V L G   E     +  E +  G+L   + K           +    
Sbjct: 100 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLG- 157

Query: 188 KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD-YNAKLSDFGLA---TDGPQGEDSH 243
           +   G    L +LH   + +++ D KA N+LL SD   A L DFG A        G+   
Sbjct: 158 QALEG----LEYLH--TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211

Query: 244 ITTCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGRR 286
               + GTE + APE +          D++S   ++L +L G  
Sbjct: 212 TGDYIPGTETHMAPEVVMGKPC-DAKVDIWSSCCMMLHMLNGCH 254

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  119 bits (301), Expect = 2e-30
 Identities = 69/286 (24%), Positives = 112/286 (39%), Gaps = 43/286 (15%)

Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD----VNGSQGHREWLAEVI 134
             + R  +LG+GGF K ++     +       +  A K++     +   Q  +    E+ 
Sbjct: 41  RRYVRGRFLGKGGFAKCFEI---SDADTK---EVFAGKIVPKSLLLKPHQREK-MSMEIS 93

Query: 135 FLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA--I 191
               L H H+V   G+  ED   + +V E     +L +   +  + T P   R  +   +
Sbjct: 94  IHRSLAHQHVVGFHGFF-EDNDFVFVVLELCRRRSLLELHKRRKALTEP-EARYYLRQIV 151

Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
                  +LH     VI+RD K  N+ L+ D   K+ DFGLAT      +     C  GT
Sbjct: 152 LG---CQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GT 204

Query: 252 EGYAAPEYIN-TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF 310
             Y APE ++  GH +   DV+S G ++  LL G+   E         L E         
Sbjct: 205 PNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFE------TSCLKE----TYLRI 253

Query: 311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
            K +  I   +        A  L     + L  +P +RPT+  ++ 
Sbjct: 254 KKNEYSIPKHI-----NPVAASL---IQKMLQTDPTARPTINELLN 291

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  118 bits (298), Expect = 2e-30
 Identities = 69/285 (24%), Positives = 112/285 (39%), Gaps = 43/285 (15%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD----VNGSQGHREWLAEVIF 135
            + R  +LG+GGF K ++     +       +  A K++     +   Q  +    E+  
Sbjct: 16  RYVRGRFLGKGGFAKCFEI---SDADTK---EVFAGKIVPKSLLLKPHQREK-MSMEISI 68

Query: 136 LGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA--IG 192
              L H H+V   G+  ED   + +V E     +L +   +  + T P   R  +   + 
Sbjct: 69  HRSLAHQHVVGFHGFF-EDNDFVFVVLELCRRRSLLELHKRRKALTEP-EARYYLRQIVL 126

Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE 252
                 +LH     VI+RD K  N+ L+ D   K+ DFGLAT      +     C  GT 
Sbjct: 127 G---CQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTP 179

Query: 253 GYAAPEYIN-TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFT 311
            Y APE ++  GH +   DV+S G ++  LL G+   E         L E          
Sbjct: 180 NYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFE------TSCLKE----TYLRIK 228

Query: 312 KLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
           K +  I   +        A  L     + L  +P +RPT+  ++ 
Sbjct: 229 KNEYSIPKHI-----NPVAASLIQ---KMLQTDPTARPTINELLN 265

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  118 bits (299), Expect = 2e-30
 Identities = 63/318 (19%), Positives = 118/318 (37%), Gaps = 53/318 (16%)

Query: 71  LKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGH--RE 128
            + + +    +S    +G GG  KV++   +         Q  A+K +++  +       
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKK-------QIYAIKYVNLEEADNQTLDS 72

Query: 129 WLAEVIFLGQLKHP--HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTR 186
           +  E+ +L +L+     ++ L  Y   D++  +V E     +L+  L K  S        
Sbjct: 73  YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKS 131

Query: 187 IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITT 246
               +     +  +H  +  +++ D K +N L+      KL DFG+A        S +  
Sbjct: 132 YWKNM--LEAVHTIH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD 186

Query: 247 CVMGTEGYAAPEYI-----------NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKR 295
             +GT  Y  PE I           +   ++   DV+S G +L  +  G+          
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--------- 237

Query: 296 EKDLVEWARP---MLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMT 352
                    P   ++   +KL  IID   E  +     K L  V   CL  +PK R ++ 
Sbjct: 238 ---------PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 288

Query: 353 TVVKALE-PLLDLNDIPI 369
              + L  P + +   P+
Sbjct: 289 ---ELLAHPYVQIQTHPV 303

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  119 bits (299), Expect = 3e-30
 Identities = 38/346 (10%), Positives = 79/346 (22%), Gaps = 65/346 (18%)

Query: 50  SPISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLK 109
               +  +++++   N        L          + L  G    V+    D        
Sbjct: 33  PAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFL-VRDVERL---- 87

Query: 110 AQTVAVKVLDVNGSQGHREW---LAEVIFLGQLKHPHLVNLIGYC--------------- 151
            +  A+KV  +       E            +L                           
Sbjct: 88  -EDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146

Query: 152 -----------CEDEHRLLVYEYMA--LGNLHDQLFKNYS--STLPWLTRIKIAIGAARC 196
                          + LL+    +  L  L   L   Y        L    +     R 
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRL 206

Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
            A L    K +++  F   N+ +  D    L D          +             YA 
Sbjct: 207 AANLQ--SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW-----KVGTRGPASSVPVTYAP 259

Query: 257 PEYINTGHL--TTMCDVFSFGVVLLELLTGR----RSVEKNRCKREKDLVEWARPMLKDF 310
            E++N      T   + +  G+ +  +              +   ++  +         F
Sbjct: 260 REFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAF 319

Query: 311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                +           +  K L     + L+ + + R      ++
Sbjct: 320 GSCTPL----------PDFVKTLIG---RFLNFDRRRRLLPLEAME 352

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  116 bits (293), Expect = 7e-30
 Identities = 64/207 (30%), Positives = 89/207 (42%), Gaps = 27/207 (13%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD----VNGSQGHREWLAEVIFLGQLKHP 142
           LG+G FG VY        +       +A+KVL           H+    EV     L+HP
Sbjct: 17  LGKGKFGNVYLA---REKQSK---FILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHP 69

Query: 143 HLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLP-WLTRIKIA--IGAARCLA 198
           +++ L GY   D  R+ L+ EY  LG ++ +L K   S      T   I     A   L+
Sbjct: 70  NILRLYGYF-HDATRVYLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANA---LS 123

Query: 199 FLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPE 258
           + H   K VI+RD K  N+LL S    K++DFG +   P         C  GT  Y  PE
Sbjct: 124 YCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRTDLC--GTLDYLPPE 177

Query: 259 YINTGHLTTMCDVFSFGVVLLELLTGR 285
            I         D++S GV+  E L G+
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  117 bits (296), Expect = 1e-29
 Identities = 60/291 (20%), Positives = 108/291 (37%), Gaps = 49/291 (16%)

Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFL 136
             +S    +G GG  KV++   +         Q  A+K +++    +Q    +  E+ +L
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNEKK-------QIYAIKYVNLEEADNQTLDSYRNEIAYL 108

Query: 137 GQLKHP--HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA 194
            +L+     ++ L  Y   D++  +V E     +L+  L K  S            +   
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNM--L 165

Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
             +  +H  +  +++ D K +N L+      KL DFG+A        S +    +G   Y
Sbjct: 166 EAVHTIH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNY 222

Query: 255 AAPEYI-----------NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA 303
             PE I           +   ++   DV+S G +L  +  G+                  
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT----------------- 265

Query: 304 RP---MLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM 351
            P   ++   +KL  IID   E  +     K L  V   CL  +PK R ++
Sbjct: 266 -PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 315

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  118 bits (298), Expect = 2e-29
 Identities = 64/314 (20%), Positives = 112/314 (35%), Gaps = 63/314 (20%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           +F   D LG G  G +    + DN       + VAVK +             EV  L + 
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDN-------RDVAVKRILPECFSFADR---EVQLLRES 74

Query: 140 -KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLA 198
            +HP+++       + + + +  E  A   L +   +        L  I +       LA
Sbjct: 75  DEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQE-YVEQKDFAHLGLEPITLLQQTTSGLA 132

Query: 199 FLHGEEKPVIYRDFKASNILL-----DSDYNAKLSDFGLAT--DGPQGEDSHITTCVMGT 251
            LH     +++RD K  NIL+          A +SDFGL       +   S  +    GT
Sbjct: 133 HLH--SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-GT 189

Query: 252 EGYAAPEYIN---TGHLTTMCDVFSFGVVLLELLTG-------RRSVEKNRCKREKDLVE 301
           EG+ APE ++     + T   D+FS G V   +++            + N       L  
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSL-- 247

Query: 302 WARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT---------MT 352
                           D    +++    A+ L     + ++ +P+ RP+           
Sbjct: 248 ----------------DCLHPEKHEDVIARELIE---KMIAMDPQKRPSAKHVLKHPFFW 288

Query: 353 TVVKALEPLLDLND 366
           ++ K L+   D++D
Sbjct: 289 SLEKQLQFFQDVSD 302

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  115 bits (291), Expect = 2e-29
 Identities = 65/280 (23%), Positives = 114/280 (40%), Gaps = 53/280 (18%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G +G VY G    +L        +A+K +    S+  +    E+     LKH ++V 
Sbjct: 30  LGKGTYGIVYAGR---DLSNQ---VRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ 83

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQL------FKNYSSTLPWLTRIKIAIGAARCLAFL 200
            +G   E+    +  E +  G+L   L       K+   T+ + T+ +I  G    L +L
Sbjct: 84  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-QILEG----LKYL 138

Query: 201 HGEEKPVIYRDFKASNILLDS-DYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEY 259
           H  +  +++RD K  N+L+++     K+SDFG +     G +    T   GT  Y APE 
Sbjct: 139 H--DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR-LAGINPCTETFT-GTLQYMAPEI 194

Query: 260 IN---TGHLTTMCDVFSFGVVLLELLTGRR--SVEKNRCKREKDLVEWARPMLKDFTKLD 314
           I+    G+     D++S G  ++E+ TG+              +L E    M K      
Sbjct: 195 IDKGPRGY-GKAADIWSLGCTIIEMATGKPPFY----------ELGEPQAAMFK------ 237

Query: 315 QIIDSR----LEDRYSTEGAKRLAAVAHQCLSHNPKSRPT 350
            +   +    + +  S E    +     +C   +P  R  
Sbjct: 238 -VGMFKVHPEIPESMSAEAKAFIL----KCFEPDPDKRAC 272

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  116 bits (292), Expect = 2e-29
 Identities = 76/329 (23%), Positives = 118/329 (35%), Gaps = 61/329 (18%)

Query: 46  SNPGSPISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNL- 104
                   ++  + S  G+    + L+ L            +G GG G VY+   D    
Sbjct: 13  GLVPRGSHMDGTAESREGTQFGPYRLRRL------------VGRGGMGDVYEA-EDTVRE 59

Query: 105 RPGLKAQTVAVKVLDVNGSQGHREWLAEVIFL----------GQLKHPHLVNLIGYCCED 154
           R       VA+K++            ++ +F           G+L+ PH+V +  +   D
Sbjct: 60  RI------VALKLM-------SETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID 106

Query: 155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKA 214
               +    +   +L   L +     L     + I       L   H       +RD K 
Sbjct: 107 GQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAH--AAGATHRDVKP 162

Query: 215 SNILLDSDYNAKLSDFGLATDGPQGEDSHITT--CVMGTEGYAAPEYINTGHLTTMCDVF 272
            NIL+ +D  A L DFG+A+      D  +T     +GT  Y APE  +  H T   D++
Sbjct: 163 ENILVSADDFAYLVDFGIAS---ATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIY 219

Query: 273 SFGVVLLELLTGRR-------SVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRL---- 321
           +   VL E LTG         SV      +        RP +      D +I   +    
Sbjct: 220 ALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPV--AFDAVIARGMAKNP 277

Query: 322 EDRYSTEGAKRLAAVAHQCLSHNPKSRPT 350
           EDRY T     L+A AH  L+   + R T
Sbjct: 278 EDRYVT--CGDLSAAAHAALATADQDRAT 304

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  115 bits (290), Expect = 2e-29
 Identities = 62/311 (19%), Positives = 103/311 (33%), Gaps = 77/311 (24%)

Query: 80  NFSRSDYLGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFL 136
            F   + +G G FG V+K     D           A+K       GS   +  L EV   
Sbjct: 12  EFHELEKIGSGEFGSVFKCVKRLDG-------CIYAIKRSKKPLAGSVDEQNALREVYAH 64

Query: 137 GQL-KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLP------WLTRIKI 189
             L +H H+V       ED+H L+  EY   G+L D + +NY               +++
Sbjct: 65  AVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124

Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSD-------------------YNAKLSDF 230
             G    L ++H     +++ D K SNI +                         K+ D 
Sbjct: 125 GRG----LRYIH--SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 178

Query: 231 GLATDGPQGEDSHITTCVMGTEGYAAPEYI--NTGHLTTMCDVFSFGVVLLELLTGRRSV 288
           G  T       S       G   + A E +  N  HL    D+F+  + ++         
Sbjct: 179 GHVT-----RISSPQVEE-GDSRFLANEVLQENYTHL-PKADIFALALTVVCAAGA---- 227

Query: 289 EKNRCKREKDLVEWARPMLKDFTKLDQIIDS---RLEDRYSTEGAKRLAAVAHQCLSHNP 345
                           P+ ++  +  +I      R+    S E  + L       +  +P
Sbjct: 228 ---------------EPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLK----VMIHPDP 268

Query: 346 KSRPTMTTVVK 356
           + RP+   +VK
Sbjct: 269 ERRPSAMALVK 279

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  119 bits (301), Expect = 3e-29
 Identities = 60/290 (20%), Positives = 110/290 (37%), Gaps = 36/290 (12%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFLGQLKHPHLV 145
           +  GG G +Y   +D N+      + V +K L  +G    +   +AE  FL ++ HP +V
Sbjct: 88  IAHGGLGWIYLA-LDRNV----NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIV 142

Query: 146 NLIGYCCEDEHRL-----LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFL 200
            +  +    +        +V EY+   +L           LP    I   +     L++L
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPALSYL 198

Query: 201 HGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI 260
           H     ++Y D K  NI+L  +   KL D G  +             + GT G+ APE I
Sbjct: 199 H--SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPE-I 248

Query: 261 NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSR 320
                T   D+++ G  L  L     +          +      P+LK +    +++   
Sbjct: 249 VRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDD----PVLKTYDSYGRLLRRA 304

Query: 321 L----EDRYST--EGAKRLAAVAHQCLSHNPKS-RPTMTTVVKALEPLLD 363
           +      R++T  E + +L  V  + ++ +    RP ++T+         
Sbjct: 305 IDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLSTIFSPSRSTFG 354

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  116 bits (292), Expect = 3e-29
 Identities = 61/291 (20%), Positives = 109/291 (37%), Gaps = 49/291 (16%)

Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFL 136
             +S    +G GG  KV++   +         Q  A+K +++    +Q    +  E+ +L
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKK-------QIYAIKYVNLEEADNQTLDSYRNEIAYL 61

Query: 137 GQLKHP--HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA 194
            +L+     ++ L  Y   D++  +V E     +L+  L K  S            +   
Sbjct: 62  NKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNM--L 118

Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
             +  +H  +  +++ D K +N L+      KL DFG+A        S +    +GT  Y
Sbjct: 119 EAVHTIH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 175

Query: 255 AAPEYI-----------NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA 303
             PE I           +   ++   DV+S G +L  +  G+                  
Sbjct: 176 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT----------------- 218

Query: 304 RP---MLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM 351
            P   ++   +KL  IID   E  +     K L  V   CL  +PK R ++
Sbjct: 219 -PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 268

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  119 bits (299), Expect = 4e-29
 Identities = 63/220 (28%), Positives = 92/220 (41%), Gaps = 26/220 (11%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFLGQ 138
            +   + LG GGFG V +     +   G   + VA+K      S  +RE W  E+  + +
Sbjct: 15  PWEMKERLGTGGFGYVLRWI---HQDTG---EQVAIKQCRQELSPKNRERWCLEIQIMKK 68

Query: 139 LKHPHLVNLI------GYCCEDEHRLLVYEYMALGNLHDQLFKN-YSSTLPWLTRIKIA- 190
           L HP++V+             ++  LL  EY   G+L   L +      L       +  
Sbjct: 69  LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128

Query: 191 -IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNA---KLSDFGLATDGPQGEDSHITT 246
            I +A  L +LH  E  +I+RD K  NI+L         K+ D G A +  QGE      
Sbjct: 129 DISSA--LRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT-EF 183

Query: 247 CVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRR 286
              GT  Y APE +     T   D +SFG +  E +TG R
Sbjct: 184 V--GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  116 bits (292), Expect = 5e-29
 Identities = 62/326 (19%), Positives = 108/326 (33%), Gaps = 46/326 (14%)

Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEV 133
               H +  SD LG+G    V++G    + + G      A+KV +        +  + E 
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGR---HKKTG---DLFAIKVFNNISFLRPVDVQMREF 58

Query: 134 IFLGQLKHPHLVNLIGY--CCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA- 190
             L +L H ++V L          H++L+ E+   G+L+  L +   S    L   +   
Sbjct: 59  EVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP--SNAYGLPESEFLI 116

Query: 191 ----IGAARCLAFLHGEEKPVIYRDFKASNILL----DSDYNAKLSDFGLATDGPQGEDS 242
               +     +  L   E  +++R+ K  NI+     D     KL+DFG A +    +D 
Sbjct: 117 VLRDVVGG--MNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDE 170

Query: 243 HITTCVMGTEGYAAPEYINTGHLTTM--------CDVFSFGVVLLELLTGR--------- 285
              +   GTE Y  P+      L            D++S GV      TG          
Sbjct: 171 QFVSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229

Query: 286 RSVEK--NRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSH 343
           R  ++   +    K     +     +   +D   D  +    S      L  V    L  
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289

Query: 344 NPKSRPTMTTVVKALEPLLDLNDIPI 369
           + +              +L    I +
Sbjct: 290 DQEKCWGFDQFFAETSDILHRMVIHV 315

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  113 bits (286), Expect = 6e-29
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 27/207 (13%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD----VNGSQGHREWLAEVIFLGQLKHP 142
           LG+G FG VY        +       +A+KVL           H+    E+     L+HP
Sbjct: 22  LGKGKFGNVYLA---REKQNK---FIMALKVLFKSQLEKEGVEHQ-LRREIEIQSHLRHP 74

Query: 143 HLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLP-WLTRIKIA--IGAARCLA 198
           +++ +  Y   D  R+ L+ E+   G L+ +L K+         +   +     A   L 
Sbjct: 75  NILRMYNYF-HDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADA---LH 128

Query: 199 FLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPE 258
           + H  E+ VI+RD K  N+L+      K++DFG +   P       T C  GT  Y  PE
Sbjct: 129 YCH--ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--LRRRTMC--GTLDYLPPE 182

Query: 259 YINTGHLTTMCDVFSFGVVLLELLTGR 285
            I         D++  GV+  E L G 
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  115 bits (289), Expect = 7e-29
 Identities = 47/228 (20%), Positives = 89/228 (39%), Gaps = 46/228 (20%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA--------------- 131
           L +G F K+   C  DN       +  A+K  + +  +  R++                 
Sbjct: 39  LNQGKFNKIIL-CEKDN-------KFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90

Query: 132 --EVIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIK 188
             E+  +  +K+ + +   G    +   + ++YEYM   ++       +     +   I 
Sbjct: 91  KNELQIITDIKNEYCLTCEGII-TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 189 IAIGAARC--------LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGE 240
           I +   +C         +++H  EK + +RD K SNIL+D +   KLSDFG +       
Sbjct: 150 IQV--IKCIIKSVLNSFSYIH-NEKNICHRDVKPSNILMDKNGRVKLSDFGESE---YMV 203

Query: 241 DSHI-TTCVMGTEGYAAPEYINT--GHLTTMCDVFSFGVVLLELLTGR 285
           D  I  +   GT  +  PE+ +    +     D++S G+ L  +    
Sbjct: 204 DKKIKGSR--GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  114 bits (287), Expect = 8e-29
 Identities = 61/326 (18%), Positives = 107/326 (32%), Gaps = 46/326 (14%)

Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEV 133
               H +  SD LG+G    V++G    + + G      A+KV +        +  + E 
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGR---HKKTG---DLFAIKVFNNISFLRPVDVQMREF 58

Query: 134 IFLGQLKHPHLVNLIGY--CCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA- 190
             L +L H ++V L          H++L+ E+   G+L+  L +   S    L   +   
Sbjct: 59  EVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP--SNAYGLPESEFLI 116

Query: 191 ----IGAARCLAFLHGEEKPVIYRDFKASNILL----DSDYNAKLSDFGLATDGPQGEDS 242
               +     +  L   E  +++R+ K  NI+     D     KL+DFG A +    +D 
Sbjct: 117 VLRDVVGG--MNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDE 170

Query: 243 HITTCVMGTEGYAAPEYINTGHLTTM--------CDVFSFGVVLLELLTGR--------- 285
              +   GTE Y  P+      L            D++S GV      TG          
Sbjct: 171 QFVSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229

Query: 286 RSVEK--NRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSH 343
           R  ++   +    K     +     +   +D   D  +    S      L  V    L  
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289

Query: 344 NPKSRPTMTTVVKALEPLLDLNDIPI 369
           + +              +L   +   
Sbjct: 290 DQEKCWGFDQFFAETSDILHRGNSHH 315

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  114 bits (287), Expect = 2e-28
 Identities = 72/295 (24%), Positives = 119/295 (40%), Gaps = 48/295 (16%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA-EVIFLGQLKHPHLV 145
           LG G  G V+K     +   G     +A K++ +      R  +  E+  L +   P++V
Sbjct: 41  LGAGNGGVVFKVS---HKPSG---LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
              G    D    +  E+M  G+L DQ+ K  +  +P     K++I   + L +L  + K
Sbjct: 95  GFYGAFYSDGEISICMEHMDGGSL-DQVLK-KAGRIPEQILGKVSIAVIKGLTYLREKHK 152

Query: 206 PVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
            +++RD K SNIL++S    KL DFG++    Q  DS   + V GT  Y +PE +   H 
Sbjct: 153 -IMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV-GTRSYMSPERLQGTHY 207

Query: 266 TTMCDVFSFGVVLLELLTGR--------------------------RSVEKNRCKREKDL 299
           +   D++S G+ L+E+  GR                              +   +     
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267

Query: 300 VEWARPMLKDFTKLDQIIDSR----LEDRYSTEGAKRLAAVAHQCLSHNPKSRPT 350
              +RP +  F  LD I++          +S E         ++CL  NP  R  
Sbjct: 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLE----FQDFVNKCLIKNPAERAD 318

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  109 bits (275), Expect = 2e-27
 Identities = 56/223 (25%), Positives = 106/223 (47%), Gaps = 25/223 (11%)

Query: 71  LKELQMITHN------FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ 124
           L++L+ I         ++R + +G+G  G VY      ++  G   Q VA++ +++    
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAM---DVATG---QEVAIRQMNLQQQP 59

Query: 125 GHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWL 184
                + E++ + + K+P++VN +      +   +V EY+A G+L D + +        +
Sbjct: 60  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC------M 113

Query: 185 TRIKIAI---GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGED 241
              +IA       + L FLH  +   I+RD K+ NILL  D + KL+DFG        + 
Sbjct: 114 DEGQIAAVCRECLQALEFLHSNQV--IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171

Query: 242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
              T  ++GT  + APE +         D++S G++ +E++ G
Sbjct: 172 KRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  109 bits (275), Expect = 3e-27
 Identities = 56/213 (26%), Positives = 86/213 (40%), Gaps = 34/213 (15%)

Query: 87  LGEGGFGKVYKGCVDDNL-RPGLKAQTVAVKVLDVNGSQGHREWLAEVIFL--------- 136
           LG GG   VY    D  L         VA+K +             +   L         
Sbjct: 19  LGGGGMSTVYLA-EDTILNIK------VAIKAI-------FIPPREKEETLKRFEREVHN 64

Query: 137 -GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
             QL H ++V++I    ED+   LV EY+    L + +  +    L   T I        
Sbjct: 65  SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILD 122

Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITT--CVMGTEG 253
            +   H  +  +++RD K  NIL+DS+   K+ DFG+A       ++ +T    V+GT  
Sbjct: 123 GIKHAH--DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL---SETSLTQTNHVLGTVQ 177

Query: 254 YAAPEYINTGHLTTMCDVFSFGVVLLELLTGRR 286
           Y +PE           D++S G+VL E+L G  
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  111 bits (278), Expect = 3e-27
 Identities = 37/326 (11%), Positives = 88/326 (26%), Gaps = 85/326 (26%)

Query: 78  THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD------------------ 119
                R   LG+       +     +   G   ++  V V                    
Sbjct: 72  PRTLVRGTVLGQEDPYAYLEAT---DQETG---ESFEVHVPYFTERPPSNAIKQMKEEVL 125

Query: 120 ----------VNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE--HRLLVYEYMA-- 165
                        ++ H  ++     +   +   ++ +     +     R  +Y  M   
Sbjct: 126 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 185

Query: 166 LGNLHDQLFKNYSS--TLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY 223
           L    + L  + S+  +L    R+++ +   R LA LH     +++   +  +I+LD   
Sbjct: 186 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH--HYGLVHTYLRPVDIVLDQRG 243

Query: 224 NAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT-----------GHLTTMCDVF 272
              L+ F         + + + +    + G+  PE                 +T   D +
Sbjct: 244 GVFLTGFEHLVR----DGARVVSS--VSRGFEPPELEARRATISYHRDRRTLMTFSFDAW 297

Query: 273 SFGVVLLELLTGRR--SVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGA 330
           + G+V+  +       + +      E                       R       +  
Sbjct: 298 ALGLVIYWIWCADLPITKDAALGGSEWIF--------------------RSCKNIP-QPV 336

Query: 331 KRLAAVAHQCLSHNPKSRPTMTTVVK 356
           + L       L +  + R      ++
Sbjct: 337 RAL---LEGFLRYPKEDRLLPLQAME 359

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  109 bits (275), Expect = 3e-27
 Identities = 72/281 (25%), Positives = 117/281 (41%), Gaps = 51/281 (18%)

Query: 81  FSRSDYLGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGSQGHREWL-AEVIFLGQ 138
           F++ + +G+G FG+V+KG             + VA+K++D+  ++   E +  E+  L Q
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQ-------KVVAIKIIDLEEAEDEIEDIQQEITVLSQ 76

Query: 139 LKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI---GAAR 195
              P++    G   +D    ++ EY+  G+  D L          L   +IA       +
Sbjct: 77  CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP------LDETQIATILREILK 130

Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L +LH E+K  I+RD KA+N+LL      KL+DFG+A      +    T   +GT  + 
Sbjct: 131 GLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWM 186

Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK--- 312
           APE I      +  D++S G+  +EL  G                    P   +      
Sbjct: 187 APEVIKQSAYDSKADIWSLGITAIELARG-------------------EPPHSELHPMKV 227

Query: 313 LDQIIDS---RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT 350
           L  I  +    LE  YS    + +      CL+  P  RPT
Sbjct: 228 LFLIPKNNPPTLEGNYSKPLKEFVE----ACLNKEPSFRPT 264

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  109 bits (274), Expect = 4e-27
 Identities = 59/222 (26%), Positives = 93/222 (41%), Gaps = 28/222 (12%)

Query: 82  SRSDY-----LGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA-EVI 134
           +R DY     +G G    V    C           + VA+K +++   Q   + L  E+ 
Sbjct: 13  NRDDYELQEVIGSGATAVVQAAYCAPKK-------EKVAIKRINLEKCQTSMDELLKEIQ 65

Query: 135 FLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHD---QLFKNYSSTLPWLTRIKIAI 191
            + Q  HP++V+        +   LV + ++ G++ D    +          L    IA 
Sbjct: 66  AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 125

Query: 192 ---GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFG----LATDGPQGEDSHI 244
                   L +LH   +  I+RD KA NILL  D + +++DFG    LAT G    +   
Sbjct: 126 ILREVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 183

Query: 245 TTCVMGTEGYAAPEYINTGHL-TTMCDVFSFGVVLLELLTGR 285
            T V GT  + APE +          D++SFG+  +EL TG 
Sbjct: 184 KTFV-GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  110 bits (276), Expect = 8e-27
 Identities = 39/249 (15%), Positives = 73/249 (29%), Gaps = 58/249 (23%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-------SQGHREWLAEV 133
             R   LG+       +   D         ++  V V             Q   E L   
Sbjct: 80  LVRGTVLGQEDPYAYLE-ATDQETG-----ESFEVHVPYFTERPPSNAIKQMKEEVLRLR 133

Query: 134 IFLGQ------------------LKHPHLVNLIGYCCEDEH-----RLLVYEYMA--LGN 168
           +  G                   +K P    +I    ++       R  +Y  M   L  
Sbjct: 134 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 193

Query: 169 LHDQLFKNYSS--TLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAK 226
             + L  + S+  +L    R+++ +   R LA LH     +++   +  +I+LD      
Sbjct: 194 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH--HYGLVHTYLRPVDIVLDQRGGVF 251

Query: 227 LSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI----------NTGHLTTMCDVFSFGV 276
           L+ F        G     +       G+A PE            +   +T   D ++ G+
Sbjct: 252 LTGFEHLV--RDGA----SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305

Query: 277 VLLELLTGR 285
            +  +    
Sbjct: 306 AIYWIWCAD 314

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  111 bits (279), Expect = 1e-26
 Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 25/209 (11%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHREW-LAEVIFLGQLKHPH 143
           LG GGFG+V+   +          +  A K L       +   +  + E   L ++    
Sbjct: 193 LGRGGFGEVFACQMKAT------GKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246

Query: 144 LVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPW-LTRIK-----IAIGAARC 196
           +V+L  Y  E +  L LV   M  G++   ++        +   R       I  G    
Sbjct: 247 IVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG---- 301

Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L  LH  ++ +IYRD K  N+LLD D N ++SD GLA +   G+         GT G+ A
Sbjct: 302 LEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA--GTPGFMA 357

Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           PE +         D F+ GV L E++  R
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  111 bits (279), Expect = 2e-26
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 20/205 (9%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHREW-LAEVIFLGQLKHPH 143
           LG+GGFG+V    V          +  A K L       +      L E   L ++    
Sbjct: 192 LGKGGFGEVCACQVRAT------GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245

Query: 144 LVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC-LAFLH 201
           +V+L  Y  E +  L LV   M  G+L   ++    +  P   R         C L  LH
Sbjct: 246 VVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP-EARAVFYAAEICCGLEDLH 303

Query: 202 GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI- 260
              + ++YRD K  NILLD   + ++SD GLA   P+G+         GT GY APE + 
Sbjct: 304 --RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK-GRV--GTVGYMAPEVVK 358

Query: 261 NTGHLTTMCDVFSFGVVLLELLTGR 285
           N  + T   D ++ G +L E++ G+
Sbjct: 359 NERY-TFSPDWWALGCLLYEMIAGQ 382

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  107 bits (270), Expect = 2e-26
 Identities = 66/303 (21%), Positives = 117/303 (38%), Gaps = 68/303 (22%)

Query: 71  LKELQMITHN------FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ 124
              L+M+               +GEG  G V       +       + VAVK++D+   Q
Sbjct: 31  KAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHS------GRQVAVKMMDLRKQQ 84

Query: 125 GHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWL 184
                  EV+ +   +H ++V +       E   ++ E++  G L D + +        L
Sbjct: 85  RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR------L 138

Query: 185 TRIKIAIGAARC---LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ--G 239
              +IA         LA+LH +    I+RD K+ +ILL  D   KLSDFG      Q   
Sbjct: 139 NEEQIATVCEAVLQALAYLHAQGV--IHRDIKSDSILLTLDGRVKLSDFGFCA---QISK 193

Query: 240 EDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR------------RS 287
           +     + V GT  + APE I+     T  D++S G++++E++ G             + 
Sbjct: 194 DVPKRKSLV-GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR 252

Query: 288 VEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKS 347
           +  +   + K+  + + P+L+DF +                          + L  +P+ 
Sbjct: 253 LRDSPPPKLKNSHKVS-PVLRDFLE--------------------------RMLVRDPQE 285

Query: 348 RPT 350
           R T
Sbjct: 286 RAT 288

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  106 bits (267), Expect = 4e-26
 Identities = 52/212 (24%), Positives = 92/212 (43%), Gaps = 22/212 (10%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK 140
           +     LG+G FGKVYK     N   G      A KV++    +   +++ E+  L    
Sbjct: 21  WEIVGELGDGAFGKVYKAK---NKETG---ALAAAKVIETKSEEELEDYIVEIEILATCD 74

Query: 141 HPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI---GAARCL 197
           HP++V L+G    D    ++ E+   G +   +          LT  +I +        L
Sbjct: 75  HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRG---LTEPQIQVVCRQMLEAL 130

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAP 257
            FLH +    I+RD KA N+L+  + + +L+DFG++    +      +   +GT  + AP
Sbjct: 131 NFLHSKRI--IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAP 186

Query: 258 EYINTGHLT-----TMCDVFSFGVVLLELLTG 284
           E +    +         D++S G+ L+E+   
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  104 bits (262), Expect = 2e-25
 Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 23/210 (10%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
            F   + LGEG +G VYK     +   G   Q VA+K + V      +E + E+  + Q 
Sbjct: 30  VFDVLEKLGEGSYGSVYKAI---HKETG---QIVAIKQVPVE--SDLQEIIKEISIMQQC 81

Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI---GAARC 196
             PH+V   G   ++    +V EY   G++ D + +  + TL   T  +IA       + 
Sbjct: 82  DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTL---TEDEIATILQSTLKG 137

Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI--TTCVMGTEGY 254
           L +LH   K  I+RD KA NILL+++ +AKL+DFG+A    Q  D+     T + GT  +
Sbjct: 138 LEYLHFMRK--IHRDIKAGNILLNTEGHAKLADFGVAG---QLTDTMAKRNTVI-GTPFW 191

Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            APE I       + D++S G+  +E+  G
Sbjct: 192 MAPEVIQEIGYNCVADIWSLGITAIEMAEG 221

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  105 bits (265), Expect = 3e-25
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 29/211 (13%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD-----VNGSQGHREWLAEVIFLGQLKH 141
           +G+G FGKV     +D        +  A+K ++           +     E+  +  L+H
Sbjct: 23  IGKGSFGKVCIVQKNDT------KKMYAMKYMNKQKCVERNEVRNV--FKELQIMQGLEH 74

Query: 142 PHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA-IGAARCLAF 199
           P LVNL  Y  +DE  + +V + +  G+L   L +N         ++ I  +  A  L +
Sbjct: 75  PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET-VKLFICELVMA--LDY 130

Query: 200 LHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEY 259
           L    + +I+RD K  NILLD   +  ++DF +A   P+      T    GT+ Y APE 
Sbjct: 131 LQ--NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT-TMA--GTKPYMAPEM 185

Query: 260 IN----TGHLTTMCDVFSFGVVLLELLTGRR 286
            +     G+ +   D +S GV   ELL GRR
Sbjct: 186 FSSRKGAGY-SFAVDWWSLGVTAYELLRGRR 215

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  107 bits (269), Expect = 3e-25
 Identities = 57/211 (27%), Positives = 88/211 (41%), Gaps = 31/211 (14%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL---------DVNGSQGHREWLAEVIFLG 137
           +G GGFG+VY     D        +  A+K L             +   R  L+ V    
Sbjct: 197 IGRGGFGEVYGCRKADT------GKMYAMKCLDKKRIKMKQGETLALNERIMLSLV---S 247

Query: 138 QLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
               P +V +  Y      +L  + + M  G+LH  L ++   +      ++    A   
Sbjct: 248 TGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA---DMRFYA-AEII 302

Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L   H   + V+YRD K +NILLD   + ++SD GLA D  + +     +   GT GY A
Sbjct: 303 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV--GTHGYMA 358

Query: 257 PEYI--NTGHLTTMCDVFSFGVVLLELLTGR 285
           PE +     +  +  D FS G +L +LL G 
Sbjct: 359 PEVLQKGVAY-DSSADWFSLGCMLFKLLRGH 388

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  106 bits (265), Expect = 3e-25
 Identities = 74/336 (22%), Positives = 113/336 (33%), Gaps = 76/336 (22%)

Query: 75  QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVI 134
           Q + +       LG G  G V               + VAVK + ++          E+ 
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVFQGSFQG-------RPVAVKRMLIDFCDIALM---EIK 60

Query: 135 FLGQLK-HPHLVNLIGYCCEDEHRLLVYEYMALGNLHD-----QLFKNYSSTLPWLTRIK 188
            L +   HP+++        D    +  E     NL D      +             I 
Sbjct: 61  LLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPIS 119

Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDS-------------DYNAKLSDFGLATD 235
           +    A  +A LH     +I+RD K  NIL+ +             +    +SDFGL   
Sbjct: 120 LLRQIASGVAHLH--SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177

Query: 236 GPQGEDSHITTC--VMGTEGYAAPEYIN-------TGHLTTMCDVFSFGVVLLELLTG-- 284
              G+ S  T      GT G+ APE +           LT   D+FS G V   +L+   
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237

Query: 285 -----RRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQ 339
                + S E N              +++    LD+ +    +     E A  L +   Q
Sbjct: 238 HPFGDKYSRESN--------------IIRGIFSLDE-MKCLHDRSLIAE-ATDLIS---Q 278

Query: 340 CLSHNPKSRPTMTTV---------VKALEPLLDLND 366
            + H+P  RPT   V          K LE LL ++D
Sbjct: 279 MIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVSD 314

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  103 bits (258), Expect = 7e-25
 Identities = 57/216 (26%), Positives = 86/216 (39%), Gaps = 34/216 (15%)

Query: 87  LGEGGFGKVYKGCVDDNL-RPGLKAQTVAVKVLDVNGSQGHREWLAEVIFL--------- 136
           LG GG  +V+    D    R       VAVKVL         +   +  F          
Sbjct: 20  LGFGGMSEVHLA-RDLRDHRD------VAVKVL-------RADLARDPSFYLRFRREAQN 65

Query: 137 -GQLKHPHLVNLIGYCCEDEHRL----LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI 191
              L HP +V +      +        +V EY+    L D +       +     I++  
Sbjct: 66  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIA 123

Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS-HITTCVMG 250
            A + L F H  +  +I+RD K +NI++ +    K+ DFG+A       +S   T  V+G
Sbjct: 124 DACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181

Query: 251 TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRR 286
           T  Y +PE      +    DV+S G VL E+LTG  
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  102 bits (257), Expect = 7e-25
 Identities = 72/294 (24%), Positives = 112/294 (38%), Gaps = 55/294 (18%)

Query: 78  THNFSRSDY-----LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLA 131
           +      D      LG G +G V K     ++  G   Q +AVK +    + Q  +  L 
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMR---HVPSG---QIMAVKRIRATVNSQEQKRLLM 54

Query: 132 EV-IFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRI--- 187
           ++ I +  +  P  V   G    +    +  E M        L K Y   +     I   
Sbjct: 55  DLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTS-----LDKFYKQVIDKGQTIPED 109

Query: 188 ---KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI 244
              KIA+   + L  LH +   VI+RD K SN+L+++    K+ DFG++       D   
Sbjct: 110 ILGKIAVSIVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVA 165

Query: 245 TTCVMGTEGYAAPEYINTGHL----TTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV 300
                G + Y APE IN        +   D++S G+ ++EL   R               
Sbjct: 166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP-----------YD 214

Query: 301 EWARPMLKDFTKLDQIIDS---RL-EDRYSTEGAKRLAAVAHQCLSHNPKSRPT 350
            W  P      +L Q+++    +L  D++S E          QCL  N K RPT
Sbjct: 215 SWGTPF----QQLKQVVEEPSPQLPADKFSAE----FVDFTSQCLKKNSKERPT 260

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  103 bits (259), Expect = 1e-24
 Identities = 55/335 (16%), Positives = 98/335 (29%), Gaps = 60/335 (17%)

Query: 64  SNLHVFTLKELQMITHNFSRSDY-----LGEG--GFGKVYKG-CVDDNLRPGLKAQTVAV 115
            + H+  L    M +       Y     +G+G      V                + V V
Sbjct: 5   HHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTG-------EYVTV 57

Query: 116 KVLDV-NGSQGHREWL-AEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQL 173
           + +++   S     +L  E+       HP++V        D    +V  +MA G+  D +
Sbjct: 58  RRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI 117

Query: 174 FKNYSSTLPWLTRIKIAI---GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDF 230
             ++   +     + IA    G  + L ++H      ++R  KAS+IL+  D    LS  
Sbjct: 118 CTHFMDGMN---ELAIAYILQGVLKALDYIHHMGY--VHRSVKASHILISVDGKVYLSGL 172

Query: 231 GLA-----TDGPQGEDSHITTCVMGTEGYAAPEYI--NTGHLTTMCDVFSFGVVLLELLT 283
                       Q          +    + +PE +  N        D++S G+   EL  
Sbjct: 173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN 232

Query: 284 G------------------------RRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDS 319
           G                          +      +                +        
Sbjct: 233 GHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRP 292

Query: 320 RLEDRYSTEGAKRLAAVAH----QCLSHNPKSRPT 350
              D  S    +  +   H    QCL  NP +RP+
Sbjct: 293 SNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS 327

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  102 bits (255), Expect = 2e-24
 Identities = 60/221 (27%), Positives = 92/221 (41%), Gaps = 23/221 (10%)

Query: 78  THNFSRSDY-----LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLA 131
             +F+  D      +G G +G V K     +   G   Q +AVK +      +  ++ L 
Sbjct: 16  HWDFTAEDLKDLGEIGRGAYGSVNKMV---HKPSG---QIMAVKRIRSTVDEKEQKQLLM 69

Query: 132 EV-IFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMA--LGNLHDQLFKNYSSTLPWLTRIK 188
           ++ + +     P++V   G    +    +  E M+      +  ++      +P     K
Sbjct: 70  DLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGK 129

Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
           I +   + L  L    K +I+RD K SNILLD   N KL DFG++    Q  DS   T  
Sbjct: 130 ITLATVKALNHLKENLK-IIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRD 185

Query: 249 MGTEGYAAPEYINTGHL----TTMCDVFSFGVVLLELLTGR 285
            G   Y APE I+            DV+S G+ L EL TGR
Sbjct: 186 AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  102 bits (255), Expect = 2e-24
 Identities = 57/284 (20%), Positives = 99/284 (34%), Gaps = 63/284 (22%)

Query: 54  LNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKA--Q 111
           ++       G     F    L  +   +     +G+G +G V    ++            
Sbjct: 1   MHHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRV-AIE-------NQTRA 52

Query: 112 TVAVKVLD----VNGSQGHREWLA-EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMAL 166
             A+K+++       +    E +  EV  + +L HP++  L     ++++  LV E    
Sbjct: 53  IRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHG 112

Query: 167 GNLHDQLFKNYSSTLPWLTRIKIAIG-------------------------------AAR 195
           G+L D+L      +        +                                   + 
Sbjct: 113 GHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISN 172

Query: 196 C-------LAFLHGEEKPVIYRDFKASNILLDSDYNA--KLSDFGLAT---DGPQGEDSH 243
                   L +LH   + + +RD K  N L  ++ +   KL DFGL+        GE   
Sbjct: 173 IMRQIFSALHYLH--NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYG 230

Query: 244 ITTCVMGTEGYAAPEYINTGHL--TTMCDVFSFGVVLLELLTGR 285
           +TT   GT  + APE +NT +      CD +S GV+L  LL G 
Sbjct: 231 MTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  100 bits (252), Expect = 3e-24
 Identities = 61/211 (28%), Positives = 90/211 (42%), Gaps = 32/211 (15%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA-EVIFLGQLKHPHLV 145
           LGEG +G+V       N       + VAVK++D+  +    E +  E+     L H ++V
Sbjct: 15  LGEGAYGEVQLAV---NRVTE---EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR--------CL 197
              G+  E   + L  EY + G L D++             I +    A+         +
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEP----------DIGMPEPDAQRFFHQLMAGV 118

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI--TTCVMGTEGYA 255
            +LHG    + +RD K  N+LLD   N K+SDFGLAT         +    C  GT  Y 
Sbjct: 119 VYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYV 174

Query: 256 APEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
           APE +          DV+S G+VL  +L G 
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  102 bits (255), Expect = 3e-24
 Identities = 67/213 (31%), Positives = 97/213 (45%), Gaps = 28/213 (13%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREW---LAEVIFLG 137
           FS    +G G FG VY      ++R     + VA+K +  +G Q + +W   + EV FL 
Sbjct: 56  FSDLREIGHGSFGAVYFAR---DVRNS---EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109

Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI---GAA 194
           +L+HP+ +   G    +    LV EY   G+  D L + +   L     ++IA    GA 
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASD-LLEVHKKPL---QEVEIAAVTHGAL 164

Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
           + LA+LH      I+RD KA NILL      KL DFG A        +   +  +GT  +
Sbjct: 165 QGLAYLHSHNM--IHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANS-FVGTPYW 216

Query: 255 AAPEYINT---GHLTTMCDVFSFGVVLLELLTG 284
            APE I     G      DV+S G+  +EL   
Sbjct: 217 MAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  101 bits (253), Expect = 3e-24
 Identities = 55/213 (25%), Positives = 88/213 (41%), Gaps = 21/213 (9%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD----VNGSQGHREWLAEVIF 135
           +F     LGEG F  V         R        A+K+L+    +  ++       E   
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSRE------YAIKILEKRHIIKENKVPYV-TRERDV 83

Query: 136 LGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA-IGA 193
           + +L HP  V L  +  +D+ +L     Y   G L   + K  S      TR   A I +
Sbjct: 84  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-CTRFYTAEIVS 141

Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
           A  L +LH   K +I+RD K  NILL+ D + +++DFG A               +GT  
Sbjct: 142 A--LEYLH--GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197

Query: 254 YAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
           Y +PE +          D+++ G ++ +L+ G 
Sbjct: 198 YVSPELLTEKSA-CKSSDLWALGCIIYQLVAGL 229

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  100 bits (251), Expect = 9e-24
 Identities = 70/208 (33%), Positives = 100/208 (48%), Gaps = 25/208 (12%)

Query: 87  LGEGGFGKVY----KGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHREWLAEVIFLGQLK 140
           LG+G FGKV+        D         Q  A+KVL       +       E   L ++ 
Sbjct: 32  LGQGSFGKVFLVKKISGSDAR-------QLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84

Query: 141 HPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA-IGAARCLA 198
           HP +V L  Y  + E +L L+ +++  G+L  +L K    T     +  +A +  A  L 
Sbjct: 85  HPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED-VKFYLAELALA--LD 140

Query: 199 FLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPE 258
            LH     +IYRD K  NILLD + + KL+DFGL+ +    E    + C  GT  Y APE
Sbjct: 141 HLH--SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC--GTVEYMAPE 196

Query: 259 YIN-TGHLTTMCDVFSFGVVLLELLTGR 285
            +N  GH T   D +SFGV++ E+LTG 
Sbjct: 197 VVNRRGH-TQSADWWSFGVLMFEMLTGT 223

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  100 bits (251), Expect = 1e-23
 Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 25/209 (11%)

Query: 87  LGEGGFGKVY---KGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHREW-LAEVIFLGQL 139
           LG+GG+GKV+   K    +        +  A+KVL    +  +        AE   L ++
Sbjct: 25  LGKGGYGKVFQVRKVTGANT------GKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78

Query: 140 KHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA-IGAARCL 197
           KHP +V+LI Y  +   +L L+ EY++ G L  QL +             +A I  A  L
Sbjct: 79  KHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT-ACFYLAEISMA--L 134

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAP 257
             LH  +K +IYRD K  NI+L+   + KL+DFGL  +         T C  GT  Y AP
Sbjct: 135 GHLH--QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC--GTIEYMAP 190

Query: 258 EYIN-TGHLTTMCDVFSFGVVLLELLTGR 285
           E +  +GH     D +S G ++ ++LTG 
Sbjct: 191 EILMRSGH-NRAVDWWSLGALMYDMLTGA 218

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 99.7 bits (249), Expect = 1e-23
 Identities = 61/211 (28%), Positives = 90/211 (42%), Gaps = 32/211 (15%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA-EVIFLGQLKHPHLV 145
           LGEG +G+V       N       + VAVK++D+  +    E +  E+     L H ++V
Sbjct: 15  LGEGAYGEVQLAV---NRVTE---EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC--------L 197
              G+  E   + L  EY + G L D++             I +    A+         +
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEP----------DIGMPEPDAQRFFHQLMAGV 118

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI--TTCVMGTEGYA 255
            +LHG    + +RD K  N+LLD   N K+SDFGLAT         +    C  GT  Y 
Sbjct: 119 VYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYV 174

Query: 256 APEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
           APE +          DV+S G+VL  +L G 
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  101 bits (254), Expect = 2e-23
 Identities = 75/319 (23%), Positives = 122/319 (38%), Gaps = 53/319 (16%)

Query: 47  NPGSPISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRP 106
           +     +L             +F   +   ++  + R   LG G +G+V   C D     
Sbjct: 7   HSSGRENLYFQGDLQATPG--MFITSKKGHLSEMYQRVKKLGSGAYGEVLL-CRD----- 58

Query: 107 GLKA--QTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL-LVY 161
             K      A+K++      +  + + L EV  L  L HP+++ L  +  ED+    LV 
Sbjct: 59  --KVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF-FEDKRNYYLVM 115

Query: 162 EYMALGNLHDQLFK--NYS----STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKAS 215
           E    G L D++     ++    + +     IK  +     + +LH  +  +++RD K  
Sbjct: 116 ECYKGGELFDEIIHRMKFNEVDAAVI-----IKQVLSG---VTYLH--KHNIVHRDLKPE 165

Query: 216 NILLDS---DYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVF 272
           N+LL+S   D   K+ DFGL+      E+       +GT  Y APE +        CDV+
Sbjct: 166 NLLLESKEKDALIKIVDFGLSA---VFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVW 221

Query: 273 SFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKR 332
           S GV+L  LL G         +     VE  +     F       DS      S   AK 
Sbjct: 222 SIGVILFILLAGYPPFGGQTDQEILRKVEKGKY---TF-------DSPEWKNVSEG-AKD 270

Query: 333 LAAVAHQCLSHNPKSRPTM 351
           L     Q L  + + R + 
Sbjct: 271 LIK---QMLQFDSQRRISA 286

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 48/217 (22%), Positives = 84/217 (38%), Gaps = 37/217 (17%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA----EVIFLGQLKHP 142
           LGEG +GKV +     +          AVK+L     +      A    E+  L +L+H 
Sbjct: 13  LGEGSYGKVKEVL---DSETL---CRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66

Query: 143 HLVNL--IGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC---- 196
           +++ L  + Y  E +   +V EY   G    ++  +       +   +  +  A      
Sbjct: 67  NVIQLVDVLYNEEKQKMYMVMEYCVCGM--QEML-DS------VPEKRFPVCQAHGYFCQ 117

Query: 197 ----LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI--TTCVMG 250
               L +LH   + ++++D K  N+LL +    K+S  G+A             T+   G
Sbjct: 118 LIDGLEYLHS--QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--G 173

Query: 251 TEGYAAPEYINTGHL--TTMCDVFSFGVVLLELLTGR 285
           +  +  PE  N          D++S GV L  + TG 
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  101 bits (253), Expect = 2e-23
 Identities = 69/233 (29%), Positives = 106/233 (45%), Gaps = 38/233 (16%)

Query: 68  VFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKA--QTVAVKVLD---VNG 122
           +F      + +  +     LG+G FG+V   C D       K   Q  AVKV+    V  
Sbjct: 15  MFVQHSTAIFSDRYKGQRVLGKGSFGEVIL-CKD-------KITGQECAVKVISKRQVKQ 66

Query: 123 SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFK--NYS- 178
                  L EV  L QL HP+++ L  +  ED+    LV E    G L D++     +S 
Sbjct: 67  KTDKESLLREVQLLKQLDHPNIMKLYEF-FEDKGYFYLVGEVYTGGELFDEIISRKRFSE 125

Query: 179 ---STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS---DYNAKLSDFGL 232
              + +     I+  +     + ++H  +  +++RD K  N+LL+S   D N ++ DFGL
Sbjct: 126 VDAARI-----IRQVLSG---ITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGL 175

Query: 233 ATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           +T     E S      +GT  Y APE ++ G     CDV+S GV+L  LL+G 
Sbjct: 176 ST---HFEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGC 224

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 99.0 bits (247), Expect = 2e-23
 Identities = 64/277 (23%), Positives = 109/277 (39%), Gaps = 45/277 (16%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEV-IFLGQLKHPHL 144
           +G G  G+V+K       + G     +AVK +  +G+ + ++  L ++ + L     P++
Sbjct: 33  MGSGTCGQVWKMR---FRKTG---HVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86

Query: 145 VNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE 203
           V   G        + +  E M      ++L K     +P     K+ +   + L +L  +
Sbjct: 87  VQCFG-TFITNTDVFIAMELMGTCA--EKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143

Query: 204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTG 263
              VI+RD K SNILLD     KL DFG++    +  D        G   Y APE I+  
Sbjct: 144 HG-VIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPP 199

Query: 264 HL-----TTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIID 318
                      DV+S G+ L+EL TG+                  +    DF  L +++ 
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQFPY---------------KNCKTDFEVLTKVLQ 244

Query: 319 S---RLED--RYSTEGAKRLAAVAHQCLSHNPKSRPT 350
                L     +S +      +    CL+ + + RP 
Sbjct: 245 EEPPLLPGHMGFSGD----FQSFVKDCLTKDHRKRPK 277

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 99.8 bits (249), Expect = 4e-23
 Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 34/220 (15%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKA--QTVAVKVLDVNGSQGHREWLAEVI 134
           +   +   + LG G FG V++ CV+       KA  +    K ++            E+ 
Sbjct: 49  VYDYYDILEELGSGAFGVVHR-CVE-------KATGRVFVAKFINTPYPLDKYTVKNEIS 100

Query: 135 FLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFK---NYSSTLPWLTRIKIA 190
            + QL HP L+NL     ED++ + L+ E+++ G L D++       S            
Sbjct: 101 IMNQLHHPKLINLHDA-FEDKYEMVLILEFLSGGELFDRIAAEDYKMSE--------AEV 151

Query: 191 IGAAR----CLAFLHGEEKPVIYRDFKASNILLDSDYNA--KLSDFGLATDGPQGEDSHI 244
           I   R     L  +H  E  +++ D K  NI+ ++   +  K+ DFGLAT   +     I
Sbjct: 152 INYMRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEI 206

Query: 245 TTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
                 T  +AAPE ++   +    D+++ GV+   LL+G
Sbjct: 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 98.6 bits (246), Expect = 4e-23
 Identities = 59/219 (26%), Positives = 93/219 (42%), Gaps = 29/219 (13%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL- 139
           F   + +G G +G+VYKG    +++ G   Q  A+KV+DV G     E   E+  L +  
Sbjct: 26  FELVELVGNGTYGQVYKGR---HVKTG---QLAAIKVMDVTG-DEEEEIKQEINMLKKYS 78

Query: 140 KHPHLVNLIG-----YCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAI-- 191
            H ++    G          + +L LV E+   G++ D +     +TL       IA   
Sbjct: 79  HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL---KEEWIAYIC 135

Query: 192 -GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG 250
               R L+ LH  +   I+RD K  N+LL  +   KL DFG++            T + G
Sbjct: 136 REILRGLSHLHQHKV--IHRDIKGQNVLLTENAEVKLVDFGVSAQ-LDRTVGRRNTFI-G 191

Query: 251 TEGYAAPEYINTGHLTTM-----CDVFSFGVVLLELLTG 284
           T  + APE I              D++S G+  +E+  G
Sbjct: 192 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 98.2 bits (245), Expect = 9e-23
 Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 34/217 (15%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKA--QTVAVKVLDVNGSQGHREWLAEVIFLG 137
             S+++ LG G FG+V+K C +        A    +A K++   G +   E   E+  + 
Sbjct: 90  TVSKTEILGGGRFGQVHK-CEE-------TATGLKLAAKIIKTRGMKDKEEVKNEISVMN 141

Query: 138 QLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFK---NYSSTLPWLTRIKIAIGA 193
           QL H +L+ L     E ++ + LV EY+  G L D++     N +            I  
Sbjct: 142 QLDHANLIQLYDA-FESKNDIVLVMEYVDGGELFDRIIDESYNLTE--------LDTILF 192

Query: 194 AR----CLAFLHGEEKPVIYRDFKASNILLDS--DYNAKLSDFGLATDGPQGEDSHITTC 247
            +     +  +H  +  +++ D K  NIL  +      K+ DFGLA      E       
Sbjct: 193 MKQICEGIRHMH--QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKV 247

Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
             GT  + APE +N   ++   D++S GV+   LL+G
Sbjct: 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 99.0 bits (247), Expect = 1e-22
 Identities = 56/243 (23%), Positives = 102/243 (41%), Gaps = 46/243 (18%)

Query: 68  VFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKA--QTVAVKVLD------ 119
           ++  K+   I  ++ +   LG G +G+V   C +       K      A+KV+       
Sbjct: 25  MYVRKKEGKIGESYFKVRKLGSGAYGEVLL-CKE-------KNGHSEKAIKVIKKSQFDK 76

Query: 120 ------VNGSQGHREWLA-EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQ 172
                     +   E +  E+  L  L HP+++ L     + ++  LV E+   G L +Q
Sbjct: 77  GRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQ 136

Query: 173 L--FKNYS----STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS---DY 223
           +     +     + +     +K  +     + +LH  +  +++RD K  NILL++     
Sbjct: 137 IINRHKFDECDAANI-----MKQILSG---ICYLH--KHNIVHRDIKPENILLENKNSLL 186

Query: 224 NAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT 283
           N K+ DFGL++   +     +   + GT  Y APE +        CDV+S GV++  LL 
Sbjct: 187 NIKIVDFGLSSFFSKDY--KLRDRL-GTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLC 242

Query: 284 GRR 286
           G  
Sbjct: 243 GYP 245

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 64/210 (30%), Positives = 93/210 (44%), Gaps = 30/210 (14%)

Query: 87  LGEGGFGKVY----KGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHREW-LAE-VIFLGQ 138
           +G+G FGKV     K           +    AVKVL       +   +  ++E  + L  
Sbjct: 46  IGKGSFGKVLLARHKA----------EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKN 95

Query: 139 LKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA-IGAARC 196
           +KHP LV L  +  +   +L  V +Y+  G L   L +      P   R   A I +A  
Sbjct: 96  VKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR-ARFYAAEIASA-- 151

Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L +LH     ++YRD K  NILLDS  +  L+DFGL  +  +   +  T C  GT  Y A
Sbjct: 152 LGYLH--SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC--GTPEYLA 207

Query: 257 PEYIN-TGHLTTMCDVFSFGVVLLELLTGR 285
           PE ++   +     D +  G VL E+L G 
Sbjct: 208 PEVLHKQPY-DRTVDWWCLGAVLYEMLYGL 236

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 95.4 bits (238), Expect = 2e-22
 Identities = 65/211 (30%), Positives = 96/211 (45%), Gaps = 33/211 (15%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLA-EVIFLGQLKHPH 143
           LG G FGKV  G    +   G     VAVK+L+     S      +  E+  L   +HPH
Sbjct: 19  LGVGTFGKVKIGE---HQLTG---HKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72

Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC------- 196
           ++ L           +V EY++ G L D + K+           ++    AR        
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG----------RVEEMEARRLFQQILS 122

Query: 197 -LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            + + H     V++RD K  N+LLD+  NAK++DFGL+     GE    T+C  G+  YA
Sbjct: 123 AVDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR-TSC--GSPNYA 177

Query: 256 APEYIN-TGHLTTMCDVFSFGVVLLELLTGR 285
           APE I+   +     D++S GV+L  LL G 
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGT 208

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 65/209 (31%), Positives = 92/209 (44%), Gaps = 28/209 (13%)

Query: 87  LGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHREW-LAE-VIFLGQ 138
           LG+G FGKV    +K             Q  A+K L  DV       E  + E  +    
Sbjct: 25  LGKGSFGKVFLAEFKK----------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 74

Query: 139 LKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA-IGAARC 196
            +HP L ++     + +  L  V EY+  G+L   +   +   L        A I     
Sbjct: 75  WEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSR-ATFYAAEIILG-- 130

Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L FLH   K ++YRD K  NILLD D + K++DFG+  +   G+    T C  GT  Y A
Sbjct: 131 LQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC--GTPDYIA 186

Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           PE +         D +SFGV+L E+L G+
Sbjct: 187 PEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 96.1 bits (239), Expect = 3e-22
 Identities = 50/249 (20%), Positives = 89/249 (35%), Gaps = 40/249 (16%)

Query: 123 SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLP 182
                    ++  +      + V  +       +  +  +     NL D + +  S    
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161

Query: 183 WLTRI-----KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP 237
                     +IA      + FLH   K +++RD K SNI    D   K+ DFGL T   
Sbjct: 162 EHGVCLHIFIQIAEA----VEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 215

Query: 238 QGEDSHIT----------TCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS 287
           Q E+              T  +GT+ Y +PE I+  + +   D+FS G++L ELL    +
Sbjct: 216 QDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST 275

Query: 288 VEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKS 347
                 + E+  +          T +  +    L  +   +       +    LS +P  
Sbjct: 276 ------QMERVRI---------ITDVRNLKFPLLFTQKYPQ----EHMMVQDMLSPSPTE 316

Query: 348 RPTMTTVVK 356
           RP  T +++
Sbjct: 317 RPEATDIIE 325

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 42.6 bits (100), Expect = 1e-04
 Identities = 23/102 (22%), Positives = 38/102 (37%), Gaps = 9/102 (8%)

Query: 80  NFSRSDYLGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFLG 137
           +F     +G GGFG V++     D+          A+K + +   +  RE  + EV  L 
Sbjct: 7   DFEPIQCMGRGGFGVVFEAKNKVDD-------CNYAIKRIRLPNRELAREKVMREVKALA 59

Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSS 179
           +L+HP +V       E        E   +    +      SS
Sbjct: 60  KLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSS 101

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 95.7 bits (239), Expect = 3e-22
 Identities = 50/210 (23%), Positives = 92/210 (43%), Gaps = 35/210 (16%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKA--QTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHL 144
           LG G F +V+            +   +  A+K +  + +        E+  L ++KH ++
Sbjct: 17  LGSGAFSEVFL-VKQ-------RLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENI 68

Query: 145 VNLIGYCCEDEHRL-LVYEYMALGNLHDQLFK--NYS----STLPWLTRIKIAIGAARCL 197
           V L     E      LV + ++ G L D++ +   Y+    S +     I+  + A   +
Sbjct: 69  VTLEDIY-ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV-----IQQVLSA---V 119

Query: 198 AFLHGEEKPVIYRDFKASNILLDS---DYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
            +LH  E  +++RD K  N+L  +   +    ++DFGL+      ++  ++T   GT GY
Sbjct: 120 KYLH--ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK---MEQNGIMSTAC-GTPGY 173

Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            APE +     +   D +S GV+   LL G
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 95.8 bits (239), Expect = 4e-22
 Identities = 42/218 (19%), Positives = 90/218 (41%), Gaps = 31/218 (14%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKA--QTVAVKVLDVNGSQGHREWLAEVI 134
           +   +  ++ LG G FG V++ CV+        +  +T   K + V G         E+ 
Sbjct: 3   LYEKYMIAEDLGRGEFGIVHR-CVE-------TSSKKTYMAKFVKVKG-TDQVLVKKEIS 53

Query: 135 FLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLF-KNYSSTLPWLTRIKIAIG 192
            L   +H ++++L     E    L +++E+++  ++ +++    +          +  + 
Sbjct: 54  ILNIARHRNILHLHESF-ESMEELVMIFEFISGLDIFERINTSAFELNE------REIVS 106

Query: 193 AAR----CLAFLHGEEKPVIYRDFKASNILLDSDYNA--KLSDFGLATDGPQGEDSHITT 246
                   L FLH     + + D +  NI+  +  ++  K+ +FG A     G+      
Sbjct: 107 YVHQVCEALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFR 161

Query: 247 CVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            +     Y APE      ++T  D++S G ++  LL+G
Sbjct: 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 98.0 bits (244), Expect = 4e-22
 Identities = 51/216 (23%), Positives = 90/216 (41%), Gaps = 26/216 (12%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKA--QTVAVKVLDVNGSQGHREWLAEVI 134
           +  ++   + LG G FG V++   +       +A     A K +             E+ 
Sbjct: 155 VLDHYDIHEELGTGAFGVVHR-VTE-------RATGNNFAAKFVMTPHESDKETVRKEIQ 206

Query: 135 FLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA 194
            +  L+HP LVNL     +D   +++YE+M+ G L +++   ++     ++    A+   
Sbjct: 207 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK----MSE-DEAVEYM 261

Query: 195 R----CLAFLHGEEKPVIYRDFKASNILLDS--DYNAKLSDFGLATDGPQGEDSHITTCV 248
           R     L  +H  E   ++ D K  NI+  +      KL DFGL       +   +    
Sbjct: 262 RQVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---T 316

Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            GT  +AAPE      +    D++S GV+   LL+G
Sbjct: 317 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 95.8 bits (239), Expect = 5e-22
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 30/210 (14%)

Query: 87  LGEGGFGKVY----KGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHREW-LAE-VIFLGQ 138
           +G G + KV     K             +  A+KV+  ++       +W   E  +F   
Sbjct: 17  IGRGSYAKVLLVRLKK----------TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA 66

Query: 139 LKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA-IGAARC 196
             HP LV L   C + E RL  V EY+  G+L   + +          R   A I  A  
Sbjct: 67  SNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH-ARFYSAEISLA-- 122

Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L +LH  E+ +IYRD K  N+LLDS+ + KL+D+G+  +G +  D+  T C  GT  Y A
Sbjct: 123 LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC--GTPNYIA 178

Query: 257 PEYIN-TGHLTTMCDVFSFGVVLLELLTGR 285
           PE +    +     D ++ GV++ E++ GR
Sbjct: 179 PEILRGEDY-GFSVDWWALGVLMFEMMAGR 207

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 95.1 bits (237), Expect = 7e-22
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 44/216 (20%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD------VNGSQGHREWLAEVIFLGQLK 140
           +G+G F KV       ++  G +   VA+K++D       +  +  RE    V  +  L 
Sbjct: 23  IGKGNFAKVKLAR---HILTGRE---VAIKIIDKTQLNPTSLQKLFRE----VRIMKILN 72

Query: 141 HPHLVNLIGY-CCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC-- 196
           HP++V L  +   E E  L L+ EY + G + D L  +           ++    AR   
Sbjct: 73  HPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAHG----------RMKEKEARSKF 120

Query: 197 ------LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG 250
                 + + H  +K +++RD KA N+LLD+D N K++DFG + +   G       C  G
Sbjct: 121 RQIVSAVQYCH--QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD-AFC--G 175

Query: 251 TEGYAAPEYIN-TGHLTTMCDVFSFGVVLLELLTGR 285
              YAAPE      +     DV+S GV+L  L++G 
Sbjct: 176 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 211

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 95.4 bits (238), Expect = 8e-22
 Identities = 67/213 (31%), Positives = 96/213 (45%), Gaps = 29/213 (13%)

Query: 87  LGEGGFGKVY---KGCVDDNLRPGLKAQTVAVKVL---DVNGSQGHREW-LAE-VIFLGQ 138
           LG G +GKV+   K    D        +  A+KVL    +       E    E  +    
Sbjct: 62  LGTGAYGKVFLVRKISGHDT------GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115

Query: 139 LKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA-IGAARC 196
            + P LV L  Y  + E +L L+ +Y+  G L   L +    T     +I +  I  A  
Sbjct: 116 RQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-VQIYVGEIVLA-- 171

Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITT-CVMGTEGYA 255
           L  LH  +  +IYRD K  NILLDS+ +  L+DFGL+ +    E       C  GT  Y 
Sbjct: 172 LEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC--GTIEYM 227

Query: 256 APEYI---NTGHLTTMCDVFSFGVVLLELLTGR 285
           AP+ +   ++GH     D +S GV++ ELLTG 
Sbjct: 228 APDIVRGGDSGH-DKAVDWWSLGVLMYELLTGA 259

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 93.8 bits (234), Expect = 8e-22
 Identities = 64/223 (28%), Positives = 95/223 (42%), Gaps = 36/223 (16%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA-EVIF 135
           I   F     LG G FG V+    + +           +K ++ + SQ   E +  E+  
Sbjct: 20  IDDLFIFKRKLGSGAFGDVHL-VEERS-----SGLERVIKTINKDRSQVPMEQIEAEIEV 73

Query: 136 LGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQL------FKNYS----STLPWL 184
           L  L HP+++ +     ED H + +V E    G L +++       K  S    + L   
Sbjct: 74  LKSLDHPNIIKIFEV-FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL--- 129

Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS---DYNAKLSDFGLATDGPQGED 241
             +K  + A   LA+ H   + V+++D K  NIL          K+ DFGLA      E 
Sbjct: 130 --MKQMMNA---LAYFH--SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE- 181

Query: 242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            H T    GT  Y APE      +T  CD++S GVV+  LLTG
Sbjct: 182 -HSTNAA-GTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTG 221

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 95.0 bits (237), Expect = 8e-22
 Identities = 69/210 (32%), Positives = 93/210 (44%), Gaps = 30/210 (14%)

Query: 87  LGEGGFGKVY----KGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHREW-LAE-VIFLGQ 138
           LG+G FGKV     K                AVKVL  DV       E  + E  I    
Sbjct: 31  LGKGSFGKVMLARVKE----------TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80

Query: 139 LKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA-IGAARC 196
             HP L  L   C +   RL  V E++  G+L   + K+         R   A I +A  
Sbjct: 81  RNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEAR-ARFYAAEIISA-- 136

Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L FLH  +K +IYRD K  N+LLD + + KL+DFG+  +G     +  T C  GT  Y A
Sbjct: 137 LMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC--GTPDYIA 192

Query: 257 PEYIN-TGHLTTMCDVFSFGVVLLELLTGR 285
           PE +    +     D ++ GV+L E+L G 
Sbjct: 193 PEILQEMLY-GPAVDWWAMGVLLYEMLCGH 221

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 95.9 bits (239), Expect = 9e-22
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 30/210 (14%)

Query: 87  LGEGGFGKVY----KGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHREW-LAE-VIFLGQ 138
           +G G + KV     K             +  A++V+  ++       +W   E  +F   
Sbjct: 60  IGRGSYAKVLLVRLKK----------TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA 109

Query: 139 LKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA-IGAARC 196
             HP LV L   C + E RL  V EY+  G+L   + +          R   A I  A  
Sbjct: 110 SNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH-ARFYSAEISLA-- 165

Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L +LH  E+ +IYRD K  N+LLDS+ + KL+D+G+  +G +  D+  T C  GT  Y A
Sbjct: 166 LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC--GTPNYIA 221

Query: 257 PEYIN-TGHLTTMCDVFSFGVVLLELLTGR 285
           PE +    +     D ++ GV++ E++ GR
Sbjct: 222 PEILRGEDY-GFSVDWWALGVLMFEMMAGR 250

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 95.0 bits (237), Expect = 1e-21
 Identities = 66/210 (31%), Positives = 92/210 (43%), Gaps = 30/210 (14%)

Query: 87  LGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHREW-LAE-VIFLGQ 138
           LG+G FGKV     KG            +  AVK+L  DV       E  + E  +    
Sbjct: 28  LGKGSFGKVMLSERKG----------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 77

Query: 139 LKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA-IGAARC 196
            K P L  L   C +   RL  V EY+  G+L   + +      P       A I     
Sbjct: 78  GKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH-AVFYAAEIAIG-- 133

Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L FL    K +IYRD K  N++LDS+ + K++DFG+  +      +  T C  GT  Y A
Sbjct: 134 LFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC--GTPDYIA 189

Query: 257 PEYIN-TGHLTTMCDVFSFGVVLLELLTGR 285
           PE I    +     D ++FGV+L E+L G+
Sbjct: 190 PEIIAYQPY-GKSVDWWAFGVLLYEMLAGQ 218

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 65/209 (31%), Positives = 93/209 (44%), Gaps = 29/209 (13%)

Query: 87  LGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHREW-LAEVIFLGQL 139
           LG+G FGKV     K             +  A+K+L  +V  ++      + E   L   
Sbjct: 13  LGKGTFGKVILVREKA----------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62

Query: 140 KHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA-IGAARCL 197
           +HP L  L  Y  +   RL  V EY   G L   L +    T     R   A I +A  L
Sbjct: 63  RHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER-ARFYGAEIVSA--L 118

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAP 257
            +LH   + V+YRD K  N++LD D + K++DFGL  +G     +  T C  GT  Y AP
Sbjct: 119 EYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC--GTPEYLAP 174

Query: 258 EYIN-TGHLTTMCDVFSFGVVLLELLTGR 285
           E +    +     D +  GVV+ E++ GR
Sbjct: 175 EVLEDNDY-GRAVDWWGLGVVMYEMMCGR 202

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 51/239 (21%), Positives = 92/239 (38%), Gaps = 62/239 (25%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD------VNGSQGHREWLA--------- 131
           +G+G +G V       N          A+KVL         G                  
Sbjct: 21  IGKGSYGVVKLAY---NENDN---TYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74

Query: 132 -----------EVIFLGQLKHPHLVNL--IGYCCEDEHRLLVYEYMALGNLHDQLFKNYS 178
                      E+  L +L HP++V L  +     ++H  +V+E +  G + +       
Sbjct: 75  QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK-- 132

Query: 179 STLPWLTRIKIAIGAARC--------LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDF 230
                     ++   AR         + +LH   + +I+RD K SN+L+  D + K++DF
Sbjct: 133 ---------PLSEDQARFYFQDLIKGIEYLH--YQKIIHRDIKPSNLLVGEDGHIKIADF 181

Query: 231 GLATDGPQGEDSHI-TTCVMGTEGYAAPEYINTGHLT---TMCDVFSFGVVLLELLTGR 285
           G++ +  +G D+ +  T   GT  + APE ++           DV++ GV L   + G+
Sbjct: 182 GVSNE-FKGSDALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 57/230 (24%), Positives = 95/230 (41%), Gaps = 41/230 (17%)

Query: 72  KELQMITHNFSRSDY-----LGEGGFGKVYKGCVDDNLRPGLKA--QTVAVKVLDVNGSQ 124
           ++L   +  F    Y     +G G +    + C+        KA     AVK++D +   
Sbjct: 11  QQLHRNSIQF-TDGYEVKEDIGVGSYSVCKR-CIH-------KATNMEFAVKIIDKSKRD 61

Query: 125 GHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK--NYS---- 178
              E     I L   +HP+++ L     + ++  +V E M  G L D++ +   +S    
Sbjct: 62  PTEE---IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREA 118

Query: 179 STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILL-DSDYNA---KLSDFGLAT 234
           S +     +         + +LH   + V++RD K SNIL  D   N    ++ DFG A 
Sbjct: 119 SAV-----LFTITKT---VEYLH--AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168

Query: 235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
                    +T C   T  + APE +        CD++S GV+L  +LTG
Sbjct: 169 QLRAENGLLMTPC--YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 95.5 bits (238), Expect = 2e-21
 Identities = 67/224 (29%), Positives = 103/224 (45%), Gaps = 37/224 (16%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKA--QTVAVKVLDVN--GSQGHREWLAE 132
               ++    LG+G FG+V K C D       +   Q  AVKV++     ++     L E
Sbjct: 20  FAERYNIVCMLGKGSFGEVLK-CKD-------RITQQEYAVKVINKASAKNKDTSTILRE 71

Query: 133 VIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFK--NYS----STLPWLT 185
           V  L +L HP+++ L     ED     +V E    G L D++ K   +S    + +    
Sbjct: 72  VELLKKLDHPNIMKLFEI-LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI---- 126

Query: 186 RIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS---DYNAKLSDFGLATDGPQGEDS 242
            IK        + ++H  +  +++RD K  NILL+S   D + K+ DFGL+T   Q    
Sbjct: 127 -IKQVFSG---ITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-- 178

Query: 243 HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRR 286
            +   + GT  Y APE +  G     CDV+S GV+L  LL+G  
Sbjct: 179 KMKDRI-GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTP 220

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 92.6 bits (231), Expect = 2e-21
 Identities = 54/227 (23%), Positives = 92/227 (40%), Gaps = 41/227 (18%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKA--QTVAVKVLDVNGSQGHREWLA--- 131
           +  ++   + LG G F  V K C         K   +  A K +        R  ++   
Sbjct: 3   VEDHYEMGEELGSGQFAIVRK-CRQ-------KGTGKEYAAKFIKKRRLSSSRRGVSREE 54

Query: 132 ---EVIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFK--NYSSTLPWLT 185
              EV  L +++HP+++ L     E++  + L+ E ++ G L D L +  + +       
Sbjct: 55  IEREVNILREIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKESLTE------ 107

Query: 186 RIKIAIGAAR----CLAFLHGEEKPVIYRDFKASNILLDS----DYNAKLSDFGLATDGP 237
               A    +     + +LH   K + + D K  NI+L      +   KL DFG+A    
Sbjct: 108 --DEATQFLKQILDGVHYLH--SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163

Query: 238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            G        + GT  + APE +N   L    D++S GV+   LL+G
Sbjct: 164 AGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 94.8 bits (236), Expect = 3e-21
 Identities = 67/208 (32%), Positives = 94/208 (45%), Gaps = 26/208 (12%)

Query: 87  LGEGGFGKVY----KGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHREW-LAEVIFLGQL 139
           LG+G FGKV     K             +  A+K+L  +V  ++      L E   L   
Sbjct: 156 LGKGTFGKVILVKEKA----------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 205

Query: 140 KHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA-IGAARCL 197
           +HP L  L  Y  +   RL  V EY   G L   L +    +     R   A I +A  L
Sbjct: 206 RHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-RARFYGAEIVSA--L 261

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAP 257
            +LH E K V+YRD K  N++LD D + K++DFGL  +G +   +  T C  GT  Y AP
Sbjct: 262 DYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC--GTPEYLAP 318

Query: 258 EYINTGHLTTMCDVFSFGVVLLELLTGR 285
           E +         D +  GVV+ E++ GR
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 93.6 bits (233), Expect = 3e-21
 Identities = 68/290 (23%), Positives = 109/290 (37%), Gaps = 46/290 (15%)

Query: 19  ATNKPSCMSKVHVSNQVSTQRLLLTDVSNPGSPISLNELSSSLVGSNLHVFTLKELQMIT 78
              + + +  +      S   L      N   P     L    +G    +      +   
Sbjct: 34  REQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFY 93

Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKA--QTVAVKVLDVNGSQGHREWLA----- 131
             +   D +G G    V + CV        +A     AVK+++V   +   E L      
Sbjct: 94  QKYDPKDVIGRGVSSVVRR-CVH-------RATGHEFAVKIMEVTAERLSPEQLEEVREA 145

Query: 132 ---EVIFLGQLK-HPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFK--NYS----ST 180
              E   L Q+  HPH++ LI    E    + LV++ M  G L D L +    S     +
Sbjct: 146 TRRETHILRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRS 204

Query: 181 LPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGE 240
           +     ++  + A   ++FLH     +++RD K  NILLD +   +LSDFG +       
Sbjct: 205 I-----MRSLLEA---VSFLH--ANNIVHRDLKPENILLDDNMQIRLSDFGFSCH--LEP 252

Query: 241 DSHITTCVMGTEGYAAPEYINTGHLTTM------CDVFSFGVVLLELLTG 284
              +     GT GY APE +      T        D+++ GV+L  LL G
Sbjct: 253 GEKLRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 92.7 bits (231), Expect = 6e-21
 Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 32/216 (14%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKA--QTVAVKVLDVNGSQGHREW-----LAEVIFLGQL 139
           +G+G F  V + C++       +   Q  AVK++DV                E      L
Sbjct: 32  IGKGPFSVVRR-CIN-------RETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83

Query: 140 KHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTR-----IKIAIGA 193
           KHPH+V L+      +  L +V+E+M   +L  ++ K   +   +        ++  + A
Sbjct: 84  KHPHIVELLET-YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142

Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDS---DYNAKLSDFGLATDGPQGEDSHITTCVMG 250
              L + H  +  +I+RD K   +LL S       KL  FG+A    +           G
Sbjct: 143 ---LRYCH--DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV--G 195

Query: 251 TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRR 286
           T  + APE +         DV+  GV+L  LL+G  
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCL 231

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 91.1 bits (227), Expect = 6e-21
 Identities = 54/218 (24%), Positives = 91/218 (41%), Gaps = 31/218 (14%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFL 136
           I   ++  + +G G +G+V    V    R        A K +     +    +  E+  +
Sbjct: 7   INQYYTLENTIGRGSWGEVKI-AVQKGTR-----IRRAAKKIPKYFVEDVDRFKQEIEIM 60

Query: 137 GQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFK--NYS----STLPWLTRIKI 189
             L HP+++ L     ED   + LV E    G L +++     +     + +     +K 
Sbjct: 61  KSLDHPNIIRLYET-FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-----MKD 114

Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDS---DYNAKLSDFGLATDGPQGEDSHITT 246
            + A   +A+ H  +  V +RD K  N L  +   D   KL DFGLA     G+   + T
Sbjct: 115 VLSA---VAYCH--KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MMRT 167

Query: 247 CVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            V GT  Y +P+ +   +    CD +S GV++  LL G
Sbjct: 168 KV-GTPYYVSPQVLEGLY-GPECDEWSAGVMMYVLLCG 203

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 92.7 bits (231), Expect = 6e-21
 Identities = 61/215 (28%), Positives = 89/215 (41%), Gaps = 28/215 (13%)

Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD----VNGSQ-GHREWLAEV 133
             F R   LG G FG+V      ++          A+K+LD    V   Q  H   L E 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES------GNHYAMKILDKQKVVKLKQIEHT--LNEK 92

Query: 134 IFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA-I 191
             L  +  P LV L  +  +D   L +V EY+A G +   L +    + P   R   A I
Sbjct: 93  RILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYAAQI 150

Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
                  +LH     +IYRD K  N+L+D     +++DFG A           T  + GT
Sbjct: 151 VLT--FEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGT 201

Query: 252 EGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
               APE I + G+     D ++ GV++ E+  G 
Sbjct: 202 PEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGY 235

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 91.6 bits (228), Expect = 6e-21
 Identities = 59/223 (26%), Positives = 88/223 (39%), Gaps = 47/223 (21%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKA--QTVAVKVLD--------VNGSQGHREWLA-EVIF 135
           LG G    V + C+        K   +  AVK++D            Q  RE    EV  
Sbjct: 25  LGRGVSSVVRR-CIH-------KPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76

Query: 136 LGQLK-HPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFK--NYS----STLPWLTRI 187
           L ++  HP+++ L     E      LV++ M  G L D L +    S      +     +
Sbjct: 77  LRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI-----M 130

Query: 188 KIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC 247
           +  +     +  LH  +  +++RD K  NILLD D N KL+DFG +          +   
Sbjct: 131 RALLEV---ICALH--KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEKLREV 183

Query: 248 VMGTEGYAAPE------YINTGHLTTMCDVFSFGVVLLELLTG 284
             GT  Y APE        N        D++S GV++  LL G
Sbjct: 184 C-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 91.5 bits (228), Expect = 1e-20
 Identities = 58/227 (25%), Positives = 94/227 (41%), Gaps = 41/227 (18%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKA--QTVAVKVLDVNGSQGHREWLA--- 131
           +   +   + LG G F  V K C +       K+     A K +    S+  R  ++   
Sbjct: 10  VEDFYDIGEELGSGQFAIVKK-CRE-------KSTGLEYAAKFIKKRQSRASRRGVSREE 61

Query: 132 ---EVIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFK--NYSSTLPWLT 185
              EV  L Q+ H +++ L     E+   + L+ E ++ G L D L +  + S       
Sbjct: 62  IEREVSILRQVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESLSE------ 114

Query: 186 RIKIAIGAAR----CLAFLHGEEKPVIYRDFKASNILLDS----DYNAKLSDFGLATDGP 237
             + A    +     + +LH   K + + D K  NI+L        + KL DFGLA    
Sbjct: 115 --EEATSFIKQILDGVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--- 167

Query: 238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           + ED      + GT  + APE +N   L    D++S GV+   LL+G
Sbjct: 168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 90.8 bits (226), Expect = 1e-20
 Identities = 66/223 (29%), Positives = 103/223 (46%), Gaps = 39/223 (17%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKA--QTVAVKVLD---VNGSQGHREWLA 131
               ++    LG+G FG+V K C D       +   Q  AVKV++             L 
Sbjct: 20  FAERYNIVCMLGKGSFGEVLK-CKD-------RITQQEYAVKVINKASAKNKDTSTI-LR 70

Query: 132 EVIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFK--NYS----STLPWL 184
           EV  L +L HP+++ L     ED     +V E    G L D++ K   +S    + +   
Sbjct: 71  EVELLKKLDHPNIMKLFEI-LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI--- 126

Query: 185 TRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS---DYNAKLSDFGLATDGPQGED 241
             IK        + ++H  +  +++RD K  NILL+S   D + K+ DFGL+T     ++
Sbjct: 127 --IKQVFSG---ITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQN 177

Query: 242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           + +   + GT  Y APE +  G     CDV+S GV+L  LL+G
Sbjct: 178 TKMKDRI-GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 92.9 bits (231), Expect = 1e-20
 Identities = 54/228 (23%), Positives = 99/228 (43%), Gaps = 28/228 (12%)

Query: 71  LKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD----VNGSQGH 126
           +K++++   +F     +G G FG+V        ++     +  A+K+L+    +  ++  
Sbjct: 66  VKQMRLHREDFEILKVIGRGAFGEVAV------VKLKNADKVFAMKILNKWEMLKRAETA 119

Query: 127 REWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLP-WL 184
                E   L       +  L  Y  +D++ L LV +Y   G+L   L K +   LP  +
Sbjct: 120 CFR-EERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSK-FEDRLPEEM 176

Query: 185 TRIKIA-IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSH 243
            R  +A +  A  +  +H  +   ++RD K  NIL+D + + +L+DFG      +     
Sbjct: 177 ARFYLAEMVIA--IDSVH--QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 232

Query: 244 ITTCVMGTEGYAAPEYINT------GHLTTMCDVFSFGVVLLELLTGR 285
            +  V GT  Y +PE +         +    CD +S GV + E+L G 
Sbjct: 233 SSVAV-GTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGE 278

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 59/227 (25%), Positives = 94/227 (41%), Gaps = 41/227 (18%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKA--QTVAVKVLDVNGSQGHREWLA--- 131
           +   +   + LG G F  V K C +       K+     A K +    S+  R  +    
Sbjct: 10  VEDFYDIGEELGSGQFAIVKK-CRE-------KSTGLEYAAKFIKKRQSRASRRGVCREE 61

Query: 132 ---EVIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFK--NYSSTLPWLT 185
              EV  L Q+ HP+++ L     E+   + L+ E ++ G L D L +  + S       
Sbjct: 62  IEREVSILRQVLHPNIITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESLSE------ 114

Query: 186 RIKIAIGAAR----CLAFLHGEEKPVIYRDFKASNILLDS----DYNAKLSDFGLATDGP 237
             + A    +     + +LH   K + + D K  NI+L        + KL DFGLA    
Sbjct: 115 --EEATSFIKQILDGVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--- 167

Query: 238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           + ED      + GT  + APE +N   L    D++S GV+   LL+G
Sbjct: 168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 93.5 bits (232), Expect = 1e-20
 Identities = 66/209 (31%), Positives = 91/209 (43%), Gaps = 28/209 (13%)

Query: 87  LGEGGFGKV----YKGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHREW-LAE-VIFLGQ 138
           LG+G FGKV     KG            +  AVK+L  DV       E  + E  +    
Sbjct: 349 LGKGSFGKVMLSERKG----------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 398

Query: 139 LKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA-IGAARC 196
            K P L  L   C +   RL  V EY+  G+L   + +      P       A I     
Sbjct: 399 GKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-HAVFYAAEIAIG-- 454

Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L FL    K +IYRD K  N++LDS+ + K++DFG+  +      +  T C  GT  Y A
Sbjct: 455 LFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC--GTPDYIA 510

Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           PE I         D ++FGV+L E+L G+
Sbjct: 511 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 56/225 (24%), Positives = 93/225 (41%), Gaps = 37/225 (16%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKA--QTVAVKVLDVNGSQGHREWLA--- 131
           +   +   + LG G F  V K C +       K+     A K +    ++  R  ++   
Sbjct: 9   VDDYYDTGEELGSGQFAVVKK-CRE-------KSTGLQYAAKFIKKRRTKSSRRGVSRED 60

Query: 132 ---EVIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRI 187
              EV  L +++HP+++ L     E++  + L+ E +A G L D L +  S T       
Sbjct: 61  IEREVSILKEIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFLAEKESLTE------ 113

Query: 188 KIAIGAAR----CLAFLHGEEKPVIYRDFKASNILLDS----DYNAKLSDFGLATDGPQG 239
           + A    +     + +LH     + + D K  NI+L          K+ DFGLA     G
Sbjct: 114 EEATEFLKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 171

Query: 240 EDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
                   + GT  + APE +N   L    D++S GV+   LL+G
Sbjct: 172 N---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 90.9 bits (226), Expect = 2e-20
 Identities = 69/344 (20%), Positives = 122/344 (35%), Gaps = 64/344 (18%)

Query: 26  MSKVHVSNQVSTQRLLLTDVSNPGSPISLNELSSSLVGSNLHVFTLKELQMITHNFSRSD 85
           M   H  +  S+  +       P + +   +L+             KE + +   +    
Sbjct: 1   MGSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPG-----------KEKEPLESQYQVGP 49

Query: 86  YLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLA----EVIFLGQL 139
            LG GGFG VY G     +   L    VA+K ++ +     G          EV+ L ++
Sbjct: 50  LLGSGGFGSVYSGI---RVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103

Query: 140 KH--PHLVNLIGYCCEDEHRLLVYEYMA-LGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
                 ++ L+ +    +  +L+ E    + +L D + +     L               
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEA 161

Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDY-NAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
           +   H     V++RD K  NIL+D +    KL DFG        +D+  T    GT  Y+
Sbjct: 162 VRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGA---LLKDTVYTDFD-GTRVYS 215

Query: 256 APEYINTGHL--TTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKL 313
            PE+I   H        V+S G++L +++ G                    P    F   
Sbjct: 216 PPEWIR-YHRYHGRSAAVWSLGILLYDMVCGD------------------IP----FEHD 252

Query: 314 DQIIDSRLED-RYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
           ++II  ++   +  +   + L      CL+  P  RPT   +  
Sbjct: 253 EEIIRGQVFFRQRVSSECQHL---IRWCLALRPSDRPTFEEIQN 293

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 91.3 bits (227), Expect = 2e-20
 Identities = 50/213 (23%), Positives = 79/213 (37%), Gaps = 39/213 (18%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFLGQLKHPH 143
           +G G FG         +       + VAVK ++          RE    +I    L+HP+
Sbjct: 28  IGSGNFGVARLM---RDKLTK---ELVAVKYIERGAAIDENVQRE----IINHRSLRHPN 77

Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR-------- 195
           +V          H  ++ EY + G L++++            R       AR        
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGGELYERICNA--------GRFSED--EARFFFQQLLS 127

Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDY--NAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
            +++ H     + +RD K  N LLD       K+ DFG +           +T   GT  
Sbjct: 128 GVSYCH--SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-STV--GTPA 182

Query: 254 YAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
           Y APE +    +   + DV+S GV L  +L G 
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 92.5 bits (230), Expect = 2e-20
 Identities = 65/211 (30%), Positives = 96/211 (45%), Gaps = 33/211 (15%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLA-EVIFLGQLKHPH 143
           LG G FGKV  G    +   G     VAVK+L+     S      +  E+  L   +HPH
Sbjct: 24  LGVGTFGKVKVGK---HELTG---HKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77

Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR-------- 195
           ++ L           +V EY++ G L D + KN           ++    +R        
Sbjct: 78  IIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG----------RLDEKESRRLFQQILS 127

Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            + + H     V++RD K  N+LLD+  NAK++DFGL+     GE    T+C  G+  YA
Sbjct: 128 GVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR-TSC--GSPNYA 182

Query: 256 APEYIN-TGHLTTMCDVFSFGVVLLELLTGR 285
           APE I+   +     D++S GV+L  LL G 
Sbjct: 183 APEVISGRLYAGPEVDIWSSGVILYALLCGT 213

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 60/211 (28%), Positives = 93/211 (44%), Gaps = 34/211 (16%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA---EVIFLGQLKHPH 143
           LGEG FGKV       + +     Q VA+K +     +     +    E+ +L  L+HPH
Sbjct: 17  LGEGSFGKVKLAT---HYKTQ---QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70

Query: 144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC------- 196
           ++ L          ++V EY A G L D + +            ++     R        
Sbjct: 71  IIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKK----------RMTEDEGRRFFQQIIC 119

Query: 197 -LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            + + H     +++RD K  N+LLD + N K++DFGL+     G     T+C  G+  YA
Sbjct: 120 AIEYCH--RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK-TSC--GSPNYA 174

Query: 256 APEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
           APE I    +     DV+S G+VL  +L GR
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 89.5 bits (223), Expect = 3e-20
 Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 36/212 (16%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKA--QTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHP 142
           LG+G F  V + CV        K      A K+++     ++  ++   E     +L+HP
Sbjct: 14  LGKGAFSVVRR-CVH-------KTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65

Query: 143 HLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFK--NYS----STLPWLTRIKIAIGAAR 195
           ++V L     ++E    LV++ +  G L + +     YS    S       I+  + +  
Sbjct: 66  NIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-----IQQILES-- 117

Query: 196 CLAFLHGEEKPVIYRDFKASNILLDS---DYNAKLSDFGLATDGPQGEDSHITTCVMGTE 252
            +A+ H     +++R+ K  N+LL S       KL+DFGLA    +  DS       GT 
Sbjct: 118 -IAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTP 171

Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           GY +PE +     +   D+++ GV+L  LL G
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 90.4 bits (225), Expect = 3e-20
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 31/208 (14%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-HPHLV 145
           LGEG F    K CV          Q  AVK++        ++   E+  L   + HP++V
Sbjct: 19  LGEGSFSICRK-CVHKKSN-----QAFAVKIISKRMEANTQK---EITALKLCEGHPNIV 69

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFK--NYS----STLPWLTRIKIAIGAARCLAF 199
            L     +  H  LV E +  G L +++ K  ++S    S +     ++  + A   ++ 
Sbjct: 70  KLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI-----MRKLVSA---VSH 121

Query: 200 LHGEEKPVIYRDFKASNILL---DSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           +H  +  V++RD K  N+L    + +   K+ DFG A   P       T C   T  YAA
Sbjct: 122 MH--DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC--FTLHYAA 177

Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTG 284
           PE +N       CD++S GV+L  +L+G
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSG 205

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 91.3 bits (227), Expect = 3e-20
 Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 44/220 (20%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKA--QTVAVKVLD----VNGSQGHREWLA----EVIFL 136
           LG G  G+V     +       +   + VA++++       GS    +       E+  L
Sbjct: 143 LGSGACGEVKL-AFE-------RKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194

Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKN--YS----STLPWLTRIKIA 190
            +L HP ++ +  +  + E   +V E M  G L D++  N                    
Sbjct: 195 KKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY-----FYQM 248

Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDS---DYNAKLSDFGLATDGPQGEDSHITTC 247
           + A   + +LH  E  +I+RD K  N+LL S   D   K++DFG +     GE S + T 
Sbjct: 249 LLA---VQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTL 301

Query: 248 VMGTEGYAAPEYINTGHL---TTMCDVFSFGVVLLELLTG 284
             GT  Y APE + +          D +S GV+L   L+G
Sbjct: 302 C-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 90.0 bits (224), Expect = 4e-20
 Identities = 57/220 (25%), Positives = 90/220 (40%), Gaps = 44/220 (20%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKA--QTVAVKVLD----VNGSQGHREWLA----EVIFL 136
           LG G  G+V     +       +   + VA+K++       GS    +       E+  L
Sbjct: 18  LGSGACGEVKL-AFE-------RKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69

Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKN--YS----STLPWLTRIKIA 190
            +L HP ++ +  +  + E   +V E M  G L D++  N                    
Sbjct: 70  KKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY-----FYQM 123

Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDS---DYNAKLSDFGLATDGPQGEDSHITTC 247
           + A   + +LH  E  +I+RD K  N+LL S   D   K++DFG +     GE S + T 
Sbjct: 124 LLA---VQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTL 176

Query: 248 VMGTEGYAAPEYINTGHL---TTMCDVFSFGVVLLELLTG 284
             GT  Y APE + +          D +S GV+L   L+G
Sbjct: 177 C-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 89.8 bits (223), Expect = 4e-20
 Identities = 61/285 (21%), Positives = 106/285 (37%), Gaps = 57/285 (20%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD----VNGSQGHREWLA----EVIFLGQ 138
           LG G FG V+      +       + V VK +     +         L     E+  L +
Sbjct: 32  LGSGAFGFVWTAV---DKEKN---KEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85

Query: 139 LKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLT-----RIKIAIGA 193
           ++H +++ ++          LV E    G     LF  +    P L       I   + +
Sbjct: 86  VEHANIIKVLDIFENQGFFQLVMEKHGSGL---DLF-AFIDRHPRLDEPLASYIFRQLVS 141

Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
           A  + +L    K +I+RD K  NI++  D+  KL DFG A    +G+  + T C  GT  
Sbjct: 142 A--VGYLR--LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY-TFC--GTIE 194

Query: 254 YAAPEYIN-TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK 312
           Y APE +    +     +++S GV L  L+                      P    F +
Sbjct: 195 YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE------------------NP----FCE 232

Query: 313 LDQIIDSRLED-RYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
           L++ +++ +      ++    L       L   P+ R T+  +V 
Sbjct: 233 LEETVEAAIHPPYLVSKELMSL---VSGLLQPVPERRTTLEKLVT 274

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 90.5 bits (225), Expect = 5e-20
 Identities = 56/229 (24%), Positives = 92/229 (40%), Gaps = 28/229 (12%)

Query: 71  LKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD----VNGSQGH 126
           LKE+++   +F     +G G F +V        ++     Q  A+K+++    +   +  
Sbjct: 53  LKEVRLQRDDFEILKVIGRGAFSEVAV------VKMKQTGQVYAMKIMNKWDMLKRGEVS 106

Query: 127 REWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLP-WL 184
                E   L       +  L  +  +DE+ L LV EY   G+L   L   +   +P  +
Sbjct: 107 CFR-EERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLL-SKFGERIPAEM 163

Query: 185 TRIKIA-IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSH 243
            R  +A I  A  +  +H      ++RD K  NILLD   + +L+DFG            
Sbjct: 164 ARFYLAEIVMA--IDSVH--RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR 219

Query: 244 ITTCVMGTEGYAAPEYI-------NTGHLTTMCDVFSFGVVLLELLTGR 285
               V GT  Y +PE +        TG     CD ++ GV   E+  G+
Sbjct: 220 SLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 89.5 bits (223), Expect = 5e-20
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 28/215 (13%)

Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD----VNGSQ-GHREWLAEV 133
            +F     LG G FG+V+      N       +  A+KVL     V   Q  H     E 
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHN------GRYYAMKVLKKEIVVRLKQVEHT--NDER 57

Query: 134 IFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA-I 191
           + L  + HP ++ +     +D  ++ ++ +Y+  G L   L K+     P + +   A +
Sbjct: 58  LMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP-VAKFYAAEV 115

Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
             A  L +LH   K +IYRD K  NILLD + + K++DFG A       D   T C  GT
Sbjct: 116 CLA--LEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAK---YVPDVTYTLC--GT 166

Query: 252 EGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
             Y APE +    +     D +SFG+++ E+L G 
Sbjct: 167 PDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGY 200

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 90.1 bits (224), Expect = 6e-20
 Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 36/212 (16%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKA--QTVAVKVLDVNGSQG--HREWLAEVIFLGQLKHP 142
           LG+G F  V + CV        K      A K+++         ++   E     +L+HP
Sbjct: 37  LGKGAFSVVRR-CVH-------KTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88

Query: 143 HLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFK--NYS----STLPWLTRIKIAIGAAR 195
           ++V L     ++E    LV++ +  G L + +     YS    S       I+  + +  
Sbjct: 89  NIVRLHDS-IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-----IQQILES-- 140

Query: 196 CLAFLHGEEKPVIYRDFKASNILLDS---DYNAKLSDFGLATDGPQGEDSHITTCVMGTE 252
            +A+ H     +++R+ K  N+LL S       KL+DFGLA    +  DS       GT 
Sbjct: 141 -IAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTP 194

Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           GY +PE +     +   D+++ GV+L  LL G
Sbjct: 195 GYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 89.2 bits (222), Expect = 7e-20
 Identities = 55/215 (25%), Positives = 85/215 (39%), Gaps = 39/215 (18%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKA--QTVAVKVLDVN--GSQGHREWLAEVIFLGQLKH- 141
           LG G F  V + C+        K+  Q  A K L     G     E L E+  L   K  
Sbjct: 37  LGRGKFAVVRQ-CIS-------KSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSC 88

Query: 142 PHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQL----FKNYSSTLPWLTRIKIAIGAAR- 195
           P ++NL     E+   + L+ EY A G +         +  S            I   + 
Sbjct: 89  PRVINLHEVY-ENTSEIILILEYAAGGEIFSLCLPELAEMVSE--------NDVIRLIKQ 139

Query: 196 ---CLAFLHGEEKPVIYRDFKASNILL---DSDYNAKLSDFGLATDGPQGEDSHITTCVM 249
               + +LH  +  +++ D K  NILL       + K+ DFG++              +M
Sbjct: 140 ILEGVYYLH--QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIM 194

Query: 250 GTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
           GT  Y APE +N   +TT  D+++ G++   LLT 
Sbjct: 195 GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 90.1 bits (224), Expect = 8e-20
 Identities = 60/230 (26%), Positives = 93/230 (40%), Gaps = 35/230 (15%)

Query: 71  LKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD----VNGSQGH 126
           +++L+M   ++     +G G FG+V        +R     +  A+K+L     +  S   
Sbjct: 61  IRDLRMKAEDYEVVKVIGRGAFGEVQL------VRHKSTRKVYAMKLLSKFEMIKRSDSA 114

Query: 127 REWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLT 185
             W  E   +     P +V L  Y  +D+  L +V EYM  G+L           +  ++
Sbjct: 115 FFW-EERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDL-----------VNLMS 161

Query: 186 RIKIAIGAAR------CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQG 239
              +    AR       LA         I+RD K  N+LLD   + KL+DFG      + 
Sbjct: 162 NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221

Query: 240 EDSHITTCVMGTEGYAAPEYI----NTGHLTTMCDVFSFGVVLLELLTGR 285
                 T V GT  Y +PE +      G+    CD +S GV L E+L G 
Sbjct: 222 GMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 73/320 (22%), Positives = 123/320 (38%), Gaps = 74/320 (23%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLA----EVIFLGQL- 139
           LG+GGFG V+ G     L   L+   VA+KV+  N                EV  L ++ 
Sbjct: 39  LGKGGFGTVFAG---HRLTDRLQ---VAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92

Query: 140 ---KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
               HP ++ L+ +    E  +LV E          LF +Y +      +  +  G +RC
Sbjct: 93  AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQ---DLF-DYITE-----KGPLGEGPSRC 143

Query: 197 --------LAFLHGEEKPVIYRDFKASNILLDSDYNA-KLSDFGLATDGPQGEDSHITTC 247
                   +   H   + V++RD K  NIL+D      KL DFG         D   T  
Sbjct: 144 FFGQVVAAIQHCH--SRGVVHRDIKDENILIDLRRGCAKLIDFGSGA---LLHDEPYTDF 198

Query: 248 VMGTEGYAAPEYINTGHLT-TMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPM 306
             GT  Y+ PE+I+          V+S G++L +++ G                    P 
Sbjct: 199 D-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD------------------IP- 238

Query: 307 LKDFTKLDQIIDSRLEDRYS-TEGAKRLAAVAHQCLSHNPKSRPTMTTVVK-------AL 358
              F +  +I+++ L      +     L     +CL+  P SRP++  ++        A 
Sbjct: 239 ---FERDQEILEAELHFPAHVSPDCCAL---IRRCLAPKPSSRPSLEEILLDPWMQTPAE 292

Query: 359 EPLLDLNDIPIGPFVYTVVP 378
           +  L+ +     P  ++++P
Sbjct: 293 DVPLNPSKGGPAPLAWSLLP 312

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 60/222 (27%), Positives = 97/222 (43%), Gaps = 40/222 (18%)

Query: 85  DYLGEGGFGKVYKGCVDDNLRPGLKA--QTVAVKVLDVNGSQGHREWLAEVIFLGQLK-H 141
           D LGEG   +V   C++           Q  AVK+++            EV  L Q + H
Sbjct: 19  DVLGEGAHARVQT-CIN-------LITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70

Query: 142 PHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFK--NYS----STLPWLTRIKIAIGAAR 195
            +++ LI +  E++   LV+E M  G++   + K  +++    S +     ++    A  
Sbjct: 71  RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV-----VQDVASA-- 123

Query: 196 CLAFLHGEEKPVIYRDFKASNILL---DSDYNAKLSDFGLATD-GPQGEDSHITTCVM-- 249
            L FLH   K + +RD K  NIL    +     K+ DF L +     G+ S I+T  +  
Sbjct: 124 -LDFLH--NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180

Query: 250 --GTEGYAAPEYINTGHLTTM-----CDVFSFGVVLLELLTG 284
             G+  Y APE +             CD++S GV+L  LL+G
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 89.7 bits (223), Expect = 2e-19
 Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 31/210 (14%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDV-NGSQGHREWLA-EVIFLGQLKHPHL 144
           LG+G F  V + CV          Q  A  +++    S    + L  E      LKHP++
Sbjct: 19  LGKGAFSVVRR-CVKVLAG-----QEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72

Query: 145 VNLIGYCCEDEHRL-LVYEYMALGNLHDQLFK--NYS----STLPWLTRIKIAIGAARCL 197
           V L      +E    L+++ +  G L + +     YS    S       I+  + A   +
Sbjct: 73  VRLHDS-ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-----IQQILEA---V 123

Query: 198 AFLHGEEKPVIYRDFKASNILLDS---DYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
              H  +  V++R+ K  N+LL S       KL+DFGLA +    + +       GT GY
Sbjct: 124 LHCH--QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGY 179

Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
            +PE +         D+++ GV+L  LL G
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 84.7 bits (210), Expect = 3e-18
 Identities = 57/217 (26%), Positives = 88/217 (40%), Gaps = 47/217 (21%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKA--QTVAVKVLDVNGSQGHREWLAEV-IFLGQLKHPH 143
           LG G  GKV + C         +   Q  A+K+L    S   R+   EV         PH
Sbjct: 37  LGLGVNGKVLE-CFH-------RRTGQKCALKLLY--DSPKARQ---EVDHHWQASGGPH 83

Query: 144 LVNLIGYCCEDEHR-----LLVYEYMALGNLHD----QLFKNYS----STLPWLTRIKIA 190
           +V ++    E+ H      L++ E M  G L      +  + ++    + +     ++  
Sbjct: 84  IVCILDVY-ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEI-----MRDI 137

Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILL---DSDYNAKLSDFGLATDGPQGEDSHITTC 247
             A   + FLH     + +RD K  N+L    + D   KL+DFG A +  Q      T C
Sbjct: 138 GTA---IQFLH--SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ--TPC 190

Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
              T  Y APE +        CD++S GV++  LL G
Sbjct: 191 --YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 85.1 bits (211), Expect = 4e-18
 Identities = 65/224 (29%), Positives = 104/224 (46%), Gaps = 32/224 (14%)

Query: 75  QMITHNFSRSDYLGEGGFGKVYKG-CVDDNLRPGLKAQTVAVK-VLDVNGSQGHREWLAE 132
           +    +++ +  +G G FG VY+    D         + VA+K VL     Q  R    E
Sbjct: 50  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSG-------ELVAIKKVL-----QDKRFKNRE 97

Query: 133 VIFLGQLKHPHLVNLIGY-----CCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTR 186
           +  + +L H ++V L  +       +DE  L LV +Y+    ++ ++ ++YS     L  
Sbjct: 98  LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVY-RVARHYSRAKQTLPV 155

Query: 187 IKIAIGA---ARCLAFLHGEEKPVIYRDFKASNILLDSDYNA-KLSDFGLATDGPQGEDS 242
           I + +      R LA++H     + +RD K  N+LLD D    KL DFG A    +GE +
Sbjct: 156 IYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213

Query: 243 HITTCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
              + +  +  Y APE I      T+  DV+S G VL ELL G+
Sbjct: 214 --VSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 83.9 bits (208), Expect = 5e-18
 Identities = 64/268 (23%), Positives = 110/268 (41%), Gaps = 34/268 (12%)

Query: 29  VHVSNQVSTQRLLLTDVSNPGSPISLNELSSSLVGSNLHVFTL--KELQMITHNFSRSDY 86
           +H  +  S+   L T+     S  S+   ++    S +  + +       ++  F     
Sbjct: 1   MHHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESE 60

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G    VY+ C     +     +  A+KVL    +   +    E+  L +L HP+++ 
Sbjct: 61  LGRGATSIVYR-CKQKGTQ-----KPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNIIK 112

Query: 147 LIGYCCEDEHRL-LVYEYMALGNLHDQLFK--NYS----STLPWLTRIKIAIGAARCLAF 199
           L     E    + LV E +  G L D++ +   YS    +       +K  + A   +A+
Sbjct: 113 LKEIF-ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA-----VKQILEA---VAY 163

Query: 200 LHGEEKPVIYRDFKASNILL---DSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           LH  E  +++RD K  N+L      D   K++DFGL+          + T   GT GY A
Sbjct: 164 LH--ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQVLMKTVC-GTPGYCA 218

Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTG 284
           PE +         D++S G++   LL G
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCG 246

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 84.0 bits (208), Expect = 6e-18
 Identities = 47/223 (21%), Positives = 84/223 (37%), Gaps = 37/223 (16%)

Query: 85  DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK---- 140
             LG G F  V+    D           VA+K++             E+  L ++     
Sbjct: 25  RKLGWGHFSTVWL-AKDMVNN-----THVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADN 77

Query: 141 -------HPHLVNLIGY----CCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIK- 188
                    H++ L+ +         H ++V+E +   NL   + K     +P L  +K 
Sbjct: 78  TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIP-LIYVKQ 135

Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLD------SDYNAKLSDFGLATDGPQGEDS 242
           I+      L ++H     +I+ D K  N+L++      +    K++D G A       D 
Sbjct: 136 ISKQLLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW----YDE 190

Query: 243 HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           H T  +  T  Y +PE +         D++S   ++ EL+TG 
Sbjct: 191 HYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 84.5 bits (209), Expect = 6e-18
 Identities = 51/218 (23%), Positives = 96/218 (44%), Gaps = 32/218 (14%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           +G G +G VYK       + G   +  A+K ++  G         E+  L +LKHP++++
Sbjct: 29  VGRGTYGHVYKAKR----KDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVIS 82

Query: 147 LIGYCCED-EHRL-LVYEYMALGNLHD--QLFKNYSSTLPWLTRIKIAIGAARC------ 196
           L        + ++ L+++Y      HD   + K + ++      +++  G  +       
Sbjct: 83  LQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138

Query: 197 --LAFLHGEEKPVIYRDFKASNILLDSDYNA----KLSDFGLAT--DGPQGEDSHITTCV 248
             + +LH     V++RD K +NIL+  +       K++D G A   + P    + +   V
Sbjct: 139 DGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196

Query: 249 MGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
           + T  Y APE +    H T   D+++ G +  ELLT  
Sbjct: 197 V-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 82.0 bits (203), Expect = 3e-17
 Identities = 62/223 (27%), Positives = 90/223 (40%), Gaps = 28/223 (12%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKG-CVDDNLRPGLKAQTVAVK-VLDVNGSQGHREWLAEVI 134
               F      G+G FG V  G              +VA+K V+  +    +RE L  + 
Sbjct: 21  EMDRFQVERMAGQGTFGTVQLGKEKSTG-------MSVAIKKVIQ-DPRFRNRE-LQIMQ 71

Query: 135 FLGQLKHPHLVNLI------GYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRI 187
            L  L HP++V L       G     +  L +V EY+    LH +  +NY         I
Sbjct: 72  DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLH-RCCRNYYRRQVAPPPI 129

Query: 188 KIAIGA---ARCLAFLHGEEKPVIYRDFKASNILLD-SDYNAKLSDFGLATDGPQGEDSH 243
            I +      R +  LH     V +RD K  N+L++ +D   KL DFG A      E + 
Sbjct: 130 LIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV 189

Query: 244 ITTCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
              C   +  Y APE I    H TT  D++S G +  E++ G 
Sbjct: 190 AYIC---SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 82.5 bits (204), Expect = 3e-17
 Identities = 56/216 (25%), Positives = 87/216 (40%), Gaps = 44/216 (20%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKA--QTVAVKVLDVNGSQGHREWLAEV-IFLGQLKHPH 143
           LG G  GKV +   +       K   +  A+K+L        R    EV +     + PH
Sbjct: 70  LGLGINGKVLQ-IFN-------KRTQEKFALKMLQ--DCPKARR---EVELHWRASQCPH 116

Query: 144 LVNLIGYC----CEDEHRLLVYEYMALGNLHD----QLFKNYS----STLPWLTRIKIAI 191
           +V ++          +  L+V E +  G L      +  + ++    S +     +K   
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI-----MKSIG 171

Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDS-DYNA--KLSDFGLATDGPQGEDSHITTCV 248
            A   + +LH     + +RD K  N+L  S   NA  KL+DFG A       +S  T C 
Sbjct: 172 EA---IQYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPC- 224

Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
             T  Y APE +        CD++S GV++  LL G
Sbjct: 225 -YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 80.3 bits (199), Expect = 6e-17
 Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 28/215 (13%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGH-----REWLAEVI 134
            + + D LGEG +  VYKG              VA+K + +   +G      RE    V 
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLT------DNLVALKEIRLEHEEGAPCTAIRE----VS 52

Query: 135 FLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHD--QLFKNYSSTLPWLTRIK-IAI 191
            L  LKH ++V L      ++   LV+EY+      D  Q   +  + +  +  +K    
Sbjct: 53  LLKDLKHANIVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIIN-MHNVKLFLF 107

Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
              R LA+ H   + V++RD K  N+L++     KL+DFGLA    +   +      + T
Sbjct: 108 QLLRGLAYCH--RQKVLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYDNEVVT 163

Query: 252 EGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
             Y  P+ +  +   +T  D++  G +  E+ TGR
Sbjct: 164 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 79.5 bits (197), Expect = 7e-17
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 29/217 (13%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL----DVNG--SQGHREWLAEV 133
            + + + +GEG +G V+K     N       + VA+K +    D  G  S   RE    +
Sbjct: 3   KYEKLEKIGEGTYGTVFKAK---NRETH---EIVALKRVRLDDDDEGVPSSALRE----I 52

Query: 134 IFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHD--QLFKNYSSTLPWLTRIK-IA 190
             L +LKH ++V L      D+   LV+E+       D  + F + +  L     +K   
Sbjct: 53  CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLD-PEIVKSFL 107

Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG 250
               + L F H   + V++RD K  N+L++ +   KL++FGLA     G      +  + 
Sbjct: 108 FQLLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLAR--AFGIPVRCYSAEVV 163

Query: 251 TEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGRR 286
           T  Y  P+ +      +T  D++S G +  EL    R
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 79.4 bits (196), Expect = 8e-17
 Identities = 30/204 (14%), Positives = 58/204 (28%), Gaps = 46/204 (22%)

Query: 87  LGEGGFGKVYKGCVDDNL-RPGLKAQTVAVKVLDVNGS---QGHREWLAEVIFLGQLKHP 142
            G     + ++  +D  L R       VA+  +D  G       +E L+  + L ++  P
Sbjct: 39  HGGVPPLQFWQA-LDTALDRQ------VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKP 91

Query: 143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
            +  ++         L+V E++  G+L +       ++   +  I+     A      H 
Sbjct: 92  GVARVLDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGAIRAMQSLAAAADAAH- 146

Query: 203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT 262
               V       S + +  D +  L+                                  
Sbjct: 147 -RAGVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA---- 179

Query: 263 GHLTTMCDVFSFGVVLLELLTGRR 286
                  D+   G  L  LL  R 
Sbjct: 180 ---NPQDDIRGIGASLYALLVNRW 200

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 80.4 bits (199), Expect = 9e-17
 Identities = 55/233 (23%), Positives = 95/233 (40%), Gaps = 51/233 (21%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREW-------LAE 132
            + +   +G+G FG+V+K     + + G   Q VA+K + +       E        L E
Sbjct: 18  KYEKLAKIGQGTFGEVFKAR---HRKTG---QKVALKKVLM-----ENEKEGFPITALRE 66

Query: 133 VIFLGQLKHPHLVNLIGYCCEDEHRL--------LVYEYMALGNLHDQLFKNYSSTLPWL 184
           +  L  LKH ++VNLI  C               LV+++      HD       S +   
Sbjct: 67  IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE----HD--LAGLLSNVL-- 118

Query: 185 TRIKIAIGAARC--------LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA--- 233
             +K  +   +         L ++H     +++RD KA+N+L+  D   KL+DFGLA   
Sbjct: 119 --VKFTLSEIKRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAF 174

Query: 234 TDGPQGEDSHITTCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
           +     + +  T  V+ T  Y  PE +          D++  G ++ E+ T  
Sbjct: 175 SLAKNSQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 80.5 bits (199), Expect = 1e-16
 Identities = 52/210 (24%), Positives = 87/210 (41%), Gaps = 23/210 (10%)

Query: 85  DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHP-- 142
             +G+G FG+V K   D   +     + VA+K++  N      +   EV  L  +     
Sbjct: 60  SLIGKGSFGQVVK-AYDRVEQ-----EWVAIKII-KNKKAFLNQAQIEVRLLELMNKHDT 112

Query: 143 ----HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIK-IAIGAARCL 197
               ++V+L  +     H  LV+E ++  NL+D L       +  L   +  A      L
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVS-LNLTRKFAQQMCTAL 170

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNA--KLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            FL   E  +I+ D K  NILL +   +  K+ DFG +          I   +  +  Y 
Sbjct: 171 LFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ----LGQRIYQYIQ-SRFYR 225

Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           +PE +         D++S G +L+E+ TG 
Sbjct: 226 SPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 79.1 bits (196), Expect = 2e-16
 Identities = 60/217 (27%), Positives = 84/217 (38%), Gaps = 31/217 (14%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVK--VLDVNGSQGHREW-----LAE 132
            + +   +GEG +G V+K     N   G   Q VA+K  +                 L E
Sbjct: 4   KYEKIGKIGEGSYGVVFKCR---NRDTG---QIVAIKKFLES-----EDDPVIKKIALRE 52

Query: 133 VIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHD--QLFKNYSSTLPWLTRIKIA 190
           +  L QLKHP+LVNL+          LV+EY      H        Y   +P      I 
Sbjct: 53  IRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD----HTVLHELDRYQRGVPEHLVKSIT 108

Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA-TDGPQGEDSHITTCVM 249
               + + F H  +   I+RD K  NIL+      KL DFG A       +  +    V 
Sbjct: 109 WQTLQAVNFCH--KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--YYDDEVA 164

Query: 250 GTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
            T  Y +PE +          DV++ G V  ELL+G 
Sbjct: 165 -TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 31/221 (14%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVK-VLDVNGSQGHREWLAEVIF 135
               ++    +G G FG V++  + ++         VA+K VL     Q  R    E+  
Sbjct: 38  REIAYTNCKVIGNGSFGVVFQAKLVES-------DEVAIKKVL-----QDKRFKNRELQI 85

Query: 136 LGQLKHPHLVNLIGY-----CCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKI 189
           +  +KHP++V+L  +       +DE  L LV EY+    ++ +  ++Y+     +  + I
Sbjct: 86  MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVY-RASRHYAKLKQTMPMLLI 143

Query: 190 AIGA---ARCLAFLHGEEKPVIYRDFKASNILLDSDYNA-KLSDFGLATDGPQGEDSHIT 245
            +      R LA++H     + +RD K  N+LLD      KL DFG A     GE +   
Sbjct: 144 KLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN--- 198

Query: 246 TCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
              + +  Y APE I    + TT  D++S G V+ EL+ G+
Sbjct: 199 VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 23/215 (10%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGH-----REWLAEVI 134
            F + + LG G +  VYKG              VA+K + ++  +G      RE    + 
Sbjct: 6   QFKQLEKLGNGTYATVYKG------LNKTTGVYVALKEVKLDSEEGTPSTAIRE----IS 55

Query: 135 FLGQLKHPHLVNLIGYCCEDEHRLLVYEYMA--LGNLHDQLFKNYSSTLPWLTRIK-IAI 191
            + +LKH ++V L      +    LV+E+M   L    D      +     L  +K    
Sbjct: 56  LMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW 115

Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
              + LAF H  E  +++RD K  N+L++     KL DFGLA     G   +  +  + T
Sbjct: 116 QLLQGLAFCH--ENKILHRDLKPQNLLINKRGQLKLGDFGLA--RAFGIPVNTFSSEVVT 171

Query: 252 EGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
             Y AP+ +  +   +T  D++S G +L E++TG+
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 78.4 bits (194), Expect = 3e-16
 Identities = 52/216 (24%), Positives = 86/216 (39%), Gaps = 29/216 (13%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVK--VLDVNGSQGHREW-----LAE 132
            +     +GEG +G V K     N   G   + VA+K  +   +      +      + E
Sbjct: 26  KYENLGLVGEGSYGMVMKC---RNKDTG---RIVAIKKFLESDD-----DKMVKKIAMRE 74

Query: 133 VIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHD--QLFKNYSSTLPWLTRIKIA 190
           +  L QL+H +LVNL+  C + +   LV+E++     H      + + + L +    K  
Sbjct: 75  IKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVD----HTILDDLELFPNGLDYQVVQKYL 130

Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG 250
                 + F H     +I+RD K  NIL+      KL DFG A          +    + 
Sbjct: 131 FQIINGIGFCH--SHNIIHRDIKPENILVSQSGVVKLCDFGFA--RTLAAPGEVYDDEVA 186

Query: 251 TEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
           T  Y APE +          DV++ G ++ E+  G 
Sbjct: 187 TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 78.0 bits (193), Expect = 5e-16
 Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 40/223 (17%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-----WLAEVI 134
            + + D+LGEG F  VYK     +       Q VA+K + +      ++      L E+ 
Sbjct: 11  RYEKLDFLGEGQFATVYKAR---DKNTN---QIVAIKKIKLGHRSEAKDGINRTALREIK 64

Query: 135 FLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHD--QLFKNYSSTLPWLTRIK-IAI 191
            L +L HP+++ L+       +  LV+++M      D   + K+ S  L   + IK   +
Sbjct: 65  LLQELSHPNIIGLLDAFGHKSNISLVFDFM----ETDLEVIIKDNSLVLT-PSHIKAYML 119

Query: 192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT--DGPQGEDSHITTCVM 249
              + L +LH  +  +++RD K +N+LLD +   KL+DFGLA     P    +H    V+
Sbjct: 120 MTLQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH---QVV 174

Query: 250 GTEGYAAPE-------YINTGHLTTMCDVFSFGVVLLELLTGR 285
            T  Y APE       Y          D+++ G +L ELL   
Sbjct: 175 -TRWYRAPELLFGARMY------GVGVDMWAVGCILAELLLRV 210

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 77.2 bits (191), Expect = 7e-16
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 30/216 (13%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL----DVNG--SQGHREWLAEV 133
            + + + +GEG +G VYK             + VA+K +    +  G  S   RE    +
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQG-------RIVALKRIRLDAEDEGIPSTAIRE----I 70

Query: 134 IFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHD--QLFKNYSSTLPWLTRIK-IA 190
             L +L HP++V+LI     +    LV+E+M      D  ++     + L   ++IK   
Sbjct: 71  SLLKELHHPNIVSLIDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQ-DSQIKIYL 125

Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG 250
               R +A  H  +  +++RD K  N+L++SD   KL+DFGLA     G      T  + 
Sbjct: 126 YQLLRGVAHCH--QHRILHRDLKPQNLLINSDGALKLADFGLAR--AFGIPVRSYTHEVV 181

Query: 251 TEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
           T  Y AP+ +  +   +T  D++S G +  E++TG+
Sbjct: 182 TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 76.0 bits (188), Expect = 1e-15
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 30/216 (13%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL----DVNG--SQGHREWLAEV 133
            +   + +GEG +G VYK   +     G   +T A+K +    +  G  S   RE    +
Sbjct: 3   KYHGLEKIGEGTYGVVYKA-QN---NYG---ETFALKKIRLEKEDEGIPSTTIRE----I 51

Query: 134 IFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHD--QLFKNYSSTLPWLTRIK-IA 190
             L +LKH ++V L       +  +LV+E++      D  +L       L      K   
Sbjct: 52  SILKELKHSNIVKLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLE-SVTAKSFL 106

Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG 250
           +     +A+ H  ++ V++RD K  N+L++ +   K++DFGLA     G      T  + 
Sbjct: 107 LQLLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLAR--AFGIPVRKYTHEIV 162

Query: 251 TEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
           T  Y AP+ +  +   +T  D++S G +  E++ G 
Sbjct: 163 TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 25/210 (11%)

Query: 85  DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKH--- 141
             +G+G FG+V K   D  +      Q VA+K++  N  + HR+   E+  L  L+    
Sbjct: 103 KVIGKGSFGQVVK-AYDHKVH-----QHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDK 155

Query: 142 ---PHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIK-IAIGAARCL 197
               ++++++       H  + +E +++ NL++ + KN       L  ++  A    +CL
Sbjct: 156 DNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFS-LPLVRKFAHSILQCL 213

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNA--KLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
             LH  +  +I+ D K  NILL     +  K+ DFG +      E   + T +  +  Y 
Sbjct: 214 DALH--KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY----EHQRVYTYIQ-SRFYR 266

Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           APE I         D++S G +L ELLTG 
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLTGY 296

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 74.6 bits (184), Expect = 7e-15
 Identities = 55/221 (24%), Positives = 89/221 (40%), Gaps = 35/221 (15%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL----DVNG--SQGHREWLAEV 133
            + R   LGEG +G+VYK     +       +TVA+K +    +  G      RE    V
Sbjct: 35  RYRRITKLGEGTYGEVYKA---IDTVTN---ETVAIKRIRLEHEEEGVPGTAIRE----V 84

Query: 134 IFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGA 193
             L +L+H +++ L      +    L++EY      +D   K Y    P ++   I    
Sbjct: 85  SLLKELQHRNIIELKSVIHHNHRLHLIFEYAE----ND--LKKYMDKNPDVSMRVIKSFL 138

Query: 194 A---RCLAFLHGEEKPVIYRDFKASNILLDSDYNA-----KLSDFGLATDGPQGEDSHIT 245
                 + F H   +  ++RD K  N+LL     +     K+ DFGLA     G      
Sbjct: 139 YQLINGVNFCH--SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR--AFGIPIRQF 194

Query: 246 TCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
           T  + T  Y  PE +  + H +T  D++S   +  E+L   
Sbjct: 195 THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 73.8 bits (182), Expect = 1e-14
 Identities = 58/227 (25%), Positives = 92/227 (40%), Gaps = 41/227 (18%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREW-----LAEVI 134
            +     +G G +G VYK     +   G     VA+K + V    G         + EV 
Sbjct: 10  RYEPVAEIGVGAYGTVYKA---RDPHSG---HFVALKSVRVPNGGGGGGGLPISTVREVA 63

Query: 135 FLGQLK---HPHLVNLI----GYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTR 186
            L +L+   HP++V L+        + E ++ LV+E++      DQ  + Y    P    
Sbjct: 64  LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV------DQDLRTYLDKAP---P 114

Query: 187 IKIAIGAARC--------LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ 238
             +     +         L FLH     +++RD K  NIL+ S    KL+DFGLA     
Sbjct: 115 PGLPAETIKDLMRQFLRGLDFLH--ANCIVHRDLKPENILVTSGGTVKLADFGLAR--IY 170

Query: 239 GEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
                +T  V+ T  Y APE +      T  D++S G +  E+   +
Sbjct: 171 SYQMALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 73.8 bits (181), Expect = 1e-14
 Identities = 52/227 (22%), Positives = 82/227 (36%), Gaps = 25/227 (11%)

Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAF 199
               L ++           +  + ++     +     Y   L     I  +   A+ + F
Sbjct: 149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 208

Query: 200 LHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEY 259
           L    +  I+RD  A NILL      K+ DFGLA D  +  D            + APE 
Sbjct: 209 L--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 266

Query: 260 INTGHLTTMCDVFSFGVVLLELLT-GRR---SVEKNRCKREKDLVEWARPMLKDFTKLDQ 315
           I     T   DV+SFGV+L E+ + G      V+ +      +        LK+ T++  
Sbjct: 267 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCR----RLKEGTRMRA 317

Query: 316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
                    Y+T     +      C    P  RPT + +V+ L  LL
Sbjct: 318 -------PDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 62.6 bits (152), Expect = 6e-11
 Identities = 29/104 (27%), Positives = 50/104 (48%), Gaps = 4/104 (3%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL-DVNGSQGHREWLAEVIFLGQL-KHPHL 144
           LG G FG+V +      +      +TVAVK+L +      HR  ++E+  L  +  H ++
Sbjct: 30  LGRGAFGQVIEA-DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88

Query: 145 VNLIGYCC-EDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRI 187
           VNL+G C       +++ E+   GNL   L    +  +P+ T+ 
Sbjct: 89  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKG 132

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 62/228 (27%), Positives = 93/228 (40%), Gaps = 45/228 (19%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL----DVNG--SQGHREWLAEV 133
            +     +GEG +GKV+K    D    G   + VA+K +       G      RE    V
Sbjct: 12  QYECVAEIGEGAYGKVFKAR--DLKNGG---RFVALKRVRVQTGEEGMPLSTIRE----V 62

Query: 134 IFLGQLK---HPHLVNLI----GYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLT 185
             L  L+   HP++V L         + E +L LV+E++      DQ    Y   +P   
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV------DQDLTTYLDKVP--- 113

Query: 186 RIKIAIGAARC--------LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP 237
              +     +         L FLH     V++RD K  NIL+ S    KL+DFGLA    
Sbjct: 114 EPGVPTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLAR--I 169

Query: 238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
                 +T+ V+ T  Y APE +      T  D++S G +  E+   +
Sbjct: 170 YSFQMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 73.0 bits (179), Expect = 4e-14
 Identities = 51/227 (22%), Positives = 86/227 (37%), Gaps = 44/227 (19%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVK-VLDVNGSQGH-REWLAEVI 134
           +   +     +G G  G V     D  L      + VA+K +     +Q H +    E++
Sbjct: 60  VLKRYQNLKPIGSGAQGIVCA-AYDAVLD-----RNVAIKKLSRPFQNQTHAKRAYRELV 113

Query: 135 FLGQLKHPHLVNLI-----GYCCEDEHRL-LVYEYM----------ALGNLHDQLFKNYS 178
            +  + H ++++L+         E+   + LV E M           L +          
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL--LY 171

Query: 179 STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ 238
             L               +  LH     +I+RD K SNI++ SD   K+ DFGLA     
Sbjct: 172 QML-------------CGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR--TA 214

Query: 239 GEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
           G    +T  V+ T  Y APE I         D++S G ++ E++  +
Sbjct: 215 GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 71.2 bits (175), Expect = 9e-14
 Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 44/229 (19%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGH-REWLAEVIF 135
           +   ++   Y+GEG +G V     D+  +       VA+K +     Q + +  L E+  
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCS-AYDNLNK-----VRVAIKKISPFEHQTYCQRTLREIKI 78

Query: 136 LGQLKHPHLVNLI-----GYCCEDEHRLLVYEYM-----------ALGNLHDQLFKNYSS 179
           L + +H +++ +          + +   +V + M            L N H   F  Y  
Sbjct: 79  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL-YQ- 136

Query: 180 TLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA--TDGP 237
            L             R L ++H     V++RD K SN+LL++  + K+ DFGLA   D  
Sbjct: 137 IL-------------RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181

Query: 238 QGEDSHITTCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
                 +T  V  T  Y APE + N+   T   D++S G +L E+L+ R
Sbjct: 182 HDHTGFLTEYVA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 48/228 (21%), Positives = 91/228 (39%), Gaps = 47/228 (20%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVK-VLDVNGSQGH-REWLAEVI 134
           +   +    ++G G +G V    +D         + VA+K +     S+   +    E++
Sbjct: 22  LPKTYVSPTHVGSGAYGSVCS-AIDKRSG-----EKVAIKKLSRPFQSEIFAKRAYRELL 75

Query: 135 FLGQLKHPHLVNLI------GYCCEDEHRLLVYEYM----------ALGNLHDQLFKNYS 178
            L  ++H +++ L+                LV  +M                 Q      
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYL---- 131

Query: 179 STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ 238
                + ++       + L ++H     V++RD K  N+ ++ D   K+ DFGLA    +
Sbjct: 132 -----VYQM------LKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLA----R 174

Query: 239 GEDSHITTCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
             D+ +T  V+ T  Y APE I +  H     D++S G ++ E+LTG+
Sbjct: 175 HADAEMTGYVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 51/218 (23%), Positives = 87/218 (39%), Gaps = 26/218 (11%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVK-VLDVNGSQGH-REWLAEVI 134
           +   +     +G G  G V     D  L      + VA+K +     +Q H +    E++
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCA-AYDAILE-----RNVAIKKLSRPFQNQTHAKRAYRELV 76

Query: 135 FLGQLKHPHLVNLI-----GYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIK 188
            +  + H +++ L+         E+   + +V E M   NL   +            R+ 
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHE-----RMS 130

Query: 189 -IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC 247
            +       +  LH     +I+RD K SNI++ SD   K+ DFGLA        S + T 
Sbjct: 131 YLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTP 185

Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR 285
            + T  Y APE I         D++S G ++ E++ G 
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 68.8 bits (169), Expect = 5e-13
 Identities = 61/236 (25%), Positives = 91/236 (38%), Gaps = 51/236 (21%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGH-REWLAEVIF 135
           I+ +F     LGEG +G V               + VA+K ++           L E+  
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCS-ATHKPTG-----EIVAIKKIEPFDKPLFALRTLREIKI 62

Query: 136 LGQLKHPHLVNLI-----GYCCEDEHRLLVYEYM-----------ALGNLHDQLFKNYSS 179
           L   KH +++ +                ++ E M            L + H Q F  Y  
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI-YQ- 120

Query: 180 TLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA------ 233
           TL             R +  LHG    VI+RD K SN+L++S+ + K+ DFGLA      
Sbjct: 121 TL-------------RAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165

Query: 234 ---TDGPQGEDSHITTCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
                 P G+ S +   V  T  Y APE +  +   +   DV+S G +L EL   R
Sbjct: 166 AADNSEPTGQQSGMVEFVA-TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 68.5 bits (168), Expect = 7e-13
 Identities = 60/230 (26%), Positives = 93/230 (40%), Gaps = 49/230 (21%)

Query: 85  DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHP-- 142
             LGEG FGKV + C+D + R       VA+K++  N  +       E+  L ++K    
Sbjct: 25  GNLGEGTFGKVVE-CLD-HARGK---SQVALKII-RNVGKYREAARLEINVLKKIKEKDK 78

Query: 143 ----HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIK-IAIGAARCL 197
                 V +  +     H  + +E +   N  + L +N     P L  ++ +A      L
Sbjct: 79  ENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYP-LPHVRHMAYQLCHAL 136

Query: 198 AFLHGEEKPVIYRDFKASNILL-DSDYNA------------------KLSDFGLATDGPQ 238
            FLH  E  + + D K  NIL  +S++                    +++DFG AT    
Sbjct: 137 RFLH--ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--- 191

Query: 239 GEDSHITTCVMGTEGYAAPEYINTGHL----TTMCDVFSFGVVLLELLTG 284
            +  H TT ++ T  Y  PE I    L       CDV+S G +L E   G
Sbjct: 192 -DHEHHTT-IVATRHYRPPEVI----LELGWAQPCDVWSIGCILFEYYRG 235

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 64/227 (28%), Positives = 97/227 (42%), Gaps = 43/227 (18%)

Query: 85  DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHP-- 142
           D LGEG FGKV + C+D         + VAVK++  N  +      +E+  L  L     
Sbjct: 20  DTLGEGAFGKVVE-CIDHKA----GGRHVAVKIV-KNVDRYCEAARSEIQVLEHLNTTDP 73

Query: 143 ----HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIK-IAIGAARCL 197
                 V ++ +     H  +V+E + L + +D + +N       L  I+ +A    + +
Sbjct: 74  NSTFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFR-LDHIRKMAYQICKSV 131

Query: 198 AFLHGEEKPVIYRDFKASNILL-DSDYNA------------------KLSDFGLATDGPQ 238
            FLH     + + D K  NIL   SDY                    K+ DFG AT    
Sbjct: 132 NFLH--SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY--- 186

Query: 239 GEDSHITTCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTG 284
            +D H +T ++ T  Y APE I   G  +  CDV+S G +L+E   G
Sbjct: 187 -DDEHHST-LVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLG 230

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 55/218 (25%), Positives = 83/218 (38%), Gaps = 39/218 (17%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLGQLKHPHL 144
           +GEG FG +++G    NL      Q VA+K      +  Q   E+    +  G      +
Sbjct: 18  IGEGSFGVIFEGT---NLLNN---QQVAIKFEPRRSDAPQLRDEYRTYKLLAGC---TGI 68

Query: 145 VNLIGYCCEDEHRLLVYEYMALG-NLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE 203
            N+  +  E  H +LV +   LG +L D L           T    A      +  +H  
Sbjct: 69  PNVYYFGQEGLHNVLVIDL--LGPSLED-LLDLCGRKFSVKTVAMAAKQMLARVQSIH-- 123

Query: 204 EKPVIYRDFKASNILLDSDYNAK-----LSDFGLAT---DGPQGEDSHITTC----VMGT 251
           EK ++YRD K  N L+    +       + DFG+     D    +  HI       + GT
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ--HIPYREKKNLSGT 181

Query: 252 EGYAAPEYINTGHL-TTMC---DVFSFGVVLLELLTGR 285
             Y +   INT HL        D+ + G V +  L G 
Sbjct: 182 ARYMS---INT-HLGREQSRRDDLEALGHVFMYFLRGS 215

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 51/231 (22%), Positives = 82/231 (35%), Gaps = 41/231 (17%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREW------- 129
           +   ++   ++  G +G V    VD       +   VA+K +    S G           
Sbjct: 20  MQSPYTVQRFISSGSYGAVCA-GVDS------EGIPVAIKRVFNTVSDGRTVNILSDSFL 72

Query: 130 ----LAEVIFLGQLKHPHLVNLI-----GYCCEDEHRLLVYEYMALGNLHDQLFKNYSST 180
               L E+  L    HP+++ L                LV E M   +L  Q+       
Sbjct: 73  CKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLA-QVIH---DQ 127

Query: 181 LPWLTRIKIA-----IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD 235
              ++   I      I     L  LH     V++RD    NILL  + +  + DF LA  
Sbjct: 128 RIVISPQHIQYFMYHI--LLGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAR- 182

Query: 236 GPQGEDSHITTCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
                D++ T  V     Y APE +      T + D++S G V+ E+   +
Sbjct: 183 -EDTADANKTHYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 53/229 (23%), Positives = 92/229 (40%), Gaps = 48/229 (20%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVK-VLDVNGSQGH-REWLAEVI 134
           +   +     +G G +G V    VD           VA+K +     S+   +    E+ 
Sbjct: 23  VRAVYRDLQPVGSGAYGAVCS-AVDGRTG-----AKVAIKKLYRPFQSELFAKRAYRELR 76

Query: 135 FLGQLKHPHLVNLI-----GYCCEDEHRL-LVYEYM-----------ALGNLHDQLFKNY 177
            L  ++H +++ L+         +D     LV  +M            LG    Q     
Sbjct: 77  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFL--- 133

Query: 178 SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP 237
                 + ++       + L ++H     +I+RD K  N+ ++ D   K+ DFGLA    
Sbjct: 134 ------VYQM------LKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLA---- 175

Query: 238 QGEDSHITTCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
           +  DS +T  V+ T  Y APE I N    T   D++S G ++ E++TG+
Sbjct: 176 RQADSEMTGYVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 41/226 (18%), Positives = 79/226 (34%), Gaps = 37/226 (16%)

Query: 87  LGEGGFGKVYKGC--VDDNLRPGLKAQTVAVKVLDVNG----------SQGHREWLAEVI 134
                 G +Y+           G + Q  ++K+   +G                 + +  
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 135 FLGQLKHPHLVNLIGY-CCEDEHRLLVYEYMALG-NLHDQLFKNYSSTLPWLTRIKIAIG 192
            L       +   +G+   +D++R LV     LG +L   L  +    L   + +++A  
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPS--LGRSLQSALDVSPKHVLSERSVLQVACR 167

Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAK--LSDFGLA----TDG---PQGEDSH 243
               L FLH  E   ++ +  A NI +D +  ++  L+ +G A      G      E S 
Sbjct: 168 LLDALEFLH--ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSR 225

Query: 244 ITTCVMGTEGYAAPEYINTGHLTTMC----DVFSFGVVLLELLTGR 285
             +   G   + +   ++  H         D+ S G  +L+ L G 
Sbjct: 226 --SPHEGDLEFIS---MDL-HKGCGPSRRSDLQSLGYCMLKWLYGF 265

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 59/229 (25%), Positives = 91/229 (39%), Gaps = 48/229 (20%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVK-VLDVNGSQGH-REWLAEVI 134
           +   +     +G G +G V     D           VAVK +     S  H +    E+ 
Sbjct: 27  VPERYQNLSPVGSGAYGSVCA-AFDTKTG-----LRVAVKKLSRPFQSIIHAKRTYRELR 80

Query: 135 FLGQLKHPHLVNLI-----GYCCEDEHRL-LVYEYM-----------ALGNLHDQLFKNY 177
            L  +KH +++ L+         E+ + + LV   M            L + H Q    Y
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-Y 139

Query: 178 SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP 237
              L             R L ++H  +  +I+RD K SN+ ++ D   K+ DFGLA    
Sbjct: 140 Q-IL-------------RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA---- 179

Query: 238 QGEDSHITTCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGR 285
           +     +T  V  T  Y APE + N  H     D++S G ++ ELLTGR
Sbjct: 180 RHTADEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 66.7 bits (163), Expect = 3e-12
 Identities = 44/226 (19%), Positives = 86/226 (38%), Gaps = 37/226 (16%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREW-----LAEVIFLGQLKH 141
           +G+GGFG +Y   ++ +   G       VKV   +      E       A+   + +   
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSD-APCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 142 PHLVNLIG----------YCCEDEHRLLVYEYMALG-NLHDQLFKNYSSTLPWLTRIKIA 190
              +  +G                +R ++ +    G +L   +++  +      T ++++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDR--FGSDLQK-IYEANAKRFSRKTVLQLS 158

Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAK--LSDFGLATD-GPQGEDSHIT-- 245
           +     L ++H  E   ++ D KASN+LL+     +  L D+GLA    P+G        
Sbjct: 159 LRILDILEYIH--EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAAD 216

Query: 246 --TCVMGTEGYAAPEYINTGHLTTMC----DVFSFGVVLLELLTGR 285
              C  GT  + +   I+  H         D+   G  +++ LTG 
Sbjct: 217 PKRCHDGTIEFTS---IDA-HNGVAPSRRGDLEILGYCMIQWLTGH 258

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 66.9 bits (163), Expect = 3e-12
 Identities = 64/355 (18%), Positives = 107/355 (30%), Gaps = 105/355 (29%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-----H 141
           LG G F  V+    D   +     + VA+KV+  +        L E+  L  ++      
Sbjct: 45  LGWGHFSTVWL-SWDIQGK-----KFVAMKVV-KSAEHYTETALDEIRLLKSVRNSDPND 97

Query: 142 P---HLVNLIGY----CCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA 194
           P    +V L+           H  +V+E +   +L   + K+    LP     KI     
Sbjct: 98  PNREMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVL 156

Query: 195 RCLAFLHGEEKPVIYRDFKASNILL----------------------------------- 219
           + L +LH + + +I+ D K  NILL                                   
Sbjct: 157 QGLDYLHTKCR-IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 220 --------------DSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL 265
                               K++D G A         H T  +  T  Y + E +     
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWV----HKHFTEDIQ-TRQYRSLEVLIGSGY 270

Query: 266 TTMCDVFSFGVVLLELLTGRR---SVEKNRCKREKDLV------------EWA---RPML 307
            T  D++S   +  EL TG             R++D +            +     +   
Sbjct: 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSK 330

Query: 308 KDFTK------LDQIIDSRLEDR------YSTEGAKRLAAVAHQCLSHNPKSRPT 350
           + FTK      + ++    L +       +S E A          L   P+ R T
Sbjct: 331 EFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRAT 385

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 56/217 (25%), Positives = 86/217 (39%), Gaps = 39/217 (17%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLGQLKH-PH 143
           +G G FG +Y G    ++  G   + VA+K+  +     Q H E          ++    
Sbjct: 17  IGSGSFGDIYLGT---DIAAG---EEVAIKLECVKTKHPQLHIES----KIYKMMQGGVG 66

Query: 144 LVNLIGYCCEDEHRLLVYEYMALG-NLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
           +  +     E ++ ++V E   LG +L D LF   S      T + +A      + ++H 
Sbjct: 67  IPTIRWCGAEGDYNVMVMEL--LGPSLED-LFNFCSRKFSLKTVLLLADQMISRIEYIH- 122

Query: 203 EEKPVIYRDFKASNILLDSDYNAK---LSDFGLA---TDGPQGEDSHITTC----VMGTE 252
             K  I+RD K  N L+          + DFGLA    D    +  HI       + GT 
Sbjct: 123 -SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ--HIPYRENKNLTGTA 179

Query: 253 GYAAPEYINTGHLTTMC----DVFSFGVVLLELLTGR 285
            YA+   INT HL        D+ S G VL+    G 
Sbjct: 180 RYAS---INT-HLGIEQSRRDDLESLGYVLMYFNLGS 212

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 55/218 (25%), Positives = 84/218 (38%), Gaps = 39/218 (17%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLGQLKHPHL 144
           +G G FG++  G    NL      + VA+K+  +     Q H E+              +
Sbjct: 17  IGCGNFGELRLGK---NLYTN---EYVAIKLEPMKSRAPQLHLEYRFYKQLGSG---DGI 67

Query: 145 VNLIGYCCEDEHRLLVYEYMALG-NLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE 203
             +  +    ++  +V E   LG +L D LF     T    T + IAI     + ++H  
Sbjct: 68  PQVYYFGPCGKYNAMVLEL--LGPSLED-LFDLCDRTFSLKTVLMIAIQLISRMEYVH-- 122

Query: 204 EKPVIYRDFKASNILLDSDYNAK-----LSDFGLAT---DGPQGEDSHITTC----VMGT 251
            K +IYRD K  N L+    N       + DF LA    D    +  HI       + GT
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKK--HIPYREHKSLTGT 180

Query: 252 EGYAAPEYINTGHLTTMC----DVFSFGVVLLELLTGR 285
             Y +   INT HL        D+ + G + +  L G 
Sbjct: 181 ARYMS---INT-HLGKEQSRRDDLEALGHMFMYFLRGS 214

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 66.1 bits (162), Expect = 4e-12
 Identities = 58/252 (23%), Positives = 103/252 (40%), Gaps = 63/252 (25%)

Query: 65  NLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVK--VLDVNG 122
           N+H F       +   +     LG GG G V+   VD++       + VA+K  VL  + 
Sbjct: 3   NIHGFD------LGSRYMDLKPLGCGGNGLVFS-AVDNDCD-----KRVAIKKIVLT-DP 49

Query: 123 SQGHREWLAEVIFLGQLKHPHLVNLI-------------GYCCEDEHRL-LVYEYM---- 164
                  L E+  + +L H ++V +                   + + + +V EYM    
Sbjct: 50  QSVKHA-LREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDL 108

Query: 165 -------ALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNI 217
                   L   H +LF  Y   L             R L ++H     V++RD K +N+
Sbjct: 109 ANVLEQGPLLEEHARLFM-YQ-LL-------------RGLKYIHSAN--VLHRDLKPANL 151

Query: 218 LLDS-DYNAKLSDFGLA--TDGPQGEDSHITTCVMGTEGYAAPEYI-NTGHLTTMCDVFS 273
            +++ D   K+ DFGLA   D       H++  ++ T+ Y +P  + +  + T   D+++
Sbjct: 152 FINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWA 210

Query: 274 FGVVLLELLTGR 285
            G +  E+LTG+
Sbjct: 211 AGCIFAEMLTGK 222

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 66.3 bits (162), Expect = 5e-12
 Identities = 53/255 (20%), Positives = 94/255 (36%), Gaps = 66/255 (25%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
            +  +S    LG G FG V +   ++         +  A+K +  +    +RE    +  
Sbjct: 5   SSKKYSLGKTLGTGSFGIVCEVFDIESG-------KRFALKKVLQDPRYKNRE----LDI 53

Query: 136 LGQLKHPHLVNLIGY-------------------------------------CCEDEHRL 158
           +  L H +++ L+ Y                                            L
Sbjct: 54  MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113

Query: 159 -LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGA---ARCLAFLHGEEKPVIYRDFKA 214
            ++ EY+    LH ++ K++  +   +    I+I      R + F+H     + +RD K 
Sbjct: 114 NVIMEYVPD-TLH-KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKP 169

Query: 215 SNILLDS-DYNAKLSDFGLATDGPQGED--SHITTCVMGTEGYAAPEYI-NTGHLTTMCD 270
            N+L++S D   KL DFG A      E   ++I +       Y APE +      T   D
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEYTPSID 224

Query: 271 VFSFGVVLLELLTGR 285
           ++S G V  EL+ G+
Sbjct: 225 LWSIGCVFGELILGK 239

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 65.4 bits (160), Expect = 8e-12
 Identities = 58/232 (25%), Positives = 96/232 (41%), Gaps = 49/232 (21%)

Query: 85  DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKH--- 141
             +G+G FG+V   C   + +     +  AVKV+  N  +  R    E   L ++++   
Sbjct: 41  RKMGDGTFGRVLL-CQHIDNK-----KYYAVKVV-RNIKKYTRSAKIEADILKKIQNDDI 93

Query: 142 --PHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIK-IAIGAARCLA 198
              ++V   G     +H  L++E +   +L++ + +N  +    +  IK   I   + L 
Sbjct: 94  NNNNIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFH-IEDIKLYCIEILKALN 151

Query: 199 FLHGEEKPVIYRDFKASNILL-DSDYNA------------------------KLSDFGLA 233
           +L   +  + + D K  NILL D  +                          KL DFG A
Sbjct: 152 YLR--KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209

Query: 234 TDGPQGEDSHITTCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTG 284
           T     +  +  + ++ T  Y APE I N G      D++SFG VL EL TG
Sbjct: 210 TF----KSDYHGS-IINTRQYRAPEVILNLGW-DVSSDMWSFGCVLAELYTG 255

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 48/217 (22%), Positives = 81/217 (37%), Gaps = 67/217 (30%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKA--QTVAVKVLDVNGSQGHREWLAEV-IFLGQLKHPH 143
           LG G  GKV +   +       K   +  A+K+L        R    EV +     + PH
Sbjct: 26  LGLGINGKVLQ-IFN-------KRTQEKFALKMLQ--DCPKARR---EVELHWRASQCPH 72

Query: 144 LVNLIGYCCEDEHR-----LLVYEYMALGNLHDQL----FKNYS----STLPWLTRIKIA 190
           +V ++    E+ +      L+V E +  G L  ++     + ++    S +     +K  
Sbjct: 73  IVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI-----MKSI 126

Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDS---DYNAKLSDFGLATDGPQGEDSHITTC 247
             A   + +LH     + +RD K  N+L  S   +   KL+DFG                
Sbjct: 127 GEA---IQYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------- 166

Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG 284
                   A E     +    CD++S GV++  LL G
Sbjct: 167 --------AKETTGEKY-DKSCDMWSLGVIMYILLCG 194

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 59/217 (27%), Positives = 91/217 (41%), Gaps = 39/217 (17%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKV--LDVNGSQGHREWLAEVIFLGQLK-HPH 143
           +G G FG++Y G    N++     + VA+K+  +     Q   E          L+    
Sbjct: 15  IGSGSFGEIYLGT---NIQTN---EEVAIKLENVKTKHPQLLYES----KIYRILQGGTG 64

Query: 144 LVNLIGYCCEDEHRLLVYEYMALG-NLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
           + N+  +  E ++ +LV +   LG +L D LF   S  L   T + +A      + F+H 
Sbjct: 65  IPNVRWFGVEGDYNVLVMDL--LGPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVH- 120

Query: 203 EEKPVIYRDFKASNILLDSDYNAK---LSDFGLA---TDGPQGEDSHITTC----VMGTE 252
             K  ++RD K  N L+     A    + DFGLA    D    +  HI       + GT 
Sbjct: 121 -SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ--HIPYRENKNLTGTA 177

Query: 253 GYAAPEYINTGHL-TTMC---DVFSFGVVLLELLTGR 285
            YA+   +NT HL        D+ S G VL+  L G 
Sbjct: 178 RYAS---VNT-HLGIEQSRRDDLESLGYVLMYFLRGS 210

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 63.7 bits (155), Expect = 4e-11
 Identities = 56/265 (21%), Positives = 93/265 (35%), Gaps = 70/265 (26%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVK-VLDVNGSQGH--REWLAEV 133
           I   +     +G G +G V +   D   +     + VA+K +L V        R  L E+
Sbjct: 51  IPDRYEIRHLIGTGSYGHVCE-AYDKLEK-----RVVAIKKILRVFEDLIDCKRI-LREI 103

Query: 134 IFLGQLKHPHLVNLI-----GYCCEDEHRLLVYEYM------------ALGNLHDQLFKN 176
             L +L H H+V ++         + +   +V E               L  LH +    
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLL- 162

Query: 177 YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA--T 234
           Y+  L               + ++H     +++RD K +N L++ D + K+ DFGLA   
Sbjct: 163 YN-LL-------------VGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTV 206

Query: 235 DGPQGEDSHITTCVMGTEG-----------------------YAAPEYI-NTGHLTTMCD 270
           D P+  +S +       +                        Y APE I    + T   D
Sbjct: 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAID 266

Query: 271 VFSFGVVLLELLTGRRSVEKNRCKR 295
           V+S G +  ELL   +        R
Sbjct: 267 VWSIGCIFAELLNMIKENVAYHADR 291

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 62.8 bits (153), Expect = 7e-11
 Identities = 57/261 (21%), Positives = 92/261 (35%), Gaps = 65/261 (24%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVK-VLDVNGSQGH-REWLAEVI 134
           +  N+     +G G +G VY    D N       + VA+K V  +       +  L E+ 
Sbjct: 24  VPDNYIIKHLIGRGSYGYVYL-AYDKNTE-----KNVAIKKVNRMFEDLIDCKRILREIT 77

Query: 135 FLGQLKHPHLVNLI-----GYCCEDEHRLLVYEYM------------ALGNLHDQLFKNY 177
            L +LK  +++ L          + +   +V E               L   H +    Y
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTIL-Y 136

Query: 178 SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA---- 233
           +  L                 F+H     +I+RD K +N LL+ D + K+ DFGLA    
Sbjct: 137 N-LL-------------LGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180

Query: 234 -----------------TDGPQGEDSHITTCVMGTEGYAAPEYI-NTGHLTTMCDVFSFG 275
                                +     +T+ V+ T  Y APE I    + T   D++S G
Sbjct: 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVV-TRWYRAPELILLQENYTKSIDIWSTG 239

Query: 276 VVLLELLTGRRSVEKNRCKRE 296
            +  ELL   +S   +   R 
Sbjct: 240 CIFAELLNMLQSHINDPTNRF 260

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 60.1 bits (146), Expect = 4e-10
 Identities = 47/226 (20%), Positives = 81/226 (35%), Gaps = 40/226 (17%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREW-----LAEVIFLGQLKH 141
           +G GGFG +Y            K     VKV          E      +A+   + +   
Sbjct: 45  IGSGGFGLIYLAF---PTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIE 101

Query: 142 PHLVNLIG----YCC------EDEHRLLVYEYMALG-NLHDQLFKNYSSTLPWLTRIKIA 190
              ++ +G    Y           +R +V E   LG +L   +    + T    T +++ 
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMER--LGIDLQK-IS-GQNGTFKKSTVLQLG 157

Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAK--LSDFGLATD-GPQGEDSHI--- 244
           I     L ++H  E   ++ D KA+N+LL      +  L+D+GL+    P G        
Sbjct: 158 IRMLDVLEYIH--ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQEN 215

Query: 245 -TTCVMGTEGYAAPEYINTGHL-TTMC---DVFSFGVVLLELLTGR 285
                 GT  + +   ++  H    +    DV   G  +L  L G+
Sbjct: 216 PRKGHNGTIEFTS---LDA-HKGVALSRRSDVEILGYCMLRWLCGK 257

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 58.4 bits (142), Expect = 1e-09
 Identities = 39/222 (17%), Positives = 87/222 (39%), Gaps = 38/222 (17%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFL 136
              ++     LG G + +V++     N+      + V VK+L        ++   E+  L
Sbjct: 34  NQDDYQLVRKLGRGKYSEVFEAI---NITNN---EKVVVKILKP---VKKKKIKREIKIL 84

Query: 137 GQLK-HPHLVNLIGYCCEDEHR--LLVYEYMALGNLH-------DQLFKNYSSTLPWLTR 186
             L+  P+++ L     +   R   LV+E++   +         D   + Y   +     
Sbjct: 85  ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEI----- 139

Query: 187 IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNA-KLSDFGLATDGPQGEDSHIT 245
                   + L + H     +++RD K  N+++D ++   +L D+GLA     G++    
Sbjct: 140 -------LKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--- 187

Query: 246 TCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGRR 286
              + +  +  PE + +        D++S G +L  ++  + 
Sbjct: 188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 60/247 (24%), Positives = 102/247 (41%), Gaps = 63/247 (25%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVK-VLDVNGSQGH--REWLAEV 133
           +   +     LG+G +G V+K  +D         + VAVK + D   +     R    E+
Sbjct: 7   VLRKYELVKKLGKGAYGIVWK-SIDRRTG-----EVVAVKKIFDAFQNSTDAQRT-FREI 59

Query: 134 IFLGQLK-HPHLVNL--IGYCCEDEHRLLVYEYM-----------ALGNLHDQLFKNYSS 179
           + L +L  H ++VNL  +     D    LV++YM            L  +H Q    Y  
Sbjct: 60  MILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVV-YQ- 117

Query: 180 TLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA------ 233
            +             + + +LH     +++RD K SNILL+++ + K++DFGL+      
Sbjct: 118 LI-------------KVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162

Query: 234 --------------TDGPQGEDSHITTCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVL 278
                         T+    +   +T  V  T  Y APE +  +   T   D++S G +L
Sbjct: 163 RRVTNNIPLSINENTENFDDDQPILTDYV-ATRWYRAPEILLGSTKYTKGIDMWSLGCIL 221

Query: 279 LELLTGR 285
            E+L G+
Sbjct: 222 GEILCGK 228

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 54.9 bits (131), Expect = 4e-08
 Identities = 53/362 (14%), Positives = 95/362 (26%), Gaps = 112/362 (30%)

Query: 2   ALIKSFTWKIILPSCIKA-TNKPS--------CMSKVHVSNQVSTQRLLLTDVSNPGSPI 52
            L  ++ +   L S IK    +PS           +++  NQV  +     +VS     +
Sbjct: 86  VLRINYKF---LMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKY----NVSRLQPYL 138

Query: 53  SLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYL---GEGGFGKVYKGCVDDNLRPGLK 109
            L +              L EL+        +  +   G  G GK               
Sbjct: 139 KLRQ-------------ALLELR-------PAKNVLIDGVLGSGK--------------- 163

Query: 110 AQTVAVKVLDVNGSQGHRE----WLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMA 165
              VA+ V      Q   +    WL                 +  C   E  L       
Sbjct: 164 -TWVALDVCLSYKVQCKMDFKIFWLN----------------LKNCNSPETVL-----EM 201

Query: 166 LGNLHDQLFKNYSSTLPWLTRIKIAIGAA--RCLAFLHGEEKP---VIYRDFKASNILLD 220
           L  L  Q+  N++S     + IK+ I +        L  +      ++  + + +     
Sbjct: 202 LQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNA 261

Query: 221 SDYNAKL----SDFGLATDGPQGEDSHITTCVMGTEGYAAPE-------YINT--GHL-T 266
            + + K+        +         +HI+     +      E       Y++     L  
Sbjct: 262 FNLSCKILLTTRFKQVTDFLSAATTTHISL-DHHSMTLTPDEVKSLLLKYLDCRPQDLPR 320

Query: 267 TMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYS 326
            +          L ++                   W         KL  II+S L     
Sbjct: 321 EVLTTNPR---RLSIIAESIRDGLATWDN------WKHVNCD---KLTTIIESSLNVLEP 368

Query: 327 TE 328
            E
Sbjct: 369 AE 370

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 53.0 bits (126), Expect = 7e-08
 Identities = 38/203 (18%), Positives = 59/203 (29%), Gaps = 59/203 (29%)

Query: 78  THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGH--------REW 129
           T    R + +GEG FG+V++   D           VA+K++ + G             E 
Sbjct: 19  TEKLQRCEKIGEGVFGEVFQTIADH--------TPVAIKIIAIEGPDLVNGSHQKTFEEI 70

Query: 130 LAEVIFLGQL---------KHPHLVNLIGYCC---------------------------- 152
           L E+I   +L         +    + L    C                            
Sbjct: 71  LPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPD 130

Query: 153 --EDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYR 210
             +D+   +V E+   G   +Q+    SS     T   I       LA          +R
Sbjct: 131 FFKDDQLFIVLEFEFGGIDLEQMRTKLSS---LATAKSILHQLTASLAVAE-ASLRFEHR 186

Query: 211 DFKASNILLDSDYNAKLSDFGLA 233
           D    N+LL      KL      
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNG 209

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	449
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.98
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.82
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.71
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.41
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.23
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.1
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.06
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.7
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.6
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.59
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.53
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.4
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.24
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.17
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.05
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.8
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.72
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.5
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.41
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.21
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.21
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.18
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.1
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.09
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.09
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.05
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.65
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.32
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.05
3mes_A	424	Choline kinase; malaria, structural genomics, stru	93.47
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.58
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	92.12
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	91.0
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	83.79

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.8e-59  Score=452.39  Aligned_cols=267  Identities=26%  Similarity=0.372  Sum_probs=213.0

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      ++|.+.+.||+|+||.||+|.+... .+..+++.||||+++.......+.|.+|+++|++++|||||+++++|.+.+.+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~-~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNL-LPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSS-CC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCc-ccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            5677889999999999999987642 233457899999998666566678999999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcE
Q 013105          159 LVYEYMALGNLHDQLFKNY-------------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNA  225 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~  225 (449)
                      ||||||++|+|.+++....             ...+++.+++.++.|++.||.|||  +++||||||||+||||+.++.+
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH--~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA--GLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh--cCCeecccccHhhEEECCCCcE
Confidence            9999999999999997542             246899999999999999999999  6779999999999999999999


Q ss_pred             EEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhh
Q 013105          226 KLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWAR  304 (449)
Q Consensus       226 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~  304 (449)
                      ||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.........+    
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i----  273 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI----  273 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH----
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH----
Confidence            9999999987654443334455679999999999999999999999999999999999 89999865322111111    


Q ss_pred             hhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCC
Q 013105          305 PMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN  365 (449)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  365 (449)
                                   ........+..+++++.+|+.+||+.||++|||+.+|+++|+.+.+..
T Consensus       274 -------------~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p  321 (329)
T 4aoj_A          274 -------------TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP  321 (329)
T ss_dssp             -------------HHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred             -------------HcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence                         111122344566778999999999999999999999999999987653

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.9e-60  Score=451.05  Aligned_cols=268  Identities=26%  Similarity=0.384  Sum_probs=218.3

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      .++|.+.+.||+|+||.||+|.+... ....++..||||+++.......++|.+|+++|++++|||||++++++.+++..
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~-~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~   90 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNL-CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   90 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSC-C----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCc-ccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            35788899999999999999987642 22345789999999866656667899999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhc-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEE
Q 013105          158 LLVYEYMALGNLHDQLFKN-----------YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAK  226 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~-----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~k  226 (449)
                      |||||||++|+|.++|...           ....+++..++.++.|++.||.|||  +++||||||||+||||+.++.+|
T Consensus        91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH--~~~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA--SQHFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCccCHhhEEECCCCcEE
Confidence            9999999999999999753           2357999999999999999999999  67799999999999999999999


Q ss_pred             EeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhh
Q 013105          227 LSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARP  305 (449)
Q Consensus       227 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~  305 (449)
                      |+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||.+......   ...   
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~~---  242 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---IEC---  242 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---HHH---
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH---
Confidence            999999986543332222333568999999999999999999999999999999998 8999986532211   111   


Q ss_pred             hhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCC
Q 013105          306 MLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN  365 (449)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  365 (449)
                                + ........+..+++++.+|+.+||+.||++|||+.+|++.|+.+....
T Consensus       243 ----------i-~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~  291 (299)
T 4asz_A          243 ----------I-TQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS  291 (299)
T ss_dssp             ----------H-HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             ----------H-HcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence                      1 111122345566778999999999999999999999999999876543

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1e-59  Score=454.74  Aligned_cols=252  Identities=23%  Similarity=0.365  Sum_probs=207.7

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      ++|++.+.||+|+||+||+|.+..      +++.||||+++...  ......+.+|+.+|++|+|||||++++++.+++.
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~   97 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTE------DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGS   97 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETT------TCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             cceEEeEEEecCCCeEEEEEEECC------CCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCE
Confidence            689999999999999999998765      58999999997543  3345678999999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      +|||||||+||+|.++|..+....+++..+..++.|++.||.|||  ++|||||||||+||||+.+|.+||+|||+|+..
T Consensus        98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  175 (350)
T 4b9d_A           98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH--DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL  175 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HTTCEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCCHHHEEECCCCCEEEcccccceee
Confidence            999999999999999998776677899999999999999999999  678999999999999999999999999999865


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHh
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI  316 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (449)
                      ...  .......+||+.|||||++.+..|+.++|||||||+||||++|++||.+........                .+
T Consensus       176 ~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~----------------~i  237 (350)
T 4b9d_A          176 NST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL----------------KI  237 (350)
T ss_dssp             CHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH----------------HH
T ss_pred             cCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH----------------HH
Confidence            432  122344679999999999999999999999999999999999999998653221111                11


Q ss_pred             hcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .... ....+..+++++.+||.+||+.||++|||+.|+++|
T Consensus       238 ~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          238 ISGS-FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             HHTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HcCC-CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1111 112334556779999999999999999999999986

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.2e-59  Score=449.75  Aligned_cols=251  Identities=23%  Similarity=0.341  Sum_probs=211.8

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      +.|++.+.||+|+||.||+|.+..      +++.||||+++.......+.+.+|+.+|+.++|||||++++++.+++.+|
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~------tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  147 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRS------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW  147 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECC------CCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            569999999999999999998776      58999999998665555567889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCC
Q 013105          159 LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~  238 (449)
                      ||||||+||+|.+++.+   ..+++..+..++.|++.||.|||  ++|||||||||+||||+.+|.+||+|||+|+....
T Consensus       148 ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  222 (346)
T 4fih_A          148 VVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  222 (346)
T ss_dssp             EEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence            99999999999998865   46999999999999999999999  67899999999999999999999999999986643


Q ss_pred             CCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhc
Q 013105          239 GEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIID  318 (449)
Q Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (449)
                      ..  ......+||+.|||||++.+..|+.++|||||||+||||++|++||.+.........+   .   ..         
T Consensus       223 ~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i---~---~~---------  285 (346)
T 4fih_A          223 EV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---R---DN---------  285 (346)
T ss_dssp             SS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---H---HS---------
T ss_pred             CC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH---H---cC---------
Confidence            32  2244578999999999999999999999999999999999999999865322211111   0   00         


Q ss_pred             ccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          319 SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       319 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ..........+++++.+||.+||+.||++|||+.|+++|
T Consensus       286 ~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          286 LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             SCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            000111223456679999999999999999999999987

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.2e-59  Score=443.27  Aligned_cols=250  Identities=21%  Similarity=0.283  Sum_probs=212.1

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ++|++.+.||+|+||+||+|.+..      +++.||||+++..   .......+.+|+++|+.++|||||++++++.+++
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~------~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  105 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELA------TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE  105 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cccEEEEEEecccCeEEEEEEECC------CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            579999999999999999998765      5899999999642   2334577899999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      .+|||||||+||+|.+++.+.  +.+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||+|+.
T Consensus       106 ~~yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH--~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~  181 (311)
T 4aw0_A          106 KLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLH--GKGIIHRDLKPENILLNEDMHIQITDFGTAKV  181 (311)
T ss_dssp             EEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCCHHHeEEcCCCCEEEEEcCCcee
Confidence            999999999999999999775  57999999999999999999999  67899999999999999999999999999987


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      .............+||+.|||||++.+..|+.++|||||||+||||++|++||.+........                .
T Consensus       182 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~----------------~  245 (311)
T 4aw0_A          182 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFA----------------K  245 (311)
T ss_dssp             CCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----------------H
T ss_pred             cCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH----------------H
Confidence            654444444556789999999999999999999999999999999999999998653221111                1


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK  356 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  356 (449)
                      +...  ...++..+++++.+||.+||+.||++|||+.|++.
T Consensus       246 i~~~--~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          246 IIKL--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             HHHT--CCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             HHcC--CCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence            1111  11233445667999999999999999999998653

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.2e-58  Score=443.48  Aligned_cols=256  Identities=22%  Similarity=0.224  Sum_probs=211.1

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      +.|.+.+.||+|+||.||+|.+..      +++.||||+++....     ..+|+.+|+.++|||||++++++.+++.+|
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~------~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~  126 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQ------TGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVN  126 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECC------CCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            468888999999999999998765      589999999975432     246999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC-cEEEeeeccccCCC
Q 013105          159 LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY-NAKLSDFGLATDGP  237 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~-~~kl~DfGla~~~~  237 (449)
                      ||||||+||+|.+++.+.  +.+++..+..++.|++.||.|||  +++||||||||+||||+.+| .+||+|||+|+...
T Consensus       127 ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~  202 (336)
T 4g3f_A          127 IFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLH--TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQ  202 (336)
T ss_dssp             EEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred             EEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence            999999999999999765  57999999999999999999999  78899999999999999988 69999999998654


Q ss_pred             CCCCC---ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          238 QGEDS---HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       238 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      .....   ......+||+.|||||++.+..|+.++|||||||+||||++|++||.+........                
T Consensus       203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~----------------  266 (336)
T 4g3f_A          203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL----------------  266 (336)
T ss_dssp             -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH----------------
T ss_pred             CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH----------------
Confidence            33211   11234679999999999999999999999999999999999999997653222111                


Q ss_pred             Hhhccc-ccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCC
Q 013105          315 QIIDSR-LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN  365 (449)
Q Consensus       315 ~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  365 (449)
                      .+.... ....++..+++.+.+||.+||+.||++|||+.|++++|...+...
T Consensus       267 ~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~  318 (336)
T 4g3f_A          267 KIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV  318 (336)
T ss_dssp             HHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence            111111 112345566778999999999999999999999999998776543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.9e-59  Score=445.33  Aligned_cols=264  Identities=26%  Similarity=0.396  Sum_probs=214.3

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      .++++.+.||+|+||+||+|.+... ....+++.||||+++... ....+.|.+|+.+|++++|||||+++++|.+++.+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~-~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~  104 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGP-APGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL  104 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC--------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCC-ccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence            3466778999999999999987532 223357899999997443 33457899999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNY--------------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY  223 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~  223 (449)
                      +||||||++|+|.++|....              ...+++..++.++.|++.||.|||  +++||||||||+||||+.++
T Consensus       105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH--~~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS--SHHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH--hCCCCCCCccccceEECCCC
Confidence            99999999999999996532              246899999999999999999999  67799999999999999999


Q ss_pred             cEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHh
Q 013105          224 NAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEW  302 (449)
Q Consensus       224 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~  302 (449)
                      ++||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |..||.+.....   ....
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~~~~  259 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VVEM  259 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---HHHH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---HHHH
Confidence            999999999986544333333445679999999999999999999999999999999998 899998653221   1111


Q ss_pred             hhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccc
Q 013105          303 ARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL  362 (449)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  362 (449)
                                    +......+.+..++..+.+|+.+||+.||++|||+.+|+++|+.+.
T Consensus       260 --------------i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          260 --------------IRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             --------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             --------------HHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence                          1111222345567788999999999999999999999999998764

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.8e-58  Score=436.91  Aligned_cols=261  Identities=26%  Similarity=0.403  Sum_probs=205.0

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      -.+++.+.+.||+|+||+||+|.+.         ..||||+++...  ....+.|.+|+.+|++++|||||++++++. +
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~---------~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~  103 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWH---------GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-K  103 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESS---------SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEEC---------CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-C
Confidence            3467888999999999999999753         359999997543  334567999999999999999999999875 4


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +.+|||||||+||+|.+++... ...+++..++.++.|++.||+|||  +++||||||||+||||+.++++||+|||+|+
T Consensus       104 ~~~~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH--~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  180 (307)
T 3omv_A          104 DNLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLH--AKNIIHRDMKSNNIFLHEGLTVKIGDFGLAT  180 (307)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCCSSSEEEETTEEEEECCCSSCB
T ss_pred             CeEEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCccCCccCHHHEEECCCCcEEEeeccCce
Confidence            5689999999999999999654 357999999999999999999999  6779999999999999999999999999998


Q ss_pred             CCCCCCCCceeeecCCCCcccccccccc---CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcccc
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINT---GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFT  311 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  311 (449)
                      ..............+||+.|||||++.+   ..|+.++|||||||+||||+||+.||.+........  ....   ..  
T Consensus       181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~--~~~~---~~--  253 (307)
T 3omv_A          181 VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQII--FMVG---RG--  253 (307)
T ss_dssp             C------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH--HHHH---TT--
T ss_pred             ecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHH--HHHh---cC--
Confidence            7654333334455789999999999964   358999999999999999999999997643221110  0000   00  


Q ss_pred             chhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccc
Q 013105          312 KLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL  362 (449)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  362 (449)
                           ...+.....+..+++.+.+|+.+||+.||++|||+.+|+++|+.+.
T Consensus       254 -----~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          254 -----YASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             -----CCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             -----CCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence                 0011112334566778999999999999999999999999998664

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.4e-57  Score=449.72  Aligned_cols=251  Identities=23%  Similarity=0.347  Sum_probs=212.0

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      +.|++.+.||+|+||.||+|.+..      +++.||||+++.......+.+.+|+.+|+.++|||||++++++.+++.+|
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~------tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  224 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRS------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW  224 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECC------CCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEE
Confidence            569999999999999999998766      58999999998766555667889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCC
Q 013105          159 LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~  238 (449)
                      ||||||+||+|.+++..   ..+++..+..++.|++.||.|||  ++|||||||||+||||+.+|.+||+|||+|+....
T Consensus       225 iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH--~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~  299 (423)
T 4fie_A          225 VVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  299 (423)
T ss_dssp             EEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHH--HCCeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence            99999999999998865   36999999999999999999999  67899999999999999999999999999986644


Q ss_pred             CCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhc
Q 013105          239 GEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIID  318 (449)
Q Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (449)
                      ...  .....+||+.|||||++.+..|+.++|||||||+||||++|++||.+.........+   .   ...        
T Consensus       300 ~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i---~---~~~--------  363 (423)
T 4fie_A          300 EVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---R---DNL--------  363 (423)
T ss_dssp             SCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---H---HSC--------
T ss_pred             CCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH---H---cCC--------
Confidence            322  244567999999999999999999999999999999999999999765322211111   0   000        


Q ss_pred             ccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          319 SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       319 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       .........+++++.+||.+||+.||++|||+.|+++|
T Consensus       364 -~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          364 -PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             -CCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             00111223456679999999999999999999999987

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.6e-57  Score=428.71  Aligned_cols=248  Identities=23%  Similarity=0.352  Sum_probs=200.2

Q ss_pred             CCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEe----CC
Q 013105           82 SRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE----DE  155 (449)
Q Consensus        82 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~----~~  155 (449)
                      ++.+.||+|+||+||+|.+..      ++..||+|++...  .....+.+.+|+.+|++++|||||++++++.+    ++
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~  102 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTE------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEE
T ss_pred             EeeeEEecCcCcEEEEEEECC------CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCc
Confidence            566789999999999998776      5889999999643  23345678999999999999999999999875    35


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC-CCcEEEeeecccc
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS-DYNAKLSDFGLAT  234 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~-~~~~kl~DfGla~  234 (449)
                      .+|||||||+||+|.+++.+.  ..+++..+..++.|++.||.|||+++.+||||||||+||||+. +|.+||+|||+|+
T Consensus       103 ~~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          103 CIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            689999999999999999765  5799999999999999999999954344999999999999984 7899999999998


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ....    ......+||+.|||||++.+ .|+.++|||||||+||||+||+.||.+......  +...            
T Consensus       181 ~~~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~~~------------  241 (290)
T 3fpq_A          181 LKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRR------------  241 (290)
T ss_dssp             GCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHH------------
T ss_pred             eCCC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HHHH------------
Confidence            5432    22445789999999999875 699999999999999999999999975422111  1110            


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       +.....+..++...++++.+||.+||+.||++|||+.++++|
T Consensus       242 -i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          242 -VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             -HTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -HHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             001111111223344568999999999999999999999987

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.4e-57  Score=424.36  Aligned_cols=247  Identities=26%  Similarity=0.391  Sum_probs=194.5

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ++|++.+.||+|+||+||+|.+..      +++.||||+++..   .......+.+|+.+|+.++|||||++++++.+++
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   86 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTT------TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD   86 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTT------TCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             eCeEEEEEEecCcCeEEEEEEECC------CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            689999999999999999997655      6899999999743   2334567899999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      .+||||||+ +|+|.+++.++  ..+++..+..++.|++.||+|||  ++||+||||||+|||++.++++||+|||+|+.
T Consensus        87 ~~~ivmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~  161 (275)
T 3hyh_A           87 EIIMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCH--RHKIVHRDLKPENLLLDEHLNVKIADFGLSNI  161 (275)
T ss_dssp             EEEEEEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCTTTEEECTTCCEEECCSSCC--
T ss_pred             EEEEEEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCChHHeEECCCCCEEEeecCCCee
Confidence            999999999 68999999765  57999999999999999999999  67899999999999999999999999999986


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCC-CcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHL-TTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      .....   .....+||+.|||||++.+..| +.++|||||||++|||++|+.||.+.....   ...   .         
T Consensus       162 ~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~---~~~---~---------  223 (275)
T 3hyh_A          162 MTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV---LFK---N---------  223 (275)
T ss_dssp             ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---H---------
T ss_pred             cCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHH---H---------
Confidence            54322   2345679999999999988776 579999999999999999999997643211   111   0         


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       +...  ...++..+++++.+|+.+||+.||++|||+.|+++|
T Consensus       224 -i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          224 -ISNG--VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             -HHHT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             -HHcC--CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence             0011  112234456679999999999999999999999997

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.3e-57  Score=443.07  Aligned_cols=277  Identities=26%  Similarity=0.367  Sum_probs=226.0

Q ss_pred             cCHHHHHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCC-CCcce
Q 013105           69 FTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKH-PHLVN  146 (449)
Q Consensus        69 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~nIv~  146 (449)
                      +...++++-.++|++.+.||+|+||.||+|.+... .....++.||||++..... ...+.+.+|+.+|.++.| ||||+
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~-~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~  132 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN  132 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETS-SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCC-CcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence            44556677778999999999999999999988753 3344567899999975433 345678999999999965 99999


Q ss_pred             eeeEEEeC-CEEEEEEEecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 013105          147 LIGYCCED-EHRLLVYEYMALGNLHDQLFKNY--------------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRD  211 (449)
Q Consensus       147 ~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrD  211 (449)
                      ++++|.+. +.+|||||||++|+|.++|....              ...+++..++.++.|++.||.|||  +++|||||
T Consensus       133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH--~~~iiHRD  210 (353)
T 4ase_A          133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRD  210 (353)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH--HTTCCCSC
T ss_pred             EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh--hCCeecCc
Confidence            99999764 56899999999999999996532              245889999999999999999999  67799999


Q ss_pred             CCCCceEEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccc
Q 013105          212 FKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEK  290 (449)
Q Consensus       212 ikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~  290 (449)
                      |||+|||++.++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||.+
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999997655444444455679999999999999999999999999999999998 9999986


Q ss_pred             cccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          291 NRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                      ......  +              ...+........+..+++++.+|+.+||+.||++|||+.+|+++|+.+++.
T Consensus       291 ~~~~~~--~--------------~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          291 VKIDEE--F--------------CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             CCCSHH--H--------------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCHHHH--H--------------HHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            432211  1              111111222334455677899999999999999999999999999988753

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.8e-57  Score=429.74  Aligned_cols=252  Identities=27%  Similarity=0.340  Sum_probs=201.9

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      ++|++.+.||+|+||+||+|....+   ..+++.||||+++...  ......+.+|+.+|++++|||||++++++.+++.
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~---~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  100 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISG---SDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK  100 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSS---TTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccC---CCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            5799999999999999999976432   2357899999996432  2223467889999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      +|||||||+||+|.+++.+.  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.+|.+||+|||+|+..
T Consensus       101 ~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          101 LYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLH--SLGIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            99999999999999999775  57999999999999999999999  678999999999999999999999999999865


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHh
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI  316 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (449)
                      .....  .....+||+.|||||++.+..|+.++|||||||+||||++|++||.+.........                +
T Consensus       177 ~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~----------------i  238 (304)
T 3ubd_A          177 IDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTM----------------I  238 (304)
T ss_dssp             ----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----------------H
T ss_pred             cCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHH----------------H
Confidence            43222  23446799999999999999999999999999999999999999986532211111                1


Q ss_pred             hcccccccCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 013105          317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM-----TTVVKA  357 (449)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~eil~~  357 (449)
                      ...  ...++..+++++.+||.+||+.||++|||+     +|+++|
T Consensus       239 ~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          239 LKA--KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             HHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             HcC--CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence            111  112344556779999999999999999984     678776

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4.8e-55  Score=416.52  Aligned_cols=252  Identities=25%  Similarity=0.368  Sum_probs=190.2

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCC--
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE--  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--  155 (449)
                      ++|++.+.||+|+||+||+|.+..      +++.||||+++.... ...+.+.+|+.+|++++|||||++++++.+.+  
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~------~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~   78 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKV------DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT   78 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETT------TCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--
T ss_pred             hhCEEeeEEecCCCeEEEEEEECC------CCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcc
Confidence            469999999999999999998765      588999999975543 33467899999999999999999999987644  


Q ss_pred             ----------EEEEEEEecCCCChHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCc
Q 013105          156 ----------HRLLVYEYMALGNLHDQLFKNYS-STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYN  224 (449)
Q Consensus       156 ----------~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~  224 (449)
                                .+|||||||.||+|.+++..... ...++..++.++.|++.||.|||  ++||+||||||+|||++.++.
T Consensus        79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH--~~~IiHRDlKp~NILl~~~~~  156 (299)
T 4g31_A           79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH--SKGLMHRDLKPSNIFFTMDDV  156 (299)
T ss_dssp             --------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCC
T ss_pred             ccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH--HCcCccccCcHHHeEECCCCc
Confidence                      37999999999999999976522 23456678899999999999999  678999999999999999999


Q ss_pred             EEEeeeccccCCCCCCCC----------ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccc
Q 013105          225 AKLSDFGLATDGPQGEDS----------HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCK  294 (449)
Q Consensus       225 ~kl~DfGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~  294 (449)
                      +||+|||+|+........          ......+||+.|||||++.+..|+.++|||||||+||||++   ||......
T Consensus       157 vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~  233 (299)
T 4g31_A          157 VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER  233 (299)
T ss_dssp             EEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH
T ss_pred             EEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH
Confidence            999999999865433211          11234579999999999999999999999999999999996   77542110


Q ss_pred             cchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          295 REKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                           ....          ..+..... +......++.+.+||.+||+.||++|||+.++++|
T Consensus       234 -----~~~~----------~~~~~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          234 -----VRTL----------TDVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             -----HHHH----------HHHHTTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -----HHHH----------HHHhcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                 0000          00001111 11112334557889999999999999999999986

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=5.2e-55  Score=417.98  Aligned_cols=275  Identities=24%  Similarity=0.350  Sum_probs=201.6

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC--
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE--  155 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--  155 (449)
                      .++|.+.+.||+|+||+||+|.+.        ++.||||+++..... ...+..|+..+.+++|||||++++++.+++  
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~~--------g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~   72 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKWR--------GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGT   72 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEET--------TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEEC--------CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCC
Confidence            356788899999999999999763        578999999643211 122334666667889999999999998654  


Q ss_pred             --EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCeeeccCCCCceEEcCCCcEEE
Q 013105          156 --HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE------EKPVIYRDFKASNILLDSDYNAKL  227 (449)
Q Consensus       156 --~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~------~~~ivHrDikp~Nill~~~~~~kl  227 (449)
                        .+|||||||+||+|.+++...   .+++..+..++.|++.||+|||++      ..+||||||||+||||+.++++||
T Consensus        73 ~~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki  149 (303)
T 3hmm_A           73 WTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  149 (303)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             ceEEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEE
Confidence              689999999999999999763   689999999999999999999954      348999999999999999999999


Q ss_pred             eeeccccCCCCCCCC--ceeeecCCCCccccccccccC------CCCcccchhhhHHHHHHHHhCCCcccccccccchhh
Q 013105          228 SDFGLATDGPQGEDS--HITTCVMGTEGYAAPEYINTG------HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDL  299 (449)
Q Consensus       228 ~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~  299 (449)
                      +|||+|+........  ......+||+.|||||++.+.      .|+.++|||||||+||||+||.+||.......... 
T Consensus       150 ~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~-  228 (303)
T 3hmm_A          150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-  228 (303)
T ss_dssp             CCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT-
T ss_pred             EeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc-
Confidence            999999865433221  122345799999999999654      46789999999999999999998876432211100 


Q ss_pred             HHhhhhhhccccchhH-hhcccccccC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCCC
Q 013105          300 VEWARPMLKDFTKLDQ-IIDSRLEDRY-----STEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLND  366 (449)
Q Consensus       300 ~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~  366 (449)
                      .... +.......+.. +......+..     ..++++.+.+|+.+||+.||++|||+.+|++.|+.+.+.+.
T Consensus       229 ~~~~-~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~  300 (303)
T 3hmm_A          229 YDLV-PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  300 (303)
T ss_dssp             TTTS-CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             hhcc-cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcC
Confidence            0000 00000000111 1111111111     34567789999999999999999999999999998876543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-53  Score=418.83  Aligned_cols=269  Identities=20%  Similarity=0.272  Sum_probs=206.4

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEe--
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCE--  153 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--  153 (449)
                      .++|++.+.||+|+||+||+|.+..      +++.||||+++...  ......+.+|+.+|+.++|||||++++++..  
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~------t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  126 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRL------TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTV  126 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSS
T ss_pred             CCCeEEEEEEecccCeEEEEEEECC------CCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccc
Confidence            4679999999999999999998765      68999999997442  2334678899999999999999999999764  


Q ss_pred             ----CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEee
Q 013105          154 ----DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSD  229 (449)
Q Consensus       154 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~D  229 (449)
                          .+.+|||||||. |+|.+++...  ..+++..+..++.|++.||.|||  ++|||||||||+|||++.++.+||+|
T Consensus       127 ~~~~~~~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH--~~~iiHRDlKP~NIl~~~~~~~Ki~D  201 (398)
T 4b99_A          127 PYGEFKSVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMH--SAQVIHRDLKPSNLLVNENCELKIGD  201 (398)
T ss_dssp             CTTTCCCEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTCCEEECC
T ss_pred             ccccCCEEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCcCcCCCcCccccccCCCCCEEEee
Confidence                367899999996 6899998664  68999999999999999999999  67899999999999999999999999


Q ss_pred             eccccCCCCCC--CCceeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhh
Q 013105          230 FGLATDGPQGE--DSHITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPM  306 (449)
Q Consensus       230 fGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~  306 (449)
                      ||+|+......  ........+||+.|||||++.+. .|+.++||||+||++|||++|++||.+.........+......
T Consensus       202 FGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~  281 (398)
T 4b99_A          202 FGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGT  281 (398)
T ss_dssp             CTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             cceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99998653321  12234457899999999998765 5699999999999999999999999876543332222111000


Q ss_pred             --hcccc-----chhHhhccc-ccc-----cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          307 --LKDFT-----KLDQIIDSR-LED-----RYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       307 --~~~~~-----~~~~~~~~~-~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                        .....     .....+... ...     ...+..++++.+||.+||..||++|||+.|+|+|
T Consensus       282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence              00000     000000000 000     0112345678999999999999999999999997

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=6.2e-52  Score=405.46  Aligned_cols=270  Identities=23%  Similarity=0.272  Sum_probs=201.5

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcC-CCCCcceeeeEEEeC
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCED  154 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~  154 (449)
                      .+.++|++.+.||+|+||+||+|..+.+   ..+++.||+|.+....  ...++.+|+++|+.+ +||||+++++++.++
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~---~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQ---VGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN   92 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBT---TSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEccc---CCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence            3567899999999999999999987521   2257899999986432  345678999999998 699999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC-CcEEEeeeccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD-YNAKLSDFGLA  233 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~-~~~kl~DfGla  233 (449)
                      +++||||||++||+|.+++     ..+++.++..++.|++.||.|||  ++||+||||||+|||++.+ +.+||+|||+|
T Consensus        93 ~~~~lvmE~~~g~~L~~~~-----~~l~~~~~~~~~~qll~al~ylH--~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla  165 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDIL-----NSLSFQEVREYMLNLFKALKRIH--QFGIVHRDVKPSNFLYNRRLKKYALVDFGLA  165 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHH-----TTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             CEEEEEEeCCCcccHHHHH-----cCCCHHHHHHHHHHHHHHHHHHH--HCCeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence            9999999999999999988     35899999999999999999999  6789999999999999877 79999999999


Q ss_pred             cCCCCCCC--------------------------CceeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCC
Q 013105          234 TDGPQGED--------------------------SHITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRR  286 (449)
Q Consensus       234 ~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~  286 (449)
                      +.......                          .......+||+.|||||++.+. .|+.++||||+||++|||++|+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~  245 (361)
T 4f9c_A          166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY  245 (361)
T ss_dssp             EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence            75432211                          0112345799999999999765 58999999999999999999999


Q ss_pred             cccccccccc-hhhHH----------hhhhhhcc--------ccchhHhhc------c------------cccccCCHHH
Q 013105          287 SVEKNRCKRE-KDLVE----------WARPMLKD--------FTKLDQIID------S------------RLEDRYSTEG  329 (449)
Q Consensus       287 pf~~~~~~~~-~~~~~----------~~~~~~~~--------~~~~~~~~~------~------------~~~~~~~~~~  329 (449)
                      ||.......+ ...+.          +.......        .........      .            ..........
T Consensus       246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i  325 (361)
T 4f9c_A          246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV  325 (361)
T ss_dssp             SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred             CCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence            9965432111 00000          00000000        000000000      0            0000111234


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          330 AKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       330 ~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ++++.+|+.+||+.||++|||++|+++|
T Consensus       326 s~~a~DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          326 PDEAYDLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             CHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            5678999999999999999999999997

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.1e-51  Score=425.37  Aligned_cols=250  Identities=25%  Similarity=0.366  Sum_probs=204.8

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHH---HHHHHHHhcCCCCCcceeeeEEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREW---LAEVIFLGQLKHPHLVNLIGYCC  152 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~---~~E~~~l~~l~h~nIv~~~~~~~  152 (449)
                      ++|++.++||+|+||.||+|....      +++.||||+++..   .......+   ..++.+++.++|||||+++++|.
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~------tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~  262 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKAD------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH  262 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECC------CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence            679999999999999999998765      6899999999632   11222223   33467778889999999999999


Q ss_pred             eCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecc
Q 013105          153 EDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL  232 (449)
Q Consensus       153 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGl  232 (449)
                      +.+.+|||||||.||+|.++|.+.  +.+++..+..++.||+.||.|||  ++|||||||||+||||+.+|++||+|||+
T Consensus       263 ~~~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH--~~gIiHRDLKPeNILld~~G~vKL~DFGl  338 (689)
T 3v5w_A          263 TPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGL  338 (689)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ECCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCchHHeEEeCCCCEEecccce
Confidence            999999999999999999999775  57999999999999999999999  78899999999999999999999999999


Q ss_pred             ccCCCCCCCCceeeecCCCCccccccccc-cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcccc
Q 013105          233 ATDGPQGEDSHITTCVMGTEGYAAPEYIN-TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFT  311 (449)
Q Consensus       233 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  311 (449)
                      |+......    ....+||+.|||||++. +..|+.++|||||||+||||++|.+||.+............         
T Consensus       339 A~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~---------  405 (689)
T 3v5w_A          339 ACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---------  405 (689)
T ss_dssp             CEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHH---------
T ss_pred             eeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh---------
Confidence            98654332    34467999999999996 45799999999999999999999999976533222111110         


Q ss_pred             chhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 013105          312 KLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT-----MTTVVKA  357 (449)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~  357 (449)
                          +..  ....++..+++++.+||.+||+.||.+|++     +.+|++|
T Consensus       406 ----i~~--~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          406 ----TLT--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             ----HHH--CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             ----hcC--CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence                011  112234456677999999999999999998     6888877

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.1e-51  Score=427.09  Aligned_cols=254  Identities=22%  Similarity=0.314  Sum_probs=213.0

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      .++|++.+.||+|+||.||+|.+..      +++.||+|++..........+.+|+.+|+.++|||||++++++.+++.+
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~------tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  229 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERA------TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM  229 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECC------CCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            4689999999999999999998766      6899999999866555567788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC--CcEEEeeeccccC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD--YNAKLSDFGLATD  235 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~--~~~kl~DfGla~~  235 (449)
                      |||||||.||+|.++|... ...+++..+..++.||+.||.|||  +++|+||||||+|||++.+  +.+||+|||+|+.
T Consensus       230 ~iv~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH--~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~  306 (573)
T 3uto_A          230 VMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  306 (573)
T ss_dssp             EEEEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred             EEEEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence            9999999999999998653 357899999999999999999999  6789999999999999854  8999999999997


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      .....   .....+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.........+.      ..      
T Consensus       307 ~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~------~~------  371 (573)
T 3uto_A          307 LDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK------SC------  371 (573)
T ss_dssp             CCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH------TT------
T ss_pred             ccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH------hC------
Confidence            65432   3445679999999999999999999999999999999999999998654322111110      00      


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                        ...+.......+++++.+||.+||+.||.+|||+.|+++|
T Consensus       372 --~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          372 --DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             --CCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              0011112223455678999999999999999999999997

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=7e-50  Score=386.43  Aligned_cols=282  Identities=39%  Similarity=0.689  Sum_probs=232.7

Q ss_pred             HHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           74 LQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        74 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      +....++|.+.+.||+|+||.||+|.+.       +++.||||++..........+.+|+.+++.++||||+++++++.+
T Consensus        34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  106 (321)
T 2qkw_B           34 LEEATNNFDHKFLIGHGVFGKVYKGVLR-------DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE  106 (321)
T ss_dssp             CCCCCCCCSCCCCSCBCSSSEEEEEECT-------TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred             HHHHHhccCccceeecCCCeeEEEEEEC-------CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            3446789999999999999999999753       368999999986666667889999999999999999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeec
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNY--SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFG  231 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfG  231 (449)
                      .+..++||||+.+|+|.+++....  ...+++..++.++.|++.||.|||  .+||+||||||+|||++.++.+||+|||
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg  184 (321)
T 2qkw_B          107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDFG  184 (321)
T ss_dssp             TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCSTTEEECTTCCEEECCCT
T ss_pred             CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc--CCCeecCCCCHHHEEECCCCCEEEeecc
Confidence            999999999999999999886542  235899999999999999999999  6789999999999999999999999999


Q ss_pred             cccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcccc
Q 013105          232 LATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFT  311 (449)
Q Consensus       232 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  311 (449)
                      ++................||+.|+|||++.+..++.++|||||||++|||++|+.||.............+...... ..
T Consensus       185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~  263 (321)
T 2qkw_B          185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-NG  263 (321)
T ss_dssp             TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT-TT
T ss_pred             cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc-cc
Confidence            99865433322223345689999999999888999999999999999999999999987655444444443322111 12


Q ss_pred             chhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCC
Q 013105          312 KLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN  365 (449)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  365 (449)
                      .+...++...........+..+.+++.+||+.||++|||+.+++++|+.++...
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~  317 (321)
T 2qkw_B          264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ  317 (321)
T ss_dssp             CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence            223333444455667889999999999999999999999999999999887644

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.6e-48  Score=369.73  Aligned_cols=252  Identities=22%  Similarity=0.376  Sum_probs=211.0

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      .++|++.+.||+|+||.||+|.+..      +++.||||++..........+.+|+.+++.++||||+++++++...+..
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   92 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVA------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL   92 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTT------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECC------CCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence            4689999999999999999997654      5889999999766555667789999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+.||+|.+++...   .+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++....
T Consensus        93 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (297)
T 3fxz_A           93 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (297)
T ss_dssp             EEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH--hCCceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence            9999999999999998764   6899999999999999999999  6789999999999999999999999999988654


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII  317 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (449)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|..||.............  .             
T Consensus       168 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~--~-------------  230 (297)
T 3fxz_A          168 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA--T-------------  230 (297)
T ss_dssp             STTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH--H-------------
T ss_pred             Cccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--h-------------
Confidence            4322  2334579999999999999999999999999999999999999997643221111100  0             


Q ss_pred             cccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          318 DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       318 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ........+..++..+.+++.+||+.||++|||+.++++|
T Consensus       231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          231 NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             HCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            0001111233456679999999999999999999999987

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.6e-48  Score=374.38  Aligned_cols=286  Identities=42%  Similarity=0.704  Sum_probs=232.4

Q ss_pred             CccccCHHHHHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCC
Q 013105           65 NLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPH  143 (449)
Q Consensus        65 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~n  143 (449)
                      ....++..++....++|.+.+.||+|+||.||+|.+.       +++.||||++..... .....+.+|+.+++.++|||
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~   88 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-------DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN   88 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-------SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTT
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-------CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCC
Confidence            3456888999999999999999999999999999543       378899999975422 22236889999999999999


Q ss_pred             cceeeeEEEeCCEEEEEEEecCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhcCCC---CeeeccCCCCceE
Q 013105          144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNY--SSTLPWLTRIKIAIGAARCLAFLHGEEK---PVIYRDFKASNIL  218 (449)
Q Consensus       144 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---~ivHrDikp~Nil  218 (449)
                      |+++++++.+.+..++||||+.+|+|.+++....  ...+++..+..++.|++.||.|||  ..   ||+||||||+|||
T Consensus        89 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~~~~ivH~Dlkp~Nil  166 (326)
T 3uim_A           89 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH--DHCDPKIIHRDVKAANIL  166 (326)
T ss_dssp             BCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHH--HSSSSCEECCCCSGGGEE
T ss_pred             ccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEeCCCchhhEE
Confidence            9999999999999999999999999999997653  345899999999999999999999  55   8999999999999


Q ss_pred             EcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccc--cc
Q 013105          219 LDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCK--RE  296 (449)
Q Consensus       219 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~--~~  296 (449)
                      ++.++.+||+|||++....... ........||+.|+|||++.+..++.++|||||||++|+|++|..||......  ..
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  245 (326)
T 3uim_A          167 LDEEFEAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD  245 (326)
T ss_dssp             ECTTCCEEECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSC
T ss_pred             ECCCCCEEeccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccc
Confidence            9999999999999998654332 22344456999999999998888999999999999999999999999743221  11


Q ss_pred             hhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcc
Q 013105          297 KDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL  361 (449)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  361 (449)
                      .....+....... .......+......++...+..+.+++..||+.||.+|||+.+|+++|+..
T Consensus       246 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          246 VMLLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             SBHHHHHTTTTSS-CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             hhHHHHHHHHhhc-hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            2223333322222 233344444555667788899999999999999999999999999999864

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.6e-48  Score=382.86  Aligned_cols=268  Identities=25%  Similarity=0.366  Sum_probs=217.2

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCC-CCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcC-CCCCcceeeeEEEe
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNL-RPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQL-KHPHLVNLIGYCCE  153 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~  153 (449)
                      ..++|.+.+.||+|+||.||+|.+.... .....+..||||++..... .....+.+|+.+++.+ +||||+++++++.+
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            3467999999999999999999875321 1223567899999975432 3456789999999999 89999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEE
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNY--------------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILL  219 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill  219 (449)
                      .+..|+||||+.+|+|.+++....              ...+++..++.++.|++.||.|||  .+||+||||||+|||+
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA--SQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEE
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCeeccccchhhEEE
Confidence            999999999999999999997643              235789999999999999999999  6789999999999999


Q ss_pred             cCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchh
Q 013105          220 DSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKD  298 (449)
Q Consensus       220 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~  298 (449)
                      +.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|||++ |..||.+....... 
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~-  315 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF-  315 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-
Confidence            9999999999999986544332222334557889999999998899999999999999999999 99999764322111 


Q ss_pred             hHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          299 LVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                        .              .+........+..++..+.+++.+||+.||++|||+.+++++|+.++.
T Consensus       316 --~--------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          316 --K--------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             --H--------------HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --H--------------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence              1              111111223344566779999999999999999999999999998764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=369.29  Aligned_cols=262  Identities=25%  Similarity=0.392  Sum_probs=214.0

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      .++|.+.+.||+|+||.||+|.+..      ++..||+|++..........+.+|+.+++.++||||+++++++.+++..
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~------~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   82 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRE------TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL   82 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETT------TCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECC------CCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence            3578999999999999999998865      5789999998765566677899999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+.+|+|.+++... ...+++..+..++.|++.||.|||  +++|+||||||+|||++.++.+||+|||++....
T Consensus        83 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  159 (310)
T 3s95_A           83 NFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLH--SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMV  159 (310)
T ss_dssp             EEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence            9999999999999998764 357999999999999999999999  6779999999999999999999999999998653


Q ss_pred             CCCCCc------------eeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhh
Q 013105          238 QGEDSH------------ITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARP  305 (449)
Q Consensus       238 ~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~  305 (449)
                      ......            ......||+.|+|||++.+..++.++|||||||++|||++|..||..........       
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~-------  232 (310)
T 3s95_A          160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF-------  232 (310)
T ss_dssp             --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-------
T ss_pred             cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-------
Confidence            322111            1114579999999999999999999999999999999999999987542221110       


Q ss_pred             hhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          306 MLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                          ..........    ..+..+++.+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       233 ----~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~  282 (310)
T 3s95_A          233 ----GLNVRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM  282 (310)
T ss_dssp             ----SBCHHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----hhhhhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                0011111111    1233445568999999999999999999999999988754

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=6.9e-48  Score=373.42  Aligned_cols=250  Identities=25%  Similarity=0.383  Sum_probs=209.0

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      ..++|++.+.||+|+||.||+|.+..      +++.||||++...  .......+.+|+.+|+.++||||+++++++.+.
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~   86 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHIL------TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE   86 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECC------CCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            45689999999999999999998765      5889999999744  333456788999999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +..|+||||+.||+|.+++...  ..+++.....++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++.
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  162 (328)
T 3fe3_A           87 KTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCH--QKRIVHRDLKAENLLLDADMNIKIADFGFSN  162 (328)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECSTTCCG
T ss_pred             CEEEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCEeccCCCHHHEEEcCCCCEEEeeccCce
Confidence            9999999999999999999765  57999999999999999999999  6789999999999999999999999999998


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccCCCC-cccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccch
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLT-TMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      ......   .....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.........+             
T Consensus       163 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i-------------  226 (328)
T 3fe3_A          163 EFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV-------------  226 (328)
T ss_dssp             GGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------------
T ss_pred             ecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH-------------
Confidence            654322   23446799999999999877764 7999999999999999999999865322111111             


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                         ...  ....+...+.++.+|+.+||+.||.+|||+.++++|
T Consensus       227 ---~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          227 ---LRG--KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             ---HHC--CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             ---HhC--CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence               011  111233345678999999999999999999999987

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.7e-47  Score=367.74  Aligned_cols=262  Identities=26%  Similarity=0.411  Sum_probs=205.7

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      ...++|++.+.||+|+||.||+|.+.        +..||||++....  ......+.+|+.++++++||||+++++++.+
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  105 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEWH--------GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ  105 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET--------TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CChhHceeeeEeecCCCeEEEEEEEC--------CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence            34578999999999999999999763        5789999997543  2334678899999999999999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCC--eeeccCCCCceEEcCCCcEEEeee
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNY-SSTLPWLTRIKIAIGAARCLAFLHGEEKP--VIYRDFKASNILLDSDYNAKLSDF  230 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~--ivHrDikp~Nill~~~~~~kl~Df  230 (449)
                      .+..++||||+.+|+|.+++.... ...+++..++.++.|++.||.|||  +.|  |+||||||+|||++.++.+||+||
T Consensus       106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~~~ivH~Dikp~NIll~~~~~~kL~Df  183 (309)
T 3p86_A          106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH--NRNPPIVHRNLKSPNLLVDKKYTVKVCDF  183 (309)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH--TSSSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred             CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--cCCCCEECCCCChhhEEEeCCCcEEECCC
Confidence            999999999999999999987542 123899999999999999999999  667  999999999999999999999999


Q ss_pred             ccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccc
Q 013105          231 GLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF  310 (449)
Q Consensus       231 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  310 (449)
                      |++.......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||............          
T Consensus       184 g~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~----------  251 (309)
T 3p86_A          184 GLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV----------  251 (309)
T ss_dssp             C-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH----------
T ss_pred             CCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----------
Confidence            9997543321  1133456999999999999989999999999999999999999999765322111111          


Q ss_pred             cchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCC
Q 013105          311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN  365 (449)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  365 (449)
                            .........+..+++.+.+|+.+||+.||.+|||+.++++.|+.++...
T Consensus       252 ------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          252 ------GFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             ------HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             ------HhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence                  0011122234455667999999999999999999999999999988654

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4.3e-47  Score=369.03  Aligned_cols=250  Identities=26%  Similarity=0.372  Sum_probs=208.9

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      .++|++.+.||+|+||.||+|....      +++.||+|++...   .......+.+|+.+|+.++||||+++++++.+.
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~   77 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKA------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH   77 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECC------CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC
Confidence            3679999999999999999998765      5889999999643   233456788999999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +..|+||||+.||+|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.+|.+||+|||++.
T Consensus        78 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~  153 (337)
T 1o6l_A           78 DRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCK  153 (337)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCcCCHHHEEECCCCCEEEeeccchh
Confidence            9999999999999999998765  57899999999999999999999  6789999999999999999999999999998


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      .......  .....+||+.|+|||++.+..++.++|||||||++|||++|..||...........               
T Consensus       154 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~---------------  216 (337)
T 1o6l_A          154 EGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL---------------  216 (337)
T ss_dssp             CSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---------------
T ss_pred             hcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHH---------------
Confidence            6433221  23446799999999999988999999999999999999999999976432111110               


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRP-----TMTTVVKA  357 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  357 (449)
                       +...  ...++..+++++.+||.+||+.||++||     ++.++++|
T Consensus       217 -i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          217 -ILME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -HHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -HHcC--CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence             0011  1123344566799999999999999999     89999987

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.1e-47  Score=371.39  Aligned_cols=272  Identities=24%  Similarity=0.345  Sum_probs=208.3

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC--
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE--  155 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--  155 (449)
                      .++|++.+.||+|+||.||+|.+.        ++.||||++.... ........|+.++..++||||+++++++....  
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--------NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV   93 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--------TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred             hhhchhhheecccCceEEEEEEEC--------CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence            467999999999999999999764        5789999996443 23345567999999999999999999998743  


Q ss_pred             --EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC----------CeeeccCCCCceEEcCCC
Q 013105          156 --HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK----------PVIYRDFKASNILLDSDY  223 (449)
Q Consensus       156 --~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~----------~ivHrDikp~Nill~~~~  223 (449)
                        .+++||||+.+|+|.+++...   .+++..+..++.|++.||.|||  +.          +|+||||||+|||++.++
T Consensus        94 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH--~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~  168 (322)
T 3soc_A           94 DVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLH--EDIPGLKDGHKPAISHRDIKSKNVLLKNNL  168 (322)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHT--CCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred             CceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH--hhccccccccCCCEEeCCCChHhEEECCCC
Confidence              479999999999999999763   5899999999999999999999  56          899999999999999999


Q ss_pred             cEEEeeeccccCCCCCCCCceeeecCCCCcccccccccc-----CCCCcccchhhhHHHHHHHHhCCCcccccccccchh
Q 013105          224 NAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT-----GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKD  298 (449)
Q Consensus       224 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~  298 (449)
                      .+||+|||++................||+.|+|||++.+     ..++.++|||||||++|||++|+.||.+........
T Consensus       169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~  248 (322)
T 3soc_A          169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP  248 (322)
T ss_dssp             CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred             eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence            999999999976544333222334579999999999976     356678999999999999999999998654322221


Q ss_pred             hHHhhhhhhccccchhH-hhccccccc-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          299 LVEWARPMLKDFTKLDQ-IIDSRLEDR-----YSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       299 ~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                      +....... .....+.. .........     .....+..+.+|+.+||+.||++|||+.++++.|+.+...
T Consensus       249 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          249 FEEEIGQH-PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             THHHHCSS-CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hhhhhccC-CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            11110000 00000111 011111111     1235667799999999999999999999999999987543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3e-47  Score=373.46  Aligned_cols=254  Identities=22%  Similarity=0.297  Sum_probs=208.7

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc------chHHHHHHHHHHHhcCCCCCcceeeeE
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS------QGHREWLAEVIFLGQLKHPHLVNLIGY  150 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~~~~~  150 (449)
                      +.++|.+.+.||+|+||.||+|....      +++.||+|++.....      .....+.+|+.+|+.++||||++++++
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~------~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~   83 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKS------TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDV   83 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECC------CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEE
Confidence            45789999999999999999998765      588999999975422      135678899999999999999999999


Q ss_pred             EEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC----cEE
Q 013105          151 CCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY----NAK  226 (449)
Q Consensus       151 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~----~~k  226 (449)
                      +.+.+..++||||+.||+|.+++...  ..+++..+..++.|++.||.|||  .+||+||||||+|||++.++    .+|
T Consensus        84 ~~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDlkp~NIll~~~~~~~~~vk  159 (361)
T 2yab_A           84 YENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIK  159 (361)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred             EEeCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEeCCCCCccCEE
Confidence            99999999999999999999999654  57999999999999999999999  67899999999999998877    799


Q ss_pred             EeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhh
Q 013105          227 LSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPM  306 (449)
Q Consensus       227 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~  306 (449)
                      |+|||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+      
T Consensus       160 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i------  230 (361)
T 2yab_A          160 LIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI------  230 (361)
T ss_dssp             ECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------
T ss_pred             EEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------
Confidence            99999998654432   233457999999999999889999999999999999999999999765322111110      


Q ss_pred             hccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          307 LKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .....        .....+....+..+.+||.+||..||.+|||+.++++|
T Consensus       231 ~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          231 TAVSY--------DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             HTTCC--------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HhcCC--------CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            00000        00111112335568999999999999999999999986

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=6.9e-48  Score=378.06  Aligned_cols=276  Identities=26%  Similarity=0.370  Sum_probs=221.1

Q ss_pred             cCHHHHHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcC-CCCCcce
Q 013105           69 FTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQL-KHPHLVN  146 (449)
Q Consensus        69 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~  146 (449)
                      +....++...++|++.+.||+|+||.||+|.+... ....+++.||||++..... .....+.+|+.++..+ +||||++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESS-SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccc-cccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            44556666778999999999999999999987542 2345678999999975433 3346789999999999 7999999


Q ss_pred             eeeEEEeCC-EEEEEEEecCCCChHHHHhhcCC-----------------------------------------------
Q 013105          147 LIGYCCEDE-HRLLVYEYMALGNLHDQLFKNYS-----------------------------------------------  178 (449)
Q Consensus       147 ~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------  178 (449)
                      +++++.+.+ ..++||||+.+|+|.+++.....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            999998754 48999999999999999976432                                               


Q ss_pred             -----------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCC
Q 013105          179 -----------------STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGED  241 (449)
Q Consensus       179 -----------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~  241 (449)
                                       ..+++..++.++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++........
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH--~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                             12889999999999999999999  67899999999999999999999999999986644433


Q ss_pred             CceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHhhccc
Q 013105          242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSR  320 (449)
Q Consensus       242 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (449)
                      ........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.......  .              ..+...
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~--------------~~~~~~  312 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--C--------------RRLKEG  312 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--H--------------HHHHHT
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--H--------------HHHHcC
Confidence            333445568999999999998899999999999999999998 99999764322111  0              011111


Q ss_pred             ccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       321 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                      .....+..+++.+.+++..||+.||.+|||+.+++++|+.++.
T Consensus       313 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            1222233455679999999999999999999999999998764

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=6.1e-47  Score=373.61  Aligned_cols=252  Identities=26%  Similarity=0.370  Sum_probs=207.6

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      .++|.+.+.||+|+||.||+|.+..      +++.||+|++...   .......+.+|+.+|+.++||||+++++++.+.
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~------~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~   87 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKND------TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE   87 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECC------CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            3679999999999999999998765      5889999999632   233456788999999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +..|+||||+.||+|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.+|.+||+|||++.
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NIll~~~g~vkL~DFG~a~  163 (384)
T 4fr4_A           88 EDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQ--NQRIIHRDMKPDNILLDEHGHVHITDFNIAA  163 (384)
T ss_dssp             SEEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCcHHHeEECCCCCEEEeccceee
Confidence            9999999999999999998764  57999999999999999999999  6789999999999999999999999999998


Q ss_pred             CCCCCCCCceeeecCCCCccccccccc---cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcccc
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYIN---TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFT  311 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  311 (449)
                      ......   ......||+.|+|||++.   +..|+.++|||||||++|||++|..||.................      
T Consensus       164 ~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~------  234 (384)
T 4fr4_A          164 MLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET------  234 (384)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH------
T ss_pred             eccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh------
Confidence            654322   234567999999999986   34589999999999999999999999975433222221111100      


Q ss_pred             chhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHH
Q 013105          312 KLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT-MTTVVKA  357 (449)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~~  357 (449)
                               ....++..++..+.+||.+||+.||.+||+ +.++++|
T Consensus       235 ---------~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h  272 (384)
T 4fr4_A          235 ---------TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF  272 (384)
T ss_dssp             ---------CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred             ---------cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence                     112234455667999999999999999998 7777764

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=5.3e-47  Score=361.83  Aligned_cols=266  Identities=24%  Similarity=0.326  Sum_probs=211.6

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      +.++|++.+.||+|+||.||+|.+..      ++..||+|++....   ......+.+|+.++..++||||+++++++.+
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~   82 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTI------LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE   82 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETT------TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECC------CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee
Confidence            45789999999999999999997765      57899999986432   2334678899999999999999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      .+..|+||||++|++|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++
T Consensus        83 ~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  158 (294)
T 4eqm_A           83 DDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAH--DMRIVHRDIKPQNILIDSNKTLKIFDFGIA  158 (294)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECCCSSS
T ss_pred             CCeEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEEeCCCc
Confidence            99999999999999999999765  57999999999999999999999  678999999999999999999999999999


Q ss_pred             cCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccch
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      ........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.......  ...   ......  
T Consensus       159 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~--~~~---~~~~~~--  230 (294)
T 4eqm_A          159 KALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA--IKH---IQDSVP--  230 (294)
T ss_dssp             TTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH--HHH---HSSCCC--
T ss_pred             cccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH--HHH---hhccCC--
Confidence            86543221 2233456999999999999989999999999999999999999999865321110  000   000000  


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHhhccccCCC
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRP-TMTTVVKALEPLLDLND  366 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~~~~~~~  366 (449)
                            .........+++.+.+++.+||+.||.+|| ++.++.+.|+.++....
T Consensus       231 ------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~  278 (294)
T 4eqm_A          231 ------NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR  278 (294)
T ss_dssp             ------CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred             ------CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence                  011122334566799999999999999998 99999999998876543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3e-47  Score=368.44  Aligned_cols=256  Identities=25%  Similarity=0.364  Sum_probs=205.4

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      +.++|++.+.||+|+||.||+|.+..      +++.||||++..... .....+.+|+.+++.++||||+++++++.+.+
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~   78 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRV------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN   78 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECC------CCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            35789999999999999999998765      578999999975432 22356789999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..|+||||+.+|+|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++..
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH--~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~  154 (323)
T 3tki_A           79 IQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATV  154 (323)
T ss_dssp             EEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccccchHHEEEeCCCCEEEEEeeccce
Confidence            999999999999999988654  56999999999999999999999  67899999999999999999999999999986


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCC-CcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHL-TTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ..............||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ ....+.           
T Consensus       155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~-----------  222 (323)
T 3tki_A          155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK-----------  222 (323)
T ss_dssp             CEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHH-----------
T ss_pred             eccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHh-----------
Confidence            543332222345679999999999987665 7899999999999999999999976432211 111111           


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                         ...........++..+.+|+.+||+.||++|||+.+++++
T Consensus       223 ---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          223 ---EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             ---TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ---cccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence               0000001112345568899999999999999999999987

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=9.7e-46  Score=354.89  Aligned_cols=284  Identities=36%  Similarity=0.595  Sum_probs=228.1

Q ss_pred             CccccCHHHHHHHhcCCCCc------ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC----CcchHHHHHHHHH
Q 013105           65 NLHVFTLKELQMITHNFSRS------DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN----GSQGHREWLAEVI  134 (449)
Q Consensus        65 ~~~~~~~~~~~~~~~~y~~~------~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~  134 (449)
                      ..+.|+..++..++++|...      +.||+|+||.||+|.+        .++.||+|++...    .......+.+|+.
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~   82 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--------NNTTVAVKKLAAMVDITTEELKQQFDQEIK   82 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--------SSCEEEEEEECCCTTSCTTTHHHHHHHHHH
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--------CCceEEEEEEecccCcchHHHHHHHHHHHH
Confidence            45678888999998888776      8999999999999965        3578999998643    2334567889999


Q ss_pred             HHhcCCCCCcceeeeEEEeCCEEEEEEEecCCCChHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCC
Q 013105          135 FLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKN-YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFK  213 (449)
Q Consensus       135 ~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDik  213 (449)
                      +++.++||||+++++++.+.+..++||||+.+|+|.+++... ....+++..++.++.|++.||.|||  ++||+|||||
T Consensus        83 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dlk  160 (307)
T 2nru_A           83 VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIK  160 (307)
T ss_dssp             HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCC
T ss_pred             HHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh--cCCeecCCCC
Confidence            999999999999999999999999999999999999998643 3456899999999999999999999  6789999999


Q ss_pred             CCceEEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCccccccc
Q 013105          214 ASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRC  293 (449)
Q Consensus       214 p~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~  293 (449)
                      |+|||++.++.+||+|||++................||+.|+|||++.+ .++.++|||||||++|+|++|..||.....
T Consensus       161 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  239 (307)
T 2nru_A          161 SANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE  239 (307)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred             HHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence            9999999999999999999986544333333344579999999998875 589999999999999999999999986543


Q ss_pred             ccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccc
Q 013105          294 KREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL  362 (449)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  362 (449)
                      .....  .+..........+...++... ...+...+..+.+++..||+.||.+|||+.+++++|+.+.
T Consensus       240 ~~~~~--~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          240 PQLLL--DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             SSBTT--HHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             hHHHH--HHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            22111  111111111222333333322 3346778889999999999999999999999999998764

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.5e-47  Score=368.44  Aligned_cols=268  Identities=29%  Similarity=0.392  Sum_probs=217.7

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      ...++|.+.+.||+|+||.||+|.+... .....+..||+|++.... ......+.+|+.+++.++||||+++++++.+.
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   98 (314)
T 2ivs_A           20 FPRKNLVLGKTLGEGEFGKVVKATAFHL-KGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD   98 (314)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEETG-GGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             cchhheeeeeeecccCCeeEEEEEEecc-CcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence            3457899999999999999999987532 122346899999997543 33456788999999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccC
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYS----------------------STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDF  212 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~----------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDi  212 (449)
                      +..++||||+.+|+|.+++.....                      ..+++..++.++.|++.||.|||  ++||+||||
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~di  176 (314)
T 2ivs_A           99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA--EMKLVHRDL  176 (314)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH--HTTEECCCC
T ss_pred             CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH--HCCCccccc
Confidence            999999999999999999976432                      34889999999999999999999  677999999


Q ss_pred             CCCceEEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCccccc
Q 013105          213 KASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKN  291 (449)
Q Consensus       213 kp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~  291 (449)
                      ||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus       177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  256 (314)
T 2ivs_A          177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  256 (314)
T ss_dssp             SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999986544333222334457889999999988889999999999999999999 99999765


Q ss_pred             ccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          292 RCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                      .......                 .+........+..+++.+.+++.+||+.||++|||+.+++++|+.++.
T Consensus       257 ~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          257 PPERLFN-----------------LLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             CGGGHHH-----------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHHHHHH-----------------HhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            3221111                 111111222334556779999999999999999999999999998765

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.9e-47  Score=367.25  Aligned_cols=266  Identities=25%  Similarity=0.392  Sum_probs=213.9

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC-CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ..++|.+.+.||+|+||.||+|.+..+   ...+..||||++... .......+.+|+.+++.++||||+++++++.+.+
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  123 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVP---GQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR  123 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCT---TSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecC---CCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            346799999999999999999988642   123557999999754 3334567899999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..++||||+.+|+|.+++... ...+++..++.++.|++.||.|||  +.||+||||||+|||++.++.+||+|||++..
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLS--DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             ccEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            999999999999999998653 357999999999999999999999  67899999999999999999999999999986


Q ss_pred             CCCCCCC-ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccch
Q 013105          236 GPQGEDS-HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       236 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      ....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||...........              
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~--------------  266 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS--------------  266 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH--------------
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHH--------------
Confidence            5443221 12223346788999999998899999999999999999999 9999976432211111              


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCC
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN  365 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  365 (449)
                         +........+..++..+.+|+..||+.||++|||+.+|++.|+.++...
T Consensus       267 ---~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          267 ---VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             ---HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             ---HHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence               1111122234455677999999999999999999999999999987643

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-47  Score=365.59  Aligned_cols=254  Identities=18%  Similarity=0.257  Sum_probs=208.5

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      +.++|.+.+.||+|+||.||+|.+..      +++.||+|++... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~   75 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETS------SKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEE   75 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECC------CCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCE
Confidence            35789999999999999999998765      5889999999744 3345668899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC--CCcEEEeeecccc
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS--DYNAKLSDFGLAT  234 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~--~~~~kl~DfGla~  234 (449)
                      .++||||+.||+|.+++... ...+++..+..++.|++.||.|||  ++||+||||||+|||++.  ++.+||+|||++.
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH--~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~  152 (321)
T 1tki_A           76 LVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR  152 (321)
T ss_dssp             EEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred             EEEEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence            99999999999999998653 346899999999999999999999  678999999999999987  7899999999998


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+      ......  
T Consensus       153 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i------~~~~~~--  221 (321)
T 1tki_A          153 QLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI------MNAEYT--  221 (321)
T ss_dssp             ECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHTCCC--
T ss_pred             ECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH------HcCCCC--
Confidence            764432   234456999999999999888999999999999999999999999765322111110      000000  


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                            ........++.++.+|+.+||+.||.+|||+.++++|
T Consensus       222 ------~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          222 ------FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             ------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ------CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                  0000011345678999999999999999999999997

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=4.2e-47  Score=371.41  Aligned_cols=252  Identities=27%  Similarity=0.390  Sum_probs=204.1

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcC-CCCCcceeeeEE
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQL-KHPHLVNLIGYC  151 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~  151 (449)
                      ...++|++.+.||+|+||.||+|.+..      +++.||||++...   .......+.+|..++..+ +||||+++++++
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~------~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~   93 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKE------TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF   93 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcC------CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE
Confidence            345789999999999999999998765      5889999999743   223456678899999988 699999999999


Q ss_pred             EeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeec
Q 013105          152 CEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFG  231 (449)
Q Consensus       152 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfG  231 (449)
                      .+.+..|+||||+.||+|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||
T Consensus        94 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NILl~~~g~ikL~DFG  169 (353)
T 3txo_A           94 QTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFG  169 (353)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCcccCCCHHHEEECCCCCEEEcccc
Confidence            9999999999999999999999765  57999999999999999999999  6789999999999999999999999999


Q ss_pred             cccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcccc
Q 013105          232 LATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFT  311 (449)
Q Consensus       232 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  311 (449)
                      ++.......  ......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.........            
T Consensus       170 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~------------  235 (353)
T 3txo_A          170 MCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA------------  235 (353)
T ss_dssp             TCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------------
T ss_pred             ceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHH------------
Confidence            998543322  223456799999999999888899999999999999999999999986532211111            


Q ss_pred             chhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 013105          312 KLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM------TTVVKA  357 (449)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~eil~~  357 (449)
                          +...  ...++...+..+.+|+.+||+.||.+||++      .++++|
T Consensus       236 ----i~~~--~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          236 ----ILND--EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             ----HHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             ----HHcC--CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence                1111  112233455678999999999999999998      788876

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.9e-46  Score=377.25  Aligned_cols=256  Identities=21%  Similarity=0.297  Sum_probs=208.4

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc--chHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      .+.++|++.+.||+|+||.||+|.+..      +++.||+|++.....  .....+.+|+.+++.++||||+++++++.+
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~------~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~   81 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVL------AGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE   81 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETT------TTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECC------CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE
Confidence            456789999999999999999997765      588999999975432  334568899999999999999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEc---CCCcEEEeee
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD---SDYNAKLSDF  230 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~---~~~~~kl~Df  230 (449)
                      .+..|+||||+.||+|.+.+...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++   .++.+||+||
T Consensus        82 ~~~~~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH--~~givHrDlKp~NIll~~~~~~~~vkL~DF  157 (444)
T 3soa_A           82 EGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCH--QMGVVHRNLKPENLLLASKLKGAAVKLADF  157 (444)
T ss_dssp             SSEEEEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSSTTEEESBSSTTCCEEECCC
T ss_pred             CCEEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEeccCCCCcEEEccC
Confidence            99999999999999999999765  57999999999999999999999  67899999999999998   4578999999


Q ss_pred             ccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccc
Q 013105          231 GLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF  310 (449)
Q Consensus       231 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  310 (449)
                      |++........  ......||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.........+.      .. 
T Consensus       158 G~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~------~~-  228 (444)
T 3soa_A          158 GLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK------AG-  228 (444)
T ss_dssp             SSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH------HT-
T ss_pred             ceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHH------hC-
Confidence            99986544322  2334679999999999998899999999999999999999999997643221111110      00 


Q ss_pred             cchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                             ...........+++.+.+|+.+||+.||++|||+.++++|
T Consensus       229 -------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          229 -------AYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             -------CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -------CCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                   0001111122445679999999999999999999999997

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=364.74  Aligned_cols=254  Identities=23%  Similarity=0.325  Sum_probs=208.1

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc------chHHHHHHHHHHHhcCCCCCcceeeeE
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS------QGHREWLAEVIFLGQLKHPHLVNLIGY  150 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~~~~~  150 (449)
                      +.++|.+.+.||+|+||.||+|.+..      ++..||+|++.....      .....+.+|+.+|+.++||||++++++
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   82 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKS------TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV   82 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETT------TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECC------CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            44679999999999999999998765      588999999975422      235778999999999999999999999


Q ss_pred             EEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC----cEE
Q 013105          151 CCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY----NAK  226 (449)
Q Consensus       151 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~----~~k  226 (449)
                      +.+.+..++||||+.+|+|.+++...  ..+++..+..++.|++.||.|||  .+||+||||||+|||++.++    .+|
T Consensus        83 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~NIll~~~~~~~~~~k  158 (326)
T 2y0a_A           83 YENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIK  158 (326)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESCSSSSSCCEE
T ss_pred             EEeCCEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHH--HCCeEcCCCCHHHEEEecCCCCCCCEE
Confidence            99999999999999999999998654  57899999999999999999999  67899999999999998887    899


Q ss_pred             EeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhh
Q 013105          227 LSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPM  306 (449)
Q Consensus       227 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~  306 (449)
                      |+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+.   . 
T Consensus       159 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~---~-  231 (326)
T 2y0a_A          159 IIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS---A-  231 (326)
T ss_dssp             ECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH---H-
T ss_pred             EEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH---h-
Confidence            999999986543221   234569999999999998899999999999999999999999997643221111110   0 


Q ss_pred             hccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          307 LKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                        .        ............+..+.+|+.+||+.||++|||+.++++|
T Consensus       232 --~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          232 --V--------NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             --T--------CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             --c--------CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence              0        0000111112335568999999999999999999999997

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.3e-46  Score=360.02  Aligned_cols=261  Identities=23%  Similarity=0.323  Sum_probs=212.8

Q ss_pred             cCHHHHHHHhcC----------CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhc
Q 013105           69 FTLKELQMITHN----------FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ  138 (449)
Q Consensus        69 ~~~~~~~~~~~~----------y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~  138 (449)
                      ++..++..+.+.          |...+.||+|+||.||+|.+..      +++.||||++..........+.+|+.+++.
T Consensus        25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~   98 (321)
T 2c30_A           25 VTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKH------SGRQVAVKMMDLRKQQRRELLFNEVVIMRD   98 (321)
T ss_dssp             CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEETTTCCSHHHHHHHHHHHTT
T ss_pred             CcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECC------CCcEEEEEEEeccchhHHHHHHHHHHHHHh
Confidence            455555555432          6677899999999999998765      478999999987666667788999999999


Q ss_pred             CCCCCcceeeeEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceE
Q 013105          139 LKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNIL  218 (449)
Q Consensus       139 l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nil  218 (449)
                      ++||||+++++++...+..++||||+.+++|.+++..   ..+++..+..++.|++.||.|||  .+||+||||||+|||
T Consensus        99 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIl  173 (321)
T 2c30_A           99 YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLH--AQGVIHRDIKSDSIL  173 (321)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEE
T ss_pred             CCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEE
Confidence            9999999999999999999999999999999998854   46899999999999999999999  678999999999999


Q ss_pred             EcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchh
Q 013105          219 LDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKD  298 (449)
Q Consensus       219 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~  298 (449)
                      ++.++.+||+|||++........  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........  
T Consensus       174 l~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~--  249 (321)
T 2c30_A          174 LTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--  249 (321)
T ss_dssp             ECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--
T ss_pred             ECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--
Confidence            99999999999999886543221  13345799999999999988999999999999999999999999976432211  


Q ss_pred             hHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          299 LVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       ......   ..       .  ........++..+.+++.+||+.||++|||+.+++++
T Consensus       250 -~~~~~~---~~-------~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          250 -MKRLRD---SP-------P--PKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             -HHHHHH---SS-------C--CCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -HHHHhc---CC-------C--CCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             111000   00       0  0001122345678999999999999999999999987

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-46  Score=373.13  Aligned_cols=273  Identities=26%  Similarity=0.378  Sum_probs=220.5

Q ss_pred             HHHhcCCCCcccccccCceEEEEEEEcCCCC-CCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcC-CCCCcceeeeEE
Q 013105           75 QMITHNFSRSDYLGEGGFGKVYKGCVDDNLR-PGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQL-KHPHLVNLIGYC  151 (449)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~  151 (449)
                      +...++|.+.+.||+|+||.||+|.+..... ....+..||||++.... ......+.+|+.+++.+ +||||+++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            3445789999999999999999998754211 12345689999997543 33446788999999999 899999999999


Q ss_pred             EeCCEEEEEEEecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCce
Q 013105          152 CEDEHRLLVYEYMALGNLHDQLFKNY--------------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNI  217 (449)
Q Consensus       152 ~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Ni  217 (449)
                      .+.+..++||||+.+|+|.+++....              ...+++..++.++.|++.||.|||  +.+|+||||||+||
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NI  222 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNV  222 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGE
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCcceE
Confidence            99999999999999999999997653              245899999999999999999999  67899999999999


Q ss_pred             EEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccc
Q 013105          218 LLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKRE  296 (449)
Q Consensus       218 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~  296 (449)
                      |++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~  302 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  302 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999999986654333233344567899999999998999999999999999999999 9999976432211


Q ss_pred             hhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCCC
Q 013105          297 KDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLND  366 (449)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~  366 (449)
                         ..              .+........+..++.++.+|+.+||+.||++|||+.+|+++|+.+.....
T Consensus       303 ---~~--------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  355 (382)
T 3tt0_A          303 ---FK--------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS  355 (382)
T ss_dssp             ---HH--------------HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             ---HH--------------HHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence               11              111111222234456679999999999999999999999999999876554

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-47  Score=376.91  Aligned_cols=268  Identities=27%  Similarity=0.384  Sum_probs=213.2

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC-CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      .++|.+.+.||+|+||.||+|.+... ....++..||||++... .......+.+|+.+++.++||||+++++++.+...
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  148 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGM-PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  148 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccC-CCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            46799999999999999999986542 22346788999999644 33445578899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC---cEEEe
Q 013105          157 RLLVYEYMALGNLHDQLFKNY-----SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY---NAKLS  228 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~---~~kl~  228 (449)
                      .++||||+.+|+|.+++....     ...+++..++.++.|++.||.|||  ++||+||||||+|||++.++   .+||+
T Consensus       149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            999999999999999997643     245899999999999999999999  67899999999999999555   59999


Q ss_pred             eeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhh
Q 013105          229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPML  307 (449)
Q Consensus       229 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  307 (449)
                      |||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||...........        
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~--------  298 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF--------  298 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH--------
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--------
Confidence            9999974322121222344568999999999988899999999999999999998 9999976532211111        


Q ss_pred             ccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCC
Q 013105          308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN  365 (449)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  365 (449)
                               +........+..++..+.+|+.+||+.||++|||+.+|+++|+.+....
T Consensus       299 ---------i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          299 ---------VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             ---------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             ---------HHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence                     1111112223445667999999999999999999999999999886643

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.6e-46  Score=368.98  Aligned_cols=255  Identities=22%  Similarity=0.334  Sum_probs=208.3

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      .+.++|.+.+.||+|+||.||+|.+..      +++.||+|++....  ......+.+|+.+++.++||||+++++++.+
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~   99 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKT------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE   99 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECC------CCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence            456789999999999999999998765      58899999997543  2345678899999999999999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC---cEEEeee
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY---NAKLSDF  230 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~---~~kl~Df  230 (449)
                      .+..|+||||+.||+|.+++...  ..+++..+..++.|++.||.|||  .+||+||||||+|||++.++   .+||+||
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~Dlkp~NIll~~~~~~~~~kl~Df  175 (362)
T 2bdw_A          100 ESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADF  175 (362)
T ss_dssp             SSEEEEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             CCEEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCchHHEEEecCCCCCCEEEeec
Confidence            99999999999999999998764  57899999999999999999999  67899999999999997654   5999999


Q ss_pred             ccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccc
Q 013105          231 GLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF  310 (449)
Q Consensus       231 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  310 (449)
                      |++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+   .   ...
T Consensus       176 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i---~---~~~  246 (362)
T 2bdw_A          176 GLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI---K---AGA  246 (362)
T ss_dssp             TTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---H---HTC
T ss_pred             CcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH---H---hCC
Confidence            9998665332   133457999999999999889999999999999999999999999764322111100   0   000


Q ss_pred             cchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                              ..........+++.+.+|+.+||+.||++|||+.++++|
T Consensus       247 --------~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          247 --------YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             --------CCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             --------CCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                    000111112345678999999999999999999999987

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.7e-46  Score=357.81  Aligned_cols=273  Identities=21%  Similarity=0.269  Sum_probs=213.1

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC-
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE-  155 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-  155 (449)
                      .++|.+.+.||+|+||.||+|.+..      +++.||||++.... ......+.+|+.+++.++||||+++++++...+ 
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   81 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKK------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT   81 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECC------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCC
Confidence            4679999999999999999998765      57899999997432 334567889999999999999999999998765 


Q ss_pred             -EEEEEEEecCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEE----cCCCcEEEee
Q 013105          156 -HRLLVYEYMALGNLHDQLFKNY-SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILL----DSDYNAKLSD  229 (449)
Q Consensus       156 -~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill----~~~~~~kl~D  229 (449)
                       ..++||||+.+++|.+++.... ...+++..++.++.|++.||.|||  +.||+||||||+|||+    +.++.+||+|
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (319)
T 4euu_A           82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (319)
T ss_dssp             CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred             ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEEeccCCCCceEEEcc
Confidence             7899999999999999997643 234999999999999999999999  6789999999999999    7888899999


Q ss_pred             eccccCCCCCCCCceeeecCCCCccccccccc--------cCCCCcccchhhhHHHHHHHHhCCCcccccccccch-hhH
Q 013105          230 FGLATDGPQGEDSHITTCVMGTEGYAAPEYIN--------TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREK-DLV  300 (449)
Q Consensus       230 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~-~~~  300 (449)
                      ||++........   .....||+.|+|||++.        +..++.++|||||||++|||++|..||......... ...
T Consensus       160 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  236 (319)
T 4euu_A          160 FGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM  236 (319)
T ss_dssp             CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred             CCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence            999986544322   23456999999999985        567899999999999999999999999754322111 111


Q ss_pred             Hh-hhhhhc-cccchhHhh--------cccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcc
Q 013105          301 EW-ARPMLK-DFTKLDQII--------DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL  361 (449)
Q Consensus       301 ~~-~~~~~~-~~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  361 (449)
                      .. ...... ....+....        .......+....+..+.+++.+||+.||++|||+.+++++..+-
T Consensus       237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            10 000000 000000000        01112245678889999999999999999999999999997654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.7e-46  Score=371.74  Aligned_cols=257  Identities=24%  Similarity=0.385  Sum_probs=205.6

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcC-CCCCcceeeeEEEe
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQL-KHPHLVNLIGYCCE  153 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~  153 (449)
                      .++|++.+.||+|+||.||+|.+..      +++.||+|+++...   ......+.+|..++.++ +||||+++++++.+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~------~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~  124 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKK------TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT  124 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECC------CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE
Confidence            4679999999999999999998765      58899999997432   22234577899999876 89999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      .+..|+||||+.||+|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++
T Consensus       125 ~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH--~~givHrDLKp~NILl~~~g~ikL~DFGla  200 (396)
T 4dc2_A          125 ESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC  200 (396)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCEEeccCCHHHEEECCCCCEEEeeccee
Confidence            99999999999999999998765  57999999999999999999999  678999999999999999999999999999


Q ss_pred             cCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchh--hHHhhhhhhcccc
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKD--LVEWARPMLKDFT  311 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~--~~~~~~~~~~~~~  311 (449)
                      +......  ......+||+.|+|||++.+..++.++|||||||++|||++|++||..........  .....        
T Consensus       201 ~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~--------  270 (396)
T 4dc2_A          201 KEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL--------  270 (396)
T ss_dssp             BCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHH--------
T ss_pred             eecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHH--------
Confidence            8633222  22445679999999999999999999999999999999999999996432111100  00000        


Q ss_pred             chhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 013105          312 KLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM------TTVVKA  357 (449)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~eil~~  357 (449)
                       ...+...  ...++..++.++.+||.+||+.||.+||++      .+|++|
T Consensus       271 -~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          271 -FQVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             -HHHHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             -HHHHhcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence             0011111  122344566779999999999999999985      677776

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.2e-47  Score=377.22  Aligned_cols=262  Identities=24%  Similarity=0.390  Sum_probs=211.7

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      ...++|.+.+.||+|+||.||+|.+..      +++.||||++..... .....+.+|+.+|+.++||||+++++++.+.
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  184 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRA------DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK  184 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETT------TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEec------CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence            345678899999999999999998865      478999999874422 2334688999999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +..++||||+++|+|.+++... ...+++..+..++.|++.||.|||  +++|+||||||+|||++.++.+||+|||+++
T Consensus       185 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~  261 (377)
T 3cbl_A          185 QPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLE--SKCCIHRDLAARNCLVTEKNVLKISDFGMSR  261 (377)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             CCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCcCCcccCHHHEEEcCCCcEEECcCCCce
Confidence            9999999999999999998754 246899999999999999999999  6779999999999999999999999999998


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccch
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      ...............+++.|+|||++.+..++.++|||||||++|||++ |..||...........              
T Consensus       262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~--------------  327 (377)
T 3cbl_A          262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF--------------  327 (377)
T ss_dssp             ECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHH--------------
T ss_pred             ecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--------------
Confidence            5433211111111235678999999988889999999999999999998 9999976532211111              


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                         +........+..+++.+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus       328 ---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          328 ---VEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             ---HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence               11111222344456779999999999999999999999999987753

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-46  Score=367.59  Aligned_cols=270  Identities=24%  Similarity=0.369  Sum_probs=214.7

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcC-CCCCcceeeeEEEe
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQL-KHPHLVNLIGYCCE  153 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~  153 (449)
                      ...++|.+.+.||+|+||.||+|.+... .....+..||+|++.... ......+.+|+.++.++ +||||+++++++..
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGI-SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESC-SSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeecc-ccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            3457899999999999999999987432 122356789999997442 23346788999999999 89999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccC
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYS---------------------STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDF  212 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDi  212 (449)
                      .+..++||||+++|+|.+++.....                     ..+++..++.++.|++.||.|||  .+||+||||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Di  198 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHRDL  198 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH--HTTEEETTC
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCcccCCC
Confidence            9999999999999999999976432                     23789999999999999999999  678999999


Q ss_pred             CCCceEEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCccccc
Q 013105          213 KASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKN  291 (449)
Q Consensus       213 kp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~  291 (449)
                      ||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence            99999999999999999999986544333333344557889999999988899999999999999999998 99999765


Q ss_pred             ccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          292 RCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                      .....  ..              ..+........+..+++.+.+|+.+||+.||.+|||+.+++++|+.++..
T Consensus       279 ~~~~~--~~--------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          279 PVDAN--FY--------------KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             CCSHH--HH--------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             CcHHH--HH--------------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            32111  11              11111112223344567799999999999999999999999999988754

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-46  Score=369.23  Aligned_cols=255  Identities=22%  Similarity=0.319  Sum_probs=210.0

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      +.++|.+.+.||+|+||.||+|.+..      +++.||+|++..........+.+|+.+|+.++||||+++++++.+.+.
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~------~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  122 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKA------TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE  122 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECC------CCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE
Confidence            34689999999999999999998765      578999999976554555678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC--CCcEEEeeecccc
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS--DYNAKLSDFGLAT  234 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~--~~~~kl~DfGla~  234 (449)
                      .++||||+.||+|.+++... ...+++..+..++.|++.||.|||  ++||+||||||+|||++.  ++.+||+|||++.
T Consensus       123 ~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~  199 (387)
T 1kob_A          123 MVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLAT  199 (387)
T ss_dssp             EEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred             EEEEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccchHHeEEecCCCCceEEEecccce
Confidence            99999999999999988653 346899999999999999999999  678999999999999974  4689999999998


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ......   ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.........+      ...     
T Consensus       200 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i------~~~-----  265 (387)
T 1kob_A          200 KLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV------KRC-----  265 (387)
T ss_dssp             ECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------HHC-----
T ss_pred             ecCCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHH------HhC-----
Confidence            664432   233456999999999999889999999999999999999999999865322111100      000     


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                         ...........++.++.+||.+||+.||.+|||+.++++|
T Consensus       266 ---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          266 ---DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             ---CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ---CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence               0011112223456679999999999999999999999987

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.6e-46  Score=363.92  Aligned_cols=263  Identities=22%  Similarity=0.344  Sum_probs=206.3

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC-CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      .++|++.+.||+|+||.||+|.+..+  .......||+|.+... .......+.+|+.+++.++||||+++++++.+.. 
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   90 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPE--GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCC--CceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence            35799999999999999999987652  1112335788888533 2344578899999999999999999999998755 


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||+.+|+|.+++... ...+++..++.++.|++.||.|||  +++|+||||||+|||++.++.+||+|||+++..
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           91 VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             eEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHh--hCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            78999999999999998764 357899999999999999999999  678999999999999999999999999999865


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      .............||+.|+|||++.+..++.++|||||||++|||++ |..||.+.......                 .
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-----------------~  230 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------------S  230 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-----------------H
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH-----------------H
Confidence            44333333344557889999999999999999999999999999999 99999765322211                 1


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                      .+........+..++..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          231 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             HHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             HHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            111111222334456679999999999999999999999999988765

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-46  Score=359.84  Aligned_cols=247  Identities=26%  Similarity=0.399  Sum_probs=207.4

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      .++|++.+.||+|+||.||+|....      +++.||+|++...   .......+.+|+.+++.++||||+++++++.+.
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~   78 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRH------NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA   78 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC
Confidence            3679999999999999999998765      5889999999643   123456678899999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +..|+||||+.||+|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.+|.+||+|||++.
T Consensus        79 ~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~  154 (318)
T 1fot_A           79 QQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAK  154 (318)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             CEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChheEEEcCCCCEEEeecCcce
Confidence            9999999999999999999764  57899999999999999999999  7889999999999999999999999999998


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      .....     ....+||+.|+|||++.+..++.++|||||||++|||++|..||.........                .
T Consensus       155 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----------------~  213 (318)
T 1fot_A          155 YVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY----------------E  213 (318)
T ss_dssp             ECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----------------H
T ss_pred             ecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH----------------H
Confidence            64321     23457999999999999889999999999999999999999999764321111                1


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRP-----TMTTVVKA  357 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  357 (449)
                      .+...  ...++...+.++.+++.+||+.||++||     +++++++|
T Consensus       214 ~i~~~--~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          214 KILNA--ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             HHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHHhC--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence            11111  1122344556799999999999999999     89999987

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.6e-46  Score=367.44  Aligned_cols=256  Identities=23%  Similarity=0.324  Sum_probs=206.3

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC-----CcchHHHHHHHHHHHhcCCCCCcceeeeEE
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-----GSQGHREWLAEVIFLGQLKHPHLVNLIGYC  151 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~  151 (449)
                      +.++|++.+.||+|+||.||+|.+..      +++.||||++...     .......+.+|+.+++.++||||+++++++
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~   95 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRE------TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY   95 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECC------CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            45679999999999999999998765      5889999998632     122457789999999999999999999999


Q ss_pred             EeCCEEEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCc---EE
Q 013105          152 CEDEHRLLVYEYMALGNLHDQLFKN--YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYN---AK  226 (449)
Q Consensus       152 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~---~k  226 (449)
                      .+.+..|+||||+.||+|.+.+...  ....+++..+..++.|++.||.|||  +++|+||||||+|||++.++.   +|
T Consensus        96 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH--~~~ivHrDlkp~NIl~~~~~~~~~vk  173 (351)
T 3c0i_A           96 SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH--DNNIIHRDVKPHCVLLASKENSAPVK  173 (351)
T ss_dssp             EETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECSSSTTCCEE
T ss_pred             EeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCChHHeEEecCCCCCcEE
Confidence            9999999999999999999888653  2346899999999999999999999  678999999999999987654   99


Q ss_pred             EeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhh
Q 013105          227 LSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPM  306 (449)
Q Consensus       227 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~  306 (449)
                      |+|||++.......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+...    ......   
T Consensus       174 l~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~i---  244 (351)
T 3c0i_A          174 LGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFEGI---  244 (351)
T ss_dssp             ECCCTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHHHH---
T ss_pred             EecCcceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHHHH---
Confidence            99999998654422  123345799999999999988999999999999999999999999976421    111100   


Q ss_pred             hccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          307 LKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .....        .........++..+.+|+.+||+.||++|||+.++++|
T Consensus       245 ~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          245 IKGKY--------KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             HHTCC--------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HcCCC--------CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            00000        00000011235678999999999999999999999986

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-46  Score=367.17  Aligned_cols=270  Identities=24%  Similarity=0.366  Sum_probs=216.2

Q ss_pred             HHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           75 QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      ....++|.+.+.||+|+||.||+|.+... ....+++.||||++..... .....+.+|+.+++.++||||+++++++.+
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGL-LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETS-STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCc-CCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            34567899999999999999999988642 1223568999999975433 335678899999999999999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNY----------------------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRD  211 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrD  211 (449)
                      .+..++||||+.+|+|.+++....                      ...+++..++.++.|++.||.|||  ++||+|||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--~~~ivH~D  199 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHRD  199 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSC
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCC
Confidence            999999999999999999997642                      157899999999999999999999  67899999


Q ss_pred             CCCCceEEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccc
Q 013105          212 FKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEK  290 (449)
Q Consensus       212 ikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~  290 (449)
                      |||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|||++ |..||.+
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            999999999999999999999875433222222334568999999999988889999999999999999999 9999976


Q ss_pred             cccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          291 NRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                      .......   ..             + ........+..++..+.+|+..||+.||++|||+.+++++|+.+...
T Consensus       280 ~~~~~~~---~~-------------~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          280 MAHEEVI---YY-------------V-RDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             SCHHHHH---HH-------------H-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             CChHHHH---HH-------------H-hCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            4321111   10             0 00111123345566799999999999999999999999999988653

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.8e-46  Score=362.64  Aligned_cols=268  Identities=19%  Similarity=0.198  Sum_probs=213.1

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcC-CCCCcceeeeEEEeCC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCEDE  155 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~  155 (449)
                      +.++|++.+.||+|+||.||+|.+..      +++.||||++.....  ...+.+|+.+++.+ +||||+++++++...+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   78 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLY------TNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGK   78 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETT------TTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETT
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECC------CCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCC
Confidence            35789999999999999999998755      588999999975432  23577899999999 8999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCc-----EEEeee
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYN-----AKLSDF  230 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~-----~kl~Df  230 (449)
                      ..++||||+ +++|.+++... ...+++..++.++.|++.||.|||  ++||+||||||+|||++.++.     +||+||
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH--~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DF  154 (330)
T 2izr_A           79 YNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVH--SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDF  154 (330)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECCGGGTCTTSEEECCC
T ss_pred             ccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeeeccCCCCCCceEEEEEc
Confidence            999999999 89999998754 467999999999999999999999  678999999999999998887     999999


Q ss_pred             ccccCCCCCCCCc-----eeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhh
Q 013105          231 GLATDGPQGEDSH-----ITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARP  305 (449)
Q Consensus       231 Gla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~  305 (449)
                      |++..........     ......||+.|+|||++.+..++.++|||||||++|||++|..||.+...............
T Consensus       155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~  234 (330)
T 2izr_A          155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD  234 (330)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred             ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence            9998653322111     12346799999999999999999999999999999999999999987533222221111100


Q ss_pred             hhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCCCC
Q 013105          306 MLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDI  367 (449)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~  367 (449)
                      ...          ..........++ ++.+++..||+.||.+||++.+|++.|+.+......
T Consensus       235 ~~~----------~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~  285 (330)
T 2izr_A          235 TKR----------ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY  285 (330)
T ss_dssp             HHH----------HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             hhc----------cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence            000          000000111234 799999999999999999999999999988765543

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=7.4e-47  Score=360.69  Aligned_cols=278  Identities=23%  Similarity=0.347  Sum_probs=213.2

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEe--C
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE--D  154 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~  154 (449)
                      ..++|++.+.||+|+||.||+|.+..  ....+++.||||++..........+.+|+.+++.++||||+++++++..  .
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   85 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDP--LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   85 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECT--TCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEec--ccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            35679999999999999999998643  2334688999999986666666788999999999999999999999865  3


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      ...++||||+.+|+|.+++... ...+++..++.++.|++.||.|||  +.||+||||||+|||++.++.+||+|||++.
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             CceEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHh--cCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            5689999999999999999764 245899999999999999999999  6789999999999999999999999999998


Q ss_pred             CCCCCCCC-ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcc---c
Q 013105          235 DGPQGEDS-HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKD---F  310 (449)
Q Consensus       235 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~  310 (449)
                      ........ .......|+..|+|||++.+..++.++|||||||++|||++|..||.......    ..........   .
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~----~~~~~~~~~~~~~~  238 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF----MRMIGNDKQGQMIV  238 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHH----HHHHCTTCCTHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHH----HhhhcCccccchhH
Confidence            65433211 12223457788999999998899999999999999999999999986532110    0000000000   0


Q ss_pred             cchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                      ......+........+..+++.+.+|+.+||+.||++|||+.++++.|+.+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~  291 (295)
T 3ugc_A          239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  291 (295)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            01111112222233455667789999999999999999999999999998764

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.3e-46  Score=354.06  Aligned_cols=257  Identities=24%  Similarity=0.396  Sum_probs=210.6

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      .++|++.+.||+|+||.||+|.+..       ++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLN-------KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI   80 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-------TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             hhhceeeheecCCCccEEEEEEecC-------CCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence            4678999999999999999998754       5679999997543 3356789999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+++++|.+++... ...+++..++.++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  157 (269)
T 4hcu_A           81 CLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL  157 (269)
T ss_dssp             EEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred             EEEEEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHH--hCCeecCCcchheEEEcCCCCEEecccccccccc
Confidence            9999999999999998654 356899999999999999999999  6789999999999999999999999999998543


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI  316 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (449)
                      ... ........||+.|+|||++.+..++.++|||||||++|+|++ |..||............                
T Consensus       158 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~----------------  220 (269)
T 4hcu_A          158 DDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI----------------  220 (269)
T ss_dssp             CHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH----------------
T ss_pred             ccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH----------------
Confidence            321 111223446788999999998899999999999999999999 99999764322111100                


Q ss_pred             hcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                       ........+...++.+.+++..||+.||++|||+.+++++|+.+..
T Consensus       221 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          221 -STGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             -HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -hcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence             1111112233345679999999999999999999999999998764

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.2e-46  Score=351.19  Aligned_cols=259  Identities=24%  Similarity=0.349  Sum_probs=211.4

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      ..++|++.+.||+|+||.||+|.+..       +..||+|++.... .....+.+|+.++..++||||+++++++.+.+.
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   77 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKG-------QYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP   77 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETT-------TEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeeccCCCceEEEEEecC-------ceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCc
Confidence            35679999999999999999997654       5679999997543 335678999999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||+++++|.+++... ...+++..++.++.|++.||.|||  +.||+||||||+|||++.++.++|+|||++...
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  154 (268)
T 3sxs_A           78 IYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLE--SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV  154 (268)
T ss_dssp             EEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHH--HTTEEESSCSGGGEEECTTCCEEECCTTCEEEC
T ss_pred             eEEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCcCcceEEECCCCCEEEccCccceec
Confidence            99999999999999998764 346899999999999999999999  678999999999999999999999999999865


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ..... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||............               
T Consensus       155 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~---------------  218 (268)
T 3sxs_A          155 LDDQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV---------------  218 (268)
T ss_dssp             CTTCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH---------------
T ss_pred             chhhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH---------------
Confidence            44321 12223446778999999998889999999999999999999 99999754322111100               


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                        ........+...++.+.+++..||+.||++|||+.+++++|+.+...
T Consensus       219 --~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          219 --SQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             --HTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             --HcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence              00011112233456799999999999999999999999999988653

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5.3e-46  Score=354.31  Aligned_cols=267  Identities=20%  Similarity=0.277  Sum_probs=203.3

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      ++|++.+.||+|+||.||+|.+..      +++.||+|++....  ......+.+|+.+++.++||||+++++++.+++.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   75 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRE------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK   75 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETT------TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCceeeeEecCCCCeEEEEEEECC------CCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCE
Confidence            579999999999999999998765      57899999997543  2334678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||+.+ +|.+.+... ...+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++...
T Consensus        76 ~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH--~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  151 (292)
T 3o0g_A           76 LTLVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAF  151 (292)
T ss_dssp             EEEEEECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            9999999985 666666543 367999999999999999999999  678999999999999999999999999999865


Q ss_pred             CCCCCCceeeecCCCCccccccccccCC-CCcccchhhhHHHHHHHHhCCCccccccccc-chhhH-Hhh-hhhhccccc
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGH-LTTMCDVFSFGVVLLELLTGRRSVEKNRCKR-EKDLV-EWA-RPMLKDFTK  312 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~vl~elltg~~pf~~~~~~~-~~~~~-~~~-~~~~~~~~~  312 (449)
                      ....  .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||....... ....+ ... .+....+..
T Consensus       152 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~  229 (292)
T 3o0g_A          152 GIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             CSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred             CCcc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhh
Confidence            4322  1233456899999999997655 8999999999999999999888864332111 11100 000 000000111


Q ss_pred             hhHhhcc---------cccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          313 LDQIIDS---------RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       313 ~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .......         ..........+..+.+|+.+||+.||++|||+.++++|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            1110000         00111223456678999999999999999999999987

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.1e-46  Score=360.31  Aligned_cols=270  Identities=27%  Similarity=0.378  Sum_probs=218.7

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcC-CCCCcceeeeEEEe
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQL-KHPHLVNLIGYCCE  153 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~  153 (449)
                      ...++|.+.+.||+|+||.||+|.+... ....+++.||+|++..... .....+.+|+.++.++ +||||+++++++.+
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           20 FPRNRLSFGKTLGAGAFGKVVEATAYGL-IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESS-SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cChhhhhHHHhhCccCCcceEEEEEeec-cccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            3457899999999999999999986431 2234678999999975433 3456788999999999 89999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCC----------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCce
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYS----------------STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNI  217 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~----------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Ni  217 (449)
                      .+..++||||+.+|+|.+++.....                ..+++..++.++.|++.||.|||  ++||+||||||+||
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Ni  176 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNI  176 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGE
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCccceE
Confidence            9999999999999999999976532                24899999999999999999999  67899999999999


Q ss_pred             EEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccc
Q 013105          218 LLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKRE  296 (449)
Q Consensus       218 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~  296 (449)
                      |++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus       177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  256 (313)
T 1t46_A          177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (313)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence            999999999999999987655443333334557889999999988899999999999999999999 9999976432211


Q ss_pred             hhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          297 KDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                        ..              ..+........+..++..+.+++.+||+.||.+|||+.+++++|+.++..
T Consensus       257 --~~--------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          257 --FY--------------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             --HH--------------HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --HH--------------HHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence              10              11111111222334556799999999999999999999999999987753

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.3e-46  Score=366.63  Aligned_cols=253  Identities=25%  Similarity=0.361  Sum_probs=207.4

Q ss_pred             HHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcC-CCCCcceeeeE
Q 013105           75 QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQL-KHPHLVNLIGY  150 (449)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~  150 (449)
                      ....++|.+.+.||+|+||.||+|.+..      +++.||||+++..   .......+..|..++..+ +||||++++++
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~   86 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKK------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCT   86 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETT------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECC------CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEE
Confidence            3445789999999999999999998765      5889999999743   123456678899999876 89999999999


Q ss_pred             EEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeee
Q 013105          151 CCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDF  230 (449)
Q Consensus       151 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~Df  230 (449)
                      +.+.+..|+||||+.||+|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.+|.+||+||
T Consensus        87 ~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~vkL~DF  162 (345)
T 1xjd_A           87 FQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADF  162 (345)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCChhhEEECCCCCEEEeEC
Confidence            99999999999999999999999765  57899999999999999999999  678999999999999999999999999


Q ss_pred             ccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccc
Q 013105          231 GLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF  310 (449)
Q Consensus       231 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  310 (449)
                      |++........  .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.........+          
T Consensus       163 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i----------  230 (345)
T 1xjd_A          163 GMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI----------  230 (345)
T ss_dssp             TTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----------
T ss_pred             hhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH----------
Confidence            99986433222  234567999999999999889999999999999999999999999764322111110          


Q ss_pred             cchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHHHH
Q 013105          311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMT-TVVKA  357 (449)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil~~  357 (449)
                            ...  ...++..++.++.+|+.+||+.||++||++. +|++|
T Consensus       231 ------~~~--~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          231 ------RMD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             ------HHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             ------HhC--CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence                  000  1122334556799999999999999999998 77765

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.4e-46  Score=361.89  Aligned_cols=268  Identities=25%  Similarity=0.385  Sum_probs=198.9

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      ..++|++.+.||+|+||.||+|.+...   ......||||++...  .......+.+|+.+++.++||||+++++++...
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   97 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQE---DGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS   97 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC----------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred             ChhHeEEeceecccCCeEEEEEEEccc---CCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence            456899999999999999999977642   111237999999754  344567889999999999999999999999877


Q ss_pred             CEE------EEEEEecCCCChHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCc
Q 013105          155 EHR------LLVYEYMALGNLHDQLFKNY----SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYN  224 (449)
Q Consensus       155 ~~~------~lv~e~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~  224 (449)
                      ...      ++||||+.+|+|.+++....    ...+++..++.++.|++.||.|||  ++||+||||||+|||++.++.
T Consensus        98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH--~~~ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS--SRNFIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTSC
T ss_pred             ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH--cCCcccCCCCcceEEEcCCCC
Confidence            655      99999999999999986532    225899999999999999999999  678999999999999999999


Q ss_pred             EEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhh
Q 013105          225 AKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWA  303 (449)
Q Consensus       225 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~  303 (449)
                      +||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||.+..........   
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~---  252 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL---  252 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH---
Confidence            99999999986544333222334457889999999998899999999999999999999 99999765322111110   


Q ss_pred             hhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCCC
Q 013105          304 RPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLND  366 (449)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~  366 (449)
                                    ........+..+++.+.+|+.+||+.||++|||+.++++.|+.++....
T Consensus       253 --------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~  301 (323)
T 3qup_A          253 --------------IGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS  301 (323)
T ss_dssp             --------------HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             --------------hcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence                          1111122234556679999999999999999999999999999887553

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.8e-46  Score=383.34  Aligned_cols=262  Identities=24%  Similarity=0.411  Sum_probs=217.9

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      +..++|.+.+.||+|+||.||+|.+..      ++..||||++.... .....+.+|+.+|++++||||+++++++.+.+
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  289 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP  289 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGG------GTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcC------CCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            345678889999999999999998875      47899999997543 34678999999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..+|||||+.+|+|.+++.......+++..++.++.|++.||.|||  +++|+||||||+|||++.++.+||+|||+++.
T Consensus       290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  367 (495)
T 1opk_A          290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRNLAARNCLVGENHLVKVADFGLSRL  367 (495)
T ss_dssp             SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred             cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChhhEEECCCCcEEEeeccccee
Confidence            9999999999999999998765667999999999999999999999  67899999999999999999999999999986


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchh
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ..... ........+++.|+|||++.+..++.++|||||||+||||++ |..||.+........                
T Consensus       368 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~----------------  430 (495)
T 1opk_A          368 MTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE----------------  430 (495)
T ss_dssp             CTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH----------------
T ss_pred             ccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHH----------------
Confidence            54322 111222346789999999988889999999999999999999 999997653221111                


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                       .+........+..+++.+.+||.+||+.||++|||+.+|++.|+.++..
T Consensus       431 -~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          431 -LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             -HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             -HHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence             1111122233445667799999999999999999999999999988653

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.8e-46  Score=364.27  Aligned_cols=248  Identities=25%  Similarity=0.372  Sum_probs=205.2

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      .++|.+.+.||+|+||.||+|.+..      +++.||+|++...   .......+.+|+.+++.++||||+++++++.+.
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~   81 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYK------TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP   81 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECC------CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence            4689999999999999999998765      5889999998632   122235688999999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +..++||||+ +|+|.+++...  ..+++..+..++.|++.||.|||  +.||+||||||+|||++.++.+||+|||++.
T Consensus        82 ~~~~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH--~~givH~Dlkp~NIll~~~~~~kl~DFG~s~  156 (336)
T 3h4j_B           82 TDIVMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCH--RHKIVHRDLKPENLLLDDNLNVKIADFGLSN  156 (336)
T ss_dssp             SEEEEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH--HHTCCCCCCSTTTEEECTTCCEEECCSSCTB
T ss_pred             CEEEEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCchhhEEEcCCCCEEEEEeccce
Confidence            9999999999 68999988765  57999999999999999999999  6789999999999999999999999999998


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccCCC-CcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccch
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHL-TTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      ......   .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..........          .    
T Consensus       157 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----------~----  219 (336)
T 3h4j_B          157 IMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----------K----  219 (336)
T ss_dssp             TTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----------C----
T ss_pred             eccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH----------H----
Confidence            654432   2334569999999999987776 789999999999999999999997642211100          0    


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                         +.. .....+..+++.+.+|+.+||+.||.+|||+.+++++
T Consensus       220 ---i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          220 ---VNS-CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             ---CCS-SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             ---HHc-CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence               000 0112233455678999999999999999999999987

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=8e-46  Score=353.73  Aligned_cols=276  Identities=18%  Similarity=0.168  Sum_probs=217.5

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcC-CCCCcceeeeEEEeCC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCEDE  155 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~  155 (449)
                      +.++|++.+.||+|+||.||+|.+..      +++.||||++....  ....+.+|+.++..+ +|+||+++++++.+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~   79 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLL------NNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL   79 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETT------TTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred             cccceEEEEEEeecCCEEEEEEEECC------CCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence            45789999999999999999998755      58899999986432  224577899999999 7999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCc-----EEEeee
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYN-----AKLSDF  230 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~-----~kl~Df  230 (449)
                      ..++||||+ +++|.+++... ...+++..+..++.|++.||.|||  ++||+||||||+|||++.++.     +||+||
T Consensus        80 ~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df  155 (298)
T 1csn_A           80 HNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF  155 (298)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             eeEEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence            999999999 89999999754 346999999999999999999999  788999999999999987766     999999


Q ss_pred             ccccCCCCCCCC-----ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhh
Q 013105          231 GLATDGPQGEDS-----HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARP  305 (449)
Q Consensus       231 Gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~  305 (449)
                      |++.........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.................
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (298)
T 1csn_A          156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE  235 (298)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred             ccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence            999865433221     113345699999999999988999999999999999999999999987543222221111100


Q ss_pred             hhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCCCCC-CCCcee
Q 013105          306 MLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDIP-IGPFVY  374 (449)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~-~~~~~~  374 (449)
                      ..          ...........+++.+.+++..||+.||++|||+.+|++.|+.++...... ..++.|
T Consensus       236 ~~----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw  295 (298)
T 1csn_A          236 KK----------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW  295 (298)
T ss_dssp             HH----------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred             hc----------cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCcccc
Confidence            00          000011112234567999999999999999999999999999987654332 345555

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=5.9e-46  Score=363.15  Aligned_cols=251  Identities=26%  Similarity=0.350  Sum_probs=207.6

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcC-CCCCcceeeeEEE
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQL-KHPHLVNLIGYCC  152 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~  152 (449)
                      ..++|.+.+.||+|+||.||+|....      +++.||||++...   .......+..|..++..+ +||||+++++++.
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~------~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~   91 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKG------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ   91 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETT------EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECC------CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE
Confidence            45789999999999999999998765      5789999999743   223456778899999988 7999999999999


Q ss_pred             eCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecc
Q 013105          153 EDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL  232 (449)
Q Consensus       153 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGl  232 (449)
                      +.+..|+||||+.||+|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.+|.+||+|||+
T Consensus        92 ~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NIll~~~g~vkL~DFG~  167 (353)
T 2i0e_A           92 TMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGM  167 (353)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCEEeccCCHHHEEEcCCCcEEEEeCCc
Confidence            999999999999999999999765  46899999999999999999999  67899999999999999999999999999


Q ss_pred             ccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccc
Q 013105          233 ATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK  312 (449)
Q Consensus       233 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  312 (449)
                      +.......  ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+......   ..           
T Consensus       168 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---~~-----------  231 (353)
T 2i0e_A          168 CKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---FQ-----------  231 (353)
T ss_dssp             CBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH-----------
T ss_pred             ccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH---HH-----------
Confidence            98643222  123456799999999999989999999999999999999999999976432111   10           


Q ss_pred             hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 013105          313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT-----MTTVVKA  357 (449)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~  357 (449)
                        .+...  ...++..++.++.+||.+||+.||.+||+     +.+|++|
T Consensus       232 --~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          232 --SIMEH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             --HHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             --HHHhC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence              11111  11233455667999999999999999995     5788776

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.1e-46  Score=358.08  Aligned_cols=261  Identities=25%  Similarity=0.422  Sum_probs=218.7

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ...++|++.+.||+|+||.||+|.+..      ++..||+|++... ......+.+|+.+++.++||||+++++++.+.+
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   82 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   82 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGG------GTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ccccceeEEeecCCCCceeEEEeEecC------CCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            456789999999999999999998875      4789999999743 345678899999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..++||||+.+++|.+++.......+++..++.++.|++.||.|||  +.||+||||||+||+++.++.++|+|||++..
T Consensus        83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  160 (288)
T 3kfa_A           83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRL  160 (288)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH--HHTCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred             CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH--HCCccCCCCCcceEEEcCCCCEEEccCcccee
Confidence            9999999999999999998766677999999999999999999999  67899999999999999999999999999986


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchh
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ...... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||..........                
T Consensus       161 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~----------------  223 (288)
T 3kfa_A          161 MTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE----------------  223 (288)
T ss_dssp             SCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH----------------
T ss_pred             ccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----------------
Confidence            543322 22333457889999999998899999999999999999999 999997653221111                


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                       .+........+..+++.+.+|+..||+.||.+|||+.++++.|+.++.
T Consensus       224 -~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          224 -LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             -HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence             111111222334556779999999999999999999999999998765

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=5e-46  Score=363.48  Aligned_cols=247  Identities=23%  Similarity=0.313  Sum_probs=207.7

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      .++|++.+.||+|+||.||+|.+..      +++.||+|++...   .......+.+|+.+|+.++||||+++++++.+.
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  113 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKE------SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN  113 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECC------CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            3679999999999999999998765      5889999999643   223456788999999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +..|+||||+.||+|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++.
T Consensus       114 ~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~  189 (350)
T 1rdq_E          114 SNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK  189 (350)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCccceEEECCCCCEEEcccccce
Confidence            9999999999999999999765  56899999999999999999999  6789999999999999999999999999998


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      .....     ....+||+.|+|||++.+..++.++|||||||++|||++|..||..........                
T Consensus       190 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~----------------  248 (350)
T 1rdq_E          190 RVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE----------------  248 (350)
T ss_dssp             ECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----------------
T ss_pred             eccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHH----------------
Confidence            65332     233569999999999998899999999999999999999999997643211110                


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT-----MTTVVKA  357 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~  357 (449)
                      .+...  ...++..++..+.+||.+||+.||.+||+     +.+|++|
T Consensus       249 ~i~~~--~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          249 KIVSG--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             HHHHC--CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHHcC--CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence            11111  11233445667999999999999999998     8999886

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.5e-46  Score=362.27  Aligned_cols=264  Identities=24%  Similarity=0.360  Sum_probs=207.8

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      .++|++.+.||+|+||.||+|.+..+  .......||+|.+.... ......+.+|+.++..++||||+++++++. ++.
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~   88 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPE--GESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS   88 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCT--TCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCC--CceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence            35799999999999999999988652  11123348888875332 233355678999999999999999999886 566


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||+.+|+|.+++... ...+++..+..++.|++.||.|||  ..||+||||||+|||++.++.+||+|||++...
T Consensus        89 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           89 LQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLE--EHGMVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHH--HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             cEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHH--hCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence            89999999999999998654 346888899999999999999999  677999999999999999999999999999876


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      .............||+.|+|||++.+..++.++|||||||++|+|++ |..||.+..........               
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~---------------  230 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL---------------  230 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH---------------
T ss_pred             CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH---------------
Confidence            55444333455668889999999998899999999999999999999 99999865322211111               


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                        ........+..++..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus       231 --~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          231 --EKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             --HTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             --HcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence              11111122233445688999999999999999999999999988653

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=8.1e-46  Score=374.39  Aligned_cols=253  Identities=27%  Similarity=0.401  Sum_probs=209.7

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC-
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE-  155 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-  155 (449)
                      ..++|++.+.||+|+||.||+|.+.        ++.||||+++...  ..+.+.+|+.+|++++||||+++++++.+.+ 
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~--------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  260 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR--------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG  260 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET--------TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec--------CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC
Confidence            3467888999999999999999764        4689999997543  4567899999999999999999999987765 


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..++||||+.+|+|.+++.......+++..++.++.|++.||.|||  +++|+||||||+|||++.++.+||+|||+++.
T Consensus       261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  338 (450)
T 1k9a_A          261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE  338 (450)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence            7999999999999999998765556899999999999999999999  67899999999999999999999999999985


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchh
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ....     .....+++.|+|||++.+..++.++|||||||+||||++ |..||..........                
T Consensus       339 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~----------------  397 (450)
T 1k9a_A          339 ASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP----------------  397 (450)
T ss_dssp             CC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH----------------
T ss_pred             cccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----------------
Confidence            4321     122357899999999998999999999999999999998 999997653221111                


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                       .+........+..+++.+.+||..||+.||++|||+.++++.|+.+..
T Consensus       398 -~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          398 -RVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             -HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence             111111223345567789999999999999999999999999998764

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.1e-46  Score=356.98  Aligned_cols=251  Identities=23%  Similarity=0.328  Sum_probs=198.2

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc--------------------------chHHHHHH
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--------------------------QGHREWLA  131 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~  131 (449)
                      .++|++.+.||+|+||.||+|.+..      +++.||||++.....                          .....+.+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNEN------DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQ   85 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETT------TTEEEEEEEEECC-------------------------------CHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECC------CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHH
Confidence            4689999999999999999998765      588999999964321                          11346789


Q ss_pred             HHHHHhcCCCCCcceeeeEEEe--CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 013105          132 EVIFLGQLKHPHLVNLIGYCCE--DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIY  209 (449)
Q Consensus       132 E~~~l~~l~h~nIv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH  209 (449)
                      |+.+++.++||||+++++++.+  .+..++||||+.+++|.+++.   ...+++..+..++.|++.||.|||  .+||+|
T Consensus        86 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH  160 (298)
T 2zv2_A           86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLH--YQKIIH  160 (298)
T ss_dssp             HHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHH--HTTEEC
T ss_pred             HHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHH--HCCeec
Confidence            9999999999999999999987  678999999999999987653   257999999999999999999999  678999


Q ss_pred             ccCCCCceEEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCC---CCcccchhhhHHHHHHHHhCCC
Q 013105          210 RDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGH---LTTMCDVFSFGVVLLELLTGRR  286 (449)
Q Consensus       210 rDikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~vl~elltg~~  286 (449)
                      |||||+|||++.++.+||+|||++.......  .......||+.|+|||++.+..   ++.++|||||||++|+|++|..
T Consensus       161 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~  238 (298)
T 2zv2_A          161 RDIKPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC  238 (298)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCCCHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence            9999999999999999999999998654322  1234457999999999997654   4788999999999999999999


Q ss_pred             cccccccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          287 SVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       287 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ||........   ...             +............+++.+.+|+.+||+.||++|||+.++++|
T Consensus       239 pf~~~~~~~~---~~~-------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          239 PFMDERIMCL---HSK-------------IKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             SSCCSSHHHH---HHH-------------HHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             CCCCccHHHH---HHH-------------HhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            9976432111   000             000111111122345679999999999999999999999876

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1e-45  Score=360.72  Aligned_cols=256  Identities=25%  Similarity=0.394  Sum_probs=205.8

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcC-CCCCcceeeeEEEeC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCED  154 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~  154 (449)
                      ++|++.+.||+|+||.||+|.+..      +++.||+|++...   .......+.+|..++..+ +||||+++++++.+.
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~   82 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKK------TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE   82 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             hheEEEEEEEecCCeEEEEEEECC------CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC
Confidence            579999999999999999998765      5889999999744   223345678899999987 899999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +..|+||||+.||+|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||+++
T Consensus        83 ~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~  158 (345)
T 3a8x_A           83 SRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK  158 (345)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCGGGCB
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCHHHEEECCCCCEEEEeccccc
Confidence            9999999999999999998765  57899999999999999999999  6789999999999999999999999999998


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchh--hHHhhhhhhccccc
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKD--LVEWARPMLKDFTK  312 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~--~~~~~~~~~~~~~~  312 (449)
                      ......  ......+||+.|+|||++.+..++.++|||||||++|||++|..||..........  .....         
T Consensus       159 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~---------  227 (345)
T 3a8x_A          159 EGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL---------  227 (345)
T ss_dssp             CSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHH---------
T ss_pred             cccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHH---------
Confidence            643222  12345679999999999998899999999999999999999999996432111000  00000         


Q ss_pred             hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 013105          313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM------TTVVKA  357 (449)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~eil~~  357 (449)
                      ...+...  ...++...+..+.+|+.+||+.||.+||++      .++++|
T Consensus       228 ~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          228 FQVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             HHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             HHHHHcC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence            0001111  112344556679999999999999999996      677765

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.3e-46  Score=357.75  Aligned_cols=268  Identities=22%  Similarity=0.298  Sum_probs=204.2

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      +.++|++.+.||+|+||.||+|.+..       ++.||+|++....  ......+.+|+.+++.++||||+++++++.+.
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   91 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQ-------GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE   91 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETT-------SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECC-------CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC
Confidence            55789999999999999999997743       6899999997442  22346788999999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +..++||||+. |+|.+.+... ...+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++.
T Consensus        92 ~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  167 (311)
T 3niz_A           92 RCLTLVFEFME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCH--QHRILHRDLKPQNLLINSDGALKLADFGLAR  167 (311)
T ss_dssp             SCEEEEEECCS-EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CEEEEEEcCCC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCchHhEEECCCCCEEEccCcCce
Confidence            99999999998 5888887654 356899999999999999999999  6789999999999999999999999999998


Q ss_pred             CCCCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhh--hhhcccc
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR--PMLKDFT  311 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~  311 (449)
                      .......  ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+....  +....+.
T Consensus       168 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  245 (311)
T 3niz_A          168 AFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP  245 (311)
T ss_dssp             ETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred             ecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence            6543221  2334568999999999875 568999999999999999999999998654333222111000  0000000


Q ss_pred             ---chhHhhc-------ccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          312 ---KLDQIID-------SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       312 ---~~~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                         .+.....       ..........+++++.+|+.+||+.||++|||+.++++|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence               0000000       000011122345678999999999999999999999987

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.3e-46  Score=368.17  Aligned_cols=264  Identities=26%  Similarity=0.424  Sum_probs=202.7

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      .++|.+.+.||+|+||.||+|.+...   ...+..||||+++... ......+.+|+.++.+++||||+++++++.+.+.
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  120 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLP---SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP  120 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCT---TSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecC---CCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence            46799999999999999999976521   1246789999997543 3345678999999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||+++|+|.+++... ...+++..++.++.|++.||.|||  ++||+||||||+|||++.++.+||+|||+++..
T Consensus       121 ~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          121 VMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             eEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            99999999999999998654 357899999999999999999999  678999999999999999999999999999865


Q ss_pred             CCCCCCc-eeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchh
Q 013105          237 PQGEDSH-ITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       237 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ....... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||........   ..             
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~---~~-------------  261 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV---IK-------------  261 (373)
T ss_dssp             ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH---HH-------------
T ss_pred             ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH-------------
Confidence            4332111 1222345788999999998899999999999999999998 9999975432111   11             


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                       .+........+..++..+.+|+..||+.||.+||++.+|++.|+.+...
T Consensus       262 -~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          262 -AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             -HHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -HHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence             1111111222345567799999999999999999999999999988754

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.4e-46  Score=366.39  Aligned_cols=275  Identities=23%  Similarity=0.275  Sum_probs=211.7

Q ss_pred             ccCHHHHHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC-----CC
Q 013105           68 VFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-----HP  142 (449)
Q Consensus        68 ~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~  142 (449)
                      .++..+...+.++|.+.+.||+|+||.||+|.+..      +++.||||++... ......+..|+.+++.+.     ||
T Consensus        24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~   96 (360)
T 3llt_A           24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHID------NKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNN   96 (360)
T ss_dssp             SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred             eeeeecceEecCEEEEEEEEcccCCeEEEEEEECC------CCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCC
Confidence            34455556678899999999999999999998765      4789999999632 333456778999999986     99


Q ss_pred             CcceeeeEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC-
Q 013105          143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS-  221 (449)
Q Consensus       143 nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~-  221 (449)
                      ||+++++++...+..++||||+ +++|.+++.......+++..+..++.|++.||.|||  ++||+||||||+|||++. 
T Consensus        97 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~  173 (360)
T 3llt_A           97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR--KMSLTHTDLKPENILLDDP  173 (360)
T ss_dssp             GBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESCT
T ss_pred             CeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCcccEEEccc
Confidence            9999999999999999999999 899999998776667999999999999999999999  678999999999999975 


Q ss_pred             ------------------------CCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHH
Q 013105          222 ------------------------DYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVV  277 (449)
Q Consensus       222 ------------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~v  277 (449)
                                              ++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||+
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i  248 (360)
T 3llt_A          174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCV  248 (360)
T ss_dssp             TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred             cccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHH
Confidence                                    789999999999854332     234569999999999999999999999999999


Q ss_pred             HHHHHhCCCcccccccccchhhHHhhhhhhccc-------cchhHhhcc-----cccc----------------cCCHHH
Q 013105          278 LLELLTGRRSVEKNRCKREKDLVEWARPMLKDF-------TKLDQIIDS-----RLED----------------RYSTEG  329 (449)
Q Consensus       278 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~-----~~~~----------------~~~~~~  329 (449)
                      +|+|++|+.||......................       ......+..     ..+.                .+....
T Consensus       249 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  328 (360)
T 3llt_A          249 LAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIK  328 (360)
T ss_dssp             HHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCC
T ss_pred             HHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccch
Confidence            999999999997654332221111110000000       000000000     0000                000011


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          330 AKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       330 ~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ++.+.+|+.+||+.||++|||+.++++|
T Consensus       329 ~~~l~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          329 HELFCDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            2568899999999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=6.4e-46  Score=365.12  Aligned_cols=289  Identities=19%  Similarity=0.208  Sum_probs=214.8

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchH-----------HHHHHHHHHHhcCCCCCcc
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGH-----------REWLAEVIFLGQLKHPHLV  145 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~nIv  145 (449)
                      ..++|++.+.||+|+||.||+|.+..+ .....++.||||++........           ..+..|+..+..++||||+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSS-ESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCS-SCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCc-cccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            346899999999999999999988653 2233468899999875432111           1234566778888999999


Q ss_pred             eeeeEEEeC----CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEc-
Q 013105          146 NLIGYCCED----EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD-  220 (449)
Q Consensus       146 ~~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~-  220 (449)
                      ++++++...    ...||||||+ |++|.+++... ...+++..++.++.|++.||.|||  .+||+||||||+|||++ 
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH--~~~iiHrDlkp~Nill~~  187 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIH--EHEYVHGDIKASNLLLNY  187 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEEES
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH--HCCeEEecCCHHHEEEec
Confidence            999998764    5589999999 99999998763 467999999999999999999999  67899999999999999 


Q ss_pred             -CCCcEEEeeeccccCCCCCCCC-----ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccc
Q 013105          221 -SDYNAKLSDFGLATDGPQGEDS-----HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCK  294 (449)
Q Consensus       221 -~~~~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~  294 (449)
                       .++.+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence             8899999999999754322111     1123455999999999999889999999999999999999999999864322


Q ss_pred             cchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCCCCC-CCCce
Q 013105          295 REKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDIP-IGPFV  373 (449)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~-~~~~~  373 (449)
                      ..  .........  ...+..+++..+.   ...++.++.+++..||+.||.+||++.+|++.|+.++...... ..++.
T Consensus       268 ~~--~~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~d  340 (364)
T 3op5_A          268 PK--YVRDSKIRY--RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLD  340 (364)
T ss_dssp             HH--HHHHHHHHH--HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCC
T ss_pred             HH--HHHHHHHHh--hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccc
Confidence            11  111111000  0112222222211   1233567999999999999999999999999999988765544 34556


Q ss_pred             eeec
Q 013105          374 YTVV  377 (449)
Q Consensus       374 ~~~~  377 (449)
                      |...
T Consensus       341 w~~~  344 (364)
T 3op5_A          341 LSVV  344 (364)
T ss_dssp             C---
T ss_pred             eEec
Confidence            6543

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.6e-46  Score=360.11  Aligned_cols=264  Identities=22%  Similarity=0.341  Sum_probs=205.4

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC-CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      .++|++.+.||+|+||.||+|.+..+  .......||+|.+... .......+.+|+.+++.++||||+++++++.... 
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   90 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPE--GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCT--TCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCC--CceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence            46799999999999999999987652  1112334688877533 3445678899999999999999999999998765 


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||+|+.+|+|.+++... ...+++..++.++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++...
T Consensus        91 ~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             ceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHh--hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            78999999999999998764 356899999999999999999999  678999999999999999999999999999866


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      .............||+.|+|||++.+..++.++|||||||++|||++ |..||.........                 .
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-----------------~  230 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------------S  230 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-----------------H
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-----------------H
Confidence            44333333344557889999999998999999999999999999999 99999765322211                 1


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                      .+........+..++..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       231 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          231 ILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             HHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             HHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            1111112223344566799999999999999999999999999988753

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=8.2e-46  Score=367.60  Aligned_cols=270  Identities=18%  Similarity=0.251  Sum_probs=207.0

Q ss_pred             hcCCCCccccccc--CceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           78 THNFSRSDYLGEG--GFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        78 ~~~y~~~~~lG~G--~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      .++|++.+.||+|  +||.||+|.+..      +++.||||++....  ......+.+|+.+++.++||||+++++++.+
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   97 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKP------TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA   97 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETT------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcC------CCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE
Confidence            4679999999999  999999998765      58899999997542  3334668889999999999999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      .+..|+||||+.+|+|.+++.......+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~NIll~~~~~~kl~dfg~~  175 (389)
T 3gni_B           98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH--HMGYVHRSVKASHILISVDGKVYLSGLRSN  175 (389)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred             CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEcccccc
Confidence            999999999999999999998776677999999999999999999999  677999999999999999999999999988


Q ss_pred             cCCCCCC-----CCceeeecCCCCcccccccccc--CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhh
Q 013105          234 TDGPQGE-----DSHITTCVMGTEGYAAPEYINT--GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPM  306 (449)
Q Consensus       234 ~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~  306 (449)
                      .......     .........||+.|+|||++.+  ..++.++|||||||++|||++|+.||.+........  ......
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~  253 (389)
T 3gni_B          176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL--EKLNGT  253 (389)
T ss_dssp             EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH--HC----
T ss_pred             eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHhcCC
Confidence            6432111     0111222468999999999977  578999999999999999999999997643222111  000000


Q ss_pred             hccc---c------------------chhHhh---------cccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 013105          307 LKDF---T------------------KLDQII---------DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK  356 (449)
Q Consensus       307 ~~~~---~------------------~~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  356 (449)
                      ....   .                  ......         .......++..+++.+.+||.+||+.||++|||+.++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            0000   0                  000000         000011233445677999999999999999999999998


Q ss_pred             H
Q 013105          357 A  357 (449)
Q Consensus       357 ~  357 (449)
                      |
T Consensus       334 h  334 (389)
T 3gni_B          334 H  334 (389)
T ss_dssp             S
T ss_pred             C
Confidence            7

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=6.9e-46  Score=364.30  Aligned_cols=254  Identities=20%  Similarity=0.268  Sum_probs=195.4

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      .++|.+.+.||+|+||.||+|....      +++.||||++..... ....+.+|+.+++.++||||+++++++.+.+..
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   91 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKL------TKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHL   91 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETT------TCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECC------CCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence            4679999999999999999998765      588999999975432 235678999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCc--EEEeeeccccC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYN--AKLSDFGLATD  235 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~--~kl~DfGla~~  235 (449)
                      ++||||+.+|+|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++.  +||+|||+++.
T Consensus        92 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH--~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A           92 AIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCH--SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  167 (361)
T ss_dssp             EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred             EEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence            9999999999999998765  56999999999999999999999  678999999999999987765  99999999974


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcc-cchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTM-CDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      .....   ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||..........  ....          
T Consensus       168 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~--~~~~----------  232 (361)
T 3uc3_A          168 SVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR--KTIQ----------  232 (361)
T ss_dssp             ----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHH--HHHH----------
T ss_pred             ccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHH--HHHH----------
Confidence            33221   1234569999999999987777655 899999999999999999998653222111  0000          


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .+............+++.+.+||.+||+.||++|||+.++++|
T Consensus       233 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          233 RILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             HHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            0111111111111245668999999999999999999999987

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.5e-45  Score=350.12  Aligned_cols=254  Identities=28%  Similarity=0.527  Sum_probs=205.6

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcch-------HHHHHHHHHHHhcCCCCCcceeeeE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG-------HREWLAEVIFLGQLKHPHLVNLIGY  150 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~nIv~~~~~  150 (449)
                      .++|++.+.||+|+||.||+|.+..      +++.||+|++.......       .+.+.+|+.+++.++||||++++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   91 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVK------DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL   91 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETT------TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hccceehhccccCCceeEEEEEEcC------CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhhee
Confidence            4679999999999999999998865      47899999986432211       1578899999999999999999999


Q ss_pred             EEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--eeeccCCCCceEEcCCCc----
Q 013105          151 CCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP--VIYRDFKASNILLDSDYN----  224 (449)
Q Consensus       151 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~--ivHrDikp~Nill~~~~~----  224 (449)
                      +.+..  ++||||+.+|+|.+++... ...+++..++.++.|++.||.|||  .++  |+||||||+|||++.++.    
T Consensus        92 ~~~~~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH--~~~~~ivH~dikp~Nil~~~~~~~~~~  166 (287)
T 4f0f_A           92 MHNPP--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQ--NQNPPIVHRDLRSPNIFLQSLDENAPV  166 (287)
T ss_dssp             ETTTT--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHH--TSSSCCBCSCCSGGGEEESCCCTTCSC
T ss_pred             ecCCC--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHH--hCCCCeecCCCCcceEEEeccCCCCce
Confidence            86655  6999999999999888654 357999999999999999999999  666  999999999999988776    


Q ss_pred             -EEEeeeccccCCCCCCCCceeeecCCCCcccccccc--ccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHH
Q 013105          225 -AKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI--NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVE  301 (449)
Q Consensus       225 -~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~  301 (449)
                       +||+|||++.....     ......||+.|+|||++  ....++.++|||||||++|+|++|..||.......... . 
T Consensus       167 ~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~-  239 (287)
T 4f0f_A          167 CAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF-I-  239 (287)
T ss_dssp             CEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH-H-
T ss_pred             eEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH-H-
Confidence             99999999985432     23446799999999998  34567899999999999999999999997543221110 0 


Q ss_pred             hhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcc
Q 013105          302 WARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL  361 (449)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  361 (449)
                                  ............+..+++.+.+++..||+.||.+|||+.++++.|+.+
T Consensus       240 ------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          240 ------------NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             ------------HHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ------------HHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                        111112223334455667899999999999999999999999998753

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.5e-46  Score=353.78  Aligned_cols=259  Identities=21%  Similarity=0.350  Sum_probs=208.7

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      ..++|++.+.||+|+||.||+|.+..       +..||+|++.... .....+.+|+.++..++||||+++++++.+.+.
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   93 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRG-------QYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP   93 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETT-------TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcC-------CCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence            35679999999999999999997754       5689999997543 335678999999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||+.+++|.+++... ...+++..++.++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++...
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  170 (283)
T 3gen_A           94 IFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV  170 (283)
T ss_dssp             EEEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred             eEEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHH--HCCccCCCCccceEEEcCCCCEEEccccccccc
Confidence            99999999999999998653 246999999999999999999999  678999999999999999999999999999854


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      .... ........||+.|+|||++.+..++.++|||||||++|+|++ |+.||...........+               
T Consensus       171 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~---------------  234 (283)
T 3gen_A          171 LDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI---------------  234 (283)
T ss_dssp             CCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH---------------
T ss_pred             cccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH---------------
Confidence            3321 111222346788999999998899999999999999999998 99999764322111111               


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                        ........+...++.+.+++.+||+.||++|||+.+++++|..++..
T Consensus       235 --~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          235 --AQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             --HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --hcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence              11111112233456799999999999999999999999999988753

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.2e-45  Score=356.30  Aligned_cols=269  Identities=23%  Similarity=0.318  Sum_probs=192.7

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      .++|++.+.||+|+||.||+|.+..      +++.||+|++.... ......+.+|+.+++.++||||+++++++.+++.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   77 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKT------TGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENK   77 (317)
T ss_dssp             ---------------CEEEEEECSS------SCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECC------CCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCe
Confidence            3579999999999999999997654      58899999997543 2334678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecc
Q 013105          157 RLLVYEYMALGNLHDQLFKNY----SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL  232 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGl  232 (449)
                      .++||||+. |+|.+++....    ...+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||+
T Consensus        78 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH--~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  154 (317)
T 2pmi_A           78 LTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH--ENKILHRDLKPQNLLINKRGQLKLGDFGL  154 (317)
T ss_dssp             EEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCCSS
T ss_pred             EEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCChHHeEEcCCCCEEECcCcc
Confidence            999999998 69999886532    245889999999999999999999  67899999999999999999999999999


Q ss_pred             ccCCCCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhh--hhhcc
Q 013105          233 ATDGPQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR--PMLKD  309 (449)
Q Consensus       233 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~  309 (449)
                      +........  ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+....  +....
T Consensus       155 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  232 (317)
T 2pmi_A          155 ARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL  232 (317)
T ss_dssp             CEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTT
T ss_pred             ceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH
Confidence            986543221  1234568999999999976 468999999999999999999999998654332221111000  00000


Q ss_pred             ccchhHh------hcc--------cccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          310 FTKLDQI------IDS--------RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       310 ~~~~~~~------~~~--------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      +......      +..        ..........+.++.+|+.+||+.||++|||+.++++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence            0000000      000        00011112345679999999999999999999999987

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=8.8e-46  Score=358.62  Aligned_cols=254  Identities=26%  Similarity=0.356  Sum_probs=200.2

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      +.++|++.+.||+|+||.||+|.+..      +++.||||++.... ....+.+.+|+.+|+.++||||+++++++.+..
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   77 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKV------DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETP   77 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETT------TCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECC
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcC------CCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEec
Confidence            45679999999999999999998765      57899999997543 334577899999999999999999999986543


Q ss_pred             ---------------------------------------------------------EEEEEEEecCCCChHHHHhhcCC
Q 013105          156 ---------------------------------------------------------HRLLVYEYMALGNLHDQLFKNYS  178 (449)
Q Consensus       156 ---------------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~  178 (449)
                                                                               ..++||||+.+|+|.+++.....
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~  157 (332)
T 3qd2_B           78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS  157 (332)
T ss_dssp             SCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS
T ss_pred             cchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC
Confidence                                                                     38999999999999999976422


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCC----------ceeee
Q 013105          179 -STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS----------HITTC  247 (449)
Q Consensus       179 -~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~----------~~~~~  247 (449)
                       ...++..++.++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++.........          .....
T Consensus       158 ~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T 3qd2_B          158 LEDREHGVCLHIFIQIAEAVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG  235 (332)
T ss_dssp             GGGSCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCS
T ss_pred             ccchhhHHHHHHHHHHHHHHHHHH--hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccc
Confidence             34566678999999999999999  678999999999999999999999999999865443211          11233


Q ss_pred             cCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccccccCCH
Q 013105          248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYST  327 (449)
Q Consensus       248 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (449)
                      ..||+.|+|||++.+..++.++|||||||++|||++|..|+.....     ....             . .....+....
T Consensus       236 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~-----~~~~-------------~-~~~~~~~~~~  296 (332)
T 3qd2_B          236 QVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR-----IITD-------------V-RNLKFPLLFT  296 (332)
T ss_dssp             CC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH-----HHHH-------------H-HTTCCCHHHH
T ss_pred             cCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH-----HHHH-------------h-hccCCCcccc
Confidence            5699999999999988999999999999999999999877643210     0000             0 0000111123


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          328 EGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       328 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ..++.+.+|+.+||+.||++|||+.+++++
T Consensus       297 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          297 QKYPQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             cCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence            445668999999999999999999999987

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.6e-46  Score=378.52  Aligned_cols=263  Identities=27%  Similarity=0.395  Sum_probs=214.5

Q ss_pred             HHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           74 LQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        74 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      +++..++|.+.+.||+|+||.||+|.+..       +..||||+++... ...+.+.+|+.+|+.++||||+++++++. 
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-  253 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYNK-------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-  253 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEETT-------TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEECC-------ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-
Confidence            34556789999999999999999998754       5789999997543 45678999999999999999999999986 


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      .+..++||||+.+|+|.+++.......+++..++.++.|++.||.|||  +++|+||||||+|||++.++.+||+|||++
T Consensus       254 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~Nill~~~~~~kl~DFG~a  331 (454)
T 1qcf_A          254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGLA  331 (454)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred             CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence            667899999999999999997654457889999999999999999999  677999999999999999999999999999


Q ss_pred             cCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccc
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTK  312 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  312 (449)
                      +....... .......+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+.........+            
T Consensus       332 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i------------  398 (454)
T 1qcf_A          332 RVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL------------  398 (454)
T ss_dssp             GGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH------------
T ss_pred             eEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH------------
Confidence            86533211 11122346789999999988899999999999999999999 99999765322111111            


Q ss_pred             hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCC
Q 013105          313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN  365 (449)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  365 (449)
                           ........+..+++.+.+||.+||+.||++|||+.+|++.|+.+....
T Consensus       399 -----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          399 -----ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             -----HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             -----HcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence                 111112223456677999999999999999999999999999887543

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.5e-46  Score=374.06  Aligned_cols=256  Identities=21%  Similarity=0.278  Sum_probs=206.5

Q ss_pred             HHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeE
Q 013105           74 LQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGY  150 (449)
Q Consensus        74 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~  150 (449)
                      +....++|.+.+.||+|+||.||+|.+..      +++.||+|++...   .......+.+|+.++..++||||++++++
T Consensus        64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~------~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~  137 (410)
T 3v8s_A           64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKS------TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA  137 (410)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccCccccEEEEEEEcCCCEEEEEEEECC------CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            33445789999999999999999998765      5889999999632   11222347789999999999999999999


Q ss_pred             EEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeee
Q 013105          151 CCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDF  230 (449)
Q Consensus       151 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~Df  230 (449)
                      +.+.+..||||||++||+|.+++..   ..+++..+..++.|++.||.|||  ++||+||||||+|||++.+|.+||+||
T Consensus       138 ~~~~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH--~~givHrDLKp~NILl~~~g~ikL~DF  212 (410)
T 3v8s_A          138 FQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIH--SMGFIHRDVKPDNMLLDKSGHLKLADF  212 (410)
T ss_dssp             EECSSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEECCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeeECCCCCEEEecc
Confidence            9999999999999999999998865   36899999999999999999999  678999999999999999999999999


Q ss_pred             ccccCCCCCCCCceeeecCCCCccccccccccCC----CCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhh
Q 013105          231 GLATDGPQGEDSHITTCVMGTEGYAAPEYINTGH----LTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPM  306 (449)
Q Consensus       231 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~  306 (449)
                      |++....... .......+||+.|+|||++.+..    |+.++|||||||++|||++|..||.+.........+      
T Consensus       213 G~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i------  285 (410)
T 3v8s_A          213 GTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI------  285 (410)
T ss_dssp             TTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------
T ss_pred             ceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHH------
Confidence            9998654322 11233567999999999997654    889999999999999999999999865322111111      


Q ss_pred             hccccchhHhhccc--ccccCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 013105          307 LKDFTKLDQIIDSR--LEDRYSTEGAKRLAAVAHQCLSHNPKS--RPTMTTVVKA  357 (449)
Q Consensus       307 ~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~  357 (449)
                                +...  ..-+....++.++.+||.+||..+|.+  ||++.+|++|
T Consensus       286 ----------~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          286 ----------MNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             ----------HTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             ----------HhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence                      1100  000111234567999999999999988  9999999998

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.9e-46  Score=359.78  Aligned_cols=275  Identities=27%  Similarity=0.370  Sum_probs=218.7

Q ss_pred             CHHHHHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcC-CCCCccee
Q 013105           70 TLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQL-KHPHLVNL  147 (449)
Q Consensus        70 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~  147 (449)
                      ....+....++|++.+.||+|+||.||+|.+... ....+++.||||++..... .....+.+|+.++..+ +||||+++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESS-SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecC-CccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            3445555678899999999999999999986531 2334678999999975433 3346788999999999 69999999


Q ss_pred             eeEEEeCC-EEEEEEEecCCCChHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccC
Q 013105          148 IGYCCEDE-HRLLVYEYMALGNLHDQLFKNYS--------------STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDF  212 (449)
Q Consensus       148 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDi  212 (449)
                      ++++...+ ..++||||+.+|+|.+++.....              ..+++..++.++.|++.||.|||  ++||+||||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~di  174 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDL  174 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH--HTTCCCSCC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH--hCCcccccC
Confidence            99987754 58999999999999999976532              12789999999999999999999  678999999


Q ss_pred             CCCceEEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCccccc
Q 013105          213 KASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKN  291 (449)
Q Consensus       213 kp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~  291 (449)
                      ||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999999999986654433333344567899999999988899999999999999999998 99999764


Q ss_pred             ccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          292 RCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                      .....  ...              .+........+..+++.+.+++..||+.||.+|||+.+++++|+.+++
T Consensus       255 ~~~~~--~~~--------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          255 KIDEE--FCR--------------RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             CCSHH--HHH--------------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chhHH--HHH--------------HhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            32211  110              001111112233445679999999999999999999999999998865

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.6e-46  Score=362.04  Aligned_cols=252  Identities=25%  Similarity=0.373  Sum_probs=197.8

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCC--CCcceeeeEEEe
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKH--PHLVNLIGYCCE  153 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~  153 (449)
                      .++|++.+.||+|+||.||+|.+.       .++.||||++....  ......+.+|+.+|..++|  |||+++++++.+
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   80 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE-------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT   80 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT-------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC-------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee
Confidence            467999999999999999999763       36889999997543  2334678899999999976  999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      .+..++||| +.+++|.+++...  ..+++..+..++.|++.||.|||  .+||+||||||+|||++ ++.+||+|||++
T Consensus        81 ~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH--~~~iiHrDikp~NIll~-~~~~kl~DFG~a  154 (343)
T 3dbq_A           81 DQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIV-DGMLKLIDFGIA  154 (343)
T ss_dssp             SSEEEEEEC-CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred             CCEEEEEEe-CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCcceEEEE-CCcEEEeecccc
Confidence            999999999 5578999999765  57899999999999999999999  67899999999999997 578999999999


Q ss_pred             cCCCCCCCCceeeecCCCCcccccccccc-----------CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHh
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINT-----------GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEW  302 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~  302 (449)
                      ................||+.|+|||++.+           ..++.++|||||||++|||++|+.||.......       
T Consensus       155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------  227 (343)
T 3dbq_A          155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-------  227 (343)
T ss_dssp             CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-------
T ss_pred             cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-------
Confidence            87654433333445679999999999864           678999999999999999999999997532110       


Q ss_pred             hhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          303 ARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                              ..+...+.......++...+..+.+|+.+||+.||.+|||+.++++|
T Consensus       228 --------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          228 --------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             --------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --------HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence                    01111122222223333445678999999999999999999999987

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.5e-46  Score=375.42  Aligned_cols=251  Identities=25%  Similarity=0.372  Sum_probs=199.3

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      .++|++.+.||+|+||.||+|....      +++.||||++...   .......+.+|+.+++.++||||+++++++.+.
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~  220 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKA------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH  220 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcC------CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC
Confidence            4679999999999999999998765      5889999999742   333445678899999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +..||||||+.+|+|.+++...  ..+++..+..++.|++.||.|||+ .+||+||||||+|||++.++.+||+|||++.
T Consensus       221 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~-~~giiHrDlkp~NIll~~~~~~kl~DFG~a~  297 (446)
T 4ejn_A          221 DRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCK  297 (446)
T ss_dssp             TEEEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred             CEEEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhh-cCCEEECCCCHHHEEECCCCCEEEccCCCce
Confidence            9999999999999999998765  578999999999999999999993 1779999999999999999999999999998


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ......  ......+||+.|+|||++.+..++.++|||||||+||||++|+.||...........+              
T Consensus       298 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i--------------  361 (446)
T 4ejn_A          298 EGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--------------  361 (446)
T ss_dssp             TTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------------
T ss_pred             eccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH--------------
Confidence            643322  2234467999999999999999999999999999999999999999764322111111              


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRP-----TMTTVVKA  357 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  357 (449)
                        ...  ...++..+++++.+||.+||+.||.+||     ++.++++|
T Consensus       362 --~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          362 --LME--EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             --HHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             --HhC--CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence              010  1123344556799999999999999999     99999987

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.4e-46  Score=362.30  Aligned_cols=269  Identities=25%  Similarity=0.366  Sum_probs=215.1

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcC-CCCCcceeeeEEEe
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQL-KHPHLVNLIGYCCE  153 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~  153 (449)
                      ...++|.+.+.||+|+||.||+|.+... ........||+|++..... .....+.+|+.++..+ +||||+++++++.+
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGL-GKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTC-SSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCC-CcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            3457899999999999999999987653 2223346899999975432 3456788999999999 89999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNY------------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS  221 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~  221 (449)
                      .+..++||||+.+|+|.+++....            ...+++..++.++.|++.||.|||  .+||+||||||+|||++.
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~NIl~~~  199 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA--SKNCIHRDVAARNVLLTN  199 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGCEEEG
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh--cCCcccCCcccceEEECC
Confidence            999999999999999999986532            346899999999999999999999  678999999999999999


Q ss_pred             CCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhH
Q 013105          222 DYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLV  300 (449)
Q Consensus       222 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~  300 (449)
                      ++.+||+|||++................||+.|+|||++.+..++.++|||||||++|||++ |..||.+.......  .
T Consensus       200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~--~  277 (333)
T 2i1m_A          200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF--Y  277 (333)
T ss_dssp             GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH--H
T ss_pred             CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH--H
Confidence            99999999999986544333223334457889999999988899999999999999999998 99999764322111  0


Q ss_pred             HhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          301 EWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                                    ..+........+..++..+.+|+..||+.||.+|||+.+++++|+.+..
T Consensus       278 --------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  326 (333)
T 2i1m_A          278 --------------KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ  326 (333)
T ss_dssp             --------------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------------HHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence                          1111111112233345679999999999999999999999999987653

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=9.8e-46  Score=358.31  Aligned_cols=281  Identities=23%  Similarity=0.313  Sum_probs=217.9

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEE--eCC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCC--EDE  155 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~--~~~  155 (449)
                      .++|++.+.||+|+||.||+|.+..  ....++..||||++........+.+.+|+.+++.++||||+++++++.  +..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   99 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDP--LGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ   99 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECT--TSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred             hhhhhhhhhccCCCCeEEEEEEecc--CCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence            3679999999999999999998643  233468899999998666666677899999999999999999999987  457


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++..
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          100 SLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLG--SRRCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             eEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCChhhEEECCCCCEEEccccccee
Confidence            7899999999999999987642 46899999999999999999999  67899999999999999999999999999986


Q ss_pred             CCCCCCC-ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          236 GPQGEDS-HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       236 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||............ . .........+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~-~-~~~~~~~~~~~  254 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG-C-ERDVPALSRLL  254 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc-c-ccccccHHHHH
Confidence            5433221 1122345888999999998888999999999999999999999999754321100000 0 00000001112


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCC
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN  365 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  365 (449)
                      ..+........+..+++.+.+|+..||+.||++|||+.+++++|+.+....
T Consensus       255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            222222333445566778999999999999999999999999999887644

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=8.4e-46  Score=350.98  Aligned_cols=262  Identities=26%  Similarity=0.368  Sum_probs=201.0

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ..++|++.+.||+|+||.||+|.+...   ...+..||+|++..... .....+.+|+.+++.++||||+++++++ .++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~   88 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSP---ENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TEN   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC-----CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSS
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecC---CCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccC
Confidence            456899999999999999999987642   12356799999875432 3346788999999999999999999998 456


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..++||||+.+|+|.+++... ...+++..++.++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++..
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           89 PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             SCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             ccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--hCCeecccccHHHEEECCCCCEEECccccccc
Confidence            789999999999999998754 346899999999999999999999  67899999999999999999999999999986


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchh
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ....... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||...........+              
T Consensus       166 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i--------------  230 (281)
T 1mp8_A          166 MEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI--------------  230 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH--------------
T ss_pred             cCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH--------------
Confidence            5432211 1233457889999999988899999999999999999996 99999764322111100              


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                         ........+..+++.+.+++.+||+.||++|||+.+++++|+.++.
T Consensus       231 ---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          231 ---ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             ---HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence               1111122344556779999999999999999999999999998764

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=9.1e-46  Score=348.56  Aligned_cols=251  Identities=29%  Similarity=0.452  Sum_probs=196.2

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC----cchHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG----SQGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      .++|++.+.||+|+||.||+|.+.        +..||||++....    ....+.+.+|+.+++.++||||+++++++.+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   77 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK   77 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            467999999999999999999763        5789999986442    2234678899999999999999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC---eeeccCCCCceEEcC--------C
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP---VIYRDFKASNILLDS--------D  222 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~---ivHrDikp~Nill~~--------~  222 (449)
                      .+..++||||+.+++|.+++..   ..+++..++.++.|++.||.|||  +++   |+||||||+|||++.        +
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH--~~~~~~i~H~dikp~Nil~~~~~~~~~~~~  152 (271)
T 3dtc_A           78 EPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLH--DEAIVPIIHRDLKSSNILILQKVENGDLSN  152 (271)
T ss_dssp             C--CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHH--HSSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred             CCceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH--hCCCCceeecCCchHHEEEecccccccccC
Confidence            9999999999999999988853   47899999999999999999999  566   999999999999986        6


Q ss_pred             CcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHh
Q 013105          223 YNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEW  302 (449)
Q Consensus       223 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~  302 (449)
                      +.+||+|||++.......    .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..........    
T Consensus       153 ~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----  224 (271)
T 3dtc_A          153 KILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY----  224 (271)
T ss_dssp             CCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH----
T ss_pred             cceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----
Confidence            789999999998654322    223468999999999998889999999999999999999999997643211110    


Q ss_pred             hhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcc
Q 013105          303 ARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL  361 (449)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  361 (449)
                                  ...........+..+++.+.+++.+||+.||.+|||+.+++++|+.+
T Consensus       225 ------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          225 ------------GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ------------HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ------------hhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                        01111122223445567799999999999999999999999999753

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.7e-45  Score=352.34  Aligned_cols=275  Identities=25%  Similarity=0.379  Sum_probs=212.9

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC-CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC--C
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED--E  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~  155 (449)
                      +.|++.+.||+|+||.||+|.+..  ....+++.||+|++... .......+.+|+.+++.++||||+++++++.+.  .
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   98 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDP--EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   98 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECT--TSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred             hhhhhhhccCCCCceEEEEEEEcc--ccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence            458899999999999999998643  23446899999999744 234457789999999999999999999999876  6


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..++||||+.+|+|.+++... ...+++..++.++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++..
T Consensus        99 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A           99 GIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLG--SRQYVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             CEEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             eEEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhh--cCCcccCCCchheEEEcCCCCEEECccccccc
Confidence            789999999999999998654 356899999999999999999999  67899999999999999999999999999986


Q ss_pred             CCCCCCC-ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhc--cccc
Q 013105          236 GPQGEDS-HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK--DFTK  312 (449)
Q Consensus       236 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~  312 (449)
                      ....... .......||..|+|||++.+..++.++|||||||++|+|++|..|+......    ......+...  ....
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~  251 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL----FLKMIGPTHGQMTVTR  251 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHHCSCCGGGHHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH----HhhccCCcccccCHHH
Confidence            5443221 1223456888999999998888999999999999999999999987543111    0000000000  0011


Q ss_pred             hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccc
Q 013105          313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL  362 (449)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  362 (449)
                      +...+........+..+++.+.+|+.+||+.||.+|||+.++++.|+.++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            11112222233344566778999999999999999999999999998765

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.3e-46  Score=375.43  Aligned_cols=263  Identities=19%  Similarity=0.253  Sum_probs=209.3

Q ss_pred             HHHHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceee
Q 013105           72 KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLI  148 (449)
Q Consensus        72 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~  148 (449)
                      .++....++|++.+.||+|+||.||+|.+..      +++.||+|++....   ......+.+|..++..++||||++++
T Consensus        67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~  140 (437)
T 4aw2_A           67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKN------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH  140 (437)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEE
T ss_pred             hcccCChhheEEEEEEEeCCCEEEEEEEEcC------CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence            3444556889999999999999999998765      57899999996321   11223477899999999999999999


Q ss_pred             eEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEe
Q 013105          149 GYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLS  228 (449)
Q Consensus       149 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~  228 (449)
                      +++.+.+..||||||+.||+|.+++... ...+++..+..++.|++.||.|||  +++|+||||||+|||++.++.+||+
T Consensus       141 ~~~~~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH--~~giiHrDLKp~NILl~~~g~vkL~  217 (437)
T 4aw2_A          141 YAFQDDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVH--QLHYVHRDIKPDNILMDMNGHIRLA  217 (437)
T ss_dssp             EEEECSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             EEEeeCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHH--hCCeEecccCHHHeeEcCCCCEEEc
Confidence            9999999999999999999999999763 357999999999999999999999  6789999999999999999999999


Q ss_pred             eeccccCCCCCCCCceeeecCCCCccccccccc-----cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhh
Q 013105          229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN-----TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA  303 (449)
Q Consensus       229 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~  303 (449)
                      |||+++....... ......+||+.|+|||++.     ...|+.++|||||||++|||++|++||.+.........+.  
T Consensus       218 DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~--  294 (437)
T 4aw2_A          218 DFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM--  294 (437)
T ss_dssp             CCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--
T ss_pred             chhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhh--
Confidence            9999976543322 2233467999999999986     4578999999999999999999999998653222111110  


Q ss_pred             hhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 013105          304 RPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKS--RPTMTTVVKA  357 (449)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~  357 (449)
                          ..    .   .....+.....+++++.+||.+||..+|++  ||+++++++|
T Consensus       295 ----~~----~---~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          295 ----NH----K---ERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             ----TH----H---HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             ----hc----c---ccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence                00    0   000011111234567899999999998888  9999999987

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=6.5e-46  Score=375.29  Aligned_cols=262  Identities=27%  Similarity=0.378  Sum_probs=209.8

Q ss_pred             HHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           75 QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      ++..++|++.+.||+|+||.||+|.+..       +..||||+++... ...+.+.+|+.+|+.++||||+++++++.+ 
T Consensus       180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-  250 (452)
T 1fmk_A          180 EIPRESLRLEVKLGQGCFGEVWMGTWNG-------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-  250 (452)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETT-------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             ccChhHceeeeeecCCCCeEEEEEEECC-------CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence            3445678899999999999999998764       4679999997543 345678999999999999999999999866 


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +..++||||+.+|+|.+++.......+++..++.++.|++.||.|||  +++|+||||||+|||++.++.+||+|||+++
T Consensus       251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  328 (452)
T 1fmk_A          251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLAR  328 (452)
T ss_dssp             SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred             CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChhhEEECCCCCEEECCCccce
Confidence            67899999999999999997654467899999999999999999999  6789999999999999999999999999998


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccch
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      ....... .......+++.|+|||++.+..++.++|||||||+||||++ |+.||.+.........              
T Consensus       329 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~--------------  393 (452)
T 1fmk_A          329 LIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ--------------  393 (452)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH--------------
T ss_pred             ecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH--------------
Confidence            6543221 11223447889999999988899999999999999999999 9999976532211110              


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCC
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN  365 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  365 (449)
                         +........+..+++.+.+||.+||+.||++|||+.+|++.|+.++...
T Consensus       394 ---i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          394 ---VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             ---HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             ---HHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence               0111122234456677999999999999999999999999999987654

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.9e-46  Score=366.89  Aligned_cols=269  Identities=24%  Similarity=0.365  Sum_probs=196.1

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCC-CCCcceeeeEEE
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLK-HPHLVNLIGYCC  152 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~  152 (449)
                      .+.++|++.+.||+|+||.||+|.+..      +++.||||++...  .......+.+|+.++..+. ||||+++++++.
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~   79 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRR------TGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLR   79 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETT------TCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECC------CCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEe
Confidence            467899999999999999999998765      5889999998533  3344567889999999997 999999999998


Q ss_pred             eCC--EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeee
Q 013105          153 EDE--HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDF  230 (449)
Q Consensus       153 ~~~--~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~Df  230 (449)
                      ..+  ..|+||||+. |+|.+++..   ..+++..+..++.|++.||.|||  +.||+||||||+|||++.++.+||+||
T Consensus        80 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NIll~~~~~~kl~DF  153 (388)
T 3oz6_A           80 ADNDRDVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLH--SGGLLHRDMKPSNILLNAECHVKVADF  153 (388)
T ss_dssp             CTTSSCEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             cCCCCEEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCCCHHHeEEcCCCCEEecCC
Confidence            654  7899999997 689888865   47899999999999999999999  677999999999999999999999999


Q ss_pred             ccccCCCCCC-------------------CCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccc
Q 013105          231 GLATDGPQGE-------------------DSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEK  290 (449)
Q Consensus       231 Gla~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~  290 (449)
                      |+++......                   ........+||++|+|||++.+ ..++.++|||||||++|||++|++||.+
T Consensus       154 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  233 (388)
T 3oz6_A          154 GLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG  233 (388)
T ss_dssp             TTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence            9997543210                   1112334679999999999976 6789999999999999999999999987


Q ss_pred             cccccchhhHHhhhhhhccccch--------hHhhc----------ccccc------------cCCHHHHHHHHHHHHHh
Q 013105          291 NRCKREKDLVEWARPMLKDFTKL--------DQIID----------SRLED------------RYSTEGAKRLAAVAHQC  340 (449)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~----------~~~~~------------~~~~~~~~~l~~li~~c  340 (449)
                      .........+...... .....+        ...+.          .....            .....+++++.+|+.+|
T Consensus       234 ~~~~~~~~~i~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~  312 (388)
T 3oz6_A          234 SSTMNQLERIIGVIDF-PSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKL  312 (388)
T ss_dssp             SSHHHHHHHHHHHHCC-CCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHhcCC-CCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHh
Confidence            6433322211100000 000000        00000          00000            00113356789999999


Q ss_pred             ccCCCCCCCCHHHHHHH
Q 013105          341 LSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       341 l~~dP~~RPs~~eil~~  357 (449)
                      |+.||++|||+.++++|
T Consensus       313 L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          313 LQFNPNKRISANDALKH  329 (388)
T ss_dssp             CCSSGGGSCCHHHHTTS
T ss_pred             hccCcccCCCHHHHhCC
Confidence            99999999999999998

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=354.46  Aligned_cols=249  Identities=25%  Similarity=0.277  Sum_probs=197.0

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc--chHHHHHHHHHHHhcC-CCCCcceeeeEEE
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQL-KHPHLVNLIGYCC  152 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~  152 (449)
                      .+.++|++.+.||+|+||+||+|.+..      +++.||||++.....  ........|+..+..+ +||||+++++++.
T Consensus        54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~  127 (311)
T 3p1a_A           54 FFQQSFQRLSRLGHGSYGEVFKVRSKE------DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE  127 (311)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETT------TSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhhheeeeheeccCCCeEEEEEEECC------CCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE
Confidence            345789999999999999999998875      478999999864422  2333455666655554 8999999999999


Q ss_pred             eCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecc
Q 013105          153 EDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL  232 (449)
Q Consensus       153 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGl  232 (449)
                      +.+..++||||+ +++|.+++... ...+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||+
T Consensus       128 ~~~~~~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIll~~~~~~kl~DFG~  203 (311)
T 3p1a_A          128 EGGILYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLH--SQGLVHLDVKPANIFLGPRGRCKLGDFGL  203 (311)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECGGGCEEECCCTT
T ss_pred             eCCEEEEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEECCCCCEEEcccee
Confidence            999999999999 67998888765 357999999999999999999999  67799999999999999999999999999


Q ss_pred             ccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccc
Q 013105          233 ATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK  312 (449)
Q Consensus       233 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  312 (449)
                      +.......   ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.......                 
T Consensus       204 a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-----------------  262 (311)
T 3p1a_A          204 LVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ-----------------  262 (311)
T ss_dssp             CEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH-----------------
T ss_pred             eeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-----------------
Confidence            88654322   2334569999999999876 78999999999999999999977665431100                 


Q ss_pred             hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                        .+........++..+++.+.+++.+||+.||++|||+.+++++
T Consensus       263 --~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          263 --QLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             --HHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             --HHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence              0001111111222345679999999999999999999999986

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.4e-45  Score=346.90  Aligned_cols=253  Identities=21%  Similarity=0.298  Sum_probs=207.5

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      +.++|++.+.||+|+||.||+|.+..      ++..||+|++..........+.+|+.+++.++||||+++++++.+.+.
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKG------TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTD   80 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCC------CCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe
Confidence            45779999999999999999998765      578999999976555567789999999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEE---cCCCcEEEeeeccc
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILL---DSDYNAKLSDFGLA  233 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill---~~~~~~kl~DfGla  233 (449)
                      .++||||+.+++|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||+   +.++.++|+|||++
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~  156 (277)
T 3f3z_A           81 IYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCH--KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA  156 (277)
T ss_dssp             EEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence            99999999999999988765  56899999999999999999999  6789999999999999   78889999999999


Q ss_pred             cCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccch
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      .......   ......||+.|+|||++.+ .++.++|||||||++|+|++|..||............      .....  
T Consensus       157 ~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~------~~~~~--  224 (277)
T 3f3z_A          157 ARFKPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI------REGTF--  224 (277)
T ss_dssp             EECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCCC--
T ss_pred             eeccCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH------HhCCC--
Confidence            8654332   2334569999999999875 4899999999999999999999999764322111100      00000  


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                            .........+++.+.+++.+||+.||++|||+.++++|
T Consensus       225 ------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          225 ------TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             ------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             ------CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  00000001235679999999999999999999999986

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=353.73  Aligned_cols=270  Identities=26%  Similarity=0.299  Sum_probs=203.3

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-----cchHHHHHHHHHHHhcC---CCCCccee
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-----SQGHREWLAEVIFLGQL---KHPHLVNL  147 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~h~nIv~~  147 (449)
                      .+.++|++.+.||+|+||.||+|.+..      +++.||||++....     ......+.+|+.+++.+   +||||+++
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~   79 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPH------SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRL   79 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTT------TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECC------CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEe
Confidence            456899999999999999999997654      58899999996432     11224566777777666   49999999


Q ss_pred             eeEEEeCC-----EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC
Q 013105          148 IGYCCEDE-----HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD  222 (449)
Q Consensus       148 ~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~  222 (449)
                      ++++....     ..++||||+. |+|.+++.......+++..+..++.|++.||.|||  +++|+||||||+|||++.+
T Consensus        80 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~Nil~~~~  156 (308)
T 3g33_A           80 MDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH--ANCIVHRDLKPENILVTSG  156 (308)
T ss_dssp             EEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCTTTEEECTT
T ss_pred             eeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEcCC
Confidence            99998765     5899999997 69999998776566999999999999999999999  6779999999999999999


Q ss_pred             CcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHh
Q 013105          223 YNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEW  302 (449)
Q Consensus       223 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~  302 (449)
                      +.+||+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|++||.+.........+..
T Consensus       157 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~  233 (308)
T 3g33_A          157 GTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD  233 (308)
T ss_dssp             SCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHH
T ss_pred             CCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9999999999986543222   3345699999999999888999999999999999999999999986543322211110


Q ss_pred             hhhh--hccccchhHhhccccc-------ccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          303 ARPM--LKDFTKLDQIIDSRLE-------DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       303 ~~~~--~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ....  ...+............       ......+++.+.+|+.+||+.||++|||+.++++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            0000  0000000000000000       01122345678999999999999999999999987

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.6e-45  Score=346.53  Aligned_cols=253  Identities=23%  Similarity=0.351  Sum_probs=208.0

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeC-
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCED-  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-  154 (449)
                      .++|.+.+.||+|+||.||+|.+.        +..||||++....  ....+.+.+|+.+++.++||||+++++++.+. 
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   80 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP   80 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC
Confidence            467999999999999999999873        5789999997553  33346789999999999999999999999877 


Q ss_pred             -CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--eeeccCCCCceEEcCCCcEEEeeec
Q 013105          155 -EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP--VIYRDFKASNILLDSDYNAKLSDFG  231 (449)
Q Consensus       155 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~--ivHrDikp~Nill~~~~~~kl~DfG  231 (449)
                       +..++||||+++|+|.+++.......+++..++.++.|++.||.|||  +.+  |+||||||+|||++.++.++|+|||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~~~i~H~dikp~Nil~~~~~~~~l~~~~  158 (271)
T 3kmu_A           81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH--TLEPLIPRHALNSRSVMIDEDMTARISMAD  158 (271)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT--TSSSCCTTCCCSGGGEEECTTSCEEEEGGG
T ss_pred             CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh--cCCCceecCCCccceEEEcCCcceeEEecc
Confidence             78899999999999999998765557999999999999999999999  566  9999999999999999999999998


Q ss_pred             cccCCCCCCCCceeeecCCCCccccccccccCCCCc---ccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhc
Q 013105          232 LATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTT---MCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK  308 (449)
Q Consensus       232 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  308 (449)
                      ++.....       ....||+.|+|||++.+..++.   ++|||||||++|||++|+.||.........           
T Consensus       159 ~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-----------  220 (271)
T 3kmu_A          159 VKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG-----------  220 (271)
T ss_dssp             SCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH-----------
T ss_pred             ceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH-----------
Confidence            8764322       2245899999999998665544   799999999999999999999764322110           


Q ss_pred             cccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                           ............+..+++.+.+++..||+.||++|||+.++++.|+.+.+
T Consensus       221 -----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          221 -----MKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             -----HHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             -----HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                 11111122233345566779999999999999999999999999987653

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.4e-45  Score=378.98  Aligned_cols=255  Identities=26%  Similarity=0.408  Sum_probs=211.3

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      .++|.+.+.||+|+||.||+|.+..      +++.||+|++...   .......+.+|+.+|..++||||+++++++.+.
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~------tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  256 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRA------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK  256 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECC------CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC
Confidence            4679999999999999999998765      5889999999642   223356688999999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +..|+||||+.||+|.+++.......+++..+..++.|++.||.|||  .+||+||||||+|||++.+|.+||+|||++.
T Consensus       257 ~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH--~~gIvHrDLKPeNILld~~g~vKL~DFGla~  334 (576)
T 2acx_A          257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH--RERIVYRDLKPENILLDDHGHIRISDLGLAV  334 (576)
T ss_dssp             SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCEeccCCchheEEEeCCCCeEEEecccce
Confidence            99999999999999999998765566999999999999999999999  6789999999999999999999999999998


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ......   .....+||+.|+|||++.+..|+.++|||||||++|||++|..||...........+.             
T Consensus       335 ~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~-------------  398 (576)
T 2acx_A          335 HVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE-------------  398 (576)
T ss_dssp             ECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH-------------
T ss_pred             ecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH-------------
Confidence            654332   2344579999999999998889999999999999999999999998653221111110             


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRP-----TMTTVVKA  357 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  357 (449)
                      ..+. .....++..++.++.+||.+||+.||.+||     ++.+|++|
T Consensus       399 ~~i~-~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          399 RLVK-EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             HHHH-HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             HHhh-cccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence            0000 011223445567799999999999999999     78999887

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=363.05  Aligned_cols=248  Identities=25%  Similarity=0.324  Sum_probs=198.6

Q ss_pred             cccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEEEe
Q 013105           84 SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEY  163 (449)
Q Consensus        84 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  163 (449)
                      .+.||+|+||.||+|.+..      +++.||+|++..........+.+|+.+|+.++||||+++++++.+.+..+|||||
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~  167 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETA------TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY  167 (373)
T ss_dssp             EEECC-----CEEEEEETT------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ceEEecCcCEEEEEEEEcC------CCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence            5689999999999998765      5789999999866555667889999999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEE--cCCCcEEEeeeccccCCCCCCC
Q 013105          164 MALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILL--DSDYNAKLSDFGLATDGPQGED  241 (449)
Q Consensus       164 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill--~~~~~~kl~DfGla~~~~~~~~  241 (449)
                      +++|+|.+++... ...+++..+..++.|++.||.|||  +.+|+||||||+|||+  +.++.+||+|||++........
T Consensus       168 ~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~  244 (373)
T 2x4f_A          168 VDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMH--QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK  244 (373)
T ss_dssp             CTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred             CCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence            9999999988654 246899999999999999999999  6789999999999999  5678999999999986544321


Q ss_pred             CceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccc
Q 013105          242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRL  321 (449)
Q Consensus       242 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (449)
                         .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.........+      .....        ..
T Consensus       245 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i------~~~~~--------~~  307 (373)
T 2x4f_A          245 ---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI------LACRW--------DL  307 (373)
T ss_dssp             ---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHTCC--------CS
T ss_pred             ---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhccC--------CC
Confidence               23346999999999999888999999999999999999999999765322111100      00000        00


Q ss_pred             cccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          322 EDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       322 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .......+++++.+||.+||+.||.+|||+.++++|
T Consensus       308 ~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          308 EDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            111112345679999999999999999999999987

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=359.94  Aligned_cols=254  Identities=23%  Similarity=0.316  Sum_probs=193.3

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      .+.++|.+.+.||+|+||.||+|.+..      +++.||||++....  ..+.+.+|+.+++.++||||+++++++.+.+
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  121 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKG------TQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT  121 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSS
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECC------CCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCC
Confidence            356789999999999999999998765      47899999997442  3456788999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC---CCcEEEeeecc
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS---DYNAKLSDFGL  232 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~---~~~~kl~DfGl  232 (449)
                      ..++||||+.+|+|.+++...  ..+++..+..++.|++.||.|||  +.||+||||||+|||++.   ++.+||+|||+
T Consensus       122 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~  197 (349)
T 2w4o_A          122 EISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLH--ENGIVHRDLKPENLLYATPAPDAPLKIADFGL  197 (349)
T ss_dssp             EEEEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred             eEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCcccEEEecCCCCCCEEEccCcc
Confidence            999999999999999998764  56899999999999999999999  678999999999999975   88999999999


Q ss_pred             ccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccc
Q 013105          233 ATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK  312 (449)
Q Consensus       233 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  312 (449)
                      +.......   ......||+.|+|||++.+..++.++|||||||++|||++|..||........  ...   .....   
T Consensus       198 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~---~i~~~---  266 (349)
T 2w4o_A          198 SKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MFR---RILNC---  266 (349)
T ss_dssp             ------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HHH---HHHTT---
T ss_pred             ccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HHH---HHHhC---
Confidence            98654321   23345699999999999988999999999999999999999999975432110  000   00000   


Q ss_pred             hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                           ...........++..+.+|+.+||+.||++|||+.+++++
T Consensus       267 -----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          267 -----EYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             -----CCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -----CCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 0001112223455679999999999999999999999997

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.5e-45  Score=365.65  Aligned_cols=252  Identities=24%  Similarity=0.367  Sum_probs=197.9

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCC--CCCcceeeeEEEe
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLK--HPHLVNLIGYCCE  153 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~nIv~~~~~~~~  153 (449)
                      ..+|.+.+.||+|+||.||+|.+.       .++.||||++....  ......+.+|+.+|..++  ||||+++++++..
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~  127 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNE-------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT  127 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECT-------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             CCceEEEEEEccCCCeEEEEEEcC-------CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec
Confidence            346999999999999999999653       26889999997543  334567899999999996  5999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      .+..||||| +.+++|.+++...  ..+++..+..++.|++.||.|||  .++|+||||||+|||++ ++.+||+|||++
T Consensus       128 ~~~~~lv~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH--~~~ivHrDlkp~NIll~-~~~~kl~DFG~a  201 (390)
T 2zmd_A          128 DQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIV-DGMLKLIDFGIA  201 (390)
T ss_dssp             SSEEEEEEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHH--TTTCCCCCCCGGGEEES-SSCEEECCCSSS
T ss_pred             CCEEEEEEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHEEEE-CCeEEEEecCcc
Confidence            999999999 5678999999765  47888999999999999999999  77899999999999995 579999999999


Q ss_pred             cCCCCCCCCceeeecCCCCcccccccccc-----------CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHh
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINT-----------GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEW  302 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~  302 (449)
                      ...............+||+.|+|||++.+           ..++.++|||||||+||||++|..||.......     . 
T Consensus       202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~-  275 (390)
T 2zmd_A          202 NQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----S-  275 (390)
T ss_dssp             CCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----H-
T ss_pred             ccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-----H-
Confidence            87654333323345679999999999864           368999999999999999999999997532110     0 


Q ss_pred             hhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          303 ARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                               .+..++.......++...+..+.+|+.+||+.||.+|||+.+++++
T Consensus       276 ---------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          276 ---------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             ---------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ---------HHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence                     0111112111222223335678999999999999999999999987

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.3e-45  Score=346.35  Aligned_cols=254  Identities=22%  Similarity=0.339  Sum_probs=207.8

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      +.++|++.+.||+|+||.||+|.+..      +++.||+|++....  ......+.+|+.+++.++||||+++++++.+.
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   77 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKT------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE   77 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcC------CCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC
Confidence            45789999999999999999998765      57899999997442  33456788999999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCc---EEEeeec
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYN---AKLSDFG  231 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~---~kl~DfG  231 (449)
                      +..++||||+.+++|.+.+...  ..+++..+..++.|++.||.|||  +.||+||||||+|||++.++.   +||+|||
T Consensus        78 ~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg  153 (284)
T 3kk8_A           78 SFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFG  153 (284)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             CEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcCcCCCCHHHEEEecCCCCCcEEEeece
Confidence            9999999999999999988765  57899999999999999999999  678999999999999987655   9999999


Q ss_pred             cccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcccc
Q 013105          232 LATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFT  311 (449)
Q Consensus       232 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  311 (449)
                      ++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.............      ..  
T Consensus       154 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~------~~--  222 (284)
T 3kk8_A          154 LAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK------AG--  222 (284)
T ss_dssp             TCEECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HT--
T ss_pred             eeEEcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHH------hc--
Confidence            997654322   1234569999999999998899999999999999999999999997643221111110      00  


Q ss_pred             chhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          312 KLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                            ...........+++.+.+++.+||+.||++|||+.+++++
T Consensus       223 ------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          223 ------AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             ------CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ------cccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                  0001111122445679999999999999999999999987

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.5e-45  Score=355.55  Aligned_cols=253  Identities=27%  Similarity=0.360  Sum_probs=198.6

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC----cchHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG----SQGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      .++|++.+.||+|+||.||+|....+   ..+++.||+|++....    ......+.+|+.+|+.++||||+++++++.+
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   92 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTG---ANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSS---TTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEecc---CCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence            46799999999999999999977421   2357899999997432    2234567789999999999999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      .+..|+||||+.||+|.+++...  ..+++..+..++.|++.||.|||  .+||+||||||+|||++.++.+||+|||++
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           93 GGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLH--QKGIIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             SSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--hCCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            99999999999999999999765  56889999999999999999999  678999999999999999999999999999


Q ss_pred             cCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccch
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      .......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||..........               
T Consensus       169 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---------------  231 (327)
T 3a62_A          169 KESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID---------------  231 (327)
T ss_dssp             ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---------------
T ss_pred             cccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHH---------------
Confidence            7543221  12334579999999999998889999999999999999999999997643221111               


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRP-----TMTTVVKA  357 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  357 (449)
                       .+...  ...++..++..+.+++.+||+.||.+||     ++.++++|
T Consensus       232 -~i~~~--~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          232 -KILKC--KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             -HHHHT--CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             -HHHhC--CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence             01111  1122334556799999999999999999     78899887

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=9.1e-46  Score=360.63  Aligned_cols=254  Identities=20%  Similarity=0.339  Sum_probs=203.5

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcC-CCCCcceeeeEEEeCC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCEDE  155 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~  155 (449)
                      +.++|++.+.||+|+||.||+|.+..      +++.||||++......    ..+|++++.++ +||||+++++++.+.+
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~   89 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKA------TNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGK   89 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECC------CCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence            45789999999999999999998765      5889999999754332    34578888777 7999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC----CcEEEeeec
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD----YNAKLSDFG  231 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~----~~~kl~DfG  231 (449)
                      ..|+||||+.||+|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||+..+    +.+||+|||
T Consensus        90 ~~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH--~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg  165 (342)
T 2qr7_A           90 YVYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLH--AQGVVHRDLKPSNILYVDESGNPESIRICDFG  165 (342)
T ss_dssp             EEEEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred             EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence            999999999999999999765  57899999999999999999999  6789999999999998543    359999999


Q ss_pred             cccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcccc
Q 013105          232 LATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFT  311 (449)
Q Consensus       232 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  311 (449)
                      ++........  .....+||+.|+|||++.+..|+.++|||||||++|||++|..||................   ..  
T Consensus       166 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~---~~--  238 (342)
T 2qr7_A          166 FAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG---SG--  238 (342)
T ss_dssp             TCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH---HC--
T ss_pred             CcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc---cC--
Confidence            9986543322  2334579999999999988889999999999999999999999997542221111111110   00  


Q ss_pred             chhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          312 KLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                            .......+...+++.+.+|+.+||+.||++|||+.++++|
T Consensus       239 ------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          239 ------KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             ------CCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             ------CcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                  0011122234456679999999999999999999999987

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.3e-45  Score=358.66  Aligned_cols=270  Identities=26%  Similarity=0.374  Sum_probs=215.3

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCC-CCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcC-CCCCcceeeeEEEe
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLR-PGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQL-KHPHLVNLIGYCCE  153 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~  153 (449)
                      ..++|.+.+.||+|+||.||+|.+..... ....+..||+|++.... ......+.+|+.+++.+ +||||+++++++.+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            35789999999999999999998753111 12357789999997543 23456788999999999 89999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEE
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYS--------------STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILL  219 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill  219 (449)
                      .+..++||||+.+|+|.+++.....              ..+++..++.++.|++.||.|||  .+||+||||||+|||+
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA--SQKCIHRDLAARNVLV  190 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCccceEEE
Confidence            9999999999999999999976432              34889999999999999999999  6789999999999999


Q ss_pred             cCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchh
Q 013105          220 DSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKD  298 (449)
Q Consensus       220 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~  298 (449)
                      +.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.+......  
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--  268 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL--  268 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH--
Confidence            9999999999999986544332222334457889999999988889999999999999999999 9999976432111  


Q ss_pred             hHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCC
Q 013105          299 LVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN  365 (449)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  365 (449)
                       ...              +........+..++..+.+++.+||+.||.+|||+.+++++|+.++...
T Consensus       269 -~~~--------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~  320 (334)
T 2pvf_A          269 -FKL--------------LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  320 (334)
T ss_dssp             -HHH--------------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -HHH--------------HhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence             110              0111112233445667999999999999999999999999999887543

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.2e-46  Score=361.78  Aligned_cols=272  Identities=24%  Similarity=0.360  Sum_probs=215.9

Q ss_pred             HHHHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeE
Q 013105           72 KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGY  150 (449)
Q Consensus        72 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~  150 (449)
                      .+++...++|.+.+.||+|+||.||+|.+... .....+..||+|++..... .....+.+|+.+++.++||||++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   96 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGV-VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV   96 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEE-ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCc-cCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence            34455678899999999999999999977531 1112467899999974432 334568899999999999999999999


Q ss_pred             EEeCCEEEEEEEecCCCChHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC
Q 013105          151 CCEDEHRLLVYEYMALGNLHDQLFKNY--------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD  222 (449)
Q Consensus       151 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~  222 (449)
                      +.+.+..++||||+.+|+|.+++....        ...+++..++.++.|++.||.|||  ++||+||||||+|||++.+
T Consensus        97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAED  174 (322)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCSGGGEEECTT
T ss_pred             EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH--HCCCccCCCccceEEEcCC
Confidence            999999999999999999999986532        145789999999999999999999  6789999999999999999


Q ss_pred             CcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHH
Q 013105          223 YNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVE  301 (449)
Q Consensus       223 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~  301 (449)
                      +.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.........   .
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~  251 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL---R  251 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH---H
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH---H
Confidence            9999999999975433222222223456889999999988889999999999999999999 89999764321111   1


Q ss_pred             hhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          302 WARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                      ..              ........+..++..+.+++.+||+.||.+|||+.+++++|+..+.
T Consensus       252 ~~--------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          252 FV--------------MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HH--------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HH--------------HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            00              0001112234456679999999999999999999999999998765

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.2e-45  Score=357.46  Aligned_cols=249  Identities=24%  Similarity=0.343  Sum_probs=181.3

Q ss_pred             cccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC-CCCcceeeeEEEeCCEEEEEEE
Q 013105           84 SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-HPHLVNLIGYCCEDEHRLLVYE  162 (449)
Q Consensus        84 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e  162 (449)
                      .+.||+|+||.||+|.+..      +++.||||++...   ....+.+|+.+++.+. ||||+++++++.+....|+|||
T Consensus        16 ~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e   86 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKK------SNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVME   86 (325)
T ss_dssp             SCCSEEETTEEEEEEEETT------TCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCccccCCCeEEEEEEECC------CCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEE
Confidence            3789999999999998765      5889999999642   3456778999999997 9999999999999999999999


Q ss_pred             ecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC---cEEEeeeccccCCCCC
Q 013105          163 YMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY---NAKLSDFGLATDGPQG  239 (449)
Q Consensus       163 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~---~~kl~DfGla~~~~~~  239 (449)
                      |+.||+|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++   .+||+|||++......
T Consensus        87 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  162 (325)
T 3kn6_A           87 LLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMH--DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD  162 (325)
T ss_dssp             CCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred             ccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence            99999999999765  67999999999999999999999  67899999999999997765   8999999999865432


Q ss_pred             CCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccch-hhHHhhhhhhccccchhHhhc
Q 013105          240 EDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREK-DLVEWARPMLKDFTKLDQIID  318 (449)
Q Consensus       240 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  318 (449)
                      ..  ......||+.|+|||++.+..++.++|||||||++|+|++|..||......... .......          .+..
T Consensus       163 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~----------~i~~  230 (325)
T 3kn6_A          163 NQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK----------KIKK  230 (325)
T ss_dssp             -----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHH----------HHTT
T ss_pred             CC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHH----------HHHc
Confidence            22  233456899999999999889999999999999999999999999764321110 0011100          0111


Q ss_pred             cc--ccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          319 SR--LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       319 ~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ..  ........+++++.+|+.+||+.||.+|||+.++++|
T Consensus       231 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          231 GDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             TCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             CCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            10  0111112346679999999999999999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.1e-45  Score=354.66  Aligned_cols=276  Identities=28%  Similarity=0.427  Sum_probs=214.4

Q ss_pred             cCC-CCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEe--C
Q 013105           79 HNF-SRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCE--D  154 (449)
Q Consensus        79 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~  154 (449)
                      ++| ++.+.||+|+||.||++++..  ....+++.||||++..... .....+.+|+.+++.++||||+++++++.+  .
T Consensus        30 ~r~~~~~~~lG~G~~g~V~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (318)
T 3lxp_A           30 KRYLKKIRDLGEGHFGKVSLYCYDP--TNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA  107 (318)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECS--CC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred             HHHHhhhheecCCCCeEEEEEEEcc--CCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence            444 889999999999999997754  3344688999999975532 335678899999999999999999999988  4


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      ...++||||+.+|+|.+++...   .+++..++.++.|++.||.|||  +.||+||||||+|||++.++.+||+|||++.
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH--~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  182 (318)
T 3lxp_A          108 ASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLH--AQHYIHRDLAARNVLLDNDRLVKIGDFGLAK  182 (318)
T ss_dssp             TEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             ceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCchheEEEcCCCCEEECCccccc
Confidence            6889999999999999998664   5899999999999999999999  6789999999999999999999999999998


Q ss_pred             CCCCCCCC-ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccch
Q 013105          235 DGPQGEDS-HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       235 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      ........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ....+.... .....+
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~-~~~~~~  260 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQ-MTVLRL  260 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHH-HHHHHH
T ss_pred             cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccc-hhHHHH
Confidence            76543221 122335588899999999988899999999999999999999999975421100 000000000 000111


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                      ...+........+..++..+.+|+.+||+.||++|||+.++++.|+.+..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  310 (318)
T 3lxp_A          261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE  310 (318)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            22222333334455667789999999999999999999999999988754

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.7e-45  Score=354.40  Aligned_cols=254  Identities=22%  Similarity=0.293  Sum_probs=207.7

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc------chHHHHHHHHHHHhcCCCCCcceeeeE
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS------QGHREWLAEVIFLGQLKHPHLVNLIGY  150 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~~~~~  150 (449)
                      +.++|.+.+.||+|+||.||+|.+..      +++.||+|++.....      .....+.+|+.+++.++||||++++++
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   83 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKS------TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDV   83 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECC------CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            45679999999999999999998765      578999999975422      135778999999999999999999999


Q ss_pred             EEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC----cEE
Q 013105          151 CCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY----NAK  226 (449)
Q Consensus       151 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~----~~k  226 (449)
                      +.+.+..++||||+.+++|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++    .+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH--~~~ivH~dikp~NIl~~~~~~~~~~~k  159 (321)
T 2a2a_A           84 YENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIK  159 (321)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred             EecCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCChHHEEEecCCCCcCCEE
Confidence            99999999999999999999999754  57899999999999999999999  67899999999999999888    799


Q ss_pred             EeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhh
Q 013105          227 LSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPM  306 (449)
Q Consensus       227 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~  306 (449)
                      |+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+      
T Consensus       160 l~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i------  230 (321)
T 2a2a_A          160 LIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI------  230 (321)
T ss_dssp             ECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------
T ss_pred             EccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------
Confidence            999999986544321   23456999999999999889999999999999999999999999764322111100      


Q ss_pred             hccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          307 LKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .....        ..........+..+.+|+.+||+.||++|||+.++++|
T Consensus       231 ~~~~~--------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          231 TSVSY--------DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             HTTCC--------CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             Hhccc--------ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00000        00011112334568999999999999999999999997

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.5e-45  Score=349.28  Aligned_cols=263  Identities=28%  Similarity=0.450  Sum_probs=197.6

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      +..++|++.+.||+|+||.||+|.+.         ..||+|++....  ......+.+|+.+++.++||||+++++++ .
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~   90 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWH---------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T   90 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESS---------SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-C
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEc---------CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-c
Confidence            34578999999999999999999653         359999997543  33446788999999999999999999965 5


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      ....++||||+.+++|.+++... ...+++..++.++.|++.||.|||  +.+|+||||||+|||++.++.+||+|||++
T Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH--~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  167 (289)
T 3og7_A           91 APQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLH--AKSIIHRDLKSNNIFLHEDNTVKIGDFGLA  167 (289)
T ss_dssp             SSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred             CCccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH--hCCcccccCccceEEECCCCCEEEccceec
Confidence            56789999999999999988654 357899999999999999999999  678999999999999999999999999999


Q ss_pred             cCCCCCCCCceeeecCCCCccccccccc---cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccc
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYIN---TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF  310 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  310 (449)
                      ................||+.|+|||++.   +..++.++|||||||++|+|++|+.||........  ........    
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~----  241 (289)
T 3og7_A          168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVGRG----  241 (289)
T ss_dssp             ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHHHHT----
T ss_pred             cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHhccc----
Confidence            8654333333344467999999999986   56788899999999999999999999976432211  11111000    


Q ss_pred             cchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                            ............+++.+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       242 ------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          242 ------SLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             ------SCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ------ccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence                  00011112234556779999999999999999999999999988753

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.1e-45  Score=345.80  Aligned_cols=248  Identities=28%  Similarity=0.426  Sum_probs=204.5

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      .++|++.+.||+|+||.||+|.+..      ++..||+|++....   ......+.+|+.+++.++||||+++++++.+.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   81 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQ------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA   81 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccEEEeeEEecCCCeEEEEEEEcc------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC
Confidence            4679999999999999999998766      57899999985321   22345688999999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +..++||||+.+|+|.+++...  ..+++..+..++.|++.||.|||  ..||+||||||+|||++.++.++|+|||++.
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH--~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~  157 (279)
T 3fdn_A           82 TRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSV  157 (279)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--TTTCEECCCCGGGEEECTTSCEEECSCCEES
T ss_pred             CEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCEecccCChHhEEEcCCCCEEEEeccccc
Confidence            9999999999999999998765  56899999999999999999999  7889999999999999999999999999987


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ......    .....||+.|+|||++.+..++.++|||||||++|+|++|..||.............             
T Consensus       158 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------------  220 (279)
T 3fdn_A          158 HAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------------  220 (279)
T ss_dssp             CC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-------------
T ss_pred             cCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH-------------
Confidence            543322    234568999999999998899999999999999999999999997643221111110             


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                         .  ....++...++.+.+|+.+||+.||.+|||+.++++|
T Consensus       221 ---~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          221 ---R--VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             ---H--TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             ---h--CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence               0  1112233445678999999999999999999999997

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.7e-45  Score=348.85  Aligned_cols=266  Identities=21%  Similarity=0.287  Sum_probs=200.8

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc--chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      ++|++.+.||+|+||.||+|.+.       +++.||+|++.....  .....+.+|+.+++.++||||+++++++.+.+.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNN-------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             ccchhhhhcccCCCEEEEEEEcC-------CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe
Confidence            57999999999999999999763       378999999975432  223678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||+. ++|.+++... ...+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++...
T Consensus        75 ~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (288)
T 1ob3_A           75 LVLVFEHLD-QDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLARAF  150 (288)
T ss_dssp             EEEEEECCS-EEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             EEEEEEecC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCCEEEeECcccccc
Confidence            999999998 4898887653 357899999999999999999999  678999999999999999999999999999754


Q ss_pred             CCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHh-h-hhhhccccch
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEW-A-RPMLKDFTKL  313 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~-~-~~~~~~~~~~  313 (449)
                      ....  .......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+............ . .+....+...
T Consensus       151 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (288)
T 1ob3_A          151 GIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV  228 (288)
T ss_dssp             CC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             Cccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhh
Confidence            3221  11233468999999999965 4589999999999999999999999986543221111100 0 0000000000


Q ss_pred             hHhh---------cccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          314 DQII---------DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       314 ~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ....         ...........+++.+.+|+.+||+.||++|||+.++++|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            0000         0000111223456678999999999999999999999987

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.5e-45  Score=373.32  Aligned_cols=265  Identities=20%  Similarity=0.260  Sum_probs=198.7

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      +.++|++.+.||+|+||.||+|.+..      +++.||||++...  .......+.+|+.+|+.++||||+++++++...
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~------~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  133 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAV------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ  133 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETT------TTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECC------CCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccC
Confidence            35789999999999999999997765      5889999999743  334456788999999999999999999999654


Q ss_pred             ------CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEe
Q 013105          155 ------EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLS  228 (449)
Q Consensus       155 ------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~  228 (449)
                            ...||||||+.+ +|.+.+.    ..+++..+..++.|++.||.|||  +.||+||||||+|||++.++.+||+
T Consensus       134 ~~~~~~~~~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH--~~~iiHrDlkp~NIll~~~~~~kl~  206 (464)
T 3ttj_A          134 KTLEEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKIL  206 (464)
T ss_dssp             CSTTTCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred             CccccCCeEEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChHhEEEeCCCCEEEE
Confidence                  467999999985 5666663    34889999999999999999999  6779999999999999999999999


Q ss_pred             eeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhh--h-
Q 013105          229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR--P-  305 (449)
Q Consensus       229 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~--~-  305 (449)
                      |||+++......   .....+||+.|+|||++.+..|+.++|||||||+||||++|++||.+.........+....  + 
T Consensus       207 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~  283 (464)
T 3ttj_A          207 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC  283 (464)
T ss_dssp             CCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred             EEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            999998654322   2344679999999999999999999999999999999999999998754322221110000  0 


Q ss_pred             --hhccc-cchhHhhcc---------------ccc---ccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          306 --MLKDF-TKLDQIIDS---------------RLE---DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       306 --~~~~~-~~~~~~~~~---------------~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                        .+... ......+..               ...   .......+.++.+|+.+||+.||++|||+.|+++|
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence              00000 000000000               000   00111236779999999999999999999999998

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7.2e-45  Score=350.30  Aligned_cols=268  Identities=24%  Similarity=0.303  Sum_probs=201.0

Q ss_pred             HhcCCCCc-ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcC-CCCCcceeeeEEEeC
Q 013105           77 ITHNFSRS-DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCED  154 (449)
Q Consensus        77 ~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~  154 (449)
                      +.+.|.+. +.||+|+||.||+|.+..      +++.||||++..........+.+|+.++.++ +||||+++++++.+.
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~   83 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCINLI------TSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE   83 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEECSS------SCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             cceeEEecCceecCCceEEEEEEEEcC------CCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            34678884 789999999999997654      5789999999866555677889999999885 799999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCc---EEEeeec
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYN---AKLSDFG  231 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~---~kl~DfG  231 (449)
                      +..|+||||+.+|+|.+++...  ..+++..+..++.|++.||.|||  +++|+||||||+|||++.++.   +||+|||
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg  159 (316)
T 2ac3_A           84 DRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLH--NKGIAHRDLKPENILCEHPNQVSPVKICDFD  159 (316)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred             CEEEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH--hCCceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence            9999999999999999999765  57899999999999999999999  678999999999999988776   9999999


Q ss_pred             cccCCCCCCC-----CceeeecCCCCcccccccccc-----CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHH
Q 013105          232 LATDGPQGED-----SHITTCVMGTEGYAAPEYINT-----GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVE  301 (449)
Q Consensus       232 la~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~  301 (449)
                      ++........     ........||+.|+|||++.+     ..++.++|||||||++|||++|..||.............
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~  239 (316)
T 2ac3_A          160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG  239 (316)
T ss_dssp             CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred             CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence            9875432211     111223469999999999864     458999999999999999999999997653221000000


Q ss_pred             hhhhhhccccchhHhhcccccccCC----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          302 WARPMLKDFTKLDQIIDSRLEDRYS----TEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ...+.. .......+....  ..++    ..++..+.+|+.+||+.||++|||+.++++|
T Consensus       240 ~~~~~~-~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          240 EACPAC-QNMLFESIQEGK--YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             -CCHHH-HHHHHHHHHHCC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ccchhH-HHHHHHHHhccC--cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            000000 000000000100  0111    1245679999999999999999999999997

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.9e-45  Score=364.62  Aligned_cols=254  Identities=22%  Similarity=0.294  Sum_probs=194.5

Q ss_pred             HhcCCCCc-ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHH-hcCCCCCcceeeeEEEe-
Q 013105           77 ITHNFSRS-DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFL-GQLKHPHLVNLIGYCCE-  153 (449)
Q Consensus        77 ~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~~~~~~~~-  153 (449)
                      +.++|.+. +.||+|+||.||+|.+..      +++.||||++...     ..+.+|+.++ +..+||||+++++++.. 
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~------~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~  127 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKR------TQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL  127 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECC------CCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeec
Confidence            34567776 789999999999998765      5889999999632     4566788887 44589999999999876 


Q ss_pred             ---CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC---CCcEEE
Q 013105          154 ---DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS---DYNAKL  227 (449)
Q Consensus       154 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~---~~~~kl  227 (449)
                         ...+||||||+.||+|.+++.......+++..+..++.|++.||.|||  +.||+||||||+|||++.   ++.+||
T Consensus       128 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~~~~kl  205 (400)
T 1nxk_A          128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAILKL  205 (400)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSTTCCEEE
T ss_pred             ccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCcCcceEEEecCCCCccEEE
Confidence               567899999999999999998765567999999999999999999999  678999999999999987   789999


Q ss_pred             eeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchh-hHHhhhhh
Q 013105          228 SDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKD-LVEWARPM  306 (449)
Q Consensus       228 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~-~~~~~~~~  306 (449)
                      +|||++.......   .....+||+.|+|||++.+..|+.++|||||||++|||++|..||.......... ....... 
T Consensus       206 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~-  281 (400)
T 1nxk_A          206 TDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM-  281 (400)
T ss_dssp             CCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH-
T ss_pred             EecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc-
Confidence            9999998654322   2334568999999999998999999999999999999999999997653221100 0000000 


Q ss_pred             hccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          307 LKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       .         ...........++.++.+||.+||+.||++|||+.++++|
T Consensus       282 -~---------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          282 -G---------QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             -T---------CCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -C---------cccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence             0         0001111113455679999999999999999999999997

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=4.1e-45  Score=351.58  Aligned_cols=266  Identities=24%  Similarity=0.393  Sum_probs=203.1

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      ..++|.+.+.||+|+||.||+|.+...   ..++..||+|++....  ......+.+|+.+++.++||||+++++++.+.
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQE---DGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECT---TSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             CHHHeeeccceeecCCeEEEEEEEecc---CCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            456799999999999999999987642   2246689999997543  33346788999999999999999999999875


Q ss_pred             C-----EEEEEEEecCCCChHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcE
Q 013105          155 E-----HRLLVYEYMALGNLHDQLFKN----YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNA  225 (449)
Q Consensus       155 ~-----~~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~  225 (449)
                      +     ..++||||+.+|+|.+++...    ....+++..++.++.|++.||.|||  ++||+||||||+|||++.++.+
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS--NRNFLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH--TTTCCCCCCSGGGEEECTTSCE
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCcceEEEcCCCcE
Confidence            4     359999999999999998532    3467899999999999999999999  7789999999999999999999


Q ss_pred             EEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhh
Q 013105          226 KLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWAR  304 (449)
Q Consensus       226 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~  304 (449)
                      ||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||...........     
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-----  261 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY-----  261 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-----
T ss_pred             EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH-----
Confidence            9999999986544332222334457889999999998899999999999999999999 8999976432211110     


Q ss_pred             hhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          305 PMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                                  +........+..+++.+.+++.+||+.||.+|||+.+++++|+.++..
T Consensus       262 ------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~  309 (313)
T 3brb_A          262 ------------LLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES  309 (313)
T ss_dssp             ------------HHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------------HHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                        011111222344556799999999999999999999999999988653

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=6.4e-46  Score=357.13  Aligned_cols=262  Identities=24%  Similarity=0.323  Sum_probs=198.8

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc---chHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS---QGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      +.++|++.+.||+|+||.||+|.+..      +++.||||++.....   .....+.+|+.++..++||||+++++++..
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   83 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLR------DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA   83 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECC------CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeec
Confidence            45789999999999999999998765      588999999975422   234568899999999999999999999876


Q ss_pred             CC----EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEee
Q 013105          154 DE----HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSD  229 (449)
Q Consensus       154 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~D  229 (449)
                      ..    ..|+||||++|++|.+++...  ..+++..++.++.|++.||.|||  +++|+||||||+|||++.++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~D  159 (311)
T 3ork_A           84 ETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMD  159 (311)
T ss_dssp             EETTEEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEETTSCEEECC
T ss_pred             cCCCCcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCCcCCCCHHHEEEcCCCCEEEee
Confidence            43    349999999999999999765  57899999999999999999999  67899999999999999999999999


Q ss_pred             eccccCCCCCCCC-ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhc
Q 013105          230 FGLATDGPQGEDS-HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK  308 (449)
Q Consensus       230 fGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  308 (449)
                      ||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+........      ....
T Consensus       160 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~------~~~~  233 (311)
T 3ork_A          160 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY------QHVR  233 (311)
T ss_dssp             CSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHH
T ss_pred             ccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHhc
Confidence            9999865432211 22334569999999999998899999999999999999999999997653221110      0000


Q ss_pred             cccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH-hhccc
Q 013105          309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA-LEPLL  362 (449)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~-L~~~~  362 (449)
                      ...        .........++.++.+|+.+||+.||++||+..+++.+ |....
T Consensus       234 ~~~--------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          234 EDP--------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             CCC--------CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCC--------CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            000        00001122345679999999999999999977666654 44443

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=6.7e-46  Score=352.81  Aligned_cols=259  Identities=26%  Similarity=0.436  Sum_probs=206.1

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCC-CCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLR-PGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      .++|.+.+.||+|+||.||+|.+..... ....+..||+|++........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            4679999999999999999998765210 111235799999976656667889999999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCc--------EEEe
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYN--------AKLS  228 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~--------~kl~  228 (449)
                      .++||||+.+|+|.+++... ...+++..+..++.|++.||.|||  +++|+||||||+|||++.++.        +||+
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLE--ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             CEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHh--hCCeECCCcCcceEEEecCCcccccccceeeec
Confidence            99999999999999999764 234899999999999999999999  677999999999999998887        9999


Q ss_pred             eeccccCCCCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCC-CcccccccccchhhHHhhhhh
Q 013105          229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGR-RSVEKNRCKREKDLVEWARPM  306 (449)
Q Consensus       229 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~-~pf~~~~~~~~~~~~~~~~~~  306 (449)
                      |||++.....      .....||+.|+|||++.+ ..++.++|||||||++|||++|. +||.............     
T Consensus       164 Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~-----  232 (289)
T 4fvq_A          164 DPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE-----  232 (289)
T ss_dssp             CCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-----
T ss_pred             cCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh-----
Confidence            9999875432      123458999999999987 67899999999999999999955 4444322111100000     


Q ss_pred             hccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          307 LKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                        .            ....+...+..+.+|+.+||+.||++|||+.+++++|+.++..
T Consensus       233 --~------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          233 --D------------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             --T------------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             --c------------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence              0            0111122234588999999999999999999999999998763

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.8e-45  Score=348.24  Aligned_cols=265  Identities=24%  Similarity=0.396  Sum_probs=199.9

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhc--CCCCCcceeeeEEEe-
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ--LKHPHLVNLIGYCCE-  153 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~~~~~~~~-  153 (449)
                      +.++|++.+.||+|+||.||+|.+.        ++.||||++...   ....+..|.+++..  ++||||+++++++.. 
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~   74 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSWQ--------GENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTS   74 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEET--------TEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEEC--------CEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccc
Confidence            4678999999999999999999763        678999998643   33455666666665  799999999998754 


Q ss_pred             ---CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCeeeccCCCCceEEcCCCc
Q 013105          154 ---DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE------EKPVIYRDFKASNILLDSDYN  224 (449)
Q Consensus       154 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~------~~~ivHrDikp~Nill~~~~~  224 (449)
                         ....++||||+.+|+|.+++..   ..+++..++.++.|++.||.|||+.      +++|+||||||+|||++.++.
T Consensus        75 ~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~  151 (301)
T 3q4u_A           75 RHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ  151 (301)
T ss_dssp             ETTEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred             cCCCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC
Confidence               3568999999999999999954   4799999999999999999999933      467999999999999999999


Q ss_pred             EEEeeeccccCCCCCCCCc--eeeecCCCCccccccccccC------CCCcccchhhhHHHHHHHHhC----------CC
Q 013105          225 AKLSDFGLATDGPQGEDSH--ITTCVMGTEGYAAPEYINTG------HLTTMCDVFSFGVVLLELLTG----------RR  286 (449)
Q Consensus       225 ~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~vl~elltg----------~~  286 (449)
                      +||+|||++..........  ......||+.|+|||++.+.      .++.++|||||||++|||++|          ..
T Consensus       152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~  231 (301)
T 3q4u_A          152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP  231 (301)
T ss_dssp             EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence            9999999997543322111  12234699999999999766      455799999999999999999          77


Q ss_pred             cccccccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcc
Q 013105          287 SVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL  361 (449)
Q Consensus       287 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  361 (449)
                      ||.......... .......... ..    ............++..+.+|+.+||+.||++|||+.++++.|+.+
T Consensus       232 pf~~~~~~~~~~-~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          232 PFYDVVPNDPSF-EDMRKVVCVD-QQ----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTTTTSCSSCCH-HHHHHHHTTS-CC----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccccCCCCcch-hhhhHHHhcc-CC----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            776432211110 0000000000 00    000011112345778899999999999999999999999998764

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.1e-45  Score=370.07  Aligned_cols=249  Identities=27%  Similarity=0.387  Sum_probs=206.9

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      .++|.+.+.||+|+||.||+|.+..      +++.||||++...   .......+.+|+.+++.++||||+++++++.+.
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~   88 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHEL------TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP   88 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETT------TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECC------CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            4679999999999999999998765      5889999999643   123356788999999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +..|+||||+.||+|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++.
T Consensus        89 ~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDLkp~NIll~~~~~vkL~DFG~a~  164 (476)
T 2y94_A           89 SDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSN  164 (476)
T ss_dssp             SEEEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCCcccccHHHEEEecCCCeEEEeccchh
Confidence            9999999999999999998654  57999999999999999999999  7789999999999999999999999999998


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccCCC-CcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccch
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHL-TTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      ......   .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........   ..            
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~---~~------------  226 (476)
T 2y94_A          165 MMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL---FK------------  226 (476)
T ss_dssp             ECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH---HH------------
T ss_pred             hccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH---HH------------
Confidence            654432   2334579999999999987765 7899999999999999999999976432111   10            


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       .+....  ...+..+++.+.+|+.+||+.||.+|||+.++++|
T Consensus       227 -~i~~~~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          227 -KICDGI--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             -HHHTTC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             -HHhcCC--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence             011110  01123345668999999999999999999999986

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-46  Score=370.49  Aligned_cols=262  Identities=19%  Similarity=0.222  Sum_probs=207.1

Q ss_pred             HHHHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceee
Q 013105           72 KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLI  148 (449)
Q Consensus        72 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~  148 (449)
                      .+.....++|++.+.||+|+||.||+|....      +++.||||++....   ......+.+|..++..++||||++++
T Consensus        54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~------~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~  127 (412)
T 2vd5_A           54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ------TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH  127 (412)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEE
T ss_pred             hhccCChhhEEEEEEEeeCCCeEEEEEEECC------CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence            3444556889999999999999999998765      58899999996421   12223477899999999999999999


Q ss_pred             eEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEe
Q 013105          149 GYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLS  228 (449)
Q Consensus       149 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~  228 (449)
                      +++.+.+.+||||||+.||+|.+++.+. ...+++..+..++.|++.||.|||  ++||+||||||+|||++.++++||+
T Consensus       128 ~~~~~~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH--~~giiHrDLKp~NILld~~g~vkL~  204 (412)
T 2vd5_A          128 FAFQDENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVH--RLGYVHRDIKPDNILLDRCGHIRLA  204 (412)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             EEEeeCCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCeeecccCHHHeeecCCCCEEEe
Confidence            9999999999999999999999999764 247899999999999999999999  6789999999999999999999999


Q ss_pred             eeccccCCCCCCCCceeeecCCCCccccccccc-------cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHH
Q 013105          229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN-------TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVE  301 (449)
Q Consensus       229 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~  301 (449)
                      |||++........ ......+||+.|+|||++.       +..|+.++|||||||++|||++|+.||...........+.
T Consensus       205 DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~  283 (412)
T 2vd5_A          205 DFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV  283 (412)
T ss_dssp             CCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             echhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999986543221 1223457999999999986       3568999999999999999999999997653221111110


Q ss_pred             hhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCC---CCHHHHHHH
Q 013105          302 WARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSR---PTMTTVVKA  357 (449)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~eil~~  357 (449)
                      ...             .....+.....++.++.+||.+||. +|.+|   |+++++++|
T Consensus       284 ~~~-------------~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          284 HYK-------------EHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             THH-------------HHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             hcc-------------cCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            000             0000011123455679999999999 99998   699999987

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.1e-45  Score=358.42  Aligned_cols=261  Identities=22%  Similarity=0.255  Sum_probs=202.2

Q ss_pred             HHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC-----CcchHHHHHHHHHHHhcCCCCCcceeee
Q 013105           75 QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-----GSQGHREWLAEVIFLGQLKHPHLVNLIG  149 (449)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~~~~  149 (449)
                      ..+.++|++.+.||+|+||.||+|.+..      ++..||+|++...     .......+.+|+.+++.++||||+++++
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~   95 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQ------TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYE   95 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECC------CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeeh
Confidence            4567889999999999999999998765      5789999998632     2345678899999999999999999999


Q ss_pred             EEEeCCEEEEEEEecCCCChHHHHhhcC--------------------------------------CCCCCHHHHHHHHH
Q 013105          150 YCCEDEHRLLVYEYMALGNLHDQLFKNY--------------------------------------SSTLPWLTRIKIAI  191 (449)
Q Consensus       150 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------~~~l~~~~~~~i~~  191 (449)
                      ++.+.+..++||||++||+|.+++....                                      ...+++..+..++.
T Consensus        96 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  175 (345)
T 3hko_A           96 VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR  175 (345)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred             hhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence            9999999999999999999999884210                                      11235677888999


Q ss_pred             HHHHHHHHhhcCCCCeeeccCCCCceEEcCCC--cEEEeeeccccCCCCCC--CCceeeecCCCCcccccccccc--CCC
Q 013105          192 GAARCLAFLHGEEKPVIYRDFKASNILLDSDY--NAKLSDFGLATDGPQGE--DSHITTCVMGTEGYAAPEYINT--GHL  265 (449)
Q Consensus       192 ~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~--~~kl~DfGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~~  265 (449)
                      |++.||.|||  +++|+||||||+|||++.++  .+||+|||++.......  .........||+.|+|||++.+  ..+
T Consensus       176 qi~~~l~~LH--~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  253 (345)
T 3hko_A          176 QIFSALHYLH--NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY  253 (345)
T ss_dssp             HHHHHHHHHH--HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCC
T ss_pred             HHHHHHHHHH--HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCC
Confidence            9999999999  67899999999999998776  89999999997542211  1112344569999999999965  678


Q ss_pred             CcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCC
Q 013105          266 TTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNP  345 (449)
Q Consensus       266 ~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP  345 (449)
                      +.++|||||||++|||++|+.||.+..........      ....        ..........+++.+.+|+.+||+.||
T Consensus       254 ~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~------~~~~--------~~~~~~~~~~~~~~~~~li~~~l~~~p  319 (345)
T 3hko_A          254 GPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQV------LNKK--------LCFENPNYNVLSPLARDLLSNLLNRNV  319 (345)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCC--------CCTTSGGGGGSCHHHHHHHHHHSCSCT
T ss_pred             CcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHH------Hhcc--------cccCCcccccCCHHHHHHHHHHcCCCh
Confidence            99999999999999999999999765322111110      0000        000111112345679999999999999


Q ss_pred             CCCCCHHHHHHH
Q 013105          346 KSRPTMTTVVKA  357 (449)
Q Consensus       346 ~~RPs~~eil~~  357 (449)
                      .+|||+.+++++
T Consensus       320 ~~Rps~~~~l~h  331 (345)
T 3hko_A          320 DERFDAMRALQH  331 (345)
T ss_dssp             TTSCCHHHHHHS
T ss_pred             hHCCCHHHHhcC
Confidence            999999999987

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.1e-45  Score=345.69  Aligned_cols=256  Identities=25%  Similarity=0.358  Sum_probs=207.0

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      +.++|++.+.||+|+||.||+|.+..      +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRV------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN   78 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETT------TCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             eecceEEEEEeecCCCcEEEEEEECC------CCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC
Confidence            45689999999999999999998765      47899999997443 334567889999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..++||||+.+++|.+++...  ..+++..+..++.|++.||.|||  ++||+|+||||+||+++.++.+||+|||++..
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  154 (276)
T 2yex_A           79 IQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATV  154 (276)
T ss_dssp             EEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCChHHEEEccCCCEEEeeCCCccc
Confidence            999999999999999988643  56899999999999999999999  67899999999999999999999999999975


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCC-CcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHL-TTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ..............||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ ....+..          
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~----------  223 (276)
T 2yex_A          155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKE----------  223 (276)
T ss_dssp             CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHT----------
T ss_pred             cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhh----------
Confidence            533222222344569999999999987665 7899999999999999999999976432111 1111110          


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                          ...........+..+.+|+.+||+.||.+|||+.+++++
T Consensus       224 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          224 ----KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             ----TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ----cccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence                000001112345568999999999999999999999986

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.9e-45  Score=349.78  Aligned_cols=257  Identities=27%  Similarity=0.464  Sum_probs=200.1

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      ++|++.+.||+|+||.||+|.+.        ++.||+|++...  .....+.+|+.++++++||||+++++++.  +..+
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~   75 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--------AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVC   75 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--------TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTE
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--------CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcE
Confidence            57889999999999999999764        578999998633  34577899999999999999999999876  3478


Q ss_pred             EEEEecCCCChHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCC-CCeeeccCCCCceEEcCCCc-EEEeeeccccC
Q 013105          159 LVYEYMALGNLHDQLFKNYS-STLPWLTRIKIAIGAARCLAFLHGEE-KPVIYRDFKASNILLDSDYN-AKLSDFGLATD  235 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~-~~ivHrDikp~Nill~~~~~-~kl~DfGla~~  235 (449)
                      +||||+++|+|.+++..... ..++...++.++.|++.||.|||+.. +||+||||||+|||++.++. +||+|||++..
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~  155 (307)
T 2eva_A           76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD  155 (307)
T ss_dssp             EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred             EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence            99999999999999975432 24788899999999999999999422 78999999999999998886 79999999975


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ..+.            
T Consensus       156 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~------------  216 (307)
T 2eva_A          156 IQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWA------------  216 (307)
T ss_dssp             --------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH--HHHH------------
T ss_pred             cccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH--HHHH------------
Confidence            4322     22345999999999999889999999999999999999999999753211100  0000            


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCCCC
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDI  367 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~  367 (449)
                       ............++..+.+++.+||+.||++|||+.+++++|+.+...-+.
T Consensus       217 -~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  267 (307)
T 2eva_A          217 -VHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG  267 (307)
T ss_dssp             -HHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred             -HhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence             001111222334556799999999999999999999999999988765443

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=9.5e-45  Score=348.65  Aligned_cols=263  Identities=22%  Similarity=0.243  Sum_probs=203.1

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      ..++|++.+.||+|+||.||+|.+..      +++.||+|++....   ......+.+|+.+++.++||||+++++++..
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~  105 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTV------RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI  105 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETT------TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcC------CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee
Confidence            35789999999999999999998765      47899999997442   2234678899999999999999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      ++..++||||+.+++|.+++...  ..+++..++.++.|++.||.|||  .+||+||||||+|||++.++.+||+|||++
T Consensus       106 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~  181 (309)
T 2h34_A          106 DGQLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAH--AAGATHRDVKPENILVSADDFAYLVDFGIA  181 (309)
T ss_dssp             TTEEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECSCCC-
T ss_pred             CCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCcCCcCCCChHHEEEcCCCCEEEecCccC
Confidence            99999999999999999999765  57899999999999999999999  678999999999999999999999999999


Q ss_pred             cCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccch
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      ........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||........   .....   ..    
T Consensus       182 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~---~~----  250 (309)
T 2h34_A          182 SATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM---GAHIN---QA----  250 (309)
T ss_dssp             ----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH---HHHHH---SC----
T ss_pred             cccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH---HHHhc---cC----
Confidence            76543221 122345689999999999988999999999999999999999999986532210   00000   00    


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHhhccccCC
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRP-TMTTVVKALEPLLDLN  365 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~~~~~~  365 (449)
                           .......+..++..+.+++.+||+.||++|| ++.++++.|+.++...
T Consensus       251 -----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          251 -----IPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             -----CCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             -----CCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence                 0011122344556799999999999999999 9999999999877644

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=6.7e-45  Score=345.63  Aligned_cols=254  Identities=24%  Similarity=0.328  Sum_probs=201.3

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      +.++|.+.+.||+|+||.||+|....      ++..||+|++.... ......+.+|+.+++.++||||+++++++.+.+
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   93 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERS------SGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH   93 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhhheeecceeccCCCeEEEEEEEcc------CCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCC
Confidence            44679999999999999999998765      57899999997543 344678899999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEE---cCCCcEEEeee
Q 013105          156 HRLLVYEYMALGNLHDQLFKN--YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILL---DSDYNAKLSDF  230 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill---~~~~~~kl~Df  230 (449)
                      ..++||||+.+|+|.+++...  ....+++..+..++.|++.||.|||  ++||+||||||+|||+   +.++.+||+||
T Consensus        94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~dikp~NIl~~~~~~~~~~kl~Df  171 (285)
T 3is5_A           94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH--SQHVVHKDLKPENILFQDTSPHSPIKIIDF  171 (285)
T ss_dssp             EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH--hCCEEECCCCHHHEEEecCCCCCCEEEEee
Confidence            999999999999999988543  3467999999999999999999999  6789999999999999   45678999999


Q ss_pred             ccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccc
Q 013105          231 GLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF  310 (449)
Q Consensus       231 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  310 (449)
                      |++.......   ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+...............     
T Consensus       172 g~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-----  242 (285)
T 3is5_A          172 GLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP-----  242 (285)
T ss_dssp             CCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----
T ss_pred             ecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc-----
Confidence            9998654322   133456999999999986 5689999999999999999999999986532221111110000     


Q ss_pred             cchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                               . ........++.+.+|+.+||+.||++|||+.+++++
T Consensus       243 ---------~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          243 ---------N-YAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             ---------C-CCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             ---------c-cccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                     0 000011134568899999999999999999999986

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.6e-45  Score=348.60  Aligned_cols=267  Identities=24%  Similarity=0.293  Sum_probs=201.2

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc--hHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ--GHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      .++|++.+.||+|+||.||+|.+..      +++.||+|++......  ....+.+|+.+++.++||||+++++++.+.+
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   75 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRD------TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR   75 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cccceEeeEEeecCCeEEEEEEeCC------CCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCC
Confidence            4689999999999999999998765      5889999998654322  2456789999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..++||||+.+++|.+++...  ..+++..+..++.|++.||.|||  +.||+||||||+|||++.++.+||+|||++..
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  151 (311)
T 4agu_A           76 RLHLVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCH--KHNCIHRDVKPENILITKHSVIKLCDFGFARL  151 (311)
T ss_dssp             EEEEEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             eEEEEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCCChhhEEEcCCCCEEEeeCCCchh
Confidence            999999999999998877544  56899999999999999999999  67899999999999999999999999999986


Q ss_pred             CCCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhh-hh-------
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR-PM-------  306 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~-~~-------  306 (449)
                      ......  ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.............. ..       
T Consensus       152 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (311)
T 4agu_A          152 LTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV  229 (311)
T ss_dssp             CC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             ccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccc
Confidence            543221  2234568999999999875 578999999999999999999999998754332222111100 00       


Q ss_pred             hccccchhHhhcccccc------cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          307 LKDFTKLDQIIDSRLED------RYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       307 ~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .......... ......      .....++..+.+|+.+||+.||++|||+.++++|
T Consensus       230 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          230 FSTNQYFSGV-KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             HHTCGGGTTC-CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccccccccC-cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0000000000 000000      0012345678999999999999999999999987

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=8.1e-46  Score=350.52  Aligned_cols=262  Identities=28%  Similarity=0.399  Sum_probs=211.8

Q ss_pred             HHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           74 LQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        74 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      ++...++|++.+.||+|+||.||+|.+..       +..||+|++.... .....+.+|+.+++.++||||+++++++. 
T Consensus         8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-   78 (279)
T 1qpc_A            8 WEVPRETLKLVERLGAGQFGEVWMGYYNG-------HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-   78 (279)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETT-------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             cccCHHhhhheeeecCCCCeEEEEEEEcC-------CcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-
Confidence            34456789999999999999999998653       5689999997543 34577899999999999999999999986 


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      .+..++||||+.+++|.+++.......+++..++.++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++
T Consensus        79 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  156 (279)
T 1qpc_A           79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLA  156 (279)
T ss_dssp             SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHhhEEEcCCCCEEECCCccc
Confidence            456899999999999999987543347899999999999999999999  678999999999999999999999999999


Q ss_pred             cCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccc
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTK  312 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  312 (449)
                      ........ .......|++.|+|||++.+..++.++|||||||++|||++ |..||.+......   ....         
T Consensus       157 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~~---------  223 (279)
T 1qpc_A          157 RLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---IQNL---------  223 (279)
T ss_dssp             EECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHH---------
T ss_pred             ccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH---HHHH---------
Confidence            86543221 11223446889999999988889999999999999999999 9999976432211   1100         


Q ss_pred             hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                           ........+..++..+.+++..||+.||++|||+.++++.|+.++..
T Consensus       224 -----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          224 -----ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             -----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----hcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence                 01111122334556799999999999999999999999999988754

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-44  Score=349.30  Aligned_cols=269  Identities=24%  Similarity=0.385  Sum_probs=205.2

Q ss_pred             HHHHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcC--CCCCcceeee
Q 013105           72 KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL--KHPHLVNLIG  149 (449)
Q Consensus        72 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~nIv~~~~  149 (449)
                      .....+.++|++.+.||+|+||.||+|.+.        ++.||||++...   ....+..|.+++..+  +||||+++++
T Consensus        30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~   98 (337)
T 3mdy_A           30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--------GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIA   98 (337)
T ss_dssp             HHHTTHHHHCEEEEEEEEETTEEEEEEEET--------TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred             ccccccccceEEEeEeecCCCeEEEEEEEC--------CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEE
Confidence            334556788999999999999999999763        578999998633   234455566666655  8999999999


Q ss_pred             EEEeC----CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCeeeccCCCCceEE
Q 013105          150 YCCED----EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE------EKPVIYRDFKASNILL  219 (449)
Q Consensus       150 ~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~------~~~ivHrDikp~Nill  219 (449)
                      ++...    ...++||||+.+|+|.+++...   .+++..++.++.|++.||.|||+.      ..||+||||||+|||+
T Consensus        99 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill  175 (337)
T 3mdy_A           99 ADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV  175 (337)
T ss_dssp             EEEESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE
T ss_pred             EEccCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE
Confidence            99887    7899999999999999999653   689999999999999999999943      2289999999999999


Q ss_pred             cCCCcEEEeeeccccCCCCCCCCc--eeeecCCCCccccccccccCCCCcc------cchhhhHHHHHHHHhC-------
Q 013105          220 DSDYNAKLSDFGLATDGPQGEDSH--ITTCVMGTEGYAAPEYINTGHLTTM------CDVFSFGVVLLELLTG-------  284 (449)
Q Consensus       220 ~~~~~~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~vl~elltg-------  284 (449)
                      +.++.+||+|||++..........  ......||+.|+|||++.+..++..      +|||||||++|||++|       
T Consensus       176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~  255 (337)
T 3mdy_A          176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV  255 (337)
T ss_dssp             CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence            999999999999997554322111  1124569999999999987766655      9999999999999999       


Q ss_pred             ---CCcccccccccchhhHHhhhhhhccccchhHhh-cccccccC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 013105          285 ---RRSVEKNRCKREKDLVEWARPMLKDFTKLDQII-DSRLEDRY-----STEGAKRLAAVAHQCLSHNPKSRPTMTTVV  355 (449)
Q Consensus       285 ---~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil  355 (449)
                         ..||..........            ......+ ........     ...+++.+.+|+.+||+.||++|||+.+++
T Consensus       256 ~~~~~p~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell  323 (337)
T 3mdy_A          256 EEYQLPYHDLVPSDPSY------------EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK  323 (337)
T ss_dssp             CCCCCTTTTTSCSSCCH------------HHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             ccccccHhhhcCCCCch------------hhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHH
Confidence               55554321111000            0000000 01111111     237888899999999999999999999999


Q ss_pred             HHhhccccCCC
Q 013105          356 KALEPLLDLND  366 (449)
Q Consensus       356 ~~L~~~~~~~~  366 (449)
                      ++|+.+....+
T Consensus       324 ~~L~~l~~~~~  334 (337)
T 3mdy_A          324 KTLAKMSESQD  334 (337)
T ss_dssp             HHHHHHHHTTT
T ss_pred             HHHHHHHhhcc
Confidence            99999887654

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.7e-45  Score=355.29  Aligned_cols=260  Identities=22%  Similarity=0.309  Sum_probs=209.0

Q ss_pred             HHHHHhcCCCCc-ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCC-CCCcceee
Q 013105           73 ELQMITHNFSRS-DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLK-HPHLVNLI  148 (449)
Q Consensus        73 ~~~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~nIv~~~  148 (449)
                      ..+.+.+.|.+. +.||+|+||.||+|.+..      +++.||+|++...  .......+.+|+.++..+. ||||++++
T Consensus        22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~   95 (327)
T 3lm5_A           22 SMENFNNFYILTSKELGRGKFAVVRQCISKS------TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH   95 (327)
T ss_dssp             CHHHHHHHEEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             HHHhhhhEEeeccceeCCCCCeEEEEEEECC------CCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence            345667788887 899999999999998765      5889999999743  2344677889999999995 79999999


Q ss_pred             eEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC---CCcE
Q 013105          149 GYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS---DYNA  225 (449)
Q Consensus       149 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~---~~~~  225 (449)
                      +++.+.+..++||||+.+|+|.+++.......+++..++.++.|++.||.|||  .+||+||||||+|||++.   ++.+
T Consensus        96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH--~~givH~Dikp~NIl~~~~~~~~~~  173 (327)
T 3lm5_A           96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH--QNNIVHLDLKPQNILLSSIYPLGDI  173 (327)
T ss_dssp             EEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEESCBTTBCCE
T ss_pred             EEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--HCCeecCcCChHHEEEecCCCCCcE
Confidence            99999999999999999999999987665678999999999999999999999  678999999999999987   7899


Q ss_pred             EEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhh
Q 013105          226 KLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARP  305 (449)
Q Consensus       226 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~  305 (449)
                      ||+|||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..   
T Consensus       174 kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~---  247 (327)
T 3lm5_A          174 KIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ---  247 (327)
T ss_dssp             EECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---
T ss_pred             EEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHh---
Confidence            999999998654322   12345699999999999988999999999999999999999999976532211111000   


Q ss_pred             hhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          306 MLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                                 ............+++.+.+|+.+||+.||.+|||+.+++++
T Consensus       248 -----------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          248 -----------VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             -----------TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             -----------cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence                       00111122223456679999999999999999999999987

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-45  Score=353.58  Aligned_cols=266  Identities=26%  Similarity=0.416  Sum_probs=206.8

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      .++|.+.+.||+|+||.||+|.+...  ....+..||||++..... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  120 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTS--SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP  120 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC-----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecC--CCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence            45788889999999999999987652  122345799999975432 334568899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||+.+|+|.+++... ...+++..++.++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++...
T Consensus       121 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          121 MMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             cEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            99999999999999998654 357899999999999999999999  678999999999999999999999999999865


Q ss_pred             CCCCCC-ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchh
Q 013105          237 PQGEDS-HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       237 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||........   ...            
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~---~~~------------  262 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---MKA------------  262 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHH------------
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH---HHH------------
Confidence            432211 11223346889999999998899999999999999999999 9999975432111   110            


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCC
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN  365 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  365 (449)
                        +........+..++..+.+++.+||+.||++||++.+++++|+.++...
T Consensus       263 --~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          263 --INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             --HHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             --HHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence              0111111223445667999999999999999999999999999887543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.7e-45  Score=371.66  Aligned_cols=270  Identities=21%  Similarity=0.282  Sum_probs=189.2

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEe-
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE-  153 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-  153 (449)
                      +.++|++.+.||+|+||.||+|.+..      +++.||||++...  .......+.+|+.+|+.++||||+++++++.. 
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  124 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKL------EKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPK  124 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--------CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECC------CCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecC
Confidence            34789999999999999999998765      5889999999643  23345678899999999999999999999844 


Q ss_pred             ----CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEee
Q 013105          154 ----DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSD  229 (449)
Q Consensus       154 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~D  229 (449)
                          ....|+||||+. |+|.+++...  ..+++..+..++.|++.||.|||  +.||+||||||+||||+.++.+||+|
T Consensus       125 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH--~~~iiHrDlKp~NILl~~~~~~kl~D  199 (458)
T 3rp9_A          125 DVEKFDELYVVLEIAD-SDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVH--SAGILHRDLKPANCLVNQDCSVKVCD  199 (458)
T ss_dssp             CTTTCCCEEEEECCCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTCCEEECC
T ss_pred             CcccCceEEEEEeccc-cchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHH--hCCcCCCCCChhhEEECCCCCEeecc
Confidence                357899999985 7999888654  57999999999999999999999  67899999999999999999999999


Q ss_pred             eccccCCCCCCCC-------------------------ceeeecCCCCcccccccc-ccCCCCcccchhhhHHHHHHHHh
Q 013105          230 FGLATDGPQGEDS-------------------------HITTCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLT  283 (449)
Q Consensus       230 fGla~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~vl~ellt  283 (449)
                      ||+++........                         ......+||++|+|||++ .+..|+.++|||||||+||||++
T Consensus       200 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          200 FGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             CTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             cccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            9999865422111                         123446789999999986 56679999999999999999999


Q ss_pred             -----------CCCcccccccccc-----------------hhhHHhhhhhhcccc----------chhHhhcc---c--
Q 013105          284 -----------GRRSVEKNRCKRE-----------------KDLVEWARPMLKDFT----------KLDQIIDS---R--  320 (449)
Q Consensus       284 -----------g~~pf~~~~~~~~-----------------~~~~~~~~~~~~~~~----------~~~~~~~~---~--  320 (449)
                                 |+++|.+......                 .+........+....          .....+..   .  
T Consensus       280 g~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~  359 (458)
T 3rp9_A          280 MIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREG  359 (458)
T ss_dssp             TSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCC
T ss_pred             hccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCC
Confidence                       6777765431100                 000000000000000          00000000   0  


Q ss_pred             -ccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          321 -LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       321 -~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       ......+..+.++.+||.+||..||++|||+.|+++|
T Consensus       360 ~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H  397 (458)
T 3rp9_A          360 TDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH  397 (458)
T ss_dssp             CCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence             0001122346679999999999999999999999998

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.8e-45  Score=360.93  Aligned_cols=245  Identities=26%  Similarity=0.350  Sum_probs=193.8

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHH-HhcCCCCCcceeeeEEEe
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIF-LGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~nIv~~~~~~~~  153 (449)
                      .++|++.+.||+|+||.||+|.+..      +++.||||++....   ......+.+|..+ ++.++||||+++++++.+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~------~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~  110 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKA------EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT  110 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETT------TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcC------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe
Confidence            4679999999999999999998765      57899999997442   2233456677776 567899999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      .+..|+||||+.||+|.+++.+.  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.+|.+||+|||++
T Consensus       111 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NIll~~~g~ikL~DFG~a  186 (373)
T 2r5t_A          111 ADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLH--SLNIVYRDLKPENILLDSQGHIVLTDFGLC  186 (373)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECCCCBC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCHHHEEECCCCCEEEeeCccc
Confidence            99999999999999999999765  57889999999999999999999  678999999999999999999999999999


Q ss_pred             cCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccch
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      +......  ......+||+.|+|||++.+..++.++|||||||++|||++|..||..........               
T Consensus       187 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~---------------  249 (373)
T 2r5t_A          187 KENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD---------------  249 (373)
T ss_dssp             GGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHH---------------
T ss_pred             cccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH---------------
Confidence            8533222  12345679999999999999999999999999999999999999997643221111               


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMT  352 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  352 (449)
                       .++..  ...++..++..+.+||.+||+.||.+||++.
T Consensus       250 -~i~~~--~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~  285 (373)
T 2r5t_A          250 -NILNK--PLQLKPNITNSARHLLEGLLQKDRTKRLGAK  285 (373)
T ss_dssp             -HHHHS--CCCCCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred             -HHHhc--ccCCCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence             11111  1112334556799999999999999999985

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.8e-45  Score=357.19  Aligned_cols=247  Identities=29%  Similarity=0.409  Sum_probs=201.9

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc---chHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS---QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      +.|.+.+.||+|+||.||+|....      +++.||||++.....   .....+.+|+.+++.++||||+++++++.+.+
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  127 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVR------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH  127 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hheeeeeEEccCCCEEEEEEEEcc------CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            458899999999999999998755      588999999975432   22356889999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..++||||+. |+|.+++... ...+++..+..++.|++.||.|||  .+||+||||||+|||++.++.+||+|||++..
T Consensus       128 ~~~lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~  203 (348)
T 1u5q_A          128 TAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI  203 (348)
T ss_dssp             EEEEEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred             eEEEEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEECCCCCEEEeeccCcee
Confidence            9999999997 6888877543 357899999999999999999999  67799999999999999999999999999986


Q ss_pred             CCCCCCCceeeecCCCCccccccccc---cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccc
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYIN---TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK  312 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  312 (449)
                      ...      .....||+.|+|||++.   +..++.++|||||||++|||++|+.||..........              
T Consensus       204 ~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~--------------  263 (348)
T 1u5q_A          204 MAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--------------  263 (348)
T ss_dssp             SSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--------------
T ss_pred             cCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH--------------
Confidence            533      22356999999999984   5678999999999999999999999997643211110              


Q ss_pred             hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                        .+............+++.+.+|+.+||+.||++|||+.+++++
T Consensus       264 --~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          264 --HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             --HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             --HHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence              0001111111123445678999999999999999999999987

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=7.2e-45  Score=348.51  Aligned_cols=253  Identities=21%  Similarity=0.333  Sum_probs=205.7

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      +.++|.+.+.||+|+||.||+|.+..      +++.||+|++..........+.+|+.+++.++||||+++++++.+.+.
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRL------TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTH   80 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccceeeeeccCCCCceEEEEEECC------CCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCE
Confidence            45789999999999999999998765      578999999986544445678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEE---cCCCcEEEeeeccc
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILL---DSDYNAKLSDFGLA  233 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill---~~~~~~kl~DfGla  233 (449)
                      .++||||+.+++|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||+   +.++.++|+|||++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~  156 (304)
T 2jam_A           81 YYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLH--ENGIVHRDLKPENLLYLTPEENSKIMITDFGLS  156 (304)
T ss_dssp             EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTT
T ss_pred             EEEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEecCCCCCCEEEccCCcc
Confidence            99999999999999998765  56899999999999999999999  6789999999999999   77889999999998


Q ss_pred             cCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccch
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      .......    .....||+.|+|||++.+..++.++|||||||++|+|++|..||........   ....   ....   
T Consensus       157 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i---~~~~---  223 (304)
T 2jam_A          157 KMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL---FEKI---KEGY---  223 (304)
T ss_dssp             CCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHH---HHCC---
T ss_pred             eecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---HHHH---HcCC---
Confidence            7543321    2334589999999999988999999999999999999999999976432111   1100   0000   


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                           ..........++..+.+++.+||+.||++|||+.+++++
T Consensus       224 -----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          224 -----YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             -----CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             -----CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                 001112233456679999999999999999999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.8e-45  Score=345.72  Aligned_cols=252  Identities=24%  Similarity=0.361  Sum_probs=208.1

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEe--
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE--  153 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--  153 (449)
                      .+.++|++.+.||+|+||.||+|.+..      +++.||+|++....    ..+.+|+.+++.++||||+++++++..  
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   77 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRI------DGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFD   77 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETT------TCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEE
T ss_pred             hhccccceeeeeccCCceEEEEEEEcC------CCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccc
Confidence            456789999999999999999998765      47899999997543    345689999999999999999998864  


Q ss_pred             --------------CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEE
Q 013105          154 --------------DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILL  219 (449)
Q Consensus       154 --------------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill  219 (449)
                                    ....++||||+.+|+|.+++.......+++..++.++.|++.||.|||  ++||+||||||+|||+
T Consensus        78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dlkp~Nil~  155 (284)
T 2a19_B           78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH--SKKLINRDLKPSNIFL  155 (284)
T ss_dssp             EC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEE
T ss_pred             cCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCCHHHEEE
Confidence                          455899999999999999997765578999999999999999999999  6789999999999999


Q ss_pred             cCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhh
Q 013105          220 DSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDL  299 (449)
Q Consensus       220 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~  299 (449)
                      +.++.+||+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....     .
T Consensus       156 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-----~  227 (284)
T 2a19_B          156 VDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK-----F  227 (284)
T ss_dssp             EETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH-----H
T ss_pred             cCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH-----H
Confidence            9999999999999886543321   2334699999999999988999999999999999999999998753210     0


Q ss_pred             HHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          300 VEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                      ..             .+....    .+..++..+.+++.+||+.||.+|||+.+++++|..+...
T Consensus       228 ~~-------------~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          228 FT-------------DLRDGI----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             HH-------------HHHTTC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             HH-------------Hhhccc----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence            00             000111    1223345688999999999999999999999999887643

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=8.9e-45  Score=345.68  Aligned_cols=260  Identities=28%  Similarity=0.388  Sum_probs=208.7

Q ss_pred             hcCCCCcc-cccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           78 THNFSRSD-YLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        78 ~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      .++|.+.+ .||+|+||.||+|.+..    ...++.||||++....  ......+.+|+.+++.++||||+++++++ ..
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~   89 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQM----KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA   89 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEEC----SSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred             chhhhhccCccccccCeeeEeeeecC----CCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence            45688887 99999999999997643    1247889999997542  23356789999999999999999999999 66


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +..++||||+.+++|.+++...  ..+++..++.++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++.
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  165 (291)
T 1xbb_A           90 ESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSK  165 (291)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             CCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHH--hCCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence            7789999999999999999764  56899999999999999999999  6789999999999999999999999999998


Q ss_pred             CCCCCCCC-ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccc
Q 013105          235 DGPQGEDS-HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTK  312 (449)
Q Consensus       235 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  312 (449)
                      ........ .......||+.|+|||++.+..++.++|||||||++|+|++ |..||..........              
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~--------------  231 (291)
T 1xbb_A          166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA--------------  231 (291)
T ss_dssp             ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH--------------
T ss_pred             eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--------------
Confidence            65443221 11222346789999999988889999999999999999999 999997643221111              


Q ss_pred             hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                         .+........+..+++.+.+++..||+.||.+|||+.++++.|+.++.
T Consensus       232 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  279 (291)
T 1xbb_A          232 ---MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  279 (291)
T ss_dssp             ---HHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ---HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence               111111222344556779999999999999999999999999998875

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=5.4e-45  Score=351.30  Aligned_cols=263  Identities=22%  Similarity=0.300  Sum_probs=206.9

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEe----
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE----  153 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~----  153 (449)
                      .++|++.+.||+|+||.||+|....      +++.||||++..........+.+|+.+++.++||||+++++++..    
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLH------DGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA  101 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETT------TCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecC------CCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence            4679999999999999999998755      578999999976655666788999999999999999999999873    


Q ss_pred             CCEEEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeec
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKN--YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFG  231 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfG  231 (449)
                      ....++||||+.+|+|.+++...  ....+++..++.++.|++.||.|||  .++|+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~dlkp~NIl~~~~~~~kl~dfg  179 (317)
T 2buj_A          102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH--AKGYAHRDLKPTNILLGDEGQPVLMDLG  179 (317)
T ss_dssp             EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred             CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEcCCCCEEEEecC
Confidence            35789999999999999998653  3467999999999999999999999  6789999999999999999999999999


Q ss_pred             cccCCCCCCCCc-------eeeecCCCCccccccccccCC---CCcccchhhhHHHHHHHHhCCCcccccccccchhhHH
Q 013105          232 LATDGPQGEDSH-------ITTCVMGTEGYAAPEYINTGH---LTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVE  301 (449)
Q Consensus       232 la~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~  301 (449)
                      ++..........       ......||+.|+|||++.+..   ++.++|||||||++|+|++|..||.........    
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----  255 (317)
T 2buj_A          180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS----  255 (317)
T ss_dssp             SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC----
T ss_pred             cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch----
Confidence            987543211100       011235799999999987543   689999999999999999999999753211110    


Q ss_pred             hhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          302 WARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                                 ................++..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus       256 -----------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          256 -----------VALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             -----------HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             -----------hhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence                       000011111111223445679999999999999999999999999988754

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.7e-45  Score=343.53  Aligned_cols=257  Identities=24%  Similarity=0.382  Sum_probs=209.8

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      .++|++.+.||+|+||.||+|.+..       +..||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   78 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLN-------KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI   78 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT-------TEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeEecCCCceeEEEEEecC-------CCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence            3678999999999999999998753       57899999975433 346789999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+++++|.+++... ...+++..+..++.|++.||.|||  ++||+||||||+||+++.++.+||+|||++....
T Consensus        79 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  155 (267)
T 3t9t_A           79 CLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL  155 (267)
T ss_dssp             EEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred             EEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCchheEEECCCCCEEEcccccccccc
Confidence            9999999999999998654 356899999999999999999999  6789999999999999999999999999998543


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI  316 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (449)
                      ... ........||+.|+|||++.+..++.++||||||+++|+|++ |..||.........   ...             
T Consensus       156 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~i-------------  218 (267)
T 3t9t_A          156 DDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV---EDI-------------  218 (267)
T ss_dssp             CHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHH-------------
T ss_pred             ccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHH---HHH-------------
Confidence            211 111123457889999999988889999999999999999999 89999764321111   000             


Q ss_pred             hcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                       ........+...+..+.+++.+||+.||++|||+.+++++|+.+..
T Consensus       219 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          219 -STGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             -HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -hcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence             0011111223345679999999999999999999999999998764

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=6.3e-45  Score=344.87  Aligned_cols=262  Identities=26%  Similarity=0.382  Sum_probs=208.1

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ..++|.+.+.||+|+||.||+|.+...   ...+..||+|++.... ......+.+|+.+++.++||||+++++++.+ +
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~   85 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNH---KGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-E   85 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECT---TCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-S
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCC---CCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-C
Confidence            346799999999999999999987642   2245679999997543 3345678899999999999999999999865 4


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..++||||+.+++|.+++... ...+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++..
T Consensus        86 ~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           86 PTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLE--SINCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             SCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             CCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            568999999999999998764 356899999999999999999999  67899999999999999999999999999986


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchh
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ....... ......||+.|+|||++.+..++.++|||||||++|+|++ |+.||............              
T Consensus       163 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~--------------  227 (281)
T 3cc6_A          163 IEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL--------------  227 (281)
T ss_dssp             C----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH--------------
T ss_pred             ccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH--------------
Confidence            5432211 1233457889999999988899999999999999999998 99999754322111111              


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                         ........+..+++.+.+++.+||+.||++|||+.+++++|+.+.+
T Consensus       228 ---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          228 ---EKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             ---HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---hcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence               0001112233455679999999999999999999999999998764

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-45  Score=345.35  Aligned_cols=263  Identities=28%  Similarity=0.382  Sum_probs=210.8

Q ss_pred             hcCCCCcc-cccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           78 THNFSRSD-YLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        78 ~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      .++|.+.+ .||+|+||.||+|.+...    ..+..||+|++.... ......+.+|+.+++.++||||+++++++ ..+
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~   82 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMR----KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE   82 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC-------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred             HHHhhhhhccccccCceeEEEeEeccC----CCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence            35666666 899999999999986431    246789999997643 33456788999999999999999999999 556


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..++||||+.+++|.+++... ...+++..+..++.|++.||.|||  +.||+||||||+|||++.++.+||+|||++..
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  159 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKA  159 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             CcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHH--HCCEeeCCCchheEEEcCCCCEEECcccceee
Confidence            799999999999999998643 356899999999999999999999  67899999999999999999999999999986


Q ss_pred             CCCCCCC-ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccch
Q 013105          236 GPQGEDS-HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       236 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      ....... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||........   ...           
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~-----------  225 (287)
T 1u59_A          160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MAF-----------  225 (287)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---HHH-----------
T ss_pred             eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH---HHH-----------
Confidence            5433221 11223446899999999988889999999999999999998 9999976432211   111           


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCC
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN  365 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  365 (449)
                         +........+..+++.+.+++..||+.||++||++.+++++|+.++...
T Consensus       226 ---i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  274 (287)
T 1u59_A          226 ---IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  274 (287)
T ss_dssp             ---HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ---HhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence               1111122334456678999999999999999999999999999887543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.2e-45  Score=355.98  Aligned_cols=244  Identities=23%  Similarity=0.303  Sum_probs=203.5

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc--------chHHHHHHHHHHHhcCCCCCcceee
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--------QGHREWLAEVIFLGQLKHPHLVNLI  148 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~~~  148 (449)
                      +.++|++.+.||+|+||.||+|.+..      +++.||||++.....        .....+.+|+.+++.++||||++++
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~   95 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKE------KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVL   95 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETT------TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEE
T ss_pred             cccceEEEeEEEecCCEEEEEEEECC------CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            55789999999999999999998765      588999999975421        1233567799999999999999999


Q ss_pred             eEEEeCCEEEEEEEecCCC-ChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEE
Q 013105          149 GYCCEDEHRLLVYEYMALG-NLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKL  227 (449)
Q Consensus       149 ~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl  227 (449)
                      +++.+.+..++||||+.+| +|.+++...  ..+++..+..++.|++.||.|||  .+||+||||||+|||++.++.+||
T Consensus        96 ~~~~~~~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~kL  171 (335)
T 3dls_A           96 DIFENQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLR--LKDIIHRDIKDENIVIAEDFTIKL  171 (335)
T ss_dssp             EEEECSSEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEE
T ss_pred             EEEeeCCEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeEEeccCHHHEEEcCCCcEEE
Confidence            9999999999999999766 999988664  57999999999999999999999  678999999999999999999999


Q ss_pred             eeeccccCCCCCCCCceeeecCCCCccccccccccCCC-CcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhh
Q 013105          228 SDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL-TTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPM  306 (449)
Q Consensus       228 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~  306 (449)
                      +|||++........   .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......           
T Consensus       172 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----------  237 (335)
T 3dls_A          172 IDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-----------  237 (335)
T ss_dssp             CCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-----------
T ss_pred             eecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-----------
Confidence            99999986544322   334569999999999987776 889999999999999999999997532100           


Q ss_pred             hccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          307 LKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                                 ....  ..+..+++++.+|+..||+.||++|||+.+++++
T Consensus       238 -----------~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          238 -----------EAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -----------TTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -----------hhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                       0000  0112244568999999999999999999999997

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=8.6e-45  Score=346.07  Aligned_cols=277  Identities=19%  Similarity=0.226  Sum_probs=210.1

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEE-EeCC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYC-CEDE  155 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~-~~~~  155 (449)
                      +.++|++.+.||+|+||.||+|.+..      +++.||||++.....  ...+.+|+.+++.++|++++..+..+ ...+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIA------AGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGD   78 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETT------TTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcC------CCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCC
Confidence            56789999999999999999998765      578999998764322  23477899999999988777666554 6788


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEE---cCCCcEEEeeecc
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILL---DSDYNAKLSDFGL  232 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill---~~~~~~kl~DfGl  232 (449)
                      ..++||||+ +++|.+++... ...+++..+..++.|++.||.|||  ++||+||||||+|||+   +.++.+||+|||+
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~  154 (296)
T 4hgt_A           79 YNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL  154 (296)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred             ceEEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence            899999999 89999988643 356999999999999999999999  6779999999999999   7889999999999


Q ss_pred             ccCCCCCCCC-----ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhh
Q 013105          233 ATDGPQGEDS-----HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML  307 (449)
Q Consensus       233 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~  307 (449)
                      +.........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...................
T Consensus       155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  234 (296)
T 4hgt_A          155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK  234 (296)
T ss_dssp             CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred             ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc
Confidence            9865433221     11234579999999999998899999999999999999999999998654332222111110000


Q ss_pred             ccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCCCCCC-CCceee
Q 013105          308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDIPI-GPFVYT  375 (449)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~-~~~~~~  375 (449)
                                ...........+++.+.+|+..||+.||++|||+.++++.|+.++....... .+++|.
T Consensus       235 ----------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~  293 (296)
T 4hgt_A          235 ----------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN  293 (296)
T ss_dssp             ----------HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGG
T ss_pred             ----------ccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchh
Confidence                      0000001112335679999999999999999999999999999887655443 345543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.3e-44  Score=347.73  Aligned_cols=264  Identities=22%  Similarity=0.327  Sum_probs=201.4

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      .++|++.+.||+|+||.||+|....      ++..||+|++...   .......+.+|+.+++.++||||+++++++...
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~  104 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLL------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED  104 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETT------TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             ccceEEEEeecCCCCceEEEEEEcC------CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            3579999999999999999998765      4789999999753   233456788999999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKN--YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL  232 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGl  232 (449)
                      +..++||||+.+++|.+++...  ....+++..++.++.|++.||.|||  ++||+||||||+|||++.++.+||+|||+
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~  182 (310)
T 2wqm_A          105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGL  182 (310)
T ss_dssp             TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECCC--
T ss_pred             CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh--hCCeeCCCCcHHHEEEcCCCCEEEEeccc
Confidence            9999999999999999988642  3467899999999999999999999  67899999999999999999999999999


Q ss_pred             ccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccc
Q 013105          233 ATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK  312 (449)
Q Consensus       233 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  312 (449)
                      +........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... .......         
T Consensus       183 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~---------  250 (310)
T 2wqm_A          183 GRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKI---------  250 (310)
T ss_dssp             ------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHHHHHH---------
T ss_pred             eeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHHHHHh---------
Confidence            886543221  1233568999999999998899999999999999999999999997542211 0111000         


Q ss_pred             hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCC
Q 013105          313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN  365 (449)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  365 (449)
                          ............++..+.+|+.+||+.||++|||+.++++.|+.+....
T Consensus       251 ----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~  299 (310)
T 2wqm_A          251 ----EQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT  299 (310)
T ss_dssp             ----HTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ----hcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence                0011111112344567999999999999999999999999999886543

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.1e-45  Score=359.59  Aligned_cols=266  Identities=25%  Similarity=0.381  Sum_probs=207.1

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      .++|++.+.||+|+||.||+|.+..      ++..||+|++.... ......+.+|+.+++.++||||+++++++.+++.
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  105 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKP------SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE  105 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred             cccceeeeeecCCCCeEEEEEEECC------CCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence            4679999999999999999998765      57899999997553 3334678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK-PVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      .++||||+.+++|.+++...  ..+++..+..++.+++.||.|||  .. ||+||||||+|||++.++.+||+|||++..
T Consensus       106 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh--~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  181 (360)
T 3eqc_A          106 ISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  181 (360)
T ss_dssp             EEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred             EEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HhCCEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence            99999999999999999765  46899999999999999999999  54 799999999999999999999999999864


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhh------------
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA------------  303 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~------------  303 (449)
                      ....    ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...............            
T Consensus       182 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (360)
T 3eqc_A          182 LIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP  257 (360)
T ss_dssp             HHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred             cccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence            3211    123356999999999999889999999999999999999999999764322211110000            


Q ss_pred             --------------hhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          304 --------------RPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       304 --------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                                    .+..........+............++.++.+|+.+||+.||++|||+.++++|
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             ----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                          000000000111111111111122346679999999999999999999999987

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.4e-45  Score=361.51  Aligned_cols=276  Identities=21%  Similarity=0.267  Sum_probs=214.7

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC-
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE-  155 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-  155 (449)
                      .++|.+.+.||+|+||.||+|.+..      +++.||||++.... ......+.+|+.+++.++||||+++++++...+ 
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~   81 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKK------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT   81 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECC------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC
Confidence            4679999999999999999998765      57899999997432 234567889999999999999999999998765 


Q ss_pred             -EEEEEEEecCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEE----cCCCcEEEee
Q 013105          156 -HRLLVYEYMALGNLHDQLFKNY-SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILL----DSDYNAKLSD  229 (449)
Q Consensus       156 -~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill----~~~~~~kl~D  229 (449)
                       ..++||||+.+|+|.+++.... ...+++..++.++.|++.||.|||  ++||+||||||+|||+    +.++.+||+|
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (396)
T 4eut_A           82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (396)
T ss_dssp             CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred             CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH--HCCEEECCcCHHHEEEeecCCCceeEEEec
Confidence             7899999999999999997642 234999999999999999999999  6789999999999999    7778899999


Q ss_pred             eccccCCCCCCCCceeeecCCCCcccccccccc--------CCCCcccchhhhHHHHHHHHhCCCcccccccccch-hhH
Q 013105          230 FGLATDGPQGEDSHITTCVMGTEGYAAPEYINT--------GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREK-DLV  300 (449)
Q Consensus       230 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~-~~~  300 (449)
                      ||++.......   ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||......... ...
T Consensus       160 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~  236 (396)
T 4eut_A          160 FGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM  236 (396)
T ss_dssp             GGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH
T ss_pred             CCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH
Confidence            99998654322   2334569999999999864        56788999999999999999999999754322111 111


Q ss_pred             H-hhhhhhc-cccchhHhh--------cccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          301 E-WARPMLK-DFTKLDQII--------DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       301 ~-~~~~~~~-~~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                      . ....... .........        .......+...++..+.+++..||+.||++||++.++++.+..++..
T Consensus       237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            1 0000000 000000000        01112345578889999999999999999999999999999988764

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.5e-44  Score=368.95  Aligned_cols=253  Identities=26%  Similarity=0.345  Sum_probs=205.2

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      +.++|++.+.||+|+||.||+|.+..      +++.||||++...  .......+.+|+.+|+.++||||+++++++.+.
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   93 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRI------TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS   93 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETT------TCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECC------CCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC
Confidence            55789999999999999999998765      5889999998632  233457789999999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEc---CCCcEEEeeec
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD---SDYNAKLSDFG  231 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~---~~~~~kl~DfG  231 (449)
                      ...|+||||+.+|+|.+.+...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++   .++.+||+|||
T Consensus        94 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  169 (486)
T 3mwu_A           94 SSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFG  169 (486)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred             CEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCchHHEEEecCCCCCCEEEEECC
Confidence            9999999999999999998765  57899999999999999999999  67899999999999995   45679999999


Q ss_pred             cccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcccc
Q 013105          232 LATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFT  311 (449)
Q Consensus       232 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  311 (449)
                      ++.......   ......||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.........+..      .  
T Consensus       170 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~------~--  237 (486)
T 3mwu_A          170 LSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET------G--  237 (486)
T ss_dssp             CTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------T--
T ss_pred             cCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------C--
Confidence            998654322   2334579999999999975 599999999999999999999999976532211111100      0  


Q ss_pred             chhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          312 KLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                            ...........+++.+.+||.+||+.||.+|||+.++++|
T Consensus       238 ------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          238 ------KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             ------CCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             ------CCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                  0000111112345679999999999999999999999997

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.6e-45  Score=378.24  Aligned_cols=262  Identities=28%  Similarity=0.379  Sum_probs=213.4

Q ss_pred             HHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           75 QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      ++..++|++.+.||+|+||.||+|.+..       +..||||+++... ...+.+.+|+.+|+.++||||+++++++.+ 
T Consensus       263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-  333 (535)
T 2h8h_A          263 EIPRESLRLEVKLGQGCFGEVWMGTWNG-------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-  333 (535)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEETT-------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             ecchhhhhhheecccCCCeEEEEEEECC-------CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence            3445678899999999999999998764       4679999997543 345779999999999999999999999865 


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +..||||||+.+|+|.+++.......+++..++.++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++
T Consensus       334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  411 (535)
T 2h8h_A          334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLAR  411 (535)
T ss_dssp             SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred             ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCHhhEEEcCCCcEEEcccccce
Confidence            67899999999999999997654457899999999999999999999  6789999999999999999999999999998


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccch
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      ...... ........++..|+|||++.+..++.++|||||||+||||++ |+.||.+.........+             
T Consensus       412 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i-------------  477 (535)
T 2h8h_A          412 LIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-------------  477 (535)
T ss_dssp             TCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH-------------
T ss_pred             ecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------------
Confidence            654321 111122346789999999988899999999999999999999 99999765322111110             


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCC
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN  365 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  365 (449)
                          ........+..++..+.+||.+||+.||++|||+.+|++.|+.++...
T Consensus       478 ----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          478 ----ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             ----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             ----HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence                111112233456677999999999999999999999999999887644

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=7.5e-45  Score=352.09  Aligned_cols=259  Identities=29%  Similarity=0.438  Sum_probs=207.5

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcE--EEEEEeccC-CcchHHHHHHHHHHHhcC-CCCCcceeeeEEEeC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT--VAVKVLDVN-GSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCED  154 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~  154 (449)
                      ++|++.+.||+|+||.||+|.+..      ++..  +|+|.+... .......+.+|+.+++++ +||||+++++++.+.
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~   98 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKK------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   98 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEE------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             HHccceeeeecCCCceEEEEEEcc------CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC
Confidence            679999999999999999998765      3454  599998743 233446788999999999 899999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNY--------------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD  220 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~  220 (449)
                      +..++||||+++|+|.+++....              ...+++..++.++.|++.||.|||  ++||+||||||+|||++
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIl~~  176 (327)
T 1fvr_A           99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVG  176 (327)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEC
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCccceEEEc
Confidence            99999999999999999987542              347899999999999999999999  67899999999999999


Q ss_pred             CCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhh
Q 013105          221 SDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDL  299 (449)
Q Consensus       221 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~  299 (449)
                      .++.+||+|||++.......   ......+++.|+|||++.+..++.++|||||||++|||++ |..||........   
T Consensus       177 ~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~---  250 (327)
T 1fvr_A          177 ENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---  250 (327)
T ss_dssp             GGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---
T ss_pred             CCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH---
Confidence            99999999999997433211   1223347889999999988889999999999999999998 9999976532211   


Q ss_pred             HHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCC
Q 013105          300 VEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN  365 (449)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  365 (449)
                      ...              +........+..+++.+.+|+.+||+.||.+|||+.+++++|+.++...
T Consensus       251 ~~~--------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          251 YEK--------------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             HHH--------------GGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             HHH--------------hhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence            110              0111111223345567999999999999999999999999999887654

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.2e-44  Score=343.38  Aligned_cols=277  Identities=19%  Similarity=0.227  Sum_probs=214.0

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEE-EeCC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYC-CEDE  155 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~-~~~~  155 (449)
                      +.++|++.+.||+|+||.||+|.+..      +++.||||++.....  ...+.+|+.+++.++|++++..+.++ ...+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIA------AGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGD   78 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETT------TTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcC------CCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCC
Confidence            35789999999999999999998755      588999999875433  24578899999999988766655554 6778


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEE---cCCCcEEEeeecc
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILL---DSDYNAKLSDFGL  232 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill---~~~~~~kl~DfGl  232 (449)
                      ..++||||+ +++|.+++... ...+++..+..++.|++.||.|||  ++||+||||||+|||+   +.++.+||+|||+
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  154 (296)
T 3uzp_A           79 YNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL  154 (296)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred             ceEEEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence            889999999 89999998643 357999999999999999999999  6789999999999999   4888999999999


Q ss_pred             ccCCCCCCCC-----ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhh
Q 013105          233 ATDGPQGEDS-----HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML  307 (449)
Q Consensus       233 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~  307 (449)
                      +.........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.................. 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-  233 (296)
T 3uzp_A          155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK-  233 (296)
T ss_dssp             CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH-
T ss_pred             cccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc-
Confidence            9865443221     1123457999999999999889999999999999999999999999864332222111111000 


Q ss_pred             ccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCCCCC-CCCceee
Q 013105          308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDIP-IGPFVYT  375 (449)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~-~~~~~~~  375 (449)
                              ... .........+++.+.+++..||+.||++|||+.++++.|+.+....... ..+++|.
T Consensus       234 --------~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~  293 (296)
T 3uzp_A          234 --------KMS-TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN  293 (296)
T ss_dssp             --------HHH-SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGG
T ss_pred             --------ccC-CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccccc
Confidence                    000 0001112334567999999999999999999999999999988766544 3345553

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.7e-45  Score=355.26  Aligned_cols=269  Identities=27%  Similarity=0.388  Sum_probs=207.7

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC-CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ..++|.+.+.||+|+||.||+|.+... ....++..||||++... .......+.+|+.+++.++||||+++++++.+.+
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGM-PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC---------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCC-CCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            457899999999999999999975431 12335789999999744 2334567889999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC---CCcEEE
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYS-----STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS---DYNAKL  227 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~---~~~~kl  227 (449)
                      ..|+||||+.+|+|.+++.....     ..+++..++.++.|++.||.|||  .+||+||||||+|||++.   +..+||
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH--~~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh--hCCeecCcCCHhHEEEecCCCcceEEE
Confidence            99999999999999999976532     45889999999999999999999  678999999999999984   446999


Q ss_pred             eeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhh
Q 013105          228 SDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPM  306 (449)
Q Consensus       228 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~  306 (449)
                      +|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||........   ....   
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~~---  258 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV---LEFV---  258 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HHHH---
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH---HHHH---
Confidence            99999874332222222334568999999999988889999999999999999998 9999976432111   1110   


Q ss_pred             hccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCC
Q 013105          307 LKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN  365 (449)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  365 (449)
                                 ........+..++..+.+++.+||+.||.+|||+.+++++|+.+....
T Consensus       259 -----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          259 -----------TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             -----------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             -----------hcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence                       111111223345567999999999999999999999999999876543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.3e-44  Score=341.48  Aligned_cols=248  Identities=22%  Similarity=0.345  Sum_probs=200.0

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEe----
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE----  153 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~----  153 (449)
                      .|.+.+.||+|+||.||+|.+..      ++..||+|++...  .......+.+|+.+++.++||||+++++++..    
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~------~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  100 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTE------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG  100 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred             eEEeeeeccCCCCeEEEEeEecC------CceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCC
Confidence            47788899999999999998765      5789999998743  23345678899999999999999999999875    


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--eeeccCCCCceEEc-CCCcEEEeee
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP--VIYRDFKASNILLD-SDYNAKLSDF  230 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~--ivHrDikp~Nill~-~~~~~kl~Df  230 (449)
                      ....++||||+.+|+|.+++...  ..+++..+..++.|++.||.|||  ..+  |+||||||+|||++ .++.+||+||
T Consensus       101 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~~~i~H~dikp~Nil~~~~~~~~kl~Df  176 (290)
T 1t4h_A          101 KKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH--TRTPPIIHRDLKCDNIFITGPTGSVKIGDL  176 (290)
T ss_dssp             CEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--TSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred             CceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHH--cCCCCEEECCCCHHHEEEECCCCCEEEeeC
Confidence            46689999999999999999765  57899999999999999999999  566  99999999999997 7889999999


Q ss_pred             ccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccc
Q 013105          231 GLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF  310 (449)
Q Consensus       231 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  310 (449)
                      |++......    ......||+.|+|||++.+ .++.++|||||||++|+|++|..||........  ....   .    
T Consensus       177 g~~~~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~---~----  242 (290)
T 1t4h_A          177 GLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRR---V----  242 (290)
T ss_dssp             TGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHH---H----
T ss_pred             CCccccccc----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH--HHHH---H----
Confidence            999754332    2334569999999998874 589999999999999999999999975422111  1100   0    


Q ss_pred             cchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                            .........+...++.+.+++.+||+.||.+|||+.++++|
T Consensus       243 ------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          243 ------TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             ------TTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ------hccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                  01111111222234568999999999999999999999987

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.4e-44  Score=342.68  Aligned_cols=254  Identities=22%  Similarity=0.325  Sum_probs=204.4

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc------chHHHHHHHHHHHhcCCCCCcceeeeE
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS------QGHREWLAEVIFLGQLKHPHLVNLIGY  150 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~~~~~  150 (449)
                      +.++|++.+.||+|+||.||+|.+..      +++.||+|++.....      .....+.+|+.+++.++||||++++++
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   76 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKG------TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDI   76 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcC------CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhe
Confidence            45679999999999999999998765      478999999874321      236778999999999999999999999


Q ss_pred             EEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC----cEE
Q 013105          151 CCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY----NAK  226 (449)
Q Consensus       151 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~----~~k  226 (449)
                      +.+.+..++||||+.+++|.+++...  ..+++..+..++.|++.||.|||  .+||+||||||+||+++.++    .+|
T Consensus        77 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~~~~k  152 (283)
T 3bhy_A           77 FENKTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLH--SKRIAHFDLKPENIMLLDKNVPNPRIK  152 (283)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESCSSSSSCCEE
T ss_pred             ecCCCeEEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCChHHEEEecCCCCCCceE
Confidence            99999999999999999999999764  57899999999999999999999  67899999999999998877    899


Q ss_pred             EeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhh
Q 013105          227 LSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPM  306 (449)
Q Consensus       227 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~  306 (449)
                      |+|||++.......   ......||+.|+|||++.+..++.++||||||+++|+|++|..||.............     
T Consensus       153 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----  224 (283)
T 3bhy_A          153 LIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS-----  224 (283)
T ss_dssp             ECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-----
T ss_pred             EEecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhH-----
Confidence            99999998654322   1234569999999999998899999999999999999999999997643221111000     


Q ss_pred             hccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          307 LKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       ..        ............+..+.+++.+||+.||++|||+.+++++
T Consensus       225 -~~--------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          225 -AV--------NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             -TT--------CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             -hc--------ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence             00        0000011112334568999999999999999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.1e-44  Score=371.28  Aligned_cols=255  Identities=24%  Similarity=0.360  Sum_probs=208.5

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ++|.+.+.||+|+||.||+|.+..      +++.||+|++...   .......+.+|+.+|+.++||||+++++++.+.+
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~------tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  258 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKA------TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT  258 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hheEEEEEEeeCCCeEEEEEEECC------CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC
Confidence            679999999999999999998765      5889999999643   2234567889999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          156 HRLLVYEYMALGNLHDQLFKNY--SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      .+|+||||+.||+|.+++....  ...+++..+..++.|++.||.|||  ++||+||||||+|||++.+|.+||+|||++
T Consensus       259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH--~~gIvHrDLKP~NILl~~~g~vkL~DFGla  336 (543)
T 3c4z_A          259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLA  336 (543)
T ss_dssp             EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH--HcCCcccCCChHHEEEeCCCCEEEeeccee
Confidence            9999999999999999987643  456899999999999999999999  678999999999999999999999999999


Q ss_pred             cCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccch
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      ........  .....+||+.|+|||++.+..|+.++|||||||++|||++|..||..........  ....         
T Consensus       337 ~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~--~~~~---------  403 (543)
T 3c4z_A          337 VELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQ---------  403 (543)
T ss_dssp             EECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHH--HHHH---------
T ss_pred             eeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHH--HHHH---------
Confidence            86544322  1334579999999999999899999999999999999999999998653211111  0000         


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM-----TTVVKA  357 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~eil~~  357 (449)
                       .+...  ...++..++..+.+||.+||+.||.+||++     .+|++|
T Consensus       404 -~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          404 -RVLEQ--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             -HHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             -HHhhc--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence             01111  112344556779999999999999999965     677765

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4e-45  Score=357.73  Aligned_cols=284  Identities=17%  Similarity=0.220  Sum_probs=213.3

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCC--CCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcce---------
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLR--PGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN---------  146 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~---------  146 (449)
                      .++|.+.+.||+|+||.||+|.+..+..  ....++.||+|++...     ..+.+|+.+++.++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3679999999999999999998764200  0013688999999743     35778999999999999987         


Q ss_pred             ------eeeEEEe-CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEE
Q 013105          147 ------LIGYCCE-DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILL  219 (449)
Q Consensus       147 ------~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill  219 (449)
                            +++++.. ++..++||||+ +++|.+++.......+++..++.++.|++.||.|||  ++||+||||||+|||+
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH--ENEYVHGNVTAENIFV  192 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCCGGGEEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCCHHHEEE
Confidence                  6777776 78899999999 999999998754568999999999999999999999  6789999999999999


Q ss_pred             cCCC--cEEEeeeccccCCCCCCCC-----ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccc
Q 013105          220 DSDY--NAKLSDFGLATDGPQGEDS-----HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNR  292 (449)
Q Consensus       220 ~~~~--~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~  292 (449)
                      +.++  .+||+|||++.........     .......||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            9998  8999999999865432111     11233479999999999998899999999999999999999999998653


Q ss_pred             cccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCCCCC-CCC
Q 013105          293 CKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDIP-IGP  371 (449)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~-~~~  371 (449)
                      .... ...............+   ...   ......++..+.+|+..||+.||++|||+.+|++.|+.++...... ..+
T Consensus       273 ~~~~-~~~~~~~~~~~~~~~~---~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~  345 (352)
T 2jii_A          273 PNTE-DIMKQKQKFVDKPGPF---VGP---CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDP  345 (352)
T ss_dssp             TCHH-HHHHHHHHHHHSCCCE---ECT---TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSC
T ss_pred             cCHH-HHHHHHHhccCChhhh---hhh---ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCcc
Confidence            2111 1111111000000000   000   0001123466999999999999999999999999999988765544 445


Q ss_pred             ceeee
Q 013105          372 FVYTV  376 (449)
Q Consensus       372 ~~~~~  376 (449)
                      +.|..
T Consensus       346 ~dw~~  350 (352)
T 2jii_A          346 IGLPM  350 (352)
T ss_dssp             CCCCC
T ss_pred             ccCcC
Confidence            55543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=5.7e-45  Score=353.36  Aligned_cols=269  Identities=20%  Similarity=0.241  Sum_probs=197.0

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc--chHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--QGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      ...++|++.+.||+|+||.||+|.+..      +++.||||++.....  .....+.+|+.+++.++||||+++++++.+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTV------TNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH  104 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETT------TTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECC------CCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec
Confidence            345789999999999999999997765      588999999975432  224567789999999999999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEc-----CCCcEEEe
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD-----SDYNAKLS  228 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~-----~~~~~kl~  228 (449)
                      ++..++||||+. |+|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++     .++.+||+
T Consensus       105 ~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~  179 (329)
T 3gbz_A          105 NHRLHLIFEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCH--SRRCLHRDLKPQNLLLSVSDASETPVLKIG  179 (329)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred             CCEEEEEEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCEECCCCCHHHEEEecCCCCccceEEEC
Confidence            999999999998 5999998765  56899999999999999999999  67899999999999994     45569999


Q ss_pred             eeccccCCCCCCCCceeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhh--h
Q 013105          229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR--P  305 (449)
Q Consensus       229 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~--~  305 (449)
                      |||++........  ......||+.|+|||++.+. .++.++|||||||++|||++|..||................  +
T Consensus       180 Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  257 (329)
T 3gbz_A          180 DFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLP  257 (329)
T ss_dssp             CTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             cCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCC
Confidence            9999975432211  23335689999999999764 58999999999999999999999998654322211110000  0


Q ss_pred             hhccccchhHh----------hcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          306 MLKDFTKLDQI----------IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       306 ~~~~~~~~~~~----------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ....+......          ............+++++.+|+.+||+.||++|||+.++++|
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            00000000000          00000000111245678999999999999999999999987

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.8e-45  Score=353.14  Aligned_cols=267  Identities=22%  Similarity=0.300  Sum_probs=198.0

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcch-HHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG-HREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      ++|.+.+.||+|+||.||+|.+..      +++.||+|++....... ...+.+|+.+++.++||||+++++++.+.+..
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   75 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKL------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSL   75 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECC------CCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEE
Confidence            579999999999999999998765      57899999997443221 12345799999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+. |+|.+++... ...+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++....
T Consensus        76 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           76 TLVFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCH--RQKVLHRDLKPQNLLINERGELKLADFGLARAKS  151 (324)
T ss_dssp             EEEEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH--HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred             EEEecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence            99999997 6898888664 356899999999999999999999  6789999999999999999999999999998554


Q ss_pred             CCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhh--hhccccch-
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARP--MLKDFTKL-  313 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~-  313 (449)
                      ...  .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.....  ....+... 
T Consensus       152 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  229 (324)
T 3mtl_A          152 IPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL  229 (324)
T ss_dssp             -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             CCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhh
Confidence            322  12334568999999999876 5689999999999999999999999987643322221111000  00000000 


Q ss_pred             --hHhhccccc-------ccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          314 --DQIIDSRLE-------DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       314 --~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                        .........       ......++.++.+|+.+||+.||++|||+.++++|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence              000000000       00112345678999999999999999999999997

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=341.85  Aligned_cols=251  Identities=25%  Similarity=0.377  Sum_probs=185.9

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      .++|.+.+.||+|+||.||+|.+..      +++.||+|++....   ......+.+|+.+++.++||||+++++++.+.
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   83 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIH------TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS   83 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS
T ss_pred             cccceeeeeecCCCceEEEEEEEcc------CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC
Confidence            3679999999999999999998765      47899999996331   22346788999999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +..++||||+.+++|.+++... ...+++..+..++.|++.||.|||  ++||+||||||+||+++.++.+||+|||++.
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~  160 (278)
T 3cok_A           84 NYVYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLH--SHGILHRDLTLSNLLLTRNMNIKIADFGLAT  160 (278)
T ss_dssp             SEEEEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHH--HTTEECSSCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CeEEEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCCEEEEeeccee
Confidence            9999999999999999988654 357899999999999999999999  6789999999999999999999999999998


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ........  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..........                
T Consensus       161 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----------------  222 (278)
T 3cok_A          161 QLKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN----------------  222 (278)
T ss_dssp             ECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------
T ss_pred             eccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH----------------
Confidence            65432211  223568999999999988889999999999999999999999997643221110                


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .....  ....+..++.++.+++.+||+.||++|||+.+++++
T Consensus       223 ~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          223 KVVLA--DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             -CCSS--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             HHhhc--ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence            00000  011233345678999999999999999999999986

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-44  Score=353.13  Aligned_cols=270  Identities=24%  Similarity=0.323  Sum_probs=199.3

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc-----hHHHHHHHHHHHhcCCCCCcceeeeE
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ-----GHREWLAEVIFLGQLKHPHLVNLIGY  150 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~~~~~  150 (449)
                      ...++|.+.+.||+|+||.||+|.+..      +++.||||++......     ....+.+|+.+++.++||||++++++
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   80 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKN------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA   80 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSS------CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECC------CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEE
Confidence            345789999999999999999997654      5789999999743221     12467889999999999999999999


Q ss_pred             EEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeee
Q 013105          151 CCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDF  230 (449)
Q Consensus       151 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~Df  230 (449)
                      +.+.+..++||||+.+ +|.+++... ...+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+||
T Consensus        81 ~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~~~kl~Df  156 (346)
T 1ua2_A           81 FGHKSNISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADF  156 (346)
T ss_dssp             ECCTTCCEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             EeeCCceEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHH--HCCEECCCCCHHHEEEcCCCCEEEEec
Confidence            9999999999999985 888877653 356888899999999999999999  677999999999999999999999999


Q ss_pred             ccccCCCCCCCCceeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCCcccccccccchhhH-Hhh-hhhh
Q 013105          231 GLATDGPQGEDSHITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV-EWA-RPML  307 (449)
Q Consensus       231 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~-~~~-~~~~  307 (449)
                      |++........  ......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.........+ ... .+..
T Consensus       157 g~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~  234 (346)
T 1ua2_A          157 GLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTE  234 (346)
T ss_dssp             GGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred             ccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence            99986543221  23345689999999998654 5899999999999999999999999865432221111 000 0000


Q ss_pred             ccccchhH---hhcccccc-----cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          308 KDFTKLDQ---IIDSRLED-----RYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       308 ~~~~~~~~---~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ..+.....   .+......     ......+..+.+|+.+||+.||++|||+.++++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            01111000   00000000     0113345679999999999999999999999997

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.4e-44  Score=353.93  Aligned_cols=261  Identities=19%  Similarity=0.213  Sum_probs=208.3

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC---CCCcceeeeEEE
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK---HPHLVNLIGYCC  152 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~  152 (449)
                      ...++|.+.+.||+|+||.||+|.+... .....++.||||++...   ....+..|++++..++   |+||+.+++++.
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDL-NDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC--------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCC-cccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence            3457799999999999999999964331 23346889999999744   3456777888888886   999999999999


Q ss_pred             eCCEEEEEEEecCCCChHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC--------
Q 013105          153 EDEHRLLVYEYMALGNLHDQLFKN---YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS--------  221 (449)
Q Consensus       153 ~~~~~~lv~e~~~~g~L~~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~--------  221 (449)
                      ..+..||||||+.+|+|.+++...   ....+++..++.++.|++.||.|||  ++||+||||||+|||++.        
T Consensus       138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH--~~~ivHrDiKp~NIll~~~~~~~~~~  215 (365)
T 3e7e_A          138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH--DCEIIHGDIKPDNFILGNGFLEQDDE  215 (365)
T ss_dssp             CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCSGGGEEECGGGTCC---
T ss_pred             cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh--hCCeecCCCCHHHEEecccccCcccc
Confidence            999999999999999999999642   3467999999999999999999999  788999999999999998        


Q ss_pred             ---CCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchh
Q 013105          222 ---DYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKD  298 (449)
Q Consensus       222 ---~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~  298 (449)
                         ++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||++|+.||......... 
T Consensus       216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-  294 (365)
T 3e7e_A          216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK-  294 (365)
T ss_dssp             ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-
T ss_pred             ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-
Confidence               8999999999997543323334455677999999999999989999999999999999999999999654221100 


Q ss_pred             hHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCC-CCHHHHHHHhhccccC
Q 013105          299 LVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSR-PTMTTVVKALEPLLDL  364 (449)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~eil~~L~~~~~~  364 (449)
                                    .    .... ..+  ..++.+.+++..||+.+|.+| |++.++.+.|+.++..
T Consensus       295 --------------~----~~~~-~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          295 --------------P----EGLF-RRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             --------------E----CSCC-TTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             --------------e----chhc-ccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence                          0    0000 011  124567889999999999999 6888888888887653

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.9e-44  Score=368.81  Aligned_cols=253  Identities=23%  Similarity=0.341  Sum_probs=201.6

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      +.++|++.+.||+|+||.||+|.+..      ++..||+|++....  ......+.+|+.+++.++||||+++++++.+.
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  108 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKV------THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK  108 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETT------TCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECC------CCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence            45679999999999999999998765      57899999997542  33356788999999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC---CcEEEeeec
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD---YNAKLSDFG  231 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~---~~~kl~DfG  231 (449)
                      ...|+||||+.+|+|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++..   +.+||+|||
T Consensus       109 ~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG  184 (494)
T 3lij_A          109 RNYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLH--KHNIVHRDLKPENLLLESKEKDALIKIVDFG  184 (494)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCChhhEEEeCCCCCCcEEEEECC
Confidence            9999999999999999988765  57899999999999999999999  6789999999999999764   459999999


Q ss_pred             cccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcccc
Q 013105          232 LATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFT  311 (449)
Q Consensus       232 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  311 (449)
                      ++.......   ......||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.........+..      .. 
T Consensus       185 ~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~------~~-  253 (494)
T 3lij_A          185 LSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK------GK-  253 (494)
T ss_dssp             TCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------TC-
T ss_pred             CCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------CC-
Confidence            998654322   233456999999999986 5699999999999999999999999986543221111100      00 


Q ss_pred             chhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          312 KLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                             ..........+++.+.+|+.+||+.||.+|||+.++++|
T Consensus       254 -------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          254 -------YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             -------CCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             -------CCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence                   000111112345668999999999999999999999986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-44  Score=344.03  Aligned_cols=262  Identities=27%  Similarity=0.358  Sum_probs=206.5

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE-
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR-  157 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~-  157 (449)
                      .|.+.+.||+|+||.||+|.+..+   ...+..||+|++..... .....+.+|+.+++.++||||+++++++.+.+.. 
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQ---AQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECS---SSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             EEccCceeccCCCceEEEEEEecC---CCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence            356678999999999999987653   12345799999975433 3456788999999999999999999999876555 


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+.+|+|.+++... ...+++..++.++.|++.||.|||  +.||+||||||+|||++.++.+||+|||++....
T Consensus        99 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLA--EQKFVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EEEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            9999999999999998653 467899999999999999999999  6789999999999999999999999999998553


Q ss_pred             CCC--CCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCc-ccccccccchhhHHhhhhhhccccchh
Q 013105          238 QGE--DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS-VEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       238 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ...  .........||+.|+|||.+.+..++.++|||||||++|+|++|..| |........   .              
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~---~--------------  238 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL---T--------------  238 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH---H--------------
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHH---H--------------
Confidence            321  11122335678999999999988999999999999999999995555 443221111   1              


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                      ..+........+..+++.+.+++..||+.||.+|||+.++++.|+.++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  288 (298)
T 3pls_A          239 HFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA  288 (298)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            11111111222334556799999999999999999999999999988653

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=8.7e-45  Score=352.32  Aligned_cols=268  Identities=22%  Similarity=0.338  Sum_probs=201.9

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc--hHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ--GHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      .++|++.+.||+|+||.||+|.+..      +++.||||++......  ....+.+|+.+++.++||||+++++++.+.+
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   97 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKD------TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK   97 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETT------TCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hhhheeeeEEeecCCEEEEEEEECC------CCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC
Confidence            3679999999999999999998765      5789999998644322  2455789999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..++||||+.+++|.+++...  ..+++..+..++.|++.||.|||  ..||+||||||+|||++.++.+||+|||++..
T Consensus        98 ~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  173 (331)
T 4aaa_A           98 RWYLVFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCH--SHNIIHRDIKPENILVSQSGVVKLCDFGFART  173 (331)
T ss_dssp             EEEEEEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             EEEEEEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH--HCCEEccCcChheEEEcCCCcEEEEeCCCcee
Confidence            999999999988888776543  57999999999999999999999  67899999999999999999999999999976


Q ss_pred             CCCCCCCceeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhh-hhh-------
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA-RPM-------  306 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~-~~~-------  306 (449)
                      .....  .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||............... ...       
T Consensus       174 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (331)
T 4aaa_A          174 LAAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL  251 (331)
T ss_dssp             ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             ecCCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence            54322  123345689999999999765 7899999999999999999999999865432221111000 000       


Q ss_pred             hccccchh-----HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          307 LKDFTKLD-----QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       307 ~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ........     ............+.+++.+.+|+.+||+.||++|||+.++++|
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            00000000     0000000011112346779999999999999999999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.5e-44  Score=341.25  Aligned_cols=248  Identities=23%  Similarity=0.356  Sum_probs=206.7

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      .++|.+.+.||+|+||.||+|.+..      ++..||+|++...   .......+.+|+.+++.++||||+++++++.+.
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   86 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQ------NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR   86 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hhhceeeheecCCCCeEEEEEEEcC------CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC
Confidence            3679999999999999999998765      4789999998632   122346788999999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +..++||||+.+|+|.+++...  ..+++.....++.|++.||.|||  ++||+||||||+||+++.++.+||+|||++.
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~  162 (284)
T 2vgo_A           87 KRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCH--ERKVIHRDIKPENLLMGYKGELKIADFGWSV  162 (284)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCHHHEEEcCCCCEEEecccccc
Confidence            9999999999999999999765  46899999999999999999999  7889999999999999999999999999987


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ......    .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........               
T Consensus       163 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---------------  223 (284)
T 2vgo_A          163 HAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR---------------  223 (284)
T ss_dssp             ECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---------------
T ss_pred             cCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHH---------------
Confidence            543321    2345699999999999988899999999999999999999999976432111100               


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       +...  ...++...+..+.+++.+||+.||.+|||+.++++|
T Consensus       224 -~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          224 -IVNV--DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             -HHTT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             -Hhcc--ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence             0000  111233455678999999999999999999999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=8.6e-45  Score=370.51  Aligned_cols=253  Identities=25%  Similarity=0.352  Sum_probs=207.5

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      +.++|++.+.||+|+||.||+|....      +++.||||++....   ......+.+|+.+++.++||||+++++++.+
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   97 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKI------TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED   97 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECC------CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            45679999999999999999998765      58899999996432   3456788999999999999999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEE---cCCCcEEEeee
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILL---DSDYNAKLSDF  230 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill---~~~~~~kl~Df  230 (449)
                      .+..|+||||+.+|+|.+++...  ..+++..+..++.|++.||.|||  .+||+||||||+|||+   +.++.+||+||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  173 (484)
T 3nyv_A           98 KGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDF  173 (484)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESSSSTTCCEEECCT
T ss_pred             CCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEEecCCCCCcEEEEee
Confidence            99999999999999999998765  57899999999999999999999  6779999999999999   56789999999


Q ss_pred             ccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccc
Q 013105          231 GLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF  310 (449)
Q Consensus       231 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  310 (449)
                      |++.......   ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.........+.      ...
T Consensus       174 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~------~~~  243 (484)
T 3nyv_A          174 GLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE------KGK  243 (484)
T ss_dssp             THHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCC
T ss_pred             eeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH------cCC
Confidence            9998654332   2334569999999999975 69999999999999999999999998653221111110      000


Q ss_pred             cchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                              ..........+++.+.+|+.+||+.||.+|||+.++++|
T Consensus       244 --------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          244 --------YTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             --------CCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --------CCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence                    000111112445679999999999999999999999987

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.9e-44  Score=342.01  Aligned_cols=247  Identities=23%  Similarity=0.309  Sum_probs=201.7

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcC-CCCCcceeeeEEEe
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCE  153 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~  153 (449)
                      +.++|++.+.||+|+||.||+|.+..      +++.||+|++...  .......+.+|+..+..+ +||||+++++++.+
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~   82 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRL------DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE   82 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcC------CCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec
Confidence            45779999999999999999998765      4789999999754  234456788999999999 89999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC---------
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNY--SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD---------  222 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~---------  222 (449)
                      .+..++||||+++++|.+++....  ...+++..+..++.|++.||.|||  ++||+||||||+|||++.+         
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dikp~NIl~~~~~~~~~~~~~  160 (289)
T 1x8b_A           83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH--SMSLVHMDIKPSNIFISRTSIPNAASEE  160 (289)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEC-----------
T ss_pred             CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH--hCCEeecCCCHHHEEEcCCCCCcccccc
Confidence            999999999999999999997642  257899999999999999999999  6789999999999999844         


Q ss_pred             ----------CcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCCccccc
Q 013105          223 ----------YNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKN  291 (449)
Q Consensus       223 ----------~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~~~  291 (449)
                                ..+||+|||++.......      ...||+.|+|||++.+. .++.++|||||||++|+|++|.+++...
T Consensus       161 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~  234 (289)
T 1x8b_A          161 GDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG  234 (289)
T ss_dssp             ---------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred             cccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence                      479999999998654322      23489999999999765 5678999999999999999999877543


Q ss_pred             ccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          292 RCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ...     ..              +.. ......+..+++.+.+++.+||+.||++|||+.++++|
T Consensus       235 ~~~-----~~--------------~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          235 DQW-----HE--------------IRQ-GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             HHH-----HH--------------HHT-TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             hHH-----HH--------------HHc-CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence            110     00              000 11112233455679999999999999999999999987

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.5e-44  Score=345.17  Aligned_cols=263  Identities=27%  Similarity=0.379  Sum_probs=204.8

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEE-eCCE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCC-EDEH  156 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~-~~~~  156 (449)
                      .+|++.+.||+|+||.||+|.+..+   ......+|+|.+.... ......+.+|+.++++++||||+++++++. .++.
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  101 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC--------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             eehhhcceeeecCCceEEEEEEecC---CCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence            4688899999999999999987542   1234568999987543 334567889999999999999999999864 4568


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||+.+|+|.+++... ...+++..++.++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++...
T Consensus       102 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             eEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCchheEEECCCCCEEECcccccccc
Confidence            89999999999999998653 356889999999999999999999  678999999999999999999999999999865


Q ss_pred             CCCCC--CceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccch
Q 013105          237 PQGED--SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       237 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      .....  ........||+.|+|||.+.+..++.++|||||||++|+|++ |.+||...........              
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~--------------  244 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY--------------  244 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH--------------
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH--------------
Confidence            43221  111233457889999999998899999999999999999999 5666654322111100              


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                         +........+..+++.+.+++.+||+.||.+|||+.++++.|+.++..
T Consensus       245 ---~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  292 (298)
T 3f66_A          245 ---LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  292 (298)
T ss_dssp             ---HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ---HhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence               011111112334456799999999999999999999999999988753

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=353.26  Aligned_cols=270  Identities=21%  Similarity=0.214  Sum_probs=200.9

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcch-----------HHHHHHHHHHHhcCCCCCcce
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG-----------HREWLAEVIFLGQLKHPHLVN  146 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~nIv~  146 (449)
                      .++|.+.+.||+|+||.||+|.+...   ...+..||+|++.......           ...+.+|+.++..++||||++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~  112 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNK---PEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL  112 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSS---CGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCC---CCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence            46799999999999999999988642   2246789999997543221           123567889999999999999


Q ss_pred             eeeEEEe----CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC
Q 013105          147 LIGYCCE----DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD  222 (449)
Q Consensus       147 ~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~  222 (449)
                      +++++..    ....|+||||+ +++|.+++...  ..+++..++.++.|++.||.|||  ++||+||||||+|||++.+
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIH--ENEYVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEESS
T ss_pred             eecccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCcCHHHEEEccC
Confidence            9999988    78899999999 99999998765  37999999999999999999999  6789999999999999888


Q ss_pred             C--cEEEeeeccccCCCCCCC-----CceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCccccccccc
Q 013105          223 Y--NAKLSDFGLATDGPQGED-----SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKR  295 (449)
Q Consensus       223 ~--~~kl~DfGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~  295 (449)
                      +  .+||+|||+++.......     ........||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence            7  999999999975432211     111234579999999999998899999999999999999999999996532111


Q ss_pred             chhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccc
Q 013105          296 EKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL  362 (449)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  362 (449)
                      .. ...........   +...+.....   ...++..+.+++..||+.||++|||+.+|++.|+.+.
T Consensus       268 ~~-~~~~~~~~~~~---~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          268 VA-VQTAKTNLLDE---LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             HH-HHHHHHHHHHT---TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             HH-HHHHHHhhccc---ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            11 11100000000   0000000000   1134557999999999999999999999999998754

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.8e-44  Score=361.16  Aligned_cols=256  Identities=23%  Similarity=0.335  Sum_probs=195.0

Q ss_pred             HHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--------cchHHHHHHHHHHHhcCCCCCcce
Q 013105           75 QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--------SQGHREWLAEVIFLGQLKHPHLVN  146 (449)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~nIv~  146 (449)
                      ..+.++|.+.+.||+|+||.||+|.+..      +++.||||++....        ......+.+|+.+|++++||||++
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  204 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERK------TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK  204 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETT------TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCC
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECC------CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEee
Confidence            4567899999999999999999998766      57899999986431        111234788999999999999999


Q ss_pred             eeeEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC---
Q 013105          147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY---  223 (449)
Q Consensus       147 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~---  223 (449)
                      +++++. .+..|+||||+.+|+|.+++...  ..+++.....++.|++.||.|||  +++|+||||||+|||++.++   
T Consensus       205 l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH--~~~ivHrDlkp~NIll~~~~~~~  279 (419)
T 3i6u_A          205 IKNFFD-AEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQEEDC  279 (419)
T ss_dssp             CCEEEE-SSEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESSSSSSC
T ss_pred             EEEEEe-cCceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChHhEEEecCCCcc
Confidence            999975 56689999999999999988654  57999999999999999999999  67799999999999997544   


Q ss_pred             cEEEeeeccccCCCCCCCCceeeecCCCCcccccccccc---CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhH
Q 013105          224 NAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT---GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV  300 (449)
Q Consensus       224 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~  300 (449)
                      .+||+|||++.......   ......||+.|+|||++.+   ..++.++|||||||++|+|++|..||.........  .
T Consensus       280 ~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~--~  354 (419)
T 3i6u_A          280 LIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--K  354 (419)
T ss_dssp             CEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH--H
T ss_pred             eEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH--H
Confidence            59999999998654322   2344679999999999853   57889999999999999999999999754322111  1


Q ss_pred             HhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          301 EWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ......  ..         .........+++.+.+|+.+||+.||++|||+.++++|
T Consensus       355 ~~i~~~--~~---------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          355 DQITSG--KY---------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             HHHHTT--CC---------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHhcC--CC---------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            000000  00         00000112245679999999999999999999999997

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.7e-44  Score=362.96  Aligned_cols=201  Identities=27%  Similarity=0.357  Sum_probs=167.7

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      +.++|.+.+.||+|+||.||+|.+..      +++.||||++...  .......+.+|+.+|+.++||||+++++++...
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~------~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~   97 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKN------TEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPD   97 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETT------TTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECC------CCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecC
Confidence            45789999999999999999998765      5889999999743  233456788999999999999999999999766


Q ss_pred             -----CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEee
Q 013105          155 -----EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSD  229 (449)
Q Consensus       155 -----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~D  229 (449)
                           ...|+||||+. |+|.+++...  ..+++..+..++.|++.||.|||  +.||+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH--~~givHrDlkp~NILl~~~~~~kL~D  172 (432)
T 3n9x_A           98 DLLKFDELYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIH--ESGIIHRDLKPANCLLNQDCSVKVCD  172 (432)
T ss_dssp             CTTTCCCEEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcCCeEEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCCCCCCCHHHeEECCCCCEEEcc
Confidence                 67999999986 6999988654  57999999999999999999999  67799999999999999999999999


Q ss_pred             eccccCCCCCCCC--------------------ceeeecCCCCcccccccc-ccCCCCcccchhhhHHHHHHHHhCCCcc
Q 013105          230 FGLATDGPQGEDS--------------------HITTCVMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGRRSV  288 (449)
Q Consensus       230 fGla~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~vl~elltg~~pf  288 (449)
                      ||+++........                    ......+||++|+|||++ .+..|+.++|||||||++|||++|..||
T Consensus       173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             CTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            9999865432211                    123556799999999986 5667999999999999999999854444

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5e-44  Score=342.53  Aligned_cols=254  Identities=21%  Similarity=0.293  Sum_probs=202.8

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC----cchHHHHHHHHHHHhcCCCCCcceeeeEEE
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG----SQGHREWLAEVIFLGQLKHPHLVNLIGYCC  152 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~  152 (449)
                      +.++|.+.+.||+|+||.||+|.+..      +++.||+|++....    ......+.+|+.+++.++||||+++++++.
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   76 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSE------TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLY   76 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTT------TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccceeEeeEEecCCCeEEEEEEECC------CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEE
Confidence            45789999999999999999997655      57899999996431    234567899999999999999999999984


Q ss_pred             --eCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeee
Q 013105          153 --EDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDF  230 (449)
Q Consensus       153 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~Df  230 (449)
                        +....++||||+.++ |.+++.......+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+||
T Consensus        77 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--~~~i~H~dlkp~NIl~~~~~~~kl~df  153 (305)
T 2wtk_C           77 NEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH--SQGIVHKDIKPGNLLLTTGGTLKISAL  153 (305)
T ss_dssp             CC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             cCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCcccEEEcCCCcEEeecc
Confidence              456789999999866 778777665678999999999999999999999  678999999999999999999999999


Q ss_pred             ccccCCCCCCCCceeeecCCCCccccccccccCC--CCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhc
Q 013105          231 GLATDGPQGEDSHITTCVMGTEGYAAPEYINTGH--LTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK  308 (449)
Q Consensus       231 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  308 (449)
                      |++................||+.|+|||++.+..  ++.++|||||||++|+|++|..||...........+        
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i--------  225 (305)
T 2wtk_C          154 GVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI--------  225 (305)
T ss_dssp             TTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--------
T ss_pred             ccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHH--------
Confidence            9998654433333344566999999999997643  478999999999999999999999864321111000        


Q ss_pred             cccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                              ...  ....+..++..+.+++.+||+.||.+|||+.+++++
T Consensus       226 --------~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          226 --------GKG--SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             --------HHC--CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             --------hcC--CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                    000  011233445678999999999999999999999987

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.3e-44  Score=367.86  Aligned_cols=253  Identities=23%  Similarity=0.317  Sum_probs=203.8

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-------------chHHHHHHHHHHHhcCCCCC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-------------QGHREWLAEVIFLGQLKHPH  143 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~n  143 (449)
                      +.++|.+.+.||+|+||.||+|.+..      ++..||+|++.....             .....+.+|+.+|+.++|||
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  107 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKN------GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPN  107 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETT------TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTT
T ss_pred             cccceEEEeEecccCCeEEEEEEECC------CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCC
Confidence            56789999999999999999998765      578999999974321             23567889999999999999


Q ss_pred             cceeeeEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC
Q 013105          144 LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY  223 (449)
Q Consensus       144 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~  223 (449)
                      |+++++++.+....|+||||+.||+|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++
T Consensus       108 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~  183 (504)
T 3q5i_A          108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLH--KHNIVHRDIKPENILLENKN  183 (504)
T ss_dssp             BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESSTT
T ss_pred             CCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCcHHHEEEecCC
Confidence            999999999999999999999999999998765  57999999999999999999999  67899999999999998776


Q ss_pred             ---cEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhH
Q 013105          224 ---NAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV  300 (449)
Q Consensus       224 ---~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~  300 (449)
                         .+||+|||++.......   ......||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.........+
T Consensus       184 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  259 (504)
T 3q5i_A          184 SLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV  259 (504)
T ss_dssp             CCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence               69999999998654432   233456999999999987 46899999999999999999999999865332211111


Q ss_pred             HhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          301 EWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ..      ...        .........+++.+.+|+.+||+.||.+|||+.++++|
T Consensus       260 ~~------~~~--------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          260 EK------GKY--------YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             HH------CCC--------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             Hc------CCC--------CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            10      000        00000012245679999999999999999999999987

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.6e-45  Score=357.81  Aligned_cols=262  Identities=27%  Similarity=0.386  Sum_probs=198.9

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC-CcchHHHHHHHHHHHhcCCCCCcceeeeEEEe-CCEE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE-DEHR  157 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~~~~  157 (449)
                      .|.+.+.||+|+||.||+|.+...   ......||+|.+... .......+.+|+.++++++||||+++++++.. ++..
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  166 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  166 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEET---TTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred             eeecCcEeeeCCCeEEEEEEEECC---CCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence            466778999999999999987542   113457899998643 33456789999999999999999999998754 5678


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+.+|+|.+++... ...+++..++.++.|++.||.|||  ++||+||||||+|||++.++.+||+|||+++...
T Consensus       167 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHH--HCCEecCccchheEEECCCCCEEEeecccccccc
Confidence            9999999999999998653 356889999999999999999999  6789999999999999999999999999998653


Q ss_pred             CCCCC--ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchh
Q 013105          238 QGEDS--HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       238 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      .....  .......||+.|+|||++.+..++.++|||||||++|||++ |.+||............              
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~--------------  309 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL--------------  309 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH--------------
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH--------------
Confidence            32211  11223457889999999998899999999999999999999 67787654322111110              


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                         ........+..++..+.+++.+||+.||++|||+.++++.|+.++..
T Consensus       310 ---~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~  356 (373)
T 3c1x_A          310 ---LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  356 (373)
T ss_dssp             ---HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ---HcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence               00111112334566799999999999999999999999999988754

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=7.2e-45  Score=343.94  Aligned_cols=252  Identities=27%  Similarity=0.405  Sum_probs=200.7

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC-CE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED-EH  156 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-~~  156 (449)
                      .++|++.+.||+|+||.||+|.+.        ++.||||++...  ...+.+.+|+.+++.++||||+++++++.+. +.
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--------GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   89 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--------TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--------CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence            467999999999999999999763        578999999643  3456789999999999999999999997654 47


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||+.+++|.+++.......+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++...
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  167 (278)
T 1byg_A           90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  167 (278)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred             eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCcceEEEeCCCcEEEeeccccccc
Confidence            899999999999999997654345889999999999999999999  678999999999999999999999999998854


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ...     .....+++.|+|||++.+..++.++|||||||++|+|++ |..||........   ..              
T Consensus       168 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~--------------  225 (278)
T 1byg_A          168 SST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VP--------------  225 (278)
T ss_dssp             -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HH--------------
T ss_pred             ccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH--------------
Confidence            332     122357899999999988899999999999999999998 9999976432111   10              


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                      .+........+..+++.+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       226 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          226 RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             HHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence            011111122334556779999999999999999999999999988754

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.9e-44  Score=364.51  Aligned_cols=270  Identities=21%  Similarity=0.255  Sum_probs=212.1

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCC-CCcceeeeEEEeCC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKH-PHLVNLIGYCCEDE  155 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~~~  155 (449)
                      +.++|++.+.||+|+||.||+|.+..      +++.||||++......  ..+.+|+.+++.++| ++|..+..++...+
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~   76 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQ------TNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGD   76 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETT------TCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETT
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECC------CCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCC
Confidence            45789999999999999999998765      5789999998754322  347789999999986 66666777778889


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEE---cCCCcEEEeeecc
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILL---DSDYNAKLSDFGL  232 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill---~~~~~~kl~DfGl  232 (449)
                      ..+|||||+ +++|.+++... ...+++..++.++.||+.||.|||  .++|+||||||+||||   +.++.+||+|||+
T Consensus        77 ~~~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH--~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl  152 (483)
T 3sv0_A           77 YNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL  152 (483)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred             EEEEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccCcceEEEecCCCCCeEEEEeCCc
Confidence            999999999 89999998643 357999999999999999999999  6789999999999999   6889999999999


Q ss_pred             ccCCCCCCCC-----ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhh
Q 013105          233 ATDGPQGEDS-----HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML  307 (449)
Q Consensus       233 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~  307 (449)
                      +.........     .......||+.|+|||++.+..++.++|||||||+||||++|+.||.+.................
T Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~  232 (483)
T 3sv0_A          153 AKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK  232 (483)
T ss_dssp             CEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH
T ss_pred             ceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc
Confidence            9865443221     11225679999999999999999999999999999999999999998754332222221111000


Q ss_pred             ccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCCCCC
Q 013105          308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDIP  368 (449)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~  368 (449)
                               +.. ....+...++.++.+|+..||+.||++||++.+|++.|+.++.....+
T Consensus       233 ---------~~~-~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~  283 (483)
T 3sv0_A          233 ---------VAT-SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQ  283 (483)
T ss_dssp             ---------HHS-CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             ---------ccc-cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCC
Confidence                     000 000111233567999999999999999999999999999987655444

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.6e-44  Score=349.58  Aligned_cols=250  Identities=24%  Similarity=0.365  Sum_probs=207.6

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      .++|.+.+.||+|+||.||+|.+..      +++.||+|++...   .......+.+|+.+++.++||||+++++++.+.
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  113 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDAD------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN  113 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECC------CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            4679999999999999999998765      5789999998643   223456788999999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +..++||||+.+++|.+++...  ..+++..++.++.|++.||.|||  .+||+||||||+|||++.++.+||+|||++.
T Consensus       114 ~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  189 (335)
T 2owb_A          114 DFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT  189 (335)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CeEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCEecCCCchhEEEcCCCCEEEeeccCce
Confidence            9999999999999999988765  57899999999999999999999  6789999999999999999999999999998


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      .......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+      .       
T Consensus       190 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~------~-------  254 (335)
T 2owb_A          190 KVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI------K-------  254 (335)
T ss_dssp             ECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------H-------
T ss_pred             ecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH------h-------
Confidence            6543222  133456999999999999888999999999999999999999999764321111000      0       


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                         ..  ....+..++..+.+|+.+||+.||++|||+.+++++
T Consensus       255 ---~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          255 ---KN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             ---HT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ---cC--CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               00  011223445568999999999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=5.8e-44  Score=340.32  Aligned_cols=254  Identities=21%  Similarity=0.295  Sum_probs=202.2

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      ++|.....||+|+||.||+|.+..      ++..||||++..........+.+|+.+++.++||||+++++++.+.+..+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   95 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLS------NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK   95 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETT------TCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECC------CCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEE
Confidence            345556689999999999998765      57899999998665556678899999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC-CCcEEEeeeccccCC
Q 013105          159 LVYEYMALGNLHDQLFKNY-SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS-DYNAKLSDFGLATDG  236 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~-~~~~kl~DfGla~~~  236 (449)
                      +||||+.+++|.+++.... ...+++..+..++.|++.||.|||  .+||+|+||||+|||++. ++.+||+|||++...
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~  173 (295)
T 2clq_A           96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH--DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL  173 (295)
T ss_dssp             EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred             EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH--hCCEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence            9999999999999987652 345678889999999999999999  678999999999999987 899999999999865


Q ss_pred             CCCCCCceeeecCCCCccccccccccC--CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTG--HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      .....  ......||+.|+|||++.+.  .++.++|||||||++|+|++|+.||......... ...  .          
T Consensus       174 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~--~----------  238 (295)
T 2clq_A          174 AGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-MFK--V----------  238 (295)
T ss_dssp             CC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-HHH--H----------
T ss_pred             CCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-HHh--h----------
Confidence            43221  12345689999999999654  3889999999999999999999999753221110 000  0          


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                        .........+..++..+.+++.+||+.||++|||+.+++++
T Consensus       239 --~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          239 --GMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             --HHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             --ccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence              00011222344556679999999999999999999999986

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.9e-44  Score=341.70  Aligned_cols=250  Identities=24%  Similarity=0.366  Sum_probs=207.4

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      .++|.+.+.||+|+||.||+|.+..      +++.||+|++...   .......+.+|+.+++.++||||+++++++.+.
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   87 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDAD------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN   87 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             ccceEEEEEEeecCCEEEEEEEECC------CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence            4679999999999999999998765      5789999998643   223456788999999999999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +..++||||+.+++|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++.
T Consensus        88 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  163 (294)
T 2rku_A           88 DFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT  163 (294)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChHhEEEcCCCCEEEEeccCce
Confidence            9999999999999999988765  57899999999999999999999  6789999999999999999999999999998


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      .......  ......||+.|+|||++.+..++.++||||||+++|+|++|..||..........      ...       
T Consensus       164 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~-------  228 (294)
T 2rku_A          164 KVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL------RIK-------  228 (294)
T ss_dssp             ECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHH-------
T ss_pred             ecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHh-------
Confidence            6543222  1334569999999999998889999999999999999999999997643211100      000       


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                         ..  ....+...+..+.+++.+||+.||++|||+.+++++
T Consensus       229 ---~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          229 ---KN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             ---TT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ---hc--cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence               00  011233445678999999999999999999999986

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.5e-44  Score=347.33  Aligned_cols=276  Identities=22%  Similarity=0.345  Sum_probs=213.7

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC--
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE--  155 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--  155 (449)
                      .++|++.+.||+|+||.||+|.+..  ....+++.||||++..........+.+|+.+++.++||||+++++++...+  
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  117 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDP--LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR  117 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECT--TSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred             HHHceeeeeeccCCCeEEEEEEecc--ccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence            4678999999999999999997642  123468899999998766666678999999999999999999999986543  


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..++||||+++++|.+++... ...+++..++.++.|++.||.|||  .+||+||||||+|||++.++.+||+|||++..
T Consensus       118 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          118 NLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             ceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH--hCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            789999999999999998764 346899999999999999999999  67899999999999999999999999999986


Q ss_pred             CCCCCCCc-eeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhc---ccc
Q 013105          236 GPQGEDSH-ITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK---DFT  311 (449)
Q Consensus       236 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~---~~~  311 (449)
                      ........ ......|+..|+|||++.+..++.++|||||||++|||++|..||......    +.........   ...
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~----~~~~~~~~~~~~~~~~  270 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQMIVF  270 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH----HHHHHCTTCCTHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH----HHHhhccccchhhhHH
Confidence            54432211 122245778899999998888999999999999999999999998643110    0000000000   000


Q ss_pred             chhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccc
Q 013105          312 KLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL  362 (449)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  362 (449)
                      .+...+........+..++..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            111112222222334556778999999999999999999999999998764

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.4e-45  Score=351.76  Aligned_cols=255  Identities=27%  Similarity=0.377  Sum_probs=200.5

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcC-CCCCcceeeeEEEe-
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCE-  153 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~-  153 (449)
                      ...++|++.+.||+|+||.||+|.+..      +++.||||++.... .....+.+|+.+++.+ +||||+++++++.. 
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVK------TGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECC------CCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            356789999999999999999998765      47899999997543 3346788999999998 79999999999987 


Q ss_pred             -----CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEe
Q 013105          154 -----DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLS  228 (449)
Q Consensus       154 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~  228 (449)
                           .+..++||||+.+|+|.+++.......+++..+..++.|++.||.|||  .+||+|+||||+|||++.++.+||+
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~NIl~~~~~~~kl~  171 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLV  171 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCcHHHEEEcCCCCEEEe
Confidence                 568999999999999999998765567999999999999999999999  6789999999999999999999999


Q ss_pred             eeccccCCCCCCCCceeeecCCCCccccccccc-----cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhh
Q 013105          229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN-----TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA  303 (449)
Q Consensus       229 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~  303 (449)
                      |||++........  ......||+.|+|||++.     +..++.++|||||||++|+|++|..||...........    
T Consensus       172 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----  245 (326)
T 2x7f_A          172 DFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----  245 (326)
T ss_dssp             CCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----
T ss_pred             eCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH----
Confidence            9999886543211  123456999999999986     56789999999999999999999999975432111100    


Q ss_pred             hhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          304 RPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                                  +............++..+.+++.+||+.||.+|||+.+++++
T Consensus       246 ------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          246 ------------IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             ------------HHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ------------hhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                        001111111123345679999999999999999999999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.8e-44  Score=358.27  Aligned_cols=266  Identities=23%  Similarity=0.257  Sum_probs=206.8

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC--------CCCcceee
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK--------HPHLVNLI  148 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~nIv~~~  148 (449)
                      +.++|++.+.||+|+||.||+|.+..      +++.||||++... ......+.+|+.+++.++        |+||++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~  107 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQ------GKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL  107 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecC------CCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence            45789999999999999999997765      5889999999733 334567889999999885        78899999


Q ss_pred             eEEE----eCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CeeeccCCCCceEEcCCC
Q 013105          149 GYCC----EDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK-PVIYRDFKASNILLDSDY  223 (449)
Q Consensus       149 ~~~~----~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~ivHrDikp~Nill~~~~  223 (449)
                      +++.    .....++||||+ +++|.+.+.......+++..+..++.|++.||.|||  .+ ||+||||||+|||++.++
T Consensus       108 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH--~~~givHrDikp~NIll~~~~  184 (397)
T 1wak_A          108 DDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNE  184 (397)
T ss_dssp             EEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH--HTTCEECCCCSGGGEEECCCH
T ss_pred             cceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--HhCCEecCCCCHHHeeEeccc
Confidence            9987    456899999999 678888887665567999999999999999999999  56 899999999999998775


Q ss_pred             -------------------------------------------------cEEEeeeccccCCCCCCCCceeeecCCCCcc
Q 013105          224 -------------------------------------------------NAKLSDFGLATDGPQGEDSHITTCVMGTEGY  254 (449)
Q Consensus       224 -------------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y  254 (449)
                                                                       .+||+|||++......     .....||+.|
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y  259 (397)
T 1wak_A          185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQY  259 (397)
T ss_dssp             HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGG
T ss_pred             hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcc
Confidence                                                             7999999999865432     2334699999


Q ss_pred             ccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccch---hhHHhhhhhhccccc------------------h
Q 013105          255 AAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREK---DLVEWARPMLKDFTK------------------L  313 (449)
Q Consensus       255 ~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~---~~~~~~~~~~~~~~~------------------~  313 (449)
                      +|||++.+..++.++|||||||+||||++|+.||.........   ...............                  +
T Consensus       260 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  339 (397)
T 1wak_A          260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL  339 (397)
T ss_dssp             CCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSB
T ss_pred             cCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccc
Confidence            9999999889999999999999999999999999764322211   111100000000000                  0


Q ss_pred             hHhhcc---------cccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          314 DQIIDS---------RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       314 ~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ..+...         ......+...+..+.+||.+||+.||++|||+.++++|
T Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          340 KHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             SSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             ccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence            000000         00113456778899999999999999999999999987

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-44  Score=355.24  Aligned_cols=264  Identities=19%  Similarity=0.258  Sum_probs=198.9

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      +.++|++.+.||+|+||.||+|.+..      +++.||||++...  .......+.+|+.+|+.++||||+++++++...
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~   96 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGR------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPD   96 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETT------TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECC------CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecC
Confidence            35789999999999999999998765      5889999999643  223346788999999999999999999999765


Q ss_pred             ------CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEe
Q 013105          155 ------EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLS  228 (449)
Q Consensus       155 ------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~  228 (449)
                            ...|+||||+ +++|.+++..   ..+++..+..++.|++.||.|||  +.||+||||||+|||++.++.+||+
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~kl~  170 (367)
T 1cm8_A           97 ETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCELKIL  170 (367)
T ss_dssp             SSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred             CccccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCcCHHHEEEcCCCCEEEE
Confidence                  3469999999 7899998865   46899999999999999999999  6789999999999999999999999


Q ss_pred             eeccccCCCCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhh--
Q 013105          229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARP--  305 (449)
Q Consensus       229 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~--  305 (449)
                      |||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.........+.....  
T Consensus       171 Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~  245 (367)
T 1cm8_A          171 DFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP  245 (367)
T ss_dssp             CCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             eeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99999865332     234568999999999876 6799999999999999999999999987543322211110000  


Q ss_pred             ---hhcccc--chhHhhc------ccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          306 ---MLKDFT--KLDQIID------SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       306 ---~~~~~~--~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                         ......  .....+.      ...........++.+.+|+.+||+.||.+|||+.++++|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          246 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence               000000  0000000      000111223456679999999999999999999999997

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.8e-44  Score=352.52  Aligned_cols=259  Identities=24%  Similarity=0.375  Sum_probs=207.0

Q ss_pred             HHHHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc--------chHHHHHHHHHHHhcC-CCC
Q 013105           72 KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--------QGHREWLAEVIFLGQL-KHP  142 (449)
Q Consensus        72 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~  142 (449)
                      .....+.++|.+.+.||+|+||.||+|.+..      +++.||||++.....        .....+.+|+.++..+ +||
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp  160 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA------TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP  160 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCT
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECC------CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            3345566889999999999999999998765      478999999975431        1134577899999999 799


Q ss_pred             CcceeeeEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC
Q 013105          143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD  222 (449)
Q Consensus       143 nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~  222 (449)
                      ||+++++++...+..++||||+.|++|.+++...  ..+++..+..++.|++.||.|||  ..||+||||||+|||++.+
T Consensus       161 ~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH--~~gi~H~Dlkp~NIl~~~~  236 (365)
T 2y7j_A          161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLH--ANNIVHRDLKPENILLDDN  236 (365)
T ss_dssp             TBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTT
T ss_pred             CEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCC
Confidence            9999999999999999999999999999999765  57899999999999999999999  6789999999999999999


Q ss_pred             CcEEEeeeccccCCCCCCCCceeeecCCCCcccccccccc------CCCCcccchhhhHHHHHHHHhCCCcccccccccc
Q 013105          223 YNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT------GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE  296 (449)
Q Consensus       223 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~  296 (449)
                      +.+||+|||++........   .....||+.|+|||++.+      ..++.++|||||||++|+|++|..||........
T Consensus       237 ~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  313 (365)
T 2y7j_A          237 MQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM  313 (365)
T ss_dssp             CCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             CCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence            9999999999986544322   334679999999999853      3588999999999999999999999976432111


Q ss_pred             hhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          297 KDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ...+      ......        .........+..+.+++.+||+.||++|||+.++++|
T Consensus       314 ~~~i------~~~~~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          314 LRMI------MEGQYQ--------FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HHHH------HHTCCC--------CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHH------HhCCCC--------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1100      000000        0000001234568999999999999999999999987

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.9e-44  Score=343.18  Aligned_cols=250  Identities=26%  Similarity=0.393  Sum_probs=207.9

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      .+.|.+.+.||+|+||.||+|.+..      +++.||||++.... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   94 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNR------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK   94 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETT------TCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECC------CCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence            3568999999999999999998765      57899999997543 3456788999999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||+.+++|.+++..   ..+++..+..++.|++.||.|||  ..||+||||||+|||++.++.+||+|||++...
T Consensus        95 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  169 (303)
T 3a7i_A           95 LWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLH--SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL  169 (303)
T ss_dssp             EEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCChheEEECCCCCEEEeecccceec
Confidence            9999999999999998854   47899999999999999999999  678999999999999999999999999999765


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHh
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI  316 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (449)
                      .....  ......||+.|+|||++.+..++.++|||||||++|+|++|..||............                
T Consensus       170 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----------------  231 (303)
T 3a7i_A          170 TDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI----------------  231 (303)
T ss_dssp             BTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH----------------
T ss_pred             Ccccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh----------------
Confidence            43221  123456999999999999889999999999999999999999999754321111000                


Q ss_pred             hcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       ...........++..+.+|+..||+.||.+|||+.+++++
T Consensus       232 -~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          232 -PKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             -HHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             -hcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence             0011112233445669999999999999999999999987

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.5e-44  Score=379.67  Aligned_cols=251  Identities=26%  Similarity=0.345  Sum_probs=208.6

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcC-CCCCcceeeeEEE
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQL-KHPHLVNLIGYCC  152 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~  152 (449)
                      ..++|.+.+.||+|+||.||+|.+..      +++.||||++...   .......+..|..+|..+ +||||+.+++++.
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~  412 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKG------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ  412 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESS------SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB
T ss_pred             cccceEEEEEEccCCCEEEEEEEECC------CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE
Confidence            34689999999999999999998765      5889999999742   223446678899999988 6999999999999


Q ss_pred             eCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecc
Q 013105          153 EDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL  232 (449)
Q Consensus       153 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGl  232 (449)
                      +.+.+||||||+.||+|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+||||+.++.+||+|||+
T Consensus       413 ~~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~gIiHrDLKp~NILl~~~g~ikL~DFGl  488 (674)
T 3pfq_A          413 TMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGM  488 (674)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTSEECCCCCSTTEEECSSSCEEECCCTT
T ss_pred             eCCEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeEeccCChhhEEEcCCCcEEEeecce
Confidence            999999999999999999999765  57999999999999999999999  67899999999999999999999999999


Q ss_pred             ccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccc
Q 013105          233 ATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK  312 (449)
Q Consensus       233 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  312 (449)
                      ++.......  .....+||+.|+|||++.+..|+.++|||||||+||||++|.+||.+........              
T Consensus       489 a~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~--------------  552 (674)
T 3pfq_A          489 CKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ--------------  552 (674)
T ss_dssp             CEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--------------
T ss_pred             eeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHH--------------
Confidence            985433222  2445679999999999999999999999999999999999999998653221111              


Q ss_pred             hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 013105          313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM-----TTVVKA  357 (449)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~eil~~  357 (449)
                        .++..  ...++..++.++.+||.+||+.||++||++     .+|++|
T Consensus       553 --~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          553 --SIMEH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             --HHHSS--CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             --HHHhC--CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence              11111  112344566779999999999999999998     777775

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4.7e-44  Score=359.15  Aligned_cols=266  Identities=23%  Similarity=0.295  Sum_probs=205.6

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcC------CCCCcceeeeE
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL------KHPHLVNLIGY  150 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~nIv~~~~~  150 (449)
                      +..+|++.+.||+|+||.||+|.+..      +++.||||++... ......+.+|+.+++.+      .|+||++++++
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~------~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~  167 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHK------VHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN  167 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETT------TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECC------CCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence            45689999999999999999998765      5889999999743 33345677788887776      57899999999


Q ss_pred             EEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCc--EEEe
Q 013105          151 CCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYN--AKLS  228 (449)
Q Consensus       151 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~--~kl~  228 (449)
                      +...+..++||||+. ++|.+++.......+++..+..++.|++.||.|||  .++|+||||||+|||++.++.  +||+
T Consensus       168 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlKp~NILl~~~~~~~vkL~  244 (429)
T 3kvw_A          168 FTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH--KNRIIHCDLKPENILLKQQGRSGIKVI  244 (429)
T ss_dssp             EEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HHTEECSCCSGGGEEESSTTSCCEEEC
T ss_pred             cccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEEccCCCcceEEe
Confidence            999999999999996 79999998776667999999999999999999999  678999999999999999987  9999


Q ss_pred             eeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhh----
Q 013105          229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR----  304 (449)
Q Consensus       229 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~----  304 (449)
                      |||++......     .....||+.|+|||++.+..++.++|||||||+||||++|.+||.+.........+....    
T Consensus       245 DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~  319 (429)
T 3kvw_A          245 DFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS  319 (429)
T ss_dssp             CCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             ecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            99999754322     233569999999999998899999999999999999999999998764332221111000    


Q ss_pred             -hhhccccchhHhhcccc------------------------------------cccCCHHHHHHHHHHHHHhccCCCCC
Q 013105          305 -PMLKDFTKLDQIIDSRL------------------------------------EDRYSTEGAKRLAAVAHQCLSHNPKS  347 (449)
Q Consensus       305 -~~~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~l~~li~~cl~~dP~~  347 (449)
                       .+..........+....                                    ........++.+.+||.+||+.||++
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~  399 (429)
T 3kvw_A          320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAV  399 (429)
T ss_dssp             HHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhh
Confidence             00000000000000000                                    00011112466899999999999999


Q ss_pred             CCCHHHHHHH
Q 013105          348 RPTMTTVVKA  357 (449)
Q Consensus       348 RPs~~eil~~  357 (449)
                      |||+.++++|
T Consensus       400 Rpta~e~L~H  409 (429)
T 3kvw_A          400 RMTPGQALRH  409 (429)
T ss_dssp             SCCHHHHHTS
T ss_pred             CCCHHHHhCC
Confidence            9999999997

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.6e-44  Score=374.21  Aligned_cols=260  Identities=28%  Similarity=0.378  Sum_probs=205.9

Q ss_pred             cCCCCcc-cccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           79 HNFSRSD-YLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        79 ~~y~~~~-~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      +++.+.+ .||+|+||.||+|.+...    ..+..||||+++... ......+.+|+.+|+.++||||+++++++.. +.
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~----~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~  409 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMR----KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA  409 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECS----SCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecC----CCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence            3444444 799999999999987642    245789999997543 3456789999999999999999999999976 56


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .+|||||+.+|+|.+++... ...+++..+..++.|++.||.|||  +++|+||||||+|||++.++.+||+|||+++..
T Consensus       410 ~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH--~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~  486 (613)
T 2ozo_A          410 LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE--EKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL  486 (613)
T ss_dssp             EEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred             eEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH--HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence            99999999999999998654 457899999999999999999999  678999999999999999999999999999865


Q ss_pred             CCCCCC-ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchh
Q 013105          237 PQGEDS-HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       237 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ...... .......+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+........                
T Consensus       487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~----------------  550 (613)
T 2ozo_A          487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA----------------  550 (613)
T ss_dssp             C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHH----------------
T ss_pred             cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH----------------
Confidence            432211 11222346789999999998899999999999999999998 999998653221111                


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                       .+........+..+++.+.+||..||+.||++||++.+|++.|+.++.
T Consensus       551 -~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  598 (613)
T 2ozo_A          551 -FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  598 (613)
T ss_dssp             -HHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -HHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence             111111223345567789999999999999999999999999998754

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.6e-44  Score=348.43  Aligned_cols=271  Identities=21%  Similarity=0.385  Sum_probs=197.5

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHH--HhcCCCCCcceeeeEEEe--
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF--LGQLKHPHLVNLIGYCCE--  153 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~nIv~~~~~~~~--  153 (449)
                      .++|++.+.||+|+||.||+|.+        +++.||||++....   ...+..|..+  +..++||||+++++.+..  
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--------~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~   80 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--------DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVT   80 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--------TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             hHHhheeeecccCCCeEEEEEEE--------CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccc
Confidence            46899999999999999999965        36799999997432   3344444444  445899999999986643  


Q ss_pred             ---CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC---------CeeeccCCCCceEEcC
Q 013105          154 ---DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK---------PVIYRDFKASNILLDS  221 (449)
Q Consensus       154 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---------~ivHrDikp~Nill~~  221 (449)
                         ...+++||||+++|+|.+++...   ..++.....++.|++.||.|||  ..         ||+||||||+|||++.
T Consensus        81 ~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH--~~~~~~~~~~~~ivH~Dikp~Nill~~  155 (336)
T 3g2f_A           81 ADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLH--TELPRGDHYKPAISHRDLNSRNVLVKN  155 (336)
T ss_dssp             TTSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHH--CCBCCGGGCBCCEECSSCSGGGEEECT
T ss_pred             cCCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHH--hhhccccccccceeecccccceEEEcC
Confidence               23678999999999999999664   4588899999999999999999  55         8999999999999999


Q ss_pred             CCcEEEeeeccccCCCCCC------CCceeeecCCCCcccccccccc-------CCCCcccchhhhHHHHHHHHhCCCcc
Q 013105          222 DYNAKLSDFGLATDGPQGE------DSHITTCVMGTEGYAAPEYINT-------GHLTTMCDVFSFGVVLLELLTGRRSV  288 (449)
Q Consensus       222 ~~~~kl~DfGla~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~vl~elltg~~pf  288 (449)
                      ++.+||+|||++.......      .........||+.|+|||++.+       ..++.++|||||||++|||++|..||
T Consensus       156 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~  235 (336)
T 3g2f_A          156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL  235 (336)
T ss_dssp             TSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred             CCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence            9999999999997654321      1112234569999999999976       45677899999999999999998777


Q ss_pred             cccccccchh-hHHhhhhhhccccchhHhhc-ccccccC------CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 013105          289 EKNRCKREKD-LVEWARPMLKDFTKLDQIID-SRLEDRY------STEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEP  360 (449)
Q Consensus       289 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-~~~~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  360 (449)
                      .......... ..................+. ......+      ...+++.+.+||.+||+.||++|||+.++++.|+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~  315 (336)
T 3g2f_A          236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE  315 (336)
T ss_dssp             STTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             CCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence            5432221110 00000000000000000000 1111111      23467789999999999999999999999999999


Q ss_pred             cccC
Q 013105          361 LLDL  364 (449)
Q Consensus       361 ~~~~  364 (449)
                      ++..
T Consensus       316 ll~~  319 (336)
T 3g2f_A          316 LMMI  319 (336)
T ss_dssp             HHHC
T ss_pred             HHHH
Confidence            8753

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=349.89  Aligned_cols=261  Identities=25%  Similarity=0.324  Sum_probs=192.4

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC-CCCcceeeeEEE----
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-HPHLVNLIGYCC----  152 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~----  152 (449)
                      ..+|++.+.||+|+||.||+|.+..      +++.||||++..........+.+|+.++..+. ||||+++++++.    
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~  100 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVG------SGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE  100 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETT------TCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred             CceEEEEEEEccCCceEEEEEEECC------CCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence            4579999999999999999998765      57899999987665556677899999999996 999999999994    


Q ss_pred             ----eCCEEEEEEEecCCCChHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--eeeccCCCCceEEcCCCcE
Q 013105          153 ----EDEHRLLVYEYMALGNLHDQLFKN-YSSTLPWLTRIKIAIGAARCLAFLHGEEKP--VIYRDFKASNILLDSDYNA  225 (449)
Q Consensus       153 ----~~~~~~lv~e~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~--ivHrDikp~Nill~~~~~~  225 (449)
                          .....++||||+. |+|.+++... ....+++..++.++.|++.||.|||  ..+  |+||||||+|||++.++.+
T Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~~~ivH~Dikp~NIl~~~~~~~  177 (337)
T 3ll6_A          101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH--RQKPPIIHRDLKVENLLLSNQGTI  177 (337)
T ss_dssp             TSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH--TSSSCCBCCCCCGGGCEECTTSCE
T ss_pred             ccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--hCCCCEEEccCCcccEEECCCCCE
Confidence                3455899999996 7998888652 3457999999999999999999999  566  9999999999999999999


Q ss_pred             EEeeeccccCCCCCCCCc----------eeeecCCCCcccccccc---ccCCCCcccchhhhHHHHHHHHhCCCcccccc
Q 013105          226 KLSDFGLATDGPQGEDSH----------ITTCVMGTEGYAAPEYI---NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNR  292 (449)
Q Consensus       226 kl~DfGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~vl~elltg~~pf~~~~  292 (449)
                      ||+|||++..........          ......||+.|+|||++   .+..++.++|||||||++|+|++|..||....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            999999998654322111          11134589999999998   56678999999999999999999999997542


Q ss_pred             cccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCCCC
Q 013105          293 CKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDI  367 (449)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~  367 (449)
                      ....   .                 ............+..+.+|+.+||+.||.+|||+.+++++|+.+......
T Consensus       258 ~~~~---~-----------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~  312 (337)
T 3ll6_A          258 KLRI---V-----------------NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV  312 (337)
T ss_dssp             ----------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred             HHHh---h-----------------cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence            1110   0                 00000011112233488999999999999999999999999988765443

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.1e-44  Score=350.65  Aligned_cols=274  Identities=23%  Similarity=0.256  Sum_probs=194.1

Q ss_pred             HHHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEE
Q 013105           73 ELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCC  152 (449)
Q Consensus        73 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~  152 (449)
                      ......++|++.+.||+|+||.||+|.+..      +++.||||++.... .....+.+|++.+..++||||+++++++.
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~   89 (360)
T 3e3p_A           17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKS------TGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFY   89 (360)
T ss_dssp             HHHHHHTTEEEC----------CEEEEETT------TCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             hchhhccceEEEEEEecCCCeEEEEEEECC------CCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhh
Confidence            345567899999999999999999998765      57899999986432 22345667888889899999999999997


Q ss_pred             eCCE-------EEEEEEecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC-C
Q 013105          153 EDEH-------RLLVYEYMALGNLHDQLFK--NYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS-D  222 (449)
Q Consensus       153 ~~~~-------~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~-~  222 (449)
                      ..+.       .++||||+.+ +|.+.+..  .....+++..+..++.|++.||.|||.+.+||+||||||+|||++. +
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~  168 (360)
T 3e3p_A           90 TLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEAD  168 (360)
T ss_dssp             EECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTT
T ss_pred             ccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCC
Confidence            6433       8899999985 66555432  2346788999999999999999999977788999999999999997 8


Q ss_pred             CcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHH
Q 013105          223 YNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVE  301 (449)
Q Consensus       223 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~  301 (449)
                      +.+||+|||++........   .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+.
T Consensus       169 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~  245 (360)
T 3e3p_A          169 GTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIV  245 (360)
T ss_dssp             TEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHH
Confidence            9999999999986654322   2345689999999998654 48999999999999999999999998754322221111


Q ss_pred             hh---------hhhhccccchhHhhc-----ccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          302 WA---------RPMLKDFTKLDQIID-----SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       302 ~~---------~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ..         ...............     ...........+..+.+|+.+||+.||.+|||+.++++|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            00         000000000000000     000111222356789999999999999999999999987

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=9.2e-45  Score=343.15  Aligned_cols=255  Identities=22%  Similarity=0.297  Sum_probs=204.7

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEe--
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCE--  153 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--  153 (449)
                      .++|++.+.||+|+||.||+|.+..      +++.||+|++....  ....+.+.+|+.+++.++||||+++++++.+  
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKS------DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT   78 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETT------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG
T ss_pred             hhheeeehhccCCCCcEEEEEEECC------CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC
Confidence            4679999999999999999998765      57899999997543  2345678899999999999999999998854  


Q ss_pred             CCEEEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-----eeeccCCCCceEEcCCCcEE
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKN--YSSTLPWLTRIKIAIGAARCLAFLHGEEKP-----VIYRDFKASNILLDSDYNAK  226 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-----ivHrDikp~Nill~~~~~~k  226 (449)
                      ....++||||+++++|.+++...  ....+++..++.++.|++.||.|||  ..+     |+||||||+|||++.++.+|
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~~~~~~ivH~dl~p~NIl~~~~~~~k  156 (279)
T 2w5a_A           79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH--RRSDGGHTVLHRDLKPANVFLDGKQNVK  156 (279)
T ss_dssp             GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HHC------CCCCCSGGGEEECSSSCEE
T ss_pred             CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh--cccCCCCeeEEeccchhhEEEcCCCCEE
Confidence            67899999999999999998753  2345899999999999999999999  566     99999999999999999999


Q ss_pred             EeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhh
Q 013105          227 LSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPM  306 (449)
Q Consensus       227 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~  306 (449)
                      |+|||++.......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||........   ....   
T Consensus       157 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~i---  228 (279)
T 2w5a_A          157 LGDFGLARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---AGKI---  228 (279)
T ss_dssp             ECCCCHHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH---
T ss_pred             EecCchheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH---HHHH---
Confidence            99999997654321  112234689999999999988899999999999999999999999976532111   1100   


Q ss_pred             hccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 013105          307 LKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE  359 (449)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  359 (449)
                                 ........+..++..+.+++.+||+.||.+|||+.++++++.
T Consensus       229 -----------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          229 -----------REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             -----------HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             -----------hhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence                       001111233445667999999999999999999999998743

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.2e-45  Score=361.83  Aligned_cols=243  Identities=16%  Similarity=0.203  Sum_probs=190.3

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHH---HHHhcCCCCCcceee---
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEV---IFLGQLKHPHLVNLI---  148 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~nIv~~~---  148 (449)
                      .++|.+.+.||+|+||.||+|.+..      +++.||||++...   .....+.+.+|+   ++|+.++||||++++   
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~  145 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQE------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF  145 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-C------CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCB
T ss_pred             CceEEEcceeecCCCEEEEEEEECC------CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhh
Confidence            3678889999999999999997654      5789999999733   334567788999   555566899999998   


Q ss_pred             ----eEEEeCC-----------------EEEEEEEecCCCChHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHhhc
Q 013105          149 ----GYCCEDE-----------------HRLLVYEYMALGNLHDQLFKNYS-----STLPWLTRIKIAIGAARCLAFLHG  202 (449)
Q Consensus       149 ----~~~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~  202 (449)
                          +++.+.+                 ..||||||+ +|+|.+++.....     ..+++..++.++.|++.||.||| 
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-  223 (377)
T 3byv_A          146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH-  223 (377)
T ss_dssp             CCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH-
T ss_pred             hhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH-
Confidence                7766553                 289999999 5899999976421     12335788889999999999999 


Q ss_pred             CCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccC-----------CCCcccch
Q 013105          203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTG-----------HLTTMCDV  271 (449)
Q Consensus       203 ~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv  271 (449)
                       ++||+||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++||
T Consensus       224 -~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv  296 (377)
T 3byv_A          224 -HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA  296 (377)
T ss_dssp             -HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred             -hCCeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence             67799999999999999999999999999985322     2445668 999999999877           89999999


Q ss_pred             hhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 013105          272 FSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM  351 (449)
Q Consensus       272 wslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  351 (449)
                      |||||++|||++|+.||..........                .+..      ....+++.+.+|+.+||+.||++|||+
T Consensus       297 wSlG~il~elltg~~Pf~~~~~~~~~~----------------~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~  354 (377)
T 3byv_A          297 WALGLVIYWIWCADLPITKDAALGGSE----------------WIFR------SCKNIPQPVRALLEGFLRYPKEDRLLP  354 (377)
T ss_dssp             HHHHHHHHHHHHSSCCC------CCSG----------------GGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCH
T ss_pred             HHHHHHHHHHHHCCCCCcccccccchh----------------hhhh------hccCCCHHHHHHHHHHcCCCchhCCCH
Confidence            999999999999999997643221110                0000      012334568999999999999999999


Q ss_pred             HHHHHH
Q 013105          352 TTVVKA  357 (449)
Q Consensus       352 ~eil~~  357 (449)
                      .+++++
T Consensus       355 ~e~l~h  360 (377)
T 3byv_A          355 LQAMET  360 (377)
T ss_dssp             HHHHTS
T ss_pred             HHHhhC
Confidence            999975

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.7e-44  Score=354.24  Aligned_cols=267  Identities=21%  Similarity=0.269  Sum_probs=199.6

Q ss_pred             HHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEe-
Q 013105           75 QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE-  153 (449)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-  153 (449)
                      +...++|++.+.||+|+||.||+|.+..      +++.||||++......    ..+|+.+++.++||||+++++++.. 
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~------~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~   72 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIE------SGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTT   72 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETT------TCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECC------CCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeec
Confidence            4456789999999999999999998765      5889999998644222    2369999999999999999999844 


Q ss_pred             -------------------------------------CCEEEEEEEecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHH
Q 013105          154 -------------------------------------DEHRLLVYEYMALGNLHDQLFK--NYSSTLPWLTRIKIAIGAA  194 (449)
Q Consensus       154 -------------------------------------~~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~  194 (449)
                                                           ....++||||+. |+|.+.+..  .....+++..+..++.|++
T Consensus        73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~  151 (383)
T 3eb0_A           73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLF  151 (383)
T ss_dssp             -------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHH
T ss_pred             CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence                                                 344899999998 588777754  3346799999999999999


Q ss_pred             HHHHHhhcCCCCeeeccCCCCceEEc-CCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccC-CCCcccchh
Q 013105          195 RCLAFLHGEEKPVIYRDFKASNILLD-SDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTG-HLTTMCDVF  272 (449)
Q Consensus       195 ~~l~~lH~~~~~ivHrDikp~Nill~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvw  272 (449)
                      .||.|||  +.||+||||||+|||++ .++.+||+|||++........   .....||+.|+|||++.+. .++.++|||
T Consensus       152 ~aL~~LH--~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  226 (383)
T 3eb0_A          152 RAVGFIH--SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLW  226 (383)
T ss_dssp             HHHHHHH--TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred             HHHHHHH--HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence            9999999  78899999999999997 688999999999986543322   2335689999999998764 589999999


Q ss_pred             hhHHHHHHHHhCCCcccccccccchhhHHhhh--h-------hhcccc--chhHhhcccccccCCHHHHHHHHHHHHHhc
Q 013105          273 SFGVVLLELLTGRRSVEKNRCKREKDLVEWAR--P-------MLKDFT--KLDQIIDSRLEDRYSTEGAKRLAAVAHQCL  341 (449)
Q Consensus       273 slG~vl~elltg~~pf~~~~~~~~~~~~~~~~--~-------~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  341 (449)
                      ||||++|||++|++||.+.........+....  +       ....+.  .............++...+..+.+|+.+||
T Consensus       227 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  306 (383)
T 3eb0_A          227 SIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL  306 (383)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence            99999999999999998754322211110000  0       000000  000000001111233445667999999999


Q ss_pred             cCCCCCCCCHHHHHHH
Q 013105          342 SHNPKSRPTMTTVVKA  357 (449)
Q Consensus       342 ~~dP~~RPs~~eil~~  357 (449)
                      +.||.+|||+.++++|
T Consensus       307 ~~dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          307 RYEPDLRINPYEAMAH  322 (383)
T ss_dssp             CSSGGGSCCHHHHHTS
T ss_pred             cCChhhCCCHHHHhcC
Confidence            9999999999999987

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4.1e-44  Score=375.60  Aligned_cols=252  Identities=28%  Similarity=0.393  Sum_probs=202.1

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYE  162 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  162 (449)
                      +.||+|+||.||+|.+...    ..++.||||+++..  .......+.+|+.+|+.++||||+++++++.. +..+||||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~----~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E  449 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMK----KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVME  449 (635)
T ss_dssp             EEEEECSSEEEEEEEEECS----SCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCC----CcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEE
Confidence            4799999999999976531    24688999999753  23346789999999999999999999999964 56899999


Q ss_pred             ecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCC-
Q 013105          163 YMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGED-  241 (449)
Q Consensus       163 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~-  241 (449)
                      |+.+|+|.+++...  ..+++..++.++.|++.||.|||  +++|+||||||+|||++.++.+||+|||+++....... 
T Consensus       450 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH--~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~  525 (635)
T 4fl3_A          450 MAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  525 (635)
T ss_dssp             CCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred             ccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHH--HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence            99999999999754  57899999999999999999999  67899999999999999999999999999986543321 


Q ss_pred             CceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHhhccc
Q 013105          242 SHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSR  320 (449)
Q Consensus       242 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (449)
                      ........||+.|+|||++.+..++.++|||||||+||||++ |+.||.+........                 .+...
T Consensus       526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~-----------------~i~~~  588 (635)
T 4fl3_A          526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-----------------MLEKG  588 (635)
T ss_dssp             ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-----------------HHHTT
T ss_pred             cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-----------------HHHcC
Confidence            112223447889999999998899999999999999999998 999998653321111                 11111


Q ss_pred             ccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccc
Q 013105          321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL  362 (449)
Q Consensus       321 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  362 (449)
                      .....+..+++++.+||..||+.||++|||+.+|++.|+.++
T Consensus       589 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  630 (635)
T 4fl3_A          589 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  630 (635)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            122334556678999999999999999999999999998775

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.3e-43  Score=349.15  Aligned_cols=270  Identities=21%  Similarity=0.231  Sum_probs=208.0

Q ss_pred             HHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC-CC-----Ccceee
Q 013105           75 QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-HP-----HLVNLI  148 (449)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----nIv~~~  148 (449)
                      ..+.++|++.+.||+|+||.||+|.+..      +++.||||++... ......+..|+.++..++ |+     +|+.++
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~  122 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRV------EQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK  122 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETT------TTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcC------CCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence            3456889999999999999999998765      5789999999733 333456778888888874 55     499999


Q ss_pred             eEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEc--CCCcEE
Q 013105          149 GYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD--SDYNAK  226 (449)
Q Consensus       149 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~--~~~~~k  226 (449)
                      +++...+..++||||+. |+|.+++.......+++..+..++.|++.||.|||+++.||+||||||+|||++  .++.+|
T Consensus       123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~k  201 (382)
T 2vx3_A          123 RHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIK  201 (382)
T ss_dssp             EEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEE
T ss_pred             eeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEE
Confidence            99999999999999996 699999987655679999999999999999999998778999999999999995  477899


Q ss_pred             EeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhh-
Q 013105          227 LSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARP-  305 (449)
Q Consensus       227 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~-  305 (449)
                      |+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|++||.+.........+..... 
T Consensus       202 L~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~  276 (382)
T 2vx3_A          202 IVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI  276 (382)
T ss_dssp             ECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred             EEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            9999999865432     2345699999999999988999999999999999999999999986543322211110000 


Q ss_pred             ----hhccccchhHhhccc-----------------------------------------ccccCCHHHHHHHHHHHHHh
Q 013105          306 ----MLKDFTKLDQIIDSR-----------------------------------------LEDRYSTEGAKRLAAVAHQC  340 (449)
Q Consensus       306 ----~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~l~~li~~c  340 (449)
                          ...........+...                                         -.........+.+.+||.+|
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m  356 (382)
T 2vx3_A          277 PPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRM  356 (382)
T ss_dssp             CCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHh
Confidence                000000000000000                                         00011223446799999999


Q ss_pred             ccCCCCCCCCHHHHHHH
Q 013105          341 LSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       341 l~~dP~~RPs~~eil~~  357 (449)
                      |+.||++|||+.++++|
T Consensus       357 L~~dP~~Rpta~e~L~h  373 (382)
T 2vx3_A          357 LDYDPKTRIQPYYALQH  373 (382)
T ss_dssp             TCSCTTTSCCHHHHTTS
T ss_pred             cCCChhhCCCHHHHhcC
Confidence            99999999999999987

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.1e-43  Score=347.34  Aligned_cols=270  Identities=21%  Similarity=0.283  Sum_probs=202.3

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEe--
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCE--  153 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--  153 (449)
                      .++|++.+.||+|+||.||+|.+..      +++.||+|++....  ......+.+|+.+++.++||||+++++++..  
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   89 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRK------TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA   89 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETT------TCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred             ccceeEEEEEecCCCcEEEEEEECC------CCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccc
Confidence            3679999999999999999998765      57899999986442  2234567899999999999999999999987  


Q ss_pred             ------CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEE
Q 013105          154 ------DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKL  227 (449)
Q Consensus       154 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl  227 (449)
                            .+..++||||+. |+|.+.+... ...+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||
T Consensus        90 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIl~~~~~~~kl  165 (351)
T 3mi9_A           90 SPYNRCKGSIYLVFDFCE-HDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKL  165 (351)
T ss_dssp             -------CEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEE
T ss_pred             cccccCCceEEEEEeccC-CCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCHHHEEEcCCCCEEE
Confidence                  456899999998 5777777543 356999999999999999999999  678999999999999999999999


Q ss_pred             eeeccccCCCCCCC--CceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhh
Q 013105          228 SDFGLATDGPQGED--SHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR  304 (449)
Q Consensus       228 ~DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~  304 (449)
                      +|||++........  ........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.........+....
T Consensus       166 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~  245 (351)
T 3mi9_A          166 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC  245 (351)
T ss_dssp             CCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             ccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            99999976542211  122334568999999999875 468999999999999999999999998754332222211110


Q ss_pred             hhhc--cccchhH--hhc---cc--ccccCCHH-----HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          305 PMLK--DFTKLDQ--IID---SR--LEDRYSTE-----GAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       305 ~~~~--~~~~~~~--~~~---~~--~~~~~~~~-----~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ....  .+.....  ...   ..  ........     .++.+.+|+.+||+.||++|||+.++++|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            0000  0000000  000   00  00000001     14568899999999999999999999997

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=9.1e-44  Score=335.79  Aligned_cols=250  Identities=26%  Similarity=0.379  Sum_probs=198.5

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      ..++|.+.+.||+|+||.||+|.+..      +++.||||++...   .......+.+|+.+++.++||||+++++++.+
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   82 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQL------TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST   82 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECC------CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence            34789999999999999999998765      4789999999643   22335678899999999999999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      .+..++||||+.+++|.+++...  ..+++..+..++.|++.||.|||  .+||+|+||||+|||++.++.++|+|||++
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~  158 (276)
T 2h6d_A           83 PTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLS  158 (276)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH--HHCSSCCCCCGGGEEECTTSCEEECCCCGG
T ss_pred             CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCChhhEEECCCCCEEEeecccc
Confidence            99999999999999999999765  46899999999999999999999  678999999999999999999999999999


Q ss_pred             cCCCCCCCCceeeecCCCCccccccccccCCC-CcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccc
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINTGHL-TTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK  312 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  312 (449)
                      .......   ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||........   .....        
T Consensus       159 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~--------  224 (276)
T 2h6d_A          159 NMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL---FKKIR--------  224 (276)
T ss_dssp             GCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH--------
T ss_pred             cccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH---HHHhh--------
Confidence            8654322   1233568999999999987665 6899999999999999999999975422111   11000        


Q ss_pred             hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                           ..  ....+..++..+.+++.+||+.||.+|||+.++++|
T Consensus       225 -----~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          225 -----GG--VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             -----HC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -----cC--cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                 00  011223345668999999999999999999999997

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.9e-43  Score=344.06  Aligned_cols=274  Identities=25%  Similarity=0.393  Sum_probs=210.1

Q ss_pred             HHHHHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhc--CCCCCcceee
Q 013105           71 LKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ--LKHPHLVNLI  148 (449)
Q Consensus        71 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~~~  148 (449)
                      ......+.++|.+.+.||+|+||.||+|.+.        ++.||||++...   ....+.+|++++..  ++||||++++
T Consensus        34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~  102 (342)
T 1b6c_B           34 LLVQRTIARTIVLQESIGKGRFGEVWRGKWR--------GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFI  102 (342)
T ss_dssp             HHHHHHHHHHCEEEEEEEEETTEEEEEEEET--------TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEE
T ss_pred             eeecccccccEEEEeeecCCCCcEEEEEEEc--------CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEE
Confidence            3344567789999999999999999999763        678999999633   34567788888887  7899999999


Q ss_pred             eEEEeCC----EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCeeeccCCCCceE
Q 013105          149 GYCCEDE----HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE------EKPVIYRDFKASNIL  218 (449)
Q Consensus       149 ~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~------~~~ivHrDikp~Nil  218 (449)
                      +++....    ..++||||+.+|+|.+++...   .+++..++.++.|++.||.|||+.      .++|+||||||+|||
T Consensus       103 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIl  179 (342)
T 1b6c_B          103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL  179 (342)
T ss_dssp             EEEECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEE
T ss_pred             eeecccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEE
Confidence            9998876    899999999999999999753   689999999999999999999943      467999999999999


Q ss_pred             EcCCCcEEEeeeccccCCCCCCCCc--eeeecCCCCccccccccccC------CCCcccchhhhHHHHHHHHhC------
Q 013105          219 LDSDYNAKLSDFGLATDGPQGEDSH--ITTCVMGTEGYAAPEYINTG------HLTTMCDVFSFGVVLLELLTG------  284 (449)
Q Consensus       219 l~~~~~~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~vl~elltg------  284 (449)
                      ++.++.+||+|||++..........  ......||+.|+|||++.+.      .++.++|||||||++|||++|      
T Consensus       180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~  259 (342)
T 1b6c_B          180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  259 (342)
T ss_dssp             ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred             ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence            9999999999999997544322111  12345699999999999765      234789999999999999999      


Q ss_pred             ----CCcccccccccchhhHHhhhhhhccccchhHhhccccccc-CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 013105          285 ----RRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDR-YSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE  359 (449)
Q Consensus       285 ----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  359 (449)
                          ..||......... ...+.......      ......... ....+++.+.+|+.+||+.||++|||+.+|+++|+
T Consensus       260 ~~~~~~p~~~~~~~~~~-~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~  332 (342)
T 1b6c_B          260 HEDYQLPYYDLVPSDPS-VEEMRKVVCEQ------KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS  332 (342)
T ss_dssp             CCCCCCTTTTTSCSSCC-HHHHHHHHTTS------CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred             ccccccCccccCcCccc-HHHHHHHHHHH------HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence                6677543211100 00000000000      000111111 13467788999999999999999999999999999


Q ss_pred             ccccCC
Q 013105          360 PLLDLN  365 (449)
Q Consensus       360 ~~~~~~  365 (449)
                      .+....
T Consensus       333 ~i~~~~  338 (342)
T 1b6c_B          333 QLSQQE  338 (342)
T ss_dssp             HHHHTT
T ss_pred             HHHHHh
Confidence            987654

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.2e-43  Score=339.56  Aligned_cols=254  Identities=27%  Similarity=0.390  Sum_probs=201.9

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ...++|.+.+.||+|+||.||+|.+..      +++.||+|++....  ....+.+|+.+++.++||||+++++++...+
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   97 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKE------TGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNT   97 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETT------TCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECC------CCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCC
Confidence            356789999999999999999998765      57899999997543  3467889999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..++||||+.+++|.+++... ...+++..+..++.+++.||.|||  ..||+|+||||+||+++.++.+||+|||++..
T Consensus        98 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  174 (314)
T 3com_A           98 DLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLH--FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQ  174 (314)
T ss_dssp             EEEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--hCCCcCCCcCHHHEEECCCCCEEEeecccchh
Confidence            999999999999999988643 367899999999999999999999  67899999999999999999999999999976


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||............      ...      
T Consensus       175 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~~------  240 (314)
T 3com_A          175 LTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI------PTN------  240 (314)
T ss_dssp             CBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------HHS------
T ss_pred             hhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH------hcC------
Confidence            543211  123456899999999999888999999999999999999999999754321111000      000      


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                         .......+..++..+.+|+.+||+.||.+|||+.+++++
T Consensus       241 ---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          241 ---PPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             ---CCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ---CCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence               000011123345679999999999999999999999986

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.3e-43  Score=348.72  Aligned_cols=268  Identities=22%  Similarity=0.282  Sum_probs=204.0

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeC--
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCED--  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--  154 (449)
                      .++|++.+.||+|+||.||+|.+..      ++..||||++.... ......+.+|+.++..++||||+++++++...  
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   99 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNL------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   99 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             cccEEEEEEeecCCCeEEEEEEECC------CCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence            4689999999999999999998765      57899999997443 23346788999999999999999999999765  


Q ss_pred             ---CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeec
Q 013105          155 ---EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFG  231 (449)
Q Consensus       155 ---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfG  231 (449)
                         ...|+||||+. |+|.+++..   ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||
T Consensus       100 ~~~~~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  173 (364)
T 3qyz_A          100 EQMKDVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTTCDLKICDFG  173 (364)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             cccceEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCChHhEEECCCCCEEEEeCc
Confidence               47899999997 699988865   36999999999999999999999  6789999999999999999999999999


Q ss_pred             cccCCCCCCCC-ceeeecCCCCccccccccc-cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhh---
Q 013105          232 LATDGPQGEDS-HITTCVMGTEGYAAPEYIN-TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPM---  306 (449)
Q Consensus       232 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~---  306 (449)
                      ++......... .......||+.|+|||++. +..++.++|||||||++|+|++|++||.+.........+......   
T Consensus       174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  253 (364)
T 3qyz_A          174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ  253 (364)
T ss_dssp             TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH
T ss_pred             ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            99865432211 1123457999999999875 455899999999999999999999999876433322211100000   


Q ss_pred             --hcccc--chhHhhcc-cc-----cccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          307 --LKDFT--KLDQIIDS-RL-----EDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       307 --~~~~~--~~~~~~~~-~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                        .....  ........ ..     .......++..+.+|+.+||+.||++|||+.++++|
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence              00000  00000000 00     011122345679999999999999999999999987

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.5e-43  Score=338.06  Aligned_cols=255  Identities=26%  Similarity=0.367  Sum_probs=205.9

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc---------chHHHHHHHHHHHhcCC-CCCcc
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS---------QGHREWLAEVIFLGQLK-HPHLV  145 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~nIv  145 (449)
                      .+.++|++.+.||+|+||.||+|.+..      +++.||||+++....         .....+.+|+.+++++. ||||+
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~   87 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKP------TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII   87 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBC
T ss_pred             chhhccceeeeecCCCceEEEEEEEcC------cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEe
Confidence            356789999999999999999998765      578999999975431         12346788999999995 99999


Q ss_pred             eeeeEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcE
Q 013105          146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNA  225 (449)
Q Consensus       146 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~  225 (449)
                      ++++++...+..++||||+.+++|.+++...  ..+++..+..++.|++.||.|||  .+||+|+||||+||+++.++.+
T Consensus        88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~  163 (298)
T 1phk_A           88 QLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALH--KLNIVHRDLKPENILLDDDMNI  163 (298)
T ss_dssp             CEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCE
T ss_pred             eeeeeeccCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEEcCCCcE
Confidence            9999999999999999999999999999765  57899999999999999999999  6789999999999999999999


Q ss_pred             EEeeeccccCCCCCCCCceeeecCCCCccccccccc------cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhh
Q 013105          226 KLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN------TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDL  299 (449)
Q Consensus       226 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~  299 (449)
                      ||+|||++........   .....||+.|+|||++.      ...++.++|||||||++|+|++|..||...........
T Consensus       164 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~  240 (298)
T 1phk_A          164 KLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM  240 (298)
T ss_dssp             EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             EEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHH
Confidence            9999999986543321   23456899999999984      45688999999999999999999999975432111110


Q ss_pred             HHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          300 VEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      +      ...        ...........++..+.+++.+||+.||.+|||+.++++|
T Consensus       241 ~------~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          241 I------MSG--------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             H------HHT--------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             H------hcC--------CcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence            0      000        0000111113445679999999999999999999999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.3e-44  Score=346.07  Aligned_cols=267  Identities=24%  Similarity=0.355  Sum_probs=188.8

Q ss_pred             HHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           75 QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      ....++|.+.+.||+|+||.||+|.+..      +++.||||++.... ......+.+|+.+++.++||||+++++++..
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   84 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAP------KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV   84 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----------CEEEEECCC----------------CCCCCCCTTBCCEEEEEES
T ss_pred             ccchhhhhhhheeccccceEEEEEEECC------CCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee
Confidence            4456789999999999999999997654      47899999986543 2334678899999999999999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhc------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEE
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKN------YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKL  227 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl  227 (449)
                      .+..++||||+.+++|.+++...      ....+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl  162 (303)
T 2vwi_A           85 KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH--KNGQIHRDVKAGNILLGEDGSVQI  162 (303)
T ss_dssp             SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEECTTCCEEE
T ss_pred             cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCCCCChhhEEEcCCCCEEE
Confidence            99999999999999999998641      2356899999999999999999999  678999999999999999999999


Q ss_pred             eeeccccCCCCCCC---CceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhh
Q 013105          228 SDFGLATDGPQGED---SHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA  303 (449)
Q Consensus       228 ~DfGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~  303 (449)
                      +|||++........   ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||............  .
T Consensus       163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~  240 (303)
T 2vwi_A          163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT--L  240 (303)
T ss_dssp             CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH--H
T ss_pred             EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH--h
Confidence            99999875433211   111234569999999999865 56899999999999999999999999765332211100  0


Q ss_pred             hhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          304 RPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                         .........   ..........++..+.+++.+||+.||.+|||+.+++++
T Consensus       241 ---~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          241 ---QNDPPSLET---GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             ---TSSCCCTTC--------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ---ccCCCcccc---ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence               000000000   000111222345568999999999999999999999987

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.2e-44  Score=340.46  Aligned_cols=254  Identities=24%  Similarity=0.320  Sum_probs=189.6

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHH-HHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHR-EWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~-~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      ..++|++.+.||+|+||.||+|.+..      +++.||+|++..... .... .+.++...++.++||||+++++++.+.
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~   78 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVP------SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE   78 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecC------CCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc
Confidence            45789999999999999999998765      588999999975422 2222 344455568888999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CeeeccCCCCceEEcCCCcEEEeeec
Q 013105          155 EHRLLVYEYMALGNLHDQLFK--NYSSTLPWLTRIKIAIGAARCLAFLHGEEK-PVIYRDFKASNILLDSDYNAKLSDFG  231 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~ivHrDikp~Nill~~~~~~kl~DfG  231 (449)
                      +..++||||+. |+|.+++..  .....+++..+..++.|++.||.|||  .+ ||+||||||+|||++.++.+||+|||
T Consensus        79 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T 3fme_A           79 GDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFG  155 (290)
T ss_dssp             SSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HHSCCCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred             CCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh--hcCCeecCCCCHHHEEECCCCCEEEeecC
Confidence            99999999997 588777754  23467999999999999999999999  55 89999999999999999999999999


Q ss_pred             cccCCCCCCCCceeeecCCCCcccccccc----ccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhh
Q 013105          232 LATDGPQGEDSHITTCVMGTEGYAAPEYI----NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML  307 (449)
Q Consensus       232 la~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~  307 (449)
                      ++........   .....||+.|+|||++    .+..++.++|||||||++|+|++|..||........ .         
T Consensus       156 ~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~---------  222 (290)
T 3fme_A          156 ISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-Q---------  222 (290)
T ss_dssp             -----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-H---------
T ss_pred             Cccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-H---------
Confidence            9986543221   2334699999999996    556789999999999999999999999975321110 0         


Q ss_pred             ccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                           +...............++..+.+++.+||+.||++|||+.++++|
T Consensus       223 -----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          223 -----LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             -----HHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             -----HHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence                 011111111111123445679999999999999999999999986

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=9.7e-44  Score=344.48  Aligned_cols=261  Identities=16%  Similarity=0.251  Sum_probs=201.0

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC-CCCcceeeeEEEe--C
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-HPHLVNLIGYCCE--D  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~--~  154 (449)
                      .++|++.+.||+|+||.||+|.+..      +++.||||++...   ....+.+|+.+++.++ ||||+++++++.+  .
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~  105 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINIT------NNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVS  105 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred             CCceEEEEEecccCCeEEEEEEECC------CCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC
Confidence            3679999999999999999998765      5789999999633   3467889999999997 9999999999988  6


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC-cEEEeeeccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY-NAKLSDFGLA  233 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~-~~kl~DfGla  233 (449)
                      ...++||||+.+++|.+++.     .++...+..++.|++.||.|||  ++||+||||||+|||++.++ .+||+|||++
T Consensus       106 ~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a  178 (330)
T 3nsz_A          106 RTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA  178 (330)
T ss_dssp             CCEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             CceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCc
Confidence            78899999999999998873     4888999999999999999999  67899999999999999777 8999999999


Q ss_pred             cCCCCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchh-----------hHH
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKD-----------LVE  301 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~-----------~~~  301 (449)
                      ........   .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........-           ...
T Consensus       179 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~  255 (330)
T 3nsz_A          179 EFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD  255 (330)
T ss_dssp             EECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred             eEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhh
Confidence            86543322   233568999999999876 678999999999999999999999995432211100           000


Q ss_pred             hhhhhh-ccccchhHhhcc--------cccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          302 WARPML-KDFTKLDQIIDS--------RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       302 ~~~~~~-~~~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      +..... ............        .........+++.+.+||.+||+.||++|||+.++++|
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             HHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            000000 000000000000        00111122356779999999999999999999999997

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.8e-43  Score=343.22  Aligned_cols=267  Identities=23%  Similarity=0.301  Sum_probs=207.4

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCC------CcceeeeE
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHP------HLVNLIGY  150 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------nIv~~~~~  150 (449)
                      +.++|++.+.||+|+||.||+|.+...     .++.||||++... ......+.+|+.+++.++|+      +|++++++
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~   85 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKA-----GGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW   85 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTT-----TTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCC-----CCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence            457899999999999999999987432     4789999999643 23456678899999888655      49999999


Q ss_pred             EEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC---------
Q 013105          151 CCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS---------  221 (449)
Q Consensus       151 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~---------  221 (449)
                      +...+..++||||+ +++|.+++.......+++..+..++.|++.||.|||  ++||+||||||+|||++.         
T Consensus        86 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           86 FEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH--SNKLTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred             cccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHHHEEEeccccccccCC
Confidence            99999999999999 799999998775567899999999999999999999  678999999999999987         


Q ss_pred             ----------CCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCccccc
Q 013105          222 ----------DYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKN  291 (449)
Q Consensus       222 ----------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~  291 (449)
                                ++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus       163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  237 (339)
T 1z57_A          163 KIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH  237 (339)
T ss_dssp             ---CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence                      668999999999864332     23356999999999999889999999999999999999999999865


Q ss_pred             ccccchhhHHhhhhhhcc------------------cc---chhHhhc----c-cccccCCHHHHHHHHHHHHHhccCCC
Q 013105          292 RCKREKDLVEWARPMLKD------------------FT---KLDQIID----S-RLEDRYSTEGAKRLAAVAHQCLSHNP  345 (449)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~------------------~~---~~~~~~~----~-~~~~~~~~~~~~~l~~li~~cl~~dP  345 (449)
                      ..................                  +.   .....+.    . ..........++.+.+|+.+||+.||
T Consensus       238 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  317 (339)
T 1z57_A          238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP  317 (339)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             ChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence            433222111111000000                  00   0000000    0 00011234567889999999999999


Q ss_pred             CCCCCHHHHHHH
Q 013105          346 KSRPTMTTVVKA  357 (449)
Q Consensus       346 ~~RPs~~eil~~  357 (449)
                      .+|||+.++++|
T Consensus       318 ~~Rpt~~ell~h  329 (339)
T 1z57_A          318 AKRITLREALKH  329 (339)
T ss_dssp             TTSCCHHHHTTS
T ss_pred             ccccCHHHHhcC
Confidence            999999999987

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.2e-44  Score=343.36  Aligned_cols=255  Identities=22%  Similarity=0.358  Sum_probs=201.4

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      ..++|++.+.||+|+||.||+|.+..      ++..||+|++..........+.+|+.++..++||||+++++++...+.
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKE------TGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGK   90 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETT------TCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C
T ss_pred             CccceeecceeccCCCeEEEEEEEcC------CCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe
Confidence            45789999999999999999998765      578999999986666667889999999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||||+.+++|.+++... ...+++..+..++.|++.||.|||  ..||+||||||+|||++.++.+||+|||++...
T Consensus        91 ~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  167 (302)
T 2j7t_A           91 LWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLH--SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN  167 (302)
T ss_dssp             EEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred             EEEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHh--cCCcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence            99999999999999888653 356899999999999999999999  678999999999999999999999999987532


Q ss_pred             CCCCCCceeeecCCCCcccccccc-----ccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcccc
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYI-----NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFT  311 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  311 (449)
                      ...  ........||+.|+|||++     .+..++.++|||||||++|+|++|..||.........  ...    ...  
T Consensus       168 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~----~~~--  237 (302)
T 2j7t_A          168 LKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL--LKI----AKS--  237 (302)
T ss_dssp             HHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HHH----HHS--
T ss_pred             ccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH--HHH----hcc--
Confidence            110  0112234689999999998     3567899999999999999999999999764321110  000    000  


Q ss_pred             chhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          312 KLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                             .......+..++..+.+++..||+.||++|||+.++++|
T Consensus       238 -------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          238 -------DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             -------CCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             -------CCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                   000011123445679999999999999999999999986

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-44  Score=352.18  Aligned_cols=259  Identities=26%  Similarity=0.334  Sum_probs=204.6

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC----cchHHHHHHHHHHHhcC-CCCCcceeeeEEE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG----SQGHREWLAEVIFLGQL-KHPHLVNLIGYCC  152 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~  152 (449)
                      .++|.+.+.||+|+||.||+|....+   ..+++.||||+++...    ......+.+|+.+|..+ +||||+++++++.
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  129 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISG---HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ  129 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSS---TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             ccceEEEEEeccCCCEEEEEEEEccc---CCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence            36799999999999999999987431   2257899999986421    12234566799999999 6999999999999


Q ss_pred             eCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecc
Q 013105          153 EDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL  232 (449)
Q Consensus       153 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGl  232 (449)
                      ..+..++||||+.+|+|.+++...  ..+++..+..++.|++.||.|||  +++|+||||||+|||++.++.+||+|||+
T Consensus       130 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kl~DfG~  205 (355)
T 1vzo_A          130 TETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGL  205 (355)
T ss_dssp             ETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             eCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence            999999999999999999999765  47899999999999999999999  67899999999999999999999999999


Q ss_pred             ccCCCCCCCCceeeecCCCCcccccccccc--CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccc
Q 013105          233 ATDGPQGEDSHITTCVMGTEGYAAPEYINT--GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF  310 (449)
Q Consensus       233 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  310 (449)
                      ++....... .......||+.|+|||++.+  ..++.++|||||||+||||++|..||..........  ......    
T Consensus       206 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~~----  278 (355)
T 1vzo_A          206 SKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRRI----  278 (355)
T ss_dssp             EEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHHHH----
T ss_pred             CeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH--HHHHHH----
Confidence            986533221 12334579999999999975  347899999999999999999999997543221111  100000    


Q ss_pred             cchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHHh
Q 013105          311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRP-----TMTTVVKAL  358 (449)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L  358 (449)
                            ..  ....++..++..+.+||.+||+.||.+||     ++.+++++.
T Consensus       279 ------~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          279 ------LK--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             ------HH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             ------hc--cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                  00  11223445566789999999999999999     999999873

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.4e-43  Score=349.37  Aligned_cols=264  Identities=19%  Similarity=0.242  Sum_probs=195.1

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      .++|++.+.||+|+||.||+|.+..      +++.||||++....  ......+.+|+.+++.++||||+++++++...+
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   97 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAI------LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK   97 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECC------CCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccc
Confidence            4789999999999999999997765      57899999997532  233466889999999999999999999997654


Q ss_pred             ------EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEee
Q 013105          156 ------HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSD  229 (449)
Q Consensus       156 ------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~D  229 (449)
                            ..|+||||+. |+|.+.+.    ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~NIl~~~~~~~kl~D  170 (371)
T 2xrw_A           98 SLEEFQDVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILD  170 (371)
T ss_dssp             STTTCCEEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccccccceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHH--HCCeecccCCHHHEEEcCCCCEEEEE
Confidence                  7899999997 57888774    35889999999999999999999  67899999999999999999999999


Q ss_pred             eccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHH--------
Q 013105          230 FGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVE--------  301 (449)
Q Consensus       230 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~--------  301 (449)
                      ||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+.        
T Consensus       171 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  247 (371)
T 2xrw_A          171 FGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP  247 (371)
T ss_dssp             CCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCH
T ss_pred             eeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            99998654321   2334569999999999998899999999999999999999999998654322111100        


Q ss_pred             -hhh-------hhhcccc-----chhHhhccccc---ccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          302 -WAR-------PMLKDFT-----KLDQIIDSRLE---DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       302 -~~~-------~~~~~~~-----~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       +..       .......     .+.........   .......+..+.+|+.+||+.||++|||+.++++|
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence             000       0000000     00000000000   00112346789999999999999999999999997

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.9e-44  Score=340.86  Aligned_cols=263  Identities=27%  Similarity=0.369  Sum_probs=201.0

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      .++|++.+.||+|+||.||+|.+...   ...+..||+|++...   .......+.+|+.+++.++||||+++++++.+.
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAP---SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP   93 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECT---TSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccC---CCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence            46799999999999999999987542   112346999998743   234457789999999999999999999999876


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      . .++||||+.+++|.+++... ...+++..+..++.|++.||.|||  +++|+||||||+|||++.++.+||+|||++.
T Consensus        94 ~-~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           94 P-MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             S-CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             C-ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHH--hCCcccCCCchheEEEcCCCCEEEccccccc
Confidence            5 88999999999999998764 246889999999999999999999  6789999999999999999999999999998


Q ss_pred             CCCCCCCCc-eeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccc
Q 013105          235 DGPQGEDSH-ITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTK  312 (449)
Q Consensus       235 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  312 (449)
                      ......... ......||..|+|||++.+..++.++|||||||++|+|++ |..||.........   .           
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~-----------  235 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL---H-----------  235 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---H-----------
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHH---H-----------
Confidence            664432211 1223457889999999988889999999999999999999 99999765322111   0           


Q ss_pred             hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                        .+.........+..++..+.+++.+||+.||++|||+.+++++|+.+..
T Consensus       236 --~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          236 --KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             --HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             --HHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence              0111111112234456679999999999999999999999999987754

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=6.6e-44  Score=350.82  Aligned_cols=264  Identities=22%  Similarity=0.287  Sum_probs=187.1

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      +.++|++.+.||+|+||.||+|.+..      +++.||||++...  .......+.+|+.+|+.++||||+++++++...
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  100 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTK------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA  100 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETT------TTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECC------CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence            34789999999999999999998765      5889999999643  223456788999999999999999999998654


Q ss_pred             ------CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEe
Q 013105          155 ------EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLS  228 (449)
Q Consensus       155 ------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~  228 (449)
                            ...|+|||++ +++|.+++..   ..+++..+..++.|++.||.|||  +.||+||||||+|||++.++.+||+
T Consensus       101 ~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH--~~givH~Dlkp~NIll~~~~~~kL~  174 (367)
T 2fst_X          101 RSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKIL  174 (367)
T ss_dssp             SSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHhhEEECCCCCEEEe
Confidence                  5679999999 6899888754   47999999999999999999999  6789999999999999999999999


Q ss_pred             eeccccCCCCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhh--
Q 013105          229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARP--  305 (449)
Q Consensus       229 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~--  305 (449)
                      |||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+.....  
T Consensus       175 DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p  249 (367)
T 2fst_X          175 DFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP  249 (367)
T ss_dssp             C--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred             ecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            99999864321     334579999999999876 6789999999999999999999999987543322211110000  


Q ss_pred             ---hhcccc--chhHhhccc---cc---ccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          306 ---MLKDFT--KLDQIIDSR---LE---DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       306 ---~~~~~~--~~~~~~~~~---~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                         ......  .....+...   ..   .......++.+.+|+.+||+.||++|||+.++++|
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence               000000  000000000   00   00112335678999999999999999999999987

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.3e-43  Score=347.63  Aligned_cols=263  Identities=20%  Similarity=0.283  Sum_probs=202.8

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC-----------CCCcce
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-----------HPHLVN  146 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~  146 (449)
                      .++|.+.+.||+|+||.||+|.+..      +++.||||++... ......+.+|+.+++.+.           ||||++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~   90 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMV------NNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK   90 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecC------CCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence            4679999999999999999998765      5889999999743 333466788999998886           899999


Q ss_pred             eeeEEEeCC----EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CeeeccCCCCceEEc-
Q 013105          147 LIGYCCEDE----HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK-PVIYRDFKASNILLD-  220 (449)
Q Consensus       147 ~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~ivHrDikp~Nill~-  220 (449)
                      +++++...+    ..++||||+ +++|.+++.......+++..+..++.|++.||.|||  .+ ||+||||||+|||++ 
T Consensus        91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH--~~~~ivH~Dikp~NIll~~  167 (373)
T 1q8y_A           91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEI  167 (373)
T ss_dssp             CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH--HTTCEECSCCSGGGEEEEE
T ss_pred             HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH--hcCCEEecCCChHHeEEec
Confidence            999998654    789999999 899999998765667999999999999999999999  56 899999999999994 


Q ss_pred             -----CCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCccccccccc
Q 013105          221 -----SDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKR  295 (449)
Q Consensus       221 -----~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~  295 (449)
                           ..+.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus       168 ~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  242 (373)
T 1q8y_A          168 VDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS  242 (373)
T ss_dssp             EETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccc
Confidence                 3448999999999865432     233468999999999998899999999999999999999999998653211


Q ss_pred             c---hhhHHhhhhhhcccc-----------------------------chhHhhcccccccCCHHHHHHHHHHHHHhccC
Q 013105          296 E---KDLVEWARPMLKDFT-----------------------------KLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSH  343 (449)
Q Consensus       296 ~---~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  343 (449)
                      .   ..............+                             .+.....  ....++...+..+.+||.+||+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~  320 (373)
T 1q8y_A          243 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT--EKYKFSKDEAKEISDFLSPMLQL  320 (373)
T ss_dssp             --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH--HTTCCCHHHHHHHHHHHGGGGCS
T ss_pred             cCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhh--hcccCCcchHHHHHHHHHHHhcc
Confidence            1   011100000000000                             0000000  11234677889999999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 013105          344 NPKSRPTMTTVVKA  357 (449)
Q Consensus       344 dP~~RPs~~eil~~  357 (449)
                      ||++|||+.++++|
T Consensus       321 dP~~Rpt~~ell~h  334 (373)
T 1q8y_A          321 DPRKRADAGGLVNH  334 (373)
T ss_dssp             STTTCBCHHHHHTC
T ss_pred             CccccCCHHHHhhC
Confidence            99999999999987

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.2e-43  Score=355.24  Aligned_cols=264  Identities=25%  Similarity=0.310  Sum_probs=196.3

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC---
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED---  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~---  154 (449)
                      ..+|.+.+.||+|+||.||+|.+..      +++.||||++.....    ...+|+++|+.++||||+++++++...   
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~------~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~  122 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEK  122 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECC------CCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCC
Confidence            3468999999999999999998865      578999999864322    234699999999999999999998542   


Q ss_pred             ---CEEEEEEEecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC-CcEEEe
Q 013105          155 ---EHRLLVYEYMALGNLHDQLFK--NYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD-YNAKLS  228 (449)
Q Consensus       155 ---~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~-~~~kl~  228 (449)
                         ..+++||||+.+ +|.+.+..  .....+++..+..++.|++.||.|||  .+||+||||||+|||++.+ +.+||+
T Consensus       123 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NILl~~~~~~~kl~  199 (420)
T 1j1b_A          123 KDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLC  199 (420)
T ss_dssp             TTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred             CcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChhhEEEeCCCCeEEec
Confidence               236799999984 66666543  23467999999999999999999999  7889999999999999965 578999


Q ss_pred             eeccccCCCCCCCCceeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCCcccccccccchhhH-Hhh---
Q 013105          229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV-EWA---  303 (449)
Q Consensus       229 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~-~~~---  303 (449)
                      |||+++.......   .....||+.|+|||++.+. .++.++|||||||+||||++|++||.+.........+ ...   
T Consensus       200 DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p  276 (420)
T 1j1b_A          200 DFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP  276 (420)
T ss_dssp             CCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred             cchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999986543322   2335689999999998654 7899999999999999999999999875432211111 000   


Q ss_pred             -----hhhhccccc--hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          304 -----RPMLKDFTK--LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       304 -----~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                           ......+..  +..+........++...+.++.+||.+||+.||.+|||+.++++|
T Consensus       277 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             CHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence                 000000000  000000000111233456779999999999999999999999987

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.8e-43  Score=341.61  Aligned_cols=255  Identities=24%  Similarity=0.351  Sum_probs=198.8

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--------cchHHHHHHHHHHHhcCCCCCccee
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--------SQGHREWLAEVIFLGQLKHPHLVNL  147 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~nIv~~  147 (449)
                      .+.++|.+.+.||+|+||.||+|.+..      +++.||||++....        ......+.+|+.+++.++||||+++
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~   80 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERK------TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI   80 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCE
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcC------CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceE
Confidence            456789999999999999999998765      57899999986432        1122357889999999999999999


Q ss_pred             eeEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCc---
Q 013105          148 IGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYN---  224 (449)
Q Consensus       148 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~---  224 (449)
                      ++++..++ .|+||||+.+++|.+++...  ..+++.....++.|++.||.|||  .+||+||||||+|||++.++.   
T Consensus        81 ~~~~~~~~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~NIl~~~~~~~~~  155 (322)
T 2ycf_A           81 KNFFDAED-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQEEDCL  155 (322)
T ss_dssp             EEEEESSS-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESSSSSSCC
T ss_pred             eeEEcCCc-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEEecCCCCCe
Confidence            99987655 89999999999999988654  57899999999999999999999  678999999999999987664   


Q ss_pred             EEEeeeccccCCCCCCCCceeeecCCCCccccccccc---cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHH
Q 013105          225 AKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYIN---TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVE  301 (449)
Q Consensus       225 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~  301 (449)
                      +||+|||++......   .......||+.|+|||++.   ...++.++|||||||++|+|++|..||........  +..
T Consensus       156 ~kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~  230 (322)
T 2ycf_A          156 IKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD  230 (322)
T ss_dssp             EEECCCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHH
T ss_pred             EEEccCccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHH
Confidence            999999999865332   1223456999999999973   46789999999999999999999999975432211  111


Q ss_pred             hhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          302 WARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .....  ...         ........++..+.+|+.+||+.||++|||+.++++|
T Consensus       231 ~~~~~--~~~---------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          231 QITSG--KYN---------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             HHHHT--CCC---------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHhC--ccc---------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            00000  000         0000112235678999999999999999999999976

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=7.8e-44  Score=351.14  Aligned_cols=254  Identities=12%  Similarity=0.040  Sum_probs=183.1

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc---chHHHHHHHH---HHHhcCCCCCcceee----
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS---QGHREWLAEV---IFLGQLKHPHLVNLI----  148 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~h~nIv~~~----  148 (449)
                      .+|.+.+.||+|+||.||+|.+..      +++.||||++.....   .....+.+|+   .+|+. +||||++++    
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~  134 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVE------RLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLL  134 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBC
T ss_pred             eeeeeeeeccCCCCEEEEEEEECC------CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEE
Confidence            458899999999999999998765      478999999986532   2344566774   55555 799988755    


Q ss_pred             ---eEEEeC-----------------CEEEEEEEecCCCChHHHHhhcCCCCCCHHHH------HHHHHHHHHHHHHhhc
Q 013105          149 ---GYCCED-----------------EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTR------IKIAIGAARCLAFLHG  202 (449)
Q Consensus       149 ---~~~~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~------~~i~~~i~~~l~~lH~  202 (449)
                         +++...                 ...||||||+. |+|.+++.... ..+++..+      ..++.|++.||.||| 
T Consensus       135 ~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH-  211 (371)
T 3q60_A          135 LPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQ-  211 (371)
T ss_dssp             CCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHH-
T ss_pred             eeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHH-
Confidence               555443                 34899999998 89999997642 23344555      677899999999999 


Q ss_pred             CCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCcccccccccc--CCCCcccchhhhHHHHHH
Q 013105          203 EEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT--GHLTTMCDVFSFGVVLLE  280 (449)
Q Consensus       203 ~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~vl~e  280 (449)
                       ++||+||||||+|||++.++.+||+|||++.....     ......||+.|+|||++.+  ..++.++|||||||+|||
T Consensus       212 -~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~e  285 (371)
T 3q60_A          212 -SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR  285 (371)
T ss_dssp             -HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHH
T ss_pred             -HCCCccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHH
Confidence             67799999999999999999999999999985532     1224557899999999987  679999999999999999


Q ss_pred             HHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          281 LLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       281 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      |++|+.||............        .. .................+++.+.+|+.+||+.||++|||+.++++|
T Consensus       286 lltg~~Pf~~~~~~~~~~~~--------~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          286 VWCLFLPFGLVTPGIKGSWK--------RP-SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             HHHSSCSTTBCCTTCTTCCC--------BC-CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             HHhCCCCCCCcCcccccchh--------hh-hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            99999999865322111000        00 0000000111111123456679999999999999999999999876

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.1e-43  Score=348.67  Aligned_cols=274  Identities=19%  Similarity=0.258  Sum_probs=200.7

Q ss_pred             CHHHHHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-----------chHHHHHHHHHHHhc
Q 013105           70 TLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-----------QGHREWLAEVIFLGQ  138 (449)
Q Consensus        70 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~  138 (449)
                      ...++..+.++|.+.+.||+|+||.||+|.+.       .+..||||++.....           ...+.+.+|+.+++.
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   85 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNH   85 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECT-------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECC-------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHh
Confidence            35677888899999999999999999999754       278999999853221           123678999999999


Q ss_pred             CCCCCcceeeeEEEe-----CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCC
Q 013105          139 LKHPHLVNLIGYCCE-----DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFK  213 (449)
Q Consensus       139 l~h~nIv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDik  213 (449)
                      ++||||+++++++..     ....|+||||+. |+|.+++... ...+++..+..++.|++.||.|||  .+||+|||||
T Consensus        86 l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlk  161 (362)
T 3pg1_A           86 FHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLH--EAGVVHRDLH  161 (362)
T ss_dssp             CCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCC
T ss_pred             CCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH--HCcCEecCCC
Confidence            999999999999854     346899999998 6888887643 357899999999999999999999  6789999999


Q ss_pred             CCceEEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccc
Q 013105          214 ASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNR  292 (449)
Q Consensus       214 p~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~  292 (449)
                      |+|||++.++.+||+|||++.......   ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..
T Consensus       162 p~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  238 (362)
T 3pg1_A          162 PGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST  238 (362)
T ss_dssp             GGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             hHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999997543322   1334568999999999876 678999999999999999999999998654


Q ss_pred             cccchhhHHh-hhh-hhc-----cccchhHhhccc-------ccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          293 CKREKDLVEW-ARP-MLK-----DFTKLDQIIDSR-------LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       293 ~~~~~~~~~~-~~~-~~~-----~~~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .......+.. ... ...     ........+...       .........++.+.+|+.+||+.||++|||+.++++|
T Consensus       239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          239 FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            3222111100 000 000     000000000000       0011122345679999999999999999999999987

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=341.13  Aligned_cols=269  Identities=21%  Similarity=0.292  Sum_probs=198.1

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEE----
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCC----  152 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~----  152 (449)
                      +.++|.+.+.||+|+||.||+|.+..      +++.||+|++..........+.+|+.+++.++||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   82 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDND------CDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS   82 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETT------TTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECC------CCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccc
Confidence            35789999999999999999998765      57899999998666566678899999999999999999999873    


Q ss_pred             ----------eCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEc-C
Q 013105          153 ----------EDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD-S  221 (449)
Q Consensus       153 ----------~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~-~  221 (449)
                                +....++||||+. |+|.+++..   ..+++..+..++.|++.||.|||  ++||+||||||+|||++ .
T Consensus        83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~  156 (320)
T 2i6l_A           83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIH--SANVLHRDLKPANLFINTE  156 (320)
T ss_dssp             BCCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEEEETT
T ss_pred             ccccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCC
Confidence                      4478899999998 699998854   46899999999999999999999  67899999999999997 5


Q ss_pred             CCcEEEeeeccccCCCCCCC-CceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhh
Q 013105          222 DYNAKLSDFGLATDGPQGED-SHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDL  299 (449)
Q Consensus       222 ~~~~kl~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~  299 (449)
                      ++.+||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........
T Consensus       157 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  236 (320)
T 2i6l_A          157 DLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL  236 (320)
T ss_dssp             TTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             CCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            67999999999986543211 111233457999999998865 6789999999999999999999999986543222111


Q ss_pred             HHhhhhhhcc--c----cchhHhhcccc------cccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          300 VEWARPMLKD--F----TKLDQIIDSRL------EDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       300 ~~~~~~~~~~--~----~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      +....+....  .    ..+...+....      .......++..+.+++.+||+.||++|||+.++++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            1100000000  0    00000000000      001122356679999999999999999999999987

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.5e-43  Score=351.55  Aligned_cols=278  Identities=21%  Similarity=0.285  Sum_probs=188.7

Q ss_pred             HhcCCCC-cccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEe--
Q 013105           77 ITHNFSR-SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE--  153 (449)
Q Consensus        77 ~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--  153 (449)
                      +.+.|.+ .++||+|+||.||+|.+.+.    .++..||||++.....  ...+.+|+.+|+.++||||+++++++..  
T Consensus        18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~----~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   91 (405)
T 3rgf_A           18 VEDLFEYEGCKVGRGTYGHVYKAKRKDG----KDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHA   91 (405)
T ss_dssp             HHHHEECSSCCCC-----EEEEEEESSS----SCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETT
T ss_pred             hhhhhhhcCcEeeecCCeEEEEEEEccC----CCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCC
Confidence            3455766 56899999999999987531    2578899999974432  3467899999999999999999999965  


Q ss_pred             CCEEEEEEEecCCCChHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEE----cCC
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKN-------YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILL----DSD  222 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill----~~~  222 (449)
                      ....|+||||+. |+|.+++...       ....+++..+..++.|++.||.|||  .+||+||||||+|||+    +.+
T Consensus        92 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~ivH~Dlkp~NIll~~~~~~~  168 (405)
T 3rgf_A           92 DRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPER  168 (405)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECCSSTTT
T ss_pred             CCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH--hCCEeCCCcCHHHeEEecCCCCC
Confidence            678999999997 5888877532       1235899999999999999999999  6779999999999999    677


Q ss_pred             CcEEEeeeccccCCCCCCC-CceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccc----
Q 013105          223 YNAKLSDFGLATDGPQGED-SHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE----  296 (449)
Q Consensus       223 ~~~kl~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~----  296 (449)
                      +.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+......    
T Consensus       169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~  248 (405)
T 3rgf_A          169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP  248 (405)
T ss_dssp             TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred             CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence            8999999999986543211 122334679999999999976 4589999999999999999999999975432110    


Q ss_pred             --hhhHHhhhhh-----hccccchh------Hhhccccccc------------CCHHHHHHHHHHHHHhccCCCCCCCCH
Q 013105          297 --KDLVEWARPM-----LKDFTKLD------QIIDSRLEDR------------YSTEGAKRLAAVAHQCLSHNPKSRPTM  351 (449)
Q Consensus       297 --~~~~~~~~~~-----~~~~~~~~------~~~~~~~~~~------------~~~~~~~~l~~li~~cl~~dP~~RPs~  351 (449)
                        .+........     ...+..+.      ..........            .....+..+.+||.+||+.||.+|||+
T Consensus       249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta  328 (405)
T 3rgf_A          249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS  328 (405)
T ss_dssp             CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred             chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence              0000000000     00000000      0000000000            000114568899999999999999999


Q ss_pred             HHHHHHhhccccCC
Q 013105          352 TTVVKALEPLLDLN  365 (449)
Q Consensus       352 ~eil~~L~~~~~~~  365 (449)
                      .++++|  .++...
T Consensus       329 ~e~L~h--p~f~~~  340 (405)
T 3rgf_A          329 EQAMQD--PYFLED  340 (405)
T ss_dssp             HHHHTS--GGGTSS
T ss_pred             HHHhcC--hhhccC
Confidence            999997  555443

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=5.4e-44  Score=343.89  Aligned_cols=254  Identities=24%  Similarity=0.360  Sum_probs=196.9

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCC--CCCcceeeeEE
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLK--HPHLVNLIGYC  151 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~nIv~~~~~~  151 (449)
                      ...++|++.+.||+|+||.||+|.+.       .++.||||++....  ......+.+|+.++..++  ||||+++++++
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   97 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNE-------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   97 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECT-------TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcC-------CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence            34567999999999999999999764       36889999997543  334567889999999997  59999999999


Q ss_pred             EeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeec
Q 013105          152 CEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFG  231 (449)
Q Consensus       152 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfG  231 (449)
                      .+.+..++||| +.+++|.+++...  ..+++..+..++.|++.||.|||  +++|+||||||+|||++. +.+||+|||
T Consensus        98 ~~~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIl~~~-~~~kL~Dfg  171 (313)
T 3cek_A           98 ITDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIVD-GMLKLIDFG  171 (313)
T ss_dssp             ECSSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred             ecCCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCcccEEEEC-CeEEEeecc
Confidence            99999999999 5678999999765  57899999999999999999999  678999999999999964 799999999


Q ss_pred             cccCCCCCCCCceeeecCCCCcccccccccc-----------CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhH
Q 013105          232 LATDGPQGEDSHITTCVMGTEGYAAPEYINT-----------GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV  300 (449)
Q Consensus       232 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~  300 (449)
                      ++................||+.|+|||++.+           ..++.++|||||||++|+|++|..||........    
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~----  247 (313)
T 3cek_A          172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS----  247 (313)
T ss_dssp             SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH----
T ss_pred             ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH----
Confidence            9986644332222334569999999999865           4688899999999999999999999975321100    


Q ss_pred             HhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          301 EWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                                 .+...+.......++...+..+.+++.+||+.||.+|||+.+++++
T Consensus       248 -----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          248 -----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             -----------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -----------HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence                       0111111111222233335679999999999999999999999987

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.3e-43  Score=343.94  Aligned_cols=269  Identities=23%  Similarity=0.275  Sum_probs=202.5

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeC-
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCED-  154 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-  154 (449)
                      +.++|.+.+.||+|+||.||+|.+..      +++.||||++.... ......+.+|+.+++.++||||+++++++... 
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   82 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKP------TGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDS   82 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECC------CCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccc
Confidence            45789999999999999999998765      57899999996433 23345688999999999999999999988654 


Q ss_pred             ----CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeee
Q 013105          155 ----EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDF  230 (449)
Q Consensus       155 ----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~Df  230 (449)
                          ...++||||+. |+|.+++..   ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+||
T Consensus        83 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH--~~~ivH~Dlkp~Nil~~~~~~~kl~Df  156 (353)
T 2b9h_A           83 FENFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLH--GSNVIHRDLKPSNLLINSNCDLKVCDF  156 (353)
T ss_dssp             STTCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTCCEEECCC
T ss_pred             cCccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEEcCCCcEEEEec
Confidence                67899999997 689988865   46899999999999999999999  678999999999999999999999999


Q ss_pred             ccccCCCCCCCCc--------eeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHH
Q 013105          231 GLATDGPQGEDSH--------ITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVE  301 (449)
Q Consensus       231 Gla~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~  301 (449)
                      |++..........        ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+...........
T Consensus       157 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  236 (353)
T 2b9h_A          157 GLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF  236 (353)
T ss_dssp             TTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence            9998654321110        1223568999999998754 678999999999999999999999998754322111110


Q ss_pred             hhhhhhc------c--ccchhHhhccc------ccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          302 WARPMLK------D--FTKLDQIIDSR------LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       302 ~~~~~~~------~--~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .......      .  .......+...      ........++..+.+|+.+||+.||++|||+.++++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0000000      0  00000000000      0001122456678999999999999999999999987

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1e-42  Score=340.22  Aligned_cols=267  Identities=21%  Similarity=0.272  Sum_probs=205.5

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCC------cceeeeE
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPH------LVNLIGY  150 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~~~~~  150 (449)
                      +.++|++.+.||+|+||.||+|.+...     .+..||+|++... ......+.+|+.+++.++|++      ++.++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~   90 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHAR-----GKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDW   90 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTT-----TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCC-----CceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence            457899999999999999999987652     2378999999643 334566788999999987665      9999999


Q ss_pred             EEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEE-----------
Q 013105          151 CCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILL-----------  219 (449)
Q Consensus       151 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill-----------  219 (449)
                      +...+..++||||+ +++|.+++.......+++..+..++.|++.||.|||  ++||+||||||+|||+           
T Consensus        91 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH--~~~ivH~Dlkp~NIll~~~~~~~~~~~  167 (355)
T 2eu9_A           91 FNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH--ENQLTHTDLKPENILFVNSEFETLYNE  167 (355)
T ss_dssp             EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEESCCCEEEEECC
T ss_pred             eeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEecccccccccc
Confidence            99999999999999 678888887765567999999999999999999999  7789999999999999           


Q ss_pred             --------cCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCccccc
Q 013105          220 --------DSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKN  291 (449)
Q Consensus       220 --------~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~  291 (449)
                              +.++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus       168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (355)
T 2eu9_A          168 HKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH  242 (355)
T ss_dssp             C-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence                    56789999999999854332     23356999999999999889999999999999999999999999865


Q ss_pred             ccccchhhHHhhhhhhc-----cc----------------cchhHhhcc-----cccccCCHHHHHHHHHHHHHhccCCC
Q 013105          292 RCKREKDLVEWARPMLK-----DF----------------TKLDQIIDS-----RLEDRYSTEGAKRLAAVAHQCLSHNP  345 (449)
Q Consensus       292 ~~~~~~~~~~~~~~~~~-----~~----------------~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~dP  345 (449)
                      .................     ..                .........     ..........+..+.+|+.+||+.||
T Consensus       243 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  322 (355)
T 2eu9_A          243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP  322 (355)
T ss_dssp             SHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             CHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence            43222111111000000     00                000000000     00011223456789999999999999


Q ss_pred             CCCCCHHHHHHH
Q 013105          346 KSRPTMTTVVKA  357 (449)
Q Consensus       346 ~~RPs~~eil~~  357 (449)
                      ++|||+.++++|
T Consensus       323 ~~Rpt~~e~l~h  334 (355)
T 2eu9_A          323 AQRITLAEALLH  334 (355)
T ss_dssp             TTSCCHHHHTTS
T ss_pred             hhCcCHHHHhcC
Confidence            999999999987

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=5e-43  Score=338.81  Aligned_cols=270  Identities=26%  Similarity=0.331  Sum_probs=203.8

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcC---CCCCcceeeeEE
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQL---KHPHLVNLIGYC  151 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~nIv~~~~~~  151 (449)
                      ..++|++.+.||+|+||.||+|.+...     .++.||+|++....  ......+.+|+.+++.+   +||||+++++++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~   83 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKN-----GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVC   83 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTT-----TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCC-----CCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeee
Confidence            457899999999999999999987421     47889999986432  11123455677666655   899999999998


Q ss_pred             E-----eCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEE
Q 013105          152 C-----EDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAK  226 (449)
Q Consensus       152 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~k  226 (449)
                      .     .....++||||+. |+|.+++.......+++..+..++.|++.||.|||  .+||+||||||+|||++.++.+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~gi~H~dlkp~Nili~~~~~~k  160 (326)
T 1blx_A           84 TVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIK  160 (326)
T ss_dssp             EEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEE
T ss_pred             eecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCHHHeEEcCCCCEE
Confidence            7     5577899999998 69999998765567999999999999999999999  67899999999999999999999


Q ss_pred             EeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhh--
Q 013105          227 LSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR--  304 (449)
Q Consensus       227 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~--  304 (449)
                      |+|||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+....  
T Consensus       161 l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  237 (326)
T 1blx_A          161 LADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL  237 (326)
T ss_dssp             ECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             EecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC
Confidence            99999998654221   2334568999999999988889999999999999999999999998654322211110000  


Q ss_pred             hhhccccch----hHhhc---ccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          305 PMLKDFTKL----DQIID---SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       305 ~~~~~~~~~----~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      +....+...    .....   ......+...++..+.+|+.+||+.||++|||+.++++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            000000000    00000   001112233456679999999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.6e-43  Score=345.46  Aligned_cols=266  Identities=20%  Similarity=0.254  Sum_probs=205.2

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc---c--------------hHHHHHHHHHHHhcC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS---Q--------------GHREWLAEVIFLGQL  139 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~--------------~~~~~~~E~~~l~~l  139 (449)
                      ..++|.+.+.||+|+||.||+|.+        +++.||||++.....   .              ....+.+|+.+++.+
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  100 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK--------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI  100 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE--------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc--------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC
Confidence            347899999999999999999976        378999999963311   1              127789999999999


Q ss_pred             CCCCcceeeeEEEeCCEEEEEEEecCCCChHHH------HhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCC
Q 013105          140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQ------LFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFK  213 (449)
Q Consensus       140 ~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDik  213 (449)
                      +||||+++++++.+.+..++||||+++|+|.++      +.......+++..+..++.|++.||.|||+ .+||+|||||
T Consensus       101 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dl~  179 (348)
T 2pml_X          101 KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN-EKNICHRDVK  179 (348)
T ss_dssp             CCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TSCEECCCCC
T ss_pred             CCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc-cCCEeecCCC
Confidence            999999999999999999999999999999998      655446789999999999999999999993 1789999999


Q ss_pred             CCceEEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccC-CCCc-ccchhhhHHHHHHHHhCCCccccc
Q 013105          214 ASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTG-HLTT-MCDVFSFGVVLLELLTGRRSVEKN  291 (449)
Q Consensus       214 p~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~vl~elltg~~pf~~~  291 (449)
                      |+|||++.++.+||+|||++......    ......||+.|+|||++.+. .++. ++|||||||++|||++|..||...
T Consensus       180 p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  255 (348)
T 2pml_X          180 PSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK  255 (348)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             hHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999865332    23446799999999999876 6666 999999999999999999999865


Q ss_pred             ccccchhhHHhhhhhhccccch-hHh---hcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          292 RCKREKDLVEWARPMLKDFTKL-DQI---IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~-~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ...  ................. ...   ............++..+.+|+.+||+.||.+|||+.++++|
T Consensus       256 ~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          256 ISL--VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             SCS--HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CcH--HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            331  11111111000000000 000   00000000113455679999999999999999999999986

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=6.8e-43  Score=332.00  Aligned_cols=255  Identities=25%  Similarity=0.337  Sum_probs=205.1

Q ss_pred             HHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEE
Q 013105           75 QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCC  152 (449)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~  152 (449)
                      ..+.++|++.+.||+|+||.||+|.+..      +++.||+|++...  .......+.+|+.++++++||||+++++++.
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   91 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRI------TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE   91 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcC------CCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe
Confidence            3456789999999999999999998765      4789999998643  2345678899999999999999999999999


Q ss_pred             eCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC---CcEEEee
Q 013105          153 EDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD---YNAKLSD  229 (449)
Q Consensus       153 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~---~~~kl~D  229 (449)
                      +.+..++||||+.+++|.+++...  ..+++..+..++.|++.||.|||  .+||+||||||+|||++.+   +.+||+|
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dl~p~NIlv~~~~~~~~~kL~D  167 (287)
T 2wei_A           92 DSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMH--KHNIVHRDLKPENILLESKEKDCDIKIID  167 (287)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESCSSTTCCEEECS
T ss_pred             CCCeEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCChhhEEEecCCCcccEEEec
Confidence            999999999999999999988765  46899999999999999999999  6789999999999999764   4799999


Q ss_pred             eccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcc
Q 013105          230 FGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKD  309 (449)
Q Consensus       230 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  309 (449)
                      ||++........   .....||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+   .   ..
T Consensus       168 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~---~~  237 (287)
T 2wei_A          168 FGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV---E---TG  237 (287)
T ss_dssp             TTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---H---HC
T ss_pred             cCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH---H---cC
Confidence            999986543221   223458999999999875 4899999999999999999999999765322111100   0   00


Q ss_pred             ccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          310 FTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .        ..........++..+.+++.+||+.||++|||+.+++++
T Consensus       238 ~--------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          238 K--------YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             C--------CCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             C--------CCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            0        000000112345679999999999999999999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.6e-43  Score=350.00  Aligned_cols=263  Identities=24%  Similarity=0.300  Sum_probs=194.2

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC--
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE--  155 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--  155 (449)
                      ..+|.+.+.||+|+||.||+|.+..       +..||+|.+......    ..+|+.+++.++||||+++++++...+  
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~-------~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~  107 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVE-------SDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDK  107 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETT-------TEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECC-------CCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence            4579999999999999999998765       344888887543221    236999999999999999999996543  


Q ss_pred             ----EEEEEEEecCCCChHHHHh--hcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEc-CCCcEEEe
Q 013105          156 ----HRLLVYEYMALGNLHDQLF--KNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD-SDYNAKLS  228 (449)
Q Consensus       156 ----~~~lv~e~~~~g~L~~~l~--~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~-~~~~~kl~  228 (449)
                          ..++||||+.++ +...+.  ......+++..+..++.|++.||.|||  ++||+||||||+|||++ .++.+||+
T Consensus       108 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~~kL~  184 (394)
T 4e7w_A          108 KDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH--SIGICHRDIKPQNLLLDPPSGVLKLI  184 (394)
T ss_dssp             SSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred             CCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--HCCccCCCCCHHHEEEcCCCCcEEEe
Confidence                388999999854 444432  223467999999999999999999999  67899999999999999 78999999


Q ss_pred             eeccccCCCCCCCCceeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhh---
Q 013105          229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR---  304 (449)
Q Consensus       229 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~---  304 (449)
                      |||+++.......   .....||+.|+|||++.+. .++.++|||||||++|||++|++||.+.........+....   
T Consensus       185 DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p  261 (394)
T 4e7w_A          185 DFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP  261 (394)
T ss_dssp             CCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             eCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999986543322   2345689999999998654 58999999999999999999999998754322211110000   


Q ss_pred             ------hhhccc--cchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          305 ------PMLKDF--TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       305 ------~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                            .....+  ..+...........+....++++.+|+.+||+.||.+|||+.++++|
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence                  000000  00000000011111233456679999999999999999999999987

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.6e-43  Score=340.91  Aligned_cols=255  Identities=23%  Similarity=0.300  Sum_probs=177.1

Q ss_pred             HhcCCCCc-ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEe--
Q 013105           77 ITHNFSRS-DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE--  153 (449)
Q Consensus        77 ~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--  153 (449)
                      +.++|.+. ++||+|+||.||+|.+..      +++.||||++...    ..........+..+.||||+++++++..  
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~   95 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRR------TGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMH   95 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECC------CCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhcc
Confidence            56789885 469999999999998765      5889999999642    1112222334566799999999999976  


Q ss_pred             --CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC---CCcEEEe
Q 013105          154 --DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS---DYNAKLS  228 (449)
Q Consensus       154 --~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~---~~~~kl~  228 (449)
                        ....++||||+.||+|.+++.......+++..++.++.|++.||.|||  .+||+||||||+|||++.   ++.+||+
T Consensus        96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH--~~~ivH~dlkp~NIll~~~~~~~~~kl~  173 (336)
T 3fhr_A           96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH--SHNIAHRDVKPENLLYTSKEKDAVLKLT  173 (336)
T ss_dssp             TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEEecCCCceEEEe
Confidence              456899999999999999998776668999999999999999999999  678999999999999976   4559999


Q ss_pred             eeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhc
Q 013105          229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK  308 (449)
Q Consensus       229 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  308 (449)
                      |||++.......    .....||+.|+|||++.+..++.++|||||||++|+|++|..||.............      .
T Consensus       174 Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~------~  243 (336)
T 3fhr_A          174 DFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK------R  243 (336)
T ss_dssp             CCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------
T ss_pred             ccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH------H
Confidence            999998554321    234568999999999988889999999999999999999999997543221100000      0


Q ss_pred             cccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .   . ..............++..+.+|+.+||+.||.+|||+.++++|
T Consensus       244 ~---~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          244 R---I-RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             -----------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             h---h-hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0   0 0000011111123456679999999999999999999999997

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.3e-42  Score=331.74  Aligned_cols=255  Identities=23%  Similarity=0.388  Sum_probs=196.0

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEe---
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE---  153 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~---  153 (449)
                      +.++|++.+.||+|+||.||+|.+..      +++.||||++... ......+.+|+.+++.++||||+++++++.+   
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   76 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNAL------DSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRN   76 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcC------CCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcc
Confidence            45679999999999999999998765      5789999999643 3345678899999999999999999998865   


Q ss_pred             ----------CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC
Q 013105          154 ----------DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY  223 (449)
Q Consensus       154 ----------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~  223 (449)
                                .+..++||||+.+|+|.+++... ...+++..++.++.|++.||.|||  ++||+||||||+|||++.++
T Consensus        77 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dlkp~Nil~~~~~  153 (303)
T 1zy4_A           77 FVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIH--SQGIIHRDLKPMNIFIDESR  153 (303)
T ss_dssp             CCC------CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTS
T ss_pred             hhhhhcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHH--hCCeecccCCHHhEEEcCCC
Confidence                      35789999999999999999753 346788899999999999999999  67899999999999999999


Q ss_pred             cEEEeeeccccCCCCCCC------------CceeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCCcccc
Q 013105          224 NAKLSDFGLATDGPQGED------------SHITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEK  290 (449)
Q Consensus       224 ~~kl~DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~~  290 (449)
                      .+||+|||++........            ........||+.|+|||++.+. .++.++|||||||++|+|++   ||..
T Consensus       154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~  230 (303)
T 1zy4_A          154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST  230 (303)
T ss_dssp             CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred             CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence            999999999986542210            1122345689999999999754 68999999999999999998   4442


Q ss_pred             cccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          291 NRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ....  ........   .        .....+..++...+..+.+++.+||+.||.+|||+.+++++
T Consensus       231 ~~~~--~~~~~~~~---~--------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          231 GMER--VNILKKLR---S--------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             HHHH--HHHHHHHH---S--------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             chhH--HHHHHhcc---c--------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            2110  01111000   0        01112333445566778999999999999999999999997

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.5e-44  Score=345.06  Aligned_cols=262  Identities=21%  Similarity=0.303  Sum_probs=200.5

Q ss_pred             HHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEE
Q 013105           75 QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCC  152 (449)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~  152 (449)
                      .+..++|++.+.||+|+||.||+|.+..         .+|+|++....  ......+.+|+.+++.++||||+++++++.
T Consensus        29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   99 (319)
T 2y4i_B           29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM   99 (319)
T ss_dssp             SSCCSCEECCCBCCCSSSSEEEEEEESS---------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE
T ss_pred             cCCHHHeEEeeEeccCCceEEEEEEEcC---------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence            4456789999999999999999997643         49999987432  223345778999999999999999999999


Q ss_pred             eCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecc
Q 013105          153 EDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL  232 (449)
Q Consensus       153 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGl  232 (449)
                      +.+..++||||+.+++|.+++... ...+++..++.++.|++.||.|||  ++||+||||||+|||++ ++.+||+|||+
T Consensus       100 ~~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH--~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~  175 (319)
T 2y4i_B          100 SPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLH--AKGILHKDLKSKNVFYD-NGKVVITDFGL  175 (319)
T ss_dssp             CSSCEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHH--HTTCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred             cCCceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCChhhEEEe-CCCEEEeecCC
Confidence            999999999999999999998653 356889999999999999999999  67899999999999998 67999999999


Q ss_pred             ccCCCCCC---CCceeeecCCCCcccccccccc---------CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhH
Q 013105          233 ATDGPQGE---DSHITTCVMGTEGYAAPEYINT---------GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV  300 (449)
Q Consensus       233 a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~  300 (449)
                      +.......   .........||+.|+|||++.+         ..++.++|||||||++|||++|..||............
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  255 (319)
T 2y4i_B          176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM  255 (319)
T ss_dssp             CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred             ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence            87543211   1112233458999999999864         35788999999999999999999999764322111000


Q ss_pred             HhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCC
Q 013105          301 EWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN  365 (449)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  365 (449)
                                      ............++..+.+++..||+.||++|||+.++++.|+.+....
T Consensus       256 ----------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          256 ----------------GTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             ----------------HTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             ----------------ccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence                            0000011111123456899999999999999999999999999887654

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.1e-42  Score=342.78  Aligned_cols=263  Identities=19%  Similarity=0.292  Sum_probs=199.2

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      +.++|.+.+.||+|+||.||+|.+..      +++.||||++....  ......+.+|+.+++.++||||+++++++...
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  113 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKR------SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPA  113 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECC------CCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheecc
Confidence            45789999999999999999998765      58899999997542  22346788999999999999999999999877


Q ss_pred             CEE------EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEe
Q 013105          155 EHR------LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLS  228 (449)
Q Consensus       155 ~~~------~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~  228 (449)
                      +..      ++||||+. ++|.+.+.    ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+
T Consensus       114 ~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIll~~~~~~kL~  186 (371)
T 4exu_A          114 SSLRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIH--SAGVVHRDLKPGNLAVNEDCELKIL  186 (371)
T ss_dssp             SSSTTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred             CCcccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCcCHHHeEECCCCCEEEE
Confidence            654      99999997 68877763    35899999999999999999999  6789999999999999999999999


Q ss_pred             eeccccCCCCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhh--
Q 013105          229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARP--  305 (449)
Q Consensus       229 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~--  305 (449)
                      |||++......     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...............  
T Consensus       187 Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~  261 (371)
T 4exu_A          187 DFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP  261 (371)
T ss_dssp             STTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99999854322     334568999999999876 6789999999999999999999999986543222111100000  


Q ss_pred             ---hhccc--cchhHhhcc---ccc---ccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          306 ---MLKDF--TKLDQIIDS---RLE---DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       306 ---~~~~~--~~~~~~~~~---~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                         .....  .........   ...   ......+++.+.+|+.+||+.||++|||+.++++|
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          262 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence               00000  000000000   000   01122345679999999999999999999999987

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=7.4e-43  Score=367.38  Aligned_cols=264  Identities=26%  Similarity=0.370  Sum_probs=209.6

Q ss_pred             HHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           75 QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      ....++|.+.+.||+|+||.||+|.+...   ...+..||+|++..... .....+.+|+.+++.++||||+++++++. 
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-  461 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSP---ENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-  461 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCS---SSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecC---CCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence            34457799999999999999999988642   12456899999875433 33467899999999999999999999984 


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      ++..++||||+.+|+|.+++... ...+++..++.++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++
T Consensus       462 ~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDikp~NILl~~~~~vkL~DFG~a  538 (656)
T 2j0j_A          462 ENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLS  538 (656)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred             cCceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH--hCCccccccchHhEEEeCCCCEEEEecCCC
Confidence            56689999999999999998754 346899999999999999999999  678999999999999999999999999999


Q ss_pred             cCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccc
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTK  312 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  312 (449)
                      ......... ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+......   ....         
T Consensus       539 ~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---~~~i---------  605 (656)
T 2j0j_A          539 RYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRI---------  605 (656)
T ss_dssp             CSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHH---------
T ss_pred             eecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHH---------
Confidence            876443221 1223457889999999988899999999999999999997 9999976432211   1100         


Q ss_pred             hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                           ........+..++..+.+|+.+||+.||++|||+.++++.|+.++.
T Consensus       606 -----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          606 -----ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             -----HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----HcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence                 0111122344556779999999999999999999999999998764

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.3e-42  Score=336.37  Aligned_cols=256  Identities=25%  Similarity=0.338  Sum_probs=181.3

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHH-HHhcCCCCCcceeeeEEEeCC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVI-FLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      .++|++.+.||+|+||.||+|.+..      +++.||||++..... .....+..|+. +++.++||||+++++++.+.+
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~   94 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKP------SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG   94 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETT------TTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS
T ss_pred             HHHhhehheeccCCCEEEEEEEEcC------CCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC
Confidence            4689999999999999999998765      578999999975432 33345666666 777889999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CeeeccCCCCceEEcCCCcEEEeeec
Q 013105          156 HRLLVYEYMALGNLHDQLFK---NYSSTLPWLTRIKIAIGAARCLAFLHGEEK-PVIYRDFKASNILLDSDYNAKLSDFG  231 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~---~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~ivHrDikp~Nill~~~~~~kl~DfG  231 (449)
                      ..++||||+. |+|.+++..   .....+++..+..++.|++.||.|||  .. ||+||||||+|||++.++.+||+|||
T Consensus        95 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~~ivH~dlkp~NIll~~~~~~kl~Dfg  171 (327)
T 3aln_A           95 DCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFG  171 (327)
T ss_dssp             EEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH--HHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred             ceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh--ccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence            9999999998 478777653   23467899999999999999999999  56 89999999999999999999999999


Q ss_pred             cccCCCCCCCCceeeecCCCCcccccccc----ccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhh
Q 013105          232 LATDGPQGEDSHITTCVMGTEGYAAPEYI----NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML  307 (449)
Q Consensus       232 la~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~  307 (449)
                      ++........   .....||+.|+|||++    .+..++.++|||||||++|+|++|..||........     ......
T Consensus       172 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~  243 (327)
T 3aln_A          172 ISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLTQVV  243 (327)
T ss_dssp             SSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCC
T ss_pred             Cceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHHHHh
Confidence            9986543221   2234699999999998    456789999999999999999999999975421100     000000


Q ss_pred             ccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ..       ............++..+.+|+.+||+.||++|||+.+++++
T Consensus       244 ~~-------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          244 KG-------DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             CS-------CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             cC-------CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            00       00011111122345679999999999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5e-43  Score=336.89  Aligned_cols=247  Identities=25%  Similarity=0.383  Sum_probs=193.0

Q ss_pred             HHHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc------hHHHHHHHHHHHhcC----CCC
Q 013105           73 ELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ------GHREWLAEVIFLGQL----KHP  142 (449)
Q Consensus        73 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~  142 (449)
                      +.+.+.++|++.+.||+|+||.||+|.+..      +++.||||++......      ....+.+|+.++.++    +||
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~   98 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLT------DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP   98 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTT------TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCS
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEcc------CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCC
Confidence            345667899999999999999999997654      5789999999754321      123355788888888    899


Q ss_pred             CcceeeeEEEeCCEEEEEEEe-cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEc-
Q 013105          143 HLVNLIGYCCEDEHRLLVYEY-MALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD-  220 (449)
Q Consensus       143 nIv~~~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~-  220 (449)
                      ||+++++++...+..++|||+ +.+++|.+++...  ..+++..++.++.|++.||.|||  ++||+||||||+|||++ 
T Consensus        99 ~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~  174 (312)
T 2iwi_A           99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCH--SRGVVHRDIKDENILIDL  174 (312)
T ss_dssp             SBCCEEEEC-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH--HHTEECCCCSGGGEEEET
T ss_pred             CeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCChhhEEEeC
Confidence            999999999999999999999 7899999999765  46899999999999999999999  67899999999999999 


Q ss_pred             CCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCC-CcccchhhhHHHHHHHHhCCCcccccccccchhh
Q 013105          221 SDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL-TTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDL  299 (449)
Q Consensus       221 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~  299 (449)
                      .++.+||+|||++.......    .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......     
T Consensus       175 ~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----  245 (312)
T 2iwi_A          175 RRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI-----  245 (312)
T ss_dssp             TTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-----
T ss_pred             CCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH-----
Confidence            88999999999998654322    234569999999999976665 45899999999999999999999753210     


Q ss_pred             HHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          300 VEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .                 ..  ...++..++..+.+++.+||+.||++|||+.+++++
T Consensus       246 ~-----------------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          246 L-----------------EA--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             H-----------------HT--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             h-----------------hh--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0                 00  011223445678999999999999999999999987

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.1e-43  Score=339.86  Aligned_cols=248  Identities=23%  Similarity=0.339  Sum_probs=201.5

Q ss_pred             HHHHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc------hHHHHHHHHHHHhcCC--CCC
Q 013105           72 KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ------GHREWLAEVIFLGQLK--HPH  143 (449)
Q Consensus        72 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~n  143 (449)
                      .+...+.++|++.+.||+|+||.||+|.+..      +++.||||++......      ....+.+|+.+++.++  |+|
T Consensus        36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~  109 (320)
T 3a99_A           36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVS------DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG  109 (320)
T ss_dssp             ----CCTTTEEEEEECSSSSSCEEEEEEETT------TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCS
T ss_pred             cccCCccCceEEEEEEeeCCCeEEEEEEECC------CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCC
Confidence            4445667889999999999999999998765      5789999999643211      1234667999999996  599


Q ss_pred             cceeeeEEEeCCEEEEEEEecCC-CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEc-C
Q 013105          144 LVNLIGYCCEDEHRLLVYEYMAL-GNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD-S  221 (449)
Q Consensus       144 Iv~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~-~  221 (449)
                      |+++++++...+..++|||++.+ ++|.+++...  ..+++..+..++.|++.||.|||  +.||+||||||+|||++ .
T Consensus       110 i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~  185 (320)
T 3a99_A          110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLN  185 (320)
T ss_dssp             BCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETT
T ss_pred             ceEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcEeCCCCHHHEEEeCC
Confidence            99999999999999999999986 8999998765  57899999999999999999999  67899999999999999 7


Q ss_pred             CCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCC-CcccchhhhHHHHHHHHhCCCcccccccccchhhH
Q 013105          222 DYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL-TTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV  300 (449)
Q Consensus       222 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~  300 (449)
                      ++.+||+|||++.......    .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||......     .
T Consensus       186 ~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~  256 (320)
T 3a99_A          186 RGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----I  256 (320)
T ss_dssp             TTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-----H
T ss_pred             CCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh-----h
Confidence            7899999999998654322    233569999999999976665 78899999999999999999999753210     0


Q ss_pred             HhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          301 EWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                             ..            ...++..+++.+.+|+.+||+.||++|||+.+++++
T Consensus       257 -------~~------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          257 -------RG------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             -------HC------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -------cc------------cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                   00            001122344568999999999999999999999986

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.8e-42  Score=337.68  Aligned_cols=262  Identities=19%  Similarity=0.280  Sum_probs=198.6

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      .++|.+.+.||+|+||.||+|.+..      +++.||||++....  ......+.+|+.+++.++||||+++++++...+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   96 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKR------SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS   96 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             CceEEEeeeEecCCCeEEEEEEECC------CCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccc
Confidence            4679999999999999999998765      58899999997542  223467889999999999999999999998765


Q ss_pred             E------EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEee
Q 013105          156 H------RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSD  229 (449)
Q Consensus       156 ~------~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~D  229 (449)
                      .      .|+||||+. ++|.+++.    ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|
T Consensus        97 ~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH--~~~ivH~dlkp~NIl~~~~~~~kl~D  169 (353)
T 3coi_A           97 SLRNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIH--SAGVVHRDLKPGNLAVNEDCELKILD  169 (353)
T ss_dssp             SGGGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCCGGGEEECTTCCEEECS
T ss_pred             ccccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEeECCCCcEEEee
Confidence            4      499999997 68877663    35899999999999999999999  67899999999999999999999999


Q ss_pred             eccccCCCCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhh---
Q 013105          230 FGLATDGPQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARP---  305 (449)
Q Consensus       230 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~---  305 (449)
                      ||++......     .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.....   
T Consensus       170 fg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  244 (353)
T 3coi_A          170 FGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG  244 (353)
T ss_dssp             TTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCC
T ss_pred             cccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9999864322     233568999999999876 6789999999999999999999999987543221111100000   


Q ss_pred             --hhcccc--chhHhhc---ccc---cccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          306 --MLKDFT--KLDQIID---SRL---EDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       306 --~~~~~~--~~~~~~~---~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                        ......  .....+.   ...   ........+..+.+|+.+||+.||++|||+.++++|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence              000000  0000000   000   011223456779999999999999999999999987

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=9.8e-42  Score=328.42  Aligned_cols=253  Identities=23%  Similarity=0.349  Sum_probs=180.7

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc-hH-HHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ-GH-REWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~-~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      .++|++.+.||+|+||.||+|.+..      +++.||||++...... .. ..+..+..+++.++||||+++++++.+.+
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~   97 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRK------TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT   97 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETT------TCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             hccccccceeeecCCeeEEEEEEec------CCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence            4678999999999999999998765      4789999999754322 22 23444556788889999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK-PVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      ..++||||+ ++.+..+. ......+++..+..++.|++.||.|||  .+ ||+||||||+|||++.++.+||+|||++.
T Consensus        98 ~~~lv~e~~-~~~~~~l~-~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  173 (318)
T 2dyl_A           98 DVFIAMELM-GTCAEKLK-KRMQGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGISG  173 (318)
T ss_dssp             EEEEEECCC-SEEHHHHH-HHHTSCCCHHHHHHHHHHHHHHHHHHH--HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred             cEEEEEecc-CCcHHHHH-HHhccCCCHHHHHHHHHHHHHHHHHHH--hhCCEEeCCCCHHHEEECCCCCEEEEECCCch
Confidence            999999999 45554444 333467999999999999999999999  54 79999999999999999999999999997


Q ss_pred             CCCCCCCCceeeecCCCCccccccccc-----cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcc
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYIN-----TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKD  309 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  309 (449)
                      ......   ......||+.|+|||++.     +..++.++|||||||++|+|++|..||.......  ....   .....
T Consensus       174 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~---~~~~~  245 (318)
T 2dyl_A          174 RLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF--EVLT---KVLQE  245 (318)
T ss_dssp             ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHHH---HHHHS
T ss_pred             hccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH--HHHH---HHhcc
Confidence            654322   123346899999999984     4568899999999999999999999997532111  1110   00000


Q ss_pred             ccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          310 FTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                               ..........++..+.+++.+||+.||.+|||+.+++++
T Consensus       246 ---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          246 ---------EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             ---------CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ---------CCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                     000000112345669999999999999999999999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.5e-41  Score=341.55  Aligned_cols=253  Identities=25%  Similarity=0.332  Sum_probs=186.5

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcC-CCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~  157 (449)
                      +.|.+.+.||+|+||+||.+...       +++.||||++...   ....+.+|+.+|..+ +||||+++++++.+.+..
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~-------~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~   84 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSF-------QGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFL   84 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEES-------SSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred             heeeccCeEeeCCCeEEEEEEEE-------CCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeE
Confidence            45666789999999999865332       4789999998643   245678899999876 899999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCC-----CHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC----------
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTL-----PWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD----------  222 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l-----~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~----------  222 (449)
                      ||||||+. |+|.+++........     .+..++.++.|++.||.|||  ++||+||||||+|||++.+          
T Consensus        85 ~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDLkp~NILl~~~~~~~~~~~~~  161 (434)
T 2rio_A           85 YIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH--SLKIIHRDLKPQNILVSTSSRFTADQQTG  161 (434)
T ss_dssp             EEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred             EEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH--HCCccccCCChHhEEEecCcccccccccC
Confidence            99999996 699999976422111     22345679999999999999  6789999999999999754          


Q ss_pred             ---CcEEEeeeccccCCCCCCCC--ceeeecCCCCcccccccccc-------CCCCcccchhhhHHHHHHHHh-CCCccc
Q 013105          223 ---YNAKLSDFGLATDGPQGEDS--HITTCVMGTEGYAAPEYINT-------GHLTTMCDVFSFGVVLLELLT-GRRSVE  289 (449)
Q Consensus       223 ---~~~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~vl~ellt-g~~pf~  289 (449)
                         +.+||+|||++.........  .......||+.|+|||++.+       ..++.++|||||||++|||++ |..||.
T Consensus       162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~  241 (434)
T 2rio_A          162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG  241 (434)
T ss_dssp             CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence               48999999999866543221  11234579999999999965       568999999999999999999 999996


Q ss_pred             ccccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          290 KNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ...... ....   .    .....     ..........++.++.+|+.+||+.||.+|||+.++++|
T Consensus       242 ~~~~~~-~~i~---~----~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          242 DKYSRE-SNII---R----GIFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             STTTHH-HHHH---H----TCCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CchhhH-HHHh---c----CCCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence            532111 1100   0    00000     001111245678889999999999999999999999976

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.9e-41  Score=337.19  Aligned_cols=250  Identities=24%  Similarity=0.305  Sum_probs=185.1

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcC-CCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~  157 (449)
                      .+|.+.+.||+|+||+||.....       +++.||||++......   .+.+|+.+|+.+ +||||+++++++.+....
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~-------~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~   93 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMF-------DNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQ   93 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEES-------SSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred             EEEecCCeeecCcCEEEEEEEEe-------CCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence            45888999999999996643222       4789999999644322   345799999999 799999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC-----CCcEEEeeecc
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS-----DYNAKLSDFGL  232 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~-----~~~~kl~DfGl  232 (449)
                      ||||||+. |+|.+++.... ........+.++.|++.||.|||  ++||+||||||+|||++.     ...+||+|||+
T Consensus        94 ~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~  169 (432)
T 3p23_A           94 YIAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLH--SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL  169 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHH--HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred             EEEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHH--HCcCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence            99999996 69999987653 33444556789999999999999  677999999999999953     23588999999


Q ss_pred             ccCCCCCCCC-ceeeecCCCCccccccccc---cCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhh
Q 013105          233 ATDGPQGEDS-HITTCVMGTEGYAAPEYIN---TGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPML  307 (449)
Q Consensus       233 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  307 (449)
                      +......... .......||+.|+|||++.   +..++.++|||||||++|||++ |..||.........    .   ..
T Consensus       170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~----~---~~  242 (432)
T 3p23_A          170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN----I---LL  242 (432)
T ss_dssp             EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH----H---HT
T ss_pred             eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH----H---Hh
Confidence            9866433211 2233467999999999997   4567889999999999999999 99998643211100    0   00


Q ss_pred             ccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .. .       ...........+..+.+|+.+||+.||.+|||+.++++|
T Consensus       243 ~~-~-------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          243 GA-C-------SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             TC-C-------CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cc-C-------CccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence            00 0       000011123456678999999999999999999999986

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.5e-40  Score=315.85  Aligned_cols=236  Identities=14%  Similarity=0.119  Sum_probs=186.8

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc---chHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS---QGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      +.++|++.+.||+|+||.||+|.+..      +++.||||++.....   .....+.+|+.++..++||||+++++++.+
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~  102 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTA------LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT  102 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETT------TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecC------CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE
Confidence            45789999999999999999998765      578999999975432   234678899999999999999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      .+..|+||||++|++|.+++...    ........++.|++.||.|||  ++||+||||||+|||++.++.+||+++|  
T Consensus       103 ~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH--~~givH~Dikp~NIll~~~g~~kl~~~~--  174 (286)
T 3uqc_A          103 RAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAH--RAGVALSIDHPSRVRVSIDGDVVLAYPA--  174 (286)
T ss_dssp             TTEEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEEETTSCEEECSCC--
T ss_pred             CCcEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHH--HCCCccCCCCcccEEEcCCCCEEEEecc--
Confidence            99999999999999999998432    355578889999999999999  6789999999999999999999998443  


Q ss_pred             cCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccch
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                                          |++       .++.++|||||||++|||++|+.||.+..........   ......    
T Consensus       175 --------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---~~~~~~----  220 (286)
T 3uqc_A          175 --------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---ERDTAG----  220 (286)
T ss_dssp             --------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---CBCTTS----
T ss_pred             --------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---HHHhcc----
Confidence                                333       3789999999999999999999999865432111000   000000    


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCC
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN  365 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  365 (449)
                          ...........+++.+.+|+.+||+.||++| |+.++++.|+.+....
T Consensus       221 ----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          221 ----QPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             ----CBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             ----CCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence                0000111223456679999999999999999 9999999999876543

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.8e-41  Score=348.77  Aligned_cols=271  Identities=27%  Similarity=0.366  Sum_probs=203.5

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC-CcchHHHHHHHHHHHhcCCCCCcceeeeEEEe---
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE---  153 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~---  153 (449)
                      .++|++.+.||+|+||.||+|.+..      +++.||||++... .......+.+|+.+++.++||||+++++++..   
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~------tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~   86 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQD------TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK   86 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTT------TTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECC------CCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence            4789999999999999999996544      5889999998754 23345678899999999999999999998755   


Q ss_pred             ---CCEEEEEEEecCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCc---EE
Q 013105          154 ---DEHRLLVYEYMALGNLHDQLFKNY-SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYN---AK  226 (449)
Q Consensus       154 ---~~~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~---~k  226 (449)
                         ++..++||||+.||+|.+++.... ...+++..+..++.+++.||.|||  ..||+||||||+|||++.++.   +|
T Consensus        87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH--s~gIVHrDLKP~NILl~~~g~~~~vK  164 (676)
T 3qa8_A           87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHK  164 (676)
T ss_dssp             CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH--HTTBCCCCCCSTTEEEECCSSSCEEE
T ss_pred             ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCCHHHeEeecCCCceeEE
Confidence               677899999999999999997642 236888999999999999999999  678999999999999987764   99


Q ss_pred             EeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhh
Q 013105          227 LSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPM  306 (449)
Q Consensus       227 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~  306 (449)
                      |+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||......     ..|....
T Consensus       165 L~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i  236 (676)
T 3qa8_A          165 IIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKV  236 (676)
T ss_dssp             ECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTC
T ss_pred             Ecccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhh
Confidence            999999987644322   23457999999999999899999999999999999999999999753211     1110000


Q ss_pred             hc-------cccchhHhh----cccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHH-----HHHhhccccC
Q 013105          307 LK-------DFTKLDQII----DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTV-----VKALEPLLDL  364 (449)
Q Consensus       307 ~~-------~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei-----l~~L~~~~~~  364 (449)
                      ..       ........+    ....+......+++.+.+++..||+.||++|||+.++     .+.+..++..
T Consensus       237 ~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~  310 (676)
T 3qa8_A          237 REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL  310 (676)
T ss_dssp             C------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred             hcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence            00       000000000    0011233456678899999999999999999999884     4445555443

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.7e-40  Score=315.14  Aligned_cols=234  Identities=22%  Similarity=0.298  Sum_probs=182.3

Q ss_pred             HhcCCCCc-ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHH-hcCCCCCcceeeeEEEe-
Q 013105           77 ITHNFSRS-DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFL-GQLKHPHLVNLIGYCCE-  153 (449)
Q Consensus        77 ~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~~~~~~~~-  153 (449)
                      +.++|.+. +.||+|+||.||+|.+..      +++.||+|++..     ...+.+|+.++ +.++||||+++++++.. 
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~   83 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKR------TQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL   83 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcC------CCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence            34567776 789999999999998765      578999999963     24566788887 66689999999999987 


Q ss_pred             ---CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC---CCcEEE
Q 013105          154 ---DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS---DYNAKL  227 (449)
Q Consensus       154 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~---~~~~kl  227 (449)
                         ....++||||+.+|+|.+++.......+++..+..++.|++.||.|||  ..||+||||||+|||++.   ++.+||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~~~kl  161 (299)
T 3m2w_A           84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAILKL  161 (299)
T ss_dssp             ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESSSSTTCCEEE
T ss_pred             cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEecCCCCCcEEE
Confidence               678899999999999999998876668999999999999999999999  677999999999999998   789999


Q ss_pred             eeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhh
Q 013105          228 SDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML  307 (449)
Q Consensus       228 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~  307 (449)
                      +|||++....                        +..++.++|||||||++|||++|..||..........      ...
T Consensus       162 ~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~------~~~  211 (299)
T 3m2w_A          162 TDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP------GMK  211 (299)
T ss_dssp             CCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C------CSC
T ss_pred             eccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH------HHH
Confidence            9999986321                        2457889999999999999999999997543211000      000


Q ss_pred             ccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ....    .............+++.+.+++.+||+.||.+|||+.++++|
T Consensus       212 ~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          212 TRIR----MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             CSSC----TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHh----hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            0000    000000000012345679999999999999999999999987

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.8e-40  Score=351.93  Aligned_cols=244  Identities=23%  Similarity=0.373  Sum_probs=194.4

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      .+.++|++.+.||+|+||.||+|.+...     +++.||||++.... ......+.+|+.++..++||||+++++++...
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  151 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNV-----NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHT  151 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGG-----TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCC-----CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence            3458899999999999999999987641     46889999986443 23445788999999999999999999999876


Q ss_pred             CE-----EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEee
Q 013105          155 EH-----RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSD  229 (449)
Q Consensus       155 ~~-----~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~D  229 (449)
                      +.     .||||||+.|++|.+++..    .+++..++.++.|++.||.|||  ++||+||||||+|||++.+ .+||+|
T Consensus       152 ~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH--~~giiHrDlkp~NIll~~~-~~kl~D  224 (681)
T 2pzi_A          152 DRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLH--SIGLVYNDLKPENIMLTEE-QLKLID  224 (681)
T ss_dssp             CTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECSS-CEEECC
T ss_pred             CCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH--HCCCeecccChHHeEEeCC-cEEEEe
Confidence            55     7999999999999887643    6899999999999999999999  6779999999999999886 999999


Q ss_pred             eccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcc
Q 013105          230 FGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKD  309 (449)
Q Consensus       230 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  309 (449)
                      ||++......      ....||+.|+|||++.+. ++.++|||||||+||+|++|.+||.+......             
T Consensus       225 FG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-------------  284 (681)
T 2pzi_A          225 LGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL-------------  284 (681)
T ss_dssp             CTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC-------------
T ss_pred             cccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc-------------
Confidence            9999865432      335699999999998764 48899999999999999999999875311100             


Q ss_pred             ccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHHhhccc
Q 013105          310 FTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT-MTTVVKALEPLL  362 (449)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~~L~~~~  362 (449)
                       .          ........++.+.+||.+||+.||.+||+ ++++.+.|..++
T Consensus       285 -~----------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          285 -P----------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             -C----------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -c----------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence             0          00001123456899999999999999995 555666665543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.2e-40  Score=329.79  Aligned_cols=242  Identities=17%  Similarity=0.196  Sum_probs=181.2

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc---chHHHHHHHHHHHhcCCC-CCcc---------
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS---QGHREWLAEVIFLGQLKH-PHLV---------  145 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~nIv---------  145 (449)
                      .+|...+.||+|+||.||+|.+..      +++.||||++.....   ...+.+.+|+.++..+.| .|+.         
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~  151 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQE------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI  151 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred             eeEEEecccccCCCEEEEEEEecC------CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccc
Confidence            347778899999999999998765      578999999974332   225678899999999977 2211         


Q ss_pred             e------------eeeEEEe-----CCEEEEEEEecCCCChHHHHh-----hcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 013105          146 N------------LIGYCCE-----DEHRLLVYEYMALGNLHDQLF-----KNYSSTLPWLTRIKIAIGAARCLAFLHGE  203 (449)
Q Consensus       146 ~------------~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~-----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~  203 (449)
                      .            +..++..     ...++++|+++ +++|.+++.     ......+++..++.++.|++.||.|||  
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--  228 (413)
T 3dzo_A          152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH--  228 (413)
T ss_dssp             CCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH--
T ss_pred             cchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH--
Confidence            1            1111111     23467788876 589998884     222345778889999999999999999  


Q ss_pred             CCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCcccccccc----------ccCCCCcccchhh
Q 013105          204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI----------NTGHLTTMCDVFS  273 (449)
Q Consensus       204 ~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dvws  273 (449)
                      ++||+||||||+|||++.++.+||+|||+++.....     ....+| +.|+|||++          .+..++.++||||
T Consensus       229 ~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS  302 (413)
T 3dzo_A          229 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT  302 (413)
T ss_dssp             HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred             hCCcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence            678999999999999999999999999998854321     344568 999999999          5556888999999


Q ss_pred             hHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 013105          274 FGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTT  353 (449)
Q Consensus       274 lG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  353 (449)
                      |||++|||++|+.||..........                .++..  .    ..+++.+.+|+.+||+.||++||++.+
T Consensus       303 lGvil~elltg~~Pf~~~~~~~~~~----------------~~~~~--~----~~~~~~~~~li~~~l~~dP~~Rpt~~~  360 (413)
T 3dzo_A          303 LGLAIYWIWCADLPNTDDAALGGSE----------------WIFRS--C----KNIPQPVRALLEGFLRYPKEDRLLPLQ  360 (413)
T ss_dssp             HHHHHHHHHHSSCCCCTTGGGSCSG----------------GGGSS--C----CCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHHCCCCCCCcchhhhHH----------------HHHhh--c----ccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            9999999999999997643221110                01110  0    123466999999999999999999888


Q ss_pred             HHHH
Q 013105          354 VVKA  357 (449)
Q Consensus       354 il~~  357 (449)
                      ++++
T Consensus       361 ~l~~  364 (413)
T 3dzo_A          361 AMET  364 (413)
T ss_dssp             HTTS
T ss_pred             HHhC
Confidence            8654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1e-39  Score=317.31  Aligned_cols=244  Identities=18%  Similarity=0.245  Sum_probs=186.2

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--------cchHHHHHHHHHHHhcCC---------
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--------SQGHREWLAEVIFLGQLK---------  140 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------  140 (449)
                      .++|++.+.||+|+||.||+|.+        +++.||||++....        ......+.+|+.+++.++         
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~   90 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNR   90 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSB
T ss_pred             cccchheeeecccCceEEEEEEe--------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhcccccc
Confidence            46789999999999999999976        35899999997542        223467888999988885         


Q ss_pred             CCCcceeeeEEE------------------------------eCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHH
Q 013105          141 HPHLVNLIGYCC------------------------------EDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA  190 (449)
Q Consensus       141 h~nIv~~~~~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~  190 (449)
                      ||||+++.+++.                              ..+..||||||+.+|++.+.+.+   ..+++..+..++
T Consensus        91 h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~  167 (336)
T 2vuw_A           91 TEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSIL  167 (336)
T ss_dssp             CCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHH
T ss_pred             CCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHH
Confidence            777777776643                              26889999999999987777644   468999999999


Q ss_pred             HHHHHHHHHhh-cCCCCeeeccCCCCceEEcCCC--------------------cEEEeeeccccCCCCCCCCceeeecC
Q 013105          191 IGAARCLAFLH-GEEKPVIYRDFKASNILLDSDY--------------------NAKLSDFGLATDGPQGEDSHITTCVM  249 (449)
Q Consensus       191 ~~i~~~l~~lH-~~~~~ivHrDikp~Nill~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~  249 (449)
                      .|++.||.||| +  +||+||||||+|||++.++                    .+||+|||+|+.....       ...
T Consensus       168 ~qi~~aL~~lH~~--~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~  238 (336)
T 2vuw_A          168 HQLTASLAVAEAS--LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVV  238 (336)
T ss_dssp             HHHHHHHHHHHHH--HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEE
T ss_pred             HHHHHHHHHHHHh--CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEE
Confidence            99999999999 5  4599999999999999887                    8999999999854321       236


Q ss_pred             CCCccccccccccCCCCcccchhhhHHH-HHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcccccccCCHH
Q 013105          250 GTEGYAAPEYINTGHLTTMCDVFSFGVV-LLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTE  328 (449)
Q Consensus       250 gt~~y~aPE~~~~~~~~~~~DvwslG~v-l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (449)
                      ||+.|+|||++.+.. +.++||||||++ .+++++|..||.......  .....   .....     .............
T Consensus       239 gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~--~~~~~---~~~~~-----~~~~~~~~~~~~~  307 (336)
T 2vuw_A          239 FCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLH--YLTDK---MLKQM-----TFKTKCNTPAMKQ  307 (336)
T ss_dssp             CCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHH--HHHHH---HHHTC-----CCSSCCCSHHHHH
T ss_pred             EeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhh--HHHHh---hhhhh-----ccCcccchhhhhh
Confidence            999999999998666 889999998777 778999999986421100  00000   00000     0001111222356


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCHHHHH-HH
Q 013105          329 GAKRLAAVAHQCLSHNPKSRPTMTTVV-KA  357 (449)
Q Consensus       329 ~~~~l~~li~~cl~~dP~~RPs~~eil-~~  357 (449)
                      +++++.+||.+||+.|     |+.+++ +|
T Consensus       308 ~s~~~~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          308 IKRKIQEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred             cCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence            7889999999999977     999999 76

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.98  E-value=4.9e-34  Score=295.07  Aligned_cols=186  Identities=19%  Similarity=0.072  Sum_probs=130.7

Q ss_pred             ccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC----------cchHHHHHHHHHHHhcC-CCCCcceeeeEEEeCC
Q 013105           87 LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG----------SQGHREWLAEVIFLGQL-KHPHLVNLIGYCCEDE  155 (449)
Q Consensus        87 lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~  155 (449)
                      ++.|++|.+..+      +....++.|++|++....          ....+++.+|+++|+++ .|+||+++++++++++
T Consensus       242 ~~~~~~~~h~~~------rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~  315 (569)
T 4azs_A          242 PYAGAGLAHKRS------RRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ  315 (569)
T ss_dssp             -C--------CC------EEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS
T ss_pred             cccCCccccccc------ccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC
Confidence            455555554443      223357889999996432          12235689999999999 6999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..||||||++|++|.++|.+.  +.++..   .|+.||+.||+|||  ++|||||||||+||||+.+|.+||+|||+|+.
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH--~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~  388 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALE--KQGFWHDDVRPWNVMVDARQHARLIDFGSIVT  388 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHH--HTTCEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred             EEEEEEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHH--HCCceeccCchHhEEECCCCCEEEeecccCee
Confidence            999999999999999999765  456654   47899999999999  78899999999999999999999999999986


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcc
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSV  288 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf  288 (449)
                      .....  ......+||+.|||||++.+ .+..++|+||+|+++++|.++..++
T Consensus       389 ~~~~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          389 TPQDC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             CC-----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             CCCCC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence            64432  22345679999999999975 4678899999999999987776554

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=4.4e-29  Score=256.61  Aligned_cols=185  Identities=17%  Similarity=0.211  Sum_probs=143.2

Q ss_pred             CCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc--c------hHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           82 SRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--Q------GHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        82 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      ...+.||+|+||.||+|..        .+..+++|.......  .      ..+.+.+|+++|++++||||+.+..++..
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~--------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  410 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY--------LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD  410 (540)
T ss_dssp             ---------CCEEEEEEEC--------SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE--------CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe
Confidence            3457899999999999943        357899998753221  1      13457899999999999999966666667


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      .+..||||||++|++|.+++..          ...++.|++.||.|||  +++|+||||||+|||++.  .+||+|||++
T Consensus       411 ~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH--~~gIiHrDiKp~NILl~~--~~kL~DFGla  476 (540)
T 3en9_A          411 LDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLH--KNDVIHNDLTTSNFIFDK--DLYIIDFGLG  476 (540)
T ss_dssp             TTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHH--HTTEECTTCCTTSEEESS--SEEECCCTTC
T ss_pred             CCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHH--HCcCccCCCCHHHEEECC--eEEEEECccC
Confidence            7788999999999999999854          4688999999999999  678999999999999998  9999999999


Q ss_pred             cCCCCCCCCc-----eeeecCCCCcccccccccc--CCCCcccchhhhHHHHHHHHhCCCcc
Q 013105          234 TDGPQGEDSH-----ITTCVMGTEGYAAPEYINT--GHLTTMCDVFSFGVVLLELLTGRRSV  288 (449)
Q Consensus       234 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~vl~elltg~~pf  288 (449)
                      +.........     ......||+.|||||++..  ..|+..+|+|+..+-..+.+.++.+|
T Consensus       477 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          477 KISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             EECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             EECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            8764422111     1234679999999999976  56888999999999888888777665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=2.5e-25  Score=210.17  Aligned_cols=158  Identities=16%  Similarity=0.095  Sum_probs=122.8

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc------------------chHHHHHHHHHHHhcC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS------------------QGHREWLAEVIFLGQL  139 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l  139 (449)
                      ...|.+.+.||+|+||.||+|.+ .      +++.||+|+++....                  .....+.+|+.+++.+
T Consensus        89 ~~~~~~~~~iG~G~~g~Vy~~~~-~------~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l  161 (282)
T 1zar_A           89 GKVDAIGKLMGEGKESAVFNCYS-E------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL  161 (282)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEEE-T------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             CeEEEecCEeccCCCceEEEEEe-C------CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence            34577779999999999999987 3      478999999964321                  1245688999999999


Q ss_pred             CCCCcceeeeEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEE
Q 013105          140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILL  219 (449)
Q Consensus       140 ~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill  219 (449)
                      +  | +++.+++.. +..|+||||++||+|.+ +..        .....++.|++.||.|||  +.||+||||||+|||+
T Consensus       162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH--~~giiHrDlkp~NILl  226 (282)
T 1zar_A          162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFY--HRGIVHGDLSQYNVLV  226 (282)
T ss_dssp             T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHH--HTTEECSCCSTTSEEE
T ss_pred             c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHH--HCCCEeCCCCHHHEEE
Confidence            8  4 666665544 45699999999999987 421        124468999999999999  6789999999999999


Q ss_pred             cCCCcEEEeeeccccCCCCCCCCceeeecCCCCcccccccccc----------CCCCcccchhh
Q 013105          220 DSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT----------GHLTTMCDVFS  273 (449)
Q Consensus       220 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Dvws  273 (449)
                      + ++.+||+|||+++               ++..|+|||.+..          ..|+..+|+|.
T Consensus       227 ~-~~~vkl~DFG~a~---------------~~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          227 S-EEGIWIIDFPQSV---------------EVGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             E-TTEEEECCCTTCE---------------ETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             E-CCcEEEEECCCCe---------------ECCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            9 9999999999986               2456789998753          33555566654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.82  E-value=1.3e-20  Score=175.56  Aligned_cols=137  Identities=17%  Similarity=0.094  Sum_probs=103.6

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcE--EEEEEeccCCcc------------------------hHHHHHHHHH
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQT--VAVKVLDVNGSQ------------------------GHREWLAEVI  134 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~  134 (449)
                      |.+.+.||+|+||.||+|.+..      +++.  ||||+++.....                        ....+.+|+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~------~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  122 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVF------DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFR  122 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEE------TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcC------CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHH
Confidence            6678999999999999998743      3678  999997543111                        0135788999


Q ss_pred             HHhcCCCCCc--ceeeeEEEeCCEEEEEEEecCC-C----ChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCC
Q 013105          135 FLGQLKHPHL--VNLIGYCCEDEHRLLVYEYMAL-G----NLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLH-GEEKP  206 (449)
Q Consensus       135 ~l~~l~h~nI--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH-~~~~~  206 (449)
                      +|..+.|++|  +.++++    +..+|||||+.+ |    +|.+....     .++.....++.|++.+|.||| .  .|
T Consensus       123 ~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~--~g  191 (258)
T 1zth_A          123 NLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQE--AE  191 (258)
T ss_dssp             HHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHT--SC
T ss_pred             HHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHH--CC
Confidence            9999988764  444432    246899999942 3    67665432     123456788999999999999 5  46


Q ss_pred             eeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          207 VIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       207 ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      |+||||||+|||++.  .++|+|||+|...
T Consensus       192 ivHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          192 LVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999999988  9999999999743

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.71  E-value=1.6e-18  Score=168.31  Aligned_cols=136  Identities=13%  Similarity=0.139  Sum_probs=96.9

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc--------------chHHH--------HHHHHHHHhc
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS--------------QGHRE--------WLAEVIFLGQ  138 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~E~~~l~~  138 (449)
                      |.+...||+|+||.||+|...       .|+.||||+++....              .....        ...|...|.+
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r  169 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA  169 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEecCEeeeCCceEEEEEECC-------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence            899999999999999999754       378999999753210              00111        2346777777


Q ss_pred             CCCCCcceeeeEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceE
Q 013105          139 LKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNIL  218 (449)
Q Consensus       139 l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nil  218 (449)
                      +.+.++.-..-+....  .+|||||+.|++|.++..      .+  ....++.|++.+|.+||  ..|||||||||.|||
T Consensus       170 L~~~gv~vp~p~~~~~--~~LVME~i~G~~L~~l~~------~~--~~~~l~~qll~~l~~lH--~~gIVHrDLKp~NIL  237 (397)
T 4gyi_A          170 LYEEGFPVPEPIAQSR--HTIVMSLVDALPMRQVSS------VP--DPASLYADLIALILRLA--KHGLIHGDFNEFNIL  237 (397)
T ss_dssp             HHHTTCSCCCEEEEET--TEEEEECCSCEEGGGCCC------CS--CHHHHHHHHHHHHHHHH--HTTEECSCCSTTSEE
T ss_pred             HHhcCCCCCeeeeccC--ceEEEEecCCccHhhhcc------cH--HHHHHHHHHHHHHHHHH--HCCCcCCCCCHHHEE
Confidence            7544433222222222  379999999888865431      11  23567899999999999  678999999999999


Q ss_pred             EcCCC----------cEEEeeeccccC
Q 013105          219 LDSDY----------NAKLSDFGLATD  235 (449)
Q Consensus       219 l~~~~----------~~kl~DfGla~~  235 (449)
                      ++.++          .+.|+||+-+..
T Consensus       238 l~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          238 IREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             EeCCCCcccccccccceEEEEeCCccc
Confidence            98876          389999997763

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.41  E-value=6.7e-13  Score=123.38  Aligned_cols=145  Identities=14%  Similarity=0.074  Sum_probs=111.2

Q ss_pred             HHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC-CCCcceeeeEEEe
Q 013105           75 QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-HPHLVNLIGYCCE  153 (449)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~  153 (449)
                      ......|.+...++.|+.+.||++..        .++.+++|+...........+.+|+.+++.+. +..+.++++++.+
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~--------~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~   81 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVG--------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH   81 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEEC--------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEEC--------CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec
Confidence            34456798889999999999999842        25789999986421122235778999998884 6788899999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----------------------------
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE-----------------------------  204 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-----------------------------  204 (449)
                      .+..|+||||++|.+|.+.+..       ......++.+++.+|..||+..                             
T Consensus        82 ~~~~~lv~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (263)
T 3tm0_A           82 DGWSNLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD  154 (263)
T ss_dssp             TTEEEEEEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCS
T ss_pred             CCceEEEEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccc
Confidence            9999999999999998775311       1123467788888999999610                             


Q ss_pred             ----------------------------CCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          205 ----------------------------KPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       205 ----------------------------~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                                                  ..++|+|++|.|||++.++.+.|+||+.+.
T Consensus       155 ~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                        458999999999999876566799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.23  E-value=1.2e-11  Score=114.31  Aligned_cols=135  Identities=15%  Similarity=0.045  Sum_probs=95.9

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCC--cceeeeEEEeCCEE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPH--LVNLIGYCCEDEHR  157 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~~~~~~~~~~~~  157 (449)
                      +|.+..+.+.|..+.||++...       .+..+++|+....   ....+.+|+.+++.+.+.+  +.+++++....+..
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~-------~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~   90 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQ-------GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD   90 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECT-------TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred             CCceEecccCCCCceEEEEecC-------CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCC
Confidence            4444444445667999998532       2567999997643   2234677898888885434  56688988888889


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC---------------------------------
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE---------------------------------  204 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---------------------------------  204 (449)
                      ++||||++|.+|.  +.     ...   ...++.+++..|..||+..                                 
T Consensus        91 ~~v~e~i~G~~l~--~~-----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (264)
T 1nd4_A           91 WLLLGEVPGQDLL--SS-----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE  160 (264)
T ss_dssp             EEEEECCSSEETT--TS-----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred             EEEEEecCCcccC--cC-----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence            9999999998884  21     111   1245667777788887432                                 


Q ss_pred             -----------------------CCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          205 -----------------------KPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       205 -----------------------~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                                             ..++|+|++|.|||++.++.+.|+|||.+.
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                   129999999999999877667799999765

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.10  E-value=1.8e-10  Score=112.02  Aligned_cols=141  Identities=15%  Similarity=0.191  Sum_probs=104.4

Q ss_pred             CcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEec--cCC-cchHHHHHHHHHHHhcCC--CCCcceeeeEEEeC---
Q 013105           83 RSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD--VNG-SQGHREWLAEVIFLGQLK--HPHLVNLIGYCCED---  154 (449)
Q Consensus        83 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~nIv~~~~~~~~~---  154 (449)
                      ..+.|+.|.++.||+....        +..+++|+..  ... ......+.+|+.+++.+.  +..+++++.++.+.   
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~  113 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVI  113 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTT
T ss_pred             eEEEcCCcccceEEEEEEC--------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCcc
Confidence            3567899999999997542        3578888875  321 122346778999999886  45688899888766   


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC-------------------------------
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE-------------------------------  203 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-------------------------------  203 (449)
                      +..|+||||++|..+.+..    ...++......++.+++..|..||..                               
T Consensus       114 g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (359)
T 3dxp_A          114 GRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS  189 (359)
T ss_dssp             SSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence            4589999999987774321    13467778888999999999999962                               


Q ss_pred             -------------------------CCCeeeccCCCCceEEcCCCc--EEEeeeccccC
Q 013105          204 -------------------------EKPVIYRDFKASNILLDSDYN--AKLSDFGLATD  235 (449)
Q Consensus       204 -------------------------~~~ivHrDikp~Nill~~~~~--~kl~DfGla~~  235 (449)
                                               ...++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                     246999999999999987753  68999998874

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.06  E-value=3.7e-11  Score=114.17  Aligned_cols=184  Identities=20%  Similarity=0.203  Sum_probs=120.2

Q ss_pred             cccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC-CCC--cceeeeEEEeCC---EE
Q 013105           84 SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-HPH--LVNLIGYCCEDE---HR  157 (449)
Q Consensus        84 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--Iv~~~~~~~~~~---~~  157 (449)
                      .+.++.|....||+.           +..+++|+....  .....+.+|+.+|+.+. +..  +..++......+   ..
T Consensus        25 i~~~~~G~~n~v~~v-----------~~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~   91 (304)
T 3sg8_A           25 IEISGEGNDCIAYEI-----------NRDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMS   91 (304)
T ss_dssp             CCEEEECSSEEEEES-----------TTSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCS
T ss_pred             eEecCCCCcceEEEE-----------CCEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcc
Confidence            456899999999985           246899986422  33467888999998873 333  445555443333   34


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE----------------------------------  203 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~----------------------------------  203 (449)
                      |+||++++|.+|.+...    ..++..+...++.+++..|..||+.                                  
T Consensus        92 ~~vm~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (304)
T 3sg8_A           92 FAGFTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG  167 (304)
T ss_dssp             CEEEECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred             eEEEcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence            89999999988865432    2456666667777777777777741                                  


Q ss_pred             ----------------------CCCeeeccCCCCceEEcC--CCcEEEeeeccccCCCCCCCCceeeecCCCCcc---cc
Q 013105          204 ----------------------EKPVIYRDFKASNILLDS--DYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY---AA  256 (449)
Q Consensus       204 ----------------------~~~ivHrDikp~Nill~~--~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y---~a  256 (449)
                                            ...++|+|++|.||+++.  .+.+.|+||+.+.......+.      .....+   ..
T Consensus       168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl------~~~~~~~~~~~  241 (304)
T 3sg8_A          168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF------ISLMEDDEEYG  241 (304)
T ss_dssp             HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH------HTTCCTTTSCC
T ss_pred             ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH------HHHHhhccccC
Confidence                                  134799999999999988  456789999988754321110      001111   22


Q ss_pred             cccccc--CCC------------CcccchhhhHHHHHHHHhCCCcccc
Q 013105          257 PEYINT--GHL------------TTMCDVFSFGVVLLELLTGRRSVEK  290 (449)
Q Consensus       257 PE~~~~--~~~------------~~~~DvwslG~vl~elltg~~pf~~  290 (449)
                      |+....  ..|            ....+.|++|.++|.+.+|..+|..
T Consensus       242 ~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~  289 (304)
T 3sg8_A          242 MEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYE  289 (304)
T ss_dssp             HHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred             HHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence            332110  001            1225899999999999999988753

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.60  E-value=2.4e-07  Score=87.74  Aligned_cols=135  Identities=19%  Similarity=0.144  Sum_probs=90.0

Q ss_pred             cccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCC---CcceeeeEEE-eCCEEEE
Q 013105           84 SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHP---HLVNLIGYCC-EDEHRLL  159 (449)
Q Consensus        84 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~~~~~~~-~~~~~~l  159 (449)
                      .+.++.|....||+.           +..+++|+..  .......+.+|+.+|..+.+.   .|.+++.++. ..+..++
T Consensus        24 v~~l~~G~~n~v~~v-----------g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~   90 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----------NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFV   90 (306)
T ss_dssp             EEEEEECSSEEEEEE-----------TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEE
T ss_pred             eeecCCCcceeEEEE-----------CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEE
Confidence            356788888899986           3568899853  223346788999999998642   3667777764 3566789


Q ss_pred             EEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-------------------------------------
Q 013105          160 VYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG-------------------------------------  202 (449)
Q Consensus       160 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-------------------------------------  202 (449)
                      |||+++|.++.+....    .++......++.++...|..||+                                     
T Consensus        91 v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~  166 (306)
T 3tdw_A           91 GYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDE  166 (306)
T ss_dssp             EEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCH
T ss_pred             EEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccch
Confidence            9999998887653211    12333333333334333333332                                     


Q ss_pred             ---------------------CCCCeeeccCCCCceEEcC---CCc-EEEeeeccccC
Q 013105          203 ---------------------EEKPVIYRDFKASNILLDS---DYN-AKLSDFGLATD  235 (449)
Q Consensus       203 ---------------------~~~~ivHrDikp~Nill~~---~~~-~kl~DfGla~~  235 (449)
                                           ....++|+|++|.|||++.   ++. +.|+||+.+..
T Consensus       167 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          167 SLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             hhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                 1335799999999999987   455 48999997763

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.59  E-value=2.4e-07  Score=85.90  Aligned_cols=133  Identities=17%  Similarity=0.094  Sum_probs=91.8

Q ss_pred             ccccCce-EEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC-CCCcceeeeEEEeCCEEEEEEEec
Q 013105           87 LGEGGFG-KVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-HPHLVNLIGYCCEDEHRLLVYEYM  164 (449)
Q Consensus        87 lG~G~~g-~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e~~  164 (449)
                      +..|..| .||+.....      .+..+++|+-..   .....+.+|...|+.+. +--+.++++++.+.+..++|||++
T Consensus        32 ~~~G~S~~~v~rl~~~~------~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l  102 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKP------NAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAI  102 (272)
T ss_dssp             EECSSSSCEEEEEECCT------TCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             ccCCCcCCeEEEEEecC------CCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEee
Confidence            4445444 689865433      356799998752   23456778999988874 444778999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc------------------------------------------
Q 013105          165 ALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG------------------------------------------  202 (449)
Q Consensus       165 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~------------------------------------------  202 (449)
                      +|.++.+.....      ......+..+++..|.-||+                                          
T Consensus       103 ~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (272)
T 4gkh_A          103 PGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV  176 (272)
T ss_dssp             CSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred             CCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence            988876654321      01122344455555555553                                          


Q ss_pred             --------------CCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          203 --------------EEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       203 --------------~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                                    ....++|+|+.+.|||++.++.+-|+||+.+.
T Consensus       177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                          01137899999999999988777899998765

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.24  E-value=1.5e-06  Score=83.94  Aligned_cols=86  Identities=5%  Similarity=-0.136  Sum_probs=53.4

Q ss_pred             ccc-cccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCC-C--CCcceeeeEEEeC---
Q 013105           85 DYL-GEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLK-H--PHLVNLIGYCCED---  154 (449)
Q Consensus        85 ~~l-G~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~nIv~~~~~~~~~---  154 (449)
                      +.| +.|....+|+............+..+++|+.....   ......+.+|+.+++.+. +  -.+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            567 78888999987543000000014678999865322   001134667888888774 2  3577788877654   


Q ss_pred             CEEEEEEEecCCCChH
Q 013105          155 EHRLLVYEYMALGNLH  170 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~  170 (449)
                      +..|+||||++|..+.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3578999999976653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.17  E-value=4.8e-06  Score=81.78  Aligned_cols=76  Identities=13%  Similarity=0.086  Sum_probs=48.9

Q ss_pred             cccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-------chHHHHHHHHHHHhcCCC--C-CcceeeeEEEe
Q 013105           84 SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-------QGHREWLAEVIFLGQLKH--P-HLVNLIGYCCE  153 (449)
Q Consensus        84 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-nIv~~~~~~~~  153 (449)
                      .+.||.|.++.||++....      .+..++||.......       .....+..|.++|..+..  + .+.+++.+  +
T Consensus        35 ~~~lg~G~~n~vyrv~~~~------~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d  106 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQE------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D  106 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E
T ss_pred             EEECCCCceEEEEEEEECC------CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c
Confidence            4679999999999986533      256899998642211       123456778888887632  3 34456543  4


Q ss_pred             CCEEEEEEEecCCC
Q 013105          154 DEHRLLVYEYMALG  167 (449)
Q Consensus       154 ~~~~~lv~e~~~~g  167 (449)
                      .+..++|||++.|.
T Consensus       107 ~~~~~lvmE~l~g~  120 (397)
T 2olc_A          107 TEMAVTVMEDLSHL  120 (397)
T ss_dssp             TTTTEEEECCCTTS
T ss_pred             CCccEEEEEeCCCc
Confidence            55568999999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.05  E-value=2.8e-05  Score=74.33  Aligned_cols=31  Identities=16%  Similarity=0.248  Sum_probs=27.8

Q ss_pred             CCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          204 EKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       204 ~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      ...++|+|+++.|||++.++.+.|+||+.+.
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            5679999999999999888899999998765

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.80  E-value=0.00012  Score=69.18  Aligned_cols=75  Identities=20%  Similarity=0.163  Sum_probs=58.8

Q ss_pred             cccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC---CCCcceeeeEEEeCCEEEEE
Q 013105           84 SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK---HPHLVNLIGYCCEDEHRLLV  160 (449)
Q Consensus        84 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~lv  160 (449)
                      .+.|+.|....+|+...        .+..+++|+....   ....+..|+..|+.|.   ...+++++.++...+..++|
T Consensus        41 ~~~l~gG~~n~~y~v~~--------~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lv  109 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--------EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLL  109 (312)
T ss_dssp             EEEECCSSSSEEEEEES--------SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEE
T ss_pred             eEEeCCccceeeeEEEE--------CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEE
Confidence            45689999999999753        2567899987532   3456788988888873   36788899998888899999


Q ss_pred             EEecCCCCh
Q 013105          161 YEYMALGNL  169 (449)
Q Consensus       161 ~e~~~~g~L  169 (449)
                      |||++|..+
T Consensus       110 me~l~G~~~  118 (312)
T 3jr1_A          110 LEALNKSKN  118 (312)
T ss_dssp             EECCCCCCC
T ss_pred             EEeccCCCC
Confidence            999998764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.72  E-value=0.00011  Score=68.50  Aligned_cols=79  Identities=19%  Similarity=0.178  Sum_probs=54.8

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCC---CCcceeeeEEEeCCE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKH---PHLVNLIGYCCEDEH  156 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~nIv~~~~~~~~~~~  156 (449)
                      ...-.+.+|.|..+.||+....+       |+.|++|+...........+..|+..|+.|.-   --+++++++.  .  
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~D-------G~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--   84 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELAD-------GTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--   84 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETT-------SCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--
T ss_pred             CeEEEEecCCCCCeEEEEEEECC-------CCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--
Confidence            44456779999999999987654       67899998764433333457789988887742   2345555542  2  


Q ss_pred             EEEEEEecCCCCh
Q 013105          157 RLLVYEYMALGNL  169 (449)
Q Consensus       157 ~~lv~e~~~~g~L  169 (449)
                      .++||||+.++..
T Consensus        85 ~~lv~e~l~~~~~   97 (288)
T 3f7w_A           85 RTLAMEWVDERPP   97 (288)
T ss_dssp             TEEEEECCCCCCC
T ss_pred             ceEEEEeecccCC
Confidence            3789999987653

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.50  E-value=0.00038  Score=68.71  Aligned_cols=79  Identities=14%  Similarity=0.068  Sum_probs=46.2

Q ss_pred             CCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCC---CCcccchhhhHHHHHH
Q 013105          204 EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGH---LTTMCDVFSFGVVLLE  280 (449)
Q Consensus       204 ~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~vl~e  280 (449)
                      ...++|+|++|.|||++.++ +.|+||+.+.......+....-. .-...|++|+......   -....++..+...+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLG-NLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHH-HHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHH-HHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            56799999999999998876 99999998874332111000000 0013456665443111   1122444567777777


Q ss_pred             HHhC
Q 013105          281 LLTG  284 (449)
Q Consensus       281 lltg  284 (449)
                      .+++
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7664

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.41  E-value=0.00079  Score=59.14  Aligned_cols=100  Identities=14%  Similarity=0.053  Sum_probs=64.4

Q ss_pred             ChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCCceeee
Q 013105          168 NLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC  247 (449)
Q Consensus       168 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~  247 (449)
                      +|.+.|.. .+.++++.++|.++.|.+.+|.-+-. ...-..+=+.|..|++..+|.|.+.+ +.+.             
T Consensus        34 SL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~-~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------   97 (229)
T 2yle_A           34 SLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAAR-RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------   97 (229)
T ss_dssp             EHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred             cHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhh-cccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence            67777754 45899999999999999998876611 11111333457899999999988764 1110             


Q ss_pred             cCCCCccccccccccCCCCcccchhhhHHHHHHHHhCC
Q 013105          248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR  285 (449)
Q Consensus       248 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~  285 (449)
                       .....+.|||... ...+.+.=|||||++||..+--.
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence             0123466888764 34567888999999999988633

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.21  E-value=0.00027  Score=66.33  Aligned_cols=71  Identities=7%  Similarity=0.095  Sum_probs=43.4

Q ss_pred             cccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCc-ceeeeEEEeCCEEEEEEE
Q 013105           84 SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHL-VNLIGYCCEDEHRLLVYE  162 (449)
Q Consensus        84 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv~e  162 (449)
                      .+.|+.|....+|+.            ..+++|+....... .....+|+.+++.+...++ .+++.+  +.+.-++|+|
T Consensus        23 i~~l~gG~tN~~~~~------------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e   87 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTR   87 (301)
T ss_dssp             CEEEESCSSEEEEEE------------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEE
T ss_pred             eeEcCCcccccccee------------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEe
Confidence            577888999999997            24888987642111 1122457777776642222 455544  3444578999


Q ss_pred             ec-CCCCh
Q 013105          163 YM-ALGNL  169 (449)
Q Consensus       163 ~~-~~g~L  169 (449)
                      |+ .|.++
T Consensus        88 ~i~~g~~l   95 (301)
T 3dxq_A           88 YIAGAQTM   95 (301)
T ss_dssp             CCTTCEEC
T ss_pred             ecCCCccC
Confidence            99 65444

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.21  E-value=0.0055  Score=57.68  Aligned_cols=156  Identities=12%  Similarity=0.093  Sum_probs=82.3

Q ss_pred             cCHHHHHHHhcCCCCc-----ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCC-
Q 013105           69 FTLKELQMITHNFSRS-----DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHP-  142 (449)
Q Consensus        69 ~~~~~~~~~~~~y~~~-----~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~-  142 (449)
                      ++..++..+...|.+.     +.|+.|....+|+....        +..+++|+......  ...+..|+.++..|... 
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~--------~g~~vlk~~~~~~~--~~~l~~e~~~l~~L~~~g   76 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT--------KDPLILTLYEKRVE--KNDLPFFLGLMQHLAAKG   76 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES--------SCCEEEEEECC-----CCHHHHHHHHHHHHHHTT
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC--------CccEEEEEeCCCCC--HHHHHHHHHHHHHHHHCC
Confidence            3445555555566652     34667888899997543        23689999864211  12344566666655311 


Q ss_pred             -Ccceeee------EEEeCCEEEEEEEecCCCChHH-----------H---Hhh---cCCCC----CC---HHHHHH---
Q 013105          143 -HLVNLIG------YCCEDEHRLLVYEYMALGNLHD-----------Q---LFK---NYSST----LP---WLTRIK---  188 (449)
Q Consensus       143 -nIv~~~~------~~~~~~~~~lv~e~~~~g~L~~-----------~---l~~---~~~~~----l~---~~~~~~---  188 (449)
                       .+.+++.      +....+..+++|+|++|..+..           .   +..   .....    ..   |.....   
T Consensus        77 ~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~  156 (322)
T 2ppq_A           77 LSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSE  156 (322)
T ss_dssp             CCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHG
T ss_pred             CCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHH
Confidence             1333332      1233567899999999764310           0   111   10111    11   111000   


Q ss_pred             ---------HHHHHHHHHHHhhc-----CCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          189 ---------IAIGAARCLAFLHG-----EEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       189 ---------i~~~i~~~l~~lH~-----~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                               +...+...+..+..     ...+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus       157 ~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          157 ERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             GGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                     00012233444431     13469999999999999887666899998665

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.18  E-value=0.0017  Score=61.75  Aligned_cols=33  Identities=30%  Similarity=0.385  Sum_probs=28.2

Q ss_pred             CCCeeeccCCCCceEEcCC----CcEEEeeeccccCC
Q 013105          204 EKPVIYRDFKASNILLDSD----YNAKLSDFGLATDG  236 (449)
Q Consensus       204 ~~~ivHrDikp~Nill~~~----~~~kl~DfGla~~~  236 (449)
                      ...++|+|+.+.|||++.+    +.+.|+||+.+...
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            4579999999999999874    68999999988744

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.10  E-value=0.0051  Score=58.12  Aligned_cols=140  Identities=16%  Similarity=0.098  Sum_probs=77.6

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCC--CCcceeeeE-----EEeCCEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKH--PHLVNLIGY-----CCEDEHR  157 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~~~~~-----~~~~~~~  157 (449)
                      ..|+ |....||+....       .++.+++|+..... .....+..|..++..+..  -.+++++..     ....+..
T Consensus        32 ~~l~-g~~n~~y~v~~~-------~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~  102 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-------DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFY  102 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-------TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEE
T ss_pred             Eeec-CcccceEEEEcC-------CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEE
Confidence            3466 777889986432       24579999986321 234456668777776631  123444432     2335677


Q ss_pred             EEEEEecCCCChH----H-------H---Hhh---cCC----CCCCHHHH----------------------HHHHHHHH
Q 013105          158 LLVYEYMALGNLH----D-------Q---LFK---NYS----STLPWLTR----------------------IKIAIGAA  194 (449)
Q Consensus       158 ~lv~e~~~~g~L~----~-------~---l~~---~~~----~~l~~~~~----------------------~~i~~~i~  194 (449)
                      +++|++++|..+.    +       .   +..   ...    ........                      ...+..++
T Consensus       103 ~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  182 (328)
T 1zyl_A          103 FAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELI  182 (328)
T ss_dssp             EEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHH
T ss_pred             EEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHH
Confidence            8999999874431    1       1   110   000    11121111                      01111122


Q ss_pred             HHHHHhh--cCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          195 RCLAFLH--GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       195 ~~l~~lH--~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..+.-+-  .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       183 ~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          183 AAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            2222111  0245689999999999999 4 899999987763

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.09  E-value=0.0012  Score=63.92  Aligned_cols=145  Identities=17%  Similarity=0.165  Sum_probs=79.3

Q ss_pred             ccccccCceEEEEEEEcCCCC-CCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC-CCCcceeeeEEEeCCEEEEEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLR-PGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-HPHLVNLIGYCCEDEHRLLVYE  162 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e  162 (449)
                      +.|..|-...+|++...++.. ....+..+++++... .......+.+|..+++.|. +.-..++++++.  +  .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEEE
Confidence            456667778899986532100 011346899998632 2223456678999988874 333456666553  3  29999


Q ss_pred             ecCCCChHH--------------HHhhcC------CCCCC--HHHHHHHHHHHHH-------------------HHH---
Q 013105          163 YMALGNLHD--------------QLFKNY------SSTLP--WLTRIKIAIGAAR-------------------CLA---  198 (449)
Q Consensus       163 ~~~~g~L~~--------------~l~~~~------~~~l~--~~~~~~i~~~i~~-------------------~l~---  198 (449)
                      |++|.+|..              .+.+-.      .....  +.++..+..++..                   .+.   
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            999755421              111100      11112  2333333332211                   122   


Q ss_pred             -Hhhc--CCCCeeeccCCCCceEEcCC----CcEEEeeecccc
Q 013105          199 -FLHG--EEKPVIYRDFKASNILLDSD----YNAKLSDFGLAT  234 (449)
Q Consensus       199 -~lH~--~~~~ivHrDikp~Nill~~~----~~~kl~DfGla~  234 (449)
                       .|..  ....++|+|+.+.|||++.+    +.+.|+||..+.
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence             2221  13458899999999999876    789999998765

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.09  E-value=0.0027  Score=63.23  Aligned_cols=74  Identities=11%  Similarity=0.000  Sum_probs=45.1

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCc-ceeeeEEEeCCEEEEEEEe
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHL-VNLIGYCCEDEHRLLVYEY  163 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv~e~  163 (449)
                      +.|+.|-...+|+....+      .+..+++|+....... .-...+|..++..|...++ .++++++  .+  .+||||
T Consensus       114 ~~lsgG~tN~~y~v~~~~------~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~  182 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMS------KQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEF  182 (458)
T ss_dssp             EEECC--CEEEEEEEETT------TTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEEC
T ss_pred             EEcCCCeEeEEEEEEECC------CCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEe
Confidence            457778889999986532      2367889987532211 1112468888888864444 5677665  23  259999


Q ss_pred             cCCCCh
Q 013105          164 MALGNL  169 (449)
Q Consensus       164 ~~~g~L  169 (449)
                      ++|.+|
T Consensus       183 I~G~~l  188 (458)
T 2qg7_A          183 MDGYAL  188 (458)
T ss_dssp             CCSEEC
T ss_pred             eCCccC
Confidence            987443

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.05  E-value=0.0012  Score=65.38  Aligned_cols=79  Identities=14%  Similarity=0.089  Sum_probs=48.9

Q ss_pred             cccccccCceEEEEEEEcCCCC-CCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCC-cceeeeEEEeCCEEEEEE
Q 013105           84 SDYLGEGGFGKVYKGCVDDNLR-PGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPH-LVNLIGYCCEDEHRLLVY  161 (449)
Q Consensus        84 ~~~lG~G~~g~V~~~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~lv~  161 (449)
                      .+.|+.|....||++...+... ....+..+++|+.....  ....+.+|..++..|...+ .+++++.+.  +  .+||
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence            3567888889999987643100 01124689999884321  1245567998888875333 356766543  2  2899


Q ss_pred             EecCCCC
Q 013105          162 EYMALGN  168 (449)
Q Consensus       162 e~~~~g~  168 (449)
                      ||++|.+
T Consensus       152 e~l~G~~  158 (429)
T 1nw1_A          152 EYIPSRP  158 (429)
T ss_dssp             CCCCEEE
T ss_pred             EEeCCcc
Confidence            9998643

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.65  E-value=0.0017  Score=62.72  Aligned_cols=79  Identities=6%  Similarity=0.015  Sum_probs=42.3

Q ss_pred             ccccccCceEEEEEEEcCCC--CCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCC-cceeeeEEEeCCEEEEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNL--RPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPH-LVNLIGYCCEDEHRLLVY  161 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~lv~  161 (449)
                      +.|+.|....+|+....+..  .....+..+++|+..... ........|..+++.+...+ +.++++..  .+  ++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEE
Confidence            45777888899998653200  000112578889875321 11112356777777774223 45666543  22  6899


Q ss_pred             EecCCCC
Q 013105          162 EYMALGN  168 (449)
Q Consensus       162 e~~~~g~  168 (449)
                      ||++|..
T Consensus       114 e~i~G~~  120 (369)
T 3c5i_A          114 EWLYGDP  120 (369)
T ss_dssp             ECCCSEE
T ss_pred             EEecCCc
Confidence            9998754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.32  E-value=0.032  Score=53.04  Aligned_cols=31  Identities=16%  Similarity=0.190  Sum_probs=27.3

Q ss_pred             CCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          205 KPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       205 ~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4699999999999999888899999987663

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=93.47  E-value=0.14  Score=50.22  Aligned_cols=80  Identities=13%  Similarity=0.050  Sum_probs=46.4

Q ss_pred             ccccccCceEEEEEEEcCCCC-CCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC-CCCcceeeeEEEeCCEEEEEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLR-PGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-HPHLVNLIGYCCEDEHRLLVYE  162 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e  162 (449)
                      +.|..|-...+|+........ ....+..+++++..... ...-...+|..+++.+. +.-..++++.+  .+  ++|||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEEE
Confidence            456667788899987642100 00115789999864322 11122346888887774 33345566533  22  68999


Q ss_pred             ecCCCCh
Q 013105          163 YMALGNL  169 (449)
Q Consensus       163 ~~~~g~L  169 (449)
                      |++|.+|
T Consensus       151 fI~G~~l  157 (424)
T 3mes_A          151 FIDGEPL  157 (424)
T ss_dssp             CCCSEEC
T ss_pred             EeCCccC
Confidence            9998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.58  E-value=0.43  Score=46.30  Aligned_cols=28  Identities=29%  Similarity=0.383  Sum_probs=24.0

Q ss_pred             eeeccCCCCceEE------cCCCcEEEeeecccc
Q 013105          207 VIYRDFKASNILL------DSDYNAKLSDFGLAT  234 (449)
Q Consensus       207 ivHrDikp~Nill------~~~~~~kl~DfGla~  234 (449)
                      ++|+|+.+.|||+      +++..+.++||..|.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            5699999999999      456789999998775

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=92.12  E-value=0.35  Score=42.29  Aligned_cols=117  Identities=7%  Similarity=0.063  Sum_probs=80.3

Q ss_pred             CCCCcceeeeEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEE
Q 013105          140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILL  219 (449)
Q Consensus       140 ~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill  219 (449)
                      .||+.+.. .+-.+.+.+.+.++.-..+.-...+     ..++...+++++.+++....+++  .  =+|--|.|+||++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i-----k~~~~~eKlr~l~ni~~l~~~~~--~--r~tf~L~P~NL~f  112 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI-----KSFTKNEKLRYLLNIKNLEEVNR--T--RYTFVLAPDELFF  112 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG-----GGSCHHHHHHHHHHGGGGGGGGG--S--SEECCCSGGGEEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH-----HhcCHHHHHHHHHHHHHHHHHhc--C--ceEEEEecceEEE
Confidence            58888877 5667777777766654422222223     35778889999999888775555  3  5777899999999


Q ss_pred             cCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccc
Q 013105          220 DSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEK  290 (449)
Q Consensus       220 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~  290 (449)
                      +.++.+++.--|+-...                   +|.     ..+...=+-.+=|++..+++++..|+.
T Consensus       113 ~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~  159 (215)
T 4ann_A          113 TRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDA  159 (215)
T ss_dssp             CTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred             cCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            99999999877764322                   121     112222233677899999999988863

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=91.00  E-value=0.82  Score=40.04  Aligned_cols=116  Identities=11%  Similarity=0.102  Sum_probs=80.5

Q ss_pred             CCCCcceeeeEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHH-HhhcCCCCeeeccCCCCceE
Q 013105          140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLA-FLHGEEKPVIYRDFKASNIL  218 (449)
Q Consensus       140 ~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~-~lH~~~~~ivHrDikp~Nil  218 (449)
                      .||++  -..+-.+++.+.+.++.-.++.-...+     ..++...+++++.+++.... +++  .  -+|-=|.|+||+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-----~~~~~~eKlrll~nl~~L~~~~~~--~--r~tf~l~P~NL~  116 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-----RKTTLLSRIRAAIHLVSKVKHHSA--R--RLIFIVCPENLM  116 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-----HTSCHHHHHHHHHHHHHHHSSCCS--S--SEECCCCGGGEE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-----HhcCHHHHHHHHHHHHHHHHHhhh--C--ceeEEEeCceEE
Confidence            57887  445557788888888876554444444     35778899999999887665 454  3  677789999999


Q ss_pred             EcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccc
Q 013105          219 LDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEK  290 (449)
Q Consensus       219 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~  290 (449)
                      ++.++.++|.-.|+-..                   ++|.-     .+..-=+-.+=|++..++.++..|+.
T Consensus       117 f~~~~~p~i~hRGi~~~-------------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe~  164 (219)
T 4ano_A          117 FNRALEPFFLHVGVKES-------------------LPPDE-----WDDERLLREVKATVLALTEGEYRFDE  164 (219)
T ss_dssp             ECTTCCEEESCCEETTT-------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred             EeCCCcEEEEEcCCccc-------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            99999999987776432                   22221     11111223677899999999888763

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=83.79  E-value=0.16  Score=50.37  Aligned_cols=62  Identities=6%  Similarity=0.074  Sum_probs=18.2

Q ss_pred             CcccccccCceEEEEEEEcCCCCCCCCCcEEEE------EEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           83 RSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAV------KVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        83 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vav------K~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      +.+.||   ||.||+|.+..      ...+||+      |.....  .......+.+|..+++.++|||+++.+++...
T Consensus       146 l~~~lG---fG~v~~g~~~~------~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYK------KHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             STTTSS---BCCC---------------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             ccccCC---chhhhcccccc------cCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            456676   99999998754      2346888      665432  22333567889999999999999999888653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	449
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-70
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	8e-66
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	8e-65
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-64
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-63
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-63
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-63
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-62
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-62
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-62
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	8e-62
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-61
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-61
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-61
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	8e-61
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-60
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-58
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-58
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-58
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-57
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-57
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-56
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-56
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-55
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-55
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-55
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-55
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-54
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-54
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-53
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-52
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	8e-50
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-49
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-48
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-46
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-45
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-45
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	8e-45
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-44
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-44
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-43
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-43
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-43
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-43
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-42
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-42
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-41
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-40
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-39
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-39
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-39
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-39
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-38
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	9e-38
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-36
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	8e-36
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	8e-33
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-30
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	9e-30
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-28
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-15

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (565), Expect = 3e-70
 Identities = 71/292 (24%), Positives = 122/292 (41%), Gaps = 35/292 (11%)

Query: 81  FSRSDY-----LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEV 133
                      +G G FG VYKG              VAVK+L+V     Q  + +  EV
Sbjct: 5   IPDGQITVGQRIGSGSFGTVYKGKWHG---------DVAVKMLNVTAPTPQQLQAFKNEV 55

Query: 134 IFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGA 193
             L + +H +++  +GY        +V ++    +L+  L     +    +  I IA   
Sbjct: 56  GVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQT 113

Query: 194 ARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEG 253
           A+ + +LH   K +I+RD K++NI L  D   K+ DFGLAT   +   SH    + G+  
Sbjct: 114 AQGMDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171

Query: 254 YAAPEYI---NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF 310
           + APE I   +    +   DV++FG+VL EL+TG+        + +   +     +  D 
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL 231

Query: 311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
           +K+       ++             +  +CL      RP    ++ ++E L 
Sbjct: 232 SKVRSNCPKAMKR------------LMAECLKKKRDERPLFPQILASIELLA 271

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 8e-66
 Identities = 79/287 (27%), Positives = 114/287 (39%), Gaps = 33/287 (11%)

Query: 81  FSRSDY-----LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
             R        LG G FG+V+ G  + +         VAVK L   GS     +LAE   
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYNGH-------TKVAVKSLK-QGSMSPDAFLAEANL 61

Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
           + QL+H  LV L       E   ++ EYM  G+L D L       L     + +A   A 
Sbjct: 62  MKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120

Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            +AF+   E+  I+RD +A+NIL+    + K++DFGLA      E             + 
Sbjct: 121 GMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWT 177

Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ 315
           APE IN G  T   DV+SFG++L E++T  R            +        +    L++
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGR------------IPYPGMTNPEVIQNLER 225

Query: 316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
                  D    E    L  +   C    P+ RPT   +   LE   
Sbjct: 226 GYRMVRPDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (529), Expect = 8e-65
 Identities = 69/290 (23%), Positives = 120/290 (41%), Gaps = 23/290 (7%)

Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVIFLG 137
              +R   +G G FG+VYKG +  +   G K   VA+K L    ++  R ++L E   +G
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTS--SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 64

Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           Q  H +++ L G   + +  +++ EYM      D+  +        L  + +  G A  +
Sbjct: 65  QFSHHNIIRLEGVISKYKPMMIITEYME-NGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC-VMGTEGYAA 256
            +L       ++RD  A NIL++S+   K+SDFGL+       ++  TT        + A
Sbjct: 124 KYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI 316
           PE I+    T+  DV+SFG+V+ E++T            E                + + 
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----------------VMKA 225

Query: 317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLND 366
           I+         +    +  +  QC       RP    +V  L+ L+   D
Sbjct: 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  208 bits (529), Expect = 1e-64
 Identities = 65/307 (21%), Positives = 124/307 (40%), Gaps = 35/307 (11%)

Query: 69  FTLKELQMITHNFSR----SDY-----LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD 119
           FT ++       F++    S       +G G FG+V  G       PG +   VA+K L 
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGH---LKLPGKREIFVAIKTLK 63

Query: 120 VNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYS 178
              + +  R++L+E   +GQ  HP++++L G   +    +++ E+M  G+L D   +   
Sbjct: 64  SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQND 122

Query: 179 STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ 238
                +  + +  G A  + +L   +   ++RD  A NIL++S+   K+SDFGL+     
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 239 GEDSHITT---CVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKR 295
                  T          + APE I     T+  DV+S+G+V+ E+++       +   +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240

Query: 296 EKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVV 355
           +                +   I+         +    L  +   C   +   RP    +V
Sbjct: 241 D----------------VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284

Query: 356 KALEPLL 362
             L+ ++
Sbjct: 285 NTLDKMI 291

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 2e-63
 Identities = 70/310 (22%), Positives = 123/310 (39%), Gaps = 40/310 (12%)

Query: 74  LQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAE 132
           +++   +F +   LG G  G V+K     +         +A K++ +      R   + E
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPS------GLVMARKLIHLEIKPAIRNQIIRE 54

Query: 133 VIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIG 192
           +  L +   P++V   G    D    +  E+M  G+L   L K     +P     K++I 
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIA 112

Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE 252
             + L +L  E+  +++RD K SNIL++S    KL DFG++    Q  DS   + V GT 
Sbjct: 113 VIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV-GTR 167

Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRR-------------------------- 286
            Y +PE +   H +   D++S G+ L+E+  GR                           
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227

Query: 287 SVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPK 346
              +   +        +RP +  F  LD I++       S   +       ++CL  NP 
Sbjct: 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 287

Query: 347 SRPTMTTVVK 356
            R  +  ++ 
Sbjct: 288 ERADLKQLMV 297

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  203 bits (518), Expect = 6e-63
 Identities = 69/316 (21%), Positives = 122/316 (38%), Gaps = 42/316 (13%)

Query: 71  LKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EW 129
           L  L+   +N      +GEG FG+V++      L P      VAVK+L    S   + ++
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQA-RAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 130 LAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSST--------- 180
             E   + +  +P++V L+G C   +   L++EYMA G+L++ L      T         
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 181 -------------LPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKL 227
                        L    ++ IA   A  +A+L   E+  ++RD    N L+  +   K+
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHRDLATRNCLVGENMVVKI 181

Query: 228 SDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS 287
           +DFGL+ +    +             +  PE I     TT  DV+++GVVL E+ +    
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241

Query: 288 VEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKS 347
                   E                +  + D  +           L  +   C S  P  
Sbjct: 242 PYYGMAHEE---------------VIYYVRDGNILACPENC-PLELYNLMRLCWSKLPAD 285

Query: 348 RPTMTTVVKALEPLLD 363
           RP+  ++ + L+ + +
Sbjct: 286 RPSFCSIHRILQRMCE 301

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 7e-63
 Identities = 70/308 (22%), Positives = 126/308 (40%), Gaps = 40/308 (12%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWL--AEVIFLGQLKHPHL 144
           +G+G FG+V++G          + + VAVK+     S+  R W   AE+     L+H ++
Sbjct: 11  IGKGRFGEVWRGK--------WRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENI 59

Query: 145 VNLIGYCCEDE----HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFL 200
           +  I    +D        LV +Y   G+L D L +    T+     IK+A+  A  LA L
Sbjct: 60  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHL 116

Query: 201 HGE------EKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGED--SHITTCVMGTE 252
           H E      +  + +RD K+ NIL+  +    ++D GLA       D         +GT+
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176

Query: 253 GYAAPEYINT------GHLTTMCDVFSFGVVLLELLTGRR----SVEKNRCKREKDLVEW 302
            Y APE ++              D+++ G+V  E+           +      +    + 
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236

Query: 303 ARPMLKDFTKLDQIIDSRLEDRY-STEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL 361
           +   ++     +Q +   + +R+ S E  + +A +  +C   N  +R T   + K L  L
Sbjct: 237 SVEEMRKVV-CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295

Query: 362 LDLNDIPI 369
                I +
Sbjct: 296 SQQEGIKM 303

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 1e-62
 Identities = 69/285 (24%), Positives = 117/285 (41%), Gaps = 39/285 (13%)

Query: 81  FSRSDY-----LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
            +  +      +G+G FG V  G          +   VAVK +  + +   + +LAE   
Sbjct: 4   LNMKELKLLQTIGKGEFGDVMLGD--------YRGNKVAVKCIKNDATA--QAFLAEASV 53

Query: 136 LGQLKHPHLVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA 194
           + QL+H +LV L+G   E++  L +V EYMA G+L D L     S L     +K ++   
Sbjct: 54  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113

Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
             + +L       ++RD  A N+L+  D  AK+SDFGL  +      S           +
Sbjct: 114 EAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKW 166

Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD 314
            APE +     +T  DV+SFG++L E+ +  R            +     P+     +++
Sbjct: 167 TAPEALREKKFSTKSDVWSFGILLWEIYSFGR------------VPYPRIPLKDVVPRVE 214

Query: 315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
           +       D         +  V   C   +   RP+   + + LE
Sbjct: 215 KGYKMDAPDGCPPA----VYEVMKNCWHLDAAMRPSFLQLREQLE 255

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  201 bits (513), Expect = 2e-62
 Identities = 69/293 (23%), Positives = 126/293 (43%), Gaps = 31/293 (10%)

Query: 81  FSRSDY-----LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
             R+D      LG G +G+VY+G           + TVAVK L  +  +   E+L E   
Sbjct: 14  MERTDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEV-EEFLKEAAV 66

Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
           + ++KHP+LV L+G C  +    ++ E+M  GNL D L +     +  +  + +A   + 
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 126

Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            + +L   +K  I+RD  A N L+  ++  K++DFGL+     G+             + 
Sbjct: 127 AMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWT 183

Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ 315
           APE +     +   DV++FGV+L E+ T   S                     D +++ +
Sbjct: 184 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----------------IDLSQVYE 227

Query: 316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDIP 368
           +++            +++  +   C   NP  RP+   + +A E +   + I 
Sbjct: 228 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 280

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 4e-62
 Identities = 66/284 (23%), Positives = 120/284 (42%), Gaps = 28/284 (9%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
             +    +G G FG V+ G   +          VA+K +   G+    +++ E   + +L
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWLNK-------DKVAIKTIR-EGAMSEEDFIEEAEVMMKL 57

Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAF 199
            HP LV L G C E     LV+E+M  G L D L           T + + +     +A+
Sbjct: 58  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEGMAY 116

Query: 200 LHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEY 259
           L   E  VI+RD  A N L+  +   K+SDFG+       +    +T       +A+PE 
Sbjct: 117 LE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEV 173

Query: 260 INTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDS 319
            +    ++  DV+SFGV++ E+ +  +   +NR   E         +++D +   ++   
Sbjct: 174 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKP 224

Query: 320 RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD 363
           RL           +  + + C    P+ RP  + +++ L  + +
Sbjct: 225 RLAS-------THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 8e-62
 Identities = 81/315 (25%), Positives = 134/315 (42%), Gaps = 30/315 (9%)

Query: 52  ISLNELSSSLVGSNLHVFTLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQ 111
           I L+ L+  LV +  HV        +  +F+    +G G FG VY G + DN     K  
Sbjct: 4   IDLSALNPELVQAVQHVVIGPS--SLIVHFNEV--IGRGHFGCVYHGTLLDN---DGKKI 56

Query: 112 TVAVKVLDVNGSQGH-REWLAEVIFLGQLKHPHLVNLIGYCCEDE-HRLLVYEYMALGNL 169
             AVK L+     G   ++L E I +    HP++++L+G C   E   L+V  YM  G+L
Sbjct: 57  HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 116

Query: 170 HDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSD 229
            +   +N +        I   +  A+ + FL    K  ++RD  A N +LD  +  K++D
Sbjct: 117 RN-FIRNETHNPTVKDLIGFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVAD 173

Query: 230 FGLATD--GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS 287
           FGLA D    + +  H  T       + A E + T   TT  DV+SFGV+L EL+T    
Sbjct: 174 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA- 232

Query: 288 VEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKS 347
                   + +  +    +L+            L+  Y  +    +     +C     + 
Sbjct: 233 ----PPYPDVNTFDITVYLLQG--------RRLLQPEYCPDPLYEVML---KCWHPKAEM 277

Query: 348 RPTMTTVVKALEPLL 362
           RP+ + +V  +  + 
Sbjct: 278 RPSFSELVSRISAIF 292

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (508), Expect = 1e-61
 Identities = 74/296 (25%), Positives = 113/296 (38%), Gaps = 33/296 (11%)

Query: 81  FSRSDY-----LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIF 135
             R        LG+G FG+V+ G  +           VA+K L   G+     +L E   
Sbjct: 14  IPRESLRLEVKLGQGCFGEVWMGTWNGT-------TRVAIKTLK-PGTMSPEAFLQEAQV 65

Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
           + +L+H  LV L     E+    +V EYM+ G+L D L       L     + +A   A 
Sbjct: 66  MKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 124

Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            +A++       ++RD +A+NIL+  +   K++DFGLA      E             + 
Sbjct: 125 GMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWT 181

Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ 315
           APE    G  T   DV+SFG++L EL T  R        RE                +  
Sbjct: 182 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VLD 225

Query: 316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDIPIGP 371
            ++         E  + L  +  QC    P+ RPT   +   LE      +    P
Sbjct: 226 QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 2e-61
 Identities = 78/305 (25%), Positives = 115/305 (37%), Gaps = 41/305 (13%)

Query: 81  FSRSDY-----LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVI 134
           F R+       LG G FGKV +      L     A TVAVK+L  +     RE  ++E+ 
Sbjct: 20  FPRNRLSFGKTLGAGAFGKVVEA-TAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78

Query: 135 FLGQLK-HPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSS-------------- 179
            L  L  H ++VNL+G C      L++ EY   G+L + L +   S              
Sbjct: 79  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138

Query: 180 --TLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP 237
              L     +  +   A+ +AFL    K  I+RD  A NILL      K+ DFGLA D  
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196

Query: 238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREK 297
              +  +         + APE I     T   DV+S+G+ L EL +   S          
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS- 255

Query: 298 DLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA 357
                         K  ++I               +  +   C   +P  RPT   +V+ 
Sbjct: 256 --------------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301

Query: 358 LEPLL 362
           +E  +
Sbjct: 302 IEKQI 306

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 5e-61
 Identities = 69/334 (20%), Positives = 126/334 (37%), Gaps = 50/334 (14%)

Query: 61  LVGSNLHVFTLKELQMITHN----FSRSDY-----LGEGGFGKVYKGCVDDNLRPGLKAQ 111
           + GS+ + +   + +   ++    F R +      LG G FGKV        +     + 
Sbjct: 10  VTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNA-TAYGISKTGVSI 68

Query: 112 TVAVKVLDVNGSQGHRE-WLAEVIFLGQL-KHPHLVNLIGYCCEDEHRLLVYEYMALGNL 169
            VAVK+L        RE  ++E+  + QL  H ++VNL+G C       L++EY   G+L
Sbjct: 69  QVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDL 128

Query: 170 HDQLFKN---------------------YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVI 208
            + L                          + L +   +  A   A+ + FL    K  +
Sbjct: 129 LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCV 186

Query: 209 YRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTM 268
           +RD  A N+L+      K+ DFGLA D     +  +         + APE +  G  T  
Sbjct: 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 246

Query: 269 CDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTE 328
            DV+S+G++L E+ +   +                 P +       ++I +  +      
Sbjct: 247 SDVWSYGILLWEIFSLGVN---------------PYPGIPVDANFYKLIQNGFKMDQPFY 291

Query: 329 GAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
             + +  +   C + + + RP+   +   L   L
Sbjct: 292 ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 325

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 8e-61
 Identities = 76/291 (26%), Positives = 119/291 (40%), Gaps = 27/291 (9%)

Query: 72  KELQMITHNFSRSDY-LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-W 129
           K+L +   N   +D  LG G FG V +G      R   K   VA+KVL     +   E  
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGV----YRMRKKQIDVAIKVLKQGTEKADTEEM 56

Query: 130 LAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKI 189
           + E   + QL +P++V LIG  C+ E  +LV E    G LH  L       +P     ++
Sbjct: 57  MREAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAEL 114

Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD-GPQGEDSHITTCV 248
               +  + +L   EK  ++RD  A N+LL + + AK+SDFGL+   G         +  
Sbjct: 115 LHQVSMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172

Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
                + APE IN    ++  DV+S+GV + E L+  +   K                  
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK----------------M 216

Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
              ++   I+         E    L A+   C  +  + RP   TV + + 
Sbjct: 217 KGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 1e-60
 Identities = 55/280 (19%), Positives = 105/280 (37%), Gaps = 28/280 (10%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           + +    LG G FG V  G              VA+K++   GS    E++ E   +  L
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWRGQ-------YDVAIKMIK-EGSMSEDEFIEEAKVMMNL 56

Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAF 199
            H  LV L G C +     ++ EYMA G L + L +           +++       + +
Sbjct: 57  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEY 115

Query: 200 LHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEY 259
           L    K  ++RD  A N L++     K+SDFGL+       +   +        ++ PE 
Sbjct: 116 LE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEV 172

Query: 260 INTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDS 319
           +     ++  D+++FGV++ E+ +  +   +     E                  + I  
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----------------TAEHIAQ 216

Query: 320 RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
            L        ++++  + + C       RPT   ++  + 
Sbjct: 217 GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 2e-58
 Identities = 75/301 (24%), Positives = 124/301 (41%), Gaps = 41/301 (13%)

Query: 79  HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLG 137
           ++    D +GEG FG+V K      ++        A+K +    S   HR++  E+  L 
Sbjct: 10  NDIKFQDVIGEGNFGQVLKA----RIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 65

Query: 138 QL-KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNY--------------SSTLP 182
           +L  HP+++NL+G C    +  L  EY   GNL D L K+               +STL 
Sbjct: 66  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125

Query: 183 WLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS 242
               +  A   AR + +L   +K  I+RD  A NIL+  +Y AK++DFGL+      E  
Sbjct: 126 SQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVY 180

Query: 243 HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEW 302
              T       + A E +N    TT  DV+S+GV+L E+++   +               
Sbjct: 181 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG----------- 229

Query: 303 ARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
                    +L + +               +  +  QC    P  RP+   ++ +L  +L
Sbjct: 230 -----MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284

Query: 363 D 363
           +
Sbjct: 285 E 285

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 2e-58
 Identities = 58/283 (20%), Positives = 108/283 (38%), Gaps = 23/283 (8%)

Query: 81  FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQL 139
           F +   LG G FG VYKG              VA+K L    S + ++E L E   +  +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAF 199
            +PH+  L+   C      L+ + M  G L D + ++  +       +   +  A+ + +
Sbjct: 69  DNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGMNY 126

Query: 200 LHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEY 259
           L   ++ +++RD  A N+L+ +  + K++DFGLA      E  +          + A E 
Sbjct: 127 LE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 260 INTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDS 319
           I     T   DV+S+GV + EL+T                           +++  I++ 
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG----------------IPASEISSILEK 228

Query: 320 RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
                        +  +  +C   +  SRP    ++     + 
Sbjct: 229 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 4e-58
 Identities = 70/277 (25%), Positives = 121/277 (43%), Gaps = 28/277 (10%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG--HREWLAEVIFLGQLKHPHL 144
           LG G FG V KG      +     +TVAVK+L    +      E LAE   + QL +P++
Sbjct: 15  LGSGNFGTVKKGY----YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 145 VNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEE 204
           V +IG  CE E  +LV E   LG L+  L +N    +     I++    +  + +L   E
Sbjct: 71  VRMIG-ICEAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE--E 125

Query: 205 KPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHIT-TCVMGTEGYAAPEYINTG 263
              ++RD  A N+LL + + AK+SDFGL+      E+ +   T       + APE IN  
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185

Query: 264 HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLED 323
             ++  DV+SFGV++ E  +  +   +                    +++  +++     
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRG----------------MKGSEVTAMLEKGERM 229

Query: 324 RYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEP 360
                  + +  + + C +++ ++RP    V   L  
Sbjct: 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 2e-57
 Identities = 69/297 (23%), Positives = 122/297 (41%), Gaps = 33/297 (11%)

Query: 81  FSRSDY-----LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHR-EWLAEVI 134
            +R        LG+G FG VY+G V   +        VA+K ++   S   R E+L E  
Sbjct: 17  VAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 75

Query: 135 FLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNY--------SSTLPWLTR 186
            + +    H+V L+G   + +  L++ E M  G+L   L             +       
Sbjct: 76  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135

Query: 187 IKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITT 246
           I++A   A  +A+L+      ++RD  A N ++  D+  K+ DFG+  D  + +      
Sbjct: 136 IQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193

Query: 247 CVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPM 306
             +    + +PE +  G  TT  DV+SFGVVL E+ T                       
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE---------------QPYQG 238

Query: 307 LKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD 363
           L +   L  +++  L D+        L  +   C  +NPK RP+   ++ +++  ++
Sbjct: 239 LSNEQVLRFVMEGGLLDKPDNC-PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 3e-57
 Identities = 71/289 (24%), Positives = 113/289 (39%), Gaps = 30/289 (10%)

Query: 81  FSRSDY-----LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVI 134
             R        +GEG FG V++G       P L    VA+K      S   RE +L E +
Sbjct: 4   IQRERIELGRCIGEGQFGDVHQGIYMSPENPALA---VAIKTCKNCTSDSVREKFLQEAL 60

Query: 135 FLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA 194
            + Q  HPH+V LIG   E+    ++ E   LG L     +    +L   + I  A   +
Sbjct: 61  TMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLS 118

Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
             LA+L    K  ++RD  A N+L+ S+   KL DFGL+         +  +       +
Sbjct: 119 TALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKW 175

Query: 255 AAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD 314
            APE IN    T+  DV+ FGV + E+L                             +++
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGV------------KPFQGVKNNDVIGRIE 223

Query: 315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD 363
                 +           L ++  +C +++P  RP  T +   L  +L+
Sbjct: 224 NGERLPMPPNCPPT----LYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 3e-56
 Identities = 74/292 (25%), Positives = 117/292 (40%), Gaps = 31/292 (10%)

Query: 77  ITHNFSRSDY-----LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHRE 128
           +T      D      LG+G FG V +G  D    P  K  +VAVK L    ++  +   +
Sbjct: 1   LTCLIGEKDLRLLEKLGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDD 57

Query: 129 WLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIK 188
           ++ EV  +  L H +L+ L G       + +V E   LG+L D+L K+        T  +
Sbjct: 58  FIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH-FLLGTLSR 115

Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI-TTC 247
            A+  A  + +L    K  I+RD  A N+LL +    K+ DFGL    PQ +D ++    
Sbjct: 116 YAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 173

Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML 307
                 + APE + T   +   D + FGV L E+ T  +         +           
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ----------- 222

Query: 308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE 359
                L +I           +  + +  V  QC +H P+ RPT   +   L 
Sbjct: 223 ----ILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  186 bits (473), Expect = 4e-56
 Identities = 72/283 (25%), Positives = 109/283 (38%), Gaps = 40/283 (14%)

Query: 81  FSRSDYLGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGSQGHREW---LAEVIFL 136
           FS    +G G FG VY    V ++       + VA+K +  +G Q + +W   + EV FL
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNS-------EVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69

Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
            +L+HP+ +   G    +    LV EY                 L  +    +  GA + 
Sbjct: 70  QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQG 127

Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           LA+LH     +I+RD KA NILL      KL DFG A+              +GT  + A
Sbjct: 128 LAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMA 179

Query: 257 PEYI---NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKL 313
           PE I   + G      DV+S G+  +EL   +                     +   + L
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKP----------------PLFNMNAMSAL 223

Query: 314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
             I  +      S   ++        CL   P+ RPT   ++K
Sbjct: 224 YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 2e-55
 Identities = 66/279 (23%), Positives = 109/279 (39%), Gaps = 27/279 (9%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIFLGQ 138
           ++     LGEG +G+V       N       + VAVK++D+  +    E    E+     
Sbjct: 6   DWDLVQTLGEGAYGEVQLAV---NRVTE---EAVAVKIVDMKRAVDCPENIKKEICINKM 59

Query: 139 LKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLA 198
           L H ++V   G+  E   + L  EY + G L D++  +    +P     +        + 
Sbjct: 60  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVV 117

Query: 199 FLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPE 258
           +LH     + +RD K  N+LLD   N K+SDFGLAT         +   + GT  Y APE
Sbjct: 118 YLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175

Query: 259 YINTGHL-TTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII 317
            +          DV+S G+VL  +L G                +      ++++   +  
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELP------------WDQPSDSCQEYSDWKEKK 223

Query: 318 DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                 +        L    H+ L  NP +R T+  + K
Sbjct: 224 TYLNPWKKIDSAPLAL---LHKILVENPSARITIPDIKK 259

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 2e-55
 Identities = 83/307 (27%), Positives = 120/307 (39%), Gaps = 40/307 (13%)

Query: 81  FSRSDY-----LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG-HREWLAEVI 134
           F R        LG G FG+V +      +      +TVAVK+L    +   HR  ++E+ 
Sbjct: 10  FPRDRLKLGKPLGRGAFGQVIEA-DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 68

Query: 135 FLGQLKHPH-LVNLIGYCCEDEHRL-LVYEYMALGNLHDQLFKN--------------YS 178
            L  + H   +VNL+G C +    L ++ E+   GNL   L                 Y 
Sbjct: 69  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128

Query: 179 STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ 238
             L     I  +   A+ + FL    +  I+RD  A NILL      K+ DFGLA D  +
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186

Query: 239 GEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKD 298
             D            + APE I     T   DV+SFGV+L E+ +   S           
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVK 241

Query: 299 LVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL 358
           + E     LK+ T++      R  D  + E    +      C    P  RPT + +V+ L
Sbjct: 242 IDEEFCRRLKEGTRM------RAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 291

Query: 359 EPLLDLN 365
             LL  N
Sbjct: 292 GNLLQAN 298

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 4e-55
 Identities = 60/275 (21%), Positives = 109/275 (39%), Gaps = 31/275 (11%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG+G FGKVYK    +       +   A KV+D    +   +++ E+  L    HP++V 
Sbjct: 20  LGDGAFGKVYKAQNKET------SVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L+     + +  ++ E+ A G +   + +     L       +       L +LH  +  
Sbjct: 74  LLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLH--DNK 130

Query: 207 VIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYI-----N 261
           +I+RD KA NIL   D + KL+DFG++    +          +GT  + APE +      
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPYWMAPEVVMCETSK 188

Query: 262 TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRL 321
                   DV+S G+ L+E+              E + +     + K      +      
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPP------HHELNPMRVLLKIAK-----SEPPTLAQ 237

Query: 322 EDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
             R+S+           +CL  N  +R T + +++
Sbjct: 238 PSRWSSN----FKDFLKKCLEKNVDARWTTSQLLQ 268

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 6e-55
 Identities = 71/280 (25%), Positives = 110/280 (39%), Gaps = 35/280 (12%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFL 136
           +F     LG+G FG VY    +   +       +A+KVL    +  +    +   EV   
Sbjct: 7   DFEIGRPLGKGKFGNVYL-AREKQSK-----FILALKVLFKAQLEKAGVEHQLRREVEIQ 60

Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
             L+HP+++ L GY  +     L+ EY  LG ++ +L K   S              A  
Sbjct: 61  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANA 118

Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L++ H   K VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  
Sbjct: 119 LSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLP 172

Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI 316
           PE I         D++S GV+  E L G+   E N         E  + + +        
Sbjct: 173 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN------TYQETYKRISRVEFTFPDF 226

Query: 317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
           +     D            +  + L HNP  RP +  V++
Sbjct: 227 VTEGARD------------LISRLLKHNPSQRPMLREVLE 254

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 3e-54
 Identities = 56/277 (20%), Positives = 95/277 (34%), Gaps = 35/277 (12%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHL 144
           +G G F  VYKG   +          VA   L          + +  E   L  L+HP++
Sbjct: 17  IGRGSFKTVYKGLDTET------TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 145 VNLIGYCCE----DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFL 200
           V             +  +LV E M  G L   L +     +             + L FL
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFL 128

Query: 201 HGEEKPVIYRDFKASNILLDS-DYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEY 259
           H    P+I+RD K  NI +     + K+ D GLAT     + +     V+GT  + APE 
Sbjct: 129 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEM 184

Query: 260 INTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDS 319
                     DV++FG+ +LE+ T      + +   +                  ++   
Sbjct: 185 YE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ---------------IYRRVTSG 228

Query: 320 RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                +       +  +   C+  N   R ++  ++ 
Sbjct: 229 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 4e-54
 Identities = 74/306 (24%), Positives = 122/306 (39%), Gaps = 40/306 (13%)

Query: 81  FSRSDY-----LGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNGSQGH-REWLAEV 133
             R        LGEG FG+V     +  +     +   VAVK+L  + ++    + ++E+
Sbjct: 10  LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 69

Query: 134 IFLGQL-KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLF--------------KNYS 178
             +  + KH +++NL+G C +D    ++ EY + GNL + L                N  
Sbjct: 70  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129

Query: 179 STLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ 238
             L     +  A   AR + +L    K  I+RD  A N+L+  D   K++DFGLA D   
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187

Query: 239 GEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKD 298
            +    TT       + APE +     T   DV+SFGV+L E+ T   S           
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV------ 241

Query: 299 LVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKAL 358
                        +L +++         +     L  +   C    P  RPT   +V+ L
Sbjct: 242 ----------PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291

Query: 359 EPLLDL 364
           + ++ L
Sbjct: 292 DRIVAL 297

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 4e-53
 Identities = 63/286 (22%), Positives = 106/286 (37%), Gaps = 34/286 (11%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLG 137
           ++     +G G +G+  K     +       + +  K LD         +  ++EV  L 
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSD------GKILVWKELDYGSMTEAEKQMLVSEVNLLR 58

Query: 138 QLKHPHLVNLIGYCCEDEHRLL--VYEYMALGNLHDQLFKNYSS--TLPWLTRIKIAIGA 193
           +LKHP++V       +  +  L  V EY   G+L   + K       L     +++    
Sbjct: 59  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 118

Query: 194 ARCLAFLH---GEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMG 250
              L   H        V++RD K +N+ LD   N KL DFGLA       D+      +G
Sbjct: 119 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVG 176

Query: 251 TEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDF 310
           T  Y +PE +N        D++S G +L EL            K     +   +      
Sbjct: 177 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR---- 232

Query: 311 TKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                    R+  RYS E    L  +  + L+     RP++  +++
Sbjct: 233 ---------RIPYRYSDE----LNEIITRMLNLKDYHRPSVEEILE 265

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 1e-52
 Identities = 61/298 (20%), Positives = 122/298 (40%), Gaps = 44/298 (14%)

Query: 70  TLKELQMI------THNFSRSDYLGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLDVNG 122
            L++L+ I         ++R + +G+G  G VY    V          Q VA++ +++  
Sbjct: 5   ILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATG-------QEVAIRQMNLQQ 57

Query: 123 SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLP 182
                  + E++ + + K+P++VN +      +   +V EY+A G+L D + +       
Sbjct: 58  QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM---D 114

Query: 183 WLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS 242
                 +     + L FLH     VI+RD K+ NILL  D + KL+DFG         + 
Sbjct: 115 EGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQ 170

Query: 243 HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEW 302
              + ++GT  + APE +         D++S G++ +E++ G                  
Sbjct: 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG------------------ 212

Query: 303 ARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAH----QCLSHNPKSRPTMTTVVK 356
             P   +   L  +           +  ++L+A+      +CL  + + R +   +++
Sbjct: 213 -EPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 8e-50
 Identities = 57/293 (19%), Positives = 93/293 (31%), Gaps = 47/293 (16%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFL 136
           +F     LGEG F  V        L      +  A+K+L+   +           E   +
Sbjct: 9   DFKFGKILGEGSFSTVVLAR---ELATS---REYAIKILEKRHIIKENKVPYVTRERDVM 62

Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
            +L HP  V L     +DE       Y   G L   + K    +                
Sbjct: 63  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSA 120

Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
           L +LH   K +I+RD K  NILL+ D + +++DFG A               +GT  Y +
Sbjct: 121 LEYLH--GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178

Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTGRR--------SVEKNRCKREKDLVEWARPMLK 308
           PE +         D+++ G ++ +L+ G           + +   K E D  E   P  +
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 238

Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPL 361
           D  +                          + L  +   R     +       
Sbjct: 239 DLVE--------------------------KLLVLDATKRLGCEEMEGYGPLK 265

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  168 bits (427), Expect = 5e-49
 Identities = 59/272 (21%), Positives = 103/272 (37%), Gaps = 28/272 (10%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG V++ CV+         +    K ++            E+  + QL HP L+N
Sbjct: 37  LGSGAFGVVHR-CVEKATG-----RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     +    +L+ E+++ G L D++       +     I     A   L  +H  E  
Sbjct: 91  LHDAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH--EHS 147

Query: 207 VIYRDFKASNILLDSDYNA--KLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGH 264
           +++ D K  NI+ ++   +  K+ DFGLAT   +     I      T  +AAPE ++   
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAPEIVDREP 204

Query: 265 LTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDR 324
           +    D+++ GV+   LL+G                      L++  + D   D      
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE----------TLQNVKRCDWEFDEDAFSS 254

Query: 325 YSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
            S E            L   P+ R T+   ++
Sbjct: 255 VSPE----AKDFIKNLLQKEPRKRLTVHDALE 282

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  167 bits (425), Expect = 1e-48
 Identities = 57/272 (20%), Positives = 101/272 (37%), Gaps = 28/272 (10%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG V++         G      A K +             E+  +  L+HP LVN
Sbjct: 34  LGTGAFGVVHRVT---ERATG---NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L     +D   +++YE+M+ G L +++   ++  +     ++      + L  +H  E  
Sbjct: 88  LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMH--ENN 144

Query: 207 VIYRDFKASNILLDSDYN--AKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGH 264
            ++ D K  NI+  +  +   KL DFGL       +         GT  +AAPE      
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVAEGKP 201

Query: 265 LTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDR 324
           +    D++S GV+   LL+G                      L++    D  +D      
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFGGENDDE----------TLRNVKSCDWNMDDSAFSG 251

Query: 325 YSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
            S +          + L  +P +R T+   ++
Sbjct: 252 ISED----GKDFIRKLLLADPNTRMTIHQALE 279

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  160 bits (406), Expect = 7e-46
 Identities = 70/280 (25%), Positives = 111/280 (39%), Gaps = 38/280 (13%)

Query: 80  NFSRSDYLGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVI- 134
           +FS    +G GGFG+VY     D         +  A+K LD   +   QG    L E I 
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTG-------KMYAMKCLDKKRIKMKQGETLALNERIM 57

Query: 135 --FLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIG 192
              +     P +V +       +    + + M  G+LH  L ++   +   +      I 
Sbjct: 58  LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI- 116

Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE 252
               L  +H   + V+YRD K +NILLD   + ++SD GLA D  + +        +GT 
Sbjct: 117 -ILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTH 169

Query: 253 GYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFT 311
           GY APE +  G    +  D FS G +L +LL G     +++ K + ++      M     
Sbjct: 170 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM----- 224

Query: 312 KLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM 351
                    L D +S E    L ++    L  +   R   
Sbjct: 225 ------AVELPDSFSPE----LRSLLEGLLQRDVNRRLGC 254

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  157 bits (398), Expect = 2e-45
 Identities = 72/296 (24%), Positives = 122/296 (41%), Gaps = 33/296 (11%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG---HREWLAEV 133
           ++  +   + LG GG  +V+      +LR     + VAVKVL  + ++    +  +  E 
Sbjct: 5   LSDRYELGEILGFGGMSEVHLAR---DLRLH---RDVAVKVLRADLARDPSFYLRFRREA 58

Query: 134 IFLGQLKHPHLVNLIGYCCEDEHRL----LVYEYMALGNLHDQLFKNYSSTLPWLTRIKI 189
                L HP +V +      +        +V EY+    L D +       +     I++
Sbjct: 59  QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEV 116

Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHI-TTCV 248
              A + L F H  +  +I+RD K +NI++ +    K+ DFG+A       +S   T  V
Sbjct: 117 IADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 174

Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK 308
           +GT  Y +PE      +    DV+S G VL E+LTG               V  A   ++
Sbjct: 175 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT------GDSPVSVAYQHVR 228

Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRP-TMTTVVKALEPLLD 363
           +    D I  S   +  S +    L AV  + L+ NP++R  T   +   L  + +
Sbjct: 229 E----DPIPPSARHEGLSAD----LDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 4e-45
 Identities = 65/282 (23%), Positives = 107/282 (37%), Gaps = 34/282 (12%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE----WLAEVIF 135
           +F     LG+G FGKV+              Q  A+K L  +      +     + + + 
Sbjct: 3   DFILHKMLGKGSFGKVFL-AEFKKTN-----QFFAIKALKKDVVLMDDDVECTMVEKRVL 56

Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAAR 195
               +HP L ++       E+   V EY+  G+L   +   +            A     
Sbjct: 57  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIIL 114

Query: 196 CLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
            L FLH   K ++YRD K  NILLD D + K++DFG+  +   G+    T C  GT  Y 
Sbjct: 115 GLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC--GTPDYI 170

Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ 315
           APE +         D +SFGV+L E+L G+           +D  E    +  D     +
Sbjct: 171 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH------GQDEEELFHSIRMDNPFYPR 224

Query: 316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA 357
            ++   +D            +  +     P+ R  +   ++ 
Sbjct: 225 WLEKEAKD------------LLVKLFVREPEKRLGVRGDIRQ 254

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  156 bits (395), Expect = 8e-45
 Identities = 62/289 (21%), Positives = 110/289 (38%), Gaps = 31/289 (10%)

Query: 72  KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WL 130
           K+ + I   +   D LG G F +V      ++ R     + VA+K +     +G      
Sbjct: 2   KQAEDIRDIYDFRDVLGTGAFSEVILA---EDKRTQ---KLVAIKCIAKKALEGKEGSME 55

Query: 131 AEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA 190
            E+  L ++KHP++V L        H  L+ + ++ G L D++ +            ++ 
Sbjct: 56  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLI 113

Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILL---DSDYNAKLSDFGLATDGPQGEDSHITTC 247
                 + +LH  +  +++RD K  N+L    D D    +SDFGL+      +   + + 
Sbjct: 114 FQVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLST 168

Query: 248 VMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML 307
             GT GY APE +     +   D +S GV+   LL G                E    + 
Sbjct: 169 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD----------ENDAKLF 218

Query: 308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
           +   K +   DS   D  S              +  +P+ R T    ++
Sbjct: 219 EQILKAEYEFDSPYWDDISDS----AKDFIRHLMEKDPEKRFTCEQALQ 263

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  156 bits (395), Expect = 1e-44
 Identities = 69/279 (24%), Positives = 111/279 (39%), Gaps = 38/279 (13%)

Query: 81  FSRSDY-----LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAE 132
           +S  D+     LG G FG+V+      +   G   +  A+KVL    V   +       E
Sbjct: 1   YSLQDFQILRTLGTGSFGRVHLI---RSRHNG---RYYAMKVLKKEIVVRLKQVEHTNDE 54

Query: 133 VIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIG 192
            + L  + HP ++ + G   + +   ++ +Y+  G L   L K+     P        + 
Sbjct: 55  RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV- 113

Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE 252
               L +LH   K +IYRD K  NILLD + + K++DFG A   P      +T  + GT 
Sbjct: 114 -CLALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTP 165

Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR--------RSVEKNRCKREKDLVEWAR 304
            Y APE ++T       D +SFG+++ E+L G             +     E     +  
Sbjct: 166 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFN 225

Query: 305 PMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSH 343
             +KD   L ++I   L  R        L        +H
Sbjct: 226 EDVKDL--LSRLITRDLSQRLGN-----LQNGTEDVKNH 257

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 6e-44
 Identities = 50/272 (18%), Positives = 107/272 (39%), Gaps = 29/272 (10%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G FG V++ CV+ + +     +T   K + V G+        E+  L   +H ++++
Sbjct: 13  LGRGEFGIVHR-CVETSSK-----KTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILH 65

Query: 147 LIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKP 206
           L       E  ++++E+++  ++ +++    +  L     +         L FLH     
Sbjct: 66  LHESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEALQFLH--SHN 122

Query: 207 VIYRDFKASNILLDSDYNA--KLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGH 264
           + + D +  NI+  +  ++  K+ +FG A    Q +       +     Y APE      
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQAR---QLKPGDNFRLLFTAPEYYAPEVHQHDV 179

Query: 265 LTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDR 324
           ++T  D++S G ++  LL+G         ++          ++++    +   D      
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQ----------IIENIMNAEYTFDEEAFKE 229

Query: 325 YSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
            S E          + L    KSR T +  ++
Sbjct: 230 ISIE----AMDFVDRLLVKERKSRMTASEALQ 257

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 1e-43
 Identities = 60/290 (20%), Positives = 107/290 (36%), Gaps = 37/290 (12%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA----- 131
           +   +   + LG G F  V K C + +          A K +    ++  R  ++     
Sbjct: 8   VDDYYDTGEELGSGQFAVVKK-CREKSTG-----LQYAAKFIKKRRTKSSRRGVSREDIE 61

Query: 132 -EVIFLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIA 190
            EV  L +++HP+++ L          +L+ E +A G L D L +  S  L      +  
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFL 119

Query: 191 IGAARCLAFLHGEEKPVIYRDFKASNILLDSD----YNAKLSDFGLATDGPQGEDSHITT 246
                 + +LH     + + D K  NI+L          K+ DFGLA     G +     
Sbjct: 120 KQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FK 174

Query: 247 CVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPM 306
            + GT  + APE +N   L    D++S GV+   LL+G      +  +            
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----------T 224

Query: 307 LKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
           L + + ++   +       S            + L  +PK R T+   ++
Sbjct: 225 LANVSAVNYEFEDEYFSNTSAL----AKDFIRRLLVKDPKKRMTIQDSLQ 270

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  152 bits (384), Expect = 1e-43
 Identities = 74/293 (25%), Positives = 110/293 (37%), Gaps = 43/293 (14%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS---------QGHREWL 130
           N+   + LG G    V + C+          +  AVK++DV G          +     L
Sbjct: 4   NYEPKEILGRGVSSVVRR-CIHKPTC-----KEYAVKIIDVTGGGSFSAEEVQELREATL 57

Query: 131 AEVIFLGQLK-HPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKI 189
            EV  L ++  HP+++ L      +    LV++ M  G L D L +    TL      KI
Sbjct: 58  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKI 115

Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVM 249
                  +  LH  +  +++RD K  NILLD D N KL+DFG +    Q +       V 
Sbjct: 116 MRALLEVICALH--KLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVC 170

Query: 250 GTEGYAAPEYI------NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA 303
           GT  Y APE I      N        D++S GV++  LL G                   
Sbjct: 171 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH----------RKQ 220

Query: 304 RPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
             ML+     +    S   D YS      +  +  + L   P+ R T    + 
Sbjct: 221 MLMLRMIMSGNYQFGSPEWDDYSDT----VKDLVSRFLVVQPQKRYTAEEALA 269

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 2e-43
 Identities = 65/316 (20%), Positives = 118/316 (37%), Gaps = 31/316 (9%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHRE-WLAEVIF 135
           +   ++   Y+GEG +G V     D+  +       VA+K +     Q + +  L E+  
Sbjct: 6   VGPRYTNLSYIGEGAYGMVCS-AYDNVNK-----VRVAIKKISPFEHQTYCQRTLREIKI 59

Query: 136 LGQLKHPHLVNLIGYCCEDEHRLLVYEYM---ALGNLHDQLFKNYSSTLPWLTRIKIAIG 192
           L + +H +++ +           +   Y+    +G    +L K     L           
Sbjct: 60  LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQ 117

Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHIT-TCVMGT 251
             R L ++H     V++RD K SN+LL++  + K+ DFGLA       D     T  + T
Sbjct: 118 ILRGLKYIH--SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 175

Query: 252 EGYAAPEYINTGHLTTM-CDVFSFGVVLLELLTGR-------------RSVEKNRCKREK 297
             Y APE +      T   D++S G +L E+L+ R               +       ++
Sbjct: 176 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235

Query: 298 DLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA 357
           DL        +++       +    +R       +   +  + L+ NP  R  +   +  
Sbjct: 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295

Query: 358 --LEPLLDLNDIPIGP 371
             LE   D +D PI  
Sbjct: 296 PYLEQYYDPSDEPIAE 311

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 5e-43
 Identities = 71/291 (24%), Positives = 114/291 (39%), Gaps = 34/291 (11%)

Query: 85  DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG-----HREWLAEVIFLGQL 139
           D+LGEG F  VYK   D N       Q VA+K + +          +R  L E+  L +L
Sbjct: 4   DFLGEGQFATVYK-ARDKNTN-----QIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 57

Query: 140 KHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAF 199
            HP+++ L+       +  LV+++M      + + K+ S  L         +   + L +
Sbjct: 58  SHPNIIGLLDAFGHKSNISLVFDFM--ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 115

Query: 200 LHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEY 259
           LH  +  +++RD K +N+LLD +   KL+DFGLA     G  +   T  + T  Y APE 
Sbjct: 116 LH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYRAPEL 171

Query: 260 INTGHL-TTMCDVFSFGVVLLELLTGR-------------RSVEKNRCKREKDLVEWARP 305
           +    +     D+++ G +L ELL                R  E      E+   +    
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231

Query: 306 MLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                 K    I        + +    L          NP +R T T  +K
Sbjct: 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDL---IQGLFLFNPCARITATQALK 279

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  150 bits (379), Expect = 1e-42
 Identities = 56/285 (19%), Positives = 97/285 (34%), Gaps = 31/285 (10%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           +G G FG +Y G    ++  G   + VA+K+  V     H +   E      ++    + 
Sbjct: 15  IGSGSFGDIYLGT---DIAAG---EEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIP 66

Query: 147 LIGYCCED-EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
            I +C  + ++ ++V E +  G   + LF   S      T + +A      + ++H   K
Sbjct: 67  TIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH--SK 122

Query: 206 PVIYRDFKASNIL---LDSDYNAKLSDFGLA-----TDGPQGEDSHITTCVMGTEGYAAP 257
             I+RD K  N L           + DFGLA         Q         + GT  YA+ 
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182

Query: 258 EYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII 317
                   +   D+ S G VL+    G    +  +   ++   E                
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP------ 236

Query: 318 DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL 362
              L   Y +E     A   + C S     +P  + + +    L 
Sbjct: 237 IEVLCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  148 bits (375), Expect = 4e-42
 Identities = 56/298 (18%), Positives = 92/298 (30%), Gaps = 34/298 (11%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKH-PHLV 145
           +GEG FG +++G    NL      Q VA+K           +   E      L     + 
Sbjct: 13  IGEGSFGVIFEGT---NLLNN---QQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIP 64

Query: 146 NLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEK 205
           N+  +  E  H +LV + +  G   + L           T    A      +  +H  EK
Sbjct: 65  NVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH--EK 120

Query: 206 PVIYRDFKASNILLDSDYN-----AKLSDFGLA-----TDGPQGEDSHITTCVMGTEGYA 255
            ++YRD K  N L+    +       + DFG+          Q         + GT  Y 
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180

Query: 256 APEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ 315
           +         +   D+ + G V +  L G    +  +    K   E      K  T L +
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK-KQSTPLRE 239

Query: 316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL-DLNDIPIGPF 372
           +        +  E         H   +    + P    +      +L  LN      F
Sbjct: 240 LCAG-----FPEE----FYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENF 288

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 2e-41
 Identities = 63/290 (21%), Positives = 114/290 (39%), Gaps = 23/290 (7%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHREWLAEVIFLG 137
           NF + + +GEG +G VYK     N   G   + VA+K +  D          + E+  L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKAR---NKLTG---EVVALKKIRLDTETEGVPSTAIREISLLK 56

Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +L HP++V L+     +    LV+E++   +L   +  +  + +P            + L
Sbjct: 57  ELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGL 115

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAP 257
           AF H     V++RD K  N+L++++   KL+DFGLA           T  V+     A  
Sbjct: 116 AFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRAPE 172

Query: 258 EYINTGHLTTMCDVFSFGVVLLELLTGRR----------SVEKNRCKREKDLVEWARPM- 306
             +   + +T  D++S G +  E++T R                R     D V W     
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232

Query: 307 LKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
           + D+         +   +      +   ++  Q L ++P  R +    + 
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 3e-40
 Identities = 55/277 (19%), Positives = 93/277 (33%), Gaps = 32/277 (11%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G  GKV +   +   +     +  A+K+L  +  +  RE     +     + PH+V 
Sbjct: 20  LGLGINGKVLQ-IFNKRTQ-----EKFALKMLQ-DCPKARRE---VELHWRASQCPHIVR 69

Query: 147 LIGYC----CEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG 202
           ++          +  L+V E +  G L  ++              +I       + +LH 
Sbjct: 70  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH- 128

Query: 203 EEKPVIYRDFKASNILLDSDYN---AKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEY 259
               + +RD K  N+L  S       KL+DFG A +               T  Y APE 
Sbjct: 129 -SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEV 184

Query: 260 INTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDS 319
           +        CD++S GV++  LL G               +  +  M            +
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGY------PPFYSNHGLAISPGMKTRIRMGQYEFPN 238

Query: 320 RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
                 S E    +  +    L   P  R T+T  + 
Sbjct: 239 PEWSEVSEE----VKMLIRNLLKTEPTQRMTITEFMN 271

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  142 bits (358), Expect = 1e-39
 Identities = 52/290 (17%), Positives = 109/290 (37%), Gaps = 25/290 (8%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHREWLAEVIFLG 137
            +   + +GEG +G VYK   +         +T A+K +  +          + E+  L 
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYG-------ETFALKKIRLEKEDEGIPSTTIREISILK 55

Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +LKH ++V L       +  +LV+E++                L  +T     +     +
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGI 113

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAP 257
           A+ H  ++ V++RD K  N+L++ +   K++DFGLA         +    V      A  
Sbjct: 114 AYCH--DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT-LWYRAPD 170

Query: 258 EYINTGHLTTMCDVFSFGVVLLELLTGR-----RSVEKNRCKREKDLVEWARPMLKDFTK 312
             + +   +T  D++S G +  E++ G       S      +  + L         + T+
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230

Query: 313 LDQ------IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
           L +      + +    + +     +    +  + L  +P  R T    ++
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 3e-39
 Identities = 67/288 (23%), Positives = 111/288 (38%), Gaps = 28/288 (9%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREW-----LAEVIFLGQLKH 141
           +GEG +GKV+K     +L+ G   + VA+K + V   +          +A +  L   +H
Sbjct: 15  IGEGAYGKVFKAR---DLKNG--GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 69

Query: 142 PHLVNLIGYCCEDEHRLLVYEYMAL----GNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           P++V L   C            +       +L   L K     +P  T   +     R L
Sbjct: 70  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 129

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAP 257
            FLH     V++RD K  NIL+ S    KL+DFGLA            T V+ T  Y AP
Sbjct: 130 DFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWYRAP 184

Query: 258 EYINTGHLTTMCDVFSFGVVLLELLTGRR--SVEKNRCKREKDLVEWARPMLKDFTKLDQ 315
           E +      T  D++S G +  E+   +       +  +  K L     P  +D+ +   
Sbjct: 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244

Query: 316 IIDSRLEDRYSTEGAKRLAAVAH-------QCLSHNPKSRPTMTTVVK 356
           +       + +    K +  +         +CL+ NP  R +  + + 
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 4e-39
 Identities = 61/283 (21%), Positives = 97/283 (34%), Gaps = 53/283 (18%)

Query: 87  LGEGGFGKVYKG-CVDDNLRPGLKAQTVAVKVL------DVNGSQGHREWLAEVIFLGQL 139
           LG GGFG VY G  V DN         VA+K +      D            EV+ L ++
Sbjct: 12  LGSGGFGSVYSGIRVSDN-------LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 140 KHPH--LVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
                 ++ L+ +    +  +L+ E                + L               +
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAV 123

Query: 198 AFLHGEEKPVIYRDFKASNILLDSD-YNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
              H     V++RD K  NIL+D +    KL DFG            + T   GT  Y+ 
Sbjct: 124 RHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTRVYSP 177

Query: 257 PEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ 315
           PE+I    +      V+S G++L +++ G                         F   ++
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----------------------FEHDEE 215

Query: 316 IIDSRLE--DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVK 356
           II  ++    R S+E       +   CL+  P  RPT   +  
Sbjct: 216 IIRGQVFFRQRVSSE----CQHLIRWCLALRPSDRPTFEEIQN 254

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 5e-39
 Identities = 62/275 (22%), Positives = 95/275 (34%), Gaps = 30/275 (10%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFL 136
           +F     LG+G FGKV     +         +  A+K+L    +         + E   L
Sbjct: 6   DFDYLKLLGKGTFGKVIL-VREKATG-----RYYAMKILRKEVIIAKDEVAHTVTESRVL 59

Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
              +HP L  L       +    V EY   G L   L +    T          I     
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI----V 115

Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
            A  +   + V+YRD K  N++LD D + K++DFGL  +G    D        GT  Y A
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTPEYLA 173

Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTGRR--------SVEKNRCKREKDLVEWARPMLK 308
           PE +         D +  GVV+ E++ GR          + +     E        P  K
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAK 233

Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSH 343
               L  ++    + R     +      A + + H
Sbjct: 234 SL--LAGLLKKDPKQRLGGGPSD-----AKEVMEH 261

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 2e-38
 Identities = 67/291 (23%), Positives = 111/291 (38%), Gaps = 33/291 (11%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           +++ +  +G G FG VY+  + D+       + VA+K +     Q  R    E+  + +L
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQIMRKL 70

Query: 140 KHPHLVNLIGYCCE------DEHRLLVYEYMALGNLHDQL-FKNYSSTLPWLTRIKIAIG 192
            H ++V L  +         + +  LV +Y+          +     TLP +        
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130

Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSD-YNAKLSDFGLATDGPQGEDSHITTCVMGT 251
             R LA++H     + +RD K  N+LLD D    KL DFG A    +GE +   + +   
Sbjct: 131 LFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSR 186

Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRR---------SVEKNRCKREKDLVEW 302
              A          T+  DV+S G VL ELL G+           + +          E 
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246

Query: 303 ARPMLKDFT--KLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTM 351
            R M  ++T  K  QI        +         A+  + L + P +R T 
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 297

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 9e-38
 Identities = 65/331 (19%), Positives = 118/331 (35%), Gaps = 45/331 (13%)

Query: 69  FTLKELQMITHNFSRSDY-----LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL--DVN 121
           F  +E+        R+ Y     +G G +G V       + R G     VA+K L     
Sbjct: 4   FYRQEVTKTAWEV-RAVYRDLQPVGSGAYGAVCSAV---DGRTG---AKVAIKKLYRPFQ 56

Query: 122 GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR------LLVYEYMALGNLHDQLFK 175
                +    E+  L  ++H +++ L+     DE         LV  +M  G    +L K
Sbjct: 57  SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMK 114

Query: 176 NYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD 235
           +    L       +     + L ++H     +I+RD K  N+ ++ D   K+ DFGLA  
Sbjct: 115 HEK--LGEDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170

Query: 236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR---------- 285
                DS +T  V+     A    +N    T   D++S G ++ E++TG+          
Sbjct: 171 A----DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 226

Query: 286 ---RSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLS 342
                ++       + +        K++ K    ++ +      T  +     +  + L 
Sbjct: 227 QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLV 286

Query: 343 HNPKSRPTMTTVVKA--LEPLLDLNDIPIGP 371
            + + R T    +     E L D  D P   
Sbjct: 287 LDAEQRVTAGEALAHPYFESLHDTEDEPQVQ 317

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 2e-36
 Identities = 58/304 (19%), Positives = 114/304 (37%), Gaps = 37/304 (12%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG--HREWLAEVIFLG 137
            + +   +G+G FG+V+K     + + G   Q VA+K + +   +       L E+  L 
Sbjct: 11  KYEKLAKIGQGTFGEVFKAR---HRKTG---QKVALKKVLMENEKEGFPITALREIKILQ 64

Query: 138 QLKHPHLVNLIGYCCEDEHR--------LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKI 189
            LKH ++VNLI  C               LV+++                TL  + R+  
Sbjct: 65  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQ 124

Query: 190 AIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTC-- 247
            +         +     +++RD KA+N+L+  D   KL+DFGLA      ++S       
Sbjct: 125 ML----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180

Query: 248 VMGTEGYAAPEYI-NTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV------ 300
            + T  Y  PE +          D++  G ++ E+ T    ++ N  + +  L+      
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240

Query: 301 --EWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAH------QCLSHNPKSRPTMT 352
                 P + ++   +++   + + R   +  K      +      + L  +P  R    
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300

Query: 353 TVVK 356
             + 
Sbjct: 301 DALN 304

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 8e-36
 Identities = 57/291 (19%), Positives = 99/291 (34%), Gaps = 25/291 (8%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHREWLAEVIFLG 137
            + + + +GEG +G V+K   +         + VA+K +  D +        L E+  L 
Sbjct: 3   KYEKLEKIGEGTYGTVFK-AKNRETH-----EIVALKRVRLDDDDEGVPSSALREICLLK 56

Query: 138 QLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCL 197
           +LKH ++V L      D+   LV+E+            N                  + L
Sbjct: 57  ELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEI--VKSFLFQLLKGL 114

Query: 198 AFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAP 257
            F H   + V++RD K  N+L++ +   KL++FGLA           +  V+        
Sbjct: 115 GFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLARA-FGIPVRCYSAEVVTLWYRPPD 171

Query: 258 EYINTGHLTTMCDVFSFGVVLLELLTGRR------SVEKNRCKREKDLVEWARPMLKDFT 311
                   +T  D++S G +  EL    R       V+    +  + L           T
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231

Query: 312 KLDQIIDSRL--EDRYSTEGAKRLAAVA----HQCLSHNPKSRPTMTTVVK 356
           KL       +            +L A         L  NP  R +    ++
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  129 bits (324), Expect = 3e-34
 Identities = 61/275 (22%), Positives = 95/275 (34%), Gaps = 33/275 (12%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD---VNGSQGHREWLAEVIFL 136
            F R   LG G FG+V                  A+K+LD   V   +     L E   L
Sbjct: 42  QFDRIKTLGTGSFGRVML-VKHKESG-----NHYAMKILDKQKVVKLKQIEHTLNEKRIL 95

Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
             +  P LV L     ++ +  +V EY+A G +   L +              A      
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLT 153

Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAA 256
             +LH     +IYRD K  N+L+D     +++DFG A           T  + GT    A
Sbjct: 154 FEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALA 206

Query: 257 PEYINTGHLTTMCDVFSFGVVLLELLTGRR--------SVEKNRCKREKDLVEWARPMLK 308
           PE I +       D ++ GV++ E+  G           + +     +          LK
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266

Query: 309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSH 343
           D   L  ++   L  R+       L    +   +H
Sbjct: 267 DL--LRNLLQVDLTKRF-----GNLKNGVNDIKNH 294

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 8e-33
 Identities = 68/283 (24%), Positives = 107/283 (37%), Gaps = 34/283 (12%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLD----VNGSQGHREWLAEVIF 135
           NF     LG G +GKV+          G   +  A+KVL     V  ++       E   
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTG---KLYAMKVLKKATIVQKAKTTEHTRTERQV 81

Query: 136 LGQLKH-PHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAA 194
           L  ++  P LV L      +    L+ +Y+  G L   L +    T   +      I   
Sbjct: 82  LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI--- 138

Query: 195 RCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGY 254
             LA  H  +  +IYRD K  NILLDS+ +  L+DFGL+ +    +++       GT  Y
Sbjct: 139 -VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIEY 196

Query: 255 AAPEYINTGH--LTTMCDVFSFGVVLLELLTGRR------------SVEKNRCKREKDLV 300
            AP+ +  G        D +S GV++ ELLTG               + +   K E    
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 256

Query: 301 EWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSH 343
           +    + KD   + +++    + R            A +   H
Sbjct: 257 QEMSALAKDL--IQRLLMKDPKKRLGC-----GPRDADEIKEH 292

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  117 bits (294), Expect = 3e-30
 Identities = 53/302 (17%), Positives = 109/302 (36%), Gaps = 44/302 (14%)

Query: 80  NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQL 139
           ++     LG G + +V++     N+      + V VK+L        ++   E+  L  L
Sbjct: 36  DYQLVRKLGRGKYSEVFEAI---NITNN---EKVVVKILK---PVKKKKIKREIKILENL 86

Query: 140 K-HPHLVNLIGYCCEDEHRL--LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
           +  P+++ L     +   R   LV+E++   +           TL             + 
Sbjct: 87  RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKA 141

Query: 197 LAFLHGEEKPVIYRDFKASNILLDSD-YNAKLSDFGLATDGPQGEDSHITTCVMGTEGYA 255
           L + H     +++RD K  N+++D +    +L D+GLA     G++       + +  + 
Sbjct: 142 LDYCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFK 196

Query: 256 APE-YINTGHLTTMCDVFSFGVVLLELLTGR---RSVEKNRCKREKDLVEWARPMLKDF- 310
            PE  ++        D++S G +L  ++  +        N  +  +         L D+ 
Sbjct: 197 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256

Query: 311 TKLDQIIDSRLEDRYSTEGAKRLAAVAH----------------QCLSHNPKSRPTMTTV 354
            K +  +D R  D       KR     H                + L ++ +SR T    
Sbjct: 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316

Query: 355 VK 356
           ++
Sbjct: 317 ME 318

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 9e-30
 Identities = 60/318 (18%), Positives = 111/318 (34%), Gaps = 39/318 (12%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHREWLAEVI 134
           +   +     +G G +G V       + + G     VAVK L          +    E+ 
Sbjct: 16  VPERYQNLSPVGSGAYGSVCAAF---DTKTG---LRVAVKKLSRPFQSIIHAKRTYRELR 69

Query: 135 FLGQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNY--SSTLPWLTRIKIAIG 192
            L  +KH +++ L+             +   + +L      N      L       +   
Sbjct: 70  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 129

Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTE 252
             R L ++H     +I+RD K SN+ ++ D   K+ DFGLA       D  +T  V    
Sbjct: 130 ILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARH----TDDEMTGYVATRW 183

Query: 253 GYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR------------RSVEKNRCKREKDLV 300
             A    +N  H     D++S G ++ ELLTGR            + + +       +L+
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243

Query: 301 EW-----ARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVV 355
           +      AR  ++  T++ ++  + +    +      L     + L  +   R T    +
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL----EKMLVLDSDKRITAAQAL 299

Query: 356 KA--LEPLLDLNDIPIGP 371
                    D +D P+  
Sbjct: 300 AHAYFAQYHDPDDEPVAD 317

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 3e-28
 Identities = 55/312 (17%), Positives = 102/312 (32%), Gaps = 48/312 (15%)

Query: 77  ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVL--DVNGSQGHREWLAEVI 134
           +   +     +G G  G V     D  L      + VA+K L          +    E++
Sbjct: 15  VLKRYQNLKPIGSGAQGIVCA-AYDAVLD-----RNVAIKKLSRPFQNQTHAKRAYRELV 68

Query: 135 FLGQLKHPHLVNLIGYCC------EDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIK 188
            +  + H ++++L+          E +   LV E M          +             
Sbjct: 69  LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSY 123

Query: 189 IAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCV 248
           +       +  LH     +I+RD K SNI++ SD   K+ DFGLA        S + T  
Sbjct: 124 LLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPY 178

Query: 249 MGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR----------------RSVEKNR 292
           + T  Y APE I         D++S G ++ E++  +                  +    
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238

Query: 293 CKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVA--------HQCLSHN 344
            +  K L    R  +++  K   +   +L              +          + L  +
Sbjct: 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 298

Query: 345 PKSRPTMTTVVK 356
           P  R ++   ++
Sbjct: 299 PAKRISVDDALQ 310

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  103 bits (256), Expect = 6e-25
 Identities = 54/315 (17%), Positives = 101/315 (32%), Gaps = 53/315 (16%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVN 146
           LG G F  V+      ++        VA+K++             E+  L ++       
Sbjct: 21  LGWGHFSTVWLAK---DMVNN---THVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTK 73

Query: 147 LIGYCCEDEHRLLVY-------------EYMALGNLHDQLFKNYSSTLPWLTRIK-IAIG 192
                     +LL +              +  LG     L K Y      L  +K I+  
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 193 AARCLAFLHGEEKPVIYRDFKASNILLDS-DYNAKLSDFGLATDGPQGEDSHITTCVMGT 251
               L ++H     +I+ D K  N+L++  D    L    +A  G         T  + T
Sbjct: 134 LLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192

Query: 252 EGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEW--------- 302
             Y +PE +         D++S   ++ EL+TG    E +         +          
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252

Query: 303 ------------------ARPMLKDFTKLDQIIDSRL---EDRYSTEGAKRLAAVAHQCL 341
                             +R +L++ +KL       +   + ++S + AK ++      L
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312

Query: 342 SHNPKSRPTMTTVVK 356
             +P+ R     +V 
Sbjct: 313 QLDPRKRADAGGLVN 327

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 71.4 bits (174), Expect = 4e-15
 Identities = 20/159 (12%), Positives = 45/159 (28%), Gaps = 25/159 (15%)

Query: 87  LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS----------QGHREWLAEVIFL 136
           +GEG    V+    +             VK   V  +           G   +    I  
Sbjct: 8   MGEGKESAVFNCYSEKF-------GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 137 GQLKHPHLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARC 196
            + +   L  L G           Y +     L + +       +      ++       
Sbjct: 61  ARNEFRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEE 115

Query: 197 LAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD 235
           +A  +   + +++ D    N+L+  +    + DF  + +
Sbjct: 116 VAKFY--HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE 151

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	449
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.71
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.11
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.87
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.88
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.78
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.31

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-58  Score=429.52  Aligned_cols=255  Identities=25%  Similarity=0.360  Sum_probs=207.3

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      .++|++.+.||+|+||+||+|.+..      +++.||||+++.... ...+.+.+|+.+|++++||||+++++++.+++.
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~------~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~   77 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRV------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI   77 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECC------CCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCce
Confidence            4679999999999999999998765      588999999975432 234568899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .||||||++||+|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||+|+..
T Consensus        78 ~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH--~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~  153 (271)
T d1nvra_          78 QYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVF  153 (271)
T ss_dssp             EEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH--HcCCccCcccHHHEEECCCCCEEEccchhheee
Confidence            99999999999999998654  57999999999999999999999  678999999999999999999999999999876


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCC-CcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHL-TTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ............+||+.|||||++.+..+ +.++|||||||+||||++|++||......... ....             
T Consensus       154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~~-------------  219 (271)
T d1nvra_         154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDW-------------  219 (271)
T ss_dssp             EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHHH-------------
T ss_pred             ccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHHH-------------
Confidence            44333333455779999999999987776 67899999999999999999999764322111 1000             


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       ............+++++.+|+.+||+.||++|||+.|+++|
T Consensus       220 -~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         220 -KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             -HTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -hcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             01111111123345678899999999999999999999987

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-56  Score=423.68  Aligned_cols=251  Identities=23%  Similarity=0.382  Sum_probs=211.7

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      ++|++.+.||+|+||+||+|.+..      +++.||||++........+.+.+|+.+|+.++||||+++++++.+++..|
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~------~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   93 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVA------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW   93 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTT------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECC------CCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEE
Confidence            479999999999999999997665      58899999998665556678999999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCC
Q 013105          159 LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~  238 (449)
                      ||||||.||+|.+++.+   ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||+|+....
T Consensus        94 ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH--~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~  168 (293)
T d1yhwa1          94 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (293)
T ss_dssp             EEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHH--HCCCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence            99999999999988765   36999999999999999999999  67899999999999999999999999999987644


Q ss_pred             CCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhc
Q 013105          239 GEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIID  318 (449)
Q Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (449)
                      ...  .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+..........  ..             .
T Consensus       169 ~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~--~~-------------~  231 (293)
T d1yhwa1         169 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI--AT-------------N  231 (293)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--HH-------------H
T ss_pred             ccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHH--Hh-------------C
Confidence            322  234567999999999999999999999999999999999999999764322111100  00             0


Q ss_pred             ccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          319 SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       319 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .......+..+++.+.+||.+||+.||++|||+.|+++|
T Consensus       232 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         232 GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             CSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             CCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            011112234556779999999999999999999999987

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-57  Score=418.60  Aligned_cols=247  Identities=28%  Similarity=0.426  Sum_probs=209.9

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ++|++.+.||+|+||+||+|.+..      +++.||+|++...   .......+.+|+.+++.++||||+++++++.+++
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~   79 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQ------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT   79 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hHeEEEEEEecCCCcEEEEEEECC------CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC
Confidence            579999999999999999998765      5889999998632   2334567889999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..|||||||+||+|.+++...  ..+++..+..++.|++.||+|||  ++||+||||||+|||++.++.+||+|||+|..
T Consensus        80 ~~~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH--~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~  155 (263)
T d2j4za1          80 RVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVH  155 (263)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECCCCSCSC
T ss_pred             EEEEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeeeeccccceecCCCCEeecccceeee
Confidence            999999999999999999765  57999999999999999999999  67899999999999999999999999999986


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      .....    .....||+.|||||++.+..|+.++|||||||+||||++|+.||.+.........+               
T Consensus       156 ~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i---------------  216 (263)
T d2j4za1         156 APSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI---------------  216 (263)
T ss_dssp             CCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---------------
T ss_pred             cCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHH---------------
Confidence            54322    34567999999999999999999999999999999999999999765322111110               


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       ...  ...++..+++++.+|+.+||+.||++|||+.|+++|
T Consensus       217 -~~~--~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         217 -SRV--EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             -HTT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             -HcC--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence             010  112334456779999999999999999999999986

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-56  Score=421.26  Aligned_cols=262  Identities=27%  Similarity=0.396  Sum_probs=206.1

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      -.++|++.+.||+|+||+||+|.+.         ..||||+++..  .....+.+.+|+.+|++++||||+++++++. .
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~---------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~   75 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWH---------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-A   75 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESS---------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEEC---------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-c
Confidence            3578999999999999999999643         35999999744  3445678999999999999999999999875 4


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +.++||||||+||+|.+++... ...+++..+..++.|++.||+|||  +++||||||||+|||++.++.+||+|||+|+
T Consensus        76 ~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH--~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~  152 (276)
T d1uwha_          76 PQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT  152 (276)
T ss_dssp             SSCEEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred             cEEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHh--cCCEeccccCHHHEEEcCCCCEEEcccccee
Confidence            5689999999999999998654 356999999999999999999999  6789999999999999999999999999998


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccC---CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcccc
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTG---HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFT  311 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  311 (449)
                      ...............||+.|||||++.+.   .|+.++|||||||+||||+||+.||.+........  .....      
T Consensus       153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~--~~~~~------  224 (276)
T d1uwha_         153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII--FMVGR------  224 (276)
T ss_dssp             C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH--HHHHH------
T ss_pred             eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH--HHHhc------
Confidence            76544433344556799999999998643   58999999999999999999999998643221111  00000      


Q ss_pred             chhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          312 KLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                          ..........+..+++.+.+|+.+||+.||++|||+.+|+++|+.+..
T Consensus       225 ----~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         225 ----GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             ----TSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                001111122345566789999999999999999999999999998765

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.5e-57  Score=426.06  Aligned_cols=263  Identities=25%  Similarity=0.398  Sum_probs=219.4

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      +-.++|++.+.||+|+||+||+|.+..      +++.||||+++.. ....+++.+|+.+|++++|||||++++++.+++
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~------~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   86 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   86 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGG------GTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECC------CCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence            345678999999999999999998875      5789999999754 344678999999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..+||||||++|+|.+++.......+++..+..++.|++.||.|||  ++||+||||||+||||+.++.+||+|||+|+.
T Consensus        87 ~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH--~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~  164 (287)
T d1opja_          87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRL  164 (287)
T ss_dssp             SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred             eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH--HCCcccCccccCeEEECCCCcEEEccccceee
Confidence            9999999999999999998776788999999999999999999999  67899999999999999999999999999987


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ...... .......||+.|+|||++.+..|+.++|||||||++|||++|..||.......  .              +..
T Consensus       165 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~--~--------------~~~  227 (287)
T d1opja_         165 MTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--Q--------------VYE  227 (287)
T ss_dssp             CCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--H--------------HHH
T ss_pred             cCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH--H--------------HHH
Confidence            654322 22333458999999999999999999999999999999999776654322111  1              111


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                      .+........+..+++++.+|+.+||+.||++|||+.+|++.|+.+++.
T Consensus       228 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         228 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             HHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            1222223344556677899999999999999999999999999887653

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-56  Score=418.44  Aligned_cols=252  Identities=23%  Similarity=0.358  Sum_probs=209.4

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      +.|++.+.||+|+||.||+|.+..      +++.||||+++.......+.+.+|+++|++++|||||++++++.+++..|
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~------~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~   85 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKE------TSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW   85 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECC------CCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEE
Confidence            468999999999999999998766      58899999998766666678899999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCC
Q 013105          159 LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~  238 (449)
                      ||||||+||+|.+++.+. ...+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||+|.....
T Consensus        86 lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH--~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1          86 ILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLH--DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  162 (288)
T ss_dssp             EEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred             EEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence            999999999999987654 357999999999999999999999  67899999999999999999999999999975422


Q ss_pred             CCCCceeeecCCCCccccccccc-----cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccch
Q 013105          239 GEDSHITTCVMGTEGYAAPEYIN-----TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      .  ........||+.|+|||++.     +..|+.++|||||||+||||++|+.||.+........               
T Consensus       163 ~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~---------------  225 (288)
T d2jfla1         163 T--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL---------------  225 (288)
T ss_dssp             H--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH---------------
T ss_pred             C--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH---------------
Confidence            1  11223467999999999983     4568999999999999999999999998653222111               


Q ss_pred             hHhhccc-ccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          314 DQIIDSR-LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       314 ~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       .+.... .....+..+++++.+||.+||+.||++|||+.|+++|
T Consensus       226 -~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         226 -KIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             -HHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             -HHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             111110 1112234556779999999999999999999999987

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-56  Score=416.76  Aligned_cols=254  Identities=23%  Similarity=0.312  Sum_probs=197.5

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEe--C
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCE--D  154 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~  154 (449)
                      ++|++.+.||+|+||.||+|.+..      +++.||||++....  ....+.+.+|+++|++++||||+++++++.+  +
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   77 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKS------DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN   77 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC---
T ss_pred             hhCEEeEEEecCCCeEEEEEEECC------CCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC
Confidence            679999999999999999998765      58899999997543  2334668899999999999999999999865  4


Q ss_pred             CEEEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCC---CCeeeccCCCCceEEcCCCcEEEee
Q 013105          155 EHRLLVYEYMALGNLHDQLFKN--YSSTLPWLTRIKIAIGAARCLAFLHGEE---KPVIYRDFKASNILLDSDYNAKLSD  229 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~~ivHrDikp~Nill~~~~~~kl~D  229 (449)
                      +.+|||||||+||+|.+++.+.  ....+++..++.++.|++.||.|||+.+   .+|+||||||+|||++.++.+||+|
T Consensus        78 ~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D  157 (269)
T d2java1          78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD  157 (269)
T ss_dssp             -CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred             CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEee
Confidence            6689999999999999998643  3467999999999999999999999532   3499999999999999999999999


Q ss_pred             eccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcc
Q 013105          230 FGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKD  309 (449)
Q Consensus       230 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  309 (449)
                      ||+|+......  .......||+.|||||++.+..|+.++|||||||++|||++|+.||.+.........          
T Consensus       158 FG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~----------  225 (269)
T d2java1         158 FGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK----------  225 (269)
T ss_dssp             HHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----------
T ss_pred             ccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHH----------
Confidence            99998654322  223456799999999999999999999999999999999999999976432211110          


Q ss_pred             ccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          310 FTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                            +... .....+..+++++.+|+.+||+.||.+|||+.|+++|
T Consensus       226 ------i~~~-~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         226 ------IREG-KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             ------HHHT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ------HHcC-CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                  1111 1112334556679999999999999999999999986

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-56  Score=428.00  Aligned_cols=267  Identities=23%  Similarity=0.355  Sum_probs=208.6

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ..++|++.+.||+|+||+||+|.+..      +++.||+|+++... ......+.+|+.+|+.++|||||++++++.+++
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~------~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   77 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKP------SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG   77 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETT------TTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECC------CCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            45789999999999999999998765      58999999997553 333567899999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..||||||+.||+|.+++.+.  ..+++..+..++.|++.||.|||+ .+||+||||||+|||++.++.+||+|||+|+.
T Consensus        78 ~~~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~-~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~  154 (322)
T d1s9ja_          78 EISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  154 (322)
T ss_dssp             EEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH-HHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred             EEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH-hCCEEccccCHHHeeECCCCCEEEeeCCCccc
Confidence            999999999999999999765  579999999999999999999994 13799999999999999999999999999985


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHh-hhhhh-------
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEW-ARPML-------  307 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~-~~~~~-------  307 (449)
                      ....    .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+............ .....       
T Consensus       155 ~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (322)
T d1s9ja_         155 LIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP  230 (322)
T ss_dssp             HHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------
T ss_pred             cCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccc
Confidence            4321    12346799999999999999999999999999999999999999976533211100000 00000       


Q ss_pred             ------------------ccccchhHhhcccccccCC-HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          308 ------------------KDFTKLDQIIDSRLEDRYS-TEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       308 ------------------~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                                        ............ .....+ ...+.++.+|+.+||+.||.+|||++|+++|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNE-PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             ---------------CCCCHHHHHHHHHTS-CCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccccchhHHHHHhhhhcc-CCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                              000000000010 011111 1235678999999999999999999999987

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-56  Score=419.17  Aligned_cols=251  Identities=21%  Similarity=0.279  Sum_probs=206.7

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ++|++.+.||+|+||+||+|.+..      +++.||||++...   .......+.+|+.+|++++||||+++++++.+++
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   81 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELA------TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE   81 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECC------CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC
Confidence            579999999999999999998765      5889999999632   2334567899999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..||||||++||+|.+++...  +.+++..+..++.|++.||+|||  ++||+||||||+|||++.++.+||+|||+|+.
T Consensus        82 ~~~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH--~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~  157 (288)
T d1uu3a_          82 KLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLH--GKGIIHRDLKPENILLNEDMHIQITDFGTAKV  157 (288)
T ss_dssp             EEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhc--cccEEcCcCCccccccCCCceEEeccccccee
Confidence            999999999999999988765  57999999999999999999999  67899999999999999999999999999987


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      .............+||+.|+|||++.+..|+.++|||||||+||||++|..||.+........                .
T Consensus       158 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~----------------~  221 (288)
T d1uu3a_         158 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ----------------K  221 (288)
T ss_dssp             CC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----------------H
T ss_pred             cccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHH----------------H
Confidence            654433334455679999999999999999999999999999999999999998653221110                1


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      +...  ...++..+++++.+||.+||+.||++|||++|++.+
T Consensus       222 i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         222 IIKL--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             HHTT--CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             HHcC--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence            1111  112334456679999999999999999999997654

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=411.85  Aligned_cols=256  Identities=25%  Similarity=0.406  Sum_probs=201.5

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      ++|++.+.||+|+||+||+|.+.+       ++.||||+++.. ....+++.+|++++++++||||+++++++.+++..+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~-------~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLN-------KDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   76 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETT-------TEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECC-------CCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceE
Confidence            578899999999999999998754       568999999754 334578999999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCC
Q 013105          159 LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~  238 (449)
                      +||||+++|+|.+++... ...+++..++.++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++....
T Consensus        77 lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH--~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  153 (263)
T d1sm2a_          77 LVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  153 (263)
T ss_dssp             EEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred             EEEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhh--ccceeecccchhheeecCCCCeEecccchheeccC
Confidence            999999999999988654 356889999999999999999999  67799999999999999999999999999986544


Q ss_pred             CCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhC-CCcccccccccchhhHHhhhhhhccccchhHhh
Q 013105          239 GEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG-RRSVEKNRCKREKDLVEWARPMLKDFTKLDQII  317 (449)
Q Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (449)
                      .... ......||+.|+|||++.+..|+.++|||||||++|||+|+ .+||......   .....              +
T Consensus       154 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~---~~~~~--------------i  215 (263)
T d1sm2a_         154 DQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVED--------------I  215 (263)
T ss_dssp             ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH---HHHHH--------------H
T ss_pred             CCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH---HHHHH--------------H
Confidence            3222 23345689999999999999999999999999999999995 5555443211   11111              1


Q ss_pred             cccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          318 DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       318 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                      ........+..+++++.+|+.+||+.||++|||+++|+++|+.+.+
T Consensus       216 ~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         216 STGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            1111222344556779999999999999999999999999998754

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-55  Score=407.32  Aligned_cols=248  Identities=23%  Similarity=0.351  Sum_probs=199.3

Q ss_pred             CCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEe----CC
Q 013105           82 SRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE----DE  155 (449)
Q Consensus        82 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~----~~  155 (449)
                      ++.+.||+|+||+||+|.+..      ++..||+|++...  .....+.+.+|+++|++++||||+++++++.+    +.
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~------~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~   85 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTE------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK   85 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred             EeeeEEecCcCcEEEEEEECC------CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCC
Confidence            566789999999999998765      5789999998644  23345678899999999999999999999875    45


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEc-CCCcEEEeeecccc
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD-SDYNAKLSDFGLAT  234 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~-~~~~~kl~DfGla~  234 (449)
                      .+||||||+++|+|.+++.+.  ..+++..+..++.|++.||.|||+++.+|+||||||+|||++ .++.+||+|||+|+
T Consensus        86 ~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          86 CIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence            689999999999999999765  578999999999999999999994434499999999999996 57899999999998


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      .....    .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+......  ....   .        
T Consensus       164 ~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~~~---i--------  225 (270)
T d1t4ha_         164 LKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRR---V--------  225 (270)
T ss_dssp             GCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHH---H--------
T ss_pred             eccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HHHH---H--------
Confidence            54332    2345679999999999875 599999999999999999999999975422111  1110   0        


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                        .....+..++...++++.+|+.+||+.||++|||+.|+++|
T Consensus       226 --~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         226 --TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             --TTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             --HcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence              01111112223344568999999999999999999999986

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-55  Score=418.28  Aligned_cols=254  Identities=22%  Similarity=0.355  Sum_probs=195.6

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      +.+.|++.+.||+|+||+||+|.+..      +++.||||++..... .....+.+|+.+|+.++||||+++++++.+++
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~------~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   80 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKR------TQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGG   80 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETT------TCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             CccceEEEEEEeeccCeEEEEEEECC------CCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            45779999999999999999998765      588999999975432 23356788999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEc---CCCcEEEeeecc
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD---SDYNAKLSDFGL  232 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~---~~~~~kl~DfGl  232 (449)
                      .+|||||||+||+|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||+.   .++.+||+|||+
T Consensus        81 ~~~lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH--~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~  156 (307)
T d1a06a_          81 HLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGL  156 (307)
T ss_dssp             EEEEEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESSSSTTCCEEECCC--
T ss_pred             EEEEEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhh--hceeeeEEecccceeecccCCCceEEEeccce
Confidence            999999999999999999764  67999999999999999999999  67899999999999994   578999999999


Q ss_pred             ccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccc
Q 013105          233 ATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTK  312 (449)
Q Consensus       233 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  312 (449)
                      |+......   .....+||+.|||||++.+..|+.++|||||||+||||++|..||.+.........+      ...   
T Consensus       157 a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i------~~~---  224 (307)
T d1a06a_         157 SKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI------LKA---  224 (307)
T ss_dssp             -------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH------HTT---
T ss_pred             eEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH------hcc---
Confidence            98654322   234467999999999999999999999999999999999999999765322111100      000   


Q ss_pred             hhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          313 LDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                           ...........+++++.+|+.+||+.||++|||+.|+++|
T Consensus       225 -----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         225 -----EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             -----CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             -----CCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                 0111222334566779999999999999999999999997

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-56  Score=415.36  Aligned_cols=259  Identities=29%  Similarity=0.411  Sum_probs=210.6

Q ss_pred             HHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           76 MITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        76 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      +..++|++.+.||+|+||.||+|.+.+       +..||||+++.. ....+.+.+|+.+|++++|||||++++++.+ +
T Consensus        10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~-------~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~   80 (272)
T d1qpca_          10 VPRETLKLVERLGAGQFGEVWMGYYNG-------HTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E   80 (272)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETT-------TEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             cCHHHeEEeEEEecCCCcEEEEEEECC-------CCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence            345678999999999999999998753       578999999754 3445789999999999999999999998754 5


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..+|||||+++|+|.+++.......+++..++.++.|++.||.|||  .++|+||||||+||||+.++.+||+|||+|+.
T Consensus        81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH--~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~  158 (272)
T d1qpca_          81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARL  158 (272)
T ss_dssp             SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCccchhheeeecccceeeccccceEE
Confidence            6799999999999999886655557999999999999999999999  67799999999999999999999999999987


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCc-ccccccccchhhHHhhhhhhccccchh
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRS-VEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ..... ........||+.|+|||++.+..++.++|||||||++|||+||..| |......   ....             
T Consensus       159 ~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~---~~~~-------------  221 (272)
T d1qpca_         159 IEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQ-------------  221 (272)
T ss_dssp             CSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH-------------
T ss_pred             ccCCc-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH---HHHH-------------
Confidence            64432 2223345689999999999988999999999999999999996555 4432211   1111             


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                       .+........+..+++++.+|+.+||+.||++|||+.+|++.|++++.
T Consensus       222 -~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         222 -NLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             -HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence             111112223344566779999999999999999999999999998764

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-55  Score=422.56  Aligned_cols=263  Identities=24%  Similarity=0.381  Sum_probs=212.6

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC-CcchHHHHHHHHHHHhcC-CCCCcceeeeEEEeCC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCEDE  155 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~  155 (449)
                      .++|++.+.||+|+||+||+|.+... ........||+|.+... .......+.+|+.+|.++ +|||||++++++.+.+
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGI-SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESC-SSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCC-CcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            46799999999999999999988753 11223457999998643 233346788999999998 8999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcC---------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNY---------------------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKA  214 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp  214 (449)
                      ..|||||||++|+|.+++..+.                     ...+++..++.++.|++.||+|||  +++||||||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH--~~~IiHRDlKp  192 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHRDLAA  192 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH--HTTEEETTCSG
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCch
Confidence            9999999999999999996542                     135889999999999999999999  67899999999


Q ss_pred             CceEEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCccccccc
Q 013105          215 SNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRC  293 (449)
Q Consensus       215 ~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~  293 (449)
                      +|||++.++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |.+||.+...
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987655444333445568999999999999999999999999999999998 8999976432


Q ss_pred             ccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 013105          294 KREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALE  359 (449)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  359 (449)
                      ...                +..++........+..+++++.+||.+||+.||++|||+++|+++|.
T Consensus       273 ~~~----------------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DAN----------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SHH----------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHH----------------HHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            211                11122222233345566778999999999999999999999999985

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.2e-55  Score=416.35  Aligned_cols=263  Identities=24%  Similarity=0.394  Sum_probs=203.9

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      ++|++.+.||+|+||+||+|.+..+   ......||||.+.... ....+.|.+|+.+|++++|||||++++++.+++..
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~  102 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLP---GKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV  102 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCC---CCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            5688889999999999999987642   1123468999986543 33456799999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++|||||++|+|.+++... ...+++..+..++.|++.||.|||  +++|+||||||+||||+.++.+||+|||+|+...
T Consensus       103 ~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH--~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         103 MIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             EEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHh--hCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence            9999999999999987654 357899999999999999999999  6789999999999999999999999999998654


Q ss_pred             CCCCCc---eeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccch
Q 013105          238 QGEDSH---ITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       238 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      ......   ......||+.|||||++.+..|+.++|||||||+||||+| |++||.+......   ...           
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~---~~~-----------  245 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV---INA-----------  245 (299)
T ss_dssp             ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHH-----------
T ss_pred             CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHH---HHH-----------
Confidence            332211   1223457999999999998999999999999999999998 8999976532211   111           


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                         +........+..+++.+.+|+.+||+.||++|||+.+|++.|+.+++.
T Consensus       246 ---i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         246 ---IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             ---HHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ---HHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence               111122233455677899999999999999999999999999988753

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.8e-54  Score=419.30  Aligned_cols=254  Identities=22%  Similarity=0.310  Sum_probs=211.6

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      .++|++.+.||+|+||.||+|.+..      +++.||||++........+.+.+|+.+|++++||||+++++++.+++.+
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~------~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   98 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERA------TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM   98 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETT------TTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECC------CCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            4689999999999999999998765      5889999999766555567789999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC--CCcEEEeeeccccC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS--DYNAKLSDFGLATD  235 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~--~~~~kl~DfGla~~  235 (449)
                      |||||||+||+|.+++... ...+++..+..++.||+.||.|||  ++||+||||||+|||++.  ++.+||+|||+|+.
T Consensus        99 ~ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH--~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~  175 (350)
T d1koaa2          99 VMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  175 (350)
T ss_dssp             EEEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             EEEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH--hcCCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence            9999999999999998654 356999999999999999999999  678999999999999964  57899999999987


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      .....   ......||+.|||||++.+..|+.++|||||||++|||++|+.||.+.........+      ...      
T Consensus       176 ~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i------~~~------  240 (350)
T d1koaa2         176 LDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV------KSC------  240 (350)
T ss_dssp             CCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHT------
T ss_pred             ccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH------HhC------
Confidence            64432   244567999999999999999999999999999999999999999865322111111      000      


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                        ...........+++++.+||.+||+.||++|||+.|+++|
T Consensus       241 --~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         241 --DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             --CCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             --CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              0011112223455679999999999999999999999997

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-54  Score=401.65  Aligned_cols=253  Identities=22%  Similarity=0.357  Sum_probs=212.4

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRL  158 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  158 (449)
                      ++|++.+.||+|+||+||+|.+++       +..||||+++... ...+.+++|+.++.+++||||+++++++.+++..+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~-------~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~   75 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRG-------QYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF   75 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETT-------TEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEECC-------CCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceE
Confidence            689999999999999999998753       6789999998543 34578999999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCC
Q 013105          159 LVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQ  238 (449)
Q Consensus       159 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~  238 (449)
                      +||||+.+|+|.+++... ...+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||+++....
T Consensus        76 iv~Ey~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH--~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  152 (258)
T d1k2pa_          76 IITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  152 (258)
T ss_dssp             EEEECCTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHH--HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred             EEEEccCCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHh--hcCcccccccceeEEEcCCCcEEECcchhheeccC
Confidence            999999999999887654 357889999999999999999999  67899999999999999999999999999986554


Q ss_pred             CCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHhh
Q 013105          239 GEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII  317 (449)
Q Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (449)
                      .... ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.........                 +
T Consensus       153 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~-----------------i  214 (258)
T d1k2pa_         153 DEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-----------------I  214 (258)
T ss_dssp             SSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH-----------------H
T ss_pred             CCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHH-----------------H
Confidence            3322 2334568999999999999999999999999999999998 8999986542211111                 1


Q ss_pred             cccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 013105          318 DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEP  360 (449)
Q Consensus       318 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  360 (449)
                      ........+..+++.+.+|+.+||+.||++|||+++|+++|.+
T Consensus       215 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         215 AQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             HhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            1111223344556779999999999999999999999999865

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.7e-54  Score=419.79  Aligned_cols=254  Identities=22%  Similarity=0.319  Sum_probs=212.6

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      .++|++.+.||+|+||.||+|.+..      +++.||||+++.........+.+|+.+|++++||||+++++++.+++.+
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~------~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~  101 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKA------TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM  101 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECC------CCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            4679999999999999999998765      5889999999866555566788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEc--CCCcEEEeeeccccC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD--SDYNAKLSDFGLATD  235 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~--~~~~~kl~DfGla~~  235 (449)
                      |||||||+||+|.+++... ...+++..+..++.|++.||.|||  ++||+||||||+||||+  .++.+||+|||+|..
T Consensus       102 ~ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH--~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~  178 (352)
T d1koba_         102 VLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK  178 (352)
T ss_dssp             EEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCeeecccccccccccccCCCeEEEeeccccee
Confidence            9999999999999887553 356999999999999999999999  67899999999999997  578999999999987


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      .....   ......||+.|+|||++.+..|+.++|||||||+||||++|..||.+.........+.      ..      
T Consensus       179 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~------~~------  243 (352)
T d1koba_         179 LNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK------RC------  243 (352)
T ss_dssp             CCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH------HC------
T ss_pred             cCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hC------
Confidence            65432   2444679999999999999999999999999999999999999998653222111110      00      


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                        ...........+++++.+||.+||+.||.+|||+.|+++|
T Consensus       244 --~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         244 --DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             --CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             --CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              1111222334566779999999999999999999999987

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.8e-55  Score=414.60  Aligned_cols=246  Identities=28%  Similarity=0.381  Sum_probs=203.8

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc---chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS---QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      .|+..+.||+|+||+||+|.+..      +++.||||+++....   ...+.+.+|+.+|++++|||||++++++.+++.
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   89 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVR------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT   89 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETT------TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             hcEeeEEEecCCCeEEEEEEECC------CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCE
Confidence            48999999999999999998765      588999999975432   234568899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .|||||||.+|+|..++..+  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||+|...
T Consensus        90 ~~iv~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH--~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~  165 (309)
T d1u5ra_          90 AWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM  165 (309)
T ss_dssp             EEEEEECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred             EEEEEEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--hCCEeccCCCcceEEECCCCCEEEeeccccccc
Confidence            99999999999887666544  67999999999999999999999  678999999999999999999999999999865


Q ss_pred             CCCCCCceeeecCCCCcccccccccc---CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccch
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINT---GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      ..      .....||+.|||||++.+   ..|+.++|||||||++|||++|..||.+.......                
T Consensus       166 ~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~----------------  223 (309)
T d1u5ra_         166 AP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL----------------  223 (309)
T ss_dssp             SS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH----------------
T ss_pred             CC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH----------------
Confidence            43      233569999999999854   45899999999999999999999999764322111                


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ..+.........+..+++.+.+||.+||+.||++|||+.++++|
T Consensus       224 ~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         224 YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             HHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             HHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence            11111111112233456679999999999999999999999986

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-54  Score=406.35  Aligned_cols=252  Identities=28%  Similarity=0.394  Sum_probs=203.6

Q ss_pred             ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEEEEEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHRLLVYE  162 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  162 (449)
                      +.||+|+||+||+|.+...    ..++.||||+++..  .....+.+.+|+.+|++++||||+++++++.+ +..+||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~----~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE   87 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMK----KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVME   87 (277)
T ss_dssp             EEEEECSSEEEEEEEEECS----SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             CCcccCCCeEEEEEEEccC----CcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEE
Confidence            4699999999999987542    24678999999643  23335679999999999999999999999865 45789999


Q ss_pred             ecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCCC
Q 013105          163 YMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGEDS  242 (449)
Q Consensus       163 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~~  242 (449)
                      |+++|+|.+++...  ..+++..++.++.|++.||.|||  +++|+||||||+|||++.++.+||+|||+++........
T Consensus        88 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH--~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~  163 (277)
T d1xbba_          88 MAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  163 (277)
T ss_dssp             CCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred             cCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHH--hCCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence            99999999998765  57999999999999999999999  677999999999999999999999999999865443322


Q ss_pred             -ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHhhccc
Q 013105          243 -HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDSR  320 (449)
Q Consensus       243 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (449)
                       .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+......   ..              .+...
T Consensus       164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~---~~--------------~i~~~  226 (277)
T d1xbba_         164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---TA--------------MLEKG  226 (277)
T ss_dssp             EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HH--------------HHHTT
T ss_pred             cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH---HH--------------HHHcC
Confidence             22234568999999999998899999999999999999998 8999986532211   11              11111


Q ss_pred             ccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccc
Q 013105          321 LEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL  362 (449)
Q Consensus       321 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  362 (449)
                      .....+..+++++.+|+.+||+.||++|||+.+|++.|+.++
T Consensus       227 ~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence            223344566778999999999999999999999999887654

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-54  Score=407.63  Aligned_cols=259  Identities=28%  Similarity=0.393  Sum_probs=209.2

Q ss_pred             cCCCCccc-ccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           79 HNFSRSDY-LGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        79 ~~y~~~~~-lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      ++|.+.+. ||+|+||.||+|.+...    ..+..||||+++... ....+.+.+|+++|++++|||||++++++.+ +.
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~----~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~   82 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMR----KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA   82 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC-------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred             cCeEECCcEEecccCeEEEEEEEecC----CCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence            45667774 99999999999987542    235689999997543 3345779999999999999999999999865 56


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      +||||||+++|+|.+++... ...+++..+..++.|++.||.|||  +++|+||||||+|||++.++.+||+|||+++..
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH--~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCcCchhheeeccCCceeeccchhhhcc
Confidence            89999999999999987543 357999999999999999999999  678999999999999999999999999999866


Q ss_pred             CCCCCC-ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchh
Q 013105          237 PQGEDS-HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       237 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ...... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+......   ..             
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~---~~-------------  223 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MA-------------  223 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---HH-------------
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH---HH-------------
Confidence            443221 12233568999999999998899999999999999999998 9999986532211   11             


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccc
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL  362 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  362 (449)
                       .+........+..+++++.+|+.+||+.||++|||+.+|++.|+...
T Consensus       224 -~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         224 -FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             -HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence             11111223345566778999999999999999999999999988654

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-54  Score=406.14  Aligned_cols=265  Identities=25%  Similarity=0.409  Sum_probs=206.2

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      ++|++.++||+|+||.||+|.+..+  .......||||++..... .....+.+|+.+|++++|||||++++++.+.+..
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~--~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~   84 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTS--SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM   84 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC-----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCC--CCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence            5688899999999999999988752  112335799999975433 3345789999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+.+|++.+.+... ...+++..++.++.|++.||.|||  +++|+||||||+||||+.++.+||+|||+++...
T Consensus        85 ~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH--~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          85 MIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhcc--ccccccCccccceEEECCCCeEEEcccchhhccc
Confidence            9999999999998877654 367999999999999999999999  6779999999999999999999999999998654


Q ss_pred             CCCCC-ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHh
Q 013105          238 QGEDS-HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI  316 (449)
Q Consensus       238 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (449)
                      ..... .......||+.|+|||++.+..++.++|||||||+||||++|..||......  ....              ..
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~--------------~~  225 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVM--------------KA  225 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHH--------------HH
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHH--------------HH
Confidence            43221 2223356899999999999999999999999999999999976665432111  1111              11


Q ss_pred             hcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccC
Q 013105          317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDL  364 (449)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  364 (449)
                      +........+..++..+.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus       226 i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             HHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            122223344556677899999999999999999999999999987753

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-54  Score=407.45  Aligned_cols=254  Identities=23%  Similarity=0.313  Sum_probs=209.6

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC------cchHHHHHHHHHHHhcCCCCCcceeeeE
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG------SQGHREWLAEVIFLGQLKHPHLVNLIGY  150 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~~~~~  150 (449)
                      +.++|++.+.||+|+||+||+|.+..      +++.||||+++...      ....+.+.+|+.+|++++|||||+++++
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~------~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~   81 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKS------TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV   81 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECC------CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            45679999999999999999998765      58899999996431      2235778999999999999999999999


Q ss_pred             EEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC----cEE
Q 013105          151 CCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY----NAK  226 (449)
Q Consensus       151 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~----~~k  226 (449)
                      +.+++..|||||||+||+|.+++...  ..+++..+..++.|++.||.|||  +++|+||||||+|||++.++    .+|
T Consensus        82 ~~~~~~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH--~~~ivHrDiKp~Nill~~~~~~~~~vk  157 (293)
T d1jksa_          82 YENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIK  157 (293)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCSSSSSCCEE
T ss_pred             EEECCEEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhh--hcceeecccccceEEEecCCCcccceE
Confidence            99999999999999999999999765  57999999999999999999999  67899999999999998776    599


Q ss_pred             EeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhh
Q 013105          227 LSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPM  306 (449)
Q Consensus       227 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~  306 (449)
                      |+|||+|.......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+      
T Consensus       158 l~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i------  228 (293)
T d1jksa_         158 IIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------  228 (293)
T ss_dssp             ECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------
T ss_pred             ecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHH------
Confidence            99999998664432   233456999999999999989999999999999999999999999865322211111      


Q ss_pred             hccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          307 LKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ...        ........+..++..+.+||.+||+.||++|||+.++++|
T Consensus       229 ~~~--------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         229 SAV--------NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             HTT--------CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             Hhc--------CCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000        0001111122345678999999999999999999999987

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-53  Score=410.42  Aligned_cols=249  Identities=26%  Similarity=0.373  Sum_probs=210.3

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ++|++.+.||+|+||.||+|.+..      +++.||||+++..   .......+.+|+.+|+.++||||+++++++.+.+
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~------~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   78 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKA------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD   78 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred             HhcEEEEEEecCcCeEEEEEEECC------CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc
Confidence            579999999999999999997765      6899999999643   2334577889999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      .+|+|||||.||+|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.+|.+||+|||+|+.
T Consensus        79 ~~~iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH--~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~  154 (337)
T d1o6la_          79 RLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE  154 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             ccccceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhh--hcCccccccCHHHeEecCCCCEEEeecccccc
Confidence            999999999999999998775  57899999999999999999999  67899999999999999999999999999986


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ......  .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.........                
T Consensus       155 ~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~----------------  216 (337)
T d1o6la_         155 GISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL----------------  216 (337)
T ss_dssp             SCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----------------
T ss_pred             cccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHH----------------
Confidence            543222  23446799999999999999999999999999999999999999987543211110                


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT-----MTTVVKA  357 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~  357 (449)
                      +...  ...++..+++++.+||.+||+.||.+||+     +.++++|
T Consensus       217 i~~~--~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         217 ILME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             HHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             HhcC--CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence            1111  11234455667899999999999999995     8888886

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-54  Score=403.62  Aligned_cols=260  Identities=27%  Similarity=0.384  Sum_probs=207.2

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      .++|++.+.||+|+||.||+|.+.+       +..||||+++.. ....+.|.+|+.++++++|||||++++++.+ +..
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~-------~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~   86 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNG-------TTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI   86 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-------TEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECC-------CCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCe
Confidence            4679999999999999999998765       357999999754 3345789999999999999999999999854 567


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ++||||+.+|+|..++.......+++..++.++.|++.||+|||  .++|+||||||+||||+.++++||+|||+++...
T Consensus        87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH--~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~  164 (285)
T d1fmka3          87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIE  164 (285)
T ss_dssp             EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh--hhheecccccceEEEECCCCcEEEcccchhhhcc
Confidence            89999999999999987665567999999999999999999999  6789999999999999999999999999998654


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQII  317 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (449)
                      .... .......||+.|+|||++....++.++|||||||+||||++|..||......  ......              +
T Consensus       165 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~--------------i  227 (285)
T d1fmka3         165 DNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQ--------------V  227 (285)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHH--------------H
T ss_pred             CCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHH--------------H
Confidence            3322 2233456999999999999999999999999999999999976655432211  111111              1


Q ss_pred             cccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCC
Q 013105          318 DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN  365 (449)
Q Consensus       318 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  365 (449)
                      ........+..+++++.+|+.+||+.||++|||+++|++.|+.++...
T Consensus       228 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         228 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             HhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            111223345566778999999999999999999999999999887644

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.3e-53  Score=405.17  Aligned_cols=246  Identities=26%  Similarity=0.402  Sum_probs=208.3

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ++|++.+.||+|+||+||+|.+..      +++.||||+++..   .....+.+.+|+.+|+.++||||+++++++.+++
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   77 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRH------NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ   77 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred             hHeEEEEEEecCcCcEEEEEEECC------CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC
Confidence            579999999999999999998765      5889999999632   2334577889999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      .+|+|||||.||+|..++...  ..+++.....++.|++.||.|||  ++||+||||||+|||++.+|.+||+|||+|+.
T Consensus        78 ~~~ivmE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH--~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~  153 (316)
T d1fota_          78 QIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKY  153 (316)
T ss_dssp             EEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             eeeeEeeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhc--cCcEEccccCchheeEcCCCCEEEecCccceE
Confidence            999999999999999888765  57888888999999999999999  78899999999999999999999999999986


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ....     ....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+........                .
T Consensus       154 ~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~----------------~  212 (316)
T d1fota_         154 VPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE----------------K  212 (316)
T ss_dssp             CSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----------------H
T ss_pred             eccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHH----------------H
Confidence            5432     334679999999999999999999999999999999999999998653221111                1


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRP-----TMTTVVKA  357 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  357 (449)
                      +...  ...++..+++++.+++.+||+.||.+|+     |++++++|
T Consensus       213 i~~~--~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         213 ILNA--ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             HHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHcC--CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence            1111  1123344566799999999999999996     89999987

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-54  Score=407.53  Aligned_cols=275  Identities=26%  Similarity=0.351  Sum_probs=210.3

Q ss_pred             CHHHHHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcC-CCCCccee
Q 013105           70 TLKELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQL-KHPHLVNL  147 (449)
Q Consensus        70 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~  147 (449)
                      +...+++-.++|++.+.||+|+||.||+|.+... ....+++.||||+++... ....+.+.+|..++.++ +|+||+.+
T Consensus         4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~-~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~   82 (299)
T d1ywna1           4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   82 (299)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEEST-TSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCccccccHHHEEEeeEEeecCCeEEEEEEEcCC-CcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence            3445555567899999999999999999988653 334567899999997543 33456678888888776 68999999


Q ss_pred             eeEEEeC-CEEEEEEEecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccC
Q 013105          148 IGYCCED-EHRLLVYEYMALGNLHDQLFKNY--------------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDF  212 (449)
Q Consensus       148 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDi  212 (449)
                      ++++.+. ..+++|||||++|+|.+++....              ...+++..+..++.|++.||.|||  +++|+||||
T Consensus        83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH--~~~ivHrDl  160 (299)
T d1ywna1          83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDL  160 (299)
T ss_dssp             EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH--HTTCCCSCC
T ss_pred             eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH--hCCCcCCcC
Confidence            9988764 56899999999999999996532              235889999999999999999999  677999999


Q ss_pred             CCCceEEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhC-CCccccc
Q 013105          213 KASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTG-RRSVEKN  291 (449)
Q Consensus       213 kp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg-~~pf~~~  291 (449)
                      ||+||||+.++++||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++| .+||.+.
T Consensus       161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~  240 (299)
T d1ywna1         161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  240 (299)
T ss_dssp             CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999866544433334456799999999999999999999999999999999987 4677654


Q ss_pred             ccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          292 RCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                      .....  +              ...+........+..+++++.+|+.+||+.||++|||+.+|+++|+.+++
T Consensus       241 ~~~~~--~--------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         241 KIDEE--F--------------CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             CCSHH--H--------------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHHHH--H--------------HHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            32111  1              11111112223344566779999999999999999999999999998765

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-54  Score=401.49  Aligned_cols=261  Identities=26%  Similarity=0.372  Sum_probs=202.5

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      .++|++.+.||+|+||.||+|.+..+   ...+..||||.++.... .....+.+|+.+|++++||||+++++++. ++.
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~---~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~   81 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSP---ENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP   81 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC-----CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecC---CceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCe
Confidence            46799999999999999999987642   12356799999864433 33467899999999999999999999985 567


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .|+||||+.+|+|.+++... ...+++..++.++.|++.||.|||  +++|+||||||+|||++.++.+||+|||+|+..
T Consensus        82 ~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH--~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          82 VWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             CEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhc--ccCeeccccchhheeecCCCcEEEccchhheec
Confidence            89999999999999887654 357899999999999999999999  677999999999999999999999999999865


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ..... .......||+.|+|||++.+..|+.++|||||||++|||++ |.+||...........                
T Consensus       159 ~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~----------------  221 (273)
T d1mp8a_         159 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR----------------  221 (273)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH----------------
T ss_pred             cCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHH----------------
Confidence            44322 22344568999999999999999999999999999999998 8999976543221111                


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                       +........+..+++.+.+||.+||+.||++|||+.+|+++|+.+++
T Consensus       222 -i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         222 -IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             -HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence             11111223455667789999999999999999999999999987754

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-53  Score=404.80  Aligned_cols=262  Identities=23%  Similarity=0.345  Sum_probs=208.1

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC-CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      .+|++.+.||+|+||+||+|.+..+  .......||+|.++.. .....+.+.+|+.++++++|||||++++++.++ ..
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~   85 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPE--GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   85 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCC--CCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence            4699999999999999999988652  1112346899988643 344567899999999999999999999999865 56


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      +++||++.+|+|.+.+... ...+++..++.++.|++.||.|||  +++|+||||||+|||++.++.+||+|||+|+...
T Consensus        86 ~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH--~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             eEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHH--HcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence            7888999999999987664 467999999999999999999999  6779999999999999999999999999998765


Q ss_pred             CCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhHh
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQI  316 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (449)
                      ............||+.|+|||++.++.|+.++|||||||+||||+| |.+||.+.......                 ..
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~-----------------~~  225 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------------SI  225 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH-----------------HH
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH-----------------HH
Confidence            5444433445568999999999999999999999999999999998 78998765322211                 11


Q ss_pred             hcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          317 IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                      +........+..+++.+.+|+.+||+.||.+|||+.+|+++|..+..
T Consensus       226 i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             HHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence            11222233445667789999999999999999999999999887653

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3e-53  Score=403.70  Aligned_cols=269  Identities=24%  Similarity=0.359  Sum_probs=216.2

Q ss_pred             HHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc-hHHHHHHHHHHHhcCCCCCcceeeeEEE
Q 013105           74 LQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ-GHREWLAEVIFLGQLKHPHLVNLIGYCC  152 (449)
Q Consensus        74 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~  152 (449)
                      ++.-.++|++.+.||+|+||+||+|.+... ....+++.||||+++..... ...++.+|+.+|++++||||+++++++.
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~-~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGL-LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETS-STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCC-ccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            344567899999999999999999987642 23345678999999755433 3467999999999999999999999999


Q ss_pred             eCCEEEEEEEecCCCChHHHHhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 013105          153 EDEHRLLVYEYMALGNLHDQLFKNY----------------------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYR  210 (449)
Q Consensus       153 ~~~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHr  210 (449)
                      +.+..++||||+.+|+|.+++....                      ...+++..++.++.|++.||+|||  +++||||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH--~~~ivHr  164 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHR  164 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCS
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc--cCCeEee
Confidence            9999999999999999999986431                      234788999999999999999999  6779999


Q ss_pred             cCCCCceEEcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCC-Cccc
Q 013105          211 DFKASNILLDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR-RSVE  289 (449)
Q Consensus       211 Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~-~pf~  289 (449)
                      ||||+|||++.++.+||+|||+|+...............||+.|+|||.+.+..|+.++|||||||++|||++|. +||.
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence            999999999999999999999998554433333344567899999999999999999999999999999999996 5676


Q ss_pred             ccccccchhhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccc
Q 013105          290 KNRCKREKDLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL  362 (449)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  362 (449)
                      +.......   ..              +........+..+++++.+|+..||+.||++|||+.+|++.|+.+.
T Consensus       245 ~~~~~e~~---~~--------------v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         245 GMAHEEVI---YY--------------VRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TSCHHHHH---HH--------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCHHHHH---HH--------------HHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            54322111   11              1111122334556678999999999999999999999999998764

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1e-52  Score=395.43  Aligned_cols=262  Identities=24%  Similarity=0.320  Sum_probs=204.5

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      +.++|++.+.||+|+||.||+|.+..      +++.||||+++...   ......+.+|+++|+.++||||+++++++..
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~   78 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLR------LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA   78 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEECC------CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeee
Confidence            35779999999999999999998765      58899999997543   2334578999999999999999999999976


Q ss_pred             CC----EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEee
Q 013105          154 DE----HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSD  229 (449)
Q Consensus       154 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~D  229 (449)
                      .+    ..||||||++||+|.+++...  ..+++.++..++.|++.||.|||  ++||+||||||+|||++.++.++|+|
T Consensus        79 ~~~~~~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH--~~~iiHrDiKP~NIll~~~~~~~l~d  154 (277)
T d1o6ya_          79 ETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMD  154 (277)
T ss_dssp             ECSSSEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTSCEEECC
T ss_pred             ccCCCceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHH--hCCccCccccCcccccCccccceeeh
Confidence            53    489999999999999988765  57999999999999999999999  67899999999999999999999999


Q ss_pred             eccccCCCCCC-CCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhc
Q 013105          230 FGLATDGPQGE-DSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK  308 (449)
Q Consensus       230 fGla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  308 (449)
                      ||.+....... .........||+.|+|||++.+..|+.++|||||||++|||+||++||.+........      ....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~------~~~~  228 (277)
T d1o6ya_         155 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY------QHVR  228 (277)
T ss_dssp             CTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHH
T ss_pred             hhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHH------HHHh
Confidence            99987543322 1223344679999999999999999999999999999999999999998653221110      0011


Q ss_pred             cccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHhhccc
Q 013105          309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRP-TMTTVVKALEPLL  362 (449)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~~~  362 (449)
                      .        ...........+++.+.++|.+||+.||++|| |++++++.|..+.
T Consensus       229 ~--------~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         229 E--------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             C--------CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             c--------CCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            1        00111122334566799999999999999999 8999998887654

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.9e-52  Score=407.55  Aligned_cols=250  Identities=25%  Similarity=0.363  Sum_probs=203.2

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC---cchHHHH---HHHHHHHhcCCCCCcceeeeEEE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG---SQGHREW---LAEVIFLGQLKHPHLVNLIGYCC  152 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~nIv~~~~~~~  152 (449)
                      ++|++.+.||+|+||.||+|.+..      +++.||||++....   ......+   ..|+.+++.++||||+++++++.
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~------t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~   77 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKAD------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH   77 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECC------CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE
Confidence            679999999999999999998765      58899999986321   1112223   34577888889999999999999


Q ss_pred             eCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecc
Q 013105          153 EDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL  232 (449)
Q Consensus       153 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGl  232 (449)
                      +.+..|||||||.||+|.+++.+.  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.+|.+||+|||+
T Consensus        78 ~~~~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH--~~~iiHrDlKP~NILl~~~g~iKl~DFGl  153 (364)
T d1omwa3          78 TPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGL  153 (364)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECSSSCEEECCCTT
T ss_pred             ECCEEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHH--HCCccceeeccceeEEcCCCcEEEeeece
Confidence            999999999999999999999775  57889999999999999999999  77899999999999999999999999999


Q ss_pred             ccCCCCCCCCceeeecCCCCccccccccc-cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcccc
Q 013105          233 ATDGPQGEDSHITTCVMGTEGYAAPEYIN-TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFT  311 (449)
Q Consensus       233 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  311 (449)
                      |+......    .....||+.|+|||++. +..|+.++|||||||+||||++|+.||..............         
T Consensus       154 a~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~---------  220 (364)
T d1omwa3         154 ACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---------  220 (364)
T ss_dssp             CEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH---------
T ss_pred             eeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------
Confidence            98654432    33457999999999986 45689999999999999999999999986533221111110         


Q ss_pred             chhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 013105          312 KLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPT-----MTTVVKA  357 (449)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~  357 (449)
                            .......++..+++++.+||.+||+.||++|||     ++++++|
T Consensus       221 ------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         221 ------TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             ------SSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             ------cccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence                  001112233445667999999999999999999     6899886

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-52  Score=406.23  Aligned_cols=246  Identities=23%  Similarity=0.316  Sum_probs=208.1

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ++|++.+.||+|+||.||+|.+..      +++.||||++...   .......+.+|+.+|+.++||||+++++++.+.+
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~------~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~  114 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKE------SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS  114 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cCeEEEEEeecCcCcEEEEEEECC------CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc
Confidence            579999999999999999998765      5889999998632   2334567889999999999999999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..++||||+.||+|..++.+.  ..+++..+..++.|++.||.|||  +++||||||||+|||++.+|.+||+|||+|+.
T Consensus       115 ~~~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH--~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~  190 (350)
T d1rdqe_         115 NLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR  190 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             ccccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCEecCcCCHHHcccCCCCCEEeeeceeeee
Confidence            999999999999999999776  57999999999999999999999  67799999999999999999999999999986


Q ss_pred             CCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          236 GPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       236 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ....     .....||+.|||||++.+..|+.++|||||||+||||++|..||.+........                .
T Consensus       191 ~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~----------------~  249 (350)
T d1rdqe_         191 VKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE----------------K  249 (350)
T ss_dssp             CSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----------------H
T ss_pred             cccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHH----------------H
Confidence            5432     234569999999999999999999999999999999999999998653221111                1


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRP-----TMTTVVKA  357 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  357 (449)
                      +...  ....+..+++++.+||.+||+.||.+|+     |++++++|
T Consensus       250 i~~~--~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         250 IVSG--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             HHHC--CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HhcC--CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence            1111  1122344566799999999999999994     89999986

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.9e-52  Score=391.17  Aligned_cols=253  Identities=26%  Similarity=0.370  Sum_probs=207.7

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc---------hHHHHHHHHHHHhcCC-CCCccee
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ---------GHREWLAEVIFLGQLK-HPHLVNL  147 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~nIv~~  147 (449)
                      .++|++.+.||+|+||+||+|.+..      +++.||||+++.....         ....+.+|+.+|++++ ||||+++
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~------~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~   75 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKP------TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL   75 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             cccCEEceEEecCcCeEEEEEEECC------CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEE
Confidence            4789999999999999999997765      5889999999754211         1235789999999997 9999999


Q ss_pred             eeEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEE
Q 013105          148 IGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKL  227 (449)
Q Consensus       148 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl  227 (449)
                      ++++.+++..||||||++||+|.+++..+  ..+++..+..++.|++.||+|||  .+||+||||||+|||++.++.+||
T Consensus        76 ~~~~~~~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~Nill~~~~~~kl  151 (277)
T d1phka_          76 KDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALH--KLNIVHRDLKPENILLDDDMNIKL  151 (277)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEE
T ss_pred             EeecccCcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HcCCcccccccceEEEcCCCCeEE
Confidence            99999999999999999999999999765  57999999999999999999999  678999999999999999999999


Q ss_pred             eeeccccCCCCCCCCceeeecCCCCcccccccccc------CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHH
Q 013105          228 SDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT------GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVE  301 (449)
Q Consensus       228 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~  301 (449)
                      +|||+++.......   .....||+.|+|||.+.+      ..++.++||||+||+||||++|+.||.+.........+ 
T Consensus       152 ~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i-  227 (277)
T d1phka_         152 TDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI-  227 (277)
T ss_dssp             CCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-
T ss_pred             ccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHH-
Confidence            99999987654322   344679999999999853      34688999999999999999999999865322211111 


Q ss_pred             hhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          302 WARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                           ...        ...........+++++.+|+.+||+.||++|||+.|+++|
T Consensus       228 -----~~~--------~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         228 -----MSG--------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             -----HHT--------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             -----HhC--------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                 000        0011111223566779999999999999999999999987

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-52  Score=401.25  Aligned_cols=254  Identities=18%  Similarity=0.264  Sum_probs=208.3

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      +.++|++.+.||+|+||+||+|.+..      +++.||||+++... .....+.+|+++|+.++||||+++++++.+++.
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~------~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   75 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETS------SKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEE   75 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECC------CCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            45789999999999999999998766      58899999997543 334567899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC--CcEEEeeecccc
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD--YNAKLSDFGLAT  234 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~--~~~kl~DfGla~  234 (449)
                      +|||||||+||+|.+++... ...+++.++..++.|++.||.|||  ++||+||||||+|||++.+  +.+||+|||++.
T Consensus        76 ~~lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH--~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~  152 (321)
T d1tkia_          76 LVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR  152 (321)
T ss_dssp             EEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred             EEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HcCCCcccccccceeecCCCceEEEEcccchhh
Confidence            99999999999999998654 346899999999999999999999  6789999999999999854  489999999998


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      ......   ......||+.|+|||.+.+..|+.++|||||||++|+|++|..||...........+      .....   
T Consensus       153 ~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i------~~~~~---  220 (321)
T d1tkia_         153 QLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI------MNAEY---  220 (321)
T ss_dssp             ECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHTCC---
T ss_pred             ccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCC---
Confidence            654322   234456999999999999999999999999999999999999999865322111111      00000   


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                           .........+++++.+|+.+||+.||++|||+.|+++|
T Consensus       221 -----~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         221 -----TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             -----CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -----CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 00111112345668999999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-53  Score=392.69  Aligned_cols=251  Identities=27%  Similarity=0.403  Sum_probs=201.6

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEe-CCE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE-DEH  156 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~~~  156 (449)
                      .++|++.+.||+|+||.||+|.+.        +..||||+++..  ...+.+.+|+.++++++||||+++++++.+ .+.
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~   75 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR--------GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   75 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--------TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC--------CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCc
Confidence            356888999999999999999874        468999999643  345778999999999999999999999865 466


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      +++||||+++|+|.+++..+....+++..++.++.|++.||.|||  +++|+||||||+|||++.++.+||+|||+++..
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH--~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~  153 (262)
T d1byga_          76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  153 (262)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred             EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc--cCceeccccchHhheecCCCCEeecccccceec
Confidence            899999999999999997654456899999999999999999999  678999999999999999999999999999864


Q ss_pred             CCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccchhH
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKLDQ  315 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (449)
                      ...     .....+|+.|+|||++.+..++.++|||||||++|||+| |++||........   ..              
T Consensus       154 ~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~---~~--------------  211 (262)
T d1byga_         154 SST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VP--------------  211 (262)
T ss_dssp             -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HH--------------
T ss_pred             CCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH---HH--------------
Confidence            332     223458999999999988899999999999999999998 7888875432211   11              


Q ss_pred             hhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccc
Q 013105          316 IIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLL  362 (449)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  362 (449)
                      .+........+..+++++.+|+.+||+.||++|||+.+|+++|+.+.
T Consensus       212 ~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         212 RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             HHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            11122233445566678999999999999999999999999998764

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-52  Score=401.86  Aligned_cols=255  Identities=22%  Similarity=0.290  Sum_probs=202.5

Q ss_pred             HhcCCCCc-ccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhc-CCCCCcceeeeEEEe-
Q 013105           77 ITHNFSRS-DYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQ-LKHPHLVNLIGYCCE-  153 (449)
Q Consensus        77 ~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~~~~~~~~-  153 (449)
                      +.++|.+. +.||+|+||.||+|.+..      +++.||||+++.     ...+.+|+.++.+ ++||||+++++++.+ 
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~------~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~   77 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKR------TQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL   77 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECC------CCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence            34679876 469999999999998765      588999999963     2456789988655 589999999999876 


Q ss_pred             ---CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC---CCcEEE
Q 013105          154 ---DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS---DYNAKL  227 (449)
Q Consensus       154 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~---~~~~kl  227 (449)
                         +..+|||||||+||+|.+++.......+++..+..++.|++.||.|||  ++||+||||||+|||++.   ++.+||
T Consensus        78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH--~~~iiHRDiKp~NIll~~~~~~~~~Kl  155 (335)
T d2ozaa1          78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAILKL  155 (335)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCSSTTCCEEE
T ss_pred             ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH--HcCCccccccccccccccccccccccc
Confidence               467899999999999999998765668999999999999999999999  678999999999999975   467999


Q ss_pred             eeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhh
Q 013105          228 SDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPML  307 (449)
Q Consensus       228 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~  307 (449)
                      +|||+|+.......   .....||+.|+|||++.+..|+.++|||||||+||+|+||++||.+...........  ....
T Consensus       156 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~--~~i~  230 (335)
T d2ozaa1         156 TDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--TRIR  230 (335)
T ss_dssp             CCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCC
T ss_pred             cccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH--HHHh
Confidence            99999986554332   344679999999999999999999999999999999999999998653221111000  0000


Q ss_pred             ccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          308 KDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ..        ....+......+++++.+||.+||+.||++|||+.++++|
T Consensus       231 ~~--------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         231 MG--------QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             SC--------SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cC--------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            00        0001111123556789999999999999999999999987

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-52  Score=399.29  Aligned_cols=249  Identities=26%  Similarity=0.368  Sum_probs=206.7

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHh-cCCCCCcceeeeEEEeC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLG-QLKHPHLVNLIGYCCED  154 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~nIv~~~~~~~~~  154 (449)
                      ++|.+.+.||+|+||+||+|.+..      +++.||||+++..   .......+..|..++. .++||||+++++++.++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~------t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~   75 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKK------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK   75 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECC------CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC
Confidence            579999999999999999998765      5899999999642   2233456677777665 68999999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                      +..||||||++||+|.+++...  ..+++..+..++.|++.||.|||  +++|+||||||+|||++.++.+||+|||+++
T Consensus        76 ~~~yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH--~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~  151 (320)
T d1xjda_          76 ENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCK  151 (320)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             CceeEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCcccceeecCCCceeccccchhh
Confidence            9999999999999999999765  57899999999999999999999  6779999999999999999999999999998


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchh
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLD  314 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (449)
                      .......  ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+              
T Consensus       152 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i--------------  215 (320)
T d1xjda_         152 ENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--------------  215 (320)
T ss_dssp             CCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------------
T ss_pred             hcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH--------------
Confidence            6544322  234467999999999999999999999999999999999999999865432211111              


Q ss_pred             HhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHHHH
Q 013105          315 QIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMT-TVVKA  357 (449)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil~~  357 (449)
                        ...  ...++..+++++.+||.+||+.||++|||+. ++++|
T Consensus       216 --~~~--~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         216 --RMD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             --HHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             --HcC--CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence              011  1223445567799999999999999999995 78765

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-52  Score=393.20  Aligned_cols=269  Identities=24%  Similarity=0.289  Sum_probs=199.8

Q ss_pred             CcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcch-----HHHHHHHHHHHhcCCCCCcceeeeEEEeCCEE
Q 013105           83 RSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQG-----HREWLAEVIFLGQLKHPHLVNLIGYCCEDEHR  157 (449)
Q Consensus        83 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  157 (449)
                      .+++||+|+||+||+|.+..      +++.||||+++......     ...+.+|+.+|++++|||||++++++.+++..
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~   75 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKN------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   75 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSS------CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             cceEeccCcCeEEEEEEECC------CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCce
Confidence            35789999999999997654      58899999996442211     24588999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCC
Q 013105          158 LLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGP  237 (449)
Q Consensus       158 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~  237 (449)
                      ||||||+.++++..++..  ...+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||+|....
T Consensus        76 ~ivmE~~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH--~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~  151 (299)
T d1ua2a_          76 SLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG  151 (299)
T ss_dssp             EEEEECCSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             eehhhhhcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhh--ccceecccCCcceEEecCCCccccccCccccccC
Confidence            999999998776655433  367888999999999999999999  6789999999999999999999999999998655


Q ss_pred             CCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhh--hhhcccc---
Q 013105          238 QGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR--PMLKDFT---  311 (449)
Q Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~---  311 (449)
                      .....  ....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+....+....+....  +....+.   
T Consensus       152 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~  229 (299)
T d1ua2a_         152 SPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC  229 (299)
T ss_dssp             SCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred             CCccc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchh
Confidence            43322  334579999999999864 468999999999999999999999998654332221111000  0000000   


Q ss_pred             chhHhhccccc-----ccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCC
Q 013105          312 KLDQIIDSRLE-----DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN  365 (449)
Q Consensus       312 ~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  365 (449)
                      ...........     .......++++.+|+.+||+.||++|||+.|+++|  .++...
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H--p~f~~~  286 (299)
T d1ua2a_         230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM--KYFSNR  286 (299)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS--GGGTSS
T ss_pred             ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC--HhhCCC
Confidence            00000000000     01112345679999999999999999999999987  444443

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-52  Score=396.00  Aligned_cols=268  Identities=27%  Similarity=0.382  Sum_probs=219.1

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcC-CCCCcceeeeEEEeC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQL-KHPHLVNLIGYCCED  154 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~  154 (449)
                      -.++|++.+.||+|+||.||+|++... .....++.||||+++.... .....+.+|+.++..+ +|||||++++++.+.
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~-~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGL-IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESS-SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEecc-ccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            346889999999999999999988642 2234678999999975433 3445788999999999 699999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcC----------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceE
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNY----------------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNIL  218 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~----------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nil  218 (449)
                      +..++|||||++|+|.+++....                ...+++..+..++.|++.||+|||  +++|+||||||+|||
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH--~~~ivHrDLKp~NIl  177 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNIL  177 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccccccccc
Confidence            99999999999999999987542                235889999999999999999999  677999999999999


Q ss_pred             EcCCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccch
Q 013105          219 LDSDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREK  297 (449)
Q Consensus       219 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~  297 (449)
                      ++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |.+||.......  
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~--  255 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--  255 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--
T ss_pred             ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH--
Confidence            99999999999999997765444444455679999999999998999999999999999999999 556565432211  


Q ss_pred             hhHHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          298 DLVEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                                    .+..++........+..+++.+.+||.+||+.||++|||+.+|++.|+..+.
T Consensus       256 --------------~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         256 --------------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             --------------HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------------HHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence                          1112222233333445566789999999999999999999999999987654

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-52  Score=390.52  Aligned_cols=259  Identities=27%  Similarity=0.379  Sum_probs=201.0

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC---CcchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN---GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      ++|++.+.||+|+||.||+|.+...   ......||||++...   .....+.+.+|+.+|++++||||+++++++.+ +
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~---~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~   83 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAP---SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P   83 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECT---TSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECC---CCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence            5699999999999999999987643   123457999998643   23345679999999999999999999999965 4


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccC
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATD  235 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~  235 (449)
                      ..++||||+++|+|.+++..+ ...+++..++.++.|++.||.|||  +++|+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH--~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             chheeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhh--hCCEeeeeecHHHhccccccceeeccchhhhh
Confidence            678999999999999888764 356999999999999999999999  67799999999999999999999999999997


Q ss_pred             CCCCCCCc-eeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhhHHhhhhhhccccch
Q 013105          236 GPQGEDSH-ITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDLVEWARPMLKDFTKL  313 (449)
Q Consensus       236 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  313 (449)
                      ........ ......|+..|+|||++.+..++.++|||||||++|||+| |..||.+.......                
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~----------------  224 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL----------------  224 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----------------
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH----------------
Confidence            65443322 2233557889999999999999999999999999999998 89999765322111                


Q ss_pred             hHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 013105          314 DQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEP  360 (449)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  360 (449)
                      ..+.........+..++..+.+|+.+||+.||++|||+.+|++.|..
T Consensus       225 ~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         225 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            11111222223345566779999999999999999999999998865

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-52  Score=395.27  Aligned_cols=267  Identities=26%  Similarity=0.380  Sum_probs=212.5

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCC-CCCCcEEEEEEeccCCc-chHHHHHHHHHHHhcC-CCCCcceeeeEEEeC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRP-GLKAQTVAVKVLDVNGS-QGHREWLAEVIFLGQL-KHPHLVNLIGYCCED  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~  154 (449)
                      .++|.+.+.||+|+||.||+|........ ...+..||||+++.... ....++.+|...+.++ +||||+++++++.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            46799999999999999999987653211 12346899999976543 3456788899998888 799999999999999


Q ss_pred             CEEEEEEEecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEc
Q 013105          155 EHRLLVYEYMALGNLHDQLFKNY--------------SSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLD  220 (449)
Q Consensus       155 ~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~  220 (449)
                      +..++||||+.+|+|.+++....              ...+++.+++.++.|++.||+|||  +++||||||||+|||++
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH--~~~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVLVT  169 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEC
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh--hCCEEeeeecccceeec
Confidence            99999999999999999996543              245899999999999999999999  67799999999999999


Q ss_pred             CCCcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHh-CCCcccccccccchhh
Q 013105          221 SDYNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLT-GRRSVEKNRCKREKDL  299 (449)
Q Consensus       221 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~pf~~~~~~~~~~~  299 (449)
                      .++.+||+|||+++...............||+.|+|||.+.++.|+.++|||||||++|||++ |.+||.+......   
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~---  246 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL---  246 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---
T ss_pred             CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH---
Confidence            999999999999987654443334455678999999999999999999999999999999998 7888875432211   


Q ss_pred             HHhhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          300 VEWARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                      ..              .+........+..+++++.+||.+||+.||++|||+.+|++.|+.++.
T Consensus       247 ~~--------------~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         247 FK--------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             HH--------------HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HH--------------HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence            11              111122223344556779999999999999999999999999988764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-51  Score=388.98  Aligned_cols=268  Identities=23%  Similarity=0.309  Sum_probs=203.4

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      ++|++.+.||+|+||+||+|.+..      +++.||||+++...  ......+.+|+++|++++||||+++++++.+++.
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~   75 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKL------TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK   75 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT------TCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCCEeccEEecCcCeEEEEEEECC------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccc
Confidence            589999999999999999998865      57899999996543  2234678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .|+||||+. |++.+++.......+++..+..++.|++.||.|||  ++|||||||||+|||++.++.+||+|||+|+..
T Consensus        76 ~~iv~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH--~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~  152 (298)
T d1gz8a_          76 LYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF  152 (298)
T ss_dssp             EEEEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred             eeEEEeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh--cCCEEccccCchheeecccCcceeccCCcceec
Confidence            999999997 45556666555678999999999999999999999  678999999999999999999999999999765


Q ss_pred             CCCCCCceeeecCCCCccccccccccCC-CCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhh--hhhhccccch
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGH-LTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA--RPMLKDFTKL  313 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~  313 (449)
                      ....  .......||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.............  .+....+...
T Consensus       153 ~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  230 (298)
T d1gz8a_         153 GVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV  230 (298)
T ss_dssp             CCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             cCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccc
Confidence            4322  2233456999999999886655 588999999999999999999999865332211111000  0000000000


Q ss_pred             hHhhc---c---ccc---ccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          314 DQIID---S---RLE---DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       314 ~~~~~---~---~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .....   .   ...   ......+++++.+|+.+||+.||++|||+.|+++|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            00000   0   000   00112345678999999999999999999999997

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=393.46  Aligned_cols=261  Identities=29%  Similarity=0.426  Sum_probs=208.5

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC-CcchHHHHHHHHHHHhcC-CCCCcceeeeEEEeCCE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGHREWLAEVIFLGQL-KHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~  156 (449)
                      ++|++.+.||+|+||.||+|.+..+    .....||||.++.. .....+.+.+|+.+|.++ +||||+++++++.+++.
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~   85 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKD----GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   85 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEET----TEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCC----CeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence            6788999999999999999988652    11235788887533 333456789999999999 79999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhc--------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC
Q 013105          157 RLLVYEYMALGNLHDQLFKN--------------YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD  222 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~  222 (449)
                      .++||||++||+|.+++...              ....+++..+..++.|++.||.|||  +++|+||||||+|||++.+
T Consensus        86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH--~~~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGEN  163 (309)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECGG
T ss_pred             eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh--cCCccccccccceEEEcCC
Confidence            99999999999999998653              2467899999999999999999999  6789999999999999999


Q ss_pred             CcEEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCC-CcccccccccchhhHH
Q 013105          223 YNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR-RSVEKNRCKREKDLVE  301 (449)
Q Consensus       223 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~-~pf~~~~~~~~~~~~~  301 (449)
                      +.+||+|||+++.......   .....||..|+|||.+.+..|+.++|||||||++|||++|. +||.+.....   +..
T Consensus       164 ~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---~~~  237 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYE  237 (309)
T ss_dssp             GCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH
T ss_pred             CceEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---HHH
Confidence            9999999999986543222   22345899999999999999999999999999999999976 5665542211   111


Q ss_pred             hhhhhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCC
Q 013105          302 WARPMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLN  365 (449)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  365 (449)
                      .              +........+..+++++.+||.+||+.||++|||+.+|+++|+.+++..
T Consensus       238 ~--------------i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         238 K--------------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             H--------------GGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             H--------------HHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence            1              1111223344556778999999999999999999999999999987644

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-50  Score=385.48  Aligned_cols=258  Identities=28%  Similarity=0.409  Sum_probs=204.8

Q ss_pred             cccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC-CcchHHHHHHHHHHHhcCCCCCcceeeeEEEe-CCEEEEEE
Q 013105           84 SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN-GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE-DEHRLLVY  161 (449)
Q Consensus        84 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~~~~~lv~  161 (449)
                      .++||+|+||+||+|.+..+   ..+...||||+++.. ......++.+|+++|++++||||+++++++.+ ++..++||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~---~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC-------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECC---CCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence            57899999999999988653   113446999999743 34455789999999999999999999999876 56899999


Q ss_pred             EecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCCCCCCC
Q 013105          162 EYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDGPQGED  241 (449)
Q Consensus       162 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~~~~~~  241 (449)
                      |||++|+|.+++... ....++..++.++.|++.||.|||  +++|+||||||+|||++.++.+||+|||+++.......
T Consensus       109 E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH--~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             ECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             EEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhc--ccCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            999999999987653 456788889999999999999999  67799999999999999999999999999986544322


Q ss_pred             C--ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhccccchhHhhcc
Q 013105          242 S--HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFTKLDQIIDS  319 (449)
Q Consensus       242 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (449)
                      .  .......||+.|+|||.+....++.++|||||||++|||++|..||.......  +....              +..
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~--------------i~~  249 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVY--------------LLQ  249 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH--------------HHT
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHH--------------HHc
Confidence            1  12223568999999999998999999999999999999999888876432111  11111              111


Q ss_pred             cccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          320 RLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       320 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                      ......+..+++.+.+|+.+||+.||++|||+.||+++|+.+..
T Consensus       250 g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         250 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            11222344556779999999999999999999999999998875

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-52  Score=387.77  Aligned_cols=242  Identities=22%  Similarity=0.351  Sum_probs=198.5

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCc------chHHHHHHHHHHHhcCC--CCCcceeee
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGS------QGHREWLAEVIFLGQLK--HPHLVNLIG  149 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~nIv~~~~  149 (449)
                      .++|++.+.||+|+||.||+|.+..      +++.||||++.....      ....++.+|+.+|++++  ||||+++++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~   76 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVS------DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD   76 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECC------CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEE
Confidence            4689999999999999999998765      588999999864311      11234668999999986  899999999


Q ss_pred             EEEeCCEEEEEEEecCC-CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC-CcEEE
Q 013105          150 YCCEDEHRLLVYEYMAL-GNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD-YNAKL  227 (449)
Q Consensus       150 ~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~-~~~kl  227 (449)
                      ++.+.+..++||||+.+ +++.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.+ +.+||
T Consensus        77 ~~~~~~~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH--~~~iiHrDiKp~NIll~~~~~~vkl  152 (273)
T d1xwsa_          77 WFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKL  152 (273)
T ss_dssp             EEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEETTTTEEEE
T ss_pred             EEeeCCeEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCccccCcccceEEecCCCeEEE
Confidence            99999999999999986 5777777654  57999999999999999999999  6789999999999999854 79999


Q ss_pred             eeeccccCCCCCCCCceeeecCCCCccccccccccCCC-CcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhh
Q 013105          228 SDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHL-TTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPM  306 (449)
Q Consensus       228 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~  306 (449)
                      +|||+|......    ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....     ..      
T Consensus       153 ~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----i~------  217 (273)
T d1xwsa_         153 IDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----II------  217 (273)
T ss_dssp             CCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----HH------
T ss_pred             Cccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----Hh------
Confidence            999999865432    2344679999999999977665 6789999999999999999999975321     00      


Q ss_pred             hccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          307 LKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       ..            ...++..+++++.+||.+||+.||++|||++|+++|
T Consensus       218 -~~------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         218 -RG------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             -HC------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -hc------------ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence             00            001222345678999999999999999999999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-51  Score=392.75  Aligned_cols=269  Identities=23%  Similarity=0.354  Sum_probs=215.4

Q ss_pred             HHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEe
Q 013105           75 QMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCE  153 (449)
Q Consensus        75 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  153 (449)
                      ++..++|.+.+.||+|+||.||+|.++.. .....+..||||+++... ......+.+|+.++++++||||+++++++..
T Consensus        16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~-~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          16 EVAREKITMSRELGQGSFGMVYEGVAKGV-VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEE-ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             eecHHHeEEeeEEeeCCCeEEEEEEECCc-ccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            34457889999999999999999987531 112245789999997543 3334568999999999999999999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhc--------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcE
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKN--------YSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNA  225 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~  225 (449)
                      ++..++||||+.+|+|.+++...        ....+++..+..++.|++.||.|||  +++|+||||||+|||++.++++
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH--~~~ivHrDlk~~NiLld~~~~~  172 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTV  172 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCSGGGEEECTTCCE
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh--hCCeeeceEcCCceeecCCceE
Confidence            99999999999999999988542        1245788999999999999999999  6779999999999999999999


Q ss_pred             EEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCC-CcccccccccchhhHHhhh
Q 013105          226 KLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGR-RSVEKNRCKREKDLVEWAR  304 (449)
Q Consensus       226 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~-~pf~~~~~~~~~~~~~~~~  304 (449)
                      ||+|||+|+...............||+.|+|||.+.+..++.++|||||||+||||+||. +||.+........      
T Consensus       173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~------  246 (308)
T d1p4oa_         173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR------  246 (308)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH------
T ss_pred             EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHH------
Confidence            999999998654433333334456899999999999999999999999999999999985 7776543221111      


Q ss_pred             hhhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhcccc
Q 013105          305 PMLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLD  363 (449)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  363 (449)
                                .+.+ ......+..++..+.+||.+||+.||++|||+.+|+++|+..++
T Consensus       247 ----------~i~~-~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         247 ----------FVME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             ----------HHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             ----------HHHh-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                      1111 11222344556779999999999999999999999999988755

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-51  Score=386.43  Aligned_cols=273  Identities=25%  Similarity=0.378  Sum_probs=202.2

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHH--HHHHHhcCCCCCcceeeeEEEeCC
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLA--EVIFLGQLKHPHLVNLIGYCCEDE  155 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~h~nIv~~~~~~~~~~  155 (449)
                      .++|.+.+.||+|+||.||+|.+.        ++.||||+++...   ...+.+  |+..+..++||||+++++++.+.+
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~~--------g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~   70 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKWR--------GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDN   70 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--------TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEEC--------CEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC
Confidence            356788899999999999999763        6799999996432   233444  455556789999999999998653


Q ss_pred             ----EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCeeeccCCCCceEEcCCCcE
Q 013105          156 ----HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGE------EKPVIYRDFKASNILLDSDYNA  225 (449)
Q Consensus       156 ----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~------~~~ivHrDikp~Nill~~~~~~  225 (449)
                          ..|+||||+++|+|.+++.+.   .+++..++.++.+++.||.|||+.      .+||+||||||+||||+.++.+
T Consensus        71 ~~~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~  147 (303)
T d1vjya_          71 GTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  147 (303)
T ss_dssp             SSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCE
T ss_pred             CcceEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCe
Confidence                689999999999999999764   689999999999999999999963      4689999999999999999999


Q ss_pred             EEeeeccccCCCCCCCC--ceeeecCCCCccccccccccCC------CCcccchhhhHHHHHHHHhCCCcccccccccch
Q 013105          226 KLSDFGLATDGPQGEDS--HITTCVMGTEGYAAPEYINTGH------LTTMCDVFSFGVVLLELLTGRRSVEKNRCKREK  297 (449)
Q Consensus       226 kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~  297 (449)
                      ||+|||++.........  .......||+.|+|||++.+..      ++.++|||||||+||||+||..||.........
T Consensus       148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~  227 (303)
T d1vjya_         148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  227 (303)
T ss_dssp             EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred             EEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc
Confidence            99999999865433221  1233467999999999986542      577899999999999999999888643222111


Q ss_pred             hhHHhhhhhhccccchh-Hhhccccc----cc-CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCCC
Q 013105          298 DLVEWARPMLKDFTKLD-QIIDSRLE----DR-YSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLND  366 (449)
Q Consensus       298 ~~~~~~~~~~~~~~~~~-~~~~~~~~----~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~  366 (449)
                      ... . .........+. ........    .. ...+.+..+.+|+.+||+.||++|||+.||++.|+.+.+.++
T Consensus       228 ~~~-~-~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~  300 (303)
T d1vjya_         228 YYD-L-VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  300 (303)
T ss_dssp             TTT-T-SCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             hhh-c-ccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence            000 0 00000000000 11111111    11 133566779999999999999999999999999998876544

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-50  Score=381.51  Aligned_cols=269  Identities=26%  Similarity=0.315  Sum_probs=200.7

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcC---CCCCcceeeeEEE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQL---KHPHLVNLIGYCC  152 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~  152 (449)
                      .++|++.+.||+|+||+||+|.+..+     .++.||||+++...  ......+.+|+.+|+.|   +||||+++++++.
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~   80 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKN-----GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT   80 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTT-----TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECC-----CCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeec
Confidence            47899999999999999999987542     35679999986432  22223455677766655   7999999999986


Q ss_pred             e-----CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEE
Q 013105          153 E-----DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKL  227 (449)
Q Consensus       153 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl  227 (449)
                      .     ....+++|||+.++.+.. ........+++..+..++.|++.||+|||  +++|+||||||+|||++.++.+||
T Consensus        81 ~~~~~~~~~~~~~~e~~~~~~~~~-~~~~~~~~~~~~~~~~~~~qi~~aL~yLH--~~~ivHrDiKp~NILi~~~~~~kl  157 (305)
T d1blxa_          81 VSRTDRETKLTLVFEHVDQDLTTY-LDKVPEPGVPTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKL  157 (305)
T ss_dssp             EEECSSEEEEEEEEECCSCBHHHH-HHHSCTTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEEE
T ss_pred             ccccccCceEEEEEEeccCCchhh-hhhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCEEecCCCccEEEEcCCCCeee
Confidence            3     357899999998766543 43444577899999999999999999999  677999999999999999999999


Q ss_pred             eeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhh--
Q 013105          228 SDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARP--  305 (449)
Q Consensus       228 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~--  305 (449)
                      +|||++......   .......||+.|+|||++.+..|+.++|||||||++|||++|++||.+.........+.....  
T Consensus       158 ~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  234 (305)
T d1blxa_         158 ADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP  234 (305)
T ss_dssp             CSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             cchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCC
Confidence            999998854332   224456799999999999999999999999999999999999999987543322221111000  


Q ss_pred             hhccccc---hh-Hhh---cccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          306 MLKDFTK---LD-QII---DSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       306 ~~~~~~~---~~-~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ....+..   .. ...   .......+....++.+.+|+.+||+.||++|||+.|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0000000   00 000   0011122334456678999999999999999999999987

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.6e-50  Score=378.54  Aligned_cols=266  Identities=20%  Similarity=0.265  Sum_probs=201.5

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      ++|++.+.||+|+||+||+|.+.       +++.||||+++...  ......+.+|+.+|++++||||+++++++.+++.
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~   74 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             CCceeccEEecCCCcEEEEEEeC-------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc
Confidence            57999999999999999999775       36899999997543  2234678999999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .+++||++.++.+..+...  ...+++..+..++.|++.||+|||  +.+|+||||||+|||++.++.+||+|||++...
T Consensus        75 ~~i~~e~~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH--~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~  150 (286)
T d1ob3a_          75 LVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLARAF  150 (286)
T ss_dssp             EEEEEECCSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             eeEEEEeehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhc--cCcEEecCCCCceeeEcCCCCEEecccccceec
Confidence            9999999987666555443  368999999999999999999999  677999999999999999999999999999864


Q ss_pred             CCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhh--hhhhccccch
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA--RPMLKDFTKL  313 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~  313 (449)
                      .....  ......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.........+...  .+....+...
T Consensus       151 ~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  228 (286)
T d1ob3a_         151 GIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV  228 (286)
T ss_dssp             CC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             ccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccch
Confidence            43221  2333468999999999865 45699999999999999999999999765432221111000  0000000000


Q ss_pred             hHh---------hcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          314 DQI---------IDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       314 ~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ...         .............++.+.+|+.+||+.||++|||++|+++|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000         00011122233456679999999999999999999999987

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=8.6e-49  Score=371.27  Aligned_cols=277  Identities=18%  Similarity=0.166  Sum_probs=215.6

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCC-CCcceeeeEEEeCC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKH-PHLVNLIGYCCEDE  155 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~~~  155 (449)
                      +.++|++.+.||+|+||+||+|.+..      +++.||||++.....  ...+.+|++++..++| +||+.+++++.++.
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~------~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~   74 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLL------NNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL   74 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETT------TTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECC------CCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCC
Confidence            35789999999999999999998765      588999999864322  2346678999999965 89999999999999


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC-----CCcEEEeee
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS-----DYNAKLSDF  230 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~-----~~~~kl~Df  230 (449)
                      ..++||||+ +++|.+++... ...++......++.|++.||+|||  ++||+||||||+|||++.     ++.+||+||
T Consensus        75 ~~~~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH--~~giiHrDiKp~Nili~~~~~~~~~~vkl~DF  150 (293)
T d1csna_          75 HNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF  150 (293)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             ccEEEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHH--HCCceeccCCccceeecCcccccCCceEEccc
Confidence            999999999 68998887653 457899999999999999999999  788999999999999964     578999999


Q ss_pred             ccccCCCCCCCC-----ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhh
Q 013105          231 GLATDGPQGEDS-----HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARP  305 (449)
Q Consensus       231 Gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~  305 (449)
                      |+|+........     .......||+.|||||++.+..++.++|||||||++|||++|..||.+...............
T Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~  230 (293)
T d1csna_         151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE  230 (293)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred             ceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHh
Confidence            999865432211     123346799999999999999999999999999999999999999986543332222111110


Q ss_pred             hhccccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCCCCC-CCCceee
Q 013105          306 MLKDFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDIP-IGPFVYT  375 (449)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~-~~~~~~~  375 (449)
                      ..          ...........+|+++.+++..|++.+|++||+++.+.+.|+.++...... ..+++|.
T Consensus       231 ~~----------~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~  291 (293)
T d1csna_         231 KK----------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN  291 (293)
T ss_dssp             HH----------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred             cc----------CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCC
Confidence            00          000011122334567999999999999999999999999998877554433 3355554

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-49  Score=382.77  Aligned_cols=269  Identities=20%  Similarity=0.266  Sum_probs=198.7

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC-cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCC-
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG-SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDE-  155 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-  155 (449)
                      ..+|++.+.||+|+||+||+|.+..      +++.||||+++... ....+.+++|+.+|+.++||||+++++++.... 
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~------~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~   80 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNV------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   80 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETT------TCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECC------CCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence            4679999999999999999998765      58899999997543 334567889999999999999999999987643 


Q ss_pred             ---EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeecc
Q 013105          156 ---HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGL  232 (449)
Q Consensus       156 ---~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGl  232 (449)
                         ..+++|+++.+|+|.+++...   .+++..+..++.|++.||+|||  ++|||||||||+|||++.++.+||+|||+
T Consensus        81 ~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH--~~~iiHRDIKp~NILl~~~~~~kl~DfG~  155 (345)
T d1pmea_          81 EQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTTCDLKICDFGL  155 (345)
T ss_dssp             TTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             cccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCCCcceEEECCCCCEEEcccCc
Confidence               234445566789999998653   6899999999999999999999  67899999999999999999999999999


Q ss_pred             ccCCCCCCCC-ceeeecCCCCccccccccc-cCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcc-
Q 013105          233 ATDGPQGEDS-HITTCVMGTEGYAAPEYIN-TGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKD-  309 (449)
Q Consensus       233 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-  309 (449)
                      +......... ......+||+.|+|||++. +..++.++||||+||++|+|++|+.||..................... 
T Consensus       156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (345)
T d1pmea_         156 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE  235 (345)
T ss_dssp             CEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             eeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChh
Confidence            9865432211 1233466999999999984 456799999999999999999999999765433222111110000000 


Q ss_pred             ------ccchhHhh-ccccc-----ccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          310 ------FTKLDQII-DSRLE-----DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       310 ------~~~~~~~~-~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                            ........ .....     .......+.++.+|+.+||+.||.+|||+.++++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  00000000 00000     01112334578999999999999999999999987

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-48  Score=372.86  Aligned_cols=270  Identities=21%  Similarity=0.257  Sum_probs=197.4

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC--CcchHHHHHHHHHHHhcCCCCCcceeeeEEEe--
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN--GSQGHREWLAEVIFLGQLKHPHLVNLIGYCCE--  153 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--  153 (449)
                      .++|++.+.||+|+||+||+|.+..      +++.||||++...  .......+.+|+.+|+.++||||+++++++..  
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~   82 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRK------TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA   82 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETT------TCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECC------CCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccc
Confidence            3689999999999999999998765      5889999998644  23344678899999999999999999999855  


Q ss_pred             ------CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEE
Q 013105          154 ------DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKL  227 (449)
Q Consensus       154 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl  227 (449)
                            ++..|+||||+.++.+....  .....++...+..++.|++.||.|||  ++||+||||||+|||++.++.+||
T Consensus        83 ~~~~~~~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH--~~~ivHrDlKp~NILl~~~~~~kl  158 (318)
T d3blha1          83 SPYNRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKL  158 (318)
T ss_dssp             --------CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSCEEE
T ss_pred             ccccccCceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhc--cCCEEecCcCchheeecCCCcEEe
Confidence                  35689999999876655433  23467889999999999999999999  678999999999999999999999


Q ss_pred             eeeccccCCCCCCCC--ceeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhh
Q 013105          228 SDFGLATDGPQGEDS--HITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWAR  304 (449)
Q Consensus       228 ~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~  304 (449)
                      +|||++.........  ......+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.........+....
T Consensus       159 ~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~  238 (318)
T d3blha1         159 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC  238 (318)
T ss_dssp             CCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             eecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhc
Confidence            999999755432211  122335699999999998754 68999999999999999999999998654332222211111


Q ss_pred             hhhc-----ccc--chhHhhcccc-cc-cCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          305 PMLK-----DFT--KLDQIIDSRL-ED-RYS-----TEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       305 ~~~~-----~~~--~~~~~~~~~~-~~-~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ....     ...  .......... .. ...     ...++.+.+||.+||+.||++|||++|+++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            0000     000  0000000000 00 000     1123467889999999999999999999998

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-49  Score=380.65  Aligned_cols=264  Identities=19%  Similarity=0.244  Sum_probs=197.4

Q ss_pred             HhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeC
Q 013105           77 ITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCED  154 (449)
Q Consensus        77 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  154 (449)
                      +.++|++.+.||+|+||+||+|.+..      +++.||||+++...  ....+.+.+|+++|+.++|||||+++++|...
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~   89 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGR------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPD   89 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETT------TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECC------CCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccC
Confidence            45789999999999999999998765      58999999997542  23356788999999999999999999999765


Q ss_pred             C------EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEe
Q 013105          155 E------HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLS  228 (449)
Q Consensus       155 ~------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~  228 (449)
                      +      .+|+||||+ +++|...+..   ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+
T Consensus        90 ~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH--~~~IiHrDiKp~NIL~~~~~~~kl~  163 (346)
T d1cm8a_          90 ETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCELKIL  163 (346)
T ss_dssp             SSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred             ccccccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHH--hCCCcccccCcchhhcccccccccc
Confidence            4      579999999 5677666543   47999999999999999999999  6789999999999999999999999


Q ss_pred             eeccccCCCCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhh-
Q 013105          229 DFGLATDGPQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPM-  306 (449)
Q Consensus       229 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~-  306 (449)
                      |||+|+.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+................ 
T Consensus       164 Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~  238 (346)
T d1cm8a_         164 DFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP  238 (346)
T ss_dssp             CCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             cccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCC
Confidence            99999865432     334679999999999865 45789999999999999999999999875432221111100000 


Q ss_pred             ----hccccc-----hhHhhc---ccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          307 ----LKDFTK-----LDQIID---SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       307 ----~~~~~~-----~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                          ......     ......   ...........++.+.+||.+||..||++|||+.|+++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         239 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                000000     000000   000111223445678999999999999999999999998

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-48  Score=372.22  Aligned_cols=278  Identities=18%  Similarity=0.201  Sum_probs=208.2

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCC-cceeeeEEEeCCE
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPH-LVNLIGYCCEDEH  156 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~  156 (449)
                      .++|++.+.||+|+||.||+|.+..      +++.||||++.....  ...+..|+++++.++|+| |+.+.+++.+.+.
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~------~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~   77 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIA------AGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   77 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETT------TTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECC------CCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCE
Confidence            4679999999999999999998765      578999999875432  235778999999998666 5555666788899


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcC---CCcEEEeeeccc
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDS---DYNAKLSDFGLA  233 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~---~~~~kl~DfGla  233 (449)
                      .++||||+. ++|.+.+... ...+++..+..++.|++.||+|||  ++||+||||||+|||++.   +..+||+|||+|
T Consensus        78 ~~ivme~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a  153 (299)
T d1ckia_          78 NVMVMELLG-PSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  153 (299)
T ss_dssp             EEEEEECCC-CBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred             EEEEEEEcC-Cchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHH--HCCeeeccCCHhhccccccCCCceeeeeccCcc
Confidence            999999994 6776665443 467999999999999999999999  678999999999999854   457999999999


Q ss_pred             cCCCCCCCC-----ceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhc
Q 013105          234 TDGPQGEDS-----HITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLK  308 (449)
Q Consensus       234 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  308 (449)
                      +........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.................   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~---  230 (299)
T d1ckia_         154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE---  230 (299)
T ss_dssp             EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH---
T ss_pred             eeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc---
Confidence            865433221     123446799999999999999999999999999999999999999976533222211110000   


Q ss_pred             cccchhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhccccCCCCC-CCCceeeec
Q 013105          309 DFTKLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKALEPLLDLNDIP-IGPFVYTVV  377 (449)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~-~~~~~~~~~  377 (449)
                             .............+|+++.+++..||+.||++||++.++.+.|+.++...... ..+++|...
T Consensus       231 -------~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~~~  293 (299)
T d1ckia_         231 -------KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML  293 (299)
T ss_dssp             -------HHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHHHG
T ss_pred             -------ccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCchhh
Confidence                   00000011122345567999999999999999999999999888776543332 345665543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-48  Score=365.53  Aligned_cols=267  Identities=20%  Similarity=0.253  Sum_probs=206.4

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeCCE
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCEDEH  156 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  156 (449)
                      ++|++.+.||+|+||+||+|.+..      +++.||||+++...  ......+.+|+.+|+.++||||+++++++.+...
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   75 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRE------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK   75 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETT------TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECC------CCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccc
Confidence            579999999999999999998765      58899999997543  3345788999999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccccCC
Q 013105          157 RLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLATDG  236 (449)
Q Consensus       157 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla~~~  236 (449)
                      .++||+++.+++|..++...  ..+++..+..++.|++.||+|||  ++||+||||||+|||++.++.+||+|||.+...
T Consensus        76 ~~iv~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH--~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~  151 (292)
T d1unla_          76 LTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAF  151 (292)
T ss_dssp             EEEEEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eeEEeeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhh--cCCEeeecccCcccccccCCceeeeecchhhcc
Confidence            99999999988887776543  67899999999999999999999  678999999999999999999999999999865


Q ss_pred             CCCCCCceeeecCCCCccccccccccCC-CCcccchhhhHHHHHHHHhCCCcccccccccc-hhhHHhh--hhhhccccc
Q 013105          237 PQGEDSHITTCVMGTEGYAAPEYINTGH-LTTMCDVFSFGVVLLELLTGRRSVEKNRCKRE-KDLVEWA--RPMLKDFTK  312 (449)
Q Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~vl~elltg~~pf~~~~~~~~-~~~~~~~--~~~~~~~~~  312 (449)
                      .....  ......+++.|+|||++.+.. ++.++|||||||++|||++|+.||.......+ ...+...  .+....+..
T Consensus       152 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (292)
T d1unla_         152 GIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             CSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred             cCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhh
Confidence            44322  223345789999999987554 68999999999999999999999754322111 1111000  000000000


Q ss_pred             hhHhhc---------ccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          313 LDQIID---------SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       313 ~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      ......         ...........++.+.+|+.+||+.||.+|||++|+++|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111000         011112233455678999999999999999999999987

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-48  Score=376.60  Aligned_cols=263  Identities=26%  Similarity=0.309  Sum_probs=195.6

Q ss_pred             CCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCcceeeeEEEeC-----
Q 013105           80 NFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHLVNLIGYCCED-----  154 (449)
Q Consensus        80 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-----  154 (449)
                      +|+..++||+|+||+||+|.+..      +++.||||++......    ..+|+.+|++++||||+++++++...     
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~------~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~   90 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKD   90 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred             CcEeeeEEeeCcCeEEEEEEECC------CCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence            57788999999999999998876      5889999999754322    23699999999999999999998643     


Q ss_pred             -CEEEEEEEecCCCChHHHHh-hcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC-cEEEeeec
Q 013105          155 -EHRLLVYEYMALGNLHDQLF-KNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY-NAKLSDFG  231 (449)
Q Consensus       155 -~~~~lv~e~~~~g~L~~~l~-~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~-~~kl~DfG  231 (449)
                       .+.|||||||.++.+..... ......+++..+..++.|++.||+|||  ++||+||||||+|||++.++ .+||+|||
T Consensus        91 ~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH--~~~IiHrDiKp~NILl~~~~~~~kl~DFG  168 (350)
T d1q5ka_          91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLCDFG  168 (350)
T ss_dssp             CCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTTCCEEECCCT
T ss_pred             ceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH--hcCCcccCCCcceEEEecCCCceeEeccc
Confidence             35799999998654333322 234467999999999999999999999  78899999999999999775 89999999


Q ss_pred             cccCCCCCCCCceeeecCCCCcccccccccc-CCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhh-------
Q 013105          232 LATDGPQGEDSHITTCVMGTEGYAAPEYINT-GHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWA-------  303 (449)
Q Consensus       232 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~-------  303 (449)
                      ++........   .....||+.|+|||.+.+ ..|+.++|||||||++|||++|++||...........+...       
T Consensus       169 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~  245 (350)
T d1q5ka_         169 SAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE  245 (350)
T ss_dssp             TCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             chhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHH
Confidence            9986544322   334579999999998764 57899999999999999999999999765432221111000       


Q ss_pred             --hhhhcccc--chhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          304 --RPMLKDFT--KLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       304 --~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                        ........  ..................++++.+|+.+||+.||++|||+.|+++|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              00000000  0000000001111223456679999999999999999999999987

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.9e-48  Score=372.38  Aligned_cols=260  Identities=16%  Similarity=0.256  Sum_probs=199.1

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC-CCCcceeeeEEEe--CC
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-HPHLVNLIGYCCE--DE  155 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~--~~  155 (449)
                      ++|++.+.||+|+||+||+|.+..      +++.||||+++..   ..+.+.+|+.+|+.++ ||||+++++++..  ..
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~------~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~  105 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINIT------NNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSR  105 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECC------CCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC
Confidence            579999999999999999998765      5899999999643   3467889999999995 9999999999985  45


Q ss_pred             EEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCC-cEEEeeecccc
Q 013105          156 HRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDY-NAKLSDFGLAT  234 (449)
Q Consensus       156 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~-~~kl~DfGla~  234 (449)
                      ..++||||+.+++|....     ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++ .+||+|||+|.
T Consensus       106 ~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH--~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~  178 (328)
T d3bqca1         106 TPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE  178 (328)
T ss_dssp             SEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred             ceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHh--hcccccccccccceEEcCCCCeeeecccccce
Confidence            699999999999986653     46899999999999999999999  67799999999999998655 69999999998


Q ss_pred             CCCCCCCCceeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCCcccccccccchhhH-----------Hh
Q 013105          235 DGPQGEDSHITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLV-----------EW  302 (449)
Q Consensus       235 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~-----------~~  302 (449)
                      .......   .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||............           .+
T Consensus       179 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~  255 (328)
T d3bqca1         179 FYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY  255 (328)
T ss_dssp             ECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred             eccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhh
Confidence            6554322   3345689999999998654 5799999999999999999999999754332211000           00


Q ss_pred             hhhh-hccccchhHhhc--------ccccccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          303 ARPM-LKDFTKLDQIID--------SRLEDRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       303 ~~~~-~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                      .... ............        ..........+++++.+||.+||+.||++|||++|+|+|
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000 000000000000        001111123345678999999999999999999999987

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-48  Score=372.18  Aligned_cols=257  Identities=26%  Similarity=0.321  Sum_probs=205.5

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccC----CcchHHHHHHHHHHHhcCCC-CCcceeeeEEEe
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVN----GSQGHREWLAEVIFLGQLKH-PHLVNLIGYCCE  153 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~  153 (449)
                      ++|++.+.||+|+||+||+|....+   ..+++.||||+++..    .....+.+.+|+.+|++++| |||+++++++.+
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~---~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~  100 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISG---HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  100 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSS---TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             hceEEEEEEecCCCeEEEEEEECcc---CCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence            6799999999999999999976432   336889999998632    12234567889999999976 899999999999


Q ss_pred             CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeeeccc
Q 013105          154 DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDFGLA  233 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~DfGla  233 (449)
                      ....++||||+.+|+|.+++...  ..+++.....++.|++.||.|||  +++|+||||||+|||++.++.+||+|||++
T Consensus       101 ~~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH--~~~ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         101 ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             CCceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhh--cCCEEeccCCccceeecCCCCEEEeeccch
Confidence            99999999999999999999776  56788899999999999999999  677999999999999999999999999999


Q ss_pred             cCCCCCCCCceeeecCCCCccccccccccC--CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhhhcccc
Q 013105          234 TDGPQGEDSHITTCVMGTEGYAAPEYINTG--HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPMLKDFT  311 (449)
Q Consensus       234 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  311 (449)
                      +....... .......|++.|+|||.+.+.  .++.++|||||||+||||++|+.||.+.........+..  .      
T Consensus       177 ~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~--~------  247 (322)
T d1vzoa_         177 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--R------  247 (322)
T ss_dssp             EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH--H------
T ss_pred             hhhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH--h------
Confidence            86543322 223345799999999999654  468899999999999999999999986543322111100  0      


Q ss_pred             chhHhhcccccccCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 013105          312 KLDQIIDSRLEDRYSTEGAKRLAAVAHQCLSHNPKSRP-----TMTTVVKA  357 (449)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  357 (449)
                            .......++..+++++.+|+.+||+.||++||     |++|+++|
T Consensus       248 ------~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         248 ------ILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             ------HHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             ------cccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence                  00112233455677899999999999999999     47889876

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-47  Score=369.88  Aligned_cols=264  Identities=19%  Similarity=0.227  Sum_probs=193.7

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEe--
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCE--  153 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--  153 (449)
                      .++|++.+.||+|+||+||+|.+..      +++.||||++....  ......+.+|+.+|++++||||+++++++..  
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~------t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~   89 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAV------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK   89 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETT------TTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECC------CCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccc
Confidence            3679999999999999999998765      58999999997442  3334568899999999999999999999964  


Q ss_pred             ----CCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEee
Q 013105          154 ----DEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSD  229 (449)
Q Consensus       154 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~D  229 (449)
                          ..++|+||||+.++ +.+.+.    ..+++..+..++.|++.||.|||  .+||+||||||+|||++.++.+|++|
T Consensus        90 ~~~~~~~~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH--~~giiHrDlKP~Nil~~~~~~~kl~d  162 (355)
T d2b1pa1          90 TLEEFQDVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILD  162 (355)
T ss_dssp             STTTCCEEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECC
T ss_pred             ccccCceeEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhh--hcccccccCCccccccccccceeeec
Confidence                47899999999755 444443    46899999999999999999999  67899999999999999999999999


Q ss_pred             eccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchhhHH--------
Q 013105          230 FGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVE--------  301 (449)
Q Consensus       230 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~--------  301 (449)
                      ||+++......   ......||+.|+|||++.+..++.++||||+||++|+|++|++||.+.........+.        
T Consensus       163 f~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~  239 (355)
T d2b1pa1         163 FGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP  239 (355)
T ss_dssp             CCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             hhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCH
Confidence            99988654432   2344569999999999999999999999999999999999999997653222111110        


Q ss_pred             -hhhh-------hhcc-----ccchhHhhccccc---ccCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          302 -WARP-------MLKD-----FTKLDQIIDSRLE---DRYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       302 -~~~~-------~~~~-----~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                       +...       ....     .............   .......+.++.+|+.+||+.||++|||++|+|+|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence             0000       0000     0000111111111   11123457789999999999999999999999998

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=366.05  Aligned_cols=264  Identities=21%  Similarity=0.258  Sum_probs=197.3

Q ss_pred             hcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCC--cchHHHHHHHHHHHhcCCCCCcceeeeEEEeC-
Q 013105           78 THNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNG--SQGHREWLAEVIFLGQLKHPHLVNLIGYCCED-  154 (449)
Q Consensus        78 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-  154 (449)
                      .++|++.+.||+|+||+||+|.+..      +++.||||+++...  ......+.+|+++|+.++||||+++++++... 
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~   90 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTK------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   90 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETT------TTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECC------CCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecc
Confidence            5689999999999999999998765      58999999997543  23345788999999999999999999998643 


Q ss_pred             ----CEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCcEEEeee
Q 013105          155 ----EHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYNAKLSDF  230 (449)
Q Consensus       155 ----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~~kl~Df  230 (449)
                          ...+++|+++.||+|.+++..   ..+++..+..++.|++.||+|||  ++||+||||||+|||++.++.+|++||
T Consensus        91 ~~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH--~~giiHrDiKp~NILi~~~~~~kl~df  165 (348)
T d2gfsa1          91 SLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDF  165 (348)
T ss_dssp             STTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             ccccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHH--hCCCcccccCCcccccccccccccccc
Confidence                344666778889999998854   46999999999999999999999  678999999999999999999999999


Q ss_pred             ccccCCCCCCCCceeeecCCCCccccccccccC-CCCcccchhhhHHHHHHHHhCCCcccccccccchhhHHhhhhh---
Q 013105          231 GLATDGPQGEDSHITTCVMGTEGYAAPEYINTG-HLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKDLVEWARPM---  306 (449)
Q Consensus       231 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~~~~~~~~~---  306 (449)
                      |++.....     ......||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.........+......   
T Consensus       166 g~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~  240 (348)
T d2gfsa1         166 GLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA  240 (348)
T ss_dssp             ----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             chhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            99975432     23345689999999987655 4689999999999999999999999865433222211100000   


Q ss_pred             --hcccc--chhHhhccc--c-cc---cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 013105          307 --LKDFT--KLDQIIDSR--L-ED---RYSTEGAKRLAAVAHQCLSHNPKSRPTMTTVVKA  357 (449)
Q Consensus       307 --~~~~~--~~~~~~~~~--~-~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  357 (449)
                        .....  .........  . ..   ......++++.+||.+||+.||.+|||+.|+++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence              00000  000000000  0 00   0012345678999999999999999999999987

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.4e-41  Score=331.60  Aligned_cols=266  Identities=18%  Similarity=0.221  Sum_probs=193.9

Q ss_pred             cCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC-----------CCCccee
Q 013105           79 HNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-----------HPHLVNL  147 (449)
Q Consensus        79 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~~  147 (449)
                      ++|++.+.||+|+||+||+|.+..      +++.||||+++... ...+.+.+|+.+++.++           |+||+++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~------~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~   85 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMV------NNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   85 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECC------CCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence            359999999999999999998765      58999999997442 23456778998888775           5789999


Q ss_pred             eeEEEe--CCEEEEEEEecCCCChH-HHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCCCc
Q 013105          148 IGYCCE--DEHRLLVYEYMALGNLH-DQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSDYN  224 (449)
Q Consensus       148 ~~~~~~--~~~~~lv~e~~~~g~L~-~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~~~  224 (449)
                      ++++..  ....+++|+++..+... ..........+++..+..++.|++.||.|||+ ..||+||||||+|||++.++.
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~-~~~IvHrDlKp~NIll~~~~~  164 (362)
T d1q8ya_          86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDS  164 (362)
T ss_dssp             CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEEEET
T ss_pred             EEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh-hcCcccccCChhHeeeeccCc
Confidence            988754  46677777777655433 33344455788999999999999999999994 377999999999999987653


Q ss_pred             ------EEEeeeccccCCCCCCCCceeeecCCCCccccccccccCCCCcccchhhhHHHHHHHHhCCCcccccccccchh
Q 013105          225 ------AKLSDFGLATDGPQGEDSHITTCVMGTEGYAAPEYINTGHLTTMCDVFSFGVVLLELLTGRRSVEKNRCKREKD  298 (449)
Q Consensus       225 ------~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~pf~~~~~~~~~~  298 (449)
                            ++|+|||.+......     ....+||+.|+|||++.+..++.++||||+||++++|++|+.||..........
T Consensus       165 ~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~  239 (362)
T d1q8ya_         165 PENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK  239 (362)
T ss_dssp             TTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred             ccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccc
Confidence                  999999999854332     234569999999999998999999999999999999999999997543221111


Q ss_pred             hHHhhh---hhhccc--------cchhHhhc-------------------ccccccCCHHHHHHHHHHHHHhccCCCCCC
Q 013105          299 LVEWAR---PMLKDF--------TKLDQIID-------------------SRLEDRYSTEGAKRLAAVAHQCLSHNPKSR  348 (449)
Q Consensus       299 ~~~~~~---~~~~~~--------~~~~~~~~-------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  348 (449)
                      ......   ..+...        ........                   ...........++++.+|+.+||..||.+|
T Consensus       240 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R  319 (362)
T d1q8ya_         240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR  319 (362)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred             hhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHC
Confidence            100000   000000        00000000                   001123456778899999999999999999


Q ss_pred             CCHHHHHHH
Q 013105          349 PTMTTVVKA  357 (449)
Q Consensus       349 Ps~~eil~~  357 (449)
                      ||+.|+|+|
T Consensus       320 pta~e~L~H  328 (362)
T d1q8ya_         320 ADAGGLVNH  328 (362)
T ss_dssp             BCHHHHHTC
T ss_pred             cCHHHHhcC
Confidence            999999987

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=4.3e-25  Score=194.29  Aligned_cols=164  Identities=14%  Similarity=0.099  Sum_probs=117.8

Q ss_pred             CCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcc------------------hHHHHHHHHHHHhcCCCC
Q 013105           81 FSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQ------------------GHREWLAEVIFLGQLKHP  142 (449)
Q Consensus        81 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~h~  142 (449)
                      +.+.+.||+|+||+||+|.+.+       ++.||||+++.....                  .......|...+.++.|.
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~-------g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~   74 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEK-------FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGL   74 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETT-------TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTS
T ss_pred             chhCCEeeeCcceEEEEEECCC-------CCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCC
Confidence            3467899999999999997643       689999987532110                  012345688999999999


Q ss_pred             CcceeeeEEEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCceEEcCC
Q 013105          143 HLVNLIGYCCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHGEEKPVIYRDFKASNILLDSD  222 (449)
Q Consensus       143 nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDikp~Nill~~~  222 (449)
                      +++..+++.  .  .+++|||+.++.+.+         ++......++.|++.+|.|||  .+||+||||||+|||++++
T Consensus        75 ~v~~~~~~~--~--~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH--~~giiHrDiKP~NILv~~~  139 (191)
T d1zara2          75 AVPKVYAWE--G--NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFY--HRGIVHGDLSQYNVLVSEE  139 (191)
T ss_dssp             SSCCEEEEE--T--TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHH--HTTEECSCCSTTSEEEETT
T ss_pred             CcceEEEec--C--CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHh--hCCEEEccCChhheeeeCC
Confidence            999887653  2  379999998765532         233345678999999999999  6789999999999999865


Q ss_pred             CcEEEeeeccccCCCCCCCCceeeecCCCCccccc------cccccCCCCcccchhhhHHHH
Q 013105          223 YNAKLSDFGLATDGPQGEDSHITTCVMGTEGYAAP------EYINTGHLTTMCDVFSFGVVL  278 (449)
Q Consensus       223 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DvwslG~vl  278 (449)
                       .++|+|||+|........          ..|...      +.+ ...|+.++|+||+.--+
T Consensus       140 -~~~liDFG~a~~~~~~~~----------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         140 -GIWIIDFPQSVEVGEEGW----------REILERDVRNIITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             -EEEECCCTTCEETTSTTH----------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             -CEEEEECCCcccCCCCCc----------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence             589999999975432211          111111      111 35688999999976443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.71  E-value=3.2e-08  Score=89.21  Aligned_cols=148  Identities=17%  Similarity=0.114  Sum_probs=98.7

Q ss_pred             HHHHHHhcCCCCcccccccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC-CCCcceeeeE
Q 013105           72 KELQMITHNFSRSDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-HPHLVNLIGY  150 (449)
Q Consensus        72 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~  150 (449)
                      .++....+.|++.+..+.++.+.||+...        .++.+++|+...........+.+|...+..+. +--+.+++.+
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--------~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~   78 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHF   78 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC--------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe--------CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEE
Confidence            34556667788777665555678998743        35678899886443333344667888877664 4446788888


Q ss_pred             EEeCCEEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc----------------------------
Q 013105          151 CCEDEHRLLVYEYMALGNLHDQLFKNYSSTLPWLTRIKIAIGAARCLAFLHG----------------------------  202 (449)
Q Consensus       151 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~----------------------------  202 (449)
                      ...++..++||++++|.++.+.....    ..   ...++.+++..|..||+                            
T Consensus        79 ~~~~~~~~lv~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (263)
T d1j7la_          79 ERHDGWSNLLMSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA  151 (263)
T ss_dssp             EEETTEEEEEEECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred             EecCCceEEEEEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhh
Confidence            88899999999999987775543211    11   11223334444444442                            


Q ss_pred             -----------------------------CCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          203 -----------------------------EEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       203 -----------------------------~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                                                   ....++|+|+.|.|||+++++.+-|+||+.+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                         11237899999999999987667799998765

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.11  E-value=6.5e-06  Score=73.11  Aligned_cols=73  Identities=15%  Similarity=0.041  Sum_probs=49.8

Q ss_pred             ccccC-ceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC--CCCcceeeeEEEeCCEEEEEEEe
Q 013105           87 LGEGG-FGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK--HPHLVNLIGYCCEDEHRLLVYEY  163 (449)
Q Consensus        87 lG~G~-~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~~~~~~~~~~~~~lv~e~  163 (449)
                      +..|. -+.||+.....       +..+++|.......   ..+..|...|+.+.  .-.+.+++.+..+++..++||++
T Consensus        18 ~~~G~s~~~v~r~~~~~-------~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~   87 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQG-------RPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   87 (255)
T ss_dssp             CSCTTSSCEEEEEECTT-------SCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             cCCcccCCeEEEEEeCC-------CCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEe
Confidence            44444 36789875432       55688898764432   23556777776663  33467788888888899999999


Q ss_pred             cCCCCh
Q 013105          164 MALGNL  169 (449)
Q Consensus       164 ~~~g~L  169 (449)
                      ++|.++
T Consensus        88 i~G~~~   93 (255)
T d1nd4a_          88 VPGQDL   93 (255)
T ss_dssp             CSSEET
T ss_pred             eecccc
Confidence            987655

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.87  E-value=3.5e-05  Score=73.13  Aligned_cols=78  Identities=14%  Similarity=0.110  Sum_probs=48.5

Q ss_pred             cccccccCceEEEEEEEcCCCCCCCCCcEEEEEEecc----CC---cchHHHHHHHHHHHhcCC-C--CCcceeeeEEEe
Q 013105           84 SDYLGEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDV----NG---SQGHREWLAEVIFLGQLK-H--PHLVNLIGYCCE  153 (449)
Q Consensus        84 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~----~~---~~~~~~~~~E~~~l~~l~-h--~nIv~~~~~~~~  153 (449)
                      .+.||.|....||+....+      .++.++||.-..    ..   .....+...|+..|+.+. +  ..+++++.+  +
T Consensus        31 ~~eig~G~~N~vfrV~~~~------~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d  102 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQE------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D  102 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E
T ss_pred             EEEeCCCceEeEEEEEeCC------CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--c
Confidence            3568999999999986543      367899997532    11   112344556887777662 2  345666544  4


Q ss_pred             CCEEEEEEEecCCCCh
Q 013105          154 DEHRLLVYEYMALGNL  169 (449)
Q Consensus       154 ~~~~~lv~e~~~~g~L  169 (449)
                      .+..++|||++.+..+
T Consensus       103 ~~~~~lvmE~L~~~~~  118 (392)
T d2pula1         103 TEMAVTVMEDLSHLKI  118 (392)
T ss_dssp             TTTTEEEECCCTTSEE
T ss_pred             CCCCEEEEeccCCccc
Confidence            5567899999976543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.88  E-value=0.0031  Score=57.52  Aligned_cols=67  Identities=16%  Similarity=0.127  Sum_probs=42.6

Q ss_pred             eEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCCCCCc--ceee-----eEEEeCCEEEEEEEecC
Q 013105           93 GKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLKHPHL--VNLI-----GYCCEDEHRLLVYEYMA  165 (449)
Q Consensus        93 g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI--v~~~-----~~~~~~~~~~lv~e~~~  165 (449)
                      -.||++...+       |..|++|+.+.. .....++..|...+..|...+|  +..+     ..+...+..+.+++++.
T Consensus        36 N~vy~v~~~d-------g~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~  107 (325)
T d1zyla1          36 NRVYQFQDED-------RRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  107 (325)
T ss_dssp             SEEEEECCTT-------CCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             ceeEEEEcCC-------CCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence            5799985543       678999998643 3335667778887777642211  1111     12345678899999987


Q ss_pred             CC
Q 013105          166 LG  167 (449)
Q Consensus       166 ~g  167 (449)
                      |.
T Consensus       108 G~  109 (325)
T d1zyla1         108 GR  109 (325)
T ss_dssp             CE
T ss_pred             Cc
Confidence            64

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.78  E-value=0.0021  Score=60.44  Aligned_cols=79  Identities=16%  Similarity=0.164  Sum_probs=50.5

Q ss_pred             ccccccCceEEEEEEEcCCCCC-CCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC-CCCcceeeeEEEeCCEEEEEEE
Q 013105           85 DYLGEGGFGKVYKGCVDDNLRP-GLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK-HPHLVNLIGYCCEDEHRLLVYE  162 (449)
Q Consensus        85 ~~lG~G~~g~V~~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e  162 (449)
                      +.|+.|---.+|++...+.... ......|.+++.. . ........+|..+++.+. +.-..++++++.  +  .+|||
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~--g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C--ceEEE
Confidence            5677788889999877653211 1234567777764 2 223345567998888885 433457777663  2  68999


Q ss_pred             ecCCCCh
Q 013105          163 YMALGNL  169 (449)
Q Consensus       163 ~~~~g~L  169 (449)
                      |++|..|
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.31  E-value=0.047  Score=48.82  Aligned_cols=156  Identities=13%  Similarity=0.032  Sum_probs=80.9

Q ss_pred             cCHHHHHHHhcCCCCcccc-----cccCceEEEEEEEcCCCCCCCCCcEEEEEEeccCCcchHHHHHHHHHHHhcCC---
Q 013105           69 FTLKELQMITHNFSRSDYL-----GEGGFGKVYKGCVDDNLRPGLKAQTVAVKVLDVNGSQGHREWLAEVIFLGQLK---  140 (449)
Q Consensus        69 ~~~~~~~~~~~~y~~~~~l-----G~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---  140 (449)
                      .+..+++.+..+|.++++.     ..|---+.|+....        ...+++|+......  ...+..|+.++..|.   
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~--------~g~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g   72 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT--------KDPLILTLYEKRVE--KNDLPFFLGLMQHLAAKG   72 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES--------SCCEEEEEECC-----CCHHHHHHHHHHHHHHTT
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEEC--------CCcEEEEEcCCCCC--HHHHHHHHHHHHhhhhcc
Confidence            3556778788889876543     34555778987553        24599999864321  223344555665553   


Q ss_pred             --CCCcceee---eEEEeCCEEEEEEEecCCCChHH--------------HHhh---cCCCC----CCH-----------
Q 013105          141 --HPHLVNLI---GYCCEDEHRLLVYEYMALGNLHD--------------QLFK---NYSST----LPW-----------  183 (449)
Q Consensus       141 --h~nIv~~~---~~~~~~~~~~lv~e~~~~g~L~~--------------~l~~---~~~~~----l~~-----------  183 (449)
                        .|..+...   .+.........++.+..|.....              .+..   .....    ...           
T Consensus        73 ~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (316)
T d2ppqa1          73 LSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSE  152 (316)
T ss_dssp             CCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHG
T ss_pred             ccccccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHH
Confidence              22222211   11233556677777776543210              0000   00000    000           


Q ss_pred             -------HHHHHHHHHHHHHHHHhhc--CCCCeeeccCCCCceEEcCCCcEEEeeecccc
Q 013105          184 -------LTRIKIAIGAARCLAFLHG--EEKPVIYRDFKASNILLDSDYNAKLSDFGLAT  234 (449)
Q Consensus       184 -------~~~~~i~~~i~~~l~~lH~--~~~~ivHrDikp~Nill~~~~~~kl~DfGla~  234 (449)
                             ......+..+...+.-.+.  ...|+||+|+.++||+++.+...-|+||+.+.
T Consensus       153 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         153 ERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             GGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HhhhhcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence                   0011111222222222221  24679999999999999988777899998765